PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chmielewski, S; Olejnik, A; Sikorski, K; Pelisek, J; Blaszczyk, K; Aoqui, C; Nowicka, H; Zernecke, A; Heemann, U; Wesoly, J; Baumann, M; Bluyssen, HAR				Chmielewski, Stefan; Olejnik, Adam; Sikorski, Krzysztof; Pelisek, Jaroslav; Blaszczyk, Katarzyna; Aoqui, Cristiane; Nowicka, Hanna; Zernecke, Alma; Heemann, Uwe; Wesoly, Joanna; Baumann, Marcus; Bluyssen, Hans A. R.			STAT1-Dependent Signal Integration between IFN gamma and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; TRANSPLANTED MOUSE HEARTS; SMOOTH-MUSCLE-CELLS; INTERFERON-GAMMA; NITRIC-OXIDE; GENE-EXPRESSION; TNF-ALPHA; REDUCES ATHEROSCLEROSIS	Signal integration between IFN gamma and TLRs in immune cells has been associated with the host defense against pathogens and injury, with a predominant role of STAT1. We hypothesize that STAT1-dependent transcriptional changes in vascular cells involved in cross-talk between IFNc and TLR4, reflect pro-atherogenic responses in human atherosclerosis. Genome-wide investigation identified a set of STAT1-dependent genes that were synergistically affected by interactions between IFN gamma and TLR4 in VSMCs. These included the chemokines Cxcl9, Ccl12, Ccl8, Ccrl2, Cxcl10 and Ccl5, adhesion molecules Cd40, Cd74, and antiviral and antibacterial genes Rsad2, Mx1, Oasl1, Gbp5, Nos2, Batf2 and Tnfrsf11a. Among the amplified genes was also Irf8, of which Ccl5 was subsequently identified as a new pro-inflammatory target in VSMCs and ECs. Promoter analysis predicted transcriptional cooperation between STAT1, IRF1, IRF8 and NF kappa B, with the novel role of IRF8 providing an additional layer to the overall complexity. The synergistic interactions between IFN gamma and TLR4 also resulted in increased T-cell migration and impaired aortic contractility in a STAT1-dependent manner. Expression of the chemokines CXCL9 and CXCL10 correlated with STAT1 phosphorylation in vascular cells in plaques from human carotid arteries. Moreover, using data mining of human plaque transcriptomes, expression of a selection of these STAT1-dependent pro-atherogenic genes was found to be increased in coronary artery disease (CAD) and carotid atherosclerosis. Our study provides evidence to suggest that in ECs and VSMCs STAT1 orchestrates a platform for cross-talk between IFN gamma and TLR4, and identifies a STAT1-dependent gene signature that reflects a proatherogenic state in human atherosclerosis.	[Chmielewski, Stefan; Aoqui, Cristiane; Heemann, Uwe; Baumann, Marcus] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, D-80290 Munich, Germany; [Pelisek, Jaroslav; Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc & Endovasc Surg, D-80290 Munich, Germany; [Chmielewski, Stefan; Olejnik, Adam; Sikorski, Krzysztof; Blaszczyk, Katarzyna; Bluyssen, Hans A. R.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, Poznan, Poland; [Nowicka, Hanna; Wesoly, Joanna] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Lab High Throughput Technol, Poznan, Poland; [Zernecke, Alma] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany	Technical University of Munich; Technical University of Munich; Adam Mickiewicz University; Adam Mickiewicz University; German Centre for Cardiovascular Research; Munich Heart Alliance	Bluyssen, HAR (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, Poznan, Poland.	h.bluyss@amu.edu.pl		Bluyssen, Hans/0000-0002-4568-6259	Polish Ministry of Science and Higher Education [N N302 016339, N N301 073140, 2012/07/B/NZ1/02710, 0493/IP1/2011/71]; KNOW RNA Research Centre in Poznan [01/KNOW2/2014]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); KNOW RNA Research Centre in Poznan	This publication was supported by grants N N302 016339 (to HB); N N301 073140 (to HB); 2012/07/B/NZ1/02710 (to HB); and 0493/IP1/2011/71 (to KS) from Polish Ministry of Science and Higher Education, and by the KNOW RNA Research Centre in Poznan (No. 01/KNOW2/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Doring Y, 2012, ARTERIOSCL THROM VAS, V32, P1613, DOI 10.1161/ATVBAHA.111.236539; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Folkersen L, 2012, MOL MED, V18, P669, DOI 10.2119/molmed.2011.00479; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hiwatashi K, 2011, CANCER LETT, V308, P172, DOI 10.1016/j.canlet.2011.04.024; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Martin-Ventura JL, 2009, CARDIOVASC RES, V83, P586, DOI 10.1093/cvr/cvp141; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Naschberger E, 2004, BIOCHEM J, V379, P409, DOI 10.1042/BJ20031873; Niu XL, 2001, CIRCULATION, V103, P1115, DOI 10.1161/01.CIR.103.8.1115; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; RUSSELL PS, 1994, TRANSPLANTATION, V57, P1367, DOI 10.1097/00007890-199405150-00014; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Sikorski K, 2014, INT J MOL SCI, V15, P14313, DOI 10.3390/ijms150814313; Sikorski Krzysztof, 2012, JAKSTAT, V1, P241, DOI 10.4161/jkst.22469; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	55	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113318	10.1371/journal.pone.0113318	http://dx.doi.org/10.1371/journal.pone.0113318			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478796	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200017
J	Pita, S; Panzera, F; Sanchez, A; Panzera, Y; Palomeque, T; Lorite, P				Pita, Sebastian; Panzera, Francisco; Sanchez, Antonio; Panzera, Yanina; Palomeque, Teresa; Lorite, Pedro			Distribution and Evolution of Repeated Sequences in Genomes of Triatominae (Hemiptera-Reduviidae) Inferred from Genomic In Situ Hybridization	PLOS ONE			English	Article							SEX-CHROMOSOME EVOLUTION; DROSOPHILA Y-CHROMOSOME; TRANSPOSABLE ELEMENTS; REPETITIVE DNA; CHAGAS-DISEASE; SATELLITE DNA; HOLOCENTRIC CHROMOSOMES; INFESTANS HETEROPTERA; HORIZONTAL TRANSFER; RIBOSOMAL GENES	The subfamily Triatominae, vectors of Chagas disease, comprises 140 species characterized by a highly homogeneous chromosome number. We analyzed the chromosomal distribution and evolution of repeated sequences in Triatominae genomes by Genomic in situ Hybridization using Triatoma delpontei and Triatoma infestans genomic DNAs as probes. Hybridizations were performed on their own chromosomes and on nine species included in six genera from the two main tribes: Triatomini and Rhodniini. Genomic probes clearly generate two different hybridization patterns, dispersed or accumulated in specific regions or chromosomes. The three used probes generate the same hybridization pattern in each species. However, these patterns are species-specific. In closely related species, the probes strongly hybridized in the autosomal heterochromatic regions, resembling C-banding and DAPI patterns. However, in more distant species these co-localizations are not observed. The heterochromatic Y chromosome is constituted by highly repeated sequences, which is conserved among 10 species of Triatomini tribe suggesting be an ancestral character for this group. However, the Y chromosome in Rhodniini tribe is markedly different, supporting the early evolutionary dichotomy between both tribes. In some species, sex chromosomes and autosomes shared repeated sequences, suggesting meiotic chromatin exchanges among these heterologous chromosomes. Our GISH analyses enabled us to acquire not only reliable information about autosomal repeated sequences distribution but also an insight into sex chromosome evolution in Triatominae. Furthermore, the differentiation obtained by GISH might be a valuable marker to establish phylogenetic relationships and to test the controversial origin of the Triatominae subfamily.	[Pita, Sebastian; Panzera, Francisco; Panzera, Yanina] Univ Republica, Secc Genet Evolutiva, Fac Ciencias, Montevideo, Uruguay; [Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro] Univ Jaen, Dept Biol Expt, Area Genet, Jaen, Spain	Universidad de la Republica, Uruguay; Universidad de Jaen	Panzera, F (corresponding author), Univ Republica, Secc Genet Evolutiva, Fac Ciencias, Montevideo, Uruguay.	fcopanzera@gmail.com; plorite@ujaen.es	Palomeque, Teresa/H-6365-2015; Martínez, Pedro Lorite/K-6806-2012; Sanchez, Antonio/N-4174-2015; Pita, Sebastián/Z-6090-2019; Panzera, Francisco/M-9884-2015	Palomeque, Teresa/0000-0002-7144-4931; Martínez, Pedro Lorite/0000-0002-9692-5870; Sanchez, Antonio/0000-0002-6715-8158; Pita, Sebastián/0000-0002-4102-5808; Panzera, Francisco/0000-0001-5148-957X	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Spanish Ministerio de Educacion e Innovacion [CGL2011-23841]; European Regional Development Fund; Junta de Andalucia [BIO-220]; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay); CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay); Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Spanish Ministerio de Educacion e Innovacion(Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia(Junta de Andalucia); PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay); CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay); Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia)	This work has been supported by project grants from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay) and by the Spanish Ministerio de Educacion e Innovacion (project CGL2011-23841), co-funded by the European Regional Development Fund and by Junta de Andalucia throughout the program "Ayudas a grupos de investigacion," group BIO-220. S. Pita benefited from funding by PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay) and CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay) and by the "Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia," sponsor of Scholarship Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MJ, 2008, CHROMOSOME RES, V16, P949, DOI 10.1007/s10577-008-1253-3; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bardella VB, 2014, CYTOGENET GENOME RES, V142, P46, DOI 10.1159/000355214; Bardella VB, 2010, COMP CYTOGENET, V4, P141, DOI 10.3897/compcytogen.v4i2.50; Bardella VB, 2014, INFECT GENET EVOL, V23, P106, DOI 10.1016/j.meegid.2014.01.035; Bressa MJ, 2009, CYTOGENET GENOME RES, V125, P292, DOI 10.1159/000235936; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Carvalho AB, 2009, TRENDS GENET, V25, P270, DOI 10.1016/j.tig.2009.04.002; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; HUGHESSCHRADER S, 1961, CHROMOSOMA, V12, P327, DOI 10.1007/BF00328928; Hwang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045523; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600; Lonnig WE, 2002, ANNU REV GENET, V36, P389, DOI 10.1146/annurev.genet.36.040202.092802; Lorite P, 2012, NATURWISSENSCHAFTEN, V99, P1007, DOI 10.1007/s00114-012-0982-5; Markova M, 2009, CYTOGENET GENOME RES, V126, P368, DOI 10.1159/000275796; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Palomeque T, 2008, HEREDITY, V100, P564, DOI 10.1038/hdy.2008.24; Palomeque T, 2006, GENE, V371, P194, DOI 10.1016/j.gene.2005.11.032; Palomeque T, 2005, CHROMOSOME RES, V13, P795, DOI 10.1007/s10577-005-1013-6; PANZERA F, 1995, CHROMOSOME RES, V3, P143, DOI 10.1007/BF00710707; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2007, AM J TROP MED HYG, V76, P516, DOI 10.4269/ajtmh.2007.76.516; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Panzera Francisco, 1998, P621; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Papeschi Alba Graciela, 2006, Journal of Biological Research (Thessaloniki), V5, P3; Patterson JS, 2010, MOL PHYLOGENET EVOL, V56, P608, DOI 10.1016/j.ympev.2010.04.038; Paula AS, 2005, MOL PHYLOGENET EVOL, V35, P712; Perez R, 2000, CHROMOSOME RES, V8, P17, DOI 10.1023/A:1009266801160; Pita S, 2013, MEM I OSWALDO CRUZ, V108, P376, DOI 10.1590/S0074-02762013000300017; Sahara K, 2012, CHROMOSOME RES, V20, P83, DOI 10.1007/s10577-011-9262-z; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Singh ND, 2014, MOL BIOL EVOL, V31, P2612, DOI 10.1093/molbev/msu203; SOLARI AJ, 1979, CHROMOSOMA, V72, P225, DOI 10.1007/BF00293236; Ueshima N, 1979, ANIMAL CYTOGENETICS, V3; Weirauch C, 2009, MOL PHYLOGENET EVOL, V53, P287, DOI 10.1016/j.ympev.2009.05.039; WHO, 2014, CHAG DIS AM TRYP; Yoshido Atsuo, 2006, Journal of Insect Biotechnology and Sericology, V75, P147; Zhang HH, 2013, INSECT MOL BIOL, V22, P584, DOI 10.1111/imb.12047	44	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114298	10.1371/journal.pone.0114298	http://dx.doi.org/10.1371/journal.pone.0114298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478792	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200068
J	Suwanpimolkul, G; Grinsdale, JA; Jarlsberg, LG; Higashi, J; Osmond, DH; Hopewell, PC; Kato-Maeda, M				Suwanpimolkul, Gompol; Grinsdale, Jennifer A.; Jarlsberg, Leah G.; Higashi, Julie; Osmond, Dennis H.; Hopewell, Philip C.; Kato-Maeda, Midori			Association between Diabetes Mellitus and Tuberculosis in United States-Born and Foreign-Born Populations in San Francisco	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SOCIOECONOMIC-STATUS; CARE POPULATION; RISK-FACTORS; PREVALENCE	Setting: The impact of diabetes on tuberculosis in United States and foreign-born populations in San Francisco has not been studied. Objective: To determine the characteristics, prevalence and temporal trends of diabetes in US and foreign-born persons attending the San Francisco Tuberculosis Clinic. Design: We analyzed data from individuals seeking medical attention at the San Francisco Tuberculosis Clinic. We included patients with diagnosis of tuberculosis, latent infection, or not infected with Mycobacterium tuberculosis. We assessed the temporal trend and the characteristics of individuals with and without diabetes. Result: Between 2005 and 2012, there were 4371 (19.0%) individuals without evidence of tuberculosis infection, 17,856 (77.6%) with latent tuberculosis, and 791 (3.4%) with tuberculosis. 66% were born in the United States, China, Mexico, and the Philippines. The prevalence of diabetes was the highest among individuals with tuberculosis and increased during the study period. Patients with tuberculosis and diabetes were more likely to be male, older than 45 years and born in the Philippines. There was a disproportionate association of TB and DM relative to LTBI and DM among Filipinos in individuals older than 45 years old. Conclusions: Our data suggest that Filipinos older than 45 years old are more likely to have tuberculosis probably due to a higher prevalence of diabetes. In San Francisco, tuberculosis-screening programs in individuals with diabetes and latent tuberculosis may be beneficial in patients older than 45 years old especially from the Philippines.	[Suwanpimolkul, Gompol; Jarlsberg, Leah G.; Hopewell, Philip C.; Kato-Maeda, Midori] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA; [Suwanpimolkul, Gompol] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Suwanpimolkul, Gompol] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Grinsdale, Jennifer A.; Higashi, Julie] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Osmond, Dennis H.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; San Francisco Department of Public Health; University of California System; University of California San Francisco	Kato-Maeda, M (corresponding author), Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA.	Midori.Kato-Maeda@ucsf.edu		Jarlsberg, Leah/0000-0001-6548-6337	National Institutes of Health [NIH AI034238]; King Chulalongkorn Memorial Hospital, Thai Red Cross Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Chulalongkorn Memorial Hospital, Thai Red Cross Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health http://www.nih.gov/(NIH AI034238) and King Chulalongkorn Memorial Hospital, Thai Red Cross Society http://www.redcross.or.th/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; [Anonymous], 2003, MMWR RECOMM REP; [Anonymous], 2011, NAT DIAB STAT; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bays HE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-277; CDC, 2013, REP TUB US 2012; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gary He AA, 2005, DIABETES CALIFORNIA; Guozhong He KB, 2009, DIABETES CALIFORNIA; Holland AT, 2013, J DIABETES COMPLICAT, V27, P34, DOI 10.1016/j.jdiacomp.2012.08.006; International Diabetes Federation, 2012, DIAB ATL UPD; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kampoli AM, 2011, CURR PHARM DESIGN, V17, P4147, DOI 10.2174/138161211798764825; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Olson NA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-365; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; San Francisco Department of Public Health, 2012, COMM HLTH STAT ASS C; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sicree JS, 2003, GLOBAL BURDEN DIABET; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Suwanpimolkul GJL, 2013, AM J RESP CRIT CARE, pA1647; Suwanpimolkul G, 2013, AM J RESP CRIT CARE, V187, P998, DOI 10.1164/rccm.201212-2239OC; WHO, 2011, COLLABORATIVE FRAMEW; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2011, TUB DIAB; 2000, AM J RESP CRIT CARE, V161, P1376	33	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114442	10.1371/journal.pone.0114442	http://dx.doi.org/10.1371/journal.pone.0114442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478954	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200088
J	Butschkau, A; Wagner, NM; Genz, B; Vollmar, B				Butschkau, Antje; Wagner, Nana-Maria; Genz, Berit; Vollmar, Brigitte			Protein Z Exerts Pro-Angiogenic Effects and Upregulates CXCR4	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; Z PLASMA-LEVELS; IN-VITRO; INHIBITOR; KINASE; DEFICIENCY; ACTIVATION; PHENOTYPE; CELLS	Objective: Protein Z (PZ) is a vitamin K-dependent coagulation factor without catalytic activity. Evidence points towards PZ as an independent risk factor for the occurrence of human peripheral arterial disease. However, the role of PZ in ischemia-driven angiogenesis and vascular healing processes has not been elucidated so far. Approach: Angiogenic potency of PZ was assessed in established in vitro assays using endothelial cells. PZ-deficient (PZ(-/-)) mice and their wild-type littermates (PZ(+/+)) were subjected to hindlimb ischemia. Furthermore, PZ(-/)-mice were exposed to PZ expressing adenovirus (AdV-PZ) or control adenovirus (AdV-GFP). In an additional set of animals, PZ(-/)-mice were exposed to AdV-PZ and AdV-GFP, each in combination with the CXCR4 antagonist AMD3100. Results: In vitro, PZ stimulated migratory activity and capillary-like tube formation of endothelial cells comparable to SDF-1. PZ(-/)-mice exhibited diminished hypoxia-driven neovascularization and reperfusion in post-ischemic hindlimbs, which was restored by adenoviral gene transfer up to levels seen in PZ+/+ mice. The stimulatory impact of PZ on endothelial cells in vitro was abolished by siRNA targeting against PZ and PZ was not able to restore reduced migration after knockdown of CXCR4. The increased surface expression of CXCR4 on PZ-stimulated endothelial cells and the abrogated restoration of PZ(-/)-mice via AdV-PZ after concomitant treatment with the CXCR4 antagonist AMD3100 supports the idea that PZ mediates angiogenesis via a G-protein coupled pathway and involves the SDF1/ CXCR4 axis. This is underlined by the fact that addition of the G-protein inhibitor PTX to PZ-stimulated endothelial cells abolished the effect of PZ on capillary-like tube formation. Conclusions: The results of the current study reveal a role of PZ in ischemiainduced angiogenesis, which involves a G-protein coupled pathway and a raised	[Butschkau, Antje; Genz, Berit; Vollmar, Brigitte] Univ Hosp Rostock, Inst Expt Surg, Rostock, Germany; [Wagner, Nana-Maria] Univ Hosp Rostock, Clin Anesthesiol & Crit Care Med, Rostock, Germany	University of Rostock; University of Rostock	Butschkau, A (corresponding author), Univ Hosp Rostock, Inst Expt Surg, Rostock, Germany.	antje.butschkau@uni-rostock.de	Wagner, Nana-Maria/AAB-3953-2021; Genz, Berit/AAZ-4230-2020	Wagner, Nana-Maria/0000-0002-4610-6666	Deutsche Forschungsgemeinschaft DFG [VO 450/11-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft DFG (VO 450/11-1). BV received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2001, SCIENCE, V293, P1602, DOI 10.1126/science.1064981; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Fedi S, 2003, THROMB HAEMOSTASIS, V90, P1173, DOI 10.1160/TH03-04-0237; Fujimaki K, 1998, BIOCHEMISTRY-US, V37, P6838, DOI 10.1021/bi972002a; Gramling MW, 2010, EXP CELL RES, V316, P314, DOI 10.1016/j.yexcr.2009.10.024; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Ikeda Y, 2012, J BIOL CHEM, V287, P34256, DOI 10.1074/jbc.M112.353532; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; PROWSE CV, 1977, BIOCHEM SOC T, V5, P255, DOI 10.1042/bst0050255; Santacroce R, 2006, J THROMB HAEMOST, V4, P2417, DOI 10.1111/j.1538-7836.2006.02186.x; Sofi F, 2005, J THROMB HAEMOST, V3, P2254, DOI 10.1111/j.1538-7836.2005.01536.x; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; Sofi F, 2007, THROMB HAEMOSTASIS, V98, P1114, DOI 10.1160/TH07-04-0300; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P749, DOI 10.1160/TH09-09-0645; TANABE S, 1991, J BIOCHEM-TOKYO, V109, P924, DOI 10.1093/oxfordjournals.jbchem.a123481; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Vasse M, 2006, THROMB HAEMOSTASIS, V95, P519, DOI 10.1160/TH05-11-0723; Vasse M, 2001, LANCET, V357, P933, DOI 10.1016/S0140-6736(00)04218-5; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Whitmont K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719570; Xue ML, 2011, J BIOL CHEM, V286, P6742, DOI 10.1074/jbc.M110.181388; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113554	10.1371/journal.pone.0113554	http://dx.doi.org/10.1371/journal.pone.0113554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474349	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500085
J	Cassels, TG; Birch, SAJ				Cassels, Tracy G.; Birch, Susan A. J.			Comparisons of an Open-Ended vs. Forced-Choice 'Mind Reading' Task: Implications for Measuring Perspective-Taking and Emotion Recognition	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ASPERGER-SYNDROME; CHILDREN; PSYCHOPATHY; EMPATHY; AUTISM; ADULTS; EYES; PRESCHOOLERS; ASSOCIATION	Perspective-taking and emotion recognition are essential for successful social development and have been the focus of developmental research for many years. Although the two abilities often overlap, they are distinct and our understanding of these abilities critically rests upon the efficacy of existing measures. Lessons from the literature differentiating recall versus recognition memory tasks led us to hypothesize that an open-ended emotion recognition measure would be less reliant on compensatory strategies and hence a more specific measure of emotion recognition abilities than a forced-choice task. To this end, we compared an open-ended version of the Reading the Mind in the Eyes Task with the original forced-choice version in two studies: 118 typically-developing 4- to 8-year-olds (Study 1) and 139 5- to 12-year-olds; 85 typically-developing and 54 with learning disorders (Study 2). We found that the open-ended version of the task was a better predictor of empathy and more reliably discriminated typically-developing children from those with learning disorders. As a whole, the results suggest that the open-ended version is a more sensitive measure of emotion recognition specifically.	[Cassels, Tracy G.; Birch, Susan A. J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Cassels, TG (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	tracy@psych.ubc.ca			Hampton Research Endowment Fund, UBC; Social Sciences and Humanities Research Council of Canada, Canada Graduate Scholarship, Doctoral [767-2008-1754]	Hampton Research Endowment Fund, UBC; Social Sciences and Humanities Research Council of Canada, Canada Graduate Scholarship, Doctoral	This work was supported by funding from the Hampton Research Endowment Fund, UBC [$41,595] to Dr. Susan Birch, and the Social Sciences and Humanities Research Council of Canada, Canada Graduate Scholarship, Doctoral to Tracy G. Cassels [$105,000] Award No: 767-2008-1754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Bengtsson H., 1992, CHILD STUDY J, V22, P11; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; BREEN EK, 1993, CORTEX, V29, P91, DOI 10.1016/S0010-9452(13)80214-6; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.1111/j.1467-8624.1982.tb01331.x; CALEV A, 1984, J ABNORM PSYCHOL, V93, P172, DOI 10.1037/0021-843X.93.2.172; Carey JM, 2013, PSYCHOL ASSESSMENT, V25, P879, DOI 10.1037/a0032641; Craig JS, 2004, SCHIZOPHR RES, V69, P29, DOI 10.1016/S0920-9964(03)00154-3; DODGE KA, 1980, CHILD DEV, V51, P162, DOI 10.1111/j.1467-8624.1980.tb02522.x; Dolan M, 2006, PSYCHOL MED, V36, P1563, DOI 10.1017/S0033291706008634; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Glass SJ, 2006, J ABNORM PSYCHOL, V115, P815, DOI 10.1037/0021-843X.115.4.815; Gordon HL, 2004, BIOL PSYCHIAT, V56, P516, DOI 10.1016/j.biopsych.2004.06.030; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Happe FGE, 1995, CHILD DEV, V66, P842; HARRIGAN JA, 1984, MOTIV EMOTION, V8, P157, DOI 10.1007/BF00993071; Harris PL, 2006, HDB CHILD PSYCHOL, V2, P811; Hinnant JB, 2007, J GENET PSYCHOL, V168, P301, DOI 10.3200/GNTP.168.3.301-322; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Knafo A, 2011, EMOTION, V11, P194, DOI 10.1037/a0021240; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lee L, 2005, J AFFECT DISORDERS, V86, P247, DOI 10.1016/j.jad.2005.02.007; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Owen A, 2001, J LEARN DISABIL, V5, P267, DOI DOI 10.1177/146900470100500309; Peterson CC, 2009, RES AUTISM SPECT DIS, V3, P462, DOI 10.1016/j.rasd.2008.09.007; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; RIBORDY SC, 1988, J CLIN CHILD PSYCHOL, V17, P322, DOI 10.1207/s15374424jccp1704_4; Richell RA, 2003, NEUROPSYCHOLOGIA, V41, P523, DOI 10.1016/S0028-3932(02)00175-6; Sharp C, 2008, COGNITION EMOTION, V22, P1149, DOI 10.1080/02699930701667586; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stone V., 1998, PATIENTS AMYGDALECTO; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114; Woodcock RW, 2001, WOODCOCK JOHNSON 3 B	42	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e93653	10.1371/journal.pone.0093653	http://dx.doi.org/10.1371/journal.pone.0093653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474645	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500061
J	Cusick, KD; Fitzgerald, LA; Pirlo, RK; Cockrell, AL; Petersen, ER; Biffinger, JC				Cusick, Kathleen D.; Fitzgerald, Lisa A.; Pirlo, Russell K.; Cockrell, Allison L.; Petersen, Emily R.; Biffinger, Justin C.			Selection and Evaluation of Reference Genes for Expression Studies with Quantitative PCR in the Model Fungus Neurospora crassa under Different Environmental Conditions in Continuous Culture	PLOS ONE			English	Article							HOUSEKEEPING GENES; QUANTIFICATION; NORMALIZATION; VALIDATION; RNA	Neurospora crassa has served as a model organism for studying circadian pathways and more recently has gained attention in the biofuel industry due to its enhanced capacity for cellulase production. However, in order to optimize N. crassa for biotechnological applications, metabolic pathways during growth under different environmental conditions must be addressed. Reverse-transcription quantitative PCR (RT-qPCR) is a technique that provides a high-throughput platform from which to measure the expression of a large set of genes over time. The selection of a suitable reference gene is critical for gene expression studies using relative quantification, as this strategy is based on normalization of target gene expression to a reference gene whose expression is stable under the experimental conditions. This study evaluated twelve candidate reference genes for use with N. crassa when grown in continuous culture bioreactors under different light and temperature conditions. Based on combined stability values from NormFinder and Best Keeper software packages, the following are the most appropriate reference genes under conditions of: (1) light/dark cycling: btl, asl, and vma1; (2) all-dark growth: btl, tbp, vma1, and vma2; (3) temperature flux: btl, vma1, act, and asl; (4) all conditions combined: vma1, vma2, tbp, and btl. Since N. crassa exists as different cell types (uni- or multi-nucleated), expression changes in a subset of the candidate genes was further assessed using absolute quantification. A strong negative correlation was found to exist between ratio and threshold cycle (C-T) values, demonstrating that C-T changes serve as a reliable reflection of transcript, and not gene copy number, fluctuations. The results of this study identified genes that are appropriate for use as reference genes in RT-qPCR studies with N. crassa and demonstrated that even with the presence of different cell types, relative quantification is an acceptable method for measuring gene expression changes during growth in bioreactors.	[Cusick, Kathleen D.; Cockrell, Allison L.] US Naval Res Lab, Natl Res Council Associateship, Washington, DC 20375 USA; [Fitzgerald, Lisa A.; Pirlo, Russell K.; Petersen, Emily R.; Biffinger, Justin C.] US Naval Res Lab, Div Chem, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Cusick, KD (corresponding author), US Naval Res Lab, Natl Res Council Associateship, Washington, DC 20375 USA.	Kathleen_cusick.ctr@code6100.nrl.navy.mil	Cusick, Kathleen/AAZ-4174-2020; Pirlo, Russell/AAE-5830-2019	Cusick, Kathleen/0000-0001-7224-3472; Pirlo, Russell/0000-0002-2410-028X; , Lisa/0000-0002-2716-4908	Defense Advanced Research Projects Agency's Biochronicity program [MIPR HR001133889]	Defense Advanced Research Projects Agency's Biochronicity program	This work was funded by the Defense Advanced Research Projects Agency's Biochronicity program MIPR HR001133889. The views expressed are those of the authors and do not reflect the official policy or position of the Department of Defense or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bistis GN., 2003, FUNGAL GENET NEWSL, V50, P17, DOI [10.4148/1941-4765.1154, DOI 10.4148/1941-4765.1154]; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, P14; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Dogaris I, 2013, APPL MICROBIOL BIOT, V97, P1457, DOI 10.1007/s00253-012-4655-2; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ish-Shalom S, 2010, METHODS MOL BIOL MOL; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nevarez L, 2008, MICROBIOL-SGM, V154, P3752, DOI 10.1099/mic.0.2008/021386-0; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Rivetta A, 2013, EUKARYOT CELL, V12, P684, DOI 10.1128/EC.00017-13; Shen GM, 2013, FLA ENTOMOL, V96, P442, DOI 10.1653/024.096.0208; Shen GM, 2012, PEST MANAG SCI, V68, P1553, DOI 10.1002/ps.3340; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Steiger MG, 2010, J BIOTECHNOL, V145, P30, DOI 10.1016/j.jbiotec.2009.10.012; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Tralau T, 2007, FUNGAL GENET BIOL, V44, P754, DOI 10.1016/j.fgb.2006.11.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang Z, 2012, FUNGAL GENET BIOL, V49, P533, DOI 10.1016/j.fgb.2012.05.004; WECHSER MA, 1995, MOL GEN GENET, V249, P317, DOI 10.1007/BF00290533; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	11	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112706	10.1371/journal.pone.0112706	http://dx.doi.org/10.1371/journal.pone.0112706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474155	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500074
J	Duerksen, SW; Thiemann, GW; Budge, SM; Poulin, M; Niemi, A; Michel, C				Duerksen, Steven W.; Thiemann, Gregory W.; Budge, Suzanne M.; Poulin, Michel; Niemi, Andrea; Michel, Christine			Large, Omega-3 Rich, Pelagic Diatoms under Arctic Sea Ice: Sources and Implications for Food Webs	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PHYTOPLANKTON BLOOMS; STABLE-ISOTOPES; NORTH-ATLANTIC; SPRING BLOOM; CYCLE; DYNAMICS; GROWTH; ALGAE; OCEAN	Pelagic primary production in Arctic seas has traditionally been viewed as biologically insignificant until after the ice breakup. There is growing evidence however, that under-ice blooms of pelagic phytoplankton may be a recurrent occurrence. During the springs of 2011 and 2012, we found substantial numbers (201-5713 cells m(-3)) of the large centric diatom (diameter >250 mu m) Coscinodiscus centralis under the sea ice in the Canadian Arctic Archipelago near Resolute Bay, Nunavut. The highest numbers of these pelagic diatoms were observed in Barrow Strait. Spatial patterns of fatty acid profiles and stable isotopes indicated two source populations for C. centralis: a western origin with low light conditions and high nutrients, and a northern origin with lower nutrient levels and higher irradiances. Fatty acid analysis revealed that pelagic diatoms had significantly higher levels of polyunsaturated fatty acids (mean +/- SD: 50.3 +/- 8.9%) compared to ice-associated producers (30.6 +/- 10.3%) in our study area. In particular, C. centralis had significantly greater proportions of the long chain omega-3 fatty acid, eicosapentaenoic acid (EPA), than ice algae (24.4 +/- 5.1% versus 13.7 +/- 5.1%, respectively). Thus, C. centralis represented a significantly higher quality food source for local herbivores than ice algae, although feeding experiments did not show clear evidence of copepod grazing on C. centralis. Our results suggest that C. centralis are able to initiate growth under pack ice in this area and provide further evidence that biological productivity in ice-covered seas may be substantially higher than previously recognized.	[Duerksen, Steven W.; Thiemann, Gregory W.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Budge, Suzanne M.] Dalhousie Univ, Dept Proc Engn & Appl Sci, Halifax, NS, Canada; [Poulin, Michel] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Niemi, Andrea; Michel, Christine] Fisheries & Oceans Canada, Winnipeg, MB, Canada	York University - Canada; Dalhousie University; Fisheries & Oceans Canada	Duerksen, SW (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	swd@dal.ca	Thiemann, Gregory/J-9517-2013	Thiemann, Gregory/0000-0002-1888-900X; Budge, Suzanne/0000-0003-4984-7344	Natural Sciences and Engineering Research Council [371739-2009-RGPIN]; Fisheries and Oceans Canada (International Governance Strategy); Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants; Environment Canada; Northern Scientific Training Program (NSTP); York University Graduate Studies grants; Canadian Museum of Nature; Kenneth Molson Foundation [POLARBR-5167]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fisheries and Oceans Canada (International Governance Strategy); Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants; Environment Canada(CGIAR); Northern Scientific Training Program (NSTP); York University Graduate Studies grants; Canadian Museum of Nature; Kenneth Molson Foundation	This work was supported by grants from the Natural Sciences and Engineering Research Council (#371739-2009-RGPIN) (http://www.nserc-crsng.gc.ca/) to G.W.T. and C.M., Fisheries and Oceans Canada (International Governance Strategy) and Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants to C.M., Environment Canada and Kenneth Molson Foundation grants (POLARBR-5167) to G.W.T, Northern Scientific Training Program (NSTP) (http://www.polarcom.gc.ca/eng/content/northernscientific-training-program), and York University Graduate Studies grants (http://www.yorku.ca/grads/money_matters/rfc_fcf.html) to S.D., and by financial support to M.P. from the Canadian Museum of Nature. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt KE, 2005, MAR BIOL, V146, P513, DOI 10.1007/s00227-004-1457-9; ATKINS WRG, 1951, J MAR BIOL ASSOC UK, V29, P609, DOI 10.1017/S0025315400052802; BERARD-THERRIAULT L., 1999, PUBLICATION SPECIALE, V128, P1; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Brown TA, 2011, POLAR BIOL, V34, P1857, DOI 10.1007/s00300-010-0942-5; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Budge SM, 1999, PHYTOCHEMISTRY, V52, P561, DOI 10.1016/S0031-9422(99)00241-1; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Cleve PT, 1883, J LINNEAN SOC BOT, V20, P313; COTA GF, 1987, J GEOPHYS RES-OCEANS, V92, P1951, DOI 10.1029/JC092iC02p01951; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; GARRISON DL, 1986, POLAR BIOL, V6, P237, DOI 10.1007/BF00443401; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Graeve M, 2005, J EXP MAR BIOL ECOL, V317, P109, DOI 10.1016/j.jembe.2004.11.016; Griffiths MJ, 2010, LIPIDS, V45, P1053, DOI 10.1007/s11745-010-3468-2; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hasle Grethe Rytter, 1992, Diatom Research, V7, P37; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Hobson KA, 1995, MAR ECOL PROG SER, V128, P1, DOI 10.3354/meps128001; HORNER R, 1982, ARCTIC, V35, P485; Husson F, 2013, FACTOMINER MULTIVARI; Katsuki K, 2009, MICROPALEONTOLOGY, V55, P137; Kemp AES, 2000, DEEP-SEA RES PT II, V47, P2129, DOI 10.1016/S0967-0645(00)00019-9; LANGE CB, 1992, SARSIA, V77, P173, DOI 10.1080/00364827.1992.10413503; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Lovejoy C, 2002, DEEP-SEA RES PT II, V49, P5027, DOI 10.1016/S0967-0645(02)00176-5; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Matrai P, 2013, MAR BIOL, V160, P1297, DOI 10.1007/s00227-013-2181-0; Matsuoka A, 2009, ESTUAR COAST SHELF S, V82, P537, DOI 10.1016/j.ecss.2009.02.024; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Michel C, 1996, J GEOPHYS RES-OCEANS, V101, P18345, DOI 10.1029/96JC00045; Mundy CJ, 2014, MAR ECOL PROG SER, V497, P39, DOI 10.3354/meps10587; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Needoba JA, 2004, J PHYCOL, V40, P505, DOI 10.1111/j.1529-8817.2004.03171.x; Niehoff B, 2002, MAR BIOL, V140, P567, DOI 10.1007/s00227-001-0731-3; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PARK PW, 1994, J FOOD SCI, V59, P1262, DOI 10.1111/j.1365-2621.1994.tb14691.x; Parrish CC, 2005, MAR ECOL PROG SER, V286, P57, DOI 10.3354/meps286057; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Peter KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049632; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRINSENBERG SJ, 1987, CONT SHELF RES, V7, P913, DOI 10.1016/0278-4343(87)90006-9; R Core Team, 2021, R LANGUAGE ENV STAT; Riedel A, 2003, CAN DATA REP HYDROGR, V159, P1; Sargent J.R., 1993, Coastal and Estuarine Studies, V43, P103; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Strass VH, 1996, POLAR BIOL, V16, P409; THOMPSON PA, 1990, J PHYCOL, V26, P278, DOI 10.1111/j.0022-3646.1990.00278.x; Todorov V, 2009, J STAT SOFTW, V32, P1; Tremblay JE, 2006, LIMNOL OCEANOGR, V51, P900, DOI 10.4319/lo.2006.51.2.0900; von Quillfeldt CH, 2000, BOT MAR, V43, P499, DOI 10.1515/BOT.2000.050	56	15	16	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114070	10.1371/journal.pone.0114070	http://dx.doi.org/10.1371/journal.pone.0114070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473949	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500109
J	Froud, R; Abel, G				Froud, Robert; Abel, Gary			Using ROC Curves to Choose Minimally Important Change Thresholds when Sensitivity and Specificity Are Valued Equally: The Forgotten Lesson of Pythagoras. Theoretical Considerations and an Example Application of Change in Health Status	PLOS ONE			English	Article							LOW-BACK-PAIN; OUTCOME MEASURES; RESPONSIVENESS; INSTRUMENTS; TIME	Background: Receiver Operator Characteristic (ROC) curves are being used to identify Minimally Important Change (MIC) thresholds on scales that measure a change in health status. In quasi-continuous patient reported outcome measures, such as those that measure changes in chronic diseases with variable clinical trajectories, sensitivity and specificity are often valued equally. Notwithstanding methodologists agreeing that these should be valued equally, different approaches have been taken to estimating MIC thresholds using ROC curves. Aims and objectives: We aimed to compare the different approaches used with a new approach, exploring the extent to which the methods choose different thresholds, and considering the effect of differences on conclusions in responder analyses. Methods: Using graphical methods, hypothetical data, and data from a large randomised controlled trial of manual therapy for low back pain, we compared two existing approaches with a new approach that is based on the addition of the sums of squares of 1-sensitivity and 1-specificity. Results: There can be divergence in the thresholds chosen by different estimators. The cut-point selected by different estimators is dependent on the relationship between the cut-points in ROC space and the different contours described by the estimators. In particular, asymmetry and the number of possible cut-points affects threshold selection. Conclusion: Choice of MIC estimator is important. Different methods for choosing cut-points can lead to materially different MIC thresholds and thus affect results of responder analyses and trial conclusions. An estimator based on the smallest sum of squares of 1-sensitivity and 1-specificity is preferable when sensitivity and specificity are valued equally. Unlike other methods currently in use, the cut-point chosen by the sum of squares method always and efficiently chooses the cut-point closest to the top-left corner of ROC space, regardless of the shape of the ROC curve.	[Froud, Robert] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Froud, Robert] Norge Helsehoyskole, Oslo, Norway; [Abel, Gary] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 1TN, Cambs, England	University of Warwick; University of Cambridge	Froud, R (corresponding author), Univ Warwick, Warwick Med Sch, Clin Trials Unit, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	r.froud@warwick.ac.uk	Froud, Robert/AAQ-2429-2021; Abel, Gary/ABE-1765-2021	Froud, Robert/0000-0002-9193-2297; Abel, Gary/0000-0003-2231-5161				Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Collinson P, 1998, HEART, V80, P215, DOI 10.1136/hrt.80.3.215; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW., 2018, MEASUREMENT MED, V10th; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; de Vet HCW, 2010, J CLIN EPIDEMIOL, V63, P37, DOI 10.1016/j.jclinepi.2009.03.011; DEYO RA, 1986, J CHRON DIS, V39, P897, DOI 10.1016/0021-9681(86)90038-X; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Froud R, 2014, ROCMIC V2 0 0 STAT M; Froud R, 2010, THESIS QUEEN MARY U; Froud R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X657008; Froud R, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-35; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Lauridsen HH, 2007, PAIN, V131, P112, DOI 10.1016/j.pain.2006.12.023; Muller U, 2004, EUR SPINE J, V13, P301, DOI 10.1007/s00586-003-0665-1; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Terwee CB, 2003, QUAL LIFE RES, V12, P349, DOI 10.1023/A:1023499322593; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Underwood MR, 1999, SPINE, V24, P1104, DOI 10.1097/00007632-199906010-00010	21	56	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114468	10.1371/journal.pone.0114468	http://dx.doi.org/10.1371/journal.pone.0114468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474472	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500035
J	Lehto, M; Karilainen, T; Rog, T; Cramariuc, O; Vanhala, E; Tornaeus, J; Taberman, H; Janis, J; Alenius, H; Vattulainen, I; Laine, O				Lehto, Maili; Karilainen, Topi; Rog, Tomasz; Cramariuc, Oana; Vanhala, Esa; Tornaeus, Jarkko; Taberman, Helena; Janis, Janne; Alenius, Harri; Vattulainen, Ilpo; Laine, Olli			Co-Exposure with Fullerene May Strengthen Health Effects of Organic Industrial Chemicals	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; IN-VITRO EVALUATION; AQUEOUS SUSPENSIONS; C-60; TOXICITY; NANOPARTICLES; DYNAMICS; EXPOSURE; DISPERSIONS; PARTICLES	In vitro toxicological studies together with atomistic molecular dynamics simulations show that occupational co-exposure with C-60 fullerene may strengthen the health effects of organic industrial chemicals. The chemicals studied are acetophenone, benzaldehyde, benzyl alcohol, m-cresol, and toluene which can be used with fullerene as reagents or solvents in industrial processes. Potential co-exposure scenarios include a fullerene dust and organic chemical vapor, or a fullerene solution aerosolized in workplace air. Unfiltered and filtered mixtures of C-60 and organic chemicals represent different co-exposure scenarios in in vitro studies where acute cytotoxicity and immunotoxicity of C-60 and organic chemicals are tested together and alone by using human THP-1-derived macrophages. Statistically significant co-effects are observed for an unfiltered mixture of benzaldehyde and C-60 that is more cytotoxic than benzaldehyde alone, and for a filtered mixture of m-cresol and C-60 that is slightly less cytotoxic than m-cresol. Hydrophobicity of chemicals correlates with co-effects when secretion of pro-inflammatory cytokines IL-1 beta and TNF-alpha is considered. Complementary atomistic molecular dynamics simulations reveal that C-60 co-aggregates with all chemicals in aqueous environment. Stable aggregates have a fullerene-rich core and a chemical-rich surface layer, and while essentially all C-60 molecules aggregate together, a portion of organic molecules remains in water.	[Lehto, Maili; Vanhala, Esa; Tornaeus, Jarkko; Alenius, Harri; Laine, Olli] Finnish Inst Occupat Hlth, Helsinki, Finland; [Karilainen, Topi; Rog, Tomasz; Cramariuc, Oana; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Taberman, Helena; Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark	Finnish Institute of Occupational Health; Tampere University; University of Eastern Finland; University of Southern Denmark	Laine, O (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	olli.laine@ttl.fi	Vattulainen, Ilpo T/G-4224-2014; Rog, Tomasz/ABE-3044-2020; Jänis, Janne/B-7326-2014	Rog, Tomasz/0000-0001-6765-7013; Alenius, Harri/0000-0003-0106-8923; Vattulainen, Ilpo/0000-0001-7408-3214	Finnish Work Environment Fund [110358]; Finnish Academy of Science and Letters; Academy of Finland; European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	Finnish Work Environment Fund; Finnish Academy of Science and Letters(Academy of Finland); Academy of Finland(Academy of Finland); European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	OL received funding from the Finnish Work Environment Fund (Project 110358, www.tsr.fi), TK from the Finnish Academy of Science and Letters (Vaisalan rahasto, www.acadsci.fi), OC from the Academy of Finland (www.aka.fi), and TR and IV from the European Research Council (Advanced Grant CROWDED-PRO-LIPIDS, erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alargova RG, 2001, J AM CHEM SOC, V123, P10460, DOI 10.1021/ja010202a; Anilkumar P, 2011, CURR MED CHEM, V18, P2045, DOI 10.2174/092986711795656225; Aschberger K, 2010, REGUL TOXICOL PHARM, V58, P455, DOI 10.1016/j.yrtph.2010.08.017; Costa CLA, 2012, COMP BIOCHEM PHYS C, V155, P206, DOI 10.1016/j.cbpc.2011.08.005; Baun A, 2008, AQUAT TOXICOL, V86, P379, DOI 10.1016/j.aquatox.2007.11.019; Brant JA, 2006, LANGMUIR, V22, P3878, DOI 10.1021/la053293o; Deguchi S, 2001, LANGMUIR, V17, P6013, DOI 10.1021/la010651o; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gangwal S, 2011, ENVIRON HEALTH PERSP, V119, P1539, DOI 10.1289/ehp.1103750; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; GIRIFALCO LA, 1992, J PHYS CHEM-US, V96, P858, DOI 10.1021/j100181a061; Goulaouic S, 2008, J IMMUNOTOXICOL, V5, P337, DOI 10.1080/15476910802371016; Guldi DM, 2009, CHEM SOC REV, V38, P1587, DOI 10.1039/b900402p; Henry TB, 2011, CURR OPIN BIOTECH, V22, P533, DOI 10.1016/j.copbio.2011.05.511; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heymann D, 1996, FULLERENE SCI TECHN, V4, P509, DOI 10.1080/10641229608001567; Holder AL, 2007, CHEMOSPHERE, V70, P13, DOI 10.1016/j.chemosphere.2007.07.036; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horie M, 2010, J BIOCHEM, V148, P289, DOI 10.1093/jb/mvq068; Hu XL, 2008, ENVIRON TOXICOL CHEM, V27, P1868, DOI 10.1897/08-009.1; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnston HJ, 2010, TOXICOL SCI, V114, P162, DOI 10.1093/toxsci/kfp265; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kato H, 2010, MOL BIOSYST, V6, P1238, DOI 10.1039/c002364g; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Lens Marko, 2011, Recent Pat Biotechnol, V5, P67, DOI 10.2174/187220811796365707; Lide D. R., 2009, CRC HDB CHEM PHYS, P6; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Ma XM, 2010, ENVIRON ENG SCI, V27, P989, DOI 10.1089/ees.2010.0141; Mo YQ, 2012, TOXICOL IN VITRO, V26, P295, DOI 10.1016/j.tiv.2011.12.001; Montellano A, 2011, NANOSCALE, V3, P4035, DOI 10.1039/c1nr10783f; Monticelli L, 2012, PHYS CHEM CHEM PHYS, V14, P12526, DOI 10.1039/c2cp41117b; Monticelli L, 2012, J CHEM THEORY COMPUT, V8, P1370, DOI 10.1021/ct3000102; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nyberg M, 1999, PHYS REV B, V60, P7956, DOI 10.1103/PhysRevB.60.7956; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Parish A, 2011, ET113 INN RES PROD; Park JW, 2011, NANOTOXICOLOGY, V5, P406, DOI 10.3109/17435390.2010.525329; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Salonen E, 2008, SMALL, V4, P1986, DOI 10.1002/smll.200701279; Spohn P, 2009, ENVIRON POLLUT, V157, P1134, DOI 10.1016/j.envpol.2008.08.013; Todorovic-Markovic B, 2008, APPL SURF SCI, V255, P3283, DOI 10.1016/j.apsusc.2008.09.043; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Verschueren K, 2001, HDB ENV DATA ORGANIC, P314; Xia XR, 2010, TOXICOL LETT, V197, P128, DOI 10.1016/j.toxlet.2010.05.010; Xia XR, 2010, TOXICOL APPL PHARM, V242, P29, DOI 10.1016/j.taap.2009.09.011; Zhang LL, 2011, ENVIRON SCI TECHNOL, V45, P1341, DOI 10.1021/es102316m	54	8	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114490	10.1371/journal.pone.0114490	http://dx.doi.org/10.1371/journal.pone.0114490			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473947	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500040
J	Sanyal, C; Aprikian, A; Cury, F; Chevalier, S; Dragomir, A				Sanyal, Chiranjeev; Aprikian, Armen; Cury, Fabio; Chevalier, Simone; Dragomir, Alice			Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; RADICAL RETROPUBIC PROSTATECTOMY; ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; DOSE-RATE BRACHYTHERAPY; BIOCHEMICAL RECURRENCE; ACTIVE SURVEILLANCE; FREE SURVIVAL; RISK; MORTALITY	Background: Prostate cancer (PCa) is the most common non-skin cancer among men in developed countries. Several novel treatments have been adopted by healthcare systems to manage PCa. Most of the observational studies and randomized trials on PCa have concurrently evaluated fewer treatments over short follow-up. Further, preceding decision analytic models on PCa management have not evaluated various contemporary management options. Therefore, a contemporary decision analytic model was necessary to address limitations to the literature by synthesizing the evidence on novel treatments thereby forecasting short and long-term clinical outcomes. Objectives: To develop and validate a Markov Monte Carlo model for the contemporary clinical management of PCa, and to assess the clinical burden of the disease from diagnosis to end-of-life. Methods: A Markov Monte Carlo model was developed to simulate the management of PCa in men 65 years and older from diagnosis to end-of-life. Health states modeled were: risk at diagnosis, active surveillance, active treatment, PCa recurrence, PCa recurrence free, metastatic castrate resistant prostate cancer, overall and PCa death. Treatment trajectories were based on state transition probabilities derived from the literature. Validation and sensitivity analyses assessed the accuracy and robustness of model predicted outcomes. Results: Validation indicated model predicted rates were comparable to observed rates in the published literature. The simulated distribution of clinical outcomes for the base case was consistent with sensitivity analyses. Predicted rate of clinical outcomes and mortality varied across risk groups. Life expectancy and health adjusted life expectancy predicted for the simulated cohort was 20.9 years (95% CI 20.5-21.3) and 18.2 years (95% CI 17.9-18.5), respectively. Conclusion: Study findings indicated contemporary management strategies improved survival and quality of life in patients with PCa. This model could be used to compare long-term outcomes and life expectancy conferred of PCa management paradigms.	[Sanyal, Chiranjeev; Aprikian, Armen; Cury, Fabio; Chevalier, Simone; Dragomir, Alice] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada; [Aprikian, Armen; Chevalier, Simone; Dragomir, Alice] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Cury, Fabio] McGill Univ, Dept Radiat Oncol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Dragomir, A (corresponding author), McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada.	alice.dragomir@muhc.mcgill.ca	Cury, Fabio L./AAW-5633-2020	Cury, Fabio L./0000-0003-1293-0822	Fonds de recherche du Quebec-Sante (FRQ-S)	Fonds de recherche du Quebec-Sante (FRQ-S)	Chiranjeev Sanyal is a recipient of a doctoral research studentship from ''The Fonds de recherche du Quebec-Sante (FRQ-S)'' (www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2009, RADIOTHER ONCOL, V93, P185, DOI 10.1016/j.radonc.2009.09.001; AlDuhaiby EZ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-18; Alicikus ZA, 2011, CANCER-AM CANCER SOC, V117, P1429, DOI 10.1002/cncr.25467; [Anonymous], 2000, REPORT DEMOGRAPHIC S; [Anonymous], 1999, DEATHS PERCENT TOTAL; Astrom L, 2005, RADIOTHER ONCOL, V74, P157, DOI 10.1016/j.radonc.2004.10.014; Azoulay L, 2011, EUR UROL, V60, P1244, DOI 10.1016/j.eururo.2011.08.041; Bensimon L, 2014, CANCER CAUSE CONTROL, V25, P329, DOI 10.1007/s10552-013-0334-6; Carter H. Ballentine, 2012, Journal of the National Cancer Institute Monographs, P175, DOI 10.1093/jncimonographs/lgs036; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; COWEN ME, 1994, J CLIN EPIDEMIOL, V47, P3, DOI 10.1016/0895-4356(94)90029-9; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; Deutsch I, 2010, BRACHYTHERAPY, V9, P313, DOI 10.1016/j.brachy.2010.02.196; Dragomir A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-252; Drummond M F, 1992, Int J Technol Assess Health Care, V8, P671; Drummond MF, 2015, METHODS EC EVALUATIO; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Efstathiou JA, 2008, EUR UROL, V54, P816, DOI 10.1016/j.eururo.2008.01.021; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Fleming C, 1993, JAMA, V269, P2650; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Galalae RM, 2004, INT J RADIAT ONCOL, V58, P1048, DOI 10.1016/j.ijrobp.2003.08.003; Grover SA, 2000, CAN MED ASSOC J, V162, P977; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hogendoorn W, 2014, J VASC SURG, V59, P651, DOI 10.1016/j.jvs.2013.09.026; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Keegan KA, 2011, CANCER, V118, P3512; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Kotecha R, 2013, BRACHYTHERAPY, V12, P44, DOI 10.1016/j.brachy.2012.05.003; Merino T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-530; Oudard S, 2013, CANCER TREAT REV, V39, P275, DOI 10.1016/j.ctrv.2012.09.005; Pataky R, 2014, INT J CANC; Pierorazio PM, 2013, BJU INT; Prada PJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-31; Rodrigues G, 2012, CUAJ-CAN UROL ASSOC, V6, P121, DOI 10.5489/cuaj.11085; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Saad F, 2013, CUAJ-CAN UROL ASSOC, V7, P231, DOI 10.5489/cuaj.1542; Sathya JR, 2005, J CLIN ONCOL, V23, P1192, DOI 10.1200/JCO.2005.06.154; Siebert U, 2006, EUR J PUBLIC HEALTH, V16, P185, DOI 10.1093/eurpub/cki163; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Smith MR, 2008, J CLIN ONCOL, V26, P4333, DOI 10.1200/JCO.2008.16.5845; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Spratt DE, 2014, BJU INT; Statistics Canada, TABL 102 0122 HLTH A; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stone NN, 2010, INT J RADIAT ONCOL, V76, P355, DOI 10.1016/j.ijrobp.2009.01.078; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; U.S. Population by Age, 2010, NAT TABL TRENDS; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; van den Bergh RCN, 2009, EUR UROL, V55, P1, DOI 10.1016/j.eururo.2008.09.007; van Kempen BJH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-158; Vora SA, 2013, J UROLOGY, V190, P521, DOI 10.1016/j.juro.2013.02.012; Yu O, 2014, J CLIN ONCOL, V32, P5, DOI 10.1200/JCO.2013.49.4757; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029; Zelefsky MJ, 2010, J CLIN ONCOL, V28, P1508, DOI 10.1200/JCO.2009.22.2265	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113432	10.1371/journal.pone.0113432	http://dx.doi.org/10.1371/journal.pone.0113432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474006	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500082
J	Scheepers, E; Slinger, M; Wendel-Vos, W; Schuit, J				Scheepers, Eline; Slinger, Minke; Wendel-Vos, Wanda; Schuit, Jantine			How Combined Trip Purposes Are Associated with Transport Choice for Short Distance Trips. Results from a Cross-Sectional Study in the Netherlands	PLOS ONE			English	Article							ACTIVE TRAVEL; BEHAVIOR; POLICIES; BICYCLE; WALKING; HEALTH	Background: One way to increase physical activity is to stimulate a shift from car use to walking or cycling. In single-purpose trips, purpose was found to be an important predictor of transport choice. However, as far as known, no studies have been conducted to see how trips with combined purposes affect this decision. This study was designed to provide insight into associations between combined purposes and transport choice. Methods: An online questionnaire (N=3,663) was used to collect data concerning transport choice for four primary purposes: shopping, going to public natural spaces, sports, and commuting. Per combination of primary trip purpose and transport choice, participants were asked to give examples of secondary purposes that they combine with the primary purpose. Logistic regression analyses were used to model the odds of both cycling and walking versus car use. Results: Primary trip purposes combined with commuting, shopping, visiting private contacts or medical care were more likely to be made by car than by cycling or walking. Combinations with visiting catering facilities, trips to social infrastructure facilities, recreational outings, trips to facilities for the provision of daily requirements or private contacts during the trip were more likely to be made by walking and/or cycling than by car. Conclusion: Combined trip purposes were found to be associated with transport choice. When stimulating active transport focus should be on the combined-trip purposes which were more likely to be made by car, namely trips combined with commuting, other shopping, visiting private contacts or medical care.	[Scheepers, Eline; Slinger, Minke; Schuit, Jantine] Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [Scheepers, Eline; Slinger, Minke; Schuit, Jantine] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, NL-1081 HV Amsterdam, Netherlands; [Scheepers, Eline; Slinger, Minke; Wendel-Vos, Wanda; Schuit, Jantine] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment	Scheepers, E (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands.	eline.scheepers@rivm.nl	Schuit, Albertine J/I-3148-2018	Schuit, Jantine/0000-0002-7499-1391				ABF Research, ABF NEIGHB TYP; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Carse A, 2013, J TRANSP GEOGR, V28, P67, DOI 10.1016/j.jtrangeo.2012.10.013; Cavill N, 2006, PHYS ACTIVITY HLTH E; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; DECOS, 2010, DECOS PUBL; Emond CR, 2009, TRANSPORT RES REC, P16, DOI 10.3141/2125-03; Heesch KC, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-106; Heinen E, 2013, TRANSPORTATION, V40, P23, DOI 10.1007/s11116-012-9399-4; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Ho CQ, 2013, TRANSPORT RES A-POL, V49, P206, DOI 10.1016/j.tra.2013.01.040; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Mackett RL, 2003, TRANSPORTATION, V30, P329, DOI 10.1023/A:1023987812020; McCormack GR, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.092841; Millward H, 2013, J TRANSP GEOGR, V28, P101, DOI 10.1016/j.jtrangeo.2012.11.012; *MIN TRANSP PUBL W, 2009, CYCL NETH; Ministry of Transport Public Works and Water Management, 2010, MOB RES NETH 2009; Panter J, 2013, PREV MED, V56, P211, DOI 10.1016/j.ypmed.2013.01.014; Rietveld P, 2004, TRANSPORT RES A-POL, V38, P531, DOI 10.1016/j.tra.2004.05.003; Scheepers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073105; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; Wendel-Vos GCW, 2002, 2699600012002 RIVM; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	23	4	4	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114797	10.1371/journal.pone.0114797	http://dx.doi.org/10.1371/journal.pone.0114797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474653	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500056
J	Chen, CY; Hsu, JS; Jaw, TS; Wu, DC; Shih, MCP; Lee, CH; Kuo, CH; Chen, YT; Lai, ML; Liu, GC				Chen, Chiao-Yun; Hsu, Jui-Sheng; Jaw, Twei-Shiun; Wu, Deng-Chyang; Shih, Ming-Chen Paul; Lee, Chien-Hung; Kuo, Chao-Hung; Chen, Yi-Ting; Lai, Ming-Lai; Liu, Gin-Chung			Utility of the Iodine Overlay Technique and Virtual Nonenhanced Images for the Preoperative T Staging of Colorectal Cancer by Dual-Energy CT with Tin Filter Technology	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RENAL MASSES; PHASE; COLONOGRAPHY; ACCURACY; QUALITY; STONES	Objectives: To evaluate the diagnostic accuracy and the potential radiation dose reduction of dual-energy CT (DECT) for tumor (T) staging of colorectal cancer (CRC) using iodine overlay (IO) and virtual nonenhanced (VNE) images. Materials and Methods: This retrospective study included 103 consecutive patients who underwent nonenhanced CT and enhanced DECT for preoperative CRC staging. Enhanced weighted-average (WA), IO and VNE images were reconstructed from enhanced 80 kVp and Sn140 kVp scans. Two radiologists assessed image qualities of the true nonenhanced (TNE) and VNE images. For T-staging, another two radiologists independently interpreted all scans in two separate reading sessions: in the first session, only images derived from the single phase DECT acquisition (IO and VNE images) were read. In the second reading session after 30 to 50 (average: 42) days, the same assessment was again performed with the TNE and enhanced WA images thereby simulating conventional dual-phase single-energy CT. The tumor node metastasis (TNM) system was used for staging with histopathologic reports as gold standard. Analysis of variance was used for statistical analysis. Results: The signal-to-noise ratios (SNRs) of the tumors and normal reference tissues showed significant correlation between the TNE and VNE images (P<0.01). The mean iodine overlay value (48.4 HU +/- 12.2) and enhancement (49.4 HU +/- 11.8) value of CRCs had no significant difference (P=0.52). The mean image noise on TNE (5.0 +/- 1.1) and VNE (5.3 +/- 1.1) images were similar (P=0.07). The quantitative qualities of the VNE images were mildly inferior to the TNE images. Overall accuracy of T-stage CRC when using single-phase acquisition was slightly better than the dual-phase acquisition (90.3% vs 87.4%) (P=0.51). The mean dose of the single-phase DECT acquisition was 6.2mSv comparing with 14.3mSv of dual-phase. Conclusion: Single-phase DECT using IO and VNE images yields a high accuracy in T-staging of CRCs. Thereby, the radiation exposure of the patients can be reduced.	[Chen, Chiao-Yun; Hsu, Jui-Sheng; Liu, Gin-Chung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Jaw, Twei-Shiun; Shih, Ming-Chen Paul; Liu, Gin-Chung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Radiol, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Hsu, Jui-Sheng; Jaw, Twei-Shiun; Lai, Ming-Lai; Liu, Gin-Chung] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Wu, Deng-Chyang; Shih, Ming-Chen Paul] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Wu, Deng-Chyang; Kuo, Chao-Hung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Med, Kaohsiung, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Kuo, Chao-Hung] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yi-Ting] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Liu, GC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	gcliu@kmu.edu.tw	Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X; Chen, yiting/0000-0002-0817-1539				[Anonymous], 2010, AJCC CANC STAGING MA; Ascenti G, 2011, AM J ROENTGENOL, V196, P1408, DOI 10.2214/AJR.10.4505; Boellaard TN, 2013, CLIN RADIOL, V68, P799, DOI 10.1016/j.crad.2013.03.005; Chae EJ, 2010, J THORAC IMAG, V25, P301, DOI 10.1097/RTI.0b013e3181e16232; Dighe S, 2010, CLIN RADIOL, V65, P708, DOI 10.1016/j.crad.2010.01.024; Dighe S, 2010, BRIT J SURG, V97, P1407, DOI 10.1002/bjs.7096; Filippone A, 2004, RADIOLOGY, V231, P83, DOI 10.1148/radiol.2311021152; Gnannt R, 2012, AM J ROENTGENOL, V198, P138, DOI 10.2214/AJR.11.6957; Goshima S, 2011, RADIOLOGY, V260, P139, DOI 10.1148/radiol.11101459; Graser A, 2010, INVEST RADIOL, V45, P399, DOI 10.1097/RLI.0b013e3181e33189; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Graser A, 2009, EUR RADIOL, V19, P13, DOI 10.1007/s00330-008-1122-7; Gray PR, 2007, FOXTROT FLUOROPYRMID; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Kim JE, 2012, AM J ROENTGENOL, V198, P817, DOI 10.2214/AJR.11.6972; Mangold S, 2012, RADIOLOGY, V264, P119, DOI 10.1148/radiol.12110851; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Morrin MM, 2000, DIS COLON RECTUM, V43, P303, DOI 10.1007/BF02258293; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Petersilka M, 2008, EUR J RADIOL, V68, P362, DOI 10.1016/j.ejrad.2008.08.013; Primak AN, 2010, AM J ROENTGENOL, V195, P1164, DOI 10.2214/AJR.09.3956; Shrimpton PC, 2004, NRPBPE12004; Smith NJ, 2007, BRIT J CANCER, V96, P1030, DOI 10.1038/sj.bjc.6603646; Sommer CM, 2010, CARDIOVASC INTER RAD, V33, P498, DOI 10.1007/s00270-009-9787-0; Song KD, 2011, AM J ROENTGENOL, V197, pW1076, DOI 10.2214/AJR.11.6922; Takahashi N, 2010, RADIOLOGY, V256, P184, DOI 10.1148/radiol.10091411; Zhang LJ, 2010, EUR RADIOL, V20, P2257, DOI 10.1007/s00330-010-1778-7	28	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113589	10.1371/journal.pone.0113589	http://dx.doi.org/10.1371/journal.pone.0113589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469775	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700035
J	Heinzel, S; Gold, M; Deuschle, C; Bernhard, F; Maetzler, W; Berg, D; Dodel, R				Heinzel, Sebastian; Gold, Maike; Deuschle, Christian; Bernhard, Felix; Maetzler, Walter; Berg, Daniela; Dodel, Richard			Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson's Disease: Sources of (Error) Variance in Biomarker Assays	PLOS ONE			English	Article							DRUG-NAIVE PATIENTS; CEREBROSPINAL-FLUID; ELEVATED LEVELS; PLASMA; PROTEIN; ANTIBODIES; NEURODEGENERATION; IMMUNIZATION; IMMUNITY; DJ-1	Alpha-synuclein (alpha-Syn) plays a pivotal role in the pathophysiology of Parkinson's disease (PD), which can partly be modulated by innate and adaptive immune functions, and vice versa. Here, naturally occurring alpha-Syn autoantibodies (alpha-Syn-nAbs) may be effective against alpha-Syn pathoetiology and may serve as a PD biomarker. However, serum and cerebrospinal fluid alpha-Syn-nAbs levels still lack consistent evidence as required for a reliable PD biomarker. Serum and cerebrospinal fluid alpha-Syn-nAbs levels of 66 PD patients and 69 healthy controls were assessed using a validated ELISA assay. Moreover, potential sources of error variance including unspecific ELISA background signals, free serum hemoglobin concentrations, alpha-Syn plate coating procedures, and differences in alpha-Syn-nAbs standards, were investigated. PD patients and controls did not differ in serum (p=.49) nor cerebrospinal fluid (p=.29) alpha-Syn-nAbs levels. Interestingly, free serum hemoglobin concentrations were negatively correlated with alpha-Syn-nAbs levels in controls (Spearman rho=-.41, p<.001), but not in PD patients (rho=.16, p=.21). ELISA alpha-Syn plate coating procedures impacted inter-assay variability (same day coating: 8-16%; coating on different days: 16-58%). alpha-Syn-nAbs standards from different purification batches differed regarding optical density measured in ELISAs suggesting differences in alpha-Syn affinity. While alpha-Syn-nAbs levels may represent a potential PD biomarker, several methodological issues have to be considered to increase reproducibility of alpha-Syn-nAbs findings. Further studies using standardized protocols minimizing sources of error variance may be necessary to establish a reliable PD alpha-Syn-nAbs biomarker.	[Heinzel, Sebastian; Deuschle, Christian; Bernhard, Felix; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany; [Gold, Maike; Dodel, Richard] Univ Marburg, Dept Neurol, Marburg, Germany; [Deuschle, Christian; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heinzel, S (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany.	Sebastian.Heinzel@med.uni-tuebingen.de	Berg, Daniela/A-8728-2019; Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Heinzel, Sebastian/AFK-4188-2022	Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Heinzel, Sebastian/0000-0003-4516-0529	research exchange program of the Competence Network Degenerative Dementias (KNDD) [01GI1005B]; German Federal Ministry of Education and Research [01GI1008C]	research exchange program of the Competence Network Degenerative Dementias (KNDD); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding: This study was supported by the research exchange program of the Competence Network Degenerative Dementias (KNDD; grant number: 01GI1005B). The LANDSCAPE study is part of the KNDD, which was funded by the German Federal Ministry of Education and Research (project number 01GI1008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbo DB, 2009, J NEURAL TRANSM-SUPP, P311, DOI 10.1007/978-3-211-92660-4_26; Bach JP, 2012, ADV EXP MED BIOL, V750, P91, DOI 10.1007/978-1-4614-3461-0_7; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deleersnijder A, 2013, TRENDS MOL MED, V19, P368, DOI 10.1016/j.molmed.2013.04.002; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; GIBB WRG, 1988, POSTGRAD MED J, V64, P345, DOI 10.1136/pgmj.64.751.345; Gold M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-5; Gruden MA, 2012, NEUROIMMUNOMODULAT, V19, P334, DOI 10.1159/000341400; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Korff A, 2013, J ALZHEIMERS DIS, V36, P679, DOI 10.3233/JAD-130458; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Maetzler W, 2014, PLOS ONE, V9; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Nakai M, 2007, BIOCHEM BIOPH RES CO, V358, P104, DOI 10.1016/j.bbrc.2007.04.108; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Roettger Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067743; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	47	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114566	10.1371/journal.pone.0114566	http://dx.doi.org/10.1371/journal.pone.0114566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470145	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700122
J	Ragauskas, S; Leinonen, H; Puranen, J; Ronkko, S; Nymark, S; Gurevicius, K; Lipponen, A; Kontkanen, O; Puolivali, J; Tanila, H; Kalesnykas, G				Ragauskas, Symantas; Leinonen, Henri; Puranen, Jooseppi; Ronkko, Seppo; Nymark, Soile; Gurevicius, Kestutis; Lipponen, Arto; Kontkanen, Outi; Puolivali, Jukka; Tanila, Heikki; Kalesnykas, Giedrius			Early Retinal Function Deficit without Prominent Morphological Changes in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; GANGLION-CELL DYSFUNCTION; PATTERN ELECTRORETINOGRAM; MUTANT HUNTINGTIN; SCHEMATIC EYE; MICE; NEURODEGENERATION; EXPRESSION; GENE; TRANSMISSION	Huntington's disease (HD) is an inherited neurodegenerative disorder that primarily affects the medium-size GABAergic neurons of striatum. The R6/2 mouse line is one of the most widely used animal models of HD. Previously the hallmarks of HD-related pathology have been detected in photoreceptors and interneurons of R6/2 mouse retina. Here we aimed to explore the survival of retinal ganglion cells (RGCs) and functional integrity of distinct retinal cell populations in R6/2 mice. The pattern electroretinography (PERG) signal was lost at the age of 8 weeks in R6/2 mice in contrast to the situation in wild-type (WT) littermates. This defect may be attributable to a major reduction in photopic ERG responses in R6/2 mice which was more evident in b- than a-wave amplitudes. At the age of 4 weeks R6/2 mice had predominantly the soluble form of mutant huntingtin protein (mHtt) in the RGC layer cells, whereas the aggregated form of mHtt was found in the majority of those cells from the 12-week-old R6/2 mice and onwards. Retinal astrocytes did not contain mHtt deposits. The total numbers of RGC layer cells, retinal astrocytes as well as optic nerve axons did not differ between 18-week-old R6/2 mice and their WT controls. Our data indicate that mHtt deposition does not cause RGC degeneration or retinal astrocyte loss in R6/2 mice even at a late stage of HD-related pathology. However, due to functional deficits in the rod-and conepathways, the R6/2 mice suffer progressive deficits in visual capabilities starting as early as 4 weeks; at 8 weeks there is severe impairment. This should be taken into account in any behavioral testing conducted in R6/2 mice.	[Ragauskas, Symantas; Puranen, Jooseppi; Ronkko, Seppo; Kalesnykas, Giedrius] Univ Eastern Finland, Sch Med, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland; [Ragauskas, Symantas] Vilnius Gediminas Tech Univ, Dept Biochem, Vilnius, Lithuania; [Ragauskas, Symantas] State Res Inst Innovat Med, Vilnius, Lithuania; [Ragauskas, Symantas; Puranen, Jooseppi; Kalesnykas, Giedrius] Experimentica Ltd, Kuopio, Finland; [Leinonen, Henri; Lipponen, Arto; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland; [Nymark, Soile] Tampere Univ Technol, BioMediTech, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Kontkanen, Outi; Puolivali, Jukka] Charles River DRS Finland, Kuopio, Finland	University of Eastern Finland; Vilnius Gediminas Technical University; State Research Institute Centre for Innovative Medicine; University of Eastern Finland; Tampere University	Kalesnykas, G (corresponding author), Univ Eastern Finland, Sch Med, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland.	giedrius.kalesnykas@gmail.com	Kalesnykas, Giedrius/AAG-4084-2021; Nymark, Soile/M-9453-2016; Leinonen, Henri/V-2684-2019	Nymark, Soile/0000-0002-9274-0123; Leinonen, Henri/0000-0002-0388-832X; Lipponen, Arto/0000-0001-6201-6647	Charles River DRS Finland; Experimentica Ltd.	Charles River DRS Finland; Experimentica Ltd.	Funding: The research described was funded by Charles River DRS Finland (www.crl.com) and Experimentica Ltd. (www.experimentica.com). The funders participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bui BV, 2003, EXP EYE RES, V77, P555, DOI 10.1016/S0014-4835(03)00195-7; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Heckenlively JR, 2006, ORIGINS ELECTRORETIN, P139; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056026; Lione LA, 1999, J NEUROSCI, V19, P10428; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Miura G, 2009, EXP EYE RES, V89, P49, DOI 10.1016/j.exer.2009.02.009; Nagaraju M, 2007, INVEST OPHTH VIS SCI, V48, P4573, DOI 10.1167/iovs.07-0582; Nguyen CTO, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/796362; PAULUS W, 1993, ANN NEUROL, V34, P574, DOI 10.1002/ana.410340411; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Petrasch-Parwez E, 2005, ACTA NEUROPATHOL, V110, P523, DOI 10.1007/s00401-005-1092-7; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Ridder WH, 2002, EXP EYE RES, V75, P365, DOI 10.1006/exer.2002.2007; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Smith BJ, 2014, DOC OPHTHALMOL, V128, P155, DOI 10.1007/s10633-014-9433-2; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	48	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113317	10.1371/journal.pone.0113317	http://dx.doi.org/10.1371/journal.pone.0113317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469887	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700022
J	Busk, PK; Lange, M; Pilgaard, B; Lange, L				Busk, Peter K.; Lange, Mette; Pilgaard, Bo; Lange, Lene			Several Genes Encoding Enzymes with the Same Activity Are Necessary for Aerobic Fungal Degradation of Cellulose in Nature	PLOS ONE			English	Article							WOOD DECAY; CELLOBIOSE DEHYDROGENASE; ENZYMATIC-HYDROLYSIS; GLYCOSIDE HYDROLASES; TRICHODERMA-REESEI; SERPULA-LACRYMANS; PLANT; CONVERSION; POLYSACCHARIDES; CLASSIFICATION	The cellulose-degrading fungal enzymes are glycoside hydrolases of the GH families and lytic polysaccharide monooxygenases. The entanglement of glycoside hydrolase families and functions makes it difficult to predict the enzymatic activity of glycoside hydrolases based on their sequence. In the present study we further developed the method Peptide Pattern Recognition to an automatic approach not only to find all genes encoding glycoside hydrolases and lytic polysaccharide monooxygenases in fungal genomes but also to predict the function of the genes. The functional annotation is an important feature as it provides a direct route to predict function from primary sequence. Furthermore, we used Peptide Pattern Recognition to compare the cellulose-degrading enzyme activities encoded by 39 fungal genomes. The results indicated that cellobiohydrolases and AA9 lytic polysaccharide monooxygenases are hallmarks of cellulose-degrading fungi except brown rot fungi. Furthermore, a high number of AA9, endocellulase and beta-glucosidase genes were identified, not in what are known to be the strongest, specialized lignocellulose degraders but in saprophytic fungi that can use a wide variety of substrates whereas only few of these genes were found in fungi that have a limited number of natural, lignocellulotic substrates. This correlation suggests that enzymes with different properties are necessary for degradation of cellulose in different complex substrates. Interestingly, clustering of the fungi based on their predicted enzymes indicated that Ascomycota and Basidiomycota use the same enzymatic activities to degrade plant cell walls.	[Busk, Peter K.; Lange, Mette; Pilgaard, Bo; Lange, Lene] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-2450 Copenhagen SV, Denmark	Aalborg University	Busk, PK (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark.	pkb@bio.aau.dk	Busk, Peter/Q-8145-2016; Lange, Lene/Q-8051-2016	Busk, Peter/0000-0003-1920-636X; Lange, Lene/0000-0002-5336-1155; Pilgaard, Bo/0000-0002-8697-6041	Danish Strategic Research Council [2101-08-0041, 09-065251]; Novozymes A/S	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Novozymes A/S	This work was supported by The Danish Strategic Research Council projects 2101-08-0041 (BioRef), 09-065251 (Bio4Bio) and by Novozymes A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ainsworth GC, 1995, AINSWORTH BISBYS DIC; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Benko Z, 2008, ENZYME MICROB TECH, V43, P109, DOI 10.1016/j.enzmictec.2008.03.005; Brown CT, 2012, ARXIV12034802QBIO; Busk PK, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-47; Busk PK, 2013, APPL ENVIRON MICROB, V79, P3380, DOI 10.1128/AEM.03803-12; Busk PK, 2002, PLANT MOL BIOL REP, V20, P287, DOI 10.1007/BF02782464; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Heng L, 2012, SEQTK TOOLKIT PROCES; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HEREDIA A, 1995, Z LEBENSM UNTERS FOR, V200, P24, DOI 10.1007/BF01192903; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kaida R, 2009, MOL PLANT, V2, P904, DOI 10.1093/mp/ssp060; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Korripally P, 2013, APPL ENVIRON MICROB, V79, P2377, DOI 10.1128/AEM.03880-12; Kuhad R. C, 2007, LIGNOCELLULOSE BIOTE, P3; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lima MA, 2013, J BIOL CHEM, V288, P32991, DOI 10.1074/jbc.M113.479279; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Moore-Landecker E, 1972, FUNDAMENTALS FUNGI, P291; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Richardson M, 2009, CLIN MICROBIOL INFEC, V15, P2, DOI 10.1111/j.1469-0691.2009.02972.x; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rineau F, 2012, ENVIRON MICROBIOL, V14, P1477, DOI 10.1111/j.1462-2920.2012.02736.x; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Watkinson SC, 2012, ADV APPL MICROBIOL, V78, P121, DOI 10.1016/B978-0-12-394805-2.00005-1; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JH, 2011, BIORESOURCE TECHNOL, V102, P9090, DOI 10.1016/j.biortech.2011.06.085	59	33	36	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114138	10.1371/journal.pone.0114138	http://dx.doi.org/10.1371/journal.pone.0114138			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461894	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700104
J	Dangisso, MH; Datiko, DG; Lindtjorn, B				Dangisso, Mesay Hailu; Datiko, Daniel Gemechu; Lindtjorn, Bernt			Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings	PLOS ONE			English	Article							COMMUNITY RANDOMIZED-TRIAL; HEALTH EXTENSION WORKERS; HIV-INFECTION; GENDER; TB; PREVALENCE; DIAGNOSIS; REGION; INDIA; COINFECTION	Background: Ethiopia is one of the high tuberculosis (TB) burden countries. An analysis of trends and differentials in case notifications and treatment outcomes of TB may help improve our understanding of the performance of TB control services. Methods: A retrospective trend analysis of TB cases was conducted in the Sidama Zone in southern Ethiopia. We registered all TB cases diagnosed and treated during 2003-2012 from all health facilities in the Sidama Zone, and analysed trends of TB case notification rates and treatment outcomes. Results: The smear positive (PTB+) case notification rate (CNR) increased from 55 (95% CI 52.5-58.4) to 111 (95% CI 107.4-114.4) per 10(5) people. The CNRs of PTB+ in people older than 45 years increased by fourfold, while the mortality of cases during treatment declined from 11% to 3% for smear negative (PTB-) (chi(2)(trend), P<0.001) and from 5% to 2% for PTB+ (chi(2)(trend), P<0.001). The treatment success was higher in rural areas (AOR 1.11; CI 95%: 1.03-1.2), less for PTB-(AOR 0.86; CI 95%: 0.80-0.92) and higher for extra-pulmonary TB (AOR 1.10; CI 95%: 1.02-1.19) compared to PTB+. A higher lost-to-follow up was observed in men (AOR 1.15; CI 95%: 1.06-1.24) and among PTB-cases (AOR 1.14; CI 95%: 1.03-1.25). More deaths occurred in PTB-cases (AOR 1.65; 95% CI: 1.44-1.90) and among cases older than 65 years (AOR 3.86; CI 95%: 2.94-5.10). Lastly, retreatment cases had a higher mortality than new cases (6% vs 3%). Conclusion: Over the past decade TB CNRs and treatment outcomes improved, whereas the disparities of disease burden by gender and place of residence reduced and mortality declined. Strategies should be devised to address higher risk groups for poor treatment outcomes.	[Dangisso, Mesay Hailu; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway; [Dangisso, Mesay Hailu] Sidama Zone Hlth Dept, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Hawassa Univ, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Bergen; Hawassa University; Liverpool School of Tropical Medicine; University of Liverpool	Dangisso, MH (corresponding author), Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway.	mesayhailudangiso@yahoo.com	Dangisso, Mesay Hailu/AAU-7743-2020; Lindtjorn, Bernt/K-9465-2018; Datiko, Daniel/AAE-7019-2020; Datiko, Daniel G./AAE-6856-2020	Lindtjorn, Bernt/0000-0002-6267-6984; Datiko, Daniel/0000-0002-8556-3069; 	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Abubakar I, 2008, EPIDEMIOL INFECT, V136, P122, DOI 10.1017/S0950268807008333; Ahsan Giasuddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P126; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency of Ethiopia, 2012, POPULATION; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Daniel O J, 2006, Niger J Med, V15, P63; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Datiko DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-266; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Dogar OF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-244; dos Santos APG, 2013, INT J TUBERC LUNG D, V17, P192, DOI 10.5588/ijtld.11.0831; Federal Ministry of Health, 2011, TUB PREV CONTR PROGR; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Federal Ministry of Health of Ethiopia, 2005, FED MIN HLTH HLTH SE; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Gninafon M, 2011, INT J TUBERC LUNG D, V15, P61; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Kritski AL, 1997, CHEST, V111, P1162, DOI 10.1378/chest.111.5.1162; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011; Mukherjee A, 2012, LUNG INDIA, V29, P120, DOI 10.4103/0970-2113.95302; Muniyandi M, 2006, J Commun Dis, V38, P204; Muniyandi M, 2008, EXPERT OPIN PHARMACO, V9, P1623, DOI 10.1517/14656566.9.10.1623 ; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Park YK, 2013, TUBERC RESPIR DIS, V74, P104, DOI 10.4046/trd.2013.74.3.104; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Shargie E. B., 2005, Ethiopian Journal of Health Development, V19, P104; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sidama Zone administration, 2012, SID ZON SO PROF; Sidama Zone Health Department, 2012, SID ZON HLTH DEP ANN; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woldeyohannes Desalegn, 2011, Ethiop Med J, V49, P221; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	49	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114225	10.1371/journal.pone.0114225	http://dx.doi.org/10.1371/journal.pone.0114225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460363	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000345869700118
J	Deng, JM; Qin, BQ; Paerl, HW; Zhang, YL; Wu, P; Ma, JR; Chen, YW				Deng, Jianming; Qin, Boqiang; Paerl, Hans W.; Zhang, Yunlin; Wu, Pan; Ma, Jianrong; Chen, Yuwei			Effects of Nutrients, Temperature and Their Interactions on Spring Phytoplankton Community Succession in Lake Taihu, China	PLOS ONE			English	Article							CLIMATE-CHANGE; ALGAL BLOOMS; FRESH-WATER; PHENOLOGY; RESPONSES; CYANOBACTERIAL; EUTROPHICATION; PHOTOSYNTHESIS; VARIABILITY; ENRICHMENT	We examined the potential effects of environmental variables, and their interaction, on phytoplankton community succession in spring using long-term data from 1992 to 2012 in Lake Taihu, China. Laboratory experiments were additionally performed to test the sensitivity of the phytoplankton community to nutrient concentrations and temperature. A phytoplankton community structure analysis from 1992 to 2012 showed that Cryptomonas (Cryptophyta) was the dominant genus in spring during the early 1990s. Dominance then shifted to Ulothrix (Chlorophyta) in 1996 and 1997. However, Cryptomonas again dominated in 1999, 2000, and 2002, with Ulothrix regaining dominance from 2003 to 2006. The bloom-forming cyanobacterial genus Microcystis dominated in 1995, 2001 and 2007-2012. The results of ordinations indicated that the nutrient concentration (as indicated by the trophic state index) was the most important factor affecting phytoplankton community succession during the past two decades. In the laboratory experiments, shifts in dominance among phytoplankton taxa occurred in all nutrient addition treatments. Results of both long term monitoring and experiment indicated that nutrients exert a stronger control than water temperature on phytoplankton communities during spring. Interactive effect of nutrients and water temperature was the next principal factor. Overall, phytoplankton community composition was mediated by nutrients concentrations, but this effect was strongly enhanced by elevated water temperatures.	[Deng, Jianming; Qin, Boqiang; Zhang, Yunlin; Wu, Pan; Ma, Jianrong; Chen, Yuwei] Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Deng, Jianming; Wu, Pan; Ma, Jianrong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Paerl, Hans W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill	Qin, BQ (corresponding author), Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, 73 East Beijing Rd, Nanjing 210008, Jiangsu, Peoples R China.	qinbq@niglas.ac.cn	Deng, Jianming/F-3822-2011; Deng, Jianming/AAN-2998-2020; Qin, Boqiang/E-5900-2013; Zhang, Yunlin/N-5464-2014	Deng, Jianming/0000-0003-2432-6307; Deng, Jianming/0000-0003-2432-6307; Zhang, Yunlin/0000-0002-3382-4570	National Natural Science Foundation of China [41230744]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1214]; US National Science Foundation [ENG/CBET 0826819, 1230543, DEB 1240851]; Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135003]; Div Of Chem, Bioeng, Env, & Transp Sys [1230543] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF)); Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences(Chinese Academy of Sciences); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Research by BQQ, JMD, PW and JRM was funded by the National Natural Science Foundation of China (41230744). Both BQQ and JMD were supported by the External Cooperation Program of the Chinese Academy of Sciences (Grant No. GJHZ1214). Research by HWP was jointly supported by US National Science Foundation Grant Nos. ENG/CBET 0826819, 1230543 (INSPIRE Program) and DEB 1240851 (Dimensions in Biodiversity Program). Research by YLZ was supported by the Key Program of the Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2004, ENCY SOCIAL SCI RES; Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anneville O, 2005, FRESHWATER BIOL, V50, P1731, DOI 10.1111/j.1365-2427.2005.01429.x; [Anonymous], 1980, FRESHWATER ALGAE CHI; Apha, 1995, WPCF STAND METH EX W; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Becker V, 2009, HYDROBIOLOGIA, V628, P137, DOI 10.1007/s10750-009-9751-7; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Cai LL, 2012, WATER SCI ENG, V5, P361, DOI 10.3882/j.issn.1674-2370.2012.04.001; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deng JM, 2014, FRESHWATER BIOL, V59, P1076, DOI 10.1111/fwb.12330; Domis LND, 2007, HYDROBIOLOGIA, V584, P403, DOI 10.1007/s10750-007-0609-6; Dong XH, 2012, FRESHWATER BIOL, V57, P2044, DOI 10.1111/j.1365-2427.2011.02670.x; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Egge JK, 1998, J MARINE SYST, V16, P191, DOI 10.1016/S0924-7963(97)00113-9; Elliott JA, 2006, HYDROBIOLOGIA, V559, P401, DOI 10.1007/s10750-005-1233-y; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Helsel DR, 1992, 1992 STAT METH WAT R; Ho R, 2006, HDB UNIVARIATE MULTI, DOI DOI 10.1201/9781420011111; Hu H., 2006, FRESHWATER ALGAE CHI; Huang WY, 2001, J LAKE SCI, V13, P356; Izagirre O, 2009, SCI TOTAL ENVIRON, V407, P5694, DOI 10.1016/j.scitotenv.2009.06.049; JENSEN JP, 1994, CAN J FISH AQUAT SCI, V51, P1692, DOI 10.1139/f94-170; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E., 2010, CLIMATE CHANGE IMPAC; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Jin X., 1990, STANDARD METHODS OBS; Kotta J, 2009, ESTUAR COAST SHELF S, V84, P509, DOI 10.1016/j.ecss.2009.07.014; Liu X, 2011, HARMFUL ALGAE, V10, P337, DOI 10.1016/j.hal.2010.12.002; Low EW, 2010, RAFFLES B ZOOL, V58, P311; LYNCH M, 1981, LIMNOL OCEANOGR, V26, P86, DOI 10.4319/lo.1981.26.1.0086; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Orenzen CJ, 1967, LIMNOL OCEANOGR, V12, P343; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Peperzak L, 2003, ACTA OECOL, V24, pS139, DOI 10.1016/S1146-609X(03)00009-2; Qin B.Q., 2008, MONOGRAPHIAE BIOL, P342; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds C.S., 1988, P388; REYNOLDS CS, 1980, HOLARCTIC ECOL, V3, P141, DOI 10.1111/j.1600-0587.1980.tb00721.x; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Salmaso N, 2010, FRESHWATER BIOL, V55, P825, DOI 10.1111/j.1365-2427.2009.02325.x; Schreiber U, 2002, J PHYCOL, V38, P125, DOI 10.1046/j.1529-8817.2002.01103.x; Schreiber U, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P4253; SPAIN JC, 1980, APPL ENVIRON MICROB, V40, P726, DOI 10.1128/AEM.40.4.726-734.1980; Staehr PA, 2006, FRESHWATER BIOL, V51, P249, DOI 10.1111/j.1365-2427.2005.01490.x; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Urrutia MB, 1996, J MAR BIOL ASSOC UK, V76, P431, DOI 10.1017/S0025315400030654; Walters AW, 2013, ECOLOGY, V94, P2188, DOI 10.1890/13-0445.1; Wang S., 1998, LAKES CHINA; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yu T, 2013, ENVIRON SCI TECHNOL, V47, P9093, DOI 10.1021/es401517h; Zhang M, 2012, WATER RES, V46, P442, DOI 10.1016/j.watres.2011.11.013; [赵林林 Zhao Linlin], 2011, [水科学进展, Advances in Water Science], V22, P844	65	59	65	6	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113960	10.1371/journal.pone.0113960	http://dx.doi.org/10.1371/journal.pone.0113960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464517	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700075
J	Massanella, M; Ouchi, D; Marfil, S; Llibre, JM; Puertas, MC; Buzon, MJ; Richman, DD; Orna, E; Stevenson, M; Gatell, JM; Domingo, P; Negredo, E; Martinez-Picado, J; Clotet, B; Blanco, J				Massanella, Marta; Ouchi, Dan; Marfil, Silvia; Llibre, Josep M.; Puertas, Maria C.; Buzon, Maria J.; Richman, Douglas D.; Orna, Elisa; Stevenson, Mario; Gatell, Josep M.; Domingo, Pere; Negredo, Eugenia; Martinez-Picado, Javier; Clotet, Bonaventura; Blanco, Julia			Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals	PLOS ONE			English	Article							T-CELL RECOVERY; ANTIRETROVIRAL THERAPY; RALTEGRAVIR INTENSIFICATION; PROTEASE INHIBITORS; CONTROLLED-TRIAL; MICROBIAL TRANSLOCATION; SIV INFECTION; D-DIMER; ACTIVATION; CD4	Background: HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to normal levels. Since intensification of cART with raltegravir reduced CD8 T-cell activation in the Discor-Ral and IntegRal studies, we have evaluated the effect of raltegravir intensification on several soluble inflammation markers in these studies. Methods: Longitudinal plasma samples (0-48 weeks) from the IntegRal (n=67, 22 control and 45 intensified individuals) and the Discor-Ral studies (44 individuals with CD4 T-cell counts<350 cells/mu l, 14 control and 30 intensified) were assayed for 25 markers. Mann-Whitney, Wilcoxon, Spearman test and linear mixed models were used for analysis. Results: At baseline, different inflammatory markers were strongly associated with HCV co-infection, lower CD4 counts and with cART regimens (being higher in PI-treated individuals), but poorly correlated with detection of markers of residual viral replication. Although raltegravir intensification reduced inflammation in individuals with lower CD4 T-cell counts, no effect of intensification was observed on plasma markers of inflammation in a global analysis. An association was found, however, between reductions in immune activation and plasma levels of the coagulation marker D-dimer, which exclusively decreased in intensified patients on protease inhibitor (PI)-based cART regimens (P=0.040). Conclusions: The inflammatory profile in treated HIV-infected individuals showed a complex association with HCV co-infection, the levels of CD4 T cells and the cART regimen. Raltegravir intensification specifically reduced D-dimer levels in PI-treated patients, highlighting the link between cART composition and residual viral replication; however, raltegravir had little effect on other inflammatory markers.	[Massanella, Marta; Ouchi, Dan; Marfil, Silvia; Puertas, Maria C.; Buzon, Maria J.; Martinez-Picado, Javier; Clotet, Bonaventura; Blanco, Julia] UAB, Inst Invest Ciencies Salut Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Badalona, Spain; [Massanella, Marta; Richman, Douglas D.] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Massanella, Marta; Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Massanella, Marta; Richman, Douglas D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Llibre, Josep M.; Negredo, Eugenia; Clotet, Bonaventura] Univ Hosp Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Lluita SIDA Fdn, Badalona, Spain; [Orna, Elisa] Univ Hosp Germans Trias & Pujol, Dept Hematol, Badalona, Spain; [Stevenson, Mario] Univ Miami, Miami, FL USA; [Gatell, Josep M.] Hosp Clin IDIBAPS, Barcelona, Spain; [Domingo, Pere] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Negredo, Eugenia; Martinez-Picado, Javier; Clotet, Bonaventura; Blanco, Julia] Univ Vic UCC, Vic, Spain; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); University of Miami; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital of Santa Creu i Sant Pau; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA	Blanco, J (corresponding author), UAB, Inst Invest Ciencies Salut Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Badalona, Spain.	jblanco@irsicaixa.es	Blanco, Julià/A-5347-2008; Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021; Ouchi, Dan/R-5319-2019; Puertas, Maria/G-3251-2016; Massanella, Marta/P-8619-2016; Martinez-Picado, Javier/G-5507-2012; Buzon, Maria J/G-8286-2015	Blanco, Julià/0000-0002-2225-0217; Domingo, Pere/0000-0003-1138-5770; Ouchi, Dan/0000-0002-8630-152X; Puertas, Maria/0000-0002-6750-2318; Massanella, Marta/0000-0002-3326-151X; Martinez-Picado, Javier/0000-0002-4916-2129; Buzon, Maria J/0000-0003-4427-9413; Marfil, Silvia/0000-0003-0139-5000; Negredo, Eugenia/0000-0001-5298-1734	HIVACAT program; Instituto de Salud Carlos III-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [RD12/0017/0002]; European Community; Project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" [223131]; Department of Veterans Affairs, the UCSD Center for AIDS Research [P30 AI36214]; CARE Collaboratory [U19 AI096113]; James B. Pendleton Charitable Trust; Merck Sharp Dohme [MSD 40527]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, P30AI036214, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093306] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	HIVACAT program; Instituto de Salud Carlos III-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); European Community(European Commission); Project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)"; Department of Veterans Affairs, the UCSD Center for AIDS Research(US Department of Veterans Affairs); CARE Collaboratory; James B. Pendleton Charitable Trust; Merck Sharp Dohme(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ICREA(ICREA)	This work was supported by HIVACAT program; the RD12/0017/0002 project as part of the Plan Nacional R + D + I cofinanced by Instituto de Salud Carlos III-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); the European Community's Seventh Framework Program (FP7/2007-2013) under the Project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" grant agreement n 223131, by the Department of Veterans Affairs, the UCSD Center for AIDS Research (P30 AI36214), the CARE Collaboratory (U19 AI096113) and the James B. Pendleton Charitable Trust and by an unrestricted grant from Merck Sharp & Dohme (MSD 40527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bates D, 2012, LME4 LINEAR MIXED EF; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Letendre SL, 2000, ANTIMICROB AGENTS CH, V44, P2173, DOI 10.1128/AAC.44.8.2173-2175.2000; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Madden E, 2008, AIDS, V22, P707, DOI 10.1097/QAD.0b013e3282f560d9; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Massanella M, 2013, EXPERT REV CLIN IMMU, V9, P1135, DOI 10.1586/1744666X.2013.842897; Massanella M, 2013, CYTOM PART A, V83A, P648, DOI 10.1002/cyto.a.22299; Massanella M, 2013, JAIDS-J ACQ IMM DEF, V63, P152, DOI 10.1097/QAI.0b013e318289439a; Massanella M, 2013, CURR HIV-AIDS REP, V10, P33, DOI 10.1007/s11904-012-0150-8; Massanella M, 2012, AIDS, V26, P2285, DOI 10.1097/QAD.0b013e328359f20f; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Negredo E, 2013, J ANTIMICROB CHEMOTH, V68, P2358, DOI 10.1093/jac/dkt183; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; R Core Team, 2012, R LANG ENV STAT COMP; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Reingold JS, 2008, JAIDS-J ACQ IMM DEF, V48, P142, DOI 10.1097/QAI.0b013e3181685727; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254; Unemori P, 2013, AIDS, V27, P1735, DOI 10.1097/QAD.0b013e3283601144; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114142	10.1371/journal.pone.0114142	http://dx.doi.org/10.1371/journal.pone.0114142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462535	Green Published, gold			2022-12-27	WOS:000345869700106
J	Matsumura, Y; Nakada, T; Abe, R; Oshima, T; Oda, S				Matsumura, Yosuke; Nakada, Taka-aki; Abe, Ryuzo; Oshima, Taku; Oda, Shigeto			Serum Procalcitonin Level and SOFA Score at Discharge from the Intensive Care Unit Predict Post-Intensive Care Unit Mortality: A Prospective Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG-TERM SURVIVAL; CRITICALLY-ILL PATIENTS; ICU DISCHARGE; HOSPITAL MORTALITY; AFTER-DISCHARGE; DETERMINANTS; SEPSIS	Purpose: The final decision for discharge from the intensive care unit (ICU) is uncertain because it is made according to various patient parameters; however, it should be made on an objective evaluation. Previous reports have been inconsistent and unreliable in predicting post-ICU mortality. To identify predictive factors associated with post-ICU mortality, we analyzed physiological and laboratory data at ICU discharge. Methods: Patients admitted to our ICU between September 2012 and August 2013 and staying for critical care. 2 days were included. Sequential Organ Failure Assessment (SOFA) score; systemic inflammatory response syndrome score; white blood cell count; and serum C reactive protein, procalcitonin (PCT), interleukin-6 (IL-6), lactate, albumin, and hemoglobin levels were recorded. The primary end point was 90-day mortality after ICU discharge. Two hundred eighteen patients were enrolled (195 survivors, 23 non-survivors). Results: Non-survivors presented a higher SOFA score and serum PCT, and IL-6 levels, as well as lower serum albumin and hemoglobin levels. Serum PCT, albumin, and SOFA score were associated with 90-day mortality in multiple logistic regression analysis. Hosmer-Lemeshow test showed chi-square value of 6.96, and P value of 0.54. The area under the curve (95% confidence interval) was 0.830 (0.771-0.890) for PCT, 0.688 (0.566-0.810) for albumin, 0.861 (0.796-0.927) for SOFA score, and increased to 0.913 (0.858-0.969) when these were combined. Serum PCT level at 0.57 ng/mL, serum albumin at 2.5 g/dL and SOFA score at 5.5 predict 90-day mortality, and high PCT, low albumin and high SOFA groups had significantly higher mortality. Serum PCT and SOFA score were significantly associated with survival days after ICU discharge in Cox regression analysis. Conclusions: Serum PCT level and SOFA score at ICU discharge predict post-ICU mortality and survival days after ICU discharge. The combination of these two and albumin level might enable accurate prediction.	[Matsumura, Yosuke; Nakada, Taka-aki; Abe, Ryuzo; Oshima, Taku; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Chiba University	Nakada, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan.	taka.nakada@nifty.com	Matsumura, Yosuke/AAP-5800-2021; Oshima, Taku/AAX-1936-2021	Matsumura, Yosuke/0000-0003-4830-3791; Oshima, Taku/0000-0002-3868-8272				Al-Subaie N, 2010, BRIT J ANAESTH, V105, P318, DOI 10.1093/bja/aeq171; BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Brinkman S, 2013, CRIT CARE MED, V41, P1229, DOI 10.1097/CCM.0b013e31827ca4e1; Brinkman S, 2013, CRIT CARE MED, V41, P1237, DOI 10.1097/CCM.0b013e31827ca4f9; Charles PE, 2006, INTENS CARE MED, V32, P1577, DOI 10.1007/s00134-006-0306-3; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Cox CE, 2012, RESP CARE, V57, P859, DOI 10.4187/respcare.01719; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; Egol A, 1999, CRIT CARE MED, V27, P633; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Grander W, 2013, CLIN RES CARDIOL, V102, P599, DOI 10.1007/s00392-013-0571-4; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Meisner M, 1999, J LAB MED, V23, P263; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Ranzani OT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.013; Schuttrumpf S, 2006, CLIN INFECT DIS, V43, P468, DOI 10.1086/505394; Schuetz P, 2013, CRIT CARE, V17, DOI 10.1186/cc12787; Silvestre J, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-17; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Williams TA, 2005, INTENS CARE MED, V31, P1306, DOI 10.1007/s00134-005-2744-8; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114007	10.1371/journal.pone.0114007	http://dx.doi.org/10.1371/journal.pone.0114007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460569	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700079
J	Mohammad, AA; Rahbar, A; Lui, WO; Davoudi, B; Catrina, A; Stragliotto, G; Mellbin, L; Hamsten, A; Ryden, L; Yaiw, KC; Soderberg-Naucler, C				Mohammad, Abdul-Aleem; Rahbar, Afsar; Lui, Weng-Onn; Davoudi, Belghis; Catrina, Anca; Stragliotto, Giuseppe; Mellbin, Linda; Hamsten, Anders; Ryden, Lars; Yaiw, Koon-Chu; Soderberg-Naucler, Cecilia			Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; PERIPHERAL-BLOOD; EXPRESSION; ANTIBODIES; MICRORNAS; IDENTIFICATION; MONOCYTES; RNAS	Background: microRNAs (miRNA) are 18-22 nucleotides long non-coding RNAs that regulate gene expression at a post-transcriptional level. Human cytomegalovirus (HCMV) encodes at least 26 known mature miRNAs. hcmv-miR-UL112-3p (miR-UL112-3p) is the most well characterized HCMV miRNA, which is suggested to play role in establishment and maintenance of viral latency. Elevated miR-UL112-3p levels have been reported to be present in plasma of patients with hypertension. Objectives: In this study, we aimed to quantify miR-UL112-3p levels in the plasma/serum of patients with Diabetes Mellitus (DM; from the DIGAMI-2 cohort), Glioblastoma multiforme (GBM), Rheumatoid Arthritis (RA) and Healthy Controls (HC). Study Design: Total RNA was isolated from plasma/serum samples of 87 patients and controls, a TaqMan miRNA assay was performed to detect miR-UL112-3p and the copy numbers were normalized to 10 ng of total RNA. HCMV IgG and IgM were analysed using ELISA. Results: HCMV miR-UL112-3p was detected in 14/27 (52%) of DM, 5/20 (25%) of GBM, 1/20 (5%) of RA patients and in 2/20 (10%) of HC, respectively. Anti-HCMV IgG was detected in 85%, 65%, 75% of patients and 70% of HC, respectively. Anti-HCMV IgM was found only in one GBM patient of 87 examined patients and controls. Conclusions: A higher prevalence of miR-UL112-3p was detected in DM and GBM patients than in RA patients and HC. Elevated levels of miR-UL112-3p and higher prevalence of HCMV IgG were observed in DM patients. Whether the presence of circulating miR-UL112-3p denotes a biomarker of HCMV latency or active replication in patients warrants further investigation.	[Mohammad, Abdul-Aleem; Rahbar, Afsar; Davoudi, Belghis; Stragliotto, Giuseppe; Yaiw, Koon-Chu; Soderberg-Naucler, Cecilia] Karolinska Inst, Ctr Mol Med, Dept Med Solna, Expt Cardiovasc Res Unit, Stockholm, Sweden; [Lui, Weng-Onn] Karolinska Univ Hosp, Canc Ctr Karolinska, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Catrina, Anca] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Hamsten, Anders] Karolinska Inst, Ctr Mol Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Mellbin, Linda; Ryden, Lars] Karolinska Inst, Dept Med Solna, Cardiol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Soderberg-Naucler, C (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med Solna, Expt Cardiovasc Res Unit, Stockholm, Sweden.	cecilia.naucler@ki.se	Lui, Weng-Onn/G-6703-2013; Yaiw, Koon-Chu/AAJ-9682-2020; Lui, Weng-Onn/X-5957-2019; Mellbin, Linda/L-8779-2017	Lui, Weng-Onn/0000-0003-4717-4473; Yaiw, Koon-Chu/0000-0001-5329-1815; Lui, Weng-Onn/0000-0003-4717-4473; Davoudi, Belghis/0000-0001-8541-2538; Rahbar, Afsar/0000-0003-1158-2512	Sten A Olssons Foundation for Research and Culture; Erling-Persson Family Foundation; Torsten Soderberg Foundation; BILTEMA Foundation; IngaBritt and Arne Lundbergs Foundation; Stichting af Jochnick Foundation; Jane and Dan Olssons Research Foundation; Petrus and Augusta Hedlund Foundation; nxt2b; RATOS; Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Medical Research Council; Thematic Research Center; Stockholm County Council; Swedish Heart-Lung Foundation; Bayer; Karolinska Institution's Foundation	Sten A Olssons Foundation for Research and Culture; Erling-Persson Family Foundation; Torsten Soderberg Foundation; BILTEMA Foundation; IngaBritt and Arne Lundbergs Foundation; Stichting af Jochnick Foundation; Jane and Dan Olssons Research Foundation; Petrus and Augusta Hedlund Foundation; nxt2b; RATOS; Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Thematic Research Center; Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Bayer(Bayer AG); Karolinska Institution's Foundation	This study was funded by: Sten A Olssons Foundation for Research and Culture, Erling-Persson Family Foundation, Torsten Soderberg Foundation, BILTEMA Foundation, IngaBritt and Arne Lundbergs Foundation, Stichting af Jochnick Foundation, Jane and Dan Olssons Research Foundation, Petrus and Augusta Hedlund Foundation, nxt2b, RATOS, Swedish Cancer Foundation, Children's Cancer Foundation, Swedish Medical Research Council, Thematic Research Center and Stockholm County Council, Swedish Heart-Lung Foundation, Bayer and Karolinska Institution's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cobbs CS, 2002, CANCER RES, V62, P3347; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu M, 2014, GENE, V536, P272, DOI 10.1016/j.gene.2013.12.012; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; GRILLNER L, 1987, J VIROL METHODS, V17, P133, DOI 10.1016/0166-0934(87)90076-0; Huang YJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-51; KRECH U, 1981, B WORLD HEALTH ORGAN, V59, P605; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; LOHR JM, 1990, LANCET, V336, P644, DOI 10.1016/0140-6736(90)92145-8; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Rahbar Afsar, 2012, Herpesviridae, V3, P3, DOI 10.1186/2042-4280-3-3; SCHMITZ H, 1977, J CLIN MICROBIOL, V5, P629; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; TAMM A, 1993, J RHEUMATOL, V20, P1489; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Warnke C, 2013, J NEUROL NEUROSURG P; Yaiw Koon-Chu, 2013, Herpesviridae, V4, P3, DOI 10.1186/2042-4280-4-3	29	22	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113740	10.1371/journal.pone.0113740	http://dx.doi.org/10.1371/journal.pone.0113740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462570	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700046
J	Rahman, MM; Khan, SB; Marwani, HM; Asiri, AM				Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.			Selective Divalent Cobalt Ions Detection Using Ag2O3-ZnO Nanocones by ICP-OES Method for Environmental Remediation	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; ABSORPTION SPECTROMETRIC DETERMINATION; CHEMICAL SENSOR; IN-SITU; FUNCTIONALIZED SILICA; AQUEOUS-SOLUTIONS; TRACE AMOUNTS; HEAVY-METALS; OXIDE; FABRICATION	Here, we have synthesized Ag2O3-ZnO nanocones (NCs) by a wet-chemical route using reducing agents at low temperature. The structural, optical and morphological properties of Ag2O3-ZnO NCs were investigated by several conventional techniques such as powder XRD, XPS, FESEM, XEDS, FTIR and UV/vis. spectroscopy. The analytical parameters of prepared NCs were also calculated for a selective detection of divalent cobalt [Co(II)] prior to its determination by inductively coupled plasma-optical emission spectrometry (ICP-OES). The selectivity of NCs toward various metal ions, including Cd(II), Co(II), Cr(III), Cu(II), Fe(III), Ni(II), and Zn(II) was studied. Results of the selectivity study demonstrated that Ag2O3-ZnO NC phase was the most selective towards Co(II) ion. The uptake capacity for Co(II) ion was experimentally calculated to be similar to 76.69 mgg(-1). Moreover, adsorption isotherm data provided that the adsorption process was mainly monolayer on homogeneous adsorbent surfaces of Ag2O3-ZnO NCs. Kinetic study revealed that the adsorption of Co(II) on Ag2O3-ZnO NCs phase followed the pseudo-second-order kinetic model. In addition, thermodynamic results provided that the adsorption mechanism of Co(II) ions on Ag2O3-ZnO NCs was a spontaneous process and thermodynamically favorable. Finally, the proposed method was validated by applying it to real environmental water samples with reasonable results.	[Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia; [Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.	mmrahman@kau.edu.sa	Marwani, Hadi M/K-8893-2012; Asiri, Abdullah M./C-3458-2009; Khan, Prof. Sher Bahadar/M-7968-2019; Rahman, Mohammed M./H-5823-2012; Khan, Sher Bahadar/H-5833-2012	Marwani, Hadi M/0000-0003-0199-9488; Asiri, Abdullah M./0000-0001-7905-3209; Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Rahman, Mohammed M./0000-0003-2773-1244; Khan, Sher Bahadar/0000-0001-9635-7175	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah [CEAMR-SG-4-435]	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah	This project was funded by Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah, under grant no. (CEAMR-SG-4-435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, CLEAN-SOIL AIR WATER, V39, P74, DOI 10.1002/clen.201000125; Biparva P, 2011, CLEAN-SOIL AIR WATER, V39, P1081, DOI 10.1002/clen.201000198; CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077; Castro Gustavo Rocha de, 2004, Mat. Res., V7, P329, DOI 10.1590/S1516-14392004000200018; Cho HJ, 2011, B KOREAN CHEM SOC, V32, P489, DOI 10.5012/bkcs.2011.32.2.489; Dahiya S, 2008, J HAZARD MATER, V150, P376, DOI 10.1016/j.jhazmat.2007.04.134; Faisal M, 2012, APPL SURF SCI, V258, P7515, DOI 10.1016/j.apsusc.2012.04.075; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Fang GZ, 2010, J CHROMATOGR A, V1217, P1567, DOI 10.1016/j.chroma.2010.01.010; Fujii T, 1999, PHYS REV B, V59, P3195, DOI 10.1103/PhysRevB.59.3195; Gao XY, 2011, THIN SOLID FILMS, V519, P6620, DOI 10.1016/j.tsf.2011.04.028; Ghilane J, 2007, NANO LETT, V7, P1406, DOI 10.1021/nl070268p; Han DM, 2005, J CHROMATOGR A, V1100, P131, DOI 10.1016/j.chroma.2005.09.035; Hara K, 2000, SOL ENERG MAT SOL C, V64, P115, DOI 10.1016/S0927-0248(00)00065-9; Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040; Hu ZS, 2012, APPL SURF SCI, V258, P8049, DOI 10.1016/j.apsusc.2012.04.170; Huang H, 2013, CHEM ENG J, V225, P447, DOI 10.1016/j.cej.2013.04.018; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Javed MA, 2007, SEP SCI TECHNOL, V42, P3641, DOI 10.1080/01496390701710794; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Lee CJ, 2002, APPL PHYS LETT, V81, P3648, DOI 10.1063/1.1518810; Lesage E, 2007, ECOL ENG, V30, P320, DOI 10.1016/j.ecoleng.2007.04.007; Li QH, 2004, APPL PHYS LETT, V85, P6389, DOI 10.1063/1.1840116; Lin DD, 2009, CHEM MATER, V21, P3479, DOI 10.1021/cm900225p; Liu YH, 2010, CHEM ENG J, V158, P108, DOI 10.1016/j.cej.2009.12.012; Lu WW, 2008, J PHYS CHEM C, V112, P16792, DOI 10.1021/jp803654k; Manzoori JL, 2007, MICROCHIM ACTA, V159, P71, DOI 10.1007/s00604-006-0727-2; Marwani HM, 2012, DESALIN WATER TREAT, V45, P128, DOI 10.1080/19443994.2012.692019; MCKAY G, 1982, J APPL POLYM SCI, V27, P3043, DOI 10.1002/app.1982.070270827; Mohammadi SZ, 2010, CENT EUR J CHEM, V8, P662, DOI 10.2478/s11532-010-0029-8; Nasu A, 1997, ANAL SCI, V13, P903, DOI 10.2116/analsci.13.903; Ng HT, 2004, NANO LETT, V4, P1247, DOI 10.1021/nl049461z; PEI SQ, 1994, ANAL CHIM ACTA, V294, P185, DOI 10.1016/0003-2670(94)80193-2; Pyrzynska K, 2005, SPECTROCHIM ACTA B, V60, P1316, DOI 10.1016/j.sab.2005.06.010; Qiu SP, 2006, MAT SCI ENG A-STRUCT, V435, P327, DOI 10.1016/j.msea.2006.07.062; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rahman MM, 2011, J BIOMED NANOTECHNOL, V7, P351, DOI 10.1166/jbn.2011.1299; Rahman MM, 2009, SENSOR ACTUAT B-CHEM, V137, P327, DOI 10.1016/j.snb.2008.10.060; Rahman MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100327; Rahman MM, 2012, TALANTA, V99, P924, DOI 10.1016/j.talanta.2012.07.060; Rahman MM, 2012, CHEM ENG J, V192, P122, DOI 10.1016/j.cej.2012.03.045; Rahman MM, 2012, TALANTA, V95, P18, DOI 10.1016/j.talanta.2012.03.027; Rahman MM, 2012, MICROCHIM ACTA, V178, P99, DOI 10.1007/s00604-012-0817-2; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, ACS APPL MATER INTER, V3, P1346, DOI 10.1021/am200151f; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Sahay PP, 2008, SENSOR ACTUAT B-CHEM, V134, P654, DOI 10.1016/j.snb.2008.06.006; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; Sekine R, 2013, ENVIRON SCI TECHNOL, V47, P9308, DOI 10.1021/es400839h; Shaker Medhat A., 2007, American Journal of Applied Sciences, V4, P605, DOI 10.3844/ajassp.2007.605.612; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Soylak M, 2006, J HAZARD MATER, V137, P1035, DOI 10.1016/j.jhazmat.2006.03.031; Tanikkul S, 2004, TALANTA, V64, P1241, DOI 10.1016/j.talanta.2004.05.060; Tao A, 2003, NANO LETT, V3, P1229, DOI 10.1021/nl0344209; Tao GH, 1998, FRESEN J ANAL CHEM, V360, P156, DOI 10.1007/s002160050667; Toma M, 2013, NANO LETT, V13, P6164, DOI 10.1021/nl403496a; Tong SS, 2011, MICROCHIM ACTA, V174, P257, DOI 10.1007/s00604-011-0622-3; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Vijaya JJ, 2008, J HAZARD MATER, V153, P767, DOI 10.1016/j.jhazmat.2007.09.022; Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Wei K, 2011, CHINESE J CHEM, V29, P143, DOI 10.1002/cjoc.201190042; Wei WF, 2011, J MATER CHEM, V21, P432, DOI 10.1039/c0jm02214d; Xu H, 2011, CHINESE J CHEM, V29, P805, DOI 10.1002/cjoc.201190162; Zhang L, 2011, MICROCHIM ACTA, V174, P391, DOI 10.1007/s00604-011-0643-y; Zhang Z, 2008, J PHYS CHEM C, V112, P9579, DOI 10.1021/jp710837h; Zhou L, 2014, NANO LETT, V14, P1093, DOI 10.1021/nl500008y; Zhu J, 2009, NANO LETT, V9, P279, DOI 10.1021/nl802886y; Zubkov T, 2005, J PHYS CHEM B, V109, P14144, DOI 10.1021/jp0517854	72	9	9	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114084	10.1371/journal.pone.0114084	http://dx.doi.org/10.1371/journal.pone.0114084			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464507	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700094
J	Weyler, L; Engelbrecht, M; Forsberg, MM; Brehwens, K; Vare, D; Vielfort, K; Wojcik, A; Aro, H				Weyler, Linda; Engelbrecht, Mattias; Forsberg, Manuel Mata; Brehwens, Karl; Vare, Daniel; Vielfort, Katarina; Wojcik, Andrzej; Aro, Helena			Restriction Endonucleases from Invasive Neisseria gonorrhoeae Cause Double-Strand Breaks and Distort Mitosis in Epithelial Cells during Infection	PLOS ONE			English	Article							PROSTATE-CANCER; SEXUAL-BEHAVIOR; UP-REGULATION; IN-VITRO; HOST; CHECKPOINT; MICRONUCLEUS; TARGETS; ALUI; ORGANIZATION	The host epithelium is both a barrier against, and the target for microbial infections. Maintaining regulated cell growth ensures an intact protective layer towards microbial-induced cellular damage. Neisseria gonorrhoeae infections disrupt host cell cycle regulation machinery and the infection causes DNA double strand breaks that delay progression through the G2/M phase. We show that intracellular gonococci upregulate and release restriction endonucleases that enter the nucleus and damage human chromosomal DNA. Bacterial lysates containing restriction endonucleases were able to fragment genomic DNA as detected by PFGE. Lysates were also microinjected into the cytoplasm of cells in interphase and after 20 h, DNA double strand breaks were identified by 53BP1 staining. In addition, by using live-cell microscopy and NHS-ester stained live gonococci we visualized the subcellular location of the bacteria upon mitosis. Infected cells show dysregulation of the spindle assembly checkpoint proteins MAD1 and MAD2, impaired and prolonged M-phase, nuclear swelling, micronuclei formation and chromosomal instability. These data highlight basic molecular functions of how gonococcal infections affect host cell cycle regulation, cause DNA double strand breaks and predispose cellular malignancies.	[Weyler, Linda; Engelbrecht, Mattias; Forsberg, Manuel Mata; Brehwens, Karl; Vare, Daniel; Wojcik, Andrzej; Aro, Helena] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Vielfort, Katarina] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Stockholm University; University of Gothenburg	Aro, H (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	Helena.Aro@su.se		Vare, Daniel/0000-0002-6666-2635; Vielfort, Katarina/0000-0002-9988-6336	Swedish Cancer Society (Cancerfonden); Carl Tryggers stiftelse; Borgstroms stiftelse; Granholms Stiftelse; SE Goljes minne	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Carl Tryggers stiftelse; Borgstroms stiftelse; Granholms Stiftelse; SE Goljes minne	This work was funded by the Swedish Cancer Society (Cancerfonden), Carl Tryggers stiftelse, Borgstroms stiftelse, and Granholms Stiftelse. LW was supported by S&E Goljes minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Binnicker MJ, 2003, CELL MICROBIOL, V5, P549, DOI 10.1046/j.1462-5822.2003.00300.x; Chan YA, 2012, MICROB DRUG RESIST, V18, P271, DOI 10.1089/mdr.2012.0001; Cloud KA, 2002, INFECT IMMUN, V70, P2752, DOI 10.1128/IAI.70.6.2752-2757.2002; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Evdokimova V, 2012, ENDOCR-RELAT CANCER, V19, P271, DOI 10.1530/ERC-11-0314; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Follows SA, 2009, INFECT IMMUN, V77, P3602, DOI 10.1128/IAI.01366-08; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HERRERO R, 1990, CANCER-AM CANCER SOC, V65, P380, DOI 10.1002/1097-0142(19900115)65:2<380::AID-CNCR2820650234>3.0.CO;2-9; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; JOHANNES C, 1991, INT J RADIAT BIOL, V59, P1379, DOI 10.1080/09553009114551241; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; KHARSANY ABM, 1993, GENITOURIN MED, V69, P357; KJAER SK, 1992, CANCER CAUSE CONTROL, V3, P339, DOI 10.1007/BF00146887; LeVan A, 2012, J BACTERIOL, V194, P6468, DOI 10.1128/JB.00969-12; Lofmark S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016369; Maniotis AJ, 2005, AM J PATHOL, V166, P1187, DOI 10.1016/S0002-9440(10)62338-3; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; Muller WU, 2004, STRAHLENTHER ONKOL, V180, P655, DOI 10.1007/s00066-004-1255-9; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Ryan SD, 2012, P NATL ACAD SCI USA, V109, pE2205, DOI 10.1073/pnas.1201911109; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Song WX, 2000, J EXP MED, V191, P949, DOI 10.1084/jem.191.6.949; Suzuki Keiji, 2010, Genome Integr, V1, P4, DOI 10.1186/2041-9414-1-4; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vielfort K, 2013, J CELL SCI, V126, P339, DOI 10.1242/jcs.117721; Ward D, 2013, GENOME SEQUENCE NEIS; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539; Wojcik A, 1996, RADIAT RES, V146, P577, DOI 10.2307/3579559	43	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114208	10.1371/journal.pone.0114208	http://dx.doi.org/10.1371/journal.pone.0114208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460012	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700116
J	Witowski, V; Foraita, R; Pitsiladis, Y; Pigeot, I; Wirsik, N				Witowski, Vitali; Foraita, Ronja; Pitsiladis, Yannis; Pigeot, Iris; Wirsik, Norman			Using Hidden Markov Models to Improve Quantifying Physical Activity in Accelerometer Data - A Simulation Study	PLOS ONE			English	Article							ENERGY-EXPENDITURE; VALIDATION; CALIBRATION; CHILDREN	Introduction: The use of accelerometers to objectively measure physical activity (PA) has become the most preferred method of choice in recent years. Traditionally, cutpoints are used to assign impulse counts recorded by the devices to sedentary and activity ranges. Here, hidden Markov models (HMM) are used to improve the cutpoint method to achieve a more accurate identification of the sequence of modes of PA. Methods: 1,000 days of labeled accelerometer data have been simulated. For the simulated data the actual sedentary behavior and activity range of each count is known. The cutpoint method is compared with HMMs based on the Poisson distribution (HMM[Pois]), the generalized Poisson distribution (HMM[GenPois]) and the Gaussian distribution (HMM[Gauss]) with regard to misclassification rate (MCR), bout detection, detection of the number of activities performed during the day and runtime. Results: The cutpoint method had a misclassification rate (MCR) of 11% followed by HMM[Pois] with 8%, HMM[GenPois] with 3% and HMM[Gauss] having the best MCR with less than 2%. HMM[Gauss] detected the correct number of bouts in 12.8% of the days, HMM[GenPois] in 16.1%, HMM[Pois] and the cutpoint method in none. HMM[GenPois] identified the correct number of activities in 61.3% of the days, whereas HMM[Gauss] only in 26.8%. HMM[Pois] did not identify the correct number at all and seemed to overestimate the number of activities. Runtime varied between 0.01 seconds (cutpoint), 2.0 minutes (HMM[Gauss]) and 14.2 minutes (HMM[GenPois]). Conclusions: Using simulated data, HMM-based methods were superior in activity classification when compared to the traditional cutpoint method and seem to be appropriate to model accelerometer data. Of the HMM-based methods, HMM[Gauss] seemed to be the most appropriate choice to assess real-life accelerometer data.	[Witowski, Vitali; Foraita, Ronja; Pigeot, Iris; Wirsik, Norman] Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Biometry & Data Management, Bremen, Germany; [Witowski, Vitali; Pigeot, Iris] Univ Bremen, Dept Math & Comp Sci, D-28359 Bremen, Germany; [Pitsiladis, Yannis] Univ Brighton, Sch Sport & Serv Management, Eastbourne, England	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; University of Brighton	Witowski, V (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Biometry & Data Management, Bremen, Germany.	wirsik@bips.uni-bremen.de	Pigeot, Iris/A-2722-2012	Pigeot, Iris/0000-0001-7483-0726; Pitsiladis, Yannis/0000-0001-6210-2449				Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Centers for Disease Control and Prevention, 2011, MUCH PHYS ACT DO CHI; Crouter SE, 2012, MED SCI SPORT EXER, V44, P1177, DOI 10.1249/MSS.0b013e3182447825; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Guinhouya CB, 2009, ACTA PAEDIATR, V98, P708, DOI 10.1111/j.1651-2227.2008.01187.x; Hislop JF, 2012, PEDIATR EXERC SCI, V24, P450, DOI 10.1123/pes.24.3.450; Janz KF, 2010, MED SCI SPORT EXER, V42, P1072, DOI 10.1249/MSS.0b013e3181c619b2; Joe H, 2005, BIOMETRICAL J, V47, P219, DOI 10.1002/bimj.200410102; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Ojiambo R, 2012, J APPL PHYSIOL, V113, P1530, DOI 10.1152/japplphysiol.01290.2011; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Pober DM, 2006, MED SCI SPORT EXER, V38, P1626, DOI 10.1249/01.mss.0000227542.43669.45; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Witowski V, 2013, HMMPA ANAL ACCELEROM; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	30	11	11	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114089	10.1371/journal.pone.0114089	http://dx.doi.org/10.1371/journal.pone.0114089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464514	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700095
J	Worker, A; Blain, C; Jarosz, J; Chaudhuri, KR; Barker, GJ; Williams, SCR; Brown, R; Leigh, PN; Simmons, A				Worker, Amanda; Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steven C. R.; Brown, Richard; Leigh, P. Nigel; Simmons, Andrew			Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE IMAGES; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; DIAGNOSTIC-CRITERIA; DISORDERS; DEMENTIA; SURVIVAL; STATE; MRI	Objective: Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are neurodegenerative diseases that can be difficult to distinguish clinically. The objective of the current study was to use surface-based analysis techniques to assess cortical thickness, surface area and grey matter volume to identify unique morphological patterns of cortical atrophy in PD, MSA and PSP and to relate these patterns of change to disease duration and clinical features. Methods: High resolution 3D T1-weighted MRI volumes were acquired from 14 PD patients, 18 MSA, 14 PSP and 19 healthy control participants. Cortical thickness, surface area and volume analyses were carried out using the automated surface-based analysis package FreeSurfer (version 5.1.0). Measures of disease severity and duration were assessed for correlation with cortical morphometric changes in each clinical group. Results: Results show that in PSP, widespread cortical thinning and volume loss occurs within the frontal lobe, particularly the superior frontal gyrus. In addition, PSP patients also displayed increased surface area in the pericalcarine. In comparison, PD and MSA did not display significant changes in cortical morphology. Conclusion: These results demonstrate that patients with clinically established PSP exhibit distinct patterns of cortical atrophy, particularly affecting the frontal lobe. These results could be used in the future to develop a useful clinical application of MRI to distinguish PSP patients from PD and MSA patients.	[Worker, Amanda; Blain, Camilla; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steven C. R.; Brown, Richard; Simmons, Andrew] Kings Coll London, Inst Psychiat, London, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steven C. R.; Brown, Richard; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Worker, Amanda; Chaudhuri, K. Ray; Brown, Richard; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Unit Dementia, London, England; [Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray] Kings Coll Hosp London, London, England; [Leigh, P. Nigel] Trafford Ctr Biomed Res, Brighton, E Sussex, England; [Leigh, P. Nigel] Univ Sussex, Sussex Med Sch, Brighton, E Sussex, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Brighton; University of Sussex	Simmons, A (corresponding author), Kings Coll London, Inst Psychiat, London, England.	andy.simmons@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Leigh, Peter/AAD-5638-2019; Barker, Gareth J/C-9616-2009; Williams, Steve C/D-6979-2011; Brown, Richard G/A-9599-2010	Simmons, Andrew/0000-0003-2306-5811; Barker, Gareth J/0000-0002-5214-7421; Williams, Steve C/0000-0003-4299-1941; Brown, Richard G/0000-0001-9021-0172; opoku, anita/0000-0001-7243-8157; Ray Chaudhuri, K/0000-0003-2815-0505	NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	Support for this study was provided by the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOSTER NL, 1988, ANN NEUROL, V24, P399, DOI 10.1002/ana.410240308; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; JOHNSON KA, 1992, J NUCL MED, V33, P704; Josephs KA, 2013, MOVEMENT DISORDERS; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; Marquand AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069237; Mattis S, 1988, DEMENTIA RATING SCAL; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Pellicano C, 2012, EUR J NEUROL, V19, P172, DOI 10.1111/j.1468-1331.2011.03465.x; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Talairach J., 1988, COPLANAR STEREOTAXIC; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Whitwell JL, 2011, PARKINSONISM RELAT D, V17, P599, DOI 10.1016/j.parkreldis.2011.05.013	37	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114167	10.1371/journal.pone.0114167	http://dx.doi.org/10.1371/journal.pone.0114167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463618	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000345869700110
J	Schwarz, H; Schmittner, M; Duschl, A; Horejs-Hoeck, J				Schwarz, Harald; Schmittner, Maria; Duschl, Albert; Horejs-Hoeck, Jutta			Residual Endotoxin Contaminations in Recombinant Proteins Are Sufficient to Activate Human CD1c(+) Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FEEDBACK INHIBITOR; HUMAN MONOCYTES; LIPOPOLYSACCHARIDE; CD14; RECOGNITION; RECEPTOR; TOLL-LIKE-RECEPTOR-4; EXPRESSION; IMMATURE	Many commercially available recombinant proteins are produced in Escherichia coli, and most suppliers guarantee contamination levels of less than 1 endotoxin unit (EU). When we analysed commercially available proteins for their endotoxin content, we found contamination levels in the same range as generally stated in the data sheets, but also some that were higher. To analyse whether these low levels of contamination have an effect on immune cells, we stimulated the monocytic cell line THP-1, primary human monocytes, in vitro differentiated human monocyte-derived dendritic cells, and primary human CD1c(+) dendritic cells (DCs) with very low concentrations of lipopolysaccharide (LPS; ranging from 0.002-2 ng/ml). We show that CD1c(+) DCs especially can be activated by minimal amounts of LPS, equivalent to the levels of endotoxin contamination we detected in some commercially available proteins. Notably, the enhanced endotoxin sensitivity of CD1c(+) DCs was closely correlated with high CD14 expression levels observed in CD1c(+) DCs that had been maintained in cell culture medium for 24 hours. When working with cells that are particularly sensitive to LPS, even low endotoxin contamination may generate erroneous data. We therefore recommend that recombinant proteins be thoroughly screened for endotoxin contamination using the limulus amebocyte lysate test, fluorescence-based assays, or a luciferase based NF-kappa B reporter assay involving highly LPS-sensitive cells overexpressing TLR4, MD-2 and CD14.	[Schwarz, Harald; Schmittner, Maria; Duschl, Albert; Horejs-Hoeck, Jutta] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Horejs-Hoeck, J (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	jutta.horejs_hoeck@sbg.ac.at	Duschl, Albert/E-5872-2011; Horejs-Hoeck, Jutta/AAF-1735-2019; Horejs-Hoeck, Jutta/E-5010-2011	Duschl, Albert/0000-0002-7034-9860; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Schwarz, Harald/0000-0002-2898-7826	Austrian Science Fund (FWF) [P22202, P23933]; Austrian Science Fund (FWF) [P 23933] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), grant numbers P22202 and P23933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINK M, 1994, LEUKEMIA, V8, P1579; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dawson ME, 1988, PHARM ENG, V8, P9; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; EGNER W, 1993, ADV EXP MED BIOL, V329, P263; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Perera PY, 1997, J IMMUNOL, V158, P4422; Peters M, 2012, INNATE IMMUN-LONDON, V18, P694, DOI 10.1177/1753425912436590; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Proksch P, 2005, J IMMUNOL, V174, P7075, DOI 10.4049/jimmunol.174.11.7075; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schwarz H, 2013, IMMUNOBIOLOGY, V218, P533, DOI 10.1016/j.imbio.2012.06.007; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; ZIEGLERHEITBROCK HWL, 1986, CANCER RES, V46, P5947	30	100	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113840	10.1371/journal.pone.0113840	http://dx.doi.org/10.1371/journal.pone.0113840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478795	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200034
J	Kage-Nakadai, E; Imae, R; Suehiro, Y; Yoshina, S; Hori, S; Mitani, S				Kage-Nakadai, Eriko; Imae, Rieko; Suehiro, Yuji; Yoshina, Sawako; Hori, Sayaka; Mitani, Shohei			A Conditional Knockout Toolkit for Caenorhabditis elegans Based on the Cre/loxP Recombination	PLOS ONE			English	Article							SINGLE/LOW-COPY INTEGRATION; SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; C. ELEGANS; GENOME; TRIMETHYLPSORALEN; SYSTEM; ULTRAVIOLET; TRANSGENES; FLP	Conditional knockout (cKO) based on site-specific recombination (SSR) technology is a powerful approach for estimating gene functions in a spatially and temporally specific manner in many model animals. In Caenorhabditis elegans (C. elegans), spatial- and temporal-specific gene functions have been largely determined by mosaic analyses, rescue experiments and feeding RNAi methods. To develop a systematic and stable cKO system in C. elegans, we generated Cre recombinase expression vectors that are driven by various tissue-specific or heat-shock promoters. Validation using Cre-mediated fluorescence protein inactivation or activation systems demonstrated successful Cre-dependent loxP excision. We established a collection of multi-copy Cre transgenic strains for each evaluated vector. To evaluate our Cre/loxP-based cKO system, we generated sid-1 deletion mutants harboring floxed sid-1 single-copy integration (SCI) using ultraviolet trimethylpsoralen (UV/TMP) methods. sid-1 mutants that were rescued by the floxed sid-1 SCI were then crossed with the Pdpy-7:: Cre strain for cKO in the hypodermis. The sid-1 cKO animals were resistant to bli-3 RNAi, which causes the Bli-phenotyple in the hypodermis, but they were sensitive to unc-22 RNAi, which leads to twitching of the body wall muscle. Our system, which is based on the combination of a transgenic Cre collection, pre-existing deletion mutants, and UV/TMP SCI methods, provided a systematic approach for cKO in C. elegans.	[Kage-Nakadai, Eriko; Imae, Rieko; Suehiro, Yuji; Yoshina, Sawako; Hori, Sayaka; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kage-Nakadai, Eriko] Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol, Osaka 558, Japan	Tokyo Women's Medical University; Osaka Metropolitan University	Mitani, S (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan.	mitani.shohei@twmu.ac.jp	Sayaka, Hori/AAU-7866-2020		Japan Society for the promotion of Science (JSPS)	Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the promotion of Science (JSPS) (to E.K.-N. and S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; BRENNER S, 1974, GENETICS, V77, P71; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Cheng Z, 2013, NAT BIOTECHNOL, V31, P934, DOI 10.1038/nbt.2674; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hoier EF, 2000, GENE DEV, V14, P874; Hubbard EJA, 2014, METHODS, V68, P417, DOI 10.1016/j.ymeth.2014.05.007; Kage-Nakadai E, 2014, METHODS, V68, P397, DOI 10.1016/j.ymeth.2014.02.036; Kage-Nakadai E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-1; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Liu PP, 2014, CELL RES, V24, P886, DOI 10.1038/cr.2014.73; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mello C, 1995, DNA TRANSFORMATION; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Shen Z, 2014, DEV CELL; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Voutev R, 2008, GENETICS, V180, P103, DOI 10.1534/genetics.108.090274	24	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114680	10.1371/journal.pone.0114680	http://dx.doi.org/10.1371/journal.pone.0114680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474529	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500054
J	Kang, HH; Kang, JY; Ha, JH; Lee, J; Kim, SK; Moon, HS; Lee, SH				Kang, Hyeon Hui; Kang, Ji Young; Ha, Jick Hwan; Lee, Jongmin; Kim, Sung Kyoung; Moon, Hwa Sik; Lee, Sang Haak			The Associations between Anthropometric Indices and Obstructive Sleep Apnea in a Korean Population	PLOS ONE			English	Article							NECK CIRCUMFERENCE; METABOLIC SYNDROME; FAT DISTRIBUTION; OBESITY; PREVALENCE; DIAGNOSIS; SEVERITY; WEIGHT	Background: Obesity is a major risk factor for the development of obstructive sleep apnea (OSA). Although clinical and epidemiological studies have shown that OSA and obesity are strongly associated, few Asian studies have examined the associations between anthropometric obesity indices and OSA, especially in the Korean population. The purpose of this study was to evaluate the influence of anthropometric obesity indices on OSA in a Korean population. Methods: Anthropometric indices, including neck circumference, waist circumference, and body mass index, were assessed in 383 consecutive subjects with suspected OSA. Results: Of the 383 subjects assessed, 316 (82.5%) were diagnosed with OSA. Neck circumference (r=0.518), waist circumference (r=0.570), and body mass index (r=0.512) were correlated with the apnea-hypopnea index (p<0.001, for all). After adjusting for age, sex, alcohol consumption, and smoking, a logistic regression model showed that neck circumference [odds ratio (OR), 1.414; p<0.001)], waist circumference (OR, 1.114; p<0.001), and body mass index (OR, 1.364; p<0.001) were associated with OSA. The linear regression model showed that neck circumference (beta=3.748, p<0.001), waist circumference (beta=1.272, p<0.001), and body mass index (beta=3.082, p<0.001) were associated with apnea-hypopnea index. The cut-off values for predicting OSA were determined as 34.5 cm for neck circumference, 76.5 cm for waist circumference, and 23.05 kg/m(2) for body mass index for females, and 38.75 cm for neck circumference, 88.5 cm for waist circumference, and 24.95 kg/m(2) for body mass index for males. Conclusion: Increased anthropometric indices were significantly associated with the presence and severity of OSA in a Korean population. In addition, this study demonstrated the cut-off values for body mass index, waist circumference, and neck circumference for increased OSA risk.	[Kang, Hyeon Hui; Kang, Ji Young; Lee, Jongmin; Kim, Sung Kyoung; Moon, Hwa Sik; Lee, Sang Haak] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Seoul, South Korea	Catholic University of Korea	Lee, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Seoul, South Korea.	mdlee@catholic.ac.kr		Kim, Sung Kyoung/0000-0003-2226-8262				Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chan ASL, 2010, INTERN MED J, V40, P102, DOI 10.1111/j.1445-5994.2009.02069.x; Cizza G, 2014, METAB SYNDR RELAT D, V12, P231, DOI 10.1089/met.2013.0093; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; Davidson TM, 2008, LARYNGOSCOPE, V118, P339, DOI 10.1097/MLG.0b013e3181587d7c; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Iber C., 2007, AASM MANUAL SCORING; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kagawa M, 2007, ASIA PAC J CLIN NUTR, V16, P31; Kang SG, 2013, KOREAN J BIOL PSYCHI, V20, P55; Lam JCM, 2012, RESPIROLOGY, V17, P223, DOI 10.1111/j.1440-1843.2011.02081.x; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Martins Andrea Barral, 2007, J. bras. pneumol., V33, P93, DOI 10.1590/S1806-37132007000100017; McNicholas Walter T, 2008, Proc Am Thorac Soc, V5, P154, DOI 10.1513/pats.200708-118MG; MILLMAN RP, 1995, CHEST, V107, P362, DOI 10.1378/chest.107.2.362; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Phillips BG, 2000, AM J PHYSIOL-HEART C, V279, pH234, DOI 10.1152/ajpheart.2000.279.1.H234; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Serafini FM, 2001, OBES SURG, V11, P28, DOI 10.1381/096089201321454079; Sharma SK, 2006, CHEST, V130, P149, DOI 10.1378/chest.130.1.149; Simpson L, 2010, SLEEP, V33, P467, DOI 10.1093/sleep/33.4.467; Soylu AC, 2012, SLEEP BREATH, V16, P1151, DOI 10.1007/s11325-011-0623-9; Subramanian S, 2011, SLEEP BREATH, V15, P711, DOI 10.1007/s11325-010-0426-4; Yamagishi K, 2010, EUR RESPIR J, V36, P379, DOI 10.1183/09031936.00118609; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76	31	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114463	10.1371/journal.pone.0114463	http://dx.doi.org/10.1371/journal.pone.0114463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474257	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500033
J	Yadav, D; Singh, R; Vatsa, M; Noore, A				Yadav, Daksha; Singh, Richa; Vatsa, Mayank; Noore, Afzel			Recognizing Age-Separated Face Images: Humans and Machines	PLOS ONE			English	Article							CLASSIFICATION; RECOGNITION; CLASSIFIERS; INFORMATION; QUALITY; BIAS; SEX	Humans utilize facial appearance, gender, expression, aging pattern, and other ancillary information to recognize individuals. It is interesting to observe how humans perceive facial age. Analyzing these properties can help in understanding the phenomenon of facial aging and incorporating the findings can help in designing effective algorithms. Such a study has two components - facial age estimation and age-separated face recognition. Age estimation involves predicting the age of an individual given his/her facial image. On the other hand, age-separated face recognition consists of recognizing an individual given his/her age-separated images. In this research, we investigate which facial cues are utilized by humans for estimating the age of people belonging to various age groups along with analyzing the effect of one's gender, age, and ethnicity on age estimation skills. We also analyze how various facial regions such as binocular and mouth regions influence age estimation and recognition capabilities. Finally, we propose an age-invariant face recognition algorithm that incorporates the knowledge learned from these observations. Key observations of our research are: (1) the age group of newborns and toddlers is easiest to estimate, (2) gender and ethnicity do not affect the judgment of age group estimation, (3) face as a global feature, is essential to achieve good performance in age-separated face recognition, and (4) the proposed algorithm yields improved recognition performance compared to existing algorithms and also outperforms a commercial system in the young image as probe scenario.	[Yadav, Daksha; Noore, Afzel] W Virginia Univ, Morgantown, WV 26506 USA; [Singh, Richa; Vatsa, Mayank] IIIT Delhi, Delhi, India	West Virginia University; Indraprastha Institute of Information Technology Delhi	Vatsa, M (corresponding author), IIIT Delhi, Delhi, India.	mayank@iiitd.ac.in	Singh, Richa/M-9961-2017; Vatsa, Mayank/AAR-7199-2020; Vatsa, Mayank/I-5050-2013	Singh, Richa/0000-0003-4060-4573; Vatsa, Mayank/0000-0001-5952-2274; Vatsa, Mayank/0000-0001-5952-2274	Department of Information Technology, Government of India	Department of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	The research is partly supported through a grant from Department of Information Technology, Government of India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allev TR, 1988, SOCIAL APPL ASPECTS; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Anzures G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011679; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Carbon CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079164; CROSS JF, 1971, PERCEPT PSYCHOPHYS, V10, P393, DOI 10.3758/BF03210319; Fu Y, 2008, IEEE T MULTIMEDIA, V10, P578, DOI 10.1109/TMM.2008.921847; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; George PA, 1998, PERCEPTION, V27, P295, DOI 10.1068/p270295; Guodong Guo, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3392, DOI 10.1109/ICPR.2010.828; JONES G, 1984, J EXP CHILD PSYCHOL, V38, P328, DOI 10.1016/0022-0965(84)90129-2; Kittler J, 1998, PATTERN ANAL APPL, V1, P18, DOI 10.1007/BF01238023; Kwon YH, 1999, COMPUT VIS IMAGE UND, V74, P1, DOI 10.1006/cviu.1997.0549; Lanitis A, 2004, IEEE T SYST MAN CY B, V34, P621, DOI 10.1109/TSMCB.2003.817091; Lanitis A, 2002, IEEE T PATTERN ANAL, V24, P442, DOI 10.1109/34.993553; Lanitis A, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/239480; Li ZF, 2011, IEEE T INF FOREN SEC, V6, P1028, DOI 10.1109/TIFS.2011.2156787; Macmillan N. A., 2004, DETECTION THEORY USE; Mayes AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015270; McNicol D., 2005, PRIMER SIGNAL DETECT; Megreya AM, 2011, ACTA PSYCHOL, V137, P83, DOI 10.1016/j.actpsy.2011.03.003; Megvii I., 2013, FACE RES TOOLKIT; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Norwich K. H., 1993, INFORM SENSATION PER; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Paik M. C., 2013, STAT METHODS RATES P; Patterson E., 2007, 2007 1 IEEE INT C BI, P1; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Ricanek K, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P341; Ross A, 2003, PATTERN RECOGN LETT, V24, P2115, DOI 10.1016/S0167-8655(03)00079-5; Singh M, 2014, IEEE ACCESS, V2, P822, DOI 10.1109/ACCESS.2014.2344667; Tistarelli Massimo, 2013, Age Factors in Biometric Processing, P253, DOI 10.1049/PBSP010E_ch14; Vapnik V., 1998, STAT LEARNING THEORY; Vatsa M, 2007, INT J NEURAL SYST, V17, P343, DOI 10.1142/S0129065707001196; Wolf L., 2008, WORKSH FAC INR LIF I; Yadav D, 2013, IEEE COMPUT SOC CONF, P173, DOI 10.1109/CVPRW.2013.33; Yang ZG, 2007, LECT NOTES COMPUT SC, V4642, P464	43	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112234	10.1371/journal.pone.0112234	http://dx.doi.org/10.1371/journal.pone.0112234			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474200	Green Published, gold			2022-12-27	WOS:000346382500066
J	Crivello, F; Tzourio-Mazoyer, N; Tzourio, C; Mazoyer, B				Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Tzourio, Christophe; Mazoyer, Bernard			Longitudinal Assessment of Global and Regional Rate of Grey Matter Atrophy in 1,172 Healthy Older Adults: Modulation by Sex and Age	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GENERAL ELDERLY POPULATION; CORTICAL THICKNESS; REPLACEMENT THERAPY; ENTORHINAL CORTEX; BRAIN ATROPHY; MRI; HIPPOCAMPAL; VOLUMES; ESTROGEN	To characterize the neuroanatomical changes in healthy older adults is important to differentiate pathological from normal brain structural aging. The present study investigated the annualized rate of GM atrophy in a large sample of older participants, focusing on the hippocampus, and searching for modulation by age and sex. In this 4-year longitudinal community cohort study, we used a VBM analysis to estimate the annualized rate of GM loss, at both the global and regional levels, in 1,172 healthy older adults (65-82 years) scanned at 1.5T. The global annualized rate of GM was -4.0 cm(3)/year (-0.83%/year). The highest rates of regional GM loss were found in the frontal and parietal cortices, middle occipital gyri, temporal cortex and hippocampus. The rate of GM atrophy was higher in women (-4.7 cm(3)/year, 20.91%/year) than men (-3.3 cm(3)/year, -0.65%/year). The global annualized rate of GM atrophy remained constant throughout the age range of the cohort, in both sexes. This pattern was replicated at the regional level, with the exception of the hippocampi, which showed a rate of GM atrophy that accelerated with age (2.8%/year per year of age) similarly for men and women. The present study reports a global and regional description of the annualized rate of grey matter loss and its evolution after the age of 65. Our results suggest greater anatomical vulnerability of women in late life and highlight a specific vulnerability of the hippocampus to the aging processes after 65 years of age.	[Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] Univ Bordeaux, GIN, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] CNRS, GIN, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] CEA, GIN, UMR 5296, Bordeaux, France; [Tzourio, Christophe] Victor Segalen Univ, INSERM, U708, Bordeaux, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Crivello, F (corresponding author), Univ Bordeaux, GIN, UMR 5296, Bordeaux, France.	fabrice.crivello@u-bordeaux2.fr	Tzourio, christophe/L-6344-2019; Tzourio-Mazoyer, Nathalie/B-5598-2008; Crivello, Fabrice/ABB-4531-2021; Tzourio, christophe/B-4015-2009; mazoyer, bernard m/A-5369-2009	Tzourio, christophe/0000-0002-6517-2984; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; Tzourio, christophe/0000-0002-6517-2984; mazoyer, bernard m/0000-0003-0970-2837; Crivello, Fabrice/0000-0001-6950-984X	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	Funding: The Fondation pour la Recherche Medicale funded the study preparation and initiation. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Alperovitch A, 2002, CR BIOL, V325, P665, DOI 10.1016/S1631-0691(02)01476-2; [Anonymous], NEUROIMAGE, V20, P22; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Cook IA, 2002, INT J GERIATR PSYCH, V17, P610, DOI 10.1002/gps.644; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Dumurgier J, 2012, NEUROIMAGE, V60, P871, DOI 10.1016/j.neuroimage.2012.01.102; Eberling JL, 2003, NEUROBIOL AGING, V24, P725, DOI 10.1016/S0197-4580(02)00056-8; Erickson KI, 2005, NEUROBIOL AGING, V26, P1205, DOI 10.1016/j.neurobiolaging.2004.11.009; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Gandy S, 2003, NEUROCHEM RES, V28, P1003, DOI 10.1023/A:1023246921127; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goto M, 2011, J MAGN RESON IMAGING, V33, P48, DOI 10.1002/jmri.22328; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Pell GS, 2008, NEUROIMAGE, V41, P1324, DOI 10.1016/j.neuroimage.2008.02.050; Pepe A, 2014, NEUROIMAGE, V100, P444, DOI 10.1016/j.neuroimage.2014.06.029; Raz N, 2004, NEUROREPORT, V15, P2531, DOI 10.1097/00001756-200411150-00020; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Resnick SM, 2009, NEUROLOGY, V72, P135, DOI 10.1212/01.wnl.0000339037.76336.cf; Resnick SM, 2003, J NEUROSCI, V23, P3295; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Robertson D, 2009, CLIMACTERIC, V12, P301, DOI 10.1080/13697130902730742; Salmond CH, 2002, NEUROIMAGE, V17, P507, DOI 10.1006/nimg.2002.1191; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Velsen EFS, 2013, NEUROSCI LETT, V550, P189, DOI 10.1016/j.neulet.2013.06.063; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007	62	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114478	10.1371/journal.pone.0114478	http://dx.doi.org/10.1371/journal.pone.0114478			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469789	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700119
J	Davies, JM; Hua, HU; Dheer, R; Martinez, M; Bhattacharya, SK; Abreu, MT				Davies, Julie M.; Hua, Hong-Uyen; Dheer, Rishu; Martinez, Mitchell; Bhattacharya, Sanjoy K.; Abreu, Maria T.			Stool Phospholipid Signature is Altered by Diet and Tumors	PLOS ONE			English	Article							CHRONIC ULCERATIVE-COLITIS; INFLAMMATORY-BOWEL-DISEASE; BODY-MASS INDEX; COLORECTAL-CANCER; CROHNS-DISEASE; GUT MICROBIOTA; INTESTINAL MUCUS; INDUCED OBESITY; PHOSPHATIDYLCHOLINE; FAT	Intake of saturated fat is a risk factor for ulcerative colitis (UC) and colon cancer. Changes in the microbiota have been implicated in the development of UC and colon cancer. The host and the microbiota generate metabolites that may contribute to or reflect disease pathogenesis. We used lipid class specific quantitative mass spectrometry to assess the phospholipid (PL) profile (phosphatidylcholine [PC], phosphatidylethanolamine [PE], phosphatidylinositol [PI], phosphatidylserine [PS]) of stool from mice fed a high fat (HFD) or control diet with or without induction of colitis-associated tumors using azoxymethane and dextran sodium sulfate. The microbiota was assessed using qPCR for several bacterial groups. Colitis-associated tumors were associated with reduced bulk PI and PE levels in control diet fed mice compared to untreated mice. Significant decreases in the relative quantities of several PC species were found in colitis-associated tumor bearing mice fed either diet. Statistical analysis of the PL profile revealed distinct clustering by treatment group. Partial least squares regression analysis found that the relative quantities of the PS class profile best predicted bacterial abundance of Clostridium leptum and Prevotella groups. Abundance of selected PL species correlated with bacterial group quantities. Thus, we have described that a HFD and colitisassociated tumors are associated with changes in phospholipids and may reflect host-microbial interactions and disease states.	[Davies, Julie M.; Dheer, Rishu; Abreu, Maria T.] Univ Miami, Div Gastroenterol, Dept Med, Miller Sch Med, Miami, FL 33124 USA; [Hua, Hong-Uyen; Martinez, Mitchell; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	University of Miami; Bascom Palmer Eye Institute; University of Miami	Abreu, MT (corresponding author), Univ Miami, Div Gastroenterol, Dept Med, Miller Sch Med, Miami, FL 33124 USA.	mabreu1@med.miami.edu	Davies, Julie/AAU-7129-2021	Abreu, Maria T./0000-0002-7294-0574; Hua, Hong-Uyen/0000-0001-9541-2558; Davies, Julie/0000-0003-4035-6047	National Institutes of Health, National Cancer Institute [5R01CA137869-05]; National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK099076-06A1]; Crohn's and Colitis Foundation of America; Department of Defense [W81XWH-09-1-0674]; Research to Prevent Blindness;  [EY016112];  [EY016112S1];  [P30-EY14801]; NATIONAL CANCER INSTITUTE [R01CA137869] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016112, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; Department of Defense(United States Department of Defense); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this study was provided by grants to MTA (National Institutes of Health, National Cancer Institute 5R01CA137869-05, National Institute of Diabetes and Digestive and Kidney Diseases 2R01DK099076-06A1; Crohn's and Colitis Foundation of America Senior Investigator Award) and SKB (EY016112; EY016112S1; P30-EY14801; Department of Defense Grant W81XWH-09-1-0674; Research to Prevent Blindness unrestricted grant to Department of Ophthalmology, University of Miami). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; Andersen NN, 2013, WORLD J GASTROENTERO, V19, P7561, DOI 10.3748/wjg.v19.i43.7561; Aribindi K, 2013, INVEST OPHTH VIS SCI, V54, P3037, DOI 10.1167/iovs.12-10517; AWAD AB, 1989, J NUTR, V119, P1376, DOI 10.1093/jn/119.10.1376; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bezabeh T, 2001, AM J GASTROENTEROL, V96, P442; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; CUMMINGS JH, 1978, J CLIN INVEST, V61, P953, DOI 10.1172/JCI109020; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Doubeni CA, 2012, JNCI-J NATL CANCER I, V104, P1353, DOI 10.1093/jnci/djs346; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Edwards G, 2014, BIOCHIMIE; Ehehalt R, 2004, SCAND J GASTROENTERO, V39, P737, DOI 10.1080/00365520410006233; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; FRIEDMAN HI, 1980, AM J CLIN NUTR, V33, P1108, DOI 10.1093/ajcn/33.5.1108; Gregory KE, 2013, ANAL CHEM, V85, P1114, DOI 10.1021/ac303011k; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Inafuku M, 2013, MOL NUTR FOOD RES, V57, P1671, DOI 10.1002/mnfr.201200607; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liao J, 2007, CARCINOGENESIS, V28, P446, DOI 10.1093/carcin/bgl154; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manna SK, 2014, GASTROENTEROLOGY, V146, P1313, DOI 10.1053/j.gastro.2014.01.017; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Murphy TK, 2000, AM J EPIDEMIOL, V152, P847, DOI 10.1093/aje/152.9.847; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shimizu K, 2010, J AGR FOOD CHEM; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; Stremmel W, 2007, ANN INTERN MED, V147, P603, DOI 10.7326/0003-4819-147-9-200711060-00004; Sun W, 2009, TXB GASTROENTEROLOGY; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Dieren JM, 2011, EUR J IMMUNOL, V41, P1047, DOI 10.1002/eji.201040899; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	67	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114352	10.1371/journal.pone.0114352	http://dx.doi.org/10.1371/journal.pone.0114352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469718	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700104
J	Edelmann, MJ; Shack, LA; Naske, CD; Walters, KB; Nanduri, B				Edelmann, Mariola J.; Shack, Leslie A.; Naske, Caitlin D.; Walters, Keisha B.; Nanduri, Bindu			SILAC-Based Quantitative Proteomic Analysis of Human Lung Cell Response to Copper Oxide Nanoparticles	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN S3; TRANSLATION INITIATION; MOLECULAR RESPONSES; ANDROGEN RECEPTOR; MAMMALIAN TARGET; EPITHELIAL-CELLS; BINDING PROTEIN; EXCISION-REPAIR; PHOSPHATASE 2A; CANCER CELLS	Copper (II) oxide (CuO) nanoparticles (NP) are widely used in industry and medicine. In our study we evaluated the response of BEAS-2B human lung cells to CuO NP, using Stable isotope labeling by amino acids in cell culture (SILAC)-based proteomics and phosphoproteomics. Pathway modeling of the protein differential expression showed that CuO NP affect proteins relevant in cellular function and maintenance, protein synthesis, cell death and survival, cell cycle and cell morphology. Some of the signaling pathways represented by BEAS-2B proteins responsive to the NP included mTOR signaling, protein ubiquitination pathway, actin cytoskeleton signaling and epithelial adherens junction signaling. Follow-up experiments showed that CuO NP altered actin cytoskeleton, protein phosphorylation and protein ubiquitination level.	[Edelmann, Mariola J.; Nanduri, Bindu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Edelmann, Mariola J.; Shack, Leslie A.; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS USA; [Naske, Caitlin D.; Walters, Keisha B.] Mississippi State Univ, Dept Chem Engn, Mississippi State, MS USA	Mississippi State University; Mississippi State University; Mississippi State University	Nanduri, B (corresponding author), Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA.	bnanduri@cvm.msstate.edu	Walters, Keisha/AAP-9819-2021	Walters, Keisha/0000-0002-0875-2659	National Science Foundation (Mississippi) [EPSCoR-0903787]; MAFES Special Research Initiative [160000-018100-027100-329180]; Mississippi INBRE by an Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [P20GM103476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER; EPSCoR [0903787] Funding Source: National Science Foundation	National Science Foundation (Mississippi)(National Science Foundation (NSF)); MAFES Special Research Initiative; Mississippi INBRE by an Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding: The National Science Foundation (Mississippi EPSCoR-0903787), MAFES Special Research Initiative (160000-018100-027100-329180) and the Mississippi INBRE, funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Aufderheide M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/734137; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Berntsen P, 2010, J R SOC INTERFACE, V7, pS331, DOI 10.1098/rsif.2010.0068.focus; Borkow G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011295; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Choe J, 2012, J BIOL CHEM, V287, P18500, DOI 10.1074/jbc.M111.327528; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Hegde V, 2004, BIOCHEMISTRY-US, V43, P14211, DOI 10.1021/bi049234b; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Kim JT, 2006, FEBS LETT, V580, P6375, DOI 10.1016/j.febslet.2006.10.049; Kim TS, 2009, J BIOL CHEM, V284, P21201, DOI 10.1074/jbc.M109.018168; Laha D, 2014, BBA-GEN SUBJECTS, V1840, P1, DOI 10.1016/j.bbagen.2013.08.011; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Majumdar S, 2013, SCIENCE, V339, P446, DOI 10.1126/science.1231789; Metral S, 2009, J BIOL CHEM, V284, P2409, DOI 10.1074/jbc.M801324200; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Ren GG, 2009, INT J ANTIMICROB AG, V33, P587, DOI 10.1016/j.ijantimicag.2008.12.004; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Shi M, 2012, ACS NANO, V6, P2157, DOI 10.1021/nn300445d; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Triboulet S, 2013, MOL CELL PROTEOMICS, V12, P3108, DOI 10.1074/mcp.M113.030742; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang ZY, 2012, CHEM RES TOXICOL, V25, P1512, DOI 10.1021/tx3002093; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Win-Shwe TT, 2011, INT J MOL SCI, V12, P6267, DOI 10.3390/ijms12096267; Wisniewski JR, 2008, PROTEINS, V73, P710, DOI 10.1002/prot.22104; Xi LJ, 2009, ENVIRON TOXICOL, V24, P211, DOI 10.1002/tox.20418; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yang ZM, 2007, MOL ENDOCRINOL, V21, P343, DOI 10.1210/me.2006-0104; Zatcoff Richard C, 2008, Foot (Edinb), V18, P136, DOI 10.1016/j.foot.2008.03.005; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160; ZIEMNIAK SE, 1992, J SOLUTION CHEM, V21, P179, DOI 10.1007/BF00647007	66	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114390	10.1371/journal.pone.0114390	http://dx.doi.org/10.1371/journal.pone.0114390			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470785	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700114
J	Ellis, RJ; Duan, ZY; Wang, Y				Ellis, Robert J.; Duan, Zhiyan; Wang, Ye			Quantifying Auditory Temporal Stability in a Large Database of Recorded Music	PLOS ONE			English	Article							PARKINSONS-DISEASE; INFORMATION-RETRIEVAL; PHYSICAL-THERAPY; EXERCISE DOMAIN; BEAT TRACKING; GAIT DYNAMICS; OLDER-ADULTS; TIME; SENSITIVITY; DISCRIMINATION	"Moving to the beat" is both one of the most basic and one of the most profound means by which humans (and a few other species) interact with music. Computer algorithms that detect the precise temporal location of beats (i.e., pulses of musical "energy") in recorded music have important practical applications, such as the creation of playlists with a particular tempo for rehabilitation (e.g., rhythmic gait training), exercise (e.g., jogging), or entertainment (e.g., continuous dance mixes). Although several such algorithms return simple point estimates of an audio file's temporal structure (e.g., "average tempo", "time signature"), none has sought to quantify the temporal stability of a series of detected beats. Such a method-a "Balanced Evaluation of Auditory Temporal Stability" (BEATS)-is proposed here, and is illustrated using the Million Song Dataset (a collection of audio features and music metadata for nearly one million audio files). A publically accessible web interface is also presented, which combines the thresholdable statistics of BEATS with queryable metadata terms, fostering potential avenues of research and facilitating the creation of highly personalized music playlists for clinical or recreational applications.	[Ellis, Robert J.; Duan, Zhiyan; Wang, Ye] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	National University of Singapore	Wang, Y (corresponding author), Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore.	wangye@comp.nus.edu.sg		ELLIS, ROBERT/0000-0002-3590-614X	National Research Foundation (NRF)	National Research Foundation (NRF)	This research was supported by the National Research Foundation (NRF; http://www.nrf.gov.sg/) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO; http://www.idm.sg/) hosted by the Media Development Authority of Singapore (MDA;http://www.mda.gov.sg/) under the Centre of Social Media Innovations for Communities (COSMIC; http://cosmic.nus.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AllMusic, 2013, ALLMUSIC REL; [Anonymous], 2011, P 12 INT SOC MUSIC I; [Anonymous], 2013, ECHO NEST; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bertin-Mahieux Thierry, 2011, P 12 INT SOC MUS INF, DOI DOI 10.7916/D8NZ8J07; Bigand E, 1997, J EXP PSYCHOL HUMAN, V23, P808, DOI 10.1037/0096-1523.23.3.808; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Botev Z., 2011, KERNEL DENSITY ESTIM; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; BROWNLEY KA, 1995, INT J PSYCHOPHYSIOL, V19, P193, DOI 10.1016/0167-8760(95)00007-F; Cai Z, 2013, P 14 INT C MUS INF R, P541; Casey MA, 2008, P IEEE, V96, P668, DOI 10.1109/JPROC.2008.916370; Chen CW, 2009, EIGHTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P602, DOI 10.1109/ICMLA.2009.54; Cope TE, 2012, J ACOUST SOC AM, V131, P4013, DOI 10.1121/1.3699266; COPELAND BL, 1991, J SPORT MED PHYS FIT, V31, P100; Davis JC, 2010, OSTEOPOROSIS INT, V21, P1295, DOI 10.1007/s00198-009-1162-0; de Bruin N, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/483530; de Dreu M J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS114, DOI 10.1016/S1353-8020(11)70036-0; de I'Etoile SK, 2008, INT J REHABIL RES, V31, P155, DOI 10.1097/MRR.0b013e3282fc0f44; Delval A, 2008, MOVEMENT DISORD, V23, P1446, DOI 10.1002/mds.22125; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Ellis D, 2011, MATLAB INTRO; Ellis DPW, 2007, J NEW MUSIC RES, V36, P51, DOI 10.1080/09298210701653344; Ellis RJ, 2010, ATTEN PERCEPT PSYCHO, V72, P2274, DOI 10.3758/APP.72.8.2274; FRIBERG A, 1995, J ACOUST SOC AM, V98, P2524, DOI 10.1121/1.413218; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Gouyon F, 2006, IEEE T AUDIO SPEECH, V14, P1832, DOI 10.1109/TSA.2005.858509; Grieg E, 1888, OP 46 NO 4 HALL MOUN; Grondin S., 2004, Acoustical Science and Technology, V25, P159, DOI 10.1250/ast.25.159; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Guzman-Garcia A, 2013, INT J GERIATR PSYCH, V28, P914, DOI 10.1002/gps.3913; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Jang JSR, 2001, LECT NOTES COMPUT SC, V2195, P590; Jehan T, 2011, ANAL DOCUMENTATION; Johnson G, 2001, J MUSIC THER, V38, P82, DOI 10.1093/jmt/38.2.82; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Jones MR, 1997, J EXP PSYCHOL HUMAN, V23, P693, DOI 10.1037/0096-1523.23.3.693; Jones MR., 2008, OXFORD HDB MUSIC PSY, P81; Kaminskas M, 2012, COMPUT SCI REV, V6, P89, DOI 10.1016/j.cosrev.2012.04.002; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Karageorghis CI, 2012, J SPORT SCI, V30, P953, DOI 10.1080/02640414.2012.676665; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Klapuri AP, 2006, IEEE T AUDIO SPEECH, V14, P342, DOI 10.1109/TSA.2005.854090; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Krumhansl CL, 2010, SPRINGER HANDB AUDIT, V36, P51, DOI 10.1007/978-1-4419-6114-3_3; Lamere P, 2011, ARTIST TERMS WHAT IS; Large EW, 2010, SPRINGER HANDB AUDIT, V36, P201, DOI 10.1007/978-1-4419-6114-3_7; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Li Z, 2010, P INT C MULT, P627; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Martin J.P., 1967, BASAL GANGLIA POSTUR; McAuley JD, 2007, PERCEPT PSYCHOPHYS, V69, P709, DOI 10.3758/BF03193773; McAuley JD, 2010, SPRINGER HANDB AUDIT, V36, P165, DOI 10.1007/978-1-4419-6114-3_6; McKinney MF, 2007, J NEW MUSIC RES, V36, P1, DOI 10.1080/09298210701653252; McKinney MF, 2006, MUSIC PERCEPT, V24, P155, DOI 10.1525/mp.2006.24.2.155; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Miller NS, 2005, PERCEPT PSYCHOPHYS, V67, P1150, DOI 10.3758/BF03193548; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Nettl B, 2000, ORIGINS OF MUSIC, P463; Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Pouliot M, 2005, MUSIC PERCEPT, V22, P389, DOI 10.1525/mp.2005.22.3.389; Ras Z.W., 2010, ADV MUSIC INFORM RET; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schulze HH, 2005, MUSIC PERCEPT, V22, P461, DOI 10.1525/mp.2005.22.3.461; SCHULZE HH, 1978, PSYCHOL RES-PSYCH FO, V40, P173, DOI 10.1007/BF00308412; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; SORKIN RD, 1982, J EXP PSYCHOL HUMAN, V8, P46, DOI 10.1037/0096-1523.8.1.46; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Thaut M.H., 1993, J NEUROL REHABIL, V7, P9; Thaut MH, 1998, HUM MOVEMENT SCI, V17, P839, DOI 10.1016/S0167-9457(98)00031-1; Thaut MH, 1999, MOVEMENT DISORD, V14, P808, DOI 10.1002/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; The S2S2 Consortium, 2007, ROADM SOUND MUS COMP; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Tomic ST, 2008, J ACOUST SOC AM, V124, P4024, DOI 10.1121/1.3006382; Verghese J, 2006, J AM GERIATR SOC, V54, P1241, DOI 10.1111/j.1532-5415.2006.00808.x; Von Wilzenben HD, 1942, METHODS TREATMENT PO; Wang A, 2006, COMMUN ACM, V49, P44, DOI 10.1145/1145287.1145312; Wikipedia, 2014, COMP ONL MUS STOR; Wikipedia, 2014, LIST ONL MUS DAT; Wikipedia, 2014, COMP ON DEM STREAM M; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Wittwer JE, 2013, DISABIL REHABIL, V35, P164, DOI 10.3109/09638288.2012.690495; Woodrow H., 1951, HDB EXPT PSYCHOL, P1224; Yi Y, 2011, P 1 INT ACM WORKSH M, P13; Zapata JR, 2011, P AUD ENG SOC 42 INT, P1; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107; Zhu S, 2014, P 22 ACM INT C MULT	103	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110452	10.1371/journal.pone.0110452	http://dx.doi.org/10.1371/journal.pone.0110452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469636	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700005
J	Povero, D; Eguchi, A; Li, HY; Johnson, CD; Papouchado, BG; Wree, A; Messer, K; Feldstein, AE				Povero, Davide; Eguchi, Akiko; Li, Hongying; Johnson, Casey D.; Papouchado, Bettina G.; Wree, Alexander; Messer, Karen; Feldstein, Ariel E.			Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL-CELLS; MICROPARTICLES; LIPOTOXICITY; EXOSOMES; HEPATOCYTES; EXPRESSION; BLOOD; MICROVESICLES	Background & Aim: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in both adult and children. Currently there are no reliable methods to determine disease severity, monitor disease progression, or efficacy of therapy, other than an invasive liver biopsy. Design: Choline Deficient L-Amino Acid (CDAA) and high fat diets were used as physiologically relevant mouse models of NAFLD. Circulating extracellular vesicles were isolated, fully characterized by proteomics and molecular analyses and compared to control groups. Liver-related microRNAs were isolated from purified extracellular vesicles and liver specimens. Results: We observed statistically significant differences in the level of extracellular vesicles (EVs) in liver and blood between two control groups and NAFLD animals. Time-course studies showed that EV levels increase early during disease development and reflect changes in liver histolopathology. EV levels correlated with hepatocyte cell death (r(2)=0.64, p<0.05), fibrosis (r(2)=0.66, p<0.05) and pathological angiogenesis (r(2)=0.71, p<0.05). Extensive characterization of blood EVs identified both microparticles (MPs) and exosomes (EXO) present in blood of NAFLD animals. Proteomic analysis of blood EVs detected various differentially expressed proteins in NAFLD versus control animals. Moreover, unsupervised hierarchical clustering identified a signature that allowed for discrimination between NAFLD and controls. Finally, the liver appears to be an important source of circulating EVs in NAFLD animals as evidenced by the enrichment in blood with miR-122 and 192 - two microRNAs previously described in chronic liver diseases,coupled with a corresponding decrease in expression of these microRNAs in the liver. Conclusions: These findings suggest a potential for using specific circulating EVs as sensitive and specific biomarkers for the noninvasive diagnosis and monitoring of NAFLD.	[Povero, Davide; Eguchi, Akiko; Johnson, Casey D.; Wree, Alexander; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Li, Hongying; Messer, Karen] Univ Calif San Diego, Moores Canc Ctr, Dept Biostat Bioinformat, La Jolla, CA 92093 USA; [Papouchado, Bettina G.] VA San Diego Healthcare Syst, Dept Pathol, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Feldstein, AE (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	afeldstein@ucsd.edu	Eguchi, Akiko/E-3086-2010	Wree, Alexander/0000-0002-2968-1335	NIH [DK076852, DK082451]; American Liver Foundation Postdoctoral Research Fellowship;  [NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451, R01DK076852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation Postdoctoral Research Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by NIH grants DK076852 and DK082451 to AEF, American Liver Foundation Postdoctoral Research Fellowship to DP, grant NS047101 to Jennifer Santini for the UCSD Microscopy Facility and Gilead Sciences Research Scholars Program in Liver Disease to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ashburner M, 2001, GENOME RES, V11, P1425; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bruand J, 2011, J PROTEOME RES, V10, P4734, DOI 10.1021/pr2005378; Bruand J, 2011, J PROTEOME RES, V10, P1915, DOI 10.1021/pr101159e; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Denzer K, 2000, J CELL SCI, V113, P3365; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fink K, 2011, CRIT CARE, V15, DOI 10.1186/cc10512; Garzetti L., 2013, J LEUKOC BIOL; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hallsworth K, 2012, J HEPATOL; Kitade M, 2009, WORLD J GASTROENTERO, V15, P5193, DOI 10.3748/wjg.15.5193; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Nanda K, 2004, PEDIATR TRANSPLANT, V8, P613, DOI 10.1111/j.1399-3046.2004.00241.x; Pan QW, 2012, GUT, V61, P1330, DOI 10.1136/gutjnl-2011-300449; Pirola CJ, 2014, GUT; Povero D, 2013, HEPATOLOGY, V58, p574A; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Richardson J, 2006, FRONT BIOSCI-LANDMRK, V11, P1042, DOI 10.2741/1862; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takaki Y, 2014, CANC SCI; Takeshita J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000507; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Teoh NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104376; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Vrijenhoek JE, 2014, EUR J PREV CARDIOL; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	52	176	189	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113651	10.1371/journal.pone.0113651	http://dx.doi.org/10.1371/journal.pone.0113651			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470250	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700039
J	Ribeiro, AI; Olhero, A; Teixeira, H; Magalhaes, A; Pina, MF				Ribeiro, Ana Isabel; Olhero, Andreia; Teixeira, Hugo; Magalhaes, Alexandre; Pina, Maria Fatima			Tools for Address Georeferencing - Limitations and Opportunities Every Public Health Professional Should Be Aware Of	PLOS ONE			English	Article							EPIDEMIOLOGIC RESEARCH; POSITIONAL ACCURACY; CHILDREN; BIAS	Various address georeferencing (AG) tools are currently available. But little is known about the quality of each tool. Using data from the EPIPorto cohort we compared the most commonly used AG tools in terms of positional error (PE) and subjects' misclassification according to census tract socioeconomic status (SES), a widely used variable in epidemiologic studies. Participants of the EPIPorto cohort (n=2427) were georeferenced using Geographical Information Systems (GIS) and Google Earth (GE). One hundred were randomly selected and georeferenced using three additional tools: 1) cadastral maps (gold-standard); 2) Global Positioning Systems (GPS) and 3) Google Earth, single and in a batch. Mean PE and the proportion of misclassified individuals were compared. Google Earth showed lower PE than GIS, but 10% of the addresses were imprecisely positioned. Thirty-eight, 27, 16 and 14% of the participants were located in the wrong census tract by GIS, GPS, GE (batch) and GE (single), respectively (p<0.001). Misclassification according to SES was less frequent but still non-negligible -14.4, 8.1, 4.2 and 2% (p<0.001). The quality of georeferencing differed substantially between AG tools. GE seems to be the best tool, but only if prudently used. Epidemiologic studies using spatial data should start including information on the quality and accuracy of their georeferencing tools and spatial datasets.	[Ribeiro, Ana Isabel; Olhero, Andreia; Teixeira, Hugo; Magalhaes, Alexandre; Pina, Maria Fatima] Univ Porto, Inst Engn Biomed INEB, P-4100 Oporto, Portugal; [Ribeiro, Ana Isabel; Magalhaes, Alexandre; Pina, Maria Fatima] Univ Porto, Fac Med Porto, Dept Epidemiol Clin Med Preditiva & Saude Publ, P-4100 Oporto, Portugal; [Ribeiro, Ana Isabel; Olhero, Andreia; Teixeira, Hugo; Magalhaes, Alexandre; Pina, Maria Fatima] ISPUP, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Ribeiro, AI (corresponding author), Univ Porto, Inst Engn Biomed INEB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ana.isabel.ribeiro@ineb.up.pt	Ribeiro, Ana Cristina/HHN-7466-2022; Pina, Maria de Fatima/N-7574-2014	Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Ana Isabel/0000-0001-8880-6962; Magalhaes, Alexandre/0000-0002-8798-9709; Teixeira, Hugo/0000-0001-8283-5826; Pina, Maria de Fatima/0000-0002-1521-7865	FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-EPI/113424/2009, SFRH/BD/82529/2011]	FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	Funding: This work was financed by FCT - Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/) in the framework of the project PTDC/SAU-EPI/113424/2009 and SFRH/BD/82529/2011 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1103; [Anonymous], 1834, RAPP MARCH EFF CHOL; Aronoff S., 1989, GEOGRAPHIC INFORM SY; ESRI, 2004, ARCVIEW; Foote K, 2000, ERROR ACCURACY PRECI; Goldberg DW, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-60; Griffith DA, 2007, IMPACTS POSITIONAL E; HOWE HL, 1986, AM J PUBLIC HEALTH, V76, P1459, DOI 10.2105/AJPH.76.12.1459-b; John S, 1855, MODE COMMUNICATION C; Krieger N, 2001, AM J PUBLIC HEALTH, V91, P1114, DOI 10.2105/AJPH.91.7.1114; McElroy JA, 2003, EPIDEMIOLOGY, V14, P399, DOI 10.1097/01.EDE.0000073160.79633.c1; Oliver M Norman, 2005, Int J Health Geogr, V4, P29, DOI 10.1186/1476-072X-4-29; Quesada J, 2013, REV ESP SALUD PUBLIC, V87, P201, DOI [10.4321/S1135-57272013000200009, 10.4321/s1135-57272013000200009]; Santos AC, 2003, PUBLIC HEALTH, V117, P430, DOI 10.1016/S0033-3506(03)00139-2; Schootman M, 2007, ANN EPIDEMIOL, V17, P464, DOI 10.1016/j.annepidem.2006.10.015; Vach W, 1997, STAT MED, V16, P57; Wey CL, 2009, HEALTH PLACE, V15, P1108, DOI 10.1016/j.healthplace.2009.06.001; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; Zandbergen PA, 2008, COMPUT ENVIRON URBAN, V32, P214, DOI 10.1016/j.compenvurbsys.2007.11.006; Zandbergen PA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-37; Zandbergen Paul A, 2006, Int J Health Geogr, V5, P23, DOI 10.1186/1476-072X-5-23; Zandbergen PA, 2007, ENVIRON HEALTH PERSP, V115, P1363, DOI 10.1289/ehp.9668; Zhan FB, 2006, ANN EPIDEMIOL, V16, P842, DOI 10.1016/j.annepidem.2006.08.001	23	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114130	10.1371/journal.pone.0114130	http://dx.doi.org/10.1371/journal.pone.0114130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469514	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700074
J	Alderliesten, T; Favie, LMA; Neijzen, RW; Auwarter, V; Nijboer, CHA; Marges, REJ; Rademaker, CMA; Kempf, J; van Bel, F; Groenendaal, F				Alderliesten, Thomas; Favie, Laurent M. A.; Neijzen, Robert W.; Auwaerter, Volker; Nijboer, Cora H. A.; Marges, Roland E. J.; Rademaker, Carin M. A.; Kempf, Juergen; van Bel, Frank; Groenendaal, Floris			Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets	PLOS ONE			English	Article							HYPOXIA-ISCHEMIA; BIRTH ASPHYXIA; XENON; MODEL; HYPOTHERMIA; INJURY; SYSTEM; PIGS	Hypothermia is ineffective in 45% of neonates with hypoxic-ischemic encephalopathy. Xenon has additive neuroprotective properties, but is expensive, and its application complicated. Argon gas is cheaper, easier to apply, and also has neuroprotective properties in experimental settings. The aim was to explore the safety of argon ventilation in newborn piglets. Methods: Eight newborn piglets (weight 1.4-3.0 kg) were used. Heart rate, blood pressure, regional cerebral saturation, and electrocortical brain activity were measured continuously. All experiments had a 30 min. baseline period, followed by three 60 min. periods of argon ventilation alternated with 30 min argon washout periods. Two animals were ventilated with increasing concentrations of argon (1h 30%, 1 h 50%, and 1 h 80%), two were subjected to 60 min. hypoxia (FiO(2) 0.08) before commencing 50% argon ventilation, and two animals received hypothermia following hypoxia as well as 50% argon ventilation. Two animals served as home cage controls and were terminated immediately. Results: Argon ventilation did not result in a significant change of heart rate (mean +/- s.d. -3.5 +/- 3.6 bpm), blood pressure (-0.60 +/- 1.11 mmHg), cerebral oxygen saturation (0.3 +/- 0.9%), electrocortical brain activity (-0.4 +/- 0.7 mV), or blood gas values. Argon ventilation resulted in elevated argon concentrations compared to the home cage controls (34.5, 25.4, and 22.4 vs. 7.3 mu l/ml). Conclusion: Ventilation with up to 80% argon during normoxia, and 50% argon after hypoxia did not affect heart rate, blood pressure, electrocortical brain activity. Clinical safety studies of argon ventilation in humans seem justified.	[Alderliesten, Thomas] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Favie, Laurent M. A.; Neijzen, Robert W.; Rademaker, Carin M. A.; van Bel, Frank; Groenendaal, Floris] Univ Med Ctr Utrecht, Div Lab Med & Pharm, Dept Clin Pharm, Utrecht, Netherlands; [Auwaerter, Volker; Kempf, Juergen] Univ Med Ctr Freiburg, Inst Forens Med, Dept Forens Toxicol, Freiburg, Germany; [Nijboer, Cora H. A.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Marges, Roland E. J.] Univ Med Ctr Utrecht, Dept Med Technol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Freiburg; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Groenendaal, F (corresponding author), Univ Med Ctr Utrecht, Div Lab Med & Pharm, Dept Clin Pharm, Utrecht, Netherlands.	F.Groenendaal@umcutrecht.nl	Groenendaal, Floris/P-6872-2019; Auwarter, Volker/D-1075-2012	Groenendaal, Floris/0000-0002-9284-1637; Auwarter, Volker/0000-0002-1883-2804	department of Neonatology, University Medical Center Utrecht, Utrecht, The Netherland; department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands	department of Neonatology, University Medical Center Utrecht, Utrecht, The Netherland; department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands	The Stephanie Neonatal ventilator is a donation of Fritz Stephan GmbH, Gackenbach, Germany. In addition, this study was funded by the departments of Neonatology, and of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands upon request of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Chakkarapani E, 2009, ANESTH ANALG, V109, P451, DOI 10.1213/ane.0b013e3181aa9550; Chakkarapani E, 2012, INTENS CARE MED, V38, P316, DOI 10.1007/s00134-011-2442-7; Dingley J, 2014, PEDIATRICS; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Faulkner SD, 2012, EUR J ANAESTH, V29, P577, DOI 10.1097/EJA.0b013e3283583c4b; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; HEISS HW, 1976, BASIC RES CARDIOL, V71, P658, DOI 10.1007/BF01906411; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Lemmers PMA, 2013, PEDIATR RES, V74, P180, DOI 10.1038/pr.2013.84; Lingwood BE, 2008, J NEUROSCI METH, V171, P140, DOI 10.1016/j.jneumeth.2008.02.011; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; MAYNARD D, 1969, BRIT MED J, V4, P545, DOI 10.1136/bmj.4.5682.545-a; Pagel PS, 2010, J CARDIOTHOR VASC AN, V24, P143, DOI 10.1053/j.jvca.2009.03.016; RAU G, 1969, ARCH KREISLAUFFORSCH, V58, P322, DOI 10.1007/BF02119667; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Robertson NJ, 2012, J PEDIATR-US, V160, P544, DOI 10.1016/j.jpeds.2011.12.052; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	26	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113575	10.1371/journal.pone.0113575	http://dx.doi.org/10.1371/journal.pone.0113575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460166	gold, Green Published			2022-12-27	WOS:000345869700037
J	Brosh, T; Rozitsky, D; Geron, S; Pilo, R				Brosh, Tamar; Rozitsky, Doron; Geron, Silvia; Pilo, Raphael			Tensile Mechanical Properties of Swine Cortical Mandibular Bone	PLOS ONE			English	Article							ORTHODONTIC MINI-IMPLANTS; STRESS-DISTRIBUTION; MINISCREW IMPLANTS; ELASTIC PROPERTIES; THICKNESS; STRENGTH; STABILITY; ANCHORAGE; FAILURE; PRESERVATION	Temporary orthodontic mini implants serve as anchorage devices in orthodontic treatments. Often, they are inserted in the jaw bones, between the roots of the teeth. The stability of the mini implants within the bone is one of the major factors affecting their success and, consequently, that of the orthodontic treatment. Bone mechanical properties are important for implant stability. The aim of this study was to determine the tensile properties of the alveolar and basal mandible bones in a swine model. The diametral compression test was employed to study the properties in two orthogonal directions: mesio-distal and occluso-gingival. Small cylindrical cortical bone specimens (2.6 mm diameter, 1.5 mm thickness) were obtained from 7 mandibles using a trephine drill. The sites included different locations (anterior and posterior) and aspects (buccal and lingual) for a total of 16 specimens from each mandible. The load-displacement curves were continuously monitored while loading half of the specimens in the oclluso-gingival direction and half in the mesiodistal direction. The stiffness was calculated from the linear portion of the curve. The mesio-distal direction was 31% stiffer than the occluso-gingival direction. The basal bone was 40% stiffer than the alveolar bone. The posterior zone was 46% stiffer than the anterior zone. The lingual aspect was stiffer than the buccal aspect. Although bone specimens do not behave as brittle materials, the diametral compression test can be adequately used for determining tensile behavior when only small bone specimens can be obtained. In conclusion, to obtain maximal orthodontic mini implant stability, the force components on the implants should be oriented mostly in the mesio-distal direction.	[Brosh, Tamar] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel; [Rozitsky, Doron] Tel Aviv Univ, Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel; [Geron, Silvia] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Orthodont, IL-69978 Tel Aviv, Israel; [Pilo, Raphael] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Brosh, T (corresponding author), Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.	tbrosh@post.tau.ac.il		Brosh, Tamar/0000-0001-6181-3310; pilo, raphael/0000-0002-8361-9516	Alfa Omega Foundation [0601913321]; Tel Aviv University	Alfa Omega Foundation; Tel Aviv University	Part of the study was supported by a grant from Alfa Omega Foundation No. 0601913321, Tel Aviv University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding sources of this study were received.	Antoszewska J, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.03.031, 10.1016/j.ajodo.2009.03.032]; Apicella D, 2010, J BIOMED MATER RES B, V93B, P150, DOI 10.1002/jbm.b.31569; BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201; Baumgaertel S, 2009, AM J ORTHOD DENTOFAC, V136, P230, DOI 10.1016/j.ajodo.2007.10.045; Buchter A, 2005, CLIN ORAL IMPLAN RES, V16, P473, DOI 10.1111/j.1600-0501.2005.01149.x; Chang JZC, 2012, AM J ORTHOD DENTOFAC, V141, P279, DOI 10.1016/j.ajodo.2011.09.008; Chen Y, 2009, AM J ORTHOD DENTOFAC, V135, P284, DOI 10.1016/j.ajodo.2007.08.017; Chun YS, 2009, ORTHOD CRANIOFAC RES, V12, P25, DOI 10.1111/j.1601-6343.2008.01434.x; Chung DH, 2011, J ANAT, V218, P26, DOI 10.1111/j.1469-7580.2010.01320.x; Daegling DJ, 2011, AM J PHYS ANTHROPOL, V144, P421, DOI 10.1002/ajpa.21423; Daegling DJ, 2011, ARCH ORAL BIOL, V56, P220, DOI 10.1016/j.archoralbio.2010.10.008; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Deguchi T, 2003, J DENT RES, V82, P377, DOI 10.1177/154405910308200510; Farnsworth D, 2011, AM J ORTHOD DENTOFAC, V139, P495, DOI 10.1016/j.ajodo.2009.03.057; Feng LA, 2010, J BIOMED MATER RES A, V95A, P580, DOI 10.1002/jbm.a.32837; Holm L, 2012, ANGLE ORTHOD, V82, P1022, DOI 10.2319/011912-47.1; Huang SH, 2012, ACTA BIOMATER, V8, P1597, DOI 10.1016/j.actbio.2011.12.036; Huja SS, 2007, J DENT RES, V86, P237, DOI 10.1177/154405910708600308; Iijima M, 2013, EUR J ORTHODONT, V35, P583, DOI 10.1093/ejo/cjs066; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, P9, DOI 10.1016/j.ajodo.2005.02.032; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Lertchirakarn V, 2001, J DENT RES, V80, P453, DOI 10.1177/00220345010800021001; Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3; Lin TS, 2013, AM J ORTHOD DENTOFAC, V143, P182, DOI 10.1016/j.ajodo.2012.09.012; Liou EJW, 2004, AM J ORTHOD DENTOFAC, V126, P42, DOI 10.1016/j.ajodo.2003.06.018; Misch CE, 2008, CONT IMPLANT DENT, P9; Moreno J, 2002, BIOMATERIALS, V23, P2615, DOI 10.1016/S0142-9612(01)00402-1; Motoyoshi M, 2009, INT J ORAL MAX SURG, V38, P13, DOI 10.1016/j.ijom.2008.09.006; Motoyoshi M, 2007, INT J ORAL MAX IMPL, V22, P779; Nomura T, 2003, DENT MATER, V19, P167, DOI 10.1016/S0109-5641(02)00026-X; Papadopoulos MA, 2011, J DENT RES, V90, P969, DOI 10.1177/0022034511409236; Park HS, 2008, AM J ORTHOD DENTOFAC, V133, P30, DOI 10.1016/j.ajodo.2006.01.044; Rapoff AJ, 2008, AM J PHYS ANTHROPOL, V135, P100, DOI 10.1002/ajpa.20714; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rozen B, 2009, CELL TISSUE BANK, V10, P27, DOI 10.1007/s10561-008-9106-z; Schwartz-Dabney CL, 2003, AM J PHYS ANTHROPOL, V120, P252, DOI 10.1002/ajpa.10121; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; Suzuki M, 2013, AM J ORTHOD DENTOFAC, V144, P251, DOI 10.1016/j.ajodo.2013.03.021; Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8; van Eijden TMGJ, 2000, CRIT REV ORAL BIOL M, V11, P123, DOI 10.1177/10454411000110010101; van Haaren EH, 2008, ACTA ORTHOP, V79, P708, DOI 10.1080/17453670810016759; WAGNER HD, 1992, J BIOMECH, V25, P1311, DOI 10.1016/0021-9290(92)90286-A	42	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113229	10.1371/journal.pone.0113229	http://dx.doi.org/10.1371/journal.pone.0113229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463971	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700031
J	Halldin, M; Brismar, K; Fahlstadius, P; Vikstrom, M; de Faire, U; Hellenius, ML				Halldin, Mats; Brismar, Kerstin; Fahlstadius, Per; Vikstrom, Max; de Faire, Ulf; Hellenius, Mai-Lis			The Metabolic Syndrome and ECG Detected Left Ventricular Hypertrophy - Influences from IGF-1 and IGF-Binding Protein-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; GENDER-DIFFERENCES; INSULIN; SERUM; POPULATION; DETERMINANTS; DIAGNOSIS; GEOMETRY; THERAPY; OBESITY	Background and Aims: The metabolic syndrome (MetS) is associated with an increased risk for left ventricular hypertrophy (LVH) and cardiovascular mortality. The aim of this study was to investigate potential influences from insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) on the relationship between the MetS and LVH, also taking into account the role of physical activity (PA), use of oestrogen and gender. Methods and Results: In a population-based cross-sectional study of 60-year-old men (n=1822) and women (n=2049) participants underwent physical examination and laboratory tests, including electrocardiography (ECG), and completed an extensive questionnaire. Women showed higher levels of IGFBP-1 than men (37.0 vs. 28.0 mu g/l, p<0.001), and women with LVH had lower levels of IGFBP-1 than women without LVH (31.0 mu g/l vs. 37.0 mu g/l, p<0.001). Furthermore, women with low levels of IGFBP-1 had a significantly increased risk of having LVH (crude OR approximate to 2.5). When stratifying for PA and oestrogen, respectively, a weaker association between IGFBP-1 and LVH was demonstrated in physically active men and women, compared to inactive individuals, as well as in women using oestrogen, compared to non-users. Conclusion: In a representative sample of 60-year-old Swedish men and women, the main findings were higher levels of IGFBP-1 in women than in men; lower levels of IGFBP-1 in women with LVH, compared to women without LVH; and an increased risk of having LVH in women with low levels of IGFBP-1. The association between IGFBP-1 and LVH was diminished in physically active men and women, as well as in women using oestrogen.	[Halldin, Mats; Fahlstadius, Per; Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Dept Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Brismar, Kerstin] Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Karolinska Inst, Stockholm, Sweden; [de Faire, Ulf; Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Halldin, M (corresponding author), Karolinska Inst, Inst Environm Med, Dept Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	Mats.Halldin@ki.se		Brismar, Kerstin/0000-0002-5241-514X	Stockholm County Council; Swedish Heart and Lung Foundation; Swedish Medical Research Council [04224]; Longitudinal Research; Family Erling-Persson Foundation; King Gustaf V:s and Queen Victoria's Foundation; AstraZeneca; Pfizer	Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Longitudinal Research; Family Erling-Persson Foundation; King Gustaf V:s and Queen Victoria's Foundation; AstraZeneca(AstraZeneca); Pfizer(Pfizer)	This study was supported by grants from the Stockholm County Council (UDF, M-LH), the Swedish Heart and Lung Foundation (UDF, M-LH), the Swedish Medical Research Council (04224 (KB), Longitudinal Research (UDF, M-LH)), Family Erling-Persson Foundation (KB), King Gustaf V:s and Queen Victoria's Foundation (M-LH), AstraZeneca and Pfizer (UDF, M-LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2009, BRIT J SPORT MED, V43, P6, DOI 10.1136/bjsm.2008.052449; Akanji AO, 2012, METAB SYNDR RELAT D, V10, P3, DOI 10.1089/met.2011.0083; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ALLAIN CC, 1974, CLIN CHEM, V20, P470; BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620; Bohm C, 2013, AM J PHYSIOL-HEART C, V305, pH211, DOI 10.1152/ajpheart.00593.2012; BRISMAR K, 1991, METABOLISM, V40, P728, DOI 10.1016/0026-0495(91)90092-B; da Costa W, 2008, J ELECTROCARDIOL, V41, P724, DOI 10.1016/j.jelectrocard.2008.05.010; Ferrara LA, 2007, J HUM HYPERTENS, V21, P795, DOI 10.1038/sj.jhh.1002232; FOSSATI P, 1980, CLIN CHEM, V26, P227; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedrich N, 2010, J HYPERTENS, V28, P856, DOI 10.1097/HJH.0b013e328336274a; Frystyk J, 2002, J CLIN ENDOCR METAB, V87, P260, DOI 10.1210/jc.87.1.260; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Halldin M, 2012, BLOOD PRESSURE, V21, P153, DOI 10.3109/08037051.2012.641267; HILDING A, 1995, J CLIN ENDOCR METAB, V80, P2646, DOI 10.1210/jc.80.9.2646; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; Hoang Khiet C, 2007, J Cardiometab Syndr, V2, P276, DOI 10.1111/j.1559-4564.2007.07491.x; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kotronen A, 2008, J CLIN ENDOCR METAB, V93, P4867, DOI 10.1210/jc.2008-1245; Light KC, 2001, J HYPERTENS, V19, P269, DOI 10.1097/00004872-200102000-00014; Lim WK, 1999, AM J CARDIOL, V83, P1132, DOI 10.1016/S0002-9149(99)00029-6; Macfarlane PW, 2006, CARDIOL CLIN, V24, P401, DOI 10.1016/j.ccl.2006.04.013; Mule G, 2005, J INTERN MED, V257, P503, DOI 10.1111/j.1365-2796.2005.01493.x; Oberman A, 2006, AM J CARDIOL, V97, P512, DOI 10.1016/j.amjcard.2005.08.071; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; POVOA G, 1984, ACTA ENDOCRINOL-COP, V107, P563, DOI 10.1530/acta.0.1070563; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Prineas RJ, 2010, MINNESOTA CODE MANUA; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Satoh S, 2014, HEART VESSELS, V29, P659, DOI 10.1007/s00380-013-0397-z; Schwarz S, 2010, MATURITAS, V66, P212, DOI 10.1016/j.maturitas.2010.03.014; Soderberg S, 2001, EUR J ENDOCRINOL, V144, P283, DOI 10.1530/eje.0.1440283; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e108872	10.1371/journal.pone.0108872	http://dx.doi.org/10.1371/journal.pone.0108872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461385	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700001
J	Hasegawa, A; Sato, K; Shirai, R; Watanabe, R; Yamamoto, K; Watanabe, K; Nohtomi, K; Hirano, T; Watanabe, T				Hasegawa, Akinori; Sato, Kengo; Shirai, Remina; Watanabe, Rena; Yamamoto, Keigo; Watanabe, Kaho; Nohtomi, Kyoko; Hirano, Tsutomu; Watanabe, Takuya			Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo	PLOS ONE			English	Article							FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; MONOCYTE-DERIVED MACROPHAGES; ENDOTHELIAL-CELLS; ANGIOTENSIN-II; HEART-FAILURE; EXPRESSION; HUMANS; ATHEROGENESIS	Aim: Atherosclerosis is the complex lesion that consists of endothelial inflammation, macrophage foam cell formation, vascular smooth muscle cell (VSMC) migration and proliferation, and extracellular matrix production. Human urocortin 1 (Ucn1), a 40-amino acid peptide member of the corticotrophin-releasing factor/urotensin I family, has potent cardiovascular protective effects. This peptide induces potent and long-lasting hypotension and coronary vasodilation. However, the relationship of Ucn1 with atherosclerosis remains unclear. The present study was performed to clarify the effects of Ucn1 on atherosclerosis. Methods: We assessed the effects of Ucn1 on the inflammatory response and proliferation of human endothelial cells (ECs), human macrophage foam cell formation, migration and proliferation of human VSMCs, extracellular matrix expression in VSMCs, and the development of atherosclerosis in apolipoprotein E-deficient (Apoe(-/-)) mice. Results: Ucn1 significantly suppressed cell proliferation without inducing apoptosis, and lipopolysaccharide-induced up-regulation of monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 in human ECs. Ucn1 significantly reduced oxidized low-density lipoprotein-induced foam cell formation with a significant down-regulation of CD36 and acyl-CoA: cholesterol acyltransferase 1 in human monocyte-derived macrophages. Ucn1 significantly suppressed the migration and proliferation of human VSMCs and increased the activities of matrix metalloproteinase-2 (MMP2) and MMP9 in human VSMCs.Intraperitoneal injection of Ucn1 into Apoe(-/-) mice for 4 weeks significantly retarded the development of aortic atherosclerotic lesions. Conclusions: This study provided the first evidence that Ucn1 prevents the development of atherosclerosis by suppressing EC inflammatory response and proliferation, macrophage foam cell formation, and VSMC migration and proliferation. Thus, Ucn1 could serve as a novel therapeutic target for atherosclerotic cardiovascular diseases.	[Hasegawa, Akinori; Sato, Kengo; Shirai, Remina; Watanabe, Rena; Yamamoto, Keigo; Watanabe, Kaho; Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan; [Nohtomi, Kyoko; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Tokyo 142, Japan	Tokyo University of Pharmacy & Life Sciences; Showa University	Watanabe, T (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan.	watanabe@toyaku.ac.jp						Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; Boonprasert P, 2008, INT J CARDIOL, V127, P307, DOI 10.1016/j.ijcard.2007.11.026; Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chen JD, 2009, PEPTIDES, V30, P1117, DOI 10.1016/j.peptides.2009.02.014; Chen ZW, 2005, CARDIOVASC RES, V65, P913, DOI 10.1016/j.cardiores.2004.11.018; Cureton EL, 2009, ENDOCRINOLOGY, V150, P5428, DOI 10.1210/en.2009-0489; Davidson SM, 2009, PHARMACOL REP, V61, P172, DOI 10.1016/S1734-1140(09)70019-2; Davis ME, 2005, CLIN SCI, V109, P381, DOI 10.1042/CS20050079; Davis ME, 2004, J CLIN ENDOCR METAB, V89, P1402, DOI 10.1210/jc.2003-031231; DellItalia LJ, 1997, J CLIN INVEST, V100, P253, DOI 10.1172/JCI119529; Emeto TI, 2014, CLIN SCI, V126, P517, DOI 10.1042/CS20130425; Emeto TI, 2011, J MOL CELL CARDIOL, V51, P299, DOI 10.1016/j.yjmcc.2011.06.002; Gonzalez-Rey E, 2007, ARTHRITIS RHEUM-US, V56, P531, DOI 10.1002/art.22394; Greene EL, 2001, HYPERTENSION, V37, P308, DOI 10.1161/01.HYP.37.2.308; Honjo T, 2006, J VASC RES, V43, P131, DOI 10.1159/000090132; Ikeda K, 2002, LIFE SCI, V71, P1929, DOI 10.1016/S0024-3205(02)01945-8; Ikeda K, 2009, J MOL ENDOCRINOL, V42, P479, DOI 10.1677/JME-08-0151; Kageyama K, 2006, ENDOCRINOLOGY, V147, P4454, DOI 10.1210/en.2006-0008; Knight RA, 2008, FEBS LETT, V582, P984, DOI 10.1016/j.febslet.2008.02.035; Konii H, 2013, HYPERTENSION, V62, P942, DOI 10.1161/HYPERTENSIONAHA.113.01653; Li W, 2005, J CLIN ENDOCR METAB, V90, P6569, DOI 10.1210/jc.2005-1445; Lin CS, 2012, CARDIOVASC RES, V95, P346, DOI 10.1093/cvr/cvs189; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Nishikimi T, 2000, AM J PHYSIOL-HEART C, V279, pH3031, DOI 10.1152/ajpheart.2000.279.6.H3031; Obikane H, 2010, ATHEROSCLEROSIS, V212, P116, DOI 10.1016/j.atherosclerosis.2010.05.029; Onorati F, 2013, CARDIOVASC DRUG THER, V27, P451, DOI 10.1007/s10557-013-6468-7; Phrommintikul A, 2010, EUR J CLIN INVEST, V40, P874, DOI 10.1111/j.1365-2362.2010.02343.x; Rademaker MT, 2007, AM J PHYSIOL-HEART C, V293, pH1536, DOI 10.1152/ajpheart.00377.2007; Richards AM, 2013, HDB BIOL ACTIVE PEPT, P1428; ROSS R, 1992, DIABETOLOGIA, V35, pS34, DOI 10.1007/BF00586277; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Takahashi K, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/395284; Torricelli M, 2009, AM J REPROD IMMUNOL, V62, P224, DOI 10.1111/j.1600-0897.2009.00729.x; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Villalon AL, 2005, BRIT J PHARMACOL, V145, P490; Watanabe T, 2005, HYPERTENSION, V46, P738, DOI 10.1161/01.HYP.0000184226.99196.b5; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Wright SP, 2009, CIRC-HEART FAIL, V2, P465, DOI 10.1161/CIRCHEARTFAILURE.108.840207; Xu G, 2009, CIRC RES, V105, P500, DOI 10.1161/CIRCRESAHA.109.193870; Xu Y, 2009, BRIT J PHARMACOL, V157, P1368, DOI 10.1111/j.1476-5381.2009.00210.x; Yang C, 2010, CAN J PHYSIOL PHARM, V88, P168, DOI 10.1139/Y09-119; Zaiou M, 2009, CURR PHARM DESIGN, V15, P3193, DOI 10.2174/138161209789058011; Zhang RJ, 2009, BRIT J PHARMACOL, V158, P819, DOI 10.1111/j.1476-5381.2009.00346.x; Zhu C, 2014, CELL SIGNAL, V26, P1125, DOI 10.1016/j.cellsig.2014.02.002	45	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110866	10.1371/journal.pone.0110866	http://dx.doi.org/10.1371/journal.pone.0110866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462164	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700005
J	Jin, XT; Song, L; Liu, XY; Chen, ML; Li, ZY; Cheng, L; Ren, H				Jin, Xiaoting; Song, Li; Liu, Xiangyuan; Chen, Meilan; Li, Zhuoyu; Cheng, Long; Ren, Hua			Protective Efficacy of Vitamins C and E on p,p '-DDT-Induced Cytotoxicity via the ROS-Mediated Mitochondrial Pathway and NF-kappa B/FasL Pathway	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; FAS LIGAND; IN-VITRO; ANTIOXIDANT ACTIVITY; HUMAN ERYTHROCYTES; DDT; APOPTOSIS; CELLS; LIVER; EXPOSURE	Dichlorodiphenoxytrichloroethane (DDT) is a known persistent organic pollutant and liver damage toxicant. However, there has been little emphasis on the mechanism underlying liver damage toxicity of DDT and the relevant effective inhibitors. Hence, the present study was conducted to explore the protective effects of vitamin C (VC) and vitamin E (VE) on the cytotoxicity of DDT in HL-7702 cells and elaborate the specific molecular mechanisms. The results demonstrated that p,p'-DDT exposure at over 10 mu M depleted cell viability of HL-7702 cells and led to cell apoptotic. p,p'-DDT treatment elevated the level of reactive oxygen species (ROS) generation, induced mitochondrial membrane potential, and released cytochrome c into the cytosol, with subsequent elevations of Bax and p53, along with suppression of Bcl-2. In addition, the activations of caspase-3 and -8 were triggered. Furthermore, p,p'-DDT promoted the expressions of NF-kappa B and FasL. When the cells were exposed to the NF-kappa B inhibitor (PDTC), the up-regulated expression of FasL was attenuated. Strikingly, these alterations caused by DDT treatment were prevented or reversed by the addition of VC or VE, and the protective effects of co-treatment with VC and VE were higher than the single supplement with p,p'-DDT. Taken together, these findings provide novel experimental evidences supporting that VC or/and VE could reduce p,p'-DDT-induced cytotoxicity of HL-7702 cells via the ROS-mediated mitochondrial pathway and NF-kappa B/FasL pathway.	[Jin, Xiaoting; Song, Li; Liu, Xiangyuan; Chen, Meilan; Li, Zhuoyu] Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan 030006, Peoples R China; [Li, Zhuoyu] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou 310053, Zhejiang, Peoples R China; [Cheng, Long] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; [Ren, Hua] Shanxi Coll Tradit Chinese Med, Taiyuan 030013, Peoples R China; [Ren, Hua] Western Med Hosp, Taiyuan 030013, Peoples R China	Shanxi University; Zhejiang Chinese Medical University; Harvard University; Harvard Medical School	Li, ZY (corresponding author), Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan 030006, Peoples R China.	lzy@sxu.edu.cn			National Natural Sciences Foundation of China [31271516, 21207084]; Research Fund for the Doctoral Program of Higher Education of China [20111401110011]; China Postdoctoral Science Foundation [2012M521178]; Natural Science Foundation of Shanxi [2009021035-2]; Oversea scientists funds of Shanxi province [20111009/10]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); Oversea scientists funds of Shanxi province	This work was supported by the National Natural Sciences Foundation of China (No. 31271516, No. 21207084), Research Fund for the Doctoral Program of Higher Education of China (20111401110011), China Postdoctoral Science Foundation (2012M521178) and Natural Science Foundation of Shanxi (2009021035-2) and Oversea scientists funds of Shanxi province (20111009/10), Research Fund for the Doctoral Program of Higher Education of China (20111401110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2013, CHEMOSPHERE, V93, P2514, DOI 10.1016/j.chemosphere.2013.09.047; Aneck-Hahn NH, 2007, J ANDROL, V28, P423, DOI 10.2164/jandrol.106.001701; Aziz R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/839538; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bi SX, 2014, J BIOMED MATER RES A, V102, P1518, DOI 10.1002/jbm.a.34794; Blasiak J, 2001, PESTIC BIOCHEM PHYS, V71, P88, DOI 10.1006/pest.2001.2557; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bratton MR, 2012, ENVIRON HEALTH PERSP, V120, P1291, DOI 10.1289/ehp.1104296; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Castillo J, 2000, J AGR FOOD CHEM, V48, P1738, DOI 10.1021/jf990665o; Cataudella E, 2012, ACTA MEDICA MEDITERR, V28, P245; Chowdhury AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073672; Cinar M, 2014, BIOL TRACE ELEM RES, V158, P186, DOI 10.1007/s12011-014-9926-6; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Durak D, 2009, ENVIRON TOXICOL, V24, P235, DOI 10.1002/tox.20423; Eroglu S, 2013, BIOL RES, V46, P33, DOI 10.4067/S0716-97602013000100005; Feng G, 2011, TOXICOL APPL PHARM, V251, P245, DOI 10.1016/j.taap.2011.01.009; Feng HP, 2004, J BIOMED BIOTECHNOL, P41; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FITZHUGH OG, 1947, J PHARMACOL EXP THER, V89, P18; Franks N, 2002, TOXICOL LETT, V130, P1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harabawy ASA, 2014, ECOTOX ENVIRON SAFE, V104, P28, DOI 10.1016/j.ecoenv.2014.02.015; Harapanhalli RS, 1996, RES COMMUN MOL PATH, V94, P271; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HODA Q, 1993, MUTAT RES, V299, P29, DOI 10.1016/0165-1218(93)90116-U; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Jin XT, 2014, TOXICOL LETT, V225, P158, DOI 10.1016/j.toxlet.2013.12.006; Karasavvas N, 2005, BLOOD, V105, P4004, DOI 10.1182/blood-2003-03-0772; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kiyosawa N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-487; Kobori Y, 2014, ARCH ITAL UROL ANDRO, V86, P1, DOI 10.4081/aiua.2014.1.1; Krieger R.I., 2001, HDB PESTICIDE TOXICO; Lin X, 2012, FOOD CHEM TOXICOL, V50, P3413, DOI 10.1016/j.fct.2012.07.053; Liu FY, 2012, J BIOL CHEM, V287, P25530, DOI 10.1074/jbc.M112.356279; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MATHUR DS, 1962, EXPERIENTIA, V18, P506, DOI 10.1007/BF02151600; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Organization WH, 1979, DDT ITS DER PUBL JOI; Qiu XH, 2005, ENVIRON SCI TECHNOL, V39, P4385, DOI 10.1021/es050342a; Robinson O, 2014, J HEPATOL, V60, P96, DOI 10.1016/j.jhep.2013.07.039; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Shen Y, 2013, J NAT PROD, V76, P2337, DOI 10.1021/np400784v; Shi Y, 2009, J BIOMEDICINE BIOTEC, V2009; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Song Y, 2011, TOXICOL LETT, V202, P55, DOI 10.1016/j.toxlet.2011.01.020; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tebourbi O, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P297; Tomiyama Naruto, 2004, J Toxicol Sci, V29, P505, DOI 10.2131/jts.29.505; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Vatassery GT, 1998, GERIATRICS, V53, pS25; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Yanez L, 2004, ENVIRON RES, V94, P18, DOI 10.1016/S0013-9351(03)00047-1; Yanez L, 2002, ENVIRON RES, V88, P174, DOI 10.1006/enrs.2002.4333; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069913; Zhao MR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043823, 10.1371/journal.pone.0051910]	60	33	36	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113257	10.1371/journal.pone.0113257	http://dx.doi.org/10.1371/journal.pone.0113257			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464339	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700033
J	Pang, LJ; Li, QX; Wei, CL; Zou, H; Li, SG; Cao, WW; He, JW; Zhou, Y; Ju, XX; Lan, JJ; Wei, YT; Wang, CY; Zhao, W; Hu, JM; Jia, W; Qi, Y; Liu, FD; Jiang, JF; Li, L; Zhao, J; Liang, WH; Xie, JX; Li, F				Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Li, Shugang; Cao, Weiwei; He, Jianwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wei, Yutao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Li, Li; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng			TGF-beta 1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China	PLOS ONE			English	Article							ADENOCARCINOMA; METASTASIS; EXPRESSION; RECEPTOR; DISEASE	Invasion and metastasis are the major causes of death in patients with esophageal squamous cell carcinoma (ESCC). Epithelial-mesenchymal transition (EMT) is a critical step in tumor progression and transforming growth factor-beta 1 (TGF-beta 1) signaling has been shown to play an important role in EMT. In this study, we investigated how TGF-beta 1 signaling pathways contributed to EMT in three ESCC cell lines as well as 100 patients of nomadic ethnic Kazakhs residing in northwest Xinjiang Province of China. In vitro analyses included Western blotting to detect the expression of TGF-beta 1/Smad and EMT-associated proteins in Eca109, EC9706 and KYSE150 cell lines following stimulation with recombinant TGF-beta 1 and SB431542, a potent inhibitor of ALK5 that also inhibits TGF-beta type II receptor. TGF-beta-activated Smad2/3 signaling in EMT was significantly upregulated as indicated by mesenchymal markers of N-cadherin and Vimentin, and in the meantime, epithelial marker, E-cadherin, was markedly downregulated. In contrast, SB431542 addition downregulated the expression of N-cadherin and Vimentin, but upregulated the expression of E-cadherin. Moreover, the TGF-beta 1-induced EMT promoted invasion capability of Eca109 cells. Tumor cells undergoing EMT acquire fibroblastoid-like phenotype. Expressed levels of TGF-beta 1/Smad signaling molecules and EMT-associated proteins were examined using immunohistochemical analyses in 100 ESCC tissues of Kazakh patients and 58 matched noncancerous adjacent tissues. The results showed that ESCC tissues exhibited upregulated expression of TGF-beta 1/Smad. We also analyzed the relationship between the above proteins and the patients' clinicopathological characteristics. The TGF-beta 1/Smad signaling pathway in human Eca109 ESCC cells may carry similar features as in Kazakh ESCC patients, suggesting that TGF-beta 1/Smad signaling pathway may be involved in the regulation of EMT in ethnic Kazakh patients with ESCC from Xinjiang, China.	[Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Cao, Weiwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Cao, Weiwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Li, Shugang] Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Xinjiang, Peoples R China; [He, Jianwei] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Clin Diag Lab, Shihezi, Xinjiang, Peoples R China; [Wei, Yutao] Hosp Xingjian Prod, Dept Thorac & Cardiovasc Surg, Urumqi, Xinjiang, Peoples R China; [Wei, Yutao] Construct Corps, Urumqi, Xinjiang, Peoples R China; [Li, Li] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Li, Qiuxiang; Liu, Fudong] Peoples Hosp Lianyuan, Dept Oncol, Lianyuan, Hunan, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; Shihezi University	Xie, JX (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.	xiejianxin9017@sina.com; lifeng7855@126.com	Sui, Yanwei/AAH-9928-2021; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022		National Natural Science Foundation of China [81160018]; Ministry of Human Resource and Social Security of People's Republic of China [2011LX004]; National Key Technology RD Program [2009BAI82B03]; International S&T Cooperation Program of China [2010DFB34100]; Corps Doctor Foundation [2014BB018, 2014BB019]; One Thousand Youth Talents Plan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Human Resource and Social Security of People's Republic of China; National Key Technology RD Program(National Key Technology R&D Program); International S&T Cooperation Program of China; Corps Doctor Foundation; One Thousand Youth Talents Plan	This work was supported by the National Natural Science Foundation of China (No. 81160018), Research Scholar Grant from the Ministry of Human Resource and Social Security of People's Republic of China (2011LX004), National Key Technology R&D Program (2009BAI82B03), the International S&T Cooperation Program of China (2010DFB34100), the Corps Doctor Foundation (No. 2014BB018, No. 2014BB019), and the One Thousand Youth Talents Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borthwick LA, 2012, CANCER MICROENVIRON, V5, P45, DOI 10.1007/s12307-011-0080-9; Di Martino E, 2006, BIOMARKERS, V11, P547, DOI 10.1080/13547500600896791; Ferlay J., 2012, INT AGENCY RES CANC; Gabbert HE, 2000, TUMORS DIGESTIVE SYS, P11; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Li Ke, 2009, Ai Zheng, V28, P8; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Pi LM, 2012, ZHONGHUA ER BI YAN H, V47, P749; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zhou Q, 2002, DIS ESOPHAGUS, V15, P74, DOI 10.1046/j.1442-2050.2002.00227.x; Zimowska Malgorzata, 2006, Postepy Biochem, V52, P360	23	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112300	10.1371/journal.pone.0112300	http://dx.doi.org/10.1371/journal.pone.0112300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464508	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700014
J	Wang, AX; Li, ZX; Luo, YX; Liu, XX; Guo, XH; Wu, SL; Zhao, XQ; Jonas, JB				Wang, Anxin; Li, Zhaoxia; Luo, Yanxia; Liu, Xiaoxue; Guo, Xiuhua; Wu, Shouling; Zhao, Xingquan; Jonas, Jost B.			Asymptomatic Intracranial Arterial Stenosis and Metabolic Syndrome: The APAC Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; RISK-FACTORS; ATHEROSCLEROSIS; PREVALENCE; DISEASE; INJURIES; COUNTY; STROKE	Purpose: The metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. We investigated potential associations between MetS and asymptomatic intracranial arterial stenosis (ICAS) in a general population. Methods: The community-based "Asymptomatic Polyvascular Abnormalities in Community Study'' examined asymptomatic polyvascular abnormalities in a Chinese population aged 40+ years without history of stroke and coronary heart disease. MetS was defined by the International Diabetes Federation criteria. Asymptomatic ICAS was diagnosed by transcranial color-coded Doppler sonography. Results: Out of 5393 study participants, asymptomatic ICAS was detected in 713 (13.2%) participants, and MetS in 1323 (24.5%) individuals. Prevalence of asymptomatic ICAS increased significantly from 7.5% to 24.2% with increasing number of MetS components. After adjusting for age, gender, physical activity, body mass index, low-density lipoprotein cholesterol and high-sensitivity C-reactive protein, MetS was significantly associated with asymptomatic ICAS (OR: 1.50; 95% CI: 1.23,1.83). Compared with the subgroup without MetS, the ORs for asymptomatic ICAS increased (P<0.0001) for each of 5 components of MetS from 1.71 (95% CI: 1.27,2.30), to 2.20 (95% CI: 1.63,2.98), 2.79 (95CI: 2.01,3.88), 3.08 (95% CI: 2.11,4.51) and 4.27 (95% CI: 2.22,8.20). Conclusions: In multivariate analysis, MetS was an independent and additional factor associated with asymptomatic ICAS. Study participants with 5 MetS components had a 4 times higher risk of asymptomatic ICAS than participants with no MetS component.	[Wang, Anxin; Li, Zhaoxia; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Liu, Xiaoxue] Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Seegartenklin Heidelberg, D-69115 Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	guoxiuh@ccmu.edu.cn; drwusl@163.com; zxq@vip.163.com	Wang, Anxin/AAD-4073-2021		National Natural Science Foundation of China [81202279]; advanced health care professional development project of Beijing Municipal Health Bureau [2009-3-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); advanced health care professional development project of Beijing Municipal Health Bureau	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279), and by a grant from advanced health care professional development project of Beijing Municipal Health Bureau (Grant No. 2009-3-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclosure/Conflict of Interest: None.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bang Oh Young, 2005, J Clin Neurol, V1, P69, DOI 10.3988/jcn.2005.1.1.69; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; De Silva DA, 2009, J STROKE CEREBROVASC, V18, P424, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.010; Ding X, 2014, INT J NEUROSCI, V124, P834, DOI 10.3109/00207454.2013.879580; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mi DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051421; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2007.01682.x; Park JH, 2011, STROKE, V42, P3040, DOI 10.1161/STROKEAHA.111.620104; Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang AX, 2014, J HYPERTENS, V32, P1600, DOI 10.1097/HJH.0000000000000230; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Zhang S, 2013, EUR J NEUROL, V20, P1479, DOI 10.1111/ene.12210; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	29	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113205	10.1371/journal.pone.0113205	http://dx.doi.org/10.1371/journal.pone.0113205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463628	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700030
J	Ma, Y; Lai, YL; Lachin, JM				Ma, Yong; Lai, Yinglei; Lachin, John M.			Identifying Change Points in a Covariate Effect on Time-to-Event Analysis with Reduced Isotonic Regression	PLOS ONE			English	Article								Isotonic regression is a useful tool to investigate the relationship between a quantitative covariate and a time-to-event outcome. The resulting non-parametric model is a monotonic step function of a covariate X and the steps can be viewed as change points in the underlying hazard function. However, when there are too many steps, over-fitting can occur and further reduction is desirable. We propose a reduced isotonic regression approach to allow combination of small neighboring steps that are not statistically significantly different. In this approach, a second stage, the reduction stage, is integrated into the usual monotonic step building algorithm by comparing the adjacent steps using appropriate statistical testing. This is achieved through a modified dynamic programming algorithm. We implemented the approach with the simple exponential distribution and then its extension, the Weibull distribution. Simulation studies are used to investigate the properties of the resulting isotonic functions. We apply this methodology to the Diabetes Control and Complication Trial (DCCT) data set to identify potential change points in the association between HbA1c and the risk of severe hypoglycemia.	[Ma, Yong; Lai, Yinglei; Lachin, John M.] George Washington Univ, Biostat Ctr, Rockville, MD 20852 USA; [Ma, Yong; Lachin, John M.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Lai, Yinglei] George Washington Univ, Dept Stat, Washington, DC 20052 USA	George Washington University; George Washington University; George Washington University	Ma, Y (corresponding author), George Washington Univ, Biostat Ctr, Rockville, MD 20852 USA.	yma@bsc.gwu.edu		Lachin, John/0000-0001-9838-2841				Ancukiewicz M, 2003, STAT MED, V22, P3151, DOI 10.1002/sim.1561; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GEHAN EA, 1969, BIOMETRIKA, V56, P127, DOI 10.2307/2334697; Han G, 2014, STAT MED, V33, P59, DOI 10.1002/sim.5915; Lachin JM., 2011, BIOSTATISTICAL METHO, V2nd; Lai Y., 2011, PLOS ONE, V6; Lai YL, 2014, STAT MED, V33, P1015, DOI 10.1002/sim.5996; LEE ET, 1975, BIOMETRIKA, V62, P425, DOI 10.1093/biomet/62.2.425; Ma Y, 2010, THESIS GEORGE WASHIN; Salanti Georgia, 2005, BMC Med Res Methodol, V5, P36, DOI 10.1186/1471-2288-5-36; Schell MJ, 1997, J AM STAT ASSOC, V92, P128, DOI 10.2307/2291456; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	14	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113948	10.1371/journal.pone.0113948	http://dx.doi.org/10.1371/journal.pone.0113948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473827	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500099
J	Nikolic, N; Bocker, R; Kostic-Kravljanac, L; Nikolic, M				Nikolic, Nina; Boecker, Reinhard; Kostic-Kravljanac, Ljiljana; Nikolic, Miroslav			Assembly Processes under Severe Abiotic Filtering: Adaptation Mechanisms of Weed Vegetation to the Gradient of Soil Constraints	PLOS ONE			English	Article							NUTRIENT-ACQUISITION STRATEGIES; ENVIRONMENTAL GRADIENT; ECOSYSTEMS; DIVERSITY; ABUNDANCE; COPPER; PLANTS; WHEAT	Questions: Effects of soil on vegetation patterns are commonly obscured by other environmental factors; clear and general relationships are difficult to find. How would community assembly processes be affected by a substantial change in soil characteristics when all other relevant factors are held constant? In particular, can we identify some functional adaptations which would underpin such soil-induced vegetation response? Location: Eastern Serbia: fields partially damaged by long-term and large-scale fluvial deposition of sulphidic waste from a Cu mine; subcontinental/submediterranean climate. Methods: We analysed the multivariate response of cereal weed assemblages (including biomass and foliar analyses) to a strong man-made soil gradient (from highly calcareous to highly acidic, nutrient-poor soils) over short distances (field scale). Results: The soil gradient favoured a substitution of calcicoles by calcifuges, and an increase in abundance of pseudometallophytes, with preferences for Atlantic climate, broad geographical distribution, hemicryptophytic life form, adapted to low-nutrient and acidic soils, with lower concentrations of Ca, and very narrow range of Cu concentrations in leaves. The trends of abundance of the different ecological groups of indicator species along the soil gradient were systematically reflected in the maintenance of leaf P concentrations, and strong homeostasis in biomass N:P ratio. Conclusion: Using annual weed vegetation at the field scale as a fairly simple model, we demonstrated links between gradients in soil properties (pH, nutrient availability) and floristic composition that are normally encountered over large geographic distances. We showed that leaf nutrient status, in particular the maintenance of leaf P concentrations and strong homeostasis of biomass N:P ratio, underpinned a clear functional response of vegetation to mineral stress. These findings can help to understand assembly processes leading to unusual, novel combinations of species which are typically observed as a consequence of strong environmental filtering, as for instance on sites affected by industrial activities.	[Nikolic, Nina; Kostic-Kravljanac, Ljiljana; Nikolic, Miroslav] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Boecker, Reinhard] Univ Hohenheim, Stuttgart, Germany	University of Belgrade; University Hohenheim	Nikolic, N (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia.	nina@imsi.bg.ac.rs	Nikolic, Nina/AAB-9448-2021; Nikolic, Miroslav/H-8657-2014; Kravljanac, Ljiljana Kostic/AAT-7315-2020	Nikolic, Nina/0000-0002-4214-3291; Nikolic, Miroslav/0000-0001-9643-138X; Kravljanac, Ljiljana Kostic/0000-0003-2586-0739	Serbian Ministry of Education, Science and Technological Development [173028]	Serbian Ministry of Education, Science and Technological Development	This work was supported by the Serbian Ministry of Education, Science and Technological Development Grant #173028 to MN (http://www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ALVAREZ H, 1974, AM MIDL NAT, V92, P1, DOI 10.2307/2424198; Austin M. P., 2005, VEGETATION ECOLOGY, P52; AUSTIN MP, 1994, J VEG SCI, V5, P215, DOI 10.2307/3236154; BAKER AJM, 1987, NEW PHYTOL, V106, P93; Barker AV, 2007, HDB PLANT NUTR, P22; Becker T, 2007, FOLIA GEOBOT, V42, P11, DOI 10.1007/BF02835100; Bergmann W, 1986, EMAHRUNGSSTORUNGEN B; BROWN G, 1994, VEGETATIO, V115, P77; Cimalova S, 2009, PLANT ECOL, V203, P45, DOI 10.1007/s11258-008-9503-1; CLARK RK, 1981, NEW PHYTOL, V87, P799, DOI 10.1111/j.1469-8137.1981.tb01715.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Ellenberg H, 1988, VEGETATION ECOLOGY C, P621; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Fageria NK, 2001, COMMUN SOIL SCI PLAN, V32, P1659, DOI 10.1081/CSS-100104220; Fried G, 2008, AGR ECOSYST ENVIRON, V128, P68, DOI 10.1016/j.agee.2008.05.003; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Hallett Lauren M., 2013, P16; Hayes P, 2014, J ECOL, V102, P396, DOI 10.1111/1365-2745.12196; HilleRisLambers J, 2013, OIKOS, V122, P1649, DOI 10.1111/j.1600-0706.2013.00698.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HOLZNER W, 1978, VEGETATIO, V38, P13, DOI 10.1007/BF00141295; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lee JA, 1999, ADV BOT RES, V29, P1; Lososova Z, 2008, J BIOGEOGR, V35, P177, DOI 10.1111/j.1365-2699.2007.01778.x; Lososova Z, 2006, FOLIA GEOBOT, V41, P259, DOI 10.1007/BF02904941; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mielke P. W., 2001, PERMUTATION METHODS; MILIJIC S, 1980, ARH POLJOPR NAUKE, V41, P201; Misic V., 1997, VEGETATION SERBIA, P311; Nagy L, 1997, NEW PHYTOL, V137, P267, DOI 10.1046/j.1469-8137.1997.00799.x; Nikolic N, 2012, SCI TOTAL ENVIRON, V425, P146, DOI 10.1016/j.scitotenv.2012.02.076; Nikolic N, 2011, PLANT SOIL, V339, P485, DOI 10.1007/s11104-010-0605-x; NORVELL WA, 1984, SOIL SCI SOC AM J, V48, P1285, DOI 10.2136/sssaj1984.03615995004800060017x; Petit S, 2012, J VEG SCI, V23, P1137, DOI 10.1111/j.1654-1103.2012.01421.x; Sanchez C., 2007, HDB PLANT NUTR, P51; SMITH RAH, 1979, J APPL ECOL, V16, P595, DOI 10.2307/2402534; THOMPSON J, 1983, NEW PHYTOL, V94, P297, DOI 10.1111/j.1469-8137.1983.tb04502.x; Thompson K, 1997, NEW PHYTOL, V136, P679, DOI 10.1046/j.1469-8137.1997.00787.x; Tischew S, 2014, APPL VEG SCI, V17, P288, DOI 10.1111/avsc.12078; van der Maarel E, 2007, J VEG SCI, V18, P767, DOI 10.1111/j.1654-1103.2007.tb02592.x; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wiegleb G, 2001, ECOL ENG, V17, P199, DOI 10.1016/S0925-8574(00)00159-2	54	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114290	10.1371/journal.pone.0114290	http://dx.doi.org/10.1371/journal.pone.0114290			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474688	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500011
J	Pelle, DW; Peacock, JD; Schmidt, CL; Kampfschulte, K; Scholten, DJ; Russo, SS; Easton, KJ; Steensma, MR				Pelle, Dominic W.; Peacock, Jacqueline D.; Schmidt, Courtney L.; Kampfschulte, Kevin; Scholten, Donald J., II; Russo, Scott S.; Easton, Kenneth J.; Steensma, Matthew R.			Genetic and Functional Studies of the Intervertebral Disc: A Novel Murine Intervertebral Disc Model	PLOS ONE			English	Article							EARLY DEGENERATIVE CHANGES; NUCLEUS PULPOSUS CELLS; ORGAN-CULTURE SYSTEM; MOUSE MODELS; EXPRESSION; RECEPTOR; POLYMORPHISMS; PREVALENCE; ACTIVATION; INDUCTION	Intervertebral disc (IVD) homeostasis is mediated through a combination of micro-environmental and biomechanical factors, all of which are subject to genetic influences. The aim of this study is to develop and characterize a genetically tractable, ex vivo organ culture model that can be used to further elucidate mechanisms of intervertebral disc disease. Specifically, we demonstrate that IVD disc explants (1) maintain their native phenotype in prolonged culture, (2) are responsive to exogenous stimuli, and (3) that relevant homeostatic regulatory mechanisms can be modulated through ex-vivo genetic recombination. We present a novel technique for isolation of murine IVD explants with demonstration of explant viability (CMFDA/propidium iodide staining), disc anatomy (H&E), maintenance of extracellular matrix (ECM) (Alcian Blue staining), and native expression profile (qRT-PCR) as well as ex vivo genetic recombination (mT/mG reporter mice; AdCre) following 14 days of culture in DMEM media containing 10% fetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin. IVD explants maintained their micro-anatomic integrity, ECM proteoglycan content, viability, and gene expression profile consistent with a homeostatic drive in culture. Treatment of genetically engineered explants with cre-expressing adenovirus efficaciously induced ex vivo genetic recombination in a variety of genetically engineered mouse models. Exogenous administration of IL-1 beta and TGF-beta 3 resulted in predicted catabolic and anabolic responses, respectively. Genetic recombination of TGFBR1(fl/fl) explants resulted in constitutively active TGF-beta signaling that matched that of exogenously administered TGF-beta 3. Our results illustrate the utility of the murine intervertebral disc explant to investigate mechanisms of intervertebral disc degeneration.	[Pelle, Dominic W.; Peacock, Jacqueline D.; Schmidt, Courtney L.; Kampfschulte, Kevin; Scholten, Donald J., II; Steensma, Matthew R.] Van Andel Inst, Lab Musculoskeletal Oncol, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI 49503 USA; [Pelle, Dominic W.] Grand Rapids Med Educ Partners, Dept Orthopaed Surg, Grand Rapids, MI USA; [Scholten, Donald J., II; Steensma, Matthew R.] Michigan State Univ, Coll Human Med, Dept Surg, Grand Rapids, MI USA; [Russo, Scott S.; Easton, Kenneth J.] Orthopaed Associates Michigan, Sect Spine Surg, Grand Rapids, MI USA; [Steensma, Matthew R.] Helen DeVos Childrens Hosp, Spectrum Hlth Med Grp, Dept Surg, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Michigan State University College of Human Medicine; Spectrum Health Medical Group	Pelle, DW (corresponding author), Van Andel Inst, Lab Musculoskeletal Oncol, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI 49503 USA.	dominic.pelle@vai.org			Jay and Betty Van Andel Foundation	Jay and Betty Van Andel Foundation	This work was supported by the Jay and Betty Van Andel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Chan SCW, 2012, JOVE-J VIS EXP, DOI 10.3791/3490; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chiba K, 1998, SPINE, V23, P1821, DOI 10.1097/00007632-199809010-00002; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Fosang AJ, 2008, NAT CLIN PRACT RHEUM, V4, P420, DOI 10.1038/ncprheum0841; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Haschtmann D, 2006, SPINE, V31, P2918, DOI 10.1097/01.brs.0000247954.69438.ae; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Huang K, 2011, MOL BIOL REP, V38, P3569, DOI 10.1007/s11033-010-0467-6; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jin HT, 2011, FEBS LETT, V585, P1209, DOI 10.1016/j.febslet.2011.03.034; Kepler CK, 2013, SPINE, V38, P873, DOI 10.1097/BRS.0b013e318285ae08; Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Muders MH, 2009, CANCER RES, V69, P6042, DOI 10.1158/0008-5472.CAN-09-0552; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parolin M, 2010, Evid Based Spine Care J, V1, P67, DOI 10.1055/s-0028-1100919; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Ponnappan RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3494; Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, SPINE, V31, P884, DOI 10.1097/01.brs.0000209335.57767.b5; Roberts S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-24; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; Seol D, 2013, J ORTHOP RES, V31, P838, DOI 10.1002/jor.22285; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Wang JR, 2013, ARTHRITIS RHEUM-US, V65, P832, DOI 10.1002/art.37819; Wang MN, 2012, ARTHRITIS RHEUM-US, V64, P2611, DOI 10.1002/art.34469; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Wuertz K, 2012, EUR CELLS MATER, V23, P103; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhu Y, 2013, J ORTHOP RES, V31, P1144, DOI 10.1002/jor.22337	47	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112454	10.1371/journal.pone.0112454	http://dx.doi.org/10.1371/journal.pone.0112454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474689	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500071
J	Kalderon, Z; Kumar, S; Engelberg-Kulka, H				Kalderon, Ziva; Kumar, Sathish; Engelberg-Kulka, Hanna			The SOS Response is Permitted in Escherichia coli Strains Deficient in the Expression of the mazEF Pathway	PLOS ONE			English	Article							MEDIATED CELL-DEATH; BACTERIOPHAGE-LAMBDA; MESSENGER-RNAS; MUTATION; MODULE	The Escherichia coli (E. coli) SOS response is the largest, most complex, and best characterized bacterial network induced by DNA damage. It is controlled by a complex network involving the RecA and LexA proteins. We have previously shown that the SOS response to DNA damage is inhibited by various elements involved in the expression of the E. coli toxin-antitoxin mazEF pathway. Since the mazEF module is present on the chromosomes of most E. coli strains, here we asked: Why is the SOS response found in so many E. coli strains? Is the mazEF module present but inactive in those strains? We examined three E. coli strains used for studies of the SOS response, strains AB1932, BW25113, and MG1655. We found that each of these strains is either missing or inhibiting one of several elements involved in the expression of the mazEF-mediated death pathway. Thus, the SOS response only takes place in E. coli cells in which one or more elements of the E. coli toxin-antitoxin module mazEF or its downstream pathway is not functioning.	[Kalderon, Ziva; Kumar, Sathish; Engelberg-Kulka, Hanna] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	hanita@cc.huji.il	Kumar, Sathish/L-1367-2019; Kumar, Sathish/Y-9397-2018	Kumar, Sathish/0000-0001-8875-9537	Israel Science Foundation [66/10]; United States Army [W911NF-09-1-0212]	Israel Science Foundation(Israel Science Foundation); United States Army(United States Department of DefenseUnited States Army)	Funding: This work was supported by the Israel Science Foundation (grant 66/10) and the United States Army (grant W911NF-09-1-0212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BELFORT M, 1978, J VIROL, V28, P270, DOI 10.1128/JVI.28.1.270-278.1978; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Courcelle J, 2001, GENETICS, V158, P41; Datsenko A, 2005, P NATL ACAD SCI USA, V97, P6640; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Engelberg-Kulka H, 1998, P NATL ACAD SCI USA, V95, P15481, DOI 10.1073/pnas.95.26.15481; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; HAYES S, 1973, MOL GEN GENET, V126, P275, DOI 10.1007/BF00269438; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hersh MN, 2004, RES MICROBIOL, V155, P352, DOI 10.1016/j.resmic.2004.01.020; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; LANDSMANN J, 1982, GENE, V20, P11, DOI 10.1016/0378-1119(82)90083-X; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; METZGER S, 1989, J BIOL CHEM, V264, P21146; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Moolenaar GF, 2002, P NATL ACAD SCI USA, V99, P1467, DOI 10.1073/pnas.032584099; MOUNT DW, 1972, J BACTERIOL, V112, P886, DOI 10.1128/JB.112.2.886-893.1972; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	31	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114380	10.1371/journal.pone.0114380	http://dx.doi.org/10.1371/journal.pone.0114380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470502	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700111
J	Pan, H; He, MH; Liu, RX; Brecha, NC; Yu, ACH; Pu, ML				Pan, Hong; He, Meihua; Liu, Ruixing; Brecha, Nicholas C.; Yu, Albert Cheung Hoi; Pu, Mingliang			Sulforaphane Protects Rodent Retinas against Ischemia-Reperfusion Injury through the Activation of the Nrf2/HO-1 Antioxidant Pathway	PLOS ONE			English	Article							NRF2-DEPENDENT PHASE-2 ENZYME; OXIDATIVE STRESS; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION INJURY; PHARMACOLOGICAL INDUCTION; CALCIUM DOBESILATE; RESPONSE ELEMENT; KAPPA-B; CELLS; GENE	Retinal ischemia-reperfusion (I/R) injury induces oxidative stress, leukocyte infiltration, and neuronal cell death. Sulforaphane (SF), which can be obtained in cruciferous vegetables such as broccoli, exerts protective effects in response to oxidative stress in various tissues. These effects can be initiated through nuclear factor E2-related factor 2 (Nrf2)-mediated induction of heme oxygenase-1 (HO-1). This investigation was designed to elucidate the neural protective mechanisms of SF in the retinal I/R rat model. Animals were intraperitoneally (i.p.) injected with SF (12.5 mg/kg) or vehicle (corn oil) once a day for 7 consecutive days. Then, retinal I/R was made by elevating the intraocular pressure (IOP) to 130 mmHg for 1 h. To determine if HO-1 was involved in the Nrf2 antioxidant pathway, rats were subjected to protoporphyrin IX zinc (II) (ZnPP, 30 mg/kg, i.p.) treatments at 24 h before retinal ischemia. The neuroprotective effects of SF were assessed by determining the morphology of the retina, counting the infiltrating inflammatory cells and the surviving retinal ganglion cells (RGCs) and amacrine cells, and measuring apoptosis in the retinal layers. The expression of Nrf2 and HO-1 was studied by immunofluorescence analysis and western blotting. I/R induced a marked increase of ROS generation, caused pronounced inflammation, increased the apoptosis of RGCs and amacrine cells and caused the thinning of the inner retinal layer (IRL), and these effects were diminished or abolished by SF pretreatment. Meanwhile, SF pretreatment significantly elevated the nuclear accumulation of Nrf2 and the level of HO-1 expression in the I/R retinas; however, ZnPP reversed the protective effects of SF on I/R retinas. Together, we offer direct evidence that SF had protective effects on I/R retinas, which could be attributed, at least in part, to the activation of the Nrf2/HO-1 antioxidant pathway.	[Pan, Hong; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Dept Anat Embryol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Pan, Hong] Binzhou Med Coll, Dept Phys, Yantai, Shandong, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Key Lab Visual Impairment & Restorat, Minist Educ, Beijing 100871, Peoples R China; [Brecha, Nicholas C.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med Los Angeles, Jules Stein Eye Inst,CURE Digest Dis Res Ctr,Dept, Los Angeles, CA 90024 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Hlth Syst, Los Angeles, CA USA	Peking University; Peking University; Binzhou Medical University; Peking University; Peking University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Pu, ML (corresponding author), Peking Univ, Dept Anat Embryol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	mpu@hsc.pku.edu.cn	He, Meihua/D-4312-2017		National Basic Research Program of China (973 Program) [2011CB510206]; National Science Foundation of China [30831160516, 81200691]; Ministry of Education of China [20090001120075]; Azalea Endowment Fund; Fundamental Research Fund for the Central Universities [21609101]; NIH [EY04067]; VA Merit Review; NATIONAL EYE INSTITUTE [R56EY004067, R01EY004067] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Azalea Endowment Fund; Fundamental Research Fund for the Central Universities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants obtained from the National Basic Research Program of China (973 Program, 2011CB510206 [MP]), the National Science Foundation of China (30831160516 [MP] and 81200691 [MH]), the Ministry of Education of China (20090001120075 [MH]), Azalea (1972) Endowment Fund (KS & RC), and the Fundamental Research Fund for the Central Universities (21609101, KS), NIH EY04067 (NCB) and VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp H, 2012, EUR REV MED PHARMACO, V16, P144; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Cekauskas A, 2013, ANN TRANSPL, V18, P488, DOI 10.12659/AOT.884013; Chao HM, 2013, J OCUL PHARMACOL TH, V29, P539, DOI 10.1089/jop.2012.0179; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dvoriantchikova G, 2012, INVEST OPHTH VIS SCI, V53, P2823, DOI 10.1167/iovs.12-9526; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Fan JW, 2012, INVEST OPHTH VIS SCI, V53, P6541, DOI 10.1167/iovs.11-9241; Fang IM, 2013, EXP EYE RES, V113, P49, DOI 10.1016/j.exer.2013.05.007; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; Gunhan E, 2002, J NEUROSCI, V22, P2265, DOI 10.1523/JNEUROSCI.22-06-02265.2002; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hong Seong Min, 2012, Korean J Ophthalmol, V26, P248, DOI 10.3341/kjo.2012.26.4.248; Ishizuka F, 2013, INVEST OPHTH VIS SCI, V54, P5807, DOI 10.1167/iovs.13-11932; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kleszczynski K, 2013, PHARMACOL RES, V78, P28, DOI 10.1016/j.phrs.2013.09.009; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Kusari J, 2011, INVEST OPHTH VIS SCI, V52, P5424, DOI 10.1167/iovs.10-6262; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Leal EC, 2010, DIABETES, V59, P2637, DOI 10.2337/db09-1421; Li JB, 2014, CELL BIOCHEM BIOPHYS, V68, P275, DOI 10.1007/s12013-013-9707-4; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Nerland DE, 2007, DRUG METAB REV, V39, P235, DOI 10.1080/03602530601125000; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ren JW, 2011, NEUROCHEM RES, V36, P2352, DOI 10.1007/s11064-011-0561-8; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Shima C, 2012, OPHTHALMIC RES, V48, P199, DOI 10.1159/000340059; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Szabo ME, 2001, EUR J PHARMACOL, V428, P277, DOI 10.1016/S0014-2999(01)01196-7; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Tsuji Y, 2005, ONCOGENE, V24, P7567, DOI 10.1038/sj.onc.1208901; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P4766, DOI 10.1167/iovs.06-0871; Yoon HY, 2008, BIOCHEM PHARMACOL, V75, P2214, DOI 10.1016/j.bcp.2008.02.029; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhang ZZ, 2012, CURR EYE RES, V37, P429, DOI 10.3109/02713683.2011.653616; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807	60	54	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114186	10.1371/journal.pone.0114186	http://dx.doi.org/10.1371/journal.pone.0114186			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470382	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700082
J	Thanassekos, S; Cox, MJ; Reid, K				Thanassekos, Stephane; Cox, Martin J.; Reid, Keith			Investigating the Effect of Recruitment Variability on Length-Based Recruitment Indices for Antarctic Krill Using an Individual-Based Population Dynamics Model	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; EUPHAUSIA-SUPERBA; BIOMASS; DENSITY; GROWTH; MORTALITY; ECOSYSTEM; LINKS; AGE	Antarctic krill (Euphausia superba; herein krill) is monitored as part of an on-going fisheries observer program that collects length-frequency data. A krill feedback management programme is currently being developed, and as part of this development, the utility of data-derived indices describing population level processes is being assessed. To date, however, little work has been carried out on the selection of optimum recruitment indices and it has not been possible to assess the performance of length-based recruitment indices across a range of recruitment variability. Neither has there been an assessment of uncertainty in the relationship between an index and the actual level of recruitment. Thus, until now, it has not been possible to take into account recruitment index uncertainty in krill stock management or when investigating relationships between recruitment and environmental drivers. Using length-frequency samples from a simulated population - where recruitment is known - the performance of six potential length-based recruitment indices is assessed, by exploring the index-to-recruitment relationship under increasing levels of recruitment variability (from +/- 10% to +/- 100% around a mean annual recruitment). The annual minimum of the proportion of individuals smaller than 40 mm (F40 min, %) was selected because it had the most robust index-to-recruitment relationship across differing levels of recruitment variability. The relationship was curvilinear and best described by a power law. Model uncertainty was described using the 95% prediction intervals, which were used to calculate coverage probabilities and assess model performance. Despite being the optimum recruitment index, the performance of F40 min degraded under high (>50%) recruitment variability. Due to the persistence of cohorts in the population over several years, the inclusion of F40 min values from preceding years in the relationship used to estimate recruitment in a given year improved its accuracy (mean bias reduction of 8.3% when including three F40 min values under a recruitment variability of 60%).	[Thanassekos, Stephane; Reid, Keith] Commiss Conservat Antarct Marine Living Resources, Hobart, Tas, Australia; [Cox, Martin J.] Southern Ocean Ecosyst Change, Australian Antarct Div, Kingston, Tas, Australia	Australian Antarctic Division	Thanassekos, S (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	thanassekos@vims.edu			Australian Research Council [FS110200057]	Australian Research Council(Australian Research Council)	MJC is funded by the Australian Research Council's 'Superscience' fellowship scheme FS110200057 (http://www.arc.gov.au/ncgp/ssf/ssf_default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; CCAMLR, 2013, 32 M SCI COMM HOB; Constable AJ, 2012, REP WORK GR ECOSYST; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; de la Mare W., 1994, CCAMLR SCI, V1, P55; Hewitt RP, 2003, AQUAT LIVING RESOUR, V16, P205, DOI 10.1016/S0990-7440(03)00019-6; Houde Edward D., 2002, P64; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Kawaguchi S, 2007, MAR ECOL PROG SER, V345, P199, DOI 10.3354/meps06934; Kinzey D, 2013, CCAMLR SCI, V20, P81; Kinzey D, 2011, WGEMM1143; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Nicol S, 2000, CAN J FISH AQUAT SCI, V57, P168, DOI 10.1139/cjfas-57-S3-168; Nicol S, 2006, BIOSCIENCE, P56; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.4000/etudesromanes.3205, DOI 10.4000/ETUDESROMANES.3205]; Reid K, 2010, MAR ECOL PROG SER, V399, P243, DOI 10.3354/meps08356; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; ROSENBERG AA, 1986, NATURE, V324, P152, DOI 10.1038/324152a0; Siegel V, 1998, POLAR BIOL, V19, P393, DOI 10.1007/s003000050264; SIEGEL V, 1987, MAR BIOL, V96, P483, DOI 10.1007/BF00397966; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Siegel V, 2000, CAN J FISH AQUAT SCI, V57, P130, DOI 10.1139/cjfas-57-S3-130; Siegel V., 1997, CCAMLR Science, V4, P19; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Wiedenmann J, 2009, LIMNOL OCEANOGR, V54, P799, DOI 10.4319/lo.2009.54.3.0799; Ziegler PE, 2011, CCAMLR SCI, V18, P57	31	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114378	10.1371/journal.pone.0114378	http://dx.doi.org/10.1371/journal.pone.0114378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470296	Green Published, gold			2022-12-27	WOS:000349128700109
J	Becker, K; Hahn, CM; Saghafi, S; Jahrling, N; Wanis, M; Dodt, HU				Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich			Reduction of Photo Bleaching and Long Term Archiving of Chemically Cleared GFP-Expressing Mouse Brains	PLOS ONE			English	Article							EPOXY-RESIN; MICROSCOPY; SECTIONS	Tissue clearing allows microscopy of large specimens as whole mouse brains or embryos. However, lipophilic tissue clearing agents as dibenzyl ether limit storage time of GFP-expressing samples to several days and do not prevent them from photobleaching during microscopy. To preserve GFP fluorescence, we developed a transparent solid resin formulation, which maintains the specimens' transparency and provides a constant signal to noise ratio even after hours of continuous laser irradiation. If required, high-power illumination or long exposure times can be applied with virtually no loss in signal quality and samples can be archived for years.	[Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Chair Bioelect, A-1040 Vienna, Austria; [Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Technische Universitat Wien; Medical University of Vienna	Becker, K (corresponding author), Vienna Univ Technol, FKE, Chair Bioelect, A-1040 Vienna, Austria.	klaus.becker@tuwien.ac.at		saghafi, saiedeh/0000-0002-7598-541X; Becker, Klaus/0000-0002-2406-0476	Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF); Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish	Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Becker K, 2012, PLOS ONE, V7; Brorson SH, 1998, MICRON, V29, P89, DOI 10.1016/S0968-4328(98)00010-9; CAVEY MJ, 1993, T AM MICROSC SOC, V112, P81, DOI 10.2307/3226787; DENT JA, 1989, DEVELOPMENT, V105, P61; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; EICHEL FG, 1949, IND ENG CHEM, V41, P2623, DOI 10.1021/ie50479a054; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Groos S, 2001, J HISTOCHEM CYTOCHEM, V49, P397, DOI 10.1177/002215540104900313; Hardie NA, 2004, BRAIN RES, V1000, P200, DOI 10.1016/j.brainres.2003.10.071; Lee H, 1981, HDB RESINS; Lockwood WR, 1964, ANAT REC; Luft J, 1961, CYTOLOGY, V9, P409; Murray JM, 2007, J MICROSCOPY, V228, P30; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Tuchin VV, 2005, J PHYS D APPL PHYS, V38, P2497, DOI 10.1088/0022-3727/38/15/001; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922	17	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114149	10.1371/journal.pone.0114149	http://dx.doi.org/10.1371/journal.pone.0114149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463047	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700108
J	Lu, S; Ren, TS; Lu, YL; Meng, P; Sun, SY				Lu, Sen; Ren, Tusheng; Lu, Yili; Meng, Ping; Sun, Shiyou			Extrapolative Capability of Two Models That Estimating Soil Water Retention Curve between Saturation and Oven Dryness	PLOS ONE			English	Article							DESCRIBE; EQUATION	Accurate estimation of soil water retention curve (SWRC) at the dry region is required to describe the relation between soil water content and matric suction from saturation to oven dryness. In this study, the extrapolative capability of two models for predicting the complete SWRC from limited ranges of soil water retention data was evaluated. When the model parameters were obtained from SWRC data in the 0-1500 kPa range, the FX model (Fredlund and Xing, 1994) estimations agreed well with measurements from saturation to oven dryness with RMSEs less than 0.01. The GG model (Groenevelt and Grant, 2004) produced larger errors at the dry region, with significantly larger RMSEs and MEs than the FX model. Further evaluations indicated that when SWRC measurements in the 0-100 kPa suction range was applied for model establishment, the FX model was capable of producing acceptable SWRCs across the entire water content range. For a higher accuracy, the FX model requires soil water retention data at least in the 0- to 300-kPa range to extend the SWRC to oven dryness. Comparing with the Khlosi et al. (2006) model, which requires measurements in the 0-500 kPa range to reproduce the complete SWRCs, the FX model has the advantage of requiring less SWRC measurements. Thus the FX modeling approach has the potential to eliminate the processes for measuring soil water retention in the dry range.	[Lu, Sen; Meng, Ping] Chinese Acad Forestry, Res Inst Forestry, State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing 100091, Peoples R China; [Lu, Sen; Meng, Ping] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustaintable Forestry Sout, Nanjing 210037, Jiangsu, Peoples R China; [Ren, Tusheng; Lu, Yili] China Agr Univ, Dept Soil & Water, Beijing 100193, Peoples R China; [Sun, Shiyou] Hebei Acad Agr & Forestry Sci, Inst Agroresources & Environm, Shijiazhuang 050051, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Nanjing Forestry University; China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences	Ren, TS (corresponding author), China Agr Univ, Dept Soil & Water, Beijing 100193, Peoples R China.	tsren@cau.edu.cn	Lu, Yili/AAQ-2041-2020	Lu, Yili/0000-0001-7716-7173	Natural Science Foundation of China [41371240]; Beijing Natural Science Foundation [6133035]; Basic Research Fund of RIF [RIF2014-09]; CFERN & GENE Award Funds on Ecological Paper	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Basic Research Fund of RIF; CFERN & GENE Award Funds on Ecological Paper	This study was funded by the Natural Science Foundation of China (No. 41371240), the Beijing Natural Science Foundation (No. 6133035), the Basic Research Fund of RIF (No. RIF2014-09), and the CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders are not linked in any way to a profit making organization.	Campbell G., 1992, P INT WORKSH IND MET, P317; FAYER MJ, 1995, WATER RESOUR RES, V31, P1233, DOI 10.1029/95WR00173; FREDLUND DG, 1994, CAN GEOTECH J, V31, P521, DOI 10.1139/t94-061; Groenevelt PH, 2004, EUR J SOIL SCI, V55, P479, DOI 10.1111/j.1365-2389.2004.00617.x; Khlosi M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004699; Khlosi M, 2008, VADOSE ZONE J, V7, P87, DOI 10.2136/vzj2007.0099; Lu S, 2008, SOIL SCI SOC AM J, V72, P1542, DOI 10.2136/sssaj2007.0307N; PREBBLE RE, 1991, 113 CSIRO DIV SOILS; ROSS PJ, 1991, SOIL SCI SOC AM J, V55, P923, DOI 10.2136/sssaj1991.03615995005500040004x; ROSSI C, 1994, WATER RESOUR RES, V30, P701, DOI 10.1029/93WR03238; Schneider M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011049; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059475; Webb SW, 2000, WATER RESOUR RES, V36, P1425, DOI 10.1029/2000WR900057; Wolfram S., 2003, MATH BOOK	15	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113518	10.1371/journal.pone.0113518	http://dx.doi.org/10.1371/journal.pone.0113518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464503	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700034
J	van de Put, MAJ; Hoeksema, L; Wanders, W; Nolte, IM; Hooymans, JMM; Los, LI				van de Put, Mathijs A. J.; Hoeksema, Lisette; Wanders, Wouter; Nolte, Ilja M.; Hooymans, Johanna M. M.; Los, Leonoor I.			Postoperative Vision-Related Quality of Life in Macula-Off Rhegmatogenous Retinal Detachment Patients and Its Relation to Visual Function	PLOS ONE			English	Article							FUNCTION QUESTIONNAIRE; CONTRAST SENSITIVITY; HOLE SURGERY; VITRECTOMY; CLASSIFICATION; RECOVERY; DURATION; HEIGHT	Objective: To determine the vision-related quality of life (VR-QOL) after surgery for macula-off rhegmatogenous retinal detachment (RRD) in relation to visual acuity, contrast acuity, and color vision. Methods: In a prospective observational study, we included 55 patients with a macula-off RRD. Best corrected visual acuity (BCVA), color vision (saturated and desaturated color confusion indices (CCI)) and contrast acuity were measured at 12 months postoperatively in both the RRD eye and the fellow control eye, and the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) was filled out. Results: Operated and fellow control eyes differed significantly in mean LogMAR BCVA (P<0.0001), median Log contrast acuity (P<0.0001), saturated CCI (P=0.009), and desaturated CCI (P=0.016). Significant correlations were observed between the NEI VFQ-25 overall composite score and postoperative LogMAR BCVA (R=-0.551, P<0.0001), contrast acuity (R=0.472, P<0.0001), saturated CCI (R=-0.315, P=0.023), and desaturated CCI (R=-0.283, P=0.044). Conclusions: A lower VR-QOL was highly correlated to a worse postoperative BCVA and contrast acuity and to a lesser extent to color vision disturbances.	[van de Put, Mathijs A. J.; Hoeksema, Lisette; Wanders, Wouter; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hoeksema, Lisette; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Grad Sch Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl			Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek; Stichting blindenhulp	Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek; Stichting blindenhulp	Financial support was provided by Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, and Stichting blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON C, 1981, ACTA OPHTHALMOL, V59, P161; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Ghazi-Nouri SMS, 2006, BRIT J OPHTHALMOL, V90, P559, DOI 10.1136/bjo.2005.085142; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hirneiss C, 2007, BRIT J OPHTHALMOL, V91, P481, DOI 10.1136/bjo.2006.102376; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Klein R, 2001, ARCH OPHTHALMOL; Kreissig I, 1981, Dev Ophthalmol, V2, P77; Maguire M, 2004, OPHTHALMOLOGY, V111, P1307; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2013, NEI VFQ SCORING ALGO; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Matsuoka Y, 2012, INVEST OPHTH VIS SCI, V53, P3054, DOI 10.1167/iovs.11-9153; Mitry D, 2012, BR J OPHTHALMOL, P1; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Ozgur S, 2007, RETINA, V27, P359; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Rosser DA, 2003, INVEST OPHTH VIS SCI, V44, P3278, DOI 10.1167/iovs.02-1100; RUBIN GS, 1994, OPTOMETRY VISION SCI, V71, P750, DOI 10.1097/00006324-199412000-00005; Schweitzer KD, 2011, CAN J OPHTHALMOL, V46, P232, DOI 10.1016/j.jcjo.2011.05.010; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Tranos PG, 2004, AM J OPHTHALMOL, V138, P995, DOI 10.1016/j.ajo.2004.07.049; Van de Put MAJ, 2014, POSTOPERATIVE RECOVE; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Van der Sterre GW, 2013, NATL EYE I VISUAL FU; Zou HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028597	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114489	10.1371/journal.pone.0114489	http://dx.doi.org/10.1371/journal.pone.0114489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460011	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700136
J	Zhang, N; Wang, R; Li, X; Liu, X; Tang, ZB; Liu, YD				Zhang, Nan; Wang, Rong; Li, Xue; Liu, Xu; Tang, Zhaobing; Liu, Yunde			Are Ureaplasma spp. a Cause of Nongonococcal Urethritis? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							UREALYTICUM BIOVAR-2; ASSOCIATION; PARVUM; ETIOLOGY; MEN	Background: Nongonococcal urethritis (NGU) is the most common male reproductive tract syndrome. Ureaplasmas spp. including U. urealyticum and U. parvum, have been increasingly reported to be implicated in NGU. However, there are still many contradictions about their pathogenic role in NGU. Aims: The goals of this study were to evaluate the association of Ureaplasmas spp. with NGU, and to compare the prevalence of Ureaplasmas spp. infection in China relative to the world average. Methods: A systematic review and meta-analysis was conducted following standard guidelines for meta-analysis. The quality of included studies was assessed by Newcastle-Ottawa scale. Results: A total of seven studies involving 1,507 NGU patients and 1,223 controls were eligible for meta-analysis. There was no significant difference in the Ureaplasma spp. positive rate between the NGU and control groups. However, the U. urealyticum positive rate was significantly higher in NGU patients compared to controls; the U. parvum positive rate was significantly higher in controls compared to NGU patients. Furthermore, within the NGU patient group, the positive rate of U. urealyticum was significantly higher than that of U. parvum, whereas within the control group, the opposite trend was observed. Compared to the world average, a significantly higher positive rate of Ureaplasma spp. was observed in both the NGU and control groups in China. Conclusions: Our analysis supports that U. urealyticum, but not U. parvum, is an etiological agent in NGU. More detailed studies of these two species in China and the world could contribute to a better understanding of the epidemiology and pathogenesis, and facilitate the development of better strategies for treatment and prevention of NGU.	[Zhang, Nan; Liu, Xu] Tianjin Univ Tradit Chinese Med, Dept Clin Lab, Teaching Hosp 1, Tianjin, Peoples R China; [Wang, Rong; Li, Xue; Liu, Yunde] Tianjin Med Univ, Sch Lab Med, Div Clin Microbiol, Tianjin, Peoples R China; [Tang, Zhaobing] Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, Chongqing, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin Medical University; Chongqing Medical University	Wang, R (corresponding author), Tianjin Med Univ, Sch Lab Med, Div Clin Microbiol, Tianjin, Peoples R China.	wangrong825@126.com; yundeliu@126.com			Key Discipline Project of Tianjin Medical University [2004xk47]; Young Scholar Project of Tianjin Medical University [2009ky07]	Key Discipline Project of Tianjin Medical University; Young Scholar Project of Tianjin Medical University	This study is supported by the Key Discipline Project (2004xk47) and the Young Scholar Project (2009ky07) of Tianjin Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; *CDCP, 2005, SEX TRANSM DIS SURV; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Couldwell DL, 2010, INT J STD AIDS, V21, P337, DOI 10.1258/ijsa.2009.009499; De Francesco MA, 2009, EUR J CLIN MICROBIOL, V28, P641, DOI 10.1007/s10096-008-0687-z; Deguchi T, 2004, SEX TRANSM DIS, V31, P192, DOI 10.1097/01.OLQ.0000114653.26951.71; FORD DK, 1962, J BACTERIOL, V84, P1028, DOI 10.1128/JB.84.5.1028-1034.1962; [龚向东 Gong Xiangdong], 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P178; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horner P, 2001, CLIN INFECT DIS, V32, P995, DOI 10.1086/319594; Jiang Juan, 2005, Chinese Journal of Dermatology, V38, P600; Jiang Juan, 2006, Zhonghua Pifuke Zazhi, V39, P278; Kong FR, 1999, INT J SYST BACTERIOL, V49, P1879; Kong FR, 2000, J CLIN MICROBIOL, V38, P1175, DOI 10.1128/JCM.38.3.1175-1179.2000; Larsen B., 2010, INFECT DIS OBSTET GY, V2010, P1, DOI [10.1155/2010/521921, DOI 10.1155/2010/521921]; LEE Y-H, 1976, Journal of the American Venereal Disease Association, V3, P25; Li BL, 2009, CHIN J DERM VENEREOL, V23, P97; [李琴 Li Qin], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P4853; Lu F, 2009, INT J STD AIDS, V20, P241, DOI 10.1258/ijsa.2008.008290; Martin David H, 2008, Curr Infect Dis Rep, V10, P128, DOI 10.1007/s11908-008-0023-x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; OLEARY WM, 1990, CRIT REV MICROBIOL, V17, P161, DOI 10.3109/10408419009105723; Ondondo RO, 2010, SEX TRANSM INFECT, V86, P271, DOI 10.1136/sti.2009.040394; Povlsen K, 2002, EUR J CLIN MICROBIOL, V21, P97, DOI 10.1007/s10096-001-0665-1; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; SHEPARD M C, 1954, Am J Syph Gonorrhea Vener Dis, V38, P113; Shimada Y, 2014, INT J STD AIDS, V25, P294, DOI 10.1177/0956462413504556; SWARTZ SL, 1978, J INFECT DIS, V138, P445, DOI 10.1093/infdis/138.4.445; TAYLORROBINSON D, 1977, Q J MED, V46, P309; Wang S, 2007, CHINA J LEPR SKIN DI, V23, P465; Wang X, 2007, MED J QILU, V22, P147; Wells G.A., NEWCASTLE OTTAWA SCA; Wetmore CM, 2011, J INFECT DIS, V204, P1274, DOI 10.1093/infdis/jir517; WILLCOX RR, 1979, BRIT J VENER DIS, V55, P149; Xie Hui, 2002, Chinese Journal of Parasitic Disease Control, V15, P148; Yang J, 2010, CHIN J AIDS STD, V16, P396; Yoshida T, 2005, SEX TRANSM DIS, V32, P454, DOI 10.1097/01.olq.0000158932.78183.95; [周世航 ZHOU Shihang], 2005, [中国微生态学杂志, Chinese Journal of Microecology], V17, P427	40	31	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113771	10.1371/journal.pone.0113771	http://dx.doi.org/10.1371/journal.pone.0113771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463970	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700051
J	Weber, B; Tranfield, EM; Hoog, JL; Baum, D; Antony, C; Hyman, T; Verbavatz, JM; Prohaska, S				Weber, Britta; Tranfield, Erin M.; Hoeoeg, Johanna L.; Baum, Daniel; Antony, Claude; Hyman, Tony; Verbavatz, Jean-Marc; Prohaska, Steffen			Automated Stitching of Microtubule Centerlines across Serial Electron Tomograms	PLOS ONE			English	Article							MICROSCOPY; ELEGANS; YEAST; RECONSTRUCTION; REGISTRATION; CYTOSKELETON; ARCHITECTURE; PARAMETERS; ALIGNMENT; FEATURES	Tracing microtubule centerlines in serial section electron tomography requires microtubules to be stitched across sections, that is lines from different sections need to be aligned, endpoints need to be matched at section boundaries to establish a correspondence between neighboring sections, and corresponding lines need to be connected across multiple sections. We present computational methods for these tasks: 1) An initial alignment is computed using a distance compatibility graph. 2) A fine alignment is then computed with a probabilistic variant of the iterative closest points algorithm, which we extended to handle the orientation of lines by introducing a periodic random variable to the probabilistic formulation. 3) Endpoint correspondence is established by formulating a matching problem in terms of a Markov random field and computing the best matching with belief propagation. Belief propagation is not generally guaranteed to converge to a minimum. We show how convergence can be achieved, nonetheless, with minimal manual input. In addition to stitching microtubule centerlines, the correspondence is also applied to transform and merge the electron tomograms. We applied the proposed methods to samples from the mitotic spindle in C. elegans, the meiotic spindle in X. laevis, and sub-pellicular microtubule arrays in T. brucei. The methods were able to stitch microtubules across section boundaries in good agreement with experts' opinions for the spindle samples. Results, however, were not satisfactory for the microtubule arrays. For certain experiments, such as an analysis of the spindle, the proposed methods can replace manual expert tracing and thus enable the analysis of microtubules over long distances with reasonable manual effort.	[Weber, Britta; Baum, Daniel; Prohaska, Steffen] Zuse Inst Berlin, Berlin, Germany; [Tranfield, Erin M.; Antony, Claude] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Weber, Britta; Hoeoeg, Johanna L.; Hyman, Tony; Verbavatz, Jean-Marc] Max Planck Inst Mol Biol & Genet, Dresden, Germany; [Hoeoeg, Johanna L.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Zuse Institute Berlin; European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Oxford	Verbavatz, JM (corresponding author), Max Planck Inst Mol Biol & Genet, Dresden, Germany.	verbavat@mpi-cbg.de; prohaska@zib.de	Tranfield, Erin M/AAU-4177-2020; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Tranfield, Erin M/0000-0002-1542-7459; Hyman, Anthony A/0000-0003-3664-154X; Hoog, Johanna/0000-0003-2162-3816; Baum, Daniel/0000-0003-1550-7245; Verbavatz, Jean-Marc/0000-0002-4654-1174	Sir Henry Wellcome postdoctoral fellowship; NIH-NCRR [P41-RR000592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Sir Henry Wellcome postdoctoral fellowship; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: JLH's research was funded by a Sir Henry Wellcome postdoctoral fellowship. JLH's imaging at The Boulder Lab for 3D Electron Microscopy was supported by NIH-NCRR, Grant P41-RR000592 to Andreas Hoenger. The other authors received no specific funding for this work.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Baum D, 2006, LECT NOTES COMPUT SC, V4216, P183; Bishop C. M., 2006, J ELECT IMAG, V16, P140; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Caetano TS, 2006, IEEE T PATTERN ANAL, V28, P1646, DOI 10.1109/TPAMI.2006.207; Dekking F, 2010, SPRINGER TEXTS STAT; Dercksen VJ, 2009, I S BIOMED IMAGING, P971, DOI 10.1109/ISBI.2009.5193216; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Elidan G, 2006, P 22 C UNC AI UAI BO; Farr H, 2012, CYTOSKELETON, V69, P931, DOI 10.1002/cm.21074; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Frank J., 2006, ELECT TOMOGRAPHY MET, P17, DOI 10.1007/978-0-387-69008-7_2; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Hoog JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01479; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hoog JL, 2010, METHOD CELL BIOL, V96, P175, DOI 10.1016/S0091-679X(10)96008-1; Hogrebe L, 2012, J NEUROSCI METH, V207, P200, DOI 10.1016/j.jneumeth.2012.03.002; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Li J, 2008, NEUROCOMPUTING, V71, P1771, DOI 10.1016/j.neucom.2007.11.032; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Mardia K.V., 2000, WILEY SERIES PROBABI; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McIntosh JR, 2013, J CELL BIOL, V200, P459, DOI 10.1083/jcb.201209154; Mooij JM, 2010, J MACH LEARN RES, V11, P2169; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Myronenko A., 2009, CLOSED FORM SOLUTION; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; O'Toole E, 2012, PLOS ONE, V7, P140, DOI 10.1371/journal.pone.0029795; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Rangarajan A, 1997, Med Image Anal, V1, P379; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Sanghavi S, 2011, IEEE T INFORM THEORY, V57, P2203, DOI 10.1109/TIT.2011.2110170; Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920; Sorokine V, 1998, IEEE T INFORM THEORY, V44, P410, DOI 10.1109/18.651072; Stalling D., 2005, VISUAL HDB, V38, P749, DOI DOI 10.1016/B978-012387582-2/50040-X; UMEYAMA S, 1991, IEEE T PATTERN ANAL, V13, P376, DOI 10.1109/34.88573; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; WALKER MW, 1991, CVGIP-IMAG UNDERSTAN, V54, P358, DOI 10.1016/1049-9660(91)90036-O; Weber B, 2012, J STRUCT BIOL, V178, P129, DOI 10.1016/j.jsb.2011.12.004; Wells WM, 1997, INT J COMPUT VISION, V21, P63, DOI 10.1023/A:1007923522710; Yao JA, 2010, IEEE IMAGE PROC, P4321, DOI 10.1109/ICIP.2010.5652449	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113222	10.1371/journal.pone.0113222	http://dx.doi.org/10.1371/journal.pone.0113222			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438148	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900035
J	Huang, X; Tan, H; Li, X; Zhou, SJ; Wen, SW; Luo, ML				Huang, Xin; Tan, Hongzhuan; Li, Xun; Zhou, Shujin; Wen, Shi Wu; Luo, Meiling			Maternal Chronic HBV Infection Would Not Increase the Risk of Pregnancy-Induced Hypertension - Results from Pregnancy Cohort in Liuyang Rural China	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CARRIER STATUS; PREECLAMPSIA; PREVENTION; PREVALENCE; MORTALITY; OUTCOMES; WOMEN; EPIDEMIOLOGY; MOTHERS	The relationship between maternal HBV (hepatitis B virus) infection and pregnancy-induced hypertension (PIH) is inconclusive. Few studies have been conducted in rural areas of China. In order to examine the association between maternal chronic HBV infection and risk of PIH in Liuyang rural area China, we enrolled 6,195 eligible pregnant women in 2010-2011 in selected 14 towns of Liuyang on their first prenatal visit to local maternity care unit. A total of 461 subjects (7.44% (95%CI: 6.79%, 8.10%)) were identified with positive HBsAg status (exposed group) and 5734 were non-HBV carriers (unexposed group). Multivariate log-binomial regression models were used to estimate the risk of PIH, gestational hypertension (GH), and preeclampsia (PE) in relation to maternal chronic HBV infection. There are total of 455 subjects diagnosed with PIH (7.34% (95% CI: 6.70%, 7.99%)), including 371 GH (5.99% (95% CI: 5.40%, 6.58%)) and 81 PE (1.31% (95% CI: 1.07%, 1.64%)). The crude risk ratio between PIH, GH, PE and maternal HBV infection were 1.20 (95% CI: 0.88, 1.64), 1.30(95% CI: 0.93, 1.81) and 0.79 (95% CI: 0.32, 1.93), respectively. After adjustment for gravidity history, abortion history, family history of Diabetes Mellitus (DM) and family history of hypertension, positive HBsAg status was still not significantly associated with PIH (RR=1.18, 95% CI: 0.87, 1.62), GH (RR=1.27, 95% CI: 0.91, 1.78) or PE (RR=0.79, 95% CI: 0.32, 1.95). Additional adjustment for maternal age, marital status, parity history, family history of DM, Body Mass Index at first antenatal visit, folic acid supplementation, smoking status during pregnancy and economic status of living area, multivariate analysis provided similar results. In conclusion, our study found that maternal chronic HBV infection prevalence rate is 7.4% among Liuyang rural area and there is no significant association between maternal HBV infection and the risk of PIH, GH or PE.	[Huang, Xin; Tan, Hongzhuan; Li, Xun; Wen, Shi Wu; Luo, Meiling] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Zhou, Shujin] Liuyang Municipal Hosp Maternal & Child Hlth, Liuyang, Hunan, Peoples R China; [Wen, Shi Wu] Univ Ottawa, OMNI Res Grp, Dept Obstet & Gynaecol, Ottawa, ON, Canada	Central South University; University of Ottawa	Tan, H (corresponding author), Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	tanhz99@qq.com		Huang, Xin/0000-0002-4874-3626	Canadian Institute of Health Research [CIHR MOP 115183, CIHR MOP 86562]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	HT and SWW received funding from the Canadian Institute of Health Research (grants CIHR MOP 115183, CIHR MOP 86562) to do this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Changsha City Bureau of Statistics National Bureau of Changsha Survey Organization, 2010, CHANGSH STAT YB 2010, P417; Chen XK, 2006, BJOG-INT J OBSTET GY, V113, P544, DOI 10.1111/j.1471-0528.2006.00898.x; Connell LE, 2011, LIVER INT, V31, P1163, DOI 10.1111/j.1478-3231.2011.02556.x; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hudu SA, 2014, CURR ISSUES MOL BIOL, V16, P69; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Ishizaka N, 2002, CIRCULATION, V105, P1028, DOI 10.1161/hc0902.105718; Ji ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097474; Lao TT, 2013, J VIRAL HEPATITIS, V20, P343, DOI 10.1111/jvh.12037; Lao TT, 2007, J HEPATOL, V47, P46, DOI 10.1016/j.jhep.2007.02.014; Li F, 2012, VACCINE, V30, P7118, DOI 10.1016/j.vaccine.2012.09.031; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lobstein S, 2011, DIGESTION, V83, P76, DOI 10.1159/000320455; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Rao AK, 2006, AM J OBSTET GYNECOL, V195, P834, DOI 10.1016/j.ajog.2006.06.079; Reddick KLB, 2011, J VIRAL HEPATITIS, V18, pE394, DOI 10.1111/j.1365-2893.2011.01436.x; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; Saleh-Gargari S, 2009, HEPAT MON, V9, P180; Sarin SK, 2009, CLIN GASTROENT-SER, P185, DOI 10.1007/978-1-59745-565-7_7; Sirilert S, 2014, INT J GYNECOL OBSTET, V126, P106, DOI 10.1016/j.ijgo.2014.02.019; Sung J, 2007, STROKE, V38, P1436, DOI 10.1161/STROKEAHA.106.466268; To WWK, 2003, AUST NZ J OBSTET GYN, V43, P119, DOI 10.1046/j.0004-8666.2003.00029.x; Tse KY, 2005, J HEPATOL, V43, P771, DOI 10.1016/j.jhep.2005.05.023; Wong SF, 1999, AM J PERINAT, V16, P485, DOI 10.1055/s-1999-6802; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; Zhang Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-25	32	14	14	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114248	10.1371/journal.pone.0114248	http://dx.doi.org/10.1371/journal.pone.0114248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479003	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200055
J	Pearce, CW; Young, PG				Pearce, Christopher W.; Young, Philippe G.			On the Pressure Response in the Brain due to Short Duration Blunt Impacts	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; HEAD-INJURY; BIOMECHANICS	When the head is subject to non-penetrating (blunt) impact, contusion-type injuries are commonly identified beneath the impact site (the coup) and, in some instances, at the opposite pole (the contre-coup). This pattern of injury has long eluded satisfactory explanation and blunt head injury mechanisms in general remain poorly understood. There are only a small number of studies in the open literature investigating the head's response to short duration impacts, which can occur in collisions with light projectiles. As such, the head impact literature to date has focussed almost exclusively on impact scenarios which lead to a quasi-static pressure response in the brain. In order to investigate the response of the head to a wide range of impact durations, parametric numerical studies were performed on a highly bio-fidelic finite element model of the human head created from in vivo magnetic resonance imaging (MRI) scan data with non-linear tissue material properties. We demonstrate that short duration head impacts can lead to potentially deleterious transients of positive and negative intra-cranial pressure over an order of magnitude larger than those observed in the quasi-static regime despite reduced impact force and energy. The onset of this phenomenon is shown to be effectively predicted by the ratio of impact duration to the period of oscillation of the first ovalling mode of the system. These findings point to dramatically different pressure distributions in the brain and hence different patterns of injury depending on projectile mass, and provide a potential explanation for dual coup/contre-coup injuries observed clinically.	[Pearce, Christopher W.; Young, Philippe G.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	University of Exeter	Young, PG (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Harrison Bldg,North Pk Rd, Exeter EX4 4QF, Devon, England.	philippe.g.young@exeter.ac.uk						Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Bhateja A, 2009, INDIAN J NEUROTRAUM, V6, P115, DOI 10.1016/S0973-0508(09)80004-X; Bradshaw D., 2001, P 17 INT TECHN C ENH, P1; Brennen CE, 2003, P 5 INT S CAV OS JAP; Cifu D.X., 2010, TRAUMATIC BRAIN INJU; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; Gadd C. W., 1970, P 14 STAPP CAR CRASH, P356; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Johnsen E, 2009, P 7 INT S CAV MICH U; KABO JM, 1983, J BIOMECH, V16, P313, DOI 10.1016/0021-9290(83)90015-5; KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maruoka K, 2001, MAT SCI SPORTS S, V7514, P145; Mathai KI, 2009, INDIAN J NEUROTRAUM, V6, P17; Nahum A.M., 1977, 21 STAPP CAR CRASH C; NASA, 1995, MAN SYST INT STAND, V1; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; R&A Rules Ltd, 2008, IN VEL TEST PROC; Roberts J., 2001, SPORTS ENG, V4, P191, DOI [10.1046/j.1460-2687.2001.00084.x, DOI 10.1046/J.1460-2687.2001.00084.X]; Sauren A, 1993, INT IRCOBI C BIOM IM, P241; Suh CM, 2005, J MECH SCI TECHNOL, V19, P1424, DOI 10.1007/BF03023901; US Centers for Disease Control and Prevention, 2010, GET STATS TRAUM BRAI; WAHI KK, 1977, ANN BIOMED ENG, V5, P303, DOI 10.1007/BF02367311; Ward C., 1980, SAE TECHNICAL PAPER; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090; Young PG, 2003, J SOUND VIB, V267, P1107, DOI 10.1016/S0022-460X(03)00200-1; Young PG, 1998, IRCOBI C GOT SEPT, P391; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	35	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114292	10.1371/journal.pone.0114292	http://dx.doi.org/10.1371/journal.pone.0114292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478695	Green Published, gold			2022-12-27	WOS:000346907200067
J	dos Santos, FK; Maia, JAR; Gomes, TNQF; Daca, T; Madeira, A; Katzmarzyk, PT; Prista, A				dos Santos, Fernanda Karina; Maia, Jose A. R.; Gomes, Thayse Natacha Q. F.; Daca, Timoteo; Madeira, Aspacia; Katzmarzyk, Peter T.; Prista, Antonio			Secular Trends in Growth and Nutritional Status of Mozambican School-Aged Children and Adolescents	PLOS ONE			English	Article							HEIGHT; OBESITY; WEIGHT; HEALTH; UNDERWEIGHT; TRANSITION	Objectives: The purpose of this study was to examine secular changes in growth and nutritional status of Mozambican children and adolescents between 1992, 1999 and 2012. Methods: 3374 subjects (1600 boys, 1774 girls), distributed across the three time points (523 subjects in 1992; 1565 in 1999; and 1286 in 2012), were studied. Height and weight were measured, BMI was computed, and WHO cut-points were used to define nutritional status. ANCOVA models were used to compare height, weight and BMI across study years; chi-square was used to determine differences in the nutritional status prevalence across the years. Results: Significant differences for boys were found for height and weight (p<0.05) across the three time points, where those from 2012 were the heaviest, but those in 1999 were the tallest, and for BMI the highest value was observed in 2012 (1992<2012, 1999<2012). Among girls, those from 1999 were the tallest (1992<1999, 1999>2012), and those from 2012 had the highest BMI (1999<2012). In general, similar patterns were observed when mean values were analyzed by age. A positive trend was observed for overweight and obesity prevalences, whereas a negative trend emerged for wasting, stunting-wasting (in boys), and normal-weight (in girls); no clear trend was evident for stunting. Conclusion: Significant positive changes in growth and nutritional status were observed among Mozambican youth from 1992 to 2012, which are associated with economic, social and cultural transitional processes, expressing a dual burden in this population, with reduction in malnourished youth in association with an increase in the prevalence of overweight and obesity.	[dos Santos, Fernanda Karina; Maia, Jose A. R.; Gomes, Thayse Natacha Q. F.] Univ Porto, Fac Sport, Kinanthropometry Lab, CIFI2D, P-4100 Oporto, Portugal; [dos Santos, Fernanda Karina] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Daca, Timoteo; Madeira, Aspacia; Prista, Antonio] Pedag Univ, Fac Phys Educ & Sports, Maputo, Mozambique; [Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA	Universidade do Porto; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Prista, A (corresponding author), Pedag Univ, Fac Phys Educ & Sports, Maputo, Mozambique.	aprista1@gmail.com	Katzmarzyk, Peter T/N-1974-2017; Prista, António/ABE-7056-2020; Daca, Timoteo Salvador Lucas/AAE-5460-2022; Daca, Timoteo/AAE-5432-2022; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020	Katzmarzyk, Peter T/0000-0002-9280-6022; Daca, Timoteo/0000-0002-7914-4984; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238				African Development Bank Group, 2011, REP MOZ COUNTR STRAT; Akachi Y, 2007, ANN HUM BIOL, V34, P397, DOI 10.1080/03014460701452868; Amugsi DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-960; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Araujo M., 2003, GEOUSP ESPACO TEMPO, V14, P165, DOI DOI 10.11606/ISSN.2179-0892.GEOUSP.2003.123846; Armstrong MEG, 2011, EUR J CLIN NUTR, V65, P835, DOI 10.1038/ejcn.2011.46; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bi ZW, 2005, ANN HUM BIOL, V32, P650, DOI 10.1080/03014460500154418; Castilho LV, 2001, ANN HUM BIOL, V28, P564, DOI 10.1080/03014460110045146; Danker-Hopfe H, 2000, ANN HUM BIOL, V27, P263; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Garcia J, 2007, ECON HUM BIOL, V5, P340, DOI 10.1016/j.ehb.2007.02.002; Instituto Nacional de Estatistica IP, 2013, EST CPLP 2012; Krawczynski M, 2003, ACTA PAEDIATR, V92, P277, DOI 10.1080/08035250310009176; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-166; Ministerio do Plano e Financas, 1998, MOC POL NAC POP; Nhampoca JMD, 2013, RURAL URBANO COEXIST; OECD, 2008, AFR EC OUTL 2008, P459; Padez C, 2003, ANN HUM BIOL, V30, P262, DOI 10.1080/0301446031000064530; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Prista A, 2010, DESAFIO CALANGA LUGA, P29; Prista A, 2002, SAUDE CRESCIMENTO DE, P7; Republica de Mocambique, 2010, REL OBJ DES MIL; Saranga S, 2008, R BRAS CI MOV, V16, P17; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Tanner J.M., 1982, ATLAS CHILDRENS GROW; Tanner JM., 1990, GROWTH MIRROR CONDIT, P9; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; UNICEF, 2013, MOZ STAT; United Nations Children's Fund WHO The World Bank. UNICEF-WHO-World Bank, 2012, JOINT CHILD MALN EST; United Nations Development Programme (UNDP), 2000, MOZ NAT HUM DEV REP; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United Nations Human Settlements Programme, 2008, MOZ URB SECT PROF; Vorster HH, 2010, LINK POVERTY MALNUTR; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2000, OB PREV MAN GLOB EP; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization, 2013, WHO AFR REG MOZ SAT; World Health Organization, 1995, PHYS STAT US INT ANT; Zellner K, 2004, ECON HUM BIOL, V2, P281, DOI 10.1016/j.ehb.2004.04.006	44	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114068	10.1371/journal.pone.0114068	http://dx.doi.org/10.1371/journal.pone.0114068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473837	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500108
J	Frostegard, AG; Su, J; Hua, X; Vikstrom, M; de Faire, U; Frostegard, J				Frostegard, Anna G.; Su, Jun; Hua, Xiang; Vikstrom, Max; de Faire, Ulf; Frostegard, Johan			Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; CARDIOVASCULAR-DISEASE; EUROPEAN LACIDIPINE; PROTECTIVE FACTORS; APOPTOTIC CELLS; EXTERNALIZATION; HYPERTENSION; RECOGNITION; CLEARANCE	Background: Antibodies against cardiolipin and phosphatidylserine (anti-CL and anti-PS) are associated with thrombosis. In contrast, we determined that IgM antibodies against oxidized CL and PS (OxCL and OxPS) and phosphorylcholine (anti-PC) could be protection markers for cardiovascular disease (CVD). Methods: 226 individuals with established hypertension (diastolic pressure >95 mmHg) from the European Lacidipine Study on Atherosclerosis. Antibodies were tested by ELISA. As a surrogate measure of atherosclerosis, the mean of the maximum intima-media thicknesses (IMT) in the far walls of common carotids and bifurcations was determined by ultrasonography at the time of inclusion and 4 years following inclusion. Results: Increases in IMT measures at follow-up were significantly less common in subjects which at baseline had high IgM anti-OxPS and anti-PC at above 75th percentile: OR 0,45, CI (0,23-0,86) and OR 0.37, CI (0,19-0,71), p=0.0137 respectively and above 90th percentile: OR 0.32, CI (0,12-0,84) and OR 0.39, CI (0,15-1.00), p=0.050 and OR 0,22, CI (0,08-0,59) p=0,0029. IgM anti-OxCL was negatively associated with IMT increases (OR, 0.32, CI (0,12-0,84), p=0231). There were no associations for IgM anti-PS or anti-CL. Anti-PC, as determined herein by a commercial ELISA, was strongly associated with data from our previously published in house ELISA (R=0,87; p=0,0001).) Anti-PC was also a risk marker at low levels (below 25th percentile; OR=2,37 (1,16-4,82), p=0,0177). Conclusions: High levels of IgM anti-OxPS and anti-OxCL, but not traditional antiphospholipid antibodies (anti-PS and anti-CL), are associated with protection against atherosclerosis development. In addition, low IgM anti-PC was a risk marker but high a protection marker.	[Frostegard, Anna G.; Su, Jun; Hua, Xiang; Frostegard, Johan] Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden; [Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Cardiovasc Epidemiol Unit, S-10401 Stockholm, Sweden; [Frostegard, Johan] Karolinska Univ Hosp, Dept Acute Internal Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Frostegard, AG (corresponding author), Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden.	anna.frostegard@ki.se		Frostegard, Johan/0000-0002-3569-3367	Stockholm County Council; Karolinska Institutet; Swedish Science Fund; King Gustav V 80th year's foundation; Swedish Heart Lung foundation; Swedish Rheumatism Association; CIDaT, Vinnova; Torsten Soderberg Foundation; 6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (CVDIMMUNE) [LSHM-CT-2006-037227]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Science Fund; King Gustav V 80th year's foundation; Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Swedish Rheumatism Association; CIDaT, Vinnova(Vinnova); Torsten Soderberg Foundation; 6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (CVDIMMUNE)	This study was supported by (1) (JF) The regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet; (2) (JF) the Swedish Science Fund, the King Gustav V 80th year's foundation; (3) (JF/uDF) The Swedish Heart Lung foundation; (4) (JF) The Swedish Rheumatism Association; (5) (JF) CIDaT, Vinnova; (6) (JF) Torsten Soderberg Foundation; and (7) (JF/udF)6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (grant LSHM-CT-2006-037227 CVDIMMUNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Caidahl K, 2013, INT J CARDIOL, V167, P464, DOI 10.1016/j.ijcard.2012.01.018; Cederholm A, 2005, ARTERIOSCL THROM VAS, V25, P198, DOI 10.1161/01.ATV.0000150415.18759.36; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Fiskesund Roland, 2012, Results Immunol, V2, P13, DOI 10.1016/j.rinim.2012.01.001; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Frostegard AG, 2013, CLIN EXPT IMMUNOLOGY; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Frostegard J, 2005, ARTERIOSCL THROM VAS, V25, P1776, DOI 10.1161/01.ATV.0000174800.78362.ec; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Geller BJ, 2013, J THROMB THROMBOLYSI; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; Horkko S, 1996, J CLIN INVEST, V98, P815, DOI 10.1172/JCI118854; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; NISHINARITA S, 1990, MED MICROBIOL IMMUN, V179, P205; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Sobel M, 2013, J VASC SURG, V58, P997, DOI 10.1016/j.jvs.2013.04.042; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Su J, 2013, J RHEUMATOLOGY; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Su J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-1; Tuominen A, 2006, ARTERIOSCL THROM VAS, V26, P2096, DOI 10.1161/01.ATV.0000233333.07991.4a; Zanchetti A, 1998, J HYPERTENS, V16, P949, DOI 10.1097/00004872-199816070-00008; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	30	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111764	10.1371/journal.pone.0111764	http://dx.doi.org/10.1371/journal.pone.0111764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473948	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500064
J	Gastner, MT; Markou, N; Pruessner, G; Draief, M				Gastner, Michael T.; Markou, Nikolitsa; Pruessner, Gunnar; Draief, Moez			Opinion Formation Models on a Gradient	PLOS ONE			English	Article							EXPLOSIVE PERCOLATION; INVASION PERCOLATION; DIFFUSION FRONTS; SIMULATION; EXPONENTS; CLUSTER	Statistical physicists have become interested in models of collective social behavior such as opinion formation, where individuals change their inherently preferred opinion if their friends disagree. Real preferences often depend on regional cultural differences, which we model here as a spatial gradient g in the initial opinion. The gradient does not only add reality to the model. It can also reveal that opinion clusters in two dimensions are typically in the standard (i.e., independent) percolation universality class, thus settling a recent controversy about a non-consensus model. However, using analytical and numerical tools, we also present a model where the width of the transition between opinions scales proportional to g (1/4), not proportional to g(-4/7) as in independent percolation, and the cluster size distribution is consistent with first-order percolation.	[Gastner, Michael T.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Budapest, Hungary; [Gastner, Michael T.] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Gastner, Michael T.; Pruessner, Gunnar] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Markou, Nikolitsa; Draief, Moez] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Bristol; Imperial College London; Imperial College London	Gastner, MT (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Budapest, Hungary.	mgastner@gmail.com	Gastner, Michael T./AAK-5088-2021	Gastner, Michael T./0000-0002-1097-8833	Imperial College London Junior Research Fellowship; European Commission [FP7-PEOPLE-2012-IEF 6456412013]	Imperial College London Junior Research Fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre)	MTG was supported by an Imperial College London Junior Research Fellowship: http://www3.imperial.ac.uk/juniorresearchfellowships. MTG was supported by the European Commission, project number FP7-PEOPLE-2012-IEF 6456412013: http://ec.europa.eu/research/mariecurieactions/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Amini H, 2009, LECT NOTES COMPUT SC, V5425, P17; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; BIROVLJEV A, 1991, PHYS REV LETT, V67, P584, DOI 10.1103/PhysRevLett.67.584; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Cho YS, 2013, SCIENCE, V339, P1185, DOI 10.1126/science.1230813; Christensen K, 2008, EUR PHYS J B, V62, P331, DOI 10.1140/epjb/e2008-00173-2; Clem RS, 2004, EURASIAN GEOGR ECON, V45, P475, DOI 10.2747/1538-7216.45.7.475; Cutler F, 2002, CANADA STATE FEDERAT, P367; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; DEOLIVEIRA MJ, 1992, J STAT PHYS, V66, P273, DOI 10.1007/BF01060069; DHAR D, 1981, J PHYS C SOLID STATE, V14, pL1, DOI 10.1088/0022-3719/14/1/001; EDWARDS SF, 1982, P ROY SOC LOND A MAT, V381, P17, DOI 10.1098/rspa.1982.0056; Galam S, 2005, EUROPHYS LETT, V70, P705, DOI 10.1209/epl/i2004-10526-5; Gastner MT, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103019; Gastner MT, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.128103; Gastner MT, 2009, AM NAT, V174, pE23, DOI 10.1086/599292; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; GOUYET JF, 1988, SOLID STATE IONICS, V28, P72, DOI 10.1016/S0167-2738(88)80010-9; Gouyet JF, 2005, PHYSICA A, V357, P86, DOI 10.1016/j.physa.2005.05.054; Gradowski TM, 2006, INT J MOD PHYS C, V17, P1327, DOI 10.1142/S0129183106009825; GROSSMAN T, 1986, J PHYS A-MATH GEN, V19, pL745, DOI 10.1088/0305-4470/19/12/009; Hader A, 2002, EUR PHYS J B, V28, P315, DOI 10.1140/epjb/e2002-00235-5; Klinker, 2004, FORUM, V2, P2, DOI DOI 10.2202/1540-8884.1035; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Lambiotte R, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/10/L10001; Lambiotte R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046101; Lang RE, 2008, RED, BLUE, AND PURPLE AMERICA: THE FUTURE OF ELECTION DEMOGRAPHICS, P25; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Martins ACR, 2009, PHYSICA A, V388, P3225, DOI 10.1016/j.physa.2009.04.007; Mobilia M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08029; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Newman MEJ, 2000, PHYS REV LETT, V85, P4104, DOI 10.1103/PhysRevLett.85.4104; Nolin P, 2008, ANN PROBAB, V36, P1748, DOI 10.1214/07-AOP375; Riordan O, 2011, SCIENCE, V333, P322, DOI 10.1126/science.1206241; Roca C., 2012, SOCIAL SELF ORG, P169; SAPOVAL B, 1985, J PHYS LETT-PARIS, V46, pL149, DOI 10.1051/jphyslet:01985004604014900; Sattari A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.079801; Schwarzer S, 1999, PHYS REV E, V59, P3262, DOI 10.1103/PhysRevE.59.3262; Shao J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.079802; Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701; Stauffer D, 2004, J MATH SOCIOL, V28, P25, DOI 10.1080/00222500490278531; Stauffer D, 2004, PHYSICA A, V334, P558, DOI 10.1016/j.physa.2003.12.003; Stauffer D., 1991, INTRO PERCOLATION TH; Stauffer D, 2013, J STAT PHYS, V151, P9, DOI 10.1007/s10955-012-0604-9; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Van Kampen NG, 1992, STOCHASTIC PROCESSES; VOSS RF, 1984, J PHYS A-MATH GEN, V17, pL373, DOI 10.1088/0305-4470/17/7/001; Vvedensky DD, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.025102; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527	52	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114088	10.1371/journal.pone.0114088	http://dx.doi.org/10.1371/journal.pone.0114088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474528	Green Published, Green Accepted, gold			2022-12-27	WOS:000346382500114
J	Kapetanakis, VV; Rudnicka, AR; Wathern, AK; Lennon, L; Papacosta, O; Cook, DG; Wannamethee, SG; Whincup, PH; Owen, CG				Kapetanakis, Venediktos V.; Rudnicka, Alicja R.; Wathern, Andrea K.; Lennon, Lucy; Papacosta, Olia; Cook, Derek G.; Wannamethee, S. Goya; Whincup, Peter H.; Owen, Christopher G.			Adiposity in Early, Middle and Later Adult Life and Cardiometabolic Risk Markers in Later Life; Findings from the British Regional Heart Study	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; COHORT PROFILE; WEIGHT CHANGE; BIRTH-WEIGHT; OBESITY; OVERWEIGHT; MORTALITY	Objectives: This research investigates the associations between body mass index (BMI) at 21, 40-59, 60-79 years of age on cardiometabolic risk markers at 60-79 years. Methods: A prospective study of 3464 British men with BMI measured at 40-59 and 60-79 years, when cardiometabolic risk was assessed. BMI at 21 years was ascertained from military records, or recalled from middle-age (adjusted for reporting bias); associations between BMI at different ages and later cardiometabolic risk markers were examined using linear regression. Sensitive period, accumulation and mobility life course models were devised for high BMI (defined as BMI >= 75th centile) and compared with a saturated BMI trajectory model. Results: At ages 21, 40-59 and 60-79 years, prevalences of overweight (BMI >= 25 kg/m(2)) were 12%, 53%, 70%, and obesity (>= 30 kg/m(2)) 1.6%, 6.6%, and 17.6%, respectively. BMI at 21 years was positively associated with serum insulin, blood glucose, and HbA1c at 60-79 years, with increases of 1.5% (95% CI 0.8,2.3%), 0.4% (0.1,0.6%), 0.3% (0.1,0.4%) per 1 kg/m(2), respectively, but showed no associations with blood pressure or blood cholesterol. However, these associations were modest compared to those between BMI at 60-79 years and serum insulin, blood glucose and HbA1c at 60-79 years, with increases of 8.6% (8.0,9.2%), 0.7% (0.5,0.9%), and 0.5% (0.4,0.7%) per 1 kg/m(2), respectively. BMI at 60-79 years was also associated with total cholesterol and blood pressure. Associations for BMI at 40-59 years were mainly consistent with those of BMI at 60-79 years. None of the life course models fitted the data as well as the saturated model for serum insulin. A sensitive period at 50 years for glucose and HbA1c and sensitive period at 70 years for blood pressure were identified. Conclusions: In this cohort of men who were thin compared to more contemporary cohorts, BMI in later life was the dominant influence on cardiovascular and diabetes risk. BMI in early adult life may have a small long-term effect on diabetes risk.	[Kapetanakis, Venediktos V.; Rudnicka, Alicja R.; Wathern, Andrea K.; Cook, Derek G.; Whincup, Peter H.; Owen, Christopher G.] Univ London, Populat Hlth Res Inst, London, England; [Lennon, Lucy; Papacosta, Olia; Wannamethee, S. Goya] UCL, Sch Med, London W1N 8AA, England	University of London; University of London; University College London; UCL Medical School	Kapetanakis, VV (corresponding author), Univ London, Populat Hlth Res Inst, Cranmer Terrace, London, England.	vkapetan@sgul.ac.uk	Lennon, Lucy/AFT-1973-2022; Cook, Derek G/C-3271-2008; Lennon, Lucy/ABB-9433-2020	Lennon, Lucy/0000-0002-1738-1351; Cook, Derek/0000-0002-9723-5759; Papacosta, Olia/0000-0001-8781-6747; Owen, Christopher/0000-0003-1135-5977; Whincup, Peter/0000-0002-5589-4107; Rudnicka, Alicja R/0000-0003-0369-8574	British Heart Foundation [PG/10/030/28330, RG/08/013/25942]; British Heart Foundation [PG/10/30/28330, RG/13/16/30528] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This research was supported by a project grant from the British Heart Foundation (PG/10/030/28330) [http://www.bhf.org.uk]. The British Regional Heart Study is supported by a British Heart Foundation Programme Grant (RG/08/013/25942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; [Anonymous], 2004, LIFE COURSE APPROACH; BRUCE NG, 1990, J HYPERTENS, V8, pS11; Bynner JM, 1996, 1970 BRIT COHORT STU; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Houston DK, 2009, AM J EPIDEMIOL, V169, P927, DOI 10.1093/aje/kwp007; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Li L, 2007, J HYPERTENS, V25, P1215, DOI 10.1097/HJH.0b013e3280f3c01a; Lloyd LJ, 2009, INT J OBES LOND; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Organization WH, 2009, GLOB HLTH RISKS MORT; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pereira SMP, 2013, EUR HEART J, V34, P1215, DOI 10.1093/eurheartj/ehs333; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Sabia S, 2009, AM J CLIN NUTR, V89, P601, DOI 10.3945/ajcn.2008.26482; Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Vistisen D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001602; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; WHINCUP PH, 1992, J EPIDEMIOL COMMUN H, V46, P164, DOI 10.1136/jech.46.2.164; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yang X, 2007, INT J OBESITY, V31, P521, DOI 10.1038/sj.ijo.0803459	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114289	10.1371/journal.pone.0114289	http://dx.doi.org/10.1371/journal.pone.0114289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474626	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000346382500010
J	Kim, YK; Choi, HJ; Jeoung, JW; Park, KH; Kim, DM				Kim, Young Kook; Choi, Hyuk Jin; Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung			Five-Year Incidence of Primary Open-Angle Glaucoma and Rate of Progression in Health Center-Based Korean Population: The Gangnam Eye Study	PLOS ONE			English	Article							ANGELES LATINO EYE; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; RISK-FACTORS; LIFE-STYLE; PREVALENCE; ROTTERDAM; ASSOCIATION; JAPANESE; TAJIMI	Objective: To investigate the 5-year incidence and progression rate of primary open-angle glaucoma (POAG) in a health-center-based Korean population. Methods: The study population comprised 5,021 subjects who participated in standardized health screening (including non-contact tonometry and fundus photography) at the Gangnam Healthcare Center during the period from January 2005 to December 2006 and again from January 2010 to December 2011. Among these subjects, 948 (18.9%) with findings suggestive of glaucoma were subjected to a comprehensive glaucoma evaluation, which included applanation tonometry and standard automated perimetry. Based on the results, the subjects were diagnosed as POAG suspect or definite POAG. Results: The 5-year incidences of POAG suspect and definite POAG were 0.84% (42 subjects) and 0.72% (36 subjects), respectively. The rate of progression from POAG suspect to definite POAG was 4.75% per year. In subjects with a baseline intraocular pressure (IOP) >21 mmHg, the incidence of POAG suspect or definite POAG was significantly higher than in those with a baseline IOP <= 21 mmHg (32% vs. 1.05%; P<0.001). A multivariate analysis showed that the progression from POAG suspect to definite POAG was significantly associated with older age (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.03-1.10), higher baseline IOP (OR, 1.10; 95% CI, 1.01-1.24), higher body mass index (BMI) (OR, 1.15; 95% CI, 1.03-1.31), higher education level (OR, 1.57; 95% CI, 1.05-2.17), and higher hematocrit level (OR, 1.22; 95% CI, 1.08-1.43). Conclusions: In the health-center-based Korean population, the 5-year incidence of POAG was 0.72%, and the rate of progression from POAG suspect to definite POAG was 4.75% per year. This study identified old age, high baseline IOP, high BMI, high level of education, and high hematocrit level as significant risk factors for incident POAG.	[Kim, Young Kook] Jeju Natl Univ Hosp, Dept Ophthalmol, Cheju, South Korea; [Choi, Hyuk Jin; Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Choi, Hyuk Jin] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea; [Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea	Jeju National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeoung, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	neuroprotect@gmail.com		Jeoung, Jin Wook/0000-0002-1690-1239; Kim, Young Kook/0000-0002-6037-8449				da Silva TM, 2012, GENE, V502, P142, DOI 10.1016/j.gene.2012.04.047; de Voogd S, 2005, OPHTHALMOLOGY, V112, P1487, DOI 10.1016/j.ophtha.2005.04.018; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Ekstrom C, 2008, ACTA OPHTHALMOL, V86, P747, DOI 10.1111/j.1755-3768.2008.01244.x; FRAME PS, 1989, J FAM PRACTICE, V29, P150; Higginbotham EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1185, DOI 10.1001/archopht.124.8.1185; Hong C, 1987, Korean J Ophthalmol, V1, P41; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lee EJ, 2009, INVEST OPHTH VIS SCI, V50, P662, DOI 10.1167/iovs.08-1682; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; LEYDHECKER W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P662; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; Mukesh BN, 2002, OPHTHALMOLOGY, V109, P1047, DOI 10.1016/S0161-6420(02)01040-0; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Sekeroglu MA, 2011, ACTA OPHTHALMOL, V89, P429, DOI 10.1111/j.1755-3768.2009.01713.x; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Varma R, 2012, AM J OPHTHALMOL, V154, P315, DOI 10.1016/j.ajo.2012.02.014; Wu SY, 2001, AM J EPIDEMIOL, V153, P184, DOI 10.1093/aje/153.2.184; Wu Z J, 1993, Zhonghua Yan Ke Za Zhi, V29, P353; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5	29	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114058	10.1371/journal.pone.0114058	http://dx.doi.org/10.1371/journal.pone.0114058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474589	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500106
J	Krentz, NAJ; Nian, CL; Lynn, FC				Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.			TALEN/CRISPR-Mediated eGFP Knock-In Add-On at the OCT4 Locus Does Not Impact Differentiation of Human Embryonic Stem Cells towards Endoderm	PLOS ONE			English	Article							PANCREATIC PROGENITOR CELLS; GREEN FLUORESCENT PROTEIN; SELF-RENEWAL; PLURIPOTENCY; EFFICIENT; ESTABLISHMENT; EXPRESSION; LINES; MAINTENANCE; INDUCTION	Human embryonic stem cells (hESCs) have great promise as a source of unlimited transplantable cells for regenerative medicine. However, current progress on producing the desired cell type for disease treatment has been limited due to an insufficient understanding of the developmental processes that govern their differentiation, as well as a paucity of tools to systematically study differentiation in the lab. In order to overcome these limitations, cell-type reporter hESC lines will be required. Here we outline two strategies using Transcription Activator Like Effector Nucleases (TALENs) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-Associated protein (Cas) to create OCT4-eGFP knock-in add-on hESC lines. Thirty-one and forty-seven percent of clones were correctly modified using the TALEN and CRISPR-Cas9 systems, respectively. Further analysis of three correctly targeted clones demonstrated that the insertion of eGFP in-frame with OCT4 neither significantly impacted expression from the wild type allele nor did the fusion protein have a dramatically different biological stability. Importantly, the OCT4-eGFP fusion was easily detected using microscopy, flow cytometry and western blotting. The OCT4 reporter lines remained equally competent at producing CXCR4+ definitive endoderm that expressed a panel of endodermal genes. Moreover, the genomic modification did not impact the formation of NKX6.1+/SOX9+ pancreatic progenitor cells following directed differentiation. In conclusion, these findings demonstrate for the first time that CRISPR-Cas9 can be used to modify OCT4 and highlight the feasibility of creating cell-type specific reporter hESC lines utilizing genome-editing tools that facilitate homologous recombination.	[Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Child & Family Res Inst, Diabet Res Program, Vancouver, BC, Canada; [Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia	Lynn, FC (corresponding author), Child & Family Res Inst, Diabet Res Program, Vancouver, BC, Canada.	francis.lynn@ubc.ca		Lynn, Francis/0000-0001-9318-1063; Krentz, Nicole/0000-0003-3622-2652	Michael Smith Foundation; Canadian Diabetes Association; Child and Family Research Institute; Canadian Institute of Health Research-BC Transplantation Trainee Fellowship; Child and Family Research Institute Sue Carruthers Graduate Studentship; University of British Columbia Four Year Fellowship; Juvenile Diabetes Research Foundation [2-2011-91]; Canadian Institutes of Health Research [RMF-111626]; Child and Family Research Institute Canucks for Kids Fund	Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Diabetes Association; Child and Family Research Institute; Canadian Institute of Health Research-BC Transplantation Trainee Fellowship; Child and Family Research Institute Sue Carruthers Graduate Studentship; University of British Columbia Four Year Fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute Canucks for Kids Fund	FCL salary support provided by the Michael Smith Foundation for Health Research, the Canadian Diabetes Association, and the Child and Family Research Institute. NAJK is a recipient of the Canadian Institute of Health Research-BC Transplantation Trainee Fellowship, Child and Family Research Institute Sue Carruthers Graduate Studentship, and University of British Columbia Four Year Fellowship. FCL received the following grants in support of this work: Juvenile Diabetes Research Foundation 2-2011-91; Canadian Institutes of Health Research RMF-111626; Child and Family Research Institute Canucks for Kids Fund 2014. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Jauch R, 2011, STEM CELLS, V29, P940, DOI 10.1002/stem.639; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Leavitt AD, 2011, CTS-CLIN TRANSL SCI, V4, P298, DOI 10.1111/j.1752-8062.2011.00281.x; Liu YP, 2004, STEM CELLS DEV, V13, P636, DOI 10.1089/scd.2004.13.636; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald E, 2012, INT J BIOCHEM CELL B, V44, P72, DOI 10.1016/j.biocel.2011.09.008; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PETERS DT, 2013, GENOME EDITING HUMAN, DOI DOI 10.3824/STEMBOOK.1.94.1; Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Ren CP, 2005, ACTA BIOCH BIOPH SIN, V37, P68, DOI 10.1093/abbs/37.1.68; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rodriguez RT, 2007, EXP BIOL MED, V232, P1368, DOI 10.3181/0703-RM-63; Sander M, 2000, DEVELOPMENT, V127, P5533; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Seymour PA, 2012, DEVELOPMENT, V139, P3363, DOI 10.1242/dev.078733; Siemen H, 2005, STEM CELLS DEV, V14, P378, DOI 10.1089/scd.2005.14.378; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393	55	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114275	10.1371/journal.pone.0114275	http://dx.doi.org/10.1371/journal.pone.0114275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474420	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500008
J	Mazandu, GK; Mulder, NJ				Mazandu, Gaston K.; Mulder, Nicola J.			Information Content-Based Gene Ontology Functional Similarity Measures: Which One to Use for a Given Biological Data Type?	PLOS ONE			English	Article							SEMANTIC SIMILARITY; TOOL	The current increase in Gene Ontology (GO) annotations of proteins in the existing genome databases and their use in different analyses have fostered the improvement of several biomedical and biological applications. To integrate this functional data into different analyses, several protein functional similarity measures based on GO term information content (IC) have been proposed and evaluated, especially in the context of annotation-based measures. In the case of topology-based measures, each approach was set with a specific functional similarity measure depending on its conception and applications for which it was designed. However, it is not clear whether a specific functional similarity measure associated with a given approach is the most appropriate, given a biological data set or an application, i.e., achieving the best performance compared to other functional similarity measures for the biological application under consideration. We show that, in general, a specific functional similarity measure often used with a given term IC or term semantic similarity approach is not always the best for different biological data and applications. We have conducted a performance evaluation of a number of different functional similarity measures using different types of biological data in order to infer the best functional similarity measure for each different term IC and semantic similarity approach. The comparisons of different protein functional similarity measures should help researchers choose the most appropriate measure for the biological application under consideration.	[Mazandu, Gaston K.; Mulder, Nicola J.] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, IDM,Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Mazandu, Gaston K.] African Inst Math Sci, Cape Town, South Africa; [Mazandu, Gaston K.] African Inst Math Sci, Cape Coast, Ghana	University of Cape Town	Mazandu, GK (corresponding author), Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, IDM,Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	gmazandu@cbio.uct.ac.za; Nicola.Mulder@uct.ac.za	Mazandu, Gaston/AAH-6401-2019	Mazandu, Gaston/0000-0002-6441-8006; Mulder, Nicola J/0000-0003-4905-0941				Alvarez MA, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-3; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Gentleman R., 2005, VISUALIZING DISTANCE; Guzzi PH, 2011, BRIEF BIOINFORM, P1; Jiang J, 1997, INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS, 1997 DIGEST OF TECHNICAL PAPERS, P94; Li B, 2010, 10010958 ARXIV; Li HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057809, 10.1371/journal.pone.0066745]; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Mazandu Gaston K., 2012, Advances in Bioinformatics, V2012, P975783, DOI 10.1155/2012/975783; Mazandu GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292063; Mazandu GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-284; Mazandu GK, 2012, INFECT GENET EVOL, V12, P922, DOI 10.1016/j.meegid.2011.10.027; Mazandu GK, 2011, INFECT GENET EVOL, V11, P725, DOI 10.1016/j.meegid.2011.04.012; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Pesquita C, 2009, JB2009 CHALLENGES BI, V157; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Seco N, 2004, FRONT ARTIF INTEL AP, V110, P1089; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Xu YG, 2013, GENOMICS, V101, P368, DOI 10.1016/j.ygeno.2013.04.010; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129; Zhang PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-135	34	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113859	10.1371/journal.pone.0113859	http://dx.doi.org/10.1371/journal.pone.0113859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474538	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500096
J	Xia, Y; Wang, L; Jiang, YX; Dai, Q; Li, XY; Li, WB				Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Xiaoyi; Li, Wenbo			Sonographic Appearance of Primary Thyroid Lymphoma-Preliminary Experience	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; HASHIMOTOS-THYROIDITIS; DIAGNOSIS	Objective: Primary thyroid lymphoma (PTL) is an uncommon thyroid malignancy. Despite the rarity of PTL, it is important to recognize PTL promptly because its management differs from that of all the other thyroid neoplasms. This study was designed to investigate the sonographic features of PTL. Methods: Twenty-seven pathologically confirmed PTLs were categorized into diffuse and non-diffuse type. Sonographic features including thyroid size, thyroid background echotexture, lesion size, echogenecity, calcification, vascularity, cervical lymphadenopathy of each type were retrospectively analyzed. Results: All 27 PTLs were diffuse large B-cell lymphomas and were accompanied by diffuse Hashimoto's thyroiditis. Ten were diffuse type and seventeen were non-diffuse type sonographically. The observations in diffuse group included goiter (10/10, 100.0%), marked echogenesity (10/10, 100.0%), heterogeneous echotexture (10/10, 100.0%), and cervical lymphadenopathy (4/10, 40.0%). The observations in non-diffuse group included marked hypoechogenicity (17/17, 100.0%), heterogeneous background thyroid gland (17/17, 100.0%), goiter (15/17, 88.2%), increased vascularity (8/13, 61.5%), mulifocality (10/17, 58.8%), and cervical lymphadenopathy (7/17, 41.2%). Conclusions: Although some common features were found, the sonographic appearance of PTL is unspecific, especially for the diffuse type. Therefore, interventional diagnostic procedures should be warranted in the clinical settings when PTL is suspected.	[Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Wenbo] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China; [Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Xiaoyi; Li, Wenbo] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Li, Xiaoyi] Chinese Acad Med Sci, Dept Gen Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Jiang, YX (corresponding author), Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China.	yxjiangpumch@gmail.com	li, wenbo/GZM-8930-2022	Jiang, Yuxin/0000-0002-8388-7262; Xia, Yu/0000-0001-5248-9870	Peking Union Medical College Hospital	Peking Union Medical College Hospital	This study was supported by a grant from Peking Union Medical College Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 1999, SEMIN ONCOL, V26, P316; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; FRIEDBERG MH, 1994, SURGERY, V116, P1061; HAMBURGER JI, 1983, ANN INTERN MED, V99, P685, DOI 10.7326/0003-4819-99-5-685; HYJEK E, 1988, HUM PATHOL, V19, P1315, DOI 10.1016/S0046-8177(88)80287-9; Ishikawa Hitoshi, 2002, Radiat Med, V20, P9; King AD, 1997, POSTGRAD MED J, V73, P412, DOI 10.1136/pgmj.73.861.412; Mack LA, 2007, WORLD J SURG, V31, P978, DOI 10.1007/s00268-005-0768-z; MATSUZUKA F, 1993, THYROID, V3, P93, DOI 10.1089/thy.1993.3.93; Nam M, 2012, J ULTRAS MED, V31, P589, DOI 10.7863/jum.2012.31.4.589; Ota H, 2006, THYROID, V16, P983, DOI 10.1089/thy.2006.16.983; Podoloff DA, 1996, AM J ROENTGENOL, V167, P1337, DOI 10.2214/ajr.167.5.8911208; Sakorafas GH, 2010, SURG ONCOL, V19, pE124, DOI 10.1016/j.suronc.2010.06.002; Sasai K, 1996, ACTA ONCOL, V35, P457, DOI 10.3109/02841869609109922; TAKASHIMA S, 1989, RADIOLOGY, V171, P439, DOI 10.1148/radiology.171.2.2649921; Takashima S, 1997, J CLIN ULTRASOUND, V25, P279, DOI 10.1002/(SICI)1097-0096(199706)25:5<279::AID-JCU11>3.0.CO;2-E	16	19	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114080	10.1371/journal.pone.0114080	http://dx.doi.org/10.1371/journal.pone.0114080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474402	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500113
J	Bouillot, P; Brina, O; Ouared, R; Lovblad, KO; Farhat, M; Pereira, VM				Bouillot, Pierre; Brina, Olivier; Ouared, Rafik; Lovblad, Karl-Olof; Farhat, Mohamed; Pereira, Vitor Mendes			Particle Imaging Velocimetry Evaluation of Intracranial Stents in Sidewall Aneurysm: Hemodynamic Transition Related to the Stent Design	PLOS ONE			English	Article							CEREBRAL ANEURYSMS; IN-VITRO; PULSATILE FLOWS; PARENT VESSEL; BLOOD-FLOW; MODEL; PLACEMENT; STRAIGHT; STEADY; THROMBOSIS	We investigated the flow modifications induced by a large panel of commercial-off-the-shelf (COTS) intracranial stents in an idealized sidewall intracranial aneurysm (IA). Flow velocities in IA silicone model were assessed with and without stent implantation using particle imaging velocimetry (PIV). The use of the recently developed multi-time-lag method has allowed for uniform and precise measurements of both high and low velocities at IA neck and dome, respectively. Flow modification analysis of both regular (RSs) and flow diverter stents (FDSs) was subsequently correlated with relevant geometrical stent parameters. Flow reduction was found to be highly sensitive to stent porosity variations for regular stents RSs and moderately sensitive for FDSs. Consequently, two distinct IA flow change trends, with velocity reductions up to 50% and 90%, were identified for high-porosity RS and low-porosity FDS, respectively. The intermediate porosity (88%) regular braided stent provided the limit at which the transition in flow change trend occurred with a flow reduction of 84%. This transition occurred with decreasing stent porosity, as the driving force in IA neck changed from shear stress to differential pressure. Therefore, these results suggest that stents with intermediate porosities could possibly provide similar flow change patterns to FDS, favourable to curative thrombogenesis in IAs.	[Bouillot, Pierre; Brina, Olivier; Ouared, Rafik; Lovblad, Karl-Olof; Pereira, Vitor Mendes] Univ Hosp Geneva, Serv Neuroradiol, Intervent Neuroradiol Unit, Geneva, Switzerland; [Bouillot, Pierre; Farhat, Mohamed] Ecole Polytech Fed Lausanne, Lab Hydraul Machines, Lausanne, Switzerland; [Pereira, Vitor Mendes] Toronto Western Hosp, Univ Hlth Network, Dept Med Imaging, Div Neuroradiol, Toronto, ON M5T 2S8, Canada; [Pereira, Vitor Mendes] Toronto Western Hosp, Univ Hlth Network, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bouillot, P (corresponding author), Univ Hosp Geneva, Serv Neuroradiol, Intervent Neuroradiol Unit, Geneva, Switzerland.	pierre.bouillot@unige.ch	Farhat, Mohamed/H-9463-2012; Lövblad, Karl/AAF-7678-2020	Farhat, Mohamed/0000-0002-4782-2170; lovblad, karl-olof/0000-0003-2768-9779	Swiss National Science Foundation [SNF 32003B_141192]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding: This study was supported by Swiss National Science Foundation grant (SNF 32003B_141192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenis M, 1997, J BIOMECH ENG-T ASME, V119, P206, DOI 10.1115/1.2796081; Augsburger L, 2009, J NEURORADIOLOGY, V36, P270, DOI 10.1016/j.neurad.2009.03.001; Augsburger L, 2009, CLIN NEURORADIOL, V19, P204, DOI 10.1007/s00062-009-9005-0; Aurboonyawat T, 2011, NEURORADIOLOGY, V53, P659, DOI 10.1007/s00234-010-0784-4; Babiker MH, 2012, J BIOMECH, V45, P440, DOI 10.1016/j.jbiomech.2011.12.016; Becske T, 2013, RADIOLOGY, V267, P858, DOI 10.1148/radiol.13120099; Bouillot P, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1746-0; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Canton G, 2005, J NEUROSURG, V103, P891, DOI 10.3171/jns.2005.103.5.0891; Canton G, 2005, J NEUROSURG, V103, P146, DOI 10.3171/jns.2005.103.1.0146; Chien AC, 2013, J NEUROINTERV SURG, V5, pIII43, DOI 10.1136/neurintsurg-2012-010613; Chong W, 2014, AM J NEURORADIOL, V35, P136, DOI 10.3174/ajnr.A3790; Chopard B, 2007, INT J MOD PHYS C, V18, P712, DOI 10.1142/S0129183107010978; Hirabayashi M, 2006, MATH COMPUT SIMULAT, V72, P128, DOI 10.1016/j.matcom.2006.05.037; Hoi Y, 2006, J BIOMECH ENG-T ASME, V128, P844, DOI 10.1115/1.2354209; Ionita CN, 2004, PRO BIOMED OPT IMAG, V5, P295, DOI 10.1117/12.534274; Krischek O, 2012, MINIM INVAS NEROSURG, V54, P12; Kulcsar Z, 2012, ACTA NEUROCHIR, V154, P1827, DOI 10.1007/s00701-012-1482-2; Le TB, 2013, ANN BIOMED ENG, V41, P2157, DOI 10.1007/s10439-013-0811-9; Le TB, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002702; Lieber BB, 2002, ANN BIOMED ENG, V30, P768, DOI 10.1114/1.1495867; Liou TM, 2004, J BIOMECH ENG-T ASME, V126, P36, DOI 10.1115/1.1644566; Liou TM, 2004, EXP MECH, V44, P253, DOI 10.1177/0014485104039770; Liou TM, 2008, PHYS MED BIOL, V53, P3763, DOI 10.1088/0031-9155/53/14/004; Liou TM, 2008, J BIOMECH, V41, P1174, DOI 10.1016/j.jbiomech.2008.01.025; Mut F, 2014, J NEUROINTERV SURG; O'Kelly CJ, 2010, INTERV NEURORADIOL, V16, P133, DOI 10.1177/159101991001600204; Ouared R, 2008, COMPUT PHYS COMMUN, V179, P128, DOI 10.1016/j.cpc.2008.01.021; Pereira VM, 2013, AM J NEURORADIOL, V34, P808, DOI 10.3174/ajnr.A3322; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Rayz VL, 2008, ANN BIOMED ENG, V36, P1793, DOI 10.1007/s10439-008-9561-5; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2; Roszelle BN, 2013, J NEUROINTERV SURG, V5, P354, DOI 10.1136/neurintsurg-2012-010322; Scheidegger, 1963, PHYS FLOW POROUS MED; Seong J, 2007, J BIOMECH ENG-T ASME, V129, P863, DOI 10.1115/1.2800787; Shapiro M, 2014, AM J NEURORADIOL, V35, P727, DOI 10.3174/ajnr.A3742; Sobera MP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036301; Tateshima S, 2009, J NEUROSURG, V111, P22, DOI 10.3171/2009.2.JNS081324; Trager AL, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006454; Trager AL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049528; Wang ZJ, 2005, PHYS MED BIOL, V50, P3171, DOI 10.1088/0031-9155/50/13/014; Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962; Yu CH, 2012, J MECH SCI TECHNOL, V26, P1333, DOI 10.1007/s12206-012-0322-x; Yu SCM, 1999, MED ENG PHYS, V21, P133, DOI 10.1016/S1350-4533(99)00037-5; Yu SCM, 1999, EXP FLUIDS, V26, P505, DOI 10.1007/s003480050317; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	47	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113762	10.1371/journal.pone.0113762	http://dx.doi.org/10.1371/journal.pone.0113762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470724	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700043
J	Urlacher, E; Tarr, IS; Mercer, AR				Urlacher, Elodie; Tarr, Ingrid S.; Mercer, Alison R.			Social Modulation of Stress Reactivity and Learning in Young Worker Honey Bees	PLOS ONE			English	Article							DIVISION-OF-LABOR; JUVENILE-HORMONE; PROTEIN-KINASE; ANTENNAL LOBE; OLFACTORY MEMORY; QUEEN PHEROMONE; GENE-EXPRESSION; TERM-MEMORY; ACTIVATION; BEHAVIOR	Alarm pheromone and its major component isopentylacetate induce stress-like responses in forager honey bees, impairing their ability to associate odors with a food reward. We investigated whether isopentylacetate exposure decreases appetitive learning also in young worker bees. While isopentylacetate-induced learning deficits were observed in guards and foragers collected from a queen-right colony, learning impairments resulting from exposure to this pheromone could not be detected in bees cleaning cells. As cell cleaners are generally among the youngest workers in the colony, effects of isopentylacetate on learning behavior were examined further using bees of known age. Adult workers were maintained under laboratory conditions from the time of adult emergence. Fifty percent of the bees were exposed to queen mandibular pheromone during this period, whereas control bees were not exposed to this pheromone. Isopentylacetate-induced learning impairments were apparent in young (less than one week old) controls, but not in bees of the same age exposed to queen mandibular pheromone. This study reveals young worker bees can exhibit a stress-like response to alarm pheromone, but isopentylacetate-induced learning impairments in young bees are suppressed by queen mandibular pheromone. While isopentylacetate exposure reduced responses during associative learning (acquisition), it did not affect one-hour memory retrieval.	[Urlacher, Elodie; Tarr, Ingrid S.; Mercer, Alison R.] Dept Zool, Dunedin 9054, New Zealand		Urlacher, E (corresponding author), Dept Zool, 340 Great King St,POB 56, Dunedin 9054, New Zealand.	elodie.urlacher@otago.ac.nz		Tarr, Ingrid/0000-0002-4847-2838; Mercer, Alison/0000-0001-8110-4247	Fyssen Foundation; Royal Society of New Zealand Marsden Fund [U00-1207]	Fyssen Foundation; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding: This work was supported by grants from the Fyssen Foundation (www.fondation-fyssen.org, post doctoral fellowship for EU) and the Royal Society of New Zealand Marsden Fund (http://www.royalsociety.org.nz, U00-1207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2007, J CHEM ECOL, V33, P1346, DOI 10.1007/s10886-007-9301-6; Balderrama N, 2002, J COMP PHYSIOL A, V188, P485, DOI 10.1007/s00359-002-0321-y; Bates D, 2012, LME4 LINEAR MIXED EF; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Behrends A, 2012, J EXP BIOL, V215, P1076, DOI 10.1242/jeb.063297; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; COLLINS AM, 1983, J CHEM ECOL, V9, P57, DOI 10.1007/BF00987770; COLLINS AM, 1980, ANN ENTOMOL SOC AM, V73, P307, DOI 10.1093/aesa/73.3.307; COLLINS AM, 1982, J CHEM ECOL, V8, P463, DOI 10.1007/BF00987794; Elekonich MM, 2005, COMP BIOCHEM PHYS A, V141, P362, DOI 10.1016/j.cbpb.2005.04.014; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; FREE J. B., 1961, ANIMAL BEHAVIOUR, V9, P193, DOI 10.1016/0003-3472(61)90008-2; FREE JB, 1968, Z VERGL PHYSIOL, V61, P361, DOI 10.1007/BF00428008; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Giray T, 2000, BEHAV ECOL, V11, P44, DOI 10.1093/beheco/11.1.44; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Haehnel M, 2012, J EXP BIOL, V215, P559, DOI 10.1242/jeb.059626; HILDEBRANDT H, 1995, BRAIN RES, V679, P281, DOI 10.1016/0006-8993(95)00246-M; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Jarriault D, 2012, APIDOLOGIE, V43, P292, DOI 10.1007/s13592-011-0117-6; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Ledoux MN, 2001, INSECT SOC, V48, P14, DOI 10.1007/PL00001738; Louis T, 2012, EUR J NEUROSCI, V36, P3438, DOI 10.1111/j.1460-9568.2012.08261.x; Maleszka R, 2001, HORM BEHAV, V40, P403, DOI 10.1006/hbeh.2001.1705; McQuillan HJ, 2012, LEARN MEMORY, V19, P151, DOI 10.1101/lm.025353.111; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R., 1974, P195; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 2013, HDB BEHAV NEUROSCIEN, V22, P347; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; Muller U, 2012, APIDOLOGIE, V43, P322, DOI 10.1007/s13592-011-0115-8; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; R Core Team, 2021, R LANGUAGE ENV STAT; Ray S, 1999, DEV PSYCHOBIOL, V34, P21, DOI 10.1002/(SICI)1098-2302(199901)34:1<21::AID-DEV4>3.3.CO;2-B; Ray S, 1997, NEUROREPORT, V8, P789, DOI 10.1097/00001756-199702100-00042; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; Sakagami S. F., 1954, Insectes Sociaux Paris, V1, P331, DOI 10.1007/BF02329618; Sandoz JC, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08.005.2007; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vaitkevieiene G, 1999, PHEROMONES, V6, P39; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Wang SP, 2008, J INSECT PHYSIOL, V54, P833, DOI 10.1016/j.jinsphys.2008.03.004; Winston M.L., 1991, BIOL HONEY BEE	62	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113630	10.1371/journal.pone.0113630	http://dx.doi.org/10.1371/journal.pone.0113630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470128	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700038
J	Habermehl, D; Ilicic, K; Dehne, S; Rieken, S; Orschiedt, L; Brons, S; Haberer, T; Weber, KJ; Debus, J; Combs, SE				Habermehl, Daniel; Ilicic, Katarina; Dehne, Sarah; Rieken, Stefan; Orschiedt, Lena; Brons, Stephan; Haberer, Thomas; Weber, Klaus-Josef; Debus, Juergen; Combs, Stephanie E.			The Relative Biological Effectiveness for Carbon and Oxygen Ion Beams Using the Raster-Scanning Technique in Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PHASE-I; THERAPY; TEMOZOLOMIDE; IRRADIATION; SURVIVAL; DAMAGE; LIVER; MODEL	Background: Aim of this study was to evaluate the relative biological effectiveness (RBE) of carbon (12C) and oxygen ion (16O)-irradiation applied in the raster-scanning technique at the Heidelberg Ion beam Therapy center (HIT) based on clonogenic survival in hepatocellular carcinoma cell lines compared to photon irradiation. Methods: Four human HCC lines Hep3B, PLC, HepG2 and HUH7 were irradiated with photons, 12C and 16O using a customized experimental setting at HIT for invitro trials. Cells were irradiated with increasing physical photon single doses of 0, 2, 4 and 6 Gy and heavy ionsingle doses of 0, 0.125, 0.5, 1, 2, 3 Gy (12C and 16O). SOBP-penetration depth and extension was 35 mm +/-4 mm and 36 mm +/-5 mm for carbon ions and oxygen ions respectively. Mean energy level and mean linear energy transfer (LET) were 130 MeV/u and 112 keV/um for 12C, and 154 MeV/u and 146 keV/um for 16O. Clonogenic survival was computated and realtive biological effectiveness (RBE) values were defined. Results: For all cell lines and both particle modalities alpha- and beta-values were determined. As expected, alpha-values were significantly higher for 12C and 16O than for photons, reflecting a steeper decline of the initial slope of the survival curves for high-LET beams. RBE-values were in the range of 2.1-3.3 and 1.9-3.1 for 12C and 16O, respectively. Conclusion: Both irradiation with 12C and 16O using the rasterscanning technique leads to an enhanced RBE in HCC cell lines. No relevant differences between achieved RBE-values for 12C and 16O were found. Results of this work will further influence biological-adapted treatment planning for HCC patients that will undergo particle therapy with 12C or 16O.	[Habermehl, Daniel; Ilicic, Katarina; Dehne, Sarah; Rieken, Stefan; Orschiedt, Lena; Weber, Klaus-Josef; Debus, Juergen] Dept Radiat Oncol, D-69120 Heidelberg, Germany; [Brons, Stephan; Haberer, Thomas] Heidelberg Ion Beam Therapy Ctr HIT, D-69120 Heidelberg, Germany; [Habermehl, Daniel; Combs, Stephanie E.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-81675 Munich, Germany	Ruprecht Karls University Heidelberg; Technical University of Munich	Habermehl, D (corresponding author), Dept Radiat Oncol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	daniel.habermehl@tum.de		Combs, Stephanie/0000-0002-6934-2864	Klinische Forschergruppe Schwerionentherapie of the University of Heidelberg (GERMAN RESEARCH FOUNDATION) [KFO 214]	Klinische Forschergruppe Schwerionentherapie of the University of Heidelberg (GERMAN RESEARCH FOUNDATION)	The study was supported by the Klinische Forschergruppe Schwerionentherapie (KFO 214) of the University of Heidelberg (GERMAN RESEARCH FOUNDATION). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovic L, 2013, J RADIAT RES, V54, P18, DOI 10.1093/jrr/rrs070; Bassler N, 2014, ACTA ONCOL, V53, P25, DOI 10.3109/0284186X.2013.832835; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Colombo M, 2013, EUR J GASTROEN HEPAT, V25, P639, DOI 10.1097/MEG.0b013e32835e33bb; Combs SE, 2007, INT J RADIAT ONCOL, V68, P873, DOI 10.1016/j.ijrobp.2007.03.002; Combs SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-67; Combs SE, 2009, INT J RADIAT BIOL, V85, P126, DOI 10.1080/09553000802641151; El Shafie RA, 2013, J RADIAT RES, V54, P113, DOI 10.1093/jrr/rrt052; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-59; Harrabi S, 2013, INT J RADIAT BIOL, V89, P692, DOI 10.3109/09553002.2013.791406; Imada H, 2010, RADIOTHER ONCOL, V96, P231, DOI 10.1016/j.radonc.2010.05.019; Jung J, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-249; Komatsu S, 2011, CANCER-AM CANCER SOC, V117, P4890, DOI 10.1002/cncr.26134; NCCN, 2013, HEP CANC; Ofuchi T, 1999, J RADIAT RES, V40, P125, DOI 10.1269/jrr.40.125; Pathak R, 2007, MUTAT RES-GEN TOX EN, V632, P58, DOI 10.1016/j.mrgentox.2007.04.007; Scholz M, 1997, RADIAT ENVIRON BIOPH, V36, P59, DOI 10.1007/s004110050055; Son SH, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-61; Xi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063864; Zheng SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065753	21	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113591	10.1371/journal.pone.0113591	http://dx.doi.org/10.1371/journal.pone.0113591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460352	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700038
J	Snider, AJ; Ali, WH; Sticca, JA; Coant, N; Ghaleb, AM; Kawamori, T; Yang, VW; Hannun, YA; Obeid, LM				Snider, Ashley J.; Ali, Wahida H.; Sticca, Jonathan A.; Coant, Nicolas; Ghaleb, Amr M.; Kawamori, Toshihiko; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.			Distinct Roles for Hematopoietic and Extra-Hematopoietic Sphingosine Kinase-1 in Inflammatory Bowel Disease	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; ULCERATIVE-COLITIS; TNF-ALPHA; KNOCKOUT MICE; CELL-DEATH; SPHINGOSINE-1-PHOSPHATE; RECEPTORS; CERAMIDE; EGRESS; CHEMOTAXIS	Sphingosine kinase 1 (SK1), one of two SK enzymes, is highly regulated and has been shown to act as a focal point for the action of many growth factors and cytokines. SK1 leads to generation of sphingosine-1-phosphate (S1P) and potentially the activation of S1P receptors to mediate biologic effects. Our previous studies implicated SK1/S1P in the regulation of inflammatory processes, specifically in inflammatory bowel disease (IBD). These studies were conducted using a total body knockout mouse for SK1 and were unable to determine the source of SK1/S1P (hematopoietic or extra-hematopoietic) involved in the inflammatory responses. Therefore, bone marrow transplants were performed with wild-type (WT) and SK1-/- mice and colitis induced with dextran sulfate sodium (DSS). Irrespective of the source of SK1/S1P, bone marrow or tissue, DSS induced colitis in all mice; however, mice lacking SK1 in both hematopoietic and extra-hematopoietic compartments exhibited decreased crypt damage. Systemic inflammation was assessed, and mice with WT bone marrow demonstrated significant neutrophilia in response to DSS. In the local inflammatory response, mice lacking SK1/S1P in either bone marrow or tissue exhibited decreased induction of cytokines and less activation of STAT3 (signal transducer and activator of transcription 3). Interestingly, we determined that extra-hematopoietic SK1 is necessary for the induction of cyclooxygenase 2 (COX2) in colon epithelium in response to DSS-induced colitis. Taken together our data suggest that hematopoietic-derived SK1/S1P regulates specific aspects of the systemic inflammatory response, while extra-hematopoietic SK1 in the colon epithelium is necessary for the autocrine induction of COX2 in DSS-induced colitis.	[Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA; [Snider, Ashley J.; Ali, Wahida H.; Coant, Nicolas; Ghaleb, Amr M.; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.; Ghaleb, Amr M.; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Sticca, Jonathan A.] Univ S Carolina, Sch Med, Columbia, SC USA; [Kawamori, Toshihiko] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Kawamori, Toshihiko] Ichinomiya Nishi Hosp, Dept Pathol, Nagoya, Aichi, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Cancer Research Center of Hawaii; University of Hawaii System	Snider, AJ (corresponding author), Northport Vet Affairs Med Ctr, Northport, NY 11768 USA.	ashley.snider@stonybrook.edu		COANT, Nicolas/0000-0001-9237-2132; obeid, lina/0000-0002-0734-0847; Hanel, Wahida/0000-0003-0196-8040	Veterans Affairs Career Development Award; Veterans Affairs Merit Award; NIH [GM062887, CA124687]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA124687, P30CA138313, R01CA172517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Veterans Affairs Career Development Award; Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Veterans Affairs Career Development Award (AJS), a Veterans Affairs Merit Award (LMO) and as well as NIH Grant GM062887 (LMO), and CA124687 (TK). Lipid analyses provided by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). Animal experiments were performed using mice from the Animal Pathobiology Core (P01CA097132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada MM, 2013, J BIOL CHEM; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Rosillo MA, 2012, PHARMACOL RES, V66, P235, DOI 10.1016/j.phrs.2012.05.006; Baker DA, 2012, RHEUMATOL INT; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Celikbilek M, 2013, J CLIN LAB ANAL, V27, P72, DOI 10.1002/jcla.21564; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Heffernan-Stroud LA, 2012, ONCOGENE, V31, P1166, DOI 10.1038/onc.2011.302; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Orr Gandy KA, 2013, FASEB J, DOI 10.1096/fj.13-228460; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pushparaj PN, 2009, J IMMUNOL, V183, P221, DOI 10.4049/jimmunol.0803430; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Torun S, 2012, CLIN RES HEPATOL GAS, V36, P491, DOI 10.1016/j.clinre.2012.06.004; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001	39	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113998	10.1371/journal.pone.0113998	http://dx.doi.org/10.1371/journal.pone.0113998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460165	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700077
J	Wu, CX; Cheng, WY; Sun, Y; Dang, YH; Gong, FY; Zhu, HJ; Li, NS; Li, F; Zhu, ZH				Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Gong, Fengying; Zhu, Huijuan; Li, Naishi; Li, Fang; Zhu, Zhaohui			Activating Brown Adipose Tissue for Weight Loss and Lowering of Blood Glucose Levels: A MicroPET Study Using Obese and Diabetic Model Mice	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; INSULIN-RESISTANCE; FAT; THERMOGENESIS; MECHANISMS; BRL-37344	Purpose: This study aims at using F-18-FDG microPET to monitor the brown adipose tissue (BAT) glucose metabolism in obese and diabetic mouse models under different interventions, and study the therapeutic potential of BAT activation for weight loss and lowering of blood glucose in these models. Methods: Obese mice were established by a high-fat diet for eight weeks, and diabetes mellitus(DM) models were induced with Streptozocin in obese mice. F-18-FDG microPET was used to monitor BAT function during obese and DM modeling, and also after BRL37344 (a beta(3)-adrenergic receptor agonist) or levothyroxine treatment. The BAT function was correlated with the body weight and blood glucose levels. Results: Compared with the controls, the obese mice and DM mice showed successively lower F-18-FDG uptake in the interscapular BAT (P=0.036 and <0.001, respectively). After two-week BRL37344 treatment, the BAT uptake was significantly elevated in both obese mice (P=0.010) and DM mice (P=0.004), accompanied with significantly decreased blood glucose levels (P=0.023 and 0.036, respectively). The BAT uptake was negatively correlated with the blood glucose levels in both obese mice (r=-0.71, P=0.003) and DM mice (r=-0.74, P=0.010). BRL37344 treatment also caused significant weight loss in the obese mice (P=0.001). Levothyroxine treatment increased the BAT uptake in the control mice (P=0.025) and obese mice (P=0.013), but not in the DM mice (P=0.45). Conclusion: The inhibited BAT function in obese and DM mice can be re-activated by beta(3)-adrenergic receptor agonist or thyroid hormone, and effective BAT activation DMmay lead to weight loss and blood glucose lowering. Activating BAT can provide a new treatment strategy for obesity and DM.	[Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Li, Fang; Zhu, Zhaohui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China; [Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Gong, Fengying; Zhu, Huijuan; Li, Naishi; Li, Fang; Zhu, Zhaohui] Peking Union Med Coll, Beijing 100730, Peoples R China; [Gong, Fengying; Zhu, Huijuan; Li, Naishi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Cheng, WY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China.	cwypumch@126.com; zhuzhh@pumch.cn	Zhu, Zhaohui/CAA-1003-2022; Li, Naishi/ABI-7607-2020	Li, Naishi/0000-0002-2261-7349	National Natural Science Foundation of China (NSFC) [81101074, 81371588]; Graduate Student Innovation Foundation of PUMCH [2011-1002-25]; Young and Middle-aged Researcher Science Fund of PUMCH from Key Laboratory of Endocrinology of Health and Family Planning Committee; UCSF-PUMCH RAP	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Foundation of PUMCH; Young and Middle-aged Researcher Science Fund of PUMCH from Key Laboratory of Endocrinology of Health and Family Planning Committee; UCSF-PUMCH RAP	This work is supported by National Natural Science Foundation of China (NSFC) (No. 81101074, No. 81371588); Graduate Student Innovation Foundation of PUMCH (No. 2011-1002-25); 2012 Young and Middle-aged Researcher Science Fund of PUMCH, funding from Key Laboratory of Endocrinology of Health and Family Planning Committee, and an UCSF-PUMCH RAP funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bhadada SV, 2011, THER ADV ENDOCRINOL, V2, P65, DOI 10.1177/2042018810390259; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng WY, 2012, CLIN NUCL MED, V37, P514, DOI 10.1097/RLU.0b013e31824d2121; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; Drubach LA, 2011, J PEDIATR-US, V159, P939, DOI 10.1016/j.jpeds.2011.06.028; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fueger BJ, 2006, J NUCL MED, V47, P999; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; GRANNEMAN JG, 1990, J PHARMACOL EXP THER, V254, P508; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Jacene HA, 2011, MOL IMAGING BIOL, V13, P1278, DOI 10.1007/s11307-010-0379-9; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; Masuo K, 2011, J OBES, V2011, DOI 10.1155/2011/609485; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; NISOLI E, 1995, J NEUROCHEM, V65, P1580; RICHARDSON JM, 1991, J BIOL CHEM, V266, P12690; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Straznicky NE, 2012, J CLIN ENDOCR METAB, V97, P605, DOI 10.1210/jc.2011-2320; Suarez J, 2014, DIS MODEL MECH, V7, P129, DOI 10.1242/dmm.013110; Vasilijevic A, 2010, NITRIC OXIDE-BIOL CH, V23, P42, DOI 10.1016/j.niox.2010.04.001; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Vosselman MJ, 2013, MOL CELL ENDOCRINOL; Wijers SLJ, 2011, J CLIN ENDOCR METAB, V96, pE598, DOI 10.1210/jc.2010-1957; Williams CA, 1999, BRIT J PHARMACOL, V128, P1586, DOI 10.1038/sj.bjp.0702946; Williams G, 2008, AM J ROENTGENOL, V190, P1406, DOI 10.2214/AJR.07.3205; Wu CX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/159834	40	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113742	10.1371/journal.pone.0113742	http://dx.doi.org/10.1371/journal.pone.0113742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462854	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700047
J	Zhang, Y; Wang, YF; Yang, K; Tian, LC; Fu, X; Wang, Y; Sun, YQ; Jiang, Q; Lu, WJ; Wang, J				Zhang, Yi; Wang, Yingfeng; Yang, Kai; Tian, Lichun; Fu, Xin; Wang, Yan; Sun, Yueqian; Jiang, Qian; Lu, Wenju; Wang, Jian			BMP4 Increases the Expression of TRPC and Basal [Ca2+](i) via the p38MAPK and ERK1/2 Pathways Independent of BMPRII in PASMCs	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; PRIMARY PULMONARY-HYPERTENSION; CAPACITATIVE CA2+ ENTRY; RECEPTOR POTENTIAL EXPRESSION; BONE MORPHOGENETIC PROTEIN-4; II RECEPTOR; SIGNAL-TRANSDUCTION; GERMLINE MUTATIONS; INTRACELLULAR CA2+; UP-REGULATION	Multiple abnormalities of bone morphogenetic protein (BMPs) signaling are implicated in the process of pulmonary arterial hypertension (PAH). BMP4 plays an important role during the process of pulmonary arterial remodeling and mutant of the principle BMP4 receptor, BMP receptors II (BMPRII), is found to associate with the development of PAH. However, the likely mechanism defining the contribution of BMPRII to BMP4 mediated signaling in pulmonary arterial smooth muscle cells (PASMCs) remains comprehensively unclear. We previously found that enhanced store operated calcium entry (SOCE) and basal intracellular calcium concentration [Ca2+](i) were induced by BMP4 via upregulation of TRPC1, 4 and 6 expression in PASMCs, and that BMP4 modulated TRPC channel expression through activating p38MAPK and ERK1/2 signaling pathways. In this study, BMPRII siRNA was used to knockdown BMPRII expression to investigate whether BMP4 upregulates the expression of TRPC and activating Smad1/5/8, ERK1/2 and p38MAPK pathway via BMPRII in distal PASMCs. Our results showed that knockdown of BMPRII: 1) attenuated BMP4 induced activation of P-Smad1/5/8, without altering BMP4 induced P-p38MAPK and P-ERK1/2 activation in PASMCs; 2) did not attenuate the BMP4-induced TRPC1, 4 and 6 expression; 3) did not affect BMP4-enhanced SOCE and basal [Ca2+](i). Thus, we concluded that BMP4 activated Smad1/5/8 pathway is BMPRII-dependent, while the BMP4 - ERK/p-P38 - TRPC - SOCE signaling axis are likely mediated through other receptor rather than BMPRII.	[Zhang, Yi; Wang, Yingfeng; Yang, Kai; Tian, Lichun; Fu, Xin; Wang, Yan; Jiang, Qian; Lu, Wenju; Wang, Jian] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhang, Yi; Yang, Kai; Wang, Jian] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sun, Yueqian] Univ Toronto, Dept Arts & Sci, Toronto, ON, Canada; [Wang, Jian] Inner Mongolia Peoples Hosp, Dept Pulm, Hohhot, Inner Mongolia, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University; Johns Hopkins University; University of Toronto	Lu, WJ (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com; jwang31@jhmi.edu	Yang, Kai/I-6524-2019	Yang, Kai/0000-0003-3044-2240	National Institutes of Health (NIH) [R01HL093020]; National Natural Science Foundation of China [81173112, 81170052, 81220108001]; Guangdong Natural Science Foundation; Guangzhou Department of Education [12A001S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Department of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Research Grants (R01HL093020), National Natural Science Foundation of China (81173112, 81170052, 81220108001), Guangdong Natural Science Foundation team grant (2010), and Guangzhou Department of Education Yangcheng Scholarship (12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; GUTIERREZ FR, 1980, AM J ROENTGENOL, V135, P177, DOI 10.2214/ajr.135.1.177; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Hyvelin JM, 1998, AM J PHYSIOL-LUNG C, V275, pL269, DOI 10.1152/ajplung.1998.275.2.L269; Karaki H, 1997, PHARMACOL REV, V49, P157; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; LIU F, 1995, MOL CELL BIOL, V15, P3479; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1370, DOI 10.1152/ajpcell.00040.2010; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McDaniel SS, 2001, AM J PHYSIOL-LUNG C, V280, pL870, DOI 10.1152/ajplung.2001.280.5.L870; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, pL1182, DOI 10.1152/ajplung.00020.2006; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Takeda M, 2004, ENDOCRINOLOGY, V145, P4344, DOI 10.1210/en.2004-0234; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Wang J, 2005, AM J PHYSIOL-LUNG C, V288, pL1059, DOI 10.1152/ajplung.00448.2004; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Young KA, 2006, AM J PHYSIOL-LUNG C, V290, pL841, DOI 10.1152/ajplung.00158.2005; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	45	9	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112695	10.1371/journal.pone.0112695	http://dx.doi.org/10.1371/journal.pone.0112695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461595	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700022
J	Solund, C; Krarup, H; Ramirez, S; Thielsen, P; Roge, BT; Lunding, S; Barfod, TS; Madsen, LG; Tarp, B; Christensen, PB; Gerstoft, J; Laursen, AL; Bukh, J; Weis, N				Solund, Christina; Krarup, Henrik; Ramirez, Santseharay; Thielsen, Peter; Roge, Birgit T.; Lunding, Suzanne; Barfod, Toke S.; Madsen, Lone G.; Tarp, Britta; Christensen, Peer B.; Gerstoft, Jan; Laursen, Alex L.; Bukh, Jens; Weis, Nina		DANHEP Grp	Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; VIRUS; INFECTION; TELAPREVIR; INITIATION; THERAPY; REGION	Background and Aims: The first standard of care in treatment of chronic HCV genotype 1 infection involving directly acting antivirals was protease inhibitors telaprevir or boceprevir combined with pegylated-interferon and ribavirin (triple therapy). Phase III studies include highly selected patients. Thus, treatment response and development of viral resistance during triple therapy in a routine clinical setting needs to be determined. The aims of this study were to investigate treatment outcome and identify sequence variations after triple therapy in patients with chronic HCV genotype 1 infection in a routine clinical setting. Methods: 80 patients, who initiated and completed triple therapy in Denmark between May 2011 and November 2012, were included. Demographic data and treatment response were obtained from the Danish Database for Hepatitis B and C. Direct sequencing and clonal analysis of the RT-PCR amplified NS3 protease were performed in patients without cure following triple therapy. Results: 38 (47%) of the patients achieved cure, 15 (19%) discontinued treatment due to adverse events and remained infected, and 27 (34%) experienced relapse or treatment failure of whom 15 of 21 analyzed patients had well-described protease inhibitor resistance variants detected. Most frequently detected protease variants were V36M and/or R155K, and V36M, in patients with genotype 1a and 1b infection, respectively. Conclusions: The cure rate after triple therapy in a routine clinical setting was 47%, which is substantially lower than in clinical trials. Resistance variants towards protease inhibitors were seen in 71% of patients failing therapy indicating that resistance could have an important role in treatment response.	[Solund, Christina; Ramirez, Santseharay; Bukh, Jens; Weis, Nina; DANHEP Grp] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Clin Res Ctr, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Sect Mol Diagnost, Aalborg, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Med Gastroenterol, Aalborg, Denmark; [Thielsen, Peter] Copenhagen Univ Hosp, Dept Gastroenterol, Herlev, Denmark; [Roge, Birgit T.] Kolding Cty Hosp, Dept Med, Kolding, Denmark; [Lunding, Suzanne] Copenhagen Univ Hosp, Dept Infect Dis, Hillerod, Denmark; [Barfod, Toke S.] Roskilde Hosp, Dept Infect Dis, Roskilde, Denmark; [Madsen, Lone G.] Koge Hosp, Dept Gastroenterol, Koge, Denmark; [Tarp, Britta] Silkeborg Reg Hosp, Ctr Diagnost, Silkeborg, Denmark; [Christensen, Peer B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Gerstoft, Jan] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Laursen, Alex L.] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Weis, Nina] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen; Kolding Hospital; University of Copenhagen; Aarhus University; Silkeborg Central Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen	Weis, N (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark.	ninaweis@dadlnet.dk	Christensen, Peer B./B-8042-2015; Weis, Nina/GLT-4232-2022; Tarp, Britta/R-2229-2019; Ramirez, Santseharay/R-9257-2016	Tarp, Britta/0000-0003-3611-4440; Ramirez, Santseharay/0000-0003-3699-1814; Solund, Christina/0000-0001-8149-3780; Weis, Nina/0000-0002-3133-2724; Bukh, Jens/0000-0002-7815-4806; Laursen, Alex Lund/0000-0002-1206-156X; Christensen, Peer Brehm/0000-0003-1394-058X; Thomsen, Reimar/0000-0001-9135-3474; Krarup, Henrik/0000-0001-5294-2428	Danish Cancer Society [R47-A2555]; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Danish Council for Independent Research - Medical Sciences; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A.P. Moller Foundation for the Advancement of Medical Science; Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: This study was supported partly by a scholarship stipend from The Danish Cancer Society; R47-A2555 (CS) and research grants from The Lundbeck Foundation (JB), The Danish Cancer Society (JB), The Novo Nordisk Foundation (JB), A.P. Moller Foundation for the Advancement of Medical Science (NW), and the Danish Council for Independent Research - Medical Sciences (SR, JB and NW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chevaliez S, 2007, HEPATOLOGY, V46, P22, DOI 10.1002/hep.21656; Christensen PB, 2012, SCAND J GASTROENTERO, V47, P1115, DOI 10.3109/00365521.2012.694905; Christensen PB, 2012, DAN MED J, V59; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dusheiko G, 2012, GUT, V61, P1647, DOI 10.1136/gutjnl-2012-302910; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Hansen N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-177; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Krarup HB, 1998, SCAND J CLIN LAB INV, V58, P415, DOI 10.1080/00365519850186391; Krarup HB, 2000, J VIRAL HEPATITIS, V7, P435, DOI 10.1046/j.1365-2893.2000.00258.x; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019562; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Macartney MJ, 2014, ANTIVIR RES, V105, P112, DOI 10.1016/j.antiviral.2014.02.019; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Paolucci S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-245; Pockros PJ, 2011, EXPERT OPIN BIOL TH, V11, P1611, DOI 10.1517/14712598.2011.627851; POORDAD F, 2013, GASTROENTEROLOGY, V10; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Wyles DL, 2013, J INFECT DIS, V207, pS33, DOI 10.1093/infdis/jis761	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113034	10.1371/journal.pone.0113034	http://dx.doi.org/10.1371/journal.pone.0113034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438153	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900026
J	Gao, W; Cai, LT; Xu, XD; Fan, JX; Xue, XL; Yan, XJ; Qu, QR; Wang, XH; Zhang, C; Wu, GQ				Gao, Wei; Cai, Liting; Xu, Xudong; Fan, Juxiang; Xue, Xiulei; Yan, Xuejiao; Qu, Qinrong; Wang, Xihua; Zhang, Chen; Wu, Guoqiu			Anti-CTGF Single-Chain Variable Fragment Dimers Inhibit Human Airway Smooth Muscle (ASM) Cell Proliferation by Down-Regulating p-Akt and p-mTOR Levels	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; FACTOR-BETA; CCN FAMILY; EXPRESSION; HYPERPLASIA; MECHANISMS; REVEALS; DOMAINS	Connective tissue growth factor (CTGF) contributes to airway smooth muscle (ASM) cell hyperplasia in asthma. Humanized single-chain variable fragment antibody (scFv) was well characterized as a CTGF antagonist in the differentiation of fibroblast into myofibroblast and pulmonary fibrosis in our previous studies. To further improve the bioactivity of scFv, we constructed a plasmid to express scFv-linker-matrilin-6xHis fusion proteins that could self-assemble into the scFv dimers by disulfide bonds in matrilin under non-reducing conditions. An immunoreactivity assay demonstrated that the scFv dimer could highly bind to CTGF in a concentration-dependent manner. The MTT and EdU assay results revealed that CTGF (>= 10 ng/mL) promoted the proliferation of ASM cells, and this effect was inhibited when the cells were treated with anti-CTGF scFv dimer. The western blot analysis results showed that increased phosphorylation of Akt and mTOR induced by CTGF could be suppressed by this scFv dimer. Based on these findings, anti-CTGF scFv dimer may be a potential agent for the prevention of airway remodeling in asthma.	[Gao, Wei; Cai, Liting; Fan, Juxiang; Xue, Xiulei; Yan, Xuejiao; Qu, Qinrong] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Xu, Xudong] Southeast Univ, Dept Biol Engn, Nanjing 210009, Peoples R China; [Wang, Xihua] Southeast Univ, Zhongda Hosp, Dept Respirat, Nanjing 210009, Peoples R China; [Zhang, Chen; Wu, Guoqiu] Southeast Univ, Zhongda Hosp, Ctr Clin Lab Med, Nanjing 210009, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Wu, GQ (corresponding author), Southeast Univ, Zhongda Hosp, Ctr Clin Lab Med, Nanjing 210009, Peoples R China.	nationball@163.com	Wu, Guoqiu/D-6558-2015	Wu, Guoqiu/0000-0002-6825-8716	National Natural Science Foundation of China [30970809, 81271636]; Natural Science Foundation of Jiangsu Province [BK2009274]; Special Fund of Clinical Medicine, Jiangsu Province, China [BL2012063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Special Fund of Clinical Medicine, Jiangsu Province, China	The authors thank the National Natural Science Foundation of China (No. 30970809, 81271636), the Natural Science Foundation of Jiangsu Province (No. BK2009274) and the Special Fund of Clinical Medicine, Jiangsu Province, China (No. BL2012063) for the financial support to this work.	Blalock TD, 2012, INVEST OPHTH VIS SCI, V53, P3387, DOI 10.1167/iovs.12-9425; Bosse Y, 2006, AM J RESP CELL MOL, V34, P746, DOI 10.1165/rcmb.2005-0309OC; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Burgess JK, 2005, CLIN EXP PHARMACOL P, V32, P988, DOI 10.1111/j.1440-1681.2005.04296.x; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hackett TL, 2012, CURR OPIN ALLERGY CL, V12, P53, DOI 10.1097/ACI.0b013e32834ec6eb; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; James A, 2000, EUR RESPIR J, V15, P782, DOI 10.1034/j.1399-3003.2000.15d25.x; James A, 2012, AM J RESP CRIT CARE, V186, P568, DOI 10.1164/ajrccm.186.6.568; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Puthalapattu S, 2014, J INVEST MED, V62, P665, DOI 10.2310/JIM.0000000000000065; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Wang G, 2013, PLOS ONE, V8; Wang XH, 2011, RESPIROLOGY, V16, P500, DOI 10.1111/j.1440-1843.2011.01938.x; Weisser NE, 2009, BIOTECHNOL ADV, V27, P502, DOI 10.1016/j.biotechadv.2009.04.004; Wu GQ, 2012, APPL MICROBIOL BIOT, V93, P2475, DOI 10.1007/s00253-011-3755-8; Wu GQ, 2010, BIOTECHNOL APPL BIOC, V56, P95, DOI 10.1042/BA20100031; Xie SP, 2007, AM J PHYSIOL-LUNG C, V293, pL245, DOI 10.1152/ajplung.00068.2007; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2003, SCIENCE, V301, P1334, DOI 10.1126/science.1089553; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113980	10.1371/journal.pone.0113980	http://dx.doi.org/10.1371/journal.pone.0113980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478966	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200037
J	Francis, G; Tanzman, J; Matthews, WJ				Francis, Gregory; Tanzman, Jay; Matthews, William J.			Excess Success for Psychology Articles in the Journal Science	PLOS ONE			English	Article							PUBLICATION BIAS; DECISION-MAKING; GOOD FIT; CONSEQUENCES; INCENTIVES; PREVALENCE; FAILURE; TRUTH; TOO; RED	This article describes a systematic analysis of the relationship between empirical data and theoretical conclusions for a set of experimental psychology articles published in the journal Science between 2005-2012. When the success rate of a set of empirical studies is much higher than would be expected relative to the experiments' reported effects and sample sizes, it suggests that null findings have been suppressed, that the experiments or analyses were inappropriate, or that the theory does not properly follow from the data. The analyses herein indicate such excess success for 83% (15 out of 18) of the articles in Science that report four or more studies and contain sufficient information for the analysis. This result suggests a systematic pattern of excess success among psychology articles in the journal Science.	[Francis, Gregory] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Francis, Gregory] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Tanzman, Jay] Tanzman Stat Consulting, Los Angeles, CA USA; [Matthews, William J.] Univ Cambridge, Dept Psychol, Cambridge, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cambridge	Francis, G (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	gfrancis@purdue.edu	Francis, Gregory/D-1924-2010	Francis, Gregory/0000-0002-8634-794X; Tanzman, Jay/0000-0002-8361-9292				Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; ANSCOMBE FJ, 1954, BIOMETRICS, V10, P89, DOI 10.2307/3001665; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bem DJ, 2011, J PERS SOC PSYCHOL, V100, P407, DOI 10.1037/a0021524; Bones AK, 2012, PERSPECT PSYCHOL SCI, V7, P307, DOI 10.1177/1745691612441216; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Champely S., 2009, PWR BASIC FUNCTIONS; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Francis G, 2014, GENETICS, V198, P449, DOI 10.1534/genetics.114.163998; Francis G, 2014, PSYCHON B REV, V21, P1180, DOI 10.3758/s13423-014-0601-x; Francis G, 2013, J MATH PSYCHOL, V57, P190, DOI 10.1016/j.jmp.2013.06.001; Francis G, 2013, J MATH PSYCHOL, V57, P153, DOI 10.1016/j.jmp.2013.02.003; Francis G, 2013, J EXP PSYCHOL GEN, V142, P292, DOI 10.1037/a0027923; Francis G, 2012, PERSPECT PSYCHOL SCI, V7, P585, DOI 10.1177/1745691612459520; Francis G, 2012, I-PERCEPTION, V3, P176, DOI 10.1068/i0519ic; Francis G, 2012, P NATL ACAD SCI USA, V109, pE1587, DOI 10.1073/pnas.1203591109; Francis G, 2012, PSYCHON B REV, V19, P151, DOI 10.3758/s13423-012-0227-9; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Halperin E, 2011, SCIENCE, V333, P1767, DOI 10.1126/science.1202925; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Johnson CS, 2012, J PERS SOC PSYCHOL, V103, P605, DOI 10.1037/a0030145; Kelley K., 2007, J STAT SOFTWARE, V20; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kicinski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081823; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Levelt Committee; Noort Committee; Drenth Committee, 2012, FLAW SCI FRAUD RES P; Masicampo EJ, 2012, Q J EXP PSYCHOL, V65, P2271, DOI 10.1080/17470218.2012.711335; Matthews WJ, 2011, JUDGM DECIS MAK, V6, P843; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; Morewedge CK, 2010, SCIENCE, V330, P1530, DOI 10.1126/science.1195701; Morey RD, 2014, PSYCHOL SCI, V25, P1289, DOI 10.1177/0956797614525969; Myung JI, 2009, PSYCHOL REV, V116, P499, DOI 10.1037/a0016104; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Ramirez G, 2011, SCIENCE, V331, P211, DOI 10.1126/science.1199427; Renkewitz F, 2011, JUDGM DECIS MAK, V6, P870; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stapel DA, 2011, SCIENCE, V332, P251, DOI 10.1126/science.1201068; Strube MJ, 2006, BEHAV RES METHODS, V38, P24, DOI 10.3758/BF03192746; Thomas B., 2002, EDUC RES-UK, V31, P25, DOI [10.3102/0013189X031003025, DOI 10.3102/0013189X031003025]; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Weisbuch M, 2009, SCIENCE, V326, P1711, DOI 10.1126/science.1178358; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845; Wood JN, 2007, SCIENCE, V317, P1402, DOI 10.1126/science.1144663; Yong E, 2012, NATURE, DOI DOI 10.1038/NATURE.2012.11535; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	63	36	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114255	10.1371/journal.pone.0114255	http://dx.doi.org/10.1371/journal.pone.0114255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474317	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500007
J	Gonzalez-Rodriguez, PJ; Li, Y; Martinez, F; Zhang, LB				Gonzalez-Rodriguez, Pablo J.; Li, Yong; Martinez, Fabian; Zhang, Lubo			Dexamethasone Protects Neonatal Hypoxic-Ischemic Brain Injury via L-PGDS-Dependent PGD(2)-DP1-pERK Signaling Pathway	PLOS ONE			English	Article							PROSTAGLANDIN-D SYNTHASE; ALLERGIC INFLAMMATION; RECEPTOR; PHOSPHORYLATION; GLUCOCORTICOIDS; D-2; PREVENTION; STRESS; FETAL; TRACE	Background and Purpose: Glucocorticoids pretreatment confers protection against neonatal hypoxic-ischemic (HI) brain injury. However, the molecular mechanism remains poorly elucidated. We tested the hypothesis that glucocorticoids protect against HI brain injury in neonatal rat by stimulation of lipocalin-type prostaglandin D synthase (L-PGDS)-induced prostaglandin D-2 (PGD(2))-DP1-pERK mediated signaling pathway. Methods: Dexamethasone and inhibitors were administered via intracerebroventricular (i.c.v) injections into 10-day-old rat brains. Levels of L-PGD(2), D prostanoid (DP1) receptor, pERK1/2 and PGD(2) were determined by Western immunoblotting and ELISA, respectively. Brain injury was evaluated 48 hours after conduction of HI in 10-day-old rat pups. Results: Dexamethasone pretreatment significantly upregulated L-PGDS expression and the biosynthesis of PGD(2). Dexamethasone also selectively increased isoform pERK-44 level in the neonatal rat brains. Inhibitors of L-PGDS (SeCl4), DP1 (MK-0524) and MAPK (PD98059) abrogated dexamethasone-induced increases in pERK-44 level, respectively. Of importance, these inhibitors also blocked dexamethasone-mediated neuroprotective effects against HI brain injury in neonatal rat brains. Conclusion: Interaction of glucocorticoids-GR signaling and L-PGDS-PGD(2)-DP1-pERK mediated pathway underlies the neuroprotective effects of dexamethasone pretreatment in neonatal HI brain injury.	[Gonzalez-Rodriguez, Pablo J.; Li, Yong; Martinez, Fabian; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92350 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92350 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a National Institutes of Health grant HL118861 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham IM, 2001, J NEUROENDOCRINOL, V13, P749, DOI 10.1046/j.1365-2826.2001.00705.x; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Arnold Walter, 2012, P531; Feng YZ, 2008, PEDIATR RES, V64, P370, DOI 10.1203/PDR.0b013e318180ebe6; Feng YZ, 2008, BRAIN RES BULL, V76, P102, DOI 10.1016/j.brainresbull.2008.01.012; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Flavin MP, 1996, EXP NEUROL, V139, P34, DOI 10.1006/exnr.1996.0078; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Garcia-Fernandez LF, 2000, J NEUROCHEM, V75, P460, DOI 10.1046/j.1471-4159.2000.0750460.x; HERTTING G, 1989, ANN NY ACAD SCI, V559, P84; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; KAUFFMAN KS, 1994, PEDIATR RES, V35, P515, DOI 10.1203/00006450-199405000-00001; Li Y, 2013, NEUROBIOL DIS, V60, P32, DOI 10.1016/j.nbd.2013.08.011; Li Y, 2012, STROKE, V43, P2483, DOI 10.1161/STROKEAHA.112.664698; Li Y, 2012, PROG NEUROBIOL, V98, P145, DOI 10.1016/j.pneurobio.2012.05.010; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Revest JM, 2014, MOL PSYCHIATR, V19, P1001, DOI 10.1038/mp.2013.134; Saleem S, 2009, NEUROSCIENCE, V160, P248, DOI 10.1016/j.neuroscience.2009.02.039; Saleem S, 2007, EUR J NEUROSCI, V26, P73, DOI 10.1111/j.1460-9568.2007.05627.x; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Taniguchi H, 2007, NEUROSCI LETT, V420, P39, DOI 10.1016/j.neulet.2007.04.016; Taniguchi H, 2007, J NEUROSCI, V27, P4303, DOI 10.1523/JNEUROSCI.0321-07.2007; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; TOMBAUGH GC, 1992, J NEUROCHEM, V59, P137, DOI 10.1111/j.1471-4159.1992.tb08884.x; Tuor UI, 1997, NEUROSCI BIOBEHAV R, V21, P175, DOI 10.1016/S0149-7634(96)00007-3; Tuor UI, 1995, ANN NY ACAD SCI, V765, P179, DOI 10.1111/j.1749-6632.1995.tb16574.x; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Verklan MT, 2009, J PERINAT NEONAT NUR, V23, P59, DOI 10.1097/01.JPN.0000346221.48202.7e; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154	42	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114470	10.1371/journal.pone.0114470	http://dx.doi.org/10.1371/journal.pone.0114470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474649	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500037
J	Homburger, H; Schneider, MK; Hilfiker, S; Luscher, A				Homburger, Hermel; Schneider, Manuel K.; Hilfiker, Sandra; Luescher, Andreas			Inferring Behavioral States of Grazing Livestock from High-Frequency Position Data Alone	PLOS ONE			English	Article							ANIMAL MOVEMENT; SPACE MODELS; CATTLE; GPS; VEGETATION; INFERENCE; SELECTION; PASTURES	Studies of animal behavior are crucial to understanding animal-ecosystem interactions, but require substantial efforts in visual observation or sensor measurement. We investigated how classifying behavioral states of grazing livestock using global positioning data alone depends on the classification approach, the preselection of training data, and the number and type of movement metrics. Positions of grazing cows were collected at intervals of 20 seconds in six upland areas in Switzerland along with visual observations of animal behavior for comparison. A total of 87 linear and cumulative distance metrics and 15 turning angle metrics across multiple time steps were used to classify position data into the behavioral states of walking, grazing, and resting. Five random forest classification models, a linear discriminant analysis, a support vector machine, and a state-space model were evaluated. The most accurate classification of the observed behavioral states in an independent validation dataset was 83%, obtained using random forest with all available movement metrics. However, the state-specific accuracy was highly unequal (walking: 36%, grazing: 95%, resting: 58%). Random undersampling led to a prediction accuracy of 77%, with more balanced state-specific accuracies (walking: 68%, grazing: 82%, resting: 68%). The other evaluated machine-learning approaches had lower classification accuracies. The state-space model, based on distance to the preceding position and turning angle, produced a relatively low accuracy of 64%, slightly lower than a random forest model with the same predictor variables. Given the successful classification of behavioral states, our study promotes the more frequent use of global positioning data alone for animal behavior studies under the condition that data is collected at high frequency and complemented by context-specific behavioral observations. Machine-learning algorithms, notably random forest, were found very useful for classification and easy to implement. Moreover, the use of measures across multiple time steps is clearly necessary for a satisfactory classification.	[Homburger, Hermel; Schneider, Manuel K.; Hilfiker, Sandra; Luescher, Andreas] Agroscope, Inst Sustainabil Sci, CH-8046 Zurich, Switzerland; [Homburger, Hermel] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	Swiss Federal Research Station Agroscope; University of Freiburg	Schneider, MK (corresponding author), Agroscope, Inst Sustainabil Sci, Reckenholzstr 191, CH-8046 Zurich, Switzerland.	manuel.schneider@agroscope.admin.ch	Schneider, Manuel K./O-2308-2015; Lüscher, Andreas/E-2944-2018	Schneider, Manuel K./0000-0002-3842-2618; Andreas, Luescher/0000-0001-8158-1721	Fondation Sur-la-Croix; Canton of Grisons within the AlpFUTUR joint research program	Fondation Sur-la-Croix; Canton of Grisons within the AlpFUTUR joint research program	This research was supported by grants from the Fondation Sur-la-Croix (http://www.fondation-sur-la-croix.ch/) and the Canton of Grisons within the AlpFUTUR joint research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Aharoni Y, 2013, J ANIM SCI, V91, P1381, DOI 10.2527/jas.2012-5400; Anderson DM, 2012, RANGELAND J, V34, P149, DOI 10.1071/RJ11062; Bailey DW, 2006, RANGELAND ECOL MANAG, V59, P351, DOI 10.2111/04-165R2.1; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Beyer HL, 2013, METHODS ECOL EVOL, V4, P433, DOI 10.1111/2041-210X.12026; Braun U, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-164; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buho H, 2011, ADV SPACE RES, V48, P43, DOI 10.1016/j.asr.2011.02.015; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen C., 2004, USING RANDOM FOREST, V110, P24; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Davis JD, 2011, APPL ENG AGRIC, V27, P143; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; GANSKOPP D, 1987, NORTHWEST SCI, V61, P74; Ganskopp D, 2001, APPL ANIM BEHAV SCI, V73, P251, DOI 10.1016/S0168-1591(01)00148-4; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geremia C, 2014, ECOL APPL, V24, P346, DOI 10.1890/13-0137.1; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Jewell PL, 2007, AGR ECOSYST ENVIRON, V122, P377, DOI 10.1016/j.agee.2007.02.012; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Karatzoglou A., 2004, R J STAT SOFTW, V11, P1; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; MATCHES AG, 1992, J PROD AGRIC, V5, P1; Mellone U, 2011, INT J BIOMETEOROL, V55, P463, DOI 10.1007/s00484-010-0368-3; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Plummer M., 2003, P 3 INT WORKSHOP DIS; Postlethwaite CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057640; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B.D., 2005, PATTERN RECOGNITION; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Schlecht E, 2004, APPL ANIM BEHAV SCI, V85, P185, DOI 10.1016/j.applanim.2003.11.003; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Torgo L., 2010, DATA MINING R LEARNI; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935, DOI [10.1145/1273496.1273614, DOI 10.1145/1273496.1273614]; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028	45	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114522	10.1371/journal.pone.0114522	http://dx.doi.org/10.1371/journal.pone.0114522			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474315	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500043
J	Amoako, N; Asante, KP; Adjei, G; Awandare, GA; Bimi, L; Owusu-Agyei, S				Amoako, Nicholas; Asante, Kwaku Poku; Adjei, George; Awandare, Gordon A.; Bimi, Langbong; Owusu-Agyei, Seth			Associations between Red Cell Polymorphisms and Plasmodium falciparum Infection in the Middle Belt of Ghana	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; MALARIA TRANSMISSION; IMMUNE-RESPONSES; TRAIT; PROTECTION; MORBIDITY; CHILDREN; PREVALENCE; RESISTANCE; INFANTS	Background: Red blood cell (RBC) polymorphisms are common in malaria endemic regions and are known to protect against severe forms of the disease. Therefore, it is important to screen for these polymorphisms in drugs or vaccines efficacy trials. This study was undertaken to evaluate associations between clinical malaria and RBC polymorphisms to assess biological interactions that may be necessary for consideration when designing clinical trials. Method: In a cross-sectional study of 341 febrile children less than five years of age, associations between clinical malaria and common RBC polymorphisms including the sickle cell gene and G6PD deficiency was evaluated between November 2008 and June 2009 in the middle belt of Ghana, Kintampo. G6PD deficiency was determined by quantitative methods whiles haemoglobin variants were determined by haemoglobin titan gel electrophoresis. Blood smears were stained with Giemsa and parasite densities were determined microscopically. Results: The prevalence of clinical malarial among the enrolled children was 31.9%. The frequency of G6PD deficiency was 19.0% and that for the haemoglobin variants were 74.7%, 14.7%, 9.1%, 0.9% respectively for HbAA, HbAC, HbAS and HbSS. In Multivariate regression analysis, children with the HbAS genotype had 79% lower risk of malaria infection compared to those with the HbAA genotypes (OR=0.21, 95% CI: 0.06-0.73, p=0.01). HbAC genotype was not significantly associated with malaria infection relative to the HbAA genotype (OR=0.70, 95% CI: 0.35-1.42, p=0.33). G6PD deficient subgroup had a marginally increased risk of malaria infection compared to the G6PD normal subgroup (OR=1.76, 95% CI: 0.98-3.16, p=0.06). Conclusion: These results confirm previous findings showing a protective effect of sickle cell trait on clinical malaria infection. However, G6PD deficiency was associated with a marginal increase in susceptibility to clinical malaria compared to children without G6PD deficiency.	[Amoako, Nicholas; Asante, Kwaku Poku; Adjei, George; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Infect Dis Res Lab, Legon, Ghana; [Bimi, Langbong] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana	Kintampo Health Research Centre; University of Ghana; University of Ghana	Amoako, N (corresponding author), Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana.	nicholas.amoako@kintampo-hrc.org	Awandare, Gordon/J-1392-2019	Awandare, Gordon/0000-0002-8793-3641; BIMI, Langbong/0000-0002-8536-4828; Amoako, Nicholas/0000-0001-9737-4401; Owusu-Agyei, Seth/0000-0002-0807-1781	Management of Kintampo Health Research Centre (KHRC), Ghana Health Service; KHRC Research Capacity Programme	Management of Kintampo Health Research Centre (KHRC), Ghana Health Service; KHRC Research Capacity Programme	The Sponsor is the Management of Kintampo Health Research Centre (KHRC), Ghana Health Service. The grant was KHRC Research Capacity Programme. KHRC management reviewed and approved all study procedures and the study manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; BIENZLE U, 1972, LANCET, V1, P107; Breman JG, 2001, AM SOC TROPICAL MED, P1824, DOI American Society of Tropical Medicine and Hygiene; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Davenport GC, 2010, ROLE HIV 1 BACTERMIA; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; GILLES HM, 1967, LANCET, V1, P138; Gong L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-317; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Guinet F, 1997, ACTA TROP, V68, P175, DOI 10.1016/S0001-706X(97)00089-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; Kreuels B, 2010, BLOOD, V115, P4551, DOI 10.1182/blood-2009-09-241844; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; Lohr G. W., 1974, METHODS ENZYMATIC AN, V2, P636, DOI [DOI 10.1016/B978-0-12-091302-2.50026-8, 10.1016/B978-0-12-091302-2.50026-8]; LUZZATTO L, 1979, LANCET, V1, P1183; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; MARTIN SK, 1979, LANCET, V1, P524; Masiye F, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-60; Mockenhaupt FP, 2003, TROP MED INT HEALTH, V8, P118, DOI 10.1046/j.1365-3156.2003.01008.x; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MODIANO G, 1991, AM J HUM GENET, V48, P390; Moormann AM, 2003, T ROY SOC TROP MED H, V97, P513, DOI 10.1016/S0035-9203(03)80010-X; Ohene-Frempong K, 2008, PEDIATRICS, V121, pS120, DOI 10.1542/peds.2007-2022UUU; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Rumisha SF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-124; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sehgal V M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P105, DOI 10.1016/0035-9203(89)90616-0; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112868	10.1371/journal.pone.0112868	http://dx.doi.org/10.1371/journal.pone.0112868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470251	Green Published, gold			2022-12-27	WOS:000349128700011
J	Brayton, KM; Hirsch, AT; O'Brien, PJ; Cheville, A; Karaca-Mandic, P; Rockson, SG				Brayton, Kimberly M.; Hirsch, Alan T.; O'Brien, Patricia J.; Cheville, Andrea; Karaca-Mandic, Pinar; Rockson, Stanley G.			Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; LYMPHATIC VASCULAR-DISEASE; BREAST-CANCER; PNEUMATIC COMPRESSION; EXTREMITY LYMPHEDEMA; SECONDARY LYMPHEDEMA; TRIAL; MANAGEMENT; WOMEN; LIMB	Background: Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in clinical outcomes and costs associated with a defined therapeutic intervention (use of a pneumatic compression devices [PCD]) in a representative, privately insured population. Methods and Findings: Retrospective analysis of de-identified health claims data from a large national insurer for calendar years 2007 through 2013. Patients were required to have 12 months of continuous insurance coverage prior to PCD receipt (baseline), as well as a 12-month follow-up period. Analyses were performed for individuals with cancer-related lymphedema (n=1,065). Lymphedema prevalence was calculated: number of patients with a lymphedema claim in a calendar year divided by total number of enrollees. The impact of PCD use was evaluated by comparing rates of a pre-specified set of health outcomes and costs for the 12 months before and after, respectively, PCD receipt. Lymphedema prevalence among cancer survivors increased from 0.95% in 2007 to 1.24% in 2013. PCD use was associated with decreases in rates of hospitalizations (45% to 32%, p<0.0001), outpatient hospital visits (95% to 90%, p<0.0001), cellulitis diagnoses (28% to 22%, p=0.003), and physical therapy use (50% to 41%, p<0.0001). The average baseline health care costs were high ($53,422) but decreased in the year after PCD acquisition (-$11,833, p<0.0001). Conclusions: Lymphedema is a prevalent medical condition that is often a defining attribute of cancer survivorship. The problem is associated with high health care costs; Treatment (in this instance, use of PCD) is associated with significant decreases in adverse clinical outcomes and costs.	[Brayton, Kimberly M.; Rockson, Stanley G.] Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Hirsch, Alan T.] Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [O'Brien, Patricia J.] Univ Vermont, Div Hematol Oncol, Burlington, VT USA; [Cheville, Andrea] Mayo Clin, Phys Med & Rehabil, Rochester, MN USA; [Karaca-Mandic, Pinar] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Rockson, SG (corresponding author), Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	rockson@stanford.edu		rockson, stanley/0000-0003-1253-474X	NIH [HS000028]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028, F32HS000028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funding: Kimberly Brayton, MD, is supported by Grant Number HS000028 from the NIH. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the AHRQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2006, J CLIN ONCOL, V24, P2765, DOI 10.1200/JCO.2005.03.6749; [Anonymous], 2012, CURRENT POPULATION S; Badger CMA, 2000, CANCER, V88, P2832, DOI 10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.3.CO;2-L; Chang Christine J, 2013, Semin Oncol Nurs, V29, P28, DOI 10.1016/j.soncn.2012.11.005; Cull DL, 2010, J AM COLL SURGEONS, V210, P555, DOI 10.1016/j.jamcollsurg.2009.12.019; Eslami MH, 2007, J VASC SURG, V45, P55, DOI 10.1016/j.jvs.2006.09.044; Hillner BE, 2006, J NATL CANCER I, V98, P660, DOI 10.1093/jnci/djj205; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; McKenzie DC, 2003, J CLIN ONCOL, V21, P463, DOI 10.1200/JCO.2003.04.069; McWayne J, 2005, CANCER, V104, P457, DOI 10.1002/cncr.21195; Moffatt CJ, 2003, QJM-INT J MED, V96, P731, DOI 10.1093/qjmed/hcg126; Mondry TE, 2004, CANCER J, V10, P42, DOI 10.1097/00130404-200401000-00009; Muluk SC, 2013, EUR J VASC ENDOVASC, V46, P480, DOI 10.1016/j.ejvs.2013.07.012; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Radhakrisihnan K, 2008, ANN NY ACAD SCI, V1131, P155, DOI 10.1196/annals.1413.015; Ridner Sheila H., 2009, Lymphatic Research and Biology, V7, P109, DOI 10.1089/lrb.2009.0004; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Rockson SG, 2010, VASC MED, V15, P223, DOI 10.1177/1358863X10364553; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Snyder JJ, 2006, J AM SOC NEPHROL, V17, P2056, DOI 10.1681/ASN.2006030201; Stout NL, 2013, LYMPHOLOGY, V46, P27; Szuba A, 2003, J NUCL MED, V44, P43; Szuba A, 2002, CANCER, V95, P2260, DOI 10.1002/cncr.10976	27	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114597	10.1371/journal.pone.0114597	http://dx.doi.org/10.1371/journal.pone.0114597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470383	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700124
J	Hantzsch, M; Tolios, A; Beutner, F; Nagel, D; Thiery, J; Teupser, D; Holdt, LM				Haentzsch, Madlen; Tolios, Alexander; Beutner, Frank; Nagel, Dorothea; Thiery, Joachim; Teupser, Daniel; Holdt, Lesca M.			Comparison of Whole Blood RNA Preservation Tubes and Novel Generation RNA Extraction Kits for Analysis of mRNA and MiRNA Profiles	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; COLLECTION; STABILIZATION; TRANSCRIPTOME; SAMPLES; INJURY; SEQ	Background: Whole blood expression profiling is frequently performed using PAXgene (Qiagen) or Tempus (Life Technologies) tubes. Here, we compare 6 novel generation RNA isolation protocols with respect to RNA quantity, quality and recovery of mRNA and miRNA. Methods: 3 PAXgene and 3 Tempus Tubes were collected from participants of the LIFE study with (n=12) and without (n=35) acute myocardial infarction (AMI). RNA was extracted with 4 manual protocols from Qiagen (PAXgene Blood miRNA Kit), Life Technologies (MagMAX for Stabilized Blood Tubes RNA Isolation Kit), and Norgen Biotek (Norgen Preserved Blood RNA Purification Kit I and Kit II), and 2 (semi-) automated protocols on the QIAsymphony (Qiagen) and MagMAX Express-96 Magnetic Particle Processor (Life Technologies). RNA quantity and quality was determined. For biological validation, RNA from 12 representative probands, extracted with all 6 kits (n=72), was reverse transcribed and mRNAs (matrix metalloproteinase 9, arginase 1) and miRNAs (miR133a, miR1), shown to be altered by AMI, were analyzed. Results: RNA yields were highest using the Norgen Kit I with Tempus Tubes and lowest using the Norgen Kit II with PAXgene. The disease status was the second major determinant of RNA yields (LIFE-AMI 11.2 vs. LIFE 6.7 mu g, p < 0.001) followed by the choice of blood collection tube. (Semi-) automation reduced overall RNA extraction time but did not generally reduce hands-on-time. RNA yields and quality were comparable between manual and automated extraction protocols. mRNA expression was not affected by collection tubes and RNA extraction kits but by RT/qPCR reagents with exception of the Norgen Kit II, which led to mRNA depletion. For miRNAs, expression differences related to collection tubes (miR30b), RNA isolation (Norgen Kit II), and RT/qRT reagents (miR133a) were observed. Conclusion: We demonstrate that novel generation RNA isolation kits significantly differed with respect to RNA recovery and affected miRNA but not mRNA expression profiles.	[Haentzsch, Madlen; Beutner, Frank; Thiery, Joachim; Teupser, Daniel; Holdt, Lesca M.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Haentzsch, Madlen; Beutner, Frank; Thiery, Joachim] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Tolios, Alexander; Nagel, Dorothea; Teupser, Daniel; Holdt, Lesca M.] Univ Munich, Inst Lab Med, Munich, Germany; [Beutner, Frank] Univ Leipzig, Ctr Heart, Dept Cardiol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; University of Munich; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Holdt, LM (corresponding author), Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany.	lesca.holdt@med.uni-muenchen.de			LIFE - European Union; European Regional Development Fund (ERDF); Free State of Saxony within initiative of excellence	LIFE - European Union; European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within initiative of excellence	Funding: This study was supported by the LIFE project, which is funded by the European Union, the European Regional Development Fund (ERDF) and the Free State of Saxony within its initiative of excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Beutner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029070; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Cheng C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088566; Devaux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070644; Duale Nur, 2012, BMC Res Notes, V5, P510, DOI 10.1186/1756-0500-5-510; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Guzel S, 2013, KOREAN J INTERN MED, V28, P165, DOI 10.3904/kjim.2013.28.2.165; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Hsu J, 2012, CURR OPIN CARDIOL, V27, P210, DOI 10.1097/HCO.0b013e3283522198; Jaguszewski M, 2014, EUR HEART J, V35, P999, DOI 10.1093/eurheartj/eht392; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Khan HA, 2012, INT J CLIN EXP MED, V5, P50; Liu LF, 2012, J GERIATR CARDIOL, V9, P28, DOI 10.3724/SP.J.1263.2012.00028; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Matheson LA, 2008, J IMMUNOL METHODS, V339, P82, DOI 10.1016/j.jim.2008.08.003; Menke Andreas, 2012, BMC Res Notes, V5, P1, DOI 10.1186/1756-0500-5-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikula T, 2012, TRANSL RES; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rainen L, 2002, CLIN CHEM, V48, P1883; Sayed ASM, 2013, DIS MARKERS, V2013, P561, DOI 10.1155/2013/217948; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-222; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	32	44	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113298	10.1371/journal.pone.0113298	http://dx.doi.org/10.1371/journal.pone.0113298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469788	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700021
J	Li, Y; Shi, BY; Li, SL				Li, Ya; Shi, Bingyin; Li, Sheli			Association between Serum Chemerin Concentrations and Clinical Indices in Obesity or Metabolic Syndrome: A Meta-Analysis	PLOS ONE			English	Article							BARIATRIC SURGERY; ADIPOSE-TISSUE; INFLAMMATION; INSULIN; HETEROGENEITY; POPULATION; ADIPOKINE; MARKERS; ADULTS	Objective: Chemerin is a novel adipokine. Previous research has investigated the association between chemerin and clinical indices in patients with obesity or metabolic syndrome (MS), although the results obtained have been inconsistent. We conducted a meta-analysis to investigate the association between chemerin and clinical indicators of diabetes, MS and obesity with obesity or MS subjects. Design and Methods: Studies were identified by searching the PubMed, the Cochrane Library, EMBASE and CNKI, databases beginning with the original report in July 2007 until the end of May 2013. For each variable, summary correlation coefficients were estimated using random-effects or fixed-effect meta-analysis with 95% confidence interval (CI) performed by STATA software. Results: A total of eight studies with 20 clinical variables (total n=1787) met the inclusion criteria. The meta-analyse of diabetes markers showed that FSI (r(s)=0.26; 95% CI=0.21-0.31; P=0.000), 2HPG (r(s)=0.06; 95% CI=0.01-0.12; P=0.030) and HOMA-IR (r(s)=0.178; 95% CI=0.019-0.337; P=0.028) were positively correlated with chemerin, however, FPG (r(s)=0.03, 95% CI=20.02 to 0.08, P=0.240) and HbA1c (r(s)=20.05; 95% CI=20.24-0.15; P=0.641) were not significantly correlated with chemerin. The meta-analyses of MS and obesity markers indicated that TG, TC, CRP BMI, TBF%, WC, WHR and Leptin were positively correlated with chemerin, nevertheless, SBP, DBP, LDL-C, HDL-C, ALT and r-GT were not significantly correlated, adiponectin was negatively correlated. Sensitivity analysis was performed and the summary results did not change significantly. Conclusions: The results suggest that chemerin in patients with obesity or MS may be associated with obesity, imbalances in lipid and diabetes metabolism and insulin resistance. Chemerin played an important role in the pathophysiology of obesity and MS.	[Li, Ya; Shi, Bingyin] Xi An Jiao Tong Univ, Hosp 1, Dept Endocrinol, Xian 710061, Peoples R China; [Li, Ya; Li, Sheli] Yanan Univ, Affiliated Hosp, Dept Endocrinol, Yanan 716000, Peoples R China	Xi'an Jiaotong University; Yanan University	Shi, BY (corresponding author), Xi An Jiao Tong Univ, Hosp 1, Dept Endocrinol, Xian 710061, Peoples R China.	shibingy@126.com			Natural Science Foundation of Shanxi Province, China [2012sp2-08]	Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province)	Funding: This work was supported by the Natural Science Foundation of Shanxi Province, China (Grant No. 2012sp2-08), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadda AA, 2012, MOL CELLS, V33, P591, DOI 10.1007/s10059-012-0012-7; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034710; Coimbra S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701915; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Fatima SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057113; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jialal I, 2013, J CLIN ENDOCR METAB, V98, pE514, DOI 10.1210/jc.2012-3673; Kim SH, 2014, CLIN ENDOCRINOL, V80, P825, DOI 10.1111/cen.12249; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Song SH, 2010, DOMEST ANIM ENDOCRIN, V39, P97, DOI 10.1016/j.domaniend.2010.02.007; Stefanov T, 2014, ENDOCRINE, V45, P382, DOI 10.1007/s12020-013-0003-2; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Wang Ling-yan, 2009, Zhonghua Yi Xue Za Zhi, V89, P235; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wilson DB, 2001, PSYCHOL METHODS, V6, P413, DOI 10.1037//1082-989X.6.4.413; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200	30	51	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113915	10.1371/journal.pone.0113915	http://dx.doi.org/10.1371/journal.pone.0113915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469985	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700051
J	Sadeh, S; Rotter, S				Sadeh, Sadra; Rotter, Stefan			Distribution of Orientation Selectivity in Recurrent Networks of Spiking Neurons with Different Random Topologies	PLOS ONE			English	Article							CONTRAST INVARIANCE; VISUAL-CORTEX; CONNECTIVITY; EMERGENCE; INPUT; NOISE; MODEL; MICROCIRCUITS; ORGANIZATION; INHIBITION	Neurons in the primary visual cortex are more or less selective for the orientation of a light bar used for stimulation. A broad distribution of individual grades of orientation selectivity has in fact been reported in all species. A possible reason for emergence of broad distributions is the recurrent network within which the stimulus is being processed. Here we compute the distribution of orientation selectivity in randomly connected model networks that are equipped with different spatial patterns of connectivity. We show that, for a wide variety of connectivity patterns, a linear theory based on firing rates accurately approximates the outcome of direct numerical simulations of networks of spiking neurons. Distance dependent connectivity in networks with a more biologically realistic structure does not compromise our linear analysis, as long as the linearized dynamics, and hence the uniform asynchronous irregular activity state, remain stable. We conclude that linear mechanisms of stimulus processing are indeed responsible for the emergence of orientation selectivity and its distribution in recurrent networks with functionally heterogeneous synaptic connectivity.	[Rotter, Stefan] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Rotter, S (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.rotter@biologie.uni-freiburg.de		Sadeh, Sadra/0000-0001-8159-5461	German Ministry of Education and Research (BMBF; BFNT-F*T) [01GQ0830]; German Research Foundation (DFG) [EXC 1086]; University of Freiburg	German Ministry of Education and Research (BMBF; BFNT-F*T)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Funding by the German Ministry of Education and Research (BMBF; BFNT-F*T, grant 01GQ0830) and the German Research Foundation (DFG; grant EXC 1086) is gratefully acknowledged. The article processing charge was covered by the open access publication fund of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Helias M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000929; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Ishikawa AW, 2014, J NEUROSCI, V34, P12576, DOI 10.1523/JNEUROSCI.1346-14.2014; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Ostojic S, 2014, NAT NEUROSCI, V17, P594, DOI 10.1038/nn.3658; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pehlevan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089992; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rosenbaum R, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021039; Sadeh S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-148; SIEGERT AJF, 1951, PHYS REV, V81, P617, DOI 10.1103/PhysRev.81.617; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Yger P, 2011, J COMPUT NEUROSCI, V31, P229, DOI 10.1007/s10827-010-0310-z; Yim MY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032710	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114237	10.1371/journal.pone.0114237	http://dx.doi.org/10.1371/journal.pone.0114237			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469704	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700090
J	Just, MA; Cherkassky, VL; Buchweitz, A; Keller, TA; Mitchell, TM				Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.; Mitchell, Tom M.			Identifying Autism from Neural Representations of Social Interactions: Neurocognitive Markers of Autism	PLOS ONE			English	Article							PERSPECTIVE-TAKING; BRAIN ACTIVITY; CLASSIFICATION; SPECTRUM; INDIVIDUALS; DEACTIVATE; DISORDER; STATES; SELF	Autism is a psychiatric/neurological condition in which alterations in social interaction (among other symptoms) are diagnosed by behavioral psychiatric methods. The main goal of this study was to determine how the neural representations and meanings of social concepts (such as to insult) are altered in autism. A second goal was to determine whether these alterations can serve as neurocognitive markers of autism. The approach is based on previous advances in fMRI analysis methods that permit (a) the identification of a concept, such as the thought of a physical object, from its fMRI pattern, and (b) the ability to assess the semantic content of a concept from its fMRI pattern. These factor analysis and machine learning methods were applied to the fMRI activation patterns of 17 adults with high-functioning autism and matched controls, scanned while thinking about 16 social interactions. One prominent neural representation factor that emerged (manifested mainly in posterior midline regions) was related to self-representation, but this factor was present only for the control participants, and was near-absent in the autism group. Moreover, machine learning algorithms classified individuals as autistic or control with 97% accuracy from their fMRI neurocognitive markers. The findings suggest that psychiatric alterations of thought can begin to be biologically understood by assessing the form and content of the altered thought's underlying brain activation patterns.	[Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.] Carnegie Mellon Univ, Ctr Cognit Brain Imaging, Pittsburgh, PA 15213 USA; [Mitchell, Tom M.] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Buchweitz, Augusto] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul InsCer RS, Porto Alegre, RS, Brazil	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pontificia Universidade Catolica Do Rio Grande Do Sul	Just, MA (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	just@cmu.edu	Buchweitz, Augusto/J-5384-2019; Buchweitz, Augusto/G-3829-2012	Buchweitz, Augusto/0000-0003-3791-7472; Buchweitz, Augusto/0000-0003-3791-7472; Just, Marcel/0000-0003-1245-3050	National Institute of Mental Health Grant [MH029617]; National Institute of Child Health and Human Development Grant [HD055748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH029617] Funding Source: NIH RePORTER	National Institute of Mental Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health Grant MH029617 and the National Institute of Child Health and Human Development Grant HD055748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Benton AL, 1987, TEST FACIAL RECOGNIT; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Frings L, 2006, EXP BRAIN RES, V173, P661, DOI 10.1007/s00221-006-0408-8; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Grandin T, 1992, J Child Adolesc Psychopharmacol, V2, P63, DOI 10.1089/cap.1992.2.63; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kanner L, 1943, NERV CHILD, V2, P217; Kassam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066032; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mizuno A, 2011, BRAIN, V134, P2422, DOI 10.1093/brain/awr151; Morita T, 2011, SOC NEUROSCI, V22, P1; Murdaugh DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050064; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sacks O., 1996, ANTHROPOLOGIST MARS; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Uddin LQ, 2011, NEUROCASE, V17, P201, DOI 10.1080/13554794.2010.509320; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	40	53	53	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113879	10.1371/journal.pone.0113879	http://dx.doi.org/10.1371/journal.pone.0113879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461818	Green Published, gold			2022-12-27	WOS:000345869700063
J	Peng, SL; Zhao, Y; Xu, F; Jia, CJ; Xu, YQ; Dai, CL				Peng, Songlin; Zhao, Yang; Xu, Feng; Jia, Changjun; Xu, Yongqing; Dai, Chaoliu			An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma	PLOS ONE			English	Article							PHASE-III TRIAL; CLINICAL-TRIALS; RAF/MEK/ERK PATHWAY; BAY 43-9006; EFFICACY; QUALITY; ANGIOGENESIS; EXPERIENCE; INHIBITOR; TARGETS	Background: The efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) remains controversial. Therefore, we conducted a meta-analysis to evaluate the efficacy and safety of sorafenib for treating patients with advanced HCC. Methods: The PubMed, Embase, and Web of Science databases were searched. Eligible studies were randomized controlled trials (RCTs) that assessed sorafenib therapy in patients with advanced HCC. The outcomes included overall survival (OS), time to progression (TTP), overall response rate (ORR), and toxicities. Hazard ratio (HR) and risk ratio (RR) were used for the meta-analysis and were expressed with 95% confidence intervals (CIs). Results: Seven RCTs, with a total of 3807 patients, were included in this metaanalysis. All patients received sorafenib alone, or with other chemotherapeutic regimens. Pooled estimates showed that sorafenib improved the OS (HR=0.74, 95% CI: 0.61, 0.90; P=0.002), or TTP outcomes (HR=0.69, 95% CI: 0.55, 0.86; P=0.001). Subgroup analysis revealed that sorafenib was more effective in the patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 1-2 (HR=0.77, 95% CI: 0.60, 1.0; P=0.05), or macroscopic vascular invasion (MVI), and/or extrahepatic spread (EHS) (HR=0.65, 95% CI: 0.46, 0.93; P=0.02), in terms of OS. Patients who received sorafenib did not have a higher ORR (RR=0.85, 95% CI: 0.65, 1.11; P=0.10). In addition, there was a slight increase in toxicity in the sorafenib group. Conclusion: Treatment with sorafenib significantly improved OS and TTP in patients with advanced HCC. Additional large-scale, well-designed RCTs are needed to evaluate the efficacy of sorafenib-based therapy in the treatment of advanced HCC.	[Peng, Songlin; Zhao, Yang; Xu, Feng; Jia, Changjun; Xu, Yongqing; Dai, Chaoliu] China Med Univ, Affiliated Shengjing Hosp, Dept Hepatobiliary Surg, Shenyang 110004, Peoples R China	China Medical University	Dai, CL (corresponding author), China Med Univ, Affiliated Shengjing Hosp, Dept Hepatobiliary Surg, Shenyang 110004, Peoples R China.	daicl@sj-hospital.org	Xu, Feng/L-8097-2019	Xu, Feng/0000-0003-3212-6284	Shengyang science and technology project plan [F13-221-924]	Shengyang science and technology project plan	The study was supported by Shengyang science and technology project plan (F13-221-924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman O, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0655-z; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Balsom SM, 2010, ONCOLOGY-BASEL, V78, P210, DOI 10.1159/000313701; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Brunocilla PR, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0345-2; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Del Prete S, 2010, CANCER CHEMOTH PHARM, V66, P837, DOI 10.1007/s00280-009-1226-z; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Manghisi G, 1998, HEPATOLOGY, V28, P751; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pinter M, 2011, ALIMENT PHARM THER, V34, P949, DOI 10.1111/j.1365-2036.2011.04823.x; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Song TQ, 2011, EUR J GASTROEN HEPAT, V23, P1233, DOI 10.1097/MEG.0b013e32834bd2d0; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Trojniak MP, 2012, IMMUNOPHARM IMMUNOT, V34, P419, DOI 10.3109/08923973.2011.617373; Wang Z, 2013, ASIAN PAC J CANCER P, V14, P691, DOI 10.7314/APJCP.2013.14.2.691; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wood, 2006, COMMUNITY ONCOL, V3, P558; Yang YP, 2012, CELL BIOCHEM BIOPHYS, V63, P159, DOI 10.1007/s12013-012-9353-2; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Zhang X, 2012, HEPATOB PANCREAT DIS, V11, P458, DOI 10.1016/S1499-3872(12)60209-4	42	20	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112530	10.1371/journal.pone.0112530	http://dx.doi.org/10.1371/journal.pone.0112530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460347	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700018
J	Orita, M; Hayashida, N; Nukui, H; Fukuda, N; Kudo, T; Matsuda, N; Fukushima, Y; Takamura, N				Orita, Makiko; Hayashida, Naomi; Nukui, Hiroshi; Fukuda, Naoko; Kudo, Takashi; Matsuda, Naoki; Fukushima, Yoshiko; Takamura, Noboru			Internal Radiation Exposure Dose in Iwaki City, Fukushima Prefecture after the Accident at Fukushima Dai-ichi Nuclear Power Plant	PLOS ONE			English	Article							WHOLE-BODY COUNTER; BRYANSK OBLAST; RESIDENTS; RADIONUCLIDES; RADIOCESIUM; BURDEN	As a result of the accident at the Fukushima Daiichi Nuclear Power Plant (FNPP) on 11 March 2011, a huge amount of radionuclides, including radiocesium, was released and spread over a wide area of eastern Japan. Although three years have passed since the accident, residents around the FNPP are anxious about internal radiation exposure due to radiocesium. In this study, we screened internal radiation exposure doses in Iwaki city of Fukushima prefecture, using a whole-body counter. The first screening was conducted from October 2012 to February 2013, and the second screening was conducted from May to November 2013. Study participants were employees of ALPINE and their families who underwent examination. A total of 2,839 participants (1,366 men and 1,473 women, 1-86 years old) underwent the first screening, and 2,092 (1,022 men and 1,070 women, 1-86 years old) underwent the second screening. The results showed that 99% of subjects registered below 300 Bq per body in the first screening, and all subjects registered below 300 Bq per body in the second screening. The committed effective dose ranged from 0.01-0.06 mSv in the first screening and 0.01-0.02 mSv in the second screening. Long-term follow-up studies are needed to avoid unnecessary chronic internal exposure and to reduce anxiety among the residents by communicating radiation health risks.	[Orita, Makiko; Hayashida, Naomi; Nukui, Hiroshi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Fukuda, Naoko; Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radioisotope Med, Nagasaki 852, Japan; [Matsuda, Naoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Protect, Nagasaki 852, Japan; [Fukushima, Yoshiko] Hirosaki Univ, Dept Nursing, Grad Sch Hlth Sci, Hirosaki, Aomori, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Hirosaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp		Takamura, Noboru/0000-0002-5552-3234	Grants-in-Aid for Scientific Research [24651050, 26305025, 25282042] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], VER MONDAL SOFTW; [Anonymous], MON DOS CALC MOND; GRUNDY RD, 1966, J NUCL MED, V7, P676; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Harada KH, 2013, ENVIRON SCI TECHNOL, V47, P2520, DOI 10.1021/es304128t; Hayashida N, 2011, J RADIAT RES, V52, P629, DOI 10.1269/jrr.11017; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Ishigure N, MONDAL3 SUPPORT SYST; Iwaki City, 2012, ONE YEAR GREAT E JAP; Japanese Government, 2011, JAP GOV IAEA MIN C N; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Koizumi Akio, 2009, Environmental Health and Preventive Medicine, V14, P307, DOI 10.1007/s12199-009-0101-1; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Morita N, 2005, RADIAT PROT DOSIM, V113, P326, DOI 10.1093/rpd/nch457; Morita N, 2007, RADIAT PROT DOSIM, V123, P128, DOI 10.1093/rpd/ncl079; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Ohnishi T, 2011, RADIAT RES, V177, P1, DOI DOI 10.1667/FTR2830.1; Sekitani Y, 2010, RADIAT PROT DOSIM, V141, P36, DOI 10.1093/rpd/ncq137; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Taira Y, 2014, ENVIRON SCI TECHNOL, V48, P4556, DOI 10.1021/es404534y; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105	24	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114407	10.1371/journal.pone.0114407	http://dx.doi.org/10.1371/journal.pone.0114407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478794	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200085
J	Bruins, J; Jorg, F; Bruggeman, R; Slooff, C; Corpeleijn, E; Pijnenborg, M				Bruins, Jojanneke; Jorg, Frederike; Bruggeman, Richard; Slooff, Cees; Corpeleijn, Eva; Pijnenborg, Marieke			The Effects of Lifestyle Interventions on (Long-Term) Weight Management, Cardiometabolic Risk and Depressive Symptoms in People with Psychotic Disorders: A Meta-Analysis	PLOS ONE			English	Article							OLDER SCHIZOPHRENIA-PATIENTS; METABOLIC SYNDROME; PSYCHOEDUCATIONAL PROGRAM; SCHIZOAFFECTIVE DISORDER; BEHAVIORAL-THERAPY; DIABETES-MELLITUS; PHYSICAL HEALTH; OBESE-PATIENTS; GAIN; OVERWEIGHT	Aims: The aim of this study was to estimate the effects of lifestyle interventions on bodyweight and other cardiometabolic risk factors in people with psychotic disorders. Additionally, the long-term effects on body weight and the effects on depressive symptoms were examined. Material and Methods: We searched four databases for randomized controlled trials (RCTs) that compared lifestyle interventions to control conditions in patients with psychotic disorders. Lifestyle interventions were aimed at weight loss or weight gain prevention, and the study outcomes included bodyweight or metabolic parameters. Results: The search resulted in 25 RCTs -only 4 were considered high qualityshowing an overall effect of lifestyle interventions on bodyweight (effect size (ES)=-0.63, p<0.0001). Lifestyle interventions were effective in both weight loss (ES=-0.52, p<0.0001) and weight-gain-prevention (ES=-0.84, p=0.0002). There were significant long-term effects, two to six months post-intervention, for both weight-gain-prevention interventions (ES=-0.85, p=0.0002) and weight loss studies (ES=-0.46, p=0.02). Up to ten studies reported on cardiometabolic risk factors and showed that lifestyle interventions led to significant improvements in waist circumference, triglycerides, fasting glucose and insulin. No significant effects were found for blood pressure and cholesterol levels. Four studies reported on depressive symptoms and showed a significant effect (ES=-0.95, p=0.05). Conclusion: Lifestyle interventions are effective in treating and preventing obesity, and in reducing cardiometabolic risk factors. However, the quality of the studies leaves much to be desired.	[Bruins, Jojanneke; Jorg, Frederike; Bruggeman, Richard; Slooff, Cees] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands; [Jorg, Frederike] Friesland Mental Hlth Serv, Res Dept, Leeuwarden, Friesland, Netherlands; [Slooff, Cees; Pijnenborg, Marieke] GGZ Drenthe, Dept Psychot Disorders, Assen, Drenthe, Netherlands; [Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Pijnenborg, Marieke] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Bruins, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands.	j.bruins@umcg.nl	Jörg, Frederike/B-1325-2014	Bruggeman, Richard/0000-0002-3238-8471; Bruins, Jojanneke/0000-0002-5345-0748; Corpeleijn, Eva/0000-0002-2974-3305	Eli Lilly	Eli Lilly(Eli Lilly)	JB received financial support from Eli Lilly to perform the meta-analysis (http://www.lilly.com/Pages/Home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Jimenez M, 2006, J CLIN PSYCHIAT, V67, P1253, DOI 10.4088/JCP.v67n0812; Alvarez-Jimenez M, 2010, SCHIZOPHR RES, V116, P16, DOI 10.1016/j.schres.2009.10.012; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Atmaca M, 2003, J CLIN PSYCHIAT, V64, P598, DOI 10.4088/JCP.v64n0516; Attux C, 2008, SCHIZOPHR RES AMSTER, V98, P52; Ball MP, 2001, PSYCHIATR SERV, V52, P967, DOI 10.1176/appi.ps.52.7.967; Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6; Bonfioli E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-78; Brar JS, 2005, J CLIN PSYCHIAT, V66, P205, DOI 10.4088/JCP.v66n0208; Brown C, 2011, PSYCHIAT SERV, V62, P800, DOI 10.1176/ps.62.7.pss6207_0800; Brown S., 2006, J MENT HEALTH, V15, P543, DOI [DOI 10.1080/09638230600902609, 10.1080/09638230600902609]; Brown S, 2009, J MENT HEALTH, V18, P372, DOI 10.3109/09638230802522460; Bushe CJ, 2013, J PSYCHOPHARMACOL, P1; Caemmerer J, 2012, SCHIZOPHR RES, V140, P159, DOI 10.1016/j.schres.2012.03.017; Castelein S, 2008, ACTA PSYCHIAT SCAND, V118, P64, DOI 10.1111/j.1600-0447.2008.01216.x; Ching HY, 2012, EVIDENCE BASED COMPL; Cimo A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-24; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; Dickerson FB, 2006, ACTA PSYCHIAT SCAND, V113, P306, DOI 10.1111/j.1600-0447.2005.00637.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans S, 2005, AUST NZ J PSYCHIAT, V39, P479, DOI 10.1080/j.1440-1614.2005.01607.x; Fernandez-San-Martin MI, 2013, COMMUNITY MENT HLTH; Forsberg KA, 2008, NORD J PSYCHIAT, V62, P486, DOI 10.1080/08039480801985179; Gabriele JM, 2009, OBES REV, V10, P442, DOI 10.1111/j.1467-789X.2009.00570.x; Haupt DW, 2001, J CLIN PSYCHIAT, V62, P15; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOUSE A, 1987, BRIT J PSYCHIAT, V151, P773, DOI 10.1192/bjp.151.6.773; Iglesias-Garcia C, 2010, J PSYCHIATR MENT HLT, V17, P849, DOI 10.1111/j.1365-2850.2010.01590.x; Jean-Baptiste M, 2007, SCHIZOPHR RES, V96, P198, DOI 10.1016/j.schres.2007.05.022; Khazaal Y, 2007, SCHIZOPHR RES, V91, P169, DOI 10.1016/j.schres.2006.12.025; Kwon JS, 2006, J CLIN PSYCHIAT, V67, P547, DOI 10.4088/JCP.v67n0405; Littrell KH, 2003, J NURS SCHOLARSHIP, V35, P237, DOI 10.1111/j.1547-5069.2003.00237.x; Lundgren JD, 2009, INT J OBESITY, V33, P144, DOI 10.1038/ijo.2008.225; Mauri M, 2008, PHARMACOPSYCHIATRY, V41, P17, DOI 10.1055/s-2007-992148; McCreadie RG, 2005, BRIT J PSYCHIAT, V187, P346, DOI 10.1192/bjp.187.4.346; McKibbin CL, 2006, SCHIZOPHR RES, V86, P36, DOI 10.1016/j.schres.2006.05.010; McKibbin CL, 2010, SCHIZOPHR RES, V121, P203, DOI 10.1016/j.schres.2009.09.039; Melamed Y, 2008, PSYCHIATR REHABIL J, V31, P194, DOI 10.2975/31.3.2008.194.200; Methapatara W, 2011, PSYCHIAT CLIN NEUROS, V65, P374, DOI 10.1111/j.1440-1819.2011.02225.x; Milano W, 2007, ADV THER, V24, P123, DOI 10.1007/BF02850000; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Morrison N, 2001, BEHAV COGN PSYCHOTH, V29, P311, DOI 10.1017/S1352465801003058; Mueser KT, 2013, ANNU REV CLIN PSYCHO, V9, P465, DOI 10.1146/annurev-clinpsy-050212-185620; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Institute for Health and Care Excellence (NICE), 2014, PSYCH SCHIZ AD TREAT; Nover C, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-116; Orwin R.G., 1994, HDB RES SYNTHESIS; Plourde G, 2012, CAN MED ASSOC J, V184, P1039, DOI 10.1503/cmaj.111640; Porsdal V, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-42; Poulin MJ, 2007, AUST NZ J PSYCHIAT, V41, P980, DOI 10.1080/00048670701689428; Ratliff JC, 2013, PSYCHOSOMATICS, V54, P67, DOI 10.1016/j.psym.2012.03.001; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saarni SE, 2009, PSYCHOL MED, V39, P801, DOI 10.1017/S0033291708004194; Sands JR, 1999, SCHIZOPHRENIA BULL, V25, P157, DOI 10.1093/oxfordjournals.schbul.a033362; Scheewe TW, 2013, ACTA PSYCHIAT SCAND, V127, P464, DOI 10.1111/acps.12029; Scocco Paolo, 2006, Eat Behav, V7, P115, DOI 10.1016/j.eatbeh.2005.08.003; Scott David, 2011, Issues Ment Health Nurs, V32, P589, DOI 10.3109/01612840.2011.569846; Skrinar GS, 2005, PSYCHIATR REHABIL J, V29, P122, DOI 10.2975/29.2005.122.127; Subotnik KL, 1997, AM J PSYCHIAT, V154, P1551, DOI 10.1176/ajp.154.11.1551; Suvisaari JM, 2007, J CLIN PSYCHIAT, V68, P1045, DOI 10.4088/JCP.v68n0711; Tarrier N, 2004, BEHAV RES THER, V42, P1377, DOI 10.1016/j.brat.2004.06.020; Thalheimer W., 2002, CALCULATE EFFECT SIZ, DOI DOI 10.1113/jphysiol.2004.078915; Verhaeghe N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-28; Voruganti LNP, 2006, CAN J PSYCHIAT, V51, P575, DOI 10.1177/070674370605100905; Vreeland B, 2010, AM J PSYCHIATR REHAB, V13, P55, DOI 10.1080/15487761003673032; Wassink TH, 1999, AM J PSYCHIAT, V156, P315; Weber M, 2006, SCHIZOPHR RES, V83, P95, DOI 10.1016/j.schres.2006.01.008; Wu MK, 2007, PSYCHIAT SERV, V58, P544, DOI 10.1176/appi.ps.58.4.544; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b; Yalom I, 2005, THEORY PRACTICE GROU, V5th, P475; Zukley LM, 2008, DISS ABSTR INT B, P68	74	77	77	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112276	10.1371/journal.pone.0112276	http://dx.doi.org/10.1371/journal.pone.0112276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474313	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500067
J	Lopez-Torrecillas, F; Perales, JC; Nieto-Ruiz, A; Verdejo-Garcia, A				Lopez-Torrecillas, Francisca; Perales, Jose C.; Nieto-Ruiz, Ana; Verdejo-Garcia, Antonio			Temperament and Impulsivity Predictors of Smoking Cessation Outcomes	PLOS ONE			English	Article							SUBSTANCE-USE DISORDERS; NICOTINE DEPENDENCE; DECISION-MAKING; ADOLESCENT SMOKERS; FAGERSTROM TEST; SELF-REPORT; RELAPSE; COCAINE; SEEKING; VULNERABILITY	Aims: Temperament and impulsivity are powerful predictors of addiction treatment outcomes. However, a comprehensive assessment of these features has not been examined in relation to smoking cessation outcomes. Methods: Naturalistic prospective study. Treatment-seeking smokers (n5140) were recruited as they engaged in an occupational health clinic providing smoking cessation treatment between 2009 and 2013. Participants were assessed at baseline with measures of temperament (Temperament and Character Inventory), trait impulsivity (Barratt Impulsivity Scale), and cognitive impulsivity (Go/No Go, Delay Discounting and Iowa Gambling Task). The outcome measure was treatment status, coded as "dropout" versus "relapse" versus "abstinence" at 3, 6, and 12 months endpoints. Participants were telephonically contacted and reminded of follow-up face to face assessments at each endpoint. The participants that failed to answer the phone calls or self-reported discontinuation of treatment and failed to attend the upcoming follow-up session were coded as dropouts. The participants that self-reported continuing treatment, and successfully attended the upcoming follow-up session were coded as either "relapse" or "abstinence", based on the results of smoking behavior self-reports cross-validated with co-oximetry hemoglobin levels. Multinomial regression models were conducted to test whether temperament and impulsivity measures predicted dropout and relapse relative to abstinence outcomes. Results: Higher scores on temperament dimensions of novelty seeking and reward dependence predicted poorer retention across endpoints, whereas only higher scores on persistence predicted greater relapse. Higher scores on the trait dimension of non-planning impulsivity but not performance on cognitive impulsivity predicted poorer retention. Higher non-planning impulsivity and poorer performance in the Iowa Gambling Task predicted greater relapse at 3 and 6 months and 6 months respectively. Conclusion: Temperament measures, and specifically novelty seeking and reward dependence, predict smoking cessation treatment retention, whereas persistence, non-planning impulsivity and poor decision-making predict smoking relapse.	[Lopez-Torrecillas, Francisca; Verdejo-Garcia, Antonio] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Andalucia, Spain; [Lopez-Torrecillas, Francisca; Perales, Jose C.] Univ Granada, Brain Mind & Behav Res Ctr, Granada, Andalucia, Spain; [Perales, Jose C.] Univ Granada, Dept Expt Psychol, Granada, Andalucia, Spain; [Perales, Jose C.; Verdejo-Garcia, Antonio] Univ Granada, Red Trastornos Adict, Granada, Andalucia, Spain; [Nieto-Ruiz, Ana] Univ Granada, Occupat Med Area, Prevent Serv, Granada, Andalucia, Spain; [Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci F Oloriz, Granada, Andalucia, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia	University of Granada; University of Granada; University of Granada; University of Granada; University of Granada; University of Granada; Monash University	Lopez-Torrecillas, F (corresponding author), Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Andalucia, Spain.	fcalopez@ugr.es	Nieto-Ruiz, Ana/AAU-9965-2021; Lopez-Torrecillas, Francisca/C-8267-2018; Verdejo-Garcia, Antonio/AAV-1147-2021; Rueda, Maria del Mar/F-9571-2015	Verdejo-Garcia, Antonio/0000-0001-8874-9339; lopez-torrecillas, francisca/0000-0002-4541-5184; Nieto Ruiz, Ana/0000-0002-4303-6228; Rueda, Maria del Mar/0000-0002-2903-8745; Perales, Jose C./0000-0001-5163-8811	Occupational Medicine Area (Prevention Service); Department of Personality, Assessment and Psychological Treatment, University of Granada (Spain); Ministerio de Economia y Competitividad grant (MINICO) [PSI2013-45055-P]	Occupational Medicine Area (Prevention Service); Department of Personality, Assessment and Psychological Treatment, University of Granada (Spain); Ministerio de Economia y Competitividad grant (MINICO)	This research was funded by the Occupational Medicine Area (Prevention Service); Department of Personality, Assessment and Psychological Treatment, University of Granada (Spain); and Ministerio de Economia y Competitividad grant (MINICO, ref. # PSI2013-45055-P) for the first and second authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboola S, 2010, ADDICTION, V105, P1362, DOI 10.1111/j.1360-0443.2010.02996.x; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Aklin WM, 2009, PERS INDIV DIFFER, V46, P454, DOI 10.1016/j.paid.2008.11.018; Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Ashare RL, 2012, J PSYCHOPHARMACOL, V26, P1383, DOI 10.1177/0269881112449397; Batra A, 2010, J SUBST ABUSE TREAT, V38, P128, DOI 10.1016/j.jsat.2009.08.003; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Becona E, 1998, PSYCHOL REP, V83, P1455, DOI 10.2466/pr0.1998.83.3f.1455; Borrelli B, 2002, PSYCHOL ADDICT BEHAV, V16, P22, DOI 10.1037//0893-164X.16.1.22; Brandon TH, 2003, J ABNORM PSYCHOL, V112, P448, DOI 10.1037/0021-843X.112.3.448; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; *CONS IG BIEN SOC, 2008, GUIA PRACT CLIN AD T; Cyders MA, 2011, CLIN PSYCHOL REV, V31, P965, DOI 10.1016/j.cpr.2011.06.001; Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; de Leon J, 2002, J CLIN PSYCHIAT, V63, P812, DOI 10.4088/JCP.v63n0911; De Wilde B, 2013, EUR ADDICT RES, V19, P21, DOI 10.1159/000339290; Delgado-Rico E, 2012, BEHAV PHARMACOL, V23, P609, DOI 10.1097/FBP.0b013e328356c3ac; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Domjan MP, 2014, PRINCIPLES LEARNING; Doran N, 2004, NICOTINE TOB RES, V6, P641, DOI 10.1080/14622200410001727939; Etter JF, 2003, NICOTINE TOB RES, V5, P401, DOI 10.1080/1462220031000094240; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hajek P, 2009, ADDICTION, V104, P1597, DOI 10.1111/j.1360-0443.2009.02646.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helmus TC, 2001, DRUG ALCOHOL DEPEN, V61, P287, DOI 10.1016/S0376-8716(00)00153-8; Helstrom A, 2007, ADDICT BEHAV, V32, P2404, DOI 10.1016/j.addbeh.2007.02.009; Josefsson K, 2013, DEV PSYCHOPATHOL, V25, P713, DOI 10.1017/S0954579413000126; Kahler CW, 2009, PHARMACOL BIOCHEM BE, V93, P285, DOI 10.1016/j.pbb.2009.01.003; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Krishnan-Sarin S, 2007, DRUG ALCOHOL DEPEN, V88, P79, DOI 10.1016/j.drugalcdep.2006.09.006; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; LOPEZTORRECILLA.F, 1995, THESIS U GRANADA; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; Mueller ET, 2009, BEHAV PHARMACOL, V20, P461, DOI 10.1097/FBP.0b013e3283305ec7; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Nieva G, 2011, ADDICT BEHAV, V36, P965, DOI 10.1016/j.addbeh.2011.05.008; Passetti F, 2008, DRUG ALCOHOL DEPEN, V94, P82, DOI 10.1016/j.drugalcdep.2007.10.008; Passetti F, 2011, DRUG ALCOHOL DEPEN, V118, P12, DOI 10.1016/j.drugalcdep.2011.02.015; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; Schmitz JM, 2009, J ADDICT DIS, V28, P250, DOI 10.1080/10550880903028502; Sharma L, 2014, PSYCHOL BULL, V140, P374, DOI 10.1037/a0034418; Sheffer CE, 2013, J SUBST ABUSE TREAT, V45, P206, DOI 10.1016/j.jsat.2013.01.012; Stevens L, 2014, J SUBST ABUSE TREAT, V47, P58, DOI 10.1016/j.jsat.2014.01.008; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; Tomson T, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-52; *US FDA, 2004, NEW DRUG SMOK CESS; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Washio Y, 2011, EXP CLIN PSYCHOPHARM, V19, P243, DOI 10.1037/a0023617	53	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112440	10.1371/journal.pone.0112440	http://dx.doi.org/10.1371/journal.pone.0112440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474540	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500069
J	Vergetaki, A; Jeschke, U; Vrekoussis, T; Taliouri, E; Sabatini, L; Papakonstanti, EA; Makrigiannakis, A				Vergetaki, Aikaterini; Jeschke, Udo; Vrekoussis, Thomas; Taliouri, Eirini; Sabatini, Luca; Papakonstanti, Evangelia A.; Makrigiannakis, Antonis			Galectin-1 Overexpression in Endometriosis and Its Regulation by Neuropeptides (CRH, UCN) Indicating Its Important Role in Reproduction and Inflammation	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; UROCORTIN MESSENGER-RNA; BLASTOCYST IMPLANTATION; STROMAL CELLS; IN-VITRO; EXPRESSION; PROGESTERONE; TOLERANCE; RECEPTOR; DECIDUALIZATION	Endometriosis is an inflammatory disease of women of reproductive age featured by the presence of ectopic endometrium and is strongly related to infertility. Galectins, carbonhydrate-binding proteins, have been found to have pro- or anti-inflammatory roles in the reproductive tract and in pathological conditions concerning infertility. Galectin-1, which is expressed at endometrium and decidua, plays a major role in implantation and trophoblast invasion. Also, the neuropeptides, corticotropin releasing hormone (CRH) and urocortin (UCN) and their receptors are expressed in eutopic and ectopic endometrium showing a differential expression pattern in endometriotic women compared to healthy ones. The aim of this study was to examine the galectin-1 expression in endometriotic lesions and compare its expression in eutopic endometrium of endometriotic and healthy women. Furthermore, we examined the effect of CRH and UCN in galectin-1 expression in Ishikawa cell line and macrophages and investigated the implication of CRHR1 in these responses. Eutopic and ectopic endometrium specimens, Ishikawa cell line and mice macrophages were used. Immunohistochemistry and western blot analysis were performed in order to identify galectin-1 expression in ectopic and eutopic endometrium of women with and without endometriosis and the regulatory effect of CRH and UCN on galectin-1 expression. This study presents for the first time that galectin-1 is overexpressed in endometriotic lesions compared to eutopic endometrium of endometriotic women and is more abundantly expressed in eutopic endometrium of disease women compared to healthy ones. Furthermore, it is shown that CRH and UCN upregulate galectin-1 expression in Ishikawa cell line and macrophages and this effect is mediated through CRHR1. These results suggest that galectin-1 might play an important role in endometriosis pathology and infertility profile of women suffering from endometriosis by being at the same time regulated by CRH and UCN interfering in the immune disequilibrium which characterizes this pathological condition.	[Vergetaki, Aikaterini; Taliouri, Eirini; Makrigiannakis, Antonis] Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece; [Jeschke, Udo] Univ Munich, Dept Obstet & Gynecol, Munich, Germany; [Vrekoussis, Thomas] Univ Ioannina, Sch Med, Dept Obstet & Gynecol, GR-45110 Ioannina, Greece; [Sabatini, Luca] St Bartholomews Hosp, Ctr Reprod Med, London, England; [Papakonstanti, Evangelia A.] Univ Crete, Sch Med, Dept Biochem, Iraklion, Greece	University of Crete; University of Munich; University of Ioannina; University of London; Queen Mary University London; University of Crete	Makrigiannakis, A (corresponding author), Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece.	makrigia@med.uoc.gr	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235; Makrigiannakis, Antonis/0000-0002-8475-1500; Papakonstanti, Evangelia/0000-0002-7119-6026	University Laboratory of Human Reproduction [KA 2920]; Research Committee of the University of Crete [KA 3001]	University Laboratory of Human Reproduction; Research Committee of the University of Crete	This work was supported by the University Laboratory of Human Reproduction (KA 2920) (in the laboratory of A.M.) and by the Research Committee of the University of Crete (KA 3001) (in the laboratory of E.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Bamberger AM, 2006, AM J PATHOL, V168, P141, DOI 10.2353/ajpath.2006.050167; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Choe YS, 1997, MOL REPROD DEV, V48, P261, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;261::AID-MRD14&gt;3.0.CO;2-0; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Chrousos GP, 1999, AM J OBSTET GYNECOL, V180, pS249, DOI 10.1016/S0002-9378(99)70710-6; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; de Ziegler D, 1998, J REPROD IMMUNOL, V39, P149, DOI 10.1016/S0165-0378(98)00019-9; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; DiBlasio AM, 1997, J CLIN ENDOCR METAB, V82, P1594, DOI 10.1210/jc.82.5.1594; Florio P, 2004, PEPTIDES, V25, P1751, DOI 10.1016/j.peptides.2004.05.026; Florio P, 2002, J ENDOCRINOL, V173, pR9, DOI 10.1677/joe.0.173R009; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Gravanis Achille, 2002, Hormones (Athens), V1, P139; Harada T, 2001, FERTIL STERIL, V76, P1, DOI 10.1016/S0015-0282(01)01816-7; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Jeschke U, 2010, J REPROD IMMUNOL, V85, P99, DOI 10.1016/j.jri.2009.10.012; Kabir-Salmani M, 2008, MOL ENDOCRINOL, V22, P707, DOI 10.1210/me.2007-0243; Kalantaridou SN, 2007, CRIT REV CL LAB SCI, V44, P461, DOI 10.1080/10408360701548468; Kempuraj D, 2004, AM J REPROD IMMUNOL, V52, P267, DOI 10.1111/j.1600-0897.2004.00224.x; KLIMAN HJ, 1990, PLACENTA, V11, P349, DOI 10.1016/S0143-4004(05)80226-7; Kolundzic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028514; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Makrigiannakis A, 1997, ANN NY ACAD SCI, V816, P116, DOI 10.1111/j.1749-6632.1997.tb52135.x; Makrigiannakis A, 2001, NAT IMMUNOL, V2, P1018, DOI 10.1038/ni719; Makrigiannakis A, 1996, NEUROENDOCRINOLOGY, V64, P85, DOI 10.1159/000127103; Makrigiannakis A, 1999, NEUROENDOCRINOLOGY, V70, P451, DOI 10.1159/000054507; Makrigiannakis A, 1999, MOL HUM REPROD, V5, P789, DOI 10.1093/molehr/5.9.789; Minas V, 2005, REPROD BIOMED ONLINE, V10, P205, DOI 10.1016/S1472-6483(10)60942-X; Minici F, 2007, GYNECOL ENDOCRINOL, V23, P574, DOI 10.1080/09513590701581721; Noel JC, 2011, APPL IMMUNOHISTO M M, V19, P253, DOI 10.1097/PAI.0b013e3181f5a05e; Nothnick WB, 2001, FERTIL STERIL, V76, P223, DOI 10.1016/S0015-0282(01)01878-7; Novembri R, 2011, J CLIN ENDOCR METAB, V96, P1145, DOI 10.1210/jc.2010-2263; Paclik D, 2011, CELL IMMUNOL, V271, P97, DOI 10.1016/j.cellimm.2011.06.003; PALMER R., 1950, ANN ENDOCRINOL, V11, P183; PETRAGLIA F, 1992, J CLIN ENDOCR METAB, V74, P1427, DOI 10.1210/jc.74.6.1427; Rabinovich GA, 1997, J BIOCHEM-TOKYO, V122, P365; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sampson JA, 1927, AM J PATHOL, V3, P93; Shimizu Y, 2008, ENDOCR J, V55, P879, DOI 10.1507/endocrj.K08E-111; Tariverdian N, 2007, SEMIN IMMUNOPATHOL, V29, P193, DOI 10.1007/s00281-007-0077-0; Tariverdian N, 2010, J MOL MED, V88, P267, DOI 10.1007/s00109-009-0559-8; Than NG, 2008, J MATERN-FETAL NEO M, V21, P429, DOI 10.1080/14767050802041961; Tirado-Gonzalez I, 2013, MOL HUM REPROD, V19, P43, DOI 10.1093/molehr/gas043; Torricelli M, 2007, HUM REPROD, V22, P92, DOI 10.1093/humrep/del331; Vergetaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062313; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Webster EL, 1996, ENDOCRINOLOGY, V137, P5747, DOI 10.1210/en.137.12.5747; Zoumakis E, 2000, MOL HUM REPROD, V6, P344, DOI 10.1093/molehr/6.4.344	57	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114229	10.1371/journal.pone.0114229	http://dx.doi.org/10.1371/journal.pone.0114229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473847	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500003
J	Gong, XC; Zhang, Y; Pan, JY; Qu, HB				Gong, Xingchu; Zhang, Ying; Pan, Jianyang; Qu, Haibin			Optimization of the Ethanol Recycling Reflux Extraction Process for Saponins Using a Design Space Approach	PLOS ONE			English	Article							PANAX-NOTOGINSENG; MAILLARD REACTION; SUGAR; WATER; PRECIPITATION; QUALITY; TRANSFORMATION; CHROMATOGRAPHY; GINSENOSIDES; COMPONENTS	A solvent recycling reflux extraction process for Panax notoginseng was optimized using a design space approach to improve the batch-to-batch consistency of the extract. Saponin yields, total saponin purity, and pigment yield were defined as the process critical quality attributes (CQAs). Ethanol content, extraction time, and the ratio of the recycling ethanol flow rate and initial solvent volume in the extraction tank (RES) were identified as the critical process parameters (CPPs) via quantitative risk assessment. Box-Behnken design experiments were performed. Quadratic models between CPPs and process CQAs were developed, with determination coefficients higher than 0.88. As the ethanol concentration decreases, saponin yields first increase and then decrease. A longer extraction time leads to higher yields of the ginsenosides Rb-1 and Rd. The total saponin purity increases as the ethanol concentration increases. The pigment yield increases as the ethanol concentration decreases or extraction time increases. The design space was calculated using a Monte-Carlo simulation method with an acceptable probability of 0.90. Normal operation ranges to attain process CQA criteria with a probability of more than 0.914 are recommended as follows: ethanol content of 79-82%, extraction time of 6.1-7.1 h, and RES of 0.039-0.040 min(-1). Most of the results of the verification experiments agreed well with the predictions. The verification experiment results showed that the selection of proper operating ethanol content, extraction time, and RES within the design space can ensure that the CQA criteria are met.	[Gong, Xingchu; Zhang, Ying; Pan, Jianyang; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National S&T Major Project of China [2012ZX09101201-003]; Research Fund for the Doctoral Program of Higher Education of China [20110101120149]	National S&T Major Project of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National S&T Major Project of China (2012ZX09101201-003) and Research Fund for the Doctoral Program of Higher Education of China (20110101120149). Haibin Qu received the first fund. The website is (http://www.most.gov.cn/). Xingchu Gong received the second fund. The website is (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). Funds were used to buy materials, chemicals, and pay labor costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bai Changcai, 2009, Zhongguo Zhong Yao Za Zhi, V34, P677; Bouchard A, 2007, J CHEM ENG DATA, V52, P1838, DOI 10.1021/je700190m; Chen J., 2013, CHINESE J EXPT TRADI, V19, P59; Coca M, 2004, FOOD CHEM, V86, P421, DOI 10.1016/j.foodchem.2003.09.017; Davidek T, 2006, J AGR FOOD CHEM, V54, P6677, DOI 10.1021/jf060668i; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; Dong TTX, 2005, PHYTOTHER RES, V19, P684, DOI 10.1002/ptr.1728; Gong XC, 2014, SEP PURIF TECHNOL, V132, P126, DOI 10.1016/j.seppur.2014.05.014; Gong XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104493; Gong XC, 2013, SEP PURIF TECHNOL, V107, P273, DOI 10.1016/j.seppur.2013.01.029; Gong XC, 2012, J CHEM ENG DATA, V57, P3264, DOI 10.1021/je300885g; Gong XC, 2011, IND ENG CHEM RES, V50, P7542, DOI 10.1021/ie2004972; Gong XC, 2011, CHINESE J CHEM ENG, V19, P217, DOI 10.1016/S1004-9541(11)60157-2; ICH, 2009, PHARM DEV Q8 R2; Kim JS, 2008, FOOD CHEM, V108, P582, DOI 10.1016/j.foodchem.2007.11.014; Lebrun P, 2012, EUR J PHARM BIOPHARM, V80, P226, DOI 10.1016/j.ejpb.2011.09.014; Li SP, 2013, J CHROMATOGR A, V1313, P302, DOI 10.1016/j.chroma.2013.07.025; Li SX, 2013, J AGR FOOD CHEM, V61, P10599, DOI 10.1021/jf402993a; Li ZX, 2009, PHARM ENG DESIGN, V30, P35; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Peterson JJ, 2008, J BIOPHARM STAT, V18, P959, DOI 10.1080/10543400802278197; Qu Lin-hai, 2006, Zhong Yao Cai, V29, P593; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Rozet E, 2012, BIOANALYSIS, V4, P755, DOI [10.4155/bio.12.47, 10.4155/BIO.12.47]; Sun S, 2011, FOOD CHEM, V125, P1299, DOI 10.1016/j.foodchem.2010.10.049; Sun S, 2010, FOOD CHEM, V118, P307, DOI 10.1016/j.foodchem.2009.04.122; Tsavas P, 2004, IND ENG CHEM RES, V43, P8391, DOI 10.1021/ie049353n; Wan JB, 2006, J PHARMACEUT BIOMED, V41, P1596, DOI 10.1016/j.jpba.2006.01.058; Wang D, 2012, FOOD CHEM, V132, P1808, DOI 10.1016/j.foodchem.2011.12.010; Wang LL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/652373; Wang YT, 2008, FOOD CHEM, V110, P161, DOI 10.1016/j.foodchem.2008.01.028; Wu M, 2013, J JIANGXI U TCM, V25, P66; Wu W, 2012, J AGR FOOD CHEM, V60, P10007, DOI 10.1021/jf302638f; Yang G., 2012, CHIN MED J RES PRAC, V26, P29; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; [赵永亮 Zhao Yongliang], 2011, [中南大学学报. 自然科学版, Journal of Central South University of Science and Technology], V42, P38; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	39	13	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114300	10.1371/journal.pone.0114300	http://dx.doi.org/10.1371/journal.pone.0114300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470598	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700098
J	Jarocki, P; Podlesny, M; Glibowski, P; Targonski, Z				Jarocki, Piotr; Podlesny, Marcin; Glibowski, Pawel; Targonski, Zdzislaw			A New Insight into the Physiological Role of Bile Salt Hydrolase among Intestinal Bacteria from the Genus Bifidobacterium	PLOS ONE			English	Article							SODIUM DEOXYCHOLATE; CHOLESTEROL; ACID; BSH; LACTOBACILLI; PURIFICATION; STRAINS; DECONJUGATION; PROBIOTICS; SELECTION	This study analyzes the occurrence of bile salt hydrolase in fourteen strains belonging to the genus Bifidobacterium. Deconjugation activity was detected using a plate test, two-step enzymatic reaction and activity staining on a native polyacrylamide gel. Subsequently, bile salt hydrolases from B. pseudocatenulatum and B. longum subsp. suis were purified using a two-step chromatographic procedure. Biochemical characterization of the bile salt hydrolases showed that the purified enzymes hydrolyzed all of the six major human bile salts under the pH and temperature conditions commonly found in the human gastrointestinal tract. Next, the dynamic rheometry was applied to monitor the gelation process of deoxycholic acid under different conditions. The results showed that bile acids displayed aqueous media gelating properties. Finally, gel-forming abilities of bifidobacteria exhibiting bile salt hydrolase activity were analyzed. Our investigations have demonstrated that the release of deconjugated bile acids led to the gelation phenomenon of the enzymatic reaction solution containing purified BSH. The presented results suggest that bile salt hydrolase activity commonly found among intestinal microbiota increases hydrogel-forming abilities of certain bile salts. To our knowledge, this is the first report showing that bile salt hydrolase activity among Bifidobacterium is directly connected with the gelation process of bile salts. In our opinion, if such a phenomenon occurs in physiological conditions of human gut, it may improve bacterial ability to colonize the gastrointestinal tract and their survival in this specific ecological niche.	[Jarocki, Piotr; Podlesny, Marcin; Targonski, Zdzislaw] Univ Life Sci Lublin, Dept Biotechnol Human Nutr & Food Commod, Lublin, Poland; [Glibowski, Pawel] Univ Life Sci Lublin, Dept Milk Technol & Hydrocolloids, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin	Jarocki, P (corresponding author), Univ Life Sci Lublin, Dept Biotechnol Human Nutr & Food Commod, Lublin, Poland.	piotr.jarocki@wp.pl	Glibowski, Paweł/AAG-9546-2019; Glibowski, Paweł/AFO-5720-2022	Glibowski, Pawel/0000-0003-1774-6899; Jarocki, Piotr/0000-0002-0714-4512	National Science Centre [DEC-2011/01/N/NZ9/04575]; Ministry of Science and Higher Education [0195/IP1/2011/71]	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grant DEC-2011/01/N/NZ9/04575 from National Science Centre (http://www.ncn.gov.pl/?language=en) and partially by grant Nr 0195/IP1/2011/71 from Ministry of Science and Higher Education (http://www.nauka.gov.pl/en/). The funding was received by PJ, MP, and ZT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; Bhat S, 2007, TETRAHEDRON, V63, P7309, DOI 10.1016/j.tet.2007.03.118; Bielecka M, 2002, FOOD RES INT, V35, P125, DOI 10.1016/S0963-9969(01)00173-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi SB, 2015, CRIT REV BIOTECHNOL, V35, P392, DOI 10.3109/07388551.2014.889077; Christl SU, 1996, DIGEST DIS SCI, V41, P2477, DOI 10.1007/BF02100146; COLEMAN JP, 1995, APPL ENVIRON MICROB, V61, P2514, DOI 10.1128/AEM.61.7.2514-2520.1995; Dambekodi PC, 1998, J DAIRY SCI, V81, P1818, DOI 10.3168/jds.S0022-0302(98)75751-0; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; De Smet I, 1998, BRIT J NUTR, V79, P185, DOI 10.1079/BJN19980030; DESMET I, 1995, J APPL BACTERIOL, V79, P292; du Toit M, 1998, INT J FOOD MICROBIOL, V40, P93, DOI 10.1016/S0168-1605(98)00024-5; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Franz CMAP, 2001, J FOOD PROTECT, V64, P725, DOI 10.4315/0362-028X-64.5.725; GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977; Glibowski P, 2011, CARBOHYD POLYM, V83, P635, DOI 10.1016/j.carbpol.2010.08.028; Grill JP, 2000, CAN J MICROBIOL, V46, P878, DOI 10.1139/cjm-46-10-878; Grill JP, 2000, J APPL MICROBIOL, V89, P553, DOI 10.1046/j.1365-2672.2000.01147.x; GRILL JP, 1995, APPL ENVIRON MICROB, V61, P2577, DOI 10.1128/AEM.61.7.2577-2582.1995; Grill JP, 1997, MICROBIOLOGIE ALIMEN, V15, P307; Jarocki P, 2013, CURR MICROBIOL, V67, P286, DOI 10.1007/s00284-013-0362-1; Jarocki P, 2011, J MICROBIOL BIOTECHN, V21, P838, DOI 10.4014/jmb.1103.03028; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jones ML, 2013, EXPERT OPIN BIOL TH, V13, P631, DOI 10.1517/14712598.2013.758706; Jover A, 2002, LANGMUIR, V18, P987, DOI 10.1021/la011178h; KAWAMOTO K, 1989, J BIOCHEM-TOKYO, V106, P1049, DOI 10.1093/oxfordjournals.jbchem.a122962; Kim GB, 2004, APPL ENVIRON MICROB, V70, P5603, DOI 10.1128/AEM.70.9.5603-5612.2004; Kim GB, 2004, J DAIRY SCI, V87, P258, DOI 10.3168/jds.S0022-0302(04)73164-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liong MT, 2005, FOOD RES INT, V38, P135, DOI 10.1016/j.foodres.2004.08.003; Oner O, 2014, J MOL MICROB BIOTECH, V24, P12, DOI 10.1159/000354316; Patel AK, 2010, APPL BIOCHEM BIOTECH, V162, P166, DOI 10.1007/s12010-009-8738-1; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ruiz L, 2012, APPL ENVIRON MICROB, V78, P644, DOI 10.1128/AEM.05455-11; Sridevi N, 2009, EXTREMOPHILES, V13, P363, DOI 10.1007/s00792-008-0224-0; Sun XF, 2014, J PHYS CHEM B, V118, P824, DOI 10.1021/jp409626s; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; TANNOCK GW, 1989, APPL ENVIRON MICROB, V55, P1848, DOI 10.1128/AEM.55.7.1848-1851.1989; Taranto MP, 1998, J DAIRY SCI, V81, P2336, DOI 10.3168/jds.S0022-0302(98)70123-7; Taranto MP, 2003, J APPL MICROBIOL, V95, P86, DOI 10.1046/j.1365-2672.2003.01962.x; VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996; Vlahcevic ZR, 1996, HEPATOLOGY TXB LIVER, V1, P376; Xue M, 2009, TETRAHEDRON, V65, P3369, DOI 10.1016/j.tet.2009.02.056; Yin S, 2011, J BIOTECHNOL, V152, P49, DOI 10.1016/j.jbiotec.2011.01.018	48	44	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114379	10.1371/journal.pone.0114379	http://dx.doi.org/10.1371/journal.pone.0114379			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470405	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700110
J	Kiffner, C; Kioko, J; Leweri, C; Krause, S				Kiffner, Christian; Kioko, John; Leweri, Cecilia; Krause, Stefan			Seasonal Patterns of Mixed Species Groups in Large East African Mammals	PLOS ONE			English	Article							SOCIAL NETWORKS; GROUP-SIZE; BODY-SIZE; ASSOCIATION; WILD; PREDATION; NUTRIENT; UNGULATE; RISK; ORGANIZATION	Mixed mammal species groups are common in East African savannah ecosystems. Yet, it is largely unknown if co-occurrences of large mammals result from random processes or social preferences and if interspecific associations are consistent across ecosystems and seasons. Because species may exchange important information and services, understanding patterns and drivers of heterospecific interactions is crucial for advancing animal and community ecology. We recorded 5403 single and multi-species clusters in the Serengeti-Ngorongoro and Tarangire-Manyara ecosystems during dry and wet seasons and used social network analyses to detect patterns of species associations. We found statistically significant associations between multiple species and association patterns differed spatially and seasonally. Consistently, wildebeest and zebras preferred being associated with other species, whereas carnivores, African elephants, Maasai giraffes and Kirk's dik-diks avoided being in mixed groups. During the dry season, we found that the betweenness (a measure of importance in the flow of information or disease) of species did not differ from a random expectation based on species abundance. In contrast, in the wet season, we found that these patterns were not simply explained by variations in abundances, suggesting that heterospecific associations were actively formed. These seasonal differences in observed patterns suggest that interspecific associations may be driven by resource overlap when resources are limited and by resource partitioning or anti-predator advantages when resources are abundant. We discuss potential mechanisms that could drive seasonal variation in the cost-benefit tradeoffs that underpin the formation of mixed-species groups.	[Kiffner, Christian; Kioko, John; Leweri, Cecilia] Ctr Wildlife Management Studies, Sch Field Studies, Karatu, Tanzania; [Leweri, Cecilia] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Krause, Stefan] Lubeck Univ Appl Sci, Lubeck, Germany	Luebeck University of Applied Sciences	Kiffner, C (corresponding author), Ctr Wildlife Management Studies, Sch Field Studies, Karatu, Tanzania.	ckiffne@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023; Leweri, Cecilia/0000-0002-1051-6022	School For Field Studies (SFS), Centre for Wildlife Management Studies	School For Field Studies (SFS), Centre for Wildlife Management Studies	Funding: The authors received no specific funding for this work. This project was part of School For Field Studies (SFS), Centre for Wildlife Management Studies, five year research plan activities and was solely funded by the centre's budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; [Anonymous], NATURE ED KNOWLEDGE; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Astaras C, 2011, AM J PRIMATOL, V73, P127, DOI 10.1002/ajp.20877; BAENNINGER R, 1977, E AFR WILDL J, V15, P327; BELL RHV, 1982, ECOL STUD, V42, P193; BESAG J, 1989, BIOMETRIKA, V76, P633; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Caillaud D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0206; Caro T.M., 1989, Special Publication of the British Ecological Society, P41; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; COOPER SM, 1991, AFR J ECOL, V29, P130, DOI 10.1111/j.1365-2028.1991.tb00993.x; Cords M., 1987, University of California Publications in Zoology, V117, P1; CORDS M, 1990, AM J PRIMATOL, V21, P101, DOI 10.1002/ajp.1350210204; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Desbiez ALJ, 2010, ACTA ETHOL, V13, P137, DOI 10.1007/s10211-010-0068-3; Dolby AS, 2000, BEHAV ECOL, V11, P110, DOI 10.1093/beheco/11.1.110; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; ELDER W H, 1970, Mammalia, V34, P356, DOI 10.1515/mamm.1970.34.3.356; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Farine DR, 2014, BEHAV ECOL, V25, P574, DOI 10.1093/beheco/aru023; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; GARTLAN JS, 1972, J ZOOL, V68, P221; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; Goodale E, 2010, J AVIAN BIOL, V41, P99, DOI 10.1111/j.1600-048X.2009.04828.x; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; Harrison NM, 2011, ANIM BEHAV, V81, P675, DOI 10.1016/j.anbehav.2011.01.013; Heymann EW, 1997, FOLIA PRIMATOL, V68, P287, DOI 10.1159/000157254; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; King AJ, 2009, J ZOOL, V277, P111, DOI 10.1111/j.1469-7998.2008.00504.x; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Krause J, 1998, OECOLOGIA, V114, P67, DOI 10.1007/s004420050421; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Krause S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1089, DOI 10.1007/s00265-009-0746-1; Li ZQ, 2010, J MAMMAL, V91, P674, DOI 10.1644/09-MAMM-A-203.1; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MONTGOMERY WL, 1981, COPEIA, P477, DOI 10.2307/1444245; Morrison TA, 2012, J ANIM ECOL, V81, P543, DOI 10.1111/j.1365-2656.2011.01941.x; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Msoffe F. U., 2011, International Journal of Biodiversity and Conservation, V3, P280; MWALYOSI RBB, 1992, J APPL ECOL, V29, P581, DOI 10.2307/2404465; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; OATES JF, 1990, AM J PRIMATOL, V21, P129, DOI 10.1002/ajp.1350210206; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Osofsky S. A., 2005, CONSERVATION DEV INT; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Perreault C, 2010, ANIM BEHAV, V80, P551, DOI 10.1016/j.anbehav.2010.06.020; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rubenstein DI, 1986, ECOLOGICAL ASPECTS O; SHELDEN KEW, 1995, MAR MAMMAL SCI, V11, P231, DOI 10.1111/j.1748-7692.1995.tb00521.x; Sinclair A.R.E., 2008, P7; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Thomas L., 2002, ENCY ENV, V1, P544, DOI [10.2307/2532812, DOI 10.2307/2532812]; Tsuji Y, 2007, ACTA THERIOL, V52, P427, DOI 10.1007/BF03194240; VanderWaal KL, 2014, BIOL CONSERV, V169, P136, DOI 10.1016/j.biocon.2013.11.008; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Wilson ADM, 2014, BEHAV ECOL SOCIOBIOL, V68, P915, DOI 10.1007/s00265-014-1704-0; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	88	20	20	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113446	10.1371/journal.pone.0113446	http://dx.doi.org/10.1371/journal.pone.0113446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470495	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700027
J	Kubler, A; Holz, EM; Riccio, A; Zickler, C; Kaufmann, T; Kleih, SC; Staiger-Salzer, P; Desideri, L; Hoogerwerf, EJ; Mattia, D				Kuebler, Andrea; Holz, Elisa M.; Riccio, Angela; Zickler, Claudia; Kaufmann, Tobias; Kleih, Sonja C.; Staiger-Saelzer, Pit; Desideri, Lorenzo; Hoogerwerf, Evert-Jan; Mattia, Donatella			The User-Centered Design as Novel Perspective for Evaluating the Usability of BCI-Controlled Applications	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; PEOPLE; ALS; HEALTHY	Albeit research on brain-computer interfaces (BCI) for controlling applications has expanded tremendously, we still face a translational gap when bringing BCI to end-users. To bridge this gap, we adapted the user-centered design (UCD) to BCI research and development which implies a shift from focusing on single aspects, such as accuracy and information transfer rate (ITR), to a more holistic user experience. The UCD implements an iterative process between end-users and developers based on a valid evaluation procedure. Within the UCD framework usability of a device can be defined with regard to its effectiveness, efficiency, and satisfaction. We operationalized these aspects to evaluate BCI-controlled applications. Effectiveness was regarded equivalent to accuracy of selections and efficiency to the amount of information transferred per time unit and the effort invested (workload). Satisfaction was assessed with questionnaires and visual-analogue scales. These metrics have been successfully applied to several BCI-controlled applications for communication and entertainment, which were evaluated by end-users with severe motor impairment. Results of four studies, involving a total of N=19 end-users revealed: effectiveness was moderate to high; efficiency in terms of ITR was low to high and workload low to medium; depending on the match between user and technology, and type of application satisfaction was moderate to high. The here suggested evaluation metrics within the framework of the UCD proved to be an applicable and informative approach to evaluate BCI controlled	[Kuebler, Andrea; Holz, Elisa M.; Kaufmann, Tobias; Kleih, Sonja C.] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Riccio, Angela; Mattia, Donatella] IRCCS, Fdn Santa Lucia, Lab Neuroelect Imaging, Rome, Italy; [Riccio, Angela; Mattia, Donatella] IRCCS, Fdn Santa Lucia, BCI, Rome, Italy; [Zickler, Claudia] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Kaufmann, Tobias] Univ Oslo, Inst Clin Med, Psychosis Res Ctr, Oslo, Norway; [Staiger-Saelzer, Pit] BUK, Bad Kreuznach, Germany; [Desideri, Lorenzo; Hoogerwerf, Evert-Jan] AIAS Bologna Onlus Ausilioteca, Bologna, Italy	University of Wurzburg; IRCCS Santa Lucia; IRCCS Santa Lucia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo	Kubler, A (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	andrea.kuebler@uni-wuerzburg.de	Kleih-Dahms, Sonja/AAA-6650-2022; Kaufmann, Tobias/M-8972-2017; Mattia, Donatella/D-7569-2012; Riccio, Angela/K-2745-2016	Kaufmann, Tobias/0000-0002-4003-1018; Mattia, Donatella/0000-0002-3092-2511; Riccio, Angela/0000-0002-4098-9461; Kubler, Andrea/0000-0003-4876-0415; Desideri, Lorenzo/0000-0003-2091-2907	European ICT Program Project [FP7-224631, FP7- 288566]; German Research Foundation (DFG); University of Wuerzburg	European ICT Program Project; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the European ICT Program Project FP7-224631 (TOBI) and FP7- 288566 (BackHome) (http://ec.europa.eu/research/fp7/index_en.cfm). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 9241210 ISO; Arthanat S, 2007, DISABIL REHABIL-ASSI, V2, P235, DOI 10.1080/17483100701343665; BATAVIA A I, 1990, Journal of Rehabilitation Research and Development, V27, P425, DOI 10.1682/JRRD.1990.10.0425; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Choi YM, 2011, ASSIST TECHNOL, V23, P36, DOI 10.1080/10400435.2010.541407; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Corradi F, 2012, ASSIST TECHNOL, P49, DOI DOI 10.1201/B11821-5; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Demers L., 2002, TECHNOL DISABIL, V14, P101, DOI [10.3233/TAD-2002-14304, DOI 10.3233/TAD-2002-14304]; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P916, DOI 10.1016/j.clinph.2012.11.010; HART S G, 1988, P139; Hohne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104854; Holz EM, 2013, ARTIF INTELL MED, V59, P111, DOI 10.1016/j.artmed.2013.08.001; Holz EM, 2013, 5 INT BCI M AS PAC G; Holz EM, 2013, TOBI WORKSH IV SION; Holz EM, 2013, TOBI WORKSH 4 SION S; Holz EM, 2014, ARCH PHYS M IN PRESS; Hoogerwerf EJ, 2013, AAATE VIL ALG PORT; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A, 2008, 4 INT BRAIN COMP INT, P361; Kubler A, 2013, BRAIN-COMPUTER INTERFACE SYSTEMS - RECENT PROGRESS AND FUTURE PROSPECTS, P1, DOI 10.5772/55802; Kubler A, 2013, ARTIF INTELL MED, V59, P55, DOI 10.1016/j.artmed.2013.08.002; Kubler A, 2013, BRAIN, V136, DOI [10.1093/brain/awt156, 10.1093/brain/awt200]; Lorenz R, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035007; McCane LM, 2014, AMYOTROPH LAT SCL FR, V15, P207, DOI 10.3109/21678421.2013.865750; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nykopp T., 2001, STAT MODELLING ISSUE; Pasqualotto E, 2011, INT J BIOELECTROMAGN, V13, P121; Pasqualotto E, 2009, ASSIST TECHNOL RES S, V25, P882, DOI 10.3233/978.1.60750.042.1.882; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Riccio A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025028; Riccio A, 2013, 5TH INTERNATIONAL BC; Riccio A, 2011, 5 INT BRAIN COMP INT; Riccio A, 2013, TOBI WORKSH 4 SION S; Riccio A, 2015, ARCH PHYS MED REHAB, V96, pS54, DOI 10.1016/j.apmr.2014.05.029; Riccio A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00732; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Scherer MJ, 1997, DISABIL REHABIL, V19, P528, DOI 10.3109/09638289709166046; Schlogl A, 2007, BRAIN COMPUTER INTER, P373; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; van de Laar B, 2011, INT J BIOELECTROMAG, V13, P157; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, V3, P123, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.003.0001]; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zickler C, 2013, ARTIF INTELL MED, V59, P99, DOI 10.1016/j.artmed.2013.08.003; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409; Zickler C, 2009, ASSIST TECHNOL RES S, V25, P185, DOI 10.3233/978.1.60750.042.1.185	59	120	122	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112392	10.1371/journal.pone.0112392	http://dx.doi.org/10.1371/journal.pone.0112392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469774	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700007
J	Tsai, CC; Chiang, YC; Weng, IS; Lin, YS; Chou, CH				Tsai, Chi-Chu; Chiang, Yu-Chung; Weng, I-Szu; Lin, Yu-Shium; Chou, Chang-Hung			Evidence of Purifying Selection and Co-Evolution at the Fold-Back Arm of the Novel Precursor MicroRNA159 Gene in Phalaenopsis Species (Orchidaceae)	PLOS ONE			English	Article							PLANT MICRORNAS; ARABIDOPSIS; MIRNA; IDENTIFICATION; POLYMORPHISM; BIOGENESIS; SEQUENCE; DNA; CONSTRAINTS; EXPRESSION	Background: MicroRNAs (miRNAs) are small, endogenously transcribed, non-protein-coding RNAs that play important roles in regulation of gene expression in animals and plants. Here, selective constraints on the novel precursor microRNA159 (pre-miR159) gene were investigated in 42 Phalaenopsis species (Orchidaceae). Methods/Results: A novel precursor microRNA159 gene was isolated from 42 Phalaenopsis species using a new microRNA-PCR (miR-PCR) approach. Sequencing of pre-miR159 genes revealed differences from the canonical pre-miR159 gene in Phalaenopsis species and other plants. Results demonstrated that the 5' and 3' fold-back arms and the terminal loop of the novel pre-miR159 gene have undergone purifying selection and selective constraint for stabilizing the secondary hairpin structure. Two conserved motifs within the 5' fold-back arm had the highest purifying selective pressure within the novel pre-miR159 gene. Evidence of sequence co-evolution between the 5' and 3' fold-back regions was observed. Conclusions: Functional selective pressure might arise from the constraint of forming a hairpin structure and demonstrate co-evolution of sequences between the 5' and 3' fold-back regions of the novel pre-miR159 gene in Phalaenopsis species.	[Tsai, Chi-Chu; Weng, I-Szu; Lin, Yu-Shium] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 908, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 912, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan	National Pingtung University Science & Technology; National Sun Yat Sen University; China Medical University Taiwan	Chiang, YC (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan.	yuchung@mail.nsysu.edu.tw; choumasa@mail.cmu.edu.tw	Chiang, Yu-Chung/E-9143-2011		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This research was supported by funding from the Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Chen CN, 2004, MOL PHYLOGENET EVOL, V32, P616, DOI 10.1016/j.ympev.2004.01.015; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chiang YC, 2004, MOL PHYLOGENET EVOL, V31, P929, DOI 10.1016/j.ympev.2003.09.017; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Christenson EA, 2001, PHALAENOPSIS MONOGRA, P27; Contreras-Cubas C, 2012, PLANT MOL BIOL, V80, P103, DOI 10.1007/s11103-011-9847-0; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; de Meaux J, 2008, P NATL ACAD SCI USA, V105, P8994, DOI 10.1073/pnas.0803218105; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Doyle J. J., 1987, PHYTOCHEM B, P11; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; Guo XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-208; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; JUKES T H, 1969, P21; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P1048, DOI 10.1073/pnas.80.4.1048; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Liu Q, 2013, PLANT PHYSIOL, V163, P108, DOI 10.1104/pp.113.219071; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nei M, 2000, MOL EVOLUTION PHYLOG, P191; OCHMAN H, 1988, GENETICS, V120, P621; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tsai CC, 2010, PLANT SYST EVOL, V288, P77, DOI 10.1007/s00606-010-0314-1; Tsai CC, 2005, PLANT SYST EVOL, V256, P1, DOI 10.1007/s00606-005-0356-y; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Werner S, 2010, CURR BIOL, V20, P42, DOI 10.1016/j.cub.2009.10.073; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114493	10.1371/journal.pone.0114493	http://dx.doi.org/10.1371/journal.pone.0114493			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470008	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700121
J	Hayat, T; Tanveer, A; Yasmin, H; Alsaedi, A				Hayat, Tasawar; Tanveer, Anum; Yasmin, Humaira; Alsaedi, Ahmed			Homogeneous-Heterogeneous Reactions in Peristaltic Flow with Convective Conditions	PLOS ONE			English	Article							MICROPOLAR FLUID; POROUS-MEDIUM; NANOFLUID; TRANSPORT	This article addresses the effects of homogeneous-heterogeneous reactions in peristaltic transport of Carreau fluid in a channel with wall properties. Mathematical modelling and analysis have been carried out in the presence of Hall current. The channel walls satisfy the more realistic convective conditions. The governing partial differential equations along with long wavelength and low Reynolds number considerations are solved. The results of temperature and heat transfer coefficient are analyzed for various parameters of interest.	[Hayat, Tasawar; Tanveer, Anum; Yasmin, Humaira] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Yasmin, H (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	qau2011@gmail.com	Yasmin, Humaira/U-4171-2018; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/Y-2524-2019	Yasmin, Humaira/0000-0003-0199-6850; Alsaedi, Ahmed/0000-0003-3452-8922; 				Abd Elmaboud Y, 2012, COMMUN NONLINEAR SCI, V17, P685, DOI 10.1016/j.cnsns.2011.05.039; Abd-Alla AM, 2013, J MAGN MAGN MATER, V348, P33, DOI 10.1016/j.jmmm.2013.06.030; Abelman S, 2009, NONLINEAR ANAL-REAL, V10, P3322, DOI 10.1016/j.nonrwa.2008.10.067; Ali N, 2010, INT J NUMER METH FL, V64, P992, DOI 10.1002/fld.2184; Awais M, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500235; Ebaid A, 2014, COMPUT MATH APPL, V68, P77, DOI 10.1016/j.camwa.2014.05.008; El Koumy SR, 2012, TRANSPORT POROUS MED, V94, P643, DOI 10.1007/s11242-012-0016-y; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Hayat T, 2015, J BRAZ SOC MECH SCI, V37, P463, DOI 10.1007/s40430-014-0177-4; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2407, DOI 10.1016/j.cnsns.2009.09.032; Hina S, 2014, ARAB J SCI ENG, V39, P593, DOI 10.1007/s13369-013-0692-0; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Mekheimer K., 2014, J EGYPT MATH SOC, V22, P143, DOI [10.1016/j.joems.2013.05.003, DOI 10.1016/J.JOEMS.2013.05.003]; Mekheimer KS, 2008, PHYS LETT A, V372, P4271, DOI 10.1016/j.physleta.2008.03.059; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2012, INT J HEAT MASS TRAN, V55, P4871, DOI 10.1016/j.ijheatmasstransfer.2012.04.060; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Parsa AB, 2013, HEAT TRANSF-ASIAN RE, V42, P500, DOI 10.1002/htj.21054; Rashidi MM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/923487; Riaz A, 2014, ALEX ENG J, V53, P475, DOI 10.1016/j.aej.2014.01.005; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Tripathi D, 2014, INT J HEAT MASS TRAN, V70, P61, DOI 10.1016/j.ijheatmasstransfer.2013.10.044; Yasmin H, 2014, APPL MATH MECH-ENGL, V35, P697, DOI 10.1007/s10483-014-1823-6; Zhang Y, 2013, J ENVIRON SCI, V25, P1817, DOI 10.1016/S1001-0742(12)60233-2	25	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113851	10.1371/journal.pone.0113851	http://dx.doi.org/10.1371/journal.pone.0113851			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460608	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700059
J	Hendre, PS; Aggarwal, RK				Hendre, Prasad S.; Aggarwal, Ramesh K.			Development of Genic and Genomic SSR Markers of Robusta Coffee (Coffea canephora Pierre Ex A. Froehner)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MICROSATELLITE MARKERS; PLANTS; GENUS; TRANSFERABILITY; IDENTIFICATION; AMPLIFICATION; ARABICA	Coffee breeding and improvement efforts can be greatly facilitated by availability of a large repository of simple sequence repeats (SSRs) based microsatellite markers, which provides efficiency and high-resolution in genetic analyses. This study was aimed to improve SSR availability in coffee by developing new genic-/genomic-SSR markers using in-silico bioinformatics and streptavidin-biotin based enrichment approach, respectively. The expressed sequence tag (EST) based genic microsatellite markers (EST-SSRs) were developed using the publicly available dataset of 13,175 unigene ESTs, which showed a distribution of 1 SSR/3.4 kb of coffee transcriptome. Genomic SSRs, on the other hand, were developed from an SSR-enriched small-insert partial genomic library of robusta coffee. In total, 69 new SSRs (44 EST-SSRs and 25 genomic SSRs) were developed and validated as suitable genetic markers. Diversity analysis of selected coffee genotypes revealed these to be highly informative in terms of allelic diversity and PIC values, and eighteen of these markers (similar to 27%) could be mapped on a robusta linkage map. Notably, the markers described here also revealed a very high cross-species transferability. In addition to the validated markers, we have also designed primer pairs for 270 putative EST-SSRs, which are expected to provide another ca. 200 useful genetic markers considering the high success rate (88%) of marker conversion of similar pairs tested/validated in this study.	[Hendre, Prasad S.; Aggarwal, Ramesh K.] Ctr Cellular & Mol Biol CSIR CCMB, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aggarwal, RK (corresponding author), Ctr Cellular & Mol Biol CSIR CCMB, Hyderabad, Telangana, India.	rameshka@ccmb.res.in	HENDRE, PRASAD/ABF-7486-2021; Hendre, Prasad S/D-1256-2010	HENDRE, PRASAD/0000-0003-1691-183X; Hendre, Prasad S/0000-0003-1691-183X	FYP project from the Council of Scientific & Industrial Research (Govt of India) [PLOMICS_BSC0301]; Department of Biotechnology (Govt of India) [BT/PR/6292/Agr/16/575/2005]	FYP project from the Council of Scientific & Industrial Research (Govt of India); Department of Biotechnology (Govt of India)(Department of Biotechnology (DBT) India)	This work was supported by: the FYP project, PLOMICS_BSC0301, to RKA, from the Council of Scientific & Industrial Research (Govt of India); and Project grant "BT/PR/6292/Agr/16/575/2005, dated 4/12/2006," to RKA from the Department of Biotechnology (Govt of India), under which some of the DNA samples/sequences used in the present study were collected/carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Aggarwal RK, 2002, THEOR APPL GENET, V105, P680, DOI 10.1007/s00122-002-0973-6; Aggarwal RK, 2004, P 20 INT C COFF SCI, P751; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Baruah A, 2003, MOL ECOL NOTES, V3, P647, DOI 10.1046/j.1471-8286.2003.00544.x; Bhat PR, 2005, MOL ECOL NOTES, V5, P80, DOI 10.1111/j.1471-8286.2004.00839.x; CHEVALIER A, 1947, ENCY BIOL, P356; Combes MC, 2000, MOL ECOL, V9, P1178, DOI 10.1046/j.1365-294x.2000.00954-5.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Hendre Prasad S., 2007, P399, DOI 10.1007/978-1-4020-6297-1_15; Hendre PS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-51; Hendre PS, 2004, COURSE MANUAL HANDS; Hendre PS, 2007, THESIS JAWAHARLAL NE; Kumpatla S. P, 2004, THESIS; Lashermes P, 1997, THEOR APPL GENET, V94, P947, DOI 10.1007/s001220050500; Lin CW, 2005, THEOR APPL GENET, V112, P114, DOI 10.1007/s00122-005-0112-2; Moncada P, 2004, GENOME, V47, P501, DOI 10.1139/G03-129; Moriguchi Y, 2003, THEOR APPL GENET, V106, P751, DOI 10.1007/s00122-002-1149-0; OrozcoCastillo C, 1996, PLANT CELL REP, V15, P337, DOI 10.1007/BF00232367; Page RDM, 2001, TREEVIEW SOFTWARE; Peakall R, 1998, MOL BIOL EVOL, V15, P1275, DOI 10.1093/oxfordjournals.molbev.a025856; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Poncet V, 2004, GENOME, V47, P1071, DOI 10.1139/G04-064; Poncet V, 2007, GENOME, V50, P1156, DOI 10.1139/G07-073; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Riar DS, 2010, J HERED, DOI [10.1093/jhered/esg103, DOI 10.1093/JHERED/ESG103]; Rovelli P, 2000, COFFEE BIOTECHNOLOGY, P123; Ruas PM, 2003, GENET MOL BIOL, V26, P319, DOI 10.1590/S1415-47572003000300017; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; [No title captured]	36	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113661	10.1371/journal.pone.0113661	http://dx.doi.org/10.1371/journal.pone.0113661			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461752	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700043
J	Kleinman, CL; Doria, M; Orecchini, E; Giuliani, E; Galardi, S; De Jay, N; Michienzi, A				Kleinman, Claudia L.; Doria, Margherita; Orecchini, Elisa; Giuliani, Erica; Galardi, Silvia; De Jay, Nicolas; Michienzi, Alessandro			HIV-1 Infection Causes a Down-Regulation of Genes Involved in Ribosome Biogenesis	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; UPSTREAM-BINDING-FACTOR; NUCLEOLAR TRAFFICKING; MEDIATED INHIBITION; PROTEOMIC ANALYSIS; RNA; PROTEIN; REPLICATION; CELL; ACTIVATION	HIV-1 preferentially infects CD4(+) T cells, causing fundamental changes that eventually lead to the release of new viral particles and cell death. To investigate in detail alterations in the transcriptome of the CD4(+) T cells upon viral infection, we sequenced polyadenylated RNA isolated from Jurkat cells infected or not with HIV-1. We found a marked global alteration of gene expression following infection, with an overall trend toward induction of genes, indicating widespread modification of the host biology. Annotation and pathway analysis of the most deregulated genes showed that viral infection produces a down-regulation of genes associated with the nucleolus, in particular those implicated in regulating the different steps of ribosome biogenesis, such as ribosomal RNA ( rRNA) transcription, pre-rRNA processing, and ribosome maturation. The impact of HIV-1 infection on genes involved in ribosome biogenesis was further validated in primary CD4(+) T cells. Moreover, we provided evidence by Northern Blot experiments, that host pre-rRNA processing in Jurkat cells might be perturbed during HIV-1 infection, thus strengthening the hypothesis of a crosstalk between nucleolar functions and viral pathogenesis.	[Kleinman, Claudia L.; De Jay, Nicolas] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Kleinman, Claudia L.; De Jay, Nicolas] McGill Univ, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Doria, Margherita; Giuliani, Erica] IRCCS, Bambino Gesu Childrens Hosp, Lab Immunoinfectivol, Rome, Italy; [Orecchini, Elisa; Galardi, Silvia; Michienzi, Alessandro] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Lady Davis Institute; McGill University; McGill University; IRCCS Bambino Gesu; University of Rome Tor Vergata	Michienzi, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.	alessandro.michienzi@uniroma2.it	Doria, Margherita/K-3157-2016; michienzi, alessandro/I-5106-2014; Giuliani, Erica/K-3958-2016; Orecchini, Elisa/AAQ-4441-2020	Doria, Margherita/0000-0001-5533-0304; michienzi, alessandro/0000-0002-9133-8482; Giuliani, Erica/0000-0002-4190-6963; Orecchini, Elisa/0000-0002-0654-4696; GALARDI, SILVIA/0000-0002-3646-4064; Kleinman, Claudia/0000-0002-5158-7126	Ministry of Health; ISS; Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente; Fonds de Recherche du Quebec-Sante	Ministry of Health; ISS; Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported in part by the Ministry of Health, 'Programma Nazionale di ricerca sull'AIDS' in collaboration with ISS to A. M. and by grants of the Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente co-funded by the Italian 5 x 1000 contribution to M.D. C.L.K. was the recipient of a fellowship award from the Fonds de Recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-103; Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0; Belin S, 2010, RNA, V16, P131, DOI 10.1261/rna.1935610; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; Calle A, 2008, J VIROL, V82, P4762, DOI 10.1128/JVI.00077-08; Chang ST, 2011, MBIO, V2, DOI 10.1128/mBio.00134-11; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011; Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Horigome C, 2012, NUCLEUS-PHILA, V3, P22, DOI 10.4161/nucl.18930; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jarboui MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048702; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Kao CF, 2004, J BIOMED SCI, V11, P72, DOI 10.1159/000075291; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lochmann TL, 2013, VIRUS RES, V171, P304, DOI 10.1016/j.virusres.2012.09.011; Lymberopoulos MH, 2011, VIROLOGY, V412, P341, DOI 10.1016/j.virol.2011.01.016; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Michienzi A, 2002, P NATL ACAD SCI USA, V99, P14047, DOI 10.1073/pnas.212229599; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Michienzi Alessandro, 2006, AIDS Res Ther, V3, P13, DOI 10.1186/1742-6405-3-13; Mohammadi P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003161; Ni LW, 2012, J MED MICROBIOL, V61, P1637, DOI 10.1099/jmm.0.045963-0; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Peng QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014244; Ponti D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-32; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Stow ND, 2009, J GEN VIROL, V90, P69, DOI 10.1099/vir.0.006353-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113908	10.1371/journal.pone.0113908	http://dx.doi.org/10.1371/journal.pone.0113908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462981	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700067
J	Lubnow, M; Philipp, A; Foltan, M; Enger, TB; Lunz, D; Bein, T; Haneya, A; Schmid, C; Riegger, G; Muller, T; Lehle, K				Lubnow, Matthias; Philipp, Alois; Foltan, Maik; Enger, Tone Bull; Lunz, Dirk; Bein, Thomas; Haneya, Assad; Schmid, Christof; Riegger, Guenter; Mueller, Thomas; Lehle, Karla			Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange - Retrospective Analysis of 265 Cases	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; FAILURE; LUNG; INFLUENZA; ADULTS; DEPOSITS	Objectives: Technical complications are a known hazard in veno-venous extracorporeal membrane oxygenation (vvECMO). Identifying these complications and predictive factors indicating a developing system-exchange was the goal of the study. Methods: Retrospective study on prospectively collected data of technical complications including 265 adult patients (Regensburg ECMO Registry, 20092013) with acute respiratory failure treated with vvECMO. Alterations in blood flow resistance, gas transfer capability, hemolysis, coagulation and hemostasis parameters were evaluated in conjunction with a system-exchange in all patients with at least one exchange (n=83). Results: Values presented as median (interquartile range). Patient age was 50(36-60) years, the SOFA score 11(8-14.3) and the Murray lung injury Score 3.33(3.3-3.7). Cumulative ECMO support time 3411 days, 9(6-15) days per patient. Mechanical failure of the blood pump (n=5), MO (n=2) or cannula (n=1) accounted for 10% of the exchanges. Acute clot formation within the pump head (visible clots, increase in plasma free hemoglobin (frHb), serum lactate dehydrogenase (LDH), n=13) and MO (increase in pressure drop across the MO, n=16) required an urgent system-exchange, of which nearly 50% could be foreseen by measuring the parameters mentioned below. Reasons for an elective system-exchange were worsening of gas transfer capability (n=10) and device-related coagulation disorders (n=32), either local fibrinolysis in the MO due to clot formation (increased D-dimers [DD]), decreased platelet count; n=24), or device-induced hyperfibrinolysis (increased DD, decreased fibrinogen [FG], decreased platelet count, diffuse bleeding tendency; n=8), which could be reversed after system-exchange. Four MOs were exchanged due to suspicion of infection. Conclusions: The majority of ECMO system-exchanges could be predicted by regular inspection of the complete ECMO circuit, evaluation of gas exchange, pressure drop across the MO and laboratory parameters (DD, FG, platelets, LDH, frHb). These parameters should be monitored in the daily routine to reduce the risk of unexpected ECMO failure.	[Philipp, Alois; Foltan, Maik; Enger, Tone Bull; Haneya, Assad; Schmid, Christof; Lehle, Karla] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, D-93042 Regensburg, Germany; [Lubnow, Matthias; Riegger, Guenter; Mueller, Thomas] Univ Med Ctr Regensburg, Dept Internal Med 2, D-93042 Regensburg, Germany; [Lunz, Dirk; Bein, Thomas] Univ Med Ctr Regensburg, Dept Anesthesiol, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Lubnow, M (corresponding author), Univ Med Ctr Regensburg, Dept Internal Med 2, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.	matthias.lubnow@ukr.de	Haneya, Assad/Q-7748-2017; Haneya, Assad/ABE-6281-2020	Foltan, Maik/0000-0001-9350-3368	Departments of Cardiothoracic Surgery; Internal Medicine 2 of the University Medical Center Regensburg	Departments of Cardiothoracic Surgery; Internal Medicine 2 of the University Medical Center Regensburg	The study was funded by departmental resources of the Departments of Cardiothoracic Surgery and Internal Medicine 2 of the University Medical Center Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific other funding for this work.	Allen Steve, 2011, J Intensive Care Med, V26, P13, DOI 10.1177/0885066610384061; Brogan TV, 2009, INTENS CARE MED, V35, P2105, DOI 10.1007/s00134-009-1661-7; Byrnes J, 2011, ASAIO J, V57, P456, DOI 10.1097/MAT.0b013e31822e2475; Combes A, 2012, CURR OPIN CRIT CARE, V18, P99, DOI 10.1097/MCC.0b013e32834ef412; Combes A, 2011, SEMIN RESP CRIT CARE, V32, P188, DOI 10.1055/s-0031-1275531; Conrad SA, 2005, ASAIO J, V51, P4, DOI 10.1097/01.mat.0000151922.67540.E9; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dornia C, 2013, ASAIO J, V59, P439, DOI 10.1097/MAT.0b013e3182976eff; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Kniazeva T, 2012, LAB CHIP, V12, P1686, DOI 10.1039/c2lc21156d; Kuehn C, 2013, ASAIO J, V59, P368, DOI 10.1097/MAT.0b013e318299fd07; Lehle K, 2013, ARTIF ORGANS; Lehle K, 2008, ASAIO J, V54, P612, DOI 10.1097/MAT.0b013e318186a807; Lubnow M, 2013, J CRIT CARE; MacLaren G, 2012, INTENS CARE MED, V38, P210, DOI 10.1007/s00134-011-2439-2; Muller T, 2013, DTSCH ARZTEBL INT, V110, P159, DOI 10.3238/arztebl.2013.0159; Muller T, 2011, ARTIF ORGANS, V35, pE84, DOI 10.1111/j.1525-1594.2010.01185.x; Napolitano LM, 2010, CRIT CARE MED, V38, pE74, DOI 10.1097/CCM.0b013e3181cc5373; Nolan H, 2011, ORGANOGENESIS, V7, P23, DOI 10.4161/org.7.1.14025; Park PK, 2011, CRIT CARE CLIN, V27, P627, DOI 10.1016/j.ccc.2011.05.009; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Schmid C, 2012, J HEART LUNG TRANSPL, V31, P9, DOI 10.1016/j.healun.2011.07.013; Sethi S, 2011, ANN CARD ANAESTH, V14, P156, DOI [10.4103/0971-9784.81576, 10.4103/0971-9784.84030]; Sidebotham D, 2010, J CARDIOTHOR VASC AN, V24, P164, DOI 10.1053/j.jvca.2009.08.002; Yu K, 2011, ARTIF ORGANS, V35, P733, DOI 10.1111/j.1525-1594.2010.01173.x	26	101	102	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112316	10.1371/journal.pone.0112316	http://dx.doi.org/10.1371/journal.pone.0112316			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464516	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700015
J	Nabeka, H; Uematsu, K; Takechi, H; Shimokawa, T; Yamamiya, K; Li, C; Doihara, T; Saito, S; Kobayashi, N; Matsuda, S				Nabeka, Hiroaki; Uematsu, Keigo; Takechi, Hiroko; Shimokawa, Tetsuya; Yamamiya, Kimiko; Li, Cheng; Doihara, Takuya; Saito, Shouichiro; Kobayashi, Naoto; Matsuda, Seiji			Prosaposin Overexpression following Kainic Acid-Induced Neurotoxicity	PLOS ONE			English	Article							SPHINGOLIPID ACTIVATOR PROTEINS; INDUCED LEARNING-DISABILITY; FACIAL-NERVE TRANSECTION; IN-VIVO; CEREBRAL-ISCHEMIA; BETA-GLUCOSIDASE; NEURONAL DAMAGE; MESSENGER-RNA; RAT; EXPRESSION	Because excessive glutamate release is believed to play a pivotal role in numerous neuropathological disorders, such as ischemia or seizure, we aimed to investigate whether intrinsic prosaposin (PS), a neuroprotective factor when supplied exogenously in vivo or in vitro, is up-regulated after the excitotoxicity induced by kainic acid (KA), a glutamate analog. In the present study, PS immunoreactivity and its mRNA expression in the hippocampal and cortical neurons showed significant increases on day 3 after KA injection, and high PS levels were maintained even after 3 weeks. The increase in PS, but not saposins, detected by immunoblot analysis suggests that the increase in PS-like immunoreactivity after KA injection was not due to an increase in saposins as lysosomal enzymes after neuronal damage, but rather to an increase in PS as a neurotrophic factor to improve neuronal survival. Furthermore, several neurons with slender nuclei inside/outside of the pyramidal layer showed more intense PS mRNA expression than other pyramidal neurons. Based on the results from double immunostaining using anti-PS and anti-GABA antibodies, these neurons were shown to be GABAergic interneurons in the extraand intra-pyramidal layers. In the cerebral cortex, several large neurons in the V layer showed very intense PS mRNA expression 3 days after KA injection. The choroid plexus showed intense PS mRNA expression even in the normal rat, and the intensity increased significantly after KA injection. The present study indicates that inhibitory interneurons as well as stimulated hippocampal pyramidal and cortical neurons synthesize PS for neuronal survival, and the choroid plexus is highly activated to synthesize PS, which may prevent neurons from excitotoxic neuronal damage. To the best of our knowledge, this is the first study that demonstrates axonal transport and increased production of neurotrophic factor PS after KA injection.	[Nabeka, Hiroaki; Uematsu, Keigo; Takechi, Hiroko; Shimokawa, Tetsuya; Yamamiya, Kimiko; Li, Cheng; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Ehime University; Gifu University; Ehime University	Shimokawa, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	tshimo@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, of Japan [25450466, 24590254, 25462295]; Grants-in-Aid for Scientific Research [24590254] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants to TS (No. 25450466), NK (No. 24590254), and SM (No. 25462295), from the Ministry of Education, Culture, Sports, Science and Technology, of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; COYLE JT, 1987, CIBA F SYMP, V126, P186; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gao HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080032; HEGGLI DE, 1981, BRAIN RES, V230, P253, DOI 10.1016/0006-8993(81)90405-4; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Li C, 2013, HISTOL HISTOPATHOL, V28, P875, DOI 10.14670/HH-28.875; Liang R, 2009, NEUROSCIENCE, V160, P412, DOI 10.1016/j.neuroscience.2009.02.046; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Matsuda S, 1997, BRAIN RES, V769, P321, DOI 10.1016/S0006-8993(97)00724-5; Matsuda S, 1996, NEUROSCI LETT, V204, P109, DOI 10.1016/0304-3940(96)12340-5; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Morales CR, 1998, J ANDROL, V19, P156; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1980, BRAIN RES, V195, P47; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; OLNEY JW, 1978, NATURE, V271, P557, DOI 10.1038/271557a0; Qi XY, 2001, PROG NUCLEIC ACID RE, V66, P203; Saito S, 2014, CELL TISSUE RES, V356, P231, DOI 10.1007/s00441-013-1773-9; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P75, DOI 10.1016/0167-4838(92)90426-E; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Sato K, 1998, METHOD ENZYMOL, V293, P155; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Yokota N, 2001, STROKE, V32, P168, DOI 10.1161/01.STR.32.1.168; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	50	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110534	10.1371/journal.pone.0110534	http://dx.doi.org/10.1371/journal.pone.0110534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461957	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700004
J	Zitt, E; Sturm, G; Kronenberg, F; Neyer, U; Knoll, F; Lhotta, K; Weiss, G				Zitt, Emanuel; Sturm, Gisela; Kronenberg, Florian; Neyer, Ulrich; Knoll, Florian; Lhotta, Karl; Weiss, Guenter			Iron Supplementation and Mortality in Incident Dialysis Patients: An Observational Study	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; INTRAVENOUS IRON; HEMODIALYSIS-PATIENTS; BACTERIAL-INFECTIONS; PARENTERAL IRON; RISK-FACTORS; ANEMIA; OVERLOAD; BACTEREMIA; TIME	Background: Studies on the association between iron supplementation and mortality in dialysis patients are rare and conflicting. Methods: In our observational single-center cohort study (INVOR study) we prospectively studied 235 incident dialysis patients. Time-dependent Cox proportional hazards models using all measured laboratory values for up to 7.6 years were applied to study the association between iron supplementation and all-cause mortality, cardiovascular and sepsis-related mortality. Furthermore, the time-dependent association of ferritin levels with mortality in patients with normal C-reactive protein (CRP) levels (<0.5 mg/dL) and elevated CRP levels (>= 0.5 mg/dL) was evaluated by using non-linear P-splines to allow flexible modeling of the association. Results: One hundred and ninety-one (81.3%) patients received intravenous iron, 13 (5.5%) patients oral iron, whereas 31 (13.2%) patients were never supplemented with iron throughout the observation period. Eighty-two (35%) patients died during a median follow-up of 34 months, 38 patients due to cardiovascular events and 21 patients from sepsis. Baseline CRP levels were not different between patients with and without iron supplementation. However, baseline serum ferritin levels were lower in patients receiving iron during follow up (median 93 vs 251 ng/mL, p<0.001). Iron supplementation was associated with a significantly reduced all-cause mortality [HR (95% CI): 0.22 (0.08-0.58); p=0.002] and a reduced cardiovascular and sepsis-related mortality [HR (95% CI): 0.31 (0.09-1.04); p=0.06]. Increasing ferritin concentrations in patients with normal CRP were associated with a decreasing mortality, whereas in patients with elevated CRP values ferritin levels>800 ng/mL were linked with increased mortality. Conclusions: Iron supplementation is associated with reduced all-cause mortality in incident dialysis patients. While serum ferritin levels up to 800 ng/mL appear to be safe, higher ferritin levels are associated with increased mortality in the setting of concomitant inflammation.	[Zitt, Emanuel; Knoll, Florian; Lhotta, Karl] Feldkirch Acad Teaching Hosp, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Neyer, Ulrich; Lhotta, Karl] Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria; [Sturm, Gisela] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Sturm, Gisela; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Lhotta, K (corresponding author), Feldkirch Acad Teaching Hosp, Dept Nephrol & Dialysis, Feldkirch, Austria.	karl.lhotta@lkhf.at; guenter.weiss@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Zitt, Emanuel/ABE-1926-2020	Kronenberg, Florian/0000-0003-2229-1120; Zitt, Emanuel/0000-0001-6944-6041; Knoll, Florian/0000-0001-5357-8656; Weiss, Guenter/0000-0003-0709-2158	Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT); Austrian National Bank [13662]; Austrian Science Fund FWF [TRP-188]	Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT); Austrian National Bank; Austrian Science Fund FWF(Austrian Science Fund (FWF))	This study was supported by a grant from Hans Drexel to the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT to KL) and by a grant from the Austrian National Bank (Project 13662 to FK) and the Austrian Science Fund FWF (TRP-188 to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530; BOELAERT JR, 1990, NEPHROL DIAL TRANSPL, V5, P130, DOI 10.1093/ndt/5.2.130; Brewster UC, 2004, SEMIN DIALYSIS, V17, P57; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Canavese C, 2004, KIDNEY INT, V65, P1091, DOI 10.1111/j.1523-1755.2004.00480.x; Carrera F, 2010, NEPHROL DIAL TRANSPL, V25, P4009, DOI 10.1093/ndt/gfq305; Deicher R, 2003, KIDNEY INT, V64, P728, DOI 10.1046/j.1523-1755.2003.00125.x; Deicher R, 2003, CURR OPIN NEPHROL HY, V12, P139, DOI 10.1097/00041552-200303000-00003; Eschbach JW, 1999, KIDNEY INT, V55, pS35, DOI 10.1046/j.1523-1755.1999.055Suppl.69035.x; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Fell LH, 2014, NEPHROL DIAL TRANSPL, V29, P809, DOI 10.1093/ndt/gft524; Ferrari P, 2011, CLIN J AM SOC NEPHRO, V6, P77, DOI 10.2215/CJN.04190510; Goch J, 1996, NEPHRON, V73, P403; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Gupta A, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-16; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; HOEN B, 1995, NEPHROL DIAL TRANSPL, V10, P377; Horl WH, 2007, J AM SOC NEPHROL, V18, P382, DOI 10.1681/ASN.2006080856; Horl WH, 2013, NAT REV NEPHROL, V9, P291, DOI 10.1038/nrneph.2013.21; Horl WH, 2005, WIEN KLIN WOCHENSCHR, V117, P69, DOI 10.1007/s00508-005-0486-9; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KESSLER M, 1993, NEPHRON, V64, P95, DOI 10.1159/000187285; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Koch K M, 1976, Proc Eur Dial Transplant Assoc, V12, P362; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; Lindsay R M, 1973, Clin Nephrol, V1, P24; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; Macdougall IC, 2008, CLIN J AM SOC NEPHRO, V3, P200, DOI 10.2215/CJN.03840907; Macdougall IC, 2013, IRAN J KIDNEY DIS, V7, P9; Meuwese CL, 2011, NEPHROL DIAL TRANSPL, V26, P1313, DOI 10.1093/ndt/gfq557; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Oexle H, 2003, J LEUKOCYTE BIOL, V74, P287, DOI 10.1189/jlb.0802420; Patruta SI, 1998, J AM SOC NEPHROL, V9, P655; Rostoker G, 2012, AM J MED, V125, P991, DOI 10.1016/j.amjmed.2012.01.015; SEIFERT A, 1987, Q J MED, V65, P1015; Sengoelge G, 2003, J AM SOC NEPHROL, V14, P2639, DOI 10.1097/01.ASN.0000087087.61306.4A; Sonnweber T, 2011, NEPHROL DIAL TRANSPL, V26, P977, DOI 10.1093/ndt/gfq483; Stevens PE, 2012, J RENAL CARE, V38, P67, DOI 10.1111/j.1755-6686.2012.00281.x; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; Teehan GS, 2004, CLIN INFECT DIS, V38, P1090, DOI 10.1086/382878; Thomas Christian, 2005, Lab Hematol, V11, P14, DOI 10.1532/LH96.04049; TIELEMANS CL, 1989, NEPHROL DIAL TRANSPL, V4, P883, DOI 10.1093/ndt/4.10.883; Tovbin D, 2002, AM J KIDNEY DIS, V40, P1005, DOI 10.1053/ajkd.2002.36334; VANASBECK BS, 1984, J INFECTION, V8, P232, DOI 10.1016/S0163-4453(84)93955-0; Vaziri ND, 2013, AM J KIDNEY DIS, V61, P992, DOI 10.1053/j.ajkd.2012.10.027; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2003, KIDNEY INT, V64, P572, DOI 10.1046/j.1523-1755.2003.00099.x; Weiss G, 2014, KIDNEY INT IN PRESS; Zitt E, 2011, CLIN J AM SOC NEPHRO, V6, P2650, DOI 10.2215/CJN.03780411	57	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114144	10.1371/journal.pone.0114144	http://dx.doi.org/10.1371/journal.pone.0114144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462819	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700107
J	Ren, P; Chaturvedi, V; Chaturvedi, S				Ren, Ping; Chaturvedi, Vishnu; Chaturvedi, Sudha			Carbon Dioxide is a Powerful Inducer of Monokaryotic Hyphae and Spore Development in Cryptococcus gattii and Carbonic Anhydrase Activity is Dispensable in This Dimorphic Transition	PLOS ONE			English	Article							NEOFORMANS VAR.-GATTII; FUNGAL PATHOGEN CRYPTOCOCCUS; BRITISH-COLUMBIA; VANCOUVER-ISLAND; MATING-TYPE; PACIFIC-NORTHWEST; DISTINCT ROLES; SEXUAL CYCLE; VIRULENCE; CANADA	Cryptococcus gattii is unique among human pathogenic fungi with specialized ecological niche on trees. Since leaves concentrate CO2, we investigated the role of this gaseous molecule in C. gattii biology and virulence. We focused on the genetic analyses of beta-carbonic anhydrase (beta-CA) encoded by C. gattii CAN1 and CAN2 as later is critical for CO2 sensing in a closely related pathogen C. neoformans. High CO2 conditions induced robust development of monokaryotic hyphae and spores in C. gattii. Conversely, high CO2 completely repressed hyphae development in sexual mating. Both CAN1 and CAN2 were dispensable for CO2 induced morphogenetic transitions. However, C. gattii CAN2 was essential for growth in ambient air similar to its reported role in C. neoformans. Both can1 and can2 mutants retained full pathogenic potential in vitro and in vivo. These results provide insight into C. gattii adaptation for arboreal growth and production of infectious propagules by b-CA independent mechanism(s).	[Ren, Ping; Chaturvedi, Vishnu; Chaturvedi, Sudha] New York State Dept Hlth, Mycol Lab, Wadsworth Ctr, Albany, NY 12208 USA; [Chaturvedi, Vishnu; Chaturvedi, Sudha] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Chaturvedi, S (corresponding author), New York State Dept Hlth, Mycol Lab, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	Sudha.Chaturvedi@health.ny.gov		Ren, Ping/0000-0002-4022-6667; Chaturvedi, Vishnu/0000-0002-3922-9676	NIAID [AI05887702]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID AI05887702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Callejas A, 1998, MED MYCOL, V36, P341, DOI 10.1080/02681219880000531; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; FISHER D, 1993, AUST NZ J MED, V23, P678, DOI 10.1111/j.1445-5994.1993.tb04726.x; Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fu JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003335; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Granados DP, 2005, MICROB ECOL, V49, P282, DOI 10.1007/s00248-004-0236-y; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; HATCH MD, 1992, PLANT CELL PHYSIOL, V33, P333; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kidd SE, 2007, EMERG INFECT DIS, V13, P51, DOI 10.3201/eid1301.060823; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kurtzman CP, 2007, INT J SYST EVOL MICR, V57, P1154, DOI 10.1099/ijs.0.64847-0; Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Stephen C, 2002, CAN VET J, V43, P792; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	40	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113147	10.1371/journal.pone.0113147	http://dx.doi.org/10.1371/journal.pone.0113147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478697	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200016
J	Burke, JF; Langa, KM; Hayward, RA; Albin, RL				Burke, James F.; Langa, Kenneth M.; Hayward, Rodney A.; Albin, Roger L.			Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease	PLOS ONE			English	Article							HYPOTHETICAL MODEL; COST-EFFECTIVENESS; HEART-DISEASE; ASPIRIN; RISK; DIAGNOSIS; TRIALS	Objectives: In this study, we developed a model of presymptomatic treatment of Alzheimer disease (AD) after a screening diagnostic evaluation and explored the circumstances required for an AD prevention treatment to produce aggregate net population benefit. Methods: Monte Carlo simulation methods were used to estimate outcomes in a simulated population derived from data on AD incidence and mortality. A wide variety of treatment parameters were explored. Net population benefit was estimated in aggregated QALYs. Sensitivity analyses were performed by individually varying the primary parameters. Findings: In the base-case scenario, treatment effects were uniformly positive, and net benefits increased with increasing age at screening. A highly efficacious treatment (i.e. relative risk 0.6) modeled in the base-case is estimated to save 20 QALYs per 1000 patients screened and 221 QALYs per 1000 patients treated. Conclusions: Highly efficacious presymptomatic screen and treat strategies for AD are likely to produce substantial aggregate population benefits that are likely greater than the benefits of aspirin in primary prevention of moderate risk cardiovascular disease (28 QALYS per 1000 patients treated), even in the context of an imperfect treatment delivery environment.	[Burke, James F.; Albin, Roger L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Burke, James F.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Burke, James F.; Langa, Kenneth M.; Hayward, Rodney A.] VAAAHS, Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Albin, Roger L.] VAAAHS, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Albin, Roger L.] VAAAHS, Neurol Serv, Ann Arbor, MI USA; [Albin, Roger L.] Univ Michigan, Michigan Alzheimer Dis Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Burke, JF (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	jamesbur@umich.edu		Langa, Kenneth/0000-0002-2798-1836	NINDS [K08 NS082597, R01 MD008879]; NIH [P50 NS091856]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS091856, K08NS082597] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD008879] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by NINDS K08 NS082597, R01 MD008879 (JFB) and NIH P50 NS091856 (RLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, FORECASTING GLOBAL B, P1; Centers for Disease Control and Prevention, US LIF TABL 1999 200; Cohen JT, 2008, ALZHEIMERS DEMENT, V4, P212, DOI 10.1016/j.jalz.2008.02.003; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Howdey LM, 2010, AGE SEX COMPOSITION; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Koerkamp BG, 2010, MED DECIS MAKING, V30, P194, DOI 10.1177/0272989X09342277; McMahon PM, 2000, RADIOLOGY, V217, P58, DOI 10.1148/radiology.217.1.r00se1358; McMahon PM, 2003, RADIOLOGY, V228, P515, DOI 10.1148/radiol.2282020915; Parfit Derek., 1986, REASONS PERSONS; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Spackman DE, 2011, CURR ALZHEIMER RES; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; Sussman JB, 2011, CIRC-CARDIOVASC QUAL, V4, P268, DOI 10.1161/CIRCOUTCOMES.110.959239; World Health Organization, DEMENTIA PUBLIC HLTH	28	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114339	10.1371/journal.pone.0114339	http://dx.doi.org/10.1371/journal.pone.0114339			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474698	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500020
J	Li, JQ; Tseng, KK; Hsieh, ZY; Yang, CW; Huang, HN				Li, Jiaqian; Tseng, Kuo-Kun; Hsieh, Zu Yi; Yang, Ching Wen; Huang, Huang-Nan			Staining Pattern Classification of Antinuclear Autoantibodies Based on Block Segmentation in Indirect Immunofluorescence Images	PLOS ONE			English	Article								Indirect immunofluorescence based on HEp-2 cell substrate is the most commonly used staining method for antinuclear autoantibodies associated with different types of autoimmune pathologies. The aim of this paper is to design an automatic system to identify the staining patterns based on block segmentation compared to the cell segmentation most used in previous research. Various feature descriptors and classifiers are tested and compared in the classification of the staining pattern of blocks and it is found that the technique of the combination of the local binary pattern and the k-nearest neighbor algorithm achieve the best performance. Relying on the results of block pattern classification, experiments on the whole images show that classifier fusion rules are able to identify the staining patterns of the whole well (specimen image) with a total accuracy of about 94.62%.	[Li, Jiaqian; Tseng, Kuo-Kun] Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China; [Hsieh, Zu Yi] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Ching Wen] Taichung Vet Gen Hosp, Comp & Commun Ctr, Taichung, Taiwan; [Huang, Huang-Nan] Tunghai Univ, Dept Math, Taichung 40704, Taiwan	Harbin Institute of Technology; University Town of Shenzhen; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Tunghai University	Tseng, KK (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China.	kktseng@foxmail.com	Li, Jiaqian/HGE-4168-2022	Li, Jiaqian/0000-0001-6655-6069; Huang, Huang-Nan/0000-0001-7387-0427				Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Cheng CC, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-S1-S5; Cordella LP, 1999, PATTERN ANAL APPL, V2, P205, DOI 10.1007/s100440050029; Cordelli E., 2011, INT S COMP BAS MED S, P1; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Creemers C, 2011, P 4 INT S APPL SCI B, P28; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Di Cataldo S, 2012, INT C PATT RECOG, P3349; Ersoy I, 2012, INT C PATT RECOG, P3362; FUKUNAGA K, 1975, IEEE T COMPUT, VC 24, P750, DOI 10.1109/T-C.1975.224297; Ghosh S, 2012, INT C PATT RECOG, P174; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hsieh T., 2009, INT C INF COMM SIGN, P1; Huang YC, 2012, LECT NOTES ARTIF INT, V7197, P529, DOI 10.1007/978-3-642-28490-8_55; Iannello G, 2012, P 25 INT S COMP BAS, P1; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Li K, 2012, INT C PATT RECOG, P170; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Rigon A, 2007, CYTOM PART B-CLIN CY, V72B, P472, DOI 10.1002/cyto.b.20356; Sahoolizadeh AH, 2008, INT J COMPUTER SCI E, V2, P218; Snell V, 2012, INT C PATT RECOG, P3750; Soares F, 2004, INT C PATT RECOG, P604, DOI 10.1109/ICPR.2004.1334215; Soda P, 2006, WORLD ACAD SCI ENG T, V2, P829; Soda P, 2007, ICIAP 2007 P, P685; Soda P, 2006, COMP MED SY, P219, DOI 10.1109/CBMS.2006.21; Soda P, 2009, PATTERN ANAL APPL, V12, P215, DOI 10.1007/s10044-008-0116-z; Soda P, 2009, IEEE T INF TECHNOL B, V13, P322, DOI 10.1109/TITB.2008.2010855; Sorwar G, 2001, 10TH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P545, DOI 10.1109/FUZZ.2001.1009012; Strandmark P, 2012, INT C PATT RECOG, P33; Thibault G, 2012, INT C PATT RECOG, P2440; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Wang HX, 2011, 2011 TENTH INTERNATIONAL SYMPOSIUM ON DISTRIBUTED COMPUTING AND APPLICATIONS TO BUSINESS, ENGINEERING AND SCIENCE (DCABES), P175, DOI 10.1109/DCABES.2011.62; Wiliem A, 2013, ARXIV13041262; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worman HJ, 2003, AUTOIMMUN REV, V2, P211, DOI 10.1016/S1568-9972(03)00013-2; Yang Y, 2013, IEEE IMAGE PROC, P733, DOI 10.1109/ICIP.2013.6738151; Yu-Len Huang, 2008, 2008 IEEE International Conference on Sensor Networks, Ubiquitous, and Trustworthy Computing (SUTC '08), P423; Yu-Len Huang, 2008, 2008 IEEE International Conference on Sensor Networks, Ubiquitous, and Trustworthy Computing (SUTC '08), P418, DOI 10.1109/SUTC.2008.73; Zhang D., 2011, BIOMETRIC IMAGE DISC, P41, DOI [10.4018/9781591408307.ch003, DOI 10.4018/9781591408307.CH003]	42	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113132	10.1371/journal.pone.0113132	http://dx.doi.org/10.1371/journal.pone.0113132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474260	Green Published, gold			2022-12-27	WOS:000346382500075
J	Nawae, W; Hannongbua, S; Ruengjitchatchawalya, M				Nawae, Wanapinun; Hannongbua, Supa; Ruengjitchatchawalya, Marasri			Dynamic Scenario of Membrane Binding Process of Kalata B1	PLOS ONE			English	Article							GRAINED MD SIMULATIONS; MOLECULAR-DYNAMICS; DRUG DESIGN; ANTIMICROBIAL PEPTIDES; SCANNING MUTAGENESIS; BIOLOGICAL-ACTIVITY; STRUCTURAL MOTIF; PLANT CYCLOTIDES; FORCE-FIELD; PROTEINS	Kalata B1 (kB1), a cyclotide that has been used in medical applications, displays cytotoxicity related to membrane binding and oligomerization. Our molecular dynamics simulation results demonstrate that Trp19 in loop 5 of both monomeric and tetrameric kB1 is a key residue for initial anchoring in the membrane binding process. This residue also facilitates the formation of kB1 tetramers. Additionally, we elucidate that kB1 preferentially binds to the membrane interfacial zone and is unable to penetrate into the membrane. In particular, significant roles of amino acid residues in loop 5 and loop 6 on the localization of kB1 to this membrane-water interface zone are found. This study reveals the roles of amino acid residues in the bioactivity of kB1, which is information that can be useful for designing new therapeutic cyclotides with less toxicity.	[Nawae, Wanapinun] King Mongkuts Univ Technol Thonburi, Fac Engn, Biol Engn Program, Bangkok, Thailand; [Hannongbua, Supa] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Sch Bioresources & Technol, Biotechnol Program, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; Kasetsart University; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Ruengjitchatchawalya, M (corresponding author), King Mongkuts Univ Technol Thonburi Bang Khun Thi, Bioinformat & Syst Biol Program, Bangkok, Thailand.	marasri.rue@kmutt.ac.th	Hannongbua, Supa/F-8062-2011; Hannongbua, Supa/ABD-9307-2021; Ruengjitchatchawalya, Marasri/N-5694-2014	Hannongbua, Supa/0000-0002-9901-4466; Hannongbua, Supa/0000-0002-9901-4466; 	National Research Council of Thailand [57000139]; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand [P-11-01089]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand	This work was partly supported by a research grant (NRMJ: 2557A30602295#57000139) from the National Research Council of Thailand (http://en.nrct.go.th) and a grant (P-11-01089) from the National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand (http://www.biotec.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Craik DJ, 2010, TOXICON, V56, P1092, DOI 10.1016/j.toxicon.2010.02.021; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Eliasen R, 2012, J BIOL CHEM, V287, P40493, DOI 10.1074/jbc.M112.395442; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gkeka P, 2010, J PHYS CHEM B, V114, P826, DOI 10.1021/jp908320b; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Khalfa A, 2010, J PHYS CHEM B, V114, P2676, DOI 10.1021/jp9064196; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Nawae W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03933; Poth AG, 2013, BIOPOLYMERS, V100, P480, DOI 10.1002/bip.22284; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rosengren KJ, 2013, BIOPOLYMERS, V100, P453, DOI 10.1002/bip.22269; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Su ZY, 2011, J PHYS CHEM B, V115, P796, DOI 10.1021/jp107599v; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang CK, 2012, J BIOL CHEM, V287, P43884, DOI 10.1074/jbc.M112.421198; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhao J, 2013, J CHEM INF MODEL, V53, P3280, DOI 10.1021/ci400477e	55	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114473	10.1371/journal.pone.0114473	http://dx.doi.org/10.1371/journal.pone.0114473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473840	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500039
J	Xie, RJ; Li, YJ; He, SL; Zheng, YQ; Yi, SL; Lv, Q; Deng, L				Xie, Rangjin; Li, Yongjie; He, Shaolan; Zheng, Yongqiang; Yi, Shilai; Lv, Qiang; Deng, Lie			Genome-Wide Analysis of Citrus R2R3MYB Genes and Their Spatiotemporal Expression under Stresses and Hormone Treatments	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; GAMYB-LIKE GENES; FACTOR SUPERFAMILY; FLAVONOL SYNTHESIS; OVER-EXPRESSION; ARABIDOPSIS; R2R3-MYB; CELL; ACID; BIOSYNTHESIS	The R2R3MYB proteins represent one of the largest families of transcription factors, which play important roles in plant growth and development. Although genome-wide analysis of this family has been conducted in many species, little is known about R2R3MYB genes in citrus, In this study, 101 R2R3MYB genes has been identified in the citrus (Citrus sinesis and Citrus clementina) genomes, which are almost equal to the number of rice. Phylogenetic analysis revealed that they could be subdivided into 21 subgroups. The evolutionary relationships and the intro-exon organizations were also analyzed, revealing strong gene conservation but also the expansions of particular functional genes during the plant evolution. Tissue-specific expression profiles showed that 95 citrus R2R3MYB genes were expressed in at least one tissue and the other 6 genes showed very low expression in all tissues tested, suggesting that citrus R2R3MYB genes play important roles in the development of all citrus organs. The transcript abundance level analysis during abiotic conditions (NaCl, abscisic acid, jasmonic acid, drought and low temperature) identified a group of R2R3MYB genes that responded to one or multiple treatments, which showed a promising for improving citrus adaptation to stresses. Our results provided an essential foundation for the future selection of the citrus R2R3MYB genes for cloning and functional dissection with an aim of uncovering their roles in citrus growth and development.	[Xie, Rangjin; Li, Yongjie; He, Shaolan; Zheng, Yongqiang; Yi, Shilai; Lv, Qiang; Deng, Lie] Southwest Univ, Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China	Chinese Academy of Agricultural Sciences; Southwest University - China	Deng, L (corresponding author), Southwest Univ, Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China.	niwodouhao@126.com	li, yong/HDN-3885-2022	Zheng, Yongqiang/0000-0002-5513-057X	Chongqing fundamental and advanced research projects [cstc2013jcyjA80036]; southwest university basic scientific research business expenses special funds [XDJK2013C052]; National Natural Science Foundation of China [31301743]	Chongqing fundamental and advanced research projects; southwest university basic scientific research business expenses special funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Chongqing fundamental and advanced research projects (cstc2013jcyjA80036), southwest university basic scientific research business expenses special funds (XDJK2013C052) and National Natural Science Foundation of China (31301743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059; Brownfield L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000430; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chai GH, 2014, J EXP BOT, V65, P4255, DOI 10.1093/jxb/eru196; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Cultrone A, 2010, TREE GENET GENOMES, V6, P101, DOI 10.1007/s11295-009-0232-y; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; De Vos M, 2006, PLANT SIGNAL BEHAV, V1, P305, DOI 10.4161/psb.1.6.3512; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Gibbs DJ, 2014, NEW PHYTOL, V203, P1194, DOI 10.1111/nph.12879; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; He YA, 2012, J EXP BOT, V63, P1511, DOI 10.1093/jxb/err389; Huang ZA, 2012, J GENET GENOMICS, V39, P149, DOI 10.1016/j.jgg.2012.01.007; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047576; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oh JE, 2011, PLANT MOL BIOL, V77, P91, DOI 10.1007/s11103-011-9796-7; Omer S, 2013, PLANT CELL REP, V32, P161, DOI 10.1007/s00299-012-1350-9; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shan H, 2012, MOL BIOTECHNOL, V51, P160, DOI 10.1007/s12033-011-9451-1; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zhang LC, 2012, GENE, V505, P100, DOI 10.1016/j.gene.2012.05.033; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhu LH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054028, 10.1371/journal.pone.0065680]; Zou BH, 2013, FUNCT PLANT BIOL, V40, P304, DOI 10.1071/FP12253	55	13	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113971	10.1371/journal.pone.0113971	http://dx.doi.org/10.1371/journal.pone.0113971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473954	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500100
J	Yu, JL; Zheng, J; Zhao, XX; Liu, JX; Mao, ZC; Ling, YN; Chen, DN; Chen, C; Hui, LL; Cui, LM; Chen, Y; Jiang, PP; Guan, MX				Yu, Jialing; Zheng, Jing; Zhao, Xiaoxu; Liu, Junxia; Mao, Zhuochao; Ling, Yining; Chen, Danni; Chen, Chao; Hui, Lanlan; Cui, Limei; Chen, Ye; Jiang, Pingping; Guan, Min-Xin			Aminoglycoside Stress Together with the 12S rRNA 1494C > T Mutation Leads to Mitophagy	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; HAIR CELL-DEATH; MITOCHONDRIAL-DNA; NONSYNDROMIC DEAFNESS; C1494T MUTATION; QUALITY-CONTROL; A-SITE; OTOTOXICITY; AUTOPHAGY; TRANSCRIPTION	`Aminoglycosides as modifying factors modulated the phenotypic manifestation of mitochondrial rRNA mutations and the incomplete penetrance of hearing loss. In this report, using cybrids harboring the m. 1494C> T mutation, we showed that gentamycin aggravated mitochondrial dysfunction in a combination of the m. 1494C> T mutation. The m. 1494C> T mutation was responsible for the dramatic reduction in three mtDNA-encoded proteins of H-strand, with the average of 39% reduction, except of the MT-ND6 protein, accompanied with 21% reduction of ATP production and increase in mitochondrial reactive oxygen species, compared with those of control cybrids. After exposure to gentamycin, 35% reduction of mitochondrial ATP production was observed in mutant cybrids with a marked decrease of the mitochondrial membrane potential. More excessive cellular reactive oxygen species was detected with stimulus of gentamycin than those in mutant cells. Under gentamycin and m. 1494C> T stress together, more dysfunctional mitochondria were forced to fuse and exhibited mitophagy via upregulated LC3-B, as a compensatory protective response to try to optimize mitochondrial function, rather than undergo apoptosis. These findings may provide valuable information to further understand of mechanistic link between mitochondrial rRNA mutation, toxicity of AGs and hearing loss.	[Yu, Jialing; Zheng, Jing; Zhao, Xiaoxu; Liu, Junxia; Chen, Danni; Chen, Chao; Hui, Lanlan; Cui, Limei; Chen, Ye; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ye; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Mao, Zhuochao] Zhejiang Univ, Sch Basic Med Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Ling, Yining] Zhejiang Univ, Sch Agr & Biotechonl, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University	Jiang, PP (corresponding author), Zhejiang Univ, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China.	ppjiang@zju.edu.cn	Chen, Ye/D-1164-2015	Chen, Ye/0000-0003-3671-2504; Guan, Min-Xin/0000-0001-5067-6736	973 Program from the Ministry of Science and Technology of China (GMX) [2014CB541704]; Key project from National Natural Science Foundation of China (GMX) [81330024]	973 Program from the Ministry of Science and Technology of China (GMX); Key project from National Natural Science Foundation of China (GMX)	This work was supported by the 973 Program (2014CB541704) from the Ministry of Science and Technology of China (GMX) and Key project (81330024) from National Natural Science Foundation of China (GMX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Chen JF, 2007, GENE, V401, P4, DOI 10.1016/j.gene.2007.06.009; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Darrouzet J, 1974, Rev Laryngol Otol Rhinol (Bord), V95, P601; Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 2005, PHARMACOGENOMICS, V6, P27, DOI 10.1517/14622416.6.1.27; Fischel-Ghodsian N, 2003, EAR HEARING, V24, P303, DOI 10.1097/01.AUD.0000079802.82344.B5; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Pye D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl516; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Rodriguez-Ballesteros M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.042440; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tono T, 2001, ORL-J OTO-RHIN-LARYN, V63, P25, DOI 10.1159/000055702; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Ylikoski J, 2002, HEARING RES, V163, P71, DOI 10.1016/S0378-5955(01)00380-X; Yu JL, 2014, MITOCHONDRION, V14, P18, DOI 10.1016/j.mito.2013.12.004; Zavodszky E, 2013, FEBS LETT, V587, P1988, DOI 10.1016/j.febslet.2013.04.025; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	44	11	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114650	10.1371/journal.pone.0114650	http://dx.doi.org/10.1371/journal.pone.0114650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474306	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500052
J	Bredeson, S; Papaconstantinou, J; Deford, JH; Kechichian, T; Syed, TA; Saade, GR; Menon, R				Bredeson, Sarah; Papaconstantinou, John; Deford, James H.; Kechichian, Talar; Syed, Tariq A.; Saade, George R.; Menon, Ramkumar			HMGB1 Promotes a p38MAPK Associated Non-Infectious Inflammatory Response Pathway in Human Fetal Membranes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROUP BOX PROTEIN-1; PRETERM BIRTH; ALARMIN HMGB1; IN-VITRO; CYTOKINE; DNA; EXPRESSION; PHOSPHORYLATION; CELLS	Objective: Spontaneous preterm birth (PTB) and preterm prelabor rupture of membranes (pPROM) are major pregnancy complications often associated with a fetal inflammatory response. Biomolecular markers of this fetal inflammatory response to both infectious and non-infectious risk factors and their contribution to PTB and pPROM mechanism are still unclear. This study examined fetal membrane production, activation and mechanistic properties of high mobility group box 1 (HMGB1) as a contributor of the non-infectious fetal inflammatory response. Materials and Methods: HMGB1 transcripts and active HMGB1 were profiled in fetal membranes and amniotic fluids collected from PTB and normal term birth. In vitro, normal term not in labor fetal membranes were exposed to lipopolysaccharide (LPS) and water soluble cigarette smoke extract (CSE). HMGB1-transcripts and its protein concentrations were documented by RT-PCR and ELISA. Recombinant HMGB1 treated membranes and media were subjected to RT-PCR for HMGB1 receptors, mitogen activated protein kinase pathway analysis, cytokine levels, and Western blot for p38MAPK. Results: HMGB1 expression and its active forms were higher in PTB and pPROM than normal term membranes and amniotic fluid samples. Both LPS and CSE enhanced HMGB1 expression and release in vitro. Fetal membrane exposure to HMGB1 resulted in increased expression of TLR2 and 4 and dose-dependent activation of p38MAPK-mediated inflammation. Conclusions: HMGB1 increase by fetal membrane cells in response to either oxidative stress or infection can provide a positive feedback loop generating noninfectious inflammatory activation. Activation of p38MAPK by HMGB1 promotes development of the senescence phenotype and senescence associated sterile inflammation. HMGB1 activity is an important regulator of the fetal inflammatory response regardless of infection.	[Bredeson, Sarah; Kechichian, Talar; Syed, Tariq A.; Saade, George R.; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, NHLBI Prote Ctr Airway Inflammat, Galveston, TX 77555 USA; [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, UTMB Biomol Resource Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.	ra2menon@utmb.edu	Zheng, Yun/AAS-1149-2021	Zheng, Yun/0000-0003-4292-9806	dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America	dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America	Funding: The study is conducted using developmental funds provided to Dr. R. Menon by the dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bartling B, 2007, MOL NUTR FOOD RES, V51, P479, DOI 10.1002/mnfr.200600223; Buhimschi CS, 2009, AM J PATHOL, V175, P958, DOI 10.2353/ajpath.2009.090156; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134; Ciucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023766; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dubicke A, 2010, J REPROD IMMUNOL, V84, P86, DOI 10.1016/j.jri.2009.09.010; FORTUNATO SJ, 1994, AM J REPROD IMMUNOL, V32, P184, DOI 10.1111/j.1600-0897.1994.tb01112.x; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Guo ZS, 2013, AM J CANCER RES, V3, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; He ZW, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/596716; Holmlund U, 2007, IMMUNOLOGY, V122, P430, DOI 10.1111/j.1365-2567.2007.02662.x; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Menon R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.051; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; Tang DL, 2011, ANTIOXID REDOX SIGN, V15, P2185, DOI 10.1089/ars.2010.3666; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zicari A, 2008, REPROD SCI, V15, P559, DOI 10.1177/1933719107312560	46	90	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113799	10.1371/journal.pone.0113799	http://dx.doi.org/10.1371/journal.pone.0113799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469638	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700047
J	Guralnick, R; Conlin, T; Deck, J; Stucky, BJ; Cellinese, N				Guralnick, Robert; Conlin, Tom; Deck, John; Stucky, Brian J.; Cellinese, Nico			The Trouble with Triplets in Biodiversity Informatics: A Data-Driven Case against Current Identifier Practices	PLOS ONE			English	Article								The biodiversity informatics community has discussed aspirations and approaches for assigning globally unique identifiers (GUIDs) to biocollections for nearly a decade. During that time, and despite misgivings, the de facto standard identifier has become the ``Darwin Core Triplet'', which is a concatenation of values for institution code, collection code, and catalog number associated with biocollections material. Our aim is not to rehash the challenging discussions regarding which GUID system in theory best supports the biodiversity informatics use case of discovering and linking digital data across the Internet, but how well we can link those data together at this moment, utilizing the current identifier schemes that have already been deployed. We gathered Darwin Core Triplets from a subset of VertNet records, along with vertebrate records from GenBank and the Barcode of Life Data System, in order to determine how Darwin Core Triplets are deployed ``in the wild''. We asked if those triplets follow the recommended structure and whether they provide an easy and unambiguous means to track from specimen records to genetic sequence records. We show that Darwin Core Triplets are often riddled with semantic and syntactic errors when deployed and curated in practice, despite specifications about how to construct them. Our results strongly suggest that Darwin Core Triplets that have not been carefully curated are not currently serving a useful role for relinking data. We briefly consider needed next steps to overcome current limitations.	[Guralnick, Robert; Stucky, Brian J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Guralnick, Robert; Conlin, Tom] Univ Colorado, CU Museum Nat Hist, Boulder, CO 80309 USA; [Deck, John] Univ Calif Berkeley, Berkeley Nat Hist Museums, Berkeley, CA 94720 USA; [Cellinese, Nico] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; State University System of Florida; University of Florida	Guralnick, R (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	robert.guralnick@colorado.edu		Deck, John/0000-0002-5905-1617; Cellinese, Nico/0000-0002-7157-9414	National Science Foundation [DBI-0956371, DBI-0956350, DBI-0956426]	National Science Foundation(National Science Foundation (NSF))	This work was formulated as part of this BiSciCol project (http://biscicol.org/), which was supported by the National Science Foundation (DBI-0956371, DBI-0956350, and DBI-0956426). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; Clark T, 2004, BRIEF BIOINFORM, V5, P59, DOI 10.1093/bib/5.1.59; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Cryer P, 2009, AD PERS ID BIOD INF; Heath T., 2011, LINKED DATA EVOLVING; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page RDM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S5; Paskin N, 2005, DATA SCI J, V4, P12, DOI DOI 10.2481/DSJ.4.12; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Stucky BJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-257; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	13	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114069	10.1371/journal.pone.114069	http://dx.doi.org/10.1371/journal.pone.114069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470125				2022-12-27	WOS:000349128700066
J	Lander, J; Hainz, T; Hirschberg, I; Strech, D				Lander, Jonas; Hainz, Tobias; Hirschberg, Irene; Strech, Daniel			Current Practice of Public Involvement Activities in Biomedical Research and Innovation: A Systematic Qualitative Review	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; GENETIC RESEARCH; COMMUNITY ENGAGEMENT; INFORMED-CONSENT; BLOOD-SAMPLES; ATTITUDES; PARTICIPATION; PERSPECTIVES; BIOBANKING; DELIBERATION	Background: A recent report from the British Nuffield Council on Bioethics associated 'emerging biotechnologies' with a threefold challenge: 1) uncertainty about outcomes, 2) diverse public views on the values and implications attached to biotechnologies and 3) the possibility of creating radical changes regarding societal relations and practices. To address these challenges, leading international institutions stress the need for public involvement activities (PIAs). The objective of this study was to assess the state of PIA reports in the field of biomedical research. Methods: PIA reports were identified via a systematic literature search. Thematic text analysis was employed for data extraction. Results: After filtering, 35 public consultation and 11 public participation studies were included in this review. Analysis and synthesis of all 46 PIA studies resulted in 6 distinguishable PIA objectives and 37 corresponding PIA methods. Reports of outcome translation and PIA evaluation were found in 9 and 10 studies respectively (20% and 22%). The paper presents qualitative details. Discussion: The state of PIAs on biomedical research and innovation is characterized by a broad range of methods and awkward variation in the wording of objectives. Better comparability of PIAs might improve the translation of PIA findings into further policy development. PIA-specific reporting guidelines would help in this regard. The modest level of translation efforts is another pointer to the "deliberation to policy gap". The results of this review could inform the design of new PIAs and future efforts to improve PIA comparability and outcome translation.	[Lander, Jonas; Hainz, Tobias; Hirschberg, Irene; Strech, Daniel] Hannover Med Sch, CELLS, Inst Hist Eth & Philosophy Med, D-30625 Hannover, Germany	Hannover Medical School	Strech, D (corresponding author), Hannover Med Sch, CELLS, Inst Hist Eth & Philosophy Med, Carl Neuberg St 1, D-30625 Hannover, Germany.	strech.daniel@mh-hannover.de		Strech, Daniel/0000-0002-9153-079X	intramural funds of Hannover Medical School; German Research Foundation (DFG) via the grant "Cluster of Excellence REBIRTH - From Regenerative Biology to Reconstructive Therapy" [62, 24102914]	intramural funds of Hannover Medical School; German Research Foundation (DFG) via the grant "Cluster of Excellence REBIRTH - From Regenerative Biology to Reconstructive Therapy"	This project was funded by intramural funds of Hannover Medical School and by the German Research Foundation (DFG) via the grant "Cluster of Excellence 62, REBIRTH - From Regenerative Biology to Reconstructive Therapy" (http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id=24102914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; Abelson J., 2013, J PUBLIC DELIBERATIO, V9; Abelson J, 2007, SOC SCI MED, V64, P2115, DOI 10.1016/j.socscimed.2007.01.013; Abou-Zeid A, 2010, J MED ETHICS, V36, P539, DOI 10.1136/jme.2009.033100; Ahram M, 2013, EUR J HUM GENET, V21, P567, DOI 10.1038/ejhg.2012.213; Al-Qadire MM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-18; [Anonymous], 2009, TIME MAGAZINE; [Anonymous], 2012, MAK DIFF GUID EV PUB; Avard D, 2009, J PUBLIC DELIBERATIO, V5; Avard D., 2008, GENEDIT, V6, P1; Bates BR, 2005, SOC SCI MED, V60, P331, DOI 10.1016/j.socscimed.2004.05.012; Bates BR, 2004, J NATL MED ASSOC, V96, P1051; Bernhardt BA, 2003, AM J MED GENET A, V116A, P315, DOI 10.1002/ajmg.a.10040; Berth H, 2002, Z GESUNDHEITSPSYCHOL, V10, P97; Bombard Y, 2012, PEDIATRICS, V129, P239, DOI 10.1542/peds.2011-2572; Boote J, 2010, HEALTH POLICY, V95, P10, DOI 10.1016/j.healthpol.2009.11.007; Botkin JR, 2012, PEDIATRICS, V129, P231, DOI 10.1542/peds.2011-0970; Canadian Environmental Assessment Agency, 2008, PUBL PART GUID GUID; Conklin A, 2012, HLTH EXPECT; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Dixon-Woods M, 2005, SYNTHESISING QUALITA; European Commission Expert Group on Dealing with Ethical and Regulatory Challenges of International Biobank Research, 2012, BIOB EUR CHALL GOV; European Institute for Public Participation, 2009, PUBL PART EUR INT PE; Godard B, 2007, COMMUNITY GENET, V10, P147, DOI 10.1159/000101756; Godard B, 2010, PUBLIC UNDERST SCI, V19, P469, DOI 10.1177/0963662509104721; Goldenberg AJ, 2009, J PEDIATR-US, V155, P578, DOI 10.1016/j.jpeds.2009.04.034; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Goodin RE, 2006, POLIT SOC, V34, P219, DOI 10.1177/0032329206288152; Gradinger F, 2013, HLTH EXPECT; Haddow G., 2008, Critical Public Health, V18, P139, DOI 10.1080/09581590701824086; Halverson CME, 2012, J MED ETHICS, V38, P561, DOI 10.1136/medethics-2012-100600; International Association for Public Participation, 2007, IAP2 SPECTR PUBL PAR; Isler Malika Roman, 2013, N C Med J, V74, P470; Katz RV, 2007, J NATL MED ASSOC, V99, P1052; Kerath SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-114; Kobayashi E, 2011, CELL TISSUE BANK, V12, P71, DOI 10.1007/s10561-009-9166-8; Kronberger N, 2012, PUBLIC UNDERST SCI, V21, P174, DOI 10.1177/0963662511400331; Marsh V, 2013, SOC SCI MED, V96, P192, DOI 10.1016/j.socscimed.2013.07.028; McCarty CA, 2008, AM J MED GENET A, V146A, P3026, DOI 10.1002/ajmg.a.32559; Melas PA, 2010, J MED ETHICS, V36, P93, DOI 10.1136/jme.2009.032367; Menon D, 2008, HEALTH EXPECT, V11, P282, DOI 10.1111/j.1369-7625.2008.00501.x; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P57, DOI 10.4314/mmj.v20i2.10958; Miller FA, 2013, ACAD MED, V88, P519, DOI 10.1097/ACM.0b013e31828577fe; Molster C, 2013, HEALTH EXPECT, V16, P211, DOI 10.1111/j.1369-7625.2011.00701.x; Molster C, 2012, PUBLIC HEALTH GENOM, V15, P82, DOI 10.1159/000334104; Molyneux CS, 2005, SOC SCI MED, V61, P443, DOI 10.1016/j.socscimed.2004.12.003; Moran R, 2011, INT J TECHNOL ASSESS, V27, P343, DOI 10.1017/S0266462311000559; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Nanz P., 2012, HDB BURGERBETEILIGUN; Nicol D, 2012, PUBLIC UNDERST SCI, V21, P534, DOI 10.1177/0963662511402425; Nisselle A, 2008, AM J MED GENET A, V146A, P2266, DOI 10.1002/ajmg.a.32271; Nuffield Council on Bioethics, 2012, EM BIOT TECHN CHOIC; O'Daniel JM, 2012, GENET MED, V14, P243, DOI 10.1038/gim.2011.29; O'Doherty KC, 2010, PUBLIC HEALTH GENOM, V13, P197, DOI 10.1159/000279621; O'Doherty KC, 2009, PUBLIC HEALTH GENOM, V12, P203, DOI 10.1159/000167801; O'Doherty KC, 2012, SOC SCI MED, V75, P1604, DOI 10.1016/j.socscimed.2012.06.026; Organisation for Economic Co-operation and Development, 2001, CIT PARTN; Organization for Economic Cooperation and Development, 2012, PLANN GUID PUBL ENG; Organization for Economic Cooperation and Development, 2005, EV PUBL PART POL MAK; Pullman D, 2011, GENET MED; RAND Europe, 2010, INV PUBL HEALTHC POL; Roberts LW, 2005, COMPR PSYCHIAT, V46, P27, DOI 10.1016/j.comppsych.2004.07.021; Rothwell E, 2012, SOC SCI MED, V74, P1305, DOI 10.1016/j.socscimed.2011.12.047; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Rowe G, 2000, SCI TECHNOL HUM VAL, V25, P3, DOI 10.1177/016224390002500101; Rowe G, 2004, SCI TECHNOL HUM VAL, V29, P512, DOI 10.1177/0162243903259197; Schulz A, 2003, HEALTH EDUC BEHAV, V30, P151, DOI 10.1177/1090198102251026; Secko DM, 2009, SOC SCI MED, V68, P781, DOI 10.1016/j.socscimed.2008.11.020; Shepherd R, 2007, SOC SCI MED, V65, P377, DOI 10.1016/j.socscimed.2007.03.018; Shippee ND, 2013, HLTH EXPECT; Sturgis P, 2010, PUBLIC UNDERST SCI, V19, P166, DOI 10.1177/0963662508093371; Terry SF, 2012, POPUL HEALTH MANAG, V15, P78, DOI 10.1089/pop.2011.0013; Tupasela A, 2010, SCAND J PUBLIC HEALT, V38, P46, DOI 10.1177/1403494809353824; Ulrich A, 2013, AM J HEALTH BEHAV, V37, P80, DOI 10.5993/AJHB.37.1.9; Wong ML, 2004, COMMUNITY GENET, V7, P44, DOI 10.1159/000080303	76	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113274	10.1371/journal.pone.0113274	http://dx.doi.org/10.1371/journal.pone.0113274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469705	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700020
J	Loria, SF; Prendini, L				Loria, Stephanie F.; Prendini, Lorenzo			Homology of the Lateral Eyes of Scorpiones: A Six-Ocellus Model	PLOS ONE			English	Article							PHYLOGENY; PSEUDOCHACTIDAE; CHELICERATA; NEUROPILS; EVOLUTION	Scorpions possess two types of visual organs, the median and lateral eyes. Both eyes consist of simple ocelli with biconvex lenses that differ in structure and function. There is little variation in the number of median ocelli across the order. Except for a few troglomorphic species in which the median ocelli are absent, all scorpions possess a single pair. In contrast, the number of pairs of lateral ocelli varies from zero to five across Scorpiones and may vary within species. No attempt has been made to homologize lateral ocelli across the order, and their utility in scorpion systematics has been questioned, due to the variation in number. A recent study examined the number of lateral ocelli among various Asian Buthidae C. L. Koch, 1837 and proposed a "five-eye model" for the family. This model has not been examined more broadly within Buthidae, however, nor compared with the patterns of variation observed among other scorpion families. An eyespot, referred to as an accessory lateral eye, situated ventral or posteroventral to the lateral ocelli, has also been reported in some scorpions. Analysis of its structure suggests it serves a nonvisual function. We present the first comparative study of variation in the lateral ocelli across the order Scorpiones, based on examination of a broad range of exemplar species, representing all families, 160 genera (78%), 196 species (9%), and up to 12 individuals per species. We propose a six-ocellus model for Recent scorpions with four accessory ocelli observed in various taxa, homologize the individual ocelli, and correct erroneous counts in the recent literature. We also investigate the presence of the eyespot across scorpions and discover that it is more widespread than previously recognized. Future work should investigate the genetic and developmental mechanisms underlying the formation of the lateral ocelli to test the hypotheses proposed here.	[Loria, Stephanie F.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Loria, Stephanie F.; Prendini, Lorenzo] Amer Museum Nat Hist, Div Invertebrate Zool, Scorp Systemat Res Grp, New York, NY 10024 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Loria, SF (corresponding author), Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.	sloria@amnh.org	Prendini, Lorenzo/AAY-6611-2021	Prendini, Lorenzo/0000-0001-8727-7106	Richard Gilder Graduate School of the American Museum of Natural History; National Science Foundation Graduate Research Fellowship; National Science Foundation Doctoral Dissertation Improvement Grant [DEB 1310855]	Richard Gilder Graduate School of the American Museum of Natural History; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	SFL was supported by a fellowship from the Richard Gilder Graduate School of the American Museum of Natural History and a National Science Foundation Graduate Research Fellowship. Funding for this research was provided by a National Science Foundation Doctoral Dissertation Improvement Grant DEB 1310855 to LP and SFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastawade DB, 2006, STATE FAUNA SERIES, V13, P449; Bitsch C, 2005, CRUSTACEAN ISS, V16, P185, DOI 10.1201/9781420037548.ch8; Botero-Trujillo R, 2012, ZOOTAXA, P63; Botero-Trujillo Ricardo, 2009, P1; Dunlop JA, 2008, PALAEONTOLOGY, V51, P303, DOI 10.1111/j.1475-4983.2007.00749.x; Soleglad Michael E., 2009, Euscorpius, V79, P1; FLEISSNER G, 1977, J COMP PHYSIOL, V118, P101, DOI 10.1007/BF00612340; FRANCKE OF, 1981, J ARACHNOL, V9, P233; GERTSCH W J, 1972, Bulletin of the American Museum of Natural History, V148, P551; Gonzalez-Santillan Edmundo, 2013, Bulletin of the American Museum of Natural History, V382, P1; GONZALEZ-SPONGA M A, 1977, Acta Biologica Venezuelica, V9, P303; Gonzalez-Sponga M.A., 1996, GUIA IDENTIFICAR ESC; Hjelle J.T., 1990, P9; JERAM AJ, 1994, PALAEONTOLOGY, V37, P513; Jeram Andrew J., 1998, P17; KJELLESVIG-WAERING E N, 1986, Palaeontographica Americana, V55, P1; Stathi Iasmi, 2010, Euscorpius, V101, P1; Lehmann T, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-40; LOURENCO W R, 1989, Revue Arachnologique, V8, P159; Lourenco WR, 2012, CR BIOL, V335, P232, DOI 10.1016/j.crvi.2012.02.001; Melzer RR, 2009, J MORPHOL, V270, P1524, DOI 10.1002/jmor.10779; MITCHELL R W, 1968, Annales de Speleologie, V23, P753; Monod L, 2014, CLADISTICS, DOI [10.1111/cia.12067., DOI 10.1111/CIA.12067]; Ochoa JA, 2010, AM MUS NOVIT, P1, DOI 10.1206/707.1; Parker GH, 1887, B MUS COMP ZOOL HARV, V13, P173; Paulus H.F., 1979, P299; Paulus HF, 2000, J ZOOL SYST EVOL RES, V38, P189, DOI 10.1046/j.1439-0469.2000.383152.x; Polis G.A., 1990, P247; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; Prendini L, 2006, ZOOL ANZ, V245, P211, DOI 10.1016/j.jcz.2006.07.001; Root T.M., 1990, P341; SCHLIWA M, 1980, CELL TISSUE RES, V206, P95, DOI 10.1007/BF00233611; Sissom W.D., 1990, P64; Sissom W.D., 1990, P445; SISSOM WD, 1988, J ARACHNOL, V16, P365; SOLEGLAD M E, 1976, Wasmann Journal of Biology, V34, P251; Soleglad M.E., 2012, EUSCORPIUS, V143, P1; Soleglad Michael E., 2003, Euscorpius, V11, P1; Spreitzer A, 2003, ZOOL ANZ, V242, P137, DOI 10.1078/0044-5231-00098; STOCKWELL SA, 1992, J MED ENTOMOL, V29, P407, DOI 10.1093/jmedent/29.3.407; Stockwell SA, 1989, THESIS; Tikader BK, 1983, FAUNA OF INDIA, V3; Vachon M., 1985, Memoires de Biospeologie, V12, P9; Vignoli Valerio, 2009, Bulletin of the American Museum of Natural History, V326, P1; Volschenk ES, 2008, INVERTEBR SYST, V22, P235, DOI 10.1071/IS06054; Volschenk ES, 2008, ZOOL J LINN SOC-LOND, V154, P651, DOI 10.1111/j.1096-3642.2008.00426.x; Warburg M.R., 2013, Arthropods, V2, P150; Warburg M.R., 1990, P224; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928	50	36	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112913	10.1371/journal.pone.0112913	http://dx.doi.org/10.1371/journal.pone.0112913			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470485	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700013
J	Ohmiya, A; Hirashima, M; Yagi, M; Tanase, K; Yamamizo, C				Ohmiya, Akemi; Hirashima, Masumi; Yagi, Masafumi; Tanase, Koji; Yamamizo, Chihiro			Identification of Genes Associated with Chlorophyll Accumulation in Flower Petals	PLOS ONE			English	Article							HARVESTING COMPLEX-II; STAY-GREEN PROTEIN; LEAF SENESCENCE; ARABIDOPSIS; DEGRADATION; PHEOPHORBIDE; BREAKDOWN; BIOSYNTHESIS; EXPRESSION; MUTATIONS	Plants have an ability to prevent chlorophyll accumulation, which would mask the bright flower color, in their petals. In contrast, leaves contain substantial amounts of chlorophyll, as it is essential for photosynthesis. The mechanisms of organ-specific chlorophyll accumulation are unknown. To identify factors that determine the chlorophyll content in petals, we compared the expression of genes related to chlorophyll metabolism in different stages of non-green (red and white) petals (very low chlorophyll content), pale-green petals (low chlorophyll content), and leaves (high chlorophyll content) of carnation (Dianthus caryophyllus L.). The expression of many genes encoding chlorophyll biosynthesis enzymes, in particular Mg-chelatase, was lower in non-green petals than in leaves. Non-green petals also showed higher expression of genes involved in chlorophyll degradation, including STAY-GREEN gene and pheophytinase. These data suggest that the absence of chlorophylls in carnation petals may be caused by the low rate of chlorophyll biosynthesis and high rate of degradation. Similar results were obtained by the analysis of Arabidopsis microarray data. In carnation, most genes related to chlorophyll biosynthesis were expressed at similar levels in pale-green petals and leaves, whereas the expression of chlorophyll catabolic genes was higher in pale-green petals than in leaves. Therefore, we hypothesize that the difference in chlorophyll content between non-green and pale-green petals is due to different levels of chlorophyll biosynthesis. Our study provides a basis for future molecular and genetic studies on organ-specific chlorophyll accumulation.	[Ohmiya, Akemi; Hirashima, Masumi; Yagi, Masafumi; Tanase, Koji; Yamamizo, Chihiro] Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan	National Agriculture & Food Research Organization - Japan	Ohmiya, A (corresponding author), Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Fujimoto 2-1, Tsukuba, Ibaraki 3058519, Japan.	ohmiya@affrc.go.jp	Yagi, Masafumi/S-2830-2019		National Agriculture and Food Research Organization (NARO); JSPS KAKENHI [25292025]	National Agriculture and Food Research Organization (NARO); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported in part by a Grant-in-Aid from the National Agriculture and Food Research Organization (NARO) and JSPS KAKENHI Grant Number 25292025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschan G, 2003, FLORA, V198, P81, DOI 10.1078/0367-2530-00080; Aubry S, 2008, PLANT MOL BIOL, V67, P243, DOI 10.1007/s11103-008-9314-8; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; BEATOR J, 1993, PLANT PHYSIOL, V103, P191, DOI 10.1104/pp.103.1.191; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Croce R, 2012, ADV PHOTOSYNTH RESP, V34, P127, DOI 10.1007/978-94-007-1579-0_6; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Hansson A, 1999, P NATL ACAD SCI USA, V96, P1744, DOI 10.1073/pnas.96.4.1744; Hirashima M, 2009, PLANT CELL PHYSIOL, V50, P719, DOI 10.1093/pcp/pcp035; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Ito T, 2011, CURR OPIN PLANT BIOL, V14, P53, DOI 10.1016/j.pbi.2010.08.013; Jensen PE, 1996, MOL GEN GENET, V250, P383; Juneau P, 2002, PHOTOCHEM PHOTOBIOL, V75, P377, DOI 10.1562/0031-8655(2002)075<0377:RBTSAF>2.0.CO;2; Kannangara CG, 1997, MOL GEN GENET, V254, P85, DOI 10.1007/s004380050394; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; KIM J, 1994, PLANT PHYSIOL, V104, P907, DOI 10.1104/pp.104.3.907; Kruse E, 1997, PLANTA, V202, P235, DOI 10.1007/s004250050124; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Liao Y, 2007, J INTEGR PLANT BIOL, V49, P531, DOI 10.1111/j.1744-7909.2007.00444.x; Lysenko V, 2013, SCI REP-UK, V3, DOI 10.1038/srep03373; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mayak S, 1998, PLANT PHYSIOL BIOCH, V36, P835, DOI 10.1016/S0981-9428(99)80021-7; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ohmiya A, 2013, PLANT BREEDING, V132, P423, DOI 10.1111/pbr.12061; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Pontier D, 2007, J BIOL CHEM, V282, P2297, DOI 10.1074/jbc.M610286200; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Ren GD, 2007, PLANT PHYSIOL, V144, P1429, DOI 10.1104/pp.107.100172; Sakuraba Y, 2014, FEBS LETT IN PRESS; Sakuraba Y, 2014, MOL PLANT, V7, P1288, DOI 10.1093/mp/ssu045; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Sakuta M., 2011, PLANT METABOLISM BIO, P343; Sato Y, 2007, P NATL ACAD SCI USA, V104, P14169, DOI 10.1073/pnas.0705521104; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; Shemer TA, 2008, PLANT PHYSIOL, V148, P108, DOI 10.1104/pp.108.124933; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; WEISS D, 1990, PHYSIOL PLANTARUM, V78, P345, DOI 10.1111/j.1399-3054.1990.tb09046.x; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	46	50	57	10	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113738	10.1371/journal.pone.0113738	http://dx.doi.org/10.1371/journal.pone.0113738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470367	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700040
J	Sung, MW; Park, B; An, SY; Hah, JH; Jung, YH; Choi, HG				Sung, Myung-Whun; Park, Bumjung; An, Soo-Youn; Hah, J. Hun; Jung, Young Ho; Choi, Hyo Geun			Increasing Thyroid Cancer Rate and the Extent of Thyroid Surgery in Korea	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; NECK DISSECTIONS; UNITED-STATES; CARCINOMA; EPIDEMIOLOGY; RISE	Background: It is evident that the rate of thyroid cancer is increasing throughout the world. One reason is increased detection of preclinical small cancers. However, it is not clear whether the increase in thyroid cancer rate is reducing the extent of thyroid surgeries. The purpose of this study was to evaluate the thyroid cancer rate and analyze recent changes in the extent of thyroid cancer surgeries in Korea. Methods: An observational study was conducted using data from Korea's Health Insurance Review and Assessment Service (HIRAS) for thyroidectomy with/without neck dissection, with 228,051 registered patients between 2007 and 2011. Data were categorized by the extent of surgery: unilateral thyroidectomy without neck dissection (UT), bilateral thyroidectomy or radical thyroidectomy without neck dissection (TT), any thyroidectomy with unilateral selective neck dissection (SND), any thyroidectomy with unilateral modified radical neck dissection (MRND), any thyroidectomy with unilateral radical neck dissection (RND), and any thyroidectomy with bilateral neck dissection (BND). Annual rate difference for each surgery was analyzed with a linear by linear association. Results: The absolute numbers of total thyroid surgeries (UT+TT+SND+MRND+RND+BND) were increased from 28539 to 61481. The proportion of patients who underwent only thyroidectomy without neck dissection (UT+TT) decreased from 67.30% to 60.50%, whereas the proportion of patients who underwent neck dissection (SND+MRND+RND+BND) increased from 32.70% to 39.50% during the 5-year study period. Conclusion: Despite the increase in rate of thyroid cancer due to earlier detection, increased rate of neck dissection was noted.	[Sung, Myung-Whun; Hah, J. Hun] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [An, Soo-Youn] Dongnam Inst Radiol & Med Sci DIRAMS, Thyroid Head & Neck Canc Ctr, Dept Otorhinolaryngol Head & Neck Surg, Pusan, South Korea; [Jung, Young Ho] Seoul Natl Univ, Boramae Hosp, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Seoul National University (SNU); Hallym University; Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Seoul National University Hospital	Choi, HG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019; Hah, J. Hun/A-6084-2015	Choi, Hyo Geun/0000-0003-1655-9549; Hah, J. Hun/0000-0002-5110-012X				Baker SR, 2006, EUR J RADIOL, V60, P67, DOI 10.1016/j.ejrad.2006.04.022; Cappiello J, 2005, LARYNGOSCOPE, V115, P259, DOI 10.1097/01.mlg.0000154729.31281.da; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Han MA, 2011, ASIAN PAC J CANCER P, V12, P1657; Hou YY, 2012, OTOL NEUROTOL, V33, P400, DOI 10.1097/MAO.0b013e318248ea56; Ito Y, 2013, ENDOCR J, V60, P113; Kent WDT, 2007, CAN MED ASSOC J, V177, P1357, DOI 10.1503/cmaj.061730; Kim EY, 2011, HEAD NECK-J SCI SPEC, V33, P768, DOI 10.1002/hed.21536; Lee YC, 2013, EUR ARCH OTO-RHINO-L, V270, P2547, DOI 10.1007/s00405-013-2471-7; Leenhardt L, 2004, EUR J ENDOCRINOL, V150, P133, DOI 10.1530/eje.0.1500133; Londero SC, 2013, CANCER EPIDEMIOL, V37, pE1, DOI 10.1016/j.canep.2012.10.011; Mangano JJ, 1996, EUR J CANCER PREV, V5, P75; Miki H, 1998, WORLD J SURG, V22, P99, DOI 10.1007/s002689900356; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Prabhu V, 2012, J LARYNGOL OTOL, V126, P648, DOI 10.1017/S002221511200062X; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; Takada H, 2011, WORLD J SURG, V35, P1560, DOI 10.1007/s00268-011-1133-4; Trocchi P, 2012, LANGENBECK ARCH SURG, V397, P421, DOI 10.1007/s00423-011-0897-1; Xiang J, 2010, J VISC SURG, V147, pE54, DOI 10.1016/j.jviscsurg.2010.02.007; Zhu CR, 2009, THYROID, V19, P1061, DOI 10.1089/thy.2008.0342	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113464	10.1371/journal.pone.0113464	http://dx.doi.org/10.1371/journal.pone.0113464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470609	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700028
J	Takahashi, Y; Kakizaki, H				Takahashi, Yasuhiro; Kakizaki, Hirohiko			Horizontal Eye Position in Thyroid Eye Disease: A Retrospective Comparison with Normal Individuals and Changes after Orbital Decompression Surgery	PLOS ONE			English	Article							INTERPUPILLARY DISTANCE; ETHMOIDAL FORAMINA; NORMAL VALUES; POPULATION; WALL	Objective: To compare horizontal eye positions between proptotic thyroid eye disease patients and normal individuals, and to examine positional changes after orbital decompression surgery in thyroid eye disease patients. Methods: The present case-controlled and retrospective comparative study included 78 proptotic thyroid eye disease patients who underwent bilateral orbital decompression surgery [lateral orbital wall decompression (Group L), 47 patients; medial orbital wall decompression (Group M), 9 patients; and balanced orbital decompression (Group B), 22 patients] and 143 age-matched healthy volunteers as controls. The interpupillary distance was measured to determine horizontal eye positions before and 3 months after surgery in thyroid eye disease patients and was also examined in control eyes. Horizontal eye shifts were calculated by subtracting postoperative from preoperative interpupillary distances. Results: Preoperative interpupillary distances in thyroid eye disease patients were significantly larger than in controls. The interpupillary distances were significantly decreased postoperatively in Groups M and B, but were significantly increased in Group L. The order of the magnitude of the horizontal shifts was Groups M>B>L. Conclusions: Proptotic thyroid eye disease patients preoperatively showed laterally displaced eyes in comparison with controls. However, the eyes shifted medially after the medial orbital wall decompression and the balanced orbital decompression, although the former showed more shift. Medial orbital wall or balanced orbital decompression can be used to correct both lateral and anterior displacement of the eyes.	[Takahashi, Yasuhiro; Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 48011, Japan	Aichi Medical University	Kakizaki, H (corresponding author), Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 48011, Japan.	cosme@d1.dion.ne.jp						Alsuhaibani AH, 2011, OPHTHAL PLAST RECONS, V27, P158, DOI 10.1097/IOP.0b013e3181ef72b3; Beden U, 2007, EUR J OPHTHALMOL, V17, P281, DOI 10.1177/112067210701700301; BERKE RN, 1953, T AM OPHTHAL SOC, V51, P193; Bertelsen TI, 1953, ACTA OPHTHALMOL, V32, P589; Biesman BS, 2000, CURRENT CONCEPTS AES, P99; Fesharaki Hamid, 2012, J Ophthalmic Vis Res, V7, P231; Fichter N, 2013, ORBIT, V32, P239, DOI 10.3109/01676830.2013.788662; Goldberg RA, 2008, THYROID, V18, P989, DOI 10.1089/thy.2008.0033; Gupta VP, 2003, INT J CLIN PRACT, V57, P25; Kakizaki H, 2012, OPHTHAL PLAST RECONS, V28, P66, DOI 10.1097/IOP.0b013e318239321d; Kikkawa DO, 2002, OPHTHALMOLOGY, V109, P1219, DOI 10.1016/S0161-6420(02)01068-0; Krebs C, 2012, NEUROSCIENCE, P151; Lee H, 2011, J CRANIO MAXILL SURG, V39, P606, DOI 10.1016/j.jcms.2011.07.022; Marcovecchio ML, 2013, WORLD REV NUTR DIET, V106, P135, DOI 10.1159/000342545; Mourits MP, 2007, GRAVES ORBITOPATHY M, P69; PRYOR HB, 1969, PEDIATRICS, V44, P973; QUANT JR, 1992, OPTOMETRY VISION SCI, V69, P152, DOI 10.1097/00006324-199202000-00009; Rootman J, 1995, ORBITAL SURG CONCEPT, P192; Shorr N, 2000, OPHTHALMOLOGY, V107, P1459, DOI 10.1016/S0161-6420(00)00241-4; Swan LK, 2005, J FORENSIC SCI, V50, P774; Takahashi Y, 2013, ORBIT, V32, P409, DOI 10.3109/01676830.2013.833256; Takahashi Y, 2011, OPHTHAL PLAST RECONS, V27, P457, DOI 10.1097/IOP.0b013e318222eb82; Takahashi Y, 2011, OPHTHAL PLAST RECONS, V27, P125, DOI 10.1097/IOP.0b013e318201c8fd; Unal M, 2003, OPHTHALMIC PLAST REC, V19, P112, DOI 10.1097/01.IOP.0000056145.71641.F5; Wright K.W., 2003, PEDIAT OPHTHALMOLOGY, P125, DOI DOI 10.1007/978-0-387-21753-6_8	25	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114220	10.1371/journal.pone.0114220	http://dx.doi.org/10.1371/journal.pone.0114220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469505	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700088
J	Fodale, V; Kegulian, NC; Verani, M; Cariulo, C; Azzollini, L; Petricca, L; Daldin, M; Boggio, R; Padova, A; Kuhn, R; Pacifici, R; Macdonald, D; Schoenfeld, RC; Park, H; Isas, JM; Langen, R; Weiss, A; Caricasole, A				Fodale, Valentina; Kegulian, Natalie C.; Verani, Margherita; Cariulo, Cristina; Azzollini, Lucia; Petricca, Lara; Daldin, Manuel; Boggio, Roberto; Padova, Alessandro; Kuhn, Rainer; Pacifici, Robert; Macdonald, Douglas; Schoenfeld, Ryan C.; Park, Hyunsun; Isas, J. Mario; Langen, Ralf; Weiss, Andreas; Caricasole, Andrea			Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy	PLOS ONE			English	Article							N-TERMINAL FRAGMENTS; SECONDARY STRUCTURE; FLANKING SEQUENCES; POSTTRANSLATIONAL MODIFICATIONS; MONOCLONAL-ANTIBODIES; STRUCTURAL FEATURES; DYSTROPHIC NEURITES; EXPANDED HUNTINGTIN; NEURONAL NUCLEI; EXPORT SIGNAL	Background: In Huntington's disease, expansion of a CAG triplet repeat occurs in exon 1 of the huntingtin gene (HTT), resulting in a protein bearing>35 polyglutamine residues whose N-terminal fragments display a high propensity to misfold and aggregate. Recent data demonstrate that polyglutamine expansion results in conformational changes in the huntingtin protein (HTT), which likely influence its biological and biophysical properties. Developing assays to characterize and measure these conformational changes in isolated proteins and biological samples would advance the testing of novel therapeutic approaches aimed at correcting mutant HTT misfolding. Time-resolved Forster energy transfer (TR-FRET)-based assays represent high-throughput, homogeneous, sensitive immunoassays widely employed for the quantification of proteins of interest. TR-FRET is extremely sensitive to small distances and can therefore provide conformational information based on detection of exposure and relative position of epitopes present on the target protein as recognized by selective antibodies. We have previously reported TR-FRET assays to quantify HTT proteins based on the use of antibodies specific for different amino-terminal HTT epitopes. Here, we investigate the possibility of interrogating HTT protein conformation using these assays. Methodology/Principal Findings: By performing TR-FRET measurements on the same samples (purified recombinant proteins or lysates from cells expressing HTT fragments or full length protein) at different temperatures, we have discovered a temperature-dependent, reversible, polyglutamine-dependent conformational change of wild type and expanded mutant HTT proteins. Circular dichroism spectroscopy confirms the temperature and polyglutamine-dependent change in HTTstructure, revealing an effect of polyglutamine length and of temperature on the alpha-helical content of the protein. Conclusions/Significance: The temperature-and polyglutamine-dependent effects observed with TR-FRET on HTT proteins represent a simple, scalable, quantitative and sensitive assay to identify genetic and pharmacological modulators of mutant HTT conformation, and potentially to assess the relevance of conformational changes during onset and progression of Huntington's disease.	[Fodale, Valentina; Verani, Margherita; Cariulo, Cristina; Azzollini, Lucia; Petricca, Lara; Daldin, Manuel; Boggio, Roberto; Padova, Alessandro; Kuhn, Rainer; Weiss, Andreas; Caricasole, Andrea] IRBM Promidis, Rome, Italy; [Kegulian, Natalie C.; Isas, J. Mario; Langen, Ralf] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Pacifici, Robert; Macdonald, Douglas; Schoenfeld, Ryan C.; Park, Hyunsun] CHDI Management CHDI Fdn, Los Angeles, CA USA	University of Southern California	Langen, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	langen@usc.edu; andreas.weiss@evotec.com; a.caricasole@irbm.it	Kegulian, Natalie/AFF-8981-2022	Kegulian, Natalie/0000-0002-8574-1099	CHDI Foundation; Hereditary Disease Foundation; European Community [264508]	CHDI Foundation; Hereditary Disease Foundation; European Community(European Commission)	CHDI Foundation is a privately funded nonprofit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at IRBM Promidis and the University of Southern California under a sponsored research agreement. RL, MJI and NCK are also supported by the Hereditary Disease Foundation. LP has received funding from the European Community's Seventh Framework Programme FP7/2010 under grant agreement no. 264508. The authors listed all contributed to the conception, planning, and direction of the research, including generation, analysis, and interpretation of the data.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; [Anonymous], 1993, CELL, V72, P971; Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Brooks Elizabeth, 2004, V277, P103; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Cui XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05601; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dlugosz M, 2011, J PHYS CHEM B, V115, P11597, DOI 10.1021/jp206373g; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gusella J, 2002, NAT REV GENET, V3, P72, DOI 10.1038/nrg706; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; LANGSETMO K, 1989, BIOCHEMISTRY-US, V28, P3211, DOI 10.1021/bi00434a015; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Liebman SW, 2010, NAT CHEM BIOL, V6, P7, DOI 10.1038/nchembio.279; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Ma K, 2003, BIOCHEM J, V374, P687, DOI 10.1042/BJ20030702; Maat-Schieman MLC, 1999, J NEUROPATH EXP NEUR, V58, P129, DOI 10.1097/00005072-199902000-00003; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; MATHIS G, 1993, CLIN CHEM, V39, P1953; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; O'Rourke JG, 2013, CELL REP, V4, P362, DOI 10.1016/j.celrep.2013.06.034; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	70	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112262	10.1371/journal.pone.0112262	http://dx.doi.org/10.1371/journal.pone.0112262			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464275	Green Submitted, gold, Green Published			2022-12-27	WOS:000345869700012
J	Jahangiri-Noudeh, Y; Akbarpour, S; Lotfaliany, M; Zafari, N; Khalili, D; Tohidi, M; Mansournia, MA; Azizi, F; Hadaegh, F				Jahangiri-Noudeh, Younes; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Zafari, Neda; Khalili, Davood; Tohidi, Maryam; Mansournia, Mohammad Ali; Azizi, Fereidoun; Hadaegh, Farzad			Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; FOLLOW-UP; SECULAR TRENDS; NUTRITION TRANSITION; NATIONAL-HEALTH; OBESITY; WEIGHT; ADULTS; HYPERTENSION	Aims/Hypothesis: To investigate secular trends in cardiovascular disease (CVD) risk factors during a decade of follow-up in a Middle Eastern cohort, and to compare observed trends between diabetic and non-diabetic populations. Methods: In a population of 6181 participants (2622 males and 3559 females), diabetes status and CVD risk factors were evaluated in 4 study phases from 1999-2011. 1045 subjects had type 2 diabetes mellitus at baseline and 5136 participants were diabetes-free. To examine the trends of CVD risk factors, generalized estimation equation models were constructed. The interaction between the diabetes status and each phase of the study was checked in a separate model. Results: During the follow-up period diabetic females significantly gained better control of their blood pressure, serum low density lipoprotein cholesterol and general and central obesity measures compared to non-diabetic counterparts, although 60% of them had high BP and 64% had high serum LDL-C levels till the end of the study. Diabetic males however, experienced significantly better control on their serum LDL-C and general and central obesity measures compared to their non-diabetic controls; but 24% of them were still smoker, 63% had high BP and 60% had high serum LDL-C levels at the end of the follow-up (all Ps(interaction)<0.05). Use of lipid-lowering and antihypertensive medications increased consistently in both diabetic and non-diabetic populations. Conclusions/Interpretation: Although CVD risk factors have been controlled to some extent among diabetic population in Iran, still high numbers of people with diabetes have uncontrolled CVD risk factors that prompt more attention.	[Jahangiri-Noudeh, Younes; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Zafari, Neda; Khalili, Davood; Tohidi, Maryam; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Lotfaliany, Mojtaba/ABB-6325-2020; Khalili, Davood/T-2913-2017; Zafari, Neda/X-7116-2019; hadaegh, farzad/K-2460-2017; Tohidi, Maryam/V-2261-2019	Azizi, Fereidoun/0000-0002-6470-2517; Khalili, Davood/0000-0003-4956-1039; Mansournia, Mohammad Ali/0000-0003-3343-2718; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744; Jahangiri, Younes/0000-0002-3328-2919; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by Grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bozorgmanesh M, 2013, BLOOD PRESSURE, V22, P317, DOI 10.3109/08037051.2013.769294; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; Ehteshami-Afshar S, 2014, ANN HUM BIOL, V41, P249, DOI 10.3109/03014460.2013.853834; Erlich DR, 2014, AM FAM PHYSICIAN, V89, P256; Fagard RH, 2009, DIABETES CARE, V32, pS429, DOI 10.2337/dc09-S354; Ford ES, 2011, DIABETES CARE, V34, P1337, DOI 10.2337/dc10-2251; Ford ES, 2013, CARDIOVASC; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Global Health Observatory Data Repository WHO, 2013, OV OB MEAN BOD MASS; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Ingelsson E, 2009, ARCH INTERN MED, V169, P279, DOI 10.1001/archinternmed.2008.561; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Kheirandish M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-20; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Looker HC, 2001, DIABETES CARE, V24, P1917, DOI 10.2337/diacare.24.11.1917; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Onat A, 2014, CURR PHARM DESIGN, V20, P575, DOI 10.2174/138161282004140213145551; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Rasouli B, 2013, DIABETES CARE, V36, P604, DOI 10.2337/dc12-0913; Ridderstrale M, 2006, J INTERN MED, V259, P314, DOI 10.1111/j.1365-2796.2006.01617.x; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Samaranayaka S, 2013, HLTH SURVEY ENGLAND; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yunqin C, 2010, LIPIDS HLTH DIS, V9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112639	10.1371/journal.pone.0112639	http://dx.doi.org/10.1371/journal.pone.0112639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461381	gold, Green Published			2022-12-27	WOS:000345869700021
J	Li, XM; Fan, T; Song, JJ; Sun, W; Xia, KF; Liao, JP; Zhang, MY				Li, Xiumei; Fan, Tian; Song, Juanjuan; Sun, Wei; Xia, Kuaifei; Liao, Jingping; Zhang, Mingyong			Functional Conservation and Divergence of Four Ginger AP1/AGL9 MADS-Box Genes Revealed by Analysis of Their Expression and Protein-Protein Interaction, and Ectopic Expression of AhFUL Gene in Arabidopsis	PLOS ONE			English	Article							FLORAL HOMEOTIC GENES; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; DNA-BINDING PROPERTIES; FLOWER DEVELOPMENT; ORGAN IDENTITY; DOMAIN PROTEINS; EVOLUTIONARY ANALYSIS; TRANSCRIPTION FACTORS; MOLECULAR EVOLUTION; AP1/SQUA SUBFAMILY	Alpinia genus are known generally as ginger-lilies for showy flowers in the ginger family, Zingiberaceae, and their floral morphology diverges from typical monocotyledon flowers. However, little is known about the functions of ginger MADS-box genes in floral identity. In this study, four AP1/AGL9 MADS-box genes were cloned from Alpinia hainanensis, and protein-protein interactions (PPIs) and roles of the four genes in floral homeotic conversion and in floral evolution are surveyed for the first time. AhFUL is clustered to the AP1lineage, AhSEP4 and AhSEP3b to the SEP lineage, and AhAGL6-like to the AGL6 lineage. The four genes showed conserved and divergent expression patterns, and their encoded proteins were localized in the nucleus. Seven combinations of PPI (AhFUL-AhSEP4, AhFUL-AhAGL6-like, AhFUL-AhSEP3b, AhSEP4-AhAGL6-like, AhSEP4-AhSEP3b, AhAGL6-like-AhSEP3b, and AhSEP3b-AhSEP3b) were detected, and the PPI patterns in the AP1/AGL9 lineage revealed that five of the 10 possible combinations are conserved and three are variable, while conclusions cannot yet be made regarding the other two. Ectopic expression of AhFUL in Arabidopsis thaliana led to early flowering and floral organ homeotic conversion to sepal-like or leaf-like. Therefore, we conclude that the four A. hainanensis AP1/AGL9 genes show functional conservation and divergence in the floral identity from other MADS-box genes.	[Li, Xiumei; Fan, Tian; Song, Juanjuan; Liao, Jingping] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Li, Xiumei; Fan, Tian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sun, Wei] Chinese Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China; [Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou 510650, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Liao, JP (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	liaojp@scbg.ac.cn; zhangmy@scbg.ac.cn	Zhang, Mingyong/GQZ-6217-2022; li, xiu/GXV-1745-2022		South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund; National Natural Science Foundation of China [30870173, 31200176, 30900089, 31272240]; Natural Science Foundation of Guangdong [S2013020012830]	South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund, the National Natural Science Foundation of China (grants 30870173/31200176/30900089/31272240), and the Natural Science Foundation of Guangdong (S2013020012830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2010, FLOWER DEV; ANGENENT GC, 1994, PLANT J, V5, P33, DOI 10.1046/j.1365-313X.1994.5010033.x; Bartlett ME, 2010, NEW PHYTOL, V187, P521, DOI 10.1111/j.1469-8137.2010.03279.x; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Burko Y, 2013, PLANT CELL, V25, P2070, DOI 10.1105/tpc.113.113035; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chanderbali AS, 2006, INT J PLANT SCI, V167, P1075, DOI 10.1086/507586; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chen DH, 2007, PLANTA, V226, P369, DOI 10.1007/s00425-007-0488-0; Chen MK, 2008, PLANT CELL PHYSIOL, V49, P704, DOI 10.1093/pcp/pcn046; Christensen AR, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-4; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; DOYLE JJ, 1994, SYST BIOL, V43, P307; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Ferrario S, 2006, PLANT PHYSIOL, V140, P890, DOI 10.1104/pp.105.072660; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Gu Q, 1998, DEVELOPMENT, V125, P1509; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Hsu WH, 2014, PLANT J, V77, P1, DOI 10.1111/tpj.12363; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Kirchoff B. K., 1988, Aspects of floral development. Proceedings of the double symposium "Floral development: evolutionary aspects and special topics" held at the 14th International Botanical Congress in West Berlin, 24 July-1 Aug. 1987., P45; KIRCHOFF BK, 1991, AM J BOT, V78, P833, DOI 10.2307/2445074; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KOMAKI MK, 1988, DEVELOPMENT, V104, P195; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kramer EM, 2005, CURR OPIN PLANT BIOL, V8, P13, DOI 10.1016/j.pbi.2004.09.019; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li HF, 2011, PLANT CELL, V23, P2536, DOI 10.1105/tpc.111.087262; Li HF, 2010, CELL RES, V20, P299, DOI 10.1038/cr.2009.143; Li QJ, 2001, NATURE, V411, P260; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Litt A, 2003, GENETICS, V165, P821; Litt A, 2007, INT J PLANT SCI, V168, P73, DOI 10.1086/509662; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; Malcomber ST, 2005, TRENDS PLANT SCI, V10, P427, DOI 10.1016/j.tplants.2005.07.008; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Mendes MA, 2013, PLANT CELL, V25, P2560, DOI 10.1105/tpc.112.108688; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; PNUELI L, 1994, PLANT CELL, V6, P175, DOI 10.1105/tpc.6.2.175; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; PURUGGANAN MD, 1995, GENETICS, V140, P345; Reinheimer R, 2009, PLANT CELL, V21, P2591, DOI 10.1105/tpc.109.068239; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Rijpkema AS, 2009, PLANT J, V60, P1, DOI 10.1111/j.1365-313X.2009.03917.x; Ruelens P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3280; Ruokolainen S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-129; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; Shchennikova AV, 2004, PLANT PHYSIOL, V134, P1632, DOI 10.1104/pp.103.036665; Soltis DE, 2002, TRENDS PLANT SCI, V7, P22, DOI 10.1016/S1360-1385(01)02098-2; Soltis DE, 2007, TRENDS PLANT SCI, V12, P358, DOI 10.1016/j.tplants.2007.06.012; Song JJ, 2010, PLANT MOL BIOL REP, V28, P264, DOI 10.1007/s11105-009-0147-7; Song JJ, 2010, MOL BIOL REP, V37, P917, DOI 10.1007/s11033-009-9719-8; Sun W, 2014, ANN BOT-LONDON, V113, P653, DOI 10.1093/aob/mct301; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Theissen G, 2007, ANN BOT-LONDON, V100, P603, DOI 10.1093/aob/mcm143; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Van Tunen A.J., 1993, FLOWERING NEWSLETTER, V16, P33; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; Veron AS, 2007, MOL BIOL EVOL, V24, P670, DOI 10.1093/molbev/ms1197; Viaene T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-148; Wang BG, 2011, J PLANT GROWTH REGUL, V30, P343, DOI 10.1007/s00344-011-9196-x; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xia YM, 2009, J INTEGR PLANT BIOL, V51, P155, DOI 10.1111/j.1744-7909.2008.00782.x; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yockteng R, 2013, MOL BIOL EVOL, V30, P2401, DOI 10.1093/molbev/mst137; Yoo MJ, 2010, INT J PLANT SCI, V171, P121, DOI 10.1086/648986; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoo SK, 2011, PLANT J, V65, P62, DOI 10.1111/j.1365-313X.2010.04402.x; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang WX, 2013, J INTEGR PLANT BIOL, V55, P597, DOI 10.1111/jipb.12075	119	24	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114134	10.1371/journal.pone.0114134	http://dx.doi.org/10.1371/journal.pone.0114134			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461565	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700102
J	Xi, HF; Ma, L; Liu, GT; Wang, N; Wang, JF; Wang, LN; Dai, ZW; Li, SH; Wang, LJ				Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Nian; Wang, Junfang; Wang, Lina; Dai, Zhanwu; Li, Shaohua; Wang, Lijun			Transcriptomic Analysis of Grape (Vitis vinifera L.) Leaves after Exposure to Ultraviolet C Irradiation	PLOS ONE			English	Article							UV-C; CABERNET-SAUVIGNON; ANTIOXIDANT ENZYMES; STRESS RESPONSES; RADIATION; BIOSYNTHESIS; PLANTS; RESVERATROL; GENES; ACCUMULATION	Background: Only a small amount of solar ultraviolet C (UV-C) radiation reaches the Earth's surface. This is because of the filtering effects of the stratospheric ozone layer. Artificial UV-C irradiation is used on leaves and fruits to stimulate different biological processes in plants. Grapes are a major fruit crop and are grown in many parts of the world. Research has shown that UV-C irradiation induces the biosynthesis of phenols in grape leaves. However, few studies have analyzed the overall changes in gene expression in grape leaves exposed to UV-C. Methodology/Principal Findings: In the present study, transcriptional responses were investigated in grape (Vitis vinifera L.) leaves before and after exposure to UV-C irradiation (6 W.m(-2) for 10 min) using an Affymetrix Vitis vinifera (Grape) Genome Array (15,700 transcripts). A total of 5274 differentially expressed probe sets were defined, including 3564 (67.58%) probe sets that appeared at both 6 and 12 h after exposure to UV-C irradiation but not before exposure. A total of 468 (8.87%) probe sets and 1242 (23.55%) probe sets were specifically expressed at these times. The probe sets were associated with a large number of important traits and biological pathways, including cell rescue (i.e., antioxidant enzymes), protein fate (i.e., HSPs), primary and secondary metabolism, and transcription factors. Interestingly, some of the genes involved in secondary metabolism, such as stilbene synthase, responded intensely to irradiation. Some of the MYB and WRKY family transcription factors, such as VvMYBPA1, VvMYB14, VvMYB4, WRKY57-like, and WRKY 65, were also strongly up-regulated (about 100 to 200 fold). Conclusions: UV-C irridiation has an important role in some biology processes, especially cell rescue, protein fate, secondary metabolism, and regulation of transcription. These results opened up ways of exploring the molecular mechanisms underlying the effects of UV-C irradiation on grape leaves and have great implications for further studies.	[Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang; Wang, Lina; Li, Shaohua; Wang, Lijun] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang; Wang, Lina; Li, Shaohua; Wang, Lijun] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Lina; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Dai, Zhanwu] INRA, ISVV, UMR EGFV 1287, Villenave Dornon, France	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Li, SH (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	Shhli@ibcas.ac.cn; ljwang@ibcas.ac.cn	Dai, Zhanwu/V-6274-2019; Dai, Zhanwu/F-7355-2019	Dai, Zhanwu/0000-0002-7625-8337; Dai, Zhanwu/0000-0002-7625-8337; Wang, lina/0000-0001-5526-5979	National Natural Science Foundation of China [31171918]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31171918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais AJ, 2000, AUST J PLANT PHYSIOL, V27, P425; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bonomelli A, 2004, AM J ENOL VITICULT, V55, P51; Borie B, 2004, AM J ENOL VITICULT, V55, P60; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Cantos E, 2001, J AGR FOOD CHEM, V49, P5052, DOI 10.1021/jf010366a; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Colas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043681; COOHILL TP, 1989, PHOTOCHEM PHOTOBIOL, V50, P451, DOI 10.1111/j.1751-1097.1989.tb05549.x; Dai R, 2012, PLANT SCI, V197, P70, DOI 10.1016/j.plantsci.2012.09.004; Darras AI, 2012, PLANT GROWTH REGUL, V68, P343, DOI 10.1007/s10725-012-9722-2; de Costa F, 2013, PLANT PHYSIOL BIOCH, V66, P56, DOI 10.1016/j.plaphy.2013.02.003; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Dhiman N, 2001, VACCINE, V20, P22, DOI 10.1016/S0264-410X(01)00319-X; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fini A, 2012, J PLANT PHYSIOL, V169, P929, DOI 10.1016/j.jplph.2012.02.014; FREDERICK JE, 1993, PHOTOCHEM PHOTOBIOL, V57, P175, DOI 10.1111/j.1751-1097.1993.tb02274.x; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gonzalez-Aguilar GA, 2001, INT J FOOD SCI TECH, V36, P767, DOI 10.1046/j.1365-2621.2001.00522.x; Grotewold E, 2005, TRENDS PLANT SCI, V10, P57, DOI 10.1016/j.tplants.2004.12.009; Huyskens-Keil S, 2011, J APPL BOT FOOD QUAL, V84, P229; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang F, 2009, GENE, V430, P12, DOI 10.1016/j.gene.2008.09.036; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kondo S, 2011, PLANT GROWTH REGUL, V64, P83, DOI 10.1007/s10725-010-9539-9; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; Kuniga T, 2011, ACTA HORTIC, V907, P81; Lee MJ, 2014, J SCI FOOD AGR, V94, P197, DOI 10.1002/jsfa.6227; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Mackerness SAH, 1999, J PHOTOCH PHOTOBIO B, V48, P180; MADRONICH S, 1995, AMBIO, V24, P143; Navarro S, 2008, FOOD CHEM, V108, P182, DOI 10.1016/j.foodchem.2007.10.060; Nawkar GM, 2013, INT J MOL SCI, V14, P1608, DOI 10.3390/ijms14011608; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Petit AN, 2009, J EXP BOT, V60, P1155, DOI 10.1093/jxb/ern361; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Poubol J, 2012, ACTA HORTIC, V943, P235, DOI 10.17660/ActaHortic.2012.943.31; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Rodoni LM, 2012, J FOOD SCI, V77, pC632, DOI 10.1111/j.1750-3841.2012.02746.x; Romanazzi G, 2006, PLANT DIS, V90, P445, DOI 10.1094/PD-90-0445; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Selma MV, 2008, J AGR FOOD CHEM, V56, P9990, DOI 10.1021/jf8018062; Shiu CT, 2005, J EXP BOT, V56, P2851, DOI 10.1093/jxb/eri277; Singh KB, 2012, CURR OPIN PLANT BIOL, V5, P430; STAPLETON AE, 1992, PLANT CELL, V4, P1353, DOI 10.1105/tpc.4.11.1353; Stevens C, 2004, CROP PROT, V23, P551, DOI 10.1016/j.cropro.2003.10.007; Takeuchi Y, 1996, J PLANT PHYSIOL, V147, P589, DOI 10.1016/S0176-1617(96)80050-2; Todorova D, 2013, BIOTECHNOL BIOTEC EQ, V27, P3798, DOI 10.5504/BBEQ.2013.0012; Tohidi-Moghadam HR, 2012, POL J ENVIRON STUD, V21, P1417; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vivier MA, 2002, TRENDS BIOTECHNOL, V20, P472, DOI 10.1016/S0167-7799(02)02058-9; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang LJ, 2013, J AGR FOOD CHEM, V61, P7135, DOI 10.1021/jf401220m; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	61	15	16	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113772	10.1371/journal.pone.0113772	http://dx.doi.org/10.1371/journal.pone.0113772			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464056	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700052
J	Xue, B; Zhang, C; Wang, YH; Wang, JC; Zhang, J; Lu, M; Li, GD; Cao, ZH; Huang, QS				Xue, Bai; Zhang, Cheng; Wang, Yihan; Wang, Jincheng; Zhang, Jien; Lu, Min; Li, Guodong; Cao, Zhizhong; Huang, Qingshan			A Novel Controlled-Release System for Antibacterial Enzyme Lysostaphin Delivery Using Hydroxyapatite/Chitosan Composite Bone Cement	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; MORPHOGENETIC PROTEIN SYSTEM; HYDROGEN-ION CONCENTRATION; DONOR SITE; TISSUE; DIFFERENTIATION; SCAFFOLDS; CHITOSAN; DEFECTS; DESIGN	In this work, a lysostaphin-loaded, control-released, self-setting and injectable porous bone cement with efficient protein delivery was prepared by a novel setting method using hydroxyapatite/chitosan (HA/CS) composite scaffold. The cement samples were made through cementitious reactions by mixing solid powder, a mixture of HA/CS composite particles, lysostaphin, Ca(OH)(2), CaCO3 and NaHCO3, with setting liquid containing citric acid, acetic acid, NaH2PO4, CaCl2 and poloxamer. The setting parameters of the cement samples were determined. The results showed that the final setting time was 96.6 +/- 5.2 min and the pH value increased from approximately 6.2 to nearly 10 during the setting process and the porosity was 34% at the end. And the microstructure and composition were detected by scanning electron microscopy (SEM), x-ray diffraction and Fourier transform-infrared spectroscopy. For the release behavior of lysostaphin loaded in the cement sample, the in vitro cement extract experiment indicated that about 94.2 +/- 10.9% of the loaded protein was released before day 8 and the in vivo Qdot 625 fluorescence tracking experiment showed that the loaded protein released slower than the free one. Then the biocompatibility of the cement samples was evaluated using the methylthiazol tetrazolium assay, SEM and hematoxylin-eosin staining, which suggested good biocompatibility of cement samples with MC 3T3-E1 cells and subcutaneous tissues of mice. Finally the antibacterial activity assay indicated that the loaded lysostaphin had good release ability and strong antibacterial enzymatic activity against methicillin-resistant Staphylococcus aureus. Collectively, all the results suggested that the lysostaphin-loaded self-setting injectable porous bone cement released the protein in a controlled and effective way and the protein activity was well retained during the setting and releasing process. Thus this bone cement can be potentially applied as a combination of artificial bone substitute and controlled-release system for delivery of lysostaphin to treat bone defects and infections.	[Xue, Bai; Zhang, Cheng; Wang, Jincheng; Huang, Qingshan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Cheng; Wang, Yihan; Zhang, Jien; Lu, Min; Li, Guodong; Huang, Qingshan] Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai 201206, Peoples R China; [Cao, Zhizhong] Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai 200433, Peoples R China	Fudan University; Naval Medical University	Cao, ZH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Stomatol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	caozhizh@263.net; qshuang@fudan.edu.cn			Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs" [2008ZX09101-032]; Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality [12DZ1940500]; Key Medical Projects of Science and Technology Commission of Shanghai Municipality [13411951202]; Shanghai Engineering Research Center Of Industrial Microorganisms [13DZ2252000]	Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs"; Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality; Key Medical Projects of Science and Technology Commission of Shanghai Municipality; Shanghai Engineering Research Center Of Industrial Microorganisms	This work has been funded by the Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs" (No. 2008ZX09101-032), the Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality (No. 12DZ1940500), the Key Medical Projects of Science and Technology Commission of Shanghai Municipality (No. 13411951202) and Shanghai Engineering Research Center Of Industrial Microorganisms (No. 13DZ2252000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018; BLOCK JE, 1995, MED HYPOTHESES, V45, P27, DOI 10.1016/0306-9877(95)90195-7; Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E; BRODA E, 1959, EXP CELL RES, V18, P171, DOI 10.1016/0014-4827(59)90301-5; Byrne FM, 2011, INJURY, V42, pS3, DOI 10.1016/S0020-1383(11)70125-5; Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089; Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008; Climo MW, 1998, ANTIMICROB AGENTS CH, V42, P1355, DOI 10.1128/AAC.42.6.1355; DOMONKOS J, 1959, J NEUROCHEM, V4, P238, DOI 10.1111/j.1471-4159.1959.tb13199.x; Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X; GIANNOUDIS PV, 2011, INJURY S5, V42, pS1; Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007; Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008; GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7; [官叶斌 Guan Yebin], 2011, [高校地质学报, Geological Journal of China Universities], V17, P46; HIDALGO DA, 1995, PLAST RECONSTR SURG, V96, P585, DOI 10.1097/00006534-199509000-00010; Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291; Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; KLINE SA, 1994, ANAL BIOCHEM, V217, P329, DOI 10.1006/abio.1994.1127; Kobayashi H, 2007, NANO LETT, V7, P1711, DOI 10.1021/nl0707003; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Komath M, 2000, B MATER SCI, V23, P135, DOI 10.1007/BF02706555; Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009; Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414; Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1; Martins MA, 2008, J COLLOID INTERF SCI, V318, P210, DOI 10.1016/j.jcis.2007.10.008; Miao JJ, 2011, BIOMATERIALS, V32, P9557, DOI 10.1016/j.biomaterials.2011.08.080; MIRELMAN D, 1967, J BIOL CHEM, V242, P3414; MONGAR JL, 1958, J PHYSIOL-LONDON, V140, P272, DOI 10.1113/jphysiol.1958.sp005933; Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; OTSUKA M, 1994, J PHARM SCI, V83, P255, DOI 10.1002/jps.2600830229; Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007; Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Sasso RC, 1998, J BONE JOINT SURG AM, V80A, P631, DOI 10.2106/00004623-199805000-00003; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Standardization IOf, 1978, DENT ZINC PHOSPH CEM; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Teng SH, 2009, J BIOMED MATER RES B, V90B, P275, DOI 10.1002/jbm.b.31283; TENHUISEN KS, 1994, J MATER SCI-MATER M, V5, P291, DOI 10.1007/BF00122399; Tigli RS, 2009, J BIOMAT SCI-POLYM E, V20, P1899, DOI 10.1163/156856208X399945; Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375; Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252; Verron E, 2012, ACTA BIOMATER, V8, P3541, DOI 10.1016/j.actbio.2012.06.022; Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0; Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F; Yamaguchi I, 2000, KEY ENG MATER, V192-1, P673, DOI 10.4028/www.scientific.net/KEM.192-195.673; Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305; Zhao D, 2007, INORG CHEM IND, V39, P23	55	17	17	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113797	10.1371/journal.pone.0113797	http://dx.doi.org/10.1371/journal.pone.0113797			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464506	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700054
J	Zacharewicz, E; Della Gatta, P; Reynolds, J; Garnham, A; Crowley, T; Russell, AP; Lamon, S				Zacharewicz, Evelyn; Della Gatta, Paul; Reynolds, John; Garnham, Andrew; Crowley, Tamsyn; Russell, Aaron P.; Lamon, Severine			Identification of MicroRNAs Linked to Regulators of Muscle Protein Synthesis and Regeneration in Young and Old Skeletal Muscle	PLOS ONE			English	Article							RESISTANCE EXERCISE; CELL-PROLIFERATION; EXPRESSION; AGE; MTOR; CONTRIBUTES; ACTIVATION; MICROARRAY; MYOSTATIN; TARGET	Background: Over the course of ageing there is a natural and progressive loss of skeletal muscle mass. The onset and progression of age-related muscle wasting is associated with an attenuated activation of Akt-mTOR signalling and muscle protein synthesis in response to anabolic stimuli such as resistance exercise. MicroRNAs (miRNAs) are novel and important post-transcriptional regulators of numerous cellular processes. The role of miRNAs in the regulation of muscle protein synthesis following resistance exercise is poorly understood. This study investigated the changes in skeletal muscle miRNA expression following an acute bout of resistance exercise in young and old subjects with a focus on the miRNA species predicted to target Akt-mTOR signalling. Results: Ten young (24.2 +/- 0.9 years) and 10 old (66.6 +/- 1.1 years) males completed an acute resistance exercise bout known to maximise muscle protein synthesis, with muscle biopsies collected before and 2 hours after exercise. We screened the expression of 754 miRNAs in the muscle biopsies and found 26 miRNAs to be regulated with age, exercise or a combination of both factors. Nine of these miRNAs are highly predicted to regulate targets within the Akt-mTOR signalling pathway and 5 miRNAs have validated binding sites within the 3' UTRs of several members of the Akt-mTOR signalling pathway. The miR-99/100 family of miRNAs notably emerged as potentially important regulators of skeletal muscle mass in young and old subjects. Conclusion: This study has identified several miRNAs that were regulated with age or with a single bout of resistance exercise. Some of these miRNAs were predicted to influence Akt-mTOR signalling, and therefore potentially skeletal muscle mass. These miRNAs should be considered as candidate targets for in vivo modulation.	[Zacharewicz, Evelyn; Della Gatta, Paul; Garnham, Andrew; Russell, Aaron P.; Lamon, Severine] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr, Burwood, Vic, Australia; [Reynolds, John] Deakin Univ, Fac Hlth, Biostat Unit, Burwood, Vic, Australia; [Crowley, Tamsyn] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Crowley, Tamsyn] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Waurn Ponds, Vic, Australia	Deakin University; Deakin University; Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lamon, S (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr, Burwood, Vic, Australia.	severine.lamon@deakin.edu.au	Zacharewicz, Evelyn/T-5989-2019; Reynolds, John/D-2591-2013	Reynolds, John/0000-0002-8825-8625; Della Gatta, Paul/0000-0003-2231-8370; Russell, Aaron/0000-0002-7323-9501; Crowley, Tamsyn/0000-0002-3698-8917; Lamon, Severine/0000-0002-3271-6551	Deakin University [RM24071]; Swiss National Science Foundation [PBLAP3-131833, PBLAP3-137051]; Deakin University Central Research Grants Scheme [RM24183]	Deakin University; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deakin University Central Research Grants Scheme	SL is supported by an Alfred Deakin Postdoctoral Fellowship from Deakin University (RM24071) and by the Swiss National Science Foundation (PBLAP3-131833 and PBLAP3-137051). SL and APR are supported by the Deakin University Central Research Grants Scheme (RM24183). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125, DOI 10.1152/jappl.1993.75.5.2125; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Drummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079; Hausser J, 2013, TIMESCALES BOTTLENEC; Honda N, 2012, J IMMUNOL, V188, P3323, DOI 10.4049/jimmunol.1100876; Hou T, 2014, BR J CANC; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Jia L, 2014, INT J MOL SCI, V15, P296, DOI 10.3390/ijms15010296; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kashiyama K, 2012, J INVEST DERMATOL, V132, P1597, DOI 10.1038/jid.2012.22; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; Lamon S, 2014, PFLUGERS ARCH EUROPE, P1; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Payne R., 2011, INTRO GENSTAT COMMAN; Phillips SM, 2012, MEAT SCI, V92, P174, DOI 10.1016/j.meatsci.2012.04.027; Rivas DA, 2014, FASEB J; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Russell AP, 2010, CLIN EXP PHARMACOL P, V37, P378, DOI 10.1111/j.1440-1681.2009.05265.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Stefanetti RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00030; Tang HB, 2012, FASEB J, V26, P4710, DOI 10.1096/fj.11-197467; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wei F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-81; Welle S, 2002, EXP GERONTOL, V37, P833, DOI 10.1016/S0531-5565(02)00025-6; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021	51	60	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114009	10.1371/journal.pone.0114009	http://dx.doi.org/10.1371/journal.pone.0114009			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460913	Green Published, Green Accepted, gold			2022-12-27	WOS:000345869700080
J	Zhu, X; Leung, HCM; Chin, FYL; Yiu, SM; Quan, GR; Liu, B; Wang, YD				Zhu, Xiao; Leung, Henry C. M.; Chin, Francis Y. L.; Yiu, Siu Ming; Quan, Guangri; Liu, Bo; Wang, Yadong			PERGA: A Paired-End Read Guided De Novo Assembler for Extending Contigs Using SVM and Look Ahead Approach	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; SHORT DNA-SEQUENCES; BACTERIAL GENOME; ALGORITHMS; ALIGNMENT; MILLIONS; ERROR; IDBA; SNP	Since the read lengths of high throughput sequencing (HTS) technologies are short, de novo assembly which plays significant roles in many applications remains a great challenge. Most of the state-of-the-art approaches base on de Bruijn graph strategy and overlap-layout strategy. However, these approaches which depend on k-mers or read overlaps do not fully utilize information of paired-end and single-end reads when resolving branches. Since they treat all single-end reads with overlapped length larger than a fix threshold equally, they fail to use the more confident long overlapped reads for assembling and mix up with the relative short overlapped reads. Moreover, these approaches have not been special designed for handling tandem repeats (repeats occur adjacently in the genome) and they usually break down the contigs near the tandem repeats. We present PERGA (Paired-End Reads Guided Assembler), a novel sequence-reads-guided de novo assembly approach, which adopts greedy-like prediction strategy for assembling reads to contigs and scaffolds using paired-end reads and different read overlap size ranging from O-max to O-min to resolve the gaps and branches. By constructing a decision model using machine learning approach based on branch features, PERGA can determine the correct extension in 99.7% of cases. When the correct extension cannot be determined, PERGA will try to extend the contig by all feasible extensions and determine the correct extension by using look-ahead approach. Many difficult-resolved branches are due to tandem repeats which are close in the genome. PERGA detects such different copies of the repeats to resolve the branches to make the extension much longer and more accurate. We evaluated PERGA on both Illumina real and simulated datasets ranging from small bacterial genomes to large human chromosome, and it constructed longer and more accurate contigs and scaffolds than other state-of-the-art assemblers. PERGA can be freely downloaded at https://github.com/hitbio/PERGA.	[Zhu, Xiao; Liu, Bo; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China; [Leung, Henry C. M.; Chin, Francis Y. L.; Yiu, Siu Ming] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Quan, Guangri] Harbin Inst Technol, Natl Pilot Sch Software, Weihai, Shandong, Peoples R China	Harbin Institute of Technology; University of Hong Kong; Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn	Yiu, Siu Ming/C-1843-2009	Yiu, Siu Ming/0000-0002-3975-8500; Zhu, Xiao/0000-0001-9339-0033	National Nature Science Foundation of China [61173085, 61102149, 11171086]; National High-Tech Research and Development Program (863) of China [2012AA020404, 2012AA02A602, 2012AA02A604]; Hong Kong GRF [HKU 7111/12E, HKU 719709E, 719611E]; Shenzhen Basic Research Project [JCYJ20120618143038947]; Outstanding Researcher Award [102009124]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Hong Kong GRF(Hong Kong Research Grants Council); Shenzhen Basic Research Project; Outstanding Researcher Award	This work was partially supported by the National Nature Science Foundation of China (61173085, 61102149 and 11171086), the National High-Tech Research and Development Program (863) of China (2012AA020404, 2012AA02A602 and 2012AA02A604), the Hong Kong GRF (HKU 7111/12E, HKU 719709E and 719611E), the Shenzhen Basic Research Project (NO.JCYJ20120618143038947), and the Outstanding Researcher Award (102009124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Burrows M, 1994, BLOCK SORTING LOSSLE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114253	10.1371/journal.pone.0114253	http://dx.doi.org/10.1371/journal.pone.0114253			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461763	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700123
J	Melendreras, SG; Martinez-Camblor, P; Menendez, A; Bravo-Mendoza, C; Gonzalez-Vidal, A; Coto, E; Diaz-Corte, C; Ruiz-Ortega, M; Lopez-Larrea, C; Suarez-Alvarez, B				Melendreras, Susana G.; Martinez-Camblor, Pablo; Menendez, Aurora; Bravo-Mendoza, Cristina; Gonzalez-Vidal, Ana; Coto, Eliecer; Diaz-Corte, Carmen; Ruiz-Ortega, Marta; Lopez-Larrea, Carlos; Suarez-Alvarez, Beatriz			Soluble Co-Signaling Molecules Predict Long-Term Graft Outcome in Kidney-Transplanted Patients	PLOS ONE			English	Article							ANTI-CD40 MONOCLONAL-ANTIBODY; T-CELL-ACTIVATION; COSTIMULATORY MOLECULES; ACUTE REJECTION; RENAL-DISEASE; CD30 LEVELS; LIGAND; 4-1BB; PROLIFERATION; INFLAMMATION	Co-signaling molecules are responsible for full T-cell activation after solid organ transplantation. Their increased expression can lead to the release of a soluble form that can modulate the immune response post-transplantation. We analyzed the presence of co-signaling molecules (sCD30, sCD40, sCD137, sCTLA-4, sCD80, sCD28, sCD40L, sPD-1, and sPD-L1) in serum from kidney-transplanted patients (n=59) obtained at different times (before transplantation, and 15 days, 3 months and 1 year post-transplantation) and their contribution to graft outcome was evaluated using principal component analysis. Before transplantation, high levels of soluble co-signaling molecules (mainly sCD30, sCD137 and sCD40) were detected in all patients. These molecules were modulated soon after receiving an allograft but never attained similar levels to those of healthy controls. A signature based on the determination of six soluble co-stimulatory (sCD30, sCD40, sCD137 and sCD40L) and co-inhibitory (sPD-1 and sPD-L1) molecules at 3 months post-transplantation allowed a group of patients to be identified (27.12%) with a worse long-term graft outcome. Patients with high levels of soluble molecules showed a progressive and gradual deterioration of kidney function (increased creatinine and proteinuria levels and decreased estimated glomerular filtration rate) over time and a higher risk of graft loss at 6 years post-transplantation than patients with low levels of these molecules (62.55% versus 5.14%, p<0.001). Thus, our data show an aberrant expression of soluble co-signaling molecules in kidney-transplanted patients whose quantification at 3 months post-transplantation might be a useful biomarker of immune status and help to predict long-term graft evolution.	[Melendreras, Susana G.; Diaz-Corte, Carmen] Hosp Univ Cent Asturias, Dept Nephrol, Oviedo, Spain; [Melendreras, Susana G.] Hosp Son Llatzer, Dept Nephrol, Palma De Mallorca, Spain; [Martinez-Camblor, Pablo; Gonzalez-Vidal, Ana] Oficina Invest Biosanitaria Asturias OIB FICYT, Oviedo, Spain; [Martinez-Camblor, Pablo] Univ Autonoma Chile, Santiago, Chile; [Menendez, Aurora; Bravo-Mendoza, Cristina; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Coto, Eliecer] Hosp Univ Cent Asturias, Genet Mol Lab Med, Oviedo, Spain; [Ruiz-Ortega, Marta; Suarez-Alvarez, Beatriz] Univ Autonoma Madrid, Fdn Jimenez Diaz, Inst Invest Sanitaria, Cellular Biol Renal Dis Lab, Madrid, Spain; [Coto, Eliecer; Diaz-Corte, Carmen; Ruiz-Ortega, Marta; Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; Hospital Universitari Son Llatzer; Universidad Autonoma de Chile; Central University Hospital Asturias; Central University Hospital Asturias; Autonomous University of Madrid; Fundacion Jimenez Diaz	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain.	inmuno@hca.es; beatriz.suarez@fjd.es	Stefanadis, Christodoulos/ABH-2232-2020; Ruiz-Ortega, Marta/D-3584-2012; Camblor, Pablo Martinez/Z-4834-2019; Ortega, Marta Ruiz/AAN-2136-2020; Martinez-Camblor, Pablo/Q-1715-2015; RG, SMABSS/N-3322-2018; ruiz-ortega, marta/D-3584-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Ruiz-Ortega, Marta/0000-0002-1495-6535; Camblor, Pablo Martinez/0000-0001-7845-3905; Ortega, Marta Ruiz/0000-0002-1495-6535; RG, SMABSS/0000-0001-9944-3861; ruiz-ortega, marta/0000-0002-1403-2690; Lopez-Larrea, Carlos/0000-0001-9988-1730; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Plan Nacional de I+D+I; Fondo de Investigaciones Sanitaria-Fondos (FIS); FEDER European Union [PI12/02587]; Red de Investigacion Renal REDinREN [RD06/0016/1006, RD12/0021]; Institute Carlos III, Spain [002, 012, 018, 021]	Plan Nacional de I+D+I; Fondo de Investigaciones Sanitaria-Fondos (FIS); FEDER European Union(European Commission); Red de Investigacion Renal REDinREN; Institute Carlos III, Spain	This work was supported by Plan Nacional de I+D+I 2008-2011, Spanish grants from the Fondo de Investigaciones Sanitaria-Fondos (FIS), FEDER European Union (PI12/02587), and the Red de Investigacion Renal REDinREN RD06/0016/1006 and RD12/0021 (groups 002, 012, 018 and 021) from the Institute Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Cao J, 2012, INT IMMUNOPHARMACOL, V14, P585, DOI 10.1016/j.intimp.2012.08.004; Capece D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/926321; Cervelli C, 2009, TRANSPL P, V41, P1159, DOI 10.1016/j.transproceed.2009.03.077; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen YL, 2012, TRANSPLANTATION, V94, P911, DOI 10.1097/TP.0b013e31826784ad; Contin C, 2003, IMMUNOLOGY, V110, P131, DOI 10.1046/j.1365-2567.2003.01716.x; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060391; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053797; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Domingues EMFL, 2010, CLIN TRANSPLANT, V24, P821, DOI 10.1111/j.1399-0012.2009.01182.x; Esposito P, 2012, CELL IMMUNOL, V278, P10, DOI 10.1016/j.cellimm.2012.06.007; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Grinyo JM, 2013, EXPERT OPIN DRUG SAF, V12, P111, DOI 10.1517/14740338.2013.748747; Her M, 2009, LUPUS, V18, P501, DOI 10.1177/0961203308099176; Huang JP, 2013, J IMMUNOL, V190, P6250, DOI 10.4049/jimmunol.1300022; Huang JP, 2012, BLOOD, V120, P3030, DOI 10.1182/blood-2012-05-427799; Kamali K, 2009, EXP CLIN TRANSPLANT, V7, P237; Kashizuka H, 2005, TRANSPLANTATION, V79, P1045, DOI 10.1097/01.TP.0000161665.35243.21; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Kovac J, 2010, TRANSPL P, V42, P4043, DOI 10.1016/j.transproceed.2010.09.050; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lisowska KA, 2012, J CLIN IMMUNOL, V32, P189, DOI 10.1007/s10875-011-9603-x; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; Meijers RWJ, 2014, TRANSPL INT, V27, P1272, DOI 10.1111/tri.12416; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Pelzl S, 2002, TRANSPLANTATION, V73, P3, DOI 10.1097/00007890-200201150-00002; Rajakariar R, 2005, AM J TRANSPLANT, V5, P1922, DOI 10.1111/j.1600-6143.2005.00966.x; Riella LV, 2011, KIDNEY INT SUPPL, V1, P25, DOI 10.1038/kisup.2011.8; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rodriguez LM, 2007, HUM IMMUNOL, V68, P652, DOI 10.1016/j.humimm.2007.05.004; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Song MY, 2011, J IMMUNOTHER, V34, P297, DOI 10.1097/CJI.0b013e318210ed0e; Steward-Tharp SM, 2010, ANN NY ACAD SCI, V1183, P123, DOI 10.1111/j.1749-6632.2009.05124.x; Susal C, 2011, TRANSPLANTATION, V91, P1364, DOI 10.1097/TP.0b013e31821aba74; Tanaka K, 2007, J IMMUNOL, V179, P5204, DOI 10.4049/jimmunol.179.8.5204; Velasquez SY, 2013, TRANSPLANTATION, V96, P154, DOI 10.1097/TP.0b013e318296fd69; Vinay DS, 2011, CELL MOL IMMUNOL, V8, P281, DOI 10.1038/cmi.2010.82; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Watanabe M, 2013, AM J TRANSPLANT, V13, P1976, DOI 10.1111/ajt.12330; Wong CK, 2008, J CLIN IMMUNOL, V28, P36, DOI 10.1007/s10875-007-9137-4; Wu YL, 2012, INT J BIOL SCI, V8, P1420, DOI 10.7150/ijbs.5273; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yeung MY, 2011, AM J TRANSPLANT, V11, P2012, DOI 10.1111/j.1600-6143.2011.03727.x; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910	52	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113396	10.1371/journal.pone.0113396	http://dx.doi.org/10.1371/journal.pone.0113396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478957	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200020
J	Fu, F; Li, B; Dai, M; Hu, SJ; Li, X; Xu, CH; Wang, B; Yang, B; Tang, MX; Dong, XZ; Fei, Z; Shi, XT				Fu, Feng; Li, Bing; Dai, Meng; Hu, Shi-Jie; Li, Xia; Xu, Can-Hua; Wang, Bing; Yang, Bin; Tang, Meng-Xing; Dong, Xiu-Zhen; Fei, Zhou; Shi, Xue-Tao			Use of Electrical Impedance Tomography to Monitor Regional Cerebral Edema during Clinical Dehydration Treatment	PLOS ONE			English	Article							BRAIN; MANNITOL; HEMORRHAGE; PRESSURE; THERAPY; INJURY; MODEL; HEAD	Objective: Variations of conductive fluid content in brain tissue (e. g. cerebral edema) change tissue impedance and can potentially be measured by Electrical Impedance Tomography (EIT), an emerging medical imaging technique. The objective of this work is to establish the feasibility of using EIT as an imaging tool for monitoring brain fluid content. Design: a prospective study. Setting: In this study EIT was used, for the first time, to monitor variations in cerebral fluid content in a clinical model with patients undergoing clinical dehydration treatment. The EIT system was developed in house and its imaging sensitivity and spatial resolution were evaluated on a saline-filled tank. Patients: 23 patients with brain edema. Interventions: The patients were continuously imaged by EIT for two hours after initiation of dehydration treatment using 0.5 g/kg intravenous infusion of mannitol for 20 minutes. Measurement and Main Results: Overall impedance across the brain increased significantly before and after mannitol dehydration treatment (p=0.0027). Of the all 23 patients, 14 showed high-level impedance increase and maintained this around 4 hours after the dehydration treatment whereas the other 9 also showed great impedance gain during the treatment but it gradually decreased after the treatment. Further analysis of the regions of interest in the EIT images revealed that diseased regions, identified on corresponding CT images, showed significantly less impedance changes than normal regions during the monitoring period, indicating variations in different patients' responses to such treatment. Conclusions: EIT shows potential promise as an imaging tool for real-time and non-invasive monitoring of brain edema patients.	[Fu, Feng; Dai, Meng; Xu, Can-Hua; Yang, Bin; Dong, Xiu-Zhen; Shi, Xue-Tao] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Li, Bing; Hu, Shi-Jie; Li, Xia; Wang, Bing; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China; [Tang, Meng-Xing] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Air Force Military Medical University; Air Force Military Medical University; Imperial College London	Dong, XZ (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.	dongxiuzhen@fmmu.edu.cn; feizhou@fmmu.edu.cn; shixuetao@fmmu.edu.cn		Yang, Bin/0000-0001-9687-5968; Fu, Feng/0000-0002-4286-5227	National Key Technology R&D Program of China [2011BAI08B13, 2012BAI20B02]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work is partially supported by National Key Technology R&D Program of China under grant No. 2011BAI08B13 and 2012BAI20B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellani G, 2012, CURR OPIN CRIT CARE, V18, P29, DOI 10.1097/MCC.0b013e32834eb47d; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Burgess A, 2014, J CONTROL RELEASE, V192, P243, DOI 10.1016/j.jconrel.2014.07.051; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Dai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055020; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Frerichs I, 2013, PHYSIOL MEAS, V34, P567, DOI 10.1088/0967-3334/34/6/567; Gibson A, 2000, PHYSIOL MEAS, V21, P45, DOI 10.1088/0967-3334/21/1/306; Gilad O, 2009, NEUROIMAGE, V47, P514, DOI 10.1016/j.neuroimage.2009.04.085; Gregson BA, 2001, J NEUROL NEUROSUR PS, V70, P138; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Ho ML, 2012, AM J ROENTGENOL, V199, pW258, DOI 10.2214/AJR.11.8081; Holder DS, 1996, PHYSIOL MEAS, V17, pA179, DOI 10.1088/0967-3334/17/4A/022; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Li JB, 2014, IEEE T BIO-MED ENG, V61, P254, DOI 10.1109/TBME.2013.2288133; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Marmarou A, 2003, ACT NEUR S, V86, P7; Nguyen GT, 2013, NEUROIMAGE-CLIN, V2, P658, DOI 10.1016/j.nicl.2013.04.004; On NH, 2011, PHARM RES-DORDR, V28, P2505, DOI 10.1007/s11095-011-0478-6; Sadleir RJ, 2001, IEEE T BIO-MED ENG, V48, P484, DOI 10.1109/10.915715; Shi XT, 2005, P ANN INT IEEE EMBS, P1492, DOI 10.1109/IEMBS.2005.1616714; Tang T, 2010, ANN BIOMED ENG, V38, P2733, DOI 10.1007/s10439-010-0003-9; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Wang K, 2009, CHINESE MED J-PEKING, V122, P1501, DOI 10.3760/cma.j.issn.0366-6999.2009.13.005; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007	32	33	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113202	10.1371/journal.pone.0113202	http://dx.doi.org/10.1371/journal.pone.0113202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474474	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500077
J	Lino, VTS; Portela, MC; Camacho, LAB; Atie, S; Lima, MJB; Rodrigues, NCP; Barros, MBD; Andrade, MKD				Saraiva Lino, Valeria Teresa; Portela, Margareth Crisostomo; Bastos Camacho, Luiz Antonio; Atie, Soraya; Barbosa Lima, Maria Jose; Pinheiro Rodrigues, Nadia Cristina; de Lima Barros, Monica Bastos; de Noronha Andrade, Monica Kramer			Screening for Depression in Low-Income Elderly Patients at the Primary Care Level: Use of the Patient Health Questionnaire-2	PLOS ONE			English	Article							MAJOR DEPRESSION; VALIDITY; PHQ-2; RECOMMENDATIONS; PREVALENCE; VALIDATION; MORBIDITY; GENDER; LIFE	Introduction: Depression is one of the most common mental disorders and a leading cause of disability worldwide. It constitutes a serious public health problem, particularly among elderly individuals. Most depressed elderly patients are treated by primary care (PC) physicians. The "Patient Health Questionnaire" (PHQ-2) is an instrument used for the detection of depression in PC settings. Objective: Evaluate the performance of the PHQ-2 in a low-income and uneducated elderly PC population. Methods: A non-probabilistic population sample of 142 individuals was selected from the healthcare unit's users >= 60 years. Criterion validity was assessed by estimating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the PHQ-2 in comparison with the structured interview using the DSM-IV. The estimates of sensitivity and specificity were obtained from varying cut-offs of the PHQ-2 score. A Receiver Operator Characteristic (ROC) curve was constructed and the area under the curve (AUC) was calculated. Results: The group was predominantly female (73.9%), with low education level (mean 3 years of schooling). The mean age was 72.5 years old. The prevalence of depression was 26.1%. The best values of sensitivity (0.74), specificity (0.77), PPV (0.50) e NPV (0.90) were obtained with score equal to 1. The AUC was 0.77, indicating a modest performance of the test accuracy. Conclusion: The simplicity of the PHQ-2 is an advantage for its use in PC. The high NPV indicated that 90% of those who tested negative would not need additional tests. However, the low PPV indicated that the PHQ-2 is not sufficient to screen for depression. The application of the instrument could be the first step of the screening, that would include a second step to all those with positive tests formerly.	[Saraiva Lino, Valeria Teresa; Portela, Margareth Crisostomo; Bastos Camacho, Luiz Antonio; Atie, Soraya; Barbosa Lima, Maria Jose; Pinheiro Rodrigues, Nadia Cristina; de Lima Barros, Monica Bastos; de Noronha Andrade, Monica Kramer] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Lino, VTS (corresponding author), Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil.	valerialino@ensp.fiocruz.br	Portela, Margareth C/G-6699-2012; Lino, Valeria/ADI-4254-2022	Portela, Margareth C/0000-0002-9858-9276; 				Abramson J, 2009, WINPEPI PEPI WINDOWS; Almeida N, 2004, SOC SCI MED, V59, P1339, DOI 10.1016/j.socscimed.2003.11.037; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Barcelos-Ferreira R, 2010, INT PSYCHOGERIATR, V22, P712, DOI 10.1017/S1041610210000463; Blay SL, 2007, AM J GERIAT PSYCHIAT, V15, P790, DOI 10.1097/JGP.0b013e3180654179; Carvalho M, 2012, INTEGRATED TERRITORY; Castro-Costa E, 2008, REV BRAS PSIQUIATR, V30, P5; Chagas MHN, 2011, AGING MENT HEALTH, V15, P838, DOI 10.1080/13607863.2011.569482; Cutler CB, 2007, ARCH WOMEN MENT HLTH, V10, P277, DOI 10.1007/s00737-007-0202-z; de Souza ER, 2008, CIENC SAUDE COLETIVA, V13, P1153, DOI 10.1590/S1413-81232008000400011; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; First M.B., 2014, STRUCTURED CLIN INTE; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Mitchell AJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P285, DOI 10.1159/000318295; National Collaborating Center for Mental Health, 2010, NICE GUID MAN TREAT; Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x; Osorio FL, 2012, INT J PSYCHIAT MED, V44, P141, DOI 10.2190/PM.44.2.e; Park M, 2011, PSYCHIAT CLIN N AM, V34, P469, DOI 10.1016/j.psc.2011.02.009; Patel V, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P115; Phelan E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-63; Richardson TM, 2010, AM J GERIAT PSYCHIAT, V18, P1116, DOI 10.1097/JGP.0b013e3181dd1c26; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer Robert L, 1999, PATIENT HLTH QUESTIO; Steffens DC, 2009, INT PSYCHOGERIATR, V21, P879, DOI 10.1017/S1041610209990044; Suominen K, 2004, INT J GERIATR PSYCH, V19, P35, DOI 10.1002/gps.1031; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113778	10.1371/journal.pone.0113778	http://dx.doi.org/10.1371/journal.pone.0113778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25473845	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500090
J	Singh, A; Ladusingh, L				Singh, Akansha; Ladusingh, Laishram			Prevalence and Determinants of Tobacco Use in India: Evidence from Recent Global Adult Tobacco Survey Data	PLOS ONE			English	Article								Background: Tobacco use in India is characterized by a high prevalence of smoking and smokeless tobacco use, with dual use also contributing a noticeable proportion. In the context of such a high burden of tobacco use, this study examines the regional variations, and socioeconomic, demographic and other correlates of smoking, smokeless tobacco and dual use of tobacco in India. Methods and Findings: We analyzed a cross sectional, nationally representative sample of individuals from the Global Adult Tobacco Survey in India (2009-10), which covered 69,296 individuals aged 15 years and above. The current tobacco use in three forms, namely, smoking only, smokeless tobacco use only, and both smoking and smokeless tobacco use were considered as outcomes in this study. Descriptive statistics, cross tabulations and multinomial logistic regression analysis were adopted as analytical tools. Smokeless tobacco use was the major form of tobacco use in India followed by smoking and dual tobacco use. Tobacco use was higher among males, the less educated, the poor, and the rural population in India. Respondents lacking knowledge of health hazards of tobacco had higher prevalence of tobacco use in each form. The prevalence of different forms of tobacco use varies significantly by states. The prevalence of tobacco use increases concomitantly with age among females. Middle-aged adultmales had higher prevalence of tobacco use. Age, education and region were found to be significant determinants of all forms of tobacco use. Adults from the poor household had significantly higher risk of consuming smokeless tobacco. Lack of awareness about the selected hazards of tobacco significantly affects tobacco use. Conclusions: There is an urgent need to curb the use of tobacco among the subgroups of population with higher prevalence. Tobacco control policies in India should adopt a targeted, population-based approach to control and reduce tobacco consumption in the country.	[Singh, Akansha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Ladusingh, Laishram] Int Inst Populat Sci, Dept Math Demog & Stat, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Singh, A (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	akanshasinghiips@gmail.com	SINGH, AKANSHA/ABB-2447-2020	SINGH, AKANSHA/0000-0002-3443-4590				Arora M, 2005, INDIAN PEDIATR, V42, P850; Gajalakshmi V, 2010, TOB USE INSIGHTS, V3, P23; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Indian Institute of Population Sciences (IIPS), 2010, GLOB AD TOB SURV IND; International Institute for Population Sciences (IIPS) & Macro International, 2000, NAT FAM HLTH SURV NF, VI; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kaur J, 2011, INDIAN J PUBLIC HLTH, V55, P220, DOI DOI 10.4103/0019-557X.89941; National Sample Survey Organization (NSSO), 1997, 52 ROUND NAT SAMPL S; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Reddy KS, 2004, REPORT TOBACCO CONTR; Sinha Dhirendra N, 2011, Indian J Public Health, V55, P169, DOI 10.4103/0019-557X.89946; Srivastava A., 2004, NATL HOUSEHOLD SURVE; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2019, WHO REPORT GLOBAL TO	15	73	73	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114073	10.1371/journal.pone.0114073	http://dx.doi.org/10.1371/journal.pone.0114073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474196	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500111
J	Wang, X; Xu, J; Zhu, YX; Li, JK; Zhou, S; Tian, SL; Xiang, YC; Liu, XM; Zheng, Y; Pan, T				Wang, Xi; Xu, Jing; Zhu, Yuexing; Li, Jiukun; Zhou, Si; Tian, Shunliang; Xiang, Yucheng; Liu, Xingmo; Zheng, Ying; Pan, Tao			Biomechanical Analysis of a Newly Developed Shape Memory Alloy Hook in a Transforaminal Lumbar Interbody Fusion (TLIF) In Vitro Model	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; CORROSION BEHAVIOR; SPINAL-FUSION; POSTERIOR; COMPLICATIONS; STABILITY; SEGMENTS	Objective: The objective of this biomechanical study was to evaluate the stability provided by a newly developed shape memory alloy hook (SMAH) in a cadaveric transforaminal lumbar interbody fusion (TLIF) model. Methods: Six human cadaveric spines (L1-S2) were tested in an in vitro flexibility experiment by applying pure moments of +/- 8 Nm in flexion/extension, left/right lateral bending, and left/right axial rotation. After intact testing, a TLIF was performed at L4-5. Each specimen was tested for the following constructs: unilateral SMAH (USMAH); bilateral SMAH (BSMAH); unilateral pedicle screws and rods (UPS); and bilateral pedicle screws and rods (BPS). The L3-L4, L4-L5, and L5-S1 range of motion (ROM) were recorded by a Motion Analysis System. Results: Compared to the other constructs, the BPS provided the most stability. The UPS significantly reduced the ROM in extension/flexion and lateral bending; the BSMAH significantly reduced the ROM in extension/flexion, lateral bending, and axial rotation; and the USMAH significantly reduced the ROM in flexion and left lateral bending compared with the intact spine (p<0.05). The USMAH slightly reduced the ROM in extension, right lateral bending and axial rotation (p<0.05). Stability provided by the USMAH compared with the UPS was not significantly different. ROMs of adjacent segments increased in all fixed constructs (p. 0.05). Conclusions: Bilateral SMAH fixation can achieve immediate stability after L4-5 TLIF in vitro. Further studies are required to determine whether the SMAH can achieve fusion in vivo and alleviate adjacent segment degeneration.	[Wang, Xi; Xu, Jing; Zhu, Yuexing; Li, Jiukun; Xiang, Yucheng; Liu, Xingmo; Pan, Tao] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Si; Tian, Shunliang] Guilin Med Coll, Dept Anat, Guilin, Peoples R China; [Zheng, Ying] Guangdong Gen Hosp, Dept Nutr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guilin Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Pan, T (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China.	Pantao_sysu@163.com			International Program of Project 985, Sun Yat-Sen University	International Program of Project 985, Sun Yat-Sen University	This works was supported by the International Program of Project 985, Sun Yat-Sen University, http://202.116.66.140/Item/4433.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad M, 2002, BIO-MED MATER ENG, V12, P225; BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603; Cakir B, 2009, SPINE, V34, P1287, DOI 10.1097/BRS.0b013e3181a136ab; Carroll WM, 2003, J BIOMED MATER RES A, V67A, P1123, DOI 10.1002/jbm.a.10099; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Cho TK, 2014, J NEUROL SURG PART A, V75, P270, DOI 10.1055/s-0033-1349331; Chrastil J, 2012, J AM ACAD ORTHOP SUR, V20, P283, DOI 10.5435/JAAOS-20-05-283; Christensen A, 2014, EUR SPINE J, V23, P1137, DOI 10.1007/s00586-014-3238-6; CLOSKEY RF, 1993, SPINE, V18, P1011, DOI 10.1097/00007632-199306150-00010; Cole CD, 2009, CURR REV MUSCULOSKE, V2, P118, DOI 10.1007/s12178-009-9053-8; Driscoll M, 2011, MED BIOL ENG COMPUT, V49, P1437, DOI 10.1007/s11517-011-0801-8; Faundez AA, 2008, J SPINAL DISORD TECH, V21, P175, DOI 10.1097/BSD.0b013e318074bb7d; Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2; Fu LJ, 2014, SPINE, V39, P805, DOI 10.1097/BRS.0000000000000283; Harms J G, 1998, Oper Orthop Traumatol, V10, P90, DOI 10.1007/s00064-006-0112-7; Hatakeyama S, 2011, INT J NEPHROL, V2011; Humphreys SC, 2001, SPINE, V26, P567; Javernick Matthew A, 2003, Am J Orthop (Belle Mead NJ), V32, P344; Kawakita Eiji, 2012, Open Orthop J, V6, P239, DOI 10.2174/1874325001206010239; Lau D, 2011, J CLIN NEUROSCI, V18, P624, DOI 10.1016/j.jocn.2010.09.004; Li HF, 2014, J MATER SCI-MATER M, V25, P1249, DOI 10.1007/s10856-014-5158-8; Lowe TG, 2002, J SPINAL DISORD TECH, V15, P31, DOI 10.1097/00024720-200202000-00005; Mavrogenis AF, 2014, EUR J ORTHOP SURG TR, V1, P111, DOI DOI 10.1007/s00590-014-1421-4; Niesche M, 2014, CLIN NEUROL NEUROSUR, V124, P25, DOI 10.1016/j.clineuro.2014.06.020; Rohlmann A, 2007, EUR SPINE J, V16, P1223, DOI 10.1007/s00586-006-0292-8; Ryhanen J, 1997, J BIOMED MATER RES, V35, P451; Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0; Schmoelz W, 2003, J SPINAL DISORD TECH, V16, P418, DOI 10.1097/00024720-200308000-00015; Sengupta D, 2013, ADV ORTHOP, V2013, DOI 10.1155/2013/738252; Sethi A, 2011, SPINE J, V11, P863, DOI 10.1016/j.spinee.2011.06.015; Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123; Soh J, 2013, ASIAN SPINE J, V7, P273, DOI 10.4184/asj.2013.7.4.273; Suk KS, 2000, SPINE, V25, P1843; Tormenti MJ, 2012, J NEUROSURG-SPINE, V16, P44, DOI 10.3171/2011.9.SPINE11373; Tsitsopoulos PP, 2012, J SPINAL DISORD TECH, V25, pE240, DOI 10.1097/BSD.0b013e31824c820c; Wang Y, 2010, EUR SPINE J, V19, P394, DOI 10.1007/s00586-009-1207-2; Xie YZ, 2012, ORTHOPEDICS, V35, pE1517, DOI 10.3928/01477447-20120919-22; Xu H, 2013, NEUROSURGERY, V73, P198, DOI 10.1227/01.neu.0000430320.39870.f7; Xue HM, 2012, SPINE J, V12, P209, DOI 10.1016/j.spinee.2012.01.010; Yan DL, 2008, EUR SPINE J, V17, P1311, DOI 10.1007/s00586-008-0739-1; YANG PJ, 1992, CHINESE MED J-PEKING, V105, P312; YANG SW, 1986, SPINE, V11, P937; Zhang Hui, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P1128	43	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114326	10.1371/journal.pone.0114326	http://dx.doi.org/10.1371/journal.pone.0114326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474112	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500014
J	Foveau, B; Van Der Kraak, L; Beauchemin, N; Albrecht, S; LeBlanc, AC				Foveau, Benedicte; Van Der Kraak, Lauren; Beauchemin, Nicole; Albrecht, Steffen; LeBlanc, Andrea C.			Inflammation-Induced Tumorigenesis in Mouse Colon Is Caspase-6 Independent	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; AXON DEGENERATION; SELF-ACTIVATION; HUMAN NEURONS; CANCER CELLS; LAMIN-A; APOPTOSIS; CLEAVAGE	Caspases play an important role in maintaining tissue homeostasis. Active Caspase-6 (Casp6) is considered a novel therapeutic target against Alzheimer disease (AD) since it is present in AD pathological brain lesions, associated with age-dependent cognitive decline, and causes age-dependent cognitive impairment in the mouse brain. However, active Casp6 is highly expressed and activated in normal human colon epithelial cells raising concerns that inhibiting Casp6 in AD may promote colon carcinogenesis. Furthermore, others have reported rare mutations of Casp6 in human colorectal cancers and an effect of Casp6 on apoptosis and metastasis of colon cancer cell lines. Here, we investigated the role of Casp6 in inflammation-associated azoxymethane/dextran sulfate sodium (AOM/DSS) colon cancer in Casp6-overexpressing and -deficient mice. In wild-type mice, AOM/DSS-induced tumors had significantly higher Casp6 mRNA, protein and activity levels compared to normal adjacent colon tissues. Increased human Casp6 or absence of Casp6 expression in mice colon epithelial cells did not change colonic tumor multiplicity, burden or distribution. Nevertheless, the incidence of hyperplasia was slightly reduced in human Casp6-overexpressing colons and increased in Casp6 null colons. Overexpression of Casp6 did not affect the grade of the tumors while all tumors in heterozygous or homozygous Casp6 null colons were high grade compared to only 50% high grade in wild-type mice. Casp6 levels did not alter cellular proliferation and apoptosis. These results suggest that Casp6 is unlikely to be involved in colitis-associated tumors.	[Foveau, Benedicte; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Foveau, Benedicte; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Dept Biochem, Dept Med, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University	LeBlanc, AC (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	andrea.leblanc@mcgill.ca			Jewish General Hospital Ride to Conquer Cancer Fund; Canadian Foundation of Innovation; Canadian Institutes of Health Research (CIHR) [MOP-243413-BCA-CGAG-45097]; JGH Foundation	Jewish General Hospital Ride to Conquer Cancer Fund; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); JGH Foundation	This work was supported by a research grant from the Jewish General Hospital Ride to Conquer Cancer Fund, The Canadian Foundation of Innovation, Canadian Institutes of Health Research (CIHR) MOP-243413-BCA-CGAG-45097, and the JGH Foundation to ALB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Chan JY, 2008, CANCER BIOL THER, V7, P1305, DOI 10.4161/cbt.7.8.6302; Chan JY, 2009, ANTICANCER RES, V29, P3043; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Godefroy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079313; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Grossmann J, 2001, GASTROENTEROLOGY, V120, P79, DOI 10.1053/gast.2001.20879; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LeBlanc AC, 2014, CELL DEATH DIFFER, V21, P696, DOI 10.1038/cdd.2013.194; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Lee JW, 2006, APMIS, V114, P646, DOI 10.1111/j.1600-0463.2006.apm_417.x; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Suboj P, 2012, PHARMACOLOGY, V89, P91, DOI 10.1159/000335659; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tounekti O, 2004, J NEUROCHEM, V89, P561, DOI 10.1111/j.1471-4159.2004.02349.x; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Wang QS, 1998, CARCINOGENESIS, V19, P2001, DOI 10.1093/carcin/19.11.2001; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810	51	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114270	10.1371/journal.pone.0114270	http://dx.doi.org/10.1371/journal.pone.0114270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470254	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700095
J	Maisch, T; Eichner, A; Spath, A; Gollmer, A; Konig, B; Regensburger, J; Baumler, W				Maisch, Tim; Eichner, Anja; Spaeth, Andreas; Gollmer, Anita; Koenig, Burkhard; Regensburger, Johannes; Baeumler, Wolfgang			Fast and Effective Photodynamic Inactivation of Multiresistant Bacteria by Cationic Riboflavin Derivatives	PLOS ONE			English	Article							SINGLET OXYGEN; PSEUDOMONAS-AERUGINOSA; PORPHYRIN DERIVATIVES; RESISTANCE; THERAPY; COLI; PHOTOINACTIVATION; PHOTOSENSITIZERS; INFECTION; CANDIDA	Photodynamic inactivation of bacteria (PIB) proves to be an additional method to kill pathogenic bacteria. PIB requires photosensitizer molecules that effectively generate reactive oxygen species like singlet oxygen when exposed to visible light. To allow a broad application in medicine, photosensitizers should be safe when applied in humans. Substances like vitamin B2, which are most likely safe, are known to produce singlet oxygen upon irradiation. In the present study, we added positive charges to flavin derivatives to enable attachment of these molecules to the negatively charged surface of bacteria. Two of the synthesized flavin derivatives showed a high quantum yield of singlet oxygen of approximately 75%. Multidrug resistant bacteria like MRSA (Methicillin resistant Staphylococcus aureus), EHEC (enterohemorrhagic Escherichia coli), Pseudomonas aeruginosa, and Acinetobacter baumannii were incubated with these flavin derivatives in vitro and were subsequently irradiated with visible light for seconds only. Singlet oxygen production in bacteria was proved by detecting its luminescence at 1270 nm. After irradiation, the number of viable bacteria decreased up to 6 log(10) steps depending on the concentration of the flavin derivatives and the light dosimetry. The bactericidal effect of PIB was independent of the bacterial type and the corresponding antibiotic resistance pattern. In contrast, the photosensitizer concentration and light parameters used for bacteria killing did not affect cell viability of human keratinocytes (therapeutic window). Multiresistant bacteria can be safely and effectively killed by a combination of modified vitamin B2 molecules, oxygen and visible light, whereas normal skin cells survive. Further work will include these new photosensitizers for topical application to decolonize bacteria from skin and mucosa.	[Maisch, Tim; Eichner, Anja; Gollmer, Anita; Regensburger, Johannes; Baeumler, Wolfgang] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Spaeth, Andreas; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Eichner, A (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	anja.eichner@klinik.uni-regensburg.de	Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022; Koenig, Burkhard/O-8172-2019	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850	German Research Foundation [DFG-RE-3323/2-1, DFG-GO-2340/1-1]; Bavarian Research Foundation [BFS AZ 952-10]	German Research Foundation(German Research Foundation (DFG)); Bavarian Research Foundation	Johannes Regensburger and Anita Gollmer are supported by grants of the German Research Foundation (DFG-RE-3323/2-1 and DFG-GO-2340/1-1, respectively). Part of the study was supported by a grant of the Bavarian Research Foundation (BFS AZ 952-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2011, VIRULENCE, V2, P144, DOI 10.4161/viru.2.2.15014; Alves E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-70; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Baumler W, 2012, PHOTOCH PHOTOBIO SCI, V11, P107, DOI 10.1039/c1pp05142c; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; Boyle-Vavra S, 2001, ANTIMICROB AGENTS CH, V45, P280, DOI 10.1128/AAC.45.1.280-287.2001; Bradley DG, 2006, J AGR FOOD CHEM, V54, P6016, DOI 10.1021/jf053264j; Cerqueira L, 2013, BIOFOULING, V29, P829, DOI 10.1080/08927014.2013.807913; CHAPPLE RM, 1992, ARCH MICROBIOL, V157, P242, DOI 10.1007/BF00245157; Cieplik F, 2013, FREE RADICAL BIO MED, V65, P477, DOI 10.1016/j.freeradbiomed.2013.07.031; Eichner A, 2013, PHOTOCH PHOTOBIO SCI, V12, P135, DOI 10.1039/c2pp25164g; EXON JH, 1984, VET HUM TOXICOL, V26, P508; FDA, 2002, CLASS 3 SPEC CONTR G; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Food and Nutrition Board IoM, 1998, RIB DIET REF INT THI; Garcez AS, 2008, J ENDODONT, V34, P138, DOI 10.1016/j.joen.2007.10.020; Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09; Goldberg M, 2013, MICROBE MAGAZIN, V8, P307; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Kashiwabuchi RT, 2012, ARQ BRAS OFTALMOL, V75, P423, DOI 10.1590/S0004-27492012000600011; Komerik N, 2003, ANTIMICROB AGENTS CH, V47, P932, DOI 10.1128/AAC.47.3.932-940.2003; Krylov V, 2013, VIRUSES-BASEL, V5, P15, DOI 10.3390/v5010015; Kuhn R, 1935, BER DTSCH CHEM GES, V68, P1282, DOI 10.1002/cber.19350680711; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2009, J APPL MICROBIOL, V107, P1569, DOI 10.1111/j.1365-2672.2009.04342.x; Maisch T, 2007, P NATL ACAD SCI USA, V104, P7223, DOI 10.1073/pnas.0611328104; Maisch T, 2011, LASER SURG MED, V43, P176, DOI 10.1002/lsm.20970; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; NITZAN Y, 1995, PHOTOCHEM PHOTOBIOL, V62, P342, DOI 10.1111/j.1751-1097.1995.tb05279.x; Oliveira A, 2009, J APPL MICROBIOL, V106, P1986, DOI 10.1111/j.1365-2672.2009.04168.x; Page AV, 2013, MED CLIN N AM, V97, P681, DOI 10.1016/j.mcna.2013.04.001; Prates RA, 2011, J ANTIMICROB CHEMOTH, V66, P1525, DOI 10.1093/jac/dkr160; Ragas X, 2010, LASER SURG MED, V42, P384, DOI 10.1002/lsm.20922; Regensburger J, 2012, EXP DERMATOL, V21, P135, DOI 10.1111/j.1600-0625.2011.01414.x; Remucal CK, 2011, ENVIRON SCI TECHNOL, V45, P5230, DOI 10.1021/es200411a; Schafer M, 1998, INT J RADIAT BIOL, V74, P249, DOI 10.1080/095530098141636; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Sharma SK, 2011, CURR PHARM DESIGN, V17, P1303, DOI 10.2174/138161211795703735; SNELLINGS WM, 1984, TOXICOL APPL PHARM, V75, P105, DOI 10.1016/0041-008X(84)90081-4; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Thakuri P S, 2011, Nepal Med Coll J, V13, P281; Wainwright M, 2010, LETT APPL MICROBIOL, V50, P486, DOI 10.1111/j.1472-765X.2010.02825.x; Wigle DT, 2007, J TOXICOL ENV HEAL B, V10, P3, DOI 10.1080/10937400601034563; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	50	75	76	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e111792	10.1371/journal.pone.0111792	http://dx.doi.org/10.1371/journal.pone.0111792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469700	Green Published, gold			2022-12-27	WOS:000349128700006
J	Mhashal, AR; Roy, S				Mhashal, Anil R.; Roy, Sudip			Effect of Gold Nanoparticle on Structure and Fluidity of Lipid Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SILVER NANOPARTICLES; COMPUTER-SIMULATION; BILAYERS; THERMODYNAMICS; PHOSPHOLIPIDS; TRANSLOCATION; CYTOTOXICITY; RAFTS	This paper deals with the effect of different size gold nanoparticles on the fluidity of lipid membrane at different regions of the bilayer. To investigate this, we have considered significantly large bilayer leaflets and incorporated only one nanoparticle each time, which was subjected to all atomistic molecular dynamics simulations. We have observed that, lipid molecules located near to the gold nanoparticle interact directly with it, which results in deformation of lipid structure and slower dynamics of lipid molecules. However, lipid molecules far away from the interaction site of the nanoparticle get perturbed, which gives rise to increase in local ordering of the lipid domains and decrease in fluidity. The bilayer thickness and area per head group in this region also get altered. Similar trend, but with different magnitude is also observed when different size nanoparticle interact with the bilayer.	[Mhashal, Anil R.; Roy, Sudip] Natl Chem Lab, Div Phys Chem, Pune 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Roy, S (corresponding author), Natl Chem Lab, Div Phys Chem, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	s.roy@ncl.res.in	Mhashal, Anil/ABA-7245-2021	Mhashal, Anil/0000-0002-8232-8135; Roy, Sudip/0000-0001-9930-081X	Board of Research in Nuclear Sciences, India [GAP295526]	Board of Research in Nuclear Sciences, India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	Funding: The authors would also like to acknowledge the financial support from Board of Research in Nuclear Sciences (Project code GAP295526), India, for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Benting J, 1999, FEBS LETT, V462, P47, DOI 10.1016/S0014-5793(99)01501-X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Binder WH, 2007, PHYS CHEM CHEM PHYS, V9, P6435, DOI 10.1039/b711470m; Bothun Geoffrey D., 2008, Journal of Nanobiotechnology, V6, P13, DOI 10.1186/1477-3155-6-13; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caprile L, 2012, NANOSCALE, V4, P7727, DOI 10.1039/c2nr32741d; Chau PL, 1998, MOL PHYS, V93, P511, DOI 10.1080/002689798169195; DAVIS PJ, 1984, BIOCHIM BIOPHYS ACTA, V778, P305, DOI 10.1016/0005-2736(84)90373-0; Donaldson K, 2001, OCCUPATIONAL ENV MED; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Ginzburg VV, 2007, NANO LETT, V7, P3716, DOI 10.1021/nl072053l; Gopalakrishnan G, 2006, ANGEW CHEM INT EDIT, V45, P5478, DOI 10.1002/anie.200600545; Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2009, ABSTR PAP AM CHEM S, V237; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Kaneshina S, 1998, BBA-BIOMEMBRANES, V1374, P1, DOI 10.1016/S0005-2736(98)00122-9; Li Y, 2010, J PHYS CHEM B, V114, P2749, DOI 10.1021/jp904550b; Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792; Merga G, 2010, J PHYS CHEM C, V114, P14811, DOI 10.1021/jp104922a; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Park SH, 2006, COLLOID SURFACE B, V48, P112, DOI 10.1016/j.colsurfb.2006.01.006; Park SH, 2005, COLLOID SURFACE B, V44, P117, DOI 10.1016/j.colsurfb.2005.06.002; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Rasch MR, 2010, NANO LETT, V10, P3733, DOI 10.1021/nl102387n; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; TOUKAN K, 1985, PHYS REV B, V31, P2643, DOI 10.1103/PhysRevB.31.2643; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130; Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/NNANO.2010.141, 10.1038/nnano.2010.141]; Zhang LW, 2009, TOXICOL LETT, V191, P149, DOI 10.1016/j.toxlet.2009.08.017; Zopes D, 2011, EUR J INORG CHEM, P273, DOI 10.1002/ejic.201000863	42	39	39	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114152	10.1371/journal.pone.0114152	http://dx.doi.org/10.1371/journal.pone.0114152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469786	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700077
J	Mochida, K; Hasegawa, A; Otaka, N; Hama, D; Furuya, T; Yamaguchi, M; Ichikawa, E; Ijuin, M; Taguma, K; Hashimoto, M; Takashima, R; Kadota, M; Hiraiwa, N; Mekada, K; Yoshiki, A; Ogura, A				Mochida, Keiji; Hasegawa, Ayumi; Otaka, Naoki; Hama, Daiki; Furuya, Takashi; Yamaguchi, Masaki; Ichikawa, Eri; Ijuin, Maiko; Taguma, Kyuichi; Hashimoto, Michiko; Takashima, Rika; Kadota, Masayo; Hiraiwa, Noriko; Mekada, Kazuyuki; Yoshiki, Atsushi; Ogura, Atsuo			Devising Assisted Reproductive Technologies for Wild-Derived Strains of Mice: 37 Strains from Five Subspecies of Mus musculus	PLOS ONE			English	Article							C57BL/6 MOUSE SPERM; IN-VITRO; EMBRYOS; FERTILIZATION; CHOLESTEROL; SPERMATOZOA; MOLOSSINUS; MSM/MS	Wild-derived mice have long offered invaluable experimental models for mouse genetics because of their high evolutionary divergence from laboratory mice. A number of wild-derived strains are available from the RIKEN BioResource Center (BRC), but they have beenmaintained as living stocks because of the unavailability of assisted reproductive technology (ART). In this study, we sought to devise ART for 37 wild-derived strains from five subspecies of Mus musculus maintained at the BRC. Superovulation of females was effective (more than 15 oocytes per female) for 34 out of 37 strains by treatment with either equine chorionic gonadotropin or anti-inhibin serum, depending on their genetic background (subspecies). The collected oocytes could be fertilized in vitro at mean rates of 79.0% and 54.6% by the optimized protocol using fresh or frozen-thawed spermatozoa, respectively. They were cryopreserved at the 2-cell stage by vitrification with an ethylene glycol-based solution. In total, 94.6% of cryopreserved embryos survived the vitrification procedure and restored their normal morphology after warming. A conventional embryo transfer protocol could be applied to 25 out of the 35 strains tested. In the remaining 10 strains, live offspring could be obtained by a modified embryo transfer protocol using cyclosporin A treatment and co-transfer of ICR (laboratory mouse strain) embryos. Thus, ART for 37 wild-derived strains was devised successfully and is now routinely used for their preservation and transportation. The information provided here might facilitate broader use and wider distribution of wild-derived mice for biomedical research.	[Mochida, Keiji; Hasegawa, Ayumi; Otaka, Naoki; Hama, Daiki; Furuya, Takashi; Yamaguchi, Masaki; Ichikawa, Eri; Ijuin, Maiko; Taguma, Kyuichi; Hashimoto, Michiko; Takashima, Rika; Kadota, Masayo; Hiraiwa, Noriko; Mekada, Kazuyuki; Yoshiki, Atsushi; Ogura, Atsuo] RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	RIKEN; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Yoshiki, Atsushi/O-6162-2019	Ogura, Atsuo/0000-0003-0447-1988; Yoshiki, Atsushi/0000-0002-9450-5151	Ministry of Education, Culture, Sports, Science and Technology of Japan [25112009, 23220011]; RIKEN Epigenetics Program (Strategic Programs for RD)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Epigenetics Program (Strategic Programs for RD)	The work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25112009 and No. 23220011 to AO) and by the RIKEN Epigenetics Program (Strategic Programs for R&D to AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca Y, 2012, THERIOGENOLOGY, V78, P1653, DOI 10.1016/j.theriogenology.2012.08.012; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Hasegawa A, 2012, J REPROD DEVELOP, V58, P156, DOI 10.1262/jrd.11-097N; Hasegawa H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.110.089896; Holt WV, 1999, REV REPROD, V4, P143, DOI 10.1530/revreprod/4.3.143; Kikkawa Y, 2001, MAMM GENOME, V12, P750, DOI 10.1007/s003350030008; KISHI H, 1995, J ENDOCRINOL, V146, P169, DOI 10.1677/joe.0.1460169; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049316; Moriwaki K, 1999, Prog Exp Tumor Res, V35, P1; Moriwaki K, 2009, EXP ANIM TOKYO, V58, P123, DOI 10.1538/expanim.58.123; ODAKA T, 1981, J NATL CANCER I, V67, P1123; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; QUINN P, 1985, FERTIL STERIL, V44, P493; Sakai T, 2005, MAMM GENOME, V16, P11, DOI 10.1007/s00344-004-3013-9; Suzuki O, 1996, REPROD FERT DEVELOP, V8, P975, DOI 10.1071/RD9960975; Takada T, 2008, GENOME RES, V18, P500, DOI 10.1101/gr.7175308; Takada T, 2013, GENOME RES, V23, P1329, DOI 10.1101/gr.156497.113; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; Tsuchiya K, 2000, KYUSYU J EXP ANIM, V16, P23; Ward MA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100230; WHITTINGHAM DG, 1971, NATURE, V233, P125, DOI 10.1038/233125a0; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Yoshiki A, 2009, EXP ANIM TOKYO, V58, P85, DOI 10.1538/expanim.58.85	30	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114305	10.1371/journal.pone.0114305	http://dx.doi.org/10.1371/journal.pone.0114305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470728	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700099
J	Rath, SN; Brandl, A; Hiller, D; Hoppe, A; Gbureck, U; Horch, RE; Boccaccini, AR; Kneser, U				Rath, Subha N.; Brandl, Andreas; Hiller, Daniel; Hoppe, Alexander; Gbureck, Uwe; Horch, Raymund E.; Boccaccini, Aldo R.; Kneser, Ulrich			Bioactive Copper-Doped Glass Scaffolds Can Stimulate Endothelial Cells in Co-Culture in Combination with Mesenchymal Stem Cells	PLOS ONE			English	Article							ARTERIOVENOUS LOOP; CALCIUM-PHOSPHATE; BONE; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS; GROWTH; VASCULARIZATION	Bioactive glass (BG) scaffolds are being investigated for bone tissue engineering applications because of their osteoconductive and angiogenic nature. However, to increase the in vivo performance of the scaffold, including enhancing the angiogenetic growth into the scaffolds, some researchers use different modifications of the scaffold including addition of inorganic ionic components to the basic BG composition. In this study, we investigated the in vitro biocompatibility and bioactivity of Cu2+-doped BG derived scaffolds in either BMSC (bone-marrow derived mesenchymal stem cells)-only culture or co-culture of BMSC and human dermal microvascular endothelial cells (HDMEC). In BMSC-only culture, cells were seeded either directly on the scaffolds (3D or direct culture) or were exposed to ionic dissolution products of the BG scaffolds, kept in permeable cell culture inserts (2D or indirect culture). Though we did not observe any direct osteoinduction of BMSCs by alkaline phosphatase (ALP) assay or by PCR, there was increased vascular endothelial growth factor (VEGF) expression, observed by PCR and ELISA assays. Additionally, the scaffolds showed no toxicity to BMSCs and there were healthy live cells found throughout the scaffold. To analyze further the reasons behind the increased VEGF expression and to exploit the benefits of the finding, we used the indirect method with HDMECs in culture plastic and Cu2+-doped BG scaffolds with or without BMSCs in cell culture inserts. There was clear observation of increased endothelial markers by both FACS analysis and acetylated LDL (acLDL) uptake assay. Only in presence of Cu2+-doped BG scaffolds with BMSCs, a high VEGF secretion was demonstrated by ELISA; and typical tubular structures were observed in culture plastics. We conclude that Cu2+-doped BG scaffolds release Cu2+, which in turn act on BMSCs to secrete VEGF. This result is of significance for the application of BG scaffolds in bone tissue engineering approaches.	[Rath, Subha N.; Brandl, Andreas; Hiller, Daniel; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Dept Plast & Hand Surg, Erlangen, Germany; [Rath, Subha N.] Indian Inst Technol Hyderabad, Dept Biomed Engn, Yeddumailaram, Telangana, India; [Hoppe, Alexander; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, Erlangen, Germany; [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany; [Kneser, Ulrich] Heidelberg Univ, Burn Ctr, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany	University of Erlangen Nuremberg; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad; University of Erlangen Nuremberg; University of Wurzburg; Ruprecht Karls University Heidelberg	Kneser, U (corresponding author), Univ Erlangen Nurnberg, Dept Plast & Hand Surg, Erlangen, Germany.	Ulrich.kneser@bgu-ludwigshafen.de	Boccaccini, Aldo R/C-7905-2013; Boccaccini, Aldo R./N-9782-2019; Rath, Subha/AAQ-7705-2020; Horch, Raymund E./H-8128-2019; Gbureck, Uwe/G-1430-2012	Boccaccini, Aldo R./0000-0002-7377-2955; Rath, Subha/0000-0002-3414-2328; Horch, Raymund E./0000-0002-6561-2353; 	Deutsche Forschungsgemeinschaft (DFG) [KN 578/2-1]; Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg	Funding: This study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG) (KN 578/2-1) and the Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg (Project: TOPbiomat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2013, TISSUE ENG PART C-ME, V19, P479, DOI [10.1089/ten.tec.2012.0572, 10.1089/ten.TEC.2012.0572]; Baldoli E, 2012, ANGIOGENESIS, V15, P47, DOI 10.1007/s10456-011-9242-0; Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370; Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025; d'Angelo I, 2013, ACTA BIOMATER, V9, P7389, DOI 10.1016/j.actbio.2013.03.013; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; Frangoulis M, 2007, PLAST RECONSTR SURG, V119, P837, DOI 10.1097/01.prs.0000252000.59231.5e; Contreras RG, 2010, IN VIVO, V24, P507; Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009; Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032; Han P, 2013, BIOMATERIALS SCI, DOI [10.1039/C1032BM00108J, DOI 10.1039/C1032BM00108J]; Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Hoppe A, 2011, BIOMATERIALS; Hoppe A, 2013, J MATER CHEM B, V1, P5659, DOI 10.1039/c3tb21007c; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120; Kasten P, 2012, CELLS TISSUES ORGANS, V196, P523, DOI 10.1159/000337490; Kong N, 2013, J MATER CHEM B, DOI [10.1039/C1033TB21529F, DOI 10.1039/C1033TB21529F]; Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023; Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Rath SN, 2016, J TISSUE ENG REGEN M, V10, pE497, DOI 10.1002/term.1849; Rath SN, 2012, J BIOMATER APPL, V27, P277, DOI 10.1177/0885328211402243; Rath SN, 2012, J CELL MOL MED, V16, P2350, DOI 10.1111/j.1582-4934.2012.01545.x; Rodriguez JP, 2002, J CELL BIOCHEM, V85, P92, DOI 10.1002/jcb.10111; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Schmidt VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078782; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102; Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066; Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042; Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002; Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024	37	75	75	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113319	10.1371/journal.pone.0113319	http://dx.doi.org/10.1371/journal.pone.0113319			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470000	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700023
J	Scalone, L; Cesana, G; Furneri, G; Ciampichini, R; Beck-Peccoz, P; Chiodini, V; Mangioni, S; Orsi, E; Fornari, C; Mantovani, LG				Scalone, Luciana; Cesana, Giancarlo; Furneri, Gianluca; Ciampichini, Roberta; Beck-Peccoz, Paolo; Chiodini, Virginio; Mangioni, Silvia; Orsi, Emanuela; Fornari, Carla; Mantovani, Lorenzo Giovanni			Burden of Diabetes Mellitus Estimated with a Longitudinal Population-Based Study Using Administrative Databases	PLOS ONE			English	Article							RECORD-LINKAGE; PREVALENCE; COST	Objective: To assess the epidemiologic and economic burden of diabetes mellitus (DM) from a longitudinal population-based study. Research Design and Methods: Lombardy Region includes 9.9 million individuals. Its DM population was identified through a data warehouse (DENALI), which matches with a probabilistic linkage demographic, clinical and economic data of different Healthcare Administrative databases. All individuals, who, during the year 2000 had an hospital discharge with a IDC-9 CM code 250. XX, and/or two consecutive prescriptions of drugs for diabetes (ATC code A10XXXX) within one year, and/or an exemption from co-payment healthcare costs specific for DM, were selected and followed up to 9 years. We calculated prevalence, mortality and healthcare costs (hospitalizations, drugs and outpatient examinations/visits) from the National Health Service's perspective. Results: We identified 312,223 eligible subjects. The study population (51% male) had a mean age of 66 (from 0.03 to 105.12) years at the index date. Prevalence ranged from 0.4% among subjects aged <= 45 years to 10.1% among those >85 years old. Overall 43.4 deaths per 1,000 patients per year were estimated, significantly (p<0.001) higher in men than women. Overall, 3,315(sic)/patient-year were spent on average: hospitalizations were the cost driver (54.2% of total cost). Drugs contributed to 31.5%, outpatient claims represented 14.3% of total costs. Thirty-five percent of hospital costs were attributable to cerebro-/cardiovascular reasons, 6% to other complications of DM, and 4% to DM as a main diagnosis. Cardiovascular drugs contributed to 33.5% of total drug costs, 21.8% was attributable to class A (16.7% to class A10) and 4.3% to class B (2.4% to class B01) drugs. Conclusions: Merging different administrative databases can provide with many data from large populations observed for long time periods. DENALI shows to be an efficient instrument to obtain accurate estimates of burden of diseases such as diabetes mellitus.	[Scalone, Luciana; Cesana, Giancarlo; Ciampichini, Roberta; Chiodini, Virginio; Mangioni, Silvia; Fornari, Carla; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, CESP Res Ctr Publ Hlth, Milan, Italy; [Scalone, Luciana; Furneri, Gianluca] CHARTA Fdn, Milan, Italy; [Beck-Peccoz, Paolo] Univ Milan, Dept Med Sci, Unit Endocrinol & Diabetol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Orsi, Emanuela] San Giuseppe Hosp, Fdn IRCSS Ca Granda Osped Maggiore Policlin, Dept Med Sci, Endocrinol & Diabet Unit, Milan, Italy	University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Ciampichini, R (corresponding author), Univ Milano Bicocca, CESP Res Ctr Publ Hlth, Milan, Italy.	r.ciampichini@campus.unimib.it	Mantovani, Lorenzo Giovanni/AAC-4263-2021; Orsi, Emanuela/Q-3464-2016	Orsi, Emanuela/0000-0002-1255-8437; Fornari, Carla/0000-0002-9609-9556; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199				[Anonymous], DEM BAL RES POP INT; Astrup A, 2001, Public Health Nutr, V4, P499; Ayanian JZ, 1999, EUR HEART J, V20, P1689, DOI 10.1053/euhj.1999.1823; Davis WA, 2006, INTERN MED J, V36, P155, DOI 10.1111/j.1445-5994.2006.01014.x; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fornari C, 2008, EPIDEMIOL PREV, V32, P79; Global Burden of Disease Study, 2010, GBD PROF IT; Gnavi R, 2008, NUTR METAB CARDIOVAS, V18, P678, DOI 10.1016/j.numecd.2007.11.004; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Italian National Institute of Statistics (ISTAT), ANN STAT IT 2013; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kanavos P, 2012, DIABETES EXPENDITURE; Lombardo F, 2007, 0725 ISTISAN; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Monesi L, 2012, DIABETIC MED, V29, P385, DOI 10.1111/j.1464-5491.2011.03446.x; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Osservatorio ARNO Diabete, 2011, PROF ASS POP CON DIA, VXVII; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; WHO consultation, WHO CONS DEF DIAGN C	24	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113741	10.1371/journal.pone.0113741	http://dx.doi.org/10.1371/journal.pone.0113741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470484	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700041
J	Benz, R; Maier, E; Bauer, S; Ludwig, A				Benz, Roland; Maier, Elke; Bauer, Susanne; Ludwig, Albrecht			The Deletion of Several Amino Acid Stretches of Escherichia coli Alpha-Hemolysin (HlyA) Suggests That the Channel-Forming Domain Contains Beta-Strands	PLOS ONE			English	Article							PLASMID-ENCODED HEMOLYSIN; ION-PERMEABLE CHANNELS; ADENYLATE-CYCLASE TOXIN; MATRIX PROTEIN PORIN; RTX-TOXINS; MEMBRANE TRANSLOCATION; ELECTRICAL-PROPERTIES; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; ANTHRAX TOXIN	Escherichia coli alpha-hemolysin (HlyA) is a pore-forming protein of 110 kDa belonging to the family of RTX toxins. A hydrophobic region between the amino acid residues 238 and 410 in the N-terminal half of HlyA has previously been suggested to form hydrophobic and/or amphipathic alpha-helices and has been shown to be important for hemolytic activity and pore formation in biological and artificial membranes. The structure of the HlyA transmembrane channel is, however, largely unknown. For further investigation of the channel structure, we deleted in HlyA different stretches of amino acids that could form amphipathic beta-strands according to secondary structure predictions (residues 71-110, 158-167, 180-203, and 264-286). These deletions resulted in HlyA mutants with strongly reduced hemolytic activity. Lipid bilayer measurements demonstrated that HlyA(Delta 71-110) and HlyA(Delta 264-286) formed channels with much smaller single-channel conductance than wildtype HlyA, whereas their channel-forming activity was virtually_as_high as that of the wildtype toxin. HlyA(Delta 158-167) and HlyA(Delta 180-203) were unable to form defined channels in lipid bilayers. Calculations based on the single-channel data indicated that the channels generated by HlyA(Delta 71-110) and HlyA(Delta 264-286) had a smaller size (diameter about 1.4 to 1.8 nm) than wildtype HlyA channels (diameter about 2.0 to 2.6 nm), suggesting that in these mutants part of the channel-forming domain was removed. Osmotic protection experiments with erythrocytes confirmed that HlyA, HlyA(Delta 71-110), and HlyA(Delta 264-286) form defined transmembrane pores and suggested channel diameters that largely agreed with those estimated from the single-channel data. Taken together, these results suggest that the channel-forming domain of HlyA might contain beta-strands, possibly in addition to alpha-helical structures.	[Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Maier, Elke; Bauer, Susanne; Ludwig, Albrecht] Univ Wurzburg, Lehrstuhl Mikrobiol, Theodor Boveri Inst Biowissensch, Biozentrum, D-97070 Wurzburg, Germany; [Ludwig, Albrecht] Univ Frankfurt Klinikum, Inst Med Mikrobiol & Krakenhaushyg, Frankfurt, Germany	Jacobs University; University of Wurzburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Benz, R (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany.	r.benz@jacobs-university.de		Benz, Roland/0000-0002-9510-9265				Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1993, ZBL BAKT-INT J MED M, V278, P187, DOI 10.1016/S0934-8840(11)80836-4; Benz R, 2003, CEL MOL MEC TOX ACT, V5, P27; BENZ R, 1992, FEMS MICROBIOL IMMUN, V105, P55; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; BENZ R, 1994, J BIOL CHEM, V269, P27231; Benz R., 1994, BACTERIAL CELL WALL, P397; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BLIGHT MA, 1990, MOL MICROBIOL, V4, P873, DOI 10.1111/j.1365-2958.1990.tb00660.x; BUCKLEY JT, 1992, FEBS LETT, V307, P30, DOI 10.1016/0014-5793(92)80896-O; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; CHAKRABORTY T, 1990, INFECT IMMUN, V58, P2127, DOI 10.1128/IAI.58.7.2127-2132.1990; Cortajarena AL, 2001, J BIOL CHEM, V276, P12513, DOI 10.1074/jbc.M006792200; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Dobereiner A, 1996, EUR J BIOCHEM, V240, P454, DOI 10.1111/j.1432-1033.1996.0454h.x; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; GOEBEL W, 1982, J BACTERIOL, V151, P1290, DOI 10.1128/JB.151.3.1290-1298.1982; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; GRAY L, 1986, MOL GEN GENET, V205, P127, DOI 10.1007/BF02428042; Herlax V, 2009, J BIOL CHEM, V284, P25199, DOI 10.1074/jbc.M109.009365; HESS J, 1986, FEMS MICROBIOL LETT, V34, P1, DOI 10.1016/0378-1097(86)90261-2; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; JORDAN PC, 1987, BIOPHYS J, V51, P297, DOI 10.1016/S0006-3495(87)83336-2; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Ludwig A, 1996, J BACTERIOL, V178, P5422, DOI 10.1128/jb.178.18.5422-5430.1996; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; LUDWIG A, 1993, MOL GEN GENET, V241, P89, DOI 10.1007/BF00280205; LUDWIG A, 1987, MOL GEN GENET, V206, P238, DOI 10.1007/BF00333579; LUDWIG A, 1991, MOL GEN GENET, V226, P198, DOI 10.1007/BF00273604; Ludwig A., 2006, COMPREHENSIVE SOURCE, Vthird, P547, DOI DOI 10.1016/B978-012088445-2/50034-2; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; Maier E, 1996, INFECT IMMUN, V64, P4415, DOI 10.1128/IAI.64.11.4415-4423.1996; MENESTRINA G, 1988, FEBS LETT, V232, P217, DOI 10.1016/0014-5793(88)80420-4; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; NELSON AP, 1975, J THEOR BIOL, V55, P13, DOI 10.1016/S0022-5193(75)80106-8; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Osickova A, 1999, J BIOL CHEM, V274, P37644; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; Schindel C, 2001, EUR J BIOCHEM, V268, P800, DOI 10.1046/j.1432-1327.2001.01937.x; Schmidt H, 1996, EUR J BIOCHEM, V241, P594, DOI 10.1111/j.1432-1033.1996.00594.x; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Stanley P, 1999, MOL MICROBIOL, V34, P887, DOI 10.1046/j.1365-2958.1999.01648.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Valeva A, 2008, BIOL CHEM, V389, P1201, DOI 10.1515/BC.2008.136; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; VOGEL M, 1988, MOL GEN GENET, V212, P76, DOI 10.1007/BF00322447; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WELCH RA, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P195	76	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112248	10.1371/journal.pone.0112248	http://dx.doi.org/10.1371/journal.pone.0112248			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463653	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700010
J	Hayano, T; Yokota, Y; Hosomichi, K; Nakaoka, H; Yoshihara, K; Adachi, S; Kashima, K; Tsuda, H; Moriya, T; Tanaka, K; Enomoto, T; Inoue, I				Hayano, Takahide; Yokota, Yuki; Hosomichi, Kazuyoshi; Nakaoka, Hirofumi; Yoshihara, Kosuke; Adachi, Sosuke; Kashima, Katsunori; Tsuda, Hitoshi; Moriya, Takuya; Tanaka, Kenichi; Enomoto, Takayuki; Inoue, Ituro			Molecular Characterization of an Intact p53 Pathway Subtype in High-Grade Serous Ovarian Cancer	PLOS ONE			English	Article							COPY NUMBER; FUNCTIONAL IMPACT; DNA-REPAIR; GENE; EXPRESSION; MUTATIONS; SPINDLE; DISCOVERY; HELICASES; MITOSIS	High-grade serous ovarian cancer (HGSOC) is the most aggressive histological type of epithelial ovarian cancer, which is characterized by a high frequency of somatic TP53 mutations. We performed exome analyses of tumors and matched normal tissues of 34 Japanese patients with HGSOC and observed a substantial number of patients without TP53 mutation (24%, 8/34). Combined with the results of copy number variation analyses, we subdivided the 34 patients with HGSOC into subtypes designated ST1 and ST2. ST1 showed intact p53 pathway and was characterized by fewer somatic mutations and copy number alterations. In contrast, the p53 pathway was impaired in ST2, which is characterized by abundant somatic mutations and copy number alterations. Gene expression profiles combined with analyses using the Gene Ontology resource indicate the involvement of specific biological processes (mitosis and DNA helicase) that are relevant to genomic stability and cancer etiology. In particular we demonstrate the presence of a novel subtype of patients with HGSOC that is characterized by an intact p53 pathway, with limited genomic alterations and specific gene expression profiles.	[Hayano, Takahide; Hosomichi, Kazuyoshi; Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 411, Japan; [Yokota, Yuki; Yoshihara, Kosuke; Adachi, Sosuke; Kashima, Katsunori; Tanaka, Kenichi; Enomoto, Takayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 359, Japan; [Moriya, Takuya] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Tanaka, Kenichi] Niigata Med Ctr Hosp, Niigata, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Niigata University; National Defense Medical College - Japan; Kawasaki Medical School	Inoue, I (corresponding author), Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 411, Japan.	itinoue@nig.ac.jp	Moriya, Takuya/AAM-6974-2020; Yoshihara, Kosuke/AAU-9874-2020; Hosomichi, Kazuyoshi/K-9477-2015	Yoshihara, Kosuke/0000-0002-2254-3378; Hosomichi, Kazuyoshi/0000-0003-2712-1825; Nakaoka, Hirofumi/0000-0002-8454-1159; Enomoto, Takayuki/0000-0003-4538-5541	Japan Society for the Promotion of Science [23791816]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (grant No. 23791816) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/) (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardini MQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-237; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Croteau DL, 2014, ANN REV BIO IN PRESS; Darvishi K, 2010, CURR PROTOC HUM GENE, V14, P1; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Ferlay J, 2010, CANC INCIDENCE 5 CON; Futami K, 2010, INT J MOL MED, V25, P537, DOI 10.3892/ijmm_00000375; Glessner JT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1346; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaneta Y, 2013, BIOCHEM BIOPH RES CO, V442, P139, DOI 10.1016/j.bbrc.2013.04.105; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; LUNA RMD, 1995, NATURE, V378, P203; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Siffroi-Fernandez S, 2014, CELL CYCLE, V13, P984, DOI 10.4161/cc.27868; Sivakumar S, 2014, MOL BIOL CELL, V25, P594, DOI 10.1091/mbc.E13-07-0421; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turley H, 2001, BRIT J CANCER, V85, P261, DOI 10.1054/bjoc.2001.1874; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Wu ZX, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011635-1, 10.1074/mcp.M111.011635]; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114491	10.1371/journal.pone.0114491	http://dx.doi.org/10.1371/journal.pone.0114491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460179	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700137
J	Laoprasopwattana, K; Chaimongkol, W; Pruekprasert, P; Geater, A				Laoprasopwattana, Kamolwish; Chaimongkol, Wanwipa; Pruekprasert, Pornpimol; Geater, Alan			Acute Respiratory Failure and Active Bleeding Are the Important Fatality Predictive Factors for Severe Dengue Viral Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SHOCK SYNDROME; MORTALITY; CHILDREN; ADULTS; SINGAPORE; RISK	Objective: To determine the outcome of severe dengue viral infection (DVI) and the main dengue fatality risk factors. Study design: The medical records of patients aged <15 years admitted to Songklanagarind Hospital in southern Thailand during 1989-2011 were reviewed. Patients who had dengue hemorrhagic fever (DHF) grades III-IV, organ failure (cardiovascular, respiratory, liver, renal or hematologic), impaired consciousness, or aspartate aminotransferase more than 1,000 units/L, were classified as having severe DVI. To determine the fatality risk factors of severe DVI, the classification trees were constructed based on manual recursive partitioning. Results: Of the 238 children with severe DVI, 30 (12.6%) died. Compared to the non-fatal DVI cases, the fatal cases had higher rates of DHF grade IV (96.7% vs 24.5%), repeated shock (93.3% vs 27.9%), acute respiratory failure (ARF) (100% vs 6.7%), acute liver failure (ALF) (96.6% vs 6.3%), acute kidney injury (AKI) (79.3% vs 4.5%), and active bleeding requiring blood transfusion (93.3% vs 5.4%), all p<0.01. The combined risk factors of ARF and active bleeding considered together predicted fatal outcome with sensitivity, specificity, and negative and positive predictive values of 0.93 (0.78-0.99), 0.97 (0.93-0.99), 0.99 (0.97-1.00), and 0.82 (0.65-0.93), respectively. The likelihood ratios for a fatal outcome in the patients who had and did not have this risk combination were 32.4 (14.6-71.7) and 0.07 (0.02-0.26), respectively. Conclusion: Severe DVI patients who have ARF and active bleeding are at a high risk of death, while patients without these things together should survive.	[Laoprasopwattana, Kamolwish; Chaimongkol, Wanwipa; Pruekprasert, Pornpimol] Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai, Songkhla, Thailand; [Geater, Alan] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Laoprasopwattana, K (corresponding author), Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai, Songkhla, Thailand.	kamolwish@gmail.com	laoprasopwattana, kamolwish/AAQ-9092-2020	Geater, Alan/0000-0003-1219-9814	Faculty of Medicine, Prince of Songkla University, Songkhla Thailand [53-190-01-1-3]	Faculty of Medicine, Prince of Songkla University, Songkhla Thailand	All the funding was supported by grant no. 53-190-01-1-3 from the Faculty of Medicine, Prince of Songkla University, Songkhla Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Chan James C M, 2002, Pediatr Rev, V23, P47, DOI 10.1542/pir.23-2-47; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Juneja D, 2011, J CRIT CARE, V26, P449, DOI 10.1016/j.jcrc.2011.05.007; Kalayanarooj S., 1999, Dengue Bulletin, V23, P1; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Laoprasopwattana K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002287; Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123; Magpusao NS, 2003, TROP DOCT, V33, P156, DOI 10.1177/004947550303300312; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Rigau-Perez J G, 1999, P R Health Sci J, V18, P337; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Taori RN, 2010, INDIAN J PEDIATR, V77, P267, DOI 10.1007/s12098-010-0031-3; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; Wang CC, 2007, AM J TROP MED HYG, V77, P151, DOI 10.4269/ajtmh.2007.77.151; World Health Organization, 2009, DENGUE GUIDELINES DI	25	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114499	10.1371/journal.pone.0114499	http://dx.doi.org/10.1371/journal.pone.0114499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460594	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700139
J	Lerbech, AM; Opintan, JA; Bekoe, SO; Ahiabu, MA; Tersbol, BP; Hansen, M; Brightson, KTC; Ametepeh, S; Frimodt-Moller, N; Styrishave, B				Lerbech, Anne Mette; Opintan, Japheth A.; Bekoe, Samuel Oppong; Ahiabu, Mary-Anne; Tersbol, Britt Pinkowski; Hansen, Martin; Brightson, Kennedy T. C.; Ametepeh, Samuel; Frimodt-Moller, Niels; Styrishave, Bjarne			Antibiotic Exposure in a Low-Income Country: Screening Urine Samples for Presence of Antibiotics and Antibiotic Resistance in Coagulase Negative Staphylococcal Contaminants	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SELF-MEDICATION; FOOD ANIMALS; HUMAN HEALTH; GHANA; AUREUS; SUSCEPTIBILITY; HAEMOLYTICUS; CARRIAGE; USAGE	Development of antimicrobial resistance has been assigned to excess and misuse of antimicrobial agents. Staphylococci are part of the normal flora but are also potential pathogens that have become essentially resistant to many known antibiotics. Resistances in coagulase negative staphylococci (CoNS) are suggested to evolve due to positive selective pressure following antibiotic treatment. This study investigated the presence of the nine most commonly used antimicrobial agents in human urine from outpatients in two hospitals in Ghana in relation to CoNS resistance. Urine and CoNS were sampled (n=246 and n=96 respectively) from patients in two hospitals in Ghana. CoNS were identified using Gram staining, coagulase test, and MALDI-TOF/MS, and the antimicrobial susceptibility to 12 commonly used antimicrobials was determined by disk diffusion. Moreover an analytical method was developed for the determination of the nine most commonly used antimicrobial agents in Ghana by using solid-phase extraction in combination with HPLC-MS/MS using electron spray ionization. The highest frequency of resistance to CoNS was observed for penicillin V (98%), trimethoprim (67%), and tetracycline (63%). S. haemolyticus was the most common isolate (75%), followed by S. epidermidis (13%) and S. hominis (6%). S. haemolyticus was also the species displaying the highest resistance prevalence (82%). 69% of the isolated CoNS were multiple drug resistant (>= 4 antibiotics) and 45% of the CoNS were methicillin resistant. Antimicrobial agents were detected in 64% of the analysed urine samples (n=121) where the most frequently detected antimicrobials were ciprofloxacin (30%), trimethoprim (27%), and metronidazole (17%). The major findings of this study was that the prevalence of detected antimicrobials in urine was more frequent than the use reported by the patients and the prevalence of resistant S. haemolyticus was more frequent than other resistant CoNS species when antimicrobial agents were detected in the urine.	[Lerbech, Anne Mette; Bekoe, Samuel Oppong; Hansen, Martin; Styrishave, Bjarne] Univ Copenhagen, Dept Pharm, Toxicol Lab, Fac Hlth & Med Sci, Copenhagen, Denmark; [Opintan, Japheth A.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Ahiabu, Mary-Anne; Tersbol, Britt Pinkowski] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Brightson, Kennedy T. C.] Shai Osudoku Dist Hosp, Maternal Hlth Unit, Dodowa, Ghana; [Ametepeh, Samuel] Shai Osudoku Dist Hosp, Microbiol Lab, Dodowa, Ghana; [Frimodt-Moller, Niels] Hvidovre Univ Hosp, Dept Clin Microbiol, DK-2650 Copenhagen, Denmark	University of Copenhagen; University of Ghana; University of Copenhagen; University of Copenhagen	Styrishave, B (corresponding author), Univ Copenhagen, Dept Pharm, Toxicol Lab, Fac Hlth & Med Sci, Copenhagen, Denmark.	bjarne.styrishave@sund.ku.dk	Frimodt-Moller, Niels/G-1187-2018; Hansen, Martin/B-3121-2010	Frimodt-Moller, Niels/0000-0003-1966-8302; Hansen, Martin/0000-0002-4663-8742; , Britt Pinkowski Tersbol/0000-0001-8260-1317	Danida, the Ministry of Foreign Affairs of Denmark	Danida, the Ministry of Foreign Affairs of Denmark	The project was funded by Danida, the Ministry of Foreign Affairs of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo VN, 2007, J SCI TECHNOL, V27, P149, DOI [DOI 10.4314/JUST.V27I3.33067, 10.4314/just.v27i3.33067]; AduSarkodie YA, 1997, INT J STD AIDS, V8, P456, DOI 10.1258/0956462971920343; Agvald-Ohman C, 2004, CRIT CARE, V8, pR42, DOI 10.1186/cc2422; Akinkunmi EO, 2012, AFR HEALTH SCI, V12, P381, DOI 10.4314/ahs.v12i3.21; Akinkunmi E O, 2006, Afr J Med Med Sci, V35, P15; Akinkunmi EO, 2010, TROP J PHARM RES, V9, P35; [Anonymous], 2012, J VET ADV; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Bosu WK, 1998, INT J STD AIDS, V9, P551, DOI 10.1258/0956462981922692; COVE JH, 1990, J ANTIMICROB CHEMOTH, V25, P459, DOI 10.1093/jac/25.3.459; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Denno Donna M, 2002, West Afr J Med, V21, P233; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Donkor ES, 2012, TROP MED INT HEALTH, V17, P462, DOI 10.1111/j.1365-3156.2012.02955.x; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; FROGGATT JW, 1989, ANTIMICROB AGENTS CH, V33, P460, DOI 10.1128/AAC.33.4.460; Germer J, 2010, J AGR RURAL DEV TROP, V111, P41; Ghana Statistical Service, 2008, GHAN LIV STAND SURV; Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907; Gould I M, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS2, DOI 10.1016/S0924-8579(09)70549-7; Grady KE, 1988, RES HKLTH CARE SETTI; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; HOIBY N, 1995, LANCET, V346, P1235, DOI 10.1016/S0140-6736(95)92946-0; Holby N, 1997, LANCET, V349, P167, DOI 10.1016/S0140-6736(96)09229-X; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Isturiz RE, 2000, INFECT CONT HOSP EP, V21, P394, DOI 10.1086/501780; JOHN JF, 1978, J CLIN MICROBIOL, V8, P435; John Joseph F, 2007, Ther Clin Risk Manag, V3, P1143; K'oreje KO, 2012, SCI TOTAL ENVIRON, V437, P153, DOI 10.1016/j.scitotenv.2012.07.052; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Leclercq R, 2009, CLIN MICROBIOL INFEC, V15, P224, DOI 10.1111/j.1469-0691.2009.02739.x; Levy SB, 1997, CIBA F SYMP, V207, P1; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Levy SB, 1997, CIBA F SYMP, V207, P9; Ma XX, 2011, J MED MICROBIOL, V60, P1661, DOI 10.1099/jmm.0.034066-0; Ma XX, 2011, CAN J MICROBIOL, V57, P476, DOI [10.1139/W11-033, 10.1139/w11-033]; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Marshall SA, 1998, DIAGN MICR INFEC DIS, V30, P205, DOI 10.1016/S0732-8893(97)00212-5; Mills-Robertson F, 2002, FEMS MICROBIOL LETT, V215, P249, DOI [10.1016/S0378-1097(02)00967-9, 10.1111/j.1574-6968.2002.tb11398.x]; Ministry of Health, 2010, STAND TREATN GUID; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Senah KA, 1997, MONEY PROPULARITY ME, Vxvi; Tollefson L, 2004, MED MALADIES INFECT, V34, P514, DOI [10.1016/j.medmal.2004.07.028, 10.1016/j/medmal.2004.07.028]; Turkson P.K., 2008, AGR SCI REV, V41, P23; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; van den Bogaard AE, 1999, DRUGS, V58, P589, DOI 10.2165/00003495-199958040-00002; Wilcox Mark H, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS6, DOI 10.1016/S0924-8579(09)70550-3; WOLFGOULD CS, 1991, SOC SCI MED, V33, P83, DOI 10.1016/0277-9536(91)90459-P; World Bank, 2009, PHARM SECT GHANA POL	59	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113055	10.1371/journal.pone.0113055	http://dx.doi.org/10.1371/journal.pone.0113055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462162	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700025
J	Orozco, JJ; Balkin, ER; Gooley, TA; Kenoyer, A; Hamlin, DK; Wilbur, DS; Fisher, DR; Hylarides, MD; Shadman, M; Green, DJ; Gopal, AK; Press, OW; Pagel, JM				Orozco, Johnnie J.; Balkin, Ethan R.; Gooley, Ted A.; Kenoyer, Aimee; Hamlin, Donald K.; Wilbur, D. Scott; Fisher, Darrell R.; Hylarides, Mark D.; Shadman, Mazyar; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.			Anti-CD45 Radioimmunotherapy with Y-90 but Not Lu-177 Is Effective Treatment in a Syngeneic Murine Leukemia Model	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; PRETARGETED RADIOIMMUNOTHERAPY; MONOCLONAL-ANTIBODY; MYELOID-LEUKEMIA; CELL TRANSPLANTATION; RANDOMIZED-TRIAL; PHASE-I; LYMPHOMA	Radioimmunotherapy (RIT) for treatment of hematologic malignancies has primarily employed monoclonal antibodies (Ab) labeled with I-131 or Y-90 which have limitations, and alternative radionuclides are needed to facilitate wider adoption of RIT. We therefore compared the relative therapeutic efficacy and toxicity of anti-CD45 RIT employing Y-90 and Lu-177 in a syngeneic, disseminated murine myeloid leukemia (B6SJLF1/J) model. Biodistribution studies showed that both Y-90- and Lu-177-anti-murine CD45 Ab conjugates (DOTA-30F11) targeted hematologic tissues, as at 24 hours 48.8 +/- 21.2 and 156 +/- 14.6% injected dose per gram of tissue (% ID/g) of Y-90-DOTA-30F11 and 54.2 +/- 9.5 and 199 +/- 11.7% ID/g of Lu-177-DOTA-30F11 accumulated in bone marrow (BM) and spleen, respectively. However, Y-90-DOTA-30F11 RIT demonstrated a dose-dependent survival benefit: 60% of mice treated with 300 mu Ci Y-90-DOTA-30F11 lived over 180 days after therapy, and mice treated with 100 mu Ci Y-90-DOTA-30F11 had a median survival 66 days. Y-90-anti-CD45 RIT was associated with transient, mild myelotoxicity without hepatic or renal toxicity. Conversely, Lu-177-anti-CD45 RIT yielded no long-term survivors. Thus, Y-90 was more effective than Lu-177 for anti-CD45 RIT of AML in this murine leukemia model.	[Orozco, Johnnie J.; Gooley, Ted A.; Kenoyer, Aimee; Hylarides, Mark D.; Shadman, Mazyar; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Orozco, Johnnie J.; Shadman, Mazyar] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Balkin, Ethan R.; Hamlin, Donald K.; Wilbur, D. Scott; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.] Univ Washington, Seattle, WA 98195 USA; [Fisher, Darrell R.] Dade Moeller Hlth Grp, Richland, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pagel, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	jpagel@fhcrc.org		Press, Oliver/0000-0002-3147-8037; Gopal, Ajay/0000-0003-3023-6834	National Institutes of Health [R01 CA109663, R01 CA138720, R01 CA076287, R01 CA136639, R01 CA154897, P01 CA044991]; Lymphoma Research Foundation; Damon Runyon Cancer Foundation; Leukemia and Lymphoma Society; American Society of Blood and Marrow Transplantation; NATIONAL CANCER INSTITUTE [R01CA136639, P01CA044991, R01CA154897, R01CA138720, R01CA076287, R01CA109663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Damon Runyon Cancer Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Blood and Marrow Transplantation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA109663, R01 CA138720, R01 CA076287, R01 CA136639, R01 CA154897, P01 CA044991) and awards from the Lymphoma Research Foundation (OWP and JMP), Damon Runyon Cancer Foundation (JMP), Leukemia and Lymphoma Society (OWP, JMP, AKG, and JJO), and the American Society of Blood and Marrow Transplantation (JJO), as well as Frederick Kullman (JMP) and by a gift from James and Sherry Raisbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATTY BG, 1994, CANCER, V73, P958, DOI 10.1002/1097-0142(19940201)73:3+<958::AID-CNCR2820731331>3.0.CO;2-E; Bouchet LG, 2000, J NUCL MED, V41, P682; Bunjes DW, 2001, BLOOD, V98, p197A; Burke JM, 2003, BONE MARROW TRANSPL, V32, P549, DOI 10.1038/sj.bmt.1704201; CLIFT RA, 1990, BLOOD, V76, P1867; Clift RA, 1998, BLOOD, V92, P1455, DOI 10.1182/blood.V92.4.1455; CLIFT RA, 1991, BLOOD, V77, P1660; COSSET JM, 1989, RADIOTHER ONCOL, V15, P151, DOI 10.1016/0167-8140(89)90129-1; de Jong M, 2005, J NUCL MED, V46, p13S; FISHER DR, 1991, ANTIBODY IMMUNOCONJ, V4, P655; GOLDENBERG DM, 1991, J CLIN ONCOL, V9, P548, DOI 10.1200/JCO.1991.9.4.548; HUI TE, 1994, CANCER, V73, P951; MATTHEWS DC, 1991, BLOOD, V78, P1864; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; NAKANO A, 1990, ACTA PATHOL JAPON, V40, P107; OMARY MB, 1980, J EXP MED, V152, P842, DOI 10.1084/jem.152.4.842; Pagel JM, 2006, BLOOD, V107, P2184, DOI 10.1182/blood-2005-06-2317; Pagel JM, 2003, BLOOD, V101, P2340, DOI 10.1182/blood-2002-03-0874; Pagel JM, 2008, BLOOD, V111, P2261, DOI 10.1182/blood-2007-06-097451; Pagel JM, 2011, BLOOD, V118, P703, DOI 10.1182/blood-2011-04-347039; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Robertson R, 2011, J NUCL MED, V52, P1764, DOI 10.2967/jnumed.111.091710; ROSEN ST, 1987, J CLIN ONCOL, V5, P562, DOI 10.1200/JCO.1987.5.4.562; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; SCHEINBERG DA, 1990, J CLIN ONCOL, V8, P792, DOI 10.1200/JCO.1990.8.5.792; SCHWARTZ MA, 1993, J CLIN ONCOL, V11, P294, DOI 10.1200/JCO.1993.11.2.294; SHANK B, 1981, INT J RADIAT ONCOL, V7, P1240, DOI 10.1016/0360-3016(81)90567-8; SIEGEL JA, 1994, J NUCL MED, V35, P152; SOCIE G, 1991, INT J RADIAT ONCOL, V20, P397, DOI 10.1016/0360-3016(91)90048-9; TAETLE R, 1991, LEUKEMIA, V5, P309; VANDERJAGT RHC, 1992, CANCER RES, V52, P89; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113601	10.1371/journal.pone.0113601	http://dx.doi.org/10.1371/journal.pone.0113601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460570	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700039
J	Peters, EMJ; Michenko, A; Kupfer, J; Kummer, W; Wiegand, S; Niemeier, V; Potekaev, N; Lvov, A; Gieler, U				Peters, Eva Milena Johanne; Michenko, Anna; Kupfer, Joerg; Kummer, Wolfgang; Wiegand, Silke; Niemeier, Volker; Potekaev, Nikolay; Lvov, Andrey; Gieler, Uwe			Mental Stress in Atopic Dermatitis - Neuronal Plasticity and the Cholinergic System Are Affected in Atopic Dermatitis and in Response to Acute Experimental Mental Stress in a Randomized Controlled Pilot Study	PLOS ONE			English	Article							BRAIN-SKIN CONNECTION; NERVE GROWTH-FACTOR; SUBSTANCE-P; MAST-CELLS; NONNEURONAL ACETYLCHOLINE; NEUROGENIC INFLAMMATION; CLINICAL-SIGNIFICANCE; PSYCHOLOGICAL STRESS; HAIR FOLLICLE; UP-REGULATION	Rationale: In mouse models for atopic dermatitis (AD) hypothalamus pituitary adrenal axis (HPA) dysfunction and neuropeptide-dependent neurogenic inflammation explain stress-aggravated flares to some extent. Lately, cholinergic signaling has emerged as a link between innate and adaptive immunity as well as stress responses in chronic inflammatory diseases. Here we aim to determine in humans the impact of acute stress on neuro-immune interaction as well as on the non-neuronal cholinergic system (NNCS). Methods: Skin biopsies were obtained from 22 individuals (AD patients and matched healthy control subjects) before and after the Trier social stress test (TSST). To assess neuro-immune interaction, nerve fiber (NF)-density, NF-mast cell contacts and mast cell activation were determined by immunohistomorphometry. To evaluate NNCS effects, expression of secreted mammal Ly-6/urokinase-type plasminogen activator receptor-related protein (SLURP) 1 and 2 (endogenous nicotinic acetylcholine receptor ligands) and their main corresponding receptors were assessed by quantitative RT-PCR. Results: With respect to neuro-immune interaction we found higher numbers of NGF+ dermal NF in lesional compared to non-lesional AD but lower numbers of Gap43+ growing NF at baseline. Mast cell-NF contacts correlated with SCORAD and itch in lesional skin. With respect to the NNCS, nicotinic acetylcholine receptor alpha 7 (alpha 7nAChR) mRNA was significantly lower in lesional AD skin at baseline. After TSST, PGP 9.5+ NF numbers dropped in lesional AD as did their contacts with mast cells. NGF+ NF now correlated with SCORAD and mast cell-NF contacts with itch in non-lesional skin. At the same time, SLURP-2 levels increased in lesional AD skin. Conclusions: In humans chronic inflammatory and highly acute psycho-emotional stress interact to modulate cutaneous neuro-immune communication and NNCS marker expression. These findings may have consequences for understanding and treatment of chronic inflammatory diseases in the future.	[Peters, Eva Milena Johanne; Michenko, Anna] Charite, Ctr Internal Med & Dermatol, Psychoneuroimmunol Lab, D-13353 Berlin, Germany; [Peters, Eva Milena Johanne; Michenko, Anna] Univ Giessen, Dept Psychosomat Med, Psychoneuroimmunol Lab, D-35390 Giessen, Germany; [Michenko, Anna; Lvov, Andrey] IM Sechenov Moscow Med Univ, Dept Dermatol, Moscow, Russia; [Kupfer, Joerg] Univ Giessen, Inst Med Psychol, D-35390 Giessen, Germany; [Kummer, Wolfgang; Wiegand, Silke] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Gieler, Uwe] Univ Giessen, Dept Psychosomat & Psychotherapy, D-35390 Giessen, Germany; [Niemeier, Volker; Gieler, Uwe] Univ Hosp Giessen, Dept Dermatol, Giessen, Germany; [Potekaev, Nikolay] Moscow Sci & Pract Ctr Dermatovenereol & Cosmetol, Moscow, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Sechenov First Moscow State Medical University; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Peters, EMJ (corresponding author), Charite, Ctr Internal Med & Dermatol, Psychoneuroimmunol Lab, D-13353 Berlin, Germany.	eva.peters@eva-peters.com	Potekaev, Nikolay N./ABG-5286-2021; Lvov, Andrey/AAG-8980-2019; Kupfer, JOERG/A-5109-2008	Potekaev, Nikolay N./0000-0002-9578-5490; Peters, Eva Milena Johanne/0000-0003-2423-527X; Michenko, Anna/0000-0002-2985-5729; Kummer, Wolfgang/0000-0002-3946-0683	LOEWE, Hessen, Germany	LOEWE, Hessen, Germany	Funding provided by LOEWE, Hessen, Germany to EMJP, UG and WK, http://www.uni-giessen.de/cms/fbz/fb11/forschung/schwerpunkte/loewe/nncs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buske-Kirschbaum A, 2010, BRAIN BEHAV IMMUN, V24, P1347, DOI 10.1016/j.bbi.2010.06.013; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Chernyavsky AI, 2012, WOUND REPAIR REGEN, V20, P103, DOI 10.1111/j.1524-475X.2011.00753.x; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Chernyavsky AI, 2010, INT IMMUNOPHARMACOL, V10, P308, DOI 10.1016/j.intimp.2009.12.001; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Dhabhar FS, 2013, CLIN DERMATOL, V31, P18, DOI 10.1016/j.clindermatol.2011.11.003; Dou YC, 2006, ARCH DERMATOL RES, V298, P31, DOI 10.1007/s00403-006-0657-1; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; HANIFIN JM, 1989, ALLERGY PROC, V10, P397, DOI 10.2500/108854189778935827; Harvima IT, 2010, GIORN ITAL DERMAT V, V145, P195; Hendrix S, 2007, J NEUROIMMUNOL, V184, P113, DOI 10.1016/j.jneuroim.2006.11.020; Hendrix S, 2008, EXP DERMATOL, V17, P214, DOI 10.1111/j.1600-0625.2007.00653.x; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Joachim RA, 2007, J MOL MED-JMM, V85, P1369, DOI 10.1007/s00109-007-0236-8; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Kindt F, 2008, BRIT J DERMATOL, V159, P847, DOI 10.1111/j.1365-2133.2008.08774.x; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lips KS, 2007, LIFE SCI, V80, P2263, DOI 10.1016/j.lfs.2007.01.026; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Matoso A, 2013, MODERN PATHOL, V26, P665, DOI 10.1038/modpathol.2013.41; Misery L, 2004, EXP DERMATOL, V13, P665, DOI 10.1111/j.0906-6705.2004.00274.x; Mishra NC, 2008, J IMMUNOL, V180, P7655, DOI 10.4049/jimmunol.180.11.7655; Narumoto O, 2013, BIOCHEM BIOPH RES CO, V438, P175, DOI 10.1016/j.bbrc.2013.07.048; Ofek K, 2013, CHEM-BIOL INTERACT, V203, P113, DOI 10.1016/j.cbi.2012.07.007; Pavlovic S, 2008, J INVEST DERMATOL, V128, P434, DOI 10.1038/sj.jid.5701079; Pavlovic S, 2011, J IMMUNOL, V186, P848, DOI 10.4049/jimmunol.0903878; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Peters EMJ, 2012, ANN NY ACAD SCI, V1262, P118, DOI 10.1111/j.1749-6632.2012.06647.x; Peters EMJ, 2011, J INVEST DERMATOL, V131, P735, DOI 10.1038/jid.2010.317; Rohleder N, 2012, PSYCHONEUROENDOCRINO, V37, P307, DOI 10.1016/j.psyneuen.2011.12.015; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; Sinkus ML, 2011, PHYSIOL BEHAV, V104, P321, DOI 10.1016/j.physbeh.2010.11.007; Spradley JM, 2012, PAIN, V153, P1890, DOI 10.1016/j.pain.2012.05.032; Steinhoff M, 2003, ARCH DERMATOL, V139, P1479, DOI 10.1001/archderm.139.11.1479; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014	41	49	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113552	10.1371/journal.pone.0113552	http://dx.doi.org/10.1371/journal.pone.0113552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464511	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700035
J	Whitaker, KL; Scott, SE; Winstanley, K; Macleod, U; Wardle, J				Whitaker, Katriina L.; Scott, Suzanne E.; Winstanley, Kelly; Macleod, Una; Wardle, Jane			Attributions of Cancer 'Alarm' Symptoms in a Community Sample	PLOS ONE			English	Article							PATIENT DELAY; HELP-SEEKING; POPULATION-SAMPLE; PRIMARY-CARE; DIAGNOSIS; AWARENESS; INEQUALITIES; HEALTH; OVARIAN; LUNG	Background: Attribution of early cancer symptoms to a non-serious cause may lead to longer diagnostic intervals. We investigated attributions of potential cancer 'alarm' and non-alarm symptoms experienced in everyday life in a community sample of adults, without mention of a cancer context. Methods: A questionnaire was mailed to 4858 adults (>= 50 years old, no cancer diagnosis) through primary care, asking about symptom experiences in the past 3 months. The word cancer was not mentioned. Target 'alarm' symptoms, publicised by Cancer Research UK, were embedded in a longer symptom list. For each symptom experienced, respondents were asked for their attribution ('what do you think caused it'), concern about seriousness ('not at all' to 'extremely'), and help-seeking ('did you contact a doctor about it': Yes/No). Results: The response rate was 35% (n=1724). Over half the respondents (915/1724; 53%) had experienced an 'alarm' symptom, and 20 (2%) cited cancer as a possible cause. Cancer attributions were highest for 'unexplained lump'; 7% (6/87). Cancer attributions were lowest for 'unexplained weight loss' (0/47). A higher proportion (375/1638; 23%) were concerned their symptom might be 'serious', ranging from 12% (13/112) for change in a mole to 41% (100/247) for unexplained pain. Just over half had contacted their doctor about their symptom (59%), although this varied by symptom. Alarm symptoms were appraised as more serious than non-alarm symptoms, and were more likely to trigger help-seeking. Conclusions: Consistent with retrospective reports from cancer patients, 'alarm' symptoms experienced in daily life were rarely attributed to cancer. These results have implications for understanding how people appraise and act on symptoms that could be early warning signs of cancer.	[Whitaker, Katriina L.; Winstanley, Kelly; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 6BT, England; [Scott, Suzanne E.; Macleod, Una] Kings Coll London, Inst Dent, Unit Social & Behav Sci, London SE5 9RW, England; Hull York Med Sch, Ctr Hlth & Populat Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of London; University College London; University of London; King's College London; University of Hull; University of York - UK	Whitaker, KL (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 6BT, England.	k.whitaker@ucl.ac.uk	Whitaker, Katriina/AAA-6593-2020; Scott, Suzanne/A-4697-2009	Whitaker, Katriina/0000-0002-0947-1840; Scott, Suzanne/0000-0001-5536-9612	Cancer Research UK [C33872/A13216]; Cancer Research UK [13276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Postdoctoral Fellowship grant (C33872/A13216) awarded to Dr Katriina Whitaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Andersen RS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-189; Baker D, 2002, BRIT J GEN PRACT, V52, P124; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Cancer Research UK, 2014, CANC AW MEAS CAMS; Cancer Research UK, 2013, KEY SIGNS SYMPT; Cancer Research UK, 2013, CANC INC AGE; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Elliott AM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-21; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Health and Social Care Information Centre, 2012, ATTR DAT SET GP REG; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Low EL, 2013, J FAM PLAN REPROD H, V39, P163, DOI 10.1136/jfprhc-2012-100473; Lyratzopoulos G, 2013, ANN ONCOL, V24, P843, DOI 10.1093/annonc/mds526; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Mayor S, 2014, LANCET ONCOL, V15, pE7, DOI 10.1016/S1470-2045(13)70577-1; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; ONS, 2005, FOC ETHN ID DAT; ONS, 2001, CENS 2001 NAT REP 1; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Public Health England, 2014, BE CLEAR CANC; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Ristvedt SL, 2005, PSYCHO-ONCOLOGY, V14, P339, DOI 10.1002/pon.850; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; ROBBINS JM, 1991, PSYCHOL MED, V21, P1029, DOI 10.1017/S0033291700030026; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Scott S, 2010, SOC PERSONAL PSYCHOL, V4, P531, DOI 10.1111/j.1751-9004.2010.00287.x; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Svendsen RP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-686; Svendsen RP, 2010, SCAND J PRIM HEALTH, V28, P132, DOI 10.3109/02813432.2010.505412; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Walter FM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-62	38	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114028	10.1371/journal.pone.0114028	http://dx.doi.org/10.1371/journal.pone.0114028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461959	Green Published, gold			2022-12-27	WOS:000345869700084
J	Yee, K; Malliaras, K; Kanazawa, H; Tseliou, E; Cheng, K; Luthringer, DJ; Ho, CS; Takayama, K; Minamino, N; Dawkins, JF; Chowdhury, S; Duong, DT; Seinfeld, J; Middleton, RC; Dharmakumar, R; Li, DB; Marban, L; Makkar, RR; Marban, E				Yee, Kristine; Malliaras, Konstantinos; Kanazawa, Hideaki; Tseliou, Eleni; Cheng, Ke; Luthringer, Daniel J.; Ho, Chak-Sum; Takayama, Kentaro; Minamino, Naoto; Dawkins, James F.; Chowdhury, Supurna; Doan Trang Duong; Seinfeld, Jeffrey; Middleton, Ryan C.; Dharmakumar, Rohan; Li, Debiao; Marban, Linda; Makkar, Raj R.; Marban, Eduardo			Allogeneic Cardiospheres Delivered via Percutaneous Transendocardial Injection Increase Viable Myocardium, Decrease Scar Size, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy	PLOS ONE			English	Article							STEM-CELL THERAPY; BRAIN NATRIURETIC PEPTIDE; MOLECULAR-FORMS; HEART-FAILURE; FUNCTIONAL CONSEQUENCES; INFARCTION; TRANSPLANTATION; MODEL; OPTIMIZATION; REGENERATION	Background: Epicardial injection of heart-derived cell products is safe and effective post-myocardial infarction (MI), but clinically-translatable transendocardial injection has never been evaluated. We sought to assess the feasibility, safety and efficacy of percutaneous transendocardial injection of heart-derived cells in porcine chronic ischemic cardiomyopathy. Methods and Results: We studied a total of 89 minipigs; 63 completed the specified protocols. After NOGA-guided transendocardial injection, we quantified engraftment of escalating doses of allogeneic cardiospheres or cardiosphere-derived cells in minipigs (n=22) post-MI. Next, a dose-ranging, blinded, randomized, placebo-controlled ("dose optimization'') study of transendocardial injection of the better-engrafting product was performed in infarcted minipigs (n=16). Finally, the superior product and dose (150 million cardiospheres) were tested in a blinded, randomized, placebo-controlled ("pivotal'') study (n=22). Contrast-enhanced cardiac MRI revealed that all cardiosphere doses preserved systolic function and attenuated remodeling. The maximum feasible dose (150 million cells) was most effective in reducing scar size, increasing viable myocardium and improving ejection fraction. In the pivotal study, eight weeks post-injection, histopathology demonstrated no excess inflammation, and no myocyte hypertrophy, in treated minipigs versus controls. No alloreactive donor-specific antibodies developed over time. MRI showed reduced scar size, increased viable mass, and attenuation of cardiac dilatation with no effect on ejection fraction in the treated group compared to placebo. Conclusions: Dose-optimized injection of allogeneic cardiospheres is safe, decreases scar size, increases viable myocardium, and attenuates cardiac dilatation in porcine chronic ischemic cardiomyopathy. The decreases in scar size, mirrored by increases in viable myocardium, are consistent with therapeutic regeneration.	[Yee, Kristine; Malliaras, Konstantinos; Kanazawa, Hideaki; Tseliou, Eleni; Cheng, Ke; Luthringer, Daniel J.; Dawkins, James F.; Chowdhury, Supurna; Doan Trang Duong; Seinfeld, Jeffrey; Middleton, Ryan C.; Marban, Linda; Makkar, Raj R.; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Cheng, Ke] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Cheng, Ke] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Cheng, Ke] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27695 USA; [Cheng, Ke] N Carolina State Univ, Raleigh, NC 27695 USA; [Ho, Chak-Sum] Gift Life Michigan, Ann Arbor, MI USA; [Takayama, Kentaro; Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka, Japan; [Dharmakumar, Rohan; Li, Debiao] Cedars Sinai Biomed Imaging Res Inst, Los Angeles, CA USA; [Marban, Linda; Marban, Eduardo] Capricor, Beverly Hills, CA USA	Cedars Sinai Medical Center; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; National Cerebral & Cardiovascular Center - Japan; Cedars Sinai Medical Center	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	marbane@cshs.org	Cheng, Ke/HCH-8846-2022; Marban, Eduardo/GWC-8514-2022		California Institute for Regenerative Medicine (San Francisco, CA) [DR1-01461]; International Society for Heart and Lung Transplantation (Addison, TX) fellowship; Lincy Foundation (Las Vegas, NV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116273] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (San Francisco, CA)(California Institute for Regenerative Medicine); International Society for Heart and Lung Transplantation (Addison, TX) fellowship; Lincy Foundation (Las Vegas, NV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the California Institute for Regenerative Medicine (#DR1-01461, San Francisco, CA) to EM, http://www.cirm.ca.gov/. Additional support came from the International Society for Heart and Lung Transplantation (Addison, TX) fellowship to KM, http://www.ishlt.org/. Support came from the Lincy Foundation (Las Vegas, NV) to RRM, http://www.unlv.edu/lincyinstitute/foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABURAYA M, 1989, BIOCHEM BIOPH RES CO, V165, P872, DOI 10.1016/S0006-291X(89)80047-6; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Crisostomo Veronica, 2013, ISRN Cardiol, V2013, P781762, DOI 10.1155/2013/781762; Dauwe DF, 2011, CURR PHARM DESIGN, V17, P3328; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; George JC, 2008, J INTERV CARDIOL, V21, P424, DOI 10.1111/j.1540-8183.2008.00390.x; Ho CS, 2010, ANIM GENET, V41, P428, DOI 10.1111/j.1365-2052.2010.02019.x; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2011, CIRCULATION, V124; Krause K, 2010, CARDIOVASC THER, V28, pe101, DOI 10.1111/j.1755-5922.2010.00208.x; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Lehrke S, 2006, CIRC RES, V99, P553, DOI 10.1161/01.RES.0000238375.88582.d8; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2013, CIRCULATION; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; MIYATA A, 1985, BIOCHEM BIOPH RES CO, V129, P248, DOI 10.1016/0006-291X(85)91429-9; Nishikimi T, 2010, HEART, V96, P432, DOI 10.1136/hrt.2009.178392; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Perin EC, 2011, CARDIOVASC THER, V29, P211, DOI 10.1111/j.1755-5922.2010.00214.x; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasano T, 2006, NAT MED, V12, P1256, DOI 10.1038/nm1503; Schuleri KH, 2008, COMPARATIVE MED, V58, P568; Sisson DD, 2004, VET CLIN N AM-SMALL, V34, P1105, DOI 10.1016/j.cvsm.2004.05.005; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Theilmeier G, 2002, CIRCULATION, V106, P1140, DOI 10.1161/01.CIR.0000026805.41747.54; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tseliou E, 2011, CIRCULATION, V124; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x; Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Weil BR, 2013, CLIN SCI, V125, P109, DOI 10.1042/CS20120641; Williams AR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000140; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; 2014, LANCET, V383, P1279	56	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113805	10.1371/journal.pone.0113805	http://dx.doi.org/10.1371/journal.pone.0113805			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460005	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700056
J	Yu, SS; Chen, LY; Ye, LL; Fei, LN; Tang, W; Tian, YJ; Geng, Q; Yi, X; Xie, JS				Yu, Shanshan; Chen, Liyuan; Ye, Lili; Fei, Lingna; Tang, Wei; Tian, Yujiao; Geng, Qian; Yi, Xin; Xie, Jiansheng			Identification of Two Missense Mutations of ERCC6 in Three Chinese Sisters with Cockayne Syndrome by Whole Exome Sequencing	PLOS ONE			English	Article							GROUP-B GENE; NUCLEOTIDE EXCISION-REPAIR; ATPASE DOMAIN; CSB PROTEIN	Cockayne syndrome (CS) is a rare autosomal recessive disorder, the primary manifestations of which are poor growth and neurologic abnormality. Mutations of the ERCC6 and ERCC8 genes are the predominant cause of Cockayne syndrome, and the ERCC6 gene mutation is present in approximately 65% of cases. The present report describes a case of Cockayne syndrome in a Chinese family, with the patients carrying two missense mutations (c. 1595A>G, p.Asp532Gly and c. 1607T>G, p.Leu536Trp) in the ERCC6 gene in an apparently compound heterozygote status, especially, p.Asp532Gly has never been reported. The compound heterozygote mutation was found in three patients in the family using whole exome sequencing. The patients' father and mother carried a heterozygous allele at different locations of the ERCC6 gene, which was confirmed by Sanger DNA sequencing. The two mutations are both located in the highly conserved motif I of ATP-binding helicase and are considered "Damaging,'' "Probably Damaging,'' "Disease Causing,'' and "Conserved'', indicating the role of DNA damage in the pathogenetic process of the disease. The results not only enrich the ERCC6 mutations database, but also indicate that whole exome sequencing will be a powerful tool for discovering the disease causing mutations in clinical diagnosis.	[Yu, Shanshan; Ye, Lili; Fei, Lingna; Tang, Wei; Tian, Yujiao; Yi, Xin] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Chen, Liyuan; Geng, Qian; Xie, Jiansheng] Shenzhen Matern & Child Healthcare Hosp, Prenatal Diag Ctr, Shenzhen 518048, Peoples R China	Beijing Genomics Institute (BGI)	Yi, X (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	yix@genomics.cn; jsxie2007@hotmail.com			Science and Technology Project of Shenzhen [201001016]	Science and Technology Project of Shenzhen	This work was supported by the Science and Technology Project of Shenzhen (201001016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; BOOTSMA D, 1995, PHILOS T ROY SOC B, V347, P75, DOI 10.1098/rstb.1995.0012; Brosh RM, 1999, MOL BIOL CELL, V10, P3583, DOI 10.1091/mbc.10.11.3583; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; Muftuoglu M, 2002, GENE, V283, P27, DOI 10.1016/S0378-1119(01)00870-8; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Pasquier L, 2006, ARCH DIS CHILD, V91, P178, DOI 10.1136/adc.2005.080473; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Selzer RR, 2002, NUCLEIC ACIDS RES, V30, P782, DOI 10.1093/nar/30.3.782; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Xin B, 2012, MOL SYNDROMOL, V3, P288, DOI 10.1159/000345924; Zhang HW, 2011, EUR J MED GENET, V54, pE389, DOI 10.1016/j.ejmg.2011.03.012	23	6	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113914	10.1371/journal.pone.0113914	http://dx.doi.org/10.1371/journal.pone.0113914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463447	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700069
J	Agarwal, R; Denning, DW; Chakrabarti, A				Agarwal, Ritesh; Denning, David W.; Chakrabarti, Arunaloke			Estimation of the Burden of Chronic and Allergic Pulmonary Aspergillosis in India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BRONCHOPULMONARY ASPERGILLOSIS; SEVERE ASTHMA; RESPIRATORY SYMPTOMS; FUNGAL SENSITIZATION; ANTIFUNGAL TREATMENT; GLOBAL BURDEN; HEALTH SURVEY; PREVALENCE; TUBERCULOSIS	Background and Objectives: It would be of considerable interest to clinicians if the burden of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) in India were known. Herein, we estimate the burden of CPA following pulmonary tuberculosis (PTB), and ABPA (and severe asthma with fungal sensitization [SAFS]) complicating asthma. Methods: We used the population estimates for India from the 2011 census data. The burden of asthma was estimated using three different methods (Global Initiative against Asthma [GINA] report statement, World Health Survey [WHS] estimates, Indian study on the epidemiology of asthma and chronic bronchitis [INSEARCH]). Global and India-specific figures were used for calculating the prevalence of ABPA and SAFS. The World Health Organization estimates were used for calculating PTB rates while the frequency of CPA was assessed from a previously published scoping review. Sensitivity analysis was performed to determine the burden in various scenarios. Results: The total Indian population in 2011 was 1.2 billion. The asthma prevalence in adults was estimated at about 27.6 (range, 17-30) million. The burden of ABPA ranged from 0.12-6.09 million with different assumptions (best estimate, 1.38 [range, 0.86-1.52] million). The prevalence of SAFS was approximated at about 0.52-1.21 million (best estimate, 0.96 [range, 0.6-1.06] million). The incident TB cases were about 2.1 million while the annual incidence of CPA varied 27,000-0.17 million cases, with different estimates. If the mortality of CPA is estimated as 15% annually, the 5-year prevalence of CPA was placed at 290,147 cases with 5-year prevalence rate being 24 per 100,000. Conclusion: There is a significant burden of ABPA, SAFS and CPA in India. Prospective community-based studies are required to accurately determine the prevalence of these disorders.	[Agarwal, Ritesh] PGIMER, Dept Pulm Med, Chandigarh, India; [Denning, David W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M23 9LT, Lancs, England; [Chakrabarti, Arunaloke] PGIMER, Dept Med Microbiol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), PGIMER, Dept Pulm Med, Chandigarh, India.	agarwal.ritesh@live.com	Denning, David/AAC-6931-2019; Agarwal, Ritesh/A-3063-2009	Denning, David/0000-0001-5626-2251; Agarwal, Ritesh/0000-0003-2547-7668	National Institute of Allergy and Infectious Diseases, National Institute of Health Research; European Union; AstraZeneca; Astellas; GSK; Gilead; Pfizer	National Institute of Allergy and Infectious Diseases, National Institute of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)National Institute for Health Research (NIHR)); European Union(European Commission); AstraZeneca(AstraZeneca); Astellas(Astellas Pharmaceuticals); GSK(GlaxoSmithKline); Gilead(Gilead Sciences); Pfizer(Pfizer)	Dr. Denning holds founder shares in F2G Ltd a University of Manchester spin-out company and has current grant support from the National Institute of Allergy and Infectious Diseases, National Institute of Health Research, the European Union and AstraZeneca. He acts as a consultant to Trinity group, T2 Biosystems, GSK, as well as other companies over the last 5 years including Pfizer, Schering Plough (now Merck), Astellas and Gilead. In the last 3 years, he has been paid for talks on behalf of Astellas, GSK, Gilead and Pfizer. The other authors have no competing interests to report. The competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2007, CHEST, V132, P1183, DOI 10.1378/chest.07-0808; Agarwal R, 2013, FUTURE MICROBIOL, V8, P1463, DOI 10.2217/fmb.13.116; Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Agarwal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061105; Agarwal R, 2012, EXPERT REV RESP MED, V6, P363, DOI [10.1586/ers.12.35, 10.1586/ERS.12.35]; Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Agarwal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015346; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P707, DOI 10.1007/978-90-481-2408-4_42; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Agbetile J, 2013, J ALLERGY CLIN IMMUN; Al-shair K, 2013, CLIN INFECT DIS, V57, P828, DOI 10.1093/cid/cit411; [Anonymous], 1970, Tubercle, V51, P227; [Anonymous], 1968, TUBERCLE, V49, P1; Beasley R., GLOBAL BURDEN ASTHMA; Bombarda Sidney, 2003, Sao Paulo Med. J., V121, P198, DOI 10.1590/S1516-31802003000500004; Chowgule RV, 1998, AM J RESP CRIT CARE, V158, P547, DOI 10.1164/ajrccm.158.2.9708064; Denning DW, 2013, EUR RESPIR J, V41, P621, DOI 10.1183/09031936.00226911; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Denning DW, 2009, AM J RESP CRIT CARE, V179, P11, DOI 10.1164/rccm.200805-737OC; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Dhooria S, 2014, INT J TUBERC LUNG D, V18, P850, DOI 10.5588/ijtld.13.0838; Ghosh Tapashi, 2010, J Indian Med Assoc, V108, P863; Global tuberculosis database, INC MORT PERC PULM T; Hogan C, 2011, SEMIN RESP CRIT CARE, V32, P682, DOI 10.1055/s-0031-1295716; Jindal SK, 2012, INT J TUBERC LUNG D, V16, P1270, DOI 10.5588/ijtld.12.0005; KHAN ZU, 1976, SCAND J RESPIR DIS, V57, P73; Kurhade A M, 2002, Indian J Med Microbiol, V20, P141; Maurya V, 2005, CHEST, V127, P1252, DOI 10.1378/chest.127.4.1252; Shahid M, 2001, Indian J Med Microbiol, V19, P201; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; TB India, 2013, RNTCP ANN STAT REP; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204	36	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114745	10.1371/journal.pone.0114745	http://dx.doi.org/10.1371/journal.pone.0114745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478929	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200121
J	Herbert, AD; Carr, AM; Hoffmann, E				Herbert, Alex D.; Carr, Antony M.; Hoffmann, Eva			FindFoci: A Focus Detection Algorithm with Automated Parameter Training That Closely Matches Human Assignments, Reduces Human Inconsistencies and Increases Speed of Analysis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IMAGE-ANALYSIS; GAMMA-H2AX FOCI; SUBCELLULAR LOCATION; CELLS; PROTEIN; MEIOSIS; REPAIR; IDENTIFICATION; RECOMBINATION	Accurate and reproducible quantification of the accumulation of proteins into foci in cells is essential for data interpretation and for biological inferences. To improve reproducibility, much emphasis has been placed on the preparation of samples, but less attention has been given to reporting and standardizing the quantification of foci. The current standard to quantitate foci in open-source software is to manually determine a range of parameters based on the outcome of one or a few representative images and then apply the parameter combination to the analysis of a larger dataset. Here, we demonstrate the power and utility of using machine learning to train a new algorithm (FindFoci) to determine optimal parameters. FindFoci closely matches human assignments and allows rapid automated exploration of parameter space. Thus, individuals can train the algorithm to mirror their own assignments and then automate focus counting using the same parameters across a large number of images. Using the training algorithm to match human assignments of foci, we demonstrate that applying an optimal parameter combination from a single image is not broadly applicable to analysis of other images scored by the same experimenter or by other experimenters. Our analysis thus reveals wide variation in human assignment of foci and their quantification. To overcome this, we developed training on multiple images, which reduces the inconsistency of using a single or a few images to set parameters for focus detection. FindFoci is provided as an open-source plugin for ImageJ.	[Herbert, Alex D.; Carr, Antony M.; Hoffmann, Eva] Univ Sussex, Sch Life Sci, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Herbert, AD (corresponding author), Univ Sussex, Sch Life Sci, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.herbert@sussex.ac.uk	hoffmann, eva/AAM-6594-2020	hoffmann, eva/0000-0002-2588-0652; Herbert, Alex/0000-0002-9843-9980; Carr, Antony Michael/0000-0002-2028-2389	Medical Research Council [G1100074]; Medical Research Council, UK [G0902043]; Medical Research Council [G0902043] Funding Source: researchfish; MRC [G1100074, G0902043] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AMC was funded by Medical Research Council grant G1100074. ERH was funded by a Senior Research Nonclinical Fellowship G0902043 from the Medical Research Council, UK (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Bergman A, 2014, CELL ADHES MIGR, V8, P1; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; Chakravorty R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083251; Copsey A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004071; Das DK, 2013, MICRON, V45, P97, DOI 10.1016/j.micron.2012.11.002; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Gonzalez JE, 2012, ANAL QUANT CYTOL, V34, P66; Firsanov DV, 2011, CLIN EPIGENETICS, V2, P283, DOI 10.1007/s13148-011-0044-4; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Herold J, 2010, J BIOTECHNOL, V149, P299, DOI 10.1016/j.jbiotec.2010.03.004; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jakob B, 2012, RADIAT RES, V177, P524, DOI 10.1667/RR2452.1; Jucha A, 2010, MUTAT RES-GEN TOX EN, V696, P16, DOI 10.1016/j.mrgentox.2009.12.004; Kneitz B, 2000, GENE DEV, V14, P1085; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Ma LY, 2012, IEEE ACM T COMPUT BI, V9, P228, DOI 10.1109/TCBB.2011.52; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Murphy RF, 2008, I S BIOMED IMAGING, P308, DOI 10.1109/ISBI.2008.4540994; Narayanaswamy R, 2009, J PROTEOME RES, V8, P6, DOI 10.1021/pr800524g; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders WS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sheng JJ, 2011, DRUG METAB DISPOS, V39, P1334, DOI 10.1124/dmd.111.039537; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Slattery SD, 2012, ASSAY DRUG DEV TECHN, V10, P161, DOI 10.1089/adt.2011.0397; Smith K, 2014, J BIOMOL SCREEN, V19, P685, DOI 10.1177/1087057114527313; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Sundstrom A, 2012, IEEE T INF TECHNOL B, V16, P1200, DOI 10.1109/TITB.2012.2206819; Svensson CM, 2014, CYTOM PART A, V85A, P501, DOI 10.1002/cyto.a.22471; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Toyoda T, 2013, J TOXICOL PATHOL, V26, P215, DOI 10.1293/tox.26.215; Vizcaino C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000824; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095265; Wheeler RE, 2010, MULTRESP IMPERM; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891	46	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114749	10.1371/journal.pone.0114749	http://dx.doi.org/10.1371/journal.pone.0114749			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478967	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000346907200122
J	Berenbaum, F; Chauvin, P; Hudry, C; Mathoret-Philibert, F; Poussiere, M; De Chalus, T; Dreuillet, C; Russo-Marie, F; Joubert, JM; Saraux, A				Berenbaum, Francis; Chauvin, Pierre; Hudry, Christophe; Mathoret-Philibert, Florence; Poussiere, Maud; De Chalus, Thibault; Dreuillet, Caroline; Russo-Marie, Francoise; Joubert, Jean-Michel; Saraux, Alain			Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; META-ETHNOGRAPHY; DISEASE STATUS; DIAGNOSIS; INTERVENTIONS; PERCEPTIONS; PREVALENCE; VALIDATION; FRANCE	Objectives: To explore beliefs and apprehensions about disease and its treatment in patients with rheumatoid arthritis and spondyloarthritis. Methods: 25 patients with rheumatoid arthritis and 25 with spondyloarthritis participated in semi-structured interviews about their disease and its treatment. The interviews were performed by trained interviewers in participants' homes. The interviews were recorded and the main themes identified by content analysis. Results: Patients differentiated between the underlying cause of the disease, which was most frequently identified as a hereditary or individual predisposition. In patients with rheumatoid arthritis, the most frequently cited triggering factor for disease onset was a psychological factor or life-event, whereas patients with spondyloarthritis tended to focus more on an intrinsic vulnerability to disease. Stress and overexertion were considered important triggering factors for exacerbations, and relaxation techniques were frequently cited strategies to manage exacerbations. The unpredictability of the disease course was a common source of anxiety. Beliefs about the disease and apprehensions about the future tended to evolve over the course of the disease, as did treatment expectations. Conclusions: Patients with rheumatoid arthritis and spondyloarthritis hold a core set of beliefs and apprehensions that reflect their level of information about their disease and are not necessarily appropriate. The physician can initiate discussion of these beliefs in order to dispel misconceptions, align treatment expectations, provide reassurance to the patient and readjust disease management. Such a dialogue would help improve standards of care in these chronic and incapacitating diseases.	[Berenbaum, Francis] Sorbonne Univ, Univ Paris 06, Hop St Antoine, AP HP,Dept Rheumatol, Paris, France; [Chauvin, Pierre] Sorbonne Univ, Univ Paris 06, INSERM,UMR S 1136, Pierre Louis Inst Epidemiol & Publ Hlth,Dept Soci, Paris, France; [Hudry, Christophe] Hop La Pitie Salpetriere, AP HP, Dept Rheumatol, Paris, France; [Mathoret-Philibert, Florence] Hop Cochin, AP HP, Dept Clin Psychol, F-75674 Paris, France; [De Chalus, Thibault; Joubert, Jean-Michel] UCB Labs, Colombes, France; [Dreuillet, Caroline; Russo-Marie, Francoise] Arthrit Fdn Courtin, Neuilly Sur Seine, France; [Saraux, Alain] CHU La Cavale Blanche, Dept Rheumatol, Brest, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest	Berenbaum, F (corresponding author), Sorbonne Univ, Univ Paris 06, Hop St Antoine, AP HP,Dept Rheumatol, Paris, France.	francis.berenbaum@sat.aphp.fr	Berenbaum, Francis/AAO-5690-2020; Chauvin, Pierre/S-2981-2019	Berenbaum, Francis/0000-0001-8252-7815; Chauvin, Pierre/0000-0002-9183-6406; Hudry, Christophe/0000-0002-1036-3660	Arthritis Fundation; French charitable organisation; UCB Pharma	Arthritis Fundation; French charitable organisation; UCB Pharma(UCB Pharma SA)	The work was jointly funded and supported by Arthritis Fundation, a French charitable organisation dedicated to the promotion and support of biomedical research on severe joint diseases, and UCB Pharma. The funder provided support in the form of salaries for authors TDC, CD, FR-M and JMJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Berry D, 2004, RHEUMATOLOGY, V43, P901, DOI 10.1093/rheumatology/keh196; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430; Daker-White G, 2014, DISABIL REHABIL, V36, P1061, DOI 10.3109/09638288.2013.829531; de Thurah A, 2010, RHEUMATOL INT, V30, P1441, DOI 10.1007/s00296-009-1160-8; Dissanayake RK, 2010, INT J RHEUM DIS, V13, P324, DOI 10.1111/j.1756-185X.2010.01563.x; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gettings L, 2010, MUSCULOSKELET CARE, V8, P99, DOI 10.1002/msc.171; Goodacre LJ, 2004, RHEUMATOLOGY, V43, P583, DOI 10.1093/rheumatology/keh116; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Gossec L, 2012, REV RHUM, V79, pA133; Groarke A, 2004, RHEUMATOLOGY, V43, P1142, DOI 10.1093/rheumatology/keh262; Guillemin F, 2005, ANN RHEUM DIS, V64, P1427, DOI 10.1136/ard.2004.029199; HAWLEY DJ, 1995, BAILLIERE CLIN RHEUM, V9, P803, DOI 10.1016/S0950-3579(05)80315-2; Haywood KL, 2010, J RHEUMATOL, V37, P2100, DOI 10.3899/jrheum.091359; Kataria RK, 2004, AM FAM PHYSICIAN, V69, P2853; Lin WC, 2011, J NURS RES, V19, P1, DOI 10.1097/JNR.0b013e31820b0f8c; Lutze U, 2007, SCAND J CARING SCI, V21, P64, DOI 10.1111/j.1471-6712.2007.00443.x; McLeod K, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/197454; Pouchot J, 2007, JOINT BONE SPINE, V74, P622, DOI 10.1016/j.jbspin.2006.11.024; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Reveille JD, 2005, J RHEUMATOL, V32, P10; Rindfleisch JA, 2005, AM FAM PHYSICIAN, V72, P1037; Rudwaleit M, 2012, NAT REV RHEUMATOL, V8, P262, DOI 10.1038/nrrheum.2012.39; Salminen E, 2002, PREV MED, V34, P529, DOI 10.1006/pmed.2002.1015; Saraux A, 2005, ANN RHEUM DIS, V64, P1431, DOI 10.1136/ard.2004.029207; Sokka T, 2009, CURR OPIN RHEUMATOL, V21, P284, DOI 10.1097/BOR.0b013e32832a2f02; Stack RJ, 2013, ARTHRIT CARE RES, V65, P1916, DOI 10.1002/acr.22097; Stack RJ, 2012, ANN RHEUM DIS, V71, P493, DOI 10.1136/ard.2011.155416; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	31	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114350	10.1371/journal.pone.0114350	http://dx.doi.org/10.1371/journal.pone.0114350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474157	Green Published, gold			2022-12-27	WOS:000346382500023
J	Scala, G; Affinito, O; Miele, G; Monticelli, A; Cocozza, S				Scala, Giovanni; Affinito, Ornella; Miele, Gennaro; Monticelli, Antonella; Cocozza, Sergio			Evidence for Evolutionary and Nonevolutionary Forces Shaping the Distribution of Human Genetic Variants near Transcription Start Sites	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; INDUCED DNA LESIONS; HUMAN GENOME; CPG ISLANDS; GC-CONTENT; MAMMALIAN EVOLUTION; HOUSEKEEPING GENES; CHROMATIN; ORGANIZATION; REPLICATION	The regions surrounding transcription start sites (TSSs) of genes play a critical role in the regulation of gene expression. At the same time, current evidence indicates that these regions are particularly stressed by transcription-related mutagenic phenomena. In this work we performed a genome-wide analysis of the distribution of single nucleotide polymorphisms (SNPs) inside the 10 kb region flanking human TSSs by dividing SNPs into four classes according to their frequency (rare, two intermediate classes, and common). We found that, in this 10 kb region, the distribution of variants depends on their frequency and on their localization relative to the TSS. We found that the distribution of variants is generally different for TSSs located inside or outside of CpG islands. We found a significant relationship between the distribution of rare variants and nucleosome occupancy scores. Furthermore, our analysis suggests that evolutionary (purifying selection) and nonevolutionary (biased gene conversion) forces both play a role in determining the relative SNP frequency around TSSs. Finally, we analyzed the potential pathogenicity of each class of variant using the Combined Annotation Dependent Depletion score. In conclusion, this study provides a novel and detailed view of the distribution of genomic variants around TSSs, providing insight into the forces that instigate and maintain variability in such critical regions.	[Scala, Giovanni; Affinito, Ornella; Miele, Gennaro; Monticelli, Antonella; Cocozza, Sergio] Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy; [Scala, Giovanni; Miele, Gennaro] Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [Scala, Giovanni; Miele, Gennaro] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Affinito, Ornella; Cocozza, Sergio] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Affinito, Ornella; Monticelli, Antonella] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Scala, G (corresponding author), Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	gscala@na.infn.it	Cocozza, Sergio/F-6488-2010; Miele, Gennaro/F-3628-2010; Affinito, Ornella/AAC-1003-2019; Miele, Gennaro/AAG-6782-2020	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578; SCALA, GIOVANNI/0000-0002-9037-1782; , Ornella/0000-0002-8355-9509	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples; Epigenomic Flagship Project-Epigen; CNR; POR Campania FSE; CREME	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples; Epigenomic Flagship Project-Epigen; CNR(Consiglio Nazionale delle Ricerche (CNR)); POR Campania FSE(Regione Campania); CREME	GS and OA are recipients of a doctoral fellowship from the Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples. This work was partially supported by the Epigenomic Flagship Project-Epigen, CNR and by POR Campania FSE 2007-2013, Project CREME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Basak S, 2005, BIOCHEM BIOPH RES CO, V330, P629, DOI 10.1016/j.bbrc.2005.02.134; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Capra JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003684; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cui Peng, 2012, Genomics Proteomics & Bioinformatics, V10, P11, DOI 10.1016/S1672-0229(11)60029-6; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Gontijo AM, 2003, BIOCHIMIE, V85, P1133; De Maio N, 2013, MOL BIOL EVOL, V30, P2249, DOI 10.1093/molbev/mst131; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo YJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-140; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Higasa K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-66; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hurst LD, 2000, GENE, V261, P107, DOI 10.1016/S0378-1119(00)00489-3; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Kimura M, 1985, NEUTRAL THEORY MOL E; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; Necsulea A, 2009, MOL BIOL EVOL, V26, P729, DOI 10.1093/molbev/msn303; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Polak P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-187; Polak P, 2009, GENOME BIOL EVOL, V1, P189, DOI 10.1093/gbe/evp024; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	62	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114432	10.1371/journal.pone.0114432	http://dx.doi.org/10.1371/journal.pone.0114432			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474578	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500027
J	Lee, WL; Tan, JWM; Tan, CN; Loo, SCJ				Lee, Wei Li; Tan, Jun Wei Melvin; Tan, Chaoyang Nicholas; Loo, Say Chye Joachim			Modulating Drug Release from Gastric-Floating Microcapsules through Spray-Coating Layers	PLOS ONE			English	Article							RIBOFLAVIN-CONTAINING MICROBALLOONS; IN-VIVO EVALUATION; SUSTAINED-RELEASE; DELIVERY-SYSTEMS; VITRO; MICROSPHERES; PHARMACOKINETICS; BIOAVAILABILITY; MICROPARTICLES; FENOFIBRATE	Floating dosage forms with prolonged gastric residence time have garnered much interest in the field of oral delivery. However, studies had shown that slow and incomplete release of hydrophobic drugs during gastric residence period would reduce drug absorption and cause drug wastage. Herein, a spray-coated floating microcapsule system was developed to encapsulate fenofibrate and piroxicam, as model hydrophobic drugs, into the coating layers with the aim of enhancing and tuning drug release rates. Incorporating fenofibrate into rubbery poly(caprolactone) (PCL) coating layer resulted in a complete and sustained release for up to 8 h, with outermost non-drug-holding PCL coating layer serving as a rate-controlling membrane. To realize a multidrug-loaded system, both hydrophilic metformin HCl and hydrophobic fenofibrate were simultaneously incorporated into these spray-coated microcapsules, with metformin HCl and fenofibrate localized within the hollow cavity of the capsule and coating layer, respectively. Both drugs were observed to be completely released from these coated microcapsules in a sustained manner. Through specific tailoring of coating polymers and their configurations, piroxicam loaded in both the outer polyethylene glycol and inner PCL coating layers was released in a double-profile manner (i.e. an immediate burst release as the loading dose, followed by a sustained release as the maintenance dose). The fabricated microcapsules exhibited excellent buoyancy in simulated gastric fluid, and provided controlled and sustained release, thus revealing its potential as a rate-controlled oral drug delivery system.	[Lee, Wei Li; Tan, Jun Wei Melvin; Tan, Chaoyang Nicholas; Loo, Say Chye Joachim] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Loo, SCJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.	joachimloo@ntu.edu.sg	Loo, Say Chye Joachim/A-2234-2011; Lee, Wei Li/F-9095-2010	Loo, Say Chye Joachim/0000-0001-5300-1275; Lee, Wei Li/0000-0002-9720-3407	Singapore Centre on Environmental Life Sciences Engineering (SCELSE) [M4330001.C70.703012]; School of Materials Science and Engineering [M020070110]; Solar Fuels Laboratory Nanyang Technological University [M060070008]; NTU-National Healthcare Group (NTU-NHG) [ARG/14012]	Singapore Centre on Environmental Life Sciences Engineering (SCELSE); School of Materials Science and Engineering; Solar Fuels Laboratory Nanyang Technological University(Nanyang Technological University); NTU-National Healthcare Group (NTU-NHG)	The authors would also like to acknowledge the financial support from the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) (M4330001.C70.703012), the School of Materials Science and Engineering (M020070110), Solar Fuels Laboratory Nanyang Technological University (M060070008), and the NTU-National Healthcare Group (NTU-NHG) grant (ARG/14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2007, EUR J PHARM BIOPHARM, V67, P196, DOI 10.1016/j.ejpb.2006.12.015; Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007; Danki L., 2010, INT J PHARM BIO SCI, V1, P1; Dashevsky A, 2004, EUR J PHARM BIOPHARM, V58, P45, DOI 10.1016/j.ejpb.2004.03.013; DAVIES NM, 1995, DIS COLON RECTUM, V38, P1311, DOI 10.1007/BF02049158; ERNI W, 1987, European Neurology, V27, P21, DOI 10.1159/000116171; Frank A, 2005, J CONTROL RELEASE, V102, P333, DOI 10.1016/j.jconrel.2004.10.019; Girotto C, 2009, SOL ENERG MAT SOL C, V93, P454, DOI 10.1016/j.solmat.2008.11.052; Girotto C, 2009, ORG ELECTRON, V10, P735, DOI 10.1016/j.orgel.2009.03.006; He W, 2011, INT J NANOMED, V6, P521, DOI 10.2147/IJN.S17282; Hwang SJ, 1998, CRIT REV THER DRUG, V15, P243; Joseph NJ, 2002, J CONTROL RELEASE, V79, P71, DOI 10.1016/S0168-3659(01)00507-7; Krishnamachari Y, 2007, INT J PHARM, V338, P238, DOI 10.1016/j.ijpharm.2007.02.015; Kumar A., 2011, PHARM GLOBALE IJCP, V3, P1, DOI DOI 10.7763/IJET.2011.V3.191; Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024; Lee WL, 2013, J MATER CHEM B, V1, P1090, DOI 10.1039/c2tb00495j; Lee WL, 2012, J BIOMED MATER RES A, V100A, P3353, DOI 10.1002/jbm.a.34292; Lee WL, 2012, J PHARM SCI-US, V101, P2787, DOI 10.1002/jps.23191; Lee WL, 2011, J CONTROL RELEASE, V151, P229, DOI 10.1016/j.jconrel.2011.02.012; Liu YF, 2011, INT J PHARMACEUT, V413, P103, DOI 10.1016/j.ijpharm.2011.04.030; Ma NN, 2008, INT J PHARMACEUT, V358, P82, DOI 10.1016/j.ijpharm.2008.02.024; Meka L, 2008, AAPS PHARMSCITECH, V9, P612, DOI 10.1208/s12249-008-9090-4; Naha PC, 2008, J MICROENCAPSUL, V25, P248, DOI [10.1080/02652040801903843, 10.1080/02652040801903843 ]; Nayak A, 2011, MOL PHARMACEUT, V8, P2273, DOI 10.1021/mp2001395; Sastry, 2000, Pharm Sci Technol Today, V3, P138; Sato Y, 2004, J CONTROL RELEASE, V98, P75, DOI 10.1016/j.jconrel.2004.04.021; Sato Y, 2004, INT J PHARM, V275, P97, DOI 10.1016/j.ijpharm.2004.01.036; Sato Y, 2004, EUR J PHARM BIOPHARM, V57, P235, DOI 10.1016/s0939-6411(03)00185-1; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0; Singh A., 2008, WO Pat., Patent No. [WO/2008/062,440, 2008062440, WO/2008/062440]; Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7; Streubel Alexander, 2006, Expert Opin Drug Deliv, V3, P217, DOI 10.1517/17425247.3.2.217; Tang YD, 2007, INT J PHARMACEUT, V336, P159, DOI 10.1016/j.ijpharm.2006.11.060; Van Speybroeck M, 2010, EUR J PHARM SCI, V41, P623, DOI 10.1016/j.ejps.2010.09.002; VERBEECK RK, 1986, J RHEUMATOL, V13, P789; Zhu T, 2010, J CLIN PHARMACOL, V50, P914, DOI 10.1177/0091270009354995	36	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114284	10.1371/journal.pone.0114284	http://dx.doi.org/10.1371/journal.pone.0114284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470374	Green Published, gold			2022-12-27	WOS:000349128700096
J	McCrea, K; Ward, R; LaRosa, SP				McCrea, Keith; Ward, Robert; LaRosa, Steven P.			Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media	PLOS ONE			English	Article								Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) are becoming more frequent and are associated with a high mortality. At present, combination antimicrobial therapy yields the best outcomes, but treatment options are limited. Many bacteria utilize heparan sulfate to bind to human cells. We studied the ability of a biomimetic device composed of polyethylene beads with endpoint-attached heparin to bind both sensitive and (CRE) E. coli and Klebsiella pneumoniae from spiked blood samples. Greater than 90% of susceptible, E. coli, CRE E. coli and CRE Klebsiella were removed by the beads. Future studies in human bacteremia with this technology are planned.	[McCrea, Keith; Ward, Robert] ExThera Med Corp, Berkeley, CA 94710 USA; [LaRosa, Steven P.] Beverly Hosp, Lahey Hlth Syst, Beverly, MA 01915 USA	Lahey Hospital & Medical Center	LaRosa, SP (corresponding author), Beverly Hosp, Lahey Hlth Syst, 85 Herrick St, Beverly, MA 01915 USA.	slarosamd@gmail.com			ExThera Medical Corporation; ExThera	ExThera Medical Corporation; ExThera	This work was funded by ExThera Medical Corporation. This study was funded by ExThera and two of the authors RW and KM are employees of ExThera. Author SPL is a paid consultant of Exthera. All three authors played an active role in study design, data collection, and analysis, decision to publish and the preparation of this manuscript.	Arnold RS, 2011, SOUTH MED J, V104, P40, DOI 10.1097/SMJ.0b013e3181fd7d5a; Bartlett AH, 2011, BIOL EXTRACELL MATR, P31, DOI 10.1007/978-3-642-16833-8_2; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Falagas ME, 2014, ANTIMICROB AGENTS CH, V58, P654, DOI 10.1128/AAC.01222-13; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804; Mattsby-Baltzer I, 2011, J MICROBIOL BIOTECHN, V21, P659, DOI 10.4014/jmb.1102.02016; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Sahly H, 2008, ANTIMICROB AGENTS CH, V52, P3029, DOI 10.1128/AAC.00010-08	9	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e11424	10.1371/journal.pone.0114242	http://dx.doi.org/10.1371/journal.pone.0114242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469782	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700091
J	Pauletto, M; Milan, M; de Sousa, JT; Huvet, A; Joaquim, S; Matias, D; Leitao, A; Patarnello, T; Bargelloni, L				Pauletto, Marianna; Milan, Massimo; de Sousa, Joana Teixeira; Huvet, Arnaud; Joaquim, Sandra; Matias, Domitilia; Leitao, Alexandra; Patarnello, Tomaso; Bargelloni, Luca			Insights into Molecular Features of Venerupis decussata Oocytes: A Microarray-Based Study	PLOS ONE			English	Article							INDUCED MEIOSIS REINITIATION; DEDUCED PRIMARY-STRUCTURE; BARNEA-CANDIDA MOLLUSCA; PLANAR CELL POLARITY; VITELLOGENIN VG GENE; MEIOTIC MATURATION; IN-VITRO; PATINOPECTEN-YESSOENSIS; FUNDULUS-HETEROCLITUS; POSSIBLE INVOLVEMENT	The production of Venerupis decussata relies on wild seed collection, which has been recently compromised due to recruitment failure and severe mortalities. To address this issue and provide an alternative source of seed, artificial spawning and larval rearing programs were developed. However, hatchery-based seed production is a relatively new industry and it is still underdeveloped. A major hurdle in the European clam seed production is the control of spawning and reproduction, which is further hindered by the impossibility of obtaining fertile gametes by gonadal "stripping'', as meiosis re-initiation is constrained to a maturation process along the genital ducts. In the present study, oocytes were collected from 15 females and microarray analyses was performed to investigate gene expression profiles characterizing released and stripped ovarian oocytes. A total of 198 differentially expressed transcripts between stripped and spawned oocytes were detected. Functional analysis carried out on these transcripts highlighted the importance of a few biological processes, which are most probably implicated in the control of oocyte competence. Significant differences were observed for transcripts encoding proteins involved in meiosis progression (e.g. dual specificity phosphatase CDC25), WNT signalling (e.g. frizzled class receptor 8, wingless-type MMTV integration site family member 4), steroid synthesis (e.g. progestin and adipoQ receptor family member 3, cytochrome P450-C17), mRNA processing (e.g. zinc finger protein XlCOF28), calcium regulation (e.g. regucalcin, calmodulin) and ceramide metabolism (ceramidase B, sphingomyelinase). This study provides new information on transcriptional profiles putatively associated with ovarian egg infertility, and suggests potential mechanisms regulating early oocyte development in clams. Genes which were differentially expressed between stripped and spawned oocytes might have a pivotal role during maturation process in the gonadal duct and could be interesting targets for further functional studies aiming to make ovarian oocytes fertilizable.	[Pauletto, Marianna; Milan, Massimo; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy; [de Sousa, Joana Teixeira; Huvet, Arnaud] IFREMER, Lab Sci Environm Marin, Plouzane, France; [de Sousa, Joana Teixeira; Joaquim, Sandra; Matias, Domitilia; Leitao, Alexandra] IPMA, Olhao, Portugal; [Joaquim, Sandra; Matias, Domitilia] Univ Porto, CIIMAR, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Leitao, Alexandra] Qatar Univ, Ctr Environm Studies, Doha, Qatar	University of Padua; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto Portugues do Mar e da Atmosfera; Universidade do Porto; Qatar University	Pauletto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy.	marianna.pauletto@unipd.it	Pauletto, Marianna/K-5518-2019; Quality, Aquaculture Seafood/AAD-7718-2019; Milan, Massimo/H-7428-2019; MILAN, MASSIMO/ABE-6936-2021	Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Huvet, Arnaud/0000-0001-6912-881X; Leitao-BenHamadou, Alexandra/0000-0001-8903-3797; Joaquim, Sandra/0000-0002-6324-5908; PATARNELLO, Tomaso/0000-0003-1794-5791; Matias, Domitilia/0000-0002-2191-7497	EU [FP 7-KBBE-2009-1-2-11]	EU(European Commission)	Funding: This research was supported by the EU Project "Research to improve Production of SEED" (REPROSEED: FP 7-KBBE-2009-1-2-11) (http://www.reproseed.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAJID H, 1993, INT J DEV BIOL, V37, P279; ALLEN RD, 1953, BIOL BULL, V105, P213, DOI 10.2307/1538639; ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Aoki K, 1997, FEBS LETT, V401, P109, DOI 10.1016/S0014-5793(96)01444-5; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; BRASSARD M, 1988, GAMETE RES, V20, P43, DOI 10.1002/mrd.1120200105; Buschiazzo J, 2011, BIOL REPROD, V85, P808, DOI 10.1095/biolreprod.110.090365; Castro A, 2000, BIOCHEM BIOPH RES CO, V276, P515, DOI 10.1006/bbrc.2000.3482; Cesari P., 1990, TAPES PHILIPPINARUM, P23; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Corporeau C, 2012, J PROTEOMICS, V75, P5554, DOI 10.1016/j.jprot.2012.07.040; Corporeau C, 2011, MAR BIOTECHNOL, V13, P971, DOI 10.1007/s10126-010-9361-4; Cuomo A, 2005, J EXP ZOOL PART A, V303A, P193, DOI 10.1002/jez.a.152; de Sousa JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092202; DEGUCHI R, 1995, DEV BIOL, V171, P483, DOI 10.1006/dbio.1995.1298; DEGUCHI R, 1994, DEV BIOL, V166, P587, DOI 10.1006/dbio.1994.1339; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; DUBE F, 1988, DEV BIOL, V126, P233, DOI 10.1016/0012-1606(88)90134-0; DUBE F, 1982, DEV BIOL, V92, P408, DOI 10.1016/0012-1606(82)90186-5; Eichenlaub-Ritter U, 2002, HUM REPROD UPDATE, V8, P21, DOI 10.1093/humupd/8.1.21; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; FAO, 2014, CULT AQ INF PROGR RU; Gaffre M, 2011, DEVELOPMENT, V138, P3735, DOI 10.1242/dev.063974; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GUERRIER P, 1993, DEV BIOL, V159, P474, DOI 10.1006/dbio.1993.1257; Guerrier P, 1996, INVERTEBR REPROD DEV, V30, P39, DOI 10.1080/07924259.1996.9672530; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hamida L, 2004, AQUACULTURE, V239, P413, DOI 10.1016/j.aquaculture.2004.05.010; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; HIRAI S, 1988, J EXP ZOOL, V245, P318, DOI 10.1002/jez.1402450312; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huvet A, 2012, MAR BIOTECHNOL, V14, P402, DOI 10.1007/s10126-011-9421-4; Hwang DS, 2010, COMP BIOCHEM PHYS C, V151, P360, DOI 10.1016/j.cbpc.2009.12.010; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147; Joaquim S, 2008, CULTIVO BIVALVES MAT; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones KT, 2004, MOL HUM REPROD, V10, P1, DOI 10.1093/molehr/gah009; JUNEJA R, 1994, CELL CALCIUM, V15, P1, DOI 10.1016/0143-4160(94)90099-X; KANUNGO J, 1990, J EXP ZOOL, V254, P313, DOI 10.1002/jez.1402540310; Kaymak E, 2013, J BIOL CHEM, V288, P30463, DOI 10.1074/jbc.M113.496547; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Kim J, 2010, J CELL SCI, V123, P993, DOI 10.1242/jcs.060442; KRANTIC S, 1991, DEV BIOL, V146, P491, DOI 10.1016/0012-1606(91)90250-7; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; LaFleur GJ, 2005, BIOL REPROD, V73, P815, DOI 10.1095/biolreprod.105.041335; Lee KW, 2008, COMP BIOCHEM PHYS B, V150, P395, DOI 10.1016/j.cbpb.2008.04.009; Li Q, 1998, INVERTEBR REPROD DEV, V33, P1, DOI 10.1080/07924259.1998.9652337; Li Q, 1998, INVERTEBR REPROD DEV, V33, P87, DOI 10.1080/07924259.1998.9652345; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Lim J, 2005, GENESIS, V42, P150, DOI 10.1002/gene.20142; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Liu QH, 2009, IMMUNOBIOLOGY, V214, P257, DOI 10.1016/j.imbio.2008.10.003; Llera-Herrera R, 2014, AQUAC RES, V45, P448, DOI 10.1111/j.1365-2109.2012.03246.x; Longo FJ, 1983, MOLLUSCA, V3, P48; Machaty Z, 2002, BIOL REPROD, V67, P1133, DOI 10.1095/biolreprod67.4.1133; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Matsumoto T, 1997, COMP BIOCHEM PHYS B, V118, P811, DOI 10.1016/S0305-0491(97)00233-2; Matsumoto T, 2008, COMP BIOCHEM PHYS A, V149, P293, DOI 10.1016/j.cbpa.2008.01.003; Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; Moreau M, 1996, ZYGOTE, V4, P151, DOI 10.1017/S0967199400003038; Morrill GA, 1998, BIOCHEM BIOPH RES CO, V246, P359, DOI 10.1006/bbrc.1998.8620; Mouchel N, 1996, GENE, V174, P59, DOI 10.1016/0378-1119(96)00336-8; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Ni JB, 2012, COMP BIOCHEM PHYS B, V163, P246, DOI 10.1016/j.cbpb.2012.06.006; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Okazaki K, 1996, GENE, V178, P111, DOI 10.1016/0378-1119(96)00344-7; Okuno A, 2002, J EXP ZOOL, V292, P417, DOI 10.1002/jez.10083; Osada M, 2004, COMP BIOCHEM PHYS B, V139, P123, DOI 10.1016/j.cbpc.2004.07.002; Osada M, 2003, J EXP ZOOL PART A, V299A, P172, DOI 10.1002/jez.a.10276; OSADA M, 1992, NIPPON SUISAN GAKK, V58, P223; OSANAI K, 1985, Bulletin of the Marine Biological Station of Asamushi, V18, P1; OSANAI K, 1988, Bulletin of the Marine Biological Station of Asamushi, V18, P45; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PIPE RK, 1987, MAR BIOL, V95, P405, DOI 10.1007/BF00409571; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; REISHENRIQUES MA, 1990, COMP BIOCHEM PHYS A, V95, P343, DOI 10.1016/0300-9629(90)90230-P; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRUM JC, 1995, J BIOL CHEM, V270, P13541, DOI 10.1074/jbc.270.22.13541; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; SUZUKI T, 1992, MAR BIOL, V113, P239; Swan A, 2007, DEVELOPMENT, V134, P891, DOI 10.1242/dev.02784; Tadjuidje E, 2011, DEV DYNAM, V240, P1727, DOI 10.1002/dvdy.22671; Timmins-Schiffman Emma, 2012, BMC Research Notes, V5, P502, DOI 10.1186/1756-0500-5-502; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Varaksina GS, 1991, BIOL MORYA, V3, P61; Varaksina GS, 1992, BIOL MORYA MAR, V3, P77; Wang CD, 2003, INVERTEBR REPROD DEV, V44, P89, DOI 10.1080/07924259.2003.9652559; Wang C, 2007, COMP BIOCHEM PHYS B, V148, P303, DOI 10.1016/j.cbpb.2007.06.008; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wassarman PM, 1996, J CELL SCI, V109, P2001; WASSERMAN WJ, 1981, J CELL BIOL, V89, P389, DOI 10.1083/jcb.89.3.389; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113; Yamamoto TM, 2013, BBA-GENE REGUL MECH, V1829, P1034, DOI 10.1016/j.bbagrm.2013.06.001; Yang WL, 2014, THERIOGENOLOGY, V81, P535, DOI 10.1016/j.theriogenology.2013.11.005; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zheng HP, 2012, AQUACULTURE, V366, P46, DOI 10.1016/j.aquaculture.2012.08.031; Zheng P, 2006, MOL REPROD DEV, V73, P667, DOI 10.1002/mrd.20428	124	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113925	10.1371/journal.pone.0113925	http://dx.doi.org/10.1371/journal.pone.0113925			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470487	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700055
J	Popovic, M; Stefancic, H; Sluban, B; Novak, PK; Grcar, M; Mozetic, I; Puliga, M; Zlatic, V				Popovic, Marko; Stefancic, Hrvoje; Sluban, Borut; Novak, Petra Kralj; Grcar, Miha; Mozetic, Igor; Puliga, Michelangelo; Zlatic, Vinko			Extraction of Temporal Networks from Term Co-Occurrences in Online Textual Sources	PLOS ONE			English	Article								A stream of unstructured news can be a valuable source of hidden relations between different entities, such as financial institutions, countries, or persons. We present an approach to continuously collect online news, recognize relevant entities in them, and extract time-varying networks. The nodes of the network are the entities, and the links are their co-occurrences. We present a method to estimate the significance of co-occurrences, and a benchmark model against which their robustness is evaluated. The approach is applied to a large set of financial news, collected over a period of two years. The entities we consider are 50 countries which issue sovereign bonds, and which are insured by Credit Default Swaps (CDS) in turn. We compare the country co-occurrence networks to the CDS networks constructed from the correlations between the CDS. The results show relatively small, but significant overlap between the networks extracted from the news and those from the CDS correlations.	[Popovic, Marko; Stefancic, Hrvoje; Zlatic, Vinko] Rudjer Boskovic Inst, Div Theoret Phys, HR-10002 Zagreb, Croatia; [Stefancic, Hrvoje] Catholic Univ Croatia, Zagreb, Croatia; [Sluban, Borut; Novak, Petra Kralj; Grcar, Miha; Mozetic, Igor] Jozef Stefan Inst, Ljubljana, Slovenia; [Puliga, Michelangelo] IMT Alti Lucca, Lucca, Italy	Rudjer Boskovic Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; IMT School for Advanced Studies Lucca	Zlatic, V (corresponding author), Rudjer Boskovic Inst, Div Theoret Phys, POB 180, HR-10002 Zagreb, Croatia.	vinko.zlatic@irb.hr	Popovic, Marko/I-9838-2014; Zlatic, Vinko/H-9321-2012; puliga, michelangelo/AAS-9954-2020; Popovic, Marko/M-2895-2019; Novak, Petra Kralj/AAE-5852-2020; Zlatić, Vinko/AAW-2781-2020	Popovic, Marko/0000-0003-2360-3982; Zlatic, Vinko/0000-0001-7101-2154; Popovic, Marko/0000-0003-2360-3982; Mozetic, Igor/0000-0002-5466-0608; Kralj Novak, Petra/0000-0003-3385-6430	European Commission under the FP7 projects FOC) [255987]; MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems) [317532]; Slovenian Research Agency programme Knowledge Technologies [P2-103]	European Commission under the FP7 projects FOC); MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems); Slovenian Research Agency programme Knowledge Technologies	This work was supported in part by the European Commission under the FP7 projects FOC (Forecasting financial crises, grant no. 255987) and MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems, grant no. 317532), and by the Slovenian Research Agency programme Knowledge Technologies (grant no. P2-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman J, 2012, J INT MONEY FINANCE; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; [Anonymous], 2010, SOCIAL EC NETWORKS; [Anonymous], 2008, 19 ACM C HYPERTEXT H; Apache, 2010, OPENNLP; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; Cattuto C, 2007, AI COMMUN, V20, P245; Cohen AM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-103; Edmonds P, 1997, 35TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 8TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P507; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Jursic M, 2010, J UNIVERS COMPUT SCI, V16, P1190; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Mane KK, 2004, P NATL ACAD SCI USA, V101, P5287, DOI 10.1073/pnas.0307626100; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mishne G., 2006, AAAI SPRING S COMP A, P155; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Pan J, 2008, J FINANC, V63, P2345, DOI 10.1111/j.1540-6261.2008.01399.x; Popovic M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208701; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Ruiz E. J., 2012, P 5 ACM INT C WEB SE, P513, DOI DOI 10.1145/2124295.2124358; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sluban B, 2013, ACM INT C INF KNOWL; Tibely G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084133; Wilkinson DM, 2004, P NATL ACAD SCI USA, V101, P5241, DOI 10.1073/pnas.0307740100; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	33	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e99515	10.1371/journal.pone.0099515	http://dx.doi.org/10.1371/journal.pone.0099515			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470498	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700001
J	Chen, DY; Chen, YM; Tzang, BS; Lan, JL; Hsu, TC				Chen, Der-Yuan; Chen, Yi-Ming; Tzang, Bor-Show; Lan, Joung-Liang; Hsu, Tsai-Ching			Th17-Related Cytokines in Systemic Lupus Erythematosus Patients with Dilated Cardiomyopathies: A Possible Linkage to Parvovirus B19 Infection	PLOS ONE			English	Article							ACUTE VIRAL MYOCARDITIS; UNIQUE REGION PROTEIN; LEFT-VENTRICULAR DYSFUNCTION; NECROSIS-FACTOR-ALPHA; EFFECTOR T-CELLS; NONSTRUCTURAL PROTEIN; STRUCTURAL PROTEINS; HIGH PREVALENCE; TH17 CELLS; INTERLEUKIN-6	Dilated cardiomyopathies (DCM) are a major cause of mortality in patients with systemic lupus erythematosus (SLE). Immune responses induced by human parvovirus B19 (B19) are considered an important pathogenic mechanism in myocarditis or DCM. However, little is known about Th17-related cytokines in SLE patients with DCM about the linkage with B19 infection. IgM and IgG against B19 viral protein, and serum levels of Th17-related cytokines were determined using ELISA in eight SLE patients with DCM and six patients with valvular heart disease (VHD). Humoral responses of anti-B19-VP1u and anti-B19-NS1 antibody were assessed using Western blot and B19 DNA was detected by nested Polymerase Chain Reaction (PCR). Levels of interleukin (IL)-17, IL-6, IL-1 beta, and tumor necrosis factor (TNF)-alpha were significantly higher in SLE patients with DCM (mean +/- SEM, 390.99 +/- 125.48 pg/ml, 370.24 +/- 114.09 pg/ml, 36.01 +/- 16.90 pg/ml, and 183.84 +/- 82.94 pg/ml, respectively) compared to healthy controls (51.32 +/- 3.04 pg/ml, p<0.001; 36.88 +/- 6.64 pg/ml, p<0.001; 5.39 +/- 0.62 pg/ml, p<0.005; and 82.13 +/- 2.42 pg/ml, p<0.005, respectively). Levels of IL-17 and IL-6 were higher in SLE patients with DCM versus those with VHD (both p<0.01). Five (62.5%) of DCM patients had detectable anti-B19-NS1 IgG and four (50.0%) of them had anti-B19-VP1u IgG, whereas only one (16.7%) of VHD patients had detectable anti-B19-NS1 IgG and anti-B19-VP1u IgG. Serum levels of IL-17, IL-6 and IL-1 beta were markedly higher in SLE patients with anti-B19-VP1u IgG and anti-B19-NS1 IgG compared to those without anti-B19-VP1u IgG or anti-B19-NS1 IgG, respectively. These suggest a potential association of B19 with DCM and Th17-related cytokines implicated in the pathogenesis of DCM in SLE patients.	[Chen, Der-Yuan; Chen, Yi-Ming] Taichung Vet Gen Hosp, Dept Med Educ, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Chen, Der-Yuan; Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ, Immunol Res Ctr, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ, Coll Med, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Tzang, BS (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	bstzang@csmu.edu.tw; htc@csmu.edu.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Bor-Show, Tzang/0000-0003-0140-9943	National Science Council, Taiwan, Republic of China [NSC 97-2314-B040-009, NSC-98-2314-B040-008-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the grants NSC 97-2314-B040-009 and NSC-98-2314-B040-008-MY3 from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1995, VIROLOGY, V206, P626, DOI 10.1016/S0042-6822(95)80079-4; Andreoletti L, 2009, ARCH CARDIOVASC DIS, V102, P559, DOI 10.1016/j.acvd.2009.04.010; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Corcoran A, 2004, J MED MICROBIOL, V53, P459, DOI 10.1099/jmm.0.05485-0; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Doria A, 2005, LUPUS, V14, P683, DOI 10.1191/0961203305lu2200oa; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Escher F, 2008, MED SCI MONITOR, V14, pCR589; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Francis SE, 1998, J MOL CELL CARDIOL, V30, P215, DOI 10.1006/jmcc.1997.0592; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P152, DOI 10.1111/j.1365-2249.2006.03023.x; HUBER SA, 1994, J VIROL, V68, P195, DOI 10.1128/JVI.68.1.195-206.1994; Kanda T, 2004, JPN HEART J, V45, P183, DOI 10.1536/jhj.45.183; Kerr JR, 2000, RHEUMATOLOGY, V39, P903, DOI 10.1093/rheumatology/39.8.903; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kuhl U, 2008, J MED VIROL, V80, P1243, DOI 10.1002/jmv.21187; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leisi R, 2013, J VIROL, V87, P13161, DOI 10.1128/JVI.02548-13; Manger K, 2002, ANN RHEUM DIS, V61, P1065, DOI 10.1136/ard.61.12.1065; Mitchell LA, 2002, J MED VIROL, V67, P267, DOI 10.1002/jmv.2217; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Musiani M, 2000, J MED VIROL, V60, P347, DOI 10.1002/(SICI)1096-9071(200003)60:3<347::AID-JMV15>3.0.CO;2-T; NEUMANN DA, 1993, CLIN IMMUNOL IMMUNOP, V68, P181, DOI 10.1006/clin.1993.1116; Noutsias M, 2003, INT J CARDIOL, V91, P153, DOI 10.1016/S0167-5273(03)00033-0; Omdal R, 2001, SCAND J RHEUMATOL, V30, P275; Pankuweit S, 2003, HUM PATHOL, V34, P497, DOI 10.1016/S0046-8177(03)00078-9; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Satoh M, 1999, CIRCULATION, V99, P3260, DOI 10.1161/01.CIR.99.25.3260; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Tzang BS, 2008, CLIN CHIM ACTA, V395, P77, DOI 10.1016/j.cca.2008.05.012; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; Tzang BS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-13; YAMADA T, 1994, CIRCULATION, V89, P846, DOI 10.1161/01.CIR.89.2.846; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Yuan J, 2010, INT IMMUNOPHARMACOL, V10, P272, DOI 10.1016/j.intimp.2009.11.010; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	46	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113889	10.1371/journal.pone.0113889	http://dx.doi.org/10.1371/journal.pone.0113889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462010	Green Submitted, gold, Green Published			2022-12-27	WOS:000345869700064
J	Rudin-Bitterli, TS; Tills, O; Spicer, JI; Culverhouse, PF; Wielhouwer, EM; Richardson, MK; Rundle, SD				Rudin-Bitterli, Tabitha S.; Tills, Oliver; Spicer, John I.; Culverhouse, Phil F.; Wielhouwer, Eric M.; Richardson, Michael K.; Rundle, Simon D.			Combining Motion Analysis and Microfluidics - A Novel Approach for Detecting Whole-Animal Responses to Test Substances	PLOS ONE			English	Article							ZEBRAFISH EMBRYOS; LARVAL ZEBRAFISH; BEHAVIOR; SYSTEM; DISEASE; QUALITY; ETHANOL; MODELS; SPERM	Small, early life stages, such as zebrafish embryos are increasingly used to assess the biological effects of chemical compounds in vivo. However, behavioural screens of such organisms are challenging in terms of both data collection (culture techniques, drug delivery and imaging) and data evaluation (very large data sets), restricting the use of high throughput systems compared to in vitro assays. Here, we combine the use of a microfluidic flow-through culture system, or BioWell plate, with a novel motion analysis technique, (sparse optic flow - SOF) followed by spectral analysis (discrete Fourier transformation - DFT), as a first step towards automating data extraction and analysis for such screenings. Replicate zebrafish embryos housed in a BioWell plate within a custom-built imaging system were subject to a chemical exposure (1.5% ethanol). Embryo movement was videoed before (30 min), during (60 min) and after (60 min) exposure and SOF was then used to extract data on movement (angles of rotation and angular changes to the centre of mass of embryos). DFT was subsequently used to quantify the movement patterns exhibited during these periods and Multidimensional Scaling and ANOSIM were used to test for differences. Motion analysis revealed that zebrafish had significantly altered movements during both the second half of the alcohol exposure period and also the second half of the recovery period compared to their pretreatment movements. Manual quantification of tail flicking revealed the same differences between exposure-periods as detected using the automated approach. However, the automated approach also incorporates other movements visible in the organism such as blood flow and heart beat, and has greater power to discern environmentally-driven changes in the behaviour and physiology of organisms. We suggest that combining these technologies could provide a highly efficient, high throughput assay, for assessing whole embryo responses to various drugs and chemicals.	[Rudin-Bitterli, Tabitha S.; Tills, Oliver; Spicer, John I.; Rundle, Simon D.] Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Culverhouse, Phil F.] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Wielhouwer, Eric M.; Richardson, Michael K.] Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Wielhouwer, Eric M.] Syntecnos, Leiden, Netherlands	University of Plymouth; University of Plymouth; Leiden University; Leiden University - Excl LUMC	Tills, O (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	oliver.tills@plymouth.ac.uk		Tills, Oliver/0000-0001-8527-8383; Rudin-Bitterli, Tabitha/0000-0002-2779-714X; Culverhouse, Phil/0000-0002-7586-6496	Marine Institute at Plymouth University through the HEIF4 programme	Marine Institute at Plymouth University through the HEIF4 programme	The work was funded by the Marine Institute at Plymouth University through the HEIF4 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Amsler MO, 2006, MAR FRESHW BEHAV PHY, V39, P259, DOI 10.1080/10236240600980640; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, MIN 16 STAT SOFTW; Bilotta J, 2002, NEUROTOXICOL TERATOL, V24, P759, DOI 10.1016/S0892-0362(02)00319-7; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gerlai R, 2005, 5 INT C METH TECHN B; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Greer SP, 2006, BIOFOULING, V22, P125, DOI 10.1080/08927010600602082; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; Iken K, 2003, BIOFOULING, V19, P327, DOI 10.1080/08927010310001612045; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Larsen L, 2000, HUM REPROD, V15, P1562, DOI 10.1093/humrep/15.7.1562; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu QH, 2007, AQUACULTURE, V263, P20, DOI 10.1016/j.aquaculture.2006.11.017; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Lucas B. D., 1981, IJCAI, P121, DOI DOI 10.5555/1623264.1623280; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Parng Chuenlei, 2007, Journal of Pharmacological and Toxicological Methods, V55, P103, DOI 10.1016/j.vascn.2006.04.004; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Press William H., 1989, ART SCI COMPUTING, P494; Puttonen HAJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00102; Senst T, 2010, LECT NOTES COMPUT SC, V6111, P240, DOI 10.1007/978-3-642-13772-3_25; Suzuki T, 2002, INT J ANDROL, V25, P49, DOI 10.1046/j.1365-2605.2002.00324.x; Tills O, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-37; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; Williams LR, 2012, COMP BIOCHEM PHYS C, V155, P33, DOI 10.1016/j.cbpc.2011.02.010	37	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113235	10.1371/journal.pone.0113235	http://dx.doi.org/10.1371/journal.pone.0113235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464030	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700032
J	Santos, M; Domingues, SC; Costa, P; Muller, T; Galozzi, S; Marcus, K; Silva, EFDE; Silva, OADE; Rebelo, S				Santos, Mariana; Domingues, Sara C.; Costa, Patricia; Muller, Thorsten; Galozzi, Sara; Marcus, Katrin; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A.; Rebelo, Sandra			Identification of a Novel Human LAP1 Isoform That Is Regulated by Protein Phosphorylation	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; AMYLOID PRECURSOR PROTEIN; INNER NUCLEAR-MEMBRANE; ALTERNATIVE PROMOTERS; MUSCULAR-DYSTROPHY; TORSINA; LAMINA; EXPRESSION; COMPLEX; INTERACTS	Lamina associated polypeptide 1 (LAP1) is an integral protein of the inner nuclear membrane that is ubiquitously expressed. LAP1 binds to lamins and chromatin, probably contributing to the maintenance of the nuclear envelope architecture. Moreover, LAP1 also interacts with torsinA and emerin, proteins involved in DYT1 dystonia and X-linked Emery-Dreifuss muscular dystrophy disorder, respectively. Given its relevance to human pathological conditions, it is important to better understand the functional diversity of LAP1 proteins. In rat, the LAP1 gene (TOR1AIP1) undergoes alternative splicing to originate three LAP1 isoforms (LAP1A, B and C). However, it remains unclear if the same occurs with the human TOR1AIP1 gene, since only the LAP1B isoform had thus far been identified in human cells. In silico analysis suggested that, across different species, potential new LAP1 isoforms could be generated by alternative splicing. Using shRNA to induce LAP1 knockdown and HPLC-mass spectrometry analysis the presence of two isoforms in human cells was described and validated: LAP1B and LAP1C; the latter is putatively N-terminal truncated. LAP1B and LAP1C expression profiles appear to be dependent on the specific tissues analyzed and in cultured cells LAP1C was the major isoform detected. Moreover, LAP1B and LAP1C expression increased during neuronal maturation, suggesting that LAP1 is relevant in this process. Both isoforms were found to be post-translationallymodified by phosphorylation and methionine oxidation and two LAP1B/LAP1C residues were shown to be dephosphorylated by PP1. This study permitted the identification of the novel human LAP1C isoform and partially unraveled the molecular basis of LAP1 regulation.	[Santos, Mariana; Domingues, Sara C.; Costa, Patricia; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A.; Rebelo, Sandra] Univ Aveiro, SACS, Ctr Biol Celular, Lab Neurociencias & Sinalizacao, P-3800 Aveiro, Portugal; [Muller, Thorsten; Galozzi, Sara; Marcus, Katrin] Ruhr Univ Bochum, Med Proteome Ctr, Dept Funct Prote, Bochum, Germany	Universidade de Aveiro; Ruhr University Bochum	Rebelo, S (corresponding author), Univ Aveiro, SACS, Ctr Biol Celular, Lab Neurociencias & Sinalizacao, P-3800 Aveiro, Portugal.	srebelo@ua.pt	Müller, Thorsten/AAX-1652-2021; da Cruz e Silva, Odete A B/F-4072-2010; Rebelo, S/B-8973-2008; Rebelo, Sandra/Q-2215-2019; Cruz e Silva, Odete/AAH-5595-2020; Santos, Mariana/AAO-2021-2020	da Cruz e Silva, Odete A B/0000-0003-3718-9874; Rebelo, S/0000-0002-5862-5797; Rebelo, Sandra/0000-0002-5862-5797; Santos, Mariana/0000-0002-2343-2215	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (Centro de Biologia Celular, Universidade de Aveiro) [PEst-OE/SAU/UI0482/2014-, PTDC/QUI-BIQ/101317/2008, PTDC/BEX-BCM/0493/2012]; FCT [SFRH/BD/65353/2009]	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (Centro de Biologia Celular, Universidade de Aveiro); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Dr. William Dauer (Columbia University, USA) for providing the LAP1 antibody and Dr. Celso Cunha (Instituto de Higiene e Medicina Tropical, Lisbon) for supplying the pSIREN-RetroQ vector. The authors also thank Liliana Carvalho for her assistance in sequencing analysis. This work was financed by the Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (PEst-OE/SAU/UI0482/2014- the Centro de Biologia Celular, Universidade de Aveiro but also made viable by PTDC/QUI-BIQ/101317/2008 and PTDC/BEX-BCM/0493/2012). MS was recipient of a FCT fellowship (SFRH/BD/65353/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Casaca Ana, 2011, Open Virol J, V5, P12, DOI 10.2174/1874357901105010012; Charron M, 1998, P NATL ACAD SCI USA, V95, P14805, DOI 10.1073/pnas.95.25.14805; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; Henriques AG, 2007, J ALZHEIMERS DIS, V11, P85; Kayman-Kurekci G, 2014, NEUROMUSCULAR DISORD, V24, P624, DOI 10.1016/j.nmd.2014.04.007; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kim G, 2013, BIOCH BIOPHYS ACTA; KLEIN D, 1995, BIOCHEM MOL BIOL INT, V36, P59; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Korrodi-Gregorio L, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-15; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Rebelo S, 2004, J NEUROSCI RES, V76, P406, DOI 10.1002/jnr.20091; Rebelo S, 2007, NEURODEGENER DIS, V4, P78, DOI 10.1159/000101831; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Rebelo S, 2008, AM J ALZHEIMERS DIS, V23, P602, DOI 10.1177/1533317508323572; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROCHA JF, 2012, MICROSC MICROANAL S5, V18, P57, DOI DOI 10.1017/S1431927612012949; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Santos MA, 2014, MOL BIOL CELL, V25; Santos M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076788; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; Shin JY, 2013, DEV CELL, V26, P591, DOI 10.1016/j.devcel.2013.08.012; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Tsai KW, 2007, MOL CELL BIOL, V27, P5835, DOI 10.1128/MCB.00363-07; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zhang SXL, 2007, PHYSIOL GENOMICS, V32, P95, DOI 10.1152/physiolgenomics.00192.2007	56	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113732	10.1371/journal.pone.0113732	http://dx.doi.org/10.1371/journal.pone.0113732			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461922	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700044
J	Ferguson, DJP; Balaban, AE; Patzewitz, EM; Wall, RJ; Hopp, CS; Poulin, B; Mohmmed, A; Malhotra, P; Coppi, A; Sinnis, P; Tewari, R				Ferguson, David J. P.; Balaban, Amanda E.; Patzewitz, Eva-Maria; Wall, Richard J.; Hopp, Christine S.; Poulin, Benoit; Mohmmed, Asif; Malhotra, Pawan; Coppi, Alida; Sinnis, Photini; Tewari, Rita			The Repeat Region of the Circumsporozoite Protein is Critical for Sporozoite Formation and Maturation in Plasmodium	PLOS ONE			English	Article							MALARIA PARASITE; SPOROGONIC DEVELOPMENT; SALIVARY-GLANDS; FALCIPARUM; BERGHEI; VACCINE; CELL; INFECTIVITY; MOTILITY; EFFICACY	The circumsporozoite protein (CSP) is the major surface protein of the sporozoite stage of malaria parasites and has multiple functions as the parasite develops and then migrates from the mosquito midgut to the mammalian liver. The overall structure of CSP is conserved among Plasmodium species, consisting of a species-specific central tandem repeat region flanked by two conserved domains: the NH2-terminus and the thrombospondin repeat (TSR) at the COOH-terminus. Although the central repeat region is an immunodominant B-cell epitope and the basis of the only candidate malaria vaccine in Phase III clinical trials, little is known about its functional role(s). We used the rodent malaria model Plasmodium berghei to investigate the role of the CSP tandem repeat region during sporozoite development. Here we describe two mutant parasite lines, one lacking the tandem repeat region (Delta Rep) and the other lacking the NH2-terminus as well as the repeat region (Delta N Delta Rep). We show that in both mutant lines oocyst formation is unaffected but sporozoite development is defective.	[Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Balaban, Amanda E.; Hopp, Christine S.; Coppi, Alida; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Patzewitz, Eva-Maria; Wall, Richard J.; Poulin, Benoit; Tewari, Rita] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Ctr Genet & Genom, Nottingham NG2 7UH, England; [Mohmmed, Asif; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Nottingham; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sinnis, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	psinnis@jhsph.edu; rita.tewari@nottingham.ac.uk		Ferguson, David/0000-0001-5045-819X; Hopp, Christine/0000-0002-0528-9531; Wall, Richard J./0000-0003-3487-3187; Tewari, Rita/0000-0003-3943-1847	MRC [G0900109, G0900278, MR/K011782/1]; Wellcome Trust Equipment Grant; NIH [R01AI056840, T32AI107417]; Johns Hopkins Malaria Institute; Medical Research Council [G0900278, MR/K011782/1]; Department of Biotechnology (DBT) [BT/o1/CEIB/11/V/01, BT/PR5267/Med/15/87/2012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007417, R01AI056840] Funding Source: NIH RePORTER; Medical Research Council [G0900109] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Equipment Grant(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in RT laboratory is funded by MRC Investigator Award and project grants [G0900109, G0900278, MR/K011782/1]; DJPF is funded by a Wellcome Trust Equipment Grant [http://www.wellcome.ac.uk/. PS is funded by NIH R01AI056840 and AB is supported by NIH T32AI107417 [http://www.nih.gov/]. CH was supported by a fellowship from the Johns Hopkins Malaria Institute [http://www.jhsph.edu/]. EMP, BP and RJW were funded under a Medical Research Council grant [http:/www.mrc.ac.uk/] to RT (G0900278, MR/K011782/1). PM and AM were trained in parasite genetic manipulation technique under a European Commission, Director General XII INCO-DC programme. PM and AM also acknowledge the financial support provided by Department of Biotechnology (DBT) under (BT/o1/CEIB/11/V/01 and BT/PR5267/Med/15/87/2012) [http://dbtindia.nic.in/index.asp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Espinosa DA, 2013, INFECT IMMUN, V81, P2882, DOI 10.1128/IAI.00461-13; GODSON GN, 1983, NATURE, V305, P29, DOI 10.1038/305029a0; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; SINDEN RE, 1978, T ROY SOC TROP MED H, V72, P477, DOI 10.1016/0035-9203(78)90167-0; SINDEN RE, 1973, T ROY SOC TROP MED H, V67, P631, DOI 10.1016/0035-9203(73)90031-X; Sinnis P, 2002, CHEM IMMUNOL, V80, P70; Tewari R, 2005, CELL MICROBIOL, V7, P699, DOI 10.1111/j.1462-5822.2005.00503.x; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; VANDERBE.J, 1967, J CELL BIOL, V32, pC7, DOI 10.1083/jcb.32.3.C7; Wang Q, 2005, CELL MICROBIOL, V7, P1616, DOI 10.1111/j.1462-5822.2005.00579.x; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; WHO, 2013, WORLD MALARIA REPORT 2013, P1; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	35	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113923	10.1371/journal.pone.0113923	http://dx.doi.org/10.1371/journal.pone.0113923			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438048	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900095
J	Hibberd, PL; Kleimola, L; Fiorino, AM; Botelho, C; Haverkamp, M; Andreyeva, I; Poutsiaka, D; Fraser, C; Solano-Aguilar, G; Snydman, DR				Hibberd, Patricia L.; Kleimola, Lauren; Fiorino, Anne-Maria; Botelho, Christine; Haverkamp, Miriam; Andreyeva, Irina; Poutsiaka, Debra; Fraser, Claire; Solano-Aguilar, Gloria; Snydman, David R.			No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly-A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; MICROBIOME; BACTEREMIA; RECOMMENDATIONS; CHILDREN; PLACEBO; VACCINE; TRIALS; GAMMA; VITRO	Background: Although Lactobacillus rhamnosus GG ATCC 53103 (LGG) has been consumed by 2 to 5 million people daily since the mid 1990s, there are few clinical trials describing potential harms of LGG, particularly in the elderly. Objectives: The primary objective of this open label clinical trial is to assess the safety and tolerability of 161010 colony forming units (CFU) of LGG administered orally twice daily to elderly volunteers for 28 days. The secondary objectives were to evaluate the effects of LGG on the gastrointestinal microbiome, host immune response and plasma cytokines. Methods: Fifteen elderly volunteers, aged 66-80 years received LGG capsules containing 161010 CFU, twice daily for 28 days and were followed through day 56. Volunteers completed a daily diary, a telephone call on study days 3, 7 and 14 and study visits in the Clinical Research Center at baseline, day 28 and day 56 to determine whether adverse events had occurred. Assessments included prompted and open-ended questions. Results: There were no serious adverse events. The 15 volunteers had a total of 47 events (range 1-7 per volunteer), 39 (83%) of which were rated as mild and 40% of which were considered related to consuming LGG. Thirty-one (70%) of the events were expected, prompted symptoms while 16 were unexpected events. The most common adverse events were gastrointestinal (bloating, gas, and nausea), 27 rated as mild and 3 rated as moderate. In the exploratory analysis, the pro-inflammatory cytokine interleukin 8 decreased during LGG consumption, returning towards baseline one month after discontinuing LGG (p=0.038) while there was no difference in other pro- or anti-inflammatory plasma cytokines. Conclusions: Lactobacillus rhamnosus GG ATCC 53103 is safe and well tolerated in healthy adults aged 65 years and older.	[Hibberd, Patricia L.; Kleimola, Lauren; Fiorino, Anne-Maria; Botelho, Christine; Haverkamp, Miriam; Andreyeva, Irina] Massachusetts Gen Hosp Children, Div Global Hlth, Boston, MA 02114 USA; [Poutsiaka, Debra; Snydman, David R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Fraser, Claire] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Solano-Aguilar, Gloria] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA	Tufts Medical Center; University System of Maryland; University of Maryland Baltimore; United States Department of Agriculture (USDA)	Hibberd, PL (corresponding author), Massachusetts Gen Hosp Children, Div Global Hlth, Boston, MA 02114 USA.	phibberd@partners.org	Snydman, David R/O-3889-2014	Snydman, David R/0000-0003-0119-3978; Hibberd, Patricia/0000-0002-7455-8117; Fraser, Claire/0000-0003-1462-2428	National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM) [3U01AT002952, 3K24AT003683]; Harvard Catalyst and National Institutes of Health, National Center for Advancing Translational Sciences (NIH/ NCATS) [1UL1 TR001102]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [U01AT002388, U01AT002952] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT002133] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT003683] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Harvard Catalyst and National Institutes of Health, National Center for Advancing Translational Sciences (NIH/ NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support was provided by the National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM; http://nccam.nih.gov/; 3U01AT002952 (PLH) and 3K24AT003683 (PLH)) and the Harvard Catalyst and National Institutes of Health, National Center for Advancing Translational Sciences (NIH/ NCATS; http://www.ncats.nih.gov/; 1UL1 TR001102 (PLH)). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of NCCAM or NCATS. NIH/NCCAM Program Official Linda Duffy, PhD, MPH, contributed to the structuring of the U01 study design, inclusion of validation approaches and biosafety parameters, and implementation of the protocols under phased regulatory approved IND. Other than Dr. Duffy's contributions, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Bousvaros A, 2005, INFLAMM BOWEL DIS, V11, P833, DOI 10.1097/01.MIB.0000175905.00212.2c; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Clinical and Laboratory Standards Institute, 2009, CLSI PUBL, VM07-A8; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0; Fang H, 2000, FEMS IMMUNOL MED MIC, V29, P47, DOI 10.1111/j.1574-695X.2000.tb01504.x; Fang W, 1996, VET RES, V27, P3; Floch MH, 2008, J CLIN GASTROENTEROL, V42, pS104, DOI 10.1097/MCG.0b013e31816b903f; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; *FOOD DRUG ADM, 2013, FDA GUID CLIN INV SP; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; GORBACH SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Hempel Susanne, 2011, Evid Rep Technol Assess (Full Rep), P1; Hodkinson A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003436; Hudault S, 1997, APPL ENVIRON MICROB, V63, P513, DOI 10.1128/AEM.63.2.513-518.1997; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; *JOINT FOOD AGR OR, 2002, GUID EV PROB FOOD; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Licciardi PV, 2011, DISCOV MED, V12, P525; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Lopez M, 2008, J NUTR, V138, P2264, DOI 10.3945/jn.108.093658; Mackay Andrew D., 1999, Clin Microbiol Infect, V5, P290, DOI 10.1111/j.1469-0691.1999.tb00144.x; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Maggi Catia Bauer, 2014, Int J Risk Saf Med, V26, P9, DOI 10.3233/JRS-140609; Mangalat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043910; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mirpuri J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051955; *NIH NCCAM, 2014, OR PROB INTR; Oberhelman RA, 2014, AM J TROP MED HYG, V90, P777, DOI 10.4269/ajtmh.13-0639; Ocana VS, 1999, FEMS IMMUNOL MED MIC, V23, P87, DOI 10.1016/S0928-8244(98)00116-3; PETSCHOW B, 2013, ANN NY ACAD SCI, V1306, P1, DOI DOI 10.1111/nyas.12303; RAJAGOPAL N, 2014, N AM PROBIOICS MARKE; Rautio M, 1999, CLIN INFECT DIS, V28, P1159, DOI 10.1086/514766; Saxelin M, 2010, INT J FOOD MICROBIOL, V144, P293, DOI 10.1016/j.ijfoodmicro.2010.10.009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vahabnezhad E, 2013, J CLIN GASTROENTEROL, V47, P437, DOI 10.1097/MCG.0b013e318279abf0; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Wong Sook-San, 2013, BMC Res Notes, V6, P135, DOI 10.1186/1756-0500-6-135; Zein E F, 2008, Ann Biol Clin (Paris), V66, P195, DOI 10.1684/abc.2008.0210	50	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113456	10.1371/journal.pone.0113456	http://dx.doi.org/10.1371/journal.pone.0113456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438151	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900046
J	Larson, BA; Lembela-Bwalya, D; Bonawitz, R; Hammond, EE; Thea, DM; Herlihy, J				Larson, Bruce A.; Lembela-Bwalya, Deophine; Bonawitz, Rachael; Hammond, Emily E.; Thea, Donald M.; Herlihy, Julie			Finding a Needle in the Haystack: The Costs and Cost-Effectiveness of Syphilis Diagnosis and Treatment during Pregnancy to Prevent Congenital Syphilis in Kalomo District of Zambia	PLOS ONE			English	Article							CLINICAL-IMPLICATIONS; OUTCOMES; KENYA	Background: In March 2012, The Elizabeth Glaser Pediatric AIDS Foundation trained maternal and child health workers in Southern Province of Zambia to use a new rapid syphilis test (RST) during routine antenatal care. A recent study by Bonawitz et al. (2014) evaluated the impact of this roll out in Kalomo District. This paper estimates the costs and cost-effectiveness from the provider's perspective under the actual conditions observed during the first year of the RST roll out. Methods: Information on materials used and costs were extracted from program records. A decision-analytic model was used to evaluate the costs (2012 USD) and cost-effectiveness. Basic parameters needed for the model were based on the results from the evaluation study. Results: During the evaluation study, 62% of patients received a RST, and 2.8% of patients tested were positive (and 10.4% of these were treated). Even with very high RST sensitivity and specificity (98%), true prevalence of active syphilis would be substantially less (estimated at < 0.7%). For 1,000 new ANC patients, costs of screening and treatment were estimated at $2,136, and the cost per avoided disability-adjusted-life year lost (DALY) was estimated at $628. Costs change little if all positives are treated (because prevalence is low and treatment costs are small), but the cost-per-DALY avoided falls to just $66. With full adherence to guidelines, costs increase to $3,174 per 1,000 patients and the cost-per-DALY avoided falls to $60. Conclusions: Screening for syphilis is only useful for reducing adverse birth outcomes if patients testing positive are actually treated. Even with very low prevalence of syphilis (a needle in the haystack), cost effectiveness improves dramatically if those found positive are treated; additional treatment costs little but DALYs avoided are substantial. Without treatment, the needle is essentially found and thrown back into the haystack.	[Larson, Bruce A.; Bonawitz, Rachael; Hammond, Emily E.; Thea, Donald M.; Herlihy, Julie] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Lembela-Bwalya, Deophine] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Bonawitz, Rachael; Herlihy, Julie] Boston Med Ctr, Dept Pediat, Boston, MA USA	Boston University; University of Zambia; Boston Medical Center	Larson, BA (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu		White, Emily/0000-0003-2698-7002; Larson, Bruce/0000-0002-9322-2387; Thea, Donald/0000-0002-6933-1030	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001418-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GPS001418-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz RE, 2014, INTRO RAPID IN PRESS; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; [Government of Zambia Health Mo], 2014, NAT AIDS STRAT FRAM; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Larson Bruce A, 2013, Cost Eff Resour Alloc, V11, P18, DOI 10.1186/1478-7547-11-18; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Scott CA, 2013, PLOS ONE IN PRESS; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072444; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; World Health Organization, 2012, INV CAS EL MOTH TO C; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	16	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113868	10.1371/journal.pone.0113868	http://dx.doi.org/10.1371/journal.pone.0113868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478877	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200035
J	West, MA; Loughney, L; Lythgoe, D; Barben, CP; Adams, VL; Bimson, WE; Grocott, MPW; Jack, S; Kemp, GJ				West, Malcolm A.; Loughney, Lisa; Lythgoe, Daniel; Barben, Christopher P.; Adams, Valerie L.; Bimson, William E.; Grocott, Michael P. W.; Jack, Sandy; Kemp, Graham J.			The Effect of Neoadjuvant Chemoradiotherapy on Whole-Body Physical Fitness and Skeletal Muscle Mitochondrial Oxidative Phosphorylation In Vivo in Locally Advanced Rectal Cancer Patients - An Observational Pilot Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PREOPERATIVE RADIOTHERAPY; MESORECTAL EXCISION; PERIOPERATIVE RISK; EXERCISE; CHEMOTHERAPY; THERAPY; SURGERY; CHEMORADIATION; METABOLISM	Background: In the United Kingdom, patients with locally advanced rectal cancer routinely receive neoadjuvant chemoradiotherapy. However, the effects of this on physical fitness are unclear. This pilot study is aimed to investigate the effect of neoadjuvant chemoradiotherapy on objectively measured in vivo muscle mitochondrial function and whole-body physical fitness. Methods: We prospectively studied 12 patients with rectal cancer who completed standardized neoadjuvant chemoradiotherapy, recruited from a large tertiary cancer centre, between October 2012 and July 2013. All patients underwent a cardiopulmonary exercise test and a phosphorus magnetic resonance spectroscopy quadriceps muscle exercise-recovery study before and after neoadjuvant chemoradiotherapy. Data were analysed and reported blind to patient identity and clinical course. Primary variables of interest were the two physical fitness measures; oxygen uptake at estimated anaerobic threshold and oxygen uptake at Peak exercise (ml.kg (1).min (1)), and the post-exercise phosphocreatine recovery rate constant (min(-1)), a measure of muscle mitochondrial capacity in vivo. Results: Median age was 67 years (IQR 64-75). Differences (95%CI) in all three primary variables were significantly negative post-NACRT: Oxygen uptake at estimated anaerobic threshold -2.4 ml.kg(-1). min(-1) (-3.8, -0.9), p=0.004; Oxygen uptake at Peak -4.0 ml.kg(-1). min(-1) (-6.8, -1.1), p=0.011; and post-exercise phosphocreatine recovery rate constant -0.34 min(-1) (-0.51, -0.17), p<0.001. Conclusion: The significant decrease in both whole-body physical fitness and in vivo muscle mitochondrial function raises the possibility that muscle mitochondrial mechanisms, no doubt multifactorial, may be important in deterioration of physical fitness following neoadjuvant chemoradiotherapy. This may have implications for targeted interventions to improve physical fitness pre-surgery.	[West, Malcolm A.; Loughney, Lisa; Barben, Christopher P.; Grocott, Michael P. W.; Jack, Sandy] Aintree Univ Hosp NHS Fdn Trust, Colorectal Surg Res Grp, Liverpool, Merseyside, England; [West, Malcolm A.; Grocott, Michael P. W.; Jack, Sandy; Kemp, Graham J.] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [West, Malcolm A.; Grocott, Michael P. W.; Jack, Sandy; Kemp, Graham J.] Univ Liverpool, Fac Hlth & Life Sci, MRC Arthrit Res UK Ctr Integrated Res Musculoskel, Liverpool L69 3BX, Merseyside, England; [West, Malcolm A.; Adams, Valerie L.; Bimson, William E.; Grocott, Michael P. W.; Jack, Sandy; Kemp, Graham J.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr MARIARC, Liverpool L69 3BX, Merseyside, England; [Loughney, Lisa; Grocott, Michael P. W.; Jack, Sandy] Southampton NIHR Resp Biomed Res Unit, Crit Care Res Area, Southampton, Hants, England; [Loughney, Lisa; Grocott, Michael P. W.; Jack, Sandy] Univ Hosp Southampton NHS Fdn Trust, Anaesthesia & Crit Care Res Unit, Southampton, Hants, England; [Lythgoe, Daniel] Univ Liverpool, Canc Res UK Liverpool Canc Trials Unit, Liverpool L69 3BX, Merseyside, England; [Grocott, Michael P. W.; Jack, Sandy] Univ Southampton, Fac Med, Integrat Physiol & Crit Illness Grp, Southampton SO9 5NH, Hants, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of Liverpool; University of Liverpool; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Cancer Research UK; University of Liverpool; University of Southampton	West, MA (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Colorectal Surg Res Grp, Liverpool, Merseyside, England.	mwest@liverpool.ac.uk	Grocott, Michael/C-4394-2008; Jack, Sandy/N-9852-2014; Kemp, Graham J/A-7540-2008	Grocott, Michael/0000-0002-9484-7581; Jack, Sandy/0000-0003-2763-7303; Kemp, Graham J/0000-0002-8324-9666	British Oxygen Company Chair of the Royal College of Anaesthetists (MPWG) - National Institute of Academic Anaesthesia; UK Department of Health Research Biomedical Research Units funding scheme; National Institute for Health Research [ACF-2014-26-010] Funding Source: researchfish	British Oxygen Company Chair of the Royal College of Anaesthetists (MPWG) - National Institute of Academic Anaesthesia; UK Department of Health Research Biomedical Research Units funding scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded in part from the British Oxygen Company Chair of the Royal College of Anaesthetists (MPWG), awarded by the National Institute of Academic Anaesthesia. Some of this work was undertaken at University Southampton NHS Foundation Trust - University of Southampton NIHR Respiratory Biomedical Research Unit which received a portion of funding from the UK Department of Health Research Biomedical Research Units funding scheme. All funding was unrestricted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, STAT B CANC INCIDENC, P1; [Anonymous], 2010, STAT B CANC REGISTRA, P1; Association of Coloproctology of Great Britain and Ireland Royal College of Surgeons of England Health and Social Care Information Centre, 2013, NAT BOW CANC AUD ANN; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Cannon DT, 2013, J APPL PHYSIOL, V115, P839, DOI 10.1152/japplphysiol.00510.2013; Carlisle J, 2007, BRIT J SURG, V94, P966, DOI 10.1002/bjs.5734; Chan I, 2006, J CLIN ONCOL, V24, P668, DOI 10.1200/JCO.2005.04.4875; Chen Y, 2007, MOL INTERV, V7, P147, DOI 10.1124/mi.7.3.6; Finan P, 2012, NATL BOWEL CANC AUDI, P47; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Grocott MPW, 2010, BRIT J ANAESTH, V105, P243, DOI 10.1093/bja/aeq207; Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32; Hennis PJ, 2011, POSTGRAD MED J, V87, P550, DOI 10.1136/pgmj.2010.107185; Jack S, 2014, EJSO-EUR J SURG ONC, V40, P1313, DOI 10.1016/j.ejso.2014.03.010; Jones LW, 2008, LANCET ONCOL, V9, P757, DOI 10.1016/S1470-2045(08)70195-5; Jones LW, 2009, LANCET ONCOL, V10, P598, DOI 10.1016/S1470-2045(09)70031-2; Karvunidis T, 2012, INTENS CARE MED, V38, P1336, DOI 10.1007/s00134-012-2582-4; Kemp GJ, 2001, J VASC SURG, V34, P1103, DOI 10.1067/mva.2001.117152; Kemp GJ, 2012, DIABETES, V61, P1927, DOI 10.2337/db11-1725; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lai CW, 2013, BRIT J ANAESTH, V111, P607, DOI 10.1093/bja/aet193; Larson-Meyer DE, 2001, MUSCLE NERVE, V24, P1665, DOI 10.1002/mus.1202; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marijnen CAM, 2002, J CLIN ONCOL, V20, P817, DOI 10.1200/JCO.20.3.817; MASSIE BM, 1987, AM J CARDIOL, V60, P309, DOI 10.1016/0002-9149(87)90233-5; Mohiuddin M, 2006, J CLIN ONCOL, V24, P650, DOI 10.1200/JCO.2005.03.6095; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pipinos II, 2000, J VASC SURG, V31, P944, DOI 10.1067/mva.2000.106421; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Praet SFE, 2006, MAGN RESON MATER PHY, V19, P321, DOI 10.1007/s10334-006-0060-0; Puente-Maestu L, 2013, J APPL PHYSIOL, V114, P1282, DOI 10.1152/japplphysiol.00815.2012; Puente-Maestu L, 2012, AM J RESP CELL MOL, V47, P358, DOI 10.1165/rcmb.2011-0382OC; Snowden CP, 2013, ANN SURG, V257, P999, DOI 10.1097/SLA.0b013e31828dbac2; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Swellengrebel HAM, 2011, BRIT J SURG, V98, P418, DOI 10.1002/bjs.7315; Tisdale M J, 2001, Nutrition, V17, P438, DOI 10.1016/S0899-9007(01)00506-8; Tozer RG, 2008, ANTIOXID REDOX SIGN, V10, P395, DOI 10.1089/ars.2007.1919; West M, 2011, BEST PRACT RES-CLIN, V25, P427, DOI 10.1016/j.bpa.2011.07.004; West M, 2014, BR J ANAEST IN PRESS; West MA, 2014, EJSO-EUR J SURG ONC, V40, P1421, DOI 10.1016/j.ejso.2014.03.021; West MA, 2014, BRIT J SURG, V101, P1166, DOI 10.1002/bjs.9551; West MA, 2014, BRIT J ANAESTH, V112, P665, DOI 10.1093/bja/aet408; Wilson RJT, 2010, BRIT J ANAESTH, V105, P297, DOI 10.1093/bja/aeq128; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Zhao Q., 2009, DYN MED, V8, P1	47	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111526	10.1371/journal.pone.0111526	http://dx.doi.org/10.1371/journal.pone.0111526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478898	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200002
J	Wickel, EE				Wickel, Eric E.			Reporting the Reliability of Accelerometer Data with and without Missing Values	PLOS ONE			English	Article							VIGOROUS PHYSICAL-ACTIVITY; GENERALIZABILITY THEORY; CHILDREN; IMPUTATION; MODERATE; ADULTS; TIME	Objectives: Participants with complete accelerometer data often represent a low proportion of the total sample and, in some cases, may be distinguishable from participants with incomplete data. Because traditional reliability methods characterize the consistency of complete data, little is known about reliability properties for an entire sample. This study employed Generalizability theory to report an index of reliability characterizing complete (7 days) and observable (1 to 7 days) accelerometer data. Design: Cross-sectional. Methods: Accelerometer data from the Study of Early Child Care and Youth Development were analyzed in this study. Missing value analyses were conducted to describe the pattern and mechanism of missing data. Generalizability coefficients were derived from variance components to report reliability parameters for complete data and also for the entire observable sample. Analyses were conducted separately by age (9, 11, 12, and 15 yrs) and daily wear time criteria (6, 8, 10, and 12 hrs). Results: Participants with complete data were limited (<34%) and, most often, data were not considered to be missing completely at random. Across conditions, reliability coefficients for complete data were between 0.74 and 0.87. Relatively lower reliability properties were found across all observable data, ranging from 0.52 to 0.67. Sample variability increased with longer wear time criteria, but decreased with advanced age. Conclusions: A reliability coefficient that includes all participants, not just those with complete data, provides a global perspective of reliability that could be used to further understand group level associations between activity and health outcomes.	Univ Tulsa, Tulsa, OK 74104 USA	University of Tulsa	Wickel, EE (corresponding author), Univ Tulsa, Tulsa, OK 74104 USA.	eric-wickel@utulsa.edu			University of Tulsa	University of Tulsa	Internal funding from the University of Tulsa was provided to EEW. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Brennan R.L., 2001, GEN THEORY; Brennan RL, 2001, J EDUC MEAS, V38, P295, DOI 10.1111/j.1745-3984.2001.tb01129.x; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; CRONBACH L J, 1972, P410; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Herrmann SD, 2013, J PHYS ACT HEALTH, V10, P742, DOI 10.1123/jpah.10.5.742; Holbrook EA, 2013, ADAPT PHYS ACT Q, V30, P59, DOI 10.1123/apaq.30.1.59; Ishikawa S, 2013, ARCH PHYS MED REHAB, V94, P132, DOI 10.1016/j.apmr.2012.07.027; Ishikawa S, 2011, J REHABIL RES DEV, V48, P1187, DOI 10.1682/JRRD.2010.09.0190; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; Kim Y, 2012, ADAPT PHYS ACT Q, V29, P346, DOI 10.1123/apaq.29.4.346; Lee PH, 2013, AM J CLIN NUTR, V97, P965, DOI 10.3945/ajcn.112.052738; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; Morrow Jr J, 2002, PHYS ACTIVITY ASSESS, P37; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Rich C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002290; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Shavelson R.J., 1991, GENERALIZABILITY THE; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Wickel EE, 2010, MED SCI SPORT EXER, V42, P1528, DOI 10.1249/MSS.0b013e3181d107c4; Zhuang J, 2013, RES Q EXERCISE SPORT, V84, pS48, DOI 10.1080/02701367.2013.851060	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114402	10.1371/journal.pone.0114402	http://dx.doi.org/10.1371/journal.pone.0114402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478692	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200084
J	Albrechtova, K; Papousek, I; De Nys, H; Pauly, M; Anoh, E; Mossoun, A; Dolejska, M; Masarikova, M; Metzger, S; Couacy-Hymann, E; Akoua-Koffi, C; Wittig, RM; Klimes, J; Cizek, A; Leendertz, FH; Literak, I				Albrechtova, Katerina; Papousek, Ivo; De Nys, Helene; Pauly, Maude; Anoh, Etile; Mossoun, Arsene; Dolejska, Monika; Masarikova, Martina; Metzger, Sonya; Couacy-Hymann, Emmanuel; Akoua-Koffi, Chantal; Wittig, Roman M.; Klimes, Jiri; Cizek, Alois; Leendertz, Fabian H.; Literak, Ivan			Low Rates of Antimicrobial-Resistant Enterobacteriaceae in Wildlife in Tai National Park, Cote d'Ivoire, Surrounded by Villages with High Prevalence of Multiresistant ESBL-Producing Escherichia coli in People and Domestic Animals	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; MEDIATED QUINOLONE RESISTANCE; TRANSMISSION; GENES; IDENTIFICATION; HUMANS; EPIDEMIOLOGY; CARRIAGE; PLASMIDS; BACTERIA	Antimicrobial resistance genes can be found in all ecosystems, including those where antibiotic selective pressure has never been exerted. We investigated resistance genes in a collection of faecal samples of wildlife (non-human primates, mice), people and domestic animals (dogs, cats) in Cote d'Ivoire; in the chimpanzee research area of Tai "National Park (TNP) and adjacent villages. Single bacteria isolates were collected from antibiotic-containing agar plates and subjected to molecular analysis to detect Enterobacteriaceae isolates with plasmidmediated genes of extended-spectrum beta-lactamases (ESBLs) and plasmidmediated quinolone resistance (PMQR). While the prevalence of ESBL-producing E. coli in the villages was 27% in people (n=77) and 32% in dogs (n=38), no ESBL-producer was found in wildlife of TNP (n575). PMQR genes, mainly represented by qnrS1, were also present in human-and dog-originating isolates from the villages (36% and 42% in people and dogs, respectively), but no qnrS has been found in the park. In TNP, different variants of qnrB were detected in Citrobacter freundii isolates originating non-human primates and mice. In conclusion, ESBL and PMQR genes frequently found in humans and domestic animals in the villages were rather exceptional in wildlife living in the protected area. Although people enter the park, the strict biosecurity levels they are obliged to follow probably impede transmission of bacteria between them and wildlife.	[Albrechtova, Katerina; Papousek, Ivo; Dolejska, Monika; Klimes, Jiri; Literak, Ivan] Univ Vet & Pharmaceut Sci, Dept Biol & Wildlife Dis, Fac Vet Hyg & Ecol, Brno, Czech Republic; [De Nys, Helene; Metzger, Sonya; Leendertz, Fabian H.] Robert Koch Inst, Project Grp Epidemiol Highly Pathogen Microorgani, Berlin, Germany; [De Nys, Helene; Pauly, Maude; Metzger, Sonya; Wittig, Roman M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Anoh, Etile; Akoua-Koffi, Chantal] Alassane Ouattara Univ, Univ Teaching Hosp Bouake, Res Dev Ctr, Bouake, Cote Ivoire; [Mossoun, Arsene; Couacy-Hymann, Emmanuel] Lab Natl Pathol Anim, LANADA, Bingerville, Cote Ivoire; [Dolejska, Monika; Masarikova, Martina; Cizek, Alois; Literak, Ivan] Univ Vet & Pharmaceut Sci, CEITEC VFU, Brno, Czech Republic; [Masarikova, Martina; Cizek, Alois] Univ Vet & Pharmaceut Sci, Fac Vet Med, Inst Microbiol & Infect Dis, Brno, Czech Republic; [Wittig, Roman M.] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire	University of Veterinary Sciences Brno; Robert Koch Institute; Max Planck Society; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno	Albrechtova, K (corresponding author), Univ Vet & Pharmaceut Sci, Dept Biol & Wildlife Dis, Fac Vet Hyg & Ecol, Brno, Czech Republic.	albkat@seznam.cz; leendertzf@rki.de	Cizek, Alois/G-8833-2014; Leendertz, Fabian Hubertus/H-8902-2019; Papoušek, Ivo/C-6641-2013; De Nys, Helene/P-6384-2016; Masarikova, Martina/G-9690-2014	Cizek, Alois/0000-0001-5706-4601; Papoušek, Ivo/0000-0003-0172-4134; De Nys, Helene/0000-0002-2942-4531; AKOUA KOFFI, Chantal/0000-0003-0975-6632; Masarikova, Martina/0000-0002-9673-1021	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; European Social Fund [CZ.1.07/2.3.00/30.0014]	European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF))	This study was funded by the project 'CEITEC - Central European Institute of Technology' (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. MD and IP were supported by the Operational Programme ''Education for Competitiveness'' (CZ.1.07/2.3.00/30.0014) from the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup F, 2008, ANTIMICROBIAL RESIST; Albrechtova K, 2012, ANTIMICROB AGENTS CH, V56, P4013, DOI 10.1128/AAC.05859-11; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P67, DOI 10.1111/j.1469-0691.2012.03860.x; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boesch C, 2000, CHIMPANZEES TAI FORE; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Canton R, 2011, CURR OPIN PHARMACOL, V11, P477, DOI 10.1016/j.coph.2011.07.007; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; *CDC, 2004, STAND MOL SUBT FOODB; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; *CLSI, 2008, PERF STAND ANT SUSC; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Galan JC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00009; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby GA, 2011, ANTIMICROB AGENTS CH, V55, P4979, DOI 10.1128/AAC.05187-11; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Kariuki S., 2011, SITUATION ANAL ANTIB; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; KLIEBE C, 1985, ANTIMICROB AGENTS CH, V28, P302, DOI 10.1128/AAC.28.2.302; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Li B, 2010, APPL ENVIRON MICROB, V76, P6680; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Literak I, 2012, MICROB DRUG RESIST, V18, P567, DOI 10.1089/mdr.2012.0075; Lonchel CM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-53; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Ma L, 1998, ANTIMICROB AGENTS CH, V42, P1181, DOI 10.1128/AAC.42.5.1181; Macpherson CNL., 2000, DOGS ZOONOSES PUBLIC; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; Poirel L, 2002, J ANTIMICROB CHEMOTH, V50, P1031, DOI 10.1093/jac/dkf240; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09	50	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113548	10.1371/journal.pone.0113548	http://dx.doi.org/10.1371/journal.pone.0113548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474243	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500084
J	Cardone, M; Dzutsev, AK; Li, HC; Riteau, N; Gerosa, F; Shenderov, K; Winkler-Pickett, R; Provezza, L; Riboldi, E; Leighty, RM; Orr, SJ; Steinhagen, F; Wewers, MD; Sher, A; Anderson, SK; Goldszmid, R; McVicar, DW; Lyakh, L; Trinchieri, G				Cardone, Marco; Dzutsev, Amiran K.; Li, Hongchuan; Riteau, Nicolas; Gerosa, Franca; Shenderov, Kevin; Winkler-Pickett, Robin; Provezza, Lisa; Riboldi, Elena; Leighty, Robert M.; Orr, Selinda J.; Steinhagen, Folkert; Wewers, Mark D.; Sher, Alan; Anderson, Stephen K.; Goldszmid, Romina; McVicar, Daniel W.; Lyakh, Lyudmila; Trinchieri, Giorgio			Interleukin-1 and Interferon-gamma Orchestrate beta-Glucan-Activated Human Dendritic Cell Programming via I kappa B-zeta Modulation	PLOS ONE			English	Article							INDUCIBLE NUCLEAR-PROTEIN; T-HELPER-CELLS; NLRP3 INFLAMMASOME; HUMAN MACROPHAGES; CANDIDA-ALBICANS; HOST-DEFENSE; IFN-GAMMA; DIFFERENTIAL REQUIREMENT; IL-1-BETA PRODUCTION; RECEPTOR DECTIN-1	Recognition of microbial components via innate receptors including the C-type lectin receptor Dectin-1, together with the inflammatory environment, programs dendritic cells (DCs) to orchestrate the magnitude and type of adaptive immune responses. The exposure to beta-glucan, a known Dectin-1 agonist and component of fungi, yeasts, and certain immune support supplements, activates DCs to induce T helper (Th)17 cells that are essential against fungal pathogens and extracellular bacteria but may trigger inflammatory pathology or autoimmune diseases. However, the exact mechanisms of DC programming by beta-glucan have not yet been fully elucidated. Using a gene expression/perturbation approach, we demonstrate that in human DCs beta-glucan transcriptionally activates via an interleukin (IL)-1- and inflammasome-mediated positive feedback late-induced genes that bridge innate and adaptive immunity. We report that in addition to its known ability to directly prime T cells toward the Th17 lineage, IL-1 by promoting the transcriptional cofactor inhibitor of kappa B-zeta (I kappa B-zeta) also programs beta-glucan-exposed DCs to express cell adhesion and migration mediators, antimicrobial molecules, and Th17-polarizing factors. Interferon (IFN)-gamma interferes with the IL-1/I kappa B-zeta axis in beta-glucan-activated DCs and promotes T cell- mediated immune responses with increased release of IFN-gamma and IL-22, and diminished production of IL-17. Thus, our results identify IL-1 and IFN-gamma as regulators of DC programming by beta-glucan. These molecular networks provide new insights into the regulation of the Th17 response as well as new targets for the modulation of immune responses to beta-glucancontaining microorganisms.	[Cardone, Marco; Dzutsev, Amiran K.; Li, Hongchuan; Winkler-Pickett, Robin; Riboldi, Elena; Orr, Selinda J.; Steinhagen, Folkert; Anderson, Stephen K.; Goldszmid, Romina; McVicar, Daniel W.; Lyakh, Lyudmila; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Dzutsev, Amiran K.; Li, Hongchuan; Anderson, Stephen K.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD USA; [Riteau, Nicolas; Shenderov, Kevin; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Gerosa, Franca; Provezza, Lisa] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Leighty, Robert M.] Data Management Serv Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Trinchieri, Giorgio] Trans NIH Ctr Human Immunol, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Verona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	trinchig@mail.nih.gov	Anderson, Stephen K/B-1727-2012; Wewers, Mark/AAB-6202-2021; Riteau, Nicolas/ABC-1764-2020; McVicar, Daniel/G-1970-2015; Trinchieri, Giorgio/F-9369-2015	Anderson, Stephen K/0000-0002-7856-4266; Riteau, Nicolas/0000-0003-1306-6466; Trinchieri, Giorgio/0000-0001-5892-7464; Shenderov, Kevin/0000-0002-5255-6815; McVicar, Daniel/0000-0002-1112-5111; Orr, Selinda/0000-0001-8539-7825	Intramural Research Program of the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was fully supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, in part through the contract HHSN261200800001E to the Frederick National Laboratory for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biondo C, 2011, EUR J IMMUNOL, V41, P1969, DOI 10.1002/eji.201141490; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cardone M, 2014, J LEUKOCYTE BIOL, V95, P161, DOI 10.1189/jlb.0313168; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; de Castro CP, 2012, J IMMUNOL, V189, P4144, DOI 10.4049/jimmunol.1201946; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Eigenbrod T, 2013, J IMMUNOL, V190, P6533, DOI 10.4049/jimmunol.1300324; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; GHEZZI P, 1988, J IMMUNOL, V140, P4238; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Steinhagen F, 2012, J LEUKOCYTE BIOL, V92, P775, DOI 10.1189/jlb.1011522; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Voronov E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00177; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; ZIAI MR, 1986, CANCER RES, V46, P6187; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114516	10.1371/journal.pone.0114516	http://dx.doi.org/10.1371/journal.pone.0114516			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474109	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500041
J	Galabova, G; Brunner, S; Winsauer, G; Juno, C; Wanko, B; Mairhofer, A; Luhrs, P; Schneeberger, A; von Bonin, A; Mattner, F; Schmidt, W; Staffler, G				Galabova, Gergana; Brunner, Sylvia; Winsauer, Gabriele; Juno, Claudia; Wanko, Bettina; Mairhofer, Andreas; Luehrs, Petra; Schneeberger, Achim; von Bonin, Arne; Mattner, Frank; Schmidt, Walter; Staffler, Guenther			Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCLONAL-ANTIBODY; PCSK9; CHOLESTEROL; IMMUNIZATION; HYPERCHOLESTEROLEMIA; MUTATIONS; STATIN; GENE; MICE	Background: Low Density Lipoprotein (LDL) hypercholesterolemia, and its associated cardiovascular diseases, are some of the leading causes of death worldwide. The ability of proprotein convertase subtilisin/kexin 9 (PCSK9) to modulate circulating LDL cholesterol (LDLc) concentrations made it a very attractive target for LDLc management. To date, the most advanced approaches for PCSK9 inhibition are monoclonal antibody (mAb) therapies. Although shown to lower LDLc significantly, mAbs face functional limitations because of their relatively short in vivo half-lives necessitating frequent administration. Here, we evaluated the long-term efficacy and safety of PCSK9-specific active vaccines in different preclinical models. Methods and Finding: PCSK9 peptide-based vaccines were successfully selected by our proprietary technology. To test their efficacy, wild-type (wt) mice, Ldlr(+/-) mice, and rats were immunized with highly immunogenic vaccine candidates. Vaccines induced generation of high-affine PCSK9-specific antibodies in all species. Group mean total cholesterol (TC) concentration was reduced by up to 30%, and LDLc up to 50% in treated animals. Moreover, the PCSK9 vaccine-induced humoral immune response persisted for up to one year in mice, and reduced cholesterol levels significantly throughout the study. Finally, the vaccines were well tolerated in all species tested. Conclusions: Peptide-based anti-PCSK9 vaccines induce the generation of antibodies that are persistent, high-affine, and functional for up to one year. They are powerful and safe tools for long-term LDLc management, and thus may represent a novel therapeutic approach for the prevention and/or treatment of LDL hypercholesterolemia-related cardiovascular diseases in humans.	[Galabova, Gergana; Brunner, Sylvia; Winsauer, Gabriele; Juno, Claudia; Wanko, Bettina; Mairhofer, Andreas; Luehrs, Petra; Schneeberger, Achim; von Bonin, Arne; Mattner, Frank; Schmidt, Walter; Staffler, Guenther] AFFiRiS AG, A-1030 Vienna, Austria		Galabova, G (corresponding author), AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria.	Gergana.Galabova@affiris.com; Guenther.Staffler@affiris.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chong PH, 2000, DRUGS, V60, P55, DOI 10.2165/00003495-200060010-00005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; Do RQ, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0345-z; Fattori E, 2012, J LIPID RES, V53, P1654, DOI 10.1194/jlr.M028340; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Lu X, ATHEROSCLEROSIS, V225, P56; Marais DA, 2012, CURR OPIN LIPIDOL, V23, P511, DOI 10.1097/MOL.0b013e3283587563; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Ryan US, 2006, VASC PHARMACOL, V45, P253, DOI 10.1016/j.vph.2006.08.004; Schneeberger A, 2009, J NUTR HEALTH AGING, V13, P264, DOI 10.1007/s12603-009-0070-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang LW, 2012, INT J BIOL SCI, V8, P310, DOI 10.7150/ijbs.3524	27	90	92	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114469	10.1371/journal.pone.0114469	http://dx.doi.org/10.1371/journal.pone.0114469			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474576	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500036
J	Haralalka, S; Shelton, C; Cartwright, HN; Guo, FL; Trimble, R; Kumar, RP; Abmayr, SM				Haralalka, Shruti; Shelton, Claude; Cartwright, Heather N.; Guo, Fengli; Trimble, Rhonda; Kumar, Ram P.; Abmayr, Susan M.			Live Imaging Provides New Insights on Dynamic F-Actin Filopodia and Differential Endocytosis during Myoblast Fusion in Drosophila	PLOS ONE			English	Article							ROLLING-PEBBLES; ARP2/3 COMPLEX; IMMUNOGLOBULIN SUPERFAMILY; MUSCLE TYPES; BLOWN-FUSE; PROTEIN; WASP; SNS; POLYMERIZATION; ADHESION	The process of myogenesis includes the recognition, adhesion, and fusion of committed myoblasts into multinucleate syncytia. In the larval body wall muscles of Drosophila, this elaborate process is initiated by Founder Cells and Fusion-Competent Myoblasts (FCMs), and cell adhesion molecules Kin-of-IrreC (Kirre) and Sticks-and-stones (Sns) on their respective surfaces. The FCMs appear to provide the driving force for fusion, via the assembly of protrusions associated with branched F-actin and the WASp, SCAR and Arp2/3 pathways. In the present study, we utilize the dorsal pharyngeal musculature that forms in the Drosophila embryo as a model to explore myoblast fusion and visualize the fusion process in live embryos. These muscles rely on the same cell types and genes as the body wall muscles, but are amenable to live imaging since they do not undergo extensive morphogenetic movement during formation. Time-lapse imaging with F-actin and membrane markers revealed dynamic FCM-associated actin-enriched protrusions that rapidly extend and retract into the myotube from different sites within the actin focus. Ultrastructural analysis of this actin-enriched area showed that they have two morphologically distinct structures: wider invasions and/or narrow filopodia that contain long linear filaments. Consistent with this, formin Diaphanous (Dia) and branched actin nucleator, Arp3, are found decorating the filopodia or enriched at the actin focus, respectively, indicating that linear actin is present along with branched actin at sites of fusion in the FCM. Gain-of-function Dia and loss-of-function Arp3 both lead to fusion defects, a decrease of F-actin foci and prominent filopodia from the FCMs. We also observed differential endocytosis of cell surface components at sites of fusion, with actin reorganizing factors, WASp and SCAR, and Kirre remaining on the myotube surface and Sns preferentially taken up with other membrane proteins into early endosomes and lysosomes in the myotube.	[Haralalka, Shruti; Shelton, Claude; Cartwright, Heather N.; Guo, Fengli; Trimble, Rhonda; Kumar, Ram P.; Abmayr, Susan M.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Abmayr, Susan M.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Abmayr, SM (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	sma@stowers.org		Cartwright, Heather/0000-0001-6639-5808	NIH [R01-AR44274]; Stowers Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by NIH, grant number: R01-AR44274 (www.nih.gov) and the Stowers Institute for Medical Research (www.stowers.org). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Afshar K, 2000, DEVELOPMENT, V127, P1887; Artero RD, 2001, DEVELOPMENT, V128, P4251; Berger S, 2008, J CELL SCI, V121, P1303, DOI 10.1242/jcs.022269; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bothe I, 2014, DEVELOPMENT, V141, P2289, DOI 10.1242/dev.100743; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bour BA, 2000, GENE DEV, V14, P1498; Charrasse S, 2013, MOL BIOL CELL, V24, P234, DOI 10.1091/mbc.E12-02-0167; de Joussineau C, 2012, CURR TOP DEV BIOL, V98, P277, DOI 10.1016/B978-0-12-386499-4.00011-2; de Velasco B, 2006, DEV GENES EVOL, V216, P39, DOI 10.1007/s00427-005-0029-4; Dottermusch-Heidel C, 2012, DEV BIOL, V368, P18, DOI 10.1016/j.ydbio.2012.04.031; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gildor B, 2009, EMBO REP, V10, P1043, DOI 10.1038/embor.2009.129; Goncalves-Pimentel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018340; GREIG S, 1993, NATURE, V362, P630, DOI 10.1038/362630a0; Haralalka S, 2012, METHODS, V56, P55, DOI 10.1016/j.ymeth.2011.08.008; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Haralalka S, 2010, EXP CELL RES, V316, P3007, DOI 10.1016/j.yexcr.2010.05.018; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hummel T, 2000, GENE DEV, V14, P863; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Kaipa BR, 2013, J CELL SCI, V126, P360, DOI 10.1242/jcs.113860; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Nose A, 1998, DEVELOPMENT, V125, P215; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; Rau A, 2001, DEVELOPMENT, V128, P5061; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Roy S, 2012, CURR BIOL, V22, pR63, DOI 10.1016/j.cub.2011.12.031; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Stevenson V, 2002, CURR BIOL, V12, P705, DOI 10.1016/S0960-9822(02)00807-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	62	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114126	10.1371/journal.pone.0114126	http://dx.doi.org/10.1371/journal.pone.0114126			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474591	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500115
J	Li, YJ; Cai, M; Cao, L; Qin, X; Zheng, TT; Xu, XH; Sandvick, TM; Hutchinson, K; Wold, LE; Hu, KL; Sun, QH; Thomas, DP; Ren, J; He, GL				Li, Yuanjing; Cai, Ming; Cao, Li; Qin, Xing; Zheng, Tiantian; Xu, Xiaohua; Sandvick, Taylor M.; Hutchinson, Kirk; Wold, Loren E.; Hu, Keli; Sun, Qinghua; Thomas, D. Paul; Ren, Jun; He, Guanglong			Endurance Exercise Accelerates Myocardial Tissue Oxygenation Recovery and Reduces Ischemia Reperfusion Injury in Mice	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; K-ATP CHANNEL; IN-VIVO; BLOOD-FLOW; CARDIOPROTECTION; MITOCHONDRIAL; REFLOW; EPIDEMIOLOGY; HYPERTENSION; CONSUMPTION	Exercise training offers cardioprotection against ischemia and reperfusion (I/R) injury. However, few essential signals have been identified to underscore the protection from injury. In the present study, we hypothesized that exercise-induced acceleration of myocardial tissue oxygenation recovery contributes to this protection. C57BL/6 mice (4 weeks old) were trained on treadmills for 45 min/day at a treading rate of 15 m/min for 8 weeks. At the end of 8-week exercise training, mice underwent 30-min left anterior descending coronary artery occlusion followed by 60-min or 24-h reperfusion. Electron paramagnetic resonance oximetry was performed to measure myocardial tissue oxygenation. Western immunoblotting analyses, gene transfection, and myography were examined. The oximetry study demonstrated that exercise markedly shortened myocardial tissue oxygenation recovery time following reperfusion. Exercise training up-regulated Kir6.1 protein expression (a subunit of ATP-sensitive K+ channel on vascular smooth muscle cells, VSMC sarc-KATP) and protected the heart from I/R injury. In vivo gene transfer of dominant negative Kir6.1AAA prolonged the recovery time and enlarged infarct size. In addition, transfection of Kir6.1AAA increased the stiffness and reduced the relaxation capacity in the vasculature. Together, our study demonstrated that exercise training up-regulated Kir6.1, improved tissue oxygenation recovery, and protected the heart against I/R injury. This exercise-induced cardioprotective mechanism may provide a potential therapeutic intervention targeting VSMC sarc-K-ATP channels and reperfusion recovery.	[Cao, Li; Qin, Xing; Zheng, Tiantian; Sandvick, Taylor M.; Ren, Jun; He, Guanglong] Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA; [Thomas, D. Paul] Univ Wyoming, Dept Kinesiol & Hlth, Laramie, WY 82071 USA; [Wold, Loren E.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Xu, Xiaohua; Sun, Qinghua] Ohio State Univ, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Hu, Keli] Ohio State Univ, Div Pharmacol, Columbus, OH 43210 USA; [Hutchinson, Kirk] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Li, Yuanjing] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China; [Cai, Ming] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Cao, Li] Soochow Univ, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Qin, Xing] Fourth Mil Med Univ, Dept Cardiol, Xian 710032, Peoples R China	University of Wyoming; University of Wyoming; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Arizona; Chongqing Medical University; Chongqing Medical University; Soochow University - China; Air Force Military Medical University	He, GL (corresponding author), Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA.	Ghe@uwyo.edu	Li, Yuan/GXV-1310-2022; Ren, Jun/ACG-5366-2022; Wold, Loren E/E-4320-2011	Ren, Jun/0000-0002-0275-0783; Hu, Keli/0000-0002-6955-5261	National Heart, Lung and Blood Institute [HL081630]; National Institute of Environmental Health Sciences [ES016588, ES018900]; National Institute of General Medical Sciences at the National Institutes of Health [P20GM103432]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES018900, K01ES016588, R01ES019923, R01ES018900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Heart, Lung and Blood Institute HL081630, National Institute of Environmental Health Sciences ES016588, National Institute of Environmental Health Sciences ES018900, and National Institute of General Medical Sciences (P20GM103432) at the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman Ulf, 2003, Med Sci Monit, V9, pCR389; Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Belabbas H, 2008, AM J PHYSIOL-REG I, V295, pR1512, DOI 10.1152/ajpregu.00014.2008; Brown DA, 2005, J PHYSIOL-LONDON, V569, P913, DOI 10.1113/jphysiol.2005.095729; Cai M, 2011, AM J PHYSIOL-HEART C, V300, pH1069, DOI 10.1152/ajpheart.00694.2010; Davidson SM, 2009, PHARMACOL REP, V61, P172, DOI 10.1016/S1734-1140(09)70019-2; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Hamilton KL, 2004, FREE RADICAL BIO MED, V37, P1360, DOI 10.1016/j.freeradbiomed.2004.07.025; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Katz PS, 2011, BASIC RES CARDIOL, V106, P1123, DOI 10.1007/s00395-011-0201-0; Lawrence KM, 2002, CIRCULATION, V106, P1556, DOI 10.1161/01.CIR.0000028424.02525.AE; Libonati JR, 1997, MED SCI SPORT EXER, V29, P509, DOI 10.1097/00005768-199704000-00013; Magro M, 2010, NAT REV CARDIOL, V7, P480, DOI 10.1038/nrcardio.2010.117; Meilhac O, 2001, ARTERIOSCL THROM VAS, V21, P1681, DOI 10.1161/hq1001.097106; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Niemann B, 2011, BASIC RES CARDIOL; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; Rezkalla SH, 2010, J INTERV CARDIOL, V23, P429, DOI 10.1111/j.1540-8183.2010.00561.x; Shern-Brewer R, 1998, ARTERIOSCL THROM VAS, V18, P1181, DOI 10.1161/01.ATV.18.7.1181; Shinozaki N, 2007, INT HEART J, V48, P423, DOI 10.1536/ihj.48.423; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Tavazzi L, 1999, AM HEART J, V138, pS48, DOI 10.1016/S0002-8703(99)70320-0; Thakker GD, 2008, OBESITY, V16, P2593, DOI 10.1038/oby.2008.414; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Xu X, 2011, AM J PHYSL REGUL INT; Xu Y, 2008, J PHARMACOL EXP THER, V327, P402, DOI 10.1124/jpet.108.142372; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; Zhu XH, 2007, AM J PHYSIOL-HEART C, V293, pH1442, DOI 10.1152/ajpheart.00256.2007; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114205	10.1371/journal.pone.0114205	http://dx.doi.org/10.1371/journal.pone.0114205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474642	Green Published, gold			2022-12-27	WOS:000346382500001
J	Lin, J; Han, ZH; Li, XY; Ochs, T; Zhao, J; Zhang, X; Yang, JY; Liu, P; Xiong, ZY; Gai, Y; Tang, CS; Du, JB; Jin, HF				Lin, Jing; Han, Zhenhui; Li, Xueying; Ochs, Todd; Zhao, Juan; Zhang, Xi; Yang, Jinyan; Liu, Ping; Xiong, Zhenyu; Gai, Yong; Tang, Chaoshu; Du, Junbao; Jin, Hongfang			Risk Factors for Postural Tachycardia Syndrome in Children and Adolescents	PLOS ONE			English	Article							ORTHOSTATIC INTOLERANCE; WATER DRINKING; MIDODRINE HYDROCHLORIDE; SYNDROME POTS; THERAPEUTIC EFFECTIVENESS; AUTONOMIC DYSFUNCTION; SLEEP DISTURBANCES; PLASMA COPEPTIN; SYNCOPE; HYPOVOLEMIA	Background: Postural tachycardia syndrome (POTS) is prevalent in children and adolescents and has a great impact on health. But its risk factors have not been fully understood. This study aimed to explore possible risk factors for children and adolescents with POTS. Methods and Findings: 600 children and adolescents (test group) aged 7-18 (11.9 +/- 3.0) years old, 259 males and 341 females, were recruited for identifying its risk factors. Another 197 subjects aged from 7 to 18 (11.3 +/- 2.3) years old were enrolled in the validation group. Heart rate (HR) and blood pressure (BP) were monitored during upright test. Risk factors were analyzed and sensitivity and specificity for predicting POTS were tested via receiver operating characteristic curve. Among 600 subjects, 41 were confirmed with POTS patients (6.8%) based on clinical manifestation and upright test. The results showed a significant difference in daily water intake, the daily sleeping hours, supine HR, HR increment and maximum HR during upright test between POTS and the unaffected children (P<0.05). Likelihood of POTS would increase by 1.583 times if supine HR was increased by 10 beats/min (95%CI 1.184 to 2.116, P<0.01), by 3.877 times if a child's water intake was less than 800 ml/day (95%CI 1.937 to 7.760, P<0.001), or by 5.905 times (95%CI 2.972 to 11.733, P<0.001) if sleeping hours were less than 8 hours/day. Supine HR, daily water intake and sleeping hours showed the capability of predicting POTS in children and adolescents with an AUC of 83.9% (95% CI: 78.6%-89.1%), sensitivity of 80.5% and specificity of 75%. Furthermore, in validation group, predictive sensitivity and specificity were 73.3% and 72.5%. Conclusion: Faster supine HR, less water intake and shorter sleeping hours were identified as risk factors for POTS.	[Lin, Jing; Zhao, Juan; Yang, Jinyan; Liu, Ping; Du, Junbao; Jin, Hongfang] Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China; [Han, Zhenhui; Zhang, Xi; Xiong, Zhenyu; Gai, Yong] Childrens Hosp Kaifeng, Dept Pediat, Zhengzhou, Henan, Peoples R China; [Li, Xueying] Peking Univ, Dept Med Stat, Hosp 1, Beijing 100871, Peoples R China; [Ochs, Todd] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tang, Chaoshu] Peking Univ, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Du, Junbao] Minist Educ, Key Lab Mol Cardiol, Beijing, Peoples R China	Peking University; Peking University; Northwestern University; Feinberg School of Medicine; Peking University	Du, JB (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China.	Junbaodu1@126.com; jinhongfang51@126.com	Gai, Yongkang/AAF-3308-2019	Gai, Yongkang/0000-0001-6766-5240; Jin, Hongfang/0000-0002-1606-8988	National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03]; Ministry of Science and Technology, P.R. China; Major Basic Research Project of China [2012CB517806, 2011CB503904]; National Natural Science Foundation of China [81121061]; National Natural Science Foundation of China	National Twelfth Five-Year Plan for Science & Technology Support; Ministry of Science and Technology, P.R. China(Ministry of Science and Technology, China); Major Basic Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by: 1) National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03], Ministry of Science and Technology, P.R. China to HJ [HTTP://WWW.MOST.GOV.CN]; 2) Major Basic Research Project of China [2012CB517806, 2011CB503904], Ministry of Science and Technology, P.R. China to JD [HTTP://WWW.MOST.GOV.CN]; 3) National Natural Science Foundation of China [81121061], National Natural Science Foundation of China to JD [http://www.nsfc.gov.cn]. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagai K, 2013, AUTON NEUROSCI-BASIC, V177, P260, DOI 10.1016/j.autneu.2013.02.021; Bagai K, 2011, J CLIN SLEEP MED, V7, P204; Chen L, 2013, CARDIOL YOUNG, V18, P1; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; FOLLENIUS M, 1992, SLEEP, V15, P21, DOI 10.1093/sleep/15.1.21; Garland EM, 2007, NEUROLOGY, V69, P790, DOI 10.1212/01.wnl.0000267663.05398.40; [黄玉娟 HUANG Yujuan], 2007, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V22, P442; Irwin M, 2003, BRAIN BEHAV IMMUN, V17, P365, DOI 10.1016/S0889-1591(03)00031-X; Jacob G, 1997, AM J MED, V103, P128, DOI 10.1016/S0002-9343(97)00133-2; Jarhour IT, 2013, SEMIN PEDIAT NEUROL, V20, P18; Jimenez-Cohl P, 2012, REV MED CHILE, V140, P145, DOI 10.4067/S0034-98872012000200001; Johnson JN, 2010, PEDIATR NEUROL, V42, P77, DOI 10.1016/j.pediatrneurol.2009.07.002; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; Kanjwal K, 2010, INT J MED SCI, V7, P62; Kuchel O, 1998, CLIN AUTON RES, V8, P341, DOI 10.1007/BF02309625; Liao Y, 2013, AM J CARDIOL, V112, P816, DOI 10.1016/j.amjcard.2013.05.008; LOW PA, 1995, NEUROLOGY, V45, pS19; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; Mack KJ, 2010, SEMIN PEDIATR NEUROL, V17, P109, DOI 10.1016/j.spen.2010.04.006; Mathias CJ, 2012, NAT REV NEUROL, V8, P22, DOI 10.1038/nrneurol.2011.187; Mathias CJ, 2004, EUR J NEUROL, V11, P613, DOI 10.1111/j.1468-1331.2004.00840.x; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Olatunji L A, 2011, Niger J Physiol Sci, V26, P11; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Raj SR, 2005, CIRCULATION, V111, P1574, DOI 10.1161/01.CIR.0000160356.97313.5D; Schroeder C, 2002, CIRCULATION, V106, P2806, DOI 10.1161/01.CIR.0000038921.64575.D0; Shannon JR, 2002, AM J MED, V112, P355, DOI 10.1016/S0002-9343(02)01025-2; Skinner JE, 2010, J CHILD NEUROL, V25, P1210, DOI 10.1177/0883073809359539; Stewart JM, 1999, J PEDIATR-US, V135, P218, DOI 10.1016/S0022-3476(99)70025-9; Winker R, 2004, WIEN KLIN WOCHENSCHR, V116, P40; Yang JY, 2013, J PEDIATR-US, V163, P1169, DOI 10.1016/j.jpeds.2013.04.039; Z'Graggen WJ, 2010, EUR J NEUROL, V17, P1370, DOI 10.1111/j.1468-1331.2010.03030.x; Zhang QY, 2012, J PEDIATR-US, V161, P281, DOI 10.1016/j.jpeds.2012.01.054; Zhao J, 2014, AM J CARDIOL, V114, P601, DOI 10.1016/j.amjcard.2014.05.039; Zhao J, 2014, J PEDIATR-US, V165, P290, DOI 10.1016/j.jpeds.2014.04.032	37	29	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113625	10.1371/journal.pone.0113625	http://dx.doi.org/10.1371/journal.pone.0113625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474569	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500087
J	Fatima, S; Haque, R; Jadiya, P; Shamsuzzama; Kumar, L; Nazir, A				Fatima, Soobiya; Haque, Rizwanul; Jadiya, Pooja; Shamsuzzama; Kumar, Lalit; Nazir, Aamir			Ida-1, the Caenorhabditis elegans Orthologue of Mammalian Diabetes Autoantigen IA-2, Potentially Acts as a Common Modulator between Parkinson's Disease and Diabetes: Role of Daf-2/Daf-16 Insulin Like Signalling Pathway	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; TRANSMEMBRANE PROTEIN; FAMILY; GENES; CHEMOTAXIS; EXPRESSION; DAF-16; MODELS	The lack of cure to age associated Parkinson's disease (PD) has been challenging the efforts of researchers as well as health care providers. Recent evidences suggest that diabetic patients tend to show a higher future risk for PD advocating a strong correlation between PD and Diabetes, thus making it intriguing to decipher common genetic cues behind these ailments. We carried out studies on ida-1, the C. elegans orthologue of mammalian type-1 diabetes auto-antigen IA-2 towards achieving its functional workup vis-a-vis various associated endpoints of PD and Diabetes. Employing transgenic C. elegans strain expressing "human'' alpha synuclein (NL5901) under normal and increased glucose concentrations, we studied aggregation of alpha synuclein, content of dopamine, expression of dopamine transporter, content of reactive oxygen species, locomotor activity, nuclear translocation of FOXO transcription factor Daf-16, and quantification of Daf2/Daf-16 mRNA. Our findings indicate that ida-1 affords protection in the studied disease conditions as absence of ida-1 resulted in higher alpha-synuclein aggregation under conditions that mimic the blood glucose levels of diabetic patients. We also observed reduced dopamine content, decreased motility, defective Daf-16 translocation and reduced expression of Daf-2 and Daf-16. Our studies establish important function of ida-1 as a modulator in Daf-2/Daf-16 insulin like signalling pathway thus possibly being a common link between PD and Diabetes.	[Fatima, Soobiya; Haque, Rizwanul; Jadiya, Pooja; Shamsuzzama; Kumar, Lalit; Nazir, Aamir] CSIR Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), CSIR Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, Lucknow, Uttar Pradesh, India.	anazir@cdri.res.in		, Shamsuzzama/0000-0001-5289-338X; Haque, Rizwanul/0000-0002-3968-6359; Jadiya, Pooja/0000-0003-4807-9304; Nazir, Aamir/0000-0002-2503-1335	National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Department of Science and Technology, Govt. of India under Cognitive Science Research Initiative [SR/CSI/17/2012 (G)]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Office of Research Infrastructure Programs; Department of Science and Technology, Govt. of India under Cognitive Science Research Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The authors thank Caenorhabditis Genetics Center (CGC), University of Minnesota, MN, USA for providing the worm strains used in this study. Caenorhabditis Genetics Center is funded by National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). AN thanks Department of Science and Technology, Govt. of India for funding under Cognitive Science Research Initiative [SR/CSI/17/2012 (G)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Cai T, 2001, DIABETOLOGIA, V44, P81, DOI 10.1007/s001250051583; Chiang WC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002948; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P1001; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kaur S, 2012, CNS NEUROL DISORD-DR, V11, P387, DOI 10.2174/187152712800792811; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Munoz-Lobato F, 2014, ANTIOXID REDOX SIGN, V20, P217, DOI 10.1089/ars.2012.5051; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Stiernagle Theresa, 2006, WormBook, P1; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	35	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113986	10.1371/journal.pone.0113986	http://dx.doi.org/10.1371/journal.pone.0113986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469508	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700060
J	Franke, FA; Mayer, G				Franke, Franziska Anni; Mayer, Georg			Controversies Surrounding Segments and Parasegments in Onychophora: Insights from the Expression Patterns of Four "Segment Polarity Genes'' in the Peripatopsid Euperipatoides rowelli	PLOS ONE			English	Article							GLOMERIS-MARGINATA MYRIAPODA; HOX GENES; ENGRAILED GENE; EMBRYONIC-DEVELOPMENT; NERVOUS-SYSTEM; CELL LINEAGE; EVOLUTION; HEDGEHOG; WINGLESS; SUPPORT	Arthropods typically show two types of segmentation: the embryonic parasegments and the adult segments that lie out of register with each other. Such a dual nature of body segmentation has not been described from Onychophora, one of the closest arthropod relatives. Hence, it is unclear whether onychophorans have segments, parasegments, or both, and which of these features was present in the last common ancestor of Onychophora and Arthropoda. To address this issue, we analysed the expression patterns of the "segment polarity genes'' engrailed, cubitus interruptus, wingless and hedgehog in embryos of the onychophoran Euperipatoides rowelli. Our data revealed that these genes are expressed in repeated sets with a specific anterior-to-posterior order along the body in embryos of E. rowelli. In contrast to arthropods, the expression occurs after the segmental boundaries have formed. Moreover, the initial segmental furrow retains its position within the engrailed domain throughout development, whereas no new furrow is formed posterior to this domain. This suggests that no re-segmentation of the embryo occurs in E. rowelli. Irrespective of whether or not there is a morphological or genetic manifestation of parasegments in Onychophora, our data clearly show that parasegments, even if present, cannot be regarded as the initial metameric units of the onychophoran embryo, because the expression of key genes that define the parasegmental boundaries in arthropods occurs after the segmental boundaries have formed. This is in contrast to arthropods, in which parasegments rather than segments are the initial metameric units of the embryo. Our data further revealed that the expression patterns of "segment polarity genes'' correspond to organogenesis rather than segment formation. This is in line with the concept of segmentation as a result of concerted evolution of individual periodic structures rather than with the interpretation of 'segments' as holistic units.	[Franke, Franziska Anni; Mayer, Georg] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany	Leipzig University	Franke, FA (corresponding author), Univ Leipzig, Inst Biol, Talstr 33, D-04103 Leipzig, Germany.	FranziskaAnniFranke@uni-leipzig.de	Mayer, Georg/Y-9581-2018	Mayer, Georg/0000-0003-0737-2440	Emmy Noether Programme of the German Research Foundation (DFG) [Ma 4147/3-1]; German Research Foundation (DFG); Leipzig University	Emmy Noether Programme of the German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	Funding: This work was supported by the Emmy Noether Programme of the German Research Foundation (DFG, http://www.dfg.de/index.jsp) to GM (Ma 4147/3-1). The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allwood J, 2010, J BIOGEOGR, V37, P669, DOI 10.1111/j.1365-2699.2009.02233.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARIAS AM, 1988, DEVELOPMENT, V103, P157; Baer A, 2014, J ZOOL SYST EVOL RES, V52, P265, DOI 10.1111/jzs.12070; Baer A, 2012, J MORPHOL, V273, P1079, DOI 10.1002/jmor.20044; Balavoine G, 2003, INTEGR COMP BIOL, V43, P137, DOI 10.1093/icb/43.1.137; Barclay S, 2000, J ZOOL, V250, P425, DOI 10.1111/j.1469-7998.2000.tb00786.x; Barclay SD, 2000, J ZOOL, V250, P437; Blaxter M, 2011, CURR BIOL, V21, pR238, DOI 10.1016/j.cub.2011.02.017; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Deutsch JS, 2004, BIOESSAYS, V26, P1117, DOI 10.1002/bies.20111; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Dohle W, 2004, CRUSTACEAN ISS, V15, P95; DOHLE W, 1988, DEVELOPMENT, V104, P147; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Franke FA, EVOL DEV; Fusco Giuseppe, 2013, P197; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; Goodrich E. S., 1897, Quarterly J Micr Soc, Vxl, P247; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Hannibal RL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-35; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hogvall M, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-14; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hughes CL, 2002, DEV BIOL, V247, P47, DOI 10.1006/dbio.2002.0683; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; Janssen R, 2008, DEV GENES EVOL, V218, P361, DOI 10.1007/s00427-008-0231-2; Janssen R, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-22; Janssen R, 2013, DEV BIOL, V382, P224, DOI 10.1016/j.ydbio.2013.07.010; Janssen R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-374; Jeffery NW, 2012, GENETICA, V140, P497, DOI 10.1007/s10709-013-9698-5; Kanayama M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1510; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lawrence P., 1992, MAKING FLY GENETICS; LAWRENCE PA, 1988, DEVELOPMENT, V104, P61; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Martin C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnins.2014.00211, 10.3389/fnana.2014.00007]; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; Mayer G, 2006, ZOOMORPHOLOGY, V125, P1, DOI 10.1007/s00435-005-0006-5; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Mayer G, NATURE; Mayer G, STRUCTURE EVOLUTION, P20; Mayer G, EVOLUTIONARY DEV BIO, V65; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-118; Mayer G, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1440.1.2; Mayer Georg, 2010, BMC Evol Biol, V10, P255, DOI 10.1186/1471-2148-10-255; Mayer G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-230; Mayer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059090; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-339; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Mayer G, 2009, ZOOL J LINN SOC-LOND, V157, P17, DOI 10.1111/j.1096-3642.2009.00523.x; Murdock DJE, BMC EVOL BI IN PRESS; Murienne J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2648; NAGY LM, 1994, NATURE, V367, P460, DOI 10.1038/367460a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Oda H, 2007, DEVELOPMENT, V134, P2195, DOI 10.1242/dev.004598; Oliveira ID, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-73; Oliveira ID, 2013, J MORPHOL, V274, P1180, DOI 10.1002/jmor.20171; Oliveira IDS, 2013, ZOOL ANZ, V252, P495, DOI 10.1016/j.jcz.2013.01.001; Oliveira ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051220; Ou Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2272; Pang K., 2010, MNEMIONSIS LEIDYI EV, V1, P10, DOI DOI 10.1186/2041-9139-1-10; PATEL NH, 1994, DEVELOPMENT, P201; PATEL NH, 1989, DEVELOPMENT, V107, P201; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Prpic NM, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-17; Prpic NM, 2003, DEV BIOL, V260, P97, DOI 10.1016/S0012-1606(03)00217-3; Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; ROBSON EA, 1966, NATURE, V209, P533, DOI 10.1038/209533a0; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Schinko J, 2009, COLD SPRING HARB PRO, V8; SCHOLTZ G, 1995, BIOL BULL, V188, P157, DOI 10.2307/1542081; Scholtz G, 2002, ORG DIVERS EVOL, V2, P197, DOI 10.1078/1439-6092-00046; Scholtz G, 1996, INT J DEV BIOL, V40, P211; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Seaver EC, 2001, DEV BIOL, V236, P195, DOI 10.1006/dbio.2001.0309; Seaver EC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-8; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunnucks P, 2000, J ZOOL, V250, P447, DOI 10.1111/j.1469-7998.2000.tb00788.x; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Treffkorn S, 2013, GENE EXPR PATTERNS, V13, P384, DOI 10.1016/j.gep.2013.07.004; Walker MH, 2004, J ZOOL, V264, P333, DOI 10.1017/s0952836904005837; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang Zhi-Qiang, 2011, Zootaxa, V3148, P1, DOI 10.11646/zootaxa.3703.1.1	109	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114383	10.1371/journal.pone.0114383	http://dx.doi.org/10.1371/journal.pone.0114383			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470738	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700113
J	Watts, NS; Pajuelo, M; Clark, T; Loader, MCI; Verastegui, MR; Sterling, C; Friedland, JS; Garcia, HH; Gilman, RH				Watts, Nathaniel S.; Pajuelo, Monica; Clark, Taryn; Loader, Maria-Cristina I.; Verastegui, Manuela R.; Sterling, Charles; Friedland, Jon S.; Garcia, Hector H.; Gilman, Robert H.		Cysticercosis Working Grp Peru	Taenia solium Infection in Peru: A Collaboration between Peace Corps Volunteers and Researchers in a Community Based Study	PLOS ONE			English	Article							RISK-FACTORS; PORCINE CYSTICERCOSIS; RURAL VILLAGE; HYPERENDEMIC HUMAN; MASS CHEMOTHERAPY; TAPEWORM CARRIERS; NEUROCYSTICERCOSIS; PREVALENCE; FASCIOLIASIS; CAJAMARCA	Background: Neurocysticercosis is a leading cause of seizures and epilepsy in most of the world, and it occurs when Taenia solium larval cysts infect the central nervous system. T. solium tapeworm infection is endemic in much of Peru, but there are scarce data on the prevalence in many rural highland communities where it is likely to be hyper-endemic. Peace Corps Volunteers live and work in these communities; however, to our knowledge, they have not been used to facilitate public health research. Materials and Methods: We utilized Peace Corps Volunteers to estimate the prevalence of T. solium tapeworm infection in seven rural communities in northern Peru. A convenience non-random sampling frame was used. Peace Corps Volunteers facilitated the collection of stool samples (N=2,328), which were analyzed by sedimentation and microscopy. Niclosamide treatment and purgation preceded species identification, which was done by PCR-REA. Results: Taenia sp. egg-positive stool samples were found in three of the seven communities we surveyed. The overall prevalence of Taenia sp. egg positivity was 2.1% (49/2,328) (95% CI=1.6-2.8%) with prevalence up to 4.3% (42/977) (95% CI=3.1-5.8%) by community. All 34 of the specimens tested by PCR-REA were T. solium. The overall prevalence of T. solium tapeworm infection was 1.5% (34/2,328) (95% CI=1.0-2.0%). Prevalence up to 2.9% (28/977) (95% CI=1.9-4.1%) by community was observed. Conclusion/Significance: This study recorded high T. solium tapeworm prevalence, and identified hyper-endemic rural communities. It demonstrates that synergy between researchers and Peace Corps Volunteers can be an effective means to conducting large-scale, community-based studies in remote areas of Peru.	[Watts, Nathaniel S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Pajuelo, Monica] Univ Peruana Cayetano Heredia, Sch Sci & Philosophy, Unit Bioinformat & Mol Biol, Lima, Peru; [Clark, Taryn] Weill Cornell Med Coll, New York, NY USA; [Loader, Maria-Cristina I.; Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Imperial Ctr Global Hlth, London, England; [Verastegui, Manuela R.; Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci & Philosophy, Dept Microbiol, Lima, Peru; [Sterling, Charles] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA; [Gilman, Robert H.] Asociac Benef Proyectos Informat Salud Med & Agr, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Boston University; Universidad Peruana Cayetano Heredia; Cornell University; Imperial College London; Universidad Peruana Cayetano Heredia; University of Arizona; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Watts, NS (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.	natswatts@gmail.com		Friedland, Jonathan S/0000-0001-7789-9649; Verastegui, Manuela/0000-0002-7500-1353; pajuelo, monica/0000-0003-3662-2250; Loader, Maria Cristina/0000-0003-0556-2363	D43 International Global Infectious Disease Research Training Grant [5D43TW006581-10]; RG-ER fund; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-21-008] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER	D43 International Global Infectious Disease Research Training Grant; RG-ER fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by the D43 International Global Infectious Disease Research Training Grant 5D43TW006581-10. The authors also acknowledge the anonymous RG-ER fund for funding NW and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The anonymous RG-ER fund is an anonymous donor who is a person and not a fund. There is no expansion of the name possible. There is no conflict of interest with this fund. It is not an organization or a company.	ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; [Anonymous], 2005, AIDS Policy Law, V20, P2; Barnes Shawn, 2009, Community Eye Health, V22, pS1; CAMACHO SD, 1990, T ROY SOC TROP MED H, V84, P563, DOI 10.1016/0035-9203(90)90041-C; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; Gonzalez LC, 2011, ACTA TROP, V120, P119, DOI 10.1016/j.actatropica.2011.07.002; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Esteban JG, 2002, TROP MED INT HEALTH, V7, P339, DOI 10.1046/j.1365-3156.2002.00870.x; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Garcia Hector H., 2010, Rev. perú. med. exp. salud publica, V27, P592, DOI 10.1590/s1726-46342010000400016; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Huisa BN, 2005, AM J TROP MED HYG, V73, P496, DOI 10.4269/ajtmh.2005.73.496; Jayashi CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001733; Jeri C, 2004, LANCET, V363, P949, DOI 10.1016/S0140-6736(04)15791-7; Krecek RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037718; Lescano AG, 2007, AM J TROP MED HYG, V76, P376, DOI 10.4269/ajtmh.2007.76.376; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Mayta H, 2000, J CLIN MICROBIOL, V38, P133; Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; Moyano LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002692; Mullan F, 2007, JAMA-J AM MED ASSOC, V297, P744, DOI 10.1001/jama.297.7.744; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Nash TE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001964; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Nyberg BJ, 2012, JAIDS-J ACQ IMM DEF, V60, pS127, DOI 10.1097/QAI.0b013e31825da836; O'Neal SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001953; Rinaldi L, 2012, GEOSPATIAL HEALTH, V6, pS67; Rodriguez-Canul R, 1999, ANN TROP MED PARASIT, V93, P57, DOI 10.1080/00034989958807; Rodriguez-Hidalgo R, 2006, MEM I OSWALDO CRUZ, V101, P779, DOI 10.1590/S0074-02762006000700012; Roldan WH, 2009, REV INST MED TROP SP, V51, P67, DOI 10.1590/S0036-46652009000200002; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; SARTI E, 1994, T ROY SOC TROP MED H, V88, P49, DOI 10.1016/0035-9203(94)90493-6; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x; Tello R, 1988, 6 JORN CIENT; Turaga Kiran K, 2006, Hernia, V10, P294, DOI 10.1007/s10029-006-0111-5; Villaran MV, 2009, NEUROEPIDEMIOLOGY, V33, P25, DOI 10.1159/000210019	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113239	10.1371/journal.pone.0113239	http://dx.doi.org/10.1371/journal.pone.0113239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469506	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000349128700018
J	Breda, AP; de Albuquerque, ALP; Jardim, C; Morinaga, LK; Suesada, MM; Fernandes, CJC; Dias, B; Lourenco, RB; Salge, JM; Souza, R				Breda, Ana Paula; Pereira de Albuquerque, Andre Luis; Jardim, Carlos; Morinaga, Luciana Kato; Suesada, Milena Mako; Cesar Fernandes, Caio Julio; Dias, Bruno; Lourenco, Rafael Burgomeister; Salge, Joao Marcos; Souza, Rogerio			Skeletal Muscle Abnormalities in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LUNG-FUNCTION TESTS; 6-MINUTE WALK TEST; BODY-COMPOSITION; PROGNOSTIC-SIGNIFICANCE; REFERENCE VALUES; EXERCISE; DYSFUNCTION; SURVIVAL; DISEASE	Background: Pulmonary arterial hypertension is a progressive disease that is characterized by dyspnea and exercise intolerance. Impairment in skeletal muscle has recently been described in PAH, although the degree to which this impairment is solely determined by the hemodynamic profile remains uncertain. The aim of this study was to verify the association of structural and functional skeletal muscle characteristics with maximum exercise in PAH. Methods: The exercise capacity, body composition, CT area of limb muscle, quality of life, quadriceps biopsy and hemodynamics of 16 PAH patients were compared with those of 10 controls. Results: PAH patients had a significantly poorer quality of life, reduced percentage of lean body mass, reduced respiratory muscle strength, reduced resistance and strength of quadriceps and increased functional limitation at 6MWT and CPET. VO2 max was correlated with muscular variables and cardiac output. Bivariate linear regression models showed that the association between muscular structural and functional variables remained significant even after correcting for cardiac output. Conclusion: Our study showed the coexistence of ventilatory and quadriceps weakness in face of exercise intolerance in the same group of PAH patients. More interestingly, it is the first time that the independent association between muscular pattern and maximum exercise capacity is evidenced in PAH, independently of cardiac index highlighting the importance of considering rehabilitation in the treatment strategy for PAH.	[Breda, Ana Paula; Pereira de Albuquerque, Andre Luis; Jardim, Carlos; Morinaga, Luciana Kato; Suesada, Milena Mako; Cesar Fernandes, Caio Julio; Dias, Bruno; Salge, Joao Marcos; Souza, Rogerio] Univ Sao Paulo, Sch Med, Dept Pulm, Inst Heart, Sao Paulo, Brazil; [Lourenco, Rafael Burgomeister] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Souza, R (corresponding author), Univ Sao Paulo, Sch Med, Dept Pulm, Inst Heart, Sao Paulo, Brazil.	rogerio.souza@incor.usp.br	Jardim, Carlos V P/N-8061-2017; Fernandes, Caio/W-8676-2019; Fernandes, Caio JCS/K-9194-2016; Salge, Joao M/B-5157-2015; Souza, Rogerio/I-3584-2013; Albuquerque, Andre/C-8835-2012	Jardim, Carlos V P/0000-0003-0425-5548; Fernandes, Caio/0000-0002-4912-021X; Fernandes, Caio JCS/0000-0002-4912-021X; Salge, Joao M/0000-0001-5121-0129; Souza, Rogerio/0000-0003-2789-9143; Albuquerque, Andre/0000-0003-3486-5240	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2007/04862-6]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study has been done with the support of FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; grant 2007/04862-6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society European Respiratory Society, 2002, AM J RESP CRIT CARE, V166; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC; Bauer R, 2007, RESP MED, V101, P2366, DOI 10.1016/j.rmed.2007.06.014; Fernandes CJCD, 2010, J AM COLL CARDIOL, V56, P715, DOI 10.1016/j.jacc.2010.03.065; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Futter JE, 2011, EUR J HEART FAIL, V13, P207, DOI 10.1093/eurjhf/hfq218; Galie N, 2009, EUR RESP J; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Jardim C, 2010, EUR RESPIR REV, V19, P266, DOI 10.1183/09059180.00008810; Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221; Lerario MC, 2006, BRIT J NUTR, V96, P86, DOI 10.1079/BJN20061798; Mainguy V, 2010, J CARDIOPULM REHABIL, V30, P319, DOI 10.1097/HCR.0b013e3181d6f962; Mainguy V, 2010, THORAX, V65, P113, DOI 10.1136/thx.2009.117168; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Meyer FJ, 2001, CIRCULATION, V103, P2153; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729, DOI 10.1590/S0100-879X1999000600008; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Pereira CAC SB, 1992, BRAZILIAN J PULMONOL, V18, P10; Provencher S, 2010, EUR RESPIR J, V35, P958, DOI 10.1183/09031936.00007110; Satta A, 1997, EUR RESPIR J, V10, P2853, DOI 10.1183/09031936.97.10122853; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Tolle J, 2008, MED SCI SPORT EXER, V40, P3, DOI 10.1249/mss.0b013e318159d1b8; Uszko-Lencer NHMK, 2006, EUR J HEART FAIL, V8, P208, DOI 10.1016/j.ejheart.2005.07.007; Velez-Roa S, 2004, CIRCULATION, V110, P1308, DOI 10.1161/01.CIR.0000140724.90898.D3; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114101	10.1371/journal.pone.0114101	http://dx.doi.org/10.1371/journal.pone.0114101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460348	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700098
J	Senden, M; Reithler, J; Gijsen, S; Goebel, R				Senden, Mario; Reithler, Joel; Gijsen, Sven; Goebel, Rainer			Evaluating Population Receptive Field Estimation Frameworks in Terms of Robustness and Reproducibility	PLOS ONE			English	Article							VISUAL AREAS; REORGANIZATION	Within vision research retinotopic mapping and the more general receptive field estimation approach constitute not only an active field of research in itself but also underlie a plethora of interesting applications. This necessitates not only good estimation of population receptive fields (pRFs) but also that these receptive fields are consistent across time rather than dynamically changing. It is therefore of interest to maximize the accuracy with which population receptive fields can be estimated in a functional magnetic resonance imaging (fMRI) setting. This, in turn, requires an adequate estimation framework providing the data for population receptive field mapping. More specifically, adequate decisions with regard to stimulus choice and mode of presentation need to be made. Additionally, it needs to be evaluated whether the stimulation protocol should entail mean luminance periods and whether it is advantageous to average the blood oxygenation level dependent (BOLD) signal across stimulus cycles or not. By systematically studying the effects of these decisions on pRF estimates in an empirical as well as simulation setting we come to the conclusion that a bar stimulus presented at random positions and interspersed with mean luminance periods is generally most favorable. Finally, using this optimal estimation framework we furthermore tested the assumption of temporal consistency of population receptive fields. We show that the estimation of pRFs from two temporally separated sessions leads to highly similar pRF parameters.	[Senden, Mario; Reithler, Joel; Gijsen, Sven; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands; [Senden, Mario; Reithler, Joel; Gijsen, Sven; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, NL-6200 MD Maastricht, Netherlands; [Reithler, Joel; Goebel, Rainer] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, NL-1105 BA Amsterdam, Netherlands	Maastricht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Senden, M (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	mario.senden@maastrichtuniversity.nl		Senden, Mario/0000-0002-5598-6167; Goebel, Rainer/0000-0003-1780-2467	European Research Council under the European Union [269853]	European Research Council under the European Union(European Research Council (ERC))	This project was supported by the European Research Council under the European Union's Seventh Framework Programme (ERC-2010-AdG, ERC grant agreement no. 269853) http://erc.europa.eu/funding-and-grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binda P, 2013, J VISION, V13, DOI 10.1167/13.7.13; de Condorcet M, 1785, POLITICAL THEORY CON, P69; DeYoe E, 2013, J VIS, V13, P232; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Dumoulin SO, 2014, J VISION, V14, DOI 10.1167/14.5.18; Dumoulin SO, 2003, NEUROIMAGE, V18, P576, DOI 10.1016/S1053-8119(02)00058-7; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Haak KV, CORTEX; Hedges LV, 2014, STAT METHODS META AN; Kay KN, 2013, J NEUROPHYSIOL, V110, P481, DOI 10.1152/jn.00105.2013; Lee S, 2013, NEUROIMAGE, V81, P144, DOI 10.1016/j.neuroimage.2013.05.026; Peters JC, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00012; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; TIDEMAN TN, 1987, SOC CHOICE WELFARE, V4, P185, DOI 10.1007/BF00433944	21	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114054	10.1371/journal.pone.0114054	http://dx.doi.org/10.1371/journal.pone.0114054			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463652	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700090
J	Sridharamurthy, M; Kovach, A; Zhao, Y; Zhu, JK; Xu, HE; Swaminathan, K; Melcher, K				Sridharamurthy, Madhuri; Kovach, Amanda; Zhao, Yang; Zhu, Jian-Kang; Xu, H. Eric; Swaminathan, Kunchithapadam; Melcher, Karsten			H2O2 Inhibits ABA-Signaling Protein Phosphatase HAB1	PLOS ONE			English	Article							ABSCISIC-ACID ACTIVATION; INDUCED STOMATAL CLOSURE; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; NEGATIVE REGULATOR; ANION CHANNEL; WATER-STRESS; GUARD-CELLS; 2C; ARABIDOPSIS	Due to its ability to be rapidly generated and propagated over long distances, H2O2 is an important second messenger for biotic and abiotic stress signaling in plants. In response to low water potential and high salt concentrations sensed in the roots of plants, the stress hormone abscisic acid (ABA) activates NADPH oxidase to generate H2O2, which is propagated in guard cells in leaves to induce stomatal closure and prevent water loss from transpiration. Using a reconstituted system, we demonstrate that H2O2 reversibly prevents the protein phosphatase HAB1, a key component of the core ABA-signaling pathway, from inhibiting its main target in guard cells, SnRK2.6/OST1 kinase. We have identified HAB1 C186 and C274 as H2O2-sensitive thiols and demonstrate that their oxidation inhibits both HAB1 catalytic activity and its ability to physically associate with SnRK2.6 by formation of intermolecular dimers.	[Sridharamurthy, Madhuri; Kovach, Amanda; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Lab Struct Sci Struct Biol, Grand Rapids, MI USA; [Sridharamurthy, Madhuri; Kovach, Amanda; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Biochem Lab, Grand Rapids, MI USA; [Sridharamurthy, Madhuri; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Zhao, Yang; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci,Ctr Struct & Funct Drug Ta, State Key Lab Drug Res,VARI SIMM Ctr, Shanghai 200031, Peoples R China	Van Andel Institute; Van Andel Institute; National University of Singapore; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; karsten.melcher@vai.org	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020; Zhao, Yang/H-2827-2014; Zhu, Jian-Kang/F-7658-2011	Melcher, Karsten/0000-0002-9125-4027; Zhao, Yang/0000-0003-0302-3470; Zhu, Jian-Kang/0000-0001-5134-731X; Xu, H. Eric/0000-0002-6829-8144	Jay and Betty Van Andel Foundation; National Institutes of Health from the Academic Research Fund of Singapore [R01 GM102545]; National University of Singapore; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545] Funding Source: NIH RePORTER	Jay and Betty Van Andel Foundation; National Institutes of Health from the Academic Research Fund of Singapore(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Jay and Betty Van Andel Foundation (HEX and KM), by the National Institutes of Health (grant R01 GM102545 to KM), from the Academic Research Fund of Singapore (KS and MS), and by a Research Scholarship from the National University of Singapore (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2013, NEW PHYTOL, V200, P1049, DOI 10.1111/nph.12469; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Creissen G, 1999, PLANT CELL, V11, P1277, DOI 10.1105/tpc.11.7.1277; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Di YJ, 2012, EMBO J, V31, P563, DOI 10.1038/emboj.2011.438; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Jannat R, 2011, J PLANT PHYSIOL, V168, P1919, DOI 10.1016/j.jplph.2011.05.006; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Meinhard M, 2002, PLANTA, V214, P775, DOI 10.1007/s00425-001-0675-3; Meinhard M, 2001, FEBS LETT, V508, P443, DOI 10.1016/S0014-5793(01)03106-4; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Ng LM, 2014, ACTA PHARMACOL SIN, V35, P567, DOI 10.1038/aps.2014.5; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Puli MR, 2012, J EXP BOT, V63, P1349, DOI 10.1093/jxb/err364; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rhee S G, 2000, Sci STKE, V2000, ppe1; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Song YW, 2014, NEW PHYTOL, V201, P1121, DOI 10.1111/nph.12565; Soon FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047857; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Van Breusegem F, 2001, PLANT SCI, V161, P405, DOI 10.1016/S0168-9452(01)00452-6; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438	59	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113643	10.1371/journal.pone.0113643	http://dx.doi.org/10.1371/journal.pone.0113643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460914	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700040
J	Stowe, HM; Calcatera, SM; Dimmick, MA; Andrae, JG; Duckett, SK; Pratt, SL				Stowe, Heather M.; Calcatera, Samantha M.; Dimmick, Marcy A.; Andrae, John G.; Duckett, Susan K.; Pratt, Scott L.			The Bull Sperm MicroRNAome and the Effect of Fescue Toxicosis on Sperm MicroRNA Expression	PLOS ONE			English	Article							INFECTED TALL FESCUE; SPERMATOGONIAL DIFFERENTIATION; RETINOIC ACID; RNA; FERTILITY; CLUSTERS	Tall fescue [Schedonorus phoenix (Scop.) Holub] accounts for nearly 16 million hectares of pasture in the Southeastern and Mid-Atlantic U.S. due to its heat, drought, and pest resistance, conferred to the plant by its symbiotic relationship with the endophyte Neotyphodium coenophialum. The endophyte produces ergot alkaloids that have negative effects on the growth and reproduction of animals, resulting in the syndrome known as fescue toxicosis. The objectives of our study were to identify microRNA (miRNA) present in bovine sperm and to evaluate the effects of fescue toxicosis on sperm miRNA expression. Angus bulls were assigned to treatments of either toxic or non-toxic fescue seed diets. Semen was collected and subjected to RNA isolation. Three samples from each treatment group were chosen and pooled for deep sequencing. To compare miRNA expression between treatment groups, a microarray was designed and conducted. For each of the top ten expressed miRNA, target prediction analysis was conducted using TargetScan. Gene ontology enrichment was assessed using the Database for Annotation, Visualization and Integrated Discovery. Sequencing results elucidated the presence of 1,582 unique small RNA present in sperm. Of those sequences, 382 were known Bos taurus miRNA, 22 were known but novel to Bos taurus, and 816 were predicted candidate miRNA that did not map to any currently reported miRNA. Of the sequences chosen for microarray, twenty-two showed significant differential expression between treatment groups. Gene pathways of interest included: regulation of transcription, embryonic development (including blastocyst formation), Wnt and Hedgehog signaling, oocyte meiosis, and kinase and phosphatase activity. MicroRNA present in mature sperm appears to not only be left over from spermatogenic processes, but may actually serve important regulatory roles in fertilization and early developmental processes. Further, our results indicate the possibility that environmental changes may impact the expression of specific miRNA.	[Stowe, Heather M.; Calcatera, Samantha M.; Dimmick, Marcy A.; Andrae, John G.; Duckett, Susan K.; Pratt, Scott L.] Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29631 USA	Clemson University	Stowe, HM (corresponding author), Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29631 USA.	hmstowe@gmail.com			National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA) [SC-1700376]; National Research Initiative Competitive Grant from the USDA NIFA [2010-38942-20745]; Cooperative State Research, Education, and Extension Service	National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA); National Research Initiative Competitive Grant from the USDA NIFA; Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This material is based upon work supported by the National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA), under project number SC-1700376 and was supported by National Research Initiative Competitive Grant no. 2010-38942-20745 from the USDA NIFA and the Cooperative State Research, Education, and Extension Service (SKD, SLP, JGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; Allen VG, 2001, J RANGE MANAGE, V54, P409, DOI 10.2307/4003111; BACON CW, 1995, J ANIM SCI, V73, P861; BEERS KW, 1987, ARKANSAS FARM RES, V36, P7; Belesky D. P., 2009, TALL FESCUE 21 CENTU, P49; BOLING JA, 1985, PROF ANIM SCI, V1; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; EVANS KL, 1988, THERIOGENOLOGY, V30, P169, DOI 10.1016/0093-691X(88)90274-9; GAY N, 1988, APPL AGR RES, V3; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; HUANG K, 2014, BIOCHIMIE; Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747; Jones K. L., 2004, Professional Animal Scientist, V20, P437; Kocamis H, 2013, POULTRY SCI, V92, P787, DOI 10.3382/ps.2012-02691; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037039; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Looper ML, 2009, J ANIM SCI, V87, P1184, DOI 10.2527/jas.2008-1258; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; PORTER JK, 1992, J ANIM SCI, V70, P1594, DOI 10.2527/1992.7051594x; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHMIDT SP, 1986, FESCUE FUNGUS SUPPRE, V3315; Schuenemann GM, 2005, REPROD FERT DEVELOP, V17, P479, DOI 10.1071/RD05005; Schuenemann GM, 2005, THERIOGENOLOGY, V63, P1407, DOI 10.1016/j.theriogenology.2004.07.014; Stowe HM, 2013, J ANIM SCI, V91, P3686, DOI 10.2527/jas.2012-6078; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Tong MH, 2011, BIOL REPROD, V85, P189, DOI 10.1095/biolreprod.110.089458; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; WASHBURN SP, 1991, P 40 ANN C N CAR CAT, V2	46	24	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113163	10.1371/journal.pone.0113163	http://dx.doi.org/10.1371/journal.pone.0113163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462855	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700027
J	Juan, MC; Mendez-Lopez, M; Perez-Hernandez, E; Albiol-Perez, S				Juan, M. -Carmen; Mendez-Lopez, Magdalena; Perez-Hernandez, Elena; Albiol-Perez, Sergio			Augmented Reality for the Assessment of Children's Spatial Memory in Real Settings	PLOS ONE			English	Article							DEVELOPMENTAL TOPOGRAPHICAL DISORIENTATION; RADIAL-ARM MAZE; WORKING-MEMORY; SEX-DIFFERENCES; SEARCH BEHAVIOR; HIPPOCAMPUS; IMPAIRMENT; COMPONENTS; USABILITY; DAMAGE	Short-term memory can be defined as the capacity for holding a small amount of information in mind in an active state for a short period of time. Although some instruments have been developed to study spatial short-term memory in real environments, there are no instruments that are specifically designed to assess visuospatial short-term memory in an attractive way to children. In this paper, we present the ARSM (Augmented Reality Spatial Memory) task, the first Augmented Reality task that involves a user's movement to assess spatial short-term memory in healthy children. The experimental procedure of the ARSM task was designed to assess the children's skill to retain visuospatial information. They were individually asked to remember the real place where augmented reality objects were located. The children (N=76) were divided into two groups: preschool (5-6 year olds) and primary school (7-8 year olds). We found a significant improvement in ARSM task performance in the older group. The correlations between scores for the ARSM task and traditional procedures were significant. These traditional procedures were the Dot Matrix subtest for the assessment of visuospatial short-term memory of the computerized AWMA-2 battery and a parent's questionnaire about a child's everyday spatial memory. Hence, we suggest that the ARSM task has high verisimilitude with spatial short-term memory skills in real life. In addition, we evaluated the ARSM task's usability and perceived satisfaction. The study revealed that the younger children were more satisfied with the ARSM task. This novel instrument could be useful in detecting visuospatial short-term difficulties that affect specific developmental navigational disorders and/or school academic achievement.	[Juan, M. -Carmen] Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Camino Vera S-N, Valencia 46022, Spain; [Mendez-Lopez, Magdalena] Univ Zaragoza, Dept Psicol & Sociol, Zaragoza, Spain; [Perez-Hernandez, Elena] Univ Autonoma Madrid, Dept Psicol Evolut & Educ, Madrid, Spain; [Albiol-Perez, Sergio] Univ Zaragoza, Dept Informat & Ingn Sistemas, Zaragoza, Spain	Universitat Politecnica de Valencia; University of Zaragoza; Autonomous University of Madrid; University of Zaragoza	Juan, MC (corresponding author), Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Camino Vera S-N, Valencia 46022, Spain.	mcarmen@ai2.upv.es	Perez-Hernandez, Elena/H-5619-2015; Juan, M.-Carmen/I-3585-2015; Méndez-López, Magdalena/D-3059-2011	Perez-Hernandez, Elena/0000-0001-8822-6423; Juan, M.-Carmen/0000-0002-8764-1470; Méndez-López, Magdalena/0000-0002-4249-602X; Albiol Perez, Sergio/0000-0002-6280-1474	Spanish Government (MINECO); European Regional Development Fund (FEDER) in the CHILDMNEMOS project [TIN2012-37381-C02-01]; Gobierno de Aragon (Dpt. Industria e Innovacion); Fondo Social Europeo; Fundacion Universitaria Antonio Gargallo; Obra Social Ibercaja	Spanish Government (MINECO)(Spanish Government); European Regional Development Fund (FEDER) in the CHILDMNEMOS project; Gobierno de Aragon (Dpt. Industria e Innovacion); Fondo Social Europeo(European Social Fund (ESF)European Commission); Fundacion Universitaria Antonio Gargallo; Obra Social Ibercaja	Funded by the Spanish Government (MINECO) and European Regional Development Fund (FEDER) in the CHILDMNEMOS project TIN2012-37381-C02-01, Gobierno de Aragon (Dpt. Industria e Innovacion), Fondo Social Europeo, Fundacion Universitaria Antonio Gargallo and Obra Social Ibercaja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht UV, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2497; Alloway T.P., 2007, AUTOMATED WORKING ME; ALLOWAY TP, 2012, WORKING MEMORY ASSES; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Alloway TP, 2009, LEARN INDIVID DIFFER, V19, P242, DOI 10.1016/j.lindif.2008.10.003; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Baddeley A. D, 1986, WORKING MEMORY; Barnfield AMC, 1999, PERCEPT MOTOR SKILL, V89, P339, DOI 10.2466/pms.1999.89.1.339; Bavin EL, 2005, INT J LANG COMM DIS, V40, P319, DOI 10.1080/13682820400027750; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bianchini F, 2010, NEUROPSYCHOLOGIA, V48, P1563, DOI 10.1016/j.neuropsychologia.2010.01.025; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Canovas R, 2011, BEHAV BRAIN RES, V216, P116, DOI 10.1016/j.bbr.2010.07.026; Juan MC, 2011, WSCG 2011: FULL PAPERS PROCEEDINGS, P25; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cimadevilla JM, 2011, J NEUROSCI METH, V196, P45, DOI 10.1016/j.jneumeth.2010.12.026; Furio D, 2013, COMPUT EDUC, V64, P24, DOI 10.1016/j.compedu.2012.12.015; Furio D, 2013, COMPUT EDUC, V64, P1, DOI 10.1016/j.compedu.2012.12.001; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Iaria G, 2010, EXP BRAIN RES, V206, P189, DOI 10.1007/s00221-010-2256-9; Injoque-Ricle I, 2011, LEARN INDIVID DIFFER, V21, P78, DOI 10.1016/j.lindif.2010.09.012; Jones A, 1999, INTERACT COMPUT, V11, P499, DOI 10.1016/S0953-5438(98)00064-2; Juan MC, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.143; KAMPHAUS KW, 2014, CUESTIONARI IN PRESS; Kelly DM, 2007, COMP COGN BEHAV REV, V2, P111, DOI 10.3819/ccbr.2008.20007; KOENIG S, 2011, INT J DES INNOV RES, V6, P1; Lee SJ, 2011, INTERNET HIGH EDUC, V14, P158, DOI 10.1016/j.iheduc.2011.04.001; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Liu PHE, 2013, BRIT J EDUC TECHNOL, V44, pE1, DOI 10.1111/j.1467-8535.2012.01302.x; Lowe PA, 2003, ARCH CLIN NEUROPSYCH, V18, P865, DOI 10.1016/S0887-6177(02)00162-2; Lyons KE, 2011, ADV CHILD DEV BEHAV, V40, P379; Mammarella IC, 2014, CHILD NEUROPSYCHOL, V20, P255, DOI 10.1080/09297049.2013.796920; Mayes JT, 1999, INTERACT COMPUT, V11, P485, DOI 10.1016/S0953-5438(98)00065-4; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUNOZ M, 2009, NEW ENCY NEUROSCIENC, P1173; OADES RD, 1978, BEHAV BIOL, V24, P327, DOI 10.1016/S0091-6773(79)90184-6; OLTON DS, 1987, PHYSIOL BEHAV, V40, P793, DOI 10.1016/0031-9384(87)90286-1; Passolunghi MC, 2012, J LEARN DISABIL-US, V45, P341, DOI 10.1177/0022219411400746; Piccardi L, 2014, CLIN NEUROPSYCHOL, V28, P84, DOI 10.1080/13854046.2013.863976; Shore DI, 2001, COGN AFFECT BEHAV NE, V1, P83, DOI 10.3758/CABN.1.1.83; Simmons FR, 2012, J EXP CHILD PSYCHOL, V111, P139, DOI 10.1016/j.jecp.2011.08.011; Smith AD, 2005, PERCEPTION, V34, P1221, DOI 10.1068/p5270; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Squires D, 1999, INTERACT COMPUT, V11, P467, DOI 10.1016/S0953-5438(98)00063-0; Sturz BR, 2010, PSYCHOL RES-PSYCH FO, V74, P560, DOI 10.1007/s00426-010-0277-4; Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007; Szucs D, 2013, CORTEX, V49, P2674, DOI 10.1016/j.cortex.2013.06.007; Thomas E, 2011, CHILD NEUROPSYCHOL, V17, P599, DOI 10.1080/09297049.2011.567980	50	34	34	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113751	10.1371/journal.pone.0113751	http://dx.doi.org/10.1371/journal.pone.0113751			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438146	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900075
J	O'Neill, B; Goncalves, D; Ricci-Cabello, I; Ziebland, S; Valderas, J				O'Neill, Braden; Goncalves, Daniela; Ricci-Cabello, Ignacio; Ziebland, Sue; Valderas, Jose			An Overview of Self-Administered Health Literacy Instruments	PLOS ONE			English	Article							TALKING TOUCHSCREEN; CARE PROVIDERS; VALIDATION; SCALE; INTERVENTIONS; INDIVIDUALS; INFORMATION; VALIDITY; TOOL; QUESTIONNAIRE	With the increasing recognition of health literacy as a worldwide research priority, the development and refinement of indices to measure the construct is an important area of inquiry. Furthermore, the proliferation of online resources and research means that there is a growing need for self-administered instruments. We undertook a systematic overview to identify all published self-administered health literacy assessment indices to report their content and considerations associated with their administration. A primary aim of this study was to assist those seeking to employ a self-reported health literacy index to select one that has been developed and validated for an appropriate context, as well as with desired administration characteristics. Systematic searches were carried out in four electronic databases, and studies were included if they reported the development and/or validation of a novel health literacy assessment measure. Data were systematically extracted on key characteristics of the instruments: breadth of construct ("generic'' vs. "content- or context- specific'' health literacy), whether it was an original instrument or a derivative, country of origin, administration characteristics, age of target population (adult vs. pediatric), and evidence for validity. 35 articles met the inclusion criteria. There were 27 original instruments (27/35; 77.1%) and 8 derivative instruments (8/35; 22.9%). 22 indices measured "general'' health literacy (22/35; 62.9%) while the remainder measured condition-or context-specific health literacy (13/35; 37.1%). Most health literacy measures were developed in the United States (22/35; 62.9%), and about half had adequate face, content, and construct validity (16/35; 45.7%). Given the number of measures available for many specific conditions and contexts, and that several have acceptable validity, our findings suggest that the research agenda should shift towards the investigation and elaboration of health literacy as a construct itself, in order for research in health literacy measurement to progress.	[O'Neill, Braden; Goncalves, Daniela; Ricci-Cabello, Ignacio; Ziebland, Sue] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Valderas, Jose] Univ Exeter, Sch Med, Exeter, Devon, England	University of Oxford; University of Exeter	O'Neill, B (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	braden.oneill@univ.ox.ac.uk	Valderas, Jose M/Y-9814-2019; Valderas, Jose M/G-7967-2014; Ricci-Cabello, Ignacio/C-5770-2012; Ricci-Cabello, Ignacio/A-6141-2017	Valderas, Jose M/0000-0002-9299-1555; Ricci-Cabello, Ignacio/0000-0002-4725-8274; Ricci-Cabello, Ignacio/0000-0002-4725-8274; Ziebland, Sue/0000-0002-6496-4859; Goncalves Bradley, Daniela/0000-0002-5186-3792	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0608-10147]; Rhodes Trust; National Institute for Health Research [RP-PG-0608-10147, NIHR/CS/010/024] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(National Institute for Health Research (NIHR)); Rhodes Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This publication reports research conducted as part of the iPEx programme, which presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10147). The views expressed in this publication are those of the authors, representing iPEx, and not necessarily those of the NHS, the NIHR, or the Department of Health. Braden O'Neill's studentship is funded by the Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2006, ONCOL NURS FORUM, V33, P283, DOI 10.1188/06.ONF.283-289; Al Sayah F, 2013, HEALTH EDUC BEHAV, V40, P42, DOI 10.1177/1090198111436341; Allen K, 2011, J HEALTH COMMUN, V16, P55, DOI 10.1080/10810730.2011.604381; Bailey SC, 2013, J HEALTH COMMUN, V18, P5, DOI 10.1080/10810730.2013.830042; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Bann CM, 2012, J HEALTH COMMUN, V17, P191, DOI 10.1080/10810730.2012.718042; Barber MN, 2009, HEALTH PROMOT INT, V24, P252, DOI 10.1093/heapro/dap022; Begoray DL, 2012, HEALTH PROMOT INT, V27, P23, DOI 10.1093/heapro/dar015; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985; Brega AG, 2012, ETHNIC DIS, V22, P207; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chew LD, 2004, FAM MED, V36, P588; Chinn D, 2013, PATIENT EDUC COUNS, V90, P247, DOI 10.1016/j.pec.2012.10.019; Clement S, 2009, PATIENT EDUC COUNS, V75, P340, DOI 10.1016/j.pec.2009.01.008; Collins SA, 2012, J BIOMED INFORM, V45, P598, DOI 10.1016/j.jbi.2012.04.001; Department of Health, 2012, POW INF PUTT ALL US, P115; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Diviani N, 2012, PATIENT EDUC COUNS, V87, P152, DOI 10.1016/j.pec.2011.08.016; Fransen MP, 2011, J HEALTH COMMUN, V16, P134, DOI 10.1080/10810730.2011.604383; Galesic M, 2011, MED DECIS MAKING, V31, P444, DOI 10.1177/0272989X10373805; Gerber BS, 2005, DIABETES CARE, V28, P1574, DOI 10.2337/diacare.28.7.1574; Gibbs H, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120267; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Hahn EA, 2011, J HEALTH COMMUN, V16, P150, DOI 10.1080/10810730.2011.605434; Harper R, 2014, J AM COLL HEALTH, V62, P125, DOI 10.1080/07448481.2013.865625; Ilona Kickbusch I., 2013, HLTH LITERACY SOLID; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Ishikawa H, 2008, DIABETES CARE, V31, P874, DOI 10.2337/dc07-1932; Ishikawa H, 2011, PATIENT EDUC COUNS, V84, P393, DOI 10.1016/j.pec.2011.01.029; Jones K, 2014, COMMUNITY DENT HLTH, V31, P37, DOI 10.1922/CDH_3269Jones07; Jordan JE, 2013, PATIENT EDUC COUNS, V91, P228, DOI 10.1016/j.pec.2013.01.013; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Koh HK, 2012, HEALTH AFFAIR, V31, P434, DOI 10.1377/hlthaff.2011.1169; Kutner M, 2006, HLTH LITERACY AM ADU; Lupianez-Villanueva F, 2009, INFORM HEALTH SOC CA, V34, P117, DOI 10.1080/17538150903102265; Mancuso JM, 2009, NURS HEALTH SCI, V11, P77, DOI 10.1111/j.1442-2018.2008.00408.x; Massey PM, 2012, HEALTH EDUC RES, V27, P961, DOI 10.1093/her/cys054; Mazor KM, 2012, PATIENT EDUC COUNS, V88, P54, DOI 10.1016/j.pec.2011.12.009; McCormack L, 2013, J HEALTH COMMUN, V18, P9, DOI 10.1080/10810730.2013.829892; McCormack L, 2010, J HEALTH COMMUN, V15, P51, DOI 10.1080/10810730.2010.499987; Miller LMS, 2012, J AGING HEALTH, V24, P525, DOI 10.1177/0898264311428167; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; NHS England Patients and Information Directorate, 2013, TRANSF PART HLTH CAR; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Ownby RL, 2013, AIDS BEHAV, V17, P710, DOI 10.1007/s10461-012-0301-3; Paosche-Orlow MK, 2008, J GEN INTERN MED, V23, P100, DOI 10.1007/s11606-007-0447-2; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Pendlimari R, 2012, J SURG RES, V175, P221, DOI 10.1016/j.jss.2011.04.036; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Pleasant A, 2011, J HEALTH COMMUN, V16, P11, DOI 10.1080/10810730.2011.604392; Portney, 2019, FDN CLIN RES APPL PR; Puntoni S, 2011, HLTH LITERACY WALES; RATZAN SC, 2000, NATL LIB MED CURRENT; Rawson KA, 2010, J GEN INTERN MED, V25, P67, DOI 10.1007/s11606-009-1158-7; Reavley NJ, 2014, AUST NZ J PSYCHIAT, V48, P61, DOI 10.1177/0004867413491157; Reynolds JS, 2012, J NUTR EDUC BEHAV, V44, P262, DOI 10.1016/j.jneb.2011.09.006; Sauceda JA, 2012, J AM PHARM ASSOC, V52, pE231, DOI 10.1331/JAPhA.2012.11264; Scior K, 2011, RES DEV DISABIL, V32, P1530, DOI 10.1016/j.ridd.2011.01.044; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Steckelberg A, 2009, ADV HEALTH SCI EDUC, V14, P11, DOI 10.1007/s10459-007-9083-1; Takahashi Y, 2011, ASIA-PAC J PUBLIC HE, V23, P386, DOI 10.1177/1010539509344882; Tsai TI, 2011, J HEALTH COMMUN, V16, P50, DOI 10.1080/10810730.2010.529488; UNESCO, 2006, INT STANDARD CLASSIF; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Weidmer BA, 2012, MED CARE, V50, pS3, DOI 10.1097/MLR.0b013e3182652482; Weidmer BA, 2012, MED CARE, V50, pS12, DOI 10.1097/MLR.0b013e31826524a0; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Yost KJ, 2010, J HEALTH COMMUN, V15, P80, DOI 10.1080/10810730.2010.500713	71	41	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e109110	10.1371/journal.pone.0109110	http://dx.doi.org/10.1371/journal.pone.0109110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478813	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200001
J	Xie, ZL; Yi, HG; Chandrasekaran, B				Xie, Zilong; Yi, Han-Gyol; Chandrasekaran, Bharath			Nonnative Audiovisual Speech Perception in Noise: Dissociable Effects of the Speaker and Listener	PLOS ONE			English	Article							SENTENCE RECOGNITION; VISUAL ENHANCEMENT; ADVERSE CONDITIONS; NORMAL-HEARING; INTELLIGIBILITY; EXPERIENCE; INTEGRATION; LANGUAGE; CUES	Nonnative speech poses a challenge to speech perception, especially in challenging listening environments. Audiovisual (AV) cues are known to improve native speech perception in noise. The extent to which AV cues benefit nonnative speech perception in noise, however, is much less well-understood. Here, we examined native American English-speaking and native Korean-speaking listeners' perception of English sentences produced by a native American English speaker and a native Korean speaker across a range of signal-to-noise ratios (SNRs; -4 to -20 dB) in audio-only and audiovisual conditions. We employed psychometric function analyses to characterize the pattern of AV benefit across SNRs. For native English speech, the largest AV benefit occurred at intermediate SNR (i.e. -12 dB); but for nonnative English speech, the largest AV benefit occurred at a higher SNR (-4 dB). The psychometric function analyses demonstrated that the AV benefit patterns were different between native and nonnative English speech. The nativeness of the listener exerted negligible effects on the AV benefit across SNRs. However, the nonnative listeners' ability to gain AV benefit in native English speech was related to their proficiency in English. These findings suggest that the native language background of both the speaker and listener clearly modulate the optimal use of AV cues in speech recognition.	[Xie, Zilong; Yi, Han-Gyol; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Chandrasekaran, B (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.	bchandra@utexas.edu		Xie, Zilong/0000-0002-6851-7554; Yi, Han Gyol/0000-0001-7152-3712; Chandrasekaran, Bharath/0000-0002-3673-9435	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R01DC013315]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013315] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (https://www.nidcd.nih.gov/Pages/default.aspx) under Award Number R01DC013315 awarded to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audacity Developer Team, 2008, AUD VERS 1 2 6 COMP; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baker W, 2010, BILING-LANG COGN, V13, P263, DOI 10.1017/S136672890999006X; Bates D., 2012, IME4 LINEAR MIXED EF; Bent T, 2003, J ACOUST SOC AM, V114, P1600, DOI 10.1121/1.1603234; Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Boersma P., 2010, PRAAT DOING PHONETIC; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Chen T, 1998, P IEEE, V86, P837, DOI 10.1109/5.664274; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; FISHER CG, 1968, J SPEECH HEAR RES, V11, P796, DOI 10.1044/jshr.1104.796; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Hazan V, 2006, J ACOUST SOC AM, V119, P1740, DOI 10.1121/1.2166611; Hazan V, 2010, SPEECH COMMUN, V52, P996, DOI 10.1016/j.specom.2010.05.003; Helfer KS, 2005, J ACOUST SOC AM, V117, P842, DOI 10.1121/1.1836832; Irwin A, 2011, SPEECH COMMUN, V53, P807, DOI 10.1016/j.specom.2011.01.010; Ma WJ, 2009, PLOS ONE, P4; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; MILLER GA, 1951, J EXP PSYCHOL, V41, P329, DOI 10.1037/h0062491; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Ross LA, 2007, SCHIZOPHR RES, V97, P173, DOI 10.1016/j.schres.2007.08.008; Ross LA, 2011, EUR J NEUROSCI, V33, P2329, DOI 10.1111/j.1460-9568.2011.07685.x; Schneider W., 2002, E PRIME VERSION 20 C; Seidl A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00448, 10.3389/fpsyg.2012.00479]; Sommers MS, 2005, EAR HEARING, V26, P263, DOI 10.1097/00003446-200506000-00003; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; US Census Bureau, 2001, PROF FOR BORN POP US; Van Engen KJ, J SPEECH LANGUAGE HE; Wang Y, 2008, J ACOUST SOC AM, V124, P1716, DOI 10.1121/1.2956483; Yi HG, 2013, J ACOUST SOC AM, V134, pEL387, DOI 10.1121/1.4822320	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114439	10.1371/journal.pone.0114439	http://dx.doi.org/10.1371/journal.pone.0114439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474650	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500028
J	Campbell, P; Pasch, B; Warren, AL; Phelps, SM				Campbell, Polly; Pasch, Bret; Warren, Ashley L.; Phelps, Steven M.			Vocal Ontogeny in Neotropical Singing Mice (Scotinomys)	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; GEOGRAPHIC-VARIATION; VOLES; CALLS; BAT; EVOLUTION; BEHAVIOR; SOUND; SONG	Isolation calls produced by dependent young are a fundamental form of communication. For species in which vocal signals remain important to adult communication, the function and social context of vocal behavior changes dramatically with the onset of sexual maturity. The ontogenetic relationship between these distinct forms of acoustic communication is surprisingly understudied. We conducted a detailed analysis of vocal development in sister species of Neotropical singing mice, Scotinomys teguina and S. xerampelinus. Adult singing mice are remarkable for their advertisement songs, rapidly articulated trills used in long-distance communication; the vocal behavior of pups was previously undescribed. We recorded 30 S. teguina and 15 S. xerampelinus pups daily, from birth to weaning; 23 S. teguina and 11 S. xerampelinus were recorded until sexual maturity. Like other rodent species with poikilothermic young, singing mice were highly vocal during the first weeks of life and stopped vocalizing before weaning. Production of first advertisement songs coincided with the onset of sexual maturity after a silent period of >= 2 weeks. Species differences in vocal behavior emerged early in ontogeny and notes that comprise adult song were produced from birth. However, the organization and relative abundance of distinct note types was very different between pups and adults. Notably, the structure, note repetition rate, and intra-individual repeatability of pup vocalizations did not become more adult-like with age; the highly stereotyped structure of adult song appeared de novo in the first songs of young adults. We conclude that, while the basic elements of adult song are available from birth, distinct selection pressures during maternal dependency, dispersal, and territorial establishment favor major shifts in the structure and prevalence of acoustic signals. This study provides insight into how an evolutionarily conserved form of acoustic signaling provides the raw material for adult vocalizations that are highly species specific.	[Campbell, Polly] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Pasch, Bret] Cornell Lab Ornithol, Bioacoust Res Program, Ithaca, NY USA; [Pasch, Bret] Cornell Lab Ornithol, Macaulay Lib, Ithaca, NY USA; [Warren, Ashley L.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Phelps, Steven M.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Austin	Campbell, P (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	polly.campbell@okstate.edu	Campbell, Polly/I-6252-2015	Campbell, Polly/0000-0001-7660-9814	National Science Foundation [IOS 0548404, 0845455]; National Institutes of Health NRSA fellowship from National Institute on Deafness and Other Communication Disorders [F32 DC008269]; National Science Foundation DDIG [0909769]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008269] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NRSA fellowship from National Institute on Deafness and Other Communication Disorders; National Science Foundation DDIG(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: The research was funded by grants from the National Science Foundation to SMP (IOS 0548404, CAREER 0845455). PC was supported by a National Institutes of Health NRSA fellowship from the National Institute on Deafness and Other Communication Disorders (F32 DC008269). BP was supported by a National Science Foundation DDIG (0909769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Blake BH, 2012, J MAMMAL, V93, P1051, DOI 10.1644/11-MAMM-A-356.2; Blake BH, 2002, J MAMMAL, V83, P536, DOI 10.1644/1545-1542(2002)083<0536:UCIIIP>2.0.CO;2; BLAKE BH, 1992, DEV PSYCHOBIOL, V25, P581, DOI 10.1002/dev.420250805; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Bradbury Jack W., 1998, pi; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; DEFANIS E, 1995, J ZOOL, V235, P85; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ey E, 2013, BEHAV BRAIN RES, V256, P677, DOI 10.1016/j.bbr.2013.08.031; Fernandez-Vargas M, 2011, BEHAVIOUR, V148, P945, DOI 10.1163/000579511X584591; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; GANNON WL, 1989, J MAMMAL, V70, P740, DOI 10.2307/1381708; Gaub S, 2005, J COMP PHYSIOL A, V191, P1131, DOI 10.1007/s00359-005-0036-y; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hooper E.T., 1976, Miscellaneous Publs Mus Zool Univ Mich, VNo. 151, P1; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Mandelli MJ, 2004, J MAMMAL, V85, P282, DOI 10.1644/1545-1542(2004)085<0282:UVOISF>2.0.CO;2; Miller JR, 2007, J MAMMAL, V88, P1447, DOI 10.1644/06-MAMM-A-386R.1; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; Moss CF, 1997, ANIM BEHAV, V54, P131, DOI 10.1006/anbe.1996.0410; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Pasch B, 2013, AM NAT, V182, pE161, DOI 10.1086/673263; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pasch B, 2011, HORM BEHAV, V59, P90, DOI 10.1016/j.yhbeh.2010.10.011; Petric R, 2013, BEHAVIOUR, V150, P1747, DOI 10.1163/1568539X-00003118; PONTET A, 1989, BEHAVIOUR, V108, P241, DOI 10.1163/156853989X00321; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Sen A, 2014, P NATL ACAD SCI USA, V111, P3008, DOI 10.1073/pnas.1318978111; Slobodchikoff CN, 1998, J MAMMAL, V79, P1265, DOI 10.2307/1383018; SMITH JC, 1976, J COMP PHYSIOL PSYCH, V90, P1105, DOI 10.1037/h0077287; Snell-Rood EC, 2008, OECOLOGIA, V157, P545, DOI 10.1007/s00442-008-1092-0; Sterbing SJ, 2002, J MAMMAL, V83, P516, DOI 10.1644/1545-1542(2002)083<0516:PDOVAH>2.0.CO;2; Vieira ML, 2002, BEHAV PROCESS, V59, P147, DOI 10.1016/S0376-6357(02)00089-X; Wright SL, 2004, BEHAV PROCESS, V65, P155, DOI 10.1016/j.beproc.2003.09.004	49	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113628	10.1371/journal.pone.0113628	http://dx.doi.org/10.1371/journal.pone.0113628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469986	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700037
J	Devlieger, R; Guelinckx, I; Jans, G; Voets, W; Vanholsbeke, C; Vansant, G				Devlieger, Roland; Guelinckx, Isabelle; Jans, Goele; Voets, Willy; Vanholsbeke, Caroline; Vansant, Greet			Micronutrient Levels and Supplement Intake in Pregnancy after Bariatric Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							WEIGHT-LOSS; DEFICIENCIES; HEALTH; WOMEN	Background: Studies report frequent micronutrient deficiencies after bariatric surgery, but less is known about micronutrient levels of pregnant women after bariatric surgery. Objective: To prospectively evaluate micronutrient levels and supplement intake in pregnancy following bariatric surgery. Design: A multicenter prospective cohort study including women with restrictive or malabsorptive types of bariatric surgery. Nutritional deficiencies, together with supplement intake, were screened during pregnancy. Results: The total population included 18 women in the restrictive and 31 in the malabsorptive group. Most micronutrients were depleted and declined significantly during pregnancy. The proportion of women with low vitamin A and B-1 levels increased to respectively 58 and 17% at delivery (P=0.005 and 0.002). The proportion of women with vitamin D deficiency decreased from 14% at trimester 1 to 6% at delivery (P=0.030). Mild anemia was found in respectively 22 and 40% of the women at trimester 1 and delivery. In the first trimester, most women took a multivitamin (57.1%). In the second and third trimester, the majority took additional supplements (69.4 and 73.5%). No associations were found between supplement intake and micronutrient deficiencies. Conclusion: Pregnant women with bariatric surgery show frequent low micronutrient levels. Supplementation partially normalizes low levels of micronutrients.	[Devlieger, Roland; Vanholsbeke, Caroline] Univ Hosp Leuven, Dept Gynecol & Obstet, Leuven, Belgium; [Devlieger, Roland; Jans, Goele; Vanholsbeke, Caroline] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Guelinckx, Isabelle; Vansant, Greet] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Voets, Willy] Jessa Hosp, B-3500 Hasselt, Belgium; [Vanholsbeke, Caroline] Hosp Oost Limburg ZOL, B-3600 Genk, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; East Limburg Hospital	Devlieger, R (corresponding author), Univ Hosp Leuven, Dept Gynecol & Obstet, Leuven, Belgium.	roland.devlieger@uzleuven.be	Devlieger, Roland/AAS-9181-2020	Devlieger, Roland/0000-0001-7837-4684; Vansant, Greet (Margareta)/0000-0002-5781-8482	Catholic University Leuven; FWO Flanders	Catholic University Leuven(KU Leuven); FWO Flanders(FWO)	IG was funded by a postdoctoral grant from the Catholic University Leuven (2010-2011). RD is recipient of a postdoctoral research grant from the FWO Flanders (2010-2015).	Aills L, 2008, SURG OBES RELAT DIS, V4, pS73, DOI 10.1016/j.soard.2008.03.002; [Anonymous], 2011, VOED BELG HERZ 2009; [Anonymous], 2006, NAT RICHTL PREN ZORG; Berti C, 2010, MATERN CHILD NUTR, V6, P5, DOI 10.1111/j.1740-8709.2010.00269.x; Bogaerts A, 2012, CLIN OBES, V2, P150, DOI 10.1111/cob.12004; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Davies DJ, 2007, OBES SURG, V17, P1150, DOI 10.1007/s11695-007-9208-x; Devlieger RG, 2012, MATERNAL OBESITY, P209; Donadelli SP, 2012, NUTRITION, V28, P391, DOI 10.1016/j.nut.2011.07.012; Guelinckx I, 2012, OBES SURG, V22, P1456, DOI 10.1007/s11695-012-0675-3; Guelinckx I, 2009, HUM REPROD UPDATE, V15, P189, DOI 10.1093/humupd/dmn057; Ladipo OA, 2000, AM J CLIN NUTR, V72, p280S, DOI 10.1093/ajcn/72.1.280S; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Mathus-Vliegen EMH, 2007, INT J OBESITY, V31, P299, DOI 10.1038/sj.ijo.0803404; Mizon C, 2007, NUTRITION, V23, P277, DOI 10.1016/j.nut.2007.01.008; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Shankar P, 2010, NUTRITION, V26, P1031, DOI 10.1016/j.nut.2009.12.003; Valentino D, 2011, CURR OPIN CLIN NUTR, V14, P635, DOI 10.1097/MCO.0b013e32834b3355; Van Mieghem T, 2008, OBSTET GYNECOL, V112, P434, DOI 10.1097/AOG.0b013e3181649e7b; WALLINGFORD JC, 1986, J CHROMATOGR, V381, P158, DOI 10.1016/S0378-4347(00)83575-6; Nomura RMY, 2011, OBES SURG, V21, P479, DOI 10.1007/s11695-011-0376-3	22	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114192	10.1371/journal.pone.0114192	http://dx.doi.org/10.1371/journal.pone.0114192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470614	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700084
J	Inoue, H; Yoshimura, J; Iwabuchi, K				Inoue, Hiroki; Yoshimura, Jin; Iwabuchi, Kikuo			Gene Expression of Protein-Coding and Non-Coding RNAs Related to Polyembryogenesis in the Parasitic Wasp, Copidosoma floridanum	PLOS ONE			English	Article							ZYGOTIC TRANSITION; HOST EMBRYO; MICRORNA; IDENTIFICATION; HYMENOPTERA; ANNOTATION; EVOLUTION; TUDOR	Polyembryony is a unique form of development in which many embryos are clonally produced from a single egg. Polyembryony is known to occur in many animals, but the underlying genetic mechanism responsible is unknown. In a parasitic wasp, Copidosoma floridanum, polyembryogenesis is initiated during the formation and division of the morula. In the present study, cDNA libraries were constructed from embryos at the cleavage and subsequent primary morula stages, times when polyembryogenesis is likely to be controlled genetically. Of 182 and 263 cDNA clones isolated from these embryos, 38% and 70%, respectively, were very similar to protein-coding genes obtained from BLAST analysis and 55 and 65 clones, respectively, were stage-specific. In our libraries we also detected a high frequency of long non-coding RNA. Some of these showed stage-specific expression patterns in reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis. The stage-specificity of expression implies that these protein-coding and non-coding genes are related to polyembryogenesis in C. floridanum. The non-coding genes are not similar to any known non-coding RNAs and so are good candidates as regulators of polyembryogenesis.	[Inoue, Hiroki; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan; [Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan; [Yoshimura, Jin] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Kamogawa, Chiba, Japan	Tokyo University of Agriculture & Technology; Shizuoka University; Shizuoka University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University	Iwabuchi, K (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan.	kikkuo@cc.tuat.ac.jp	Satoh, Toshiyuki/C-8374-2013; Iwabuchi, Kikuo/I-7530-2012	Satoh, Toshiyuki/0000-0002-7475-6746; 	Japan Society for the Promotion of Science (JSPS) [22658015, 22255004, 22370010, 26257405]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by Grant Number 22658015 to KI, 22255004, 22370010 and 26257405 to JY from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BAEHRECKE EH, 1990, INT J INSECT MORPHOL, V19, P165, DOI 10.1016/0020-7322(90)90002-7; BAEHRECKE EH, 1992, J EXP ZOOL, V262, P30, DOI 10.1002/jez.1402620106; BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Development Core Team R, 2011, R LANG ENV STAT COMP; Donnell DM, 2006, INSECT BIOCHEM MOLEC, V36, P141, DOI 10.1016/j.ibmb.2005.11.009; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; IWABUCHI K, 1991, APPL ENTOMOL ZOOL, V26, P563, DOI 10.1303/aez.26.563; IWABUCHI K, 1995, IN VITRO CELL DEV-AN, V31, P803, DOI 10.1007/BF02634123; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; LaSalle J, 1991, REDIA, V74, P515; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Nakaguchi A, 2006, CELL TISSUE RES, V324, P167, DOI 10.1007/s00441-005-0111-2; Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi-Nakaguchi A, 2010, J MORPHOL, V271, P750, DOI 10.1002/jmor.10831; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Utsunomiya A, 2002, ENTOMOL EXP APPL, V104, P353, DOI 10.1023/A:1021205421400; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zhurov V, 2007, CELL MOL LIFE SCI, V64, P2790, DOI 10.1007/s00018-007-7047-5; Zondag L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-211	47	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114372	10.1371/journal.pone.0114372	http://dx.doi.org/10.1371/journal.pone.0114372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469914	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700106
J	Mehrabi, Z; Slade, EM; Solis, A; Mann, DJ				Mehrabi, Zia; Slade, Eleanor M.; Solis, Angel; Mann, Darren J.			The Importance of Microhabitat for Biodiversity Sampling	PLOS ONE			English	Article							DUNG BEETLES SCARABAEIDAE; SEED DISPERSAL; COMMUNITY STRUCTURE; ECOSYSTEM SERVICES; FOREST; COLEOPTERA; DIVERSITY; MONKEYS; FRAGMENTATION; CONSERVATION	Responses to microhabitat are often neglected when ecologists sample animal indicator groups. Microhabitats may be particularly influential in non-passive biodiversity sampling methods, such as baited traps or light traps, and for certain taxonomic groups which respond to fine scale environmental variation, such as insects. Here we test the effects of microhabitat on measures of species diversity, guild structure and biomass of dung beetles, a widely used ecological indicator taxon. We demonstrate that choice of trap placement influences dung beetle functional guild structure and species diversity. We found that locally measured environmental variables were unable to fully explain trap-based differences in species diversity metrics or microhabitat specialism of functional guilds. To compare the effects of habitat degradation on biodiversity across multiple sites, sampling protocols must be standardized and scale-relevant. Our work highlights the importance of considering microhabitat scale responses of indicator taxa and designing robust sampling protocols which account for variation in microhabitats during trap placement. We suggest that this can be achieved either through standardization of microhabitat or through better efforts to record relevant environmental variables that can be incorporated into analyses to account for microhabitat effects. This is especially important when rapidly assessing the consequences of human activity on biodiversity loss and associated ecosystem function and services.	[Mehrabi, Zia] Univ Oxford, Dept Zool, Biodivers Inst, Oxford, England; [Mehrabi, Zia; Mann, Darren J.] Univ Oxford, Museum Nat Hist, Hope Entomol Collect, Oxford, England; [Slade, Eleanor M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Slade, Eleanor M.] Univ Helsinki, Dept Agr Sci, Spatial Foodweb Ecol Grp, Helsinki, Finland; [Solis, Angel] Inst Nacl Biodiversidad, Unidad Artropodos, Santo Domingo De Heredia, Costa Rica	University of Oxford; University of Oxford; University of Oxford; University of Helsinki	Mehrabi, Z (corresponding author), Univ Oxford, Dept Zool, Biodivers Inst, S Parks Rd, Oxford, England.	zia.mehrabi@zoo.ox.ac.uk	Mann, Darren/AAC-1049-2020; Slade, Eleanor M/O-3874-2014	Mann, Darren/0000-0002-6732-6940; Slade, Eleanor M/0000-0002-6108-1196	British Ecological Society small research grant; Royal Geographic Society; IBG geographical fieldwork grant; Oxford University Expeditions Council	British Ecological Society small research grant; Royal Geographic Society; IBG geographical fieldwork grant; Oxford University Expeditions Council	This project was funded by a British Ecological Society small research grant, a Royal Geographic Society with IBG geographical fieldwork grant (Goldsmiths), Oxford University Expeditions Council (Alexander Allan Paton Memorial Fund), The Duke of Edinburgh, St Hilda's College (Muriel Wise Trust Fund), and The Explorers Club; www.britishecologicalsociety.org, www.rgs.org,www.explorers.org, www.st-hildas.ox.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlHouty W, 1997, J ARID ENVIRON, V35, P511, DOI 10.1006/jare.1996.0179; Allsopp P. G., 1999, Diversity and Distributions, V5, P143, DOI 10.1046/j.1472-4642.1999.00050.x; Andresen E, 1999, BIOTROPICA, V31, P145, DOI 10.1111/j.1744-7429.1999.tb00125.x; Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Andresen E, 2008, INSECT CONSERV DIVER, V1, P120, DOI 10.1111/j.1752-4598.2008.00013.x; Arellano L, 2005, BIODIVERS CONSERV, V14, P601, DOI 10.1007/s10531-004-3918-3; Barton PS, 2009, BIOL CONSERV, V142, P1701, DOI 10.1016/j.biocon.2009.03.005; Bates R, 2014, LME4 LINEAR MIXED EF; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Cambefort Y., 1991, P51; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Carrillo E, 2002, BIOL CONSERV, V108, P317, DOI 10.1016/S0006-3207(02)00118-0; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chown Steven L., 2011, P200; Christensen R., 2013, R PACKAGE VERSION 20, P08; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 2005, COMMUNITY ECOSYSTEM; Duncan FD, 2000, OECOLOGIA, V122, P452, DOI 10.1007/s004420050966; ESTRADA A, 1991, J TROP ECOL, V7, P459, DOI 10.1017/S026646740000585X; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Gill B.D., 1991, P211; Gonzalez-Megias A, 2007, ECOGRAPHY, V30, P31, DOI 10.1111/j.0906-7590.2007.04867.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JANZEN DH, 1983, OIKOS, V41, P274, DOI 10.2307/3544274; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kohlmann B, 2007, ZOOTAXA, P1; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Lawson CR, 2012, BIOTROPICA, V44, P271, DOI 10.1111/j.1744-7429.2012.00871.x; Levine N, 2002, CRIMESTAT 2 SPATIAL; Marsh CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073147; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; Mehrabi Z, 2014, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.p0c10, DOI 10.5061/DRYAD.P0C10]; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NEALIS VG, 1977, CAN J ZOOL, V55, P138, DOI 10.1139/z77-017; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nicholson E, 2009, J APPL ECOL, V46, P1139, DOI 10.1111/j.1365-2664.2009.01716.x; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Plowes R, 2005, THESIS U TEXAS AUSTI; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffler PY, 2005, J TROP ECOL, V21, P9, DOI 10.1017/S0266467404001683; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Solis A, 2012, ZOOTAXA, V32, P5326; SOWIG P, 1995, ECOGRAPHY, V18, P147, DOI 10.1111/j.1600-0587.1995.tb00335.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1; Vulinec K, 2006, INT J PRIMATOL, V27, P855, DOI 10.1007/s10764-006-9027-2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	60	23	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114015	10.1371/journal.pone.0114015	http://dx.doi.org/10.1371/journal.pone.0114015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469770	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000349128700063
J	Mourad, R; Hsu, PY; Juan, LR; Shen, CY; Koneru, P; Lin, H; Liu, YL; Nephew, K; Huang, TH; Li, L				Mourad, Raphael; Hsu, Pei-Yin; Juan, Liran; Shen, Changyu; Koneru, Prasad; Lin, Hai; Liu, Yunlong; Nephew, Kenneth; Huang, Tim H.; Li, Lang			Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells	PLOS ONE			English	Article							HI-C DATA; GENE-EXPRESSION; CHIP-SEQ; ELEMENTS; ALPHA; ORGANIZATION; ARCHITECTURE; PRINCIPLES; TAMOXIFEN; CORRELATE	In the cell nucleus, each chromosome is confined to a chromosome territory. This spatial organization of chromosomes plays a crucial role in gene regulation and genome stability. An additional level of organization has been discovered at the chromosome scale: the spatial segregation into open and closed chromatins to form two genome-wide compartments. Although considerable progress has been made in our knowledge of chromatin organization, a fundamental issue remains the understanding of its dynamics, especially in cancer. To address this issue, we performed genome-wide mapping of chromatin interactions (Hi-C) over the time after estrogen stimulation of breast cancer cells. To biologically interpret these interactions, we integrated with estrogen receptor alpha (ER alpha) binding events, gene expression and epigenetic marks. We show that gene-rich chromosomes as well as areas of open and highly transcribed chromatins are rearranged to greater spatial proximity, thus enabling genes to share transcriptional machinery and regulatory elements. At a smaller scale, differentially interacting loci are enriched for cancer proliferation and estrogen-related genes. Moreover, these loci are correlated with higher ERa binding events and gene expression. Taken together these results reveal the role of a hormone - estrogen - on genome organization, and its effect on gene regulation in cancer.	[Mourad, Raphael; Juan, Liran; Koneru, Prasad; Lin, Hai; Liu, Yunlong; Li, Lang] Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Shen, Changyu] Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Biostat, Indianapolis, IN 46202 USA; [Hsu, Pei-Yin; Huang, Tim H.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Nephew, Kenneth] Indiana Univ, Lab Ovarian Canc Epigen, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio; Indiana University System; Indiana University Bloomington	Li, L (corresponding author), Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	lali@iupui.edu	Lin, Hai/N-3860-2016	Lin, Hai/0000-0002-2094-758X	Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB);  [NCI- U54 CA113001-07]; NATIONAL CANCER INSTITUTE [U54CA113001, P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: This study was funded by NCI- U54 CA113001-07, The Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Fudenberg G, 2012, CURRENT OPINION GENE, V22, P1; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hsu PY, 2013, CANCER CELL, V24, P197, DOI 10.1016/j.ccr.2013.07.007; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002893; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kocanova S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000922; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Osmanbeyoglu HU, 2013, NUCLEIC ACIDS RES, V41, P8061, DOI 10.1093/nar/gkt586; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Rickman DS, 2012, P NATL ACAD SCI USA, V109, P9083, DOI 10.1073/pnas.1112570109; Ross-Innes CS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-593; Rousseau M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-414; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shavit Y, 2013, BIOINFORMATICS, V29, P1206, DOI 10.1093/bioinformatics/btt120; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhang XS, 2012, P NATL ACAD SCI USA, V109, P13331, DOI 10.1073/pnas.1203280109; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	61	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113354	10.1371/journal.pone.0113354	http://dx.doi.org/10.1371/journal.pone.0113354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470140	gold, Green Published			2022-12-27	WOS:000349128700024
J	Stanne, TM; Tjarnlund-Wolf, A; Olsson, S; Jood, K; Blomstrand, C; Jern, C				Stanne, Tara M; Tjarnlund-Wolf, Anna; Olsson, Sandra; Jood, Katarina; Blomstrand, Christian; Jern, Christina			Genetic Variation at the BDNF Locus: Evidence for Association with Long-Term Outcome after Ischemic Stroke	PLOS ONE			English	Article							REDUCES INFARCT SIZE; ACTIVITY-DEPENDENT SECRETION; FACTOR G196A POLYMORPHISM; FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; SUBARACHNOID HEMORRHAGE; MOTOR CORTEX; HUMAN BRAIN; RECOVERY	Background and Purpose: Rates and extent of recovery after stroke vary considerably between individuals and genetic factors are thought to contribute to post-stroke outcome. Brain-derived neurotrophic factor (BDNF) plays important roles in brain plasticity and repair and has been shown to be involved in stroke severity, recovery, and outcome in animal models. Few clinical studies on BDNF genotypes in relation to ischemic stroke have been performed. The aims of the present study are therefore to investigate whether genetic variation at the BDNF locus is associated with initial stroke severity, recovery and/or short-term and long-term functional outcome after ischemic stroke. Methods: Four BDNF tagSNPs were analyzed in the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS; 600 patients and 600 controls, all aged 18-70 years). Stroke severity was assessed using the NIH Stroke Scale (NIHSS). Stroke recovery was defined as the change in NIHSS over a 3-month period. Short-and long-term functional outcome post-stroke was assessed using the modified Rankin Scale at 3 months and at 2 and 7 years after stroke, respectively. Results: No SNP was associated with stroke severity or recovery at 3 months and no SNP had an impact on short-term outcome. However, rs11030119 was independently associated with poor functional outcome 7-years after stroke (OR 0.66, 95% CI 0.46-0.92; P = 0.006). Conclusions: BDNF gene variants were not major contributors to ischemic stroke severity, recovery, or short-term functional outcome. However, this study suggests that variants in the BDNF gene may contribute to poor long-term functional outcome after ischemic stroke.	[Stanne, Tara M; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Clin Genet Sect, Inst Biomed, Gothenburg, Sweden; [Tjarnlund-Wolf, Anna; Olsson, Sandra; Jood, Katarina; Blomstrand, Christian] Univ Gothenburg, Sahlgrenska Acad, Sect Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Stanne, TM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Clin Genet Sect, Inst Biomed, Gothenburg, Sweden.	tara.stanne@gu.se			Swedish Research Council [K2011-65X-14605-09-6, K2010-61X-20378-04-3, 2011-3891]; Swedish Heart and Lung Foundation [20100256, 20100244, 20100228]; Swedish Stroke Association; Edit Jacobson foundation; Per-Olof Ahl foundation; Rune and Ulla Amlov foundation; John and Brit Wennerstrom foundation; Tore Nilsson foundation;  [ALFGBG-148861]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Association; Edit Jacobson foundation; Per-Olof Ahl foundation; Rune and Ulla Amlov foundation; John and Brit Wennerstrom foundation; Tore Nilsson foundation; 	This study was supported by the Swedish Research Council (K2011-65X-14605-09-6, K2010-61X-20378-04-3, and 2011-3891), the Swedish state (ALFGBG-148861), the Swedish Heart and Lung Foundation (20100256, 20100244 and 20100228), the Swedish Stroke Association, and the Edit Jacobson, Per-Olof Ahl, Rune and Ulla Amlov, John and Brit Wennerstrom, and Tore Nilsson foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cerasa A, 2010, BEHAV BRAIN RES, V207, P377, DOI 10.1016/j.bbr.2009.10.022; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gao L, 2010, ACTA NEUROL SCAND, V122, P41, DOI 10.1111/j.1600-0404.2009.01253.x; Gray LJ, 2009, J STROKE CEREBROVASC, V18, P466, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.003; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kim JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051280; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MacLellan CL, 2011, NEUROREHAB NEURAL RE, V25, P740, DOI 10.1177/1545968311407517; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Manso H, 2012, EUR J NEUROL, V19, P1151, DOI 10.1111/j.1468-1331.2011.03625.x; Martinez-Gonzalez NA, 2006, J NEUROL NEUROSUR PS, V77, P1329, DOI 10.1136/jnnp.2006.097543; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Mirowska-Guzel D, 2012, J NEUROIMMUNOL, V249, P71, DOI 10.1016/j.jneuroim.2012.04.011; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Quinn TJ, 2007, STROKE, V38, P2257, DOI 10.1161/STROKEAHA.106.480723; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061	37	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114156	10.1371/journal.pone.0114156	http://dx.doi.org/10.1371/journal.pone.0114156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470006	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700079
J	Yun, YJ; Srinivas, G; Kuenzel, S; Linnenbrink, M; Alnahas, S; Bruce, KD; Steinhoff, U; Baines, JF; Schaible, UE				Yun, Yeojun; Srinivas, Girish; Kuenzel, Sven; Linnenbrink, Miriam; Alnahas, Safa; Bruce, Kenneth D.; Steinhoff, Ulrich; Baines, John F.; Schaible, Ulrich E.			Environmentally Determined Differences in the Murine Lung Microbiota and Their Relation to Alveolar Architecture	PLOS ONE			English	Article							BACTERIA; IDENTIFICATION; DIVERSITY; GLYCOSPHINGOLIPIDS; COMMUNITIES; INFECTIONS; EXPRESSION; PICKETTII; ALLERGY; MICE	Commensal bacteria control the micro-ecology of metazoan epithelial surfaces with pivotal effect on tissue homeostasis and host defense. In contrast to the upper respiratory tract, the lower respiratory tract of healthy individuals has largely been considered free of microorganisms. To understand airway micro-ecology we studied microbiota of sterilely excised lungs from mice of different origin including outbred wild mice caught in the natural environment or kept under non-specific-pathogen-free (SPF) conditions as well as inbred mice maintained in non-SPF, SPF or germ-free (GF) facilities. High-throughput pyrosequencing of reverse transcribed 16S rRNA revealed metabolically active murine lung microbiota in all but GF mice. The overall composition across samples was similar at the phylum and family level. However, species richness was significantly different between lung microbiota from SPF and non-SPF mice. Non-cultivatable Betaproteobacteria such as Ralstonia spp. made up the major constituents and were also confirmed by 16S rRNA gene cloning analysis. Additionally, Pasteurellaceae, Enterobacteria and Firmicutes were isolated from lungs of non-SPF mice. Bacterial communities were detectable by fluorescent in situ hybridization (FISH) at alveolar epithelia in the absence of inflammation. Notably, higher bacterial abundance in non-SPF mice correlated with more and smaller size alveolae, which was corroborated by transplanting Lactobacillus spp. lung isolates into GF mice. Our data indicate a common microbial composition of murine lungs, which is diversified through different environmental conditions and affects lung architecture. Identification of the microbiota of murine lungs will pave the path to study their influence on pulmonary immunity to infection and allergens using mouse models.	[Yun, Yeojun; Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Biol, Cellular Microbiol Grp, Borstel, Germany; [Srinivas, Girish; Kuenzel, Sven; Linnenbrink, Miriam; Baines, John F.] MPI Evolutionary Biol, Plon, Germany; [Srinivas, Girish] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Kuenzel, Sven; Linnenbrink, Miriam; Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Alnahas, Safa; Steinhoff, Ulrich] Univ Marburg, Inst Med Microbiol & Hosp Hyg, Marburg, Germany; [Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England	Forschungszentrum Borstel; University of Lubeck; University of Kiel; Philipps University Marburg; University of London; King's College London	Schaible, UE (corresponding author), Res Ctr Borstel, Dept Mol Infect Biol, Cellular Microbiol Grp, Borstel, Germany.	uschaible@fz-borstel.de	Baines, John F/B-3580-2010	Baines, John F/0000-0002-8132-4909; Steinhoff, Ulrich/0000-0003-2141-7756; Linnenbrink, Miriam/0000-0003-0163-3056	Research Center Borstel	Research Center Borstel	Funding: This research is supported by Research Center Borstel in house funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coenye T, 2002, EMERG INFECT DIS, V8, P692, DOI 10.3201/eid0807.010472; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dammann P, 2011, LAB ANIM-UK, V45, P271, DOI 10.1258/la.2011.010183; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KRZIWON C, 1995, INFECT IMMUN, V63, P2899, DOI 10.1128/IAI.63.8.2899-2905.1995; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Mohammadi T, 2005, J MICROBIOL METH, V61, P285, DOI 10.1016/j.mimet.2004.11.018; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Patten CC, 2010, COMPARATIVE MED, V60, P18; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Sasaki H, 2006, J VET MED SCI, V68, P639, DOI 10.1292/jvms.68.639; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stelzmueller I, 2006, CLIN MICROBIOL INFEC, V12, P99, DOI 10.1111/j.1469-0691.2005.01309.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wei B, 2010, J IMMUNOL	48	65	71	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113466	10.1371/journal.pone.0113466	http://dx.doi.org/10.1371/journal.pone.0113466			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470730	gold, Green Published			2022-12-27	WOS:000349128700029
J	Archer, DC; Costain, DA; Sherlock, C				Archer, Debra C.; Costain, Deborah A.; Sherlock, Chris			Idiopathic Focal Eosinophilic Enteritis (IFEE), an Emerging Cause of Abdominal Pain in Horses: The Effect of Age, Time and Geographical Location on Risk	PLOS ONE			English	Article							SMALL-INTESTINAL OBSTRUCTION; EPITHELIOTROPIC DISEASE; EQUINE; GASTROENTERITIS; DERMATITIS	Background: Idiopathic focal eosinophilic enteritis (IFEE) is an emerging cause of abdominal pain (colic) in horses that frequently requires surgical intervention to prevent death. The epidemiology of IFEE is poorly understood and it is difficult to diagnose pre-operatively. The aetiology of this condition and methods of possible prevention are currently unknown. The aims of this study were to investigate temporal and spatial heterogeneity in IFEE risk and to ascertain the effect of horse age on risk. Methodology/Principal Findings: A retrospective, nested case-control study was undertaken using data from 85 IFEE cases and 848 randomly selected controls admitted to a UK equine hospital for exploratory laparotomy to investigate the cause of colic over a 10-year period. Generalised additive models (GAMs) were used to quantify temporal and age effects on the odds of IFEE and to provide mapped estimates of 'residual' risk over the study region. The relative risk of IFEE increased over the study period (p=0.001) and a seasonal pattern was evident (p<0.01) with greatest risk of IFEE being identified between the months of July and November. IFEE risk decreased with increasing age (p<0.001) with younger (0-5 years old) horses being at greatest risk. The mapped surface estimate exhibited significantly atypical sub-regions (p<0.001) with increased IFEE risk in horses residing in the North-West of the study region. Conclusions/Significance: IFEE was found to exhibit both spatial and temporal variation in risk and is more likely to occur in younger horses. This information may help to identify horses at increased risk of IFEE, provide clues about the aetiology of this condition and to identify areas that require further research.	[Archer, Debra C.] Univ Liverpool, Inst Infect & Global Hlth, Sch Vet Sci, Neston, England; [Costain, Deborah A.; Sherlock, Chris] Univ Lancaster, Dept Math & Stat, Lancaster, England	University of Liverpool; Lancaster University	Archer, DC (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Sch Vet Sci, Leahurst Campus, Neston, England.	darcher@liv.ac.uk		Sherlock, Chris/0000-0002-2429-3157; Costain, Deborah/0000-0002-6187-1411	Horse Trust; Petplan Charitable Trust	Horse Trust; Petplan Charitable Trust	The authors are grateful to the Horse Trust and Petplan Charitable Trust for funding the colic survival study at the hospital from which some of the data were obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON N, 1990, J AM VET MED ASSOC, V196, P462; [Anonymous], 2014, R LANG ENV STAT COMP; Archer DC, 2008, EQUINE VET J, V40, P405, DOI 10.2746/042516408X312149; Archer DC, 2008, EQUINE VET J, V40, P224, DOI 10.2746/042516408X266079; Archer DC, 2006, VET J, V172, P29, DOI 10.1016/j.tvjl.2005.04.002; Archer D.C., 2008, 9 INT COL RES S LIV, P164; Archer DC, 2006, VET J, V171, P504, DOI 10.1016/j.tvjl.2005.02.031; Archer Debra C, 2006, BMC Vet Res, V2, P27, DOI 10.1186/1746-6148-2-27; BLIKSLAGER AT, 1992, J AM VET MED ASSOC, V201, P1249; Boden LA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-43; Breslow NE, 1980, STAT METHODS CANC RE, V1, P28; COHEN ND, 1992, J AM VET MED ASSOC, V200, P1518; Davis BP, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P484; Davison AC, 1997, BOOTSTRAP METHODS TH; Edwards G B, 2000, Equine Vet J Suppl, P86; French NP, 2005, EPIDEMIOL INFECT, V133, P343, DOI 10.1017/S0950268804003322; GIBSON KT, 1987, EQUINE VET J, V19, P247, DOI 10.1111/j.2042-3306.1987.tb01397.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Mair T, 2004, BEVA EVIDENCE BASED, P58; Makinen PE, 2008, EQUINE VET J, V40, P386, DOI [10.2746/042516408X312112, 10.2746/042516408X284646]; Marshall JF BA, 2012, EQUINE SURG, P402; Masterson JC, 2011, CURR OPIN GASTROEN, V27, P515, DOI 10.1097/MOG.0b013e32834b314c; McCue ME, 2003, J AM VET MED ASSOC, V223, P1320, DOI 10.2460/javma.2003.223.1320; McCullagh P, 1989, GEN LINEAR MODELS; Odemuyiwa SO, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P567; Olmos JFP, 2006, EQUINE VET J, V38, P354, DOI 10.2746/042516406777749308; PASS DA, 1982, VET PATHOL, V19, P486, DOI 10.1177/030098588201900504; Powell N, 2010, NAT REV GASTRO HEPAT, V7, P146, DOI 10.1038/nrgastro.2010.5; Proudman CJ, 2006, EQUINE VET J, V38, P290, DOI 10.2746/042516406777749209; Proudman CJ, 2002, EQUINE VET J, V34, P438, DOI 10.2746/042516402776117881; Schumacher J, 2000, J VET INTERN MED, V14, P258, DOI 10.1892/0891-6640(2000)014&lt;0258:CIIBDO&gt;2.3.CO;2; Scott EA, 1999, J AM VET MED ASSOC, V214, P1527; Southwood LL, 2000, VET SURG, V29, P415, DOI 10.1053/jvet.2000.7543; Stanar LS, 2002, COMP CONT EDUC PRACT, V24, P342; Suthers JM, 2013, EQUINE VET J, V45, P558, DOI 10.1111/evj.12039; Swain JM, 2003, VET REC, V152, P648, DOI 10.1136/vr.152.21.648; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; WILKIE JSN, 1985, VET PATHOL, V22, P297, DOI 10.1177/030098588502200401; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yun MY, 2007, WORLD J GASTROENTERO, V13, P1758, DOI 10.3748/wjg.v13.i11.1758	43	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112072	10.1371/journal.pone.0112072	http://dx.doi.org/10.1371/journal.pone.0112072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463382	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700009
J	Chen, HL; Lin, LL; Xie, MH; Zhang, GL; Su, WH				Chen, Haoliang; Lin, Lulu; Xie, Minghui; Zhang, Guangling; Su, Weihua			De novo Sequencing, Assembly and Characterization of Antennal Transcriptome of Anomala corpulenta Motschulsky (Coleoptera: Rutelidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS STRAIN; PHEROMONE-BINDING-PROTEIN; IMMUNOCYTOCHEMICAL LOCALIZATION; TOOL; EXPRESSION; MODEL	Background: Anomala corpulenta is an important insect pest and can cause enormous economic losses in agriculture, horticulture and forestry. It is widely distributed in China, and both larvae and adults can cause serious damage. It is difficult to control this pest because the larvae live underground. Any new control strategy should exploit alternatives to heavily and frequently used chemical insecticides. However, little genetic research has been carried out on A. corpulenta due to the lack of genomic resources. Genomic resources could be produced by next generation sequencing technologies with low cost and in a short time. In this study, we performed de novo sequencing, assembly and characterization of the antennal transcriptome of A. corpulenta. Results: Illumina sequencing technology was used to sequence the antennal transcriptome of A. corpulenta. Approximately 76.7 million total raw reads and about 68.9 million total clean reads were obtained, and then 35,656 unigenes were assembled. Of these unigenes, 21,463 of them could be annotated in the NCBI nr database, and, among the annotated unigenes, 11,154 and 6,625 unigenes could be assigned to GO and COG, respectively. Additionally, 16,350 unigenes could be annotated in the Swiss-Prot database, and 14,499 unigenes could map onto 258 pathways in the KEGG Pathway database. We also found 24 unigenes related to OBPs, 6 to CSPs, and in total 167 unigenes related to chemodetection. We analyzed 4 OBPs and 3CSPs sequences and their RT-qPCR results agreed well with their FPKM values. Conclusion: We produced the first large-scale antennal transcriptome of A. corpulenta, which is a species that has little genomic information in public databases. The identified chemodetection unigenes can promote the molecular mechanistic study of behavior in A. corpulenta. These findings provide a general sequence resource for molecular genetics research on A. corpulenta.	[Chen, Haoliang; Lin, Lulu; Xie, Minghui; Zhang, Guangling; Su, Weihua] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Peoples R China	Anhui Academy of Agricultural Sciences	Su, WH (corresponding author), Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Peoples R China.	suwh850@163.com		Chen, Haoliang/0000-0002-8997-3129	Anhui Natural Science Foundation [1308085QC52]; Anhui Academy of Agricultural Sciences [201003025, 11C1106]	Anhui Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Academy of Agricultural Sciences	This research was supported by the Anhui Natural Science Foundation (1308085QC52), Chinese Special Fund for Agro-scientific Research in the Public Interest (201003025), and Innovation team (11C1106) from Anhui Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng S, 2008, J PEANUT SCI, V37, P38; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Ge Z, 1959, ACTA ENTOMOLOGICAL S, V9, P491; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Huang H, 2011, THESIS SHENGYANG U S; Huang YW, 2010, TECHNOL CANCER RES T, V9, P139, DOI 10.1177/153303461000900203; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shu C, 2007, CURR MICROBIOL, V55, P492, DOI 10.1007/s00284-007-9018-3; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Yan GX, 2009, BIOTECHNOL LETT, V31, P697, DOI 10.1007/s10529-009-9913-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002; Zhu KY, 2009, HDB NUCL ACID PURIFI, P297	40	22	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114238	10.1371/journal.pone.0114238	http://dx.doi.org/10.1371/journal.pone.0114238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461610	Green Submitted, gold, Green Published			2022-12-27	WOS:000345869700122
J	Davies, TK; Mees, CC; Milner-Gulland, EJ				Davies, Tim K.; Mees, Chris C.; Milner-Gulland, E. J.			Modelling the Spatial Behaviour of a Tropical Tuna Purse Seine Fleet	PLOS ONE			English	Article							LOCATION CHOICE; TRIP CHOICE; FISHERIES; DYNAMICS; FISH; DISTRIBUTIONS; UNCERTAINTY; PREDICTION; KNOWLEDGE; CATCH	Industrial tuna fisheries operate in the Indian, Atlantic and Pacific Oceans, but concerns over sustainability and environmental impacts of these fisheries have resulted in increased scrutiny of how they are managed. An important but often overlooked factor in the success or failure of tuna fisheries management is the behaviour of fishers and fishing fleets. Uncertainty in how a fishing fleet will respond to management or other influences can be reduced by anticipating fleet behaviour, although to date there has been little research directed at understanding and anticipating the human dimension of tuna fisheries. The aim of this study was to address gaps in knowledge of the behaviour of tuna fleets, using the Indian Ocean tropical tuna purse seine fishery as a case study. We use statistical modelling to examine the factors that influence the spatial behaviour of the purse seine fleet at broad spatiotemporal scales. This analysis reveals very high consistency between years in the use of seasonal fishing grounds by the fleet, as well as a forcing influence of biophysical ocean conditions on the distribution of fishing effort. These findings suggest strong inertia in the spatial behaviour of the fleet, which has important implications for predicting the response of the fleet to natural events or management measures (e. g., spatial closures).	[Davies, Tim K.; Mees, Chris C.] MRAG Ltd, London, England; [Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Davies, TK (corresponding author), MRAG Ltd, London, England.	t.davies@mrag.co.uk			NERC/ESRC grant: Natural Environment Research Council (NERC); Economic and Social Research Council (ESRC)	NERC/ESRC grant: Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was part of a PhD funded under a joint NERC/ESRC grant: Natural Environment Research Council (NERC), http://www.nerc.ac.uk/; Economic and Social Research Council (ESRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camerer C, 1997, Q J ECON, V112, P407, DOI 10.1162/003355397555244; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Curtis RE, 2004, MAR RESOUR ECON, V19, P131, DOI DOI 10.1086/MRE.19.1.42629422; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Davies TK, 2014, MAR POLICY, V45, P163, DOI 10.1016/j.marpol.2013.12.014; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dowling NA, 2012, FISH FISH, V13, P139, DOI 10.1111/j.1467-2979.2011.00422.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gaertner D, 1996, AQUAT LIVING RESOUR, V56, P394; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gillis DM, 2003, CAN J ZOOL, V81, P177, DOI 10.1139/Z02-240; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; Holland DS, 2000, LAND ECON, V76, P133, DOI 10.2307/3147262; Hutton T, 2004, ICES J MAR SCI, V61, P1443, DOI 10.1016/j.icesjms.2004.08.016; ISSF, 2013, ISSF TUN STOCK STAT; Joseph JA, 2010, CONSERVATION MANAGEM, P11; LAURS RM, 1984, DEEP-SEA RES, V31, P1085, DOI 10.1016/0198-0149(84)90014-1; Marsac F., 1999, IOTC P, P147; Marsac F, 2012, IOTC P; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mohri Masahiko, 2000, Journal of National Fisheries University, V49, P1; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; Robinson J, 2010, CLIM RES, V43, P149, DOI 10.3354/cr00890; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Song LM, 2008, FISH OCEANOGR, V17, P239, DOI 10.1111/j.1365-2419.2008.00476.x; Tidd AN, 2012, FISH RES, V125, P243, DOI 10.1016/j.fishres.2012.03.004; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Valcic B, 2009, MAR POLICY, V33, P215, DOI 10.1016/j.marpol.2008.06.001; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Venables WN, 2009, ICES J MAR SCI, V66, P631, DOI 10.1093/icesjms/fsp063; Vermard Y, 2008, CAN J FISH AQUAT SCI, V65, P2444, DOI 10.1139/F08-147; WILEN JE, 1979, J FISH RES BOARD CAN, V36, P855, DOI 10.1139/f79-123; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	44	25	25	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114037	10.1371/journal.pone.0114037	http://dx.doi.org/10.1371/journal.pone.0114037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462165	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700085
J	Guo, CY; Pan, WC; Chen, MJ; Tsai, CW; Chen, NT; Su, HJ				Guo, Chao-Yu; Pan, Wen-Chi; Chen, Mu-Jean; Tsai, Chen-Wei; Chen, Nai-Tzu; Su, Huey-Jen			When Are We Most Vulnerable to Temperature Variations in a Day?	PLOS ONE			English	Article							HEAT WAVES; MORTALITY; COLD; WEATHER; EXTREMES; CITIES; RISK; POPULATIONS	Daily temperature measures are commonly used when examining the association between temperature and mortality. In fact, temperature measures are available 24 hours a day and more detailed records may provide a better prediction of mortality compared to daily statistics. In this article, monthly stratified analysis modeling for mortality is conducted for the total population as well as the stratified elderly and younger subgroups. We identified the most significant time during the day that is associated with daily mortality. Surprisingly, the estimates of relative risk and magnitude of associations derived from the hourly temperature measures are similar or even stronger compared to those modeled by the daily statistics. This phenomenon remains true for lagged hourly temperature measures and the changing patterns of associations from January through December are revealed. In summary, people are the most vulnerable to temperature variations in the early morning around 5 am and the night time around 8 pm.	[Guo, Chao-Yu; Tsai, Chen-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Div Biostat, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Biostat Consulting Ctr, Taipei 112, Taiwan; [Pan, Wen-Chi; Chen, Mu-Jean; Chen, Nai-Tzu; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Pan, Wen-Chi] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA; [Chen, Mu-Jean] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Miaoli, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; Brown University; National Health Research Institutes - Taiwan	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw		Guo, Chao-Yu/0000-0002-9066-9933; Pan, Wen-Chi/0000-0002-0588-8083	Taiwan National Science Council [NSC 99-2621-M-006-008, NSC 100-2621-M-006-001, NSC 100-2314-B-010-057-MY2, NSC 101-2621-M-006-001, NSC 101-2625-M- 006-009, NSC102-2621-M-006-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council [NSC 99-2621-M-006-008, NSC 100-2621-M-006-001, NSC 100-2314-B-010-057-MY2, NSC 101-2621-M-006-001, NSC 101-2625-M- 006-009, and NSC102-2621-M-006-001]. The funders had no role in study design, data collection and analysis.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Carrier J, 1996, CHRONOBIOL INT, V13, P373, DOI 10.3109/07420529609012661; Chang KJ, 2014, ARCH GERONTOL GERIAT, V59, P468, DOI 10.1016/j.archger.2014.04.007; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Gao Y, 2014, PLOS ONE, V18; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2009, DISTRIBUTED LAG NONL; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Ingole V, 2012, GLOB HLTH ACTION, V5, P1; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Ou CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077150; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Schifano P, 2013, ENVIRON INT, V61, P77, DOI 10.1016/j.envint.2013.09.005; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Sung TI, 2013, SCI TOTAL ENVIRON, V442, P275, DOI 10.1016/j.scitotenv.2012.09.068; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zanobetti A, 2013, EPIDEMIOLOGY, V24, P809, DOI 10.1097/01.ede.0000434432.06765.91	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113195	10.1371/journal.pone.0113195	http://dx.doi.org/10.1371/journal.pone.0113195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463354	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700029
J	Richardson, SJ; Brooks, HL; Bramley, G; Coleman, JJ				Richardson, Suzanna J.; Brooks, Hannah L.; Bramley, George; Coleman, Jamie J.			Evaluating the Effectiveness of Self-Administration of Medication (SAM) Schemes in the Hospital Setting: A Systematic Review of the Literature	PLOS ONE			English	Review							PATIENT EDUCATION; TEACHING PROGRAM; DRUG COMPLIANCE; CARE; QUALITY; SATISFACTION; INPATIENTS; MEDICINES; KNOWLEDGE; ERROR	Background: Self-administration of medicines is believed to increase patients' understanding about their medication and to promote their independence and autonomy in the hospital setting. The effect of inpatient self-administration of medication (SAM) schemes on patients, staff and institutions is currently unclear. Objective: To systematically review the literature relating to the effect of SAM schemes on the following outcomes: patient knowledge, patient compliance/medication errors, success in self-administration, patient satisfaction, staff satisfaction, staff workload, and costs. Design: Keyword and text word searches of online databases were performed between January and March 2013. Included articles described and evaluated inpatient SAM schemes. Case studies and anecdotal studies were excluded. Results: 43 papers were included for final analysis. Due to the heterogeneity of results and unclear findings it was not possible to perform a quantitative synthesis of results. Participation in SAM schemes often led to increased knowledge about drugs and drug regimens, but not side effects. However, the effect of SAM schemes on patient compliance/medication errors was inconclusive. Patients and staff were highly satisfied with their involvement in SAM schemes. Conclusions: SAM schemes appear to provide some benefits (e.g. increased patient knowledge), but their effect on other outcomes (e.g. compliance) is unclear. Few studies of high methodological quality using validated outcome measures exist. Inconsistencies in both measuring and reporting outcomes across studies make it challenging to compare results and draw substantive conclusions about the effectiveness of SAM schemes.	[Richardson, Suzanna J.; Brooks, Hannah L.; Coleman, Jamie J.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England; [Bramley, George] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Coleman, Jamie J.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Coleman, JJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England.	j.j.coleman@bham.ac.uk		Bramley, George/0000-0002-3224-1904; Coleman, Jamie/0000-0002-7512-5153	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, INSULIN ADM DIABETES, V27, ps106; Arpin M, 2007, CAN J HOSP PHARM, V60, P19; Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487; Barber N, 2002, QUAL SAF HEALTH CARE, V11, P81, DOI 10.1136/qhc.11.1.81; Barry K, 1993, J Nurs Care Qual, V8, P75; BEARDSLEY RS, 1982, CONTEMP PHARM PRACT, V5, P156; Bird C, 1990, Nurs Times, V86, P52; Bream S, 1985, Nurs Times, V81, P32; Buchanan E C, 1972, Am J Hosp Pharm, V29, P928; Buetow S, 2009, ANN FAM MED, V7, P223, DOI 10.1370/afm.941; Burrell G, 1998, J ORTHOPAEDIC NURSIN, V2, P136, DOI DOI 10.1016/S1361-3111(98)80028-9; Carter F, 1999, WORLD IR NURS, V7, P18; COLE P, 1971, AM J HOSP PHARM, V28, P954, DOI 10.1093/ajhp/28.12.954; Coleman JJ, 2013, EVALUATING EFFECTIVE; Collingsworth S, 1997, INT J NURS STUD, V34, P256, DOI 10.1016/S0020-7489(97)00013-8; Deeks PA, 2000, J ADV NURS, V31, P395, DOI 10.1046/j.1365-2648.2000.01286.x; DeProspero T, 1997, PSYCHIATR SERV, V48, P1468; Desborough JAC, 2009, INT J PHARM PRACTICE, pB49; Deshpande Amol, 2009, Open Med, V3, pe69; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Elliott Rohan A, 2009, BMC Geriatr, V9, P27, DOI 10.1186/1471-2318-9-27; Ferner RE, 2006, DRUG SAFETY, V29, P1011, DOI 10.2165/00002018-200629110-00001; Foster M, 1993, AGE AGEING S3, V22, P65; Fuller D, 1995, Prof Nurse, V10, P315; Furlong S, 1996, J ADV NURS, V23, P1254, DOI 10.1046/j.1365-2648.1996.11925.x; Gangopadhyaya KK, 2008, PRACTICAL DIABETES I, V25, P96; George J, 2006, PATIENT EDUC COUNS, V64, P50, DOI 10.1016/j.pec.2005.11.010; Grantham G, 2006, J CLIN NURS, V15, P962, DOI 10.1111/j.1365-2702.2006.01398.x; Hannay D G, 1977, Hosp Adm Can, V19, P36; Hill P, 1992, CARE ELDERLY, V4, P405; Hoffmann R P, 1978, Hosp Pharm, V13, P130; Jensen Louise, 2003, Can J Cardiovasc Nurs, V13, P35; KALLAS KD, 1984, J NURS ADMIN, V14, P38; KLEIN RH, 1974, J NERV MENT DIS, V158, P450, DOI 10.1097/00005053-197406000-00009; Lam P, 2011, J CLIN PHARM THER, V36, P80, DOI 10.1111/j.1365-2710.2009.01157.x; LOWE CJ, 1995, BRIT MED J, V310, P1229, DOI 10.1136/bmj.310.6989.1229; Lugg S, 1997, PSYCHIAT CARE, V4, P225; Macauley C, 1980, Geriatr Nurs, V1, P109; Morton S, 2013, BRIT J SPORTS MED; National Institute for Health and Care Excellence, 2012, SINGL COMP FRAM ALL; National Prescribing Centre, 2008, SERV IMPR GUID SELF; NEWCOMER DR, 1974, DRUG INTEL CLIN PHAR, V8, P374, DOI 10.1177/106002807400800602; Ng T, 1996, CAN J HOSP PHARM, V49, P80; Noy K, 1997, BRIT J NURSING, V6, P368; PARNELL MA, 1959, AM J NURS, V59, P1417, DOI 10.2307/3418020; Pearce M, 1991, NZ PHARM, V11, P18; Pelletier R D, 1983, Hosp Pharm, V18, P86; Pereles L, 1996, J AM GERIATR SOC, V44, P161, DOI 10.1111/j.1532-5415.1996.tb02433.x; Proos M, 1992, J Nurs Care Qual, VSuppl, P18; REIBEL EM, 1969, NURS RES, V18, P65; ROBERTS CJ, 1972, DRUG INTEL CLIN PHAR, V6, P408, DOI 10.1177/106002807200601202; Royal Pharmaceutical Society, 2005, SAF SEC HANDL MED TE; Samoocha D, 2010, J MED INTERNET RES, V12; Stewart D, 2010, INT J PHARM PRACTICE, V18; Tan A., 2006, PHARM PRACTICE, V28, P231; TAYLOR MD, 1984, ARCH PHYS MED REHAB, V65, P612; The Society of Hospital Pharmacists of Australia, 2002, SHPA GUID SELF ADM M; THOMAS SG, 1983, HOSP FORMUL, V18, P871; Traiger GL, 1996, CRITICAL CARE NURSE, V17, P71; Tran T, 2011, ANN PHARMACOTHER, V45, P201, DOI 10.1345/aph.1P473; Trapp M, 1998, Prof Nurse, V14, P199; VANCAMPEN C, 1995, MED CARE RES REV, V52, P109, DOI 10.1177/107755879505200107; WANDLESS I, 1977, BMJ-BRIT MED J, V1, P359, DOI 10.1136/bmj.1.6057.359; Wong FYY, 2011, BMC HEALTH SERV RES, V11, P1; Wood SI, 1992, INT J PHARM PRAC, V1, P240; WOODS JR, 1988, MED CARE, V26, P596, DOI 10.1097/00005650-198806000-00008; Wright J, 2006, PHARM WORLD SCI, V28, P140, DOI 10.1007/s11096-006-9014-x	67	29	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113912	10.1371/journal.pone.0113912	http://dx.doi.org/10.1371/journal.pone.0113912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25463269	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700068
J	Song, XS; Xie, LX; Tan, XD; Wang, ZC; Yang, YN; Yuan, YS; Deng, YP; Fu, SY; Xu, JJ; Sun, XG; Sheng, XL; Wang, Q				Song, Xiusheng; Xie, Lixin; Tan, Xiaodong; Wang, Zhichong; Yang, Yanning; Yuan, Yuansheng; Deng, Yingping; Fu, Shaoying; Xu, Jianjiang; Sun, Xuguang; Sheng, Xunlun; Wang, Qing			A Multi-Center, Cross-Sectional Study on the Burden of Infectious Keratitis in China	PLOS ONE			English	Article							SOUTH-EAST-ASIA; CORNEAL ULCERATION; HERPES-SIMPLEX; MICROBIAL KERATITIS; VILLAGE LEVEL; BLINDNESS; PREVENTION; EPIDEMIOLOGY; ANTIBIOTICS; POPULATION	Objective: To understand the prevalence and demographic characteristics of infectious keratitis and infectious corneal blindness. Methods: A multi-center, population-based cross-sectional study was conducted from January 1 to August 31, 2010. A total of 191,242 individuals of all age groups from 10 geographically representative provinces were sampled using stratified, multi-stage, random and systematic sampling procedures. A majority, 168,673 (88.2%), of those sampled participated in the study. The examination protocol included a structured interview, visual acuity testing, an external eye examination, and an anterior segment examination using a slit lamp. The causes and sequelae of corneal disease were identified using uniform customized protocols. Blindness in one eye caused by infectious keratitis was defined as infectious corneal blindness. Results: The prevalence of past and active infectious keratitis was 0.192% (95% confidence interval [CI], 0.171-0.213%), and the prevalence of viral, bacterial, and fungal keratitis was 0.11%, 0.075%, and 0.007%, respectively. There were 138 cases of infectious corneal blindness in at least one eye in the study population (prevalence of 0.082% [95% CI, 0.068%-0.095%]). Statistical analysis suggested that ocular trauma, alcoholic consumption, low socioeconomic levels, advanced age, and poor education were risk factors for infectious corneal blindness. Conclusions: Infectious keratitis is the leading cause of corneal blindness in China. Eye care strategies should focus on the prevention and rehabilitation of infectious corneal blindness.	[Song, Xiusheng; Xie, Lixin] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Shandong, Peoples R China; [Tan, Xiaodong] Wuhan Univ, Coll Publ Hlth, Wuhan 430072, Hubei Province, Peoples R China; [Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yanning] Wuhan Univ, Renmin Hosp, Dept Ophthalmol, Wuhan 430072, Hubei Province, Peoples R China; [Yuan, Yuansheng] Kunming Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Kunming, Yunnan Province, Peoples R China; [Deng, Yingping] Sichuan Univ, Ctr Eye, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Fu, Shaoying] Harbin Med Univ, Clin Coll 1, Dept Ophthalmol, Harbin, Heilongjiang Pr, Peoples R China; [Xu, Jianjiang] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Sun, Xuguang] Beijing Inst Ophthalmol, Beijing, Peoples R China; [Sheng, Xunlun] Peoples Hosp Ningxia Hui Autonomous Reg, Yinchuan, Peoples R China; [Wang, Qing] Qinghai Univ, Affiliated Hosp, Xining, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Wuhan University; Sun Yat Sen University; Wuhan University; Kunming Medical University; Sichuan University; Harbin Medical University; Fudan University; Qinghai University	Xie, LX (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Shandong, Peoples R China.	lixin_xie@yahoo.com	Xie, li/HGE-6052-2022		Consultation Program of Chinese Academy of Engineering [2009-77]	Consultation Program of Chinese Academy of Engineering	This work was supported by a grant from the Consultation Program of Chinese Academy of Engineering (No. 2009-77). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament JD, 2010, AM J OPHTHALMOL, V149, P537, DOI 10.1016/j.ajo.2009.11.001; Dandona R, 2003, BRIT J OPHTHALMOL, V87, P133, DOI 10.1136/bjo.87.2.133; Getshen K, 2006, BRIT J OPHTHALMOL, V90, P276, DOI 10.1136/bjo.2005.076083; Gonzales C A, 1996, Ophthalmic Epidemiol, V3, P159, DOI 10.3109/09286589609080122; Halberstadt M, 2002, BRIT J OPHTHALMOL, V86, P646, DOI 10.1136/bjo.86.6.646; Keay L, 2006, OPHTHALMOLOGY, V113, P109, DOI 10.1016/j.ophtha.2005.08.013; Labetoulle M, 2005, OPHTHALMOLOGY, V112, P888, DOI 10.1016/j.ophtha.2004.11.052; Lam DSC, 2002, EYE, V16, P608, DOI 10.1038/sj.eye.6700151; Li ZJ, 2009, CURR EYE RES, V34, P646, DOI 10.1080/02713680903007139; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Mariotti SP, 2004, NEW ENGL J MED, V351, P2004, DOI 10.1056/NEJMe048205; Naidoo K, 2007, CLIN EXP OPTOM, V90, P415, DOI 10.1111/j.1444-0938.2007.00197.x; *NAT BUR STAT CHIN, 2003, CHIN STAT YB 2003; National Bureau of Statistics of China, COMM MAJ FIG 2000 PO; Ngondi J, 2006, LANCET, V368, P589, DOI 10.1016/S0140-6736(06)69202-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Srinivasan M, 2006, BRIT J OPHTHALMOL, V90, P1472, DOI 10.1136/bjo.2006.103028; Upadhyay MP, 2001, BRIT J OPHTHALMOL, V85, P388, DOI 10.1136/bjo.85.4.388; Whitcher John P., 2002, International Ophthalmology Clinics, V42, P71; Whitcher JP, 1997, BRIT J OPHTHALMOL, V81, P622, DOI 10.1136/bjo.81.8.622; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; World Health Organization, VIS IMP BLINDN; Xu L, 2009, OPHTHALMOLOGY, V116, P1872, DOI 10.1016/j.ophtha.2009.04.014; ZHANG SY, 1992, CHINESE MED J-PEKING, V105, P603; Zhao Jia-liang, 2009, Zhonghua Yan Ke Za Zhi, V45, P769; Zhao JL, 1998, AM J OPHTHALMOL, V126, P506, DOI 10.1016/S0002-9394(98)00275-X	28	39	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113843	10.1371/journal.pone.0113843	http://dx.doi.org/10.1371/journal.pone.0113843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438169	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900086
J	Lee, S; Bountziouka, V; Lum, S; Stocks, J; Bonner, R; Naik, M; Fothergill, H; Wells, JCK				Lee, Simon; Bountziouka, Vassiliki; Lum, Sooky; Stocks, Janet; Bonner, Rachel; Naik, Mitesh; Fothergill, Helen; Wells, Jonathan C. K.			Ethnic Variability in Body Size, Proportions and Composition in Children Aged 5 to 11 Years: Is Ethnic-Specific Calibration of Bioelectrical Impedance Required?	PLOS ONE			English	Article							FAT-FREE MASS; PREDICTION EQUATIONS; 4-COMPONENT MODEL; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; INDEX; WATER; ADOLESCENTS; GIRLS; ANTHROPOMETRY	Background: Bioelectrical Impedance Analysis (BIA) has the potential to be used widely as a method of assessing body fatness and composition, both in clinical and community settings. BIA provides bioelectrical properties, such as whole-body impedance which ideally needs to be calibrated against a gold-standard method in order to provide accurate estimates of fat-free mass. UK studies in older children and adolescents have shown that, when used in multi-ethnic populations, calibration equations need to include ethnic-specific terms, but whether this holds true for younger children remains to be elucidated. The aims of this study were to examine ethnic differences in body size, proportions and composition in children aged 5 to 11 years, and to establish the extent to which such differences could influence BIA calibration. Methods: In a multi-ethnic population of 2171 London primary school-children (47% boys; 34% White, 29% Black African/Caribbean, 25% South Asian, 12% Other) detailed anthropometric measurements were performed and ethnic differences in body size and proportion were assessed. Ethnic differences in fat-free mass, derived by deuterium dilution, were further evaluated in a subsample of the population (n=698). Multiple linear regression models were used to calibrate BIA against deuterium dilution. Results: In children < 11 years of age, Black African/Caribbean children were significantly taller, heavier and had larger body size than children of other ethnicities. They also had larger waist and limb girths and relatively longer legs. Despite these differences, ethnic-specific terms did not contribute significantly to the BIA calibration equation (Fat-free mass=1.12+0.71*(height(2)/impedance)+0.18*weight). Conclusion: Although clear ethnic differences in body size, proportions and composition were evident in this population of young children aged 5 to 11 years, an ethnic-specific BIA calibration equation was not required.	[Lee, Simon; Bountziouka, Vassiliki; Lum, Sooky; Stocks, Janet; Bonner, Rachel] UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, London, England; [Naik, Mitesh] Guys & St Thomas NHS Fdn Trust, London, England; [Fothergill, Helen] North Devon Dist Hosp, Barnstaple, Devon, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Lee, S (corresponding author), UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, London, England.	s.lee@ucl.ac.uk	Bountziouka, Vasiliki/I-6297-2018; Wells, Jonathan/A-4604-2009; Bountziouka, Vasiliki/S-6886-2019	Bountziouka, Vasiliki/0000-0003-2522-1582; Wells, Jonathan/0000-0003-0411-8025; Bountziouka, Vasiliki/0000-0003-2522-1582	Wellcome Trust [WT094129MA]; Asthma UK [10/013]; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network	Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust [WT094129MA], Asthma UK [10/013] and the Child Growth Foundation. The SLIC study team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basterfield L, 2014, J SCI MED SPORT; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Bouthoorn SH, 2014, OBESITY SILVER SPRIN; Bray GA, 2002, AM J CLIN NUTR, V76, P980, DOI 10.1093/ajcn/76.5.980; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Deurenberg P, 2002, EUR J CLIN NUTR, V56, P214, DOI 10.1038/sj.ejcn.1601303; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; Epstein AL, 1978, ETHOS IDENTITY 3 STU; Griffiths LJ, 2011, INT J PEDIATR OBES, V6, pE423, DOI 10.3109/17477166.2010.526221; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; Haroun D, 2010, OBESITY, V18, P1252, DOI 10.1038/oby.2009.344; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; HATTORI K, 1991, J ANTHROPOL SOC NIP, V99, P141; HOFFER EC, 1969, J APPL PHYSIOL, V27, P531, DOI 10.1152/jappl.1969.27.4.531; Horlick M, 2002, AM J CLIN NUTR, V76, P991, DOI 10.1093/ajcn/76.5.991; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kyle UG, 2003, CURR OPIN CLIN NUTR, V6, P387, DOI 10.1097/01.mco.0000078988.18774.3d; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Lindsay AR, 2014, J NUTR EDUC BEHAV, V46, P43, DOI 10.1016/j.jneb.2013.03.013; Lum S, 2014, EXPLORING ETHNIC DIF; Montagnese C, 2013, EUR J CLIN NUTR, V67, pS34, DOI 10.1038/ejcn.2011.213; National Obesity Observatory, 2009, BOD MASS IND MEAS OB; Newton RL, 2005, INT J OBESITY, V29, P594, DOI 10.1038/sj.ijo.0802968; Nightingale CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076426; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Norgan NG, 2005, PUBLIC HEALTH NUTR, V8, P1108, DOI 10.1079/PHN2005799; ORGAN LW, 1994, J APPL PHYSIOL, V77, P98, DOI 10.1152/jappl.1994.77.1.98; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Ramasubramanian L, 2013, CHILD CARE HLTH DEV, V39, P134, DOI 10.1111/j.1365-2214.2011.01325.x; Ramirez E, 2012, EUR J CLIN NUTR, V66, P1099, DOI 10.1038/ejcn.2012.89; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; SCRIMGEOUR CM, 1993, BIOL MASS SPECTROM, V22, P383, DOI 10.1002/bms.1200220704; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Wells JCK, 2008, ARCH DIS CHILD, V93, P168, DOI 10.1136/adc.2007.115741; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428; Whitrow MJ, 2008, AM J RESP CRIT CARE, V177, P1262, DOI 10.1164/rccm.200706-867OC; Wu Y, 2001, J ADOLESCENT HEALTH, V28, P197, DOI 10.1016/S1054-139X(00)00163-4	45	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113883	10.1371/journal.pone.0113883	http://dx.doi.org/10.1371/journal.pone.0113883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478928	Green Published, gold			2022-12-27	WOS:000346907200036
J	Lomonaco, T; Ghimenti, S; Piga, I; Biagini, D; Onor, M; Fuoco, R; Di Francesco, F				Lomonaco, Tommaso; Ghimenti, Silvia; Piga, Isabella; Biagini, Denise; Onor, Massimo; Fuoco, Roger; Di Francesco, Fabio			Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; SALIVA; DRUGS; METABOLITES; THERAPY; PLASMA	Background and Objective: The determination of warfarin, RS/SR- and RR/SS-warfarin alcohols in oral fluid may offer additional information to the INR assay. This study aimed to establish an optimized sampling technique providing the best correlation between the oral fluid and the unbound plasma concentrations of these compounds. Materials and Methods: Samples of non-stimulated and stimulated oral fluid, and blood were collected from 14 patients undergoing warfarin therapy. After acidification, analytes were extracted with a dichloromethane/hexane mixture and determined by HPLC with fluorescence detection. Plasma samples were also ultrafiltered for the determination of the unbound fraction. The chromatographic separation was carried out in isocratic conditions with a phosphate buffer/methanol mobile phase on a C-18 reversed-phase column. The absence of interfering compounds was verified by HPLC-ESI-Q-TOF. Results: Stimulation generally increased the oral fluid pH to values close to blood pH in about 6 minutes. The concentration of warfarin and RS/SR-warfarin alcohols in oral fluid followed the same trend, whereas the concentration of RR/SS-warfarin alcohols was not affected. Six minute stimulation with chewing gum followed by collection with a polyester swab was the best sampling procedure, with a good repeatability (RSD <10%) and relatively low inter-subject variability (RSD = 30%) of the oral fluid to plasma ratio. This procedure provided strong correlations between the measured oral fluid and unbound plasma concentration of warfarin (r = 0.92, p <0.001) and RS/SR-warfarin alcohols (r = 0.84, p <0.001), as well as between stimulated oral fluid and total plasma concentration of warfarin (r = 0.78, p <0.001) and RS/SR-warfarin alcohols (r = 0.81, p <0.001). Conclusion: The very good correlation between oral fluid and unbound plasma concentration of warfarin and RS/SR-warfarin alcohols suggests that oral fluid analysis could provide clinically useful information for the monitoring of anticoagulant therapy, complementary to the INR assay.	[Lomonaco, Tommaso; Ghimenti, Silvia; Piga, Isabella; Biagini, Denise; Fuoco, Roger; Di Francesco, Fabio] Univ Pisa, Dept Chem & Ind Chem, Pisa, Italy; [Onor, Massimo] CNR, Inst Chem Organometall Cpds, I-56100 Pisa, Italy; [Di Francesco, Fabio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Di Francesco, F (corresponding author), Univ Pisa, Dept Chem & Ind Chem, Pisa, Italy.	fdifra@dcci.unipi.it	Lomonaco, Tommaso/K-8276-2016; Onor, Massimo/A-4382-2012; Piga, Isabella/H-1065-2018; Di Francesco, Fabio/I-8756-2012; Biagini, Denise/GSI-9597-2022; Biagini, Denise/AIC-4126-2022	Lomonaco, Tommaso/0000-0002-1822-7399; Onor, Massimo/0000-0003-3023-1072; Piga, Isabella/0000-0001-8221-2493; Di Francesco, Fabio/0000-0002-9285-1595; Biagini, Denise/0000-0001-6747-9712				Angelov T, 2008, J LIQ CHROMATOGR R T, V31, P188, DOI 10.1080/10826070701738787; [Anonymous], PHARM TIMES; [Anonymous], 1995, TEST 107 PART COEFF, DOI DOI 10.1787/9789264069626-EN; AVDEEF A, 1993, ANAL CHEM, V65, P42, DOI 10.1021/ac00049a010; Bardow A, 2000, Clin Oral Investig, V4, P245, DOI 10.1007/s007840000077; Bosker WM, 2009, CLIN CHEM, V55, P1910, DOI 10.1373/clinchem.2008.108670; Chicharro JL, 1998, SPORTS MED, V26, P17, DOI 10.2165/00007256-199826010-00002; Corran P, 1999, WHO TECH REP SER, V889, P1; CURRIE LA, 1995, PURE APPL CHEM, V67, P1699, DOI 10.1351/pac199567101699; FELLER K, 1977, INT J CLIN PHARM BI, V15, P468; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; Gebauer M, 2007, BIOORGAN MED CHEM, V15, P2414, DOI 10.1016/j.bmc.2007.01.014; Ghimenti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028182; HAECKEL R, 1993, ANN NY ACAD SCI, V694, P128, DOI 10.1111/j.1749-6632.1993.tb18347.x; Haeckel R, 1996, EUR J CLIN CHEM CLIN, V34, P171; Higashi T, 2012, CLIN CHIM ACTA, V414, P248, DOI 10.1016/j.cca.2012.09.031; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Hold KM, 1999, INT J DRUG TESTING, V1, P1; JUSKO WJ, 1993, ANN NY ACAD SCI, V694, P36; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; KILLMANN SA, 1955, SCAND J CLIN LAB INV, V7, P86, DOI 10.3109/00365515509134102; KNOTT C, 1982, BMJ-BRIT MED J, V284, P13, DOI 10.1136/bmj.284.6308.13; LEWIS RJ, 1973, J LAB CLIN MED, V81, P925; Lomonaco T, 2013, J CHROMATOGR A, V1314, P54, DOI 10.1016/j.chroma.2013.08.091; Manderscheid M, 2003, J CHROMATOGR SCI, V41, P323, DOI 10.1093/chromsci/41.6.323; Melanie K, 2008, CROMOSPHERE, V72, P1401; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Opong-Mensah K, 1984, J Pharm Biomed Anal, V2, P381, DOI 10.1016/0731-7085(84)80041-2; Osinbowale O, 2009, CLEV CLIN J MED, V76, P724, DOI 10.3949/ccjm.76a.09062; Takahashi H, 1998, CLIN PHARMACOL THER, V63, P519, DOI 10.1016/S0009-9236(98)90103-5; TRAGER WF, 1970, J MED CHEM, V13, P1196, DOI 10.1021/jm00300a041; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; Zhao Wei, 2011, Handb Exp Pharmacol, V205, P77, DOI 10.1007/978-3-642-20195-0_3	34	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114430	10.1371/journal.pone.0114430	http://dx.doi.org/10.1371/journal.pone.0114430			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478864	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200086
J	Riiser, K; Londal, K; Ommundsen, Y; Smastuen, MC; Misvaer, N; Helseth, S				Riiser, Kirsti; Londal, Knut; Ommundsen, Yngvar; Smastuen, Milada Cvancarova; Misvaer, Nina; Helseth, Solvi			The Outcomes of a 12-Week Internet Intervention Aimed at Improving Fitness and Health-Related Quality of Life in Overweight Adolescents: The Young & Active Controlled Trial	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; SHUTTLE-RUN TEST; PHYSICAL-ACTIVITY; BEHAVIOR-CHANGE; INTRINSIC MOTIVATION; OBESE CHILDREN; BODY-IMAGE; EXERCISE; WORLDWIDE; EXPOSURE	Background: Overweight and obesity among adolescents may have consequences, with potentially lasting effects on health and health-related quality of life (HRQoL). Excess weight is also associated with decreases in physical activity and cardiorespiratory fitness. The aim of the current study was to investigate the short-term effects of a 12-week Internet intervention in a primary care setting intended to increase cardiorespiratory fitness and HRQoL among overweight and obese adolescents. Methods: In this controlled trial, participants (13-15 years) were non-randomly allocated to an intervention-or a control group. The intervention group received 12-weeks access to an online program providing tailored physical activity counseling based on principles from Self-determination Theory and Motivational Interviewing. The control group received standard follow-up by the school nurses. The primary outcome measure of cardiorespiratory fitness was determined using a shuttle run test. The secondary outcomes: HRQoL, leisure time exercise, body image and self-determined motivation for physical activity and exercise, were assessed by selfreport measures. Age-and gender-adjusted body mass index (BMI) was calculated based on measurements of height and weight. To compare pre-to post intervention differences within groups, a paired samples t-test was used while crude differences between groups were analyzed with an independent samples t-test. Results: Of the 120 participants, 108 completed the study, 75 in the intervention group and 33 in the control group. Exposure to the intervention had a small effect on cardiorespiratory fitness (0.14; 95% CI [0.01; 0.28]; P=0.04), and a moderate effect on HRQoL (5.22; 95% CI [0.90; 9.53]; P=0.02). Moreover, the control group increased significantly in BMI, yielding a moderate preventive effect on BMI (-0.39; 95% CI [-0.74; -0.03]; P=0.03) for the intervention group. Conclusion: The results suggest that the Internet intervention with tailored physical activity counseling can have beneficial short-term effect on cardiorespiratory fitness, HRQoL and BMI among adolescents with overweight and obesity.	[Riiser, Kirsti; Ommundsen, Yngvar] Norwegian Sch Sport Sci, Oslo, Norway; [Riiser, Kirsti; Londal, Knut; Smastuen, Milada Cvancarova; Misvaer, Nina; Helseth, Solvi] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway	Norwegian School of Sport Sciences; Oslo Metropolitan University (OsloMet)	Riiser, K (corresponding author), Norwegian Sch Sport Sci, Oslo, Norway.	kirsti.riiser@hioa.no	Riiser, Kirsti/AAA-5077-2021	Riiser, Kirsti/0000-0002-0801-1121	Norwegian Extra Foundation for Health and Rehabilitation through Norwegian Women's Health Association; Oslo and Akershus University College of Applied Sciences	Norwegian Extra Foundation for Health and Rehabilitation through Norwegian Women's Health Association; Oslo and Akershus University College of Applied Sciences	The study was financially supported by the Norwegian Extra Foundation for Health and Rehabilitation through the Norwegian Women's Health Association and the Oslo and Akershus University College of Applied Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaker F., 1992, J EARLY ADOLESC, V12, P396, DOI DOI 10.1177/0272431692012004004; An JY, 2009, ADV NURS SCI, V32, P222, DOI 10.1097/ANS.0b013e3181b0d6ef; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Boddy LM, 2012, MED SCI SPORT EXER, V44, P481, DOI 10.1249/MSS.0b013e3182300267; Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639; Buttitta M, 2014, QUAL LIFE RES, V23, P1117, DOI 10.1007/s11136-013-0568-5; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crutzen R, 2011, HEALTH EDUC BEHAV, V38, P49, DOI 10.1177/1090198110372878; Edmunds J, 2008, EUR J SOC PSYCHOL, V38, P375, DOI 10.1002/ejsp.463; Morales PF, 2013, QUAL LIFE RES, V22, P1515, DOI 10.1007/s11136-012-0282-8; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Hagger M., 2008, INT REV SPORT EXER P, V1, P79, DOI [10.1080/17509840701827437, DOI 10.1080/17509840701827437]; Hamel LM, 2011, J ADV NURS, V67, P251, DOI 10.1111/j.1365-2648.2010.05493.x; Haraldstad K, 2011, J CLIN NURS, V20, P3048, DOI 10.1111/j.1365-2702.2010.03693.x; Holsen I, 2001, J HEALTH PSYCHOL, V6, P613, DOI 10.1177/135910530100600601; Ingledew DK, 2008, PSYCHOL HEALTH, V23, P807, DOI 10.1080/08870440701405704; King A, 1996, WHO Reg Publ Eur Ser, V69, P1; Kohl LF, 2013, J MED INTERNET RES, V15, P71, DOI 10.2196/jmir.2665; Lau PWC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1533; Lock K, 2010, PREVENTING CHILDHOOD, P94; Lustria MLA, 2013, J HEALTH COMMUN, V18, P1039, DOI 10.1080/10810730.2013.768727; Markland D, 2007, INTRINSIC MOTIVATION, P87; Markland D, 2007, PSYCHOL SPORT EXERC, V8, P836, DOI 10.1016/j.psychsport.2006.11.002; Mata J, 2009, HEALTH PSYCHOL, V28, P709, DOI 10.1037/a0016764; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Needham BL, 2005, J ADOLESCENT HEALTH, V36, P48, DOI 10.1016/j.jadohealth.2003.12.015; Nguyen B, 2011, OBES REV, V12, pe298, DOI 10.1111/j.1467-789X.2010.00830.x; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; Olds TS, 2011, J ADOLESCENT HEALTH, V48, P189, DOI 10.1016/j.jadohealth.2010.06.010; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rangul V, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-47; Rauner Annette, 2013, BMC Pediatr, V13, P19, DOI 10.1186/1471-2431-13-19; Reed KE, 2008, PREV MED, V46, P525, DOI 10.1016/j.ypmed.2008.02.020; Riiser K, 2014, NURS ETHICS; Riiser K, 2014, SCANDINAVIAN J PUBLI; Riiser K, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2410; Ryan R., 2007, INTRINSIC MOTIVATION, P1; Ryan R. M., 2008, EUROPEAN HLTH PSYCHO, V10, P2, DOI DOI 10.1080/17509840701827437; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sandercock G, 2012, J SPORT SCI, V30, P679, DOI 10.1080/02640414.2012.660185; Shoup JA, 2008, QUAL LIFE RES, V17, P407, DOI 10.1007/s11136-008-9312-y; Sui X, 2007, J AM GERIATR SOC, V55, P1940, DOI 10.1111/j.1532-5415.2007.01455.x; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swallen KC, 2005, PEDIATRICS, V115, P340, DOI 10.1542/peds.2004-0678; The Kidscreen Group Europe, 2006, KIDSCREEN QUESTIONNA, V3, P231; The Norwegian Directorate of Health, 2010, NAT GUID WEIGH MEAS; The Norwegian Directorate of Health, 2010, NAT GUID PREV DIAGN; Verloigne M, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-97; World Health Organization, 2004, GLOB STRAT DIET PHYS; Wright CM, 2010, ARCH DIS CHILD, V95, P612, DOI 10.1136/adc.2009.164491	56	34	34	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114732	10.1371/journal.pone.0114732	http://dx.doi.org/10.1371/journal.pone.0114732			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478791	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200119
J	Sun, HQ; Guo, DY; Su, YP; Yu, DM; Wang, QL; Wang, T; Zhou, Q; Ran, XZ; Zou, ZM				Sun, Huiqin; Guo, Deyu; Su, Yongping; Yu, Dongmei; Wang, Qingliang; Wang, Tao; Zhou, Qing; Ran, Xinze; Zou, Zhongmin			Hyperplasia of Pericytes Is One of the Main Characteristics of Microvascular Architecture in Malignant Glioma	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR ANGIOGENESIS; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-FACTOR; CANCER; HETEROGENEITY; GROWTH; PROLIFERATION; TUMORIGENESIS; VASCULATURE	Objectives: To investigate the role of pericytes in constructing the malformed microvessels (MVs) and participating microvascular architecture heterogeneity of glioma. Methods: Forty human glioma tissue samples (WHO grade II-IV) were included in present study. Observation of blood vessel patterns, quantitative analysis of endothelial cells (ECs)-and pericyte-labeled MVs and comparison between malignant grades based on single-or double-immunohistochemical staining. The MV number density (MVND), microvascular pericyte number density (MPND), and microvascular pericyte area density (MPAD) were calculated. The expression of PDGF beta was also scored after immunostaining. Results: In grade II glioma, most of tumor MVs were the thin-wall CD34(+) vessels with near normal morphology. In addition to thin-wall CD34(+) MVs, more thick-wall MVs were found in grade III glioma, which often showed alpha-SMA positive. Most of MVs in grade IV glioma were in the form of plexus, curled cell cords and glomeruloid microvascular proliferation while the alpha-SMA(+) cells were the main components. The MVs usually showed disordered arrangement, loose connection and active cell proliferation as shown by Ki67 and alpha-SMA coexpression. With the increase of glioma grades, the alpha-SMA(+) MVND, CD34(+) MVND and MPND were significantly augmented although the increase of CD34(+) MVND but not MPAD was statistically insignificant between grade III and IV. It was interesting that some vessel-like structures only consist of alpha-SMA(+) cells, assuming the guiding role of pericytes in angiogenesis. The expression level of PDGF beta was upregulated and directly correlated with the MPND in different glioma grades. Conclusion: Hyperplasia of pericytes was one of the significant characteristics of malignant glioma and locally proliferated pericytes were the main constituent of MVs in high grade glioma. The pathological characteristics of pericytes could be used as indexes of malignant grades of glioma.	[Sun, Huiqin; Su, Yongping; Wang, Tao; Zhou, Qing; Ran, Xinze] Third Mil Med Univ, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Coll Prevent Med, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Zou, Zhongmin] Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Ministry of Education, China; Army Medical University	Sun, HQ (corresponding author), Third Mil Med Univ, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Coll Prevent Med, Chongqing, Peoples R China.	huiqinsun02@163.com; zmzou@tmmu.edu.cn			National Natural Science Foundation, China [30971141]; Medical Research Project of PLA [06H030]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Medical Research Project of PLA	This work was supported by the National Natural Science Foundation, China (URL:http://www.nsfc.gov.cn) (Grant No. 30971141), the Medical Research Project of PLA (06H030) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2008, CURR CANCER DRUG TAR, V8, P447, DOI 10.2174/156800908785699360; Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bian XW, 2006, J NEURO-ONCOL, V80, P211, DOI 10.1007/s11060-006-9167-4; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Cao Y, 2013, CANCER-AM CANCER SOC, V119, P313, DOI 10.1002/cncr.27746; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Eberhard A, 2000, CANCER RES, V60, P1388; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Hida K, 2013, CANCER SCI, V104, P1391, DOI 10.1111/cas.12251; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jouanneau E, 2008, NEUROSURGERY, V62, P31, DOI 10.1227/01.NEU.0000311060.65002.4E; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kalinski T, 2009, PATHOL RES PRACT, V205, P339, DOI 10.1016/j.prp.2008.12.008; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lebelt A, 2008, FOLIA HISTOCHEM CYTO, V46, P69, DOI 10.2478/v10042-008-0009-4; Liu AY, 2013, CURR BIOL, V23, pR565, DOI 10.1016/j.cub.2013.05.023; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nolte I, 2008, CLIN NEUROL NEUROSUR, V110, P339, DOI 10.1016/j.clineuro.2007.12.008; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Takeuchi H, 2010, J NEUROSURG, V113, P218, DOI 10.3171/2009.10.JNS08631; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Virgintino D, 2008, J VASC RES, V45, P129, DOI 10.1159/000109965; Wang CJ, 2009, APPL IMMUNOHISTO M M, V17, P530, DOI 10.1097/PAI.0b013e3181a13bf2; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; WESSELING P, 1995, J NEUROPATH EXP NEUR, V54, P304, DOI 10.1097/00005072-199505000-00003; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6	38	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114246	10.1371/journal.pone.0114246	http://dx.doi.org/10.1371/journal.pone.0114246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478951	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200054
J	Fan, DY; Zhu, W; Li, DJ; Ji, D; Wang, P				Fan, Dongyan; Zhu, Wei; Li, Dejun; Ji, De; Wang, Ping			Identification of a Novel Homozygous Mutation, TMPRSS3: c.535G > A, in a Tibetan Family with Autosomal Recessive Non-Syndromic Hearing Loss	PLOS ONE			English	Article							DEAFNESS; GENE; POPULATION; PHENOTYPE; CHINESE; PROTEIN	Different ethnic groups have distinct mutation spectrums associated with inheritable deafness. In order to identify the mutations responsible for congenital hearing loss in the Tibetan population, mutation screening for 98 deafness-related genes by microarray and massively parallel sequencing of captured target exons was conducted in one Tibetan family with familiar hearing loss. A homozygous mutation, TMPRSS3: c.535G>A, was identified in two affected brothers. Both parents are heterozygotes and an unaffected sister carries wild type alleles. The same mutation was not detected in 101 control Tibetan individuals. This missense mutation results in an amino acid change (p.Ala179Thr) at a highly conserved site in the scavenger receptor cysteine rich (SRCR) domain of the TMPRSS3 protein, which is essential for protein-protein interactions. Thus, this mutation likely affects the interactions of this transmembrane protein with extracellular molecules. According to our bioinformatic analyses, the TMPRSS3: c.535G>A mutation might damage protein function and lead to hearing loss. These data suggest that the homozygous mutation TMPRSS3: c.535G>A causes prelingual hearing loss in this Tibetan family. This is the first TMPRSS3 mutation found in the Chinese Tibetan population.	[Fan, Dongyan; Zhu, Wei; Wang, Ping] Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Jilin Province, Peoples R China; [Fan, Dongyan; Ji, De] Tibet Univ, Sch Med, Lhasa, Peoples R China; [Li, Dejun] Jilin Univ, Hosp 1, Ctr Prenatal Diag, Changchun 130023, Jilin Province, Peoples R China	Jilin University; Tibet University; Jilin University	Wang, P (corresponding author), Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Jilin Province, Peoples R China.	wang_ping@jlu.edu.cn			National Science Foundation of China [8116360]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (Grant No. 8116360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Charif M, 2012, BIOCHEM BIOPH RES CO, V419, P643, DOI 10.1016/j.bbrc.2012.02.066; Chung J, 2014, J MOL MED, V92, P651, DOI 10.1007/s00109-014-1128-3; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Eisen MD, 2007, CELL MOL LIFE SCI, V64, P566, DOI 10.1007/s00018-007-6417-3; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Fan D, 2013, CHINESE SCI J HEAR S, V11, P271; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Hutchin T, 2005, CLIN GENET, V68, P506, DOI 10.1111/j.1399-0004.2005.00539.x; Kim HJ, 2010, CLIN EXP OTORHINOLAR, V3, P65, DOI 10.3342/ceo.2010.3.2.65; Lee J, 2013, GENE, V532, P276, DOI 10.1016/j.gene.2013.07.108; Lee K, 2012, CLIN GENET, V82, P56, DOI 10.1111/j.1399-0004.2011.01695.x; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Li Qi, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P893; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Molina L, 2013, HUM MOL GENET, V22, P1289, DOI 10.1093/hmg/dds532; Ouyang XM, 2009, J HUM GENET, V54, P131, DOI 10.1038/jhg.2009.4; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Vozzi D, 2014, GENE, V542, P209, DOI 10.1016/j.gene.2014.03.033; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030720	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114136	10.1371/journal.pone.0114136	http://dx.doi.org/10.1371/journal.pone.0114136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474651	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500116
J	Hina, S; Mustafa, M; Hayat, T				Hina, Sadia; Mustafa, Meraj; Hayat, Tasawar			Peristaltic Motion of Johnson-Segalman Fluid in a Curved Channel with Slip Conditions	PLOS ONE			English	Article							INDUCED MAGNETIC-FIELD; WALL PROPERTIES; MASS-TRANSFER; ASYMMETRIC CHANNEL; MAXWELL FLUID; HEAT-TRANSFER; GRADE FLUID; FLOW; TRANSPORT	Slip effects on the peristaltic transport of Johnson-Segalman fluid through a curved channel have been addressed. The influence of wall properties is also analyzed. Long wavelength and low Reynolds number assumptions have been utilized in the mathematical formulation of the problem. The equations so formed have been solved numerically by shooting method through computational software Mathematica 8. In addition the analytic solution for small Weissenberg number (elastic parameter) is computed through a regular perturbation method. An excellent agreement is noticed between the two solutions. The results indicate an increase in the magnitude of velocity with an intensification in the slip effect. Moreover the size and circulation of the trapped boluses increase with an increase in the slip parameter. Unlike the planar channel, the profiles of axial velocity are not symmetric about the central line of the channel.	[Hina, Sadia] Fatima Jinnah Women Univ, Dept Math Sci, Rawalpindi, Pakistan; [Mustafa, Meraj] Natl Univ Sci & Technol, Sch Nat Sci, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Hina, S (corresponding author), Fatima Jinnah Women Univ, Dept Math Sci, Rawalpindi, Pakistan.	quaidan85@yahoo.com	Hina, Sadia/AAE-7053-2019; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Mustafa Hashmi, Meraj/P-1769-2014	Hina, Sadia/0000-0001-8066-0399				Ali N, 2008, PHYS LETT A, V372, P1477, DOI 10.1016/j.physleta.2007.09.061; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, INT J HEAT MASS TRAN, V53, P3319, DOI 10.1016/j.ijheatmasstransfer.2010.02.036; Ali N, 2010, Z NATURFORSCH A, V65, P191, DOI 10.1515/zna-2010-0306; Ali N, 2009, CHAOS SOLITON FRACT, V39, P407, DOI 10.1016/j.chaos.2007.04.010; Davies C, 1997, J FLUID MECH, V352, P205, DOI 10.1017/S0022112097007313; Ebaid A, 2008, PHYS LETT A, V372, P4493, DOI 10.1016/j.physleta.2008.04.031; Ebaid A, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/172590; Elnaby MAA, 2008, COMMUN NONLINEAR SCI, V13, P752, DOI 10.1016/j.cnsns.2006.07.007; Elshahed M, 2005, MATH PROBL ENG, P663, DOI 10.1155/MPE.2005.663; Gad NS, 2011, APPL MATH COMPUT, V217, P4313, DOI 10.1016/j.amc.2010.08.016; Haroun MH, 2006, MATH PROBL ENG, V2006, DOI 10.1155/MPE/2006/61475; Hayat T, 2008, TRANSPORT POROUS MED, V74, P259, DOI 10.1007/s11242-007-9196-2; Hayat T, 2008, PHYS LETT A, V372, P5026, DOI 10.1016/j.physleta.2008.03.065; Hayat T, 2003, MATH PROBL ENG, P1, DOI 10.1155/S1024123X03308014; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hayat T, 2010, NONLINEAR ANAL-REAL, V11, P3155, DOI 10.1016/j.nonrwa.2009.11.010; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P1526, DOI 10.1016/j.cnsns.2009.06.032; Hayat T, 2008, MATH COMPUT MODEL, V47, P380, DOI 10.1016/j.mcm.2007.04.012; Hina S, 2014, APPL MATH MECH-ENGL, V35, P73, DOI 10.1007/s10483-014-1773-7; Hina S, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007433; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hina S, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4026168; Hina S, 2012, NONLINEAR ANAL-MODEL, V17, P297, DOI 10.15388/NA.17.3.14057; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Kothandapani A, 2008, PHYS LETT A, V372, P1265, DOI 10.1016/j.physleta.2007.09.040; Kothandapani M, 2008, PHYS LETT A, V372, P4586, DOI 10.1016/j.physleta.2008.04.050; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Latham T., 1966, THESIS MIT PRESS CAM; Mekheimer KS, 2008, PHYS LETT A, V372, P4271, DOI 10.1016/j.physleta.2008.03.059; Mekheimer KS, 2008, PHYSICA A, V387, P2403, DOI 10.1016/j.physa.2007.12.017; MITTRA TK, 1973, J BIOMECH, V6, P681, DOI 10.1016/0021-9290(73)90024-9; Mustafa M, 2014, MECCANICA, V49, P521, DOI 10.1007/s11012-013-9809-5; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Muthu P, 2008, APPL MATH MODEL, V32, P2019, DOI 10.1016/j.apm.2007.06.034; Nadeem S, 2011, J TAIWAN INST CHEM E, V42, P58, DOI 10.1016/j.jtice.2010.03.006; Radhakrishnamacharya G, 2007, CR MECANIQUE, V335, P369, DOI 10.1016/j.crme.2007.05.002; Rao IJ, 1999, ACTA MECH, V132, P209, DOI 10.1007/BF01186968; Sato H., 2000, T JAPAN SOC MECH ENG, V66, P679; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Srinivas S, 2009, COMPUT PHYS COMMUN, V180, P2115, DOI 10.1016/j.cpc.2009.06.015; Srinivas S, 2009, APPL MATH COMPUT, V213, P197, DOI 10.1016/j.amc.2009.02.054; Srivastava VP, 1997, INT J ENG SCI, V35, P1359, DOI 10.1016/S0020-7225(97)00053-0; Wang YQ, 2007, THEOR COMP FLUID DYN, V21, P369, DOI 10.1007/s00162-007-0054-1	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114168	10.1371/journal.pone.0114168	http://dx.doi.org/10.1371/journal.pone.0114168			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474212	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500120
J	Yang, SC; Sung, PJ; Lin, CF; Kuo, J; Chen, CY; Hwang, TL				Yang, Shun-Chin; Sung, Ping-Jyun; Lin, Chwan-Fwu; Kuo, Jimmy; Chen, Chun-Yu; Hwang, Tsong-Long			Anti-Inflammatory Effects of Secondary Metabolites of Marine Pseudomonas sp in Human Neutrophils Are through Inhibiting P38 MAPK, JNK, and Calcium Pathways	PLOS ONE			English	Article							ACTIVATED HUMAN NEUTROPHILS; ELASTASE RELEASE; SUPEROXIDE-PRODUCTION; LUNG INJURY; KINASE; INFLAMMATION; SHOCK; IDENTIFICATION; INNATE; SITES	Activated neutrophils play a significant role in the pathogenesis of many inflammatory diseases. The metabolites of marine microorganisms are increasingly employed as sources for developing new drugs; however, very few marine drugs have been studied in human neutrophils. Herein, we showed that secondary metabolites of marine Pseudomonas sp. (N11) significantly inhibited superoxide anion generation and elastase release in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated human neutrophils, with IC50 values of 0.67 +/- 0.38 mg/ml and 0.84 +/- 0.12 mg/ml, respectively. In cell-free systems, neither superoxide anion-scavenging effect nor inhibition of elastase activity was associated with the suppressive effects of N11. N11 inhibited the phosphorylation of p38 MAP kinase and JNK, but not Erk and Akt, in FMLP-induced human neutrophils. Also, N11 dose-dependently attenuated the transient elevation of intracellular calcium concentration in activated neutrophils. In contrast, N11 failed to alter phorbol myristate acetate-induced superoxide anion generation, and the inhibitory effects of N11 were not reversed by protein kinase A inhibitor. In conclusion, the anti-inflammatory effects of N11 on superoxide anion generation and elastase release in activated human neutrophils are through inhibiting p38 MAP kinase, JNK, and calcium pathways. Our results suggest that N11 has the potential to be developed to treat neutrophil-mediated inflammatory diseases.	[Yang, Shun-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Yang, Shun-Chin] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Dept Life Sci, Pingtung, Taiwan; [Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Grad Inst Biotechnol, Pingtung, Taiwan; [Lin, Chwan-Fwu] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Taoyuan, Taiwan; [Lin, Chwan-Fwu] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Kuo, Jimmy] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Chen, Chun-Yu] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chen, Chun-Yu] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Sch Tradit Med, Coll Med, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan	Chang Gung University; Taipei Veterans General Hospital; National Dong Hwa University; National Dong Hwa University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; National Museum of Marine Biology & Aquarium; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hwang, TL (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Sch Tradit Med, Coll Med, Taoyuan, Taiwan.	htl@mail.cgu.edu.tw	Hwang, Tsong-Long/AAE-6944-2020; Sung, Ping-Jyun/Z-4162-2019; Poubelle, Patrice E/G-6537-2013	Hwang, Tsong-Long/0000-0002-5780-3977; 	Ministry of Education [EMRPD1D901]; National Science Council [NSC 100-2628-B-182-001-MY3]; Taipei Veterans General Hospital [V103B-029]; Chang Gung Memorial Hospital, Taiwan [CMRPG3C1381, CMRPD1D0281]	Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was supported by the grant from the Ministry of Education (EMRPD1D901), National Science Council (NSC 100-2628-B-182-001-MY3), Taipei Veterans General Hospital (V103B-029), and Chang Gung Memorial Hospital (CMRPG3C1381, CMRPD1D0281), Taiwan. The funders had no role in study design, data collection and analysis, decision	Aikawa N, 2011, PULM PHARMACOL THER, V24, P549, DOI 10.1016/j.pupt.2011.03.001; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chang HL, 2008, EUR J PHARMACOL, V586, P332, DOI 10.1016/j.ejphar.2008.02.041; Chen CY, 2014, FREE RADICAL BIO MED, V72, P222, DOI 10.1016/j.freeradbiomed.2014.04.018; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen YH, 2011, MAR DRUGS, V9, P934, DOI 10.3390/md9060934; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fumagalli L, 2013, J IMMUNOL, V190, P3648, DOI 10.4049/jimmunol.1201951; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Hwang TL, 2012, TOXICOL APPL PHARM, V260, P193, DOI 10.1016/j.taap.2012.02.011; Hwang TL, 2010, BIOCHEM PHARMACOL, V80, P1190, DOI 10.1016/j.bcp.2010.06.028; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kovach MA, 2012, CURR OPIN INFECT DIS, V25, P321, DOI 10.1097/QCO.0b013e3283528c9b; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P430, DOI 10.1038/nri3703; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McNamara CE, 2005, J NAT PROD, V68, P1431, DOI 10.1021/np050171n; Menezes GB, 2011, PHARMACOL THERAPEUT, V132, P204, DOI 10.1016/j.pharmthera.2011.07.002; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pearce AN, 2007, J NAT PROD, V70, P936, DOI 10.1021/np060626o; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Rupesh KR, 2012, TOXICOL IN VITRO, V26, P571, DOI 10.1016/j.tiv.2012.01.023; Sansom CE, 2007, J NAT PROD, V70, P2042, DOI 10.1021/np070436t; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Simard JC, 2010, J LEUKOCYTE BIOL, V87, P905, DOI 10.1189/jlb.1009676; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sung PJ, 2004, CHEM PHARM BULL, V52, P1504, DOI 10.1248/cpb.52.1504; Taori K, 2007, J NAT PROD, V70, P1593, DOI 10.1021/np0702436; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Verhein KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075351; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vinothkumar S, 2013, BIOTECHNOL ADV, V31, P1826, DOI 10.1016/j.biotechadv.2013.02.006; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wei WC, 2013, MAR DRUGS, V11, P4083, DOI 10.3390/md11104083; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yang SC, 2013, MOLECULES, V18, P6455, DOI 10.3390/molecules18066455; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41; Ye SH, 2012, CARBOHYD POLYM, V87, P764, DOI 10.1016/j.carbpol.2011.08.057; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2009, BIOCHEM PHARMACOL, V78, P983, DOI 10.1016/j.bcp.2009.06.008; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	58	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114761	10.1371/journal.pone.0114761	http://dx.doi.org/10.1371/journal.pone.0114761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474595	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500055
J	Delley, CL; Laederach, J; Ziemski, M; Bolten, M; Boehringer, D; Weber-Ban, E				Delley, Cyrille L.; Laederach, Juerg; Ziemski, Michal; Bolten, Marcel; Boehringer, Daniel; Weber-Ban, Eilika			Bacterial Proteasome Activator Bpa (Rv3780) Is a Novel Ring-Shaped Interactor of the Mycobacterial Proteasome	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; UBIQUITIN-LIKE PROTEIN; WEB-SERVER; COMPLEX; TUBERCULOSIS; DEGRADATION; PATHWAY; ATPASE; PUPYLATION; BINDING	The occurrence of the proteasome in bacteria is limited to the phylum of actinobacteria, where it is maintained in parallel to the usual bacterial compartmentalizing proteases. The role it plays in these organisms is still not fully understood, but in the human pathogen Mycobacterium tuberculosis (Mtb) the proteasome supports persistence in the host. In complex with the ring-shaped ATPase Mpa (called ARC in other actinobacteria), the proteasome can degrade proteins that have been post-translationally modified with the prokaryotic ubiquitin-like protein Pup. Unlike for the eukaryotic proteasome core particle, no other bacterial proteasome interactors have been identified to date. Here we describe and characterize a novel bacterial proteasome activator of Mycobacterium tuberculosis we termed Bpa (Rv3780), using a combination of biochemical and biophysical methods. Bpa features a canonical C-terminal proteasome interaction motif referred to as the HbYX motif, and its orthologs are only found in those actinobacteria encoding the proteasomal subunits. Bpa can inhibit degradation of Pup-tagged substrates in vitro by competing with Mpa for association with the proteasome. Using negative-stain electron microscopy, we show that Bpa forms a ring-shaped homooligomer that can bind coaxially to the face of the proteasome cylinder. Interestingly, Bpa can stimulate the proteasomal degradation of the model substrate beta-casein, which suggests it could play a role in the removal of non-native or damaged proteins.	[Delley, Cyrille L.; Laederach, Juerg; Ziemski, Michal; Bolten, Marcel; Boehringer, Daniel; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Laederach, Juerg/0000-0003-0726-1070; Ziemski, Michal/0000-0001-6285-8852; Bolten, Marcel/0000-0002-3808-2481; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation [31003A_141236]; ETH Research Grant [ETH-13 11-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Research Grant	This work was supported by the Swiss National Science Foundation Grant 31003A_141236 to EWB (http://www.snf.ch/en/Pages/default.aspx), and this work was supported by ETH Research Grant ETH-13 11-2 to EWB (https://www.ethz.ch/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anandan T, 2014, J MICROBIOL, V52, P743, DOI 10.1007/s12275-014-4416-2; Barandun J, 2013, J AM CHEM SOC, V135, P6794, DOI 10.1021/ja4024012; Barandun J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-95; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; BENOIST P, 1992, J BACTERIOL, V174, P1495, DOI 10.1128/jb.174.5.1495-1504.1992; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Elharar Y, 2014, EMBO J, V33, P1802, DOI 10.15252/embj.201387076; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Hill CP, 2002, CURR TOP MICROBIOL, V268, P73; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; MA CP, 1994, J BIOL CHEM, V269, P3539; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Miller JH., 1972, EXPT MOL GENETICS; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zuhl F, 1997, FEBS LETT, V418, P189, DOI 10.1016/S0014-5793(97)01370-7	47	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114348	10.1371/journal.pone.0114348	http://dx.doi.org/10.1371/journal.pone.0114348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469515	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700102
J	Gokce, SK; Guo, SX; Ghorashian, N; Everett, WN; Jarrell, T; Kottek, A; Bovik, AC; Ben-Yakar, A				Gokce, Sertan Kutal; Guo, Samuel X.; Ghorashian, Navid; Everett, W. Neil; Jarrell, Travis; Kottek, Aubri; Bovik, Alan C.; Ben-Yakar, Adela			A Fully Automated Microfluidic Femtosecond Laser Axotomy Platform for Nerve Regeneration Studies in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MANIPULATION; BEHAVIOR; NEUROSURGERY; NANOSURGERY; MECHANISMS; MICROSCOPY; RECOVERY; NEURONS; PROTEIN	Femtosecond laser nanosurgery has been widely accepted as an axonal injury model, enabling nerve regeneration studies in the small model organism, Caenorhabditis elegans. To overcome the time limitations of manual worm handling techniques, automation and new immobilization technologies must be adopted to improve throughput in these studies. While new microfluidic immobilization techniques have been developed that promise to reduce the time required for axotomies, there is a need for automated procedures to minimize the required amount of human intervention and accelerate the axotomy processes crucial for high-throughput. Here, we report a fully automated microfluidic platform for performing laser axotomies of fluorescently tagged neurons in living Caenorhabditis elegans. The presented automation process reduces the time required to perform axotomies within individual worms to similar to 17 s/worm, at least one order of magnitude faster than manual approaches. The full automation is achieved with a unique chip design and an operation sequence that is fully computer controlled and synchronized with efficient and accurate image processing algorithms. The microfluidic device includes a T-shaped architecture and three-dimensional microfluidic interconnects to serially transport, position, and immobilize worms. The image processing algorithms can identify and precisely position axons targeted for ablation. There were no statistically significant differences observed in reconnection probabilities between axotomies carried out with the automated system and those performed manually with anesthetics. The overall success rate of automated axotomies was 67.4 +/- 3.2% of the cases (236/350) at an average processing rate of 17.0 +/- 2.4 s. This fully automated platform establishes a promising methodology for prospective genome-wide screening of nerve regeneration in C. elegans in a truly high-throughput manner.	[Gokce, Sertan Kutal; Bovik, Alan C.; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78712 USA; [Guo, Samuel X.; Ghorashian, Navid; Everett, W. Neil; Jarrell, Travis; Kottek, Aubri; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78705 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ben-Yakar, A (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	ben-yakar@mail.utexas.edu	Everett, William Neil/AAE-2101-2021; Bovik, Alan/B-6717-2012	Bovik, Alan/0000-0001-6067-710X; Kottek, Aubri/0000-0002-8625-2326; Ghorashian, Navid/0000-0002-5783-4933	National Institutes of Health (NIH) [R01 AG041135, R21 NS067340, R21 NS058646]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058646, R21NS067340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041135] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The authors would like to thank the National Institutes of Health (NIH) (www.nih.gov) for its generous support of this research. Specifically, the grants that made this work possible are the NIH Director's Transformative Award (NIH R01 AG041135), NIH R21 NS067340, and NIH R21 NS058646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 2008, J NEUROSCI METH, V173, P20, DOI 10.1016/j.jneumeth.2008.05.007; Altun ZF, 2009, INTRO WORM ATLAS; AVERY L, 1993, GENETICS, V133, P897; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Ben-Yakar A, 2009, CURR OPIN BIOTECH, V20, P100, DOI 10.1016/j.copbio.2009.01.008; Bourgeois F, 2007, OPT EXPRESS, V15, P8521, DOI 10.1364/OE.15.008521; Bovik A, 2009, ESSENTIAL GUIDE TO VIDEO PROCESSING, 2ND EDITION, P1; Britt JM, 2010, J NEUROPHYSIOL, V104, P695, DOI 10.1152/jn.01051.2009; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen LZ, 2011, TRENDS CELL BIOL, V21, P577, DOI 10.1016/j.tcb.2011.08.003; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chuang HS, 2011, LAB CHIP, V11, P599, DOI 10.1039/c0lc00532k; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Chung K, 2009, LAB CHIP, V9, P2764, DOI 10.1039/b910703g; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Di Carlo D, 2008, ANAL CHEM, V80, P2204, DOI 10.1021/ac702283m; Ding XY, 2012, P NATL ACAD SCI USA, V109, P11105, DOI 10.1073/pnas.1209288109; Ducic I, 2012, ANN PLAS SURG, V68, P180, DOI 10.1097/SAP.0b013e3182361b23; El Bejjani R, 2012, ANNU REV GENET, V46, P499, DOI 10.1146/annurev-genet-110711-155550; Ghorashian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074480; GROEN FCA, 1985, CYTOMETRY, V6, P81, DOI 10.1002/cyto.990060202; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Krajniak J, 2013, LAB CHIP, V13, P2963, DOI 10.1039/c3lc50300c; Lange D, 2005, SENSOR ACTUAT B-CHEM, V107, P904, DOI 10.1016/j.snb.2004.12.039; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; Neumann B, 2011, DEV DYNAM, V240, P1365, DOI 10.1002/dvdy.22606; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Rohde CB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1266; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	38	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113917	10.1371/journal.pone.0113917	http://dx.doi.org/10.1371/journal.pone.0113917			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470130	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700052
J	Li, S; Wei, Z; Chen, J; Chen, YH; Lv, ZB; Yu, W; Meng, QH; Jin, YF				Li, Si; Wei, Zhen; Chen, Jian; Chen, Yanhong; Lv, Zhengbing; Yu, Wei; Meng, Qiaohong; Jin, Yongfeng			Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-beta Peptide Produced in Silkworm Pupae Protects against Alzheimer's Disease in Mice	PLOS ONE			English	Article							BOMBYX-MORI; MOUSE MODEL; GM-CSF; VACCINE; SYSTEM; IMMUNOTHERAPY; IMMUNIZATION; BURDEN; SAFETY; CELLS	A key molecule in the pathogenesis of Alzheimer's disease (AD) is a 42-amino acid isoform of the amyloid-beta peptide (A beta 42), which is the most toxic element of senile plaques. In this study, to develop an edible, safe, low-cost vaccine for AD, a cholera toxin B subunit (CTB)-A beta 42 fusion protein was successfully expressed in silkworm pupae. We tested the silkworm pupae-derived oral vaccination containing CTB-A beta 42 in a transgenic mouse model of AD. Anti-A beta 42 antibodies were induced in these mice, leading to a decreased A beta deposition in the brain. We also found that the oral administration of the silk worm pupae vaccine improved the memory and cognition of mice, as assessed using a water maze test. These results suggest that the new edible CTB-A beta 42 silkworm pupae-derived vaccine has potential clinical application in the prevention of AD.	[Li, Si; Jin, Yongfeng] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Si; Chen, Jian; Lv, Zhengbing; Yu, Wei] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Wei, Zhen; Chen, Yanhong] Zhejiang Univ, Lab Anim Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Meng, Qiaohong] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Sci-Tech University; Zhejiang University; Hangzhou Normal University	Jin, YF (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	jinyf@zju.edu.cn			Natural Science Foundation of Zhejiang Province [Y3110354]; National High Technology Research and Development Programs of China [2012ZX09102301-009, 2011AA100603]; Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Education Department of Zhejiang Province [Z201018783, Y200909617]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National High Technology Research and Development Programs of China(National High Technology Research and Development Program of China); Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Education Department of Zhejiang Province	Funding: This work was financially supported by research grants from the Natural Science Foundation of Zhejiang Province (Y3110354), National High Technology Research and Development Programs of China (2012ZX09102301-009, 2011AA100603), the Open Fund of Zhejiang Provincial Top Key Discipline of Biology, and the Project of Education Department of Zhejiang Province (Z201018783, Y200909617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2001, DNA CELL BIOL, V20, P737, DOI 10.1089/10445490152717604; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; Chen J, 2006, J BIOTECHNOL, V123, P236, DOI 10.1016/j.jbiotec.2005.11.015; DaSilva KA, 2006, NEUROBIOL DIS, V23, P433, DOI 10.1016/j.nbd.2006.03.013; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Ghochikyan A, 2006, DNA CELL BIOL, V25, P571, DOI 10.1089/dna.2006.25.571; Gong ZH, 2005, J BIOTECHNOL, V119, P93, DOI 10.1016/j.jbiotec.2005.05.027; HERRINGTON DA, 1992, VACCINE, V10, P841, DOI 10.1016/0264-410X(92)90047-N; Ishii-Katsuno R, 2010, BIOCHEM BIOPH RES CO, V399, P593, DOI 10.1016/j.bbrc.2010.07.120; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kim HD, 2007, IMMUNOL LETT, V112, P30, DOI 10.1016/j.imlet.2007.06.006; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Maier M, 2005, VACCINE, V23, P5149, DOI 10.1016/j.vaccine.2005.06.018; [倪红 Ni Hong], 2003, [湖北大学学报. 自然科学版, Journal of Hubei University.Natural Science Edition], V25, P263; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nojima J, 2011, VACCINE, V29, P6252, DOI 10.1016/j.vaccine.2011.06.073; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Schenk D, 2001, J MOL NEUROSCI, V17, P259, DOI 10.1385/JMN:17:2:259; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sigurdsson EM, 2002, NEUROBIOL AGING, V23, P1001, DOI 10.1016/S0197-4580(02)00124-0; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; WOOGEN SD, 1993, J IMMUNOL, V150, P3274; Zhang JM, 2003, NEUROBIOL DIS, V14, P365, DOI 10.1016/j.nbd.2003.07.005; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	29	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113585	10.1371/journal.pone.0113585	http://dx.doi.org/10.1371/journal.pone.0113585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469702	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700034
J	Sahini, N; Selvaraj, S; Borlak, J				Sahini, Nishika; Selvaraj, Saravanakumar; Borlak, Juergen			Whole Genome Transcript Profiling of Drug Induced Steatosis in Rats Reveals a Gene Signature Predictive of Outcome	PLOS ONE			English	Article							ACID-BINDING PROTEIN; POLYCHLORINATED-BIPHENYLS PCBS; RECEPTOR-DEFICIENT MICE; HEPATIC STEATOSIS; FATTY LIVER; DOWN-REGULATION; INDUCED PHOSPHOLIPIDOSIS; PLASMA-LIPOPROTEINS; GLUCOSE-TOLERANCE; CELLULAR UPTAKE	Drug induced steatosis (DIS) is characterised by excess triglyceride accumulation in the form of lipid droplets (LD) in liver cells. To explore mechanisms underlying DIS we interrogated the publically available microarray data from the Japanese Toxicogenomics Project (TGP) to study comprehensively whole genome gene expression changes in the liver of treated rats. For this purpose a total of 17 and 12 drugs which are diverse in molecular structure and mode of action were considered based on their ability to cause either steatosis or phospholipidosis, respectively, while 7 drugs served as negative controls. In our efforts we focused on 200 genes which are considered to be mechanistically relevant in the process of lipid droplet biogenesis in hepatocytes as recently published (Sahini and Borlak, 2014). Based on mechanistic considerations we identified 19 genes which displayed dose dependent responses while 10 genes showed time dependency. Importantly, the present study defined 9 genes (ANGPTL4, FABP7, FADS1, FGF21, GOT1, LDLR, GK, STAT3, and PKLR) as signature genes to predict DIS. Moreover, cross tabulation revealed 9 genes to be regulated >= 10 times amongst the various conditions and included genes linked to glucose metabolism, lipid transport and lipogenesis as well as signalling events. Additionally, a comparison between drugs causing phospholipidosis and/or steatosis revealed 26 genes to be regulated in common including 4 signature genes to predict DIS (PKLR, GK, FABP7 and FADS1). Furthermore, a comparison between in vivo single dose (3, 6, 9 and 24 h) and findings from rat hepatocyte studies (2 h, 8 h, 24 h) identified 10 genes which are regulated in common and contained 2 DIS signature genes (FABP7, FGF21). Altogether, our studies provide comprehensive information on mechanistically linked gene expression changes of a range of drugs causing steatosis and phospholipidosis and encourage the screening of DIS signature genes at the preclinical stage.	[Sahini, Nishika; Selvaraj, Saravanakumar; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany.	borlak.juergen@mh-hannover.de			Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [031 6154]; Deutsche Forschungsgemeinschaft; DFG	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We gratefully acknowledge support from The Virtual Liver Network (grant 031 6154) of the German Federal Ministry of Education and Research (BMBF). We also acknowledge support by Deutsche Forschungsgemeinschaft; the charge for this publication was covered by the DFG sponsorship "open access publication." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, MOL NUTR FOOD RES, V56, P1665, DOI 10.1002/mnfr.201200182; Amacher DE, 2014, SEMIN LIVER DIS, V34, P205, DOI 10.1055/s-0034-1375960; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Antherieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; BENNETT E, 1994, J NEUROCHEM, V63, P1616; Bjornsson ES, 2013, GASTROENTEROLOGY, V144, P1419, DOI 10.1053/j.gastro.2013.02.006; BORLAKOGLU JT, 1990, BIOCHEM PHARMACOL, V40, P273, DOI 10.1016/0006-2952(90)90688-H; BORLAKOGLU JT, 1990, BIOCHEM PHARMACOL, V40, P265, DOI 10.1016/0006-2952(90)90687-G; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hirode M, 2008, TOXICOL APPL PHARM, V229, P290, DOI 10.1016/j.taap.2008.01.036; Holmgren G, 2014, DRUG METAB DISPOS, V42, P1401, DOI 10.1124/dmd.114.059154; Jiang S, 2014, J BIOL CHEM IN PRESS; Jozefczuk J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00339; Kawano Y, 2010, ARCH BIOCHEM BIOPHYS, V504, P221, DOI 10.1016/j.abb.2010.09.001; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kuo TY, 2014, J LIPID RES, V55, P919, DOI 10.1194/jlr.M047860; Lomonaco R, 2011, THER ADV ENDOCRINOL, V2, P211, DOI 10.1177/2042018811419157; Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012; Massart J, 2013, CURR PATHOBIOL REP, V1, P147, DOI DOI 10.1007/s40139-013-0022-y; Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Obert LA, 2007, TOXICOL PATHOL, V35, P728, DOI 10.1080/01926230701481956; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; Park S, 2012, J TOXICOL SCI, V37, P261, DOI 10.2131/jts.37.261; Persico M, 2010, WORLD J GASTROENTERO, V16, P1171, DOI 10.3748/wjg.v16.i10.1171; Portois L, 2012, INT J MOL MED, V29, P1121, DOI 10.3892/ijmm.2012.943; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Shimizu F, 1997, BBA-GENE STRUCT EXPR, V1354, P24, DOI 10.1016/S0167-4781(97)00115-2; Spener F, 2006, EUR J LIPID SCI TECH, V108, P625, DOI 10.1002/ejlt.200690056; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Takashima K, 2006, LIFE SCI, V78, P2787, DOI 10.1016/j.lfs.2005.11.010; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Donato MT, 2012, CURR DRUG METAB, V13, P1160; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Vassiliadis E, 2012, AM J TRANSL RES, V4, P403; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang L, 2014, HEPATOLOGY IN PRESS; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yachi R, 2010, J CLIN BIOCHEM NUTR, V47, P148, DOI 10.3164/jcbn.10-35; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang Y, 2012, BIOCHEM CELL BIOL, V90, P548, DOI [10.1139/O2012-012, 10.1139/o2012-012]	53	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114085	10.1371/journal.pone.0114085	http://dx.doi.org/10.1371/journal.pone.0114085			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470483	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700069
J	Zhang, B; Roh, YS; Liang, S; Liu, C; Naiki, M; Masuda, K; Seki, E				Zhang, Bi; Roh, Yoon Seok; Liang, Shuang; Liu, Cheng; Naiki, Mitsuru; Masuda, Koichi; Seki, Ekihiro			Neurotropin Suppresses Inflammatory Cytokine Expression and Cell Death through Suppression of NF-kappa B and JNK in Hepatocytes	PLOS ONE			English	Article							INDUCED NEUROPATHY; RAT MODEL; LIVER; ACTIVATION; FIBROSIS; HYPERNOCICEPTION; MICE	Inflammatory response and cell death in hepatocytes are hallmarks of chronic liver disease, and, therefore, can be effective therapeutic targets. Neurotropin (R) (NTP) is a drug widely used in Japan and China to treat chronic pain. Although NTP has been demonstrated to suppress chronic pain through the descending pain inhibitory system, the action mechanism of NTP remains elusive. We hypothesize that NTP functions to suppress inflammatory pathways, thereby attenuating disease progression. In the present study, we investigated whether NTP suppresses inflammatory signaling and cell death pathways induced by interleukin-1 beta (IL-1b) and tumor necrosis factor-alpha (TNF alpha) in hepatocytes. NTP suppressed nuclear factor-kappa B (NF-kappa B) activation induced by IL-1 beta and TNF alpha assessed by using hepatocytes isolated from NF-kappa B-green fluorescent protein (GFP) reporter mice and an NF-kappa B-luciferase reporter system. The expression of NF-kappa B target genes, II6, Nos2, Cxcl1, ccl5 and Cxcl2 induced by IL-1 beta and TNF alpha was suppressed after NTP treatment. We also found that NTP suppressed the JNK phosphorylation induced by IL-1 beta and TNF alpha. Because JNK activation contributes to hepatocyte death, we determined that NTP treatment suppressed hepatocyte death induced by IL-1 beta and TNF alpha in combination with actinomycin D. Taken together, our data demonstrate that NTP attenuates IL-1 beta and TNF alpha-mediated inflammatory cytokine expression and cell death in hepatocytes through the suppression of NF-kappa B and JNK. The results from the present study suggest that NTP may become a preventive or therapeutic strategy for alcoholic and non-alcoholic fatty liver disease in which NF-kappa B and JNK are thought to take part.	[Zhang, Bi; Roh, Yoon Seok; Liang, Shuang; Liu, Cheng; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Masuda, Koichi] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Naiki, Mitsuru] Nippon Zoki Pharmaceut Co Ltd, Inst Bioact Sci, Dept Pharmacol Res, Kato, Hyogo, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Seki, E (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	ekseki@ucsd.edu	Liu, Cheng/I-3979-2015; Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085	Nippon Zoki Pharmaceutical Company Ltd	Nippon Zoki Pharmaceutical Company Ltd	Research grant from Nippon Zoki Pharmaceutical Company Ltd. The funder provided support in the form of a salary for author MN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Cunha TM, 2008, EUR J PAIN, V12, P1059, DOI 10.1016/j.ejpain.2008.02.003; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Isonaka R, 2013, NEUROSCI LETT, V543, P101, DOI 10.1016/j.neulet.2013.03.051; Kamo A, 2013, CLIN EXP DERMATOL, V38, P665, DOI 10.1111/ced.12100; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Kawashiri T, 2009, EUR J CANCER, V45, P154, DOI 10.1016/j.ejca.2008.10.004; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Kudo T, 2011, NEUROSCI LETT, V503, P20, DOI 10.1016/j.neulet.2011.07.056; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Masuguchi K, 2014, LIFE SCI, V98, P49, DOI 10.1016/j.lfs.2013.12.229; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039; Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Roh YS, 2014, J GASTROENTEROL, V49, P185, DOI 10.1007/s00535-013-0931-x; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Starr SP, 2011, AM FAM PHYSICIAN, V84, P1353; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Suzuki T, 2005, ANESTH ANALG, V101, P793, DOI 10.1213/01.ANE.0000160582.25368.B9; Takayasu K, 2007, JPN J CLIN ONCOL, V37, P233, DOI 10.1093/jjco/hym012; Toda K, 1998, LIFE SCI, V62, P913, DOI 10.1016/S0024-3205(98)00009-5; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056	26	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114071	10.1371/journal.pone.0114071	http://dx.doi.org/10.1371/journal.pone.0114071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470242	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700067
J	Zheng, ZF; Shi, HL; Zhang, J; Zhang, YT				Zheng, Zhenfeng; Shi, Huilan; Zhang, Jing; Zhang, Yunting			Renal Water Molecular Diffusion Characteristics in Healthy Native Kidneys: Assessment with Diffusion Tensor MR Imaging	PLOS ONE			English	Article							SEX-DIFFERENCES; RECEPTOR; COEFFICIENT; EXPRESSION; ASYMMETRY; TRANSPORT; TISSUE; FLOW	Background: To explore the characteristics of diffusion tensor imaging (DTI) and magnetic resonance (MR) imaging in healthy native kidneys. Methods: Seventy-three patients without chronic kidney disease underwent DTI-MRI with spin echo-echo planar (SE-EPI) sequences accompanied by an array spatial sensitivity encoding technique (ASSET). Cortical and medullary mean, axial and radial diffusivity (MD, AD and RD), fractional anisotropy (FA) and primary, secondary and tertiary eigenvalues (lambda(1), lambda(2), lambda(3)) were analysed in both kidneys and in different genders. Results: Cortical MD, lambda(2), lambda(3), and RD values were higher than corresponding medullary values. The cortical FA value was lower than the medullary FA value. Medullary lambda(1) and RD values in the left kidney were lower than in the right kidney. Medullary lambda(2), and lambda(3) values in women were higher than those in men. Medullary FA values in women were lower than those in men. Medullary FA (r=0.351, P=0.002) and lambda(1) (r=0.277, P=0.018) positively correlated with eGFR. Medullary FA (r=20.25, P=0.033) negatively correlated with age. Conclusions: Renal water molecular diffusion differences exist in human kidneys and genders. Age and eGFR correlate with medullary FA and primary eigenvalue.	[Zheng, Zhenfeng] Tianjin Med Univ, Gen Hosp, Dept Nephrol, Tianjin, Peoples R China; [Shi, Huilan; Zhang, Jing; Zhang, Yunting] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Shi, HL (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	shihuilan@vip.126.com	zheng, zhenfeng/Q-5762-2019					Akkerman EM, 2003, MAGNET RESON MED, V49, P599, DOI 10.1002/mrm.10365; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brosnihan KB, 2008, EXP PHYSIOL, V93, P658, DOI 10.1113/expphysiol.2007.041806; Brown RD, 2012, HYPERTENSION, V59, P129, DOI 10.1161/HYPERTENSIONAHA.111.178715; CARALPS A, 1974, LANCET, V1, P534; Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155; DARMADY EM, 1973, J PATHOL, V109, P195, DOI 10.1002/path.1711090304; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Fliser D, 1996, NEPHROL DIAL TRANSPL, V11, P2; Fukuda Y, 2000, JMRI-J MAGN RESON IM, V11, P156, DOI 10.1002/(SICI)1522-2586(200002)11:2<156::AID-JMRI12>3.0.CO;2-8; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Knepper MA, 1997, AM J PHYSIOL-RENAL, V272, pF3, DOI 10.1152/ajprenal.1997.272.1.F3; Lerma EV, 2009, CLIN GERIATR MED, V25, P325, DOI 10.1016/j.cger.2009.06.007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu J, 2011, AM J PHYSIOL-RENAL, V300, pF433, DOI 10.1152/ajprenal.00199.2010; Liu X, 2014, NEURORADIOLOGY, V56, P497, DOI 10.1007/s00234-014-1342-2; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Meinild AK, 2000, AM J PHYSIOL-RENAL, V278, pF777, DOI 10.1152/ajprenal.2000.278.5.F777; Mose FH, 2013, CLIN EXP HYPERTENS, V35, P148, DOI 10.3109/10641963.2012.702835; MULLER MF, 1994, RADIOLOGY, V193, P711; Murtz P, 2002, RADIOLOGY, V224, P258, DOI 10.1148/radiol.2241011117; Namimoto T, 1999, JMRI-J MAGN RESON IM, V9, P832, DOI 10.1002/(SICI)1522-2586(199906)9:6<832::AID-JMRI10>3.0.CO;2-1; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Oh CK, 2006, TRANSPL P, V38, P1971, DOI 10.1016/j.transproceed.2006.06.022; PALLONE TL, 1990, PHYSIOL REV, V70, P885, DOI 10.1152/physrev.1990.70.3.885; Ries M, 2001, J MAGN RESON IMAGING, V14, P42, DOI 10.1002/jmri.1149; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sigmund EE, 2012, RADIOLOGY, V263, P758, DOI 10.1148/radiol.12111327; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Tan JC, 2010, KIDNEY INT, V78, P686, DOI 10.1038/ki.2010.128; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; van Onna M, 2003, HYPERTENSION, V41, P108, DOI 10.1161/01.HYP.0000050928.96979.A5	36	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113469	10.1371/journal.pone.0113469	http://dx.doi.org/10.1371/journal.pone.0113469			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470776	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700030
J	Avila-Moreno, F; Armas-Lopez, L; Alvarez-Moran, AM; Lopez-Bujanda, Z; Ortiz-Quintero, B; Hidalgo-Miranda, A; Urrea-Ramirez, F; Rivera-Rosales, RM; Vazquez-Manriquez, E; Pena-Mirabal, E; Morales-Gomez, J; Vazquez-Minero, JC; Tellez-Becerra, JL; Ramirez-Mendoza, R; Avalos-Bracho, A; de Alba, EG; Vazquez-Santillan, K; Maldonado-Lagunas, V; Santillan-Doherty, P; Pina-Sanchez, P; Zuniga-Ramos, J				Avila-Moreno, Federico; Armas-Lopez, Leonel; Alvarez-Moran, Aldo M.; Lopez-Bujanda, Zoila; Ortiz-Quintero, Blanca; Hidalgo-Miranda, Alfredo; Urrea-Ramirez, Francisco; Maria Rivera-Rosales, R.; Vazquez-Manriquez, Eugenia; Pena-Mirabal, Erika; Morales-Gomez, Jose; Vazquez-Minero, Juan C.; Tellez-Becerra, Jose L.; Ramirez-Mendoza, Roberto; Avalos-Bracho, Alejandro; Guzman de Alba, Enrique; Vazquez-Santillan, Karla; Maldonado-Lagunas, Vilma; Santillan-Doherty, Patricio; Pina-Sanchez, Patricia; Zuniga-Ramos, Joaquin			Overexpression of MEOX2 and TWIST1 Is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis	PLOS ONE			English	Article							DNA METHYLATION MARKERS; SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; IDENTIFICATION; STATISTICS; LINE; ADENOCARCINOMA; AMPLIFICATION; TRANSCRIPTION; CHROMOSOME-7	Lung cancer is the leading cause of death from malignant diseases worldwide, with the non-small cell (NSCLC) subtype accounting for the majority of cases. NSCLC is characterized by frequent genomic imbalances and copy number variations (CNVs), but the epigenetic aberrations that are associated with clinical prognosis and therapeutic failure remain not completely identify. In the present study, a total of 55 lung cancer patients were included and we conducted genomic and genetic expression analyses, immunohistochemical protein detection, DNA methylation and chromatin immunoprecipitation assays to obtain genetic and epigenetic profiles associated to prognosis and chemoresponse of NSCLC patients. Finally, siRNA transfection-mediated genetic silencing and cisplatinum cellular cytotoxicity assays in NSCLC cell lines A-427 and INER-37 were assessed to describe chemoresistance mechanisms involved. Our results identified high frequencies of CNVs (66-51% of cases) in the 7p22.3-p21.1 and 7p15.3-p15.2 cytogenetic regions. However, overexpression of genes, such as MEOX2, HDAC9, TWIST1 and AhR, at 7p21.2-p21.1 locus occurred despite the absence of CNVs and little changes in DNA methylation. In contrast, the promoter sequences of MEOX2 and TWIST1 displayed significantly lower/decrease in the repressive histone mark H3K27me3 and increased in the active histone mark H3K4me3 levels. Finally these results correlate with poor survival in NSCLC patients and cellular chemoresistance to oncologic drugs in NSCLC cell lines in a MEOX2 and TWIST1 overexpression dependent-manner. In conclusion, we report for the first time that MEOX2 participates in chemoresistance irrespective of high CNV, but it is significantly dependent upon H3K27me3 enrichment probably associated with aggressiveness and chemotherapy failure in NSCLC patients, however additional clinical studies must be performed to confirm our findings as new probable clinical markers in NSCLC patients.	[Avila-Moreno, Federico; Armas-Lopez, Leonel; Lopez-Bujanda, Zoila; Ramirez-Mendoza, Roberto] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Biomed Res Unit UBIMED, Tlalnepantla, Mexico State, Mexico; [Avila-Moreno, Federico; Alvarez-Moran, Aldo M.; Lopez-Bujanda, Zoila; Ortiz-Quintero, Blanca; Urrea-Ramirez, Francisco; Maria Rivera-Rosales, R.; Vazquez-Manriquez, Eugenia; Pena-Mirabal, Erika; Morales-Gomez, Jose; Vazquez-Minero, Juan C.; Tellez-Becerra, Jose L.; Avalos-Bracho, Alejandro; Guzman de Alba, Enrique; Santillan-Doherty, Patricio; Zuniga-Ramos, Joaquin] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Lopez-Bujanda, Zoila] Johns Hopkins Univ, Inst Med, Baltimore, MD USA; [Hidalgo-Miranda, Alfredo; Vazquez-Santillan, Karla; Maldonado-Lagunas, Vilma] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Pina-Sanchez, Patricia] Ctr Med Nacl, Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Oncol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Johns Hopkins University; Instituto Nacional de Medicina Genomica; Instituto Mexicano del Seguro Social	Avila-Moreno, F (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Biomed Res Unit UBIMED, Canc Epigen Lab 12, Tlalnepantla, Mexico State, Mexico.	avilamore@hotmail.com	Hidalgo-Miranda, Alfredo/B-2123-2010; Vazquez, Karla/ABG-7256-2020	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Vazquez, Karla/0000-0003-1380-2494; Zuniga, Joaquin/0000-0002-7143-0281; Lopez Bujanda, Zoila/0000-0001-5729-7309; ortiz, blanca/0000-0001-6298-0073; Armas Lopez, Leonel/0000-0001-9490-4294	National Council of Science and Technology (CONACyT) [0053643]; Research Direction of the National Institute of Respiratory Diseases (INER); National Autonomous University of Mexico, UNAM [IACOD-PAPIIT IA201611, PAPIIT IB202512, PAPIIT RR282512]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Research Direction of the National Institute of Respiratory Diseases (INER); National Autonomous University of Mexico, UNAM(Universidad Nacional Autonoma de Mexico)	FAM author was supported by the National Council of Science and Technology (CONACyT), Funds for Research in Basic Science, Project 0053643; Research Direction of the National Institute of Respiratory Diseases (INER); and the National Autonomous University of Mexico, UNAM, Projects IACOD-PAPIIT IA201611, PAPIIT IB202512 and PAPIIT RR282512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Castillo SD, 2010, J PATHOL, V222, P89, DOI 10.1002/path.2732; Cortese R, 2008, INT J BIOCHEM CELL B, V40, P1494, DOI 10.1016/j.biocel.2007.11.018; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; de Lucio B, 2005, CANCER SCI, V96, P774, DOI 10.1111/j.1349-7006.2005.00111.x; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Frullanti E, 2011, CLIN CANCER RES, V17, P2410, DOI 10.1158/1078-0432.CCR-10-2394; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Hoglund M, 2004, CANCER GENET CYTOGEN, V154, P99, DOI 10.1016/j.cancergencyto.2004.01.030; Irelan JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005067; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang W, 2012, CLIN LUNG CANCER, V13, P280, DOI 10.1016/j.cllc.2011.11.005; Kitada K, 2008, CANCER GENET CYTOGEN, V185, P11, DOI 10.1016/j.cancergencyto.2008.04.005; Kitada K, 2007, CANCER GENET CYTOGEN, V178, P120, DOI 10.1016/j.cancergencyto.2007.06.014; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Okudela K, 2014, INT J CLIN EXP PATHO, V7, P213; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Ponce de Leon Valeria, 2005, Cancer Cell Int, V5, P20; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Todd RC, 2010, CHEM BIOL, V17, P1334, DOI 10.1016/j.chembiol.2010.10.018; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Ubagai T, 2001, ONCOL REP, V8, P83; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020; Zhu KX, 2012, ONCOL REP, V27, P1027, DOI 10.3892/or.2012.1633	50	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114104	10.1371/journal.pone.0114104	http://dx.doi.org/10.1371/journal.pone.0114104			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460568	gold, Green Published			2022-12-27	WOS:000345869700099
J	Li, J; Shen, BX; Ma, C; Liu, L; Ren, L; Fang, YB; Dai, DW; Chen, SY; Lu, JP				Li, Jing; Shen, Bixia; Ma, Chao; Liu, Li; Ren, Li; Fang, Yibin; Dai, Dongwei; Chen, Shiyue; Lu, Jianping			3D Contrast Enhancement-MR Angiography for Imaging of Unruptured Cerebral Aneurysms: A Hospital-Based Prevalence Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TIME-OF-FLIGHT; INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; CT ANGIOGRAPHY; NEUROLOGIC COMPLICATIONS; INCIDENTAL FINDINGS; NATURAL-HISTORY; RISK-FACTORS; NEPHROPATHY	Background and Purpose: Contrast enhanced MRA (CE-MRA) can help to overcome the limitations of other techniques to clearly display the details of cerebral aneurysms at 1.5-T MR system. We investigated the prevalence of unruptured cerebral aneurysms (UCAs) using three dimensional (3D) CE-MRA in a tertiary comprehensive hospital in China. Materials and Methods: The cases were prospectively recorded at our hospital between February 2009 and October 2010. 3D CE-MRA, interpreted by 2 observers blinded to the participants' information, was used to identify the location and size of UCAs and to estimate the overall, age-specific, and sex-specific prevalence. Results: Of the 3993 patients (men: women=2159:1834), 408 UCAs were found in 350 patients (men: women=151:199). The prevalence was 8.8% overall (95% CI, 8.0-10.0%), with 7.0% for men (CI, 6.0-8.0%) and 10.9% for women (CI, 9.0-12.0%). The overall prevalence of UCAs was higher in women than in men (P<0.001) and increased with age both in men and women. Prevalence peaked at age group 75-80 years. Forty-two patients (11.7%) had multiple aneurysms, including 10 (2.9%) male patients and 32 (9.1%) female patients. The most common site of aneurysm was the carotid siphon, and most lesions (71.3%) had a maximum diameter of 3-5 mm. Conclusion: This hospital-based prevalence study suggested a high prevalence (8.8%) of UCAs and most lesions (71.3%) had a maximum diameter of 3-5 mm observed by 3D CE-MRA. Because the rupture of small cerebral aneurysms was not uncommon, an appropriate follow-up care strategy must be formulated.	[Li, Jing; Shen, Bixia; Ma, Chao; Liu, Li; Ren, Li; Chen, Shiyue; Lu, Jianping] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, Shanghai 200433, Peoples R China; [Fang, Yibin; Dai, Dongwei] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Neurosurg, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Lu, JP (corresponding author), Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, Shanghai 200433, Peoples R China.	cjr.lujianping@vip.163.com		Ma, Chao/0000-0002-2473-387X	National Key Technology R&D Program of China [2007BAI05B07]; Shanghai Changhai Hospital [CH125520800]	National Key Technology R&D Program of China(National Key Technology R&D Program); Shanghai Changhai Hospital	This work was supported by the National Key Technology R&D Program of China [2007BAI05B07]; 1255 Academic Discipline Project of Shanghai Changhai Hospital [CH125520800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.01.082; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; Burns JD, 2009, CURR NEUROL NEUROSCI, V9, P6, DOI 10.1007/s11910-009-0002-0; Cirillo M, 2013, EUR J RADIOL, V82, pE853, DOI 10.1016/j.ejrad.2013.08.052; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; HEISERMAN JE, 1994, AM J NEURORADIOL, V15, P1401; HIJDRA A, 1987, STROKE, V18, P1061, DOI 10.1161/01.STR.18.6.1061; Horikoshi T, 2002, NEUROL MED-CHIR, V42, P105, DOI 10.2176/nmc.42.105; Hunt CH, 2009, AM J ROENTGENOL, V193, P1124, DOI 10.2214/AJR.09.2520; Igase K, 2012, CEREBROVASC DIS, V33, P348, DOI 10.1159/000336015; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jayaraman MV, 2004, RADIOLOGY, V230, P510, DOI 10.1148/radiol.2302021465; Jeon TY, 2011, KOREAN J RADIOL, V12, P547, DOI 10.3348/kjr.2011.12.5.547; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Korogi Y, 1999, RADIOLOGY, V211, P497, DOI 10.1148/radiology.211.2.r99ma02497; KOROGI Y, 1994, RADIOLOGY, V193, P181, DOI 10.1148/radiology.193.1.8090889; Krings T, 2002, NEUROSCI LETT, V326, P46, DOI 10.1016/S0304-3940(02)00308-7; Leclerc X, 2002, AM J NEURORADIOL, V23, P1121; Li MH, 2014, RADIOLOGY, V271, P553, DOI 10.1148/radiol.14122770; Li MH, 2013, ANN INTERN MED, V159, P514, DOI 10.7326/0003-4819-159-8-201310150-00004; Metens T, 2000, RADIOLOGY, V216, P39, DOI 10.1148/radiology.216.1.r00jl1139; Nael K, 2008, AM J ROENTGENOL, V190, P389, DOI 10.2214/AJR.07.2297; Numminen J, 2011, ACTA RADIOL, V52, P670, DOI 10.1258/ar.2011.100421; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Polmear A, 2003, CEPHALALGIA, V23, P935, DOI 10.1046/j.1468-2982.2003.00596.x; Prokop M, 2003, EUR J RADIOL, V45, pS4, DOI 10.1016/S0720-048X(02)00358-3; Qu F, 2004, J NEUROSURG, V100, P244, DOI 10.3171/jns.2004.100.2.0244; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Solomon R, 2006, INVEST RADIOL, V41, P651, DOI 10.1097/01.rli.0000229742.54589.7b; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; WILCOCK DJ, 1995, CLIN RADIOL, V50, P526, DOI 10.1016/S0009-9260(05)83186-1; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071	44	13	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114157	10.1371/journal.pone.0114157	http://dx.doi.org/10.1371/journal.pone.0114157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463352	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700109
J	Marangon, M; Van Sluyter, SC; Waters, EJ; Menz, RI				Marangon, Matteo; Van Sluyter, Steven C.; Waters, Elizabeth J.; Menz, Robert I.			Structure of Haze Forming Proteins in White Wines: Vitis vinifera Thaumatin-Like Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MACROMOLECULAR CRYSTALLOGRAPHY; ANTIFUNGAL PROTEIN; ACID PROTEASE; STABILITY; WINEMAKING; CHITINASES; ACCUMULATE; RESOLUTION; REDUCTION	Grape thaumatin-like proteins (TLPs) play roles in plant-pathogen interactions and can cause protein haze in white wine unless removed prior to bottling. Different isoforms of TLPs have different hazing potential and aggregation behavior. Here we present the elucidation of the molecular structures of three grape TLPs that display different hazing potential. The three TLPs have very similar structures despite belonging to two different classes (F2/4JRU is a thaumatin-like protein while I/4L5H and H2/4MBT are VVTL1), and having different unfolding temperatures (56 vs. 62 degrees C), with protein F2/4JRU being heat unstable and forming haze, while I/4L5H does not. These differences in properties are attributable to the conformation of a single loop and the amino acid composition of its flanking regions.	[Marangon, Matteo; Van Sluyter, Steven C.; Waters, Elizabeth J.] Australian Wine Res Inst, Adelaide, SA, Australia; [Menz, Robert I.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Van Sluyter, Steven C.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	Australian Wine Research Institute; Flinders University South Australia; University of Melbourne	Menz, RI (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	ian.menz@flinders.edu.au	Marangon, Matteo/N-2430-2016	Marangon, Matteo/0000-0001-5358-2428	Australia's grapegrowers and winemakers; Australian Grape and Wine Authority; Australian Government; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Australia's grapegrowers and winemakers; Australian Grape and Wine Authority(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported financially by Australia's grapegrowers and winemakers through their investment body, the Australian Grape and Wine Authority, with matching funds from the Australian Government. The funder provided support in the form of salaries for author EJW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	BAKALINSKY AT, 1985, AM J ENOL VITICULT, V36, P23; Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BAYLY FRANCIS, 1967, AMER J ENOL VITICULT, V18, P18; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Charron C, 2004, ACTA CRYSTALLOGR D, V60, P83, DOI 10.1107/S0907444903022613; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dall'Antonia Y, 2005, ACTA CRYSTALLOGR F, V61, P186, DOI 10.1107/S1744309104033822; Dufrechou M, 2013, LANGMUIR, V29, P10475, DOI 10.1021/la401524w; Esteruelas M, 2009, FOOD CHEM, V113, P28, DOI 10.1016/j.foodchem.2008.07.031; Esti M, 2013, FOOD BIOPROD PROCESS, V91, P595, DOI 10.1016/j.fbp.2013.02.003; Falconer RJ, 2010, J AGR FOOD CHEM, V58, P975, DOI 10.1021/jf902843b; Ferreira RB, 2001, TRENDS FOOD SCI TECH, V12, P230, DOI 10.1016/S0924-2244(01)00080-2; Fukui M, 2003, AM J ENOL VITICULT, V54, P178; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gazzola D, 2012, J AGR FOOD CHEM, V60, P10666, DOI 10.1021/jf302916n; Ghosh R, 2008, PLANTA, V228, P883, DOI 10.1007/s00425-008-0790-5; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Kopec J, 2012, HIGH RESOLUTION STRU; LAGACE LS, 1990, AM J ENOL VITICULT, V41, P147; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Majewski P., 2011, Australian & New Zealand Grapegrower & Winemaker, P58; Marangon M, 2012, FOOD CHEM, V135, P1157, DOI 10.1016/j.foodchem.2012.05.042; Marangon M, 2011, J AGR FOOD CHEM, V59, P2652, DOI 10.1021/jf104334v; Marangon M, 2011, J AGR FOOD CHEM, V59, P733, DOI 10.1021/jf1038234; Marangon M, 2010, ANAL CHIM ACTA, V660, P110, DOI 10.1016/j.aca.2009.10.038; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Min K, 2004, PROTEINS, V54, P170, DOI 10.1002/prot.10571; Monteiro S, 2003, J AGR FOOD CHEM, V51, P4046, DOI 10.1021/jf020456v; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OGATA CM, 1992, J MOL BIOL, V228, P893, DOI 10.1016/0022-2836(92)90873-I; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pocock KF, 2006, AUST J GRAPE WINE R, V12, P212, DOI 10.1111/j.1755-0238.2006.tb00061.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sauvage FX, 2010, FOOD CHEM, V118, P26, DOI 10.1016/j.foodchem.2009.02.080; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Sluyter SC, 2013, J AGR FOOD CHEM, V61, P9705, DOI 10.1021/jf402762k; Van Sluyter SC, 2009, J AGR FOOD CHEM, V57, P11376, DOI 10.1021/jf902365r; Vincenzi S, 2005, AM J ENOL VITICULT, V56, P246; Vincenzi S, 2011, AUST J GRAPE WINE R, V17, P20, DOI 10.1111/j.1755-0238.2010.00113.x; Waters EJ, 2005, AUST J GRAPE WINE R, V11, P215, DOI 10.1111/j.1755-0238.2005.tb00289.x; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; WATERS EJ, 1992, J AGR FOOD CHEM, V40, P1514, DOI 10.1021/jf00021a008; WATERS EJ, 1991, AM J ENOL VITICULT, V42, P123; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	56	45	47	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113757	10.1371/journal.pone.0113757	http://dx.doi.org/10.1371/journal.pone.0113757			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463627	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700050
J	Ortin-Martinez, A; Valiente-Soriano, FJ; Garcia-Ayuso, D; Alarcon-Martinez, L; Jimenez-Lopez, M; Bernal-Garro, JM; Nieto-Lopez, L; Nadal-Nicolas, FM; Villegas-Perez, MP; Wheeler, LA; Vidal-Sanz, M				Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Wheeler, Larry A.; Vidal-Sanz, Manuel			A Novel In Vivo Model of Focal Light Emitting Diode-Induced Cone-Photoreceptor Phototoxicity: Neuroprotection Afforded by Brimonidine, BDNF, PEDF or bFGF	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPTICAL COHERENCE TOMOGRAPHY; FIBROBLAST-GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; EPITHELIUM-DERIVED FACTOR; ALBINO SWISS MICE; RAT RETINA; ADULT ALBINO; PIGMENT-EPITHELIUM; SPATIAL-DISTRIBUTION	We have investigated the effects of light-emitting diode (LED)-induced phototoxicity (LIP) on cone-photoreceptors and their protection with brimonidine (BMD), brain-derived neurotrophic factor (BDNF), pigment epithelium-derived factor (PEDF), ciliary neurotrophic factor (CNTF) or basic fibroblast growth factor (bFGF). In anesthetized, dark adapted, adult albino rats a blue (400 nm) LED was placed perpendicular to the cornea (10 sec, 200 lux) and the effects were investigated using Spectral Domain Optical Coherence Tomography (SD-OCT) and/or analysing the retina in oriented cross-sections or wholemounts immune-labelled for L-and S-opsin and counterstained with the nuclear stain DAPI. The effects of topical BMD (1%) or, intravitreally injected BDNF (5 mu g), PEDF (2 mu g), CNTF (0.4 mu g) or bFGF (1 mu g) after LIP were examined on wholemounts at 7 days. SD-OCT showed damage in a circular region of the superotemporal retina, whose diameter varied from 1,842.4 +/- 84.5 mu m (at 24 hours) to 1,407.7 +/- 52.8 mu m (at 7 days). This region had a progressive thickness diminution from 183.4 +/- 5 mu m (at 12 h) to 114.6 +/- 6 mu m (at 7 d). Oriented cross-sections showed within the light-damaged region of the retina massive loss of rods and cone-photoreceptors. Wholemounts documented a circular region containing lower numbers of L- and S-cones. Within a circular area (1 mm or 1.3 mm radius, respectively) in the left and in its corresponding region of the contralateral-fellow-retina, total L- or S-cones were 7,118 +/- 842 or 661 +/- 125 for the LED exposed retinas (n=7) and 14,040 +/- 1,860 or 2,255 +/- 193 for the fellow retinas (n=7), respectively. BMD, BDNF, PEDF and bFGF but not CNTF showed significant neuroprotective effects on L- or S-cones. We conclude that LIP results in rod and cone-photoreceptor loss, and is a reliable, quantifiable model to study cone-photoreceptor degeneration. Intravitreal BDNF, PEDF or bFGF, or topical BMD afford significant cone neuroprotection in this model.	[Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain; [Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel] Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia, Spain; [Wheeler, Larry A.] Zeteo Drug Discovery LLC, Irvine, CA USA	University of Murcia	Vidal-Sanz, M (corresponding author), Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain.	manuel.vidal@um.es	Valiente-Soriano, Francisco J./Z-4980-2019; Vidal-Sanz, Manuel/J-6989-2016; García-Ayuso, Diego/AAC-4954-2020	Vidal-Sanz, Manuel/0000-0002-9216-1615; García-Ayuso, Diego/0000-0002-7639-5366	Fundacion Seneca [04446/GERM/07]; Spanish Ministry of Economy and Competitiveness [SAF-2012-38328]; ISCIII-FEDER [PI10/01496, PI10/00187]; RETICS [RD07/0062/0001]; Allergan Sales LLC.	Fundacion Seneca(Fundacion Seneca); Spanish Ministry of Economy and Competitiveness(Spanish Government); ISCIII-FEDER(Spanish Government); RETICS; Allergan Sales LLC.(AbbVieAllergan)	This work was supported by Fundacion Seneca: 04446/GERM/07; Spanish Ministry of Economy and Competitiveness: SAF-2012-38328; ISCIII-FEDER: PI10/01496, PI10/00187; RETICS: RD07/0062/0001; and an unrestricted grant from Allergan Sales LLC. to MVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2002, EXP EYE RES, V74, P445, DOI 10.1006/exer.2001.1145; Arnault E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071398; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; BORGES JM, 1990, CURR EYE RES, V9, P799, DOI 10.3109/02713689008999576; Busch EM, 1999, VISION RES, V39, P1233, DOI 10.1016/S0042-6989(98)00233-8; Busch EM, 1999, EXP EYE RES, V68, P485, DOI 10.1006/exer.1998.0628; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Casson RJ, 2004, INVEST OPHTH VIS SCI, V45, P685, DOI 10.1167/iovs.03-0674; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gao H, 2002, ARCH OPHTHALMOL-CHIC, V120, P797; Garcia-Ayuso D, 2014, BRIT J OPHTHALMOL, V98, P396, DOI 10.1136/bjophthalmol-2013-303958; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Garcia-Ayuso D, 2011, MOL VIS, V17, P1716; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Glickman RD, 2002, INT J TOXICOL, V21, P473, DOI 10.1080/10915810290169909; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; Hojo M, 2004, INVEST OPHTH VIS SCI, V45, P3721, DOI 10.1167/iovs.04-0059; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Imai D, 2005, J CELL PHYSIOL, V202, P570, DOI 10.1002/jcp.20155; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Kano T, 2002, INVEST OPHTH VIS SCI, V43, P3744; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Kusari J, 2011, INVEST OPHTH VIS SCI, V52, P5424, DOI 10.1167/iovs.10-6262; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lambert WS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-4; LAVAIL MM, 1987, EXP EYE RES, V44, P877, DOI 10.1016/S0014-4835(87)80050-7; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LAVAIL MM, 1976, INVEST OPHTH VISUAL, V15, P64; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Lonngren U, 2006, BRAIN RES BULL, V71, P208, DOI 10.1016/j.brainresbull.2006.09.005; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marc RE, 2008, MOL VIS, V14, P782; Marco-Gomariz MA, 2006, J COMP NEUROL, V498, P163, DOI 10.1002/cne.21028; MASUDA K, 1995, INVEST OPHTH VIS SCI, V36, P2142; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Montalban-Soler L, 2012, MOL VIS, V18, P675; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Noell W K, 1966, Invest Ophthalmol, V5, P450; O'Driscoll C, 2008, J NEUROCHEM, V105, P524, DOI 10.1111/j.1471-4159.2007.05189.x; Okoye G, 2003, J NEUROSCI, V23, P4164; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Ortin-Martinez A, 2014, EXP EYE RES UNPUB; Ortin-Martinez A, 2014, IOVS, V55; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102392; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Paskowitz DM, 2007, INVEST OPHTH VIS SCI, V48, P430, DOI 10.1167/iovs.06-0690; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Peng M, 1998, INVEST OPHTH VIS SCI, V39, P1721; Peterson WM, 2000, J NEUROSCI, V20, P4081; Podoleanu AG, 2012, J MICROSC-OXFORD, V247, P209, DOI 10.1111/j.1365-2818.2012.03619.x; Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Reme CE, 2000, NEWS PHYSIOL SCI, V15, P120, DOI 10.1152/physiologyonline.2000.15.3.120; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Saylor M, 2009, ARCH OPHTHALMOL-CHIC, V127, P402, DOI 10.1001/archophthalmol.2009.9; Schnebelen C, 2009, GRAEF ARCH CLIN EXP, V247, P1191, DOI 10.1007/s00417-009-1094-6; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; SZEL A, 1992, EXP EYE RES, V55, P47; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tsukahara N, 2014, J VET MED SCI, V76, P93, DOI 10.1292/jvms.13-0293; Ueki Y, 2010, ADV EXP MED BIOL, V664, P655, DOI 10.1007/978-1-4419-1399-9_75; Valiente-Soriano FJ, 2014, IOVS, V55; Valiente-Soriano FJ, 2014, FRONT NEURO IN PRESS; VANNORREN D, 1990, VISION RES, V30, P1517, DOI 10.1016/0042-6989(90)90032-G; Vaughan DK, 2002, PHOTOCHEM PHOTOBIOL, V75, P547, DOI 10.1562/0031-8655(2002)075<0547:EFACRO>2.0.CO;2; Vidal-Sanz M, 2007, EYE, V21, pS42, DOI 10.1038/sj.eye.6702888; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wen R, 1996, J NEUROSCI, V16, P5986; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wen R, 2012, ADV EXP MED BIOL, V723, P93, DOI 10.1007/978-1-4614-0631-0_13; Wheeler L, 2003, SURV OPHTHALMOL, V48, pS47, DOI 10.1016/S0039-6257(03)00004-3; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285; Wilson RB, 2007, INVEST OPHTH VIS SCI, V48, P2877, DOI 10.1167/iovs.06-1079; Yang P, 2005, INVEST OPHTH VIS SCI, V46, P1755, DOI 10.1167/iovs.04-1039; Yang YP, 2014, INVEST OPHTH VIS SCI, V55, P1696, DOI 10.1167/iovs.13-12477	115	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113798	10.1371/journal.pone.0113798	http://dx.doi.org/10.1371/journal.pone.0113798			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464513	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700055
J	Lu, X; Long, Y; Lin, L; Sun, RZ; Zhong, S; Cui, ZB				Lu, Xing; Long, Yong; Lin, Li; Sun, Rongze; Zhong, Shan; Cui, Zongbin			Characterization of Zebrafish Abcc4 as an Efflux Transporter of Organochlorine Pesticides	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEINS; DICHLORODIPHENYLTRICHLOROETHANE DDT; DIGESTIVE GLAND; P-GLYCOPROTEIN; GLUTATHIONE; MRP; MRP4/ABCC4; LINDANE; GENE; TRANSFERASES	DDT and lindane are highly toxic organochlorine pesticides and posing adverse effects on the environment and public health due to their frequent usage in developing countries. ABCC4/MRP4 is an organic anion transporter that mediates cellular efflux of a wide range of exogenous and endogenous compounds such as cyclic nucleotides and anti-cancer drugs; however, it remains unclear whether ABCC4 and its orthologs function in the detoxification of organochlorine pesticides. Here, we demonstrated the roles of zebrafish Abcc4 in cellular efflux of DDT and lindane. Zebrafish abcc4 was maternally expressed in the oocytes and its transcripts were detected in the lens, pancreas, gills, liver, intestine and bladder of developing embryos and in adult tissues examined. DDT and lindane were able to induce the expression of abcc4 gene and overexpression of Abcc4 significantly decreased the cytotoxicity and accumulation of DDT and lindane in LLC-PK1 cells and developing embryos. In contrast, overexpression of an Abcc4-G1188D mutant abolished its transporter function without effects on its substrate binding activity, and sensitized LLC-PK1 cells and developing embryos to toxic pesticides. Moreover, glutathione (GSH) was involved in the efflux of cellular pesticides and ATPase activity in developing embryos can be induced by DDT or lindane. Thus, zebrafish Abcc4 plays crucial roles in cellular efflux of organochlorine pesticides and can be used a potential molecular marker for the monitor of DDT and lindane contamination in the aquatic environment.	[Lu, Xing; Lin, Li; Sun, Rongze; Zhong, Shan] Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Hubei, Peoples R China; [Long, Yong; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhong, S (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Hubei, Peoples R China.	zhongshan@whu.edu.cn; zbcui@ihb.ac.cn			National Natural Science Foundation of China [31172395]; Key Technologies Research and Development Program of China [2013BAI12B01-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (grant no. 31172395) and the Key Technologies Research and Development Program of China (grant no. 2013BAI12B01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali U, 2014, SCI TOTAL ENVIRON, V476, P705, DOI 10.1016/j.scitotenv.2013.12.107; Bai J, 2004, INT J BIOCHEM CELL B, V36, P247, DOI 10.1016/S1357-2725(03)00236-X; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Chopra AK, 2011, ENVIRON MONIT ASSESS, V173, P905, DOI 10.1007/s10661-010-1433-4; COLE SPC, 1994, CANCER RES, V54, P5902; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Della Torre C, 2012, CHEM-BIOL INTERACT, V198, P9, DOI 10.1016/j.cbi.2012.04.008; Doyotte A, 1997, AQUAT TOXICOL, V39, P93, DOI 10.1016/S0166-445X(97)00024-6; Juan ME, 2010, J NUTR, V140, P489, DOI 10.3945/jn.109.114959; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Fitzpatrick PJ, 1997, BIOMARKERS, V2, P51, DOI 10.1080/135475097231977; FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; Frias MM, 2001, J CHROMATOGR B, V760, P1; Furmanski BD, 2013, CLIN CANCER RES, V19, P4359, DOI 10.1158/1078-0432.CCR-13-0980; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Gu QL, 2013, J GENET GENOMICS, V40, P523, DOI 10.1016/j.jgg.2013.06.008; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; LAGADIC L, 1993, INSECT BIOCHEM MOLEC, V23, P467, DOI 10.1016/0965-1748(93)90054-V; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; LeDoux M, 2011, J CHROMATOGR A, V1218, P1021, DOI 10.1016/j.chroma.2010.12.097; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2011, MOL BIOL REP, V38, P1703, DOI 10.1007/s11033-010-0283-z; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P310, DOI 10.1016/j.cbpc.2010.12.001; Long Y, 2011, COMP BIOCHEM PHYS B, V158, P46, DOI 10.1016/j.cbpb.2010.09.005; Lu Y, 2010, BIOMED ENVIRON SCI, V23, P230, DOI 10.1016/S0895-3988(10)60057-8; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; MAYEUX PR, 1993, J PHARMACOL EXP THER, V266, P47; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Pathak R, 2011, REPROD TOXICOL, V31, P534, DOI 10.1016/j.reprotox.2011.02.007; Ren XQ, 2004, MOL PHARMACOL, V65, P1536, DOI 10.1124/mol.65.6.1536; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Shabbir A, 2005, TOXICOL APPL PHARM, V203, P91, DOI 10.1016/j.taap.2004.07.011; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiemann U, 2008, REPROD TOXICOL, V25, P316, DOI 10.1016/j.reprotox.2008.03.002; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Zamek-Gliszczynski MJ, 2006, J PHARMACOL EXP THER, V319, P1485, DOI 10.1124/jpet.106.110106; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	58	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111664	10.1371/journal.pone.0111664	http://dx.doi.org/10.1371/journal.pone.0111664			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478949	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200003
J	Gagnon, MP; Attieh, R; Ghandour, E; Legare, F; Ouimet, M; Estabrooks, CA; Grimshaw, J				Gagnon, Marie-Pierre; Attieh, Randa; Ghandour, El Kebir; Legare, France; Ouimet, Mathieu; Estabrooks, Carole A.; Grimshaw, Jeremy			A Systematic Review of Instruments to Assess Organizational Readiness for Knowledge Translation in Health Care	PLOS ONE			English	Review							IMPLEMENTATION; COMMUNITIES; RELIABILITY; CONTEXT	Background: The translation of research into practices has been incomplete. Organizational readiness for change (ORC) is a potential facilitator of effective knowledge translation (KT). However we know little about the best way to assess ORC. Therefore, we sought to systematically review ORC measurement instruments. Methods: We searched for published studies in bibliographic databases (Pubmed, Embase, CINAHL, PsychINFO, Web of Science, etc.) up to November 1st, 2012. We included publications that developed ORC measures and/or empirically assessed ORC using an instrument at the organizational level in the health care context. We excluded articles if they did not refer specifically to ORC, did not concern the health care domain or were limited to individual-level change readiness. We focused on identifying the psychometric properties of instruments that were developed to assess readiness in an organization prior to implementing KT interventions in health care. We used the Standards for Educational and Psychological Testing to assess the psychometric properties of identified ORC measurement instruments. Findings: We found 26 eligible instruments described in 39 publications. According to the Standards for Educational and Psychological Testing, 18 (69%) of a total of 26 measurement instruments presented both validity and reliability criteria. The Texas Christian University - ORC (TCU-ORC) scale reported the highest instrument validity with a score of 4 out of 4. Only one instrument, namely the Modified Texas Christian University - Director version (TCU-ORC-D), reported a reliability score of 2 out of 3. No information was provided regarding the reliability and validity of five (19%) instruments. Conclusion: Our findings indicate that there are few valid and reliable ORC measurement instruments that could be applied to KT in the health care sector. The TCU-ORC instrument presents the best evidence in terms of validity testing. Future studies using this instrument could provide more knowledge on its relevance to diverse clinical contexts.	[Gagnon, Marie-Pierre; Attieh, Randa; Ghandour, El Kebir; Legare, France; Ouimet, Mathieu] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Gagnon, Marie-Pierre] Univ Laval, Fac Nursing, Quebec City, PQ, Canada; [Legare, France] Univ Laval, Dept Family Med, Quebec City, PQ, Canada; [Ouimet, Mathieu] Univ Laval, Dept Polit Sci, Quebec City, PQ, Canada; [Estabrooks, Carole A.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Grimshaw, Jeremy] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Grimshaw, Jeremy] Univ Ottawa, Fac Med, Ottawa, ON, Canada	Laval University; Laval University; Laval University; Laval University; University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Gagnon, MP (corresponding author), Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada.	marie-pierre.gagnon@fsi.ulaval.ca	Ghandour, El Kebir/ABE-3147-2020; Gagnon, Marie-Pierre/I-3013-2019; Estabrooks, Carole A/A-3423-2009	Ghandour, El Kebir/0000-0002-5410-4265; Gagnon, Marie-Pierre/0000-0002-0782-5457; Estabrooks, Carole A/0000-0002-4753-6510; Legare, France/0000-0002-2296-6696	Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI) [200710CRI-179929-CRI-ADYP-112841]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	The project is funded by a team grant operated by Knowledge Translation Canada and offered from the Canadian Institutes of Health Research (CIHR) in partnership with the Canada Foundation for Innovation (CFI) (grant # 200710CRI-179929-CRI-ADYP-112841). MPG is Tier 2 Canada Research Chair in Technologies and Practices in Health. FL is Tier 2 Canada Research Chair in Implementation of Shared Decision Making in Primary Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 1994, TEAM CLIMATE INVENTO; Armenakis AA, 2002, J ORGAN CHANGE MANAG, V15, P169, DOI 10.1108/09534810210423080; ARMENAKIS AA, 1993, HUM RELAT, V46, P681, DOI 10.1177/001872679304600601; Association A.E.R., 1999, STAND ED PSYCH TEST; Attieh R, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-138; Barwick MA, 2009, J CAN ACAD CHILD ADO, V18, P16; Bazzoli GJ, 2004, MED CARE RES REV, V61, P247, DOI 10.1177/1077558704266818; Bobiak Sarah N, 2009, Qual Manag Health Care, V18, P278, DOI 10.1097/QMH.0b013e3181bee2f5; Bohman TM, 2008, J ADDICT MED, V2, P151, DOI 10.1097/ADM.0b013e3181800ae5; Boltz M, 2010, RES GERONTOL NURS, V3, P126, DOI 10.3928/19404921-20091207-98; Boltz M, 2009, CLIN NURS RES, V18, P242, DOI 10.1177/1054773809338555; Bouckenooghe D, 2012, EUR J WORK ORGAN PSY, V21, P575, DOI 10.1080/1359432X.2011.591573; Bowditch JL, 2002, PRIMER ORG BEHAV; Burnett S, QUAL SAF HLTH CARE; Chabot Guylaine, 2012, J Health Organ Manag, V26, P444; Cherry B, 2011, J GERONTOL NURS, V37, P14, DOI 10.3928/00989134-20110831-06; Cook David A, 2006, Am J Med, V119; Cummings GG, 2007, NURS RES, V56, pS24, DOI 10.1097/01.NNR.0000280629.63654.95; Demiris George, 2007, Inform Prim Care, V15, P45; Devereaux Moira W, 2006, Healthc Q, V9, P66; Feldt L. S., 1989, ED MEASUREMENT, V3rd, P105; Fuller BE, 2007, J SUBST ABUSE TREAT, V33, P183, DOI 10.1016/j.jsat.2006.12.026; Gagnon MP, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-72; Gotham HJ, 2010, J SUBST ABUSE TREAT, V38, P160, DOI 10.1016/j.jsat.2009.07.005; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Hamilton AB, 2010, J GEN INTERN MED, V25, P27, DOI 10.1007/s11606-009-1133-3; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Holt D.T., 2007, J APPL BEHAV SCI, V43, P232, DOI [DOI 10.1177/0021886306295295, 10.1177/0021886306295295]; Holt DT, 2010, J GEN INTERN MED, V25, P50, DOI 10.1007/s11606-009-1112-8; Holt DT, 2007, RES ORGAN CHAN DEV, V16, P289, DOI 10.1016/S0897-3016(06)16009-7; Jennett P, 2003, ST HEAL T, V97, P51; Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364; Kotter JohnP., 1996, LEADING CHANGE; Kristensen M, 2000, ST HEAL T, V77, P259; Lehman WEK, 2012, J OFFENDER REHABIL, V51, P96, DOI 10.1080/10509674.2012.633022; Lehman WEK, 2002, J SUBST ABUSE TREAT, V22, P197, DOI 10.1016/S0740-5472(02)00233-7; Melnyk BM, 2008, WORLDV EVID-BASED NU, V5, P208, DOI 10.1111/j.1741-6787.2008.00126.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montague TJ, 2007, CAN J CARDIOL, V23, P971, DOI 10.1016/S0828-282X(07)70859-0; Nelson JC, 1999, AM J PREV MED, V16, P103, DOI 10.1016/S0749-3797(99)00003-3; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pasmore W.A., 1988, DESIGNING EFFECTIVE; Pluye P., 2011, PROPOSAL MIXED METHO; Saldana L, 2007, J SUBST ABUSE TREAT, V33, P159, DOI 10.1016/j.jsat.2006.12.029; Scott SD, 2008, QUAL HEALTH RES, V18, P347, DOI 10.1177/1049732307313354; Snyder-Halpern R, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P702; Squires J, 2012, NURS RES PRACTICE, P8; Stablein Dona, 2003, Jt Comm J Qual Saf, V29, P336; Stamatakis KA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-65; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; Toure M, 2012, DISABIL REHABIL, V34, P167, DOI 10.3109/09638288.2011.591885; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Weiner BJ, 2008, MED CARE RES REV, V65, P379, DOI 10.1177/1077558708317802; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67; Wise CG, 2011, MILBANK Q, V89, P399, DOI 10.1111/j.1468-0009.2011.00634.x	55	65	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114338	10.1371/journal.pone.0114338	http://dx.doi.org/10.1371/journal.pone.0114338			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474622	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500019
J	Jiang, LB; Jiang, SY; Zhang, M; Zheng, ZJ; Ma, YF				Jiang, Libing; Jiang, Shouyin; Zhang, Mao; Zheng, Zhongjun; Ma, Yuefeng			Albumin versus Other Fluids for Fluid Resuscitation in Patients with Sepsis: A Meta-Analysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; EXTRAVASCULAR LUNG WATER; ACUTE KIDNEY INJURY; HYDROXYETHYL STARCH; SEVERE MALARIA; PULMONARY PERMEABILITY; CAPILLARY LEAKAGE; INFORMATION SIZE; VOLUME EXPANSION; ORGAN FUNCTION	Background: Early fluid resuscitation is vital to patients with sepsis. However, the choice of fluid has been a hot topic of discussion. The objective of this study was to evaluate whether the use of albumin-containing fluids for resuscitation in patients with sepsis was associated with a decreased mortality rate. Methods: We systematically searched PubMed, EMBASE and Cochrane library for eligible randomized controlled trials (RCTs) up to March 2014. The selection of eligible studies, assessment of methodological quality, and extraction of all relevant data were conducted by two authors independently. Results: In total, 15 RCTs were eligible for analysis. After pooling the data, we found there was no significant effect of albumin-containing fluids on mortality in patients with sepsis of any severity (RR: 0.94, 95% CI: 0.87, 1.02 and RD: -0.01, 95% CI: -0.03, 0.01). The results were robust to subgroup analyses, sensitivity analyses and trial sequential analyses. Conclusion: The present meta-analysis did not demonstrate significant advantage of using albumin-containing fluids for resuscitation in patients with sepsis of any severity. Given the cost-effectiveness of using albumin, crystalloids should be the first choice for fluid resuscitation in septic patients.	[Zhang, Mao] Zhejiang Univ, Dept Emergency Med, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Inst Emergency Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, M (corresponding author), Zhejiang Univ, Dept Emergency Med, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	zmhzjzk@163.com; mayuefengbj@163.com	ma, yue/GXE-9897-2022					Akech S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010021; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; [Anonymous], CRIT CARE MED; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Chou CD, 2009, J CHIN MED ASSOC, V72, P243, DOI 10.1016/S1726-4901(09)70064-4; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dolecek M, 2009, HEPATO-GASTROENTEROL, V56, P1622; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CURR OPIN CRIT CARE, V19, P315, DOI 10.1097/MCC.0b013e3283632e42; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Friedman G, 2008, J CLIN ANESTH, V20, P528, DOI 10.1016/j.jclinane.2008.05.022; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Karakala N, 2013, CURR OPIN CRIT CARE, V19, P537, DOI 10.1097/MCC.0000000000000028; Latour-Perez J, 2013, CRIT CARE MED, V41, pE289, DOI 10.1097/CCM.0b013e31828ced28; Lyu PF, 2014, CURR OPIN CRIT CARE, V20, P402, DOI 10.1097/MCC.0000000000000117; Maitland K, 2005, CLIN INFECT DIS, V40, P538, DOI 10.1086/427505; Maitland K, 2005, BRIT J HAEMATOL, V128, P393, DOI 10.1111/j.1365-2141.2004.05312.x; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Margarido CB, 2007, SHOCK, V27, P390, DOI 10.1097/01.shk.0000245026.01365.55; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025; Marx G, 2004, SHOCK, V21, P336, DOI 10.1097/00024382-200404000-00008; Marx G, 2006, CRIT CARE MED, V34, P3005, DOI 10.1097/01.CCM.0000242755.74063.ED; METILDI LA, 1984, SURG GYNECOL OBSTET, V158, P207; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murphy CV, 2009, CHEST, V136, P102, DOI 10.1378/chest.08-2706; Ospina-Tascon G, 2010, INTENS CARE MED, V36, P949, DOI 10.1007/s00134-010-1843-3; Palumbo D, 2006, MINERVA ANESTESIOL, V72, P655; Pandey NR, 2014, WORLD J EMERG MED, V5, P42, DOI [10.5847/wjem.j.1920-8642.2014.01.007, 10.5847/wjem.j.issn.1920-8642.2014.01.007]; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; RACKOW EC, 1983, CRIT CARE MED, V11, P839, DOI 10.1097/00003246-198311000-00001; RACKOW EC, 1989, CRIT CARE MED, V17, P394, DOI 10.1097/00003246-198905000-00003; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Trof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x; Uhlig C, 2014, CRIT CARE, V18, DOI 10.1186/cc13187; van der Heijden M, 2009, CRIT CARE MED, V37, P1275, DOI 10.1097/CCM.0b013e31819cedfd; Veneman TF, 2004, WIEN KLIN WOCHENSCHR, V116, P305, DOI 10.1007/BF03040900; Verheij J, 2006, BRIT J ANAESTH, V96, P21, DOI 10.1093/bja/aei286; Vincent JL, 2011, MINERVA ANESTESIOL, V77, P1190; Vincent Jean-Louis, 2004, Crit Care Med, V32, pS451, DOI 10.1097/01.CCM.0000142984.44321.A4; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308; Zampieri FG, 2013, SHOCK, V39, P42, DOI 10.1097/SHK.0b013e31828faf82; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430; [郑岩 Zheng Yan], 2013, [中国急救医学, Chinese Journal of Critical Care Medicine], V33, P101; [No title captured]	62	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114666	10.1371/journal.pone.0114666	http://dx.doi.org/10.1371/journal.pone.0114666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474401	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500053
J	Silva, TMA; Mol, JPS; Winter, MG; Atluri, V; Xavier, MN; Pires, SF; Paixao, TA; Andrade, HM; Santos, RL; Tsolis, RM				Silva, Teane M. A.; Mol, Juliana P. S.; Winter, Maria G.; Atluri, Vidya; Xavier, Mariana N.; Pires, Simone F.; Paixao, Tatiane A.; Andrade, Helida M.; Santos, Renato L.; Tsolis, Renee M.			The Predicted ABC Transporter AbcEDCBA Is Required for Type IV Secretion System Expression and Lysosomal Evasion by Brucella ovis	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; OUTER-MEMBRANE PROPERTIES; INTRACELLULAR SURVIVAL; MURINE MACROPHAGES; OMP25/OMP31 FAMILY; ESCHERICHIA-COLI; VIRB; ABORTUS; VIRULENCE; SUIS	Brucella ovis is a major cause of reproductive failure in rams and it is one of the few well-described Brucella species that is not zoonotic. Previous work showed that a B. ovis mutant lacking a species-specific ABC transporter (Delta abcBA) was attenuated in mice and was unable to survive in macrophages. The aim of this study was to evaluate the role of this ABC transporter during intracellular survival of B. ovis. In HeLa cells, B. ovis WT was able to survive and replicate at later time point (48 hpi), whereas an Delta abcBA mutant was attenuated at 24 hpi. The reduced survival of the DabcBA mutant was associated with a decreased ability to exclude the lysosomal marker LAMP1 from its vacuolar membrane, suggesting a failure to establish a replicative niche. The DabcBA mutant showed a reduced abundance of the Type IV secretion system (T4SS) proteins VirB8 and VirB11 in both rich and acid media, when compared to WT B. ovis. However, mRNA levels of virB1, virB8, hutC, and vjbR were similar in both strains. These results support the notion that the ABC transporter encoded by abcEDCBA or its transported substrate acts at a post-transcriptional level to promote the optimal expression of the B. ovis T4SS within infected host cells.	[Silva, Teane M. A.; Mol, Juliana P. S.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Winter, Maria G.; Atluri, Vidya; Xavier, Mariana N.; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Pires, Simone F.; Andrade, Helida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; University of California System; University of California Davis; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rls@ufmg.br; rmtsolis@ucdavis.edu	Byndloss, Mariana Xavier/ABD-5506-2021; de Lima Santos, Renato/A-1134-2008; Byndloss, Mariana X/D-9890-2014; Gomes, Teane Milagres Augusto/AAP-2686-2021; Paixao, Tatiane/A-2871-2013	Byndloss, Mariana Xavier/0000-0002-2122-4156; de Lima Santos, Renato/0000-0002-4830-0470; Byndloss, Mariana X/0000-0002-2122-4156; Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Paixao, Tatiane/0000-0001-8284-9902; Mol, Juliana/0000-0002-6946-8213; Tsolis, Renee/0000-0001-9131-6657	US PHS [AI050553, AI090387]; CNPq, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090387, R01AI050553] Funding Source: NIH RePORTER	US PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US PHS grants AI050553 and AI090387 to R.M.T. supported this work. T.M.A.S. was supported by a fellowship from CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; ANDREWS JC, 1985, J BACTERIOL, V161, P484, DOI 10.1128/JB.161.2.484-492.1985; Arocena GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035394; Blasco J. M., 1990, Animal brucellosis., P351; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; BURGESS GW, 1982, VET MICROBIOL, V7, P551, DOI 10.1016/0378-1135(82)90049-9; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; CARPENTER TE, 1987, J AM VET MED ASSOC, V190, P977; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cloeckaert A, 2002, VET MICROBIOL, V90, P229, DOI 10.1016/S0378-1135(02)00211-0; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Edwards RA, 1999, BIOTECHNIQUES, V26, P892, DOI 10.2144/99265st02; Ficapal A, 1998, SMALL RUMINANT RES, V29, P13, DOI 10.1016/S0921-4488(97)00108-9; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garza E, 2011, WORLD J MICROB BIOT, V27, P449, DOI 10.1007/s11274-010-0451-2; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9; Jenner DC, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/354649; Jubier-Maurin V, 2001, J BACTERIOL, V183, P426, DOI 10.1128/JB.183.2.426-434.2001; Ko JY, 2000, MICROB PATHOGENESIS, V29, P245, DOI 10.1006/mpat.2000.0389; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Lamontagne J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-300; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Martin-Martin AI, 2011, VET J, V189, P103, DOI 10.1016/j.tvjl.2010.05.021; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; NAIDER F, 1975, J BACTERIOL, V122, P1208, DOI 10.1128/JB.122.3.1208-1215.1975; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; PLOMMET M, 1991, ZBL BAKT-INT J MED M, V275, P436; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rolan HG, 2007, INFECT IMMUN, V75, P2965, DOI 10.1128/IAI.01896-06; Rosinha GMS, 2002, INFECT IMMUN, V70, P5036, DOI 10.1128/IAI.70.9.5036-5044.2002; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Sangari FJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-107; Vieira HGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097526; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2013, FUTURE MICROBIOL, V8, P1193, DOI 10.2217/fmb.13.83; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thoen C. O., 1993, P236; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Zhong ZJ, 2009, MICROBIOL-SGM, V155, P3392, DOI 10.1099/mic.0.030619-0	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114532	10.1371/journal.pone.0114532	http://dx.doi.org/10.1371/journal.pone.0114532			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474545	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500045
J	Smithline, ZB; Nikonova, AS; Hensley, HH; Cai, KQ; Egleston, BL; Proia, DA; Seeger-Nukpezah, T; Golemis, EA				Smithline, Zachary B.; Nikonova, Anna S.; Hensley, Harvey H.; Cai, Kathy Q.; Egleston, Brian L.; Proia, David A.; Seeger-Nukpezah, Tamina; Golemis, Erica A.			Inhibiting Heat Shock Protein 90 (HSP90) Limits the Formation of Liver Cysts Induced by Conditional Deletion of Pkd1 in Mice	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; GROWTH; GANETESPIB; EVEROLIMUS; MODEL	Polycystic liver disease (PLD) occurs in 75-90% of patients affected by autosomal dominant polycystic kidney disease (ADPKD), which affects 1: 400-1,000 adults and arises from inherited mutations in the PKD1 or PKD2 genes. PLD can lead to bile duct obstructions, infected or bleeding cysts, and hepatomegaly, which can diminish quality of life. At present, no effective, approved therapy exists for ADPKD or PLD. We recently showed that inhibition of the molecular chaperone heat shock protein 90 (HSP90) with a small molecule inhibitor, STA-2842, induced the degradation of multiple HSP90-dependent client proteins that contribute to ADPKD pathogenesis and slowed the progression of renal cystogenesis in mice with conditional deletion of Pkd1. Here, we analyzed the effects of STA-2842 on liver size and cystic burden in Pkd(-/-) mice with established PLD. Using magnetic resonance imaging over time, we demonstrate that ten weeks of STA-2842 treatment significantly reduced both liver mass and cystic index suggesting selective elimination of cystic tissue. Pre-treatment cystic epithelia contain abundant HSP90; the degree of reduction in cysts was accompanied by inhibition of proliferation-associated signaling proteins EGFR and others, and induced cleavage of caspase 8 and PARP1, and correlated with degree of HSP90 inhibition and with inactivation of ERK1/2. Our results suggest that HSP90 inhibition is worth further evaluation as a therapeutic approach for patients with PLD.	[Smithline, Zachary B.] Yale Univ, New Haven, CT 06520 USA; [Smithline, Zachary B.; Nikonova, Anna S.; Hensley, Harvey H.; Cai, Kathy Q.; Egleston, Brian L.; Seeger-Nukpezah, Tamina; Golemis, Erica A.] Fox Chase Canc Ctr, Program Mol Therapeut, Philadelphia, PA 19111 USA; [Proia, David A.] Synta Pharmaceut, Lexington, MA 02421 USA; [Seeger-Nukpezah, Tamina] Univ Hosp Cologne, Ctr Integrated Oncol, Dept Internal Med 1, D-50937 Cologne, Germany	Yale University; Fox Chase Cancer Center; University of Cologne	Seeger-Nukpezah, T (corresponding author), Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	tamina.seeger-nukpezah@uk-koeln.de; Erica.Golemis@fccc.edu	Egleston, Brian L./P-1000-2019	Egleston, Brian L./0000-0002-1633-799X; Golemis, Erica/0000-0003-3618-3673	DOD PRMRP [W81XWH-12-1-0437/PR110518]; German Research Foundation (DFG) [SE2280/1, SE2280/2]; Koln Fortune [252/2013]; National Institutes of Health Core Grant [CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	DOD PRMRP; German Research Foundation (DFG)(German Research Foundation (DFG)); Koln Fortune; National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are very thankful to Catherine and Peter Getchell and the Bucks County Chapter of the Fox Chase Board of Associates for their financial support. This work was further supported by funding from DOD PRMRP W81XWH-12-1-0437/PR110518 (to E.A. G.), from the German Research Foundation (DFG) SE2280/1, SE2280/2 and Koln Fortune 252/2013 (to T.S.-N.) and from the National Institutes of Health Core Grant CA06927 (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2014, MTOR INHIBITION POTE; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; Chrispijn M, 2013, J HEPATOL, V59, P153, DOI 10.1016/j.jhep.2013.03.004; DAGATA IDA, 1994, SEMIN LIVER DIS, V14, P215, DOI 10.1055/s-2007-1007313; GRANTHAM JJ, 1990, AM J KIDNEY DIS, V15, P110, DOI 10.1016/S0272-6386(12)80507-5; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Liu H, 2013, CLIN CANC RES OFFICI; Liu YM, 2014, TRANSPL P, V46, P66, DOI 10.1016/j.transproceed.2013.10.040; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Proia DA, 2014, CLIN CANCER RES, V20, P413, DOI 10.1158/1078-0432.CCR-13-2166; Ramalingam S, 2013, J CLIN ONCOL, V33, p18s; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2012, J AM SOC NEPHROL, V23, P1674, DOI 10.1681/ASN.2012040367; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005; Strazzabosco M, 2011, GASTROENTEROLOGY, V140, P1855, DOI 10.1053/j.gastro.2011.04.030; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923	27	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114403	10.1371/journal.pone.0114403	http://dx.doi.org/10.1371/journal.pone.0114403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474361	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500025
J	Fernandez-Arias, M; Acuna-Villaorduna, A; Miranda, JJ; Diez-Canseco, F; Malaga, G				Fernandez-Arias, Marta; Acuna-Villaorduna, Ana; Miranda, J. Jaime; Diez-Canseco, Francisco; Malaga, German			Adherence to Pharmacotherapy and Medication-Related Beliefs in Patients with Hypertension in Lima, Peru	PLOS ONE			English	Article							BLOOD-PRESSURE; MEDICINES; IMPACT	Objective: To characterize adherence to pharmacological medication and beliefs towards medication in a group of patients with hypertension in a large national hospital. Materials and Methods: Cross-sectional survey among patients with hypertension attending the outpatient clinic of a large national hospital. Exposure of interest was the patient's beliefs towards general medication and antihypertensive drugs, i.e. beliefs of harm, overuse, necessity and concern, measured using the Beliefs about Medication questionnaire. Main outcome was adherence measured using the Morisky Medication Adherence Scale-8. Multivariate analysis was conducted using Poisson distribution logistic regression, prevalence ratios and 95% confidence intervals were calculated. Results: Data from 115 participants, 67% females and mean age 62.7 years were analyzed. Low adherence was found in 57.4%. Highest scores were on the ideas of necessity and one of the most rated statements was "physicians would prescribe less medication if they spent more time with patients". Beliefs of harm about medications and concerns about antihypertensive drugs were higher in the low adherence group (p, 0.01). Those who scored higher on ideas of harm were 52% less likely of being high adherents (PR 0.48; 95% CI 0.25-0.93) and those with higher scores on concerns were 41% less likely of being high adherents (PR 0.59; 95% CI 0.39-0.91). Patients whose ideas of necessity outweighed their concerns were more likely to be adherent (PR 2.65; 95% CI 1.21-5.81). Conclusions: Low adherence to antihypertensive medication is common. High scores on ideas of harm, concern and a high necessity-concern differential were predictors of medication adherence.	[Fernandez-Arias, Marta; Acuna-Villaorduna, Ana; Miranda, J. Jaime; Diez-Canseco, Francisco; Malaga, German] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Fernandez-Arias, Marta] Global Hlth Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Acuna-Villaorduna, Ana; Malaga, German] Univ Peruana Cayetano Heredia, Unidad Conocimiento & Evidencia, Lima, Peru; [Miranda, J. Jaime; Malaga, German] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Malaga, German] Hosp Nacl Cayetano Heredia, Serv Med Interna, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Acuna-Villaorduna, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	ana.acuna.vi@gmail.com		Malaga, German/0000-0002-7828-300X; Diez-Canseco, Francisco/0000-0002-7611-8190; Miranda, J. Jaime/0000-0002-4738-5468	CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia; United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]	CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia; United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services	The authors did not receive any external funding for this work. Please note that authors JJM and FDC received funding in the form of salaries from the CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia, which is supported with Federal funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services under Contract No. HHSN268200900033C.	Buendia JA, 2012, BIOMEDICA, V32, P578, DOI [10.7705/biomedica.v32i4.421, 10.1590/S0120-41572012000400013]; Arana Morales G, 2001, REV MED HERED, V12, P120; Belendez-Vazquez M, 2007, INT J CLIN HLTH PSYC, V7, P767; Bravo Paulina, 2013, Rev. perú. med. exp. salud publica, V30, P691; Carhuallanqui Rolando, 2010, Rev Med Hered, V21, P197; Davies Alisha R, 2008, BMC Res Notes, V1, P2, DOI 10.1186/1756-0500-1-2; Del Aguila-Diaz J, 1994, REV MED IPSS, V3, P23; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, J PSYCHOSOM RES, V47, P491, DOI 10.1016/S0022-3999(99)00058-6; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Instituto Nacional de Salud del Peru, 2010, CARG ENF LES PER; Carlos Alberto Isaza, 2004, Biomed., V24, P273; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Law M, 2003, Health Technol Assess, V7, P1; Ledur PS, 2013, J AM SOC HYPERTENS, V7, P477, DOI 10.1016/j.jash.2013.07.006; Lerner Alana G, 2013, Crit Pathw Cardiol, V12, P53, DOI 10.1097/HPC.0b013e318285ef60; Matsumura K, 2013, QJM-INT J MED, V106, P909, DOI 10.1093/qjmed/hct121; Medina-Lezama J, 2007, J AM SOC HYPERTENS, V1, P216, DOI 10.1016/j.jash.2007.02.003; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Natarajan N, 2013, CAN FAM PHYSICIAN, V59, pE93; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Rajpura J, 2014, J MANAGE CARE PHARM, V20, P58, DOI 10.18553/jmcp.2014.20.1.58; Ruppar TM, 2012, GERIATR NURS, V33, P89, DOI 10.1016/j.gerinurse.2012.01.006; Shin S, 2013, HYPERTENS RES, V36, P1000, DOI 10.1038/hr.2013.85; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Val Jimenez A, 1992, Aten Primaria, V10, P767; Wong MCS, 2013, INT J CARDIOL, V167, P1438, DOI 10.1016/j.ijcard.2012.04.060; World Health Organisation, 2013, ADHERENCE LONG TERM; World Health Organization, 2008, GLOB HLTH OBS BLOOD; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	31	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112875	10.1371/journal.pone.0112875	http://dx.doi.org/10.1371/journal.pone.0112875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470372	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700012
J	Khakbazan, Z; Taghipour, A; Roudsari, RL; Mohammadi, E				Khakbazan, Zohreh; Taghipour, Ali; Roudsari, Robab Latifnejad; Mohammadi, Eesa			Help Seeking Behavior of Women with Self-Discovered Breast Cancer Symptoms: A Meta-Ethnographic Synthesis of Patient Delay	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PSYCHOLOGICAL-FACTORS; EXPERIENCES; DIAGNOSIS; AWARENESS; CONSULTATION; PREVENTION; APPRAISAL; DECISION; MODEL	Background and Objective: Patient delay makes a critical contribution to late diagnosis and poor survival in cases of breast cancer. Identifying the factors that influence patient delay could provide information for adopting strategies that shorten this delay. The aim of this meta-ethnography was to synthesize existing qualitative evidence in order to gain a new understanding of help seeking behavior in women with self-discovered breast cancer symptoms and to determine the factors that influence patient delay. Methods: The design was a meta-ethnography approach. A systematic search of the articles was performed in different databases including Elsevier, PubMed, ProQuest and SCOPUS. Qualitative studies with a focus on help seeking behaviors in women with self-discovered breast cancer symptoms and patient delay, published in the English language between 1990 and 2013 were included. The quality appraisal of the articles was carried out using the Critical Appraisal Skills Programme qualitative research checklist and 13 articles met the inclusion criteria. The synthesis was conducted according to Noblit and Hare's meta-ethnographic approach (1988), through reciprocal translational analysis and lines-of-argument. Findings: The synthesis led to identification of eight repeated key concepts including: symptom detection, initial symptom interpretation, symptom monitoring, social interaction, emotional reaction, priority of medical help, appraisal of health services and personal-environmental factors. Symptom interpretation is identified as the important step of the help seeking process and which changed across the process through active monitoring of their symptoms, social interactions and emotional reactions. The perceived seriousness of the situation, priority to receive medical attention, perceived inaccessibility and unacceptability of the health care system influenced women's decision-making about utilizing health services. Conclusion: Help seeking processes are influenced by multiple factors. Educational programs aimed at correcting misunderstandings, erroneous social beliefs and improving self-awareness could provide key strategies to improve health policy which would reduce patient delay.	[Khakbazan, Zohreh] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Mashhad, Iran; [Taghipour, Ali] Mashhad Univ Med Sci, Sch Hlth, Hlth Sci Res Ctr, Dept Epidemiol & Biostat, Mashhad, Iran; [Roudsari, Robab Latifnejad] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Evidence Based Care Res Ctr, Dept Midwifery, Mashhad, Iran; [Mohammadi, Eesa] Tarbiat Modares Univ, Fac Med Sci, Dept Nursing, Tehran, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Tarbiat Modares University	Roudsari, RL (corresponding author), Mashhad Univ Med Sci, Sch Nursing & Midwifery, Evidence Based Care Res Ctr, Dept Midwifery, Mashhad, Iran.	LatifnejadR@mums.ac.ir	Roudsari, Robab Latifnejad/AAD-3671-2019; Mohammadi, Eesa/I-9004-2018	Mohammadi, Eesa/0000-0001-6169-9829; Latifnejad Roudsari, Robab/0000-0002-1438-8822; Taghipour, Ali/0000-0001-7594-0097				Adam D., 2003, AUSTR NZ MARK AC C A, P1920; Adams E, 2011, PSYCHO-ONCOLOGY, V20, P851, DOI 10.1002/pon.1792; Alhurishi S, 2011, ASIAN PAC J CANCER P, V12, P1597; American Cancer Society, 2013, BREAST CANC FACTS FI; American Cancer Society Inc, BREAST CANC FACTS FI; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; [Anonymous], 2008, WORLD HLTH STAT 2008; Arndt V, 2001, J CLIN EPIDEMIOL, V54, P719, DOI 10.1016/S0895-4356(00)00351-6; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Austoker J, 2003, BMJ-BRIT MED J, V326, P1, DOI 10.1136/bmj.326.7379.1; Babu GR, 2011, ASIAN PAC J CANCER P, V12, P1647; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Bish A, 2005, J PSYCHOSOM RES, V58, P321, DOI 10.1016/j.jpsychores.2004.10.007; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Burgess C, 2001, BRIT J GEN PRACT, V51, P967; Burgess CC, 1998, BRIT J CANCER, V77, P1343, DOI 10.1038/bjc.1998.224; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Caplan LS, 1996, PREV MED, V25, P218, DOI 10.1006/pmed.1996.0049; Ceber E, 2010, J CLIN NURS, V19, P2363, DOI 10.1111/j.1365-2702.2009.03150.x; de Nooijer J, 2001, PATIENT EDUC COUNS, V42, P145, DOI 10.1016/S0738-3991(00)00104-X; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Drew EM, 2011, MED ANTHROPOL Q, V25, P164, DOI 10.1111/j.1548-1387.2010.01136.x; Dye TD, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/908547; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; Ferlay J., 2013, IARC CANCERBASE, V11; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Friedman LC, 2006, J BEHAV MED, V29, P327, DOI 10.1007/s10865-006-9059-2; Gates M F, 2001, Oncol Nurs Forum, V28, P529; Greenwood N, 2010, MATURITAS, V66, P268, DOI 10.1016/j.maturitas.2010.03.017; Harirchi I, 2005, PUBLIC HEALTH, V119, P885, DOI 10.1016/j.puhe.2004.11.005; Hilber AM, 2012, SOC SCI MED, V74, P1311, DOI 10.1016/j.socscimed.2011.11.032; Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388; Jones CEL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004076; Lackey N R, 2001, Oncol Nurs Forum, V28, P519; Lam WWT, 2009, J PUBLIC HEALTH-UK, V31, P59, DOI 10.1093/pubmed/fdn088; Lannin DR, 1998, JAMA-J AM MED ASSOC, V279, P1801, DOI 10.1001/jama.279.22.1801; Lannin DR, 2002, AM J SURG, V184, P418, DOI 10.1016/S0002-9610(02)01009-7; Lu MH, 2010, CANCER NURS, V33, P398, DOI 10.1097/NCC.0b013e3181d72c45; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068; MATHEWS HF, 1994, SOC SCI MED, V38, P789, DOI 10.1016/0277-9536(94)90151-1; McCready T, 2005, J CLIN NURS, V14, P570, DOI 10.1111/j.1365-2702.2004.01108.x; Meechan G, 2003, PREV MED, V36, P374, DOI 10.1016/S0091-7435(02)00053-1; Meechan Geraldine, 2002, N Z Med J, V115, pU257; Mitchell E, 2008, BRIT J CANCER, V98, P60, DOI 10.1038/sj.bjc.6604096; Mohamed IE, 2005, PREV MED, V41, P399, DOI 10.1016/j.ypmed.2004.12.012; Montazeri Ali, 2003, BMC Womens Health, V3, P4, DOI 10.1186/1472-6874-3-4; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; National Patient Safety Agency (NPSA) and Royal College of General Practitioners (RCGP), 2010, DEL DIAGN CANC THEM; NHS, 2006, CRIT APPR SKILLS PRO; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Nosarti C, 2000, BRIT J CANCER, V82, P742; Nyawata I, 2006, CLIN EFFECTIVENESS N, V9, pe68, DOI DOI 10.1016/J.CEIN.2006.10.005; O'Mahony M, 2011, EUR J ONCOL NURS, V15, P410, DOI 10.1016/j.ejon.2010.10.011; O'Mahony M, 2009, ONCOL NURS FORUM, V36, P402, DOI 10.1188/09.ONF.E178-E184; PHELAN M, 1992, J ROY SOC MED, V85, P206; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Rastad H, 2012, ASIAN PAC J CANCER P, V13, P4511, DOI 10.7314/APJCP.2012.13.9.4511; Ristvedt SL, 2005, DIS COLON RECTUM, V48, P1736, DOI 10.1007/s10350-005-0069-x; Ristvedt SL, 2005, PSYCHO-ONCOLOGY, V14, P339, DOI 10.1002/pon.850; Scott SE, 2007, J PSYCHOSOM RES, V62, P621, DOI 10.1016/j.jpsychores.2006.12.020; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Spector D, 2009, CANCER NURS, V32, P299, DOI 10.1097/NCC.0b013e31819deab0; Tacconelli E, 2010, LANCET INFECT DIS, V10, P226, DOI DOI 10.1016/S1473-3099(10)70065-7; Taib NA, 2011, ASIAN PAC J CANCER P, V12, P1601; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Unger-Saldana K, 2011, SOC SCI MED, V72, P1096, DOI 10.1016/j.socscimed.2011.01.022; WHO, 2014, BREAST CANC PREV CON	71	51	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110262	10.1371/journal.pone.0110262	http://dx.doi.org/10.1371/journal.pone.0110262			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470732	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700003
J	Tranquilli, S; Abedi-Lartey, M; Abernethy, K; Amsini, F; Asamoah, A; Balangtaa, C; Blake, S; Bouanga, E; Breuer, T; Brncic, TM; Campbell, G; Chancellor, R; Chapman, CA; Davenport, TRB; Dunn, A; Dupain, J; Ekobo, A; Eno-Nku, M; Etoga, G; Furuichi, T; Gatti, S; Ghiurghi, A; Hashimoto, C; Hart, JA; Head, J; Hega, M; Herbinger, I; Hicks, TC; Holbech, LH; Huijbregts, B; Kuhl, HS; Imong, I; Yeno, SLD; Linder, J; Marshall, P; Lero, PM; Morgan, D; Mubalama, L; N'Goran, PK; Nicholas, A; Nixon, S; Normand, E; Nziguyimpa, L; Nzooh-Dongmo, Z; Ofori-Amanfo, R; Ogunjemite, BG; Petre, CA; Rainey, HJ; Regnaut, S; Robinson, O; Rundus, A; Sanz, CM; Okon, DT; Todd, A; Warren, Y; Sommer, V				Tranquilli, Sandra; Abedi-Lartey, Michael; Abernethy, Katharine; Amsini, Fidele; Asamoah, Augustus; Balangtaa, Cletus; Blake, Stephen; Bouanga, Estelle; Breuer, Thomas; Brncic, Terry M.; Campbell, Genevieve; Chancellor, Rebecca; Chapman, Colin A.; Davenport, Tim R. B.; Dunn, Andrew; Dupain, Jef; Ekobo, Atanga; Eno-Nku, Manasseh; Etoga, Gilles; Furuichi, Takeshi; Gatti, Sylvain; Ghiurghi, Andrea; Hashimoto, Chie; Hart, John A.; Head, Josephine; Hega, Martin; Herbinger, Ilka; Hicks, Thurston C.; Holbech, Lars H.; Huijbregts, Bas; Kuhl, Hjalmar S.; Imong, Inaoyom; Yeno, Stephane Le-Duc; Linder, Joshua; Marshall, Phil; Lero, Peter Minasoma; Morgan, David; Mubalama, Leonard; N'Goran, Paul K.; Nicholas, Aaron; Nixon, Stuart; Normand, Emmanuelle; Nziguyimpa, Leonidas; Nzooh-Dongmo, Zacharie; Ofori-Amanfo, Richard; Ogunjemite, Babafemi G.; Petre, Charles-Albert; Rainey, Hugo J.; Regnaut, Sebastien; Robinson, Orume; Rundus, Aaron; Sanz, Crickette M.; Okon, David Tiku; Todd, Angelique; Warren, Ymke; Sommer, Volker			Protected Areas in Tropical Africa: Assessing Threats and Conservation Activities	PLOS ONE			English	Article							MAMMAL POPULATION DECLINES; MODEL SELECTION; CONGO BASIN; WEST; FORESTS; BUSHMEAT; EXTINCTION; BIODIVERSITY; ENFORCEMENT; MANAGEMENT	Numerous protected areas (PAs) have been created in Africa to safeguard wildlife and other natural resources. However, significant threats from anthropogenic activities and decline of wildlife populations persist, while conservation efforts in most PAs are still minimal. We assessed the impact level of the most common threats to wildlife within PAs in tropical Africa and the relationship of conservation activities with threat impact level. We collated data on 98 PAs with tropical forest cover from 15 countries across West, Central and East Africa. For this, we assembled information about local threats as well as conservation activities from published and unpublished literature, and questionnaires sent to long-term field workers. We constructed general linear models to test the significance of specific conservation activities in relation to the threat impact level. Subsistence and commercial hunting were identified as the most common direct threats to wildlife and found to be most prevalent in West and Central Africa. Agriculture and logging represented the most common indirect threats, and were most prevalent in West Africa. We found that the long-term presence of conservation activities (such as law enforcement, research and tourism) was associated with lower threat impact levels. Our results highlight deficiencies in the management effectiveness of several PAs across tropical Africa, and conclude that PA management should invest more into conservation activities with long-term duration.	[Tranquilli, Sandra; Sommer, Volker] UCL, Dept Biol Anthropol, London, England; [Abedi-Lartey, Michael] Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany; [Abedi-Lartey, Michael] Univ Konstanz, Dept Biol, Constance, Germany; [Abernethy, Katharine] Univ Stirling, Sch Nat Sci, African Forest Ecol Grp, Stirling FK9 4LA, Scotland; [Abernethy, Katharine] IRET, Libreville, Gabon; [Amsini, Fidele] Frankfurt Zool Soc, Tshopo, DEM REP CONGO; [Asamoah, Augustus] Ghana Cocoa Board, Environm Sustainabil Project, United Nations Dev Programme, Adabraka, Accra, Ghana; [Balangtaa, Cletus] Ankasa Conservat Area, Wildlife Div Forestry Commiss Ghana, Elubo, Takoradi, Ghana; [Blake, Stephen; Chapman, Colin A.; Rainey, Hugo J.] Wildlife Conservat Soc, New York, NY USA; [Blake, Stephen] Univ Missouri, Whitney Harris World Ecol Ctr, St Louis, MO 63121 USA; [Bouanga, Estelle] Minist Foret Environm & Protect Ressources Nat, Libreville, Gabon; [Breuer, Thomas] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Brncic, Terry M.] Tacugama Chimpanzee Sanctuary, Freetown, Sierra Leone; [Campbell, Genevieve] Independent Researcher, Montreal, PQ, Canada; [Chancellor, Rebecca] W Chester Univ, Dept Anthropol & Sociol & Psychol, W Chester, PA 19380 USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Davenport, Tim R. B.] Wildlife Conservat Soc, Tanzania Program, Zanzibar, Tanzania; [Dunn, Andrew; Imong, Inaoyom] Wildlife Conservat Soc, Calabar, Nigeria; [Dupain, Jef] African Wildlife Fdn, Nairobi, Kenya; [Ekobo, Atanga] World Wide Fund Nat, Limbe, Cameroon; [Eno-Nku, Manasseh] World Wide Fund Nat, Mt Cameroon NP, Limbe, Cameroon; [Etoga, Gilles; Nzooh-Dongmo, Zacharie] World Wide Fund Nat CARPO, Jengi Tridom, Yaunde, Cameroon; [Furuichi, Takeshi; Hashimoto, Chie] Kyoto Univ, Primate Res Inst, Kyoto, Japan; [Furuichi, Takeshi; Hashimoto, Chie] Support Conservat Bonobos, Luo Reserve, DEM REP CONGO; [Gatti, Sylvain] West African Primate Conservat Act, Accra, Ghana; [Ghiurghi, Andrea] Independent Researcher, Rome, Italy; [Hart, John A.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Head, Josephine; Hicks, Thurston C.; Kuhl, Hjalmar S.; Imong, Inaoyom] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Hega, Martin] Wildlife Conservat Soc, Monts Cristal, Gabon; [Herbinger, Ilka] World Wide Fund Nat, Berlin, Germany; [Hicks, Thurston C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Holbech, Lars H.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana; [Huijbregts, Bas] Cent Africa Reg Programme Off, World Wide Fund Nat, Yaounde, Cameroon; [Kuhl, Hjalmar S.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Yeno, Stephane Le-Duc] World Wide Fund Nat, Gamba, Libreville, Gabon; [Linder, Joshua] James Madison Univ, Dept Sociol & Anthropol, Harrisonburg, VA 22807 USA; [Marshall, Phil] North Eastern Parks Programme, Windhoek, Namibia; [Lero, Peter Minasoma] Minist Interior & Wildlife Conservat, Directorate Wildlife Serv, Juba, Sudan; [Morgan, David] Lester E Fisher Ctr Great Ape Res, Chicago, IL USA; [Mubalama, Leonard] World Wide Fund Nat, Itombwe Conservat Programme, Bukavu, South Kivu Prov, DEM REP CONGO; [N'Goran, Paul K.] Ctr Suisse Recherches Scientif Cote Ivoire, Abidjan, Cote Ivoire; [Nicholas, Aaron] Wildlife Conservat Soc, Ruaha Katavi Landscape, Tanzania; [Nixon, Stuart] Zool Soc London, London, England; [Normand, Emmanuelle] Wild Chimpanzee Fdn, Abidjan, Cote Ivoire; [Nziguyimpa, Leonidas] Inst Natl Environm & Conservat Nat, Bururi, Burundi; [Ofori-Amanfo, Richard] Bia Conservat Area, Sefwi Wiawso, Ghana; [Ogunjemite, Babafemi G.] Fed Univ Technol Akure, Dept Ecotourism & Wildlife Management, Akure, Nigeria; [Petre, Charles-Albert] Univ Liege, Gembloux Agro Bio Tech, Unit Forest & Nat Management, Lab Trop & Subtrop Forestry, Gembloux, Belgium; [Petre, Charles-Albert] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium; [Regnaut, Sebastien] West & Cent Afr, Protected Areas Program, Int Union Conservat Nat, Ouagadougou, Burkina Faso; [Robinson, Orume] Minist Forestry & Wildlife, Ndian, Cameroon; [Rundus, Aaron] W Chester Univ, Dept Psychol, W Chester, PA 19380 USA; [Sanz, Crickette M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Okon, David Tiku] World Wide Fund Nat, Limbe, Cameroon; [Todd, Angelique] World Wide Fund Nat, Bangui, Cent Afr Republ; [Warren, Ymke] Wildlife Conservat Soc, Limbe, Cameroon	University of London; University College London; Max Planck Society; University of Konstanz; University of Stirling; Wildlife Conservation Society; University of Missouri System; University of Missouri Saint Louis; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; McGill University; McGill University; World Wildlife Fund; World Wildlife Fund; Kyoto University; Max Planck Society; University of Amsterdam; University of Ghana; World Wildlife Fund; World Wildlife Fund; James Madison University; World Wildlife Fund; Zoological Society of London; University of Liege; Royal Belgian Institute of Natural Sciences; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Washington University (WUSTL); World Wildlife Fund; World Wildlife Fund	Tranquilli, S (corresponding author), UCL, Dept Biol Anthropol, London, England.	sandra.tranq@gmail.com	Chapman, Colin/S-1911-2019; Todd, Angelique/AAR-3087-2021; Regnaut, Sebastien/B-2433-2012; Ogunjemite, Babafemi/P-8321-2019; Hicks, Thurston/AAP-4835-2021; Holbech, Lars Haubye/W-2281-2019	Chapman, Colin/0000-0002-8827-8140; Ogunjemite, Babafemi/0000-0001-7220-2427; Morgan, Dorcas/0000-0003-0596-0572; Haubye Holbech, Lars/0000-0002-9975-7825; Abernethy, Katharine/0000-0002-0393-9342; Todd, Angelique/0000-0002-9207-4925				Abernethy KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0303; [Anonymous], 2010, R LANG ENV STAT COMP; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barnes RFW, 2002, ORYX, V36, P236, DOI 10.1017/S0030605302000443; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beier P, 2002, CONSERV BIOL, V16, P1097, DOI 10.1046/j.1523-1739.2002.01003.x; Bi SG, 2012, FOLIA PRIMATOL, V83, P11, DOI 10.1159/000338752; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Blom A, 2004, AFR J ECOL, V42, P23, DOI 10.1111/j.0141-6707.2004.00441.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chape S., 2009, BIOSCIENCE, V59, P623; Coad L, 2013, PARKS, V19, P1, DOI DOI 10.2305/IUCN.CH; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Davenport L, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P279; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; de Merode E, 2007, PACHYDERM, P52; Di Marco M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0198; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Greengrass EJ, 2009, PRIMATE CONSERVATION, V24, P1; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; Hodgkinson C, 2009, THESIS; Holbech LH, 2005, BIRD CONSERV INT, V15, P27, DOI 10.1017/S0959270905000031; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2013, IUCN RED LIST THREAT; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jachmann H, 2008, BIOL CONSERV, V141, P89, DOI 10.1016/j.biocon.2007.09.012; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2013, TRENDS ECOL EVOL, V28, P261, DOI 10.1016/j.tree.2013.01.017; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leverington F, 2010, MANAGEMENT EFFECTIVE; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Malhi Y, 2013, PHILOS T R SOC B, V368, DOI [10.1098/rstb.2012.0293, 10.1098/rstb.2012.0312]; Mubalama L, 2010, THESIS; N'Goran PK, 2012, CONSERV BIOL, V0, P1; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Oates J. F., 1999, MYTH REALITY RAIN FO; Oates JF, 2000, CONSERV BIOL, V14, P1526, DOI 10.1046/j.1523-1739.2000.99230.x; Plumptre A. J., 2001, IMPACT CIVIL WAR CON; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Remis MJ, 2011, AFR J ECOL, V49, P70, DOI 10.1111/j.1365-2028.2010.01229.x; Scholte P, 2011, TROP CONSERV SCI, V4, P1, DOI 10.1177/194008291100400102; Sinclair A.R.E., 1995, SERENGETI; Sodhi NS., 2007, TROPICAL CONSERVATIO; Sommer V, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-7403-7_1; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Terborgh J., 2010, TROPHIC CASCADES PRE; Thiollay JM, 2007, ORYX, V41, P322, DOI 10.1017/S0030605307000809; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; Venables WN., 2002, MODERN APPL STAT S 4; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wilkie DS, 2001, BIODIVERS CONSERV, V10, P691, DOI 10.1023/A:1016662027017; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmerman BL, 2012, BIOSCIENCE, V62, P479, DOI 10.1525/bio.2012.62.5.9	78	71	72	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114154	10.1371/journal.pone.0114154	http://dx.doi.org/10.1371/journal.pone.0114154			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469888	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700078
J	Kim, YP; Park, D; Kim, JJ; Choi, WJ; Lee, SH; Lee, SY; Kim, S; Chung, JM; Jeon, J; Lee, BD; Shin, JH; Lee, YI; Cho, H; Lee, JM; Kang, HC				Kim, Young Pil; Park, Dongsun; Kim, Jae Jin; Choi, Won-Jae; Lee, Sun Hee; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Jeon, Jinseon; Lee, Byoung Dae; Shin, Joo-Ho; Lee, Yun-Il; Cho, Hyeseong; Lee, Jeong-Min; Kang, Ho Chul			Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SINGLE-CHAIN FV; ANTIBODY FRAGMENT; ESCHERICHIA-COLI; STABILITY; CETUXIMAB; ANTAGONISTS; INHIBITION; CONSTRUCTS; EXPRESSION	Cetuximab, a chimeric monoclonal antibody developed for targeting the Epidermal Growth Factor Receptor (EGFR), has been intensively used to treat cancer patients with metastatic colorectal cancer and head and neck cancer. Intact immunoglobulin G (IgG) antibody like cetuximab, however, has some limitations such as high production cost and low penetration rate from vasculature into solid tumor mass due to its large size. In attempt to overcome these limitations, we engineered cetuximab to create single chain variable fragments (scFv-CH3; Minibody) that were expressed in bacterial system. Among three engineered minibodies, we found that MI061 minibody, which is composed of the variable heavy (V-H) and light (V-L) region joined by an 18-residue peptide linker, displays higher solubility and better extraction properties from bacterial lysate. In addition, we validated that purified MI061 significantly interferes ligand binding to EGFR and blocks EGFR's phosphorylation. By using a protein microarray composed of 16,368 unique human proteins covering around 2,400 plasma membrane associated proteins such as receptors and channels, we also demonstrated that MI061 only recognizes the EGFR but not other proteins as compared with cetuximab. These results indicated that engineered MI061 retains both binding specificity and affinity of cetuximab for EGFR. Although it had relatively short half-life in serum, it was shown to be highly significant anti-tumor effect by inhibiting ERK pathway in A431 xenograft model. Taken together, our present study provides compelling evidence that engineered minibody is more effective and promising agent for in vivo targeting of solid tumors.	[Kim, Young Pil; Choi, Won-Jae; Lee, Sun Hee; Lee, Jeong-Min] Sinil Pharmaceut Co, Life Sci RD Ctr, Dept Bioengn, Songnam, South Korea; [Park, Dongsun; Kim, Jae Jin; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Jeon, Jinseon; Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Kim, Jae Jin; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Cho, Hyeseong; Kang, Ho Chul] Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon 441749, South Korea; [Lee, Byoung Dae] Kyung Hee Univ, Sch Med, Dept Neurosci, Seoul, South Korea; [Shin, Joo-Ho] Sungkyunkwan Univ, Div Pharmacol, Dept Mol Cell Biol, Samsung Biomed Res Inst,Sch Med, Suwon, South Korea; [Lee, Yun-Il] Samsung Adv Inst Technol SAIT, Well Aging Res Ctr, Suwon, South Korea; [Cho, Hyeseong] Ajou Univ, Dept Biochem, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University; Kyung Hee University; Sungkyunkwan University (SKKU); Samsung; Ajou University	Cho, H (corresponding author), Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon 441749, South Korea.	hscho@ajou.ac.kr; jmlee777@hanafos.com; hckang@ajou.ac.kr	Shin, Joo-Ho/P-1417-2018	Cho, Hyeseong/0000-0002-4672-8887; Chung, Jee Min/0000-0003-1725-0770	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0030043, 2012-R1A1A1013558]; National R&D program for Cancer Control, Ministry for Health and Welfare, Korea [131280]; Samsung Advanced Institute of Technology (SAIT)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National R&D program for Cancer Control, Ministry for Health and Welfare, Korea; Samsung Advanced Institute of Technology (SAIT)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2011-0030043 & 2012-R1A1A1013558). This work was also supported in part by a grant from the National R&D program for Cancer Control, Ministry for Health and Welfare, Korea (131280). Sinil Pharmaceutical Company provided support in the form of salaries for authors YPK, SHL, WC, and JL. YL also received salary from Samsung Advanced Institute of Technology (SAIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Asano R, 2013, FEBS J, V280, P4816, DOI 10.1111/febs.12451; AYALA M, 1995, BIOTECHNIQUES, V18, P832; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Bhopale GM, 2005, CURR SCI INDIA, V89, P614; Boerner JL, 2003, EXP CELL RES, V284, P111, DOI 10.1016/S0014-4827(02)00096-4; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; GILL GN, 1984, J BIOL CHEM, V259, P7755; Hu SZ, 1996, CANCER RES, V56, P3055; Hu XJ, 2005, J BIOTECHNOL, V120, P38, DOI 10.1016/j.jbiotec.2005.05.018; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee YI, 2014, MOL CELL PROTEOMICS, V13, P63, DOI 10.1074/mcp.M113.032235; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; MASUI H, 1984, CANCER RES, V44, P1002; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Wang T, 2011, PROTEIN ENG DES SEL, V24, P649, DOI 10.1093/protein/gzr029; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Wittel UA, 2005, NUCL MED BIOL, V32, P157, DOI 10.1016/j.nucmedbio.2004.11.003; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131	29	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113442	10.1371/journal.pone.0113442	http://dx.doi.org/10.1371/journal.pone.0113442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438047	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900045
J	Romani, C; Calza, S; Todeschini, P; Tassi, RA; Zanotti, L; Bandiera, E; Sartori, E; Pecorelli, S; Ravaggi, A; Santin, AD; Bignotti, E				Romani, Chiara; Calza, Stefano; Todeschini, Paola; Tassi, Renata A.; Zanotti, Laura; Bandiera, Elisabetta; Sartori, Enrico; Pecorelli, Sergio; Ravaggi, Antonella; Santin, Alessandro D.; Bignotti, Eliana			Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; HOUSEKEEPING GENES; RT-PCR; RNA; QUANTIFICATION; CELL	Accurate normalization is a primary component of a reliable gene expression analysis based on qRT-PCR technique. While the use of one or more reference genes as internal controls is commonly accepted as the most appropriate normalization strategy, many qPCR-based published studies still contain data poorly normalized and reference genes arbitrarily chosen irrespective of the particular tissue and the specific experimental design. To date, no validated reference genes have been identified for endometrial cancer tissues. In this study, 10 normalization genes (GAPDH, B2M, ACTB, POLR2A, UBC, PPIA, HPRT1, GUSB, TBP, H3F3A) belonging to different functional and abundance classes in various tissues and used in different studies, were analyzed to determine their applicability. In total, 100 endometrioid endometrial cancer samples, which were carefully balanced according to their tumor grade, and 29 normal endometrial tissues were examined using SYBR Green Real-Time RT-PCR. The expression stability of candidate reference genes was determined and compared by means of geNorm and NormFinder softwares. Both algorithms were in agreement in identifying GAPDH, H3F3A, PPIA, and HPRT1 as the most stably expressed genes, only differing in their ranking order. Analysis performed on the expression levels of all candidate genes confirm HPRT1 and PPIA as the most stably expressed in the study groups regardless of sample type, to be used alone or better in combination. As the stable expression of HPRT1 and PPIA between normal and tumor endometrial samples fulfill the basic requirement of a reference gene to be used for normalization purposes, HPRT1 expression showed significant differences between samples from low-grade and high-grade tumors. In conclusion, our results recommend the use of PPIA as a single reference gene to be considered for improved reliability of normalization in gene expression studies involving endometrial tumor samples at different tumor degrees.	[Romani, Chiara; Todeschini, Paola; Tassi, Renata A.; Zanotti, Laura; Bandiera, Elisabetta; Sartori, Enrico; Pecorelli, Sergio; Ravaggi, Antonella; Bignotti, Eliana] Univ Brescia, Div Gynecol Oncol, Angelo Nocivelli Inst Mol Med, Brescia, Italy; [Calza, Stefano] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Calza, Stefano] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Santin, Alessandro D.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	University of Brescia; University of Brescia; Karolinska Institutet; Yale University	Romani, C (corresponding author), Univ Brescia, Div Gynecol Oncol, Angelo Nocivelli Inst Mol Med, Brescia, Italy.	cromani76@gmail.com	Calza, Stefano/AAM-9790-2021; Romani, Chiara/AAB-9920-2022; Ravaggi, Antonella/K-5585-2016	Calza, Stefano/0000-0003-4996-7995; Romani, Chiara/0000-0001-7916-2704; Ravaggi, Antonella/0000-0003-4661-9979; Zanotti, Laura/0000-0002-0471-7127	Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica), Rome, Italy [527/B4/4]; National Institutes of Health [R01 CA154460-01, U01 CA176067-01A1]; Honorable Tina Brozman Foundation; Deborah Bunn Alley Ovarian Cancer Research Foundation; Guido Berlucchi Research Foundation; NATIONAL CANCER INSTITUTE [U01CA176067, R01CA154460] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica), Rome, Italy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honorable Tina Brozman Foundation; Deborah Bunn Alley Ovarian Cancer Research Foundation; Guido Berlucchi Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica 527/B4/4), Rome, Italy, to SP and in part by R01 CA154460-01 and U01 CA176067-01A1 grants from the National Institutes of Health, the Honorable Tina Brozman Foundation, the Deborah Bunn Alley Ovarian Cancer Research Foundation, and the Guido Berlucchi Research Foundation to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2014, R LANG ENV STAT COMP; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dijkstra JR, 2014, MOL ONCOL       0102, V2; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hevir N, 2011, MOL CELL ENDOCRINOL, V331, P158, DOI 10.1016/j.mce.2010.09.011; Huber PJ, 2009, WILEY SERIES PROBABI; Lefever S, 2009, NUCLEIC ACI IN PRESS; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Meuer S.C., 2001, RAPID CYCLE REAL TIM; Mueller O, 2004, RNA INTEGRITY NUMBER; Piyamongkol W, 2003, MOL HUM REPROD, V9, P411, DOI 10.1093/molehr/gag051; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; SCHUIRMANN DL, 1981, BIOMETRICS, V37, P617; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; US Food and Drug Administration (FDA), 1992, GUID STAT PROC BIOE; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellek S., 2003, TESTING STAT HYPOTHE	32	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113781	10.1371/journal.pone.0113781	http://dx.doi.org/10.1371/journal.pone.0113781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473950	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500091
J	Shemesh, II; Rozen-Zvi, B; Kalechman, Y; Gafter, U; Sredni, B				Shemesh, Itay Israel; Rozen-Zvi, Benaya; Kalechman, Yona; Gafter, Uzi; Sredni, Benjamin			AS101 Prevents Diabetic Nephropathy Progression and Mesangial Cell Dysfunction: Regulation of the AKT Downstream Pathway	PLOS ONE			English	Article							HIGH GLUCOSE; PHOSPHOINOSITIDE 3-KINASE; KIDNEY-DISEASE; TGF-BETA; IMMUNOMODULATOR AS101; RENAL HYPERTROPHY; GROWTH; FIBROSIS; GLOMERULOSCLEROSIS; PHOSPHORYLATION	Diabetic nephropathy (DN) is characterized by proliferation of mesangial cells, mesangial expansion, hypertrophy and extracellular matrix accumulation. Previous data have cross-linked PKB (AKT) to TGF beta induced matrix modulation. The nontoxic compound AS101 has been previously shown to favorably affect renal pathology in various animal models and inhibits AKTactivity in leukemic cells. Here, we studied the pharmacological properties of AS101 against the progression of rat DN and high glucose-induced mesangial dysfunction. In-vivo administration of AS101 to Streptozotocin injected rats didn't decreased blood glucose levels but ameliorated kidney hypotrophy, proteinuria and albuminuria and downregulated cortical kidney phosphorylation of AKT, GSK3 beta and SMAD3. AS101 treatment of primary rat glomerular mesangial cells treated with high glucose significantly reduced their elevated proliferative ability, as assessed by XTT assay and cell cycle analysis. This reduction was associated with decreased levels of p-AKT, increased levels of PTEN and decreased p-GSK3 beta and p-FoxO3a expression. Pharmacological inhibition of PI3K, mTORC1 and SMAD3 decreased HG-induced collagen accumulation, while inhibition of GSK3 beta did not affect its elevated levels. AS101 also prevented HG-induced cell growth correlated to mTOR and (rp) S6 dephosphorylation. Thus, pharmacological inhibition of the AKT downstream pathway by AS101 has clinical potential in alleviating the progression of diabetic nephropathy.	[Shemesh, Itay Israel; Kalechman, Yona; Sredni, Benjamin] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Safdie Inst AIDS & Immunol Res, Ramat Gan, Israel; [Rozen-Zvi, Benaya; Gafter, Uzi] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Rozen-Zvi, Benaya; Gafter, Uzi] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Bar Ilan University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shemesh, II (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Safdie Inst AIDS & Immunol Res, Ramat Gan, Israel.	Itay.sh4@gmail.com; Benjamin.Sredni@biu.ac.il	rozen-zvi, benaya/AAR-4812-2021		Safdie Institute for AIDS and Immunology Research; Milton and Lois Shiffman Global Research Program; Dave and Florence Muskovitz Chair in Cancer Research; Comet Walerstein Cancer Research Program; Dorsha Wallman Cancer Research Endowment; Frida Stollman Cancer Memorial Fund	Safdie Institute for AIDS and Immunology Research; Milton and Lois Shiffman Global Research Program; Dave and Florence Muskovitz Chair in Cancer Research; Comet Walerstein Cancer Research Program; Dorsha Wallman Cancer Research Endowment; Frida Stollman Cancer Memorial Fund	This work was partly supported by: The Safdie Institute for AIDS and Immunology Research; The Milton and Lois Shiffman Global Research Program; The Dave and Florence Muskovitz Chair in Cancer Research; The Comet Walerstein Cancer Research Program; The Dorsha Wallman Cancer Research Endowment and the Frida Stollman Cancer Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Choudhury D, 2010, DISCOV MED, V10, P406; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Goldfarb S, 2001, Trans Am Clin Climatol Assoc, V112, P27; Goldfarb S., 2001, T AM CLIN CLIMAT ASS, V112, P33; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Ho C, 2012, AM J MED SCI, V344, P374, DOI 10.1097/MAJ.0b013e31824369c5; James LR, 2010, AM J PHYSIOL-ENDOC M, V298, pE210, DOI 10.1152/ajpendo.00232.2009; Jeong SI, 2012, FOOD CHEM TOXICOL, V50, P1045, DOI 10.1016/j.fct.2011.11.028; Kalechman Y, 2004, J BIOL CHEM, V279, P24724, DOI 10.1074/jbc.M312006200; Kalechman Y, 2003, J AM SOC NEPHROL, V14, P620, DOI 10.1097/01.ASN.0000053415.29636.4F; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Layani-Bazar A, 2014, CANCER RES, V74, P3092, DOI 10.1158/0008-5472.CAN-13-2159; LEEHEY DJ, 1995, DIABETES, V44, P929, DOI 10.2337/diabetes.44.8.929; Li XF, 2001, P NATL ACAD SCI USA, V98, P14416, DOI 10.1073/pnas.251547198; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Lu Q, 2013, EXP PHYSIOL, V98, P934, DOI 10.1113/expphysiol.2012.068361; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ricupero DA, 2001, AM J PHYSIOL-CELL PH, V281, pC99, DOI 10.1152/ajpcell.2001.281.1.C99; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Schellhase KG, 2005, FAM MED, V37, P125; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Schiffer M, 2000, KIDNEY INT, V58, pS45, DOI 10.1046/j.1523-1755.2000.07708.x; Sharma K, 2000, CYTOKINE GROWTH F R, V11, P115, DOI 10.1016/S1359-6101(99)00035-0; Sheu ML, 2004, MOL PHARMACOL, V66, P187, DOI 10.1124/mol.66.1.187; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang WX, 2012, J NEPHROL, V25, P1023, DOI 10.5301/jn.5000089; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; WOLF G, 1992, KIDNEY INT, V42, P647, DOI 10.1038/ki.1992.330; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu D, 2009, AM J PHYSIOL-RENAL, V297, pF822, DOI 10.1152/ajprenal.00054.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/289327; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	54	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114287	10.1371/journal.pone.0114287	http://dx.doi.org/10.1371/journal.pone.0114287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474550	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500009
J	Shrinet, J; Nandal, UK; Adak, T; Bhatnagar, RK; Sunil, S				Shrinet, Jatin; Nandal, Umesh Kumar; Adak, Tridibes; Bhatnagar, Raj K.; Sunil, Sujatha			Inference of the Oxidative Stress Network in Anopheles stephensi upon Plasmodium Infection	PLOS ONE			English	Article							RNA-SEQ; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MIDGUT; IMMUNITY; REDOX; GAMBIAE; SYSTEM; THIOREDOXIN; ANNOTATION	Ookinete invasion of Anopheles midgut is a critical step for malaria transmission; the parasite numbers drop drastically and practically reach a minimum during the parasite's whole life cycle. At this stage, the parasite as well as the vector undergoes immense oxidative stress. Thereafter, the vector undergoes oxidative stress at different time points as the parasite invades its tissues during the parasite development. The present study was undertaken to reconstruct the network of differentially expressed genes involved in oxidative stress in Anopheles stephensi during Plasmodium development and maturation in the midgut. Using high throughput next generation sequencing methods, we generated the transcriptome of the An. stephensi midgut during Plasmodium vinckei petteri oocyst invasion of the midgut epithelium. Further, we utilized large datasets available on public domain on Anopheles during Plasmodium ookinete invasion and Drosophila datasets and arrived upon clusters of genes that may play a role in oxidative stress. Finally, we used support vector machines for the functional prediction of the unannotated genes of An. stephensi. Integrating the results from all the different data analyses, we identified a total of 516 genes that were involved in oxidative stress in An. stephensi during Plasmodium development. The significantly regulated genes were further extracted from this gene cluster and used to infer an oxidative stress network of An. stephensi. Using system biology approaches, we have been able to ascertain the role of several putative genes in An. stephensi with respect to oxidative stress. Further experimental validations of these genes are underway.	[Shrinet, Jatin; Bhatnagar, Raj K.; Sunil, Sujatha] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Nandal, Umesh Kumar] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Adak, Tridibes] Natl Inst Malaria Res, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Amsterdam; Academic Medical Center Amsterdam; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sunil, S (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	sujatha@icgeb.res.in	SHRINET, JATIN/P-9088-2014	SHRINET, JATIN/0000-0002-4274-613X	Ramanujan fellowship, Department of Science and Technology, Government of India;  [SR/S2/RJN-53/2009]	Ramanujan fellowship, Department of Science and Technology, Government of India; 	SS is a recipient of Ramanujan fellowship, Department of Science and Technology, Government of India, and their support is duly acknowledged. The study was funded through grant number "SR/S2/RJN-53/2009". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ AMM, 1991, REV I MED TROP, V33, P421, DOI [10.1590/S0036-46651991000600001, 10.1590/S0036-46651991000600013]; Andrews S., 2010, REFERENCE SOURCE; Beutler B, 2008, CURR TOP MICROBIOL, V321, P3; Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Clark TM, 2005, TISSUE CELL, V37, P457, DOI 10.1016/j.tice.2005.08.001; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Duran-Bedolla J., 2013, OXID ANTIOXID MED SC, V2, P93, DOI [10.5455/oams.130413.rv.007, DOI 10.5455/OAMS.130413.RV.007, DOI 10.5455/0AMS.130413.RV.007]; Forst CV, 2006, INFECTIOUS DIS INFOR, P123; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gostner JM, 2013, REDOX REP, V18, P88, DOI 10.1179/1351000213Y.0000000044; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Huang Y, 2006, BIOINFORMATICS, V26, P680; HUNT NH, 1990, BLOOD CELLS, V16, P499; Hunt NH, 1989, BLOOD CELLS, V16, P527; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jomova K, 2012, J MICROBIOLOGY BIOTE, V1; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DD, 2001, ADV NEUR IN, V13, P556; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehane M. J., 1996, BIOL INSECT MIDGUT; Linksvayer TA, 2012, J EXP ZOOL PART B, V318B, P159, DOI 10.1002/jez.b.22001; Martinez-Cruz O, INVERTEBRATES MITOCH; Mohien CU, 2013, MOL CELL PROTEOMICS, V12, P120, DOI 10.1074/mcp.M112.019596; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nepveu F, 2013, FUTURE MED CHEM, V5, P1993, DOI [10.4155/FMC.13.159, 10.4155/fmc.13.159]; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Niissalo A., 2007, CYTOSCAPE ITS PLUGIN; Nubel E, 2009, PROTEOMICS, V9, P2408, DOI 10.1002/pmic.200800632; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Seyres D, 2012, BRIEF FUNCT GENOMICS, V11, P366, DOI 10.1093/bfgp/els028; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripoli G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r11; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Yan JZ, 2009, GENESIS, V47, P196, DOI 10.1002/dvg.20483; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	65	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114461	10.1371/journal.pone.0114461	http://dx.doi.org/10.1371/journal.pone.0114461			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474020	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500031
J	Ye, RS; Yang, WL; Yuan, YM; Deng, XQ				Ye, Rensong; Yang, Wenlan; Yuan, Yiming; Deng, Xingqi			The CC Genotype of the Delta-Sarcoglycan Gene Polymorphism rs13170573 Is Associated with Obstructive Sleep Apnea in the Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; GLYCOPROTEIN COMPLEX; JAPANESE PATIENTS; VASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTOR; METAANALYSIS; DYSFUNCTION	Obstructive sleep apnea (OSA) is a highly heterogeneous sleep disorder, and increasing evidence suggests that genetic factors play a role in the etiology of OSA. Airway muscle dysfunction might promote pharyngeal collapsibility, mutations or single nucleotide polymorphisms (SNPs) in the delta-sarcoglycan (SCGD) gene associated with muscle dysfunction. To evaluate if SCGD gene SNPs are associated with OSA, 101 individuals without OSA and 97 OSA patients were recruited randomly. The genotype distributions of SNPs (rs157350, rs7715464, rs32076, rs13170573 and rs1835919) in case and control populations were evaluated. The GG, GC and CC genotypes of rs13170573 in control and OSA groups were 51.5% and 37.1%, 36.6% and 35.1%, and 11.9% and 27.8%, respectively. Significantly fewer OSA patients possessed the GG genotype and significantly more possessed the CC genotype compared with controls. Further multivariate logistic regression analysis showed that the CC genotype was an independent risk factor for OSA, with an odds ratio (OR) of 2.17 (95% confidence interval [CI]: 1.19-6.01). Other factors, such as age >= 50 years, male gender, body mass index (BMI) >= 25 kg/m(2), low-density lipoprotein cholesterol (LDL-C) level >= 3.33 mg/dL, smoking and hypertension, were also independent risk factors for OSA in our multivariate logistic regression model.	[Ye, Rensong] Jiangsu Univ, Affiliated Shanghai Peoples Hosp 8, Dept Internal Med, Shanghai, Peoples R China; [Deng, Xingqi] Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China; [Yang, Wenlan] Tongji Univ, Affiliated Shanghai Pulm Hosp, Dept Resp Med, Shanghai 200092, Peoples R China; [Yuan, Yiming] Sichuan Univ, Affiliated West China Hosp, Dept Gerontol, Chengdu 610064, Peoples R China	Jiangsu University; Tongji University; Sichuan University	Deng, XQ (corresponding author), Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China.	dxq2000@hotmail.com						Abboud F, 2014, J CLIN INVEST, V124, P1454, DOI 10.1172/JCI70420; Badorff C, 2004, MED MICROBIOL IMMUN, V193, P121, DOI 10.1007/s00430-003-0189-7; Bailey EF, 2006, J APPL PHYSIOL, V101, P609, DOI 10.1152/japplphysiol.00204.2006; Chockalingam PS, 2002, AM J PHYSIOL-CELL PH, V283, pC500, DOI 10.1152/ajpcell.00529.2001; Choi JB, 2006, SLEEP, V29, P1531, DOI 10.1093/sleep/29.12.1531; Date M, 2000, AM J CARDIOL, V85, P1315, DOI 10.1016/S0002-9149(00)00762-1; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Duchna H-W, 2006, Pneumologie, V60, P568, DOI 10.1055/s-2006-944248; Eng L, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-18; Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115; GUILLEMINAULT C, 1988, CHEST, V93, P104, DOI 10.1378/chest.93.1.104; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hightower CM, 2013, J NEUROCHEM, V127, P750, DOI 10.1111/jnc.12346; Honda T, 2007, CIRC J, V71, P1263, DOI 10.1253/circj.71.1263; Jordan AS, 2002, J APPL PHYSIOL, V93, P2129, DOI 10.1152/japplphysiol.00135.2002; Kawada T, 2002, P NATL ACAD SCI USA, V99, P901, DOI 10.1073/pnas.022641799; Kendzerska T, 2014, SLEEP MED REV, V18, P49, DOI 10.1016/j.smrv.2013.01.003; Larkin EK, 2008, ANN HUM GENET, V72, P762, DOI 10.1111/j.1469-1809.2008.00472.x; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Lopez-Jimenez F, 2008, CHEST, V133, P793, DOI 10.1378/chest.07-0800; Lurie A, 2011, ADV CARDIOL, V46, P1, DOI 10.1159/000327660; Ordonez-Razo RM, 2010, GENET TEST MOL BIOMA, V14, P237, DOI 10.1089/gtmb.2009.0147; Muzumdar H, 2012, SLEEP, V35, P1311, DOI 10.5665/sleep.2094; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Ordonez-Razo RM, 2012, GENET TEST MOL BIOMA, V16, P855, DOI 10.1089/gtmb.2011.0343; Ovchinsky A, 2002, ARCH OTOLARYNGOL, V128, P815, DOI 10.1001/archotol.128.7.815; Palmer LJ, 2004, AM J RESP CRIT CARE, V169, P1314, DOI 10.1164/rccm.200304-493OC; Palmer LJ, 2003, AM J HUM GENET, V72, P340, DOI 10.1086/346064; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Relf BL, 2010, J SLEEP RES, V19, P349, DOI 10.1111/j.1365-2869.2009.00797.x; Resnick HE, 1999, BRIT MED J, V318, P531, DOI 10.1136/bmj.318.7182.531; Riha RL, 2009, EUR RESPIR J, V33, P646, DOI 10.1183/09031936.00151008; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Sanchez-Garcia S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-2; Sankri-Tarbichi Abdul Ghani, 2012, Avicenna J Med, V2, P3, DOI 10.4103/2231-0770.94803; Sasaki N, 2013, ANESTHESIOLOGY, V118, P961, DOI 10.1097/ALN.0b013e318288834f; Savas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012601; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sleiman P, 2011, SLEEP, V34, P1449, DOI 10.5665/sleep.1366; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Towbin JA, 2001, J ELECTROCARDIOL, V34, P151, DOI 10.1054/jelc.2001.28859; Varvarigou V, 2011, SLEEP, V34, P1461, DOI 10.5665/sleep.1376; Wheeler MT, 2002, HUM MOL GENET, V11, P2147, DOI 10.1093/hmg/11.18.2147; Wicklund MP, 2014, NEUROL CLIN, V32, P729, DOI 10.1016/j.ncl.2014.04.005; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099	49	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114160	10.1371/journal.pone.0114160	http://dx.doi.org/10.1371/journal.pone.0114160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474115	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500119
J	Li, AN; Xia, XC; Yeh, J; Kua, HY; Liu, HJ; Mishina, Y; Hao, AJ; Li, BJ				Li, Anna; Xia, Xuechun; Yeh, James; Kua, Huiyi; Liu, Huijuan; Mishina, Yuji; Hao, Aijun; Li, Baojie			PDGF-AA Promotes Osteogenic Differentiation and Migration of Mesenchymal Stem Cell by Down-Regulating PDGFR alpha and Derepressing BMP-Smad1/5/8 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; TGF-BETA; RECEPTOR-BETA; EXPRESSION; PROTEIN; PROLIFERATION; INDUCTION; CULTURES	Platelet-derived growth factors (PDGFs) play important roles in skeletal development and bone fracture healing, yet how PDGFs execute their functions remains incompletely understood. Here we show that PDGF-AA, but not -AB or -BB, could activate the BMP-Smad1/5/8 pathway in mesenchymal stem cells (MSCs), which requires BMPRIA as well as PDGFR alpha. PDGF-AA promotes MSC osteogenic differentiation through the BMP-Smad1/5/8-Runx2/Osx axis and MSC migration via the BMP-Smad1/5/8-Twist1/Atf4 axis. Mechanistic studies show that PDGF-AA activates BMP-Smad1/5/8 signaling by feedback down-regulating PDGFRa, which frees BMPRI and allows for BMPRI-BMPRII complex formation to activate smad1/5/8, using BMP molecules in the microenvironment. This study unravels a physical and functional interaction between PDGFRa and BMPRI, which plays an important role in MSC differentiation and migration, and establishes a link between PDGF-AA and BMPs pathways, two essential regulators of embryonic development and tissue homeostasis.	[Li, Anna; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250012, Shandong, Peoples R China; [Li, Anna; Xia, Xuechun; Yeh, James; Liu, Huijuan; Li, Baojie] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Kua, Huiyi] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138632, Singapore; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	Shandong University; Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Michigan System; University of Michigan	Hao, AJ (corresponding author), Shandong Univ, Sch Med, Dept Histol & Embryol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	aijunhao@sdu.edu.cn; libj@sjtu.edu.cn			Ministry of Science and Technology of China [2012CB966901]; National Natural Science Foundation of China [81130039, 31071229, 81121001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: The work was supported by grants from the Ministry of Science and Technology of China (The National Key Scientific Program (2012CB966901, to BL))(http://www.most.gov.cn/) and the National Natural Science Foundation of China (81130039, 31071229, and 81121001(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bordei P, 2011, J BONE JOINT SURG BR, V93B, P1653, DOI 10.1302/0301-620X.93B12.27244; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Caverzasio J, 2013, J BONE MINER RES, V28, P260, DOI 10.1002/jbmr.1748; CENTRELLA M, 1992, J CLIN INVEST, V89, P1076, DOI 10.1172/JCI115687; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Czarkowska-Paczek B, 2006, J PHYSIOL PHARMACOL, V57, P189; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Fantauzzo KA, 2014, GENE DEV, V28, P1005, DOI 10.1101/gad.238709.114; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; HUANG JS, 1983, J CELL BIOL, V97, P383, DOI 10.1083/jcb.97.2.383; Huang W, 2012, ONCOGENE, V31, P4527, DOI 10.1038/onc.2011.573; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kua HY, 2012, NAT CELL BIOL, V14, P727, DOI 10.1038/ncb2528; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li Baojie, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P208, DOI 10.2174/187153008785700127; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; Malabanan KP, 2012, AM J PATHOL, V180, P2590, DOI 10.1016/j.ajpath.2012.02.009; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pickett EA, 2008, DEVELOPMENT, V135, P589, DOI 10.1242/dev.013763; RYDZIEL S, 1994, ENDOCRINOLOGY, V134, P2541, DOI 10.1210/en.134.6.2541; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Shah P, 2012, J ORAL IMPLANTOL; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soriano P, 1997, DEVELOPMENT, V124, P2691; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Verheyen EM, 2007, DEV CELL, V13, P755, DOI 10.1016/j.devcel.2007.11.006; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yang DH, 2000, CYTOKINE, V12, P1271, DOI 10.1006/cyto.2000.0707; Yu XH, 1997, AM J PHYSIOL-CELL PH, V272, pC1709, DOI 10.1152/ajpcell.1997.272.5.C1709; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhang YY, 2012, BIOSCI TRENDS, V6, P130, DOI 10.5582/bst.2012.v6.3.130	56	65	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113785	10.1371/journal.pone.0113785	http://dx.doi.org/10.1371/journal.pone.0113785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470749	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700044
J	Merikanto, I; Lahti, T; Seitsalo, S; Kronholm, E; Laatikainen, T; Peltonen, M; Vartiainen, E; Partonen, T				Merikanto, Ilona; Lahti, Tuuli; Seitsalo, Seppo; Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki; Partonen, Timo			Behavioral Trait of Morningness-Eveningness in Association with Articular and Spinal Diseases in a Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PROSPECTIVE COHORT; DIURNAL-TYPE; SLEEP; CHRONOTYPE; DEPRESSION; ALCOHOL; RISK; PAIN; AGE	Earlier studies have revealed that the more the preference to schedule daily activities towards the evening hours is, the higher the odds for a range of health hazards are. Therefore, we wanted to analyze, whether the behavioral trait of morningness-eveningness is associated with articular and spinal diseases or those with musculoskeletal disorders. Participants (n=6089), as part of the National FINRISK 2007 Study, were derived from the general population, aged 25 to 74 years, living in Finland. Chronotype was assessed based on six items from the original Horne-Ostberg Morningness-Eveningness Questionnaire. Information about risk factors and the diagnoses of articular and spinal diseases were based on the self-reported information. Our results suggest that Evening-types have higher odds for articular and spinal diseases as compared with Morning-types, and this risk is heightened especially regarding spinal disease and backache (odds ratios of 1.8 to 2.1, and 1.6 to 1.8, respectively) and remains significant after controlling for the sex, age, education, civil status, physical activity, alcohol use, and smoking, and additionally for the body-mass index, insufficient sleep, or depressive symptoms.	[Merikanto, Ilona; Lahti, Tuuli; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland; [Merikanto, Ilona] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Merikanto, Ilona; Seitsalo, Seppo] Orton Orthopaed Hosp, Helsinki, Finland; [Lahti, Tuuli] Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland; [Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Turku, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Laatikainen, Tiina] Hosp Dist North Karelia, Joensuu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Eastern Finland	Merikanto, I (corresponding author), Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland.	ilona.merikanto@helsinki.fi	Peltonen, Markku/F-3037-2015; Partonen, Timo/G-1105-2012; merikanto, ilona/AAF-2395-2021; Laatikainen, Tiina/ABD-6622-2021	Peltonen, Markku/0000-0002-3767-4223; Partonen, Timo/0000-0003-1951-2455; Laatikainen, Tiina/0000-0002-6614-4782; lahti, tuuli/0000-0003-2311-2980; Merikanto, Ilona/0000-0002-1222-6678	Juho Vainio Foundation; Orton Orthopaedics Hospital	Juho Vainio Foundation; Orton Orthopaedics Hospital	Funding: This work was supported by a grant from Juho Vainio Foundation and funding from Orton Orthopaedics Hospital (to Ms. Merikanto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad VC, 2008, SLEEP MED REV, V12, P211, DOI 10.1016/j.smrv.2007.09.001; ADAN A, 1994, ADDICTION, V89, P455, DOI 10.1111/j.1360-0443.1994.tb00926.x; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Broms U, 2011, ADDICTION, V106, P170, DOI 10.1111/j.1360-0443.2010.03112.x; Broms U, 2012, J ADDICTION RES THER, VS2, DOI [10.4172/2155-6105.s2-002, DOI 10.4172/2155-6105.S2-002, 10.4172/2155-6105.S2-002]; Broms U, 2014, CHRONOBIOL INT, V31, P182, DOI 10.3109/07420528.2013.836534; Carrier J, 1999, CHRONOBIOL INT, V16, P79, DOI 10.3109/07420529908998714; De Cata A, 2014, EXPERT REV CLIN IMMU, V10, P687, DOI 10.1586/1744666X.2014.899904; Duffy JF, 1998, AM J PHYSIOL-REG I, V275, pR1478, DOI 10.1152/ajpregu.1998.275.5.R1478; Duffy JF, 1999, J INVEST MED, V47, P141; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Gamaldo CE, 2012, NEUROL CLIN, V30, P1313, DOI 10.1016/j.ncl.2012.08.007; Geenen R, 2012, BEST PRACT RES CL RH, V26, P305, DOI 10.1016/j.berh.2012.05.004; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gossan N, 2015, BIOGERONTOLOGY, V16, P209, DOI 10.1007/s10522-014-9522-3; Hashmi AM, 2013, J PAK MED ASSOC, V63, P899; Hatonen T, 2008, ALCOHOL ALCOHOLISM, V43, P564, DOI 10.1093/alcalc/agn057; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hunt L, 2014, NAT REV RHEUMATOL, V10, P521, DOI 10.1038/nrrheum.2014.82; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Kanerva N, 2012, CHRONOBIOL INT, V29, P920, DOI 10.3109/07420528.2012.699128; Konttinen H, 2014, CHRONOBIOL INT, V31, P554, DOI 10.3109/07420528.2013.877922; Koskenvuo M, 2007, J SLEEP RES, V16, P156, DOI 10.1111/j.1365-2869.2007.00580.x; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; McBeth J, 2014, ARTHRITIS RHEUMATOL, V66, P757, DOI 10.1002/art.38284; Merikanto I, 2014, CHRONOBIOL INT, V31, P95, DOI 10.3109/07420528.2013.826672; Merikanto I, 2013, CHRONOBIOL INT, V30, P470, DOI 10.3109/07420528.2012.741171; Merikanto I, 2012, CHRONOBIOL INT, V29, P311, DOI 10.3109/07420528.2012.655870; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Rathbun AM, 2013, RHEUMATOLOGY, V52, P1785, DOI 10.1093/rheumatology/kes356; Spies CM, 2010, J RHEUMATOL, V37, P894, DOI 10.3899/jrheum.091283; Taillard J, 2001, J BIOL RHYTHM, V16, P183, DOI 10.1177/074873001129001764; Watson NF, 2013, J CLIN SLEEP MED, V9, P1333, DOI 10.5664/jcsm.3282; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	34	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114635	10.1371/journal.pone.0114635	http://dx.doi.org/10.1371/journal.pone.0114635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470493	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700125
J	Ou, WM; Cui, LQ; Li, Y; Zheng, B; Lv, Y				Ou, Weimei; Cui, Lanqing; Li, Yun; Zheng, Bo; Lv, Yuan			Epidemiological Characteristics of bla(NDM-1) in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex in China from 2011 to 2012	PLOS ONE			English	Article							EMERGENCE; NDM-1; IDENTIFICATION; COEXISTENCE	Objectives: The study aimed to investigate the prevalence and epidemiological characteristics of bla(NDM-1) (encoding New Delhi metallo-b-lactamase 1) in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii complex (ABC) in China from July 2011 to June 2012. Methods: PCR was used to screen for the presence of bla(NDM-1) in all organisms studied. For bla(NDM-1)-positive strains, 16S rRNA analysis and Analytical Profile Index (API) strips were used to identify the bacterial genus and species. The ABCs were reconfirmed by PCR detection of bla(OXA-51-like). Antibiotic susceptibilities of the bacteria were assessed by determining minimum inhibitory concentration (MIC) of them using two-fold agar dilution test, as recommended by the Clinical and Laboratory Standards Institute (CLSI). Molecular typing was performed using pulsed-field gel electrophoresis (PFGE). S1 nuclease-pulsed-field gel electrophoresis (S1-PFGE) and Southern blot hybridization were conducted to ascertain the gene location of bla(NDM-1). Conjugation experiments were conducted to determine the transmission of bla(NDM-1)-positive strains. Results: Among 2,170 Enterobacteriaceae and 600 ABCs, seven Enterobacteriaceae strains and two A. calcoaceticus isolates from five different cities carried the bla(NDM-1) gene. The seven Enterobacteriaceae strains comprised four Klebsiella pneumoniae, one Enterobacter cloacae, one Enterobacter aerogen and one Citrobacter freundii. All seven were non-susceptible to imipenem, meropenem or ertapenem. Two A. calcoaceticus species were resistant to imipenem and meropenem. Three K. pneumoniae showed the same PFGE profiles. The bla(NDM-1) genes of eight strains were localized on plasmids, while one was chromosomal. Conclusions: Compared with previous reports, the numbers and species containing the bla(NDM-1) in Enterobacteriaceae have significantly increased in China. Most of them are able to disseminate the gene, which is cause for concern. Consecutive surveillance should be implemented and should also focus on the dissemination of bla(NDM-1) among gram-negative clinical isolates.	[Ou, Weimei; Cui, Lanqing; Li, Yun; Zheng, Bo; Lv, Yuan] Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing 100191, Peoples R China	Peking University	Lv, Y (corresponding author), Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing 100191, Peoples R China.	lyzx5857@sina.com			National Science and Technology Major Project [2012ZX09303005-003]	National Science and Technology Major Project	Funding: This work was supported by grants from the National Science and Technology Major Project (No. 2012ZX09303005-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bonnin RA, 2012, CLIN MICROBIOL INFEC, V18, pE362, DOI 10.1111/j.1469-0691.2012.03928.x; Boulanger A, 2012, ANTIMICROB AGENTS CH, V56, P2214, DOI 10.1128/AAC.05653-11; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen ZL, 2011, CLIN INFECT DIS, V52, P692, DOI 10.1093/cid/ciq231; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Decousser JW, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.31.20547; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Du XX, 2013, J MED MICROBIOL, V62, P1332, DOI 10.1099/jmm.0.057091-0; Fu Y, 2012, J ANTIMICROB CHEMOTH, V67, P2114, DOI 10.1093/jac/dks192; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P1553, DOI 10.1093/jac/dks095; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kim TW, 2010, J MICROBIOL BIOTECHN, V20, P1210, DOI 10.4014/jmb.1002.02008; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2010, LANCET INFECT DIS, V10, P832, DOI 10.1016/S1473-3099(10)70279-6; Sole M, 2011, ANTIMICROB AGENTS CH, V55, P4402, DOI 10.1128/AAC.00642-11; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yin JianWen, 2012, Disease Surveillance, V27, P211; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhou G, 2014, EMERG INFECT DIS, V20, P340, DOI 10.3201/eid2002.121263; Zhou WQ, 2013, INDIAN J MED MICROBI, V31, P206, DOI 10.4103/0255-0857.115243	30	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113852	10.1371/journal.pone.0113852	http://dx.doi.org/10.1371/journal.pone.0113852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469701	gold, Green Published			2022-12-27	WOS:000349128700048
J	Wirth, R; Bodi, N; Maroti, G; Bagyanszki, M; Talapka, P; Fekete, E; Bagi, Z; Kovacs, KL				Wirth, Roland; Bodi, Nikolett; Maroti, Gergely; Bagyanszki, Maria; Talapka, Petra; Fekete, Eva; Bagi, Zoltan; Kovacs, Kornel L.			Regionally Distinct Alterations in the Composition of the Gut Microbiota in Rats with Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							MUCOSA-ASSOCIATED MICROBIOTA; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; HEALTH; KLEBSIELLA; COMMUNITY; BACTERIA; COLON	The aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duodenum, ileum and colon were dissected, and the microbiome of the lumen material was analysed by using next-generation DNA sequencing, from phylum to genus level. The intestinal luminal contents were compared between diabetic, insulin-treated diabetic and healthy control rats. No significant differences in bacterial composition were found in the luminal contents from the duodenum of the experimental animal groups, whereas distinct patterns were seen in the ileum and colon, depending on the history of the luminal samples. Ileal samples from diabetic rats exhibited particularly striking alterations, while the richness and diversity obscured some of the modifications in the colon. Characteristic rearrangements in microbiome composition and diversity were detected after insulin treatment, though the normal gut flora was not restored. The Proteobacteria displayed more pronounced shifts than those of the predominant phyla (Firmicutes and Bacteroidetes) in the rat model of T1D. Diabetes and insulin replacement affect the composition of the gut microbiota in different, gut region-specific manners. The luminal samples from the ileum appear more suitable for diagnostic purposes than the colon/faeces. The Proteobacteria should be at the focus of diagnosis and potential therapy. Klebsiella are recommended as biomarkers of T1D.	[Wirth, Roland; Bagi, Zoltan; Kovacs, Kornel L.] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Bodi, Nikolett; Bagyanszki, Maria; Talapka, Petra; Fekete, Eva] Univ Szeged, Dept Physiol Anat & Neurosci, Szeged, Hungary; [Maroti, Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Kovacs, Kornel L.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Kovacs, Kornel L.] Univ Szeged, Dept Oral Biol & Expt Dent, Szeged, Hungary	Szeged University; Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Kovacs, KL (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.	kovacs.kornel@brc.mta.hu	Dr. Wirth, Roland/L-8886-2018	Dr. Wirth, Roland/0000-0002-2383-2323; Maroti, Gergely/0000-0002-3705-0461	Hungarian Scientific Research Fund, OTKA [PD 108309]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP-4.2.2/B-10/1-2010-0012];  [GOP-1.1.1-11-2012-0128]	Hungarian Scientific Research Fund, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; 	Funding from TAMOP-4.2.2/B-10/1-2010-0012 and GOP-1.1.1-11-2012-0128 grants is gratefully acknowledged. N.B. was supported by the Hungarian Scientific Research Fund, OTKA grant PD 108309 and by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program'. M.B. was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron M, 2013, CURR MICROBIOL, V67, P395, DOI 10.1007/s00284-013-0367-9; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bodi N, 2012, MICROCIRCULATION, V19, P316, DOI 10.1111/j.1549-8719.2012.00164.x; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Demedts I, 2013, J NEUROGASTROENTEROL, V19, P161, DOI 10.5056/jnm.2013.19.2.161; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Gutierrez-Canas I, 2006, RHEUMATOLOGY, V45, P527, DOI 10.1093/rheumatology/kei219; Hanninen A, 2007, AM J PATHOL, V170, P240, DOI 10.2353/ajpath.060142; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Izbeki F, 2008, DIABETES RES CLIN PR, V80, P192, DOI 10.1016/j.diabres.2007.12.013; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Marietta EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078687; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ordog T, 2009, Minerva Gastroenterol Dietol, V55, P315; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rashid T, 2009, EUR J GASTROEN HEPAT, V21, P843, DOI 10.1097/MEG.0b013e328318ecde; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rosztoczy A, 2004, Z GASTROENTEROL, V42, P1295, DOI 10.1055/s-2004-813618; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Vaarala O, 2013, CURR DIABETES REP, V13, P601, DOI 10.1007/s11892-013-0409-5; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vasseur MV, 2014, ANTIMICROB AGENTS CH, V58, P1744, DOI 10.1128/AAC.02135-13; Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	48	46	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110440	10.1371/journal.pone.0110440	http://dx.doi.org/10.1371/journal.pone.0110440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469509	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700004
J	Kim, H; Park, SH; Kim, EK; Kim, MJ; Park, YN; Park, HJ; Choi, JY				Kim, Honsoul; Park, Seong Ho; Kim, Eun Kyung; Kim, Myeong-Jin; Park, Young Nyun; Park, Hae-Jeong; Choi, Jin-Young			Histogram Analysis of Gadoxetic Acid-Enhanced MRI for Quantitative Hepatic Fibrosis Measurement	PLOS ONE			English	Article							GD-EOB-DTPA; LIVER FIBROSIS; DECREASED EXPRESSION; CLINICAL-EVALUATION; TEXTURE ANALYSIS; SPECTROSCOPY; TRANSPORTER; DIAGNOSIS; SYSTEMS; BIOPSY	Purpose: The diagnosis and monitoring of liver fibrosis is an important clinical issue; however, this is usually achieved by invasive methods such as biopsy. We aimed to determine whether histogram analysis of hepatobiliary phase images of gadoxetic acid-enhanced magnetic resonance imaging (MRI) can provide noninvasive quantitative measurement of liver fibrosis. Methods: This retrospective study was approved by the institutional ethics committee, and a waiver of informed consent was obtained. Hepatobiliary phase images of preoperative gadoxetic acid-enhanced MRI studies of 105 patients (69 males, 36 females; age 56.1 +/- 12.2) with pathologically documented liver fibrosis grades were analyzed. Fibrosis staging was F0/F1/F2/F3/F4 (METAVIR system) for 11/20/13/15/46 patients, respectively. Four regions-of-interest (ROI, each about 2 cm(2)) were placed on predetermined locations of representative images. The measured signal intensity of pixels in each ROI was used to calculate corrected coefficient of variation (cCV), skewness, and kurtosis. An average value of each parameter was calculated for comparison. Statistical analysis was performed by ANOVA, receiver operating characteristic (ROC) curve analysis, and linear regression. Results: The cCV showed statistically significant differences among pathological fibrosis grades (P<0.001) whereas skewness and kurtosis did not. Univariable linear regression analysis suggested cCV to be a meaningful parameter in predicting the fibrosis grade (P<0.001, beta=0.40 and standard error =0.06). For discriminating F0-3 from F4, the area under ROC score was 0.857, standard deviation 0.036, 95% confidence interval 0.785-0.928. Conclusion: Histogram analysis of hepatobiliary phase images of gadoxetic acid-enhanced MRI can provide non-invasive quantitative measurements of hepatic fibrosis.	[Kim, Honsoul; Kim, Myeong-Jin; Choi, Jin-Young] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Honsoul; Kim, Myeong-Jin; Choi, Jin-Young] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea; [Park, Seong Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Seong Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Eun Kyung; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med Radiol & Psychiat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.	gafield@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kim, Myeong-Jin/E-1623-2011	Kim, Eun-Kyung/0000-0002-3368-5013; Park, Hae-Jeong/0000-0002-4633-0756; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Young Nyun/0000-0003-0357-7967; Choi, Jin-Young/0000-0002-9025-6274				Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Balassy C, 2014, RADIOLOGY, V270, P149, DOI 10.1148/radiol.13122440; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Choi JY, 2014, YONSEI MED J, V55, P651, DOI 10.3349/ymj.2014.55.3.651; Feier D, 2013, RADIOLOGY, V269, P459, DOI 10.1148/radiol.13122482; Godfrey EM, 2012, EUR RADIOL, V22, P2790, DOI 10.1007/s00330-012-2527-x; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hinoshita E, 2001, J HEPATOL, V35, P765, DOI 10.1016/S0168-8278(01)00216-1; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Leinhard OD, 2012, EUR RADIOL, V22, P642, DOI 10.1007/s00330-011-2302-4; LERSKI RA, 1993, MAGN RESON IMAGING, V11, P873, DOI 10.1016/0730-725X(93)90205-R; MAHARAJ B, 1986, LANCET, V1, P523; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Materne R, 2002, MAGNET RESON MED, V47, P135, DOI 10.1002/mrm.10045; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Millet P, 2011, J PHARMACOL EXP THER, V336, P624, DOI 10.1124/jpet.110.175406; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Nojiri S, 2013, J GASTROEN HEPATOL, V28, P1032, DOI 10.1111/jgh.12181; Piscaglia F, 2014, EUR J RADIOL, V83, P450, DOI 10.1016/j.ejrad.2013.06.009; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Stieger B, 2012, EUR J PHARMACOL, V675, P1, DOI 10.1016/j.ejphar.2011.11.048; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Tsuda N, 2010, EUR J RADIOL, V73, P137, DOI 10.1016/j.ejrad.2008.09.036; Valkovic L, 2014, EUR RADIOL, V24, P1602, DOI 10.1007/s00330-014-3141-x; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	38	21	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114224	10.1371/journal.pone.0114224	http://dx.doi.org/10.1371/journal.pone.0114224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460180	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700117
J	Lin, RW; Yang, CN; Ku, SY; Ho, CJ; Huang, SB; Yang, MC; Chang, HW; Lin, CM; Hwang, JL; Chen, YL; Tzeng, CC; Wang, CH				Lin, Ru-Wei; Yang, Chia-Ning; Ku, ShengYu; Ho, Cheng-Jung; Huang, Shih-Bo; Yang, Min-Chi; Chang, Hsin-Wen; Lin, Chun-Mao; Hwang, Jaulang; Chen, Yeh-Long; Tzeng, Cherg-Chyi; Wang, Chihuei			CFS-1686 Causes Cell Cycle Arrest at Intra-S Phase by Interference of Interaction of Topoisomerase 1 with DNA	PLOS ONE			English	Article							I INHIBITORS; MOLECULAR-DYNAMICS; CAMPTOTHECIN; ATM; IDENTIFICATION; ANTICANCER; MECHANISM; DAMAGE; DRUGS	CFS-1686 (chemical name (E)-N-(2-(diethylamino) ethyl)-4-(2-(2-(5-nitrofuran-2yl) vinyl) quinolin-4-ylamino) benzamide) inhibits cell proliferation and triggers late apoptosis in prostate cancer cell lines. Comparing the effect of CFS-1686 on cell cycle progression with the topoisomerase 1 inhibitor camptothecin revealed that CFS-1686 and camptothecin reduced DNA synthesis in S-phase, resulting in cell cycle arrest at the intra-S phase and G1-S boundary, respectively. The DNA damage in CFS-1686 and camptothecin treated cells was evaluated by the level of ATM phosphorylation, gamma H2AX, and gamma H2AX foci, showing that camptothecin was more effective than CFS-1686. However, despite its lower DNA damage capacity, CFS-1686 demonstrated 4-fold higher inhibition of topoisomerase 1 than camptothecin in a DNA relaxation assay. Unlike camptothecin, CFS-1686 demonstrated no activity on topoisomerase 1 in a DNA cleavage assay, but nevertheless it reduced the camptothecin-induced DNA cleavage of topoisomerase 1 in a dose-dependent manner. Our results indicate that CFS-1686 might bind to topoisomerase 1 to inhibit this enzyme from interacting with DNA relaxation activity, unlike campothecin's induction of a topoisomerase 1-DNA cleavage complex. Finally, we used a computer docking strategy to localize the potential binding site of CFS-1686 to topoisomerase 1, further indicating that CFS-1686 might inhibit the binding of Top1 to DNA.	[Lin, Ru-Wei] Natl Cheng Kung Univ, Bone & Joint Res Ctr, Tainan 70101, Taiwan; [Lin, Ru-Wei] Natl Cheng Kung Univ, Med Coll & Hosp, Med Device R&D Core Lab, Tainan 70101, Taiwan; [Yang, Chia-Ning; Chang, Hsin-Wen] Natl Univ Kaohsiung, Dept Life Sci, Kaohsiung, Taiwan; [Ku, ShengYu; Huang, Shih-Bo; Yang, Min-Chi; Wang, Chihuei] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Ho, Cheng-Jung] Kaohsiung Med Univ Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Lin, Chun-Mao; Hwang, Jaulang] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Chen, Yeh-Long; Tzeng, Cherg-Chyi] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National University Kaohsiung; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University	Tzeng, CC (corresponding author), Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan.	tzengch@kmu.edu.tw; chwang@kmu.edu.tw	Huang, Shih-Bo/AAO-9699-2021	Huang, Shih-Bo/0000-0002-1048-2344; Lin, Chun-Mao/0000-0002-8366-4026	Ministry of Science and Technology of Taiwan [NSC99-2320-B-037-013-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC99-2320-B-037-013-MY3 (to CW) from Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FS, 2010, BIOORGAN MED CHEM, V18, P124, DOI 10.1016/j.bmc.2009.11.012; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chillemi G, 2007, NUCLEIC ACIDS RES, V35, P3032, DOI 10.1093/nar/gkm199; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; HSIANG YH, 1988, CANCER RES, V48, P1722; JAXEL C, 1989, CANCER RES, V49, P1465; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Siu FM, 2013, NUCLEIC ACIDS RES, V41, P10010, DOI 10.1093/nar/gkt791; Tanaka T, 2006, CELL PROLIFERAT, V39, P49, DOI 10.1111/j.1365-2184.2006.00364.x; Tomita M, 2010, J RADIAT RES, V51, P493, DOI 10.1269/jrr.10039; Tsai HP, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-49; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu N, 2010, BIOCHEMISTRY-US, V49, P10131, DOI 10.1021/bi1009419	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113832	10.1371/journal.pone.0113832	http://dx.doi.org/10.1371/journal.pone.0113832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460368	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700058
J	Nielsen, NO; Jorgensen, ME; Friis, H; Melbye, M; Soborg, B; Jeppesen, C; Lundqvist, M; Cohen, A; Hougaard, DM; Bjerregaard, P				Nielsen, Nina O.; Jorgensen, Marit E.; Friis, Henrik; Melbye, Mads; Soborg, Bolette; Jeppesen, Charlotte; Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.; Bjerregaard, Peter			Decrease in Vitamin D Status in the Greenlandic Adult Population from 1987-2010	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; GENERAL-POPULATION; INSULIN-RESISTANCE; D INSUFFICIENCY; ARCTIC SOCIETY; D DEFICIENCY; INUIT; ASSOCIATION; CALCIUM; DISEASE	Background: Low vitamin D status may be pronounced in Arctic populations due to limited sun exposure and decreasing intake of traditional food. Objective: To investigate serum 25(OH)D3 as a measure of vitamin D status among adult Inuit in Greenland, predictors of low serum 25(OH)D3 concentrations and the trend from 1987 to 2005-2010. Design: A total of 2877 randomly selected Inuit (>= 18 years) from the Inuit Health in Transition study were included. A sub-sample (n5330) donated a blood sample in 1987 which allowed assessment of time trends in vitamin D status. Results: The geometric mean serum 25(OH)D3 (25[OH]D2 concentrations were negligible and not reported) in 2005-2010 was lowest among the 18-29 year old individuals (30.7 nmol/L; 95% CI: 29.7; 31.7) and increased with age. In all age-groups it decreased from 1987 to 2005-2010 (32%-58%). Low 25(OH)D3 concentrations (<50 nmol/L) were present in 77% of the 18-29 year old and decreased with age. A characteristic seasonal variation in 25(OH)D3 concentrations was observed (range 33.2-57.1 nmol/L, p<0.001), with the highest concentrations in August to October. Age (2.0% per year increase; CI: 1.7, 2.2), female gender (7.1%; CI: 2.0; 12.5), alcohol intake (0.2% per increase in drinks/ week; 0.0; 0.4), and traditional diet (10.0% per 100 g/d increase; CI: 7.9; 12.1) were associated with increased serum 25(OH) D3, whereas smoking (-11.6%; CI: -16.2; -6.9), BMI (20.6%; CI: -1.1; -0.2) and latitude (-0.7% per degree increase; CI: -1.3; -0.2) were associated with decreased concentrations. Conclusion: We identified a remarkable decrease in vitamin D status from 1987 to 2005-2010 and a presently low vitamin D status among Inuit in Greenland. A change away from a traditional diet may well explain the observed decline. The study argues for the need of increased dietary intake of vitamin D and supplementation might be considered.	[Nielsen, Nina O.; Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Friis, Henrik] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Melbye, Mads; Soborg, Bolette] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jeppesen, Charlotte] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Bjerregaard, Peter] Univ Greenland, Greenland Ctr Hlth Res, Nuuk, Greenland	University of Southern Denmark; Steno Diabetes Center; University of Copenhagen; Statens Serum Institut; Aarhus University; Statens Serum Institut	Nielsen, NO (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	noni@niph.dk	Bjerregaard, Peter/ABD-8894-2020; Friis, Henrik/N-2047-2014; Hougaard, David/AAD-6368-2019; Friis, Henrik/P-2891-2019	Bjerregaard, Peter/0000-0001-7153-8447; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Jorgensen, Marit Eika/0000-0001-8356-5565; melbye, mads/0000-0001-8264-6785; Nielsen, Nina Odgaard/0000-0001-6127-5970	Government of Greenland's health department [2011-047012/2012-074239]; Aase and Ejnar Danielsen's Foundation [10-000444]; Dagmar Marshalls Foundation	Government of Greenland's health department; Aase and Ejnar Danielsen's Foundation; Dagmar Marshalls Foundation	The study was supported by the Government of Greenland's health department (2011-047012/2012-074239), Aase and Ejnar Danielsen's Foundation (10-000444), and Dagmar Marshalls Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Michele, 2013, Muscles Ligaments Tendons J, V3, P63, DOI 10.11138/mltj/2013.3.2.063; Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Andersen S, 2005, AM J CLIN NUTR, V81, P656; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; [Anonymous], 2008, HLTH TRANSITIONS ARC; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bell DSH, 2011, SOUTH MED J, V104, P335, DOI 10.1097/01.SMJ.0000397893.94525.0e; Bjerregaard P, 2004, SCAND J PUBLIC HEALT, V32, P390, DOI 10.1080/14034940410028398; Bjerregaard P, 2010, SIF WRITINGS GREENLA, V19; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; Dahl-Petersen IK, 2011, SCAND J PUBLIC HEALT, V39, P678, DOI 10.1177/1403494811420486; Dahl-Petersen IK, 2013, DIABETES RES CLIN PR, V102, P242, DOI 10.1016/j.diabres.2013.10.004; Deutch B, 2007, SCI TOTAL ENVIRON, V384, P106, DOI 10.1016/j.scitotenv.2007.05.042; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Friis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081142; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jahnsen J, 2002, SCAND J GASTROENTERO, V37, P192, DOI 10.1080/003655202753416876; Jamal-Allial A, 2014, J STEROID BIOCHEM, V144, P185, DOI 10.1016/j.jsbmb.2013.12.004; Jeppesen C, 2014, PUBLIC HEALTH NUTR, V17, P462, DOI 10.1017/S136898001300013X; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Kouda K, 2013, NUTRITION, V29, P1204, DOI 10.1016/j.nut.2013.03.010; Kuhnlein HV, 2008, PUBLIC HEALTH NUTR, V11, P349, DOI 10.1017/S1368980007000353; Larose TL, 2014, J EPIDEMIOL COMMUN H, V68, P165, DOI 10.1136/jech-2013-202587; Lewis John G, 2008, Clin Chem, V54, P1931, DOI 10.1373/clinchem.2008.111526; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; McCarty MF, 2003, MED HYPOTHESES, V61, P535, DOI 10.1016/S0306-9877(03)00227-5; Misfeldt J, 1988, Arctic Med Res, V47, P173; Need AG, 2002, OSTEOPOROSIS INT, V13, P83, DOI 10.1007/s198-002-8342-9; Nielsen NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080686; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Rejnmark L, 2004, CALCIFIED TISSUE INT, V74, P255, DOI 10.1007/s00223-003-0110-9; Sulistyoningrum DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043159; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Willet W., 2013, NUTR EPIDEMIOLOGY, P306; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	44	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112949	10.1371/journal.pone.0112949	http://dx.doi.org/10.1371/journal.pone.0112949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461952	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700024
J	Simmons, AD; Nguyen, TKT; Follis, JL; Ribes-Zamora, A				Simmons, Alexandra D.; Nguyen, Thao K. T.; Follis, Jack L.; Ribes-Zamora, Albert			Using a PyMOL Activity to Reinforce the Connection between Genotype and Phenotype in an Undergraduate Genetics Laboratory	PLOS ONE			English	Article								With the purpose of developing an activity that would help clarify genetic concepts related to the connection between genotype and phenotype and the nature of mutations, we designed a three hour teaching module using the PyMol software. The activity starts with two pre-laboratory assignments, one to learn how to use PyMol and the other to read about a specific protein or protein family. During the laboratory students are given instructions where and how to find additional information on a specific disease and its causal mutations in order to prepare a 10-minute, in-class presentation. Using a post activity, anonymous quiz, we found a statistically significant different grade distribution in students that participated in the PyMol activity relative to a control group. We also found a significant improvement in the student's comprehension when answering questions regarding the nature of mutations and protein structure. This demonstrates the utility of this simulation activity as a vehicle to improve student's understanding of specific key genetic concepts.	[Simmons, Alexandra D.; Nguyen, Thao K. T.; Ribes-Zamora, Albert] Univ St Thomas, Dept Biol, Houston, TX 77006 USA; [Follis, Jack L.] Univ St Thomas, Dept Math Comp Sci & Cooperat Engn, Houston, TX 77006 USA	University of Saint Thomas; University of Saint Thomas	Simmons, AD (corresponding author), Univ St Thomas, Dept Biol, 3800 Montrose Blvd, Houston, TX 77006 USA.	simmonad@stthom.edu		Nguyen, Thao/0000-0002-8272-5819				Bell R. L., 2008, NATL SCI TEACHERS AS, V3, P23; Craciun D, 2009, ROM BIOTECH LETT, V14, P4567; DeHaan R. L., 2005, J SCI EDUC TECHNOL, V14, P253, DOI DOI 10.1007/S10956-005-4425-3; Kulik J., 2002, SCH MATH SCI PROGRAM; R Core Team, 2021, R LANGUAGE ENV STAT; Rutten N, 2012, COMPUT EDUC, V58, P136, DOI 10.1016/j.compedu.2011.07.017; Shaw KRM, 2008, GENETICS, V178, P1157, DOI 10.1534/genetics.107.084194; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306	8	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114257	10.1371/journal.pone.0114257	http://dx.doi.org/10.1371/journal.pone.0114257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461967	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700124
J	Chakraborty, M; McGreal, EP; Williams, A; Davies, PL; Powell, W; Abdulla, S; Voitenok, NN; Hogwood, J; Gray, E; Spiller, B; Chambers, RC; Kotecha, S				Chakraborty, Mallinath; McGreal, Eamon P.; Williams, Andrew; Davies, Philip L.; Powell, Wendy; Abdulla, Salima; Voitenok, Nikolai N.; Hogwood, John; Gray, Elaine; Spiller, Brad; Chambers, Rachel C.; Kotecha, Sailesh			Role of Serine Proteases in the Regulation of Interleukin-8(77) during the Development of Bronchopulmonary Dysplasia in Preterm Ventilated Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; RESPIRATORY-DISTRESS SYNDROME; NEUTROPHIL CHEMOTACTIC FACTOR; BRONCHOALVEOLAR LAVAGE FLUID; TERMINAL SEQUENCE; TISSUE FACTOR; AMINO-ACID; IN-VITRO; ELASTASE; INHIBITORS	Rationale: The chemokine interleukin-8 is implicated in the development of bronchopulmonary dysplasia in preterm infants. The 77-amino acid isoform of interleukin-8 (interleukin-8(77)) is a less potent chemoattractant than other shorter isoforms. Although interleukin-8(77) is abundant in the preterm circulation, its regulation in the preterm lung is unknown. Objectives: To study expression and processing of pulmonary interleukin-8(77) in preterm infants who did and did not develop bronchopulmonary dysplasia. Methods: Total interleukin-8 and interleukin-8(77) were measured in bronchoalveolar lavage fluid from preterm infants by immunoassay. Neutrophil serine proteases were used to assess processing. Neutrophil chemotaxis assays and degranulation of neutrophil matrix metalloproteinase-9 were used to assess interleukin-8 function. Main Results: Peak total interleukin-8 and interleukin-8(77) concentrations were increased in infants who developed bronchopulmonary dysplasia compared to those who did not. Shorter forms of interleukin-8 predominated in the preterm lung (96.3% No-bronchopulmonary dysplasia vs 97.1% bronchopulmonary dysplasia, p>0.05). Preterm bronchoalveolar lavage fluid significantly converted exogenously added interleukin-8(77) to shorter isoforms (p, 0.001). Conversion was greater in bronchopulmonary dysplasia infants (p<0.05). This conversion was inhibited by alpha-1 antitrypsin and antithrombin III (p<0.01). Purified neutrophil serine proteases efficiently converted interleukin-8(77) to shorter isoforms in a time- and dose-dependent fashion; shorter interleukin-8 isoforms were primarily responsible for neutrophil chemotaxis (p<0.001). Conversion by proteinase-3 resulted in significantly increased interleukin-8 activity in vitro (p<0.01). Conclusions: Shorter, potent, isoforms interleukin-8 predominate in the preterm lung, and are increased in infants developing bronchopulmonary dysplasia, due to conversion of interleukin-8(77) by neutrophil serine proteases and thrombin. Processing of interleukin-8 provides an attractive therapeutic target to prevent development of bronchopulmonary dysplasia.	[Chakraborty, Mallinath; McGreal, Eamon P.; Davies, Philip L.; Powell, Wendy; Abdulla, Salima; Spiller, Brad; Kotecha, Sailesh] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales; [Williams, Andrew; Chambers, Rachel C.] UCL, Rayne Inst, Ctr Inflammat & Tissue Repair, London, England; [Voitenok, Nikolai N.] Fund Mol Haematol & Immunol, Moscow, Russia; [Hogwood, John; Gray, Elaine] Natl Inst Biol Stand & Controls, Div Haematol, Potters Bar, Herts, England	Cardiff University; University of London; King's College London; University College London; National Institute for Biological Standards & Control	Kotecha, S (corresponding author), Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales.	kotechas@cardiff.ac.uk	Spiller, Owen Brad/AAC-2474-2020	Spiller, Owen Brad/0000-0002-9117-6911; Chakraborty, Mallinath/0000-0002-1721-6532; Chambers, Rachel/0000-0003-1370-9417; Kotecha, Sailesh/0000-0003-3535-7627	Sparks, The Children's Medical Research Charity; Arriva Pharmaceuticals	Sparks, The Children's Medical Research Charity; Arriva Pharmaceuticals	This work was supported by Sparks, The Children's Medical Research Charity (http://www.sparks.org.uk/) and by Arriva Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Bacon K, 2003, CYTOKINE, V21, P48, DOI 10.1016/S1043-4666(02)00493-3; Beeton ML, 2011, EUR RESPIR J, V37, P1424, DOI 10.1183/09031936.00037810; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Cederqvist K, 2001, PEDIATRICS, V108, P686, DOI 10.1542/peds.108.3.686; Chakraborty M, 2010, PAEDIATR RESPIR REV, V11, P162, DOI 10.1016/j.prrv.2010.03.002; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Davies PL, 2010, THORAX, V65, P246, DOI 10.1136/thx.2009.116061; de Blic J, 2000, EUR RESPIR J, V15, P217; De Dooy J, 2007, PEDIATR PULM, V42, P193, DOI 10.1002/ppul.20511; DETMERS PA, 1991, J IMMUNOL, V147, P4211; Dik WA, 2003, PEDIATR PULM, V35, P34, DOI 10.1002/ppul.10219; Ekekezie II, 2004, PEDIATRICS, V113, P1709, DOI 10.1542/peds.113.6.1709; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Goodman RB, 1998, AM J PHYSIOL-LUNG C, V275, pL87, DOI 10.1152/ajplung.1998.275.1.L87; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; GREGORY H, 1988, BIOCHEM BIOPH RES CO, V151, P883, DOI 10.1016/S0006-291X(88)80364-4; HASLETT C, 1985, AM J PATHOL, V119, P101; HEBERT CA, 1990, J IMMUNOL, V145, P3033; Hilgendorff A, 2011, AM J RESP CRIT CARE, V184, P537, DOI 10.1164/rccm.201012-2010OC; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kambas K, 2011, J IMMUNOL, V186, P6568, DOI 10.4049/jimmunol.1003756; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Leavell KJ, 1997, J LEUKOCYTE BIOL, V61, P361, DOI 10.1002/jlb.61.3.361; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Leverence JT, 2011, CHEM-BIOL INTERACT, V189, P72, DOI 10.1016/j.cbi.2010.09.026; Lipinski S, 2011, HAMOSTASEOLOGIE, V31, P94, DOI 10.5482/ha-1134; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Maheshwari A, 2009, CYTOKINE, V46, P12, DOI 10.1016/j.cyto.2008.12.022; McGreal EP, 2010, BBA-MOL BASIS DIS, V1802, P649, DOI 10.1016/j.bbadis.2010.04.005; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; Mortier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023913; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Munshi UK, 1997, PEDIATR PULM, V24, P331; NAKAGAWA H, 1991, FEBS LETT, V282, P412, DOI 10.1016/0014-5793(91)80526-9; Nashkevich NN, 2002, J IMMUNOL METHODS, V270, P37, DOI 10.1016/S0022-1759(02)00279-X; NOURSHARGH S, 1992, J IMMUNOL, V148, P106; OGDEN BE, 1984, AM REV RESPIR DIS, V130, P817; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; SCHRODER JM, 1990, J IMMUNOL, V144, P2223; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; SPEER CP, 1993, PEDIATRICS, V91, P794; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Sveger T, 2002, ACTA PAEDIATR, V91, P934, DOI 10.1080/080352502760272614; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; VANDAMME J, 1989, EUR J BIOCHEM, V181, P337; VANDAMME J, 1988, J EXP MED, V167, P1364, DOI 10.1084/jem.167.4.1364; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; YOSHIMURA T, 1989, MOL IMMUNOL, V26, P87	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114524	10.1371/journal.pone.0114524	http://dx.doi.org/10.1371/journal.pone.0114524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474412	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500044
J	Huang, Y; Furtmuller, GJ; Tong, DD; Zhu, S; Lee, WPA; Brandacher, G; Kang, JU				Huang, Yong; Furtmueller, Georg J.; Tong, Dedi; Zhu, Shan; Lee, W. P. Andrew; Brandacher, Gerald; Kang, Jin U.			MEMS-Based Handheld Fourier Domain Doppler Optical Coherence Tomography for Intraoperative Microvascular Anastomosis Imaging	PLOS ONE			English	Article							PROBE; 3D	Purpose: To demonstrate the feasibility of a miniature handheld optical coherence tomography (OCT) imager for real time intraoperative vascular patency evaluation in the setting of super-microsurgical vessel anastomosis. Methods: A novel handheld imager Fourier domain Doppler optical coherence tomography based on a 1.3-mm central wavelength swept source for extravascular imaging was developed. The imager was minimized through the adoption of a 2.4-mm diameter microelectromechanical systems (MEMS) scanning mirror, additionally a 12.7-mm diameter lens system was designed and combined with the MEMS mirror to achieve a small form factor that optimize functionality as a handheld extravascular OCT imager. To evaluate in-vivo applicability, super-microsurgical vessel anastomosis was performed in a mouse femoral vessel cut and repair model employing conventional interrupted suture technique as well as a novel non-suture cuff technique. Vascular anastomosis patency after clinically successful repair was evaluated using the novel handheld OCT imager. Results: With an adjustable lateral image field of view up to 1.5 mm by 1.5 mm, high-resolution simultaneous structural and flow imaging of the blood vessels were successfully acquired for BALB/C mouse after orthotopic hind limb transplantation using a non-suture cuff technique and BALB/C mouse after femoral artery anastomosis using a suture technique. We experimentally quantify the axial and lateral resolution of the OCT to be 12.6 mm in air and 17.5 mm respectively. The OCT has a sensitivity of 84 dB and sensitivity roll-off of 5.7 dB/mm over an imaging range of 5 mm. Imaging with a frame rate of 36 Hz for an image size of 1000(lateral) x 512(axial) pixels using a 50,000 A-lines per second swept source was achieved. Quantitative vessel lumen patency, lumen narrowing and thrombosis analysis were performed based on acquired structure and Doppler images. Conclusions: A miniature handheld OCT imager that can be used for intraoperative evaluation of microvascular anastomosis was successfully demonstrated.	[Huang, Yong; Kang, Jin U.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Furtmueller, Georg J.; Tong, Dedi; Zhu, Shan; Lee, W. P. Andrew; Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Vascularized Composite Allotransplantat VCA Lab, Dept Plast & Reconstruct Surg, Baltimore, MD 21205 USA; [Tong, Dedi] Beijing Jishuitan Hosp, Dept Hand Surg, Beijing 10035, Peoples R China; [Zhu, Shan] Peking Union Med Coll, Beijing, Peoples R China; [Zhu, Shan] Chinese Acad Med Sci, Dept Plast & Reconstruct Surg, Plast Surg Hosp, Beijing, Peoples R China	Johns Hopkins University; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS	Huang, Y (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	yhuang60@jhu.edu; brandacher@jhmi.edu	Furtmüller, Georg J/D-8119-2019; Brandacher, Gerald/L-7540-2016	Furtmüller, Georg J/0000-0001-8286-0968; Brandacher, Gerald/0000-0001-7790-441X; Huang, Yong/0000-0002-7031-9709	NIH/NEI [5R01EY021540-03]; Yong Huang acknowledges China Scholarship Council (CSC); NATIONAL EYE INSTITUTE [R01EY021540] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Yong Huang acknowledges China Scholarship Council (CSC); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH/NEI 5R01EY021540-03. Yong Huang acknowledges China Scholarship Council (CSC) for partial support for his PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN CY, 1994, PLAST RECONSTR SURG, V93, P1481, DOI 10.1097/00006534-199406000-00022; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Huang Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111404; Huang Y, 2012, BIOMED OPT EXPRESS, V3, P2162, DOI 10.1364/BOE.3.002162; Huo L, 2010, OPT EXPRESS, V18, P14375, DOI 10.1364/OE.18.014375; Jung W, 2011, IEEE T BIO-MED ENG, V58, P741, DOI 10.1109/TBME.2010.2096816; Liang CP, 2011, OPT EXPRESS, V19, P26283, DOI 10.1364/OE.19.026283; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Martins PN, 2007, MICROSURG, V27, P678, DOI 10.1002/micr.20431; Rothwell Ann, 2011, J Perioper Pract, V21, P73; Sucher R, 2010, TRANSPLANTATION, V90, P1374, DOI 10.1097/TP.0b013e3181ff4fc3; Sun CR, 2012, BIOMED OPT EXPRESS, V3, P1404, DOI 10.1364/BOE.3.001404; Tao YKK, 2010, OPT LETT, V35, P3315, DOI 10.1364/OL.35.003315; Wang DL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086005; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926	16	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114215	10.1371/journal.pone.0114215	http://dx.doi.org/10.1371/journal.pone.0114215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474742	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500002
J	Pruthvi, V; Narasimhan, R; Nataraja, KN				Pruthvi, Vittal; Narasimhan, Rama; Nataraja, Karaba N.			Simultaneous Expression of Abiotic Stress Responsive Transcription Factors, AtDREB2A, AtHB7 and AtABF3 Improves Salinity and Drought Tolerance in Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ENHANCES TOLERANCE; TRANSGENIC RICE; GENE-EXPRESSION; SALT TOLERANCE; ARABIDOPSIS; OVEREXPRESSION; PLANTS; PROTEINS; COLD	Drought, salinity and extreme temperatures are the most common abiotic stresses, adversely affecting plant growth and productivity. Exposure of plants to stress activates stress signalling pathways that induce biochemical and physiological changes essential for stress acclimation. Stress tolerance is governed by multiple traits, and importance of a few traits in imparting tolerance has been demonstrated. Under drought, traits linked to water mining and water conservation, water use efficiency and cellular tolerance (CT) to desiccation are considered to be relevant. In this study, an attempt has been made to improve CT in drought hardy crop, peanut (Arachis hypogaea L., cv. TMV2) by co-expressing stress-responsive transcription factors (TFs), AtDREB2A, AtHB7 and AtABF3, associated with downstream gene expression. Transgenic plants simultaneously expressing these TFs showed increased tolerance to drought, salinity and oxidative stresses compared to wild type, with an increase in total plant biomass. The transgenic plants exhibited improved membrane and chlorophyll stability due to enhanced reactive oxygen species scavenging and osmotic adjustment by proline synthesis under stress. The improvement in stress tolerance in transgenic lines were associated with induced expression of various CT related genes like AhGlutaredoxin, AhAldehyde reductase, AhSerine threonine kinase like protein, AhRbx1, AhProline amino peptidase, AhHSP70, AhDIP and AhLea4. Taken together the results indicate that co-expression of stress responsive TFs can activate multiple CT pathways, and this strategy can be employed to improve abiotic stress tolerance in crop plants.	[Pruthvi, Vittal; Narasimhan, Rama; Nataraja, Karaba N.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India	University of Agricultural Sciences Bangalore	Nataraja, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	nataraja_karaba@yahoo.com		Nataraja, Karaba N./0000-0002-9766-3622	Department of Biotechnology (DBT), Ministry of Science and technology, Government of India	Department of Biotechnology (DBT), Ministry of Science and technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from Department of Biotechnology (DBT), Ministry of Science and technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Asif MA, 2011, MOL BIOTECHNOL, V49, P250, DOI 10.1007/s12033-011-9399-1; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CALKINS JB, 1990, CRYOBIOLOGY, V27, P194, DOI 10.1016/0011-2240(90)90012-S; Cheng YJ, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-30; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Rolla AAD, 2014, TRANSGENIC RES, V23, P75, DOI 10.1007/s11248-013-9723-6; de Ronde JA, 2004, EUPHYTICA, V138, P123, DOI 10.1023/B:EUPH.0000046806.68554.5b; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hamidou F, 2012, J AGRON CROP SCI; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heatley ME, 1996, IN VITRO CELL DEV-PL, V32, P115; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Inostroza-Blancheteau C, 2013, PLANT BIOLOGY, V15, P1013, DOI 10.1111/j.1438-8677.2012.00722.x; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Lai SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025090; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lee YH, 1998, PLANT MOL BIOL, V37, P377, DOI 10.1023/A:1006084305012; Li YJ, 2013, PLANT BIOTECHNOL J, V11, P747, DOI 10.1111/pbi.12066; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; Mahmood T, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue1-fulltext-1; Mishra KB, 2012, PLANT SCI, V182, P79, DOI 10.1016/j.plantsci.2011.03.022; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Naika M, 2013, PLANT CELL PHYSIOL, V54, pE8, DOI 10.1093/pcp/pcs185; Nataraja KN, 1999, PHOTOSYNTHETICA, V36, P89, DOI 10.1023/A:1007070820925; Oh SJ, 2007, PLANT BIOTECHNOL J, V5, P646, DOI 10.1111/j.1467-7652.2007.00272.x; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Parvathi MS, 2013, J PLANT BIOCHEM BIOT, V22, P193, DOI 10.1007/s13562-012-0135-0; Ponsamuel J, 1998, PLANT CELL REP, V17, P373, DOI 10.1007/s002990050409; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pruthvi V, 2013, PHYSIOL MOL BIOL PLA, V19, P277, DOI 10.1007/s12298-012-0156-0; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Saini R, 2003, PLANT CELL REP, V21, P851, DOI 10.1007/s00299-003-0574-0; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vanjildorj E, 2005, PLANT CELL TISS ORG, V83, P41, DOI 10.1007/s11240-005-3800-3; Vemanna RS, 2013, MOL BIOTECHNOL, V53, P129, DOI 10.1007/s12033-012-9499-6; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yokotani N, 2013, J PLANT RES, V126, P131, DOI 10.1007/s10265-012-0501-y; Yu LH, 2013, PLANT PHYSIOL, V162, P1378, DOI 10.1104/pp.113.217596; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zou C, 2011, P NATL ACAD SCI USA, V108, P14992, DOI 10.1073/pnas.1103202108	74	42	49	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111152	10.1371/journal.pone.0111152	http://dx.doi.org/10.1371/journal.pone.0111152			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474740	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500062
J	Siddiqi, S; Foo, JN; Vu, A; Azim, S; Silver, DL; Mansoor, A; Tay, SKH; Abbasi, S; Hashmi, AH; Janjua, J; Khalid, S; Tai, ES; Yeo, GW; Khor, CC				Siddiqi, Saima; Foo, Jia Nee; Vu, Anthony; Azim, Saad; Silver, David L.; Mansoor, Atika; Tay, Stacey Kiat Hong; Abbasi, Sumiya; Hashmi, Asraf Hussain; Janjua, Jamal; Khalid, Sumbal; Tai, E. Shyong; Yeo, Gene W.; Khor, Chiea Chuen			A Novel Splice-Site Mutation in ALS2 Establishes the Diagnosis of Juvenile Amyotrophic Lateral Sclerosis in a Family with Early Onset Anarthria and Generalized Dystonias	PLOS ONE			English	Article							REVEALS; LINKAGE; DISEASE; TOOL	The diagnosis of childhood neurological disorders remains challenging given the overlapping clinical presentation across subgroups and heterogeneous presentation within subgroups. To determine the underlying genetic cause of a severe neurological disorder in a large consanguineous Pakistani family presenting with severe scoliosis, anarthria and progressive neuromuscular degeneration, we performed genome-wide homozygosity mapping accompanied by whole-exome sequencing in two affected first cousins and their unaffected parents to find the causative mutation. We identified a novel homozygous splice-site mutation (c.3512+1G>A) in the ALS2 gene (NM_020919.3) encoding alsin that segregated with the disease in this family. Homozygous loss-of-function mutations in ALS2 are known to cause juvenile-onset amyotrophic lateral sclerosis (ALS), one of the many neurological conditions having overlapping symptoms with many neurological phenotypes. RT-PCR validation revealed that the mutation resulted in exon-skipping as well as the use of an alternative donor splice, both of which are predicted to cause loss-of-function of the resulting proteins. By examining 216 known neurological disease genes in our exome sequencing data, we also identified 9 other rare nonsynonymous mutations in these genes, some of which lie in highly conserved regions. Sequencing of a single proband might have led to mis-identification of some of these as the causative variant. Our findings established a firm diagnosis of juvenile ALS in this family, thus demonstrating the use of whole exome sequencing combined with linkage analysis in families as a powerful tool for establishing a quick and precise genetic diagnosis of complex neurological phenotypes.	[Siddiqi, Saima; Mansoor, Atika; Hashmi, Asraf Hussain] Inst Biomed & Genet Engn, Islamabad, Pakistan; [Foo, Jia Nee; Khor, Chiea Chuen] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Vu, Anthony; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Vu, Anthony; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Azim, Saad] Ali Med Ctr, Islamabad, Pakistan; [Silver, David L.; Tai, E. Shyong] Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore, Singapore; [Tay, Stacey Kiat Hong; Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Abbasi, Sumiya; Khalid, Sumbal] Int Islamic Univ, Islamabad, Pakistan; [Janjua, Jamal] Coll Phys & Surg CPSP, Islamabad, Pakistan; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Natl Univ Hosp Syst, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hosp Syst, Singapore 117548, Singapore; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; National University of Singapore; International Islamic University, Pakistan; National University of Singapore; National University of Singapore; National University of Singapore	Foo, JN (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	foojn@gis.a-star.edu.sg	Tay, Stacey/E-7029-2015; Yeo, Gene/AAE-7676-2019; Foo, Jia Nee/D-6069-2014; Siddiqi, Saima/AAJ-6584-2021	Tay, Stacey/0000-0002-3077-4184; Yeo, Gene/0000-0002-0799-6037; Foo, Jia Nee/0000-0001-9899-2308; Tai, E Shyong/0000-0003-2929-8966; /0000-0001-5751-1432; Silver, David/0000-0002-7289-9890	Government of Pakistan funding; National Institute of Health [HG004659, NS075449, U54HG007005]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659, U54HG007005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	Government of Pakistan funding; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The sample collection and clinical work was supported by Government of Pakistan funding to IBGE. The genetic analysis was supported by the Agency for Science, Technology and Research, Singapore (to C.C.K.). A.V. and G.W.Y. were supported by grants from the National Institute of Health (HG004659, NS075449 and U54HG007005) and G.W.Y. is an Alfred P. Sloan Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bird TD, 1993, GENEREVIEWSTM; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sheerin UM, 2014, NEUROLOGY, V82, P1065, DOI 10.1212/WNL.0000000000000254; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Trojsi Francesca, 2013, Acta Myol, V32, P23; Verma A, 2013, MUSCLE NERVE, V47, P330, DOI 10.1002/mus.23673; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	20	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113258	10.1371/journal.pone.0113258	http://dx.doi.org/10.1371/journal.pone.0113258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474699	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500080
J	Sieracki, JL; Bossenbroek, JM; Chadderton, WL				Sieracki, Jennifer L.; Bossenbroek, Jonathan M.; Chadderton, W. Lindsay			A Spatial Modeling Approach to Predicting the Secondary Spread of Invasive Species Due to Ballast Water Discharge	PLOS ONE			English	Article							DIKEROGAMMARUS-VILLOSUS CRUSTACEA; GREAT-LAKES; BIOLOGICAL INVASIONS; RUFFE GYMNOCEPHALUS; POTENTIAL SPREAD; MARINE INVASIONS; YELLOW PERCH; DISPERSAL; RISK; MECHANISMS	Ballast water in ships is an important contributor to the secondary spread of invasive species in the Laurentian Great Lakes. Here, we use a model previously created to determine the role ballast water management has played in the secondary spread of viral hemorrhagic septicemia virus (VHSV) to identify the future spread of one current and two potential invasive species in the Great Lakes, the Eurasian Ruffe (Gymnocephalus cernuus), killer shrimp (Dikerogammarus villosus), and golden mussel (Limnoperna fortunei), respectively. Model predictions for Eurasian Ruffe have been used to direct surveillance efforts within the Great Lakes and DNA evidence of ruffe presence was recently reported from one of three high risk port localities identified by our model. Predictions made for killer shrimp and golden mussel suggest that these two species have the potential to become rapidly widespread if introduced to the Great Lakes, reinforcing the need for proactive ballast water management. The model used here is flexible enough to be applied to any species capable of being spread by ballast water in marine or freshwater ecosystems.	[Sieracki, Jennifer L.; Bossenbroek, Jonathan M.] Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Oregon, OH 43607 USA; [Chadderton, W. Lindsay] Univ Notre Dame, Great Lakes Project, Environm Change Initiat, South Bend, IN USA	University of Toledo; University of Notre Dame	Sieracki, JL (corresponding author), Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Oregon, OH 43607 USA.	sier0010@gmail.com	Bossenbroek, Jonathan M/F-3664-2011		USDA NIFA [OHOW-2010-01479, 2010-38927-21048]; National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR [NA10NOS4780218]	USDA NIFA(United States Department of Agriculture (USDA)); National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR	Additional funding has been provided by USDA NIFA Project #OHOW-2010-01479, Award Number 2010-38927-21048, as well as National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR #NA10NOS4780218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Bailey SA, 2012, 2011104 DFO CAN SCI; Beeton AM, 2002, ENVIRON CONSERV, V29, P21, DOI 10.1017/S0376892902000036; Benson A.J., 2013, QUAGGA ZEBRA MUSSELS, P9, DOI DOI 10.1201/B15437-6; Boets P, 2010, ECOL INFORM, V5, P133, DOI 10.1016/j.ecoinf.2009.12.005; Bossenbroek JM, 2007, CONSERV BIOL, V21, P800, DOI 10.1111/j.1523-1739.2006.00614.x; BRANDT R A M, 1971, Archiv fuer Molluskenkunde, V101, P111; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; Bruijs MCM, 2001, ARCH HYDROBIOL, V152, P633; Buchan LAJ, 2000, ECOL APPL, V10, P1442, DOI 10.1890/1051-0761(2000)010[1442:PTLOEW]2.0.CO;2; Campbell ML, 2007, MAR POLLUT BULL, V55, P360, DOI 10.1016/j.marpolbul.2007.01.015; Carlton James T., 1993, P677; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Coffin M. F., 2000, P OCEAN DRILLING PRO, V183, P1; Collin SB, 2013, MAR POLLUT BULL, V73, P64, DOI 10.1016/j.marpolbul.2013.05.040; DARRIGRAN G, 1995, VELIGER, V38, P171; Devin S, 2004, INT REV HYDROBIOL, V89, P21, DOI 10.1002/iroh.200310667; Dick JTA, 2000, P ROY SOC B-BIOL SCI, V267, P977, DOI 10.1098/rspb.2000.1099; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fullerton AH, 1998, J GREAT LAKES RES, V24, P319, DOI 10.1016/S0380-1330(98)70823-8; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Karatayev AY, 2007, J SHELLFISH RES, V26, P205, DOI 10.2983/0730-8000(2007)26[205:TIBDPA]2.0.CO;2; Karatayev AY, 2007, BIOL INVASIONS, V9, P161, DOI 10.1007/s10530-006-9013-9; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McGee S, 2006, MAR POLLUT BULL, V52, P1634, DOI 10.1016/j.marpolbul.2006.06.005; Miller AW, 2011, BIOSCIENCE, V61, P880, DOI 10.1525/bio.2011.61.11.7; MILLER R. C., 1931, LINGNAN SCI JOUR, V10, P307; Mizuno T, 1970, Biol. J., V2, P77, DOI 10.1111/j.1095-8312.1970.tb01706.x; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MORTON B, 1973, Malacologia, V12, P265; Muller JC, 2002, FRESHWATER BIOL, V47, P2039, DOI 10.1046/j.1365-2427.2002.00944.x; MUSKO IB, 1994, CRUSTACEANA, V66, P144, DOI 10.1163/156854094X00639; National Ballast Information Clearinghouse, 2009, NBIC ONL DAT; Nesemann H., 1995, Miscellanea Zoologica Hungarica, V10, P49; Panetta FD, 2005, DIVERS DISTRIB, V11, P435, DOI 10.1111/j.1366-9516.2005.00179.x; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruiz GM, 2013, ECOL APPL, V23, P311, DOI 10.1890/11-1660.1; Rup MP, 2010, CAN J FISH AQUAT SCI, V67, P256, DOI 10.1139/F09-180; Savino JF, 1996, T AM FISH SOC, V125, P562, DOI 10.1577/1548-8659(1996)125<0562:CBNRAN>2.3.CO;2; Schneider DW, 1998, CONSERV BIOL, V12, P788, DOI 10.1046/j.1523-1739.1998.97042.x; Sieracki JL, 2014, BIOL INVASIONS, V16, P1043, DOI 10.1007/s10530-013-0556-2; Sierszen ME, 1996, J GREAT LAKES RES, V22, P436, DOI 10.1016/S0380-1330(96)70968-1; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Stepien CA, 1998, J GREAT LAKES RES, V24, P361, DOI 10.1016/S0380-1330(98)70827-5; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; USEPA, 2013, VESS GEN PERM DISCH; USGS, 2009, NAS NON AQ SPEC DAT	56	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114217	10.1371/journal.pone.0114217	http://dx.doi.org/10.1371/journal.pone.0114217			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470822	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700087
J	Yamashita, K; Waraya, M; Kim, MS; Sidransky, D; Katada, N; Sato, T; Nakamura, T; Watanabe, M				Yamashita, Keishi; Waraya, Mina; Kim, Myoung Sook; Sidransky, David; Katada, Natsuya; Sato, Takeo; Nakamura, Takatoshi; Watanabe, Masahiko			Detection of Methylated CDO1 in Plasma of Colorectal Cancer; A PCR Study	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; DNA METHYLATION; PROGNOSIS; CARCINOMA; GROWTH; CELLS; BLOOD	Background: Cysteine biology is important for the chemosensitivity of cancer cells. Our research has focused on the epigenetic silencing of cysteine dioxygenase type 1 (CDO1) in colorectal cancer (CRC). In this study, we describe detection of CDO1 methylation in the plasma of CRC patients using methylation specific PCR (Q-MSP) and extensive analysis of the PCR reaction. Methods: DNA was extracted from plasma, and analysed for methylation of the CDO1 gene using Q-MSP. The detection rate of CDO1 gene methylation was calculated and compared with that of diluted DNA extracted from "positive control'' DLD1 cells. CDO1 gene methylation in the plasma of 40 CRC patients that were clinicopathologically analysed was then determined. Results: (1) The cloned sequence analysis detected 93.3% methylation of the promoter CpG islands of the CDO1 gene of positive control DLD1 cells and 4.7% methylation of the negative control HepG2 CDO1 gene. (2) DLD1 CDO1 DNA could not be detected in this assay if the extracted DNA was diluted similar to 1000 fold. The more DNA that was used for the PCR reaction, the more effectively it was amplified in Q-MSP. (3) By increasing the amount of DNA used, methylated CDO1 could be clearly detected in the plasma of 8 (20%) of the CRC patients. However, the percentage of CRC patients detected by methylated CDO1 in plasma was lower than that detected by CEA (35.9%) or CA19-9 (23.1%) in preoperative serum. Combination of CEA/CA19-9 plus plasma methylated CDO1 could increase the rate of detection of curable CRC patients (39.3%) as compared to CEA/CA19-9 (25%). Conclusion: We have described detection of CDO1 methylation in the plasma of CRC patients. Although CDO1 methylation was not detected as frequently as conventional tumor markers, analysis of plasma CDO1 methylation in combination with CEA/CA19-9 levels increases the detection rate of curable CRC patients.	[Yamashita, Keishi; Waraya, Mina; Katada, Natsuya; Sato, Takeo; Nakamura, Takatoshi; Watanabe, Masahiko] Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520375, Japan; [Kim, Myoung Sook; Sidransky, David] Johns Hopkins Univ, Head & Neck Canc Res Inst, Dept Otolaryngol, Baltimore, MD 21231 USA	Kitasato University; Johns Hopkins University	Yamashita, K (corresponding author), Kitasato Univ Hosp, Dept Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520375, Japan.	keishi23@med.kitasato-u.ac.jp						Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Katoh H, 2008, WORLD J SURG, V32, P1130, DOI 10.1007/s00268-008-9535-7; Katoh H, 2008, ANTICANCER RES, V28, P1933; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2008, ONCOGENE, V27, P2045, DOI 10.1038/sj.onc.1210842; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kim MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006555; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yamashita K, 2009, CANCER SCI, V100, P195, DOI 10.1111/j.1349-7006.2008.01022.x	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113546	10.1371/journal.pone.0113546	http://dx.doi.org/10.1371/journal.pone.0113546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469504	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700032
J	Dukart, J; Bertolino, A				Dukart, Juergen; Bertolino, Alessandro			When Structure Affects Function - The Need for Partial Volume Effect Correction in Functional and Resting State Magnetic Resonance Imaging Studies	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; ADULT HUMAN BRAINS; ALZHEIMERS-DISEASE; ELECTROCONVULSIVE-THERAPY; FDG PET; FMRI; CONNECTIVITY; MRI; ACTIVATION	Both functional and also more recently resting state magnetic resonance imaging have become established tools to investigate functional brain networks. Most studies use these tools to compare different populations without controlling for potential differences in underlying brain structure which might affect the functional measurements of interest. Here, we adapt a simulation approach combined with evaluation of real resting state magnetic resonance imaging data to investigate the potential impact of partial volume effects on established functional and resting state magnetic resonance imaging analyses. We demonstrate that differences in the underlying structure lead to a significant increase in detected functional differences in both types of analyses. Largest increases in functional differences are observed for highest signal-to-noise ratios and when signal with the lowest amount of partial volume effects is compared to any other partial volume effect constellation. In real data, structural information explains about 25% of within-subject variance observed in degree centrality - an established resting state connectivity measurement. Controlling this measurement for structural information can substantially alter correlational maps obtained in group analyses. Our results question current approaches of evaluating these measurements in diseased population with known structural changes without controlling for potential differences in these measurements.	[Dukart, Juergen; Bertolino, Alessandro] F Hoffmann La Roche, pRED, NORD DTA, Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Dukart, Juergen] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bertolino, Alessandro] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy	Roche Holding; Max Planck Society; Universita degli Studi di Bari Aldo Moro	Dukart, J (corresponding author), F Hoffmann La Roche, pRED, NORD DTA, Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland.	juergen.dukart@gmail.com		Dukart, Juergen/0000-0003-0492-5644				Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Di Martino A., 2013, MOL PSYCHIAT; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dukart J, 2014, P NATL ACAD SCI USA, V111, P1156, DOI 10.1073/pnas.1321399111; Dukart J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002987; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gryga M, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00037; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Johnson SC, 2000, NEUROIMAGE, V11, P179, DOI 10.1006/nimg.1999.0530; Kaiser A, 2007, INT J PSYCHOPHYSIOL, V63, P192, DOI 10.1016/j.ijpsycho.2006.03.008; Kamphausen S., 2012, WORLD J BIOL PSYCHIA; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; Perrin JS, 2012, P NATL ACAD SCI USA, V109, P5464, DOI 10.1073/pnas.1117206109; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Quarantelli M, 2004, J NUCL MED, V45, P192; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rousset OG, 1998, J NUCL MED, V39, P904; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2002, BEHAV BRAIN RES, V130, P47, DOI 10.1016/S0166-4328(01)00437-5; Samuraki M, 2007, EUR J NUCL MED MOL I, V34, P1658, DOI 10.1007/s00259-007-0454-x; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sperling R, 2007, ANN NY ACAD SCI, V1097, P146, DOI 10.1196/annals.1379.009; Thomas BA, 2011, EUR J NUCL MED MOL I, V38, P1104, DOI 10.1007/s00259-011-1745-9; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Yanase D, 2005, EUR J NUCL MED MOL I, V32, P794, DOI 10.1007/s00259-005-1767-2; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	59	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114227	10.1371/journal.pone.0114227	http://dx.doi.org/10.1371/journal.pone.0114227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460595	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700119
J	O'Brien, K; Bhatia, A; Tsen, F; Chen, M; Wong, AK; Woodley, DT; Li, W				O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Wong, Alex K.; Woodley, David T.; Li, Wei			Identification of the Critical Therapeutic Entity in Secreted Hsp90 alpha That Promotes Wound Healing in Newly Re-Standardized Healthy and Diabetic Pig Models	PLOS ONE			English	Article							STRATUM-CORNEUM; CELL MOTILITY; GENE-TRANSFER; EPIDERMIS; GROWTH; MIGRATION; HYPOXIA; TRANSPLANTATION; THICKNESS; RECEPTOR	Chronic and non-healing skin wounds represent a significant clinical, economic and social problem worldwide. Currently, there are few effective treatments. Lack of well-defined animal models to investigate wound healing mechanisms and furthermore to identify new and more effective therapeutic agents still remains a major challenge. Pig skin wound healing is close to humans. However, standardized pig wound healing models with demonstrated validity for testing new wound healing candidates are unavailable. Here we report a systematic evaluation and establishment of both acute and diabetic wound healing models in pigs, including wound-creating pattern for drug treatment versus control, measurements of diabetic parameters and the time for detecting delayed wound healing. We find that treatment and control wounds should be on the opposite and corresponding sides of a pig. We demonstrate a strong correlation between duration of diabetic conditions and the length of delay in wound closure. Using these new models, we narrow down the minimum therapeutic entity of secreted Hsp90 alpha to a 27-amino acid peptide, called fragment-8 (F-8). In addition, results of histochemistry and immunohistochemistry analyses reveal more organized epidermis and dermis in Hsp90 alpha-healed wounds than the control. Finally, Hsp90 alpha uses a similar signaling mechanism to promote migration of isolated pig and human keratinocytes and dermal fibroblasts. This is the first report that shows standardized pig models for acute and diabetic wound healing studies and proves its usefulness with both an approved drug and a new therapeutic agent.	[O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Woodley, David T.; Li, Wei] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Woodley, David T.; Li, Wei] Univ So Calif, Keck Sch Med, Norris USC Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wong, Alex K.] Univ So Calif, Div Plast & Reconstruct Surg, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Woodley, DT (corresponding author), Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA.	dwoodley@usc.edu; wli@usc.edu		Wong, Alex/0000-0002-4068-5230	Whittier Foundation Award; National Institutes of Health (NIH) [GM066193, GM067100, AR46538, AR33625]; VA Merit Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033625, R01AR059853, R01AR046538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067100, R01GM066193] Funding Source: NIH RePORTER	Whittier Foundation Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Whittier Foundation Award (to W.L.), as well as by National Institutes of Health (NIH) grants GM066193 and GM067100 (to W.L.), AR46538 (to D.T.W.), AR33625 (to M.C. and D.T.W.), and VA Merit Award (to D.T.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2014, J SURG RES, V190, P367, DOI 10.1016/j.jss.2014.02.051; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Bergmann Juri, 2009, Eplasty, V9, pe49; Bevan S, 1997, BURNS, V23, P525, DOI 10.1016/S0305-4179(97)00018-1; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Brahmatewari J, 2000, J Cutan Med Surg, V4, P126; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Davis SC, 2005, ARCH DERMATOL RES, V297, P190, DOI 10.1007/s00403-005-0612-6; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; FINLAY AY, 1982, BRIT J DERMATOL, V107, P35, DOI 10.1111/j.1365-2133.1982.tb00287.x; Gao W, 2007, J MOL CELL CARDIOL, V42, P609, DOI 10.1016/j.yjmcc.2006.12.006; GRAY GM, 1982, BRIT J DERMATOL, V106, P59, DOI 10.1111/j.1365-2133.1982.tb00902.x; Hackl F, 2012, PLAST RECONSTR SURG, V129, p443E, DOI 10.1097/PRS.0b013e318241289c; HAYWARD PG, 1991, PROG CLIN BIOL RES, V365, P301; Hirsch T, 2008, J GENE MED, V10, P1247, DOI 10.1002/jgm.1251; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; HOLBROOK KA, 1974, J INVEST DERMATOL, V62, P415, DOI 10.1111/1523-1747.ep12701670; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Li W, 2004, MOL BIOL CELL, V15, P294, DOI 10.1091/mbc.e03-05-0352; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lindblad WJ, 2008, J BIOMAT SCI-POLYM E, V19, P1087, DOI 10.1163/156856208784909390; Meyer W, 1978, Curr Probl Dermatol, V7, P39; MONTEIRORIVIERE NA, 1990, J INVEST DERMATOL, V95, P582, DOI 10.1111/1523-1747.ep12505567; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; QUICK DC, 1984, ANAT REC, V208, P491, DOI 10.1002/ar.1092080404; ROTHBERG S, 1961, J INVEST DERMATOL, V37, P497, DOI 10.1038/jid.1961.150; Singer AJ, 2009, J BURN CARE RES, V30, P880, DOI 10.1097/BCR.0b013e3181b48a6b; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stephens P, 2013, METHODS MOL BIOL, V1037, P177, DOI 10.1007/978-1-62703-505-7_10; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Tsen F, 2013, MOL CELL BIOL, V33, P4947, DOI 10.1128/MCB.00559-13; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; Velander P, 2008, WOUND REPAIR REGEN, V16, P288, DOI 10.1111/j.1524-475X.2008.00367.x; Velander P, 2009, J SURG RES, V157, P14, DOI 10.1016/j.jss.2008.10.001; WEINSTEIN GD, 1965, J INVEST DERMATOL, V44, P413, DOI 10.1038/jid.1965.75; WEIR GC, 1981, DIABETES, V30, P590, DOI 10.2337/diabetes.30.7.590; Woodley DT, 2007, MOL THER, V15, P628, DOI 10.1038/sj.mt.6300041; Woodley DT, 2009, J CELL SCI, V122, P1495, DOI 10.1242/jcs.047894	41	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113956	10.1371/journal.pone.0113956	http://dx.doi.org/10.1371/journal.pone.0113956			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464502	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700073
J	Schiabor, KM; Quan, AS; Eisen, MB				Schiabor, Kelly M.; Quan, Allison S.; Eisen, Michael B.			Saccharomyces cerevisiae Mitochondria Are Required for Optimal Attractiveness to Drosophila melanogaster	PLOS ONE			English	Article							AROMA COMPOUNDS; AMINO-ACIDS; NITROGEN-DEFICIENT; AVOIDANCE-BEHAVIOR; VOLATILE; YEAST; OVIPOSITION; POPULATION; METABOLISM; ETHANOL	While screening a large collection of wild and laboratory yeast strains for their ability to attract Drosophila melanogaster adults, we noticed a large difference in fly preference for two nearly isogenic strains of Saccharomyces cerevisiae, BY4741 and BY4742. Using standard genetic analyses, we tracked the preference difference to the lack of mitochondria in the BY4742 strain used in the initial experiment. We used gas chromatography coupled with mass spectroscopy to examine the volatile compounds produced by BY4741 and the mitochondria-deficient BY4742, and found that they differed significantly. We observed that several ethyl esters are present at much higher levels in strains with mitochondria, even in fermentative conditions. We found that nitrogen levels in the substrate affect the production of these compounds, and that they are produced at the highest level by strains with mitochondria when fermenting natural fruit substrates. Collectively these observations demonstrate that core metabolic processes mediate the interaction between yeasts and insect vectors, and highlight the importance mitochondrial functions in yeast ecology.	[Schiabor, Kelly M.; Quan, Allison S.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Eisen, Michael/0000-0002-7528-738X; Schiabor Barrett, Kelly/0000-0001-6194-787X; Quan, Allison/0000-0003-1194-4050	Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by an investigator award from the Howard Hughes Medical Institute to MBE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070219; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Barbosa C, 2012, INT J FOOD MICROBIOL, V160, P87, DOI 10.1016/j.ijfoodmicro.2012.10.003; Barbosa C, 2009, J BIOSCI BIOENG, V108, P99, DOI 10.1016/j.jbiosc.2009.02.017; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Beltran G, 2005, J AGR FOOD CHEM, V53, P996, DOI 10.1021/jf0487001; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Calahan D, 2011, GENETICS, V189, P507, DOI 10.1534/genetics.111.130369; Cha DH, 2014, PEST MANAG SCI, V70, P324, DOI 10.1002/ps.3568; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; Garde-Cerdan T, 2008, LWT-FOOD SCI TECHNOL, V41, P501, DOI 10.1016/j.lwt.2007.03.018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hernandez-Orte P, 2006, FOOD CHEM, V98, P300, DOI 10.1016/j.foodchem.2005.05.073; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Jimenez-Marti E, 2007, ANTON LEEUW INT J G, V92, P61, DOI 10.1007/s10482-006-9135-1; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Krishnan P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-62; Montague SA, 2011, J NEUROSCI, V31, P7891, DOI 10.1523/JNEUROSCI.6254-10.2011; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Procopio S, 2013, LWT-FOOD SCI TECHNOL, V51, P423, DOI 10.1016/j.lwt.2012.11.022; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Richgels PK, 2012, CHEM SENSES, V37, P229, DOI 10.1093/chemse/bjr097; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saerens SMG, 2008, APPL AND, V74; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Sang J, 1961, J EXP BIOL, V33, P45; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Steyer D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-573; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Styger G, 2013, APPL MICROBIOL BIOT, V97, P4429, DOI 10.1007/s00253-012-4522-1; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Torrea D, 2011, FOOD CHEM, V127, P1072, DOI 10.1016/j.foodchem.2011.01.092; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; VACEK DC, 1985, BIOL J LINN SOC, V24, P175, DOI 10.1111/j.1095-8312.1985.tb00168.x; Vilanova M, 2007, APPL MICROBIOL BIOT, V77, P145, DOI 10.1007/s00253-007-1145-z; WANG SS, 1987, MOL CELL BIOL, V7, P4431, DOI 10.1128/MCB.7.12.4431; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	44	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113899	10.1371/journal.pone.0113899	http://dx.doi.org/10.1371/journal.pone.0113899			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462617	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700066
J	Wang, Y; Wu, X; Li, WZ; Zhang, Y; Li, Z; Zhou, JL				Wang, Yan; Wu, Xi; Li, Wenzao; Zhang, Yi; Li, Zhi; Zhou, Jiliu			A Reconstruction Method Based on AL0FGD for Compressed Sensing in Border Monitoring WSN System	PLOS ONE			English	Article							SPARSE SIGNALS; DECOMPOSITION; ALGORITHMS	In this paper, to monitor the border in real-time with high efficiency and accuracy, we applied the compressed sensing (CS) technology on the border monitoring wireless sensor network (WSN) system and proposed a reconstruction method based on approximately l(0) norm and fast gradient descent (AL0FGD) for CS. In the frontend of the system, the measurement matrix was used to sense the border information in a compressed manner, and then the proposed reconstruction method was applied to recover the border information at the monitoring terminal. To evaluate the performance of the proposed method, the helicopter sound signal was used as an example in the experimental simulation, and three other typical reconstruction algorithms 1) split Bregman algorithm, 2) iterative shrinkage algorithm, and 3) smoothed approximate l(0) norm (SL0), were employed for comparison. The experimental results showed that the proposed method has a better performance in recovering the helicopter sound signal in most cases, which could be used as a basis for further study of the border monitoring WSN system.	[Wang, Yan; Li, Wenzao; Li, Zhi] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yan; Wu, Xi; Li, Wenzao] Chengdu Univ Informat Technol, Dept Comp Sci, Chengdu, Sichuan, Peoples R China; [Wu, Xi; Zhang, Yi; Zhou, Jiliu] Sichuan Univ, Coll Comp Sci, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Chengdu University of Information Technology; Sichuan University	Wu, X (corresponding author), Chengdu Univ Informat Technol, Dept Comp Sci, Chengdu, Sichuan, Peoples R China.	wuxiscu@gmail.com; jlzhou@scu.edu.cn	wang, yan/AAZ-4988-2021; li, wenzao/A-6646-2018	Zhang, Yi/0000-0001-7201-2092; li, wenzao/0000-0001-5986-1073	National Science Foundation of China [61272448, 61302028, 81201158, 2012RZ0005]; Foundation of Sichuan University [2012SCU11036, 2012SCU11070]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Sichuan University	This work is supported by the grants from the National Science Foundation of China (No. 61272448, 61302028, 81201158), STMSP project (No. 2012RZ0005) and the Foundation of Sichuan University Early Career Researcher Award (No. 2012SCU11036, 2012SCU11070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2009, INT CONF ACOUST SPEE, P693, DOI 10.1109/ICASSP.2009.4959678; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Candes E., 2005, L1 MAGIC RECOVERY SP; Chartrand R, 2008, INT CONF ACOUST SPEE, P3869, DOI 10.1109/ICASSP.2008.4518498; Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Golub GH., 2013, MATRIX COMPUTATIONS; Herrmann FJ, 2007, SOC PETR ENG 69 EUR, V2007, P1625; Jiang D, 2013, NEUROCOMPUTING, V120, P415, DOI 10.1016/j.neucom.2012.07.054; Jones B, 2006, INT SOC OPTICAL ENG, V6201; Kaban A, 2012, NEUROCOMPUTING, V80, P111, DOI 10.1016/j.neucom.2011.07.025; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Knobler RA, 2008, P SPIE INT SOC OPTIC, V6943; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Michailovich OV, 2011, IEEE T IMAGE PROCESS, V20, P1281, DOI 10.1109/TIP.2010.2090532; Mohimani H, 2009, IEEE T SIGNAL PROCES, V57, P289, DOI 10.1109/TSP.2008.2007606; Nakama T, 2009, NEUROCOMPUTING, V73, P151, DOI 10.1016/j.neucom.2009.05.017; Needell D, 2010, IEEE J-STSP, V4, P310, DOI 10.1109/JSTSP.2010.2042412; NESTEROV IE, 1983, DOKL AKAD NAUK SSSR+, V269, P543; Parvaresh F, 2008, IEEE J-STSP, V2, P275, DOI 10.1109/JSTSP.2008.924384; Porter R, 2009, P SPIE INT SOC OPTIC, Vv7333; Pratap P., 2010, 2010 IEEE International Conference on Technologies for Homeland Security (HST 2010), P303, DOI 10.1109/THS.2010.5655034; Rauhut Holger, 2008, Sampling Theory in Signal and Image Processing, V7, P197; Rong Ding, 2011, 2011 International Conference on Cyber-Enabled Distributed Computing and Knowledge Discovery, P329, DOI 10.1109/CyberC.2011.59; Wang J, 2013, NEUROCOMPUTING, V115, P150, DOI 10.1016/j.neucom.2013.01.012; Wang Y, 2012, AEU-INT J ELECTRON C, V66, P575, DOI 10.1016/j.aeue.2011.11.010; Yang W, 2012, NEUROCOMPUTING, V87, P132, DOI 10.1016/j.neucom.2012.02.011; Zhi Li, 2012, ICIC Express Letters, Part B: Applications, V3, P127	30	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112932	10.1371/journal.pone.0112932	http://dx.doi.org/10.1371/journal.pone.0112932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461759	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700023
J	Solberg, MF; Fjelldal, PG; Nilsen, F; Glover, KA				Solberg, Monica Favneboe; Fjelldal, Per Gunnar; Nilsen, Frank; Glover, Kevin Alan			Hatching Time and Alevin Growth Prior to the Onset of Exogenous Feeding in Farmed, Wild and Hybrid Norwegian Atlantic Salmon	PLOS ONE			English	Article							GENE-TRANSCRIPTION PROFILES; SALAR L.; EGG SIZE; FRESH-WATER; COMPETITIVE INTERACTIONS; ONCORHYNCHUS-KETA; INCUBATION-TIME; OFFSPRING SIZE; POPULATIONS; TEMPERATURE	The onset of exogenous feeding, when juveniles emerge from the gravel, is a critical event for salmonids where early emergence and large size provide a competitive advantage in the wild. Studying 131 farmed, hybrid and wild Norwegian Atlantic salmon families, originating from four wild populations and two commercial strains, we investigated whether approximately 10 generations of selection for faster growth has also resulted in increased somatic growth prior to the onset of exogenous feeding. In addition, we tested whether relaxed selection in farms has allowed for alterations in hatching time between farmed and wild salmon. Across three cohorts, wild salmon families hatched earlier than farmed salmon families, while hybrid families displayed intermediate hatching times. While the observed differences were small, i. e., 1-15 degree-days (0-3 days, as water temperatures were c. 5-6 degrees C), these data suggest additive genetic variation for hatching time. Alevin length prior to exogenous feeding was positively related to egg size. After removal of egg size effects, no systematic differences in alevin length were observed between the wild and farmed salmon families. While these results indicate additive genetic variation for egg development timing, and wild salmon families consistently hatched earlier than farmed salmon families, these differences were so small they are unlikely to significantly influence early life history competition of farmed and wild salmon in the natural environment. This is especially the case given that the timing of spawning among females can vary by several weeks in some rivers. The general lack of difference in size between farmed and wild alevins, strongly suggest that the documented differences in somatic growth rate between wild and farmed Norwegian Atlantic salmon under hatchery conditions are first detectable after the onset of exogenous feeding.	[Solberg, Monica Favneboe; Glover, Kevin Alan] Inst Marine Res, Populat Genet Res Grp, N-5024 Bergen, Norway; [Fjelldal, Per Gunnar] Inst Marine Res, Reprod & Dev Biol Res Grp, Matre Res Stn, Matredal, Norway; [Nilsen, Frank; Glover, Kevin Alan] Univ Bergen, Sea Lice Res Ctr, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; University of Bergen	Solberg, MF (corresponding author), Inst Marine Res, Populat Genet Res Grp, POB 1870, N-5024 Bergen, Norway.	monica.solberg@imr.no		Solberg, Monica Favneboe/0000-0002-5844-9498	project INTERACT - Research Council of Norway	project INTERACT - Research Council of Norway	This project was funded within the project INTERACT, funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, STATUS NORSKE LAKSEB, P124; Bates D, 2013, IME4 LINEAR MIXED EF; BEACHAM TD, 1987, CAN J FISH AQUAT SCI, V44, P244, DOI 10.1139/f87-034; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BEACHAM TD, 1985, CAN J ZOOL, V63, P847, DOI 10.1139/z85-125; Berg OK, 1999, J FISH BIOL, V54, P636, DOI 10.1111/j.1095-8649.1999.tb00642.x; Bicskei B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-884; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Cutts CJ, 1999, J FISH BIOL, V55, P784, DOI 10.1111/j.1095-8649.1999.tb00717.x; Debes PV, 2013, HEREDITY, V111, P238, DOI 10.1038/hdy.2013.43; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Donaghy MJ, 1997, J FISH BIOL, V51, P211, DOI 10.1006/jfbi.1997.0417; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; ELLIOTT JM, 1986, J ANIM ECOL, V55, P907, DOI 10.2307/4424; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fraser DJ, 2010, CAN J FISH AQUAT SCI, V67, P1768, DOI 10.1139/F10-094; Fraser DJ, 2010, ECOL APPL, V20, P935, DOI 10.1890/09-0694.1; Friedland KD, 2009, ICES J MAR SCI, V66, P289, DOI 10.1093/icesjms/fsn210; Gilbey J, 2005, J FISH BIOL, V67, P1359, DOI 10.1111/j.0022-1112.2005.00831.x; Gilbey J, 2009, J FISH BIOL, V75, P2820, DOI 10.1111/j.1095-8649.2009.02497.x; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; GJEDREM T, 1979, Z TIERZ ZUCHTUNGSBIO, V96, P56; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Glover KA, 2006, AQUACULTURE, V254, P72, DOI 10.1016/j.aquaculture.2005.10.040; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; HEGGBERGET TG, 1988, CAN J FISH AQUAT SCI, V45, P845, DOI 10.1139/f88-102; Henderson JN, 2003, CAN J FISH AQUAT SCI, V60, P32, DOI 10.1139/F03-001; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; JENSEN AJ, 1991, ENVIRON BIOL FISH, V30, P379, DOI 10.1007/BF02027981; Johnsson JI, 1999, J FISH BIOL, V54, P469, DOI 10.1111/j.1095-8649.1999.tb00846.x; KAZAKOV RV, 1981, J FISH BIOL, V19, P353, DOI 10.1111/j.1095-8649.1981.tb05838.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Kvingedal E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1295, DOI 10.1007/s00265-011-1143-0; Lund RA, 1989, RES REPORT NORWEGIAN, V1, P1; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; R Development Core Team, 2014, R LANG ENV STAT COMP; Riedl C, 2013, ECOL FRESHW FISH, V22, P384, DOI 10.1111/eff.12033; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Robertsen G, 2013, CAN J FISH AQUAT SCI, V70, P5, DOI 10.1139/cjfas-2012-0152; Saegrov H, 1997, ICES J MAR SCI, V54, P1166, DOI 10.1016/S1054-3139(97)80023-9; Skaala O, 2005, J FISH BIOL, V67, P118, DOI 10.1111/j.0022-1112.2005.00843.x; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Skoglund H, 2012, FUNCT ECOL, V26, P104, DOI 10.1111/j.1365-2435.2011.01901.x; Skoglund H, 2011, CAN J FISH AQUAT SCI, V68, P1470, DOI [10.1139/F2011-056, 10.1139/f2011-056]; Skoglund H, 2011, J ANIM ECOL, V80, P365, DOI 10.1111/j.1365-2656.2010.01783.x; Solberg Monica F., 2012, BMC Research Notes, V5, P672, DOI 10.1186/1756-0500-5-672; Solberg MF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-234; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; SRIVASTAVA RK, 1991, CAN J ZOOL, V69, P2436, DOI 10.1139/z91-342; Tatara CP, 2012, ENVIRON BIOL FISH, V94, P7, DOI 10.1007/s10641-011-9906-z; Teletchea F, 2009, J FISH BIOL, V74, P652, DOI 10.1111/j.1095-8649.2008.02160.x; Thodesen J, 2001, AQUACULTURE, V194, P273, DOI 10.1016/S0044-8486(00)00527-5; Thodesen J, 1999, AQUACULTURE, V180, P237, DOI 10.1016/S0044-8486(99)00204-5; THORPE JE, 1984, AQUACULTURE, V43, P289, DOI 10.1016/0044-8486(84)90030-9; Webb JH, 1996, CAN J FISH AQUAT SCI, V53, P2739, DOI 10.1139/cjfas-53-12-2739; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x	73	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113697	10.1371/journal.pone.0113697	http://dx.doi.org/10.1371/journal.pone.0113697			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438050	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000347114900065
J	Zhou, JX; Pisco, AO; Qian, H; Huang, S				Zhou, Joseph Xu; Pisco, Angela Oliveira; Qian, Hong; Huang, Sui			Nonequilibrium Population Dynamics of Phenotype Conversion of Cancer Cells	PLOS ONE			English	Article							EVOLUTION; HETEROGENEITY; PROGRESSION; DIFFERENTIATION; RESISTANCE; LANDSCAPE; SELECTION; GENES	Tumorigenesis is a dynamic biological process that involves distinct cancer cell subpopulations proliferating at different rates and interconverting between them. In this paper we proposed a mathematical framework of population dynamics that considers both distinctive growth rates and intercellular transitions between cancer cell populations. Our mathematical framework showed that both growth and transition influence the ratio of cancer cell subpopulations but the latter is more significant. We derived the condition that different cancer cell types can maintain distinctive subpopulations and we also explain why there always exists a stable fixed ratio after cell sorting based on putative surface markers. The cell fraction ratio can be shifted by changing either the growth rates of the subpopulations (Darwinism selection) or by environment-instructed transitions (Lamarckism induction). This insight can help us to understand the dynamics of the heterogeneity of cancer cells and lead us to new strategies to overcome cancer drug resistance.	[Zhou, Joseph Xu; Pisco, Angela Oliveira; Huang, Sui] Inst Syst Biol, Seattle, WA 98109 USA; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Pisco, Angela Oliveira] Univ Manchester, Syst Biol Program, Fac Life Sci, Manchester, Lancs, England; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada	Institute for Systems Biology (ISB); University of California System; University of California Santa Barbara; University of Manchester; University of Washington; University of Washington Seattle; University of Calgary	Zhou, JX (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	Joseph.Zhou@systemsbiology.org; Sui.Huang@systemsbiology.org	Pisco, Angela Oliveira/K-4563-2012	Pisco, Angela Oliveira/0000-0003-0142-2355	National Science Foundation [PHY11-25915]; iCore (Alberta, Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109964] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); iCore (Alberta, Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This research was supported by the National Science Foundation under Grant No. PHY11-25915 and iCore (Alberta, Canada). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Armengol G, 2001, LAB INVEST, V81, P1703, DOI 10.1038/labinvest.3780383; Atallah J, 2009, INT REV CEL MOL BIO, V278, P119, DOI 10.1016/S1937-6448(09)78003-7; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; DELBRUCK M, 1949, C INT CTR NAT RECH S; Dowty JG, 2014, MATH MED BIOL, V31, P353, DOI 10.1093/imammb/dqt014; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2009, NATURE, V461, P183, DOI 10.1038/461183a; Fu Y, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016013; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Huang S, 2013, CANCER METAST REV, V32, P423, DOI 10.1007/s10555-013-9435-7; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kell DB, 2002, TRENDS GENET, V18, P555, DOI 10.1016/S0168-9525(02)02765-8; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Klein CA, 2004, CELL CYCLE, V3, P29; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; Lee GY, 2011, INT J HEMATOL, V93, P27, DOI 10.1007/s12185-010-0734-2; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Mehmood T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-327; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Saunders NJ, 2003, MICROBIOL-SGM, V149, P485, DOI 10.1099/mic.0.25807-0; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Wu C, 2011, BIOCOMPUT-PAC SYM, P62; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002; Zhou JX, 2012, J R SOC INTERFACE, V9, P3539, DOI 10.1098/rsif.2012.0434; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e110714	10.1371/journal.pone.0110714	http://dx.doi.org/10.1371/journal.pone.0110714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438251	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900006
J	Chen, B; Zheng, JX; Zeng, YY; Li, BF; Xie, B; Zheng, JH; Zhou, J; Zhang, WM				Chen, Bei; Zheng, Jingxian; Zeng, Yunyun; Li, Baofeng; Xie, Bo; Zheng, Jihua; Zhou, Juan; Zhang, Weimin			Sequence-Dependent Antiproliferative Effects of Gefitinib and Docetaxel on Non-Small Cell Lung Cancer (NSCLC) Cells and the Possible Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; SYNERGISTIC INTERACTION; DETERMINES RESPONSE; ERLOTINIB; CHEMOTHERAPY; COMBINATION; EGFR; MULTICENTER; CARBOPLATIN	Purpose: Recent clinical trials showed that the sequential combination of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy could prolong the PFS and/or OS of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutation. The aim of present study was to assess the optimal combination sequence and to explore its possible mechanism. Methods: PC-9 cells and A549 cells, the lung adenocarcinoma cells with mutant and wide-type EGFR respectively, were treated with docetaxel/gefitinib alone or in different combination schedules. The EGFR and K-ras gene status was determined by qPCR-HRM technique. Cell proliferation was detected by MTT assay. The expression and phosphorylation of EGFR, ERK, Akt and IGF-1R were detected by western blot. Cell cycle distribution was observed by flow cytometry. Results: Only sequential administration of docetaxel followed by gefitinib (D -> G) induced significant synergistic effect in both cell lines (Combination Index<0.9). The reverse sequence (G -> D) resulted in an antagonistic interaction in both cell lines (CI>1.1), whereas the concurrent administration (D+G) showed additive (0.9<CI<1.1)-synergistic effect in PC-9 cells and antagonistic-additive effect in A549 cells. Mechanism studies showed that docetaxel-induced phosphorylation of EGFR and ERK was repressed by subsequently used gefitinib, but not by concurrent exposure of gefitinib. The gefitinib-repressed phosphorylation of EGFR and ERK was reversed neither by concurrent nor by subsequent administration of docetaxel. D+G reinforced their inhibition on the phosphorylation of IGF-1R in PC-9 cells. Conclusions: The cytotoxic drugs followed by EGFR-TKIs may be the optimal combination for antiproliferative effects in EGFR-mutant NSCLC cells, and the phosphorylation of EGFR and ERK might contribute to this effect.	[Chen, Bei; Zheng, Jingxian; Zeng, Yunyun; Li, Baofeng; Xie, Bo; Zheng, Jihua; Zhou, Juan; Zhang, Weimin] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital	Zhang, WM (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	wmzhang79@126.com		Chen, Bei/0000-0003-2553-3279	National Natural Science Foundation of China [81172225, 81101821, 81000819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81172225, 81101821 and 81000819) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Cheng H, 2011, CANCER CHEMOTH PHARM, V67, P637, DOI 10.1007/s00280-010-1347-4; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giovannetti E, 2008, MOL PHARMACOL, V73, P1290, DOI 10.1124/mol.107.042382; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Jiang YW, 2014, J CANCER RES CLIN, V140, P1087, DOI 10.1007/s00432-014-1671-x; Kanda S, 2013, J CLIN ONCOL S, V31; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Kuiper JL, 2013, LUNG CANCER, V80, P102, DOI 10.1016/j.lungcan.2012.12.024; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Takeda K, 2010, J CLIN ONCOL, V28, P753, DOI 10.1200/JCO.2009.23.3445; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Van Schaeybroeck S, 2005, CLIN CANCER RES, V11, P7480, DOI 10.1158/1078-0432.CCR-05-0328; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Wu JD, 2006, CLIN CANCER RES, V12, P6153, DOI 10.1158/1078-0432.CCR-06-0443; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Xue MZ, 2012, CURR PHARM DESIGN, V18, P2901, DOI 10.2174/138161212800672723; Yamada T, 2013, ONCOGENE, V32, P4427, DOI 10.1038/onc.2012.446; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1	29	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114074	10.1371/journal.pone.0114074	http://dx.doi.org/10.1371/journal.pone.0114074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474307	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500112
J	Csapo, P; Raab, M				Csapo, Peter; Raab, Markus			"Hand down, Man down.'' Analysis of Defensive Adjustments in Response to the Hot Hand in Basketball Using Novel Defense Metrics	PLOS ONE			English	Article							BEHAVIOR	The hot-hand phenomenon, according to which a player's performance is significantly elevated during certain phases relative to the expected performance based on the player's base rate, has left many researchers and fans in basketball puzzled: The vast majority of players, coaches and fans believe in its existence but statistical evidence supporting this belief has been scarce. It has frequently been argued that the hot hand in basketball is unobservable because of strategic adjustments and defensive interference of the opposing team. We use a dataset with novel metrics, such as the number of defenders and the defensive intensity for each shot attempt, which enable us to directly measure defensive pressure. First, we examine how the shooting percentage of NBA players changes relative to the attributes of each metric. We find that it is of lesser importance by how many defenders a player is guarded but that defensive intensity, e.g., whether a defender raises his hand when his opponent shoots, has a larger impact on shot difficulty. Second, we explore how the underlying metrics and shooting accuracy change as a function of streak length. Our results indicate that defensive pressure and shot difficulty increase (decrease) during hot (cold) streaks, so that defenders seem to behave according to the hot-hand belief and try to force hot players into more difficult shots. However, we find that shooting percentages of presumably hot players do not increase and that shooting performance is not related to streakiness, so that the defenders' hot-hand behavior cannot be considered ecologically rational. Therefore, we are unable to find evidence in favor of the hot-hand effect even when accounting for defensive pressure.	[Csapo, Peter; Raab, Markus] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Raab, Markus] London S Bank Univ, Sch Appl Sci, London, England	German Sport University Cologne; London South Bank University	Csapo, P (corresponding author), German Sport Univ Cologne, Inst Psychol, Cologne, Germany.	peter.csapo@whu.edu	Raab, Markus/B-4919-2009	Raab, Markus/0000-0001-6546-1666	Jurgen Manchot Foundation	Jurgen Manchot Foundation	This research was supported by the Jurgen Manchot Foundation (http://www.manchot.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RM, 1992, PERCEPT MOTOR SKILL, V74, P934, DOI 10.2466/pms.1992.74.3.934; Aharoni G, 2012, APPL ECON, V44, P2309, DOI 10.1080/00036846.2011.564141; ALAMAR B, 2011, ANALYTICS MAGAZINE; Arkes J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1198; Attali Y, 2013, PSYCHOL SCI, V24, P1151, DOI 10.1177/0956797612468452; Bar-Eli M, 2006, PSYCHOL SPORT EXERC, V7, P525, DOI 10.1016/j.psychsport.2006.03.001; Bocskocsky A, 2014, HEAT CHECK NEW EVIDE; Burns BD, 2004, COGNITIVE PSYCHOL, V48, P295, DOI 10.1016/j.cogpsych.2003.07.003; Carlson KA, 2007, ORGAN BEHAV HUM DEC, V104, P113, DOI 10.1016/j.obhdp.2007.03.004; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gula B, 2004, J SPORT EXERCISE PSY, V26, P167, DOI 10.1123/jsep.26.1.167; Iso-Ahola SE, 2014, REV GEN PSYCHOL, V18, P19, DOI 10.1037/a0036406; Neiman T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1580; Raab M, 2012, J EXP PSYCHOL-APPL, V18, P81, DOI 10.1037/a0025951; Skinner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030776; Smith G, 2003, PSYCHON B REV, V10, P753, DOI 10.3758/BF03196542; Willer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049807; Yaari G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024532; 2014, NBA YEAR BY YEAR LEA	19	18	18	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114184	10.1371/journal.pone.0114184	http://dx.doi.org/10.1371/journal.pone.0114184			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474443	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346382500122
J	Gomila, M; Prince-Manzano, C; Svensson-Stadler, L; Busquets, A; Erhard, M; Martinez, DL; Lalucat, J; Moore, ERB				Gomila, Margarita; Prince-Manzano, Claudia; Svensson-Stadler, Liselott; Busquets, Antonio; Erhard, Marcel; Martinez, Deny L.; Lalucat, Jorge; Moore, Edward R. B.			Genotypic and Phenotypic Applications for the Differentiation and Species-Level Identification of Achromobacter for Clinical Diagnoses	PLOS ONE			English	Article							AD-HOC-COMMITTEE; CYSTIC-FIBROSIS; SP-NOV.; ROUTINE IDENTIFICATION; DENITRIFICANS RUGER; XYLOSOXIDANS; SAMPLES; RECLASSIFICATION; INFECTIONS; PIECHAUDII	The Achromobacter is a genus in the family Alcaligenaceae, comprising fifteen species isolated from different sources, including clinical samples. The ability to detect and correctly identify Achromobacter species, particularly A. xylosoxidans, and differentiate them from other phenotypically similar and genotypically related Gram-negative, aerobic, non-fermenting species is important for patients with cystic fibrosis (CF), as well as for nosocomial and other opportunistic infections. Traditional phenotypic profile-based analyses have been demonstrated to be inadequate for reliable identifications of isolates of Achromobacter species and genotypic-based assays, relying upon comparative 16S rRNA gene sequence analyses are not able to insure definitive identifications of Achromobacter species, due to the inherently conserved nature of the gene. The uses of alternative methodologies to enable high-resolution differentiation between the species in the genus are needed. A comparative multi-locus sequence analysis (MLSA) of four selected 'house-keeping' genes (atpD, gyrB, recA, and rpoB) assessed the individual gene sequences for their potential in developing a reliable, rapid and cost-effective diagnostic protocol for Achromobacter species identifications. The analysis of the type strains of the species of the genus and 46 strains of Achromobacter species showed congruence between the cluster analyses derived from the individual genes. The MLSA gene sequences exhibited different levels of resolution in delineating the validly published Achromobacter species and elucidated strains that represent new genotypes and probable new species of the genus. Our results also suggested that the recently described A. spritinus is a later heterotypic synonym of A. marplatensis. Strains were analyzed, using whole-cell Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF MS), as an alternative phenotypic profile-based method with the potential to support the identifications determined by the genotypic DNA sequence-based MLSA. The MALDI-TOF MS data showed good accordance in strain groupings and identifications by the MLSA data.	[Gomila, Margarita; Prince-Manzano, Claudia; Busquets, Antonio; Martinez, Deny L.; Lalucat, Jorge] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Islas Baleares, Spain; [Svensson-Stadler, Liselott; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Culture Collect Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Erhard, Marcel] RIPAC LAB GmbH, Potsdam, Germany; [Lalucat, Jorge] CSIC UIB, Mediterranean Inst Adv Studies IMEDEA, Palma De Mallorca, Islas Baleares, Spain	Universitat de les Illes Balears; University of Gothenburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Gomila, M (corresponding author), Univ Balearic Isl, Dept Biol, Palma De Mallorca, Islas Baleares, Spain.	marga.gomila@uib.es	Gomila, Margarita/H-3314-2015; Lalucat, Jorge/K-1127-2014; Busquets Bisbal, Antonio/K-9206-2014	Gomila, Margarita/0000-0001-8725-190X; Lalucat, Jorge/0000-0002-8350-6087; Moore, Edward/0000-0001-7693-924X; Busquets Bisbal, Antonio/0000-0002-2793-1388	University of the Balearic Islands - Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program; Spanish Ministry of Education and Science, Jose Castillejo Program; FEMS Research Fellowship [2009-1]; Vastra Gotaland Region (Sweden) [ALFGBG-210591, VGFOUREG-157801, VGFOUREG-232981]; Spanish MINECO [CGL2011-24318]; Consolider [CSD2009-00006]	University of the Balearic Islands - Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program; Spanish Ministry of Education and Science, Jose Castillejo Program(German Research Foundation (DFG)); FEMS Research Fellowship; Vastra Gotaland Region (Sweden); Spanish MINECO(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Margarita Gomila is the recipient of a postdoctoral contract from the University of the Balearic Islands funded by the Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program. Margarita Gomila was supported for exchange to the CCUG through fellowships from the Spanish Ministry of Education and Science, by means of the Jose Castillejo Program (2008) and from a FEMS Research Fellowship 2009-1. This work was supported also by funding from Vastra Gotaland Region (Sweden) projects ALFGBG-210591, VGFOUREG-157801 and VGFOUREG-232981, and from Spanish MINECO, through projects CGL2011-24318 and Consolider CSD2009-00006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoureux L, 2013, APPL ENVIRON MICROB, V79, P7142, DOI 10.1128/AEM.02293-13; Barrado L, 2013, J CLIN MICROBIOL, V51, P1927, DOI 10.1128/JCM.00494-13; Blumel S, 2001, INT J SYST EVOL MICR, V51, P1867, DOI 10.1099/00207713-51-5-1867; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1825, DOI 10.1099/ijs.0.02609-0; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1819, DOI 10.1099/ijs.0.02698-0; DAMATO RF, 1988, J CLIN MICROBIOL, V26, P2425, DOI 10.1128/JCM.26.11.2425-2426.1988; De Baets F, 2014, PEDIATR PULM, V49, P414, DOI 10.1002/ppul.22864; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; DELEY J, 1986, INT J SYST BACTERIOL, V36, P405, DOI 10.1099/00207713-36-3-405; Duggan JM, 1996, CLIN INFECT DIS, V23, P569, DOI 10.1093/clinids/23.3.569; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez-Olmos A, 2012, J CYST FIBROS, V11, P59, DOI 10.1016/j.jcf.2011.09.001; Gomila M, 2007, APPL ENVIRON MICROB, V73, P3787, DOI 10.1128/AEM.02934-06; Gomila M, 2011, INT J SYST EVOL MICR, V61, P2231, DOI 10.1099/ijs.0.025304-0; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hansen CR, 2013, J CYST FIBROS, V12, P609, DOI 10.1016/j.jcf.2013.05.004; Jacquier H, 2011, EUR J CLIN MICROBIOL, V30, P1579, DOI 10.1007/s10096-011-1263-5; JUKES T H, 1969, P21; Kallow W, 2010, MASS SPECTROMETRY MI, P255; Kersters K., 1984, BERGEYS MANUAL SYSTE, P361; KIREDJIAN M, 1986, INT J SYST BACTERIOL, V36, P282, DOI 10.1099/00207713-36-2-282; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Liu LX, 2002, J CLIN MICROBIOL, V40, P1210, DOI 10.1128/JCM.40.4.1210-1213.2002; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; SPEAR JB, 1988, J CLIN MICROBIOL, V26, P598, DOI 10.1128/JCM.26.3.598-599.1988; Spilker T, 2013, J CYST FIBROS, V12, P298, DOI 10.1016/j.jcf.2012.10.002; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeb LA, 2008, RES MICROBIOL, V159, P169, DOI 10.1016/j.resmic.2007.12.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandamme P, 2013, SYST APPL MICROBIOL, V36, P474, DOI 10.1016/j.syapm.2013.06.005; Vandamme P, 2013, SYST APPL MICROBIOL, V36, P1, DOI 10.1016/j.syapm.2012.10.003; Vu-Thien H, 1998, EUR J CLIN MICROBIOL, V17, P724, DOI 10.1007/s100960050168; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Ziemke F, 1998, INT J SYST BACTERIOL, V48, P179, DOI 10.1099/00207713-48-1-179	45	22	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114356	10.1371/journal.pone.0114356	http://dx.doi.org/10.1371/journal.pone.0114356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474264	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500024
J	Mukherjee, D; Royce, SG; Alexander, JA; Buckley, B; Isukapalli, SS; Bandera, EV; Zarbl, H; Georgopoulos, PG				Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Buckley, Brian; Isukapalli, Sastry S.; Bandera, Elisa V.; Zarbl, Helmut; Georgopoulos, Panos G.			Physiologically-Based Toxicokinetic Modeling of Zearalenone and Its Metabolites: Application to the Jersey Girl Study	PLOS ONE			English	Article							MYCOTOXIN ZEARALENONE; AROMATIC HYDROXYLATION; ORAL BIOAVAILABILITY; IN-VITRO; RAT; EXPOSURE; ZERANOL; BIOTRANSFORMATION; URINE; GLUCURONIDATION	Zearalenone (ZEA), a fungal mycotoxin, and its metabolite zeranol (ZAL) are known estrogen agonists in mammals, and are found as contaminants in food. Zeranol, which is more potent than ZEA and comparable in potency to estradiol, is also added as a growth additive in beef in the US and Canada. This article presents the development and application of a Physiologically-Based Toxicokinetic (PBTK) model for ZEA and ZAL and their primary metabolites, zearalenol, zearalanone, and their conjugated glucuronides, for rats and for human subjects. The PBTK modeling study explicitly simulates critical metabolic pathways in the gastrointestinal and hepatic systems. Metabolic events such as dehydrogenation and glucuronidation of the chemicals, which have direct effects on the accumulation and elimination of the toxic compounds, have been quantified. The PBTK model considers urinary and fecal excretion and biliary recirculation and compares the predicted biomarkers of blood, urinary and fecal concentrations with published in vivo measurements in rats and human subjects. Additionally, the toxicokinetic model has been coupled with a novel probabilistic dietary exposure model and applied to the Jersey Girl Study (JGS), which involved measurement of mycoestrogens as urinary biomarkers, in a cohort of young girls in New Jersey, USA. A probabilistic exposure characterization for the study population has been conducted and the predicted urinary concentrations have been compared to measurements considering inter-individual physiological and dietary variability. The in vivo measurements from the JGS fall within the high and low predicted distributions of biomarker values corresponding to dietary exposure estimates calculated by the probabilistic modeling system. The work described here is the first of its kind to present a comprehensive framework developing estimates of potential exposures to mycotoxins and linking them with biologically relevant doses and biomarker measurements, including a systematic characterization of uncertainties in exposure and dose estimation for a vulnerable population.	[Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Buckley, Brian; Isukapalli, Sastry S.; Bandera, Elisa V.; Zarbl, Helmut; Georgopoulos, Panos G.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Isukapalli, Sastry S.; Zarbl, Helmut; Georgopoulos, Panos G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Mukherjee, Dwaipayan; Georgopoulos, Panos G.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ USA; [Georgopoulos, Panos G.] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Georgopoulos, PG (corresponding author), Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.	panosg@ccl.rutgers.edu	Bandera, Elisa V/M-4169-2014; Mukherjee, Dwaipayan/AAN-6736-2020	Bandera, Elisa V/0000-0002-8789-2755; Mukherjee, Dwaipayan/0000-0002-3918-3188	National Institute of Environmental Health Sciences [P30E5S005022]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institute of Environmental Health Sciences Grant P30E5S005022 (http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN R S, 1983, Regulatory Toxicology and Pharmacology, V3, P9, DOI 10.1016/0273-2300(83)90046-6; Bandera EV, 2011, SCI TOTAL ENVIRON, V409, P5221, DOI 10.1016/j.scitotenv.2011.09.029; Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053; Beef Checkoff, 2009, TECHNICAL REPORT; BIEHL ML, 1993, TOXICOL APPL PHARM, V121, P152, DOI 10.1006/taap.1993.1140; BORIES GF, 1991, DRUG METAB DISPOS, V19, P140; Coffey R, 2009, FOOD CONTROL, V20, P239, DOI 10.1016/j.foodcont.2008.05.011; COMAS AP, 1982, LANCET, V1, P1299; Cubitt HE, 2009, PHARM RES-DORDR, V26, P1073, DOI 10.1007/s11095-008-9823-9; DERODRIGUEZ CAS, 1985, J PEDIATR-US, V107, P393, DOI 10.1016/S0022-3476(85)80513-8; DIXON SN, 1986, J VET PHARMACOL THER, V9, P353, DOI 10.1111/j.1365-2885.1986.tb00055.x; EU Directorate-GeneralXXIV, 1999, TECHNICAL REPORT; European Food Safety Authority (EFSA), 1975, EFSA J, V9; FARA GM, 1979, LANCET, V2, P295; Fink-Gremmels J, 2008, FOOD ADDIT CONTAM A, V25, P172, DOI 10.1080/02652030701823142; FitzGerald MP, 2002, AM J OBSTET GYNECOL, V187, P1384, DOI 10.1067/mob.2002.126865; FITZPATRICK DW, 1988, J ENVIRON SCI HEAL B, V23, P343, DOI 10.1080/03601238809372610; Fleck Stefanie C, 2012, Mycotoxin Res, V28, P267, DOI 10.1007/s12550-012-0143-x; Georgopoulos PG, 2006, J TOXICOL ENV HEAL B, V9, P457, DOI 10.1080/10937400600755929; Georgopoulos PG, 2014, RISK ANAL; Haritova AM, 2010, VET J, V185, P278, DOI 10.1016/j.tvjl.2009.06.007; Hildebrand A, 2010, TOXICOL LETT, V192, P379, DOI 10.1016/j.toxlet.2009.11.014; Johnson R, 2010, TECHNICAL REPORT; KIESSLING KH, 1978, ACTA PHARMACOL TOX, V43, P285; Kleinova M, 2002, J AGR FOOD CHEM, V50, P4769, DOI 10.1021/jf020160p; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Liu Suling, 2004, Breast J, V10, P514, DOI 10.1111/j.1075-122X.2004.21410.x; Malekinejad H, 2005, VET RES, V36, P799, DOI 10.1051/vetres:2005034; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Mallis LM, 2003, J CHROMATOGR B, V796, P71, DOI 10.1016/j.jchromb.2003.08.003; Massart F, 2008, J PEDIATR-US, V152, P690, DOI 10.1016/j.jpeds.2007.10.020; MIGDALOF BH, 1983, XENOBIOTICA, V13, P209, DOI 10.3109/00498258309052257; Miles CO, 1996, J AGR FOOD CHEM, V44, P3244, DOI 10.1021/jf9601325; Pearson MA, 2009, J EXPO SCI ENV EPID, V19, P336, DOI 10.1038/jes.2008.48; Pfeiffer E, 2013, MYCOTOXIN RES, V29, P177, DOI 10.1007/s12550-013-0165-z; Pfeiffer E, 2010, MOL NUTR FOOD RES, V54, P1468, DOI 10.1002/mnfr.200900524; Pfeiffer E, 2009, MOL NUTR FOOD RES, V53, P1123, DOI 10.1002/mnfr.200800584; Poulin P, 2002, J PHARM SCI, V91; Ramos AJ, 1996, INT J PHARMACEUT, V128, P129, DOI 10.1016/0378-5173(95)04239-3; Schaut A, 2008, J APPL TOXICOL, V28, P966, DOI 10.1002/jat.1362; SCHOENTAL R, 1983, LANCET, V1, P537; Sewell H, 1993, G2090 U MISS; Shephard GS, 2013, FOOD CHEM TOXICOL, V62, P217, DOI 10.1016/j.fct.2013.08.040; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1406, DOI 10.1080/15287390903212774; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1395, DOI 10.1080/15287390903212741; Skopp G, 2002, FORENSIC SCI INT, V126, P17, DOI 10.1016/S0379-0738(02)00023-3; So MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096404; Tangni EK, 2009, SCI TOTAL ENVIRON, V407, P4411, DOI 10.1016/j.scitotenv.2008.10.060; Tangni EK, 2007, J SCI FOOD AGR, V87, P1263, DOI 10.1002/jsfa.2838; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Videmann B, 2008, FOOD CHEM TOXICOL, V46, P3279, DOI 10.1016/j.fct.2008.07.011; Wang YL, 2008, ENVIRON RES, V107, P139, DOI 10.1016/j.envres.2008.01.008; Warth B, 2013, TOXICOL LETT, V220, P88, DOI 10.1016/j.toxlet.2013.04.012; World Health Organization, 2000, TECHNICAL REPORT; Zollner P, 2002, J AGR FOOD CHEM, V50, P2494, DOI 10.1021/jf0113631	55	23	23	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113632	10.1371/journal.pone.0113632	http://dx.doi.org/10.1371/journal.pone.0113632			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474635	Green Published, gold			2022-12-27	WOS:000346382500088
J	Wang, L; Peng, PA; Zhang, O; Xu, XH; Yang, SW; Zhao, YX; Zhou, YJ				Wang, Le; Peng, Pingan; Zhang, Ou; Xu, Xiaohan; Yang, Shiwei; Zhao, Yingxin; Zhou, Yujie			High-Dose Statin Pretreatment Decreases Periprocedural Myocardial Infarction and Cardiovascular Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of Twenty-Four Randomized Controlled Trials	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ATORVASTATIN PRETREATMENT; PROGNOSTIC VALUE; ADHESION MOLECULES; STENT IMPLANTATION; CAMS ATORVASTATIN; II TRIAL; ROSUVASTATIN; ANGIOPLASTY; DAMAGE	Background: Evidence suggests that high-dose statin pretreatment may reduce the risk of periprocedural myocardial infarction (PMI) and major adverse cardiac events (MACE) for certain patients; however, previous analyses have not considered patients with a history of statin maintenance treatment. In this metaanalysis of randomized controlled trials (RCTs), we reevaluated the efficacy of short-term high-dose statin pretreatment to prevent PMI and MACE in an expanded set of patients undergoing elective percutaneous coronary intervention. Methods: We searched the PubMed/Medline database for RCTs that compared high-dose statin pretreatment with no statin or low-dose statin pretreatment as a prevention of PMI and MACE. We evaluated the incidence of PMI and MACE, including death, spontaneous myocardial infarction, and target vessel revascularization at the longest follow-up for each study for subgroups stratified by disease classification and prior low-dose statin treatment. Results: Twenty-four RCTs with a total of 5,526 patients were identified. High-dose statin pretreatment was associated with 59% relative reduction in PMI (odds ratio [OR]: 0.41; 95% confidence interval [CI]: 0.34-0.49; P, 0.00001) and 39% relative reduction in MACE (OR: 0.61; 95% CI: 0.45-0.83; P50.002). The benefit of highdose statin pretreatment on MACE was significant for statin-naive patients (OR: 0.69; 95% CI: 0.50-0.95; P50.02) and prior low dose statin-treated patients (OR:0.28; 95% CI: 0.12-0.65; P50.003); and for patients with acute coronary syndrome (OR: 0.52; 95% CI: 0.34-0.79; P50.003), but not for patients with stable angina (OR: 0.71; 95% CI 0.45-1.10; P50.12). Long-term effects on survival were less obvious. Conclusions: High-dose statin pretreatment can result in a significant reduction in PMI and MACE for patients undergoing elective PCI. The positive effect of highdose statin pretreatment on PMI and MACE is significant for statin-naive patients and patients with prior treatment. The positive effect of high-dose statin pretreatment on MACE is significant for patients with acute coronary syndrome.	[Wang, Le; Peng, Pingan; Zhang, Ou; Xu, Xiaohan; Yang, Shiwei; Zhao, Yingxin; Zhou, Yujie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ,Beijing Anzhen Hosp, Beijing 100029, Peoples R China	Capital Medical University	Zhou, YJ (corresponding author), Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ,Beijing Anzhen Hosp, Beijing 100029, Peoples R China.	azzyj12@163.com	Zhou, Yu/HHN-3071-2022		National Natural Science Foundation of China [81270285, 81100198]; National Construction Program of Key Clinical specialist facility Project; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZY201303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Construction Program of Key Clinical specialist facility Project; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support	This work was supported by the National Natural Science Foundation of China NO. 81270285 and NO. 81100198, the National Construction Program of Key Clinical specialist facility Project and Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support code: ZY201303 (http://www.bjah.gov.cn/gzdt/kyjy/xzzq/201403/P020140304488636040596.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjo AM, 2013, CATHETER CARDIOVASC; Blankenship JC, 2001, J AM COLL CARDIOL, V38, P653, DOI 10.1016/S0735-1097(01)01423-1; Boaas H, 2007, ADV THER, V24, P493, DOI 10.1007/BF02848771; Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017; Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005; Buffon A, 1999, J AM COLL CARDIOL, V34, P1512, DOI 10.1016/S0735-1097(99)00348-4; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; Cay S, 2010, CARDIOVASC DRUG THER, V24, P41, DOI 10.1007/s10557-010-6224-1; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Delhaye C, 2010, AM J CARDIOL, V105, P826, DOI 10.1016/j.amjcard.2009.10.064; Delhaye C, 2009, CARDIOVASC REVASCULA, V10, P144, DOI 10.1016/j.carrev.2009.01.005; Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Ellis SG, 2001, CIRCULATION, V104, P2685, DOI 10.1161/hc4701.099782; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Fujii K, 2011, JACC-CARDIOVASC INTE, V4, P513, DOI 10.1016/j.jcin.2011.02.005; Gao Y, 2012, CHINESE MED J-PEKING, V125, P2250, DOI 10.3760/cma.j.issn.0366-6999.2012.13.002; Gordin J, 2012, AM J CARDIOL, V110, P1397, DOI 10.1016/j.amjcard.2012.06.052; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jang JS, 2013, CATHETER CARDIO INTE, V81, P959, DOI 10.1002/ccd.24542; Jang Y, 2014, J CARDIOL, V63, P335, DOI 10.1016/j.jjcc.2013.09.012; Jia XW, 2009, CHINESE MED J-PEKING, V122, P659, DOI 10.3760/cma.j.issn.0366-6999.2009.06.013; Kim JS, 2010, JACC-CARDIOVASC INTE, V3, P332, DOI 10.1016/j.jcin.2009.11.021; Kinoshita M, 2007, CIRC J, V71, P1225, DOI 10.1253/circj.71.1225; Lansky AJ, 2010, CIRC-CARDIOVASC INTE, V3, P602, DOI 10.1161/CIRCINTERVENTIONS.110.959080; Li Q, 2013, MED CLIN-BARCELONA, V140, P532, DOI 10.1016/j.medcli.2012.05.042; Luo J, 2013, INT J CARDIOL, V167, P2350, DOI 10.1016/j.ijcard.2012.11.032; Macin SM, 2005, AM HEART J, V149, P451, DOI 10.1016/j.ahj.2004.07.041; Mensah K, 2005, J AM COLL CARDIOL, V45, P1287, DOI 10.1016/j.jacc.2005.01.021; Nafasi L, 2014, CURR MED RES OPIN, V30, P381, DOI 10.1185/03007995.2013.834249; Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048; Park H, 2013, INT J CARDIOL, V167, P1547, DOI 10.1016/j.ijcard.2012.04.096; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Patti G, 2006, J AM COLL CARDIOL, V48, P1560, DOI 10.1016/j.jacc.2006.06.061; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; Patti G, 2010, J CARDIOVASC MED, V11, P795, DOI 10.2459/JCM.0b013e32833b929c; Sanguigni V, 2005, CIRCULATION, V111, P412, DOI 10.1161/01.CIR.0000153810.81187.7D; Sardella G, 2013, INT J CARDIOL, V168, P3715, DOI 10.1016/j.ijcard.2013.06.017; Sardella G, 2013, CATHETER CARDIO INTE, V81, pE36, DOI 10.1002/ccd.24403; Takano H, 2013, AM J CARDIOL, V111, P1688, DOI 10.1016/j.amjcard.2013.02.018; Toso A, 2011, J CARDIOVASC MED, V12, P318, DOI 10.2459/JCM.0b013e328341024f; Veselka J, 2011, AM J CARDIOL, V107, P1295, DOI 10.1016/j.amjcard.2010.12.040; Veselka J, 2009, AM J CARDIOL, V104, P630, DOI 10.1016/j.amjcard.2009.04.048; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; Walter DH, 2001, J AM COLL CARDIOL, V37, P839, DOI 10.1016/S0735-1097(00)01193-1; Wang ZZ, 2013, J CARDIOVASC PHARM T, V18, P327, DOI 10.1177/1074248412474346; Yu XL, 2011, CORONARY ARTERY DIS, V22, P87, DOI 10.1097/MCA.0b013e328341baee; Yun KH, 2011, INT J CARDIOL, V146, P68, DOI 10.1016/j.ijcard.2010.04.052; Zemanek D, 2013, INT J CARDIOL, V168, P2494, DOI 10.1016/j.ijcard.2013.03.002	52	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113352	10.1371/journal.pone.0113352	http://dx.doi.org/10.1371/journal.pone.0113352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473831	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500081
J	Gosney, BJ; Oreilly-Wapstra, JM; Forster, LG; Barbour, RC; Iason, GR; Potts, BM				Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Forster, Lynne G.; Barbour, Robert C.; Iason, Glenn R.; Potts, Brad M.			Genetic and Ontogenetic Variation in an Endangered Tree Structures Dependent Arthropod and Fungal Communities	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; RELATIVE IMPORTANCE; PLANT GENOTYPE; DEFENSIVE CHEMISTRY; HERBIVOROUS INSECTS; LEAF-BEETLE; RESISTANCE; CONSTRAINTS; DIVERSITY; APHIDS	Plant genetic and ontogenetic variation can significantly impact dependent fungal and arthropod communities. However, little is known of the relative importance of these extended genetic and ontogenetic effects within a species. Using a common garden trial, we compared the dependent arthropod and fungal community on 222 progeny from two highly differentiated populations of the endangered heteroblastic tree species, Eucalyptus morrisbyi. We assessed arthropod and fungal communities on both juvenile and adult foliage. The community variation was related to previous levels of marsupial browsing, as well as the variation in the physicochemical properties of leaves using near-infrared spectroscopy. We found highly significant differences in community composition, abundance and diversity parameters between eucalypt source populations in the common garden, and these were comparable to differences between the distinctive juvenile and adult foliage. The physicochemical properties assessed accounted for a significant percentage of the community variation but did not explain fully the community differences between populations and foliage types. Similarly, while differences in population susceptibility to a major marsupial herbivore may result in diffuse genetic effects on the dependent community, this still did not account for the large genetic-based differences in dependent communities between populations. Our results emphasize the importance of maintaining the populations of this rare species as separate management units, as not only are the populations highly genetically structured, this variation may alter the trajectory of biotic colonization of conservation plantings.	[Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Barbour, Robert C.; Potts, Brad M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Forster, Lynne G.] Univ Tasmania, Sch Agr Sci, Hobart, Tas, Australia; [Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Potts, Brad M.] Univ Tasmania, NCFFI, Hobart, Tas, Australia; [Iason, Glenn R.] James Hutton Inst, Aberdeen, Scotland	University of Tasmania; University of Tasmania; University of Tasmania; James Hutton Institute	Gosney, BJ (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	Ben.Gosney@utas.edu.au	Potts, Brad M/C-6489-2013; O'Reilly-Wapstra, Julianne/J-7275-2014	Potts, Brad M/0000-0001-6244-289X; Forster, Lynette/0000-0001-9195-2768; O'Reilly-Wapstra, Julianne/0000-0003-4801-4412	Australian Research Council [DP120102889, LP120200380]; BBSRC [BB/L012227/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L012227/1] Funding Source: researchfish	Australian Research Council(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: The trial studied was established by the CRC for Sustainable Production Forestry. This study is part of a PhD undertaken by Benjamin Gosney, supported by an International Postgraduate Scholarship provided by the University of Tasmania and funded by the Australian government. Trial assessment and data collection was funded by Australian Research Council linkage grants (DP120102889 and LP120200380). The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abbott Ian, 2001, Pacific Conservation Biology, V7, P101; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bailey J, 2011, ECOLOGICAL REV ECOLO; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bito Darren, 2011, Memoirs of the Queensland Museum, V55, P451; Busby PE, 2014, J ECOL, V102, P1300, DOI 10.1111/1365-2745.12270; Busby PE, 2013, J ECOL, V101, P867, DOI 10.1111/1365-2745.12112; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Carvalho MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094950; De Oliveira HG, 2010, REV COLOMB ENTOMOL, V36, P1; Dungey HS, 1997, CAN J FOREST RES, V27, P750, DOI 10.1139/cjfr-27-5-750; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; FOX LR, 1983, AUST J ECOL, V8, P139, DOI 10.1111/j.1442-9993.1983.tb01601.x; Frascaria-Lacoste N, 2012, RESTOR ECOL, V20, P296, DOI 10.1111/j.1526-100X.2012.00875.x; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Holeski LM, 2012, OECOLOGIA, V170, P695, DOI 10.1007/s00442-012-2344-6; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Jones RC, 2005, AUST J BOT, V53, P367, DOI 10.1071/BT04182; Larson KC, 1997, OECOLOGIA, V109, P575, DOI 10.1007/s004420050119; Lawrence R, 2003, ECOLOGY, V84, P1171, DOI 10.1890/0012-9658(2003)084[1171:RIOPOH]2.0.CO;2; Loch AD, 2010, FOREST ECOL MANAG, V260, P1324, DOI 10.1016/j.foreco.2010.07.025; Maherali H, 2009, NEW PHYTOL, V183, P908, DOI 10.1111/j.1469-8137.2009.02845.x; Mann AN, 2012, OIKOS, V121, P268, DOI 10.1111/j.1600-0706.2011.19667.x; Milgate AW, 2005, AUSTRALAS PLANT PATH, V34, P11, DOI 10.1071/AP04073; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; O'Reilly-Wapstra JM, 2013, TREE GENET GENOMES, V9, P943, DOI 10.1007/s11295-013-0607-y; O'Reilly-Wapstra JM, 2004, FUNCT ECOL, V18, P677, DOI 10.1111/j.0269-8463.2004.00887.x; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; O'Reilly-Wapstra JM, 2007, J CHEM ECOL, V33, P1876, DOI 10.1007/s10886-007-9366-2; PARSONS R F, 1974, Biotropica, V6, P202, DOI 10.2307/2989653; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Rapley LP, 2004, AUST J BOT, V52, P747, DOI 10.1071/BT04007; Rapley LP, 2007, CHEMOECOLOGY, V17, P235, DOI 10.1007/s00049-007-0382-z; RAYMOND CA, 1995, FOREST ECOL MANAG, V72, P21, DOI 10.1016/0378-1127(94)03451-2; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Vandegehuchte ML, 2012, INSECT CONSERV DIVER, V5, P453, DOI 10.1111/j.1752-4598.2011.00181.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Whitham TG, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P50; Wiggins NL, 2006, J CHEM ECOL, V32, P1133, DOI 10.1007/s10886-006-9076-1; Wiltshire RJE, 1998, AUST J BOT, V46, P45, DOI 10.1071/BT97020; Wise MJ, 2007, NEW PHYTOL, V175, P773, DOI 10.1111/j.1469-8137.2007.02143.x; Wise MJ, 2010, ARTHROPOD-PLANT INTE, V4, P159, DOI 10.1007/s11829-010-9094-3; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zotz G, 2011, BOT REV, V77, P109, DOI 10.1007/s12229-010-9062-8; Zytynska SE, 2011, PHILOS T R SOC B, V366, P1329, DOI 10.1098/rstb.2010.0183	58	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114132	10.1371/journal.pone.0114132	http://dx.doi.org/10.1371/journal.pone.0114132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469641	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700075
J	Hui, M; Liu, YA; Song, CW; Li, YD; Shi, GH; Cui, ZX				Hui, Min; Liu, Yuan; Song, Chengwen; Li, Yingdong; Shi, Guohui; Cui, Zhaoxia			Transcriptome Changes in Eriocheir sinensis Megalopae after Desalination Provide Insights into Osmoregulation and Stress Adaption in Larvae	PLOS ONE			English	Article							CHINESE MITTEN CRAB; OLFERSII WIEGMANN CRUSTACEA; LITOPENAEUS-VANNAMEI; ANTIOXIDANT ENZYME; SALINITY STRESS; BINDING PROTEIN; CARCINUS-MAENAS; WHITE SHRIMP; EXPRESSION; ATPASE	Eriocheir sinensis, an extremely invasive alien crab species, has important economic value in China. It encounters different salinities during its life cycle, and at the megalopal stage it faces a turning point regarding the salinity in its environment. We applied RNA sequencing to E. sinensis megalopae before (MB) and after (MA) desalination, resulting in the discovery of 21,042 unigenes and 908 differentially expressed genes (DEGs, 4.32% of the unigenes). The DEGs primarily belonged to the Gene Ontology groups "Energy metabolism," "Oxidoreductase activity," "Translation," "Transport," "Metabolism," and "Stress response." In total, 33 DEGs related to transport processes were found, including 12 proton pump genes, three ATP-binding cassettes (ABCs), 13 solute carrier (SLC) family members, two sweet sugar transporter (ST) family members and three other substance transporters. Mitochondrial genes as well as genes involved in the tricarboxylic acid cycle, glycolytic pathway, or beta-oxidation pathway, which can generate energy in the form of ATP, were typically up-regulated in MA. 11 unigenes related to amino acid metabolism and a large number of genes related to protein synthesis were differentially expressed in MB and MA, indicating that E. sinensis possibly adjusts its concentration of free amino acid osmolytes for hyper-osmoregulation. Additionally, 33 salinity and oxidative stress induced genes were found to be differentially expressed, such as the LEA2, HSPs, GST and coagulation factor genes. Notably, LEA2 is an extremely hydrophilic protein that responds to desiccation and reported for the first time in crabs. Therefore, we suppose that when the environment is hypo-osmotic, the megalopae might compensate for ion loss via hyper-osmoregulation by consuming more energy, accompanied by a series of stress induced adaptions. This study provides the first genome-wide transcriptome analysis of E. sinensis megalopae for studying its osmoregulation and stress adaption mechanisms.	[Hui, Min; Liu, Yuan; Song, Chengwen; Li, Yingdong; Shi, Guohui; Cui, Zhaoxia] Chinese Acad Sci, EMBL, Inst Oceanol, Qingdao 266071, Peoples R China; [Song, Chengwen; Shi, Guohui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Cui, Zhaoxia] Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao 266071, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZX (corresponding author), Chinese Acad Sci, EMBL, Inst Oceanol, Qingdao 266071, Peoples R China.	zhxcui@qdio.ac.cn		Li, Yingdong/0000-0002-9570-3715	Chinese National "863" Project [2012AA10A409]; National Natural Science Foundation of China [31101924, 41276165]	Chinese National "863" Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese National "863" Project (No. 2012AA10A409, http://www.most.gov.cn/eng/) and National Natural Science Foundation of China (31101924 and 41276165, http://www.nsfc.gov.cn/publish/portal1/) to ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Cheng YX, 2008, REV FISH SCI, V16, P377, DOI 10.1080/10641260701681698; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Cieluch U, 2007, MAR ECOL PROG SER, V329, P169, DOI 10.3354/meps329169; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DALLA VIA J, 1986, AQUACULTURE, V55, P307, DOI 10.1016/0044-8486(86)90171-7; de la Vega E, 2007, PHYSIOL GENOMICS, V31, P126, DOI 10.1152/physiolgenomics.00068.2007; Denekamp NY, 2010, BIOL REPROD, V82, P714, DOI 10.1095/biolreprod.109.081091; FOSKETT JK, 1977, BIOL BULL, V153, P505, DOI 10.2307/1540603; FREIRE CA, 1995, GEN COMP ENDOCR, V100, P83, DOI 10.1006/gcen.1995.1136; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Herborg LM, 2003, HYDROBIOLOGIA, V503, P21, DOI 10.1023/B:HYDR.0000008483.63314.3c; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Item CB, 2001, AM J HUM GENET, V69, P1127, DOI 10.1086/323765; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KING FD, 1985, COMP BIOCHEM PHYS B, V80, P401, DOI 10.1016/0305-0491(85)90262-7; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kong XH, 2008, MAR BIOL, V154, P269, DOI 10.1007/s00227-008-0920-4; KREBS H. A., 1960, Metabolic Pathways, V1, P129; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Liu CH, 2007, FISH SHELLFISH IMMUN, V23, P34, DOI 10.1016/j.fsi.2006.09.002; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; MCNAMARA JC, 1990, HYDROBIOLOGIA, V199, P193, DOI 10.1007/BF00006352; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Perazzolo LM, 2002, AQUACULTURE, V214, P19, DOI 10.1016/S0044-8486(02)00137-0; POLLARD HB, 1990, J MEMBRANE BIOL, V117, P101, DOI 10.1007/BF01868677; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Rodrigues AP, 2012, MAR BIOL, V159, P2061, DOI 10.1007/s00227-012-1992-8; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P29, DOI 10.1016/j.cca.2004.12.007; Sui LY, 2011, AQUACULTURE, V315, P16, DOI 10.1016/j.aquaculture.2010.06.021; Sun HY, 2011, MAR BIOL RES, V7, P623, DOI 10.1080/17451000.2010.538063; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towle DW, 2011, COMP BIOCHEM PHYS D, V6, P115, DOI 10.1016/j.cbd.2010.11.001; TOWLE DW, 1986, J EXP ZOOL, V239, P311, DOI 10.1002/jez.1402390302; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037316; Weber JM, 2011, J EXP BIOL, V214, P286, DOI 10.1242/jeb.047050; WELCOMME L, 1991, J EXP ZOOL, V257, P150, DOI 10.1002/jez.1402570203; Xu QH, 2011, MAR BIOL, V158, P2161, DOI 10.1007/s00227-011-1721-8; Zhang YQ, 1999, GENETICS, V153, P891; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P450, DOI 10.1016/j.cbpc.2009.06.012; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P224, DOI 10.1016/j.cbpc.2009.04.012	63	41	41	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114187	10.1371/journal.pone.0114187	http://dx.doi.org/10.1371/journal.pone.0114187			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470496	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700083
J	Renner, I; Funk, N; Geissler, R; Friedrich, S; Penzel, A; Behrens, SE				Renner, Ivonne; Funk, Nancy; Geissler, Rene; Friedrich, Susann; Penzel, Anika; Behrens, Sven-Erik			Antiviral Interferon-Beta Signaling Induced by Designed Transcription Activator-Like Effectors (TALE)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RIG-I; RNA REPLICATION; III EFFECTORS; RECOGNITION; MECHANISMS; IMMUNITY; BINDING; CODE	Here we show that designed transcription activator-like effectors (TALEs) that bind to defined areas of the interferon beta promoter are capable to induce IFN-beta expression and signaling in human cells. Importantly, TALE-mediated IFN-beta signaling occurs independently of pathogen pattern recognition but effectively prohibits viral RNA replication as demonstrated with a hepatitis C virus replicon. TALEs were thus indicated to be valuable tools in various applications addressing, for example, virus-host interactions.	[Renner, Ivonne; Funk, Nancy; Geissler, Rene; Friedrich, Susann; Penzel, Anika; Behrens, Sven-Erik] Univ Halle Wittenberg, Sect Microbial Biotechnol, Inst Biochem & Biotechnol, Fac Life Sci NFI, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Behrens, SE (corresponding author), Univ Halle Wittenberg, Sect Microbial Biotechnol, Inst Biochem & Biotechnol, Fac Life Sci NFI, Kurt Mothes Str 3, D-06120 Halle, Germany.	sven.behrens@biochemtech.uni-halle.de		Friedrich, Susann/0000-0001-6378-2933	Deutsche Forschungsgemeinschaft [BE 1885/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (BE 1885/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Geissler R, 2012, NUCLEIC ACIDS RES, V40, P4998, DOI 10.1093/nar/gks070; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114288	10.1371/journal.pone.0114288	http://dx.doi.org/10.1371/journal.pone.0114288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470486	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700097
J	Taylor, RA; Hammond, MD; Ai, Y; Sansing, LH				Taylor, Roslyn A.; Hammond, Matthew D.; Ai, Youxi; Sansing, Lauren H.			CX3CR1 Signaling on Monocytes Is Dispensable after Intracerebral Hemorrhage	PLOS ONE			English	Article							SPINAL-CORD-INJURY; INFLAMMATORY MONOCYTES; ISCHEMIC-STROKE; MACROPHAGES; FRACTALKINE; SUBSETS; RECRUITMENT; RECEPTOR; BLOOD; CELLS	Intracerebral hemorrhage is a subset of stroke for which there is no specific treatment. The Ly6C(hi) CCR2(+) monocytes have been shown to contribute to acute injury after intracerebral hemorrhage. The other murine monocyte subset expresses CX3CR1 and lower Ly6C levels, and contributes to repair in other disease models. We hypothesized that the Ly6C(lo) CX3CR1(+) monocytes would contribute to recovery after intracerebral hemorrhage. Intracerebral hemorrhage was modeled by blood injection in WT and CX3CR1-null bone marrow chimeras. Neurological outcomes and leukocyte recruitment were quantified at various time points. Functional outcomes were equal at 1, 3, 7, and 14 days after intracerebral hemorrhage in both genotypes. No differences were observed in leukocyte recruitment between genotypes on either 3 or 7 days after intracerebral hemorrhage. A few hundred Ly6C(lo) monocytes were found in the ipsilateral hemisphere in each genotype and they did not change over time. Peripherally derived CX3CR1(+) monocytes were observed in the perihematomal brain 7 and 14 days after intracerebral hemorrhage. Our data suggests CX3CR1 signaling on monocytes does not play an influential role in acute injury or functional recovery after intracerebral hemorrhage and therefore CX3CR1 is not a therapeutic target to improve outcome after intracerebral hemorrhage.	[Taylor, Roslyn A.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Taylor, Roslyn A.; Hammond, Matthew D.; Ai, Youxi; Sansing, Lauren H.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hammond, Matthew D.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA	University of Connecticut; Yale University; University of Connecticut	Sansing, LH (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	lauren.sansing@yale.edu		Sansing, Lauren/0000-0002-6898-1680	NIH [F31NS083231, K08NS078110]; Marlene L. Cohen and Jerome H. Fleisch Scholar Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS078110, F31NS083231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marlene L. Cohen and Jerome H. Fleisch Scholar Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by NIH F31NS083231 (MDH) and K08NS078110 (L.H.S.) and the Marlene L. Cohen and Jerome H. Fleisch Scholar Grant (L.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellavance M.-A., 2014, BRAIN STRUCT FUNCT; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Donohue MM, 2012, STROKE, V43, P2300, DOI 10.1161/STROKEAHA.112.657411; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hammond M, 2012, TRANSLATIONAL STROKE, V3; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Manno Edward M, 2012, Continuum (Minneap Minn), V18, P598, DOI 10.1212/01.CON.0000415430.99394.3e; Michaud JP, 2014, J CEREB BLOOD FLOW M; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Pereira FE, 2013, CARDIOVASC RES, V100, P74, DOI 10.1093/cvr/cvt155; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Qin WJ, 2014, NEUROSCI LETT, V569, P80, DOI 10.1016/j.neulet.2014.03.052; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Sansing LH, 2011, ACTA NEUROCHIR SUPPL, V111, P173, DOI 10.1007/978-3-7091-0693-8_29; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	34	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114472	10.1371/journal.pone.0114472	http://dx.doi.org/10.1371/journal.pone.0114472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469644	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700117
J	Christou, C; Oliver, RA; Yu, Y; Walsh, WR				Christou, Chris; Oliver, Rema A.; Yu, Yan; Walsh, William R.			The Masquelet Technique for Membrane Induction and the Healing of Ovine Critical Sized Segmental Defects	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ORTHOPEDIC TRAUMA SURGERY; MARROW STROMAL CELLS; GRAFT SUBSTITUTES; GROWTH-FACTORS; PARTICLE-SIZE; TGF-BETA; MODEL; RECONSTRUCTION; RECEPTORS	The healing of critical sized segmental defects is an ongoing clinical problem. No method has achieved pre-eminence. The Masquelet technique is a relatively new innovation involving the induction of a fibrous tissue membrane around the bone defect site taking advantage of the body's foreign body reaction to the presence of a polymethylmethacrylate (PMMA) spacer. The aim of this study was to investigate the properties and characteristics of this induced membrane and its effectiveness when used in conjunction with allograft or an allograft/autograft mix as filler materials in an ovine critical sized defect model. The resultant induced membrane was found to be effective in containing the graft materials in situ. It was demonstrated to be an organised pseudosynovial membrane which expressed bone morphogenic protein 2 (BMP2), transforming growth factor-beta (TGF beta), vascular endothelial growth factor (VEGF), von Willerbrand factor (vWF), interleukin 6 (IL-6) and interleukin 8 (IL-8). While more new bone growth was evident in the test groups compared to the controls animals at 12 weeks, the volumes were not statistically different and no defects were fully bridged. Of the two graft material groups, the allograft/autograft mix was shown to have a more rapid graft resorption rate than the allograft only group. While the Masquelet technique proved effective in producing a membrane to enclose graft materials, its ability to assist in the healing of critical sized segmental defects when compared to empty controls remained inconclusive.	[Christou, Chris; Oliver, Rema A.; Yu, Yan; Walsh, William R.] Univ New South Wales Australia, Surg & Orthopaed Res Labs, Sydney, NSW, Australia	University of New South Wales Sydney	Christou, C (corresponding author), Univ New South Wales Australia, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.	c.christou@unsw.edu.au		Walsh, William/0000-0002-5023-6148; Christou, Chris/0000-0003-3231-0356				Aho OM, 2013, J BONE JOINT SURG AM, V95A, P597, DOI 10.2106/JBJS.L.00310; Antonova E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-42; Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016; Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340; Cobos JA, 2000, J ORTHOP TRAUMA, V14, P54, DOI 10.1097/00005131-200001000-00011; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Farhadieh RD, 2004, J CRANIOFAC SURG, V15, P714, DOI 10.1097/00001665-200409000-00003; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Gruber HE, 2013, J ORTHOP TRAUMA, V27, P290, DOI 10.1097/BOT.0b013e3182691288; Gugala Z, 2002, INJURY, V33, P71, DOI 10.1016/S0020-1383(02)00135-3; Jin FC, 2013, CONNECT TISSUE RES, V54, P283, DOI 10.3109/03008207.2013.811499; Malinin Theodore I, 2007, Open Orthop J, V1, P19, DOI 10.2174/1874325000701010019; Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346; Masquelet AC, 2003, LANGENBECK ARCH SURG, V388, P344, DOI 10.1007/s00423-003-0379-1; Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Pallesen L, 2002, INT J ORAL MAX IMPL, V17, P498; Pelissier P, 2004, J ORTHOP RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7; Pluhar GE, 2006, J BONE JOINT SURG BR, V88B, P960, DOI 10.1302/0301-620X.88B7.17056; Rabillard M, 2009, VET COMP ORTHOPAED, V22, P460, DOI 10.3415/VCOT-09-04-0048; Russell N, 2013, BIOMATERIALS, V34, P8185, DOI 10.1016/j.biomaterials.2013.07.022; Sporn MB, 2006, CYTOKINE GROWTH F R, V17, P3, DOI 10.1016/j.cytogfr.2005.09.012; Stafford PR, 2010, INJURY, V41, pS72, DOI 10.1016/S0020-1383(10)70014-0; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Szpalski Marek, 2005, Acta Orthop Belg, V71, P133; Tate MLK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028702; Taylor BC, 2012, J AM ACAD ORTHOP SUR, V20, P142, DOI 10.5435/JAAOS-20-03-142; VAIL TB, 1994, VET SURG, V23, P386, DOI 10.1111/j.1532-950X.1994.tb00499.x; Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x; Viateau V, 2010, ORTHOP CLIN N AM, V41, P49, DOI 10.1016/j.ocl.2009.07.010; Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017; Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289	48	53	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114122	10.1371/journal.pone.0114122	http://dx.doi.org/10.1371/journal.pone.0114122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461340	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700101
J	Moura, RS; Carvalho-Correia, E; daMota, P; Correia-Pinto, J				Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge			Canonical Wnt Signaling Activity in Early Stages of Chick Lung Development	PLOS ONE			English	Article							BETA-CATENIN; BRANCHING MORPHOGENESIS; EXPRESSION PATTERNS; PPAR-GAMMA; GENES; PATHWAY; PROLIFERATION; FIBRONECTIN; COMPONENTS; APOPTOSIS	Wnt signaling pathway is an essential player during vertebrate embryonic development which has been associated with several developmental processes such as gastrulation, body axis formation and morphogenesis of numerous organs, namely the lung. Wnt proteins act through specific transmembrane receptors, which activate intracellular pathways that regulate cellular processes such as cell proliferation, differentiation and death. Morphogenesis of the fetal lung depends on epithelial-mesenchymal interactions that are governed by several growth and transcription factors that regulate cell proliferation, fate, migration and differentiation. This process is controlled by different signaling pathways such as FGF, Shh and Wnt among others. Wnt signaling is recognized as a key molecular player in mammalian pulmonary development but little is known about its function in avian lung development. The present work characterizes, for the first time, the expression pattern of several Wnt signaling members, such as wnt-1, wnt-2b, wnt-3a, wnt-5a, wnt-7b, wnt-8b, wnt-9a, lrp5, lrp6, sfrp1, dkk1, beta-catenin and axin2 at early stages of chick lung development. In general, their expression is similar to their mammalian counterparts. By assessing protein expression levels of active/total beta-catenin and phospho-LRP6/LRP6 it is revealed that canonical Wnt signaling is active in this embryonic tissue. In vitro inhibition studies were performed in order to evaluate the function of Wnt signaling pathway in lung branching. Lung explants treated with canonical Wnt signaling inhibitors (FH535 and PK115-584) presented an impairment of secondary branch formation after 48 h of culture along with a decrease in axin2 expression levels. Branching analysis confirmed this inhibition. Wnt-FGF crosstalk assessment revealed that this interaction is preserved in the chick lung. This study demonstrates that Wnt signaling is crucial for precise chick lung branching and further supports the avian lung as a good model for branching studies since it recapitulates early mammalian pulmonary development.	[Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Moura, Rute Silva] Univ Minho, Sch Sci, Dept Biol, Braga, Portugal; [daMota, Paulo] Hosp Braga, Dept Urol, Braga, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Universidade do Minho; Hospital de Braga; Hospital de Braga	Moura, RS (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	rutemoura@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012; Moura, Rute/GYV-3259-2022; Moura, Rute S/B-4208-2011	Correia-Pinto, Jorge/0000-0002-9265-6896; Moura, Rute S/0000-0003-1763-9014; Carvalho-Correia, Eduarda/0000-0001-5821-0893; Mota, Paulo/0000-0002-2316-373X	ON.2 SR&TD Integrated Program [N-01-01-0124-01-07]	ON.2 SR&TD Integrated Program	Rute S. Moura was supported by a grant of ON.2 SR&TD Integrated Program (N-01-01-0124-01-07), ref: UMINHO/BPD/31/2013. The funders had no role in study design, data collection and analysis,	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Church VL, 2002, INT J DEV BIOL, V46, P927; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colvin JS, 2001, DEVELOPMENT, V128, P2095; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621; Foronjy R, 2010, AM J PATHOL, V177, P598, DOI 10.2353/ajpath.2010.090803; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Geetha-Loganathan Poongodi, 2008, Organogenesis, V4, P109; Geetha-Loganathan P, 2009, DEV DYNAM, V238, P1150, DOI 10.1002/dvdy.21934; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Havens BA, 2006, ARCH ORAL BIOL, V51, P134, DOI 10.1016/j.archoralbio.2005.06.011; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Horowitz A, 2009, CIRC RES, V104, pE21, DOI 10.1161/CIRCRESAHA.108.191494; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loganathan PG, 2005, HISTOCHEM CELL BIOL, V123, P195, DOI 10.1007/s00418-005-0756-7; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Malpel S, 2000, DEVELOPMENT, V127, P3057; Matsumoto K, 2008, DEV BIOL, V319, P234, DOI 10.1016/j.ydbio.2008.04.021; McBride HJ, 2003, DEV BIOL, V256, P18, DOI 10.1016/S0012-1606(02)00118-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Moura RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017660; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Osmon, 2005, ATLAS CHICK DEV; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Quinlan R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-35; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tebar M, 2001, MECH DEVELOP, V109, P437, DOI 10.1016/S0925-4773(01)00556-1; Terry K, 2000, MECH DEVELOP, V97, P177, DOI 10.1016/S0925-4773(00)00407-X; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zhang MF, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-21	77	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112388	10.1371/journal.pone.0112388	http://dx.doi.org/10.1371/journal.pone.0112388			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460002	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700016
J	Schulze, J; Frauenknecht, T; Brodmann, P; Bagutti, C				Schulze, Juerg; Frauenknecht, Tina; Brodmann, Peter; Bagutti, Claudia			Unexpected Diversity of Feral Genetically Modified Oilseed Rape (Brassica napus L.) Despite a Cultivation and Import Ban in Switzerland	PLOS ONE			English	Article							GENE FLOW; DNA-CONTENT; TRANSGENE; SEED; INTROGRESSION; VARIETIES; DYNAMICS; PLANTS	Despite cultivation and seed import bans of genetically modified (GM) oilseed rape (Brassica napus L.), feral GM plants were found growing along railway lines and in port areas at four sites in Switzerland in 2011 and 2012. All GM plants were identified as glyphosate-resistant GM event GT73 (Roundup Ready, Monsanto). The most affected sites were the Rhine port of Basel and the St. Johann freight railway station in Basel. To assess the distribution and intra-and interspecific outcrossing of GM oilseed rape in more detail, we monitored these two sites in 2013. Leaves and seed pods of feral oilseed rape plants, their possible hybridization partners and putative hybrid plants were sampled in monthly intervals and analysed for the presence of transgenes by real-time PCR. Using flow cytometry, we measured DNA contents of cell nuclei to confirm putative hybrids. In total, 2787 plants were sampled. The presence of GT73 oilseed rape could be confirmed at all previously documented sampling locations and was additionally detected at one new sampling location within the Rhine port. Furthermore, we found the glufosinate-resistant GM events MS8xRF3, MS8 and RF3 (all traded as InVigor, Bayer) at five sampling locations in the Rhine port. To our knowledge, this is the first time that feral MS8xRF3, MS8 or RF3 plants were detected in Europe. Real-time PCR analyses of seeds showed outcrossing of GT73 into two non-GM oilseed rape plants, but no outcrossing of transgenes into related wild species was observed. We found no hybrids between oilseed rape and related species. GM plants most frequently occurred at unloading sites for ships, indicating that ship cargo traffic is the main entry pathway for GM oilseed rape. In the future, it will be of major interest to determine the source of GM oilseed rape seeds.	[Schulze, Juerg; Frauenknecht, Tina; Brodmann, Peter; Bagutti, Claudia] State Lab Basel City, Biosafety Lab, Basel, Switzerland		Bagutti, C (corresponding author), State Lab Basel City, Biosafety Lab, Basel, Switzerland.	claudia.bagutti@bs.ch			Swiss Federal Office for the Environment (FOEN)	Swiss Federal Office for the Environment (FOEN)	This work was supported by the Swiss Federal Office for the Environment (FOEN) (http://www.bafu.admin.ch/index.html?lang=en). The funder had no role in study design, data collection and analysis or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Beckie HJ, 2011, FARM POLICY J, V8, P43; Brodtbeck T, 1997, FLORA BASEL UMGEBUNG; Chevre A. M., 2004, Introgression from genetically modified plants into wild relatives, P235, DOI 10.1079/9780851998169.0235; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; D'Hertefeldt T, 2008, BIOL LETTERS, V4, P314, DOI 10.1098/rsbl.2008.0123; Damgaard C, 2005, AGR ECOSYST ENVIRON, V108, P291, DOI 10.1016/j.agee.2005.01.007; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Elling B, 2009, BASIC APPL ECOL, V10, P544, DOI 10.1016/j.baae.2009.01.005; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; European Commission, EU REG AUTH GMOS ACS; European Commission, EU REG AUTH GMOS GEN; European Commission, 2010, COMM REC 13 JUL 2010; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Huangfu CH, 2011, CROP PROT, V30, P57, DOI 10.1016/j.cropro.2010.09.009; James C., 2013, GLOBAL STATUS COMMER; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Jorgensen T, 2007, SEED SCI RES, V17, P115, DOI 10.1017/S0960258507708103; Kawata M, 2009, ENVIRON SCI POLLUT R, V16, P120, DOI 10.1007/s11356-008-0074-4; Laube I, 2010, FOOD CHEM, V118, P979, DOI 10.1016/j.foodchem.2008.09.063; Liu YB, 2013, PLANT SCI, V211, P42, DOI 10.1016/j.plantsci.2013.07.002; Londo JP, 2010, ANN BOT-LONDON, V106, P957, DOI 10.1093/aob/mcq190; Lopez-Granados F, 1998, WEED SCI, V46, P419, DOI 10.1017/S0043174500090834; Matsuoka T, 2002, J AGR FOOD CHEM, V50, P2100, DOI 10.1021/jf011157t; Mazzara M, 2007, VERIFICATION PERFORM; Nishizawa Toru, 2009, Environmental Biosafety Research, V8, P33, DOI 10.1051/ebr/2009001; OECD . Organisation for Economic Co-operation and Development, 2012, SER HARM REG OV BIOT, P142; Pallett DW, 2006, ANN APPL BIOL, V148, P147, DOI 10.1111/j.1744-7348.2006.00049.x; Pascher K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-63; Pekrun C, 1998, J AGR SCI-CAMBRIDGE, V130, P155, DOI 10.1017/S0021859697005169; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schweizer Bauernverband, 2013, STAT ERH SCHATZ LAND; Schweizer Bauernverband, 2012, STAT ERH SCHATZ LAND; Schweizer Bauernverband, 2011, STAT ERH SCHATZ LAND; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; SzewcMcFadden AK, 1996, THEOR APPL GENET, V93, P534, DOI 10.1007/BF00417944; The Federal Authorities of the Swiss Confederation, 2001, SWISS FOOD MAN SLMB; The Federal Office for Agriculture FOAG, 2013, AGR 2014 2017; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Wilkinson MJ, 2000, MOL ECOL, V9, P983, DOI 10.1046/j.1365-294x.2000.00986.x; Zeitler R, 2002, EUR FOOD RES TECHNOL, V214, P346, DOI 10.1007/s00217-001-0454-1	45	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114477	10.1371/journal.pone.0114477	http://dx.doi.org/10.1371/journal.pone.0114477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464509	gold, Green Published			2022-12-27	WOS:000345869700134
J	Di Lelio, I; Caccia, S; Coppola, M; Buonanno, M; Di Prisco, G; Varricchio, P; Franzetti, E; Corrado, G; Monti, SM; Rao, R; Casartelli, M; Pennacchio, F				Di Lelio, Ilaria; Caccia, Silvia; Coppola, Mariangela; Buonanno, Martina; Di Prisco, Gennaro; Varricchio, Paola; Franzetti, Eleonora; Corrado, Giandomenico; Monti, Simona M.; Rao, Rosa; Casartelli, Morena; Pennacchio, Francesco			A Virulence Factor Encoded by a Polydnavirus Confers Tolerance to Transgenic Tobacco Plants against Lepidopteran Larvae, by Impairing Nutrient Absorption	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; SPODOPTERA-LITTORALIS; NATURAL-PRODUCTS; AMINO-ACIDS; INSECTICIDES; GENE; RESISTANCE; EVOLUTION; TRANSPORT; PROTEINS	The biological control of insect pests is based on the use of natural enemies. However, the growing information on the molecular mechanisms underpinning the interactions between insects and their natural antagonists can be exploited to develop "bio-inspired'' pest control strategies, mimicking suppression mechanisms shaped by long co-evolutionary processes. Here we focus on a virulence factor encoded by the polydnavirus associated with the braconid wasp Toxoneuron nigriceps (TnBV), an endophagous parasitoid of noctuid moth larvae. This virulence factor (TnBVANK1) is a member of the viral ankyrin (ANK) protein family, and appears to be involved both in immunosuppression and endocrine alterations of the host. Transgenic tobacco plants expressing TnBVANK1 showed insecticide activity and caused developmental delay in Spodoptera littoralis larvae feeding on them. This effect was more evident in a transgenic line showing a higher number of transcripts of the viral gene. However, this effect was not associated with evidence of translocation into the haemocoel of the entire protein, where the receptors of TnBVANK1 are putatively located. Indeed, immunolocalization experiments evidenced the accumulation of this viral protein in the midgut, where it formed a thick layer coating the brush border of epithelial cells. In vitro transport experiments demonstrated that the presence of recombinant TnBVANK1 exerted a dose-dependent negative impact on amino acid transport. These results open new perspectives for insect control and stimulate additional research efforts to pursue the development of novel bioinsecticides, encoded by parasitoid-derived genes. However, future work will have to carefully evaluate any effect that these molecules may have on beneficial insects and on non-target organisms.	[Di Lelio, Ilaria; Caccia, Silvia; Coppola, Mariangela; Di Prisco, Gennaro; Varricchio, Paola; Franzetti, Eleonora; Corrado, Giandomenico; Rao, Rosa; Pennacchio, Francesco] Univ Naples Federico II, Dipartimento Agr, Portici, Italy; [Buonanno, Martina; Monti, Simona M.] CNR, IBB, I-80125 Naples, Italy; [Buonanno, Martina] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy; [Casartelli, Morena] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli; University of Milan	Casartelli, M (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	morena.casartelli@unimi.it; fpennacchio@unina.it	Varricchio, Paola/AAA-8409-2021; Buonanno, Martina/AFS-8501-2022; Di Prisco, Gennaro/AGY-3511-2022; Casartelli, Morena/AAG-1285-2020; MONTI, SIMONA MARIA/GQQ-0129-2022	Buonanno, Martina/0000-0003-4419-4890; Casartelli, Morena/0000-0002-1413-7660; Di Lelio, Ilaria/0000-0001-8933-0919; Corrado, Giandomenico/0000-0002-8681-6988; PENNACCHIO, Francesco/0000-0002-8794-9328; MONTI, SIMONA MARIA/0000-0001-9647-7089; CACCIA, Silvia/0000-0003-1954-7180	PON R&C - Italian Ministry of University and Research (MIUR); European Funds for the Regional Development (FESR), project GenopomPro; project Safe & Smart (Cluster Agroalimentare Nazionale) [CTN01_00230_248064]; POR Campania Region, Project CARINA	PON R&C - Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Funds for the Regional Development (FESR), project GenopomPro; project Safe & Smart (Cluster Agroalimentare Nazionale); POR Campania Region, Project CARINA	This work was supported by the PON R&C 2007-2013 Grant financed by the Italian Ministry of University and Research (MIUR) in cooperation with the European Funds for the Regional Development (FESR), project GenopomPro, coordinated by the Universita degli Studi di Napoli "Federico II", Dipartimento di Agraria, and by the project Safe & Smart (Cluster Agroalimentare Nazionale - CTN01_00230_248064). GDP is the recipient of a post-doctoral fellowship supported by the POR Campania Region (FSE 2007/2013), Project CARINA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer MJ, 2012, ANNU REV ENTOMOL, V57, P41, DOI 10.1146/annurev-ento-120709-144748; Caccia S, 2012, J INSECT PHYSIOL, V58, P1177, DOI 10.1016/j.jinsphys.2012.05.014; Campioni S, 2008, J MOL BIOL, V379, P554, DOI 10.1016/j.jmb.2008.04.002; Casartelli M, 2001, INSECT BIOCHEM MOLEC, V31, P621, DOI 10.1016/S0965-1748(00)00167-3; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Corrado G, 2008, PLANT SCI, V174, P467, DOI 10.1016/j.plantsci.2008.01.009; Danna KJ, 2001, RECENT ADV PHYTOCHEM, V35, P205, DOI 10.1016/S0079-9920(01)80011-3; Di Lelio I, 2014, J INSECT PHYSIOL, V64, P90, DOI 10.1016/j.jinsphys.2014.03.008; Dorak T, 2006, REAL TIME PCR; Duchi S, 2010, CELL MOL LIFE SCI, V67, P1699, DOI 10.1007/s00018-010-0273-2; Ehler LE, 2006, PEST MANAG SCI, V62, P787, DOI 10.1002/ps.1247; Falabella P, 2007, INSECT BIOCHEM MOLEC, V37, P453, DOI 10.1016/j.ibmb.2007.02.005; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gill TA, 2006, ADV VIRUS RES, V68, P393, DOI 10.1016/S0065-3527(06)68011-1; GIORDANA B, 1982, BIOCHIM BIOPHYS ACTA, V692, P81, DOI 10.1016/0005-2736(82)90504-1; Hilpert K, 2001, PROTEIN ENG, V14, P803, DOI 10.1093/protein/14.10.803; Horowitz AR, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P1; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Kogan M, 2003, CONCEPTS INTEGRATED, P586; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Leonardi MG, 2006, J MEMBRANE BIOL, V214, P157, DOI 10.1007/s00232-006-0042-1; Leonardi MG, 1998, AM J PHYSIOL-REG I, V274, pR1372, DOI 10.1152/ajpregu.1998.274.5.R1372; Li HM, 2009, INSECT MOL BIOL, V18, P21, DOI 10.1111/j.1365-2583.2008.00844.x; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002; PARENTI P, 1985, J EXP BIOL, V116, P69; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pennacchio F, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P269, DOI 10.1016/B978-0-12-384858-1.00022-9; Quicke D. L. J., 1997, PARASITIC WASPS; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Schmitz K. S., 1990, DYNAMIC LIGHT SCATTE; Shewmaker CK, 1190, NUCLEIC ACIDS RES, V14, P4276; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tomlin CDS, 2009, PESTICIDE MANUAL WOR; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Tortiglione C, 2003, PLANT MOL BIOL, V53, P891, DOI 10.1023/B:PLAN.0000023667.62501.ef; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Valzania L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095104; Vandenborre G, 2011, PHYTOCHEMISTRY, V72, P1538, DOI 10.1016/j.phytochem.2011.02.024; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Whitfield JB, 2003, ADV PARASIT, V54, P69, DOI 10.1016/S0065-308X(03)54002-7; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	50	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113988	10.1371/journal.pone.0113988	http://dx.doi.org/10.1371/journal.pone.0113988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438149	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900106
J	Jia, L; Chen, JY; Wang, Y; Liu, YJ; Zhang, Y; Chen, WZ				Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi			Magnetic Resonance Imaging of Osteophytic, Chondral, and Subchondral Structures in a Surgically-Induced Osteoarthritis Rabbit Model	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; DISEASE PROGRESSION; HISTOLOGIC-CHANGES; HYALINE CARTILAGE; JOINT SPACE; VOLUME; MRI; SUPPRESSION; DEFECTS	Objective: This study aimed to assess changes in osteophytic, chondral, and subchondral structures in a surgically-induced osteoarthritis (OA) rabbit model in order to correlate MRI findings with the macroscopic progress of OA and to define the timepoint for disease status in this OA model. Methods: The OA model was constructed by surgery in thirty rabbits with ten normal rabbits serving as controls (baseline). High-resolution three-dimensional MRI using a 1.5-T coil was performed at baseline, two, four, and eight weeks post-surgery. MRIs of cartilage lesions, subchondral bone lesions, and osteophyte formations were independently assessed by two blinded radiologists. Ten rabbits were sacrificed at baseline, two, four, and eight weeks post-surgery, and macroscopic evaluation was independently performed by two blinded orthopedic surgeons. Results: The signal intensities and morphologies of chondral and subchondral structures by MRI accurately reflected the degree of OA. Cartilage defects progressed from a grade of 0.05-0.15 to 1.15-1.30 to 1.90-1.97 to 3.00-3.35 at each successive time point, respectively (p< 0.05). Subchondral bone lesions progressed from a grade of 0.00 to 0.78-0.90 to 1.27-1.58 to 1.95-2.23 at each successive time point, respectively (p=0.000). Osteophytes progressed from a size (mm) of 0.00 to 0.87-1.06 to 1.24-1.87 to 2.21-3.21 at each successive time point, respectively (p=0.000). Conclusions: Serial observations revealed that MRI can accurately detect the progression of cartilage lesions and subchondral bone edema over an eight-week period but may not be accurate in detecting osteophyte sizes. Week four post-surgery was considered the timepoint between OA-negative and OA-positive status in this OA model. The combination of this OA model with MRI evaluation should provide a promising tool for the pre-clinical evaluation of new disease-modifying osteoarthritis drugs.	[Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China; [Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] Chongqing Med Univ, Minist Sci & Technol, Coll Biomed Engn, Chongqing, Peoples R China; [Jia, Lang] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, WZ (corresponding author), State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China.	chenwz@cqmu.edu.cn			National Basic Research Program 973 of China [2012CB722402, 2011CB707900]; National Natural Science Foundation of China [81127901, 30830040, 11274404, 31000435, 30970827]; Medical Scientific Research Projects Foundation of ChongQing [2012-2-064]	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Projects Foundation of ChongQing	This study was supported in part by the National Basic Research Program 973 of China (Grant No. 2012CB722402 and Grant No. 2011CB707900), National Natural Science Foundation of China (Grant No. 81127901, 30830040, 11274404, 31000435 and 30970827) and by Medical Scientific Research Projects Foundation of ChongQing(Grant No. 2012-2-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger H, 2014, KNEE SURG SPORT TR A, V22, P112, DOI 10.1007/s00167-012-2297-7; Baysal O, 2004, SWISS MED WKLY, V134, P283; Boegard T, 1998, ANN RHEUM DIS, V57, P395, DOI 10.1136/ard.57.7.395; Boileau C, 2008, ANN RHEUM DIS, V67, P926, DOI 10.1136/ard.2007.077297; Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122; Brandt KD, 1997, OSTEOARTHR CARTILAGE, V5, P438, DOI 10.1016/S1063-4584(97)80048-9; Bruyere O, 2007, OSTEOARTHR CARTILAGE, V15, P98, DOI 10.1016/j.joca.2006.06.018; Calvo E, 2001, OSTEOARTHR CARTILAGE, V9, P463, DOI 10.1053/joca.2001.0413; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; Cicuttini FM, 1996, OSTEOARTHR CARTILAGE, V4, P143, DOI 10.1016/S1063-4584(05)80323-1; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Dieppe P, 1999, OSTEOARTHR CARTILAGE, V7, P325, DOI 10.1053/joca.1998.0182; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Ding CH, 2005, OSTEOARTHR CARTILAGE, V13, P198, DOI 10.1016/j.joca.2004.11.007; Disler DG, 1997, AM J ROENTGENOL, V169, P1117, DOI 10.2214/ajr.169.4.9308475; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P2539, DOI 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T; Dupuy DE, 1996, ACAD RADIOL, V3, P919, DOI 10.1016/S1076-6332(96)80299-6; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; FERNANDEZ JC, 1995, ARTHRITIS RHEUM, V38, P1290, DOI 10.1002/art.1780380918; Guermazi A, 2003, EUR RADIOL, V13, P1370, DOI 10.1007/s00330-002-1554-4; HAMERMAN D, 1993, J AM GERIATR SOC, V41, P760, DOI 10.1111/j.1532-5415.1993.tb07469.x; Hashimoto S, 2002, OSTEOARTHR CARTILAGE, V10, P180, DOI 10.1053/joca.2001.0505; HULTH A, 1970, ACTA ORTHOP SCAND, V41, P522, DOI 10.3109/17453677008991540; Jiang D, 2012, ARTHROSCOPY, V28, P1147, DOI 10.1016/j.arthro.2012.01.001; Jovanovic DV, 2001, ARTHRITIS RHEUM-US, V44, P2320, DOI 10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; LUND F, 1980, ACTA RADIOL DIAGN, V21, P413, DOI 10.1177/028418518002100312; MCALINDON T, 1990, BRIT J RHEUMATOL, V29, P471; McAlindon TE, 1999, BEST PRACT RES CL RH, V13, P329, DOI 10.1053/berh.1999.0023; Messner K, 2001, AM J SPORT MED, V29, P151, DOI 10.1177/03635465010290020701; Mihara M, 2007, OSTEOARTHR CARTILAGE, V15, P543, DOI 10.1016/j.joca.2006.11.001; Outerbridge RE, 2001, CLIN ORTHOP RELAT R, P5; Pelletier JP, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2272; PELLETIER JP, 2006, ARTHRITIS RHEUM S, V54, P95; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Potter HG, 1998, J BONE JOINT SURG AM, V80A, P1276, DOI 10.2106/00004623-199809000-00005; Raynauld JP, 2008, ANN RHEUM DIS, V67, P683, DOI 10.1136/ard.2007.073023; RECHT MP, 1994, AM J ROENTGENOL, V163, P283, DOI 10.2214/ajr.163.2.8037016; RECHT MP, 1993, RADIOLOGY, V187, P473, DOI 10.1148/radiology.187.2.8475293; Rijk PC, 2004, ARTHROSCOPY, V20, P911, DOI 10.1016/j.arthro.2004.06.036; Sittek H, 1996, SKELETAL RADIOL, V25, P55, DOI 10.1007/s002560050032; SMITH MM, 2007, OSTEOARTHRITIS DIAGN, P107; Sonin AH, 2002, AM J ROENTGENOL, V179, P1159, DOI 10.2214/ajr.179.5.1791159; Tessier JJ, 2003, OSTEOARTHR CARTILAGE, V11, P845, DOI 10.1016/S1063-4584(03)00162-6; Wachsmuth L, 2003, OSTEOARTHR CARTILAGE, V11, P891, DOI 10.1016/j.joca.2003.08.008; Wluka A, 2001, ANN RHEUM DIS, V60, P332, DOI 10.1136/ard.60.4.332; YU LP, 1992, ARTHRITIS RHEUM, V35, P1150, DOI 10.1002/art.1780351007	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113707	10.1371/journal.pone.0113707	http://dx.doi.org/10.1371/journal.pone.0113707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438155	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900066
J	Ma, QG; Wang, CC; Wang, XY				Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi			Two-Stage Categorization in Brand Extension Evaluation: Electrophysiological Time Course Evidence	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC CATEGORIZATION; BRAIN POTENTIALS; ERP; MEMORY; N400; TASK; SIMILARITY; DECISIONS; COMPONENT	A brand name can be considered a mental category. Similarity-based categorization theory has been used to explain how consumers judge a new product as a member of a known brand, a process called brand extension evaluation. This study was an event-related potential study conducted in two experiments. The study found a two-stage categorization process reflected by the P2 and N400 components in brand extension evaluation. In experiment 1, a prime-probe paradigm was presented in a pair consisting of a brand name and a product name in three conditions, i.e., in-category extension, similar-category extension, and out-of-category extension. Although the task was unrelated to brand extension evaluation, P2 distinguished out-of-category extensions from similar-category and in-category ones, and N400 distinguished similar-category extensions from in-category ones. In experiment 2, a prime-probe paradigm with a related task was used, in which product names included subcategory and major-category product names. The N400 elicited by subcategory products was more significantly negative than that elicited by major-category products, with no salient difference in P2. We speculated that P2 could reflect the early low-level and similarity-based processing in the first stage, whereas N400 could reflect the late analytic and category-based processing in the second stage.	[Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi] Zhejiang Univ, Sch Management, Hangzhou 310027, Zhejiang, Peoples R China; [Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Cuicui] Hefei Univ Technol, Sch Management, Hefei, Peoples R China	Zhejiang University; Zhejiang University; Hefei University of Technology	Wang, XY (corresponding author), Zhejiang Univ, Sch Management, Hangzhou 310027, Zhejiang, Peoples R China.	kevinwxy@zju.edu.cn		Wang, Xiaoyi/0000-0001-7748-2296	National Natural Science Foundation [70902061, 71371167]; Zhejiang Provincial National Natural Science Foundation [LY13G020003]; MOE (Ministry of Education in China) [14YJC630129]; Zhejiang University; Technology Innovation Program for Students of Zhejiang Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial National Natural Science Foundation; MOE (Ministry of Education in China)(Ministry of Education, China); Zhejiang University; Technology Innovation Program for Students of Zhejiang Province	This work was supported by Grant No. 70902061 (Xiaoyi Wang) and 71371167 (Qingguo Ma) of the National Natural Science Foundation (http://www.nsfc.gov.cn), Grant No. LY13G020003 (Xiaoyi Wang) from the Zhejiang Provincial National Natural Science Foundation (http://www.zjnsf.gov.cn/), grant No. 14YJC630129 (Xiaoyi Wang) from the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (http://www.sinoss.net), Young Funding of Social Science Experimental Study in Zhejiang University (Xiaoyi Wang), and Technology Innovation Program for Students of Zhejiang Province in 2014 (Cuicui Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKER D, 1990, SLOAN MANAGE REV, V31, P47; AAKER DA, 1990, J MARKETING, V54, P27, DOI 10.2307/1252171; Barone MJ, 2002, J CONSUM PSYCHOL, V12, P283; Blanchet S, 2007, BRAIN RES, V1170, P59, DOI 10.1016/j.brainres.2007.07.024; Bless H., 2009, SOCIAL PSYCHOL CONSU, P109; BOUSH DM, 1991, J MARKETING RES, V28, P16, DOI 10.2307/3172723; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Fiske SusanT., 1986, HDB MOTIVATION COGNI, P167; Freunberger R, 2007, NEUROSCI LETT, V426, P181, DOI 10.1016/j.neulet.2007.08.062; Fujihara N, 1998, INT J PSYCHOPHYSIOL, V29, P65, DOI 10.1016/S0167-8760(97)00099-8; Greenhouse S. W., 1959, METHODS ANAL PROFILE; Heinze HJ, 1998, BIOL PSYCHOL, V47, P121, DOI 10.1016/S0301-0511(97)00024-0; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Hong JW, 2010, J CONSUM RES, V37, P456, DOI 10.1086/653492; Koenig P, 2005, NEUROIMAGE, V24, P369, DOI 10.1016/j.neuroimage.2004.08.045; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1985, PSYCHOPHYSIOLOGY, V22, P575; Lee AY, 1999, J CONSUM RES, V26, P115, DOI 10.1086/209554; Lei Y, 2010, EXP BRAIN RES, V204, P47, DOI 10.1007/s00221-010-2292-5; Liberman N., 2007, SOCIAL PSYCHOL HDB B, P353; Loken B, 2002, J CONSUM PSYCHOL, V12, P149, DOI 10.1207/S15327663JCP1202_07; Ma QG, 2008, NEUROSCI LETT, V431, P57, DOI 10.1016/j.neulet.2007.11.022; Ma QG, 2007, NEUROREPORT, V18, P1031, DOI 10.1097/WNR.0b013e3281667d59; Ma QG, 2010, NEUROSCI LETT, V483, P206, DOI 10.1016/j.neulet.2010.08.009; Mathalon DH, 2010, INT J PSYCHOPHYSIOL, V75, P157, DOI 10.1016/j.ijpsycho.2009.12.003; MEDIN DL, 1993, PSYCHOL REV, V100, P254, DOI 10.1037/0033-295X.100.2.254; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; MURPHY GL, 1994, COGNITIVE PSYCHOL, V27, P148, DOI 10.1006/cogp.1994.1015; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nunez-Pena MI, 2005, INT J PSYCHOPHYSIOL, V56, P45, DOI 10.1016/j.ijpsycho.2004.09.006; PARK CW, 1991, J CONSUM RES, V18, P185, DOI 10.1086/209251; Pernet C, 2003, COGNITIVE BRAIN RES, V17, P327, DOI 10.1016/S0926-6410(03)00134-4; Poiezzi D, 2008, BEHAV BRAIN RES, V187, P116, DOI 10.1016/j.bbr.2007.09.001; POLICH J, 1985, BRAIN LANG, V26, P304, DOI 10.1016/0093-934X(85)90045-8; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SMITH EE, 1974, PSYCHOL REV, V81, P214, DOI 10.1037/h0036351; Smith EE, 1981, CATEGORIES CONCEPTS; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Wang XY, 2012, NEUROSCI LETT, V525, P76, DOI 10.1016/j.neulet.2012.07.043	45	20	20	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114150	10.1371/journal.pone.0114150	http://dx.doi.org/10.1371/journal.pone.0114150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438152	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900126
J	Bond, MR; Ghosh, SK; Wang, P; Hanover, JA				Bond, Michelle R.; Ghosh, Salil K.; Wang, Peng; Hanover, John A.			Conserved Nutrient Sensor O-GlcNAc Transferase Is Integral to C. elegans Pathogen-Specific Immunity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BETA-CATENIN; SIGNALING PATHWAY; INNATE IMMUNITY; STRESS-RESPONSE; LIFE-SPAN; MODEL; ACTIVATION; GLYCOSYLATION; GLCNACYLATION	Discriminating pathogenic bacteria from bacteria used as a food source is key to Caenorhabidits elegans immunity. Using mutants defective in the enzymes of O-linked N-acetylglucosamine (O-GlcNAc) cycling, we examined the role of this nutrient-sensing pathway in the C. elegans innate immune response. Genetic analysis showed that deletion of O-GlcNAc transferase (ogt-1) yielded animals hypersensitive to the human pathogen S. aureus but not to P. aeruginosa. Genetic interaction studies revealed that nutrient-responsive OGT-1 acts through the conserved beta-catenin (BAR-1) pathway and in concert with p38 MAPK (PMK-1) to modulate the immune response to S. aureus. Moreover, whole genome transcriptional profiling revealed that O-GlcNAc cycling mutants exhibited deregulation of unique stress-and immune-responsive genes. The participation of nutrient sensor OGT-1 in an immunity module evolutionarily conserved from C. elegans to humans reveals an unexplored nexus between nutrient availability and a pathogen-specific immune response.	[Bond, Michelle R.; Hanover, John A.] NIDDK, NIH, Bethesda, MD 20892 USA; [Ghosh, Salil K.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Wang, Peng] Medstar Georgetown Univ Hosp, Dept Pathol, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Food & Drug Administration (FDA); Georgetown University	Hanover, JA (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NIDDK intramural funds (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060102, ZIADK060101] Funding Source: NIH RePORTER	NIDDK intramural funds (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK intramural funds (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Bogaerts A, 2010, DEV COMP IMMUNOL, V34, P690, DOI 10.1016/j.dci.2010.02.003; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; BRENNER S, 1974, GENETICS, V77, P71; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Cheung AL, 1998, INFECT IMMUN, V66, P5988, DOI 10.1128/IAI.66.12.5988-5993.1998; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Ha JR, 2014, EXP CELL RES, V321, P153, DOI 10.1016/j.yexcr.2013.11.021; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kneass ZT, 2004, J BIOL CHEM, V279, P45759, DOI 10.1074/jbc.M407911200; Kong C, 2014, BIOL OPEN, V3, P644, DOI 10.1242/bio.20148334; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li JJ, 2012, INT J MOL MED, V30, P157, DOI 10.3892/ijmm.2012.954; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Natarajan L, 2001, GENETICS, V159, P159; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Pattee PA, 1990, GENETIC PHYS MAPPING; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Sahu SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038200; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Simonsen KT, 2012, VIRULENCE, V3, P477, DOI 10.4161/viru.21906; Studencka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002940; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; WANG BB, 1993, CELL, V74, P29, DOI 10.1016/0092-8674(93)90292-X; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	61	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113231	10.1371/journal.pone.0113231	http://dx.doi.org/10.1371/journal.pone.0113231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474640	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500079
J	Xu, B; Wang, JW; Deng, RP; Li, M				Xu, Bo; Wang, Jianwei; Deng, Ruipu; Li, Miao			Relational Diversity Promotes Cooperation in Prisoner's Dilemma Games	PLOS ONE			English	Article							EVOLUTIONARY GAMES; HOMO-ECONOMICUS; TIE STRENGTHS; EMERGENCE	Relational diversity can be characterized by heterogeneous distributions of tie strengths in social networks and this diversity is present not only among humans, but throughout the animal world. We account for this observation by analyzing two network datasets from Facebook. We measure the strength of a tie by calculating the extent of overlap of friends between the two individuals. Based on the previous findings in human experiments, we argue that it is very unlikely that players will allocate their investments equally to their neighbors. There is a tendency that players prefer to donate more to their intimate friends. We find that if players preferentially allocate their investments to their good friends, cooperation will be promoted in PDG. We proved that the facilitation of the cooperative strategy relies mostly on the cooperative allies between best friends, resulting in the formation of cooperative clusters which are able to prevail against the defectors even when there is a large cost to cooperate. Moreover, we discover that the effect of relational diversity cannot be analyzed by adopting classical complex networks models, because neither of the artificial networks is able to produce networks with diverse distributions of tie strengths. It is of vital importance to introduce real social networks to study the influence of diverse relations especially when it comes to humans. This research proposes a brand new perspective to understand the influence of social relations on the emergence of cooperation in evolutionary prisoner's dilemma games.	[Xu, Bo; Wang, Jianwei] Northeastern Univ, Sch Business Adm, Shenyang, Peoples R China; [Deng, Ruipu] Three Gorges Finance Co Ltd, Beijing, Peoples R China; [Li, Miao] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China	Northeastern University - China; Tsinghua University	Xu, B (corresponding author), Northeastern Univ, Sch Business Adm, Shenyang, Peoples R China.	xubosuper@163.com	Wang, Jianwei/D-1852-2013		National Natural Science Foundation of China [71102120]; Startup Research Funds for Ph.D. of Liaoning Province [76114008]; Fundamental Research Funds of Northeastern University [22114001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Startup Research Funds for Ph.D. of Liaoning Province; Fundamental Research Funds of Northeastern University	The research is supported by the National Natural Science Foundation of China under Grant No. 71102120, Startup Research Funds for Ph.D. of Liaoning Province under Grant No. 76114008, and Fundamental Research Funds of Northeastern University under grant No. 22114001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cao XB, 2013, CHAOS SOLITON FRACT, V57, P35, DOI 10.1016/j.chaos.2013.08.007; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Chen XJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00248; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Erdos P., 1961, ACTA MATH HUNGARICA, V12, P261, DOI 10.1007/BF02066689; Feld SL, 1997, SOC NETWORKS, V19, P91, DOI 10.1016/S0378-8733(96)00293-6; Golder Scott A., 2010, Proceedings of the 2010 IEEE Second International Conference on Social Computing (SocialCom 2010). the Second IEEE International Conference on Privacy, Security, Risk and Trust (PASSAT 2010), P88, DOI 10.1109/SocialCom.2010.22; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harrison F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018338; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Lei CA, 2010, PHYSICA A, V389, P4708, DOI 10.1016/j.physa.2010.06.002; Levin DZ, 2004, MANAGE SCI, V50, P1477, DOI 10.1287/mnsc.1030.0136; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066560; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shi DM, 2010, EPL, V90; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05496; Szolnoki A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022804; Thaler RH, 2000, J ECON PERSPECT, V14, P133, DOI 10.1257/jep.14.1.133; Wang X., 2014, SCI REP, V4; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; White D. R., 2002, Complexity, V8, P72, DOI 10.1002/cplx.10053; Wirtz J, 2002, INT J SERV IND MANAG, V13, P141, DOI 10.1108/09564230210425340; Xia CY, 2011, PHYSICA A, V390, P4602, DOI 10.1016/j.physa.2011.06.064; Xu B., 2013, PROC 2013 C COMPUTER, P871, DOI DOI 10.1145/2441776.2441875; Xu B, 2011, PHYS LETT A, V375, P2269, DOI 10.1016/j.physleta.2011.05.014; Zhao JC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016105	43	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114464	10.1371/journal.pone.0114464	http://dx.doi.org/10.1371/journal.pone.0114464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474354	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500034
J	Brown, DM; Brameld, JM; Parr, T				Brown, David M.; Brameld, John M.; Parr, Tim			Expression of the Myosin Heavy Chain IIB Gene in Porcine Skeletal Muscle: The Role of the CArG-Box Promoter Response Element	PLOS ONE			English	Article							FIBER TYPES; ISOFORMS; LIMB; EXERCISE; BINDING; RABBIT; MOUSE; RAT	Due to its similarity to humans, the pig is increasingly being considered as a good animal model for studying a range of human diseases. Despite their physiological similarities, differential expression of the myosin heavy chain (MyHC) IIB gene (MYH4) exists in the skeletal muscles of these species, which is associated with a different muscle phenotype. The expression of different MyHC isoforms is a critical determinant of the contractile and metabolic characteristics of the muscle fibre. We aimed to elucidate whether a genomic mechanism was responsible for the drastically different expression of MYH4 between pigs and humans, thus improving our understanding of the pig as a model for human skeletal muscle research. We utilized approximately 1 kb of the MYH4 promoter from a domestic pig and a human (which do and do not express MYH4, respectively) to elucidate the role of the promoter sequence in regulating the high expression of MYH4 in porcine skeletal muscle. We identified a 3 bp genomic difference within the proximal CArG and E-box region of the MYH4 promoter of pigs and humans that dictates the differential activity of these promoters during myogenesis. Subtle species-specific genomic differences within the CArG-box region caused differential protein-DNA interactions at this site and is likely accountable for the differential MYH4 promoter activity between pigs and humans. We propose that the genomic differences identified herein explain the differential activity of the MYH4 promoter of pigs and humans, which may contribute to the differential expression patterns displayed in these otherwise physiologically similar mammals. Further, we report that both the pig and human MYH4 promoters can be induced by MyoD over-expression, but the capacity to activate the MYH4 promoter is largely influenced by the 3 bp difference located within the CArG-box region of the proximal MYH4 promoter.	[Brown, David M.; Brameld, John M.; Parr, Tim] Univ Nottingham, Div Nutr Sci, Sch Biosci, Nottingham NG7 2RD, Leics, England	University of Nottingham	Brown, DM (corresponding author), Univ Nottingham, Div Nutr Sci, Sch Biosci, Nottingham NG7 2RD, Leics, England.	D.M.Brown@Liverpool.ac.uk	Brameld, John/AAB-1745-2021	Brameld, John/0000-0003-4942-080X; Parr, Tim/0000-0003-2490-9457	Biotechnology and Biological Sciences Research Council; Zoetis; Biotechnology and Biological Sciences Research Council [976479, BB/J005320/1] Funding Source: researchfish; BBSRC [BB/J005320/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) to JB and TP and by Zoetis (formally Pfizer Animal Health) (http://www.zoetis.com/) to JB and TP. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Allen DL, 2001, J BIOL CHEM, V276, P43524, DOI 10.1074/jbc.M108017200; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; CATALA F, 1995, MOL CELL BIOL, V15, P4585; Chikuni K, 2004, MEAT SCI, V67, P87, DOI 10.1016/j.meatsci.2003.09.011; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Groisman R, 1996, J BIOL CHEM, V271, P5258; Gunawan AM, 2007, J ANIM SCI, V85, P2115, DOI 10.2527/jas.2006-540; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Hemmings KM, 2009, J ANIM SCI, V87, P3915, DOI 10.2527/jas.2009-2067; Lakich MM, 1998, J BIOL CHEM, V273, P15217, DOI 10.1074/jbc.273.24.15217; Lefaucheur L, 1998, J ANIM SCI, V76, P1584; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; Lunde IG, 2007, J PHYSIOL-LONDON, V582, P1277, DOI 10.1113/jphysiol.2007.133025; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rivero JLL, 1999, J MUSCLE RES CELL M, V20, P211, DOI 10.1023/A:1005461214800; Ruusunen M, 2004, MEAT SCI, V67, P533, DOI 10.1016/j.meatsci.2003.12.008; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; Swoap SJ, 1998, AM J PHYSIOL, V274, P681; TAKEDA S, 1995, J BIOL CHEM, V270, P15664, DOI 10.1074/jbc.270.26.15664; Talmadge RJ, 1996, J EXP ZOOL, V275, P413; Tonge DP, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-52; Toniolo L, 2007, AM J PHYSIOL-CELL PH, V292, pC1915, DOI 10.1152/ajpcell.00601.2006; WADA M, 1995, J MUSCLE RES CELL M, V16, P237, DOI 10.1007/BF00121132; Wheeler MT, 1999, AM J PHYSIOL, V276, P1069	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114365	10.1371/journal.pone.0114365	http://dx.doi.org/10.1371/journal.pone.0114365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469802	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700105
J	Kindermann, C; Narayan, EJ; Hero, JM				Kindermann, Christina; Narayan, Edward J.; Hero, Jean-Marc			The Neuro-Hormonal Control of Rapid Dynamic Skin Colour Change in an Amphibian during Amplexus	PLOS ONE			English	Article							FROG; HORMONE; TOAD; MELANOPHORES; PIGMENTATION; STIMULATION; SPERMIATION; CAMOUFLAGE; STRESS; SEASON	Sexual signalling using dynamic skin colouration is a key feature in some vertebrates; however, it is rarely studied in amphibians. Consequently, little is known about the hormonal basis of this interesting biological phenomenon for many species. Male stony creek frogs (Litoria wilcoxii) are known to change dorsal colouration from brown to lemon yellow within minutes. This striking change is faster then what has been seen most amphibians, and could therefore be under neuronal regulation, a factor that is rarely observed in amphibians. In this study, we observed colour changes in wild frogs during amplexus to determine the natural timing of colour change. We also investigated the hypothesis that colour change is mediated by either reproductive or neuro-hormones. This was achieved by injecting frogs with epinephrine, testosterone, saline solution (control 1) or sesame oil (control 2). A non-invasive approach was also used wherein hormones and controls were administered topically. Male frogs turned a vivid yellow within 5 minutes of initiation of amplexus and remained so for 3-5 hours before rapidly fading back to brown. Epinephrine-treated frogs showed a significant colour change from brown to yellow within 5 minutes, however, testosterone-treated frogs did not change colour. Our results provide evidence of the role neuronal regulation plays in colour change systems.	[Kindermann, Christina; Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Southport, Qld 4215, Australia	Griffith University	Kindermann, C (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Southport, Qld 4215, Australia.	christina.kindermann@griffithuni.edu.au	Narayan, Edward/E-8238-2016	Narayan, Edward/0000-0003-2719-0900	School of Environment at Griffith University	School of Environment at Griffith University	Funding: This study is part of CK PhD research funded by the School of Environment at Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdobeSystems, 2010, AD PHOT EXT; Aspengren S, 2009, CELL MOL LIFE SCI, V66, P187, DOI 10.1007/s00018-008-8541-0; Baayen RH, 2009, LANGUAGER DATA SETS; BAGNARA JT, 1968, J CELL BIOL, V38, P67, DOI 10.1083/jcb.38.1.67; BAGNARA JT, 1964, GEN COMP ENDOCR, V4, P290, DOI 10.1016/0016-6480(64)90024-3; BAGNARA JT, 1969, GEN COMP ENDOCR, P425, DOI 10.1016/0016-6480(69)90052-5; BAKER BI, 1993, ANN NY ACAD SCI, V680, P279, DOI 10.1111/j.1749-6632.1993.tb19690.x; Chan R, 2009, BEHAV ECOL, V20, P1334, DOI 10.1093/beheco/arp136; Volonteri MC, 2010, GEN COMP ENDOCR, V169, P197, DOI 10.1016/j.ygcen.2010.08.011; de Velasco JB, 2008, J COMP PHYSIOL B, V178, P867, DOI 10.1007/s00360-008-0274-8; Doucet SM, 2010, BIOL LETTERS, V6, P63, DOI 10.1098/rsbl.2009.0604; GILTZ M. L., 1955, OHIO JOUR SCI, V55, P47; Greenberg B, 1942, J EXP ZOOL, V91, P435, DOI 10.1002/jez.1400910308; Hayes TB, 1999, GEN COMP ENDOCR, V115, P188, DOI 10.1006/gcen.1999.7321; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kouba AJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-59; LONGSHORE MA, 1981, AM J PHYSIOL, V241, pE84, DOI 10.1152/ajpendo.1981.241.1.E84; NIELSEN HI, 1978, GEN COMP ENDOCR, V36, P543, DOI 10.1016/0016-6480(78)90094-1; Nordlund J. J., 1998, PIGMENTARY SYSTEM; Novales RR, 1969, CELLULAR ASPECTS CON; Ohta K, 2008, MAR BIOL, V153, P843, DOI 10.1007/s00227-007-0856-0; OSHIMA N, 1986, GEN COMP ENDOCR, V64, P381, DOI 10.1016/0016-6480(86)90072-9; PHILLIPS H. J., 1957, PHYSIOL ZOOL, V30, P155; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Revelle W, 2011, PROCEDURES PSYCHOL P; Ries C, 2008, J ZOOL, V276, P229, DOI 10.1111/j.1469-7998.2008.00456.x; ROBBINS SL, 1949, ENDOCRINOLOGY, V44, P384, DOI 10.1210/endo-44-4-384; Salim S, 2011, CELL MOL BIOL LETT, V16, P162, DOI 10.2478/s11658-010-0044-y; Skold HN, 2012, PIGMENT CELL MELANOM; Stegen JC, 2004, CAN J ZOOL, V82, P889, DOI 10.1139/Z04-068; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sztatecsny M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1587, DOI 10.1007/s00265-012-1412-6; Tang ZJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P397, DOI 10.1086/675678; Tattersall GJ, 2006, J EXP BIOL, V209, P1185, DOI 10.1242/jeb.02038; Van Gossum H, 2011, EVOL ECOL, V25, P139, DOI 10.1007/s10682-010-9388-z; Vasquez T, 2007, BEHAV ECOL SOCIOBIOL, V62, P127, DOI 10.1007/s00265-007-0446-7; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WILSON JX, 1995, GEN COMP ENDOCR, V98, P303, DOI 10.1006/gcen.1995.1072; Woolley SC, 2001, HORM BEHAV, V40, P483, DOI 10.1006/hbeh.2001.1713; Xu MZ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1215, DOI 10.1007/s00265-010-1134-6	44	20	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114120	10.1371/journal.pone.0114120	http://dx.doi.org/10.1371/journal.pone.0114120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470775	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700072
J	Martinez-Sanchez, JM; Ballbe, M; Fu, M; Martin-Sanchez, JC; Gottlieb, M; Salto, E; Vardavas, CI; Daynard, R; Connolly, GN; Fernandez, E				Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Martin-Sanchez, Juan C.; Gottlieb, Mark; Salto, Esteve; Vardavas, Constantine I.; Daynard, Richard; Connolly, Gregory N.; Fernandez, Esteve			Attitudes towards Electronic Cigarettes Regulation in Indoor Workplaces and Selected Public and Private Places: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							SMOKE-FREE LEGISLATION; BAR WORKERS; IMPLEMENTATION; EXPOSURE; POLICIES; ADULTS	Background: Currently, there is an intensive debate about the regulation of the use of electronic cigarettes (e-cigarettes) in indoor places. The aim of this study was to assess the attitudes toward e-cigarette use in indoor workplaces and selected public and private venues among the general population in Barcelona (Spain) in 2013-2014. Methods: This is a cross-sectional study of a representative sample of the population of Barcelona (n=736). The field work was conducted between May 2013 and February 2014. We computed the prevalence and the adjusted odds ratios (OR) derived from multivariable logistic regression models. Results: The awareness of e-cigarettes was 82.3%. Forty five percent of respondents did not agree with the use of e-cigarettes in public places and 52.3% in workplaces. The proportion of disapproval of the use of e-cigarettes in indoor places was higher at 71.5% for schools and 65.8% for hospitals and health care centers; while the prevalence of disapproval of e-cigarette use in homes and cars was lower (18.0% and 32.5%, respectively). Respondents who disagreed on the use of e-cigarettes in indoor workplaces were more likely to be older (OR=1.64 and 1.97 for groups 45-64 and >= 65 years old, respectively), those with a high educational level (OR=1.60), and never and former smokers (OR=2.34 and 2.16, respectively). Increased scores in the Fagerstrom test for cigarette dependence were also related to increased support for their use. Conclusions: Based on this population based study, half of the general population of Barcelona does not support the use of e-cigarettes in indoor workplaces and public places, with the percentage reaching 65% for use in schools, hospitals and health care centers. Consequently, there is good societal support in Spain for the politicians and legislators to promote policies restricting e-cigarettes use in workplaces and public places, including hospitality venues.	[Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Inst Catala Oncol, Canc Prevent & Control Program, Tobacco Control Unit, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Inst Invest Biomed Bellvitge IDIBELL, Canc Prevent & Control Grp, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Martin-Sanchez, Juan C.] Univ Int Catalunya, Dept Basic Sci, Biostat Unit, Sant Cugat Del Valles, Spain; [Martinez-Sanchez, Jose M.; Gottlieb, Mark; Daynard, Richard] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA; [Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Univ Barcelona, Dept Clin Sci, Barcelona, Spain; [Ballbe, Montse] Hosp Clin Barcelona, IDIBAPS, Inst Neurosci, Addict Unit, Barcelona, Spain; [Salto, Esteve] Minist Hlth, Hlth Plan Directorate, Generalitat De Catalunya, Spain; [Salto, Esteve] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Vardavas, Constantine I.; Connolly, Gregory N.] Harvard Univ, Sch Publ Hlth, Ctr Global Tobacco Control, Dept Social & Behav Sci, Boston, MA 02115 USA	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Internacional de Catalunya (UIC); Northeastern University; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Harvard University; Harvard T.H. Chan School of Public Health	Martinez-Sanchez, JM (corresponding author), Inst Catala Oncol, Canc Prevent & Control Program, Tobacco Control Unit, Barcelona, Spain.	jmmartinez@iconcologia.net	Vardavas, Constantine/O-4961-2016; Fernandez, Esteve/A-9750-2008; Gottlieb, Mark A./ABI-1826-2020; Martínez-Sánchez, Jose M/ABH-3093-2020; Martín, JuanCarlos/AAB-5440-2019; Vardavas, Constantine I/G-7598-2011; Sanchez, Juan Carlos Martin/G-5650-2019; Martínez-Sánchez, Jose/AAA-6343-2019	Vardavas, Constantine/0000-0003-0171-9570; Fernandez, Esteve/0000-0003-4239-723X; Gottlieb, Mark A./0000-0001-8679-307X; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Martín, JuanCarlos/0000-0002-1045-4802; Sanchez, Juan Carlos Martin/0000-0002-1045-4802; Fu, Marcela/0000-0002-4962-0927; Ballbe, Montse/0000-0002-0747-0924; Salto, Esteve/0000-0002-6739-8936	Instituto de Salud Carlos III, Government of Spain [RTICC RD06/0020/0089, RD12/0036/0053, BAE 14/00014, PI12/01114]; Ministry of Universities and Research, Government of Catalonia [2014SGR999]	Instituto de Salud Carlos III, Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research, Government of Catalonia	This project was funded by Instituto de Salud Carlos III, Government of Spain (RTICC RD06/0020/0089, RD12/0036/0053, BAE 14/00014, and PI12/01114), and Ministry of Universities and Research, Government of Catalonia (grant 2014SGR999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballbe M, 2014, ENVIRON RES, V135, P76, DOI 10.1016/j.envres.2014.09.005; Been JV, 2014, LANCET IN PRESS; Chapman S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3840; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Douptcheva N, 2013, J EPIDEMIOL COMMUN H, V67, P1075, DOI 10.1136/jech-2013-203152; Dutra LM, 2014, JAMA PEDIAT IN PRESS; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; European Commision, SURV TOB AN REP FLAS; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Farsalinos KE, 2014, INT J ENV RES PUB HE, V11, P4356, DOI 10.3390/ijerph110404356; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; Fu M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-320; Gallus S, 2012, TOB CONTROL, V21, P59, DOI 10.1136/tc.2010.040774; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Grupo de Trabajo sobre Tabaquismo de la Sociedad Espanola de Epidemiologia, 2009, EV IMP LEY MED SAN F; Hilton S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-206; IARC Working Group, 2009, IARC HDB CANC PREV T, P13; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Klein EG, 2007, NICOTINE TOB RES, V9, pS49, DOI 10.1080/14622200601083467; Lee YO, 2015, TOB CONTROL, V24, P410, DOI 10.1136/tobaccocontrol-2013-051437; Martinez-Sanchez JM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005894; Martinez-Sanchez JM, 2014, TOB CONTROL, V23, P204, DOI 10.1136/tobaccocontrol-2012-050877; Martinez-Sanchez JM, 2014, TOB CONTROL, V23, P238, DOI 10.1136/tobaccocontrol-2012-050700; Martinez-Sanchez JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013881; Martinez-Sanchez JM, 2010, GAC SANIT, V24, P241, DOI 10.1016/j.gaceta.2010.02.007; Martinez-Sanchez JM, 2009, PREV MED, V48, P218, DOI 10.1016/j.ypmed.2008.12.020; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pursell L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-131; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Thomson G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-64; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3859; Vardavas CI, 2014, TOB CONTROL IN PRESS; World Health Organization, WHO FRAM CONV TOB CO; World Health Organization, 2016, C PART WHO FRAM CONV; World Health Organization, 2009, TOB IND INT TOB CONT	41	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114256	10.1371/journal.pone.0114256	http://dx.doi.org/10.1371/journal.pone.0114256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469996	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700093
J	Menezes, C; Ruiz-Jarabo, I; Martos-Sitcha, JA; Leitemperger, J; Baldisserotto, B; Mancera, JM; Rosemberg, DB; Loro, VL				Menezes, Charlene; Ruiz-Jarabo, Ignacio; Antonio Martos-Sitcha, Juan; Leitemperger, Jossiele; Baldisserotto, Bernardo; Miguel Mancera, Juan; Rosemberg, Denis Broock; Loro, Vania Lucia			Diet with Diphenyl Diselenide Mitigates Quinclorac Toxicity in Silver Catfish (Rhamdia quelen)	PLOS ONE			English	Article							OXIDATIVE STRESS; CYPRINUS-CARPIO; SELENIUM; HERBICIDE; ACID; OSMOREGULATION; GROWTH; ACETYLCHOLINESTERASE; PERFORMANCE; FORMULATION	In this study, the protective effects of diphenyl diselenide [(PhSe)(2)] on quincloracinduced toxicity were investigated in silver catfish (Rhamdia quelen). The fish were fed for 60 days with a diet in the absence or in the presence of 3.0 mg/Kg (PhSe)(2). Animals were further exposed to 1 mg/L quinclorac for 8 days. At the end of experimental period, fish were euthanized and biopsies from liver and gills, as well as blood samples, were collected. The cortisol and metabolic parameters were determined in plasma, and those enzyme activities related to osmoregulation were assayed in the gills. In liver, some important enzyme activities of the intermediary metabolism and oxidative stress-related parameters, such as thiobarbituric acid-reactive substance (TBARS), protein carbonyl, catalase (CAT), superoxide dismutase (SOD), glutathione S-transferase (GST), nonprotein thiols (NPSH) and ascorbic acid contents were also evaluated. Compared to the control group, quinclorac exposure significantly decreased hepatosomatic index and increased cortisol and lactate values in plasma. Moreover, the activities of fructose biphosphatase (FBPase), glucose-6-phosphate dehydrogenase (G6Pase), glycogen phosphorilase (GPase) and aspartate aminotransferase (AST) were significantly increased in liver. Quinclorac also induced lipid peroxidation while the activity of SOD, NPSH and ascorbic acid levels decreased in the liver. However, dietary (PhSe) 2 reduced the herbicide-induced effects on the studied parameters. In conclusion, (PhSe) 2 has beneficial properties based on its ability to attenuate toxicity induced by quinclorac by regulating energy metabolism and oxidative stress-related parameters.	[Menezes, Charlene; Leitemperger, Jossiele; Rosemberg, Denis Broock; Loro, Vania Lucia] Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97119900 Santa Maria, RS, Brazil; [Ruiz-Jarabo, Ignacio; Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan] Univ Cadiz Puerto Real, Dept Biol, Fac Ciencias Mar & Ambientales, Cadiz, Spain; [Antonio Martos-Sitcha, Juan] Consejo Super Invest Cient ICMA CSIC, Inst Ciencias Marinas Andalucia, Cadiz, Spain; [Baldisserotto, Bernardo] Univ Fed Santa Maria, Dept Fisiol & Farmacol, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidade Federal de Santa Maria (UFSM)	Menezes, C (corresponding author), Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97119900 Santa Maria, RS, Brazil.	charlenemenezes@yahoo.com.br	Rosemberg, Denis B/E-5971-2016; Ruiz-Jarabo, I./AAA-6194-2020; Martos-Sitcha, Juan Antonio/L-6140-2014; Loro, Vania/E-9387-2015	Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Loro, Vania/0000-0003-2440-8791; Ruiz-Jarabo, Ignacio/0000-0002-3918-0921; Rosemberg, Denis/0000-0003-2538-8761; Wesz Leitemperger, Jossiele/0000-0002-9205-4211	CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado); CNPq; Ministry of Science and Innovation, Spain [AGL2010-14876]	CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado) to the student CM; CNPq research fellowship to VLL and BB; and by the project AGL2010-14876 (Ministry of Science and Innovation, Spain) to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa NBV, 2006, CHEM-BIOL INTERACT, V163, P230, DOI 10.1016/j.cbi.2006.08.004; Barcelo D, 2002, TRACE DETERMINATION, P1; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; David M, 2004, CHEMOSPHERE, V56, P347, DOI 10.1016/j.chemosphere.2004.02.024; de Menezes CC, 2012, ECOTOX ENVIRON SAFE, V81, P91, DOI 10.1016/j.ecoenv.2012.04.022; de Menezes CC, 2011, PESTIC BIOCHEM PHYS, V100, P145, DOI 10.1016/j.pestbp.2011.03.002; Elia AC, 2011, ECOTOX ENVIRON SAFE, V74, P166, DOI 10.1016/j.ecoenv.2010.04.006; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Glusczak L, 2007, COMP BIOCHEM PHYS C, V146, P519, DOI 10.1016/j.cbpc.2007.06.004; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Kim KW, 2003, AQUAC RES, V34, P1053, DOI 10.1046/j.1365-2109.2003.00908.x; Laiz-Carrion R, 2003, J EXP ZOOL PART A, V298A, P105, DOI 10.1002/jez.a.10256; LORENTZEN M, 1994, AQUACULTURE, V121, P359, DOI 10.1016/0044-8486(94)90270-4; Luchese C, 2010, J PHARM PHARMACOL, V62, P1146, DOI 10.1111/j.2042-7158.2010.01147.x; Mancera JM, 2000, J EXP ZOOL, V287, P263, DOI 10.1002/1097-010X(20000901)287:4&lt;263::AID-JEZ1&gt;3.0.CO;2-I; Martos-Sitcha JA, 2014, COMP BIOCHEM PHYS A, V177, P49, DOI 10.1016/j.cbpa.2014.07.021; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Menezes C, 2013, ENVIRON TOXICOL PHAR, V36, P706, DOI 10.1016/j.etap.2013.07.002; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Modesto KA, 2010, CHEMOSPHERE, V78, P294, DOI 10.1016/j.chemosphere.2009.10.047; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Monteiro D. A., 2007, Revista Brasileira de Saude e Producao Animal, V8, P32; Monteiro DA, 2009, COMP BIOCHEM PHYS C, V149, P40, DOI 10.1016/j.cbpc.2008.06.012; Moon Thomas W., 1995, Biochemistry and Molecular Biology of Fishes, V4, P65; MOORE S, 1968, J BIOL CHEM, V243, P6281; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nogueira CW, 2011, ARCH TOXICOL, V85, P1313, DOI 10.1007/s00204-011-0720-3; Nogueira CW, 2010, J BRAZIL CHEM SOC, V21, P2055, DOI 10.1590/S0103-50532010001100006; Paulmier C, 1986, SELENIUM REAGENTS IN, P84; Polakof S, 2006, J COMP PHYSIOL B, V176, P441, DOI 10.1007/s00360-006-0065-z; Pretto A, 2011, ECOTOX ENVIRON SAFE, V74, P336, DOI 10.1016/j.ecoenv.2010.10.003; Roe JH, 1954, METHOD BIOCHEM ANAL, P115; Salbego J, 2010, ARCH ENVIRON CON TOX, V58, P740, DOI 10.1007/s00244-009-9464-y; Sunohara Y, 2011, ENVIRON EXP BOT, V74, P74, DOI 10.1016/j.envexpbot.2011.05.001; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Zanella R, 2003, J SEP SCI, V26, P935, DOI 10.1002/jssc.200301309	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114233	10.1371/journal.pone.0114233	http://dx.doi.org/10.1371/journal.pone.0114233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469630	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700089
J	Njue, M; Kombe, F; Mwalukore, S; Molyneux, S; Marsh, V				Njue, Maureen; Kombe, Francis; Mwalukore, Salim; Molyneux, Sassy; Marsh, Vicki			What Are Fair Study Benefits in International Health Research? Consulting Community Members in Kenya	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; INFORMED-CONSENT; UNDUE INDUCEMENT; CLINICAL-RESEARCH; COASTAL KENYA; ETHICS; EXPLOITATION; PARTICIPANTS; EXPERIENCES; PRINCIPLE	Background: Planning study benefits and payments for participants in international health research in low-income settings can be a difficult and controversial process, with particular challenges in balancing risks of undue inducement and exploitation and understanding how researchers should take account of background inequities. At an international health research programme in Kenya, this study aimed to map local residents' informed and reasoned views on the effects of different levels of study benefits and payments to inform local policy and wider debates in international research. Methods and Findings: Using a relatively novel two-stage process community consultation approach, five participatory workshops involving 90 local residents from diverse constituencies were followed by 15 small group discussions, with components of information-sharing, deliberation and reflection to situate normative reasoning within debates. Framework Analysis drew inductively and deductively on voice-recorded discussions and field notes supported by Nvivo 10 software, and the international research ethics literature. Community members' views on study benefits and payments were diverse, with complex contextual influences and interplay between risks of giving 'too many' and ' too few' benefits, including the role of cash. While recognising important risks for free choice, research relationships and community values in giving ' too many', the greatest concerns were risks of unfairness in giving `too few' benefits, given difficulties in assessing indirect costs of participation and the serious consequences for families of underestimation, related to perceptions of researchers' responsibilities. Conclusions: Providing benefits and payments to participants in international research in low-income settings is an essential means by which researchers meet individual-level and structural forms of ethical responsibilities, but understanding how this can be achieved requires a careful account of social realities and local judgment. Concerns about undue inducement in low-income communities may often be misplaced; we argue that greater attention should be placed on avoiding unfairness, particularly for the most-poor.	[Njue, Maureen; Kombe, Francis; Mwalukore, Salim; Molyneux, Sassy; Marsh, Vicki] Wellcome Trust Res Programme, Kenya Med Res Inst KEMRI, Kilifi 80108, Kenya; [Molyneux, Sassy; Marsh, Vicki] Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England; [Molyneux, Sassy; Marsh, Vicki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford OX3 7LF, England	Kenya Medical Research Institute; University of Oxford; University of Oxford	Marsh, V (corresponding author), Wellcome Trust Res Programme, Kenya Med Res Inst KEMRI, POB 230, Kilifi 80108, Kenya.	vmarsh@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Kombe, Francis/0000-0003-0390-2336	Wellcome Trust [WT 076897]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was undertaken with infrastructural support to all authors by the Kenya Medical Research Institute (www.kemri.org) and a grant from the Wellcome Trust (www.wellcome.org) to S. Molyneux and VM (WT 076897). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ballantyne A, 2008, BIOETHICS, V22, P239, DOI 10.1111/j.1467-8519.2007.00622.x; Ballantyne A, 2008, DEV WORLD BIOETH, V8, P178, DOI 10.1111/j.1471-8847.2006.00175.x; Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672; Bryman A, 2004, FOCUS GROUPS SOCIAL; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-149; *CIOMS, 2002, INT ETH GUID BIOM RE; De Vries R, 2010, SOC SCI MED, V70, P1896, DOI 10.1016/j.socscimed.2010.02.031; Diallo DA, 2005, CLIN INFECT DIS, V41, P255, DOI 10.1086/430707; El Setouhy M, 2002, SCIENCE, V298, P2133; Emanuel EJ, 2005, LANCET, V366, P336, DOI 10.1016/S0140-6736(05)66992-9; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Green J, 2007, QUALITATIVE METHODS; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; IJsselmuiden CB, 2010, GLOB PUBLIC HEALTH, V5, P154, DOI 10.1080/17441690903436599; Institute WR, 2011, VIRTUAL KENYA; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P10, DOI 10.1111/dewb.12014; Lavery JV, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-384; London Alex John, 2010, Hastings Cent Rep, V40, P34; Marsh V, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-41; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; National Council for Science and Technology (NCST), 2004, GUID ETH COND BIOM R; Parker M, 2007, PRINCIPLES HLTH CARE; Parkin D, 1991, W E WORKS MARRIAGE S, P84; Parkin David, 1991, SACRED VOID SPATIAL; Permuth-Wey J, 2009, ANN EPIDEMIOL, V19, P280, DOI 10.1016/j.annepidem.2009.01.004; Wendler D, 2002, J PEDIATR-US, V141, P166, DOI 10.1067/mpd.2002.124381; Wertheimer Alan, 1996, EXPLOITATION	32	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113112	10.1371/journal.pone.0113112	http://dx.doi.org/10.1371/journal.pone.0113112			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470596	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700014
J	Santala, S; Karp, M; Santala, V				Santala, Suvi; Karp, Matti; Santala, Ville			Rationally Engineered Synthetic Coculture for Improved Biomass and Product Formation	PLOS ONE			English	Article							ACINETOBACTER-BAYLYI ADP1; ESCHERICHIA-COLI; ACETATE; BIOLOGY; GROWTH; EXPRESSION; BATCH	In microbial ecosystems, bacteria are dependent on dynamic interspecific interactions related to carbon and energy flow. Substrates and end-metabolites are rapidly converted to other compounds, which protects the community from high concentrations of inhibitory molecules. In biotechnological applications, pure cultures are preferred because of the more straight-forward metabolic engineering and bioprocess control. However, the accumulation of unwanted side products can limit the cell growth and process efficiency. In this study, a rationally engineered coculture with a carbon channeling system was constructed using two well-characterized model strains Escherichia coli K12 and Acinetobacter baylyi ADP1. The directed carbon flow resulted in efficient acetate removal, and the coculture showed symbiotic nature in terms of substrate utilization and growth. Recombinant protein production was used as a proof-of-principle example to demonstrate the coculture utility and the effects on product formation. As a result, the biomass and recombinant protein titers of E. coli were enhanced in both minimal and rich medium simple batch cocultures. Finally, harnessing both the strains to the production resulted in enhanced recombinant protein titers. The study demonstrates the potential of rationally engineered cocultures for synthetic biology applications.	[Santala, Suvi; Karp, Matti; Santala, Ville] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland	Tampere University	Santala, S (corresponding author), Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland.	suvi.santala@tut.fi	Karp, Matti/G-4227-2014	Karp, Matti/0000-0001-6686-4416; Santala, Suvi Maarit/0000-0002-0047-5319; Santala, Ville/0000-0002-9084-931X	Academy of Finland [272602]; Suomen Kulttuurirahasto	Academy of Finland(Academy of Finland); Suomen Kulttuurirahasto	Funding: The project was funded by Academy of Finland (project ProChassis 272602, URL: http://www.aka.fi/fi/A/), and by Suomen Kulttuurirahasto (URL: http://www.skr.fi/) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BG, 2011, BIOCONJUGATE CHEM, V22, P227, DOI 10.1021/bc100372u; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Bernstein HC, 2012, J BIOTECHNOL, V157, P159, DOI 10.1016/j.jbiotec.2011.10.001; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Eiteman Mark A, 2008, J Biol Eng, V2, P3, DOI 10.1186/1754-1611-2-3; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; FRACKMAN S, 1990, J BACTERIOL, V172, P5767, DOI 10.1128/jb.172.10.5767-5773.1990; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Hanly TJ, 2011, BIOTECHNOL BIOENG, V108, P376, DOI 10.1002/bit.22954; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Li L, 2013, BIORESOURCE TECHNOL, V143, P397, DOI 10.1016/j.biortech.2013.06.023; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Murin CD, 2012, APPL ENVIRON MICROB, V78, P280, DOI 10.1128/AEM.05597-11; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rabinovitch-Deere CA, 2013, CHEM REV; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Santala S, 2012, ACS SYNTHETIC BIOL, V1; Santala S, 2014, ACS SYNTH BIOL, V3, P145, DOI 10.1021/sb4000788; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-75; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-36; Santala V, 2004, J IMMUNOL METHODS, V284, P165, DOI 10.1016/j.jim.2003.10.008; Seppala JJ, 2011, INT J HYDROGEN ENERG, V36, P10701, DOI 10.1016/j.ijhydene.2011.05.189; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Swartz JR, 2001, CURR OPIN BIOTECH, V12, P195, DOI 10.1016/S0958-1669(00)00199-3; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823	36	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113786	10.1371/journal.pone.0113786	http://dx.doi.org/10.1371/journal.pone.0113786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470793	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700045
J	Wathen, S; Thorne, JH; Holguin, A; Schwartz, MW				Wathen, Steve; Thorne, James H.; Holguin, Andrew; Schwartz, Mark W.			Estimating the Spatial and Temporal Distribution of Species Richness within Sequoia and Kings Canyon National Parks	PLOS ONE			English	Article							CLIMATE-CHANGE; SIERRA-NEVADA; ALTITUDINAL GRADIENT; DIVERSITY; CALIFORNIA; PATTERNS; BIODIVERSITY	Evidence for significant losses of species richness or biodiversity, even within protected natural areas, is mounting. Managers are increasingly being asked to monitor biodiversity, yet estimating biodiversity is often prohibitively expensive. As a cost-effective option, we estimated the spatial and temporal distribution of species richness for four taxonomic groups (birds, mammals, herpetofauna (reptiles and amphibians), and plants) within Sequoia and Kings Canyon National Parks using only existing biological studies undertaken within the Parks and the Parks' long-term wildlife observation database. We used a rarefaction approach to model species richness for the four taxonomic groups and analyzed those groups by habitat type, elevation zone, and time period. We then mapped the spatial distributions of species richness values for the four taxonomic groups, as well as total species richness, for the Parks. We also estimated changes in species richness for birds, mammals, and herpetofauna since 1980. The modeled patterns of species richness either peaked at mid elevations (mammals, plants, and total species richness) or declined consistently with increasing elevation (herpetofauna and birds). Plants reached maximum species richness values at much higher elevations than did vertebrate taxa, and nonflying mammals reached maximum species richness values at higher elevations than did birds. Alpine plant communities, including sagebrush, had higher species richness values than did subalpine plant communities located below them in elevation. These results are supported by other papers published in the scientific literature. Perhaps reflecting climate change: birds and herpetofauna displayed declines in species richness since 1980 at low and middle elevations and mammals displayed declines in species richness since 1980 at all elevations.	[Wathen, Steve; Schwartz, Mark W.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Thorne, James H.; Holguin, Andrew] Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA; [Schwartz, Mark W.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Schwartz, MW (corresponding author), Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA.	mwschwartz@ucdavis.edu	Schwartz, Mark/G-1066-2011	Schwartz, Mark/0000-0002-3739-6542; Thorne, James/0000-0002-9130-9921				Austin J, 2013, NATURAL RESOURCE CON; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Das AJ, 2007, CAN J FOREST RES, V37, P580, DOI 10.1139/X06-262; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Grinnell J, 1912, OUR VANISHING WILD L, P22; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; HAMILTON AC, 1981, VEGETATIO, V45, P107, DOI 10.1007/BF00119220; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lomolino MV, 2010, BIOGEOGRAPHY; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; Morelli TL, 2012, P ROY SOC B-BIOL SCI, V279, P4279, DOI 10.1098/rspb.2012.1301; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; National Park Service, 2013, NPSSEKINRR2013665; Oksanen J., 2016, R PACKAG; R Core Team, 2018, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Sanchez-Gonzalez A, 2005, DIVERS DISTRIB, V11, P567, DOI 10.1111/j.1366-9516.2005.00186.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schwartz MW, 2013, NPSSEKINRR2013665; Siegel RB, 2005, LANDBIRD INVENTORY S; Thorne JH, 2009, NAT AREA J, V29, P344, DOI 10.3375/043.029.0402; Thorne James H., 2008, Madrono, V55, P223, DOI 10.3120/0024-9637-55.3.223; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Williams AE, 2005, J FISH BIOL, V67, P278	38	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112465	10.1371/journal.pone.0112465	http://dx.doi.org/10.1371/journal.pone.0112465			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469873	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700008
J	Cui, GG; Zhang, S; Geng, HY				Cui, Gege; Zhang, Shen; Geng, Haiyan			The Impact of Perceived Social Power and Dangerous Context on Social Attention	PLOS ONE			English	Article							SEX-DIFFERENCES; GAZE DIRECTION; EYE GAZE; CUES	Past research has shown that position in a social hierarchy modulates one's social attention, as in the gaze cueing effect. While studies have manipulated the social status of others with whom the participants interact, we believe that a sense of one's own social power is also a crucial factor affecting gaze following. In two experiments, we primed the social power of participants, using different approaches, to investigate the participants' performance in a subsequent gaze cueing task. The results of Experiment 1 showed a stronger gaze cueing effect among participants who were primed with low social power, compared to those primed with high social power. Our predicted gender difference (i.e., women showing a stronger gaze cueing effect than men) was confirmed and this effect was found to be dominated by the lower social power condition. Experiment 2 manipulated the level of danger in the context and replicated the joint impact of gender and one's perceived social power on gaze cueing effect, especially in the low danger context, in comparison to the high danger context. These findings demonstrate that one's perceived social power has a concerted effect on social attention evoked by gaze, along with other factors such as gender and characteristics of the environment, and suggest the importance of further research on the complex relationship between an individual's position in the social hierarchy and social attention.	[Cui, Gege; Geng, Haiyan] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhang, Shen] Univ Wisconsin, Dept Psychol, Whitewater, WI 53190 USA	Peking University; University of Wisconsin System	Geng, HY (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	hygeng@pku.edu.cn			National Natural Science Foundation of China [31271202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31271202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eagly A.H., 2013, SEX DIFFERENCES SOCI; EAGLY AH, 1982, J PERS SOC PSYCHOL, V43, P915, DOI 10.1037/0022-3514.43.5.915; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Friesen CK, 2011, COGNITION EMOTION, V25, P73, DOI 10.1080/02699931003672381; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2012, Q J EXP PSYCHOL, V65, P1895, DOI 10.1080/17470218.2012.663765; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P1450, DOI 10.1037/a0012633; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Hadjikhani N, 2008, BRAIN COGNITION, V68, P1, DOI 10.1016/j.bandc.2008.01.008; Hietanen JK, 2008, BRAIN RES, V1215, P123, DOI 10.1016/j.brainres.2008.03.091; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Lammers J, 2009, PSYCHOL SCI, V20, P1543, DOI 10.1111/j.1467-9280.2009.02479.x; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Mueller U, 1997, BEHAV ECOL, V8, P569; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Sidanius J., 2001, SOCIAL DOMINANCE INT; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Wu DWL, 2014, EVOL HUM BEHAV, V35, P211, DOI 10.1016/j.evolhumbehav.2014.01.005; Xu S, 2011, VISION RES, V51, P2048, DOI 10.1016/j.visres.2011.07.023; Zuberbuhler K, 2008, CURR BIOL, V18, pR453, DOI 10.1016/j.cub.2008.03.015	47	8	8	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114077	10.1371/journal.pone.0114077	http://dx.doi.org/10.1371/journal.pone.0114077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464385	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700093
J	Gschwendtner, S; Tejedor, J; Bimueller, C; Dannenmann, M; Knabner, IK; Schloter, M				Gschwendtner, Silvia; Tejedor, Javier; Bimueller, Carolin; Dannenmann, Michael; Knabner, Ingrid Koegel; Schloter, Michael			Climate Change Induces Shifts in Abundance and Activity Pattern of Bacteria and Archaea Catalyzing Major Transformation Steps in Nitrogen Turnover in a Soil from a Mid-European Beech Forest	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; REDUCTASE GENES NIRK; DENITRIFYING BACTERIA; CARBON-DIOXIDE; MICROBIAL COMMUNITIES; ORGANIC NITROGEN; AGGREGATED SOILS; OXIDE REDUCTASE; RIBOSOMAL-RNA; PCR PRIMERS	Ongoing climate change will lead to more extreme weather events, including severe drought periods and intense drying rewetting cycles. This will directly influence microbial nitrogen (N) turnover rates in soil by changing the water content and the oxygen partial pressure. Therefore, a space for time climate change experiment was conducted by transferring intact beech seedling-soil mesocosms from a northwest (NW) exposed site, representing today's climatic conditions, to a southwest (SW) exposed site, providing a model climate for future conditions with naturally occurring increased soil temperature (+0.8 degrees C in average). In addition, severe drought and intense rainfall was simulated by a rainout shelter at SW and manual rewetting after 39 days drought, respectively. Soil samples were taken in June, at the end of the drought period (August), 24 and 72 hours after rewetting (August) and after a regeneration period of four weeks (September). To follow dynamics of bacterial and archaeal communities involved in N turnover, abundance and activity of nitrifiers, denitrifiers, N-2-fixing microbes and N-mineralizers was analyzed based on marker genes and the related transcripts by qPCR from DNA and RNA directly extracted from soil. Abundance of the transcripts was reduced under climate change with most pronounced effects for denitrification. Our results revealed that already a transfer from NW to SW without further treatment resulted in decreased cnor and nosZ transcripts, encoding for nitric oxide reductase and nitrous oxide reductase, respectively, while nirK transcripts, encoding for nitrite reductase, remained unaffected. Severe drought additionally led to reduced nirK and cnor transcripts at SW. After rewetting, nirK transcripts increased rapidly at both sites, while cnor and nosZ transcripts increased only at NW. Our data indicate that the climate change influences activity pattern of microbial communities involved in denitrification processes to a different extend, which may impact emission rates of the greenhouse gas N2O.	[Gschwendtner, Silvia; Schloter, Michael] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Environm Genom, D-85764 Neuherberg, Germany; [Tejedor, Javier; Dannenmann, Michael] Karlsruhe Inst Technol, Atmospher Environm Res IMK IFU, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Bimueller, Carolin; Knabner, Ingrid Koegel] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Dept Ecol & Ecosyst Management, Lehrstuhl Bodenkunde, D-85350 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Karlsruhe Institute of Technology; Technical University of Munich	Schloter, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Environm Genom, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	schloter@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Tejedor, Javier/AAA-6473-2020; Dannenmann, Michael/A-7278-2013; Kögel-Knabner, Ingrid/A-7905-2008	Kögel-Knabner, Ingrid/0000-0002-7216-8326; Dannenmann, Michael/0000-0001-5924-7612; , Javier/0000-0002-5994-0131	German Science Foundation (DFG) [SCHL 447/11-1, DA 1217/2-1, KO 1035/41-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work has been supported by the German Science Foundation (DFG) under the contract numbers SCHL 447/11-1, DA 1217/2-1, and KO 1035/41-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMAR F, 1994, BIOL FERT SOILS, V17, P32, DOI 10.1007/BF00418669; Bach HJ, 2001, J MICROBIOL METH, V44, P173, DOI 10.1016/S0167-7012(00)00239-6; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Beier C, 2008, SCI TOTAL ENVIRON, V407, P692, DOI 10.1016/j.scitotenv.2008.10.001; Bilela S, 2012, FOREST ECOL MANAG, V275, P60, DOI 10.1016/j.foreco.2012.03.009; Bimuller C, 2014, SOIL BIOL BIOCHEM, V68, P241, DOI 10.1016/j.soilbio.2013.10.003; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Braker G, 2003, APPL ENVIRON MICROB, V69, P3476, DOI 10.1128/AEM.69.6.3476-3483.2003; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; COLE DW, 1995, PLANT SOIL, V168, P43, DOI 10.1007/BF00029312; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Domisch T, 2006, EUR J SOIL BIOL, V42, P74, DOI 10.1016/j.ejsobi.2005.09.017; Ekenler M, 2002, BIOL FERT SOILS, V36, P367, DOI 10.1007/s00374-002-0541-x; Ellenberg H., 1996, VEGETATION MITTELEUR, V5th ed; Emmett BA, 2004, ECOSYSTEMS, V7, P625, DOI 10.1007/s10021-004-0220-x; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2001, NEW PHYTOL, V150, P653, DOI 10.1046/j.1469-8137.2001.00136.x; Gorissen A, 2004, ECOSYSTEMS, V7, P650, DOI 10.1007/s10021-004-0218-4; Gschwendtner S, 2010, BIOL FERT SOILS, V46, P649, DOI 10.1007/s00374-010-0460-1; Halverson LJ, 2000, SOIL SCI SOC AM J, V64, P1630, DOI 10.2136/sssaj2000.6451630x; Hart SC, 2006, GLOBAL CHANGE BIOL, V12, P1032, DOI 10.1111/j.1365-2486.2006.01159.x; He HY, 2014, BIOMETALS, V27, P219, DOI 10.1007/s10534-014-9711-1; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Huang SH, 2007, ECOL ENG, V31, P9, DOI 10.1016/j.ecoleng.2007.04.001; Hwang SJ, 2000, BIORESOURCE TECHNOL, V71, P159, DOI 10.1016/S0960-8524(99)90068-8; IUSS, 2007, WORLD REF BAS SOIL R; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jung J, 2012, J MICROBIOL, V50, P365, DOI 10.1007/s12275-012-1465-2; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mikha MM, 2005, SOIL BIOL BIOCHEM, V37, P339, DOI 10.1016/j.soilbio.2004.08.003; Morley N, 2008, FEMS MICROBIOL ECOL, V65, P102, DOI 10.1111/j.1574-6941.2008.00495.x; Otte S, 1996, APPL ENVIRON MICROB, V62, P2421, DOI 10.1128/AEM.62.7.2421-2426.1996; Paul E. A., 1996, SOIL MICROBIOLOGY BI, P182; Pena R, 2013, ENVIRON EXP BOT, V87, P207, DOI 10.1016/j.envexpbot.2012.11.005; Pesaro M, 2004, APPL ENVIRON MICROB, V70, P2577, DOI 10.1128/AEM.70.5.2577-2587.2004; Prieme A, 2001, SOIL BIOL BIOCHEM, V33, P2083, DOI 10.1016/S0038-0717(01)00140-7; RENAULT P, 1994, SOIL SCI SOC AM J, V58, P1023, DOI 10.2136/sssaj1994.03615995005800040005x; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Roling WFM, 2007, FEMS MICROBIOL ECOL, V62, P202, DOI 10.1111/j.1574-6941.2007.00350.x; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schreiner K, 2010, APPL ENVIRON MICROB, V76, P4703, DOI 10.1128/AEM.00481-10; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Sharma S, 2005, APPL ENVIRON MICROB, V71, P2001, DOI 10.1128/AEM.71.4.2001-2007.2005; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; SMITH KA, 1980, J SOIL SCI, V31, P263, DOI 10.1111/j.1365-2389.1980.tb02080.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STARK JM, 1995, APPL ENVIRON MICROB, V61, P218, DOI 10.1128/AEM.61.1.218-221.1995; Stres B, 2008, FEMS MICROBIOL ECOL, V66, P110, DOI 10.1111/j.1574-6941.2008.00555.x; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Towe S, 2010, MICROB ECOL, V60, P762, DOI 10.1007/s00248-010-9695-5; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Voroney RP, 2007, SOIL MICROBIOLOGY EC, pp45, DOI DOI 10.1016/B978-0-08-047514-1.50006-8; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005; Yang LC, 2014, J HAZARD MATER, V271, P292, DOI 10.1016/j.jhazmat.2014.01.058; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	71	18	19	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114278	10.1371/journal.pone.0114278	http://dx.doi.org/10.1371/journal.pone.0114278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462589	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700126
J	Han, L; Liu, XJ; Li, HM; Zou, JQ; Yang, ZL; Han, J; Huang, W; Yu, LL; Zheng, YR; Li, L				Han, Lei; Liu, Xiaojie; Li, Hongmei; Zou, Jiaqun; Yang, Zhiling; Han, Jian; Huang, Wei; Yu, Lili; Zheng, Yingru; Li, Li			Blood Coagulation Parameters and Platelet Indices: Changes in Normal and Preeclamptic Pregnancies and Predictive Values for Preeclampsia	PLOS ONE			English	Article							COMPLICATIONS; FIBRINOLYSIS; DISORDERS; WOMEN; MPV	Background: Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear pathogeny. The dysfunction of the blood coagulation-fibrinolysis system is a salient characteristic of PE that varies in severity, and necessitates different treatments. Therefore, it is necessary to find suitable predictors for the onset and severity of PE. Objectives: We aimed to evaluate blood coagulation parameters and platelet indices as potential predictors for the onset and severity of PE. Methods: Blood samples from 3 groups of subjects, normal pregnant women (n=79), mild preeclampsia (mPE) (n=53) and severe preeclampsia (sPE) (n=42), were collected during early and late pregnancy. The levels of coagulative parameters and platelet indices were measured and compared among the groups. The receiver-operating characteristic (ROC) curves of these indices were generated, and the area under the curve (AUC) was calculated. The predictive values of the selected potential parameters were examined in binary regression analysis. Results: During late pregnancy in the normal pregnancy group, the activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and platelet count decreased, while the fibrinogen level and mean platelet volume (MPV) increased compared to early pregnancy (p<0.05). However, the PE patients presented with increased APTT, TT, MPV and D-dimer (DD) during the third trimester. In the analysis of subjects with and without PE, TT showed the largest AUC (0.743) and high predictive value. In PE patients with different severities, MPV showed the largest AUC (0.671) and ideal predictive efficiency. Conclusion: Normal pregnancy causes a maternal physiological hypercoagulable state in late pregnancy. PE may trigger complex disorders in the endogenous coagulative pathways and consume platelets and FIB, subsequently activating thrombopoiesis and fibrinolysis. Thrombin time and MPV may serve as early monitoring markers for the onset and severity of PE, respectively.	[Han, Lei; Liu, Xiaojie; Li, Hongmei; Yang, Zhiling; Han, Jian; Huang, Wei; Yu, Lili; Zheng, Yingru; Li, Li] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Han, Lei] 306th Hosp Chinese Peoples Liberat Army, Dept Obstet & Gynecol, Beijing, Peoples R China; [Zou, Jiaqun] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Gen Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, L (corresponding author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China.	cqlili@tmmu.edu.cn			National Natural Foundation of China [81170576, 81401224]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of the National Natural Foundation of China (81170576, 81401224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Al-Jameil Noura, 2014, J Clin Med Res, V6, P1, DOI 10.4021/jocmr1682w; Altinbas S, 2012, J CLIN LAB ANAL, V26, P403, DOI 10.1002/jcla.21542; Benedetto C, 2010, ANN NY ACAD SCI, V1205, P106, DOI 10.1111/j.1749-6632.2010.05674.x; Boriboonhirunsarn Dittakarn, 1995, Journal of the Medical Association of Thailand, V78, P586; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Dundar O, 2008, PRENATAL DIAG, V28, P1052, DOI 10.1002/pd.2126; Fatemeh T, 2010, J PAK MED ASSOC, V60, P707; Freitas LG, 2013, HEMATOLOGY, V18, P359, DOI 10.1179/1607845413Y.0000000098; Hayward CPM, 2012, SEMIN THROMB HEMOST, V38, P742, DOI 10.1055/s-0032-1326780; Heilmann L, 2007, CLIN APPL THROMB-HEM, V13, P285, DOI 10.1177/1076029607299986; Irminger-Finger I, 2008, INT J BIOCHEM CELL B, V40, P1979, DOI 10.1016/j.biocel.2008.04.006; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Morikawa M, 2006, J PERINAT MED, V34, P392, DOI 10.1515/JPM.2006.078; Oliver JJ, 2005, ARTERIOSCL THROM VAS, V25, P2470, DOI 10.1161/01.ATV.0000189309.05924.88; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Pinheiro MB, 2013, CLIN CHIM ACTA, V416, P67, DOI 10.1016/j.cca.2012.10.060; Pinheiro MB, 2014, CLIN CHIM ACTA, V427, P65, DOI 10.1016/j.cca.2013.09.050; Portelinha A, 2009, THROMB RES, V124, P52, DOI 10.1016/j.thromres.2008.10.005; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Sultan P, 2013, CLIN APPL THROMB-HEM, V19, P529, DOI 10.1177/1076029612441860; Tanjung MT, 2005, CLIN APPL THROMB-HEM, V11, P467, DOI 10.1177/107602960501100415; Townsley DM, 2013, SEMIN HEMATOL, V50, P222, DOI 10.1053/j.seminhematol.2013.06.004; Tzur T, 2013, HYPERTENS PREGNANCY, V32, P74, DOI 10.3109/10641955.2012.704109; Williams VK, 2007, HYPERTENS PREGNANCY, V26, P415, DOI 10.1080/10641950701548240; Yang SW, 2014, EUR J OBSTET GYNECOL	26	48	55	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114488	10.1371/journal.pone.0114488	http://dx.doi.org/10.1371/journal.pone.0114488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464515	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700135
J	Meyer, MF; Seuthe, IMC; Drebber, U; Siefer, O; Kreppel, M; Klein, MO; Mikolajczak, S; Klussmann, JP; Preuss, SF; Huebbers, CU				Meyer, Moritz F.; Seuthe, Inga M. C.; Drebber, Uta; Siefer, Oliver; Kreppel, Matthias; Klein, Marcus O.; Mikolajczak, Stefanie; Klussmann, Jens Peter; Preuss, Simon F.; Huebbers, Christian U.			Valosin-Containing Protein (VCP/p97)-Expression Correlates with Prognosis of HPV- Negative Oropharyngeal Squamous Cell Carcinoma (OSCC)	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS INFECTION; EXPRESSION LEVEL; CANCER INCIDENCE; ORAL-CAVITY; VIRAL LOAD; HEAD; P97; DEGRADATION; ASSOCIATION	Valosin-containing protein (VCP)/p97 has been shown to be associated with antiapoptotic function via activation of the nuclear factor-kappa B (NF kappa B) signaling pathway and with metastasizing of tumors in several studies. VCP is located on chromosome 9p13-p12, a region often deleted in oropharyngeal squamous cell carcinoma (OSCC). The clinical significance of VCP expression in OSCC however remains unclear. In this study, expression of VCP was determined in 106 patients (77 male (71.3%) and 31 female (28.7%); age-range: 34-79 years (mean age 57 years)) by immunohistochemistry and in a subset of 15 patients by quantitative PCR. HPV-DNA was detected by polymerase chain reaction and p16(INK4a) immunohistochemistry. The experimental findings were correlated with clinicopathological data and survival parameters. 47.2% of all OSCC specimens were analyzed as negative or weak staining intensity for VCP. 52.8% of all specimens showed a high staining intensity for VCP. 73.1% of all patients were tested HPV-negative, 26.9% were HPV-positive. The 5-year disease-free and overall survival probabilities of all patients were 71.2% and 55.7%, respectively. No correlation could be found between HPV-status and VCP expression. VCP overexpression in HPV-negative patients was associated with significantly better 5-year disease-free survival (86.4% vs., 45.6%, p=0.017). The level of VCP-intensity determined by immunohistochemistry could be an additional prognostic marker in HPV-negative OSCC. VCP expression seems not to correlate with the HPV-status.	[Meyer, Moritz F.; Seuthe, Inga M. C.; Mikolajczak, Stefanie; Preuss, Simon F.] Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, D-50931 Cologne, Germany; [Drebber, Uta] Univ Cologne, Dept Pathol, Cologne, Germany; [Siefer, Oliver; Huebbers, Christian U.] Univ Cologne, Jean Uhmacher Inst, D-50931 Cologne, Germany; [Kreppel, Matthias] Univ Cologne, Dept Oral & Maxillofacial Plast Surg, D-50931 Cologne, Germany; [Klein, Marcus O.] Clin Oral & Maxillofacial Plast Surg, Dusseldorf, Germany; [Klussmann, Jens Peter] Univ Giessen, Dept Otorhinolaryngol Head & Neck Surg, D-35390 Giessen, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Justus Liebig University Giessen	Meyer, MF (corresponding author), Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, D-50931 Cologne, Germany.	moritz.meyer@uk-koeln.de		Huebbers, Christian/0000-0002-2934-1218; Klussmann, Jens Peter/0000-0002-8223-7954				Allen C, 2007, CLIN CANCER RES, V13, P3182, DOI 10.1158/1078-0432.CCR-06-3047; American Joint Committee on Cancer Classification, CANC STAG MAN; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Eich HT, 2008, STRAHLENTHER ONKOL, V184, P23, DOI 10.1007/s00066-008-1725-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Huang CF, 2011, ORAL DIS, V17, P328, DOI 10.1111/j.1601-0825.2010.01730.x; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Klussmann JP, 2004, HNO, V52, P208, DOI 10.1007/s00106-004-1069-1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kreppel M, 2012, ORAL DIS, V18, P692, DOI 10.1111/j.1601-0825.2012.01927.x; Li W, 2004, HEAD NECK-J SCI SPEC, V26, P1, DOI 10.1002/hed.10335; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Mashhadiabbas F, 2012, OR SURG OR MED OR PA, V114, P240, DOI 10.1016/j.oooo.2012.04.009; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Meyer MF, 2014, ORAL ONCOL, V50, P27, DOI 10.1016/j.oraloncology.2013.10.009; Preuss SF, 2011, HNO, V59, P1031, DOI 10.1007/s00106-011-2391-z; Preuss SF, 2008, HEAD NECK-J SCI SPEC, V30, P1318, DOI 10.1002/hed.20876; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114170	10.1371/journal.pone.0114170	http://dx.doi.org/10.1371/journal.pone.0114170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463965	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700111
J	Pujol, M; Barquinero, JF; Puig, P; Puig, R; Caballin, MR; Barrios, L				Pujol, Monica; Barquinero, Joan-Francesc; Puig, Pedro; Puig, Roser; Rosa Caballin, Maria; Barrios, Leonardo			A New Model of Biodosimetry to Integrate Low and High Doses	PLOS ONE			English	Article							PREMATURELY CONDENSED CHROMOSOMES; BIOLOGICAL DOSIMETRY; RADIATION ACCIDENT; MITOTIC DELAY; IN-VITRO; EXPOSURES; GAMMA; LYMPHOCYTES; SUITABILITY; ABERRATIONS	Biological dosimetry, that is the estimation of the dose of an exposure to ionizing radiation by a biological parameter, is a very important tool in cases of radiation accidents. The score of dicentric chromosomes, considered to be the most accurate method for biological dosimetry, for low LET radiation and up to 5 Gy, fits very well to a linear-quadratic model of dose-effect curve assuming the Poisson distribution. The accuracy of this estimation raises difficulties for doses over 5 Gy, the highest dose of the majority of dose-effect curves used in biological dosimetry. At doses over 5 Gy most cells show difficulties in reaching mitosis and cannot be used to score dicentric chromosomes. In the present study with the treatment of lymphocyte cultures with caffeine and the standardization of the culture time, metaphases for doses up to 25 Gy have been analyzed. Here we present a new model for biological dosimetry, which includes a Gompertz-type function as the dose response, and also takes into account the underdispersion of aberration-among-cell distribution. The new model allows the estimation of doses of exposures to ionizing radiation of up to 25 Gy. Moreover, the model is more effective in estimating whole and partial body exposures than the classical method based on linear and linear-quadratic functions, suggesting their effectiveness and great potential to be used after high dose exposures of radiation.	[Pujol, Monica; Barquinero, Joan-Francesc; Puig, Roser; Rosa Caballin, Maria] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, Bellaterra, Spain; [Puig, Pedro] Univ Autonoma Barcelona, Dept Matemat, Bellaterra, Spain; [Barrios, Leonardo] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Barrios, L (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain.	Lleonard.barrios@uab.cat	Pujol-Canadell, Monica/AAY-1622-2020; Puig, Pedro/K-4414-2014; Barrios, Leonardo/L-3315-2014; Barquinero, Joan Francesc/L-6487-2014; MARIA ROSA, CABALLIN/L-9148-2014	Puig, Pedro/0000-0002-6607-9642; Barrios, Leonardo/0000-0002-6151-8503; Barquinero, Joan Francesc/0000-0003-0084-5268; MARIA ROSA, CABALLIN/0000-0002-0091-5484	Consejo de Seguridad Nuclear	Consejo de Seguridad Nuclear	This work received financial support from the Consejo de Seguridad Nuclear. The sponsor had no role in the study design, data collection, analysis or interpretation. M.R.C., L.B. and J.F.B. belong to a consolidated research group of the Generalitat de Catalunya (2014 SGR 354) and to RTICC RD06/0020/1020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CYT DOS APPL PREP RE; Balakrishnan S, 2010, MUTAT RES-GEN TOX EN, V699, P11, DOI 10.1016/j.mrgentox.2010.03.008; Barquinero JF, 1997, INT J RADIAT BIOL, V71, P435, DOI 10.1080/095530097144058; Belloni P, 2008, RADIAT RES, V169, P181, DOI 10.1667/RR1158.1; Chen Y, 2011, RADIAT MEAS, V46, P837, DOI 10.1016/j.radmeas.2011.04.001; Duran A, 2002, RADIAT RES, V157, P461, DOI 10.1667/0033-7587(2002)157[0461:SOFPTF]2.0.CO;2; EDWARDS AA, 1979, RADIAT ENVIRON BIOPH, V16, P89, DOI 10.1007/BF01323216; Gotoh E, 2005, INT J RADIAT BIOL, V81, P33, DOI 10.1080/09553000500092319; Hayata I, 2001, J Radiat Res, V42 Suppl, pS149; Heimers A, 2005, RADIAT ENVIRON BIOPH, V44, P211, DOI 10.1007/s00411-005-0014-3; Kanda R, 1999, INT J RADIAT BIOL, V75, P441, DOI 10.1080/095530099140366; Kemp AW, 2005, WILEY SER PROBAB ST, P343; Kuhne M, 2000, INT J RADIAT BIOL, V76, P891, DOI 10.1080/09553000050050909; Lamadrid AI, 2007, J RADIAT RES, V48, P1, DOI 10.1269/jrr.0625; Lamadrid AI, 2011, J RADIAT RES, V52, P531, DOI 10.1269/jrr.10096; Lindholm C, 2010, RADIAT RES, V173, P71, DOI 10.1667/RR1843.1; Liu Q, 2008, J RADIAT RES, V49, P63, DOI 10.1269/jrr.07071; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; NORMAN A, 1966, INT J RADIAT BIOL RE, V11, P321; PANTELIAS GE, 1984, RADIAT RES, V99, P140, DOI 10.2307/3576452; Puig R, 2013, MUTAT RES-GEN TOX EN, V757, P1, DOI 10.1016/j.mrgentox.2013.03.013; Pujol M, 2012, RADIAT PROT DOSIM, V149, P392, DOI 10.1093/rpd/ncr326; PURROTT RJ, 1980, MUTAT RES, V69, P275, DOI 10.1016/0027-5107(80)90092-5; RAO CR, 1956, BIOMETRICS, V12, P264, DOI 10.2307/3001466; Rao CR, 1965, SANKHYA A, V2, P331; Rodriguez P, 2009, MUTAT RES-FUND MOL M, V670, P53, DOI 10.1016/j.mrfmmm.2009.07.003; Rothkamm K, 2008, RADIAT RES, V169, P639, DOI 10.1667/RR1185.1; ROWLEY R, 1984, RADIAT RES, V97, P178, DOI 10.2307/3576199; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sasaki MS, 2003, INT J RADIAT BIOL, V79, P83, DOI 10.1080/0955300021000045655; Sevan'kaev AV, 2002, RADIAT PROT DOSIM, V102, P201, DOI 10.1093/oxfordjournals.rpd.a006090; SREEDEVI B, 1993, RADIAT PROT DOSIM, V50, P45; Terzoudi GI, 2009, INT J ONCOL, V35, P1223, DOI 10.3892/ijo_00000439; Vinnikov VA, 2013, RADIAT PROT DOSIM, V154, P186, DOI 10.1093/rpd/ncs200; Vinnikov VA, 2010, RADIAT RES, V174, P403, DOI 10.1667/RR2228.1; Weiss CH, 2013, J APPL STAT, V40, P1931, DOI 10.1080/02664763.2013.800034; Wojcik A, 2004, CYTOGENET GENOME RES, V104, P200, DOI 10.1159/000077489; Yao B, 2010, INT J RADIAT BIOL, V86, P800, DOI 10.3109/09553002.2010.481320; Yao B, 2013, MUTAT RES-GEN TOX EN, V751, P66, DOI 10.1016/j.mrgentox.2012.11.005	39	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114137	10.1371/journal.pone.0114137	http://dx.doi.org/10.1371/journal.pone.0114137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461738	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700103
J	Sangenito, LS; Menna-Barreto, RFS; d'Avila-Levy, CM; Santos, ALS; Branquinha, MH				Sangenito, Leandro S.; Menna-Barreto, Rubem F. S.; d'Avila-Levy, Claudia M.; Santos, Andre L. S.; Branquinha, Marta H.			Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model	PLOS ONE			English	Article							RHODNIUS-PROLIXUS-MIDGUT; LEISHMANIA-AMAZONENSIS; PROTEASE INHIBITORS; TRYPOMASTIGOTE FORMS; CHAGAS-DISEASE; CELL-DEATH; IN-VITRO; INFECTION; DRUGS; DIFFERENTIATION	Background: Aspartic peptidase inhibitors have shown antimicrobial action against distinct microorganisms. Due to an increase in the occurrence of Chagas' disease/AIDS co-infection, we decided to explore the effects of HIV aspartic peptidase inhibitors (HIV-PIs) on Trypanosoma cruzi, the etiologic agent of Chagas' disease. Methodology and Principal Findings: HIV-PIs presented an anti-proliferative action on epimastigotes of T. cruzi clone Dm28c, with IC50 values ranging from 0.6 to 14 mu M. The most effective inhibitors, ritonavir, lopinavir and nelfinavir, also had an anti-proliferative effect against different phylogenetic T. cruzi strains. The HIV-PIs induced some morphological alterations in clone Dm28c epimastigotes, as reduced cell size and swollen of the cellular body. Transmission electron microscopy revealed that the flagellar membrane, mitochondrion and reservosomes are the main targets of HIV-PIs in T. cruzi epimastigotes. Curiously, an increase in the epimastigote-into-trypomastigote differentiation process of clone Dm28c was observed, with many of these parasites presenting morphological alterations including the detachment of flagellum from the cell body. The pretreatment with the most effective HIV-PIs drastically reduced the interaction process between epimastigotes and the invertebrate vector Rhodnius prolixus. It was also noted that HIV-PIs induced an increase in the expression of gp63-like and calpain-related molecules, and decreased the cruzipain expression in epimastigotes as judged by flow cytometry and immunoblotting assays. The hydrolysis of a cathepsin D fluorogenic substrate was inhibited by all HIV-PIs in a dose-dependent manner, showing that the aspartic peptidase could be a possible target to these drugs. Additionally, we verified that ritonavir, lopinavir and nelfinavir reduced drastically the viability of clone Dm28c trypomastigotes, causing many morphological damages. Conclusions and Significance: The results contribute to understand the possible role of aspartic peptidases in T. cruzi physiology, adding new in vitro insights into the possibility of exploiting the use of HIV-PIs in the clinically relevant forms of the parasite.	[Sangenito, Leandro S.; Santos, Andre L. S.; Branquinha, Marta H.] Univ Fed Rio de Janeiro UFRJ, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Lab Invest Peptidases, Rio De Janeiro, Brazil; [Menna-Barreto, Rubem F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Biol Celular, Rio De Janeiro, Brazil; [d'Avila-Levy, Claudia M.] Fiocruz MS, IOC, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Santos, Andre L. S.] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Bioquim, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Branquinha, MH (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Lab Invest Peptidases, Rio De Janeiro, Brazil.	mbranquinha@micro.ufrj.br	Santos, André/Z-5853-2019; Menna-Barreto, Rubem/O-7325-2019; Branquinha, Marta/AAA-3084-2019; d'Avila-Levy, Claudia M/O-7192-2014	Santos, André/0000-0003-0821-8592; Menna-Barreto, Rubem/0000-0002-1352-0641; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Oswaldo Cruz	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2011, BIOCHIM BIOPHYS ACTA, V1824, P195; Alves CR, 2007, EXP PARASITOL, V116, P44, DOI 10.1016/j.exppara.2006.11.012; Alves CR, 2005, EXP PARASITOL, V109, P38, DOI 10.1016/j.exppara.2004.10.005; Alzate JF, 2008, ANTIMICROB AGENTS CH, V52, P3779, DOI 10.1128/AAC.01665-07; Bern C, 2012, CURR OPIN INFECT DIS, V25, P450, DOI 10.1097/QCO.0b013e328354f179; Bisaggio DFR, 2006, ACTA TROP, V98, P162, DOI 10.1016/j.actatropica.2006.04.003; Braga-Silva LA, 2011, CURR MED CHEM, V18, P2401; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Clevenbergh P, 2004, CURR HIV RES, V2, P309, DOI 10.2174/1570162043351129; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Dantas A. P., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P287; de Souza W, 2009, CELL BIO RES PROG, P497; Eder J, 2007, CURR PHARM DESIGN, V13, P271, DOI 10.2174/138161207779313560; Ennes-Vidal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018371; Fampa P, 2003, INT J PARASITOL, V33, P1019, DOI 10.1016/S0020-7519(03)00124-3; Fampa P, 2010, PARASITOL RES, V107, P443, DOI 10.1007/s00436-010-1888-9; Gallo G, 2011, BIOCHEM BIOPH RES CO, V408, P427, DOI 10.1016/j.bbrc.2011.04.038; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Haberland A, 2013, CLIN CHEM LAB MED, V51, P271, DOI 10.1515/cclm-2012-0316; Haynes PA, 1996, J CELL SCI, V109, P2979; Pittella JEH, 2009, T ROY SOC TROP MED H, V103, P973, DOI 10.1016/j.trstmh.2009.04.012; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Kumar P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000642; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mejia AM, 2012, J INFECT DIS, V206, P220, DOI 10.1093/infdis/jis331; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Fidalgo LM, 2011, PHARM RES-DORDR, V28, P2758, DOI 10.1007/s11095-011-0586-3; Murta SMF, 1998, MOL BIOCHEM PARASIT, V93, P203, DOI 10.1016/S0166-6851(98)00037-1; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perteguer MJ, 2013, CELL STRESS CHAPERON, V18, P171, DOI 10.1007/s12192-012-0368-9; Pinho RT, 2009, EXP PARASITOL, V122, P128, DOI 10.1016/j.exppara.2009.02.005; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Salomao K., 2011, EVID-BASED COMPL ALT, V2011; Salomao K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-196; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Sangenito LS, 2012, PARASITOL RES, V110, P2533, DOI 10.1007/s00436-011-2796-3; Santos LO, 2013, CURR MED CHEM, V20, P3116; Santos LO, 2013, J ANTIMICROB CHEMOTH, V68, P348, DOI 10.1093/jac/dks410; Santos LO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004918; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SERRANO AA, 1995, J BIOL CHEM, V270, P27244, DOI 10.1074/jbc.270.45.27244; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Trudel N, 2008, J INFECT DIS, V198, P1292, DOI 10.1086/592280; Uehara LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001958; Valdivieso E, 2007, EXP PARASITOL, V116, P77, DOI 10.1016/j.exppara.2006.10.006; Valdivieso E, 2010, EXP PARASITOL, V126, P557, DOI 10.1016/j.exppara.2010.06.002; Yong V, 2000, MOL BIOCHEM PARASIT, V109, P47, DOI 10.1016/S0166-6851(00)00237-1; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	60	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113957	10.1371/journal.pone.0113957	http://dx.doi.org/10.1371/journal.pone.0113957			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464510	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700074
J	Sun, PF; Fang, WT; Shin, LY; Wei, JY; Fu, SF; Chou, JY				Sun, Pei-Feng; Fang, Wei-Ta; Shin, Li-Ying; Wei, Jyuan-Yu; Fu, Shih-Feng; Chou, Jui-Yu			Indole-3-Acetic Acid-Producing Yeasts in the Phyllosphere of the Carnivorous Plant Drosera indica L.	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; INDOLEACETIC-ACID; RIBOSOMAL DNA; AZOSPIRILLUM-BRASILENSE; ASCOMYCETOUS YEASTS; TRITICUM-AESTIVUM; AUXIN TRANSPORT; GROWTH; FUNGUS; BIOSYNTHESIS	Yeasts are widely distributed in nature and exist in association with other microorganisms as normal inhabitants of soil, vegetation, and aqueous environments. In this study, 12 yeast strains were enriched and isolated from leaf samples of the carnivorous plant Drosera indica L., which is currently threatened because of restricted habitats and use in herbal industries. According to similarities in large subunit and small subunit ribosomal RNA gene sequences, we identified 2 yeast species in 2 genera of the phylum Ascomycota, and 5 yeast species in 5 genera of the phylum Basidiomycota. All of the isolated yeasts produced indole-3-acetic acid (IAA) when cultivated in YPD broth supplemented with 0.1% L-tryptophan. Growth conditions, such as the pH and temperature of the medium, influenced yeast IAA production. Our results also suggested the existence of a tryptophan-independent IAA biosynthetic pathway. We evaluated the effects of various concentrations of exogenous IAA on yeast growth and observed that IAA produced by wild yeasts modifies auxin-inducible gene expression in Arabidopsis. Our data suggest that yeasts can promote plant growth and support ongoing prospecting of yeast strains for inclusion into biofertilizer for sustainable agriculture.	[Sun, Pei-Feng; Shin, Li-Ying; Wei, Jyuan-Yu; Fu, Shih-Feng; Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan; [Fang, Wei-Ta] Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei 116, Taiwan	National Changhua University of Education; National Taiwan Normal University	Chou, JY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan.	jackyjau@cc.ncue.edu.tw			Ministry of Science and Technology [NSC102-2218-E-002-008, NSC102-2311-B018-001-MY2, NSC101-2321-B-018002-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Ministry of Science and Technology (NSC102-2218-E-002-008 to W.-T. Fang; NSC102-2311-B018-001-MY2 to J.-Y. Chou; NSC101-2321-B-018002-MY2 to S.-F. Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004572; Agamy R., 2013, African Journal of Agricultural Research, V8, P46; Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Ali B, 2009, LETT APPL MICROBIOL, V48, P542, DOI 10.1111/j.1472-765X.2009.02565.x; Amprayn KO, 2012, APPL SOIL ECOL, V61, P295, DOI 10.1016/j.apsoil.2011.11.009; Andrews JH, 2002, CAN J MICROBIOL, V48, P500, DOI 10.1139/W02-044; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Anjali Bose, 2013, Mycology - An International Journal on Fungal Biology, V4, P103, DOI 10.1080/21501203.2013.823891; Asirvatham R, 2013, ADV PHARM BULL, V3, P115, DOI 10.5681/apb.2013.019; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; Beeckman T, 2009, ANN PLANT REV; Bjorkman T, 1998, J AM SOC HORTIC SCI, V123, P35, DOI 10.21273/JASHS.123.1.35; Buxdorf K, 2013, PLANT PHYSIOL, V161, P2014, DOI 10.1104/pp.112.212969; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P793, DOI 10.1007/s00253-009-1882-2; Chung KR, 2003, FEMS MICROBIOL LETT, V226, P23, DOI 10.1016/S0378-1097(03)00605-0; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; El-Tarabily KA, 2004, J APPL MICROBIOL, V96, P69, DOI 10.1046/j.1365-2672.2003.02043.x; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Ferreira-Pinto M M, 2006, Commun Agric Appl Biol Sci, V71, P973; Gao M, 2013, MAR POLLUT BULL, V77, P172, DOI 10.1016/j.marpolbul.2013.10.008; Ghareeb H, 2011, PLANT PHYSIOL, V156, P2037, DOI 10.1104/pp.111.179499; GOPINATHAN S, 1992, Indian Journal of Experimental Biology, V30, P142; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GUNASEKARAN M, 1978, MICROBIOS, V22, P85; Hasan H. A. H., 2002, Acta Microbiologica et Immunologica Hungarica, V49, P105, DOI 10.1556/AMicr.49.2002.1.11; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jayaram K, 2006, CURR SCI INDIA, V91, P943; Jayaram K, 2007, PLANT BIOTECHNOL REP, V1, P79, DOI 10.1007/s11816-007-0014-7; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jian OY, 2000, PLANT J, V24, P327, DOI 10.1046/j.1365-313x.2000.00883.x; Kachalkin AV, 2008, MICROBIOLOGY+, V77, P474, DOI 10.1134/S0026261708040140; Kaewchai S, 2009, FUNGAL DIVERS, V38, P25; Kawagishi H, 2006, BIOSCI BIOTECH BIOCH, V70, P2800, DOI 10.1271/bbb.60376; Kulkarni GB, 2013, APPL BIOCHEM BIOTECH, V169, P1292, DOI 10.1007/s12010-012-0037-6; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; KVASNIKOV E I, 1975, Mikrobiologiya, V44, P339; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Limtong S, 2014, WORLD J MICROB BIOT, V30, P1785, DOI 10.1007/s11274-014-1602-7; Limtong S, 2012, WORLD J MICROB BIOT, V28, P3323, DOI 10.1007/s11274-012-1144-9; Liu P, 2006, P NATL ACAD SCI USA, V103, P4658, DOI 10.1073/pnas.0600366103; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McGrath MJ, 2007, APPL ENVIRON MICROB, V73, P1277, DOI 10.1128/AEM.01620-06; McGrath MJ, 2006, APPL ENVIRON MICROB, V72, P6234, DOI 10.1128/AEM.00744-06; McSteen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001479; Medeiros AO, 2012, BRAZ J MICROBIOL, V43, P1582, DOI [10.1590/S1517-83822012000400043, 10.1590/S1517-838220120004000043]; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Miller WG, 2001, APPL ENVIRON MICROB, V67, P1308, DOI 10.1128/AEM.67.3.1308-1317.2001; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Radhakrishnan R, 2013, J MICROBIOL BIOTECHN, V23, P856, DOI 10.4014/jmb.1209.09045; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Robiglio A, 2011, INT J FOOD MICROBIOL, V147, P211, DOI 10.1016/j.ijfoodmicro.2011.04.007; Ruanpanun P, 2010, WORLD J MICROB BIOT, V26, P1569, DOI 10.1007/s11274-010-0332-8; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SHIN M, 1991, CHEM PHARM BULL, V39, P1792; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen Stijn, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001438; STRZELCZYK E, 1993, SYMBIOSIS, V14, P201; Tada R, 2009, INT IMMUNOPHARMACOL, V9, P1431, DOI 10.1016/j.intimp.2009.08.014; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vande Broek A, 2005, MOL PLANT MICROBE IN, V18, P311, DOI 10.1094/MPMI-18-0311; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Waqas M, 2012, MOLECULES, V17, P10754, DOI 10.3390/molecules170910754; Woody ST, 2003, APPL ENVIRON MICROB, V69, P4892, DOI 10.1128/AEM.69.8.4892-4900.2003; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yazdani M., 2011, Advances in Environmental Biology, V5, P2182; YU PH, 1970, BOT BULL ACAD SINICA, V11, P98; Zakharova EA, 1999, EUR J BIOCHEM, V259, P572, DOI 10.1046/j.1432-1327.1999.00033.x; Zhang JZ, 2012, MYCOL PROG, V11, P499, DOI 10.1007/s11557-011-0765-y; Zhang R, 2008, J INTEGR PLANT BIOL, V50, P1070, DOI 10.1111/j.1744-7909.2008.00729.x	85	88	90	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114196	10.1371/journal.pone.0114196	http://dx.doi.org/10.1371/journal.pone.0114196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464336	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700113
J	Wallock-Richards, D; Doherty, CJ; Doherty, L; Clarke, DJ; Place, M; Govan, JRW; Campopiano, DJ				Wallock-Richards, Daynea; Doherty, Catherine J.; Doherty, Lynsey; Clarke, David J.; Place, Marc; Govan, John R. W.; Campopiano, Dominic J.			Garlic Revisited: Antimicrobial Activity of Allicin-Containing Garlic Extracts against Burkholderia cepacia Complex	PLOS ONE			English	Article							CYSTIC-FIBROSIS; ANTIBACTERIAL PRINCIPLE; INFECTION; EPIDEMIOLOGY; INHIBITION; ALLIINASE; PRODUCTS; AJOENE; GROWTH	The antimicrobial activities of garlic and other plant alliums are primarily based on allicin, a thiosulphinate present in crushed garlic bulbs. We set out to determine if pure allicin and aqueous garlic extracts (AGE) exhibit antimicrobial properties against the Burkholderia cepacia complex (Bcc), the major bacterial phytopathogen for alliums and an intrinsicallymultiresistant and life-threatening human pathogen. We prepared an AGE from commercial garlic bulbs and used HPLC to quantify the amount of allicin therein using an aqueous allicin standard (AAS). Initially we determined the minimum inhibitory concentrations (MICs) of the AGE against 38 Bcc isolates; these MICs ranged from 0.5 to 3% (v/v). The antimicrobial activity of pure allicin (AAS) was confirmed by MIC and minimum bactericidal concentration (MBC) assays against a smaller panel of five Bcc isolates; these included three representative strains of the most clinically important species, B. cenocepacia. Time kill assays, in the presence of ten times MIC, showed that the bactericidal activity of AGE and AAS against B. cenocepacia C6433 correlated with the concentration of allicin. We also used protein mass spectrometry analysis to begin to investigate the possible molecular mechanisms of allicin with a recombinant form of a thiol-dependent peroxiredoxin (BCP, Prx) from B. cenocepacia. This revealed that AAS and AGE modifies an essential BCP catalytic cysteine residue and suggests a role for allicin as a general electrophilic reagent that targets protein thiols. To our knowledge, we report the first evidence that allicin and allicin-containing garlic extracts possess inhibitory and bactericidal activities against the Bcc. Present therapeutic options against these lifethreatening pathogens are limited; thus, allicin-containing compounds merit investigation as adjuncts to existing antibiotics.	[Doherty, Catherine J.; Doherty, Lynsey; Place, Marc; Govan, John R. W.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Wallock-Richards, Daynea; Clarke, David J.; Campopiano, Dominic J.] Univ Edinburgh, EastChem Sch Chem, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Govan, JRW (corresponding author), Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland.	john.r.w.govan@ed.ac.uk; Dominic.Campopiano@ed.ac.uk	Wallock-Richards, Daynea/AAW-2062-2021	Clarke, David/0000-0002-3741-2952; Campopiano, Dominic/0000-0001-8573-6735	University of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/I013687/1]; Biotechnology and Biological Sciences Research Council [BB/I013687/1] Funding Source: researchfish; BBSRC [BB/I013687/1] Funding Source: UKRI	University of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: The authors thank The University of Edinburgh for funding a PhD School of Chemistry Tercentenary studentship (DWR). The authors also thank the Biotechnology and Biological Sciences Research Council (BBSRC) UK for funding (award number BB/I013687/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashry NA, 2013, PHARM BIOL, V51, P806, DOI 10.3109/13880209.2013.766895; Balfour-Lynn IM, 2014, J CYST FIBROS, V13, P241, DOI 10.1016/j.jcf.2014.01.003; Banerjee SK, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-4; Block E., 2010, GARLIC OTHER ALLIUMS; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; CAVALLITO CJ, 1945, J AM CHEM SOC, V67, P1032, DOI 10.1021/ja01222a501; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1952, DOI 10.1021/ja01239a049; Clarke DJ, 2010, BIOCHEMISTRY-US, V49, P1319, DOI 10.1021/bi901703m; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; FELDBERG RS, 1988, ANTIMICROB AGENTS CH, V32, P1763, DOI 10.1128/AAC.32.12.1763; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FOCKE M, 1990, FEBS LETT, V261, P106, DOI 10.1016/0014-5793(90)80647-2; Fujisawa H, 2008, J AGR FOOD CHEM, V56, P4229, DOI 10.1021/jf8000907; Fujisawa H, 2009, BIOSCI BIOTECH BIOCH, V73, P1948, DOI 10.1271/bbb.90096; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Greenberg DE, 2009, CLIN INFECT DIS, V48, P1577, DOI 10.1086/598937; Grimwood K, 2009, J CYST FIBROS, V8, P291, DOI 10.1016/j.jcf.2009.04.002; Holmes A, 1998, EMERG INFECT DIS, V4; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Horsley A, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00018; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kyung KH, 2012, CURR OPIN BIOTECH, V23, P142, DOI 10.1016/j.copbio.2011.08.004; Lawson LD, 2001, J AGR FOOD CHEM, V49, P2592, DOI 10.1021/jf001287m; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mahenthiralingam E, 2011, CHEM BIOL, V18, P665, DOI 10.1016/j.chembiol.2011.01.020; Mil-Homens D, 2012, FEMS MICROBIOL LETT, V328, P61, DOI 10.1111/j.1574-6968.2011.02476.x; Miron T, 2010, EUR J MED CHEM, V45, P1912, DOI 10.1016/j.ejmech.2010.01.031; Naganawa R, 1996, APPL ENVIRON MICROB, V62, P4238, DOI 10.1128/AEM.62.11.4238-4242.1996; National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L, V17, P1; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Papaleo MC, 2012, BIOTECHNOL ADV, V30, P272, DOI 10.1016/j.biotechadv.2011.06.011; Schwan WR, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-4; Shimon LJW, 2007, J MOL BIOL, V366, P611, DOI 10.1016/j.jmb.2006.11.041; SMALL LD, 1947, J AM CHEM SOC, V69, P1710, DOI 10.1021/ja01199a040; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Taylor K, 2007, ANTIMICROB AGENTS CH, V51, P1719, DOI 10.1128/AAC.01531-06; Tullis DE, 2014, J CYST FIBROS, V13, P296, DOI 10.1016/j.jcf.2013.08.011; Waag T, 2010, BIOORG MED CHEM LETT, V20, P5541, DOI 10.1016/j.bmcl.2010.07.062; Waters Valerie, 2006, Expert Rev Anti Infect Ther, V4, P807, DOI 10.1586/14787210.4.5.807; Zhang LL, 2013, FOOD FUNCT, V4, P1229, DOI 10.1039/c3fo60057b	46	60	64	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112726	10.1371/journal.pone.0112726	http://dx.doi.org/10.1371/journal.pone.0112726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438250	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900016
J	Nie, G; Wang, T; Lu, SJ; Liu, WQ; Li, YL; Lei, JH				Nie, Ge; Wang, Ting; Lu, Shengjun; Liu, Wenqi; Li, Yonglong; Lei, Jiahui			Detection of Clonorchis sinensis Circulating Antigen in Sera from Chinese Patients by Immunomagnetic Bead ELISA Based on IgY	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SCHISTOSOMA-JAPONICUM; CYSTEINE PROTEINASE; CAPTURE ELISA; PCR ASSAY; INFECTION; DIAGNOSIS; SERODIAGNOSIS; EXPRESSION; SAMPLES	Background: Clonorchiasis, caused by Clonorchis sinensis, is widely distributed in Southeast Asia including China. Clonorchiasis is included in control programs of neglected tropical diseases by World Health Organization (WHO) because it is one of the major health problems in most endemic areas. Diagnosis of clonorchiasis plays a key role in the control programs. However, so far, there is no satisfactory method for clonorchiasis because of low sensitivity, poor practicality and high false positivity of available diagnostic tools. Methodology/Principal Findings: We developed an immunomagnetic bead enzyme-linked immunosorbent assay (ELISA) based on IgY (egg yolk immunoglobulin) against cysteine proteinase of C. sinensis for detection of circulating antigen in serum samples of patients infected with C. sinensis. The polyclonal IgY, coated with magnetic beads, was used as a capture antibody and a monoclonal IgG labeled with horseradish peroxidase as a detection antibody in the IgY-based immunomagnetic bead ELISA system (IgY-IMB-ELISA). The results showed that the sensitivity of IgY-IMB-ELISA was 93.3% (14 of 15) in cases of heavy infection (5000 to 9999 eggs per gram feces, i.e, EPG 5000-9999), 86.7% (13 of 15) in cases of moderate infection (EPG 1000-4999) and 75.0% (9 of 12) in cases of light infection (EPG,1000) of clonorchiasis. Together 36 of total 42 (85.7%) serum samples of human clonorchiasis gave a positive reaction. There was a significant correlation between ELISA optical density and egg counts (EPG) with a correlation coefficient of 0.83 in total 42 patients. There were no positive results in patients with trichinosis (n=10) or cysticercosis (n=10). Cross-reactivity was 6.7% (2 of 30) with schistosomiasis japonica and 10.0% (3 of 30) with paragonimiasis, respectively. No positive reaction was found in 20 healthy persons. Conclusions: Our findings suggest that IgY-IMB-ELISA appears to be a sensitive and specific assay for detection of circulating antigen in human clonorchiasis.	[Nie, Ge; Wang, Ting; Lu, Shengjun; Liu, Wenqi; Li, Yonglong; Lei, Jiahui] Huazhong Univ Sci & Technol, Dept Parasitol, Sch Basic Med, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Lei, JH (corresponding author), Huazhong Univ Sci & Technol, Dept Parasitol, Sch Basic Med, Tongji Med Coll, Wuhan 430074, Peoples R China.	leijiahui@hust.edu.cn	Lei, Jiahui/HGV-0100-2022		Development Program of China (973 program) [2010CB530000]	Development Program of China (973 program)(National Basic Research Program of China)	This work was supported by Development Program of China (973 program; No. 2010CB530000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen YT, 1984, CHIN J INFECT DIS, V2, P88; Conlan JV, 2009, TROP ANIM HEALTH PRO, V41, P913, DOI 10.1007/s11250-008-9279-2; da Silva WD, 2010, VET IMMUNOL IMMUNOP, V135, P173, DOI 10.1016/j.vetimm.2009.12.011; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Gessler F, 2006, DIAGN MICR INFEC DIS, V56, P225, DOI 10.1016/j.diagmicrobio.2006.04.014; Han S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046977; HONG S-T, 1988, Korean Journal of Parasitology, V26, P1, DOI 10.3347/kjp.1988.26.1.1; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000312; Huang MJ, 1994, BEIJING MED J, V16, P11; Huang SY, 2012, PARASITOL INT, V61, P187, DOI 10.1016/j.parint.2011.07.010; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Juliarena M, 2007, VET RES COMMUN, V31, P43, DOI 10.1007/s11259-006-3422-1; Keiser J, 2010, CURR OPIN INFECT DIS, V23, P513, DOI 10.1097/QCO.0b013e32833de06a; Kessel M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008194; Kim JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001339; Lee JJ, 2012, KOREAN J PARASITOL, V50, P207, DOI 10.3347/kjp.2012.50.3.207; Lee JS, 2006, VACCINE, V24, P2358, DOI 10.1016/j.vaccine.2005.11.062; Lei JH, 2011, AM J TROP MED HYG, V85, P1054, DOI 10.4269/ajtmh.2011.11-0051; Lei JH, 2009, ACTA TROP, V111, P39, DOI 10.1016/j.actatropica.2009.02.012; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; Li Shunyu, 2004, Parasitol Res, V93, P36, DOI 10.1007/s00436-004-1097-5; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Luo JM, 1992, CHIN J ZOONOSES, V8, P27; Lv XL, 2012, PARASITOL RES, V110, P2211, DOI 10.1007/s00436-011-2751-3; Marcos LA, 2008, CURR OPIN INFECT DIS, V21, P523, DOI 10.1097/QCO.0b013e32830f9818; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; Nagano I, 2004, CLIN DIAGN LAB IMMUN, V11, P411, DOI 10.1128/CDLI.11.2.411-416.2004; Ohnishi T, 2000, J IMMUNOL METHODS, V244, P163, DOI 10.1016/S0022-1759(00)00252-0; Pei FuQuan, 2004, Journal of Tropical Medicine (Guangzhou), V4, P10; Qian MB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001377; Qiao T, 2012, PARASITOL RES, V111, P1497, DOI 10.1007/s00436-012-2986-7; Rahman SMM, 2012, PARASITOL INT, V61, P203, DOI 10.1016/j.parint.2011.08.006; Safarik Ivo, 2004, Biomagn Res Technol, V2, P7, DOI 10.1186/1477-044X-2-7; SITHITHAWORN P, 1991, PARASITOLOGY, V102, P277, DOI 10.1017/S0031182000062594; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Teixeira CF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000073; Toledo R, 2012, EUR J CLIN MICROBIOL, V31, P1705, DOI 10.1007/s10096-011-1515-4; Wang Cheng-zu, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P193; Zhang YueQing, 1995, Chinese Journal of Parasitic Disease Control, V8, P51; Zhao QP, 2004, CLIN DIAGN LAB IMMUN, V11, P814, DOI 10.1128/CDLI.11.4.814-817.2004	42	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113208	10.1371/journal.pone.0113208	http://dx.doi.org/10.1371/journal.pone.0113208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474577	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500078
J	Stepanian, A; Alcais, A; de Prost, D; Tsatsaris, V; Dreyfus, M; Treluyer, JM; Mandelbrot, L				Stepanian, Alain; Alcais, Alexandre; de Prost, Dominique; Tsatsaris, Vassilis; Dreyfus, Michel; Treluyer, Jean-Marc; Mandelbrot, Laurent		ECLAXIR Study Grp	Highly Significant Association between Two Common Single Nucleotide Polymorphisms in CORIN Gene and Preeclampsia in Caucasian Women	PLOS ONE			English	Article							SERINE-PROTEASE; HYPERTENSION; ALLELE	Preeclampsia is a frequent medical complication during pregnancy. Corin, a serine protease which activates pro-atrial natriuretic peptide, has recently been shown to be involved in the pathophysiology of preeclampsia. The aim of this study was to search for CORIN gene variations and their association to preeclampsia in Caucasian and African women. Our study population was composed of 571 pregnant women (295 with preeclampsia and 276 normotensive controls) matched for maternal and gestational age, and ethnic origin. The 22 exons of the CORIN gene were sequenced in a discovery sample (n=260), where 31 single nucleotide polymorphisms were identified. In a replication sample (n=311), 4 single nucleotide polymorphisms were tested. Two minor alleles (C for rs2271036 and G for rs2271037) were significantly associated to preeclampsia. Adjusted odds ratios [95% confidence interval] were 2.5 [1.2-3.8] (p=0.007) and 2.3 [1.5-3.5] (p=1.3 x 10(-4)), respectively. These associations were ethnic-specific, as only found in the Caucasian of subjects (odds ratio=3.5 [1.8-6.6], p=1.1 x 10(-4); odds ratio=3.1 [1.7-5.8], p=2.1 x 10(-4), for each single nucleotide polymorphism, respectively). The two single nucleotide polymorphisms are in almost perfect linkage disequilibrium (r(2)=0.93). No specific association was found with severe preeclampsia, early-onset preeclampsia nor fetal growth retardation. In conclusion, this is the first report of a highly significant association between these two single nucleotide polymorphisms in CORIN gene and preeclampsia. Our findings further support the probability of a critical role of corin in preeclamspia pathophysiology at the uteroplacental interface.	[Stepanian, Alain] Hop Lariboisiere, Serv Hematol Biol, F-75475 Paris, France; [Alcais, Alexandre] INSERM, Lab Human Genet Infect Dis, Necker Branch, U1163,Imagine Inst, Paris, France; [Alcais, Alexandre; Treluyer, Jean-Marc] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Alcais, Alexandre] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [de Prost, Dominique] Hop Louis Mourier, AP HP, Serv Hematol Biol & Transfus, F-92701 Colombes, France; [de Prost, Dominique] INSERM, Unite 770, F-94275 Le Kremlin Bicetre, France; [Tsatsaris, Vassilis] Hop Port Royal, AP HP, Serv Gynecol Obstet, Paris, France; [Tsatsaris, Vassilis] Univ Paris 05, INSERM, Unite 767, Paris, France; [Tsatsaris, Vassilis; Treluyer, Jean-Marc; Mandelbrot, Laurent] Dept Hosp Univ Risque & Grossesse, Paris, France; [Tsatsaris, Vassilis] Fondat PremUP, Paris, France; [Dreyfus, Michel] CHU Clemenceau, Unite Gynecol Obstet & Med Reprod, Caen, France; [Alcais, Alexandre; Treluyer, Jean-Marc] INSERM CIC P0901, Paris, France; [de Prost, Dominique; Mandelbrot, Laurent] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mandelbrot, Laurent] Hop Louis Mourier, AP HP, Serv Gynecol Obstet, F-92701 Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Mandelbrot, L (corresponding author), Dept Hosp Univ Risque & Grossesse, Paris, France.	laurent.mandelbrot@lmr.aphp.fr	treluyer, Jean-Marc/F-8036-2010; Mandelbrot, Laurent/AAD-3554-2019; Alcais, Alexandre/J-5882-2017	Mandelbrot, Laurent/0000-0002-5883-7597; Alcais, Alexandre/0000-0002-1012-2226; Stepanian, Alain/0000-0002-2942-0901	regional Programme Hospitalier de Recherche Clinique [P020925]; Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique) [08078]	regional Programme Hospitalier de Recherche Clinique; Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique)	This work was supported by a research grant from the regional Programme Hospitalier de Recherche Clinique, #P020925, and a grant from Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique, #08078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Anselem O, 2011, INT J GYNECOL OBSTET, V115, P153, DOI 10.1016/j.ijgo.2011.06.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Buurma AJ, 2013, HUM REPROD UPDATE, V19, P289, DOI 10.1093/humupd/dms060; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Jebbink J, 2012, BBA-MOL BASIS DIS, V1822, P1960, DOI 10.1016/j.bbadis.2012.08.004; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Stepanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006192; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097	26	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113176	10.1371/journal.pone.0113176	http://dx.doi.org/10.1371/journal.pone.0113176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474356	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500076
J	Wollman, I; Fritz, C; Poitevineau, J; McAdams, S				Wollman, Indiana; Fritz, Claudia; Poitevineau, Jacques; McAdams, Stephen			Investigating the Role of Auditory and Tactile Modalities in Violin Quality Evaluation	PLOS ONE			English	Article							VIBRATION SENSATION; PIANO PERFORMANCE; FEEDBACK; ACOUSTICS; COORDINATION	The role of auditory and tactile modalities involved in violin playing and evaluation was investigated in an experiment employing a blind violin evaluation task under different conditions: i) normal playing conditions, ii) playing with auditory masking, and iii) playing with vibrotactile masking. Under each condition, 20 violinists evaluated five violins according to criteria related to violin playing and sound characteristics and rated their overall quality and relative preference. Results show that both auditory and vibrotactile feedback are important in the violinists' evaluations but that their relative importance depends on the violinist, the violin and the type of evaluation (different criteria ratings or preference). In this way, the overall quality ratings were found to be accurately predicted by the rating criteria, which also proved to be perceptually relevant to violinists, but were poorly correlated with the preference ratings; this suggests that the two types of ratings (overall quality vs preference) may stem from different decision-making strategies. Furthermore, the experimental design confirmed that violinists agree more on the importance of criteria in their overall evaluation than on their actual ratings for different violins. In particular, greater agreement was found on the importance of criteria related to the sound of the violin. Nevertheless, this study reveals that there are fundamental differences in the way players interpret and evaluate each criterion, which may explain why correlating physical properties with perceptual properties has been challenging so far in the field of musical acoustics.	[Wollman, Indiana; Fritz, Claudia; Poitevineau, Jacques] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7190,Inst Jean le Rond, F-75015 Paris, France; [McAdams, Stephen] McGill Univ, Schulich Sch Mus, Montreal, PQ H3A 1E3, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; McGill University	Wollman, I (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, UMR 7190,Inst Jean le Rond, F-75015 Paris, France.	wollman@lam.jussieu.fr	McAdams, Stephen/GQB-0225-2022; Fritz, Claudia/E-9260-2019	McAdams, Stephen/0000-0002-6744-9035	Canadian Natural Sciences and Engineering Research Council [RGPIN 312774-2010]; Canada Research Chairs Program [950-223484]; UPMC-Ministry of Higher Education and Research, France	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); UPMC-Ministry of Higher Education and Research, France	This work was supported in part by grants from the Canadian Natural Sciences and Engineering Research Council (# RGPIN 312774-2010) and the Canada Research Chairs Program (#950-223484) to SM. IW was a recipient of a PhD fellowship from UPMC-Ministry of Higher Education and Research, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKENFELT A, 1992, MUSIC PERCEPT, V9, P311; Baader AP, 2005, COGNITIVE BRAIN RES, V23, P436, DOI 10.1016/j.cogbrainres.2004.11.008; Banton LJ, 1995, PSYCHOL MUSIC, V23, P3, DOI DOI 10.1177/0305735695231001; Bissinger G, 2004, ACTA ACUST UNITED AC, V90, P590; Bissinger G, 2008, J ACOUST SOC AM, V124, P1764, DOI 10.1121/1.2956478; Dunnwald H, 1991, J CATGUT ACOUSTICAL, P1; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Florens J-L, 2004, 5 INT GEST WORKSH, P487; Fritz C, 2012, P NATL ACAD SCI USA, V109, P760, DOI 10.1073/pnas.1114999109; Fritz C, 2010, J ACOUST SOC AM, V127, P513, DOI 10.1121/1.3266684; Fulford R, 2012, P 12 INT C MUS PERC, P335; Galembo Alexander, 2001, P INT WORKSH HUM SUP, P257; GATES A, 1974, PERCEPT PSYCHOPHYS, V16, P105, DOI 10.3758/BF03203260; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Gordon E.E., 1993, LEARNING SEQUENCES M, V6th; Hollerbach JM, 1990, VISUAL COGNITION ACT, P213; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; Hutchins C. M., 1985, J CATGUT ACOUST SOC, V44, P12; Keele S.W., 1973, ATTENTION HUMAN PERF; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lecoutre B, 1992, PAC PROGRAMME ANAL C; Marshall K. D., 1986, J CATGUT ACOUST SOC, V45, P28; MARSHALL KD, 1985, J ACOUST SOC AM, V77, P695, DOI 10.1121/1.392338; Nichols C, 2002, ORGAN SOUND, V7, P215, DOI DOI 10.1017/S135577180200211X; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Rouanet H, 2000, NEW WAYS STAT METHOD; Saitis C, 2013, P STOCKH MUS AC C ST, P123; Saitis C, 2012, J ACOUST SOC AM, V132, P4002, DOI 10.1121/1.4765081; Shliesser HF, 1968, PERCEPT MOTOR SKILL, V26, P275; Sinclair S., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P463, DOI 10.1109/WHC.2011.5945530; VERRILLO RT, 1962, J ACOUST SOC AM, V34, P1768, DOI 10.1121/1.1909124; VERRILLO RT, 1992, MUSIC PERCEPT, V9, P281; Weisenberger JM, 2008, BLACKWELL HDB SENSAT; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wills R., 2007, P 8 WORLD SCI ENG AC, P1; Woodhouse J, 1998, ACUSTICA, V84, P947	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112552	10.1371/journal.pone.0112552	http://dx.doi.org/10.1371/journal.pone.0112552			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474036	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500073
J	Landman, NH; Mapes, RH; Cochran, JK; Lignier, V; Hembree, DI; Goiran, C; Folcher, E; Brunet, P				Landman, Neil H.; Mapes, Royal H.; Cochran, J. Kirk; Lignier, Vincent; Hembree, Daniel I.; Goiran, Claire; Folcher, Eric; Brunet, Philippe			An Unusual Occurrence of Nautilus macromphalus in a Cenote in the Loyalty Islands (New Caledonia)	PLOS ONE			English	Article							POMPILIUS; CEPHALOPODA; TAPHONOMY; ISOTOPE; SHELLS; LEVEL; CAVES	Exploration of a landlocked cenote on Lifou (Loyalty Islands) revealed 37 shells of the cephalopod Nautilus macromphalus Sowerby, 1849, in saltwater on the cenote floor, approximately 40 m below the water surface. The occurrence of these shells is unusual because N. macromphalus is restricted to the open marine waters surrounding the island. All of the shells are mature, and nearly all of them are unbroken, with faded red-brown color stripes. We analyzed seven shells to determine their age. Radiocarbon dating yielded ages of 6380 +/- 30 to 7095 +/- 30 y BP. The U-238-series radionuclides Pb-210 (half-life = 522.3 y) and Ra-226 (half-life 51600 y) also were measured. Two of the samples showed radioactive equilibrium between the nuclides, consistent with the old radiocarbon dates, but the other five samples showed excess Pb-210. When corrected for radioactive decay, the Ra-226 activities were much greater than those found in living Nautilus. We conclude that exposure to high activities of Rn-222 and Ra-226 in the salty groundwater of the cenote altered the activities originally incorporated into the shells. Human placement of the shells in the cavity is rejected based on their radiocarbon age and the geometry of the cenote. The most probable explanation is that the animals entered the flooded karstic system through a connection on the seaward side at approximately 7,000 y BP, during an interval of slowly rising sea level. Unable to find an exit and/or due to anoxic bottom waters, the animals were trapped and died inside. The open connection with the sea persisted for similar to 700 y, but after similar to 6400 y BP, the connection was lost, probably due to a roof collapse. This is a rare example of Nautilus in a karstic coastal basin and provides a minimum age for the appearance of N. macromphalus in the Loyalty Islands.	[Landman, Neil H.] Amer Museum Nat Hist, Div Paleontol Invertebrates, New York, NY 10024 USA; [Mapes, Royal H.; Hembree, Daniel I.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Cochran, J. Kirk] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Lignier, Vincent] Univ Nouvelle Caledonie, Lab PPME, Noumea 98851, New Caledonia; [Goiran, Claire] Univ Nouvelle Caledonie, Labex Corail, Noumea 98851, New Caledonia; [Goiran, Claire] Univ Nouvelle Caledonie, LIVE, Noumea 98851, New Caledonia; [Brunet, Philippe] Inst Rech Dev, Noumea 98848, New Caledonia	American Museum of Natural History (AMNH); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite Nouvelle Caledonie; Universite Nouvelle Caledonie; Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Landman, NH (corresponding author), Amer Museum Nat Hist, Div Paleontol Invertebrates, New York, NY 10024 USA.	landman@amnh.org	Goiran, Claire/Y-5201-2019; Goiran, Claire/L-1257-2015	Goiran, Claire/0000-0002-1649-4418; Goiran, Claire/0000-0002-1649-4418; Hembree, Daniel/0000-0003-3630-7541	Ohio University; Laboratoire PPME, Universite de la Nouvelle Caledonie; N.D. Newell Fund at the American Museum of Natural History; Eramet-Societe Le Nickel, a mining company in New Caledonia; Betco2, a marine transport company	Ohio University; Laboratoire PPME, Universite de la Nouvelle Caledonie; N.D. Newell Fund at the American Museum of Natural History; Eramet-Societe Le Nickel, a mining company in New Caledonia; Betco2, a marine transport company	Funding: Ohio University supported shipping the specimens from New Caledonia to Ohio University. R. H. Mapes and D. I. Hembree were supported by the Baker Grant at Ohio University. V. Lignier was supported by the Laboratoire PPME, Universite de la Nouvelle Caledonie. The radiometric analyses were supported by the N.D. Newell Fund at the American Museum of Natural History. The French Federation of Speleology helped support the dive in 2009. Additional funding for the dive in 2011 was provided by the Eramet-Societe Le Nickel, a mining company in New Caledonia, and Betco2, a marine transport company operating between Noumea and the Loyalty Islands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; CHAMBERLAIN JA, 1981, PALEOBIOLOGY, V7, P494, DOI 10.1017/S0094837300025549; Cochran JK, 2010, AM J SCI, V310, P69, DOI 10.2475/02.2010.01; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; Genthon P, 2008, CR GEOSCI, V340, P513, DOI 10.1016/j.crte.2008.06.002; Gonneea ME, 2014, GEOCHIM COSMOCHIM AC, V132, P31, DOI 10.1016/j.gca.2014.01.037; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Iliffe TM, 1990, NSS NEWS, V48, P88; Mapes RH, 2010, PALAIOS, V25, P597, DOI 10.2110/palo.2009.p09-109r; Mapes RH, 2010, PALAIOS, V25, P656, DOI 10.2110/palo.2010.p10-010r; MARSHALL JF, 1978, QUATERNARY RES, V9, P186, DOI 10.1016/0033-5894(78)90066-2; Sand C, 2006, ANTIQUITY, V80, P523, DOI 10.1017/S0003598X0009400X; Saunders W. B., 1987, NAUTILUS BIOL PALEOB, P137, DOI DOI 10.1007/978-1-4899-5040-6_9; Smart PL, 2006, GEOL SOC AM SPEC PAP, V404, P105, DOI 10.1130/2006.2404(10); Sowerby G.B., 1849, THESAURUS CONCHYLIOR, V2, P463; STOCK JH, 1986, STYGOLOGIA, V2, P90; Stock JH, 1995, CONTRIB ZOOL, V65, P245; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thomas C, 1987, GROTTES NOUVELLE CAL, P1; van Hengstum PJ, 2011, MAR GEOL, V286, P35, DOI 10.1016/j.margeo.2011.05.004; Wani R, 2008, PALEONTOL RES, V12, P89, DOI 10.2517/1342-8144(2008)12[89:FDOFNP]2.0.CO;2; WARD P, 1980, VELIGER, V23, P119; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1983, CEPHALOPOD LIFE CYCL, V1, P11; Willey A., 1899, Proceedings of the Zoological Society of London, P7	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113372	10.1371/journal.pone.0113372	http://dx.doi.org/10.1371/journal.pone.0113372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470257	Green Published, gold			2022-12-27	WOS:000349128700025
J	Leclere, C; Viaux, S; Avril, M; Achard, C; Chetouani, M; Missonnier, S; Cohen, D				Leclere, Chloe; Viaux, Sylvie; Avril, Marie; Achard, Catherine; Chetouani, Mohamed; Missonnier, Sylvain; Cohen, David			Why Synchrony Matters during Mother-Child Interactions: A Systematic Review	PLOS ONE			English	Review							PARENT-INFANT SYNCHRONY; TO-FACE INTERACTION; DYADIC SYNCHRONY; NONDEPRESSED MOTHERS; GENDER-DIFFERENCES; PREVERBAL INFANTS; YOUNG-CHILDREN; FATHER-INFANT; COORDINATION; ATTACHMENT	Background: Assessment of mother-child interactions is a core issue of early child development and psychopathology. This paper focuses on the concept of "synchrony'' and examines (1) how synchrony in mother-child interaction is defined and operationalized; (2) the contribution that the concept of synchrony has brought to understanding the nature of mother-child interactions. Method: Between 1977 and 2013, we searched several databases using the following key-words: "synchrony" "interaction" and "mother-child". We focused on studies examining parent-child interactions among children aged 2 months to 5 years. From the 63 relevant studies, we extracted study description variables (authors, year, design, number of subjects, age); assessment conditions and modalities; and main findings. Results: The most common terms referring to synchrony were mutuality, reciprocity, rhythmicity, harmonious interaction, turn-taking and shared affect; all terms were used to characterize the mother-child dyad. As a consequence, we propose defining synchrony as a dynamic and reciprocal adaptation of the temporal structure of behaviors and shared affect between interactive partners. Three main types of assessment methods for studying synchrony emerged: (1) global interaction scales with dyadic items; (2) specific synchrony scales; and (3) microcoded time-series analyses. It appears that synchrony should be regarded as a social signal per se as it has been shown to be valid in both normal and pathological populations. Better mother-child synchrony is associated with familiarity (vs. unknown partner), a healthy mother (vs. pathological mother), typical development (vs. psychopathological development), and a more positive child outcomes. Discussion: Synchrony is a key feature of mother-infant interactions. Adopting an objective approach in studying synchrony is not a simple task given available assessment tools and due to its temporality and multimodal expression. We propose an integrative approach combining clinical observation and engineering techniques to improve the quality of synchrony analysis.	[Leclere, Chloe; Viaux, Sylvie; Avril, Marie; Achard, Catherine; Chetouani, Mohamed; Cohen, David] Univ Paris 06, CNRS, UMR 7222, Inst Syst Intelligents & Robot, Paris, France; [Leclere, Chloe; Viaux, Sylvie; Cohen, David] Hop La Pitie Salpetriere, AP HP, Dept Psychiat Enfant & Adolescent, Paris, France; [Leclere, Chloe; Missonnier, Sylvain] Univ Paris 05, Dept Psychopathol, Boulogne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Cohen, D (corresponding author), Univ Paris 06, CNRS, UMR 7222, Inst Syst Intelligents & Robot, Paris, France.	david.cohen@psl.aphp.fr	sylvie, viaux/ABE-4705-2021; Achard, Catherine/AAK-2130-2021; CHETOUANI, Mohamed/F-5854-2010	sylvie, viaux/0000-0002-4555-3499; CHETOUANI, Mohamed/0000-0002-2920-4539; MISSONNIER, Sylvain/0000-0003-4875-2642	Agence Nationale de la Recherche [ANR-12-SAMA-006]; Groupement de Recherche en Psychiatrie [GDR-3557]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Groupement de Recherche en Psychiatrie	Funding: The study was supported by the Agence Nationale de la Recherche (ANR-12-SAMA-006) and the Groupement de Recherche en Psychiatrie (GDR-3557). The sponsors had no involvement in the study design, data analysis, or interpretation of results.	Abraham E, 2014, P NATL ACAD SCI; Als H, 1978, Monogr Soc Res Child Dev, V43, P14, DOI 10.2307/1165848; Ambrose HN, 2013, EARLY CHILD DEV CARE, V183, P207, DOI 10.1080/03004430.2012.669756; [Anonymous], 1986, RHYTHM PSYCHOL LINGU; Anzalone SM, 2014, RES AUTISM SPECT DIS, V8, P814, DOI 10.1016/j.rasd.2014.03.002; Beebe B., 1988, PSYCHOANAL PSYCHOL, V5, P305, DOI DOI 10.1037/0736-9735.5.4.305; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BLACK B, 1995, CHILD DEV, V66, P255, DOI 10.1111/j.1467-8624.1995.tb00869.x; Blenkinsop TA, 2006, J NEUROSCI, V26, P1739, DOI 10.1523/JNEUROSCI.3677-05.2006; Bonaminio V, 1983, ETA EVOLUTIVA, V16, P110; BOOTH CL, 1984, CHILD STUDY J, V14, P95; Bornstein M. H., 2009, T MODEL DEV CHILDREN, P139, DOI [10.1037/11877-000, DOI 10.1037/11877-008]; Braten S., 1998, INTERSUBJECTIVE COMM, P15; Brazelton T.B., 1974, MOTHER INFANT INTERA; Cassel R, 2014, INTERACTION STUDIES, V14, P480, DOI DOI 10.1075/IS.14.3.08CAS; CENSULLO M, 1987, NURS RES, V36, P244; Chaby L, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P950, DOI 10.1109/SocialCom-PASSAT.2012.111; Clark G. N., 1983, INFANT MENT HEALTH J, V4, P67; Cohen D., 2012, BRAIN MIND DEV PSYCH, P3; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061402; Cole P. M., 2009, BIOPSYCHOSOCIAL REGU, P186, DOI DOI 10.1017/CBO9780511575877.009; Constant J, 2014, NEUROPSYCHIAT ENFAN, V62, P128; Cox M. J., 1997, QUALITATIVE RA UNPUB; Crandell LE, 1997, INFANT MENT HEALTH J, V18, P247, DOI 10.1002/(SICI)1097-0355(199723)18:3<247::AID-IMHJ2>3.0.CO;2-K; CRITTENDEN PM, 1981, MERRILL PALMER QUART, V27, P201; Crown CL, 2002, J PSYCHOLINGUIST RES, V31, P1, DOI 10.1023/A:1014301303616; Davenport N, 2008, M INFORM NEEDS AM PE; de Graag JA, 2012, INFANT BEHAV DEV, V35, P252, DOI 10.1016/j.infbeh.2011.12.006; de Mendonca JS, 2011, SEX ROLES, V64, P132, DOI 10.1007/s11199-010-9875-2; Deater-Deckard K, 2004, J CHILD PSYCHOL PSYC, V45, P1171, DOI 10.1111/j.1469-7610.2004.00309.x; Delaherche E, 2012, IEEE T AFFECTIVE COM; Delaherche E, 2013, RES AUTISM SPECT DIS, V7, P741, DOI 10.1016/j.rasd.2013.02.003; Di Paolo EA, 2001, BIOSYSTEMS, V59, P185, DOI 10.1016/S0303-2647(01)00102-2; DOWD JM, 1986, CHILD DEV, V57, P762; Dubrow LV, 1999, INFANT CHILD DEV, V8, P101, DOI 10.1002/(SICI)1522-7219(199906)8:2<101::AID-ICD190>3.0.CO;2-Q; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Farran D. C., 1990, J APPL DEV PSYCHOL, V11, P419, DOI [10.1016/0193-3973(90)90018-F, DOI 10.1016/0193-3973(90)90018-F]; FARRAN DC, 1980, INT J BEHAV DEV, V3, P215, DOI 10.1177/016502548000300206; Feldman R, 2004, DEV PSYCHOL, V40, P1133, DOI 10.1037/0012-1649.40.6.1133; Feldman R, 2003, INFANT MENT HEALTH J, V24, P1, DOI 10.1002/imhj.10041; Feldman R, 1996, J APPL DEV PSYCHOL, V17, P347, DOI 10.1016/S0193-3973(96)90031-3; Feldman R, 1997, INF MENTAL HLTH J, V18, P4, DOI 10.1002/(SICI)1097-0355(199721)18:1<4::AID-IMHJ2>3.0.CO;2-R; Feldman R, 2007, AM J ORTHOPSYCHIAT, V77, P582, DOI 10.1037/0002-9432.77.4.582; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Feldman R, 2013, NEUROPSYCHOPHARMACOL, V38, P1154, DOI 10.1038/npp.2013.22; Feldman R, 2012, MONOGR SOC RES CHILD, V77, P42, DOI 10.1111/j.1540-5834.2011.00660.x; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; FIELD T, 1990, DEV PSYCHOL, V26, P7, DOI 10.1037/0012-1649.26.1.7; FOGEL A, 1992, INFANT BEHAV DEV, V15, P231, DOI 10.1016/0163-6383(92)80025-P; Gandillot S, 2012, DEVENIR, V24, P141; Garcia-Sellers MJ, 2000, INFANT TODDLER INTER, V10, P259; Gogate LJ, 2013, INFANT BEHAV DEV, V36, P470, DOI 10.1016/j.infbeh.2013.03.012; Gogate LJ, 2010, J EXP CHILD PSYCHOL, V105, P178, DOI 10.1016/j.jecp.2009.10.007; Gordon I, 2010, PHYSIOL BEHAV, V101, P679, DOI 10.1016/j.physbeh.2010.08.008; Gordon I, 2008, FAM PROCESS, V47, P465, DOI 10.1111/j.1545-5300.2008.00266.x; Gratier M, 2003, COGNITIVE DEV, V18, P533, DOI 10.1016/j.cogdev.2003.09.009; Guedeney A, 2014, BEST PRACT RES CL OB, V28, P135, DOI 10.1016/j.bpobgyn.2013.08.011; Ham J, 2009, PSYCHOTHER RES, V19, P619, DOI 10.1080/10503300802609672; Harel H, 2011, INFANCY, V16, P69, DOI 10.1111/j.1532-7078.2010.00037.x; Harrist AW, 2002, DEV REV, V22, P555, DOI 10.1016/S0273-2297(02)00500-2; HARRIST AW, 1994, FAM RELAT, V43, P417, DOI 10.2307/585373; Hart S, 2010, NORTON SERIES INTERP; Hartup WW, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P177, DOI 10.1017/CBO9780511606632.011; Haskett ME, 2006, J FAM VIOLENCE, V21, P137, DOI 10.1007/s10896-005-9010-2; Healey DM, 2010, J CHILD PSYCHOL PSYC, V51, P1058, DOI 10.1111/j.1469-7610.2010.02220.x; HINDE RA, 1995, PERS RELATIONSHIP, V2, P1, DOI 10.1111/j.1475-6811.1995.tb00074.x; Howe N, 2001, MERRILL PALMER QUART, V47, P121, DOI 10.1353/mpq.2001.0002; ISABELLA RA, 1989, DEV PSYCHOL, V25, P12, DOI 10.1037/0012-1649.25.1.12; ISABELLA RA, 1991, CHILD DEV, V62, P373, DOI 10.2307/1131010; Jung C., 1967, MA VIE SOUVENIRS REV; KARGER RH, 1979, CHILD DEV, V50, P882, DOI 10.2307/1128959; Keefe MR, 1996, NURS RES, V45, P4, DOI 10.1097/00006199-199601000-00002; Keown LJ, 2002, J ABNORM CHILD PSYCH, V30, P541, DOI 10.1023/A:1020803412247; KIRSH SJ, 1995, PERS RELATIONSHIP, V2, P187, DOI 10.1111/j.1475-6811.1995.tb00085.x; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Kochanska G, 1997, CHILD DEV, V68, P94, DOI 10.2307/1131928; Kuhl P, 2003, J ACOUSTICAL SOC AM, V114; Landy S., 2001, CLIN CHILD PSYCHOL P, V6, P223, DOI [DOI 10.1177/1359104501006002005, 10.1177/1359104501006002005]; LEBOVICI S, 1985, REV FR PSYCHANAL, V49, P1307; Lebovici S, 1983, MERE NOURRISON PSYCH; LESTER BM, 1985, CHILD DEV, V56, P15, DOI 10.2307/1130169; Lindsey EW, 1997, J SOC PERS RELAT, V14, P523, DOI 10.1177/0265407597144007; Longhi E, 2009, PSYCHOL MUSIC, V37, P195, DOI 10.1177/0305735608097042; Lundy BL, 2003, INFANT BEHAV DEV, V26, P200, DOI 10.1016/S0163-6383(03)00017-1; Lundy BL, 2002, INFANT BEHAV DEV, V25, P221, DOI 10.1016/S0163-6383(02)00123-6; Mahdhaoui A, 2011, INT J METH PSYCH RES, V20, pE6, DOI 10.1002/mpr.332; Matatyaho DJ, 2008, INFANCY, V13, P172, DOI 10.1080/15250000701795655; Messinger D., 2014, SOCIAL EMOTIONS NATU, P162; Messinger DM, 2010, NEURAL NETWORKS, V23, P1004, DOI 10.1016/j.neunet.2010.08.008; Messinger DS, 2012, INFANCY, V17, P233, DOI 10.1111/j.1532-7078.2011.00074.x; Messinger DS, 2009, INFANCY, V14, P285, DOI 10.1080/15250000902839963; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Michelet S, 2012, HUM BEH UND IROS 12; Mize J, 1997, CHILD DEV, V68, P312, DOI 10.2307/1131852; Moore GA, 2004, DEV PSYCHOL, V40, P1068, DOI 10.1037/0012-1649.40.6.1068; Moss E, 1997, SOC DEV, V6, P1; Ouss L, 2014, EUR CHILD ADOLES PSY, V23, P143, DOI 10.1007/s00787-013-0430-x; Owen M. T., 1996, 54 MONTH PARENT CHIL; PENMAN R, 1983, BRIT J MED PSYCHOL, V56, P1, DOI 10.1111/j.2044-8341.1983.tb01527.x; RADKEYARROW M, 1993, J ABNORM CHILD PSYCH, V21, P683, DOI 10.1007/BF00916450; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Ravn IH, 2011, INFANT BEHAV DEV, V34, P215, DOI 10.1016/j.infbeh.2010.11.004; Reyna BA, 2012, INFANT BEHAV DEV, V35, P669, DOI 10.1016/j.infbeh.2012.06.003; Reyna BA, 2009, JOGNN-J OBST GYN NEO, V38, P470, DOI 10.1111/j.1552-6909.2009.01044.x; ROCISSANO L, 1987, DEV PSYCHOL, V23, P698, DOI 10.1037/0012-1649.23.5.698; Roe KV, 1997, AM J ORTHOPSYCHIAT, V67, P645, DOI 10.1037/h0080262; Rosenblum O, 1997, INF MENTAL HLTH J, V18, P350, DOI 10.1002/(SICI)1097-0355(199724)18:4<350::AID-IMHJ3>3.0.CO;2-P; Saffran JR, 2003, CURR DIR PSYCHOL SCI, V12, P110, DOI 10.1111/1467-8721.01243; Saint-Georges C., 2013, NEUROPSYCHIAT ENFAN, V61, P400, DOI DOI 10.1016/J.NEURENF.2013.05.005; Saint-Georges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078103; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; SHAPIRO T, 1987, J AM ACAD CHILD PSY, V26, P485, DOI 10.1097/00004583-198707000-00004; Skuban EM, 2006, INFANT BEHAV DEV, V29, P423, DOI 10.1016/j.infbeh.2006.02.004; Steiner BD, 2008, ANN FAM MED, V6, P361, DOI 10.1370/afm.866; Stern D. N., 2002, 1 RELATIONSHIP INFAN, V2nd; Stormark KM, 2004, INFANT BEHAV DEV, V27, P195, DOI 10.1016/j.infbeh.2003.09.004; Thompson LA, 2009, J REPROD INFANT PSYC, V27, P143, DOI 10.1080/02646830801918463; Tronick E. Z., 1986, ZERO 3, V6, P1; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Vallotton CD, 2009, INFANT BEHAV DEV, V32, P351, DOI 10.1016/j.infbeh.2009.06.001; Van Puyvelde M, 2010, INFANT BEHAV DEV, V33, P387, DOI 10.1016/j.infbeh.2010.04.003; Vandenberg KA, 2006, MATERNAL INFANT INTE; Venuti P, 2009, AJIDD-AM J INTELLECT, V114, P274, DOI 10.1352/1944-7558-114.4:274-288; Viaux S, 2013, NEUROPSYCHIATRIE ENF; Vinciarelli A, 2009, IMAGE VISION COMPUT, V27, P1743, DOI 10.1016/j.imavis.2008.11.007; Wahler RG, 2001, J CLIN CHILD PSYCHOL, V30, P473, DOI 10.1207/S15374424JCCP3004_04; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Weinberg MK, 2006, J CHILD PSYCHOL PSYC, V47, P670, DOI 10.1111/j.1469-7610.2005.01545.x; Weinberg MK, 1999, DEV PSYCHOL, V35, P175, DOI 10.1037/0012-1649.35.1.175; Weisman O, SOCIAL BONDING CHARA; Weisman O, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0828; Weisman O, 2013, PSYCHONEUROENDOCRINO, V38, P694, DOI 10.1016/j.psyneuen.2012.08.011; Weisman O, 2012, BIOL PSYCHIAT, V72, P982, DOI 10.1016/j.biopsych.2012.06.011; WHIPPLE EE, 1995, AM J ORTHOPSYCHIAT, V65, P153, DOI 10.1037/h0079593; Zlochower AJ, 1996, INFANT BEHAV DEV, V19, P371, DOI 10.1016/S0163-6383(96)90035-1	137	187	191	13	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113571	10.1371/journal.pone.0113571	http://dx.doi.org/10.1371/journal.pone.0113571			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469637	Green Published, gold			2022-12-27	WOS:000349128700033
J	Penarete-Vargas, DM; Boisson, A; Urbach, S; Chantelauze, H; Peyrottes, S; Fraisse, L; Vial, HJ				Penarete-Vargas, Diana Marcela; Boisson, Anais; Urbach, Serge; Chantelauze, Herve; Peyrottes, Suzanne; Fraisse, Laurent; Vial, Henri J.			A Chemical Proteomics Approach for the Search of Pharmacological Targets of the Antimalarial Clinical Candidate Albitiazolium in Plasmodium falciparum Using Photocrosslinking and Click Chemistry	PLOS ONE			English	Article							PHOSPHOLIPID-METABOLISM; MALARIA PARASITE; TRANSPORT; MEMBRANE; DATABASE; INFORMATION; DISRUPTION; INHIBITORS; MOLECULES; FLIPPASES	Plasmodium falciparum is responsible for severe malaria which is one of the most prevalent and deadly infectious diseases in the world. The antimalarial therapeutic arsenal is hampered by the onset of resistance to all known pharmacological classes of compounds, so new drugs with novel mechanisms of action are critically needed. Albitiazolium is a clinical antimalarial candidate from a series of choline analogs designed to inhibit plasmodial phospholipid metabolism. Here we developed an original chemical proteomic approach to identify parasite proteins targeted by albitiazolium during their native interaction in living parasites. We designed a bifunctional albitiazolium-derived compound (photoactivable and clickable) to covalently crosslink drug-interacting parasite proteins in situ followed by their isolation via click chemistry reactions. Mass spectrometry analysis of drug-interacting proteins and subsequent clustering on gene ontology terms revealed parasite proteins involved in lipid metabolic activities and, interestingly, also in lipid binding, transport, and vesicular transport functions. In accordance with this, the albitiazolium-derivative was localized in the endoplasmic reticulum and trans-Golgi network of P. falciparum. Importantly, during competitive assays with albitiazolium, the binding of choline/ethanolamine phosphotransferase (the enzyme involved in the last step of phosphatidylcholine synthesis) was substantially displaced, thus confirming the efficiency of this strategy for searching albitiazolium targets.	[Penarete-Vargas, Diana Marcela; Boisson, Anais; Vial, Henri J.] Univ Montpellier 2, CNRS, UMR 5235, Cc107, F-34095 Montpellier 05, France; [Urbach, Serge] Univ Montpellier 2, Univ Montpellier 1, Inst Genom Fonct, CNRS,UMR 5203,INSERM,U661, F-34094 Montpellier, France; [Chantelauze, Herve; Peyrottes, Suzanne] Univ Montpellier 2, Inst Biomol Max Mousseron, Cc1705, CNRS,UMR 5247, F-34095 Montpellier 05, France; [Fraisse, Laurent] Sanofi, Therapeut Strateg Unit Infect Dis, F-31036 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Sanofi-Aventis; Sanofi France	Penarete-Vargas, DM (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, Cc107, Pl Eugene Bataillon, F-34095 Montpellier 05, France.	dpenaret@univ-montp2.fr; vial@univ-montp2.fr	Peyrottes, Suzanne/X-7325-2019	Penarete-Vargas, Diana Marcela/0000-0002-3306-3943; PEYROTTES, Suzanne/0000-0003-1705-0576	European Community [242095]; Sanofi; Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO); InnoMad (Eurobiomed); FP7/EviMalar Network of Excellence	European Community(European Commission); Sanofi; Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO); InnoMad (Eurobiomed); FP7/EviMalar Network of Excellence	Funding: This work was supported the European Community (FP7/EviMalar Network of Excellence No. 242095; http://www.evimalar.org/), by Sanofi (www.sanofi.fr/) and by a InnoMad grant from the Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO) (http://www.eurobiomed.org/). DMPV received funding from InnoMad (Eurobiomed) and Sanofi. AB received funding from InnoMad (Eurobiomed). HC received funding from FP7/EviMalar Network of Excellence. The funders provided support in the form of salaries for authors (DMPV and LF), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Ancelin ML, 2003, ANTIMICROB AGENTS CH, V47, P2590, DOI 10.1128/AAC.47.8.2590-2597.2003; Ancelin ML, 1998, BLOOD, V91, P1426, DOI 10.1182/blood.V91.4.1426; [Anonymous], MALARIA PARASITE MET; [Anonymous], APICOMPLEXAN PARASIT; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Biagini GA, 2003, ANTIMICROB AGENTS CH, V47, P2584, DOI 10.1128/AAC.47.8.2584-2589.2003; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brehelin L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-440; Burrows JN, 2011, FUTURE MED CHEM, V3, P1401, DOI [10.4155/fmc.11.91, 10.4155/FMC.11.91]; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Hagenstein MC, 2003, ANGEW CHEM INT EDIT, V42, P5635, DOI 10.1002/anie.200352084; Hamze A, 2005, J MED CHEM, V48, P3639, DOI 10.1021/jm0492608; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-513; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Peyrottes S, 2012, CURR PHARM DESIGN, V18, P3454; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rao Aditya, 2009, In Silico Biology, V9, P195, DOI 10.3233/ISB-2009-0403; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sadakane Y, 2006, ANAL SCI, V22, P209, DOI 10.2116/analsci.22.209; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; Wein S, 2012, BRIT J PHARMACOL, V166, P2263, DOI 10.1111/j.1476-5381.2012.01966.x; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	50	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113918	10.1371/journal.pone.0113918	http://dx.doi.org/10.1371/journal.pone.0113918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470252	gold, Green Published			2022-12-27	WOS:000349128700053
J	Stalenberg, E; Wallis, IR; Cunningham, RB; Allen, C; Foley, WJ				Stalenberg, Eleanor; Wallis, Ian R.; Cunningham, Ross B.; Allen, Chris; Foley, William J.			Nutritional Correlates of Koala Persistence in a Low-Density Population	PLOS ONE			English	Article							PLANT SECONDARY METABOLITES; PHASCOLARCTOS-CINEREUS POPULATIONS; SOUTH-WEST QUEENSLAND; EUCALYPTUS FOLIAGE; HABITAT USE; TREE USE; PSEUDOCHEIRUS-PEREGRINUS; FORAGING BEHAVIOR; BOTTOM-UP; CHEMISTRY	It is widely postulated that nutritional factors drive bottom-up, resource-based patterns in herbivore ecology and distribution. There is, however, much controversy over the roles of different plant constituents and how these influence individual herbivores and herbivore populations. The density of koala (Phascolarctos cinereus) populations varies widely and many attribute population trends to variation in the nutritional quality of the eucalypt leaves of their diet, but there is little evidence to support this hypothesis. We used a nested design that involved sampling of trees at two spatial scales to investigate how leaf chemistry influences free-living koalas from a low-density population in south east New South Wales, Australia. Using koala faecal pellets as a proxy for koala visitation to trees, we found an interaction between toxins and nutrients in leaves at a small spatial scale, whereby koalas preferred trees with leaves of higher concentrations of available nitrogen but lower concentrations of sideroxylonals (secondary metabolites found exclusively in eucalypts) compared to neighbouring trees of the same species. We argue that taxonomic and phenotypic diversity is likely to be important when foraging in habitats of low nutritional quality in providing diet choice to tradeoff nutrients and toxins and minimise movement costs. Our findings suggest that immediate nutritional concerns are an important priority of folivores in low-quality habitats and imply that nutritional limitations play an important role in constraining folivore populations. We show that, with a careful experimental design, it is possible to make inferences about populations of herbivores that exist at extremely low densities and thus achieve a better understanding about how plant composition influences herbivore ecology and persistence.	[Stalenberg, Eleanor; Wallis, Ian R.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Allen, Chris] NSW Off Environm & Heritage, Natl Pk & Wildlife Serv, Far South Coast, NSW, Australia	Australian National University; Australian National University; Office of Environment & Heritage - New South Wales	Stalenberg, E (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	eleanor.stalenberg@anu.edu.au	Foley, William J/C-8069-2009; Stalenberg, Eleanor/N-4123-2013	Foley, William J/0000-0001-8587-1814; Stalenberg, Eleanor/0000-0003-2548-5967	New South Wales (NSW) Department of Environment, Climate Change Water	New South Wales (NSW) Department of Environment, Climate Change Water	Funding: IW and WF received a grant from New South Wales (NSW) Department of Environment, Climate Change & Water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2012, J TROP ECOL, V28, P385, DOI 10.1017/S0266467412000302; Andrew RL, 2007, ECOLOGY, V88, P716, DOI 10.1890/05-1858; [Anonymous], 1995, STANDARD PRACTICES I; Au J, 2013, J COMP PHYSIOL B, V183, P993, DOI 10.1007/s00360-013-0754-3; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bergvall UA, 2005, ECOLOGY, V86, P2450, DOI 10.1890/04-0978; BRAITHWAITE LW, 1984, AUST WILDLIFE RES, V11, P41; Briscoe NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0235; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Cork S. J., 1991, BIOL KOALA, P129; CORK SJ, 1983, J COMP PHYSIOL, V153, P181, DOI 10.1007/BF00689622; Crowther MS, 2014, ECOGRAPHY, V37, P336, DOI 10.1111/j.1600-0587.2013.00413.x; Dearing MD, 2005, ANNU REV ECOL EVOL S, V36, P169, DOI 10.1146/annurev.ecolsys.36.102003.152617; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; DeGabriel JL, 2014, OIKOS, V123, P298, DOI 10.1111/j.1600-0706.2013.00727.x; DeGabriel JL, 2010, CHEMOECOLOGY, V20, P97, DOI 10.1007/s00049-009-0037-3; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; Ellis WAH, 1998, WILDLIFE RES, V25, P663, DOI 10.1071/WR97028; Ellis W, 2013, AUST MAMMAL, V35, P160, DOI 10.1071/AM12023; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Foley W.J., 2004, P207; FOLEY WJ, 1992, TRENDS ECOL EVOL, V7, P159, DOI 10.1016/0169-5347(92)90210-3; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; GARBER PA, 1989, AM J PRIMATOL, V19, P203, DOI 10.1002/ajp.1350190403; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hegland SJ, 2013, FOREST ECOL MANAG, V310, P267, DOI 10.1016/j.foreco.2013.08.031; Hengeveld GM, 2009, AM NAT, V174, P102, DOI 10.1086/598500; HUNTER MD, 1992, ECOLOGY, V73, P724; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Jones PD, 2008, SOUTHEAST NAT, V7, P595, DOI 10.1656/1528-7092-7.4.595; Krockenberger A, 2003, J COMP PHYSIOL B, V173, P531, DOI 10.1007/s00360-003-0361-9; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; LUNNEY D, 1988, AUST J ECOL, V13, P67, DOI 10.1111/j.1442-9993.1988.tb01417.x; Lunney D, 1997, WILDLIFE RES, V24, P111, DOI 10.1071/WR94034; Lunney D, 2002, BIOL CONSERV, V106, P101, DOI 10.1016/S0006-3207(01)00233-6; Lunney D., 1988, Proceedings of the First national conference on Australian forest history, Canberra, 9-11 May, 1988., P23; Lunney D., 2002, AUSTR EVER CHANGING, VV, P289; Lunney D, 2014, WILDLIFE RES, V41, P22, DOI 10.1071/WR13054; Lunney D, 2009, WILDLIFE RES, V36, P262, DOI 10.1071/WR08079; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Marsh KJ, 2007, OECOLOGIA, V154, P283, DOI 10.1007/s00442-007-0828-6; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; Marsh KJ, 2014, OECOLOGIA, V174, P873, DOI 10.1007/s00442-013-2808-3; Marsh KJ, 2005, ECOLOGY, V86, P2946, DOI 10.1890/05-0303; Marsh KJ, 2003, J COMP PHYSIOL B, V173, P69, DOI 10.1007/s00360-002-0318-4; Marsh KJ, 2003, AUST J ZOOL, V51, P31, DOI 10.1071/ZO02055; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; Matthews A, 2007, WILDLIFE RES, V34, P84, DOI 10.1071/WR06075; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McGregor DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059713; Melzer Alistair, 1994, Proceedings of the Royal Society of Queensland, V104, P89; Menkhorst P, 2006, TOO CLOSE COMFORT CO, P73; Mitchell P., 1990, P171; Moore B, 2004, CHEM DETERMINANTS DI; Moore BD, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P549; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Phillips S, 2000, WILDLIFE RES, V27, P509, DOI 10.1071/WR98087; Phillips SS, 2000, CONSERV BIOL, V14, P650, DOI 10.1046/j.1523-1739.2000.99387.x; Phillips Stephen, 2011, Australian Zoologist, V35, P774; Prins Herbert H. T., 2008, V23, P129; Provenza FD, 1996, J ANIM SCI, V74, P2010; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reed P.C., 1990, P55; Reed Philip, 1990, P9; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Searle KR, 2007, ISR J ECOL EVOL, V53, P297, DOI 10.1560/IJEE.53.3.297; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Simmen B, 2012, J TROP ECOL, V28, P141, DOI 10.1017/S026646741200003X; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Smyth GK, 1996, J ROY STAT SOC B MET, V58, P565; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stephens D.W., 1986, pi; Sullivan BJ, 2003, WILDLIFE RES, V30, P583, DOI 10.1071/WR02036; Sullivan BJ, 2003, WILDLIFE RES, V30, P331, DOI 10.1071/WR00032; Sullivan BJ, 2002, WILDLIFE RES, V29, P455, DOI 10.1071/WR00110; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wiggins NL, 2006, ECOLOGY, V87, P2236, DOI 10.1890/0012-9658(2006)87[2236:SSOTPO]2.0.CO;2; Wiggins NL, 2006, OECOLOGIA, V147, P272, DOI 10.1007/s00442-005-0268-0; Wiggins NL, 2003, J CHEM ECOL, V29, P1447, DOI 10.1023/A:1024221705354; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Zuur Alain F., 2009, P1	103	19	20	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113930	10.1371/journal.pone.0113930	http://dx.doi.org/10.1371/journal.pone.0113930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470599	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700056
J	Zangenehpour, S; Javadi, P; Ervin, FR; Palmour, RM; Ptito, M				Zangenehpour, Shahin; Javadi, Pasha; Ervin, Frank R.; Palmour, Roberta M.; Ptito, Maurice			A Deficit in Face-Voice Integration in Developing Vervet Monkeys Exposed to Ethanol during Gestation	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; SPECIES INTERSENSORY PERCEPTION; PREFRONTAL CORTEX; TEMPORAL CUES; VISUAL-ATTENTION; HUMAN INFANTS; RAT PUPS; BEHAVIOR; REPRESENTATION; CONSUMPTION	Children with fetal alcohol spectrum disorders display behavioural and intellectual impairments that strongly implicate dysfunction within the frontal cortex. Deficits in social behaviour and cognition are amongst the most pervasive outcomes of prenatal ethanol exposure. Our naturalistic vervet monkey model of fetal alcohol exposure (FAE) provides an unparalleled opportunity to study the neurobehavioral outcomes of prenatal ethanol exposure in a controlled experimental setting. Recent work has revealed a significant reduction of the neuronal population in the frontal lobes of these monkeys. We used an intersensory matching procedure to investigate audiovisual perception of socially relevant stimuli in young FAE vervet monkeys. Here we show a domain-specific deficit in audiovisual integration of socially relevant stimuli. When FAE monkeys were shown a pair of side-by-side videos of a monkey concurrently presenting two different calls along with a single audio track matching the content of one of the calls, they were not able to match the correct video to the single audio track. This was manifest by their average looking time being equally spent towards both the matching and non-matching videos. However, a group of normally developing monkeys exhibited a significant preference for the non-matching video. This inability to integrate and thereby discriminate audiovisual stimuli was confined to the integration of faces and voices as revealed by the monkeys' ability to match a dynamic face to a complex tone or a black-and-white checkerboard to a pure tone, presumably based on duration and/or onset-offset synchrony. Together, these results suggest that prenatal ethanol exposure negatively affects a specific domain of audiovisual integration. This deficit is confined to the integration of information that is presented by the face and the voice and does not affect more elementary aspects of sensory integration.	[Zangenehpour, Shahin] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Javadi, Pasha; Ptito, Maurice] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Ervin, Frank R.; Palmour, Roberta M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Palmour, Roberta M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, BRAINlab, Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Psychiat Ctr Copenhagen, Lab Neuropsychiat, DK-2100 Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark	McGill University; Universite de Montreal; McGill University; McGill University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Ptito, M (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	maurice.ptito@umontreal.ca	Ptito, Maurice/G-3422-2013	Ptito, Maurice/0000-0002-5173-5862	Canadian Institutes of Health Research (CIHR); GW Stairs Foundation; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GW Stairs Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding: This work was supported by an Operating Grant from the Canadian Institutes of Health Research (CIHR; FRE, RP, MP and SZ), a CIHR Postdoctoral Fellowship (SZ), a seed grant from GW Stairs Foundation (SZ), a Canadian Foundation for Innovation grant (MP), an operating grant from the Natural Sciences and Engineering Research Council of Canada (MP), and infrastructure support from Behavioural Sciences Foundation (BSF), St Kitts, West Indies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRON S, 1991, PHARMACOL BIOCHEM BE, V39, P423, DOI 10.1016/0091-3057(91)90202-D; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Burke MW, 2009, JOVE-J VIS EXP, V29, DOI [10.3791/1260., DOI 10.3791/1260]; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1178; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Connor PD, 1999, ALCOHOL CLIN EXP RES, V23, P1395; CONRY J, 1990, ALCOHOL CLIN EXP RES, V14, P650, DOI 10.1111/j.1530-0277.1990.tb01222.x; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ERVIN FR, 1990, PHARMACOL BIOCHEM BE, V36, P367, DOI 10.1016/0091-3057(90)90417-G; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; GIBSON EJ, 1984, CHILD DEV, V55, P453, DOI 10.2307/1129956; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Jirikowic Tracy, 2008, Phys Occup Ther Pediatr, V28, P117, DOI 10.1080/01942630802031800; Jordan KE, 2006, P NATL ACAD SCI USA, V103, P3486, DOI 10.1073/pnas.0508107103; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; JUAREZ J, 1993, PHARMACOL BIOCHEM BE, V46, P985, DOI 10.1016/0091-3057(93)90232-I; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KELLY SJ, 1994, NEUROTOXICOL TERATOL, V16, P377, DOI 10.1016/0892-0362(94)90026-4; Kelly SJ, 2000, NEUROTOXICOL TERATOL, V22, P143, DOI 10.1016/S0892-0362(99)00073-2; Kerns KA, 1997, J LEARN DISABIL-US, V30, P685, DOI 10.1177/002221949703000612; KRSIAK M, 1977, J STUD ALCOHOL, V38, P1696, DOI 10.15288/jsa.1977.38.1696; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewkowicz DJ, 2008, BRAIN RES, V1242, P291, DOI 10.1016/j.brainres.2008.03.084; LEWKOWICZ DJ, 1986, INFANT BEHAV DEV, V9, P335, DOI 10.1016/0163-6383(86)90008-1; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mukherjee RAS, 2006, J ROY SOC MED, V99, P298, DOI 10.1258/jrsm.99.6.298; Olson HC, 1998, ALCOHOL CLIN EXP RES, V22, P1998, DOI 10.1097/00000374-199812000-00016; Palmour RM, 1998, PSYCHOPHARMACOLOGY, V136, P1, DOI 10.1007/s002130050532; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; ROCKWOOD GA, 1990, NEUROTOXICOL TERATOL, V12, P383, DOI 10.1016/0892-0362(90)90058-K; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; ROYALTY J, 1990, PSYCHOL REP, V66, P551, DOI 10.2466/PR0.66.2.551-560; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Sowell ER, 2001, NEUROREPORT, V12, P515, DOI 10.1097/00001756-200103050-00018; Stoler JM, 1999, J PEDIATR-US, V135, P430, DOI 10.1016/S0022-3476(99)70164-2; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; SUBRAMANIAN MG, 1992, ALCOHOL CLIN EXP RES, V16, P891, DOI 10.1111/j.1530-0277.1992.tb01888.x; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Thomas SE, 1998, ALCOHOL CLIN EXP RES, V22, P528, DOI 10.1111/j.1530-0277.1998.tb03684.x; Wass TS, 2001, AM J OBSTET GYNECOL, V185, P737, DOI 10.1067/mob.2001.117656; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; Zangenehpour S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004302	60	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114100	10.1371/journal.pone.0114100	http://dx.doi.org/10.1371/journal.pone.0114100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470725	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700071
J	Zheng, Y; Wang, SP; Sunkar, R				Zheng, Yun; Wang, Shengpeng; Sunkar, Ramanjulu			Genome-Wide Discovery and Analysis of Phased Small Interfering RNAs in Chinese Sacred Lotus	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; ARABIDOPSIS-THALIANA; REGULATORY NETWORKS; STRESS RESPONSES; BIOGENESIS; PLANTS; MICRORNAS; SECONDARY; MIRNAS; ROLES	Phased small interfering RNA (phasiRNA) generating loci (briefly as PHAS) in plants are a novel class of genes that are normally regulated by microRNAs (miRNAs). Similar to miRNAs, phasiRNAs encoded by PHAS play important regulatory roles by targeting protein coding transcripts in plant species. We performed a genome-wide discovery of PHAS loci in Chinese sacred lotus and identified a total of 106 PHAS loci. Of these, 47 loci generate 21 nucleotide (nt) phasiRNAs and 59 loci generate 24 nt phasiRNAs, respectively. We have also identified a new putative TAS3 and a putative TAS4 loci in the lotus genome. Our results show that some of the nucleotide-binding, leucine-rich repeat (NB-LRR) disease resistance proteins and MYB transcription factors potentially generate phasiRNAs. Furthermore, our results suggest that some large subunit (LSU) rRNAs can derive putative phasiRNAs, which is potentially resulted from crosstalk between small RNA biogenesis pathways that are employed to process rRNAs and PHAS loci, respectively. Some of the identified phasiRNAs have putative trans-targets with less than 4 mismatches, suggesting that the identified PHAS are involved in many different pathways. Finally, the discovery of 24 nt PHAS in lotus suggests that there are 24 nt PHAS in dicots.	[Zheng, Yun; Wang, Shengpeng] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Kunming University of Science & Technology; Oklahoma State University System; Oklahoma State University - Stillwater	Zheng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	zhengyun5488@gmail.com	Zheng, Yun/AAS-1149-2021; Zheng, Yun/I-7011-2012	Zheng, Yun/0000-0003-4292-9806; Zheng, Yun/0000-0003-4292-9806	National Natural Science Foundation of China [31460295]; Kunming University of Science and Technology, China [14078285]; Oklahoma Agricultural Experiment Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming University of Science and Technology, China; Oklahoma Agricultural Experiment Station	Funding: The research was supported in part by a grant (No. 31460295) of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) and a start-up grant (No. 14078285) of Kunming University of Science and Technology (http://www.kmust.edu.cn/), China, to YZ, and a grant of Oklahoma Agricultural Experiment Station (www.oaes.okstate.edu) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Kallman T, 2013, PLANT PHYSIOL, V162, P741, DOI 10.1104/pp.113.214643; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xia R, 2013, PLANT CELL, V25, P1555, DOI 10.1105/tpc.113.110957; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang CQ, 2014, BIOINFORMATICS, V30, P1045, DOI 10.1093/bioinformatics/btt746; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zheng Y, 2013, TROP PLANT BIOL, V6, P117, DOI 10.1007/s12042-013-9127-z; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zheng Yun, 2010, Journal of Bioinformatics and Computational Biology, V8, P763, DOI 10.1142/S0219720010004896; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084390	43	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113790	10.1371/journal.pone.0113790	http://dx.doi.org/10.1371/journal.pone.0113790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469507	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700046
J	Amegah, AK; Quansah, R; Jaakkola, JJK				Amegah, Adeladza K.; Quansah, Reginald; Jaakkola, Jouni J. K.			Household Air Pollution from Solid Fuel Use and Risk of Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of the Empirical Evidence	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CARBON-MONOXIDE; TOBACCO-SMOKE; PRENATAL EXPOSURE; PARTICULATE MATTER; PERINATAL OUTCOMES; COOKING SMOKE; BIOMASS FUEL; WOOD SMOKE; HEALTH	Background: About 41% of households globally, mainly in developing countries rely on solid fuels for cooking with consequences for fetal growth and development. Previous reviews were limited in scope, assessing only two outcomes (birth weight, stillbirth). With important evidence accumulating, there is a need to improve the previous estimates and assess additional outcomes. We conducted a systematic review and meta-analysis to evaluate the quality and strength of available evidence on household air pollution (HAP) and the whole range of adverse pregnancy outcomes. Methods: PubMed, Ovid Medline, Scopus and CINAHL were searched from their inception to the end of April 2013. All epidemiological study designs were eligible for inclusion in the review. The random-effects model was applied in computing the summary-effect estimates (EE) and their corresponding 95% confidence interval (CI). Results: Of 1505 studies screened, 19 studies satisfied the inclusion criteria. Household combustion of solid fuels resulted in an 86.43 g (95% CI: 55.49, 117.37) reduction in birth weight, and a 35% (EE=1.35, 95% CI: 1.23, 1.48) and 29% (EE=1.29, 95% CI: 1.18, 1.41) increased risk of LBW and stillbirth respectively. Conclusion: Combustion of solid fuels at home increases the risk of a wide range of adverse pregnancy outcomes. Access to clean household energy solutions is the surest way to combat HAP and mitigate their adverse effects.	[Amegah, Adeladza K.; Quansah, Reginald; Jaakkola, Jouni J. K.] Univ Oulu, Fac Med, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Amegah, Adeladza K.; Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Amegah, Adeladza K.; Jaakkola, Jouni J. K.] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Amegah, Adeladza K.; Jaakkola, Jouni J. K.] Oulu Univ Hosp, Oulu, Finland; [Jaakkola, Jouni J. K.] Oulu Univ Hosp, Resp Med Unit, Oulu, Finland; [Amegah, Adeladza K.] Univ Cape Coast, Dept Biomed & Forens Sci, Cape Coast, Ghana; [Quansah, Reginald] Univ Ghana, Sch Publ Hlth, Legon, Ghana	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Cape Coast; University of Ghana	Jaakkola, JJK (corresponding author), Univ Oulu, Fac Med, Ctr Environm & Resp Hlth Res, Oulu, Finland.	Jouni.jaakkola@oulu.fi	Amegah, AK/L-8952-2016; Jaakkola, Jouni J.K./G-4314-2012; Quansah, Reginald/AAZ-4015-2020	Amegah, AK/0000-0001-5868-6402; Quansah, Reginald/0000-0002-7318-4192; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland Medical Research Council [266314]	Academy of Finland Medical Research Council	This work was funded by Academy of Finland Medical Research Council grant No. 266314. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusalah A, 2012, MATERN CHILD HLTH J, V16, P1718, DOI 10.1007/s10995-011-0851-4; Amegah AK, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-78; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; BOSLEY ARJ, 1981, ARCH DIS CHILD, V56, P727, DOI 10.1136/adc.56.9.727; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; BUI QQ, 1986, TOXICOLOGY, V42, P195, DOI 10.1016/0300-483X(86)90009-0; Calabrese EJ, 1986, AGE SUSCEPTABILITY T; Carpenter DO, 2002, ENVIRON HEALTH PERSP, V110, P25, DOI 10.1289/ehp.02110s125; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; DICERA E, 1989, BIOCHEMISTRY-US, V28, P2631, DOI 10.1021/bi00432a041; Epstein MB, 2013, INT J HYG ENVIR HEAL, V216, P523, DOI 10.1016/j.ijheh.2012.12.006; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Kadir MM, 2010, ACTA OBSTET GYN SCAN, V89, P540, DOI 10.3109/00016340903473566; Kannan S, 2006, ENVIRON HEALTH PERSP, V114, P1636, DOI 10.1289/ehp.9081; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Kurmi OP, 2012, EUR RESPIR J, V40, P1228, DOI 10.1183/09031936.00099511; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; Lakshmi PVM, 2013, ENVIRON RES, V121, P17, DOI 10.1016/j.envres.2012.12.004; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Li ZW, 2011, AM J EPIDEMIOL, V174, P451, DOI 10.1093/aje/kwr108; LONGO LD, 1977, AM J OBSTET GYNECOL, V129, P69, DOI 10.1016/0002-9378(77)90824-9; Maisonet M, 2004, ENVIRON RES, V95, P106, DOI 10.1016/j.envres.2004.01.001; MAVALANKAR DV, 1991, B WORLD HEALTH ORGAN, V69, P435; MAVALANKAR DV, 1992, INT J EPIDEMIOL, V21, P263, DOI 10.1093/ije/21.2.263; Mishra V, 2005, INT J ENVIRON HEAL R, V15, P397, DOI 10.1080/09603120500288913; Mishra V, 2004, ANN EPIDEMIOL, V14, P740, DOI 10.1016/j.annepidem.2004.01.009; Mishra V, 2004, E W CTR WORKING PAPE, V117; Misra P, 2012, J TROP PEDIATRICS, V58, P457, DOI 10.1093/tropej/fms017; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Perera FP, 1999, ENVIRON HEALTH PERSP, V107, P451, DOI 10.1289/ehp.99107s3451; Pope DP, 2010, EPIDEMIOL REV, V32, P70, DOI 10.1093/epirev/mxq005; Salam MT, 2005, ENVIRON HEALTH PERSP, V113, P1638, DOI 10.1289/ehp.8111; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Samaraweera Y, 2010, AUST NZ J OBSTET GYN, V50, P352, DOI 10.1111/j.1479-828X.2010.01190.x; Sangalli MR, 2003, PLACENTA, V24, P8, DOI 10.1053/plac.2002.0877; Sapkota A, 2012, AIR QUAL ATMOS HLTH, V5, P369, DOI 10.1007/s11869-010-0106-3; Siddiqui AR, 2008, ENVIRON HEALTH PERSP, V116, P543, DOI 10.1289/ehp.10782; Siddiqui AR, 2005, INDOOR AIR POLLUTION; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith KR, 2002, INDOOR AIR, V12, P198, DOI 10.1034/j.1600-0668.2002.01137.x; Sreeramareddy CT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-403; Stankovic A, 2011, SRP ARK CELOK LEK, V139, P651, DOI 10.2298/SARH1110651S; Stankovic Aleksandra, 2011, Med Pregl, V64, P279; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Thompson LM, 2011, ENVIRON HEALTH PERSP, V119, P1489, DOI 10.1289/ehp.1002928; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; World Health Organization, 2014, BURD DIS AMB AIR POL; Yucra S, 2011, INT J OCCUP ENV HEAL, V17, P307; Zulu LC, 2013, ENERGY SUSTAIN DEV, V17, P127, DOI 10.1016/j.esd.2012.07.007	52	138	139	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113920	10.1371/journal.pone.0113920	http://dx.doi.org/10.1371/journal.pone.0113920			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463771	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700070
J	Holcombe, LJ; Patel, N; Colyer, A; Deusch, O; O'Flynn, C; Harris, S				Holcombe, Lucy J.; Patel, Niran; Colyer, Alison; Deusch, Oliver; O'Flynn, Ciaran; Harris, Stephen			Early Canine Plaque Biofilms: Characterization of Key Bacterial Interactions Involved in Initial Colonization of Enamel	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; PERIODONTAL HEALTH; DENTAL DISEASES; SHIFTS; COAGGREGATION; PREVALENCE; MICROBIOTA; SEARCH; DOGS	Periodontal disease (PD) is a significant problem in dogs affecting between 44% and 63.6% of the population. The main etiological agent for PD is plaque, a microbial biofilm that colonizes teeth and causes inflammation of the gingiva. Understanding how this biofilm initiates on the tooth surface is of central importance in developing interventions against PD. Although the stages of plaque development on human teeth have been well characterized little is known about how canine plaque develops. Recent studies of the canine oral microbiome have revealed distinct differences between the canine and human oral environments and the bacterial communities they support, particularly with respect to healthy plaque. These differences mean knowledge about the nature of plaque formation in humans may not be directly translatable to dogs. The aim of this study was to identify the bacterial species important in the early stages of canine plaque formation in vivo and then use isolates of these species in a laboratory biofilm model to develop an understanding of the sequential processes which take place during the initial colonization of enamel. Supra-gingival plaque samples were collected from 12 dogs at 24 and 48 hour time points following a full mouth descale and polish. Pyrosequencing of the 16S rDNA identified 134 operational taxonomic units after statistical analysis. The species with the highest relative abundance were Bergeyella zoohelcum, Neisseria shayeganii and a Moraxella species. Streptococcal species, which tend to dominate early human plaque biofilms, had very low relative abundance. In vitro testing of biofilm formation identified five primary colonizer species, three of which belonged to the genus Neisseria. Using these pioneer bacteria as a starting point, viable two and three species communities were developed. Combining in vivo and in vitro data has led us to construct novel models of how the early canine plaque biofilm develops.	[Holcombe, Lucy J.; Patel, Niran; Colyer, Alison; Deusch, Oliver; O'Flynn, Ciaran; Harris, Stephen] WALTHAM Ctr Pet Nutr, Leicester, Leics, England	Mars; WALTHAM Petcare Science Institute	Holcombe, LJ (corresponding author), WALTHAM Ctr Pet Nutr, Leicester, Leics, England.	lucy.holcombe@effem.com		Patel, Niran/0000-0002-3668-2707; Harris, Stephen/0000-0002-4422-612X; Deusch, Oliver/0000-0003-3378-6129	Mars Petcare UK	Mars Petcare UK	This work was funded by Mars Petcare UK. The WALTHAMH (R) Centre for Pet Nutrition is the fundamental research center for Mars Petcare; it employs LJH, NP, AC, OD, COF, and SH. WALTHAMH (R) was involved at all levels of this research including study design, data collection and analysis, decision to publish, and preparation of the manuscript. However, there are no conflicts of interest; this survey represents an unbiased view (in the commercial sense) of early canine plaque biofilm formation. There were no external funding sources for this study.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammann TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083090; BARTHOLOMEW JW, 1954, J BACTERIOL, V67, P689, DOI 10.1128/JB.67.6.689-691.1954; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Butkovic V, 2001, ACTA VET BRNO, V70, P203, DOI 10.2754/avb200170020203; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Elliott DR, 2006, APPL ENVIRON MICROB, V72, P5211, DOI 10.1128/AEM.01060-05; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Haffajee AD, 2005, J CLIN PERIODONTOL, V32, P33, DOI 10.1111/j.1600-051X.2004.00624.x; HAMP SE, 1984, VET RADIOLOGY, V25, P86, DOI 10.1111/j.1740-8261.1984.tb01916.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Lavy E, 2012, ISR J VET MED, V67, P244; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; Loozen G, 2014, J CLIN PERIODONTOL, V41, P1, DOI 10.1111/jcpe.12167; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Teles FR, 2012, J PERIODONTAL RES, V47, P95, DOI 10.1111/j.1600-0765.2011.01409.x; Uzel NG, 2011, J CLIN PERIODONTOL, V38, P612, DOI 10.1111/j.1600-051X.2011.01730.x; Van Dyke TE, 2009, J APPL ORAL SCI, V17; Wiggs RB., 1997, VET DENT PRINCIPLES, P186; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Zijnge V, 2013, ORAL MICROBIAL ECOLOGY: CURRENT RESEARCH AND NEW PERSPECTIVES, P47	47	41	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113744	10.1371/journal.pone.0113744	http://dx.doi.org/10.1371/journal.pone.0113744			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463050	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700048
J	Jauniaux, T; Garigliany, MM; Loos, P; Bourgain, JL; Bouveroux, T; Coignoul, F; Haelters, J; Karpouzopoulos, J; Pezeril, S; Desmecht, D				Jauniaux, Thierry; Garigliany, Mutien-Marie; Loos, Pauline; Bourgain, Jean-Luc; Bouveroux, Thibaut; Coignoul, Freddy; Haelters, Jan; Karpouzopoulos, Jacky; Pezeril, Sylvain; Desmecht, Daniel			Bite Injuries of Grey Seals (Halichoerus grypus) on Harbour Porpoises (Phocoena phocoena)	PLOS ONE			English	Article								Bite-like skin lesions on harbour porpoises (Phocoena phocoena) have been suspected to be caused by grey seals (Halichoerus grypus), and a few field observations have been reported. Bite-like skin lesions observed on stranded animals were characterized by two main components: large flaps of loose or missing skin and blubber with frayed edges and puncture lesions. Definitive demonstration of predation by a grey seal was not reported so far in those stranded animals. In this study, five stranded porpoises with bite-like skin lesions were swabbed for genetic investigations. In addition, the head of a recently dead grey seal was used to mimic bite-like skin injuries on a porpoise carcass. Subsequently, the artificial skin injuries were swabbed, along with the gum of the seal used for inflicting them (positive controls). Total DNA was extracted from the swabs and was used to retrieve a fragment of mitochondrial DNA by PCR. Primers were designed to amplify a specific stretch of mitochondrial DNA known to differ between grey seals and porpoises. The amplicon targeted was successfully amplified from the positive control and from two of the stranded porpoises, and grey seal-specific mitochondrial DNA was retrieved from all those samples. We conclude that (1) it is possible to detect grey seal DNA from dead porpoises even after several days in seawater and (2) bite-like skin lesions found on dead porpoises definitively result from grey seals attacks. The attacks are most likely linked with predation although, in a number of cases, scavenging and aggressive behaviour cannot be excluded.	[Jauniaux, Thierry; Garigliany, Mutien-Marie; Loos, Pauline; Coignoul, Freddy; Desmecht, Daniel] Univ Liege, Dept Vet Pathol Fundamental & Appl Res Anim & Hlt, B-4000 Liege, Belgium; [Bourgain, Jean-Luc; Karpouzopoulos, Jacky] Coordinat Mammal Nord France, F-62850 Alembon, France; [Bouveroux, Thibaut; Pezeril, Sylvain] Observ Conservat & Etud Anim & Milieux Marins, F-59123 Zuydcoote, France; [Haelters, Jan] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, B-8400 Oostende, Belgium	University of Liege; Royal Belgian Institute of Natural Sciences	Jauniaux, T (corresponding author), Univ Liege, Dept Vet Pathol Fundamental & Appl Res Anim & Hlt, Sart Tilman B43, B-4000 Liege, Belgium.	t.jauniaux@ulg.ac.be		Bouveroux, Thibaut/0000-0002-7339-0316; Loos, Pauline/0000-0002-0019-5579				Bouveroux T, 2014, MAR MAMMAL SCI, V30, P1542, DOI 10.1111/mms.12111; De Munnynck K, 2002, INT J LEGAL MED, V116, P295, DOI 10.1007/s00414-002-0332-9; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Haelters J, 2012, AQUAT MAMM, V38, P343, DOI 10.1578/AM.38.4.2012.343; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Masland EDP, 2010, MOL ECOL RESOUR, V10, P214, DOI 10.1111/j.1755-0998.2009.02741.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Ramon-Laca A, 2013, ELECTROPHORESIS, V34, P3370, DOI 10.1002/elps.201300324; Robinson Louise Anne, 2013, P367	10	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e108993	10.1371/journal.pone.0108993	http://dx.doi.org/10.1371/journal.pone.0108993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461599	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700002
J	Rachakonda, V; Gabbert, C; Raina, A; Bell, LN; Cooper, S; Malik, S; Behari, J				Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Bell, Lauren N.; Cooper, Sara; Malik, Shahid; Behari, Jaideep			Serum Metabolomic Profiling in Acute Alcoholic Hepatitis Identifies Multiple Dysregulated Pathways	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; LIVER-DISEASE; INDOLEAMINE 2,3-DIOXYGENASE; MOLECULAR-MECHANISMS; STEATOHEPATITIS; ASSOCIATION; BIOMARKER; CIRRHOSIS; METSCAPE	Background and Objectives: While animal studies have implicated derangements of global energy homeostasis in the pathogenesis of acute alcoholic hepatitis (AAH), the relevance of these findings to the development of human AAH remains unclear. Using global, unbiased serum metabolomics analysis, we sought to characterize alterations in metabolic pathways associated with severe AAH and identify potential biomarkers for disease prognosis. Methods: This prospective, case-control study design included 25 patients with severe AAH and 25 ambulatory patients with alcoholic cirrhosis. Serum samples were collected within 24 hours of the index clinical encounter. Global, unbiased metabolomics profiling was performed. Patients were followed for 180 days after enrollment to determine survival. Results: Levels of 234 biochemicals were altered in subjects with severe AAH. Random-forest analysis, principal component analysis, and integrated hierarchical clustering methods demonstrated that metabolomics profiles separated the two cohorts with 100% accuracy. Severe AAH was associated with enhanced triglyceride lipolysis, impaired mitochondrial fatty acid beta oxidation, and upregulated omega oxidation. Low levels of multiple lysolipids and related metabolites suggested decreased plasma membrane remodeling in severe AAH. While most measured bile acids were increased in severe AAH, low deoxycholate and glycodeoxycholate levels indicated intestinal dysbiosis. Several changes in substrate utilization for energy homeostasis were identified in severe AAH, including increased glucose consumption by the pentose phosphate pathway, altered tricarboxylic acid (TCA) cycle activity, and enhanced peptide catabolism. Finally, altered levels of small molecules related to glutathione metabolism and antioxidant vitamin depletion were observed in patients with severe AAH. Univariable logistic regression revealed 15 metabolites associated with 180-day survival in severe AAH. Conclusion: Severe AAH is characterized by a distinct metabolic phenotype spanning multiple pathways. Metabolomics profiling revealed a panel of biomarkers for disease prognosis, and future studies are planned to validate these findings in larger cohorts of patients with severe AAH.	[Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Hepatol, Pittsburgh, PA USA; [Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Nutr, Pittsburgh, PA USA; [Bell, Lauren N.] Metabolon Inc, Durham, NC USA; [Cooper, Sara] Hudson Alpha Inst Biotechnol, Huntsville, AL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Metabolon	Behari, J (corresponding author), Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA.	beharij@upmc.edu		Cooper, Sara/0000-0002-9627-0309	National Institutes of Health [5K08AA017622]; University of Pittsburgh Medical Center Pilot Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA017622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Medical Center Pilot Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by Grant 5K08AA017622 from the National Institutes of Health and a University of Pittsburgh Medical Center Pilot Grant to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arienti G, 1995, SCAND J GASTROENTERO, V30, P1204, DOI 10.3109/00365529509101632; Beckonert O, 2003, ANAL CHIM ACTA, V490, P3, DOI 10.1016/S0003-2670(03)00060-6; Casazza J P, 1987, Alcohol Alcohol Suppl, V1, P607; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fleming KM, 2010, ALIMENT PHARM THER, V32, P1343, DOI 10.1111/j.1365-2036.2010.04473.x; Forrest EH, 2012, J HEPATOL, V56, P1427, DOI 10.1016/j.jhep.2011.12.028; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; GUZMAN M, 1988, ARCH BIOCHEM BIOPHYS, V267, P580, DOI 10.1016/0003-9861(88)90065-3; Hamid R, 2011, GUT, V60, pA233, DOI 10.1136/gut.2011.239301.492; Hartmann P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00402; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Lande RG, 2009, J ADDICT DIS, V28, P158, DOI 10.1080/10550880902772506; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 1996, GASTROENTEROLOGY, V110, P1847, DOI 10.1053/gast.1996.v110.pm8964410; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; McClain CJ, 2011, ALCOHOL CLIN EXP RES, V35, P815, DOI 10.1111/j.1530-0277.2010.01405.x; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Neumann T, 2008, ALCOHOL ALCOHOLISM, V43, P431, DOI 10.1093/alcalc/agn035; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rooks MG, 2014, ISME J; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Wong P, 2004, MED HYPOTHESES, V62, P966, DOI 10.1016/j.mehy.2003.12.032; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	40	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113860	10.1371/journal.pone.0113860	http://dx.doi.org/10.1371/journal.pone.0113860			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461442	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000345869700061
J	Sueoka-Aragane, N; Sato, A; Kobayashi, N; Ide, M; Yokoo, M; Nagano, Y; Sueoka, E; Okada, S; Kimura, S				Sueoka-Aragane, Naoko; Sato, Akemi; Kobayashi, Naomi; Ide, Masaru; Yokoo, Masako; Nagano, Yumi; Sueoka, Eisaburo; Okada, Seiji; Kimura, Shinya			Correlation between Plasma DNA and Tumor Status in an Animal Model	PLOS ONE			English	Article							HUMAN LUNG-CANCER; INTRATUMOR HETEROGENEITY; ACQUIRED-RESISTANCE; DETECTION SYSTEM; CIRCULATING DNA; SCID MICE; METASTASIS; CELLS; EVOLUTION; THERAPY	Overcoming metastasis is one of the most important issues with lung cancer. Since metastasis arises through complex steps, a suitable animal model is indispensable for investigation of metastasis. To establish an animal model reflecting human metastatic lung cancers, we used NOD/SCID/Jak3(null) (NOJ) mice, which exhibit deficiencies in NK cell activity, macrophage and dendritic cell function, and complement activation, as well as T and B cell deficiencies. After screening twenty human lung cancer cell lines through expression patterns of E-cadherin and vimentin according to epithelial mesenchymal transition features, an H1975 cell line carrying EGFR mutations, L858R and T790M, was selected for investigation. Inoculation of the cells into the dorsal flanks caused systemic metastases after one month in lymph nodes, liver, lung, and peritoneum, suggesting that metastases occurred both lymphogenically and hematogenously. We confirmed the existence of H1975 cells in metastatic lesions by detection of T790M and L858R using the mutation-biased PCR and quenching probe (MBP-QP) system previously established in our laboratory. In addition, tumor-derived plasma DNA could be detected using the MBP-QP method. The amount of tumor-derived DNA was associated with tumor volume, whereas an unrelated large amount of tumor-derived DNA was circulating in the presence of metastasis. We present a novel animal model with systemic metastasis with human lung cancer cells. The amount of tumor derived DNA would be related with tumor volume and tumor progression such as metastasis.	[Sueoka-Aragane, Naoko; Sato, Akemi; Kobayashi, Naomi; Ide, Masaru; Yokoo, Masako; Nagano, Yumi; Kimura, Shinya] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 840, Japan; [Sueoka, Eisaburo] Saga Univ Hosp, Dept Lab Med, Saga, Japan; [Okada, Seiji] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Kumamoto, Japan	Saga University; Saga University; Kumamoto University	Sueoka-Aragane, N (corresponding author), Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 840, Japan.	sueokan@cc.saga-u.ac.jp			AstraZeneca [26430144]; Grants-in-Aid for Scientific Research [25461425] Funding Source: KAKEN	AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by an AstraZeneca Research & Development Grant in 2013, and the Grants-in-Aid for Scientific Research-KAKENHI 26430144 (N.S-A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garcia-Olmo DC, 2010, CANCER RES, V70, P560; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Iorns E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047995; Jahr S, 2001, CANCER RES, V61, P1659; Kondo K, 2004, ONCOL REP, V12, P991; LEON SA, 1977, CANCER RES, V37, P646; Li M, 2012, ONCOL LETT, V3, P802, DOI 10.3892/ol.2012.586; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Nakamura T, 2011, J THORAC ONCOL, V6, P1639, DOI 10.1097/JTO.0b013e31822956e8; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2011, J PATHOL, V223, P195, DOI 10.1002/path.2801; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; TANIGAWA N, 1984, CANCER RES, V44, P2309; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ulivi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057401; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Ureshino N, 2011, ONCOL REP, V26, P609, DOI 10.3892/or.2011.1341; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Yano S, 1996, INT J CANCER, V67, P211, DOI 10.1002/(SICI)1097-0215(19960717)67:2<211::AID-IJC11>3.0.CO;2-E; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	43	11	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e111881	10.1371/journal.pone.0111881	http://dx.doi.org/10.1371/journal.pone.0111881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462870	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700007
J	Kalpakidou, AK; Allin, MPG; Walshe, M; Giampietro, V; McGuire, PK; Rifkin, L; Murray, RM; Nosarti, C				Kalpakidou, Anastasia K.; Allin, Matthew P. G.; Walshe, Muriel; Giampietro, Vincent; McGuire, Philip K.; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			Functional Neuroanatomy of Executive Function after Neonatal Brain Injury in Adults Who Were Born Very Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; WORKING-MEMORY; INTRAVENTRICULAR HEMORRHAGE; ULTRASOUND APPEARANCE; ATTENTION ALLOCATION; RESPONSE-INHIBITION; BASAL GANGLIA; GRAY-MATTER; ACTIVATION; TASK	Individuals who were born very preterm (VPT; <33 gestational weeks) are at risk of experiencing deficits in tasks involving executive function in childhood and beyond. In addition, the type and severity of neonatal brain injury associated with very preterm birth may exert differential effects on executive functioning by altering its neuroanatomical substrates. Here we addressed this question by investigating with functional magnetic resonance imaging (fMRI) the haemodynamic response during executive-type processing using a phonological verbal fluency and a working memory task in VPT-born young adults who had experienced differing degrees of neonatal brain injury. 12 VPT individuals with a history of periventricular haemorrhage and ventricular dilatation (PVH+VD), 17 VPT individuals with a history of uncomplicated periventricular haemorrhage (UPVH), 13 VPT individuals with no history of neonatal brain injury and 17 controls received an MRI scan whilst completing a verbal fluency task with two cognitive loads ('easy' and 'hard' letters). Two groups of VPT individuals (PVH+VD; n=10, UPVH; n=8) performed an n-back task with three cognitive loads (1-, 2-, 3-back). Results demonstrated that VPT individuals displayed hyperactivation in frontal, temporal, and parietal cortices and in caudate nucleus, insula and thalamus compared to controls, as demands of the verbal fluency task increased, regardless of type of neonatal brain injury. On the other hand, during the n-back task and as working memory load increased, the PVH+VD group showed less engagement of the frontal cortex than the UPVH group. In conclusion, this study suggests that the functional neuroanatomy of different executive-type processes is altered following VPT birth and that neural activation associated with specific aspects of executive function (i.e., working memory) may be particularly sensitive to the extent of neonatal brain injury.	[Kalpakidou, Anastasia K.; Allin, Matthew P. G.; Walshe, Muriel; McGuire, Philip K.; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Giampietro, Vincent] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Kalpakidou, AK (corresponding author), Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England.	anastasia.kalpakidou@kcl.ac.uk	Walshe, Muriel/E-5214-2010; Giampietro, Vincent P/D-1279-2011; murray, robin/F-8658-2012; Nosarti, Chiara/G-5638-2010	Walshe, Muriel/0000-0001-6829-1105; Giampietro, Vincent P/0000-0002-9381-8201; McGuire, Philip/0000-0003-4381-0532; murray, robin/0000-0003-0829-0519; Rifkin, Larry/0000-0003-2590-9010; Nosarti, Chiara/0000-0001-6305-9710	March of Dimes Birth Defects Foundation, USA [12-FY03-41]; Cerebra Foundation For The Brain Injured Infant; MRC [MR/K004867/1] Funding Source: UKRI	March of Dimes Birth Defects Foundation, USA(March of Dimes); Cerebra Foundation For The Brain Injured Infant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the March of Dimes Birth Defects Foundation, USA (12-FY03-41) (www.marchofdimes.com/) and the Cerebra Foundation For The Brain Injured Infant (www.cerebra.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Allin M, 2008, J NEUROL NEUROSUR PS, V79, P381, DOI 10.1136/jnnp.2006.110858; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; Baddeley A. D, 1986, WORKING MEMORY; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Curtis VA, 1998, AM J PSYCHIAT, V155, P1056, DOI 10.1176/ajp.155.8.1056; Curtis WJ, 2006, DEV NEUROPSYCHOL, V29, P341, DOI 10.1207/s15326942dn2902_4; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; EVRARD P, 1992, BIOL NEONATE, V61, P1; Fu CHY, 2002, NEUROIMAGE, V17, P871, DOI 10.1006/nimg.2002.1189; Fu CHY, 1999, PHILOS T R SOC B, V354, P1359, DOI 10.1098/rstb.1999.0484; Fu CHY, 2005, AM J PSYCHIAT, V162, P485, DOI 10.1176/appi.ajp.162.3.485; Griffiths ST, 2013, PEDIATR RES, V74, P196, DOI 10.1038/pr.2013.79; *HMSO, 1991, STAND OCC CLASS; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Kalpakidou AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034858; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Larroque B, 2003, J PEDIATR-US, V143, P477, DOI 10.1067/S0022-3476(03)00417-7; Lawrence EJ, 2010, J PEDIAT; Lawrence EJ, 2009, HUM BRAIN MAPP, V30, P1038, DOI 10.1002/hbm.20564; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Low KA, 2009, PSYCHOPHYSIOLOGY, V46, P1069, DOI 10.1111/j.1469-8986.2009.00854.x; Lurito JT, 2000, HUM BRAIN MAPP, V10, P99, DOI 10.1002/1097-0193(200007)10:3<99::AID-HBM10>3.0.CO;2-Q; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Murphy K, 1997, J APPL PHYSIOL, V83, P1438, DOI 10.1152/jappl.1997.83.5.1438; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2009, NEUROIMAGE; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2009, NEUROIMAGE; Nosarti C, 2008, BRAIN; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PANETH N, 1994, BRAIN DAMAGE PRETERM; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; ROTH SC, 1993, DEV MED CHILD NEUROL, V35, P755; Rubia K, 2007, BIOL PSYCHIAT, V62, P999, DOI 10.1016/j.biopsych.2007.02.024; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Salvan P, 2013, NEUROIMAGE; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; STEWART AL, 1989, DEV MED CHILD NEUROL, V31, P756; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; STEWART AL, 1983, ARCH DIS CHILD, V58, P598, DOI 10.1136/adc.58.8.598; Talairach I., 1988, COPLANAR STEREOTACTI; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Thuy ML, 2011, PEDIATRICS, V127, pE639, DOI 10.1542/peds.2010-1421; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Vasileiadis GT, 2004, PEDIATRICS, V114, pE367, DOI 10.1542/peds.2004-0500; Volpe JJ, 1995, NEUROLOGY NEWBORN, P95; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; YETKIN FZ, 1995, AM J NEURORADIOL, V16, P1087	79	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113975	10.1371/journal.pone.0113975	http://dx.doi.org/10.1371/journal.pone.0113975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438043	Green Published, gold			2022-12-27	WOS:000347114900105
J	Norwood, Z; Nyholm, E; Otanicar, T; Johnsson, F				Norwood, Zack; Nyholm, Emil; Otanicar, Todd; Johnsson, Filip			A Geospatial Comparison of Distributed Solar Heat and Power in Europe and the US	PLOS ONE			English	Article							PERFORMANCE; COLLECTORS; SYSTEMS	The global trends for the rapid growth of distributed solar heat and power in the last decade will likely continue as the levelized cost of production for these technologies continues to decline. To be able to compare the economic potential of solar technologies one must first quantify the types and amount of solar resource that each technology can utilize; second, estimate the technological performance potential based on that resource; and third, compare the costs of each technology across regions. In this analysis, we have performed the first two steps in this process. We use physical and empirically validated models of a total of 8 representative solar system types: non-tracking photovoltaics, 2d-tracking photovoltaics, high concentration photovoltaics, flat-plate thermal, evacuated tube thermal, concentrating trough thermal, concentrating solar combined heat and power, and hybrid concentrating photovoltaic/thermal. These models are integrated into a simulation that uses typical meteorological year weather data to create a yearly time series of heat and electricity production for each system over 12,846 locations in Europe and 1,020 locations in the United States. Through this simulation, systems composed of various permutations of collector-types and technologies can be compared geospatially and temporally in terms of their typical production in each location. For example, we see that silicon solar cells show a significant advantage in yearly electricity production over thin-film cells in the colder climatic regions, but that advantage is lessened in regions that have high average irradiance. In general, the results lead to the conclusion that comparing solar technologies across technology classes simply on cost per peak watt, as is usually done, misses these often significant regional differences in annual performance. These results have implications for both solar power development and energy systems modeling of future pathways of the electricity system.	[Norwood, Zack; Nyholm, Emil; Johnsson, Filip] Chalmers Tekn Hogskola, Gothenburg, Sweden; [Otanicar, Todd] Univ Tulsa, Dept Mech Engn, Tulsa, OK 74104 USA	Chalmers University of Technology; University of Tulsa	Norwood, Z (corresponding author), Chalmers Tekn Hogskola, Gothenburg, Sweden.	donkey@berkeley.edu		Otanicar, Todd/0000-0002-4579-6183; Johnsson, Filip/0000-0003-3106-5379	research program Pathways to Sustainable European Energy Systems; Chalmers Energy Initiative; E.ON	research program Pathways to Sustainable European Energy Systems; Chalmers Energy Initiative; E.ON	This work is financed by the research program Pathways to Sustainable European Energy Systems, E.ON, and the Chalmers Energy Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burroughs S, 2013, 2941 PSEL SAND NAT L; Chang TP, 2009, SOL ENERGY, V83, P1274, DOI 10.1016/j.solener.2009.02.009; Coventry JS, 2005, SOL ENERGY, V78, P211, DOI 10.1016/j.solener.2004.03.014; DEVOS A, 1980, J PHYS D APPL PHYS, V13, P839, DOI 10.1088/0022-3727/13/5/018; Dincertco, 2011, EV TUB COLL SKY 8CPC; Duffie JA, 2013, SOLAR ENGINEERING OF THERMAL PROCESSES, 4TH EDITION, P1, DOI 10.1002/9781118671603; Eurostat, 2013, BUILD ROADS OTH ART; Fischer S, 2004, SOL ENERGY, V76, P117, DOI 10.1016/j.solener.2003.07.021; Huld T, 2011, SOL ENERG MAT SOL C, V95, P3359, DOI 10.1016/j.solmat.2011.07.026; Huld T, 2010, SOL ENERGY, V84, P324, DOI 10.1016/j.solener.2009.12.002; Institut fur Solartechnik, 2013, CONC COLL POL 1800; International Energy Agency, 2013, EN BAL; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jiang Y, 2010, P 2010 IEEE INT S IE; Kalogirou SA, 2006, ENERG CONVERS MANAGE, V47, P3368, DOI 10.1016/j.enconman.2006.01.012; Kalogirou SA, 2004, PROG ENERG COMBUST, V30, P231, DOI 10.1016/j.pecs.2004.02.001; King DL, 2004, PHOT ARR PERF MOD; Lemmon E.W., 2013, NIST REFERENCE FLUID, DOI 10.18434/T4/1502528; Marion W, 2008, USERS MANUAL TMY3 DA, DOI [10.1093/oxfordjournals.aob.a088087, DOI 10.1093/OXFORDJOURNALS.AOB.A088087]; Masson G., 2013, GLOBAL MARKET OUTLOO; Norwood Z, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044016; Otanicar TP, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4811095; Otanicar T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3514590; Otanicar TP, 2011, J SOL ENERG-T ASME, V133, DOI 10.1115/1.4003679; PV Performance Modeling Collaborative, 2012, PHYS MOD IAM; Quaschning V, 2004, SOL ENERGY, V77, P171, DOI 10.1016/j.solener.2004.04.011; REINDL DT, 1990, SOL ENERGY, V45, P1, DOI 10.1016/0038-092X(91)90123-E; Remund Jan, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy, P4388; Skoplaki E, 2009, SOL ENERGY, V83, P614, DOI 10.1016/j.solener.2008.10.008; The MathWorks Inc, 2014, MATLAB REL 2014A; THEUNISSEN PH, 1985, SOL ENERGY, V35, P311, DOI 10.1016/0038-092X(85)90139-2; Wiginton LK, 2010, COMPUT ENVIRON URBAN, V34, P345, DOI 10.1016/j.compenvurbsys.2010.01.001	32	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112442	10.1371/journal.pone.0112442	http://dx.doi.org/10.1371/journal.pone.0112442			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474632	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500070
J	Ramakrishnan, K; Okkema, PG				Ramakrishnan, Kalpana; Okkema, Peter G.			Regulation of C-elegans Neuronal Differentiation by the ZEB-Family Factor ZAG-1 and the NK-2 Homeodomain Factor CEH-28	PLOS ONE			English	Article							SMAD-INTERACTING PROTEIN-1; CAENORHABDITIS-ELEGANS; TRANSCRIPTION-FACTOR; HIRSCHSPRUNG-DISEASE; CORNEAL-DYSTROPHY; NERVOUS-SYSTEM; DNA-BINDING; GENE; EXPRESSION; MUTATIONS	The C. elegans pharyngeal neuron M4 is a multi-functional cell that acts as a cholinergic motor neuron to stimulate peristaltic pharyngeal muscle contraction and as a neuroendocrine cell secreting neuropeptides and growth factors to affect other cells both inside and outside the pharynx. The conserved transcription factors ZAG-1 and CEH-28 are co-expressed in M4 through most of development, and here we examine how these factors contribute to M4 differentiation. We find ZAG-1 functions upstream of CEH-28 in a branched pathway to activate expression of different sets of M4 differentiation markers. CEH-28 activates expression of the growth factor genes dbl-1 and egl-17, and the neuropeptide genes flp-5 and flp-2, while ZAG-1 activates expression of the serotonin receptor ser-7, as well as expression of ceh-28 and its downstream targets. Other markers of M4 differentiation are expressed normally in both zag-1 and ceh-28 mutants, including the neuropeptide gene flp-21 and the acetylcholine biosynthetic gene unc-17. Unlike ceh-28 mutants, zag-1 mutants completely lack peristaltic muscle contractions resulting from broader defects in M4 differentiation. Despite these defects, neither ZAG-1 nor CEH-28 are terminal selectors of the M4 phenotype, and we suggest they function in a hierarchy to regulate different aspects of M4 differentiation.	[Ramakrishnan, Kalpana; Okkema, Peter G.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Okkema, PG (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	okkema@uic.edu			National Institutes of Health grant [R01 GM82865]; University of Illinois at Chicago's College of Liberal Arts and Sciences; Research Open Access Publishing Fund; State of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago's College of Liberal Arts and Sciences; Research Open Access Publishing Fund; State of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a grant from the National Institutes of Health grant R01 GM82865 (http://www.nih.gov/), the University of Illinois at Chicago's College of Liberal Arts and Sciences and the Research Open Access Publishing Fund (http://www.uic.edu/), and the State of Illinois (https://www.illinois.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chen XY, 2014, J NEUROSCI, V34, P6522, DOI 10.1523/JNEUROSCI.0022-14.2014; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Cui MX, 2003, DEV BIOL, V257, P104, DOI 10.1016/S0012-1606(03)00033-2; Dillner NB, 2004, DNA CELL BIOL, V23, P25, DOI 10.1089/104454904322745907; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lewis J.A., 1995, BASIC CULTURE METHOD, V48, P4; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Mello C, 1995, CAENORHABDITIS ELEGA, P451; Papaioannou S, 2005, J NEUROBIOL, V65, P304, DOI 10.1002/neu.20201; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; RAIZEN DM, 1995, GENETICS, V141, P1365; Ramakrishnan K, 2014, DEV BIOL, V390, P149, DOI 10.1016/j.ydbio.2014.03.015; Ray P, 2008, DEV NEUROBIOL, V68, P421, DOI 10.1002/dneu.20599; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Tomassy GS, 2013, NEURON, V77, P1, DOI 10.1016/j.neuron.2012.12.026; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; WATANABE Y, 1993, J BIOCHEM-TOKYO, V114, P849, DOI 10.1093/oxfordjournals.jbchem.a124267; Winner B, 2014, HUM MOL GENET	50	10	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113893	10.1371/journal.pone.0113893	http://dx.doi.org/10.1371/journal.pone.0113893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474681	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500098
J	Stein, J; Luppa, M; Ruzanska, U; Sikorski, C; Konig, HH; Riedel-Heller, SG				Stein, Janine; Luppa, Melanie; Ruzanska, Ulrike; Sikorski, Claudia; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Measuring Negative Attitudes towards Overweight and Obesity in the German Population - Psychometric Properties and Reference Values for the German Short Version of the Fat Phobia Scale (FPS)	PLOS ONE			English	Article							DIETETICS STUDENTS; WEIGHT BIAS; STIGMA; REJECTION; UPDATE	Objective: Obesity is one of the leading public health problems worldwide. Obese individuals are often stigmatized and the psychosocial consequences of overweight and obesity are the subject of current research. To detect stigmatizing attitudes towards obese people, the Fat Phobia Scale (FPS) was developed in the USA in the early nineties. In addition, the 14-item short form of the FPS was constructed. The FPS belongs to the most commonly used instruments for measuring negative attitudes towards obese people because of its good psychometric properties. For the recently developed German short form of the FPS, however, the comprehensive investigation of the psychometric properties and the determination of reference values are still pending. Thus, the main objectives of this study were the evaluation of the psychometric quality of the scale as well as the calculation of reference values. Methods: The study was based on a representative survey in the German general population. A sample of 1,657 subjects (18-94 years) was assessed via structured telephone interviews including the 14-item German version of the FPS. Descriptive statistics and inference-statistical analyses were conducted. Reference values in terms of percentage ranks were calculated. Results: Substantial evidence for the reliability and validity of the German short version of the FPS was found. This study, for the first time in Germany, provides age-specific reference values for the German short form of the FPS allowing the interpretation of individual test scores. Conclusion: Facing the far-reaching consequences of experienced stigmatization of obese individuals, these study results provide an important basis for further studies aiming at the investigation of negative attitudes towards overweight and obesity.	[Stein, Janine; Luppa, Melanie; Ruzanska, Ulrike; Sikorski, Claudia; Riedel-Heller, Steffi G.] Univ Leipzig, Fac Med, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Ruzanska, Ulrike] Univ Leipzig, Inst Psychol, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Sikorski, Claudia] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Koenig, Hans-Helmut] Univ Hamburg, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany	Leipzig University; Leipzig University; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stein, J (corresponding author), Univ Leipzig, Fac Med, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Janine.Stein@medizin.uni-leipzig.de	König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	König, Hans-Helmut/0000-0001-5711-6862; Gisch, Ulrike/0000-0002-5431-1221	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]; German Research Foundation (DFG); Leipzig University	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Berryman DE, 2006, J AM DIET ASSOC, V106, P1678, DOI 10.1016/j.jada.2006.07.016; Bogardus ES, 1933, SOCIOL SOC RES, V17, P271; Chen EY, 2005, OBES RES, V13, P1393, DOI 10.1038/oby.2005.168; Harkness J. A., 2003, CROSS CULTURAL SURVE; Harkness JA, 2008, EUROPEAN SOCIAL SURV, P1; Hayran Osman, 2013, J Allied Health, V42, P147; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; International Obesity Task Force, 2011, ANN REPORT; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; Latner JD, 2005, OBES RES, V13, P1226, DOI 10.1038/oby.2005.145; LINK BG, 1987, AM J SOCIOL, V92, P1461, DOI 10.1086/228672; LINK BG, 1987, AM SOCIOL REV, V52, P96, DOI 10.2307/2095395; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Maske UE, 2013, PSYCHIAT PRAX, V40, P207, DOI 10.1055/s-0033-1343103; McClure KJ, 2011, J HEALTH COMMUN, V16, P359, DOI 10.1080/10810730.2010.535108; Morrison T.G., 2009, HDB ASSESSMENT METHO, P79; O'Brien KS, 2013, INT J OBESITY, V37, P455, DOI 10.1038/ijo.2012.52; O'Brien KS, 2008, OBESITY, V16, pS87, DOI 10.1038/oby.2008.456; Pantenburg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048113; Pettigrew TF, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P262, DOI 10.1002/9780470773963.ch16; Poon MY, 2009, J CLIN NURS, V18, P2355, DOI 10.1111/j.1365-2702.2008.02709.x; Poustchi Y, 2013, FAM MED, V45, P345; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl R, 2009, J AM DIET ASSOC, V109, P438, DOI 10.1016/j.jada.2008.11.034; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; ROBINSON BE, 1993, INT J EAT DISORDER, V14, P467, DOI 10.1002/1098-108X(199312)14:4&lt;467::AID-EAT2260140410&gt;3.0.CO;2-J; Sikorski C, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046924; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Wolf Corri, 2010, J Physician Assist Educ, V21, P37; World Health Organization, 2008, GLOB HLTH OBS GHO OV; Wotzel H, 2014, PSYCHIAT PRAXIS; YUKER HE, 1995, HDB ASSESSMENT METHO, P81	39	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114641	10.1371/journal.pone.0114641	http://dx.doi.org/10.1371/journal.pone.0114641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474195	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500051
J	Sundberg, JP; Stearns, TM; Joh, J; Proctor, M; Ingle, A; Silva, KA; Dadras, SS; Jenson, AB; Ghim, SJ				Sundberg, John P.; Stearns, Timothy M.; Joh, Joongho; Proctor, Mary; Ingle, Arvind; Silva, Kathleen A.; Dadras, Soheil S.; Jenson, A. Bennett; Ghim, Shin-je			Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas	PLOS ONE			English	Article							MASTOMYS-NATALENSIS PAPILLOMAVIRUS; HAMSTER ORAL PAPILLOMAVIRUS; BASAL-CELL CARCINOMA; GENE-EXPRESSION; LANCEOLATE-HAIR; SENCAR MICE; STEM-CELLS; SKIN; INFECTION; UBIQUITIN	Papillomaviruses (PVs) induce papillomas, premalignant lesions, and carcinomas in a wide variety of species. PVs are classified first based on their host and tissue tropism and then their genomic diversities. A laboratory mouse papillomavirus, MmuPV1 (formerly MusPV), was horizontally transmitted within an inbred colony of NMRI-Foxn1(nu)/Foxn1(nu) (nude; T cell deficient) mice of an unknown period of time. A ground-up, filtered papilloma inoculum was not capable of infecting C57BL/6J wild-type mice; however, immunocompetent, alopecic, S/RV/Cri-ba/ba (bare) mice developed small papillomas at injection sites that regressed. NMRI-Foxn1(nu) and B6.Cg-Foxn1(nu), but not NU/J-Foxn1(nu), mice were susceptible to MmuPV1 infection. B6 congenic strains, but not other congenic strains carrying the same allelic mutations, lacking B- and T-cells, but not B-cells alone, were susceptible to infection, indicating that mouse strain and T-cell deficiency are critical to tumor formation. Lesions initially observed were exophytic papillomas around the muzzle, exophytic papillomas on the tail, and condylomas of the vaginal lining which could be induced by separate scarification or simultaneous scarification of MmuPV1 at all four sites. On the dorsal skin, locally invasive, poorly differentiated tumors developed with features similar to human trichoblastomas. Transcriptome analysis revealed significant differences between the normal skin in these anatomic sites and in papillomas versus trichoblastomas. The primarily dysregulated genes involved molecular pathways associated with cancer, cellular development, cellular growth and proliferation, cell morphology, and connective tissue development and function. Although trichoepitheliomas are benign, aggressive tumors, few of the genes commonly associated with basal cell carcinoma or squamous cells carcinoma were highly dysregulated.	[Sundberg, John P.; Stearns, Timothy M.; Silva, Kathleen A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Joh, Joongho; Proctor, Mary; Jenson, A. Bennett; Ghim, Shin-je] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Ingle, Arvind] Tata Mem Hosp, Kharghar, Navi Mumbai, India; [Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Dermatol & Genet Dev Biol, Farmington, CT USA	Jackson Laboratory; University of Louisville; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Connecticut	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org		Stearns, Timothy/0000-0002-5533-6076	University of Louisville Clinical and Translational Science Pilot Grant Program; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	University of Louisville Clinical and Translational Science Pilot Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Louisville Clinical and Translational Science Pilot Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine K, 2005, J CELL BIOCHEM, V95, P763, DOI 10.1002/jcb.20487; Battistella M, 2013, AM J DERMATOPATHOL; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Binder RL, 1997, MOL CARCINOGEN, V20, P151, DOI 10.1002/(SICI)1098-2744(199709)20:1<151::AID-MC17>3.0.CO;2-0; Binder RL, 1998, CANCER RES, V58, P4314; Bonnez W, 1998, J VIROL, V72, P5256, DOI 10.1128/JVI.72.6.5256-5261.1998; Carney H C, 1990, J Vet Diagn Invest, V2, P294; Chen J, 2008, J INVEST DERMATOL, V128, P270, DOI 10.1038/sj.jid.5701038; Cladel NM, 2013, J VIROL, V87, P9391, DOI 10.1128/JVI.00777-13; Conti C, 1996, PATHOBIOLOGY AGING M; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; da Silva-Diz V, 2013, ONCOGENE, V32, P3732, DOI 10.1038/onc.2012.375; De Vico G, 2011, ANAL QUANT CYTOL, V33, P151; Folster-Holst R, 1999, BRIT J DERMATOL, V140, P1139; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldschmidt MH, 2002, TUMORS DOMESTIC ANIM, P58; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Handisurya A, 2013, J VIROL, V87, P13214, DOI 10.1128/JVI.02162-13; Handisurya A, 2012, VIROLOGY, V433, P385, DOI 10.1016/j.virol.2012.08.035; Harel S, 2012, J INVEST DERMATOL, V132, P2315, DOI 10.1038/jid.2012.291; HogenEsch H, 1999, PATHOBIOLOGY, V67, P45, DOI 10.1159/000028050; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Ito T, 2013, EUR J DERMATOL, V23, P277, DOI 10.1684/ejd.2013.1961; Iwasaki T, 1997, J GEN VIROL, V78, P1087, DOI 10.1099/0022-1317-78-5-1087; Joh J, 2012, EXP MOL PATHOL, V93, P416, DOI 10.1016/j.yexmp.2012.07.001; Joh J, 2011, J GEN VIROL, V92, P692, DOI 10.1099/vir.0.026138-0; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; KREIDER JW, 1986, J VIROL, V59, P369, DOI 10.1128/JVI.59.2.369-376.1986; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Lin K, 2010, J FORMOS MED ASSOC, V109, P4, DOI 10.1016/S0929-6646(10)60017-4; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Maeda H, 2005, J INT MED RES, V33, P647, DOI 10.1177/147323000503300606; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; McCarthy N, 2007, NAT REV CANCER, V7, P404, DOI 10.1038/nrc2156; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Meyer B, 2004, DIFFERENTIATION, V72, P541, DOI 10.1111/j.1432-0436.2004.07209007.x; Mikaelian I, 2004, TOXICOL PATHOL, V32, P181, DOI 10.1080/01926230490274335; Montagutelli X, 1996, J INVEST DERMATOL, V107, P20, DOI 10.1111/1523-1747.ep12297438; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nafz J, 2007, J GEN VIROL, V88, P2670, DOI 10.1099/vir.0.82955-0; Nancarrow DJ, 2008, CANC RES, V68; Osio A, 2013, AM J DERMATOPATH, V35, P284, DOI 10.1097/DAD.0b013e3182631622; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Petry IB, 2010, CLIN CANCER RES, V16, P451, DOI 10.1158/1078-0432.CCR-09-1617; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; RANDELIA HP, 1961, GENET RES, V2, P283, DOI 10.1017/S0016672300000756; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roop D, 2008, NAT GENET, V40, P1040, DOI 10.1038/ng0908-1040; Ross PL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-69; Schafer K, 2010, J VIROL METHODS, V163, P216, DOI 10.1016/j.jviromet.2009.09.020; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schirren CG, 1997, AM J DERMATOPATH, V19, P341, DOI 10.1097/00000372-199708000-00005; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schulz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047164; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; Segrelles C, 2014, STEM CELLS; Sharif M, 2006, J VET MED A, V53, P352, DOI 10.1111/j.1439-0442.2006.00834.x; Sher RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023498; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sundberg J. P., 2012, COMP ANATOMY HISTOLO, P433; Sundberg JP, 2000, VET PATHOL, V37, P1, DOI 10.1354/vp.37-1-1; SUNDBERG JP, 1990, CARCINOGENESIS, V11, P341, DOI 10.1093/carcin/11.2.341; SUNDBERG JP, 1988, VET PATHOL, V25, P356, DOI 10.1177/030098588802500504; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Sundberg JP, 2000, EXP DERMATOL, V9, P206, DOI 10.1034/j.1600-0625.2000.009003206.x; Sundberg JP, 1996, HUMAN PAPILLOMAVIRUS, P47; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; TAN CH, 1994, VIROLOGY, V198, P534, DOI 10.1006/viro.1994.1064; Tomlins C, 2010, CARCINOGENESIS, V31, P2155, DOI 10.1093/carcin/bgq200; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; Van Doorslaer K, 2011, TRENDS MICROBIOL, V19, P49, DOI 10.1016/j.tim.2010.11.004; VANRANST M, 1992, NUCLEIC ACIDS RES, V20, P2889, DOI 10.1093/nar/20.11.2889; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Weber F, 2001, BRIT J DERMATOL, V144, P1044, DOI 10.1046/j.1365-2133.2001.04196.x; White AC, 2014, NAT CELL BIOL, V16, P99, DOI 10.1038/ncb2889; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; WU H, 2003, ANAL GENE EXPRESSION; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zakrzewska K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-309; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	90	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113582	10.1371/journal.pone.0113582	http://dx.doi.org/10.1371/journal.pone.0113582			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474466	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500086
J	Tong, WC; Tribe, RM; Smith, R; Taggart, MJ				Tong, Wing-Chiu; Tribe, Rachel M.; Smith, Roger; Taggart, Michael J.			Computational Modeling Reveals Key Contributions of KCNQ and hERG Currents to the Malleability of Uterine Action Potentials Underpinning Labor	PLOS ONE			English	Article							GO-RELATED GENES; POTASSIUM CHANNELS; K+-CHANNEL; FUNCTIONAL-CHARACTERIZATION; SPLICE VARIANT; KV7 CHANNELS; EXPRESSION; MYOMETRIUM; INACTIVATION; DEPENDENCE	The electrical excitability of uterine smooth muscle cells is a key determinant of the contraction of the organ during labor and is manifested by spontaneous, periodic action potentials (APs). Near the end of term, APs vary in shape and size reflecting an ability to change the frequency, duration and amplitude of uterine contractions. A recent mathematical model quantified several ionic features of the electrical excitability in uterine smooth muscle cells. It replicated many of the experimentally recorded uterine AP configurations but its limitations were evident when trying to simulate the long-duration bursting APs characteristic of labor. A computational parameter search suggested that delayed rectifying K+ currents could be a key model component requiring improvement to produce the longer-lasting bursting APs. Of the delayed rectifying K+ currents family it is of interest that KCNQ and hERG channels have been reported to be gestationally regulated in the uterus. These currents exhibit features similar to the broadly defined uterine I-K1 of the original mathematical model. We thus formulated new quantitative descriptions for several I-KCNQ and I-hERG. Incorporation of these currents into the uterine cell model enabled simulations of the long-lasting bursting APs. Moreover, we used this modified model to simulate the effects of different contributions of IKCNQ and IhERG on AP form. Our findings suggest that the alterations in expression of hERG and KCNQ channels can potentially provide a mechanism for fine tuning of AP forms that lends a malleability for changing between plateau-like and long-lasting bursting-type APs as uterine cells prepare for parturition.	[Tong, Wing-Chiu; Taggart, Michael J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Tribe, Rachel M.] Kings Hlth Partners, London, England; [Smith, Roger] Univ Newcastle, Hunter Med Res Inst, New Lambton, NSW, Australia	Newcastle University - UK; University of London; King's College London; University of London; King's College London; Hunter Medical Research Institute; University of Newcastle	Taggart, MJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.taggart@ncl.ac.uk		Smith, Roger/0000-0003-4720-0280; Taggart, Michael/0000-0002-9981-2783; Tribe, Rachel/0000-0003-3675-9978	UK Medical Research Council [G0900525, G1100243]; Bioinformatics Training Fellowship [G0902091]; MRC [G0900525, G0902091, G1100243] Funding Source: UKRI; Medical Research Council [G0902091, G1100243, G0900525] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bioinformatics Training Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (G0900525, G1100243, www.mrc.ac.uk) including a Bioinformatics Training Fellowship to WCT (G0902091). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2006, J MEMBRANE BIOL, V211, P115, DOI 10.1007/s00232-006-0010-9; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; BOYLE MB, 1987, SCIENCE, V235, P1221, DOI 10.1126/science.2434999; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gibor G, 2004, J GEN PHYSIOL, V124, P83, DOI 10.1085/jgp.200409068; Goldbeter A, 2012, FEBS LETT, V586, P2955, DOI 10.1016/j.febslet.2012.07.041; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Inoue Y, 1999, CAN J PHYSIOL PHARM, V77, P447, DOI 10.1139/cjpp-77-6-447; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Khan RN, 1997, AM J PHYSIOL-CELL PH, V273, pC1721, DOI 10.1152/ajpcell.1997.273.5.C1721; Knock GA, 1999, J PHYSIOL-LONDON, V518, P769, DOI 10.1111/j.1469-7793.1999.0769p.x; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Larsen AP, 2011, BIOPHYS J, V101, P818, DOI 10.1016/j.bpj.2011.06.034; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; London B, 1997, CIRC RES, V81, P870; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Parkington HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5108; Peretz A, 2002, J PHYSIOL-LONDON, V545, P751, DOI 10.1113/jphysiol.2002.028381; Pervolaraki E, 2013, BIOSYSTEMS, V112, P63, DOI 10.1016/j.biosystems.2013.03.012; Pusch M, 2001, J PHYSIOL-LONDON, V533, P135, DOI 10.1111/j.1469-7793.2001.0135b.x; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roura-Ferrer M, 2009, CELL PHYSIOL BIOCHEM, V24, P325, DOI 10.1159/000257425; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Seebohm G, 2001, BRIT J PHARMACOL, V134, P1647, DOI 10.1038/sj.bjp.0704421; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Sharp GC, 2013, MOL HUM REPROD, V19, P711, DOI 10.1093/molehr/gat043; Shoeb F, 2003, J BIOL CHEM, V278, P2503, DOI 10.1074/jbc.M208525200; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Su TR, 2009, ACTA PHARMACOL SIN, V30, P1220, DOI 10.1038/aps.2009.117; Taggart MJ, 1998, J PHYSIOL-LONDON, V509, P315, DOI 10.1111/j.1469-7793.1998.315bn.x; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Wang SM, 1996, FEBS LETT, V389, P167, DOI 10.1016/0014-5793(96)00570-4; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; WILDE DW, 1988, BIOL REPROD, V38, P836, DOI 10.1095/biolreprod38.4.836; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2008, BIOCHEM BIOPH RES CO, V371, P741, DOI 10.1016/j.bbrc.2008.04.129; Yeung SYM, 2007, AM J PHYSIOL-CELL PH, V292, pC468, DOI 10.1152/ajpcell.00142.2006; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Young RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065110; Zhang ST, 2003, J PHYSIOL-LONDON, V548, P691, DOI 10.1113/jphysiol.2003.039198	53	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114034	10.1371/journal.pone.0114034	http://dx.doi.org/10.1371/journal.pone.0114034			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474527	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500105
J	Zhang, XM; Yamaoka, K; Sonomoto, K; Kaneko, H; Satake, M; Yamamoto, Y; Kondo, M; Zhao, JD; Miyagawa, I; Yamagata, K; Fukuyo, S; Okada, Y; Tanaka, Y				Zhang, Xiangmei; Yamaoka, Kunihiro; Sonomoto, Koshiro; Kaneko, Hiroaki; Satake, Makoto; Yamamoto, Yuka; Kondo, Masahiro; Zhao, Jidong; Miyagawa, Ippei; Yamagata, Kaoru; Fukuyo, Shunsuke; Okada, Yosuke; Tanaka, Yoshiya			Local Delivery of Mesenchymal Stem Cells with Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold Suppress Arthritis in Rats	PLOS ONE			English	Article							REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; BONE-MARROW; CLINICAL-APPLICATIONS; IMMUNE TOLERANCE; DIFFERENTIATION; TRANSPLANTATION; INDUCTION	Mesenchymal stem cells (MSC) have been used recently for the treatment of autoimmune diseases in murine animal models due to the immunoregulatory capacity. Current utilization of MSC requires cells in certain quantity with multiple courses of administration, leading to limitation in clinical usage. Here we efficiently treated collagen-induced arthritis rats with a single local implantation with reduced number of MSC (2 similar to 20% of previous studies) with nano-fiber poly-lactic-co-glycolic acid (nano-fiber) scaffold. MSC seeded on nano-fiber scaffold suppressed arthritis and bone destruction due to inhibition of systemic inflammatory reaction and immune response by suppressing T cell proliferation and reducing anti-type II collagen antibody production. In vivo tracing of MSC demonstrated that these cells remained within the scaffold without migrating to other organs. Meanwhile, in vitro culture of MSC with nano-fiber scaffold significantly increased TGF-beta 1 production. These results indicate an efficient utilization of MSC with the scaffold for destructive joints in rheumatoid arthritis by a single and local inoculation. Thus, our data may serve as a new strategy for MSC-based therapy in inflammatory diseases and an alternative delivery method for bone destruction treatment.	[Zhang, Xiangmei; Yamaoka, Kunihiro; Sonomoto, Koshiro; Kondo, Masahiro; Zhao, Jidong; Miyagawa, Ippei; Yamagata, Kaoru; Fukuyo, Shunsuke; Okada, Yosuke; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; [Kaneko, Hiroaki; Satake, Makoto; Yamamoto, Yuka] Teijin Ltd, Integrat Technol Res Inst, Tokyo, Japan; [Kondo, Masahiro] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 1, Yokohama, Kanagawa, Japan	University of Occupational & Environmental Health - Japan; Teijin Limited; Mitsubishi Tanabe Pharma Corporation	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan.	tanaka@med.uoeh-u.ac.jp	Okada, Yosuke/AAT-3173-2020; Miyagawa, Ippei/AHB-0789-2022		Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan; UOEH Grant for Advanced Research; Grants-in-Aid for Scientific Research [25860821] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan); UOEH Grant for Advanced Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Research Grants-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan and UOEH Grant for Advanced Research. Hiroaki Kaneko, Makoto Satake and Yuka Yamamoto are employees of the Teijin Limited. Masahiro Kondo is employee of the Mitsubishi Tanabe Pharma Corporation. Teijin Limited and Mitsubishi Tanabe Pharma Corporation provided support in the form of salaries for authors HK, MS, YY and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Behrens F, 2007, ANN RHEUM DIS, V66, P1151, DOI 10.1136/ard.2006.068320; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davies JE, 2010, ORGANOGENESIS, V6, P161, DOI 10.4161/org.6.3.12392; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Kondo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079463; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Liang J, 2009, MULT SCLER J, V15, P644, DOI 10.1177/1352458509104590; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; MacDonald GIA, 2011, ARTHRITIS RHEUM-US, V63, P2547, DOI 10.1002/art.30474; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Papadopoulou A, 2012, ANN RHEUM DIS, V71, P1733, DOI 10.1136/annrheumdis-2011-200985; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ra JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-181; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schurgers E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2939; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Sun LY, 2007, LUPUS, V16, P121, DOI 10.1177/0961203306075793; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Zheng ZH, 2008, RHEUMATOLOGY, V47, P22, DOI 10.1093/rheumatology/kem284	41	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114621	10.1371/journal.pone.0114621	http://dx.doi.org/10.1371/journal.pone.0114621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474102	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500050
J	Carney, J; Wlodarski, R; Dunbar, R				Carney, James; Wlodarski, Rafael; Dunbar, Robin			Inference or Enaction? The Impact of Genre on the Narrative Processing of Other Minds	PLOS ONE			English	Article							EMPATHY; SIMULATION; ATTENTION; RELEVANCE; EVOLUTION; AUTISM; BIAS	Do narratives shape how humans process other minds or do they presuppose an existing theory of mind? This study experimentally investigated this problem by assessing subject responses to systematic alterations in the genre, levels of intentionality, and linguistic complexity of narratives. It showed that the interaction of genre and intentionality level are crucial in determining how narratives are cognitively processed. Specifically, genres that deployed evolutionarily familiar scenarios (relationship stories) were rated as being higher in quality when levels of intentionality were increased; conversely, stories that lacked evolutionary familiarity (espionage stories) were rated as being lower in quality with increases in intentionality level. Overall, the study showed that narrative is not solely either the origin or the product of our intuitions about other minds; instead, different genres will have different-even opposite-effects on how we understand the mind states of others.	[Carney, James; Wlodarski, Rafael; Dunbar, Robin] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Carney, J (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	james.carney@psy.ox.ac.uk		Carney, James/0000-0001-6064-7867	European Commission [297854]; European Research Council [295663]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	JC was funded by a European Commission Marie Curie Fellowship (no. 297854); RD and RW were funded by a European Research Council Advanced Investigators' Grant (no. 295663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, WHY HUMANS COOPERATE; Astington J, 2008, ENCY INFANT EARLY CH, P346; Attridge Derek, 2004, SINGULARITY LIT; Bal PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055341; Beard C, 2010, J SEX MARITAL THER, V36, P216, DOI 10.1080/00926231003719616; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; Blow AJ, 2005, J MARITAL FAM THER, V31, P217, DOI 10.1111/j.1752-0606.2005.tb01556.x; BRUNER J, 1991, CRIT INQUIRY, V18, P1, DOI 10.1086/448619; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Buss David M, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P23; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Caracciolo M, 2012, PHENOMENOL COGN SCI, V11, P367, DOI 10.1007/s11097-011-9216-0; Chambers A, 2009, FINANCIAL TIMES; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; David-Barrett T, 2012, J THEOR BIOL, V308, P88, DOI 10.1016/j.jtbi.2012.05.007; Devaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087619; Dunbar R, 2005, J CULTURAL EVOLUTION, V3, P7, DOI DOI 10.1556/JCEP.3.2005.1.1; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Dunn J., 1988, BEGINNINGS SOCIAL UN; Eliot TS, 1957, SOCIAL FUNCTION POET, P15; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Fludernik M., 2004, NATURAL NARRATOLOGY; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; Gallagher S, 2008, CONSCIOUS COGN, V17, P535, DOI 10.1016/j.concog.2008.03.003; Gallagher S, 2012, SCI CONTEXT, V25, P355, DOI 10.1017/S0269889712000117; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gibson J.J., 1986, ECOLOGICAL APPROACH; Henrich Joseph, 2002, J COGN CULT, P87; Herman D, 1997, PMLA, V112, P1046, DOI 10.2307/463482; Hogan-Brown AL, 2013, AJIDD-AM J INTELLECT, V118, P77, DOI 10.1352/1944-7558-118.2.77; Hughes Susan M., 2004, SEXUALITIES EVOLUTIO, V6.1, P3, DOI DOI 10.1080/14616660410001733588; Hutto D. D., 2013, RADICALIZING ENACTIV; Hutto D.D., 2008, FOLK PSYCHOL NARRATI, DOI [10.7551/mitpress/7525.001.0001, DOI 10.7551/MITPRESS/7525.001.0001]; Hutto DD, 2011, STYLE, V45, P276; Keenan JM., 2012, MEASURING ADV ASSESS, P77; Kidd DC, 2013, SCIENCE, P1; Kleinman A., 1988, ILLNESS NARRATIVES; LOVELAND KA, 1990, BRIT J DEV PSYCHOL, V8, P9, DOI 10.1111/j.2044-835X.1990.tb00818.x; MacIntyre A., 1984, AFTER VIRTUE; Menary R, 2010, PHENOMENOL COGN SCI, V9, P605, DOI 10.1007/s11097-010-9185-8; Narvaez D, 1998, J EDUC PSYCHOL, V90, P13, DOI 10.1037/0022-0663.90.1.13; O'Regan JK, 2004, THEORY DECIS LIB A, V38, P103; Paas F, 2012, EDUC PSYCHOL REV, V24, P27, DOI 10.1007/s10648-011-9179-2; Pilkington, 1996, LANG LIT, V5, P157, DOI DOI 10.1177/096394709600500301; Plass J. L., 2010, COGNITIVE LOAD THEOR; Ribeiro AC, 2013, PHILOS LITERATURE, V37, P102, DOI 10.1353/phl.2013.0016; Rowlands Mark, 2010, NEW SCI MIND EXTENDE; Roy J., 1999, NATURALIZING PHENOME, P1; Schank RC., 1977, SCRIPTS PLANS GOALS; Schilbach L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00278; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Scholl BJ, 1999, MIND LANG, V14, P131, DOI 10.1111/1468-0017.00106; Seyfarth RM, 2013, P NATL ACAD SCI USA, V110, P10349, DOI 10.1073/pnas.1301223110; Smith P, 2004, SEX ABUSE-J RES TR, V16, P163, DOI 10.1177/107906320401600206; SOMERS MR, 1994, THEOR SOC, V23, P605, DOI 10.1007/BF00992905; Spence D.P., 1986, NARRATIVE PSYCHOL ST; SPERBER D, 1987, BEHAV BRAIN SCI, V10, P697, DOI 10.1017/S0140525X00055345; Sperber D, 2010, REV PHILOS PSYCHOL, V1, P583, DOI 10.1007/s13164-010-0025-0; Stueber KR, 2012, EMOT REV, V4, P55, DOI 10.1177/1754073911421380; Sugiyama MS, 2009, J CONSCIOUSNESS STUD, V16, P94; Sweller J., 1994, LEARN INSTR, V4, P295, DOI DOI 10.1016/0959-4752(94)90003-5; Sweller J, 2011, EXPLOR LEARN SCI, P3, DOI 10.1007/978-1-4419-8126-4; Troscianko Emily, 2014, KAFKAS COGNITIVE REA; van den Hout M, 2000, J AFFECT DISORDERS, V61, P241, DOI 10.1016/S0165-0327(00)00341-4; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wilson D., 2004, HDB PRAGMATICS, P607; Zunshine Lisa, 2006, WHY WE READ FICTION	69	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114172	10.1371/journal.pone.0114172	http://dx.doi.org/10.1371/journal.pone.0114172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470279	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000349128700081
J	Floer, M; Biecker, E; Fitzlaff, RD; Roming, H; Ameis, D; Heinecke, A; Kunsch, S; Ellenrieder, V; Strobel, P; Schepke, M; Meister, T				Floer, Martin; Biecker, Erwin; Fitzlaff, Ruediger; Roeming, Hermann; Ameis, Detlev; Heinecke, Achim; Kunsch, Steffen; Ellenrieder, Volker; Stroebel, Philipp; Schepke, Michael; Meister, Tobias			Higher Adenoma Detection Rates with Endocuff-Assisted Colonoscopy - A Randomized Controlled Multicenter Trial	PLOS ONE			English	Article							COLORECTAL-CANCER; ENDOSCOPY; QUALITY; COLON; WITHDRAWAL; MORTALITY; EVALUATE; PROGRAM; IMPACT; RISK	Objectives: The Endocuff is a device mounted on the tip of the colonoscope to help flatten the colonic folds during withdrawal. This study aimed to compare the adenoma detection rates between Endocuff-assisted (EC) colonoscopy and standard colonoscopy (SC). Methods: This randomized prospective multicenter trial was conducted at four academic endoscopy units in Germany. Participants: 500 patients (235 males, median age 64[IQR 54-73]) for colon adenoma detection purposes were included in the study. All patients were either allocated to EC or SC. The primary outcome measure was the determination of the adenoma detection rates (ADR). Results: The ADR significantly increased with the use of the Endocuff compared to standard colonoscopy (35.4%[95% confidence interval{CI} 29-41%] vs. 20.7%[95% CI 15-26%], p<0.0001). Significantly more sessile polyps were detected by EC. Overall procedure time and withdrawal time did not differ. Caecal and ileum intubation rates were similar. No major adverse events occurred in both groups. In multivariate analysis, age (odds ratio [OR] 1.03; 95%[CI] 1.01-1.05), male sex (OR 1.74; 95% CI 1.10-2.73), withdrawal time (OR 1.16; 95% CI 1.05-1.30), procedure time (OR 1.07; 95% CI 1.04-1.10), colon cleanliness (OR 0.60; 95% CI 0.39-0.94) and use of Endocuff (OR 2.09; 95% CI 1.34-3.27) were independent predictors of adenoma detection rates. Conclusions: EC increases the adenoma detection rate by 14.7%(95% CI 6.9-22.5%). EC is safe, effective, easy to handle and might reduce colorectal interval carcinomas.	[Floer, Martin; Roeming, Hermann; Meister, Tobias] HELIOS Albert Schweitzer Hosp Northeim, Dept Gastroenterol, Northeim, Germany; [Biecker, Erwin; Schepke, Michael] HELIOS Med Ctr Siegburg, Siegburg, Germany; [Fitzlaff, Ruediger; Ameis, Detlev] HELIOS St Marienberg Hosp Helmstedt, Helmstedt, Germany; [Heinecke, Achim] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Biecker, Erwin] Zollernalb Med Ctr, Dept Gastroenterol, Bailingen, Germany; [Kunsch, Steffen; Ellenrieder, Volker] Univ Med Ctr Gottingen, Dept Gastroenterol 2, Gottingen, Germany; [Stroebel, Philipp] Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany	University of Munster; University of Gottingen; University of Gottingen	Meister, T (corresponding author), HELIOS Albert Schweitzer Hosp Northeim, Dept Gastroenterol, Northeim, Germany.	tobiasmeister@gmx.de			HELIOS Research Centre [003053]	HELIOS Research Centre	This study was supported by the HELIOS Research Centre, Grant ID 003053 (www.helios-wissen.de/hrc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; Biecker E, 2014, J CLIN GASTROENTEROL; Bjorkman DJ, 2006, AM J GASTROENTEROL, V101, P864, DOI 10.1111/j.1572-0241.2006.00667.x; Cadoni S, 2014, ENDOSCOPY, V46, P212, DOI 10.1055/s-0033-1353604; Chung SJ, 2014, GUT, V63, P785, DOI 10.1136/gutjnl-2013-304578; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; de Wijkerslooth TR, 2012, GUT, V61, P1426, DOI 10.1136/gutjnl-2011-301327; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frieling T, 2013, Z GASTROENTEROL, V51, P1383, DOI 10.1055/s-0033-1335637; Frieling T, 2012, Z GASTROENTEROL, V50, P279, DOI 10.1055/s-0031-1281707; Gralnek IM, 2014, LANCET ONCOL, V15, P353, DOI 10.1016/S1470-2045(14)70020-8; Hsieh YH, 2014, AM J GASTROENTEROL; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Lee TJW, 2013, ENDOSCOPY, V45, P20, DOI 10.1055/s-0032-1325803; Leighton JA, 2011, ENDOSCOPY, V43, P123, DOI 10.1055/s-0030-1255916; Lenze F, 2014, ENDOSCOPY, V46, P610, DOI 10.1055/s-0034-1365446; Leung FW, 2013, J INTERV GASTROENTER, V3, P100; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rastogi A, 2012, GUT, V61, P402, DOI 10.1136/gutjnl-2011-300187; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex DK, 2013, GASTROENTEROL CLIN N, V42, P429, DOI 10.1016/j.gtc.2013.05.009; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Senore C, 2014, DIG LIVER DIS; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Tsiamoulos ZP, 2014, GUT, V63, pA152, DOI 10.1136/gutjnl-2014-307263.327; Tsiamoulos ZP, 2012, GASTROINTEST ENDOSC, V76, P1242, DOI 10.1016/j.gie.2012.08.019; Yen AW, 2013, GASTROINTEST ENDOSC, V77, P944, DOI 10.1016/j.gie.2013.01.011	29	80	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114267	10.1371/journal.pone.0114267	http://dx.doi.org/10.1371/journal.pone.0114267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470133	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700094
J	Shu, C; Du, W; Mao, XF; Li, Y; Zhu, Q; Wang, W; Wu, N; Mao, XM; Jin, HZ; Sun, QN				Shu, Chang; Du, Wei; Mao, Xiaofei; Li, Yun; Zhu, Qin; Wang, Wei; Wu, Nan; Mao, Xuming; Jin, Hongzhong; Sun, Qiuning			Possible Single-Nucleotide Polymorphism Loci Associated with Systemic Sclerosis Susceptibility: A Genetic Association Study in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHOB; VARIANTS; SHESIS; CELLS	Objective: The aim of this study was to confirm the association of RHOB and FAM167A-BLK gene polymorphisms with susceptibility to systemic sclerosis (SSc) in a Chinese Han population. Methods: A total of 248 SSc patients and 251 healthy controls of Chinese Han ethnicity, which visited the department of dermatology of Peking Union Medical College Hospital, were included in the study. Six selected single nucleotide polymorphisms (SNPs) in the RHOB and FAM167A-BLK regions were selected as markers and were genotyped using a MassARRAY system, which is based on the matrix-assisted laser desorption/ ionization time of flight mass spectrometry technique. Results: Three SNPs in the coding regions of the RHOB and FAM167A-BLK genes displayed an association with SSc: (1) rs1062292T, which is a newly discovered SNP in the RHOB gene (P=0.03, odds ratio [OR] = 1.62, 95% confidence interval (CI)=1.05-2.50), (2) rs2736340T (P=0.03, OR=1.39, 95% CI=1.03-1.85), and (3) rs13277113A (P=0.04, OR=1.34, 95% CI=1.011.76), both in the FAM167A-BLK gene. Our results support previous findings that vaiants in the RHOB and FAM167A-BLK genes may be associated with susceptibility to SSc. However, the loci of the SNPs in RHOB region that displayed an association with SSc are quite different from the loci which were identified in studies of Caucasian populations. Conclusion: Our results confirm that RHOB and FAM167A-BLK polymorphisms exist in Chinese Han SSc patients. Therefore, variants of the RHOB and FAM167ABLK genes are promising genetic markers for SSc.	[Shu, Chang; Du, Wei; Mao, Xiaofei; Li, Yun; Zhu, Qin; Wang, Wei; Jin, Hongzhong; Sun, Qiuning] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100005, Peoples R China; [Wu, Nan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Surg, Beijing 100005, Peoples R China; [Mao, Xuming] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Pennsylvania	Sun, QN (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100005, Peoples R China.	sunqnzhy@yahoo.com	Wu, Nan/R-2186-2017; Sun, Qiuning/AAJ-3692-2021	Wu, Nan/0000-0002-9429-2889; Sun, Qiuning/0000-0002-1912-341X	National Natural Science Foundation of China [81071300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81071300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bossini-Castillo L, 2013, ANN RHEUM DIS, V72, P602, DOI 10.1136/annrheumdis-2012-201888; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ito I, 2010, ARTHRITIS RHEUM-US, V62, P890, DOI 10.1002/art.27303; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tretter T, 2003, J EXP MED, V198, P1863, DOI 10.1084/jem.20030729; Yi L, 2013, INT J IMMUNOPATH PH, V26, P473, DOI 10.1177/039463201302600220; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113197	10.1371/journal.pone.0113197	http://dx.doi.org/10.1371/journal.pone.0113197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470816	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700017
J	Valle, KC; Nymark, M; Aamot, I; Hancke, K; Winge, P; Andresen, K; Johnsen, G; Brembu, T; Bones, AM				Valle, Kristin Colller; Nymark, Marianne; Aamot, Inga; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Brembu, Tore; Bones, Atle M.			System Responses to Equal Doses of Photosynthetically Usable Radiation of Blue, Green, and Red Light in the Marine Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							PHOTOSYSTEM-II; THALASSIOSIRA-PSEUDONANA; CHLOROPHYLL FLUORESCENCE; CARBON METABOLISM; SINGLET OXYGEN; GROWTH; PHYTOPLANKTON; COMPLEX; QUALITY; ACCLIMATION	Due to the selective attenuation of solar light and the absorption properties of seawater and seawater constituents, free-floating photosynthetic organisms have to cope with rapid and unpredictable changes in both intensity and spectral quality. We have studied the transcriptional, metabolic and photo-physiological responses to light of different spectral quality in the marine diatom Phaeodactylum tricornutum through time-series studies of cultures exposed to equal doses of photosynthetically usable radiation of blue, green and red light. The experiments showed that short-term differences in gene expression and profiles are mainly light quality-dependent. Transcription of photosynthesis-associated nuclear genes was activated mainly through a light quality-independent mechanism likely to rely on chloroplast-to-nucleus signaling. In contrast, genes encoding proteins important for photoprotection and PSII repair were highly dependent on a blue light receptor-mediated signal. Changes in energy transfer efficiency by light-harvesting pigments were spectrally dependent; furthermore, a declining trend in photosynthetic efficiency was observed in red light. The combined results suggest that diatoms possess a light quality-dependent ability to activate photoprotection and efficient repair of photodamaged PSII. In spite of approximately equal numbers of PSII-absorbed quanta in blue, green and red light, the spectral quality of light is important for diatom responses to ambient light conditions.	[Valle, Kristin Colller; Nymark, Marianne; Aamot, Inga; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Brembu, Tore; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Hancke, Kasper] Univ Southern Denmark, Inst Biol, DK-5230 Odense M, Denmark	Norwegian University of Science & Technology (NTNU); University of Southern Denmark	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway.	atle.m.bones@ntnu.no	Brembu, Tore/J-7166-2015; Nymark, Marianne/H-2535-2016; Bones, Atle M/C-6202-2014	Brembu, Tore/0000-0001-5622-8037; Nymark, Marianne/0000-0002-0672-0653; Bones, Atle M/0000-0003-0544-7437	Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council [NFR 184146/S10]; FUGE; Norwegian University of Science and Technology	Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council; FUGE; Norwegian University of Science and Technology	This work was supported by the Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council grant NFR 184146/S10 and Ph.D. grants from FUGE and Norwegian University of Science and Technology to KCV and MN, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Butler W.L., SPECTRAL CHARACTERIS, P343, DOI [10.1016/C2013-0-12536-6, DOI 10.1016/C2013-0-12536-6]; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CLAYTON R, 1980, PHOTOSYNTHESIS PHYS; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Dambek M, 2012, J EXP BOT; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Erickson RA, 2013, LAB CHIP, V13, P2893, DOI 10.1039/c3lc41429a; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fey V, 2005, J EXP BOT, V56, P1491, DOI 10.1093/jxb/eri180; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Franklin KA, 2004, J EXP BOT, V55, P271, DOI 10.1093/jxb/erh026; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLOVER HE, 1987, J EXP MAR BIOL ECOL, V105, P137, DOI 10.1016/0022-0981(87)90168-7; GOEDHEER JC, 1969, BIOCHIM BIOPHYS ACTA, V172, P252, DOI 10.1016/0005-2728(69)90068-1; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Gundermann K, 2013, BBA-BIOENERGETICS, V1827, P303, DOI 10.1016/j.bbabio.2012.10.017; Hancke TB, 2008, J PHYCOL, V44, P803, DOI 10.1111/j.1529-8817.2008.00509.x; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; HOLDSWORTH ES, 1985, MAR BIOL, V86, P253, DOI 10.1007/BF00397512; HUMPHREY GF, 1983, J EXP MAR BIOL ECOL, V66, P49, DOI 10.1016/0022-0981(83)90027-8; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Huysman MJJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r17; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juhas M, 2014, FEBS J, V281, P2299, DOI 10.1111/febs.12782; Jungandreas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099727; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; KIEFER DA, 1992, ENVIR SCI R, V43, P155; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lutz VA, 1998, J PHYCOL, V34, P214, DOI 10.1046/j.1529-8817.1998.340214.x; Marchetti J, 2013, J APPL PHYCOL, V25, P109, DOI 10.1007/s10811-012-9844-y; MAXWELL DP, 1995, PLANT PHYSIOL, V109, P787, DOI 10.1104/pp.109.3.787; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mercado JM, 2004, AQUAT BOT, V78, P265, DOI 10.1016/j.aquabot.2003.11.004; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Mohammady N. G. E., 2007, American Journal of Plant Physiology, V2, P115; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; NIELSEN MV, 1993, LIMNOL OCEANOGR, V38, P1576, DOI 10.4319/lo.1993.38.7.1576; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Pfannschmidt T, 2003, ANTIOXID REDOX SIGN, V5, P95, DOI 10.1089/152308603321223586; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Premvardhan L, 2008, J PHYS CHEM B, V112, P11838, DOI 10.1021/jp802689p; Premvardhan L, 2009, J PHYS CHEM B, V113, P12565, DOI 10.1021/jp903029g; PREZELIN BB, 1981, CAN B FISH AQUAT SCI, P1; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIVKIN RB, 1989, MAR ECOL PROG SER, V55, P291, DOI 10.3354/meps055291; Rodriguez F, 2006, MAR BIOL, V148, P963, DOI 10.1007/s00227-005-0138-7; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P977, DOI 10.1016/j.bbabio.2012.03.026; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shi LX, 2012, BBA-BIOENERGETICS, V1817, P13, DOI 10.1016/j.bbabio.2011.08.008; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; WALLEN DG, 1971, MAR BIOL, V10, P34, DOI 10.1007/BF02026764; WALLEN DG, 1971, MAR BIOL, V10, P44, DOI 10.1007/BF02026765; Wang F, 2008, PLANT CELL ENVIRON, V31, P982, DOI 10.1111/j.1365-3040.2008.01810.x; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	93	46	47	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114211	10.1371/journal.pone.0114211	http://dx.doi.org/10.1371/journal.pone.0114211			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470731	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700085
J	Wang, G; Liu, K; Li, Y; Yi, W; Yang, Y; Zhao, DJ; Fan, CX; Yang, HG; Geng, T; Xing, JZ; Zhang, Y; Tan, ST; Yi, DH				Wang, Ge; Liu, Kan; Li, Yue; Yi, Wei; Yang, Yang; Zhao, Dajun; Fan, Chongxi; Yang, Honggang; Geng, Ting; Xing, Jianzhou; Zhang, Yu; Tan, Songtao; Yi, Dinghua			Endoplasmic Reticulum Stress Mediates the Anti-Inflammatory Effect of Ethyl Pyruvate in Endothelial Cells	PLOS ONE			English	Article							ER STRESS; INDUCED APOPTOSIS; OX-LDL; INFLAMMATION; PROTEIN; ACTIVATION; 3-BROMOPYRUVATE; ANGIOGENESIS; AUTOPHAGY; PATHWAY	Ethyl pyruvate (EP) is a simple aliphatic ester of the metabolic intermediate pyruvate that has been demonstrated to be a potent anti-inflammatory agent in a variety of in vivo and in vitro model systems. However, the protective effects and mechanisms underlying the actions of EP against endothelial cell (EC) inflammatory injury are not fully understood. Previous studies have confirmed that endoplasmic reticulum stress (ERS) plays an important role in regulating the pathological process of EC inflammation. In this study, our aim was to explore the effects of EP on tumor necrosis factor-alpha (TNF-alpha)-induced inflammatory injury in human umbilical vein endothelial cells (HUVECs) and to explore the role of ERS in this process. TNF-alpha treatment not only significantly increased the adhesion of monocytes to HUVECs and inflammatory cytokine (sICAM1, sE-selectin, MCP-1 and IL-8) production in cell culture supernatants but it also increased ICAM and MMP9 protein expression in HUVECs. TNF-alpha also effectively increased the ERS-related molecules in HUVECs (GRP78, ATF4, caspase12 and p-PERK). EP treatment effectively reversed the effects of the TNF-alpha-induced adhesion of monocytes on HUVECs, inflammatory cytokines and ERS-related molecules. Furthermore, thapsigargin (THA, an ERS inducer) attenuated the protective effects of EP against TNF-alpha-induced inflammatory injury and ERS. The PERK siRNA treatment not only inhibited ERS-related molecules but also mimicked the protective effects of EP to decrease TNF-alpha-induced inflammatory injury. In summary, we have demonstrated for the first time that EP can effectively reduce vascular endothelial inflammation and that this effect at least in part depends on the attenuation of ERS.	[Wang, Ge; Yi, Wei; Yang, Yang; Zhao, Dajun; Zhang, Yu; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Liu, Kan] Fourth Mil Med Univ, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Ge; Yang, Honggang; Geng, Ting; Xing, Jianzhou; Tan, Songtao] Guangzhou Med Univ, Chinese Peoples Armed Police Forces, Guangdong Prov Corps Hosp, Dept Cardiovasc Surg, Guangzhou 510507, Guangdong, Peoples R China; [Li, Yue] PLA, Hosp 463, Dept Air Logist, Shenyang 110042, Peoples R China; [Fan, Chongxi] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Guangzhou Medical University; Air Force Military Medical University	Tan, ST (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, 127 Changle West Rd, Xian 710032, Peoples R China.	nicolas.nicolaswong@gmail.com; dinghuayi210@126.com	Li, Yue/AAU-1580-2021	Yi, Wei/0000-0002-4349-910X	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81100137, 81000938]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81100137 and 81000938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2013, CIRCULATION, V128, P579, DOI 10.1161/CIRCULATIONAHA.113.004390; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Basilio J, 2013, BIOCHEM BIOPH RES CO, V442, P221, DOI 10.1016/j.bbrc.2013.11.030; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Chen X, 2014, WORLD J GASTROENTERO, V20, P8260, DOI 10.3748/wjg.v20.i25.8260; Chen Y, 2012, DIABETOLOGIA, V55, P2533, DOI 10.1007/s00125-012-2594-1; Das UN, 2006, MED SCI MONITOR, V12, pRA79; Desai A, 2012, ATHEROSCLEROSIS, V223, P130, DOI 10.1016/j.atherosclerosis.2012.05.004; Duan WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057941; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Ganapathy-Kanniappan S, 2010, ANTICANCER RES, V30, P923; Hong D, 2014, ATHEROSCLEROSIS, V235, P310, DOI 10.1016/j.atherosclerosis.2014.04.028; Ito TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102186; Jang HJ, 2012, ANTIOXID REDOX SIGN, V17, P878, DOI 10.1089/ars.2011.3994; Jang IS, 2010, YONSEI MED J, V51, P838, DOI 10.3349/ymj.2010.51.6.838; Jang M, 2014, BRAIN BEHAV IMMUN, V38, P151, DOI 10.1016/j.bbi.2014.01.015; Jia ZQ, 2013, INT J CARDIOL, V168, P2637, DOI 10.1016/j.ijcard.2013.03.035; John L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025378; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kujiraoka T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000361; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Liu C, 2014, J CARDIOVASC PHARM; Liu XH, 2012, ATHEROSCLEROSIS, V222, P34, DOI 10.1016/j.atherosclerosis.2011.04.027; Meli G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4867; Nallasamy P, 2014, J NUTR BIOCH; Narasimhulu CA, 2014, ATHEROSCLEROSIS, V236, P133, DOI 10.1016/j.atherosclerosis.2014.06.020; Pan MY, 2012, TOXICOL APPL PHARM, V265, P325, DOI 10.1016/j.taap.2012.08.034; Pulathan Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857109; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Shinozaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075249; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Yu SJ, 2012, J BIOENERG BIOMEMBR, V44, P101, DOI 10.1007/s10863-012-9416-5; Zeng W, 2014, LIFE SCI, V103, P15, DOI 10.1016/j.lfs.2014.03.007	39	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113983	10.1371/journal.pone.0113983	http://dx.doi.org/10.1371/journal.pone.0113983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470819	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700059
J	Fukuta, M; Nakai, Y; Kirino, K; Nakagawa, M; Sekiguchi, K; Nagata, S; Matsumoto, Y; Yamamoto, T; Umeda, K; Heike, T; Okumura, N; Koizumi, N; Sato, T; Nakahata, T; Saito, M; Otsuka, T; Kinoshita, S; Ueno, M; Ikeya, M; Toguchida, J				Fukuta, Makoto; Nakai, Yoshinori; Kirino, Kosuke; Nakagawa, Masato; Sekiguchi, Kazuya; Nagata, Sanae; Matsumoto, Yoshihisa; Yamamoto, Takuya; Umeda, Katsutsugu; Heike, Toshio; Okumura, Naoki; Koizumi, Noriko; Sato, Takahiko; Nakahata, Tatsutoshi; Saito, Megumu; Otsuka, Takanobu; Kinoshita, Shigeru; Ueno, Morio; Ikeya, Makoto; Toguchida, Junya			Derivation of Mesenchymal Stromal Cells from Pluripotent Stem Cells through a Neural Crest Lineage using Small Molecule Compounds with Defined Media	PLOS ONE			English	Article							PATIENT-SPECIFIC IPSCS; PARAXIAL MESODERM; BRANCHIAL ARCHES; DIFFERENTIATION; INDUCTION; MOUSE; SPECIFICATION; MAINTENANCE; MELANOCYTES; GENERATION	Neural crest cells (NCCs) are an embryonic migratory cell population with the ability to differentiate into a wide variety of cell types that contribute to the craniofacial skeleton, cornea, peripheral nervous system, and skin pigmentation. This ability suggests the promising role of NCCs as a source for cell-based therapy. Although several methods have been used to induce human NCCs (hNCCs) from human pluripotent stem cells (hPSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), further modifications are required to improve the robustness, efficacy, and simplicity of these methods. Chemically defined medium (CDM) was used as the basal medium in the induction and maintenance steps. By optimizing the culture conditions, the combination of the GSK3 beta inhibitor and TGF beta inhibitor with a minimum growth factor (insulin) very efficiently induced hNCCs (70-80%) from hPSCs. The induced hNCCs expressed cranial NCC-related genes and stably proliferated in CDM supplemented with EGF and FGF2 up to at least 10 passages without changes being observed in the major gene expression profiles. Differentiation properties were confirmed for peripheral neurons, glia, melanocytes, and corneal endothelial cells. In addition, cells with differentiation characteristics similar to multipotent mesenchymal stromal cells (MSCs) were induced from hNCCs using CDM specific for human MSCs. Our simple and robust induction protocol using small molecule compounds with defined media enabled the generation of hNCCs as an intermediate material producing terminally differentiated cells for cell-based innovative medicine.	[Fukuta, Makoto; Sekiguchi, Kazuya; Matsumoto, Yoshihisa; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Fukuta, Makoto; Sekiguchi, Kazuya; Nagata, Sanae; Matsumoto, Yoshihisa; Ikeya, Makoto; Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Fukuta, Makoto; Matsumoto, Yoshihisa; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Nakai, Yoshinori; Sato, Takahiko; Kinoshita, Shigeru; Ueno, Morio] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kirino, Kosuke; Nakahata, Tatsutoshi; Saito, Megumu] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Nakagawa, Masato; Yamamoto, Takuya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Sekiguchi, Kazuya; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Yamamoto, Takuya] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Umeda, Katsutsugu; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Okumura, Naoki; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan	Kyoto University; Kyoto University; Nagoya City University; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Doshisha University	Ueno, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueno@koto.kpu-m.ac.jp; mikeya@cira.kyoto-u.ac.jp; togjun@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Sato, Takahiko/0000-0003-3836-7978; Ikeya, Makoto/0000-0002-3930-8032	JSPS [25293320, 20791288]; JST [AS242Z00931P]; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from JSPS (# 25293320), a grant from Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from JST, and the Leading Project for Realization of Regenerative Medicine from MEXT to MI and JT. MI was also supported by the Adaptable and Seamless Technology Transfer Program through target-driven R& D, Exploratory Research from JST (AS242Z00931P). JT was also supported by the Center for Clinical Application Research on Specific Disease/ Organ from JST. MU was also supported by Grants-in-Aid for Scientific Research from JSPS (#20791288). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chimige NO, 2010, J EXP ZOOL PART B, V314B, P95, DOI 10.1002/jez.b.21321; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; De Schauwer C, 2011, THERIOGENOLOGY, V75, P1431, DOI 10.1016/j.theriogenology.2010.11.008; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; FITCH JM, 1990, J CELL BIOL, V110, P1457, DOI 10.1083/jcb.110.4.1457; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Helms JA, 2003, NATURE, V423, P326, DOI 10.1038/nature01656; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Jiang MR, 2011, CURR TOP DEV BIOL, V94, P77, DOI 10.1016/B978-0-12-380916-2.00004-8; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kalcheim C, 2000, INT REV CYTOL, V200, P143, DOI 10.1016/S0074-7696(00)00004-8; Kimura C, 1997, DEVELOPMENT, V124, P3929; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Liu ZQ, 2013, J CELL MOL MED, V17, P782, DOI 10.1111/jcmm.12062; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Milet C, 2012, DEV BIOL, V366, P96, DOI 10.1016/j.ydbio.2012.01.016; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Motohashi T, 2006, PIGM CELL RES, V19, P284, DOI 10.1111/j.1600-0749.2006.00317.x; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Neirinckx V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064723; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Silva N.A., 2013, PROG NEUROBIOL; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105	53	95	101	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112291	10.1371/journal.pone.0112291	http://dx.doi.org/10.1371/journal.pone.0112291			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464501	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700013
J	Garcia, JD; Dewey, EB; Johnston, CA				Garcia, Joshua D.; Dewey, Evan B.; Johnston, Christopher A.			Dishevelled Binds the Discs Large 'Hook' Domain to Activate GukHolder-Dependent Spindle Positioning in Drosophila	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; GUANYLATE KINASE DOMAINS; NANCE-HORAN-SYNDROME; HETEROTRIMERIC G-PROTEINS; MITOTIC SPINDLE; TUMOR-SUPPRESSOR; SUPERTERTIARY STRUCTURE; SCAFFOLD PROTEINS; ELEGANS EMBRYOS; HUMAN HOMOLOG	Communication between cortical cell polarity cues and the mitotic spindle ensures proper orientation of cell divisions within complex tissues. Defects in mitotic spindle positioning have been linked to various developmental disorders and have recently emerged as a potential contributor to tumorigenesis. Despite the importance of this process to human health, the molecular mechanisms that regulate spindle orientation are not fully understood. Moreover, it remains unclear how diverse cortical polarity complexes might cooperate to influence spindle positioning. We and others have demonstrated spindle orientation roles for Dishevelled (Dsh), a key regulator of planar cell polarity, and Discs large (Dlg), a conserved apico-basal cell polarity regulator, effects which were previously thought to operate within distinct molecular pathways. Here we identify a novel direct interaction between the Dsh-PDZ domain and the alternatively spliced 'I3-insert'' of the Dlg-Hook domain, thus establishing a potential convergent Dsh/Dlg pathway. Furthermore, we identify a Dlg sequence motif necessary for the Dsh interaction that shares homology to the site of Dsh binding in the Frizzled receptor. Expression of Dsh enhanced Dlg-mediated spindle positioning similar to deletion of the Hook domain. This Dsh-mediated activation was dependent on the Dlg-binding partner, GukHolder (GukH). These results suggest that Dsh binding may regulate core interdomain conformational dynamics previously described for Dlg. Together, our results identify Dlg as an effector of Dsh signaling and demonstrate a Dsh-mediated mechanism for the activation of Dlg/GukH-dependent spindle positioning. Cooperation between these two evolutionarily-conserved cell polarity pathways could have important implications to both the development and maintenance of tissue homeostasis in animals.	[Garcia, Joshua D.; Dewey, Evan B.; Johnston, Christopher A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Johnston, CA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	johnstca@unm.edu		Garcia, Joshua D./0000-0002-7572-2062; Dewey, Evan/0000-0003-4330-3450	National Institutes of Health [GM060201, GM108756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108756, R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JDG is an Initiative to Maximize Student Diversity (IMSD) program scholar supported by the National Institutes of Health (GM060201). This work was also supported by the National Institutes of Health grant GM108756 (CAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bei YX, 2002, DEV CELL, V3, P113, DOI 10.1016/S1534-5807(02)00185-5; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bergstralh DT, 2013, CURR BIOL, V23, P1707, DOI 10.1016/j.cub.2013.07.017; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brooks SP, 2004, J MED GENET, V41, P768, DOI 10.1136/jmg.2004.022517; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Johnston CA, 2013, J CELL SCI, V126, P4436, DOI 10.1242/jcs.129544; Johnston CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036014; Johnston CA, 2011, P NATL ACAD SCI USA, V108, pE973, DOI 10.1073/pnas.1104365108; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koles K, 2012, COLD SPRING HARB PER, V4; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lancaster MA, 2012, CURR OPIN NEUROBIOL; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Macara IG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0012; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Senda Takao, 2005, Anatomical Science International, V80, P121, DOI 10.1111/j.1447-073x.2005.00106.x; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; WALPOLE IR, 1990, J MED GENET, V27, P632, DOI 10.1136/jmg.27.10.632; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Wu HJ, 1998, J CELL SCI, V111, P2365; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	63	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114235	10.1371/journal.pone.0114235	http://dx.doi.org/10.1371/journal.pone.0114235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461409	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700121
J	Huang, WL; Ling, SQ; Jia, XH; Lin, BW; Huang, X; Zhong, J; Li, WH; Lin, XL; Sun, YF; Yuan, J				Huang, Weilan; Ling, Shiqi; Jia, Xiuhua; Lin, Binwu; Huang, Xi; Zhong, Jing; Li, Weihua; Lin, Xiaolei; Sun, Yifang; Yuan, Jin			Tacrolimus (FK506) Suppresses TREM-1 Expression at an Early but Not at a Late Stage in a Murine Model of Fungal Keratitis	PLOS ONE			English	Article							SUSPENSION EYE DROPS; MYELOID CELLS-1; ASPERGILLUS-FUMIGATUS; REPERFUSION INJURY; IMMUNE-RESPONSES; CYCLOSPORINE-A; MOUSE MODEL; INFLAMMATION; MACROPHAGES; ISCHEMIA	Purpose: To investigate the efficacy and mechanism of tacrolimus(FK506), which is a novel macrolide immunosuppressant, in inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) expression in a murine keratitis model induced by Aspergillus fumigatus. Method: TREM-1 was detected in 11 fungus-infected human corneas by quantitative real-time PCR (qRT-PCR). RAW264.7 macrophages were divided into four groups, which received treatment with zymosan (100 mg/ml), zymosan (100 mu g/ml) + mTREM-1/Fc protein (1 mu g/ml), or zymosan (100 mu g/ml) + FK506 (20 mu M) or negative-control treatment. After this treatment, the expression of TREM-1, interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF alpha) was assayed using qRT-PCR and ELISA. The mouse model of fungal keratitis was created by intrastromal injection with Aspergillus fumigatus, and the mice were divided into 2 groups: group A received vehicle eye drops 4 times each day, and group B received 4 doses of FK506 eye drops each day. Corneal damage was evaluated by clinical scoring and histologic examination, and myeloperoxidase (MPO) protein levels were also detected by ELISA. The expression of TREM-1, IL-1 beta and TNFa was then determined at different time points using qRT-PCR and ELISA. Results: TREM-1 expression dramatically increased in the human corneas with fungal keratitis. In contrast, FK506 reduced the expression of TREM-1, IL-1b and TNF alpha in RAW264.7 macrophages stimulated with zymosan. In the mouse model, at day 1 post-infection, the corneal score of the FK506-treated group was lower than that of the control, and polymorphonuclear neutrophil (PMN) infiltration was diminished. TREM-1, IL-1 beta and TNF alpha expression was significantly reduced at the same time point. However, the statistically significant differences in cytokine expression, clinical scores and infiltration disappeared at 5 days post-infection. Conclusions: FK506 may inhibit the inflammation induced by fungi and alleviate the severity of corneal damage at an early stage of fungal keratitis by downregulating TREM-1 expression.	[Huang, Weilan; Lin, Binwu; Huang, Xi; Zhong, Jing; Li, Weihua; Lin, Xiaolei; Sun, Yifang; Yuan, Jin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Ling, Shiqi; Jia, Xiuhua] Sun Yat Sen Univ, Dept Ophthalmol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Weilan] Sun Yat Sen Univ, Phys Examinat Ctr, Affiliated Hosp 3, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yuan, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yuanjincornea@126.com	Zhang, jun/E-9359-2011	Zhang, jun/0000-0001-7835-9871	Natural Science Foundation of China [81270972]; Fundamental Research Funds for the Central Universities [11ykpy66]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Natural Science Foundation of China (81270972) and the Fundamental Research Funds for the Central Universities (11ykpy66). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY AL, 1987, ANTIMICROB AGENTS CH, V31, P343, DOI 10.1128/AAC.31.2.343; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bosnar M, 2011, INT IMMUNOPHARMACOL, V11, P424, DOI 10.1016/j.intimp.2010.12.010; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Buckland KF, 2011, IMMUNOL INVEST, V40, P692, DOI 10.3109/08820139.2011.578270; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Dang SC, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/720865; DEREPENTIGNY L, 1993, INFECT IMMUN, V61, P3791, DOI 10.1128/IAI.61.9.3791-3802.1993; Fei WL, 2008, J OCUL PHARMACOL TH, V24, P235, DOI 10.1089/jop.2007.0059; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; HENDRICKS RL, 1991, INVEST OPHTH VIS SCI, V32, P366; HIGH KP, 1994, TRANSPLANTATION, V57, P1689, DOI 10.1097/00007890-199457120-00001; Hikita N, 1997, INVEST OPHTH VIS SCI, V38, P901; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hogan AC, 2007, OPHTHALMOLOGY, V114, P1000, DOI 10.1016/j.ophtha.2007.01.026; Hutchinson IV, 1998, TRANSPLANT P, V30, P959, DOI 10.1016/S0041-1345(98)00110-9; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; KAWANO K, 1994, EUR SURG RES, V26, P108, DOI 10.1159/000129325; KEICHO N, 1991, CELL IMMUNOL, V132, P285, DOI 10.1016/0008-8749(91)90028-A; Kikuchi T, 2002, J ANTIMICROB CHEMOTH, V49, P745, DOI 10.1093/jac/dkf008; Lee HN, 2013, SEMIN IMMUNOPATHOL, V35, P151, DOI 10.1007/s00281-013-0363-y; Lee RKK, 1999, J NEUROSCI, V19, P940; LIN CS, 1991, CELL IMMUNOL, V133, P269, DOI 10.1016/0008-8749(91)90103-I; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Mansour MK, 2012, ANN NY ACAD SCI, V1273, P78, DOI 10.1111/j.1749-6632.2012.06837.x; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Ohashi Y, 2010, J OCUL PHARMACOL TH, V26, P165, DOI 10.1089/jop.2009.0087; Pereira R, 2006, TRANSPL IMMUNOL, V16, P105, DOI 10.1016/j.trim.2006.04.001; SAWADA S, 1987, J IMMUNOL, V139, P1797; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Taylor SRJ, 2010, OPHTHALMOLOGICA, V224, P46, DOI 10.1159/000318021; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Thomas PA, 2003, EYE, V17, P852, DOI 10.1038/sj.eye.6700557; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu MH, 2011, INFECT IMMUN, V79, P2709, DOI 10.1128/IAI.00144-11; Wu TG, 2003, INVEST OPHTH VIS SCI, V44, P210, DOI 10.1167/iovs.02-0446; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; YOUNG RA, 1989, DRUGS, V37, P8, DOI 10.2165/00003495-198937010-00002; Yuan J, 2012, J OCUL PHARMACOL TH, V28, P153, DOI 10.1089/jop.2011.0108; Zribi H, 2009, J EUR ACAD DERMATOL, V23, P489, DOI 10.1111/j.1468-3083.2008.02933.x	49	9	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114386	10.1371/journal.pone.0114386	http://dx.doi.org/10.1371/journal.pone.0114386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464008	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700131
J	Iacovitti, L; Wei, XT; Cai, JL; Kostuk, EW; Lin, RH; Gorodinsky, A; Roman, P; Kusek, G; Das, SS; Dufour, A; Martinez, TN; Dave, KD				Iacovitti, Lorraine; Wei, Xiaotao; Cai, Jingli; Kostuk, Eric W.; Lin, Ruihe; Gorodinsky, Alexander; Roman, Philip; Kusek, Gretchen; Das, Sonal S.; Dufour, Audrey; Martinez, Terina N.; Dave, Kuldip D.			The hTH-GFP Reporter Rat Model for the Study of Parkinson's Disease	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE GENE; MIDBRAIN DOPAMINE NEURONS; EMBRYONIC STEM-CELLS; TRANSGENIC MICE; HIGH-LEVEL; IN-VITRO; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; DEGENERATION	Parkinson disease (PD) is the second leading neurodegenerative disease in the US. As there is no known cause or cure for PD, researchers continue to investigate disease mechanisms and potential new therapies in cell culture and in animal models of PD. In PD, one of the most profoundly affected neuronal populations is the tyrosine hydroxylase (TH)-expressing dopaminergic (DA) neurons of the substantia nigra pars compacta (SNpc). These DA-producing neurons undergo degeneration while neighboring DA-producing cells of the ventral tegmental area (VTA) are largely spared. To aid in these studies, The Michael J. Fox Foundation (MJFF) partnered with Thomas Jefferson University and Taconic Inc. to generate new transgenic rat lines carrying the human TH gene promoter driving EGFP using a 11 kb construct used previously to create a hTH-GFP mouse reporter line. Of the five rat founder lines that were generated, three exhibited high level specific GFP fluorescence in DA brain structures (ie. SN, VTA, striatum, olfactory bulb, hypothalamus). As with the hTH-GFP mouse, none of the rat lines exhibit reporter expression in adrenergic structures like the adrenal gland. Line 12141, with its high levels of GFP in adult DA brain structures and minimal ectopic GFP expression in non-DA structures, was characterized in detail. We show here that this line allows for anatomical visualization and microdissection of the rat midbrain into SNpc and/or VTA, enabling detailed analysis of midbrain DA neurons and axonal projections after toxin treatment in vivo. Moreover, we further show that embryonic SNpc and/or VTA neurons, enriched by microdissection or FACS, can be used in culture or transplant studies of PD. Thus, the hTH-GFP reporter rat should be a valuable tool for Parkinson's disease research.	[Iacovitti, Lorraine; Wei, Xiaotao; Cai, Jingli; Kostuk, Eric W.; Lin, Ruihe] Thomas Jefferson Univ, Dept Neurosci, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Gorodinsky, Alexander; Roman, Philip; Kusek, Gretchen] Tacon Farms Inc, Hudson, NY USA; [Das, Sonal S.; Dufour, Audrey; Martinez, Terina N.; Dave, Kuldip D.] Michael J Fox Fdn Parkinsons Res, New York, NY USA	Jefferson University	Iacovitti, L (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Farber Inst Neurosci, Philadelphia, PA 19107 USA.	lorraine.iacovitti@jefferson.edu		Lin, Ruihe/0000-0002-7475-6359	Michael J. Fox Foundation	Michael J. Fox Foundation	This work was generously supported by a grant from the Michael J. Fox Foundation to LI. The funders: Sonal S. Das, Audrey Dufour, Terina N. Martinez, and Kuldip D. Dave analyzed the data. In addition, Kuldip D. Dave conceived and designed the experiments, and contributed to writing the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Donaldson AE, 2005, MOL CELL NEUROSCI, V30, P601, DOI 10.1016/j.mcn.2005.06.010; KANEDA N, 1991, NEURON, V6, P583, DOI 10.1016/0896-6273(91)90061-4; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Phani S, 2013, BRAIN RES, V1500, P88, DOI 10.1016/j.brainres.2013.01.017; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schleidt S, 2012, 2012 NEUR M PLANN; Stull ND, 2002, BRAIN RES, V931, P181, DOI 10.1016/S0006-8993(02)02269-2; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Ungerstedt U, 1973, Neurosci Res (N Y), V5, P73; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Yang M, 2002, EXP NEUROL, V177, P50, DOI 10.1006/exnr.2002.7989; Yang M, 2003, CELL MOL NEUROBIOL, V23, P851, DOI 10.1023/A:1025017423102; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216	25	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113151	10.1371/journal.pone.0113151	http://dx.doi.org/10.1371/journal.pone.0113151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462571	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700026
J	Jansen, CJ; Absalom, AR; de Bock, GH; van Leeuwen, BL; Izaks, GJ				Jansen, Carolien J.; Absalom, Anthony R.; de Bock, Geertruida H.; van Leeuwen, Barbara L.; Izaks, Gerbrand J.			Performance and Agreement of Risk Stratification Instruments for Postoperative Delirium in Persons Aged 50 Years or Older	PLOS ONE			English	Article							PREDICTION RULE; EXECUTIVE FUNCTION; DEPRESSION; VALIDATION; SEVERITY	Several risk stratification instruments for postoperative delirium in older people have been developed because early interventions may prevent delirium. We investigated the performance and agreement of nine commonly used risk stratification instruments in an independent validation cohort of consecutive elective and emergency surgical patients aged >= 50 years with >= 1 risk factor for postoperative delirium. Data was collected prospectively. Delirium was diagnosed according to DSM-IV-TR criteria. The observed incidence of postoperative delirium was calculated per risk score per risk stratification instrument. In addition, the risk stratification instruments were compared in terms of area under the receiver operating characteristic (ROC) curve (AUC), and positive and negative predictive value. Finally, the positive agreement between the risk stratification instruments was calculated. When data required for an exact implementation of the original risk stratification instruments was not available, we used alternative data that was comparable. The study population included 292 patients: 60% men; mean age (SD), 66 (8) years; 90% elective surgery. The incidence of postoperative delirium was 9%. The maximum observed incidence per risk score was 50% (95% CI, 15-85%); for eight risk stratification instruments, the maximum observed incidence per risk score was <= 25%. The AUC (95% CI) for the risk stratification instruments varied between 0.50 (0.36-0.64) and 0.66 (0.48-0.83). No AUC was statistically significant from 0.50 (p >= 0.11). Positive predictive values of the risk stratification instruments varied between 0-25%, negative predictive values between 89-95%. Positive agreement varied between 0-66%. No risk stratification instrument showed clearly superior performance. In conclusion, in this independent validation cohort, the performance and agreement of commonly used risk stratification instruments for postoperative delirium was poor. Although some caution is needed because the risk stratification instruments were not implemented exactly as described in the original studies, we think that their usefulness in clinical practice can be questioned.	[Jansen, Carolien J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9713 AV Groningen, Netherlands; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Izaks, GJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands.	g.j.izaks@umcg.nl	Absalom, Anthony/GPG-1582-2022; de Bock, Geertruida Hendrika/F-6529-2014; Izaks, Gerbrand/F-5089-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471; Izaks, Gerbrand/0000-0003-3213-7637; Absalom, Anthony/0000-0001-7563-9157; van Leeuwen, Barbara/0000-0002-6745-4424	University Medical Center Groningen, Groningen, the Netherlands	University Medical Center Groningen, Groningen, the Netherlands(Netherlands Government)	This study was supported by a grant from the University Medical Center Groningen, Groningen, the Netherlands, for pilot studies on cost-effectiveness (BLL GJI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Martinez JA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001599; Carthon JMB, 2013, J AM GERIATR SOC, V61, P1499, DOI 10.1111/jgs.12419; Chow WB, 2012, J AM COLL SURGEONS, V215, P453, DOI 10.1016/j.jamcollsurg.2012.06.017; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Etzioni DA, 2003, ANN SURG, V238, P170, DOI 10.1097/01.SLA.0000081085.98792.3d; Freter SH, 2005, AGE AGEING, V34, P387, DOI 10.1093/ageing/afi099; Freter SH, 2005, AGE AGEING, V34, P169, DOI 10.1093/ageing/afh245; Greene NH, 2009, ANESTHESIOLOGY, V110, P788, DOI 10.1097/ALN.0b013e31819b5ba6; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kobayashi D, 2013, AM J GERIAT PSYCHIAT, V21, P957, DOI 10.1016/j.jagp.2012.08.009; Koster S, 2009, EUR J CARDIOVASC NUR, V8, P309, DOI 10.1016/j.ejcnurse.2009.02.006; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Newcombe RG, 2000, STAT CONFIDENCE, P46; OKeeffe ST, 1996, AGE AGEING, V25, P317, DOI 10.1093/ageing/25.4.317; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Smith PJ, 2009, ANESTHESIOLOGY, V110, P781, DOI 10.1097/ALN.0b013e31819b5bc2; Van Gemert LA, 2007, BMC NURS, V6, DOI 10.1186/1472-6955-6-3	25	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113946	10.1371/journal.pone.0113946	http://dx.doi.org/10.1371/journal.pone.0113946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464335	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700072
J	Lute, ML; Bump, A; Gore, ML				Lute, Michelle L.; Bump, Adam; Gore, Meredith L.			Identity-Driven Differences in Stakeholder Concerns about Hunting Wolves	PLOS ONE			English	Article							SOCIAL IDENTITY; SELF-CATEGORIZATION; INTERGROUP CONFLICT; VALUE ORIENTATIONS; WILDLIFE; ATTITUDES; WOLF; CONSERVATION; PERCEPTIONS; NETWORKS	Whereas past wolf management in the United States was restricted to recovery, managers must now contend with publicly contentious post-recovery issues including regulated hunting seasons. Understanding stakeholder concerns associated with hunting can inform stakeholder engagement, communication, and policy development and evaluation. Social identity theory (SIT) has been used to understand how groups interact, why they conflict, and how collaboration may be achieved. Applying SIT to stakeholder conflicts about wolf hunting may help delineate groups according to their concern about, support for or opposition to the policy choice of hunting wolves. Our objective was to assess concerns about hunting as a tool to resolve conflict in Michigan, using SIT as a framework. We used a mixed-modal sampling approach (e.g., paper, Internet) with wolf hunting-related public meeting participants in March 2013. Survey questions focused on 12 concerns previously identified as associated with hunting as a management tool to resolve conflict. Respondents (n = 666) cared greatly about wolves but were divided over hunting wolves. Wolf conflicts, use of science in policy decisions, and maintaining a wolf population were the highest ranked concerns. Principle components analysis reduced concerns into three factors that explained 50.7% of total variance; concerns crystallized over justifications for hunting. General linear models revealed a lack of geographic influence on care, fear and support for hunting related to wolves. These findings challenge assumptions about regional differences and suggest a strong role for social identity in driving dichotomized public perceptions in wildlife management.	[Lute, Michelle L.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Bump, Adam] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA; [Gore, Meredith L.] Michigan State Univ, Sch Criminal Justice, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Lute, ML (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	mlute@indiana.edu	Gore, Meredith/AAY-4350-2020	Gore, Meredith/0000-0002-2613-4715	federal Pittman-Robertson Wildlife Restoration Act grant [W-147-R]; MDNR-Wildlife Division; School of Criminal Justice at Michigan State University; Department of Fisheries Wildlife	federal Pittman-Robertson Wildlife Restoration Act grant; MDNR-Wildlife Division; School of Criminal Justice at Michigan State University; Department of Fisheries Wildlife	Support for this project was provided by the MDNR-Wildlife Division with funds from the federal Pittman-Robertson Wildlife Restoration Act grant administered by the United States Fish and Wildlife Service (W-147-R: Michigan's Statewide Wildlife Research and Restoration Program), the Department of Fisheries & Wildlife, and School of Criminal Justice at Michigan State University. Authors were independent of funders for the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS D, 1990, BRIT J SOC PSYCHOL, V29, P97, DOI 10.1111/j.2044-8309.1990.tb00892.x; [Anonymous], MICH DEP NAT RES EC; Ashforth BE, 2001, SOC IDENTITY PROCESS, P31, DOI DOI 10.4324/9781315800530; BEYER D, 2006, REV SOCIAL BIOL SCI; Bright AD, 2000, WILDLIFE SOC B, V28, P218; Brown R, 2000, EUR J SOC PSYCHOL, V30, P745, DOI 10.1002/1099-0992(200011/12)30:6<745::AID-EJSP24>3.0.CO;2-O; Bruskotter JT, 2011, SCIENCE, V333, P1828, DOI 10.1126/science.1207803; Cantrill James G., 2011, Human Dimensions of Wildlife, V16, P73, DOI 10.1080/10871209.2011.542555; Danter K J., 2010, ENV COMMUNICATION; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Ellemers N, 2013, ACAD MANAGE REV, V29, P459; Enck JW, 2002, WILDLIFE SOC B, V30, P16; Ford J, 2013, HUM FACTORS, V55, P499, DOI 10.1177/0018720812465311; Frawley B. J., 2013, 2012 MICHIGAN FURBEA; Glikman J. A., 2010, Human Dimensions of Wildlife, V15, P347, DOI 10.1080/10871209.2010.505598; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Gore ML, 2013, MICH WOLF FOR DEC 20; Grey ME, 2012, INTERPRETING SIGNIFI; GRUNIG JE, 1979, ACAD MANAGE J, V22, P738, DOI 10.2307/255812; Halpern D, 2013, COMPUT HUM BEHAV, V29, P1159, DOI 10.1016/j.chb.2012.10.008; Hogg MA, 2006, LEADERSHIP QUART, V17, P335, DOI 10.1016/j.leaqua.2006.04.007; Hornsey MJ, 2008, SOC PERSONAL PSYCHOL, V2, P204, DOI 10.1111/j.1751-9004.2007.00066.x; JACKSON JW, 1993, PSYCHOL REC, V43, P395; Jacobson CA, 2010, J WILDLIFE MANAGE, V74, P203, DOI 10.2193/2008-485; Jetten J, 2002, EUR J SOC PSYCHOL, V32, P189, DOI 10.1002/ejsp.65; Jorgensen BS, 2001, J ENVIRON PSYCHOL, V21, P233, DOI 10.1006/jevp.2001.0226; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kaltenborn BP, 1999, HUMAN DIMENSIONS WIL, V4, P37; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kellert S, 1990, PUBLIC ATTITUDES BEL; Kellon D, 2011, J ENVIRON MANAGE, V92, P363, DOI 10.1016/j.jenvman.2010.10.010; Knezevic I., 2009, Human Dimensions of Wildlife, V14, P12, DOI 10.1080/10871200802562372; KROSNICK J, 1990, POLITICAL BEHAV, V0012; Labianca G, 1998, ACAD MANAGE J, V41, P55, DOI 10.2307/256897; Leong KM, 2007, ENVIRON PRAC, V9, P195, DOI 10.1017/S1466046607070330; Lute Michelle L., 2014, Human Dimensions of Wildlife, V19, P267; Lute ML, 2013, HUMAN DIMENSIONS WOL; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Manfredo M.J., 2008, WHO CARES WILDLIFE, DOI 10.1007/978-0-387-77040-6_1; MERTIG AG, 2004, ATTITUDES WOLVES MIC; Michigan Dep Nat Resour, WOLF BIOL ID; Minnis DL, 1998, WILDLIFE SOC B, V26, P75; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nie M, 2003, POLICY SCI, V36, P307, DOI 10.1023/B:OLIC.0000017484.35981.b6; Nie Martin A., 2002, Ethics Place and Environment, V5, P65, DOI 10.1080/13668790220146465; Olson ER, 2014, CONSERV LETT; Oosting J., 2013, NEW MICHIGAN GROUP S; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Peyton R., 2007, MEASURING SOCIAL CAR; Press A, 2013, WOLF HUNT REFERENDUM; Rhue L, 2014, SOC NETWORKS, V36, P40, DOI 10.1016/j.socnet.2012.06.007; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; RYAN EL, 2011, HUM DIMENS WILDL, V16, P311, DOI DOI 10.1080/10871209.2011.559530; Scales IR, 2012, GEOGR J, V178, P67, DOI 10.1111/j.1475-4959.2011.00432.x; Sherif M., 1966, GROUP CONFLICT COOPE; Skogen K, 2003, SOCIOL RURALIS, V43, P309, DOI 10.1111/1467-9523.00247; Skogen K, 2001, RURAL SOCIOL, V66, P203, DOI 10.1111/j.1549-0831.2001.tb00064.x; Slagle Kristina M., 2012, Human Dimensions of Wildlife, V17, P44, DOI 10.1080/10871209.2012.633237; Spears R, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P201, DOI 10.1007/978-1-4419-7988-9_9; Sponarski Carly C., 2013, Human Dimensions of Wildlife, V18, P239, DOI 10.1080/10871209.2013.792022; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Triezenberg Heather A., 2011, Human Dimensions of Wildlife, V16, P381, DOI 10.1080/10871209.2011.608182; TYLER TR, 1994, J PERS SOC PSYCHOL, V67, P850, DOI 10.1037/0022-3514.67.5.850; Tyler TR, 2000, INT J PSYCHOL, V35, P117, DOI 10.1080/002075900399411; Vaske J., 2008, SURVEY RES ANAL APPL; Vaske JJ, 2001, SOC NATUR RESOUR, V14, P761, DOI 10.1080/089419201753210585; Warriner GK, 1996, CANADIAN WATER RESOU, V21, P253; Webler T, 2001, ENVIRON MANAGE, V27, P435; Williamson SJ, 2008, HUM DIMENS WILDL MAN, V3, P51; Winter SC, 2001, J POLICY ANAL MANAG, V20, P675, DOI 10.1002/pam.1023; Zajac RM, 2012, J WILDLIFE MANAGE, V76, P1331, DOI 10.1002/jwmg.398	77	34	34	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114460	10.1371/journal.pone.0114460	http://dx.doi.org/10.1371/journal.pone.0114460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464276	gold, Green Published			2022-12-27	WOS:000345869700132
J	Nicolau, DV; Paszek, E; Fulga, F; Nicolau, DV				Nicolau, Dan V., Jr.; Paszek, Ewa; Fulga, Florin; Nicolau, Dan V.			Mapping Hydrophobicity on the Protein Molecular Surface at Atom-Level Resolution	PLOS ONE			English	Article							SPATIAL-ORGANIZATION; ORGANIC-MOLECULES; LIGAND-BINDING; FORCE-FIELD; FREE-ENERGY; K+-ATPASE; MEMBRANE; PREDICTION; RECOGNITION; EFFICIENT	A precise representation of the spatial distribution of hydrophobicity, hydrophilicity and charges on the molecular surface of proteins is critical for the understanding of the interaction with small molecules and larger systems. The representation of hydrophobicity is rarely done at atom-level, as this property is generally assigned to residues. A new methodology for the derivation of atomic hydrophobicity from any amino acid-based hydrophobicity scale was used to derive 8 sets of atomic hydrophobicities, one of which was used to generate the molecular surfaces for 35 proteins with convex structures, 5 of which, i.e., lysozyme, ribonuclease, hemoglobin, albumin and IgG, have been analyzed in more detail. Sets of the molecular surfaces of the model proteins have been constructed using spherical probes with increasingly large radii, from 1.4 to 20 angstrom, followed by the quantification of (i) the surface hydrophobicity; (ii) their respective molecular surface areas, i. e., total, hydrophilic and hydrophobic area; and (iii) their relative densities, i. e., divided by the total molecular area; or specific densities, i. e., divided by property-specific area. Compared with the amino acid-based formalism, the atom-level description reveals molecular surfaces which (i) present an approximately two times more hydrophilic areas; with (ii) less extended, but between 2 to 5 times more intense hydrophilic patches; and (iii) 3 to 20 times more extended hydrophobic areas. The hydrophobic areas are also approximately 2 times more hydrophobicity-intense. This, more pronounced "leopard skin"-like, design of the protein molecular surface has been confirmed by comparing the results for a restricted set of homologous proteins, i. e., hemoglobins diverging by only one residue (Trp37). These results suggest that the representation of hydrophobicity on the protein molecular surfaces at atom-level resolution, coupled with the probing of the molecular surface at different geometric resolutions, can capture processes that are otherwise obscured to the amino acid-based formalism.	[Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Paszek, Ewa; Fulga, Florin; Nicolau, Dan V.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England; [Nicolau, Dan V.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	University of California System; University of California Berkeley; University of Liverpool; McGill University	Nicolau, DV (corresponding author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.	dan.nicolau@mcgill.ca		Nicolau, Dan V/0000-0002-9956-0600	Defense Advanced Research Projects Agency (DARPA) [F30602-00-2-0614]; European Union [214538]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Union(European Commission)	This work has been supported by the Defense Advanced Research Projects Agency (DARPA, www.darpa.mil), under SymBioSys Program, Grant Contract No. F30602-00-2-0614); and by the European Union Seventh Framework Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7/index_en.cfm) under grant agreement no. 214538 project Bio-Inspired Self-assembled Nano-Enabled Surfaces (BISNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207; Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3; Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; Caron G, 2003, MINI-REV MED CHEM, V3, P821, DOI 10.2174/1389557033487665; CASARI G, 1992, J MOL BIOL, V224, P725, DOI 10.1016/0022-2836(92)90556-Y; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cozzini P, 2004, CURR MED CHEM, V11, P3093, DOI 10.2174/0929867043363929; Cristea PD, 2012, PROTEIN SURFACE ATOM, P147; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Efremov RG, 1999, BIOPHYS J, V76, P2448, DOI 10.1016/S0006-3495(99)77400-X; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P699, DOI 10.1007/BF01024971; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; FAUCHERE JL, 1988, J MOL GRAPHICS, V6, P203, DOI 10.1016/S0263-7855(98)80004-0; Fersht A., 1985, ENZYME STRUCTURE MEC; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Hawkins KR, 2007, LAB CHIP, V7, P281, DOI 10.1039/b612894g; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jamadagni SN, 2011, ANNU REV CHEM BIOMOL, V2, P147, DOI 10.1146/annurev-chembioeng-061010-114156; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kavanaugh JS, 1998, BIOCHEMISTRY-US, V37, P4358, DOI 10.1021/bi9708702; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313; Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; LAWRENCE CE, 1991, METHOD ENZYMOL, V202, P20; LESSER GJ, 1990, PROTEINS, V8, P6, DOI 10.1002/prot.340080104; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mukhopadhyay R, 2006, ANAL CHEM, V78, P7379, DOI 10.1021/ac069476c; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Nicolau DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058896; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Sandelin E, 2004, BIOPHYS J, V86, P23, DOI 10.1016/S0006-3495(04)74080-1; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SCHIFFER CA, 1993, MOL SIMULAT, V10, P121, DOI 10.1080/08927029308022162; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; VILA J, 1991, PROTEINS, V10, P199, DOI 10.1002/prot.340100305; WESSON L, 1992, PROTEIN SCI, V1, P227; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Yamaotsu N, 2008, BIOL PHARM BULL, V31, P1552, DOI 10.1248/bpb.31.1552; ZAUHAR RJ, 1990, J COMPUT CHEM, V11, P603, DOI 10.1002/jcc.540110509	68	19	19	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114042	10.1371/journal.pone.0114042	http://dx.doi.org/10.1371/journal.pone.0114042			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462574	Green Published, gold			2022-12-27	WOS:000345869700086
J	Sun, Y; Yi, XP; Peng, M; Zeng, HC; Wang, D; Li, B; Tong, Z; Chang, LL; Jin, X; Wang, XC				Sun, Yong; Yi, Xiaoping; Peng, Ming; Zeng, Huicai; Wang, Dan; Li, Bo; Tong, Zheng; Chang, Lili; Jin, Xiang; Wang, Xuchu			Proteomics of Fusarium oxysporum Race 1 and Race 4 Reveals Enzymes Involved in Carbohydrate Metabolism and Ion Transport That Might Play Important Roles in Banana Fusarium Wilt	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; RICE BLAST FUNGUS; CATALASE-PEROXIDASE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; MAGNAPORTHE-GRISEA; EXPRESSED PROTEINS; GENE CLONING; COLONIZATION; GRAMINEARUM; INFECTION	Banana Fusarium wilt is a soil-spread fungal disease caused by Fusarium oxysporum. In China, the main virulence fungi in banana are F. oxysporum race 1 (F1, weak virulence) and race 4 (F4, strong virulence). To date, no proteomic analyses have compared the two races, but the difference in virulence between F1 and F4 might result from their differentially expressed proteins. Here we report the first comparative proteomics of F1 and F4 cultured under various conditions, and finally identify 99 protein species, which represent 59 unique proteins. These proteins are mainly involved in carbohydrate metabolism, post-translational modification, energy production, and inorganic ion transport. Bioinformatics analysis indicated that among the 46 proteins identified from F4 were several enzymes that might be important for virulence. Reverse transcription PCR analysis of the genes for 15 of the 56 proteins revealed that their transcriptional patterns were similar to their protein expression patterns. Taken together, these data suggest that proteins involved in carbohydrate metabolism and ion transport may be important in the pathogenesis of banana Fusarium wilt. Some enzymes such as catalase-peroxidase, galactosidase and chitinase might contribute to the strong virulence of F4. Overexpression or knockout of the genes for the F4-specific proteins will help us to further understand the molecular mechanism of Fusarium-induced banana wilt.	[Sun, Yong; Yi, Xiaoping; Peng, Ming; Zeng, Huicai; Wang, Dan; Li, Bo; Tong, Zheng; Chang, Lili; Jin, Xiang; Wang, Xuchu] Chinese Acad Trop Agr Sci Haikou City, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Peng, M (corresponding author), Chinese Acad Trop Agr Sci Haikou City, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China.	mmpeng_2000@yahoo.com; xchwanghainan@163.com	Wang, Xuchu/E-7133-2016	Wang, Xuchu/0000-0003-3137-4390	Agro-scientific Research in Public Interest [200903049-02]; Major Technology Project of Hainan [ZDZX2013023-1]; National Natural Science Foundation [31000291, 31270712]; Grant for Top Young Talents in CATAS [ITBB130102]	Agro-scientific Research in Public Interest; Major Technology Project of Hainan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Grant for Top Young Talents in CATAS	This work was supported by the Agro-scientific Research in Public Interest (No. 200903049-02), the Major Technology Project of Hainan (No. ZDZX2013023-1), the National Natural Science Foundation (No. 31000291; 31270712), and the Grant for Top Young Talents in CATAS (No. ITBB130102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalfitano C, 2002, PHYTOCHEM ANALYSIS, V13, P277, DOI 10.1002/pca.648; Asano K, 2012, BIOCHIMIE, V94, P1291, DOI 10.1016/j.biochi.2012.02.026; Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; Caracuel Z, 2003, MOL MICROBIOL, V48, P765, DOI 10.1046/j.1365-2958.2003.03465.x; [陈石 Chen Shi], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P1503; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Dong ZY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-51; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gerke J, 2012, FUNGAL GENET BIOL, V49, P443, DOI 10.1016/j.fgb.2012.04.003; Getha K, 2002, J IND MICROBIOL BIOT, V28, P303, DOI [10.1038/sj/jim/7000247, 10.1038/sj.jim.7000247]; [郭立佳 GUO LiJia], 2007, [生物技术, Biotechnology], V17, P1; Hilti N, 2000, YEAST, V16, P1; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P719, DOI 10.1094/MPMI-11-10-0267; Kim ST, 2004, PROTEOMICS, V4, P3579, DOI 10.1002/pmic.200400969; Labroussaa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017357; Lan X, 2008, BIOSCI BIOTECH BIOCH, V72, P492, DOI 10.1271/bbb.70573; Larriba E, 2012, CAN J MICROBIOL, V58, P815, DOI [10.1139/w2012-054, 10.1139/W2012-054]; Lee HS, 2008, TOXICON, V51, P1178, DOI 10.1016/j.toxicon.2008.02.002; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Li Chi, 2010, Journal of Fruit Science, V27, P969; Li ChunYu, 2011, Acta Horticulturae Sinica, V38, P2092; Lin Fei, 2010, Genomics and Applied Biology, V29, P314; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Marin S, 1998, INT J FOOD MICROBIOL, V42, P185, DOI 10.1016/S0168-1605(98)00077-4; Moretti M, 2010, PROTEOMICS, V10, P3292, DOI 10.1002/pmic.200900716; Morita H, 2012, APPL ENVIRON MICROB, V78, P8154, DOI 10.1128/AEM.01601-12; Morita H, 2011, BIOSCI BIOTECH BIOCH, V75, P662, DOI 10.1271/bbb.100749; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; OCHI K, 1982, J BACTERIOL, V152, P400; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Pigosso LL, 2013, FUNGAL GENET BIOL, V60, P87, DOI 10.1016/j.fgb.2013.07.008; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Prados-Rosales R, 2009, PROTEOMICS, V9, P4755, DOI 10.1002/pmic.200800950; [齐兴柱 Qi Xingzhu], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P163; Rampitsch C, 2010, PROTEOMICS, V10, P124, DOI 10.1002/pmic.200800399; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Sagaram US, 2007, MICROBIOL-SGM, V153, P2850, DOI 10.1099/mic.0.2007/007708-0; Singhal N, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-14; Smulevich G, 2006, J INORG BIOCHEM, V100, P568, DOI 10.1016/j.jinorgbio.2006.01.033; [孙勇 Sun Yong], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P211; [孙勇 Sun Yong], 2012, [热带作物学报, Chinese Journal of Tropical Crops], V33, P759; Takaya N, 1998, MICROBIOL-SGM, V144, P2647, DOI 10.1099/00221287-144-9-2647; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Tanabe S, 2009, PHYSIOL PLANTARUM, V137, P148, DOI 10.1111/j.1399-3054.2009.01272.x; Taylor RD, 2008, PROTEOMICS, V8, P2256, DOI 10.1002/pmic.200700610; Van den Berg N, 2007, MOL PLANT PATHOL, V8, P333, DOI 10.1111/J.1364-3703.2007.00389.X; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Wang XC, 2012, ELECTROPHORESIS, V33, P296, DOI 10.1002/elps.201100300; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; WURSTER B, 1972, FEBS LETT, V23, P341, DOI 10.1016/0014-5793(72)80311-9; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yang Y, 2011, CHIN J TROP CROPS, V3, P94; Zamocky M, 2007, J BIOL INORG CHEM, V12, pS97; Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10	63	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113818	10.1371/journal.pone.0113818	http://dx.doi.org/10.1371/journal.pone.0113818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460190	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700057
J	Wettersten, HI; Landesman, Y; Friedlander, S; Shacham, S; Kauffman, M; Weiss, RH				Wettersten, Hiromi I.; Landesman, Yosef; Friedlander, Sharon; Shacham, Sharon; Kauffman, Michael; Weiss, Robert H.			Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; P21 EXPRESSION; RESISTANCE; CRM1; IDENTIFICATION; TARGETS; PROTEIN	Purpose: Despite the advent of FDA-approved therapeutics to a limited number of available targets (kinases and mTOR), PFS of kidney cancer (RCC) has been extended only one to two years due to the development of drug resistance. Here, we evaluate a novel therapeutic for RCC which targets the exportin-1 (XPO1) inhibitor. Materials and Methods: RCC cells were treated with the orally available XPO1 inhibitor, KPT-330, and cell viability and Annexin V (apoptosis) assays, and cell cycle analyses were performed to evaluate the efficacy of KPT-330 in two RCC cell lines. Immunoblotting and immunofluorescence analysis were performed to validate mechanisms of XPO1 inhibition. The efficacy and on-target effects of KPT-330 were further analyzed in vivo in RCC xenograft mice, and KPT-330-resistant cells were established to evaluate potential mechanisms of KPT-330 resistance. Results: KPT-330 attenuated RCC viability through growth inhibition and apoptosis induction both in vitro and in vivo, a process in which increased nuclear localization of p21 by XPO1 inhibition played a major role. In addition, KPT-330 resistant cells remained sensitive to the currently approved for RCC multi-kinase inhibitors (sunitinib, sorafenib) and mTOR inhibitors (everolimus, temsirolimus), suggesting that these targeted therapeutics would remain useful as second line therapeutics following KPT-330 treatment. Conclusion: The orally-available XPO1 inhibitor, KPT-330, represents a novel target for RCC whose in vivo efficacy approaches that of sunitinib. In addition, cells resistant to KPT-330 retain their ability to respond to available RCC therapeutics suggesting a novel approach for treatment in KPT-330-naive as well as -resistant RCC patients.	[Wettersten, Hiromi I.; Weiss, Robert H.] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Landesman, Yosef; Friedlander, Sharon; Shacham, Sharon; Kauffman, Michael] Karyopharm Therapeut Inc, Natick, MA USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Weiss, RH (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	rhweiss@ucdavis.edu			National Institutes of Health [5UO1CA86402, 1R01CA135401-01A1, 1R01DK082690-01A1]; Karyopharm Therapeutics; NATIONAL CANCER INSTITUTE [U01CA086402, P30CA093373, R01CA135401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karyopharm Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 5UO1CA86402, 1R01CA135401-01A1, and 1R01DK082690-01A1 and by Karyopharm Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Cowey CL, 2010, CLIN ADV HEMATOL ONC, V8, P357; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Inoue H, 2011, CANC BIOL THERAPY, V12; Inoue H, 2013, J UROLOGY, V189, P2317, DOI 10.1016/j.juro.2012.10.018; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Makhov PB, 2012, MOL CANCER THER, V11, P1510, DOI 10.1158/1535-7163.MCT-11-0907; Naniwa J, 2003, CANCER SCI, V94, P1099, DOI 10.1111/j.1349-7006.2003.tb01406.x; Nelson EC, 2007, CANCER TREAT REV, V33, P299, DOI 10.1016/j.ctrv.2006.12.005; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Senapedis WT, 2014, SEMIN CANCER BIOL, V27, P74, DOI 10.1016/j.semcancer.2014.04.005; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Weiss RH, 2006, KIDNEY INT, V69, P224, DOI 10.1038/sj.ki.5000065; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Wettersten HI, 2013, NAT REV UROL, V10, P336, DOI 10.1038/nrurol.2013.52; Winters ZE, 2001, EUR J CANCER, V37, P2405, DOI 10.1016/S0959-8049(01)00327-6	22	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113867	10.1371/journal.pone.0113867	http://dx.doi.org/10.1371/journal.pone.0113867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461627	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700062
J	Tait, LW; Hawes, I; Schiel, DR				Tait, Leigh W.; Hawes, Ian; Schiel, David R.			Shining Light on Benthic Macroalgae: Mechanisms of Complementarity in Layered Macroalgal Assemblages	PLOS ONE			English	Article							KELP FORESTS; PHYTOPLANKTON COMMUNITIES; BIODIVERSITY EXPERIMENTS; NICHE COMPLEMENTARITY; PRIMARY PRODUCTIVITY; DIVERSITY; ECOSYSTEM; PHOTOSYNTHESIS; CANOPY; PERFORMANCE	Phototrophs underpin most ecosystem processes, but to do this they need sufficient light. This critical resource, however, is compromised along many marine shores by increased loads of sediments and nutrients from degraded inland habitats. Increased attenuation of total irradiance within coastal water columns due to turbidity is known to reduce species' depth limits and affect the taxonomic structure and architecture of algal-dominated assemblages, but virtually no attention has been paid to the potential for changes in spectral quality of light energy to impact production dynamics. Pioneering studies over 70 years ago showed how different pigmentation of red, green and brown algae affected absorption spectra, action spectra, and photosynthetic efficiency across the PAR (photosynthetically active radiation) spectrum. Little of this, however, has found its way into ecological syntheses of the impacts of optically active contaminants on coastal macroalgal communities. Here we test the ability of macroalgal assemblages composed of multiple functional groups (including representatives from the chlorophyta, rhodophyta and phaeophyta) to use the total light resource, including different light wavelengths and examine the effects of suspended sediments on the penetration and spectral quality of light in coastal waters. We show that assemblages composed of multiple functional groups are better able to use light throughout the PAR spectrum. Macroalgal assemblages with four sub-canopy species were between 50-75% more productive than assemblages with only one or two sub-canopy species. Furthermore, attenuation of the PAR spectrum showed both a loss of quanta and a shift in spectral distribution with depth across coastal waters of different clarity, with consequences to productivity dynamics of diverse layered assemblages. The processes of light complementarity may help provide a mechanistic understanding of how altered turbidity affects macroalgal assemblages in coastal waters, which are increasingly threatened by diminishing light quantity and altered spectral distributions through sedimentation and eutrophication.	[Tait, Leigh W.; Schiel, David R.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand; [Tait, Leigh W.] Natl Inst Water & Atmosphere, Christchurch, New Zealand; [Hawes, Ian] Univ Canterbury, Christchurch 1, New Zealand	University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Canterbury	Tait, LW (corresponding author), Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand.	leigh.tait@niwa.co.nz		Hawes, Ian/0000-0003-2471-6903; Tait, Leigh/0000-0001-9153-139X	New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI); National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity	New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI)(New Zealand Foundation for Research, Science and Technology); National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity	The research was funded by the New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI), the National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity (2013-2014 SCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Babin M, 2003, LIMNOL OCEANOGR, V48, P843, DOI 10.4319/lo.2003.48.2.0843; Behl S, 2011, LIMNOL OCEANOGR, V56, P683, DOI 10.4319/lo.2011.56.2.0683; Behrenfeld MJ, 1997, OCEANOGRAPHY, V42; Binzer T, 2005, MAR ECOL PROG SER, V287, P65, DOI 10.3354/meps287065; Binzer T, 2002, MAR ECOL PROG SER, V235, P53, DOI 10.3354/meps235053; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722, DOI 10.4319/lo.2006.51.6.2722; Bischof K, 2006, MAR ECOL PROG SER, V306, P165, DOI 10.3354/meps306165; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; DRING MJ, 1981, LIMNOL OCEANOGR, V26, P271, DOI 10.4319/lo.1981.26.2.0271; Emerson R, 1959, PLANT PHYSIOL, P477; ENRIQUEZ S, 1994, OECOLOGIA, V98, P121, DOI 10.1007/BF00341462; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; French CS, 1952, J GEN PHYSIOL, P873; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Grime JP, 2002, J VEG SCI, V13, P457, DOI 10.1111/j.1654-1103.2002.tb02072.x; Harrer SL, 2013, J PHYCOL, V49, P248, DOI 10.1111/jpy.12023; HAXO FT, 1950, J GEN PHYSIOL, V33, P389, DOI 10.1085/jgp.33.4.389; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hedley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111454; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; KAUTSKY N, 1986, MAR ECOL PROG SER, V28, P1, DOI 10.3354/meps028001; Kawana K, 1975, B FACULTY FISHERIES, V26, P235; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUNING K, 1985, MAR BIOL, V87, P119, DOI 10.1007/BF00539419; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Miller RJ, 2012, OECOLOGIA, V168, P797, DOI 10.1007/s00442-011-2143-5; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Schiel DR, 2007, MAR ECOL PROG SER, V339, P1, DOI 10.3354/meps339001; Schiel DR, 2006, J EXP MAR BIOL ECOL, V338, P233, DOI 10.1016/j.jembe.2006.06.023; Schiel DR, 2011, J EXP MAR BIOL ECOL, V400, P33, DOI 10.1016/j.jembe.2011.02.026; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; Stomp M, 2007, ECOL LETT, V10, P290, DOI 10.1111/j.1461-0248.2007.01026.x; Striebel M, 2009, AM NAT, V174, P141, DOI 10.1086/599294; Striebel M, 2009, ECOLOGY, V90, P2025, DOI 10.1890/08-1409.1; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tait LW, 2010, MAR ECOL PROG SER, V416, P115, DOI 10.3354/meps08781; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Turnbull MH, 2003, FUNCT ECOL, V17, P101, DOI 10.1046/j.1365-2435.2003.00713.x; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Vojtech E, 2008, OIKOS, V117, P1351, DOI 10.1111/j.0030-1299.2008.16700.x; Walsby AE, 1997, NEW PHYTOL, V136, P189, DOI 10.1046/j.1469-8137.1997.00736.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x	70	22	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114146	10.1371/journal.pone.0114146	http://dx.doi.org/10.1371/journal.pone.0114146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438045	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900125
J	Jian, Y; Silvestri, S; Brown, J; Hickman, R; Marani, M				Jian, Yun; Silvestri, Sonia; Brown, Jeff; Hickman, Rick; Marani, Marco			The Temporal Spectrum of Adult Mosquito Population Fluctuations: Conceptual and Modeling Implications	PLOS ONE			English	Article							CULISETA MELANURA DIPTERA; CULEX MOSQUITOS; TIME-SERIES; ABUNDANCE; HABITATS; TEMPERATURE; VARIABILITY; DYNAMICS; PREDICT; DESIGN	An improved understanding of mosquito population dynamics under natural environmental forcing requires adequate field observations spanning the full range of temporal scales over which mosquito abundance fluctuates in natural conditions. Here we analyze a 9-year daily time series of uninterrupted observations of adult mosquito abundance for multiple mosquito species in North Carolina to identify characteristic scales of temporal variability, the processes generating them, and the representativeness of observations at different sampling resolutions. We focus in particular on Aedes vexans and Culiseta melanura and, using a combination of spectral analysis and modeling, we find significant population fluctuations with characteristic periodicity between 2 days and several years. Population dynamical modelling suggests that the observed fast fluctuations scales (2 days-weeks) are importantly affected by a varying mosquito activity in response to rapid changes in meteorological conditions, a process neglected in most representations of mosquito population dynamics. We further suggest that the range of time scales over which adult mosquito population variability takes place can be divided into three main parts. At small time scales (indicatively 2 days-1 month) observed population fluctuations are mainly driven by behavioral responses to rapid changes in weather conditions. At intermediate scales (1 to several month) environmentally-forced fluctuations in generation times, mortality rates, and density dependence determine the population characteristic response times. At longer scales (annual to multi-annual) mosquito populations follow seasonal and inter-annual environmental changes. We conclude that observations of adult mosquito populations should be based on a sub-weekly sampling frequency and that predictive models of mosquito abundance must include behavioral dynamics to separate the effects of a varying mosquito activity from actual changes in the abundance of the underlying population.	[Jian, Yun; Silvestri, Sonia; Marani, Marco] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Brown, Jeff; Hickman, Rick] Brunswick Cty Govt, Mosquito Control Dept, Brunswick, NC 28422 USA; [Marani, Marco] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; [Marani, Marco] Univ Padua, Dept Civil Architectural & Environm Engn, Padua, Italy	Duke University; Duke University; University of Padua	Marani, M (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marco.marani@duke.edu	Marani, Marco/F-9451-2016	Marani, Marco/0000-0002-1493-6913; SILVESTRI, SONIA/0000-0002-5114-8633	Nicholas School of the Environment	Nicholas School of the Environment	The authors acknowledge support by the Nicholas School of the Environment (graduate support to YJ, and funding to MM and SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MOSQUITOES THEIR CON; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Brunswick County Government, 2011, MOSQ CONTR; Buckner E., 2012, FEATURED CREATURES; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chuang TW, 2012, REMOTE SENS ENVIRON, V125, P147, DOI 10.1016/j.rse.2012.07.018; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Clements AN., 1992, BIOL MOSQUITOES DEV; Crans WJ, 2013, AEDES VEXANS MEIGEN; Crans WJ, 2013, CULISETA MELANURA CO; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Ermert V., 2011, MALARIA J, V10; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Hart EM, 2011, OIKOS, V120, P1227, DOI 10.1111/j.1600-0706.2011.18707.x; Horsfall W. R., 1973, BIONOMICS EMBRYOLOGY; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Jian Y, 2014, ECOL MODEL, V272, P301, DOI 10.1016/j.ecolmodel.2013.10.019; Kantz H., 2004, NONLINEAR TIME SERIE; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahmood F, 1997, J AM MOSQUITO CONTR, V13, P92; Mahmood F, 1998, J MED ENTOMOL, V35, P980, DOI 10.1093/jmedent/35.6.980; Mahmood F, 1998, J MED ENTOMOL, V35, P1007, DOI 10.1093/jmedent/35.6.1007; MALONEY JM, 1976, MOSQ NEWS, V36, P190; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; Nadeem K, 2012, OIKOS, V121, P1656, DOI 10.1111/j.1600-0706.2011.20010.x; Polansky L, 2010, ECOLOGY, V91, P1506, DOI 10.1890/08-2159.1; Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P105; Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P24; Reisen WK, 2000, J AM MOSQUITO CONTR, V16, P13; REISEN WK, 1987, J AM MOSQUITO CONTR, V3, P601; Royle J. A., 2008, HIERARCHICAL MODELIN; Russell TL, 2011, P ROY SOC B-BIOL SCI, V278, P3142, DOI 10.1098/rspb.2011.0153; Sanford MR, 2011, PLOS ONE, V6; Shaman J, 2002, EMERG INFECT DIS, V8, P6; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Shaman J, 2011, J MED ENTOMOL, V48, P867, DOI 10.1603/ME10269; Shumway R.H., 2006, TIME SERIES ANAL ITS; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; TRPIS M, 1970, CAN ENTOMOL, V102, P1048, DOI 10.4039/Ent1021048-8; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Yang GJ, 2008, POPUL ECOL, V50, P293, DOI 10.1007/s10144-008-0082-8; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	56	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114301	10.1371/journal.pone.0114301	http://dx.doi.org/10.1371/journal.pone.0114301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478861	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200069
J	Bouquie, R; Wainstein, L; Pilet, P; Mussini, JM; Deslandes, G; Clouet, J; Dailly, E; Jolliet, P; Victorri-Vigneau, C				Bouquie, Regis; Wainstein, Laura; Pilet, Paul; Mussini, Jean-Marie; Deslandes, Guillaume; Clouet, Johann; Dailly, Eric; Jolliet, Pascale; Victorri-Vigneau, Caroline			Crushed and Injected Buprenorphine Tablets: Characteristics of Princeps and Generic Solutions	PLOS ONE			English	Article							DERMATITIS NICOLAUS-SYNDROME; PARTICULATE MATTER; INFUSION PHLEBITIS; LIVEDO; FILTRATION; AUSTRALIA; DIVERSION	Self-injection of high-dose buprenorphine is responsible for well-described complications. In 2011, we have been alerted by unusual but serious cutaneous complication among injection buprenorphine users. A prospective data collection identified 30 cases of necrotic cutaneous lesions after injection of filtered buprenorphine solution, among which 25 cases occurred following injection of buprenorphine generics. The main goal of our study was to put forward particularities that could explain the cutaneous complications, by qualitatively and quantitatively confronting particles present in Subutex and generics solutions. We used the same protocol that injected-buprenorphine users: generic or subutex tablets were crushed in sterile water and filtered through 2 filters commonly used (cotton-pad and sterifilt). Solutions were analyzed by laser granulometry, flow cytometry and scanning electron microscopy. We have highlighted the wide variation of the quantity and the size of the particles present in solution between the two drugs after cotton-pad filtration. The proportion of particles <10 mu m is systematically higher in the generic solutions than with Subutex. All of the insoluble particles found in generic solutions contain silica, whereas non-organic element was to be identified in the insoluble particles of Subutex. One skin biopsy obtained from one patient who developed a necrotic lesion after intravenous injection of filtrated solution of buprenorphine generic, shows non-organic elements. Identification of particles in situ enables us to confirm the presence of silica in the biopsy. Actually the monitoring of patient receiving generic of buprenorphine must be strengthened.	[Bouquie, Regis; Wainstein, Laura; Deslandes, Guillaume] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France; [Bouquie, Regis; Jolliet, Pascale; Victorri-Vigneau, Caroline] Univ Nantes, EA Biostat Pharmacoepidemiol & Mesures Subject Sa, Nantes, France; [Pilet, Paul] Univ Nantes, INSERM, UMR 791, Lab Ingn Osteoarticulaire & Dent LIOAD, Nantes, France; [Pilet, Paul] CHU Nantes, Pole Hosp Univ 4, F-44035 Nantes 01, France; [Mussini, Jean-Marie] CHU Nantes, Anat Pathol Lab, F-44035 Nantes 01, France; [Clouet, Johann] Univ Nantes, INSERM, Unite Mixte Rech Sante UMRS 791, Lab Ingen Osteoarticulaire & Dent LIOAD, Nantes, France; [Clouet, Johann] CHU Nantes, Pole Hosp Univ 7, Pharm Cent, F-44035 Nantes 01, France; [Dailly, Eric; Jolliet, Pascale] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France; [Dailly, Eric] Univ Nantes, EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Victorri-Vigneau, Caroline] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France	Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes	Bouquie, R (corresponding author), CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France.	regis.bouquie@chu-nantes.fr	Paul, Pilet/A-3755-2015; Clouet, Johann/P-1358-2014; Jolliet, pascale/L-9026-2015; Victorri Vigneau, Caroline/L-9030-2015	Victorri-Vigneau, Caroline/0000-0002-3745-2532; Dailly, Eric/0000-0002-5400-335X; Pascale, JOLLIET/0000-0003-0191-9249				ABRAHAM JL, 1980, ENVIRON RES, V21, P94, DOI 10.1016/0013-9351(80)90011-0; *AC NAT PHARM, 2011, SEANC THEM MAT PREM; Bellot B, 2014, ARCH PEDIATRIE, V21, P377, DOI 10.1016/j.arcped.2014.01.016; BOLLINGER RO, 1978, AM J HOSP PHARM, V35, P312, DOI 10.1093/ajhp/35.3.312; Brecheteau F, 2013, J SEX MED, V10, P2866, DOI 10.1111/jsm.12282; BREWSTER D, 1981, J PHARM PHARMACOL, V33, P500, DOI 10.1111/j.2042-7158.1981.tb13848.x; Cherasse A, 2003, JOINT BONE SPINE, V70, P390, DOI 10.1016/S1297-319X(03)00137-4; Corazza M, 2001, J EUR ACAD DERMATOL, V15, P585, DOI 10.1046/j.1468-3083.2001.00320.x; DAVIS NM, 1970, AM J HOSP PHARM, V27, P822, DOI 10.1093/ajhp/27.10.822; DELUCA PP, 1975, AM J HOSP PHARM, V32, P1001, DOI 10.1093/ajhp/32.10.1001; DRESSLER FA, 1989, AM J CARDIOL, V64, P909, DOI 10.1016/0002-9149(89)90841-2; EVANS WE, 1976, AM J HOSP PHARM, V33, P1160, DOI 10.1093/ajhp/33.11.1160; Gaudez C, 2003, REV NEUROL-FRANCE, V159, P571; Gayken J, 2006, J BURN CARE RES, V27, P541, DOI 10.1097/01.BCR.0000225917.09339.03; Glaizal M, 2011, THERAPIE, V66, P545, DOI 10.2515/therapie/2011069; Grau D, 2010, NOUV REV FR, P188; Guarneri C, 2010, AM J CLIN DERMATOL, V11, P51, DOI 10.2165/1153426-S0-000000000-00000; GUYTON AC, 1997, HUM PHYSIOL MECH DIS; HAHN HH, 1969, ARCH INTERN MED, V123, P656, DOI 10.1001/archinte.123.6.656; Hornez E, 2010, ANN CHIR PLAST ESTH, V55, P159, DOI 10.1016/j.anplas.2008.12.004; Jenkinson RA, 2005, ADDICTION, V100, P197, DOI 10.1111/j.1360-0443.2004.00958.x; Just PA, 2007, AM J DERMATOPATH, V29, P72, DOI 10.1097/01.dad.0000211508.67736.d4; Kienast AK, 2008, CLIN EXP DERMATOL, V33, P555, DOI 10.1111/j.1365-2230.2008.02861.x; Kim SK, 2012, ARCH PLAST SURG-APS, V39, P249, DOI 10.5999/aps.2012.39.3.249; Marangi GF, 2010, J DERMATOL, V37, P488, DOI 10.1111/j.1346-8138.2010.00864.x; Modzelewska I, 1980, Wiad Lek, V33, P231; Nayci Sillan, 2013, Indian Dermatol Online J, V4, P152, DOI 10.4103/2229-5178.110642; Perli Daniel, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007785; Potier A, 2007, ANN DERMATOL VENER, V134, P148, DOI 10.1016/S0151-9638(07)91607-5; Rahimi-Movaghar A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007775.pub2; Roux P, 2011, DRUG ALCOHOL REV, V30, P287, DOI 10.1111/j.1465-3362.2011.00285.x; Ruffieux P, 1996, DERMATOLOGY, V193, P368, DOI 10.1159/000246298; Schneider P, 2010, ARCH DERMATOL, V146, P208, DOI 10.1001/archdermatol.2009.372; SCHROEDER HG, 1976, AM J HOSP PHARM, V33, P543, DOI 10.1093/ajhp/33.6.543; Scott J, 2005, J SUBST USE, V10, P293, DOI DOI 10.1080/14659890412331319425; STANDRING S, 2008, GRAYS ANATOMY ANATOM, P127; *TIPH CAN, RAPP 2010 DONN REC R; Wainstein L, 2015, BRIT J DERMATOL, V172, P1412, DOI 10.1111/bjd.13503; Winstock AR, 2008, INT J DRUG POLICY, V19, P450, DOI 10.1016/j.drugpo.2007.03.002; Zaragoza J, 2013, ANN DERMATOL VENER, V140, P713, DOI 10.1016/j.annder.2013.07.009	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113991	10.1371/journal.pone.0113991	http://dx.doi.org/10.1371/journal.pone.0113991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474108	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500101
J	Safarzoda, S; Bahlai, CA; Fox, AF; Landis, DA				Safarzoda, Shahlo; Bahlai, Christine A.; Fox, Aaron F.; Landis, Douglas A.			The Role of Natural Enemy Foraging Guilds in Controlling Cereal Aphids in Michigan Wheat	PLOS ONE			English	Article							SCHIZAPHIS-GRAMINUM RONDANI; RHOPALOSIPHUM-PADI L; WINTER-WHEAT; BIOLOGICAL-CONTROL; GENERALIST PREDATORS; GREENBUGS HOMOPTERA; SEASONAL ABUNDANCE; BEETLE COLEOPTERA; YIELD LOSSES; PEST	Insect natural enemies (predators and parasitoids) provide important ecosystem services by suppressing populations of insect pests in many agricultural crops. However, the role of natural enemies against cereal aphids in Michigan winter wheat (Triticum aestivum L.) is largely unknown. The objectives of this research were to characterize the natural enemy community in wheat fields and evaluate the role of different natural enemy foraging guilds (foliar-foraging versus ground-dwelling predators) in regulating cereal aphid population growth. We investigated these objectives during the spring and summer of 2012 and 2013 in four winter wheat fields on the Michigan State University campus farm in East Lansing, Michigan. We monitored and measured the impact of natural enemies by experimentally excluding or allowing their access to wheat plants infested with Rhopalosiphum padi (L.) and Sitobion avenae (F.) (Hemiptera: Aphidae). Our results indicate that the natural enemy community in the wheat fields consisted mostly of foliar-foraging and ground-dwelling predators with relatively few parasitoids. In combination, these natural enemy groups were very effective at reducing cereal aphid populations. We also investigated the role of each natural enemy foraging guild (foliar-foraging versus ground-dwelling predators) independently. Overall, our results suggest that, in combination, natural enemies can almost completely halt early-season aphid population increase. Independently, ground-dwelling predators were more effective at suppressing cereal aphid populations than foliar-foraging predators under the conditions we studied. Our results differ from studies in Europe and the US Great Plains where foliar foraging predators and parasitoids are frequently more important cereal aphid natural enemies.	[Safarzoda, Shahlo; Bahlai, Christine A.; Fox, Aaron F.; Landis, Douglas A.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Michigan State University	Bahlai, CA (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	cbahlai@msu.edu	Landis, Douglas A./L-7991-2019; Bahlai, Christie/L-5500-2019	Bahlai, Christie/0000-0002-8937-8709	United States Agency for International Development (USAID) [EPP-A-00-0400016-00]; Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology, AgBioResearch; USDA National Institute of Food and Agriculture	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology, AgBioResearch; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Support for this study was provided by the United States Agency for International Development (USAID) Cooperative Agreement No: EPP-A-00-0400016-00 for the IPM Innovation Lab managed by Virginia Tech and with a sub-award to Michigan State University (http://www.usaid.gov/). Partial support was provided by Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology ( http://www.ent.msu.edu/), AgBioResearch (http://agbioresearch.msu.edu/), and the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsuhaibani AM, 1996, ARAB GULF J SCI RES, V14, P405; Banken JAO, 1998, J ECON ENTOMOL, V91, P1, DOI 10.1093/jee/91.1.1; BASEDOW T, 1985, PESTIC SCI, V16, P325, DOI 10.1002/ps.2780160404; Brewer MJ, 2004, ANNU REV ENTOMOL, V49, P219, DOI 10.1146/annurev.ento.49.061802.123149; BROWN KC, 1983, ENVIRON ENTOMOL, V12, P1747, DOI 10.1093/ee/12.6.1747; CHAMBERS RJ, 1986, ANN APPL BIOL, V108, P219, DOI 10.1111/j.1744-7348.1986.tb07644.x; CHAMBERS RJ, 1983, J APPL ECOL, V20, P209, DOI 10.2307/2403387; Chapin JW, 2001, J ECON ENTOMOL, V94, P410, DOI 10.1603/0022-0493-94.2.410; CHIVERTON PA, 1986, ANN APPL BIOL, V109, P49, DOI 10.1111/j.1744-7348.1986.tb03183.x; Clement SL, 2004, J KANSAS ENTOMOL SOC, V77, P165, DOI 10.2317/0311.19.1; CORDEIRO GM, 1993, J ROY STAT SOC B MET, V55, P661; DiFonzo C, 2007, QUESTIONS ANSWERS AP; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; EDWARDS CA, 1979, J APPL ECOL, V16, P811, DOI 10.2307/2402855; Elliott NC, 1999, LANDSCAPE ECOL, V14, P239, DOI 10.1023/A:1008002528345; ELLIOTT NC, 1990, ENVIRON ENTOMOL, V19, P1320, DOI 10.1093/ee/19.5.1320; ELLIOTT NC, 1991, CAN ENTOMOL, V123, P13, DOI 10.4039/Ent12313-1; EVANS EW, 1992, J KANSAS ENTOMOL SOC, V65, P30; Fiedler AK, 2007, ENVIRON ENTOMOL, V36, P751, DOI 10.1603/0046-225X(2007)36[751:AOMNPT]2.0.CO;2; FLICKINGER EL, 1991, J WILDLIFE DIS, V27, P265, DOI 10.7589/0090-3558-27.2.265; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Giles KL, 2003, J ECON ENTOMOL, V96, P975, DOI 10.1603/0022-0493-96.3.975; GRIFFITHS E, 1985, ECOL ENTOMOL, V10, P181, DOI 10.1111/j.1365-2311.1985.tb00547.x; Hein G., 2006, INSECTICIDES CONTROL; KIECKHEFER RW, 1992, AGRON J, V84, P180, DOI 10.2134/agronj1992.00021962008400020011x; KIECKHEFER RW, 1988, J ECON ENTOMOL, V81, P317, DOI 10.1093/jee/81.1.317; KRAUSS J, 2011, PLOS ONE, V6; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Lee JH, 2005, ENVIRON ENTOMOL, V34, P115, DOI 10.1603/0046-225X-34.1.115; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; Losey JE, 1999, ECOL APPL, V9, P378, DOI 10.1890/1051-0761(1999)009[0378:FFSPTC]2.0.CO;2; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Miller T.D., 1999, GROWTH STAGES WHEAT; Mohamed AH, 2000, ENVIRON ENTOMOL, V29, P360, DOI 10.1603/0046-225X(2000)029[0360:AAEOPA]2.0.CO;2; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Ostman O, 2003, ECOL ECON, V45, P149, DOI 10.1016/S0921-8009(03)00007-7; PIKE KS, 1985, J ECON ENTOMOL, V78, P676, DOI 10.1093/jee/78.3.676; R Core Team, 2021, R LANGUAGE ENV STAT; Reisig DD, 2012, J ECON ENTOMOL, V105, P1612, DOI 10.1603/EC12124; RICE ME, 1988, ENVIRON ENTOMOL, V17, P836, DOI 10.1093/ee/17.5.836; Schmidt MH, 2004, ENTOMOL EXP APPL, V113, P87, DOI 10.1111/j.0013-8703.2004.00205.x; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; Shufran RA, 1997, J ECON ENTOMOL, V90, P1106, DOI 10.1093/jee/90.5.1106; Shufran RA, 1996, J ECON ENTOMOL, V89, P46, DOI 10.1093/jee/89.1.46; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Straub CS, 2008, BIOL CONTROL, V45, P225, DOI 10.1016/j.biocontrol.2007.05.013; Swinton SM, 2006, AM J AGR ECON, V88, P1160, DOI 10.1111/j.1467-8276.2006.00927.x; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; TEETES GL, 1975, J ECON ENTOMOL, V68, P214, DOI 10.1093/jee/68.2.214; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; WILES JA, 1992, PESTIC SCI, V36, P263, DOI 10.1002/ps.2780360313; Wise K., 2011, MANAGING WHEAT GROWT	56	15	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114230	10.1371/journal.pone.0114230	http://dx.doi.org/10.1371/journal.pone.0114230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473951	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500004
J	Salvemini, M; Arunkumar, KP; Nagaraju, J; Sanges, R; Petrella, V; Tomar, A; Zhang, HY; Zheng, WW; Saccone, G				Salvemini, Marco; Arunkumar, Kallare P.; Nagaraju, Javaregowda; Sanges, Remo; Petrella, Valeria; Tomar, Archana; Zhang, Hongyu; Zheng, Weiwei; Saccone, Giuseppe			De Novo Assembly and Transcriptome Analysis of the Mediterranean Fruit Fly Ceratitis capitata Early Embryos	PLOS ONE			English	Article							INTERGENIC NONCODING RNAS; SEX DETERMINATION; TRANSFORMER GENE; ANASTREPHA-SUSPENSA; DROSOPHILA-HYDEI; CHROMOSOME; EXPRESSION; INSECTS; SEQUENCE; VECTOR	The agricultural pest Ceratitis capitata, also known as the Mediterranean fruit fly or Medfly, belongs to the Tephritidae family, which includes a large number of other damaging pest species. The Medfly has been the first non-drosophilid fly species which has been genetically transformed paving the way for designing genetic-based pest control strategies. Furthermore, it is an experimentally tractable model, in which transient and transgene-mediated RNAi have been successfully used. We applied Illumina sequencing to total RNA preparations of 8-10 hours old embryos of C. capitata, This developmental window corresponds to the blastoderm cellularization stage. In summary, we assembled 42,614 transcripts which cluster in 26,319 unique transcripts of which 11,045 correspond to protein coding genes; we identified several hundreds of long ncRNAs; we found an enrichment of transcripts encoding RNA binding proteins among the highly expressed transcripts, such as CcTRA-2, known to be necessary to establish and, most likely, to maintain female sex of C. capitata. Our study is the first de novo assembly performed for Ceratitis capitata based on Illumina NGS technology during embryogenesis and it adds novel data to the previously published C. capitata EST databases. We expect that it will be useful for a variety of applications such as gene cloning and phylogenetic analyses, as well as to advance genetic research and biotechnological applications in the Medfly and other related Tephritidae.	[Salvemini, Marco; Petrella, Valeria; Saccone, Giuseppe] Univ Naples Federico II, Dept Biol, Naples, Italy; [Arunkumar, Kallare P.; Nagaraju, Javaregowda; Tomar, Archana] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Sanges, Remo] Stn Zool Anton Dohrn, Naples, Italy; [Zhang, Hongyu; Zheng, Weiwei] Huazhong Agr Univ, Coll Plant Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Zhang, Hongyu; Zheng, Weiwei] Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Urban & Hort Pests, Wuhan, Peoples R China	University of Naples Federico II; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Stazione Zoologica Anton Dohrn di Napoli; Huazhong Agricultural University; Huazhong Agricultural University	Salvemini, M (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	marco.salvemini@unina.it; hongyu.zhang@mail.hzau.edu.cn	Sanges, Remo/M-9814-2019; saccone, giuseppe/F-8627-2013; Salvemini, Marco/AAJ-5560-2021	Sanges, Remo/0000-0002-5047-9713; saccone, giuseppe/0000-0002-9835-3693; SALVEMINI, Marco/0000-0003-2297-9267; Tomar, Archana/0000-0001-5752-7020	Ministero dell'Universita e della Ricerca	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	Ministero dell'Universita e della Ricerca Grant to GS (PRIN2012). University of Naples Federico II/Fondazione Compagnia di Sanpaolo Grant to MS (STAR2014). Taskforce Project Grant from Department of Biotechnology, Government of India to KPA and JN.	Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bolger MA, 2014, BIOINFORMATICS; Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458; Bopp D, 1996, DEVELOPMENT, V122, P971; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; Carey JR, 2011, EXP GERONTOL, V46, P404, DOI 10.1016/j.exger.2010.09.009; Carvalho AB, 2013, GENOME RES, V23, P1894, DOI 10.1101/gr.156034.113; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; CLINE TW, 1978, GENETICS, V90, P683; Crisanti A, 2013, PATHOG GLOB HEALTH, V107, P458, DOI 10.1179/2047772413Z.000000000174; Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034; Dafa'alla T, 2010, J GENET, V89, P301, DOI 10.1007/s12041-010-0041-y; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Diamantidis AD, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.33; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Gao G, 2014, GENOME RES, V24, P629, DOI 10.1101/gr.165837.113; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Heffer A, 2013, ANNU REV ENTOMOL, V58, P161, DOI 10.1146/annurev-ento-120811-153601; Hokanson KE, 2014, TRANSGENIC RES, V23, P1057, DOI 10.1007/s11248-013-9769-5; Intra J, 2011, J INSECT PHYSIOL, V57, P452, DOI 10.1016/j.jinsphys.2011.01.007; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; KLASSEN W, 1994, FRUIT FLIES AND THE STERILE INSECT TECHNIQUE, P3; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koukidou M, 2014, SEX DEV, V8, P127, DOI 10.1159/000357203; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemke S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-278; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Z, 2009, NUCLEIC ACIDS RES, V37, P4308, DOI 10.1093/nar/gkp334; LOUKERIS TG, 1995, SCIENCE, V270, P2002, DOI 10.1126/science.270.5244.2002; MALACRIDA A, 1992, BIOCHEM GENET, V30, P35, DOI 10.1007/BF00554426; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MARCHINI D, 1995, J BIOL CHEM, V270, P6199, DOI 10.1074/jbc.270.11.6199; Martinez-Barnetche J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-207; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morrison NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050922; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaraju J, 2010, J GENET, V89, P269, DOI 10.1007/s12041-010-0051-9; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogaugwu CE, 2013, INSECT BIOCHEM MOLEC, V43, P1, DOI 10.1016/j.ibmb.2012.10.010; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Patel KR, 2012, PLOS ONE, V7; Peel AD, 2008, PHILOS T R SOC B, V363, P1539, DOI 10.1098/rstb.2007.2244; Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069; Saccone G, 2011, GENETICA, V139, P99, DOI 10.1007/s10709-010-9503-7; Saccone G, 1998, DEVELOPMENT, V125, P1495; Salvemini M, 2006, INSECT MOL BIOL, V15, P341, DOI 10.1111/j.1365-2583.2006.00651.x; Salvemini M, 2010, J GENET, V89, P287, DOI 10.1007/s12041-010-0040-z; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P51, DOI 10.1016/j.ibmb.2011.10.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Scolari F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046812; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shukla JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00948; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Topalis P, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-16; Vannini L, 2010, ARCH INSECT BIOCHEM, V75, P92, DOI 10.1002/arch.20382; Verhulst EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063618; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; Walker JJ, 2000, GENETICS, V155, P191; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wimmer EA, 2013, CURR BIOL, V23, pR453, DOI 10.1016/j.cub.2013.03.058; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhou Jianfeng, 2010, Recent Pat DNA Gene Seq, V4, P192, DOI 10.2174/187221510794751622; ZWIEBEL LJ, 1995, SCIENCE, V270, P2005, DOI 10.1126/science.270.5244.2005	102	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114191	10.1371/journal.pone.0114191	http://dx.doi.org/10.1371/journal.pone.0114191			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474564	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500123
J	Su, JJ; Liang, HW; Yao, WY; Wang, N; Zhang, SY; Yan, X; Feng, H; Pang, WJ; Wang, YB; Wang, XL; Fu, Z; Liu, YQ; Zhao, CH; Zhang, JF; Zhang, CY; Zen, K; Chen, X; Wang, YL				Su, Jiaojiao; Liang, Hongwei; Yao, Weiyan; Wang, Nan; Zhang, Suyang; Yan, Xin; Feng, Hui; Pang, Wenjing; Wang, Yanbo; Wang, Xueliang; Fu, Zhen; Liu, Yanqing; Zhao, Chihao; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Chen, Xi; Wang, Yalei			MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; I RECEPTOR; GROWTH; METASTASIS; EXPRESSION; PREDICTION; ONCOMIRS	Insulin-like growth factor 1 receptor (IGF1R) is a transmembrane receptor that is activated by insulin-like growth factor 1 (IGF-1) and by a related hormone called IGF-2. It belongs to the large class of tyrosine kinase receptors and plays an important role in colorectal cancer etiology and progression. In this study, we used bioinformatic analyses to search for miRNAs that potentially target IGF1R. We identified specific target sites for miR-143 and miR-145 (miR-143/145) in the 3'-untranslated region (3 '-UTR) of the IGF1R gene. These miRNAs are members of a cluster of miRNAs that have been reported to exhibit tumor suppressor activity. Consistent with the bioinformatic analyses, we identified an inverse correlation between miR-143/145 levels and IGF1R protein levels in colorectal cancer tissues. By overexpressing miR-143/145 in Caco2, HT29 and SW480 colorectal cancer cells, we experimentally validated that miR-143/145 directly recognizes the 3'-UTR of the IGF1R transcript and regulates IGF1R expression. Furthermore, the biological consequences of the targeting of IGF1R by miR-143/145 were examined by cell proliferation assays in vitro. We demonstrated that the repression of IGF1R by miR-143/145 suppressed the proliferation of Caco2 cells. Taken together, our findings provide evidence for a role of the miR-143/145 cluster as a tumor suppressor in colorectal cancer through the inhibition of IGF1R translation.	[Su, Jiaojiao; Feng, Hui; Wang, Yalei] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei 230022, Anhui, Peoples R China; [Liang, Hongwei; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Wang, Xueliang; Fu, Zhen; Liu, Yanqing; Zhao, Chihao; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yao, Weiyan; Pang, Wenjing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Anhui Medical University; Nanjing University; Shanghai Jiao Tong University; Nanjing University; Nanjing University	Chen, X (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	xichen@nju.edu.cn; alei416@163.com			National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2014CB542300), the National Natural Science Foundation of China (Nos. 81101330, 31271378 and 81250044) and the Natural Science Foundation of Jiangsu Province (Nos. BK2011013 and BK2012014).	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Bauer KM, 2012, J PROTEOME RES, V11, P4744, DOI 10.1021/pr300600r; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Davies M, 2006, INT J COLORECTAL DIS, V21, P201, DOI 10.1007/s00384-005-0776-8; Dong XQ, 2010, GASTROENTEROLOGY, V139, P464, DOI 10.1053/j.gastro.2010.04.042; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esposito DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036190; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kokki I, 2013, CROAT MED J, V54, P532, DOI 10.3325/cmj.2013.54.532; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZJ, 2013, WORLD J GASTROENTERO, V19, P7788, DOI 10.3748/wjg.v19.i43.7788; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Michael MZ, 2003, MOL CANCER RES, V1, P882; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Zhang R, 2013, J INT MED RES, V41, P1228, DOI 10.1177/0300060513487631; Zhu Z, 2014, FEBS LETT; Zumsteg A, 2012, MOL CANCER RES, V10, P800, DOI 10.1158/1541-7786.MCR-11-0522	39	77	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114420	10.1371/journal.pone.0114420	http://dx.doi.org/10.1371/journal.pone.0114420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474488	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500026
J	Weinmayr, G; Forastiere, F; Buchele, G; Jaensch, A; Strachan, DP; Nagel, G				Weinmayr, Gudrun; Forastiere, Francesco; Buechele, Gisela; Jaensch, Andrea; Strachan, David P.; Nagel, Gabriele		ISAAC Phase Two Study Grp	Overweight/Obesity and Respiratory and Allergic Disease in Children: International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION; NATIONAL-HEALTH; OBESITY; ATOPY; ASSOCIATION; SYMPTOMS; SEX; SENSITIZATION; INFECTIONS	Background: Childhood obesity and asthma are increasing worldwide. A possible link between the two conditions has been postulated. Methods: Cross-sectional studies of stratified random samples of 8-12-year-old children (n=10 652) (16 centres in affluent and 8 centres in non-affluent countries) used the standardized methodology of ISAAC Phase Two. Respiratory and allergic symptoms were ascertained by parental questionnaires. Tests for allergic disease were performed. Height and weight were measured, and overweight and obesity were defined according to international definitions. Prevalence rates and prevalence odds ratios were calculated. Results: Overweight (odds ratio=1.14, 95%-confidence interval: 0.98; 1.33) and obesity (odds ratio=1.67, 95%-confidence interval: 1.25; 2.21) were related to wheeze. The relationship was stronger in affluent than in non-affluent centres. Similar results were found for cough and phlegm, rhinitis and eczema but the associations were mostly driven by children with wheeze. There was a clear association of overweight and obesity with airways obstruction (change in FEV1/FVC, -0.90, 95%-confidence interval: -1.33%; -0.47%, for overweight and -2.46%, 95%-confidence interval: -3.84%; -1.07%, for obesity) whereas the results for the other objective markers, including atopy, were null. Conclusions: Our data from a large international child population confirm that there is a strong relation of body mass index with wheeze especially in affluent countries. Moreover, body mass index is associated with an objective marker of airways obstruction (FEV1/FVC) but no other objective markers of respiratory and allergic disorders.	[Weinmayr, Gudrun; Buechele, Gisela; Jaensch, Andrea; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Forastiere, Francesco] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England	Ulm University; University of London	Weinmayr, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gudrun.weinmayr@uni-ulm.de	Martínez-Gimeno, Antonio/A-9416-2010; De sario, Manuela/K-1932-2016; Di Domenicantonio, Riccardo/H-7867-2018; Ellwood, Philippa/G-7555-2015; KHUBCHANDANI, RAJU/AAI-9871-2020; Papadopoulou, Athina/AAR-6407-2020; EL Sharif, Nuha/AAB-1863-2019; Forastiere, Francesco/J-9067-2016; Nagel, Gabriele/C-3635-2012; Pitrez, Paulo/A-3040-2011	Martínez-Gimeno, Antonio/0000-0003-4051-1860; De sario, Manuela/0000-0002-1117-2735; Di Domenicantonio, Riccardo/0000-0002-9726-0786; Ellwood, Philippa/0000-0002-1994-4023; KHUBCHANDANI, RAJU/0000-0003-0294-119X; EL Sharif, Nuha/0000-0001-6410-4720; Forastiere, Francesco/0000-0002-9162-5684; Nagel, Gabriele/0000-0001-6185-8535; kuyucu, semanur/0000-0003-1999-6496; williams, hywel/0000-0002-5646-3093; Nilsson, Lennart/0000-0002-5680-6367; STEIN, RENATO/0000-0003-0269-0757; Pitrez, Paulo/0000-0001-7319-1133; Lund, Eiliv/0000-0002-8071-8711; Pearce, Neil/0000-0002-9938-7852; Garcia-Marcos, Luis/0000-0002-0925-3851	Fifth Framework Program of European Commission [QLK4-CT-1999-01288]; Almeria: Fondo de Investigacion Sanitaria [00/1092E]; Ankara*: Scientific and Technical Research council of Turkey [SPAG-2237]; Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology; Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria [00/1092E]; Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM) [IDS 337/4D001D, 737/69480]; Ministere de l'Emploi et de la Solidarite [227/7HL02D]; Mutuelle Generale de l'Education Nationale [257/8PL01F]; Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96 [FJ012B]; Dresden: German Ministry of Education and Research [01 EE 9411-3]; Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand; Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria [00/1092E]; Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research [01 EE 9411-3]; Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria [00/1092E]; West Sussex: South Thames National Health Service Regional Research and Development [SPGS 573]	Fifth Framework Program of European Commission; Almeria: Fondo de Investigacion Sanitaria; Ankara*: Scientific and Technical Research council of Turkey; Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology; Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria; Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Emploi et de la Solidarite; Mutuelle Generale de l'Education Nationale; Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96; Dresden: German Ministry of Education and Research; Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand; Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria; Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research; Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria; West Sussex: South Thames National Health Service Regional Research and Development	Coordination and central laboratory analyses of the European centres were funded by the Fifth Framework Program of European Commission, [grant number QLK4-CT-1999-01288]; Funding of local studies: Almeria: Fondo de Investigacion Sanitaria (grant code 00/1092E); Ankara*: Scientific and Technical Research council of Turkey (grant code SPAG-2237), Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology, and the Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria (grant code 00/1092E). Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM) (grant codes IDS 337/4D001D and 737/69480), Ministere de l'Emploi et de la Solidarite (grant code 227/7HL02D), Mutuelle Generale de l'Education Nationale (grant code 257/8PL01F) and Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96 (grant code FJ012B); Dresden: German Ministry of Education and Research (01 EE 9411-3); Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand, and Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria (grant code 00/1092E); Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research (01 EE 9411-3); Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria (grant code 00/1092E); West Sussex: South Thames National Health Service Regional Research and Development project SPGS 573. *: centres supported, at least in part, by European members of the ISAAC Steering Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; CHAMBLESS LE, 1985, COMMUN STAT-THEOR M, V14, P1377, DOI 10.1080/03610928508828982; Chatzi L, 2007, PEDIAT ALLERG IMM-UK, V18, P480, DOI 10.1111/j.1399-3038.2007.00596.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Groot EP, 2010, EUR RESPIR J, V36, P671, DOI 10.1183/09031936.00185709; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Jensen ME, 2014, PEDIATR RES, V75, P93, DOI 10.1038/pr.2013.181; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; Mai XM, 2003, ACTA PAEDIATR, V92, P1144, DOI 10.1080/08035250310005666; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Mitchell EA, 2013, CLIN EXP ALLERGY, V43, P73, DOI 10.1111/cea.12024; Murray CS, 2011, CLIN EXP ALLERGY, V41, P78, DOI 10.1111/j.1365-2222.2010.03598.x; Nagel G, 2009, EUR RESPIR J, V33, P993, DOI 10.1183/09031936.00075708; Nagel G, 2012, PEDIAT ALLERG IMM-UK, V23, P737, DOI 10.1111/pai.12007; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; PISTELLI R, 1992, EUR RESPIR J, V5, P463; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; Scholtens S, 2010, INT J OBESITY, V34, P606, DOI 10.1038/ijo.2009.194; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Tantisira KG, 2001, RESP RES, V2, P324, DOI 10.1186/rr81; Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P762, DOI 10.1111/cea.12107; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P223, DOI 10.1111/cea.12035; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wickens K, 2005, THORAX, V60, P7, DOI 10.1136/thx.2002.001529	36	75	75	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113996	10.1371/journal.pone.0113996	http://dx.doi.org/10.1371/journal.pone.0113996			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474308	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500103
J	Pomilla, C; Amaral, AR; Collins, T; Minton, G; Findlay, K; Leslie, MS; Ponnampalam, L; Baldwin, R; Rosenbaum, H				Pomilla, Cristina; Amaral, Ana R.; Collins, Tim; Minton, Gianna; Findlay, Ken; Leslie, Matthew S.; Ponnampalam, Louisa; Baldwin, Robert; Rosenbaum, Howard			The World's Most Isolated and Distinct Whale Population? Humpback Whales of the Arabian Sea	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MEGAPTERA-NOVAEANGLIAE; GENETIC-STRUCTURE; COMPUTER-PROGRAM; SIZE; ATLANTIC; ABUNDANCE; CONSERVATION; INFERENCE; COALESCENT	A clear understanding of population structure is essential for assessing conservation status and implementing management strategies. A small, non-migratory population of humpback whales in the Arabian Sea is classified as "Endangered" on the IUCN Red List of Threatened Species, an assessment constrained by a lack of data, including limited understanding of its relationship to other populations. We analysed 11 microsatellite markers and mitochondrial DNA sequences extracted from 67 Arabian Sea humpback whale tissue samples and compared them to equivalent datasets from the Southern Hemisphere and North Pacific. Results show that the Arabian Sea population is highly distinct; estimates of gene flow and divergence times suggest a Southern Indian Ocean origin but indicate that it has been isolated for approximately 70,000 years, remarkable for a species that is typically highly migratory. Genetic diversity values are significantly lower than those obtained for Southern Hemisphere populations and signatures of ancient and recent genetic bottlenecks were identified. Our findings suggest this is the world's most isolated humpback whale population, which, when combined with low population abundance estimates and anthropogenic threats, raises concern for its survival. We recommend an amendment of the status of the population to "Critically Endangered" on the IUCN Red List.	[Pomilla, Cristina; Amaral, Ana R.; Leslie, Matthew S.; Rosenbaum, Howard] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Amaral, Ana R.] Univ Nova Lisboa, Fac Ciencias, Ctr Biol Ambiental, P-1200 Lisbon, Portugal; [Collins, Tim; Leslie, Matthew S.; Rosenbaum, Howard] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA; [Minton, Gianna; Ponnampalam, Louisa; Baldwin, Robert] Environm Soc Oman, Muscat, Oman; [Minton, Gianna] World Wide Fund Nat, Libreville, Gabon; [Findlay, Ken] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	American Museum of Natural History (AMNH); Universidade de Lisboa; Universidade Nova de Lisboa; Wildlife Conservation Society; World Wildlife Fund; University of Pretoria; Universiti Malaya	Collins, T (corresponding author), Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA.	tcollins@wcs.org; hrosenbaum@wcs.org	Findlay, Ken P/A-5766-2019; Amaral, Ana Rita/ABG-4271-2021; Amaral, Ana/D-1060-2010; Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022	Findlay, Ken P/0000-0001-7154-8805; Amaral, Ana Rita/0000-0002-0595-0086; Amaral, Ana/0000-0002-0595-0086; Pomilla, Cristina/0000-0002-2581-8365; Ponnampalam, Louisa/0000-0003-0371-2620; Collins, Tim/0000-0002-7124-4876	Environment Society of Oman; Shell Oman Marketing; Petroleum Development Oman; UK Foreign and Commonwealth Office; Ford Middle East; Veritas Geophysical; Salalah Port Services; Five Oceans LLC; Tawoos LLC; Peter Scott Trust for Education Research in Conservation; Marina Bandar al Rowdha; DHL; Mustafa Sultan Communications; ABA School Muscat; British School Muscat; Sultan School Muscat; Embassy of the United States in Muscat; Emirates Airlines; Oman Air; Cathay Pacific; KPMG; Muscat Pharmacy; OHI Marine; Truck Oman; W.J. Towell and Co.; Han Padron Associates; Mark Rental Cars; WS Atkins; Wildlife Conservation Society	Environment Society of Oman; Shell Oman Marketing; Petroleum Development Oman; UK Foreign and Commonwealth Office; Ford Middle East; Veritas Geophysical; Salalah Port Services; Five Oceans LLC; Tawoos LLC; Peter Scott Trust for Education Research in Conservation; Marina Bandar al Rowdha; DHL; Mustafa Sultan Communications; ABA School Muscat; British School Muscat; Sultan School Muscat; Embassy of the United States in Muscat; Emirates Airlines; Oman Air; Cathay Pacific; KPMG; Muscat Pharmacy; OHI Marine; Truck Oman; W.J. Towell and Co.; Han Padron Associates; Mark Rental Cars; WS Atkins; Wildlife Conservation Society	Funding and other in-kind support for the work was provided by: The Environment Society of Oman, Shell Oman Marketing, Petroleum Development Oman, The UK Foreign and Commonwealth Office, Ford Middle East, Veritas Geophysical, Salalah Port Services, Five Oceans LLC, Tawoos LLC, The Peter Scott Trust for Education Research in Conservation, Marina Bandar al Rowdha, DHL, Mustafa Sultan Communications, The ABA School Muscat, The British School Muscat, The Sultan School Muscat, The Embassy of the United States in Muscat, Emirates Airlines, Oman Air, Cathay Pacific, KPMG, Muscat Pharmacy, OHI Marine, Truck Oman, W.J. Towell and Co., Han Padron Associates, Mark Rental Cars, WS Atkins and the Wildlife Conservation Society. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Amos Bill, 1996, Report of the International Whaling Commission, V46, P657; Ayres KL, 2004, MOL ECOL NOTES, V4, P315, DOI 10.1111/j.1471-8286.2004.00616.x; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; Baker Charles Scott, 2002, P84; Baker CS, 1998, MAR MAMMAL SCI, V14, P721, DOI 10.1111/j.1748-7692.1998.tb00758.x; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Baldwin R, 2000, J OMAN STUDIES, V11, P11; Banakar VK, 2010, QUATERNARY RES, V73, P535, DOI 10.1016/j.yqres.2010.02.002; BEST PB, 1993, ICES J MAR SCI, V50, P169, DOI 10.1006/jmsc.1993.1018; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Braulik GT, J CETACEAN IN PRESS; Brown S. G., 1957, Marine Observer, V27, P157; Cheesman R.E., 1926, UNKNOWN ARABIA; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clapham PJ, 1999, MAMMAL REV, V29, P35; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehlersa J, 2004, QUATERNARY GLACIAT 3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Findlay K., 2001, MEMOIRS QUEENSLAND M, V47, P411; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; George JCC, 2004, MAR MAMMAL SCI, V20, P755, DOI 10.1111/j.1748-7692.2004.tb01191.x; Gervais P, 1888, NOUVELLE ARCH MUSEUM, P199; Gilpin M, 1986, CONSERVATION BIOL SC, P13; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gupta AK, 2003, NATURE, V421, P354, DOI 10.1038/nature01340; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivashchenko Yulia V., 2012, Endangered Species Research, V18, P201, DOI 10.3354/esr00443; Jackson JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3222; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kiefer T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027097; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Lang A.R., 2010, THESIS U CALIFORNIA; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Mikhalev YA, 1997, MAR ECOL PROG SER, V149, P13, DOI 10.3354/meps149013; Mikhalev YA, 2000, SOVIET WHALING DATA, P408; Minton G., 2011, Journal of Cetacean Research and Management, P185; Minton G., 2010, Journal of Cetacean Research and Management, V11, P65; Minton G, 2008, 2009 IUCN RED LIST T; Minton G, J CETACEAN IN PRESS; Minton G, 2004, ECOLOGY CONSERVATION; Mullen KA, 2013, MAR POLICY, V42, P293, DOI 10.1016/j.marpol.2013.03.021; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Palsboll PJ, 1997, MOL ECOL, V6, P893; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; PARK S, 2001, MS TOOLKIT EXCEL ADD; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reeves RR, 1991, POSSIBLE STOCK AFFIN, P259; Robaae K.A., 1974, Bulletin Basrah nat Hist Mus, V1, P7; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruegg K, 2013, CONSERV GENET, V14, P103, DOI 10.1007/s10592-012-0432-0; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; SCHLOTTERER C, 1991, NATURE, V354, P63, DOI 10.1038/354063a0; Singh AD, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001923; Slijper EJ, 1964, BIJDRAGEN DIERKUNDE, V34, P4; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; Taylor B. L., 2007, LJ0701 NAT MAR FISH; Tomilin AG, 1967, MAMMALS USSR ADJACEN, VIX; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Weller David W., 2002, Journal of Cetacean Research and Management, V4, P7; WHITEHEAD H, 1985, Investigations on Cetacea, V17, P157; Witteveen BH, 2004, CAN J ZOOL, V82, P1352, DOI 10.1139/Z04-120; Zhdanova OL, 2008, J HERED, V99, P694, DOI 10.1093/jhered/esn061	93	27	29	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114162	10.1371/journal.pone.0114162	http://dx.doi.org/10.1371/journal.pone.0114162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470144	Green Published, gold			2022-12-27	WOS:000349128700080
J	Tufts, JAM; Meyer, KM; Calfee, MW; Lee, SD				Tufts, Jenia A. M.; Meyer, Kathryn M.; Calfee, Michael Worth; Lee, Sang Don			Composite Sampling of a Bacillus anthracis Surrogate with Cellulose Sponge Surface Samplers from a Nonporous Surface	PLOS ONE			English	Article							FOODBORNE PATHOGENS; STAINLESS-STEEL; SPORES; SURVIVAL	A series of experiments was conducted to explore the utility of composite-based collection of surface samples for the detection of a Bacillus anthracis surrogate using cellulose sponge samplers on a nonporous stainless steel surface. Two composite-based collection approaches were evaluated over a surface area of 3716 cm(2) (four separate 929 cm(2) areas), larger than the 645 cm(2) prescribed by the standard Centers for Disease Control (CDC) and Prevention cellulose sponge sampling protocol for use on nonporous surfaces. The CDC method was also compared to a modified protocol where only one surface of the sponge sampler was used for each of the four areas composited. Differences in collection efficiency compared to positive controls and the potential for contaminant transfer for each protocol were assessed. The impact of the loss of wetting buffer from the sponge sampler onto additional surface areas sampled was evaluated. Statistical tests of the results using ANOVA indicate that the collection of composite samples using the modified sampling protocol is comparable to the collection of composite samples using the standard CDC protocol (p = 0.261). Most of the surface-bound spores are collected on the first sampling pass, suggesting that multiple passes with the sponge sampler over the same surface may be unnecessary. The effect of moisture loss from the sponge sampler on collection efficiency was not significant (p = 0.720) for both methods. Contaminant transfer occurs with both sampling protocols, but the magnitude of transfer is significantly greater when using the standard protocol than when the modified protocol is used (p<0.001). The results of this study suggest that composite surface sampling, by either method presented here, could successfully be used to increase the surface area sampled per sponge sampler, resulting in reduced sampling times in the field and decreased laboratory processing cost and turn-around times.	[Tufts, Jenia A. M.; Meyer, Kathryn M.] Oak Ridge Inst Sci & Educ, Res Triangle Pk, NC USA; [Tufts, Jenia A. M.; Meyer, Kathryn M.; Calfee, Michael Worth; Lee, Sang Don] US EPA, Natl Homeland Secur Res Ctr, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency	Calfee, MW (corresponding author), US EPA, Natl Homeland Secur Res Ctr, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	calfee.worth@epa.gov		Calfee, Michael/0000-0001-6544-329X	US EPA through an Interagency Agreement; US Department of Energy's ORISE program; US EPA; ORISE	US EPA through an Interagency Agreement; US Department of Energy's ORISE program; US EPA(United States Environmental Protection Agency); ORISE(United States Department of Energy (DOE))	This work was funded by the US EPA through an Interagency Agreement with the US Department of Energy's ORISE program. Authors MWC and SDL received salary funds from the US EPA; JAT and KM received fellowship stipends through ORISE.	Calfee MW, 2013, J MICROBIOL METH, V92, P375, DOI 10.1016/j.mimet.2013.01.015; Centers for Disease Control and Prevention,, 2012, SURF SAMPL PROC BAC; EPA, 2013, 600R13068 EPA; Johnson GD, 2001, ENVIRON ECOL STAT, V8, P91, DOI 10.1023/A:1011374330176; Josephson KL, 1997, J APPL MICROBIOL, V83, P737, DOI 10.1046/j.1365-2672.1997.00308.x; Kesavan J, 2013, AEROSOL SCI TECH, V47, P1108, DOI 10.1080/02786826.2013.824552; Knobben BAS, 2007, J BIOMED MATER RES A, V80A, P790, DOI 10.1002/jbm.a.30978; Kusumaningrum HD, 2003, INT J FOOD MICROBIOL, V85, P227, DOI 10.1016/S0168-1605(02)00540-8; Lee SD, 2013, ENVIRON SCI TECHNOL, V47, P2595, DOI 10.1021/es4000356; Mattick K, 2003, INT J FOOD MICROBIOL, V85, P213, DOI 10.1016/S0168-1605(02)00510-X; Patil GP, 2010, COMPOSITE SAMPLING N; Patrick DR, 1997, EPIDEMIOL INFECT, V119, P319, DOI 10.1017/S0950268897008261; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; Rossi EM, 2013, J INFECT DEV COUNTR, V7, P229, DOI 10.3855/jidc.2472; Teshale EH, 2002, EMERG INFECT DIS, V8, P1083, DOI 10.3201/eid0810.020398	15	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114082	10.1371/journal.pone.0114082	http://dx.doi.org/10.1371/journal.pone.0114082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470365	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700068
J	Wielgus, RB; Peebles, KA				Wielgus, Robert B.; Peebles, Kaylie A.			Effects of Wolf Mortality on Livestock Depredations	PLOS ONE			English	Article							AMERICAN BLACK BEAR; CONSERVATION; VIABILITY; CATTLE; AGE	Predator control and sport hunting are often used to reduce predator populations and livestock depredations, - but the efficacy of lethal control has rarely been tested. We assessed the effects of wolf mortality on reducing livestock depredations in Idaho, Montana and Wyoming from 1987-2012 using a 25 year time series. The number of livestock depredated, livestock populations, wolf population estimates, number of breeding pairs, and wolves killed were calculated for the wolf-occupied area of each state for each year. The data were then analyzed using a negative binomial generalized linear model to test for the expected negative relationship between the number of livestock depredated in the current year and the number of wolves controlled the previous year. We found that the number of livestock depredated was positively associated with the number of livestock and the number of breeding pairs. However, we also found that the number of livestock depredated the following year was positively, not negatively, associated with the number of wolves killed the previous year. The odds of livestock depredations increased 4% for sheep and 5-6% for cattle with increased wolf control - up until wolf mortality exceeded the mean intrinsic growth rate of wolves at 25%. Possible reasons for the increased livestock depredations at <= 25% mortality may be compensatory increased breeding pairs and numbers of wolves following increased mortality. After mortality exceeded 25%, the total number of breeding pairs, wolves, and livestock depredations declined. However, mortality rates exceeding 25% are unsustainable over the long term. Lethal control of individual depredating wolves may sometimes necessary to stop depredations in the near-term, but we recommend that non-lethal alternatives also be considered.	[Wielgus, Robert B.; Peebles, Kaylie A.] Washington State Univ, Sch Environm, Large Carnivore Conservat Lab, Pullman, WA 99164 USA	Washington State University	Peebles, KA (corresponding author), Washington State Univ, Sch Environm, Large Carnivore Conservat Lab, Pullman, WA 99164 USA.	kaylie.peebles@email.wsu.edu			Washington Department of Fish and Wildlife	Washington Department of Fish and Wildlife	Funding: Funding for this research was provided solely by a research grant from the Washington Department of Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Biondi F, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00050; Bradley EH, 2005, WILDLIFE SOC B, V33, P1256, DOI 10.2193/0091-7648(2005)33[1256:AFRTWD]2.0.CO;2; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Burnham K.P., 2010, MODEL SELECTION MULT; Collins GH, 2002, URSUS, V13, P231; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Fritts Steven H., 2003, P289; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Jimenez M.D., 2012, NO ROCKY MOUNTAIN WO, P59601; Jimenez M.D., 2013, NO ROCKY MOUNTAIN WO, P59601; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; MOSTELLE.F, 1968, J AM STAT ASSOC, V63, P1, DOI 10.2307/2283825; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Rabinowitz A, 2005, CONSERV BIOL SER, V9, P278; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; United States Department of Agriculture, 2012, WASH LIV STAT; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wielgus RB, 2014, MINIMIZING MITIGATIN; Wiles G.J., 2011, WOLF CONSERVATION MA; Zimmermann B, 2003, URSUS-SERIES, V14, P72	29	65	66	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113505	10.1371/journal.pone.0113505	http://dx.doi.org/10.1371/journal.pone.0113505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470821	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700031
J	Zille, M; Riabinska, A; Terzi, MY; Balkaya, M; Prinz, V; Schmerl, B; Nieminen-Kelha, M; Endres, M; Vajkoczy, P; Pina, AL				Zille, Marietta; Riabinska, Arina; Terzi, Menderes Yusuf; Balkaya, Mustafa; Prinz, Vincent; Schmerl, Bettina; Nieminen-Kelhae, Melina; Endres, Matthias; Vajkoczy, Peter; Pina, Ana Luisa			Influence of Pigment Epithelium-Derived Factor on Outcome after Striatal Cerebral Ischemia in the Mouse	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; FACTOR PEDF; CEREBROSPINAL-FLUID; ARTERY OCCLUSION; GENE-TRANSFER; GROWTH-FACTOR; BRAIN-DAMAGE; ANGIOGENESIS; PROTECTS; INJURY	We here suggest that pigment epithelium-derived factor (PEDF) does not have an effect on lesion size, behavioral outcome, cell proliferation, or cell death after striatal ischemia in the mouse. PEDF is a neurotrophic factor with neuroprotective, antiangiogenic, and antipermeability effects. It influences self-renewal of neural stem cells and proliferation of microglia. We investigated whether intraventricular infusion of PEDF reduces infarct size and cell death, ameliorates behavioral outcome, and influences cell proliferation in the one-hour middle cerebral artery occlusion (MCAO) mouse model of focal cerebral ischemia. C57Bl6/N mice were implanted with PEDF or artificial cerebrospinal fluid (control) osmotic pumps and subjected to 60-minute MCAO 48 hours after pump implantation. They received daily BrdU injections for 7 days after MCAO in order to investigate cell proliferation. Infarct volumes were determined 24 hours after reperfusion using magnetic resonance imaging. We removed the pumps on day 5 and performed behavioral testing between day 7 and 21. Immunohistochemical staining was performed to determine the effect of PEDF on cell proliferation and cell death. Our model produced an ischemic injury confined solely to striatal damage. We detected no reduction in infarct sizes and cell death in PEDF-vs. CSF-infused MCAO mice. Behavioral outcome and cell proliferation did not differ between the groups. However, we cannot exclude that PEDF might work under different conditions in stroke. Further studies will elucidate the effect of PEDF treatment on cell proliferation and behavioral outcome in moderate to severe ischemic injury in the brain.	[Zille, Marietta; Balkaya, Mustafa; Prinz, Vincent; Endres, Matthias] Charite, Ctr Stroke Res Berlin, Dept Expt Neurol, Berlin, Germany; [Riabinska, Arina; Terzi, Menderes Yusuf; Schmerl, Bettina; Nieminen-Kelhae, Melina; Vajkoczy, Peter; Pina, Ana Luisa] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Endres, Matthias] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pina, AL (corresponding author), Charite, Dept Neurosurg, D-13353 Berlin, Germany.	ana-luisa.pina@charite.de	Terzi, Menderes Yusuf/Z-1999-2018; Zille, Marietta/P-1700-2018	Terzi, Menderes Yusuf/0000-0001-8478-0451; Zille, Marietta/0000-0002-0609-8956; Nieminen-Kelha, Melina/0000-0002-7577-8058; Vajkoczy, Peter/0000-0003-4350-392X; Schmerl, Bettina/0000-0002-6273-3897; Endres, Matthias/0000-0001-6520-3720	Charite-Rahel-Hirsch-Grant; BCRT flexible funds; Stiftung der Deutschen Wirtschaft (Foundation of German Business)	Charite-Rahel-Hirsch-Grant; BCRT flexible funds; Stiftung der Deutschen Wirtschaft (Foundation of German Business)	Funding: This work has been supported by the Charite-Rahel-Hirsch-Grant and the BCRT flexible funds to ALP. MZ was supported by a fellowship granted by the Stiftung der Deutschen Wirtschaft (Foundation of German Business). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Balkaya M, 2013, J NEUROSCI METH, V213, P179, DOI 10.1016/j.jneumeth.2012.12.021; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Falk T, 2009, NEUROSCI LETT, V458, P49, DOI 10.1016/j.neulet.2009.04.018; Fitzgerald DP, 2012, CANCER RES, V72, P144, DOI 10.1158/0008-5472.CAN-11-1904; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; Giampa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064037; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Harker KT, 2002, J NEUROSCI, V22, P1155, DOI 10.1523/JNEUROSCI.22-03-01155.2002; Jinnouchi Y, 2007, BRAIN RES, V1167, P92, DOI 10.1016/j.brainres.2007.04.088; Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Namba T, 2010, NEUROSCIENCE, V167, P372, DOI 10.1016/j.neuroscience.2010.01.033; Pardridge WM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-7; Pillai DR, 2013, J CEREBR BLOOD F MET, V33, P557, DOI 10.1038/jcbfm.2012.201; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; Sanagi T, 2010, J NEUROPATH EXP NEUR, V69, P224, DOI 10.1097/NEN.0b013e3181cfc46f; Sly DJ, 2012, JARO-J ASSOC RES OTO, V13, P1, DOI 10.1007/s10162-011-0297-9; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Taniwaki T, 1997, J NEUROCHEM, V68, P26; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 1996, Mol Vis, V2, P11; van Wagenen S., 2008, PROTEIN EXPRESSION L; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Winner B, 2008, J NEUROPATH EXP NEUR, V67, P105, DOI 10.1097/nen.0b013e3181630cff; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yasuda T, 2007, EXP NEUROL, V206, P308, DOI 10.1016/j.expneurol.2007.05.012; Zhu CH, 2012, NEUROCHEM RES, V37, P2099, DOI 10.1007/s11064-012-0831-0	38	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114595	10.1371/journal.pone.0114595	http://dx.doi.org/10.1371/journal.pone.0114595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470280	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700123
J	Santos, PP; Oliveira, F; Ferreira, VCMP; Polegato, BF; Roscani, MG; Fernandes, AA; Modesto, P; Rafacho, BPM; Zanati, SG; Di Lorenzo, A; Matsubara, LS; Paiva, SAR; Zornoff, LAM; Minicucci, MF; Azevedo, PS				Santos, Priscila P.; Oliveira, Fernando; Ferreira, Vanessa C. M. P.; Polegato, Bertha F.; Roscani, Meliza G.; Fernandes, Ana Angelica; Modesto, Pamela; Rafacho, Bruna P. M.; Zanati, Silmeia G.; Di Lorenzo, Annarita; Matsubara, Luiz S.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.; Minicucci, Marcos F.; Azevedo, Paula S.			The Role of Lipotoxicity in Smoke Cardiomyopathy	PLOS ONE			English	Article							OXIDATIVE STRESS; ENERGY-METABOLISM; HEART-FAILURE; VITAMIN-D; EXPOSURE; NICOTINE; ASSOCIATION; CHOLESTEROL; MECHANISMS; ASSAY	Background/Aims: Experimental and clinical studies have shown the direct toxic effects of cigarette smoke (CS) on the myocardium, independent of vascular effects. However, the underlying mechanisms are not well known. Methods: Wistar rats were allocated to control (C) and cigarette smoke (CS) groups. CS rats were exposed to cigarette smoke for 2 months. Results: After that morphometric, functional and biochemical parameters were measured. The echocardiographic study showed enlargement of the left atria, increase in the left ventricular systolic volume and reduced systolic function. Within the cardiac metabolism, exposure to CS decreased beta hydroxy acyl coenzyme A dehydrogenases and citrate synthases and increased lactate dehydrogenases. Peroxisome proliferator-activated receptor alpha (PPAR alpha) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) were expressed similarly in both groups. CS increased serum lipids and myocardial triacylglycerols (TGs). These data suggest that impairment in fatty acid oxidation and the accumulation of cardiac lipids characterize lipotoxicity. CS group exhibited increased oxidative stress and decreased antioxidant defense. Finally, the myocyte cross-sectional area and active Caspase 3 were increased in the CS group. Conclusion: The cardiac remodeling that was observed in the CS exposure model may be explained by abnormalities in energy metabolism, including lipotoxicity and oxidative stress.	[Santos, Priscila P.; Oliveira, Fernando; Ferreira, Vanessa C. M. P.; Polegato, Bertha F.; Roscani, Meliza G.; Modesto, Pamela; Rafacho, Bruna P. M.; Zanati, Silmeia G.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.; Minicucci, Marcos F.; Azevedo, Paula S.] UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Fernandes, Ana Angelica] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Chem & Biochem, Botucatu, SP, Brazil; [Di Lorenzo, Annarita] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, Dept Pathol & Lab Med, New York, NY 10021 USA	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Cornell University	Azevedo, PS (corresponding author), UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	paulasa@fmb.unesp.br	Fernandes, Ana Angelica Henrique/D-5291-2012; Polegato, Bertha Furlan/E-8842-2012; Minicucci, Marcos F/A-9094-2008; Rafacho, Bruna Paola Murino/AGW-5794-2022; Zornoff, Leonardo/A-5612-2008; Azevedo, Paula Schmidt/S-1597-2019; ROSCANI, MELIZA/AAA-9666-2019; Ferreira, Virginia Clara Teixeira/I-3612-2016; Paiva, Sergio AR/A-5101-2008; Roscani, Meliza/V-1300-2019; Rafacho, Bruna Paola Murino/B-5460-2013; Azevedo, Paula S/F-2701-2012; dos Santos, Priscila Portugal/U-5345-2018	Polegato, Bertha Furlan/0000-0002-2875-9532; Minicucci, Marcos F/0000-0002-5980-4367; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Zornoff, Leonardo/0000-0002-9831-8820; Azevedo, Paula Schmidt/0000-0002-5843-6232; ROSCANI, MELIZA/0000-0003-1463-551X; Ferreira, Virginia Clara Teixeira/0000-0002-4648-3461; Paiva, Sergio AR/0000-0003-4412-1990; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula S/0000-0002-5843-6232; Di Lorenzo, Annarita/0000-0003-1239-4222; Zanati Bazan, Silmeia Garcia/0000-0002-0607-8189; dos Santos, Priscila Portugal/0000-0003-1159-5030; Azevedo Perdicoulis, Teresa Paula/0000-0002-3281-5357	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP); Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP) and Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Ashakumary L, 1997, LIPIDS, V32, P311, DOI 10.1007/s11745-997-0038-8; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Azevedo PS, 2013, CARDIOL REV, V21, P135, DOI 10.1097/CRD.0b013e318274956d; Azevedo PS, 2010, ARQ BRAS CARDIOL; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Castardeli E, 2008, MED SCI MONITOR, V14, pBR62; Castardeli E, 2007, EUR J HEART FAIL, V9, P1081, DOI 10.1016/j.ejheart.2007.09.004; Castardeli Édson, 2005, Arq. Bras. Cardiol., V84, P320, DOI 10.1590/S0066-782X2005000400009; Damasceno DC, 2012, OBESITY; de Paiva Sergio Alberto Rupp, 2003, Arq Bras Cardiol, V81, P221; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Duarte DR, 2010, MED SCI MONITOR, V16, pBR255; Eaton MM, 2006, J TOXICOL ENV HEAL A, V69, P1497, DOI 10.1080/15287390500364788; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Ferrari R, 2009, CIRC J, V73, P1973, DOI 10.1253/circj.CJ-09-0573; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Gvozdjak J, 1987, Czech Med, V10, P47; GVOZDJAKOVA A, 1984, CARDIOVASC RES, V18, P229, DOI 10.1093/cvr/18.4.229; HARTZ AJ, 1984, NEW ENGL J MED, V311, P1201, DOI 10.1056/NEJM198411083111901; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maack C, 2011, J AM COLL CARDIOL, V58, P83, DOI 10.1016/j.jacc.2011.01.032; Minicucci Marcos F., 2012, Inflammation & Allergy Drug Targets, V11, P442; Moura R.A., 1982, TECNICAS LAB; Rafacho BPM, 2012, INT J CARDIOL, V155, P472, DOI 10.1016/j.ijcard.2011.12.078; Parasuraman S, 2012, J PHARMACOL PHARMACO, V3, P172, DOI 10.4103/0976-500X.95521; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Rosen BD, 2006, J AM COLL CARDIOL, V47, P1150, DOI 10.1016/j.jacc.2005.08.078; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060625; Wattanapitayakul SK, 2001, PHARMACOL THERAPEUT, V89, P187, DOI 10.1016/S0163-7258(00)00114-5; WHO WHA, 2012, WHO GLOB REP MORT AT; Yang QF, 2007, J MOL MED-JMM, V85, P697, DOI 10.1007/s00109-007-0170-9; Zhou X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040424; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zornoff LAM, 2006, TOXICOL SCI, V90, P259, DOI 10.1093/toxsci/kfj080; Zornoff Leonardo A. M., 2006, Arq. Bras. Cardiol., V86, P276, DOI 10.1590/S0066-782X2006000400007	52	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113739	10.1371/journal.pone.0113739	http://dx.doi.org/10.1371/journal.pone.0113739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462161	Green Submitted, gold, Green Published			2022-12-27	WOS:000345869700045
J	Wang, W; Wei, H; Alahuhta, M; Chen, XW; Hyman, D; Johnson, DK; Zhang, M; Himmel, ME				Wang, Wei; Wei, Hui; Alahuhta, Markus; Chen, Xiaowen; Hyman, Deborah; Johnson, David K.; Zhang, Min; Himmel, Michael E.			Heterologous Expression of Xylanase Enzymes in Lipogenic Yeast Yarrowia lipolytica	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BETA-XYLOSIDASE; PROTEIN EXPRESSION; CLONING; XLND; TRANSFORMATION; SECRETION	To develop a direct microbial sugar conversion platform for the production of lipids, drop-in fuels and chemicals from cellulosic biomass substrate, we chose Yarrowia lipolytica as a viable demonstration strain. Y. lipolytica is known to accumulate lipids intracellularly and is capable of metabolizing sugars to produce lipids; however, it lacks the lignocellulose-degrading enzymes needed to break down biomass directly. While research is continuing on the development of a Y. lipolytica strain able to degrade cellulose, in this study, we present successful expression of several xylanases in Y. lipolytica. The XynII and XlnD expressing Yarrowia strains exhibited an ability to grow on xylan mineral plates. This was shown by Congo Red staining of halo zones on xylan mineral plates. Enzymatic activity tests further demonstrated active expression of XynII and XlnD in Y. lipolytica. Furthermore, synergistic action in converting xylan to xylose was observed when XlnD acted in concert with XynII. The successful expression of these xylanases in Yarrowia further advances us toward our goal to develop a direct microbial conversion process using this organism.	[Wang, Wei; Wei, Hui; Alahuhta, Markus; Johnson, David K.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80045 USA; [Chen, Xiaowen; Hyman, Deborah; Zhang, Min] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Wang, W (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80045 USA.	wei.wang@nrel.gov; Hui.Wei@nrel.gov; Min.Zhang@nrel.gov	Alahuhta, Markus/E-9344-2012; Johnson, David K/G-4959-2011	Alahuhta, Markus/0000-0001-9375-778X; Johnson, David K/0000-0003-4815-8782; Zhang, Min/0000-0002-9015-2184	U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO) [DE-AC36-08-GO28308]	U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO)(United States Department of Energy (DOE))	Authors gratefully acknowledge support from the U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO) under Contract No. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Barth G, 1996, RECHERCHE, V67; Barth G., 1996, NONCONVENTIONAL YEAS; Boonvitthya N, 2013, MOL BIOTECHNOL, P1; Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dall MT, 1994, CURR GENET, V26, P38; DAVIDOW LS, 1985, CURR GENET, V10, P39, DOI 10.1007/BF00418492; DomOnguez A, 2010, INT MICROBIOL, V1, P131; DomOnguez A, 2008, INT MICROBIOL, V1, P131; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Duquesne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095128; Juretzek T, 2001, YEAST, V18, P97, DOI 10.1002/1097-0061(20010130)18:2<97::AID-YEA652>3.0.CO;2-U; La Grange DC, 2001, APPL ENVIRON MICROB, V67, P5512, DOI 10.1128/AEM.67.12.5512-5519.2001; LaGrange DC, 1997, APPL MICROBIOL BIOT, V47, P262; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Muller S, 1998, YEAST, V14, P1267, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Papanikolaou S, 2009, EUR J LIPID SCI TECH, V111, P1221, DOI 10.1002/ejlt.200900055; Peij N. N. M. E. van, 1997, European Journal of Biochemistry, V245, P164, DOI 10.1111/j.1432-1033.1997.00164.x; Perez-Gonzalez J, 1998, APPL ENVIRON MICROB, V64, P1412; Qing Q, 2011, BIORESOURCE TECHNOL, V102, P1359, DOI 10.1016/j.biortech.2010.09.001; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Selig MJ, 2008, APPL BIOCHEM BIOTECH, V146, P57, DOI 10.1007/s12010-007-8069-z; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; Sluiter A., 2008, BIOMASS ANAL TECHNOL; Sun J, 2012, APPL ENVIRON MICROB, V78, P3837, DOI 10.1128/AEM.07679-11; Tsigie YA, 2011, BIORESOURCE TECHNOL, V102, P9216, DOI 10.1016/j.biortech.2011.06.047	30	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e111443	10.1371/journal.pone.0111443	http://dx.doi.org/10.1371/journal.pone.0111443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462572	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700006
J	Wan, X; Xia, WK; Gendoo, Y; Chen, W; Sun, WJ; Sun, D; Cao, CC				Wan, Xin; Xia, Wenkai; Gendoo, Yasser; Chen, Wen; Sun, Wenjin; Sun, Dong; Cao, Changchun			Upregulation of Stromal Cell-Derived Factor 1 (SDF-1) is Associated with Macrophage Infiltration in Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							KIDNEY INJURY; ISCHAEMIA/REPERFUSION INJURY; CHEMOKINE RECEPTORS; SIGNAL-TRANSDUCTION; EXPRESSION; REPAIR; CXCR4; ANGIOGENESIS; RECRUITMENT; INVOLVEMENT	Background: Stromal cell-derived factor-1(SDF-1) is a chemotactic and angiogenic factor that mediates the repair of various tissues. As macrophages are important contributors to ischemic kidney injury, we examine the role of SDF-1 in a rodent model of ischemia-reperfusion (I/R) injury. Methods: Male wild-type (WT) (C57BL/6) mice were subjected to bilateral I/R injury or sham operation in the presence or absence of macrophage depletion (liposomal clodronate [0.2 ml/20-25 g body weight i.p.]). Macrophage accumulation was assessed by immunohistochemistry. Tissue levels of SDF-1 (ELISA) and SDF-1 mRNA expression (real-time PCR) were measured. The cellular location of SDF-1 was assessed using immunohistochemical staining. Results: Immunofluorescence staining of renal tissue sections confirmed macrophage depletion by liposomal clodronate. SDF-1 production was elevated in response to I/R injury and was significantly increased upon macrophage depletion. SDF-1 positive cells initially appeared initially in the cortex, and subsequently diffused to the outer medulla after I/R injury. Conclusions: Our study demonstrates that SDF-1 is significantly upregulated during renal I/R. We hypothesize that SDF-1 upregulation may be an important macrophage effector mechanism during I/R injury.	[Wan, Xin; Xia, Wenkai; Gendoo, Yasser; Sun, Wenjin; Sun, Dong; Cao, Changchun] Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Chen, Wen] Nanjing Med Univ, Nanjing Hosp 1, Dept Thorac & Cardiovasc Surg, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Cao, CC (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China.	caochangchun@njmu.edu.cn			National Natural Science Foundation of China [81370797]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Project supported by the National Natural Science Foundation of China (Grant No. 81370797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Grone HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134957; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lai PH, 2008, GRAEF ARCH CLIN EXP, V246, P1707, DOI 10.1007/s00417-008-0907-3; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Oliver JA, 2012, AM J PHYSIOL-RENAL, V302, pF1362, DOI 10.1152/ajprenal.00202.2011; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pillarisetti K, 2001, CLONING RELATIVE EXP; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SABBAHY ME, 2011, WILEY INTERDISCIPLIN, V3, P606; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vinuesa E, 2008, J PATHOL, V214, P104, DOI 10.1002/path.2259; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	32	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114564	10.1371/journal.pone.0114564	http://dx.doi.org/10.1371/journal.pone.0114564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478952	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200105
J	Guo, MX; Wang, RC; Wang, J; Hua, K; Wang, YM; Liu, XQ; Yao, SG				Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo			ALT1, a Snf2 Family Chromatin Remodeling ATPase, Negatively Regulates Alkaline Tolerance through Enhanced Defense against Oxidative Stress in Rice	PLOS ONE			English	Article							IRON-DEFICIENCY CHLOROSIS; ARABIDOPSIS-THALIANA; SALT TOLERANCE; DROUGHT RESISTANCE; ACID SYNTHESIS; GENE; AVAILABILITY; TRANSPORTER; ACTIVATION; EXPRESSION	Alkaline salt stress adversely affects rice growth, productivity and grain quality. However, the mechanism underlying this process remains elusive. We characterized here an alkaline tolerant mutant, alt1 in rice. Map-based cloning revealed that alt1 harbors a mutation in a chromatin remodeling ATPase gene. ALT1-RNAi transgenic plants under different genetic background mimicked the alt1 phenotype, exhibiting tolerance to alkaline stress in a transcript dosage-dependent manner. The predicted ALT1 protein belonged to the Ris1 subgroup of the Snf2 family and was localized in the nucleus, and transcription of ALT1 was transiently suppressed after alkaline treatment. Although the absorption of several metal ions maintained well in the mutant under alkaline stress, expression level of the genes involved in metal ions homeostasis was not altered in the alt1 mutant. Classification of differentially expressed abiotic stress related genes, as revealed by microarray analysis, found that the majority (50/78) were involved in ROS production, ROS scavenging, and DNA repair. This finding was further confirmed by that alt1 exhibited lower levels of H2O2 under alkaline stress and tolerance to methyl viologen treatment. Taken together, these results suggest that ALT1 negatively functions in alkaline tolerance mainly through the defense against oxidative damage, and provide a potential two-step strategy for improving the tolerance of rice plants to alkaline stress.	[Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo] Chinese Acad Sci, Natl Plant Gene Res Ctr, Inst Genet & Dev Biol, Beijing, Peoples R China; [Guo, Mingxin; Wang, Juan; Hua, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, SG (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	sgyao@genetics.ac.cn		Guo, Mingxin/0000-0002-7764-1194	Chinese Academy of Sciences [KSCX2-YW-N-079]; Hundred Talents Program of Chinese Academy of Sciences [KSCX2-YW-076]; National "973" Program [2013CBA01405]; State Key Laboratory of Plant Genomics	Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National "973" Program(National Basic Research Program of China); State Key Laboratory of Plant Genomics	This work was supported by grants from Chinese Academy of Sciences (KSCX2-YW-N-079), Hundred Talents Program of Chinese Academy of Sciences (KSCX2-YW-076), National "973" Program (2013CBA01405) and State Key Laboratory of Plant Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar HUR, 2008, ENVIRON EXP BOT, V63, P224, DOI 10.1016/j.envexpbot.2007.10.018; Bashir K, 2007, PLANT MOL BIOL, V65, P277, DOI 10.1007/s11103-007-9216-1; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Charlson DV, 2005, CROP SCI, V45, P2394, DOI 10.2135/cropsci2004.0510; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Deng ZY, 2007, PLANT MOL BIOL, V65, P31, DOI 10.1007/s11103-007-9195-2; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; FAO/AGL, 2000, EXT CAUS SALT AFF SO; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Garg Bharti, 2012, Physiology and Molecular Biology of Plants, V18, P217, DOI 10.1007/s12298-012-0117-7; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez-Galera S, 2012, PLANT PHYSIOL BIOCH, V53, P46, DOI 10.1016/j.plaphy.2012.01.009; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu YF, 2013, PLANT PHYSIOL BIOCH, V70, P33, DOI 10.1016/j.plaphy.2013.05.001; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kim SG, 2009, PHYSIOL PLANTARUM, V138, P1; Kim SY, 2005, J BIOCHEM MOL BIOL, V38, P218; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Kobayashi T, 2010, P JPN ACAD B-PHYS, V86, P900, DOI 10.2183/pjab.86.900; Kobayashi T, 2008, RICE, V1, P144, DOI 10.1007/s12284-008-9011-x; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Li CR, 2013, PLANT CELL ENVIRON, V36, P775, DOI 10.1111/pce.12013; Lin S, 1997, MOL BREEDING, V3, P219, DOI 10.1023/A:1009637320805; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Lu XD, 2008, CELL RES, V18, P589, DOI 10.1038/cr.2008.44; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; O'Rourke JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-476; Ogawa D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1279; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Qi DL, 2008, J GENET GENOMICS, V35, P299, DOI 10.1016/S1673-8527(08)60043-0; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Schmidt R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27540; Shao T, 2011, PLANT PHYSIOL, V156, P1386, DOI 10.1104/pp.111.177428; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; TUSEN DD, 2010, THEOR APPL GENET, V121, P229; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Yamaguchi K, 2012, PLANT J, V70, P389, DOI 10.1111/j.1365-313X.2011.04874.x; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yang YQ, 2010, PLANT CELL, V22, P1313, DOI 10.1105/tpc.109.069609; Zhang X, 2013, J INTEGR PLANT BIOL, V55, P262, DOI 10.1111/jipb.12013; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x; Zhao CF, 2012, PLANTA, V236, P1165, DOI 10.1007/s00425-012-1667-1	62	21	28	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112515	10.1371/journal.pone.0112515	http://dx.doi.org/10.1371/journal.pone.0112515			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473841	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500072
J	Lee, E; Shin, A; Jeong, KW; Jin, B; Jnawali, HN; Shin, S; Shin, SY; Kim, Y				Lee, Eunjung; Shin, Areum; Jeong, Ki-Woong; Jin, Bongwhan; Jnawali, Hum Nath; Shin, Soyoung; Shin, Song Yub; Kim, Yangmee			Role of Phenylalanine and Valine(10) Residues in the Antimicrobial Activity and Cytotoxicity of Piscidin-1	PLOS ONE			English	Article							MOLECULAR RECOGNITION; PEPTIDE ANTIBIOTICS; CATIONIC PEPTIDES; LIPID-BILAYER; MEMBRANE; FISH; ANALOGS; NEUTRALIZATION; CONFORMATION; MECHANISMS	Piscidin-1 (Pis-1) is a linear antibacterial peptide derived from mast cells of aquacultured hybrid striped bass that comprises 22 amino acids with a phenylalanine-rich amino-terminus. Pis-1 exhibits potent antibacterial activity against pathogens but is not selective for distinguishing between bacterial and mammalian cells. To determine the key residues for its antibacterial activity and those for its cytotoxicity, we investigated the role of each Phe residue near the N-terminus as well as the Val(10) residue located near the boundary of the hydrophobic and hydrophilic sectors of the helical wheel diagram. Fluorescence dye leakage and tryptophan fluorescence experiments were used to study peptide-lipid interactions, showing comparable depths of insertion of substituted peptides in different membranes. Phe(2) was found to be the most deeply inserted phenylalanine in both bacterial-and mammalian-mimic membranes. Each Phe was substituted with Ala or Lys to investigate its functional role. Phe(2) plays key roles in the cytotoxicity as well as the antibacterial activities of Pis-1, and Phe(6) is essential for the antibacterial activities of Pis-1. We also designed and synthesized a piscidin analog, Pis-V10K, in which Lys was substituted for Val10, resulting in an elevated amphipathic alpha-helical structure. Pis-V10K showed similar antibacterial activity (average minimum inhibitory concentration (MIC) = 1.6 mu M) to Pis-1 (average MIC = 1.5 mu M). However, it exhibited much lower cytotoxicity than Pis-1. Lys(10-)substituted analogs, Pis-F1K/V10K, Pis-F2K/V10K, and Pis-F6K/V10K in which Lys was substituted for Phe retained antibacterial activity toward standard and drug-resistant bacterial strains with novel bacterial cell selectivity. They exert anti-inflammatory activities via inhibition of nitric oxide production, TNF-alpha secretion, and MIP-1 and MIP-2 production. They may disrupt the binding of LPS to toll-like receptors, eventually suppressing MAPKs-mediated signaling pathways. These peptides may be good candidates for the development of peptide antibiotics with potent antibacterial activity but without cytotoxicity.	[Lee, Eunjung; Shin, Areum; Jeong, Ki-Woong; Jin, Bongwhan; Jnawali, Hum Nath; Shin, Soyoung; Kim, Yangmee] Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Res Ctr Proteineous Mat, Kwangju, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea	Konkuk University; Chosun University; Chosun University	Kim, Y (corresponding author), Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea.	ymkim@konkuk.ac.kr			Priority Research Centers Program [20090093824]; Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science, and Technology [2011-0022873, 2013R1A1A2058021]	Priority Research Centers Program; Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by grants from the Priority Research Centers Program (20090093824) and from the Basic Science Research Program (2011-0022873 and 2013R1A1A2058021) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell Susan Givens, 2003, Neonatal Netw, V22, P47; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chekmenev EY, 2006, J AM CHEM SOC, V128, P5308, DOI 10.1021/ja058385e; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Colorni A, 2008, J FISH DIS, V31, P423, DOI 10.1111/j.1365-2761.2008.00922.x; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; De Angelis AA, 2011, BIOPHYS J, V101, P1086, DOI 10.1016/j.bpj.2011.07.015; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jing WG, 2006, BIOCHEM CELL BIOL, V84, P312, DOI 10.1139/O06-052; Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee E, 2013, BMB REP, V46, P282, DOI 10.5483/BMBRep.2013.46.5.252; Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Noga EJ, 2003, DRUG NEWS PERSPECT, V16, P87, DOI 10.1358/dnp.2003.16.2.829325; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Perrin BS, 2014, J AM CHEM SOC, V136, P3491, DOI 10.1021/ja411119m; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu K, 2000, J PEPT RES, V55, P51, DOI 10.1034/j.1399-3011.2000.00146.x; Yuan TH, 2012, BIOPOLYMERS, V97, P998, DOI 10.1002/bip.22116	35	27	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114453	10.1371/journal.pone.0114453	http://dx.doi.org/10.1371/journal.pone.0114453			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473836	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500030
J	Palagani, A; Op de Beeck, K; Naulaerts, S; Diddens, J; Chirumamilla, CS; Van Camp, G; Laukens, K; Heyninck, K; Gerlo, S; Mestdagh, P; Vandesompele, J; Vanden Berghe, W				Palagani, Ajay; Op de Beeck, Ken; Naulaerts, Stefan; Diddens, Jolien; Chirumamilla, Chandra Sekhar; Van Camp, Guy; Laukens, Kris; Heyninck, Karen; Gerlo, Sarah; Mestdagh, Pieter; Vandesompele, Joke; Vanden Berghe, Wim			Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells	PLOS ONE			English	Article							LIGAND-INDEPENDENT ACTIVATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; C-MYB; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; CANCER-CELLS; NONCODING RNA; RECEPTOR; MIR-150	Glucocorticoids (GCs) selectively trigger cell death in the multiple myeloma cell line MM1S which express NR3C1/Glucocorticoid Receptor (GR) protein, but fail to kill MM1R cells which lack GR protein. Given recent demonstrations of altered microRNA profiles in a diverse range of haematological malignancies and drug resistance, we characterized GC inducible mRNA and microRNA transcription profiles in GC sensitive MM1S as compared to GC resistant MM1R cells. Transcriptome analysis revealed that GCs regulate expression of multiple genes involved in cell cycle control, cell organization, cell death and immunological disease in MM1S cells, which remain unaffected in MM1R cells. With respect to microRNAs, mir-150-5p was identified as the most time persistent GC regulated microRNA, out of 5 QPCR validated microRNAs (mir-26b, mir-125a-5p, mir-146-5p, mir-150-5p, and mir-184), which are GC inducible in MM1S but not in MM1R cells. Functional studies further revealed that ectopic transfection of a synthetic mir-150-5p mimics GR dependent gene expression changes involved in cell death and cell proliferation pathways. Remarkably, despite the gene expression changes observed, overexpression of mir-150-5p in absence of GCs did not trigger significant cytotoxicity in MM1S or MM1R cells. This suggests the requirement of additional steps in GC induced cell death, which can not be mimicked by mir-150-5p overexpression alone. Interestingly, a combination of mir-150-5p transfection with low doses GC in MM1S cells was found to sensitize therapy response, whereas opposite effects could be observed with a mir-150-5p specific antagomir. Although mir-150-5p overexpression did not substantially change GR expression levels, it was found that mir-150-5p evokes GR specific effects through indirect mRNA regulation of GR interacting transcription factors and hormone receptors, GR chaperones, as well as various effectors of unfolded protein stress and chemokine signalling. Altogether GC-inducible mir-150-5p adds another level of regulation to GC specific therapeutic responses in multiple myeloma.	[Palagani, Ajay; Diddens, Jolien; Chirumamilla, Chandra Sekhar; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signalling PPES, B-2020 Antwerp, Belgium; [Palagani, Ajay; Heyninck, Karen; Vanden Berghe, Wim] Univ Ghent, Dept Physiol, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; [Op de Beeck, Ken; Van Camp, Guy] Univ Antwerp, Dept Biomed Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [Op de Beeck, Ken] Univ Antwerp, Univ Antwerp Hosp, Dept Med Oncol, Lab Canc Res & Clin Oncol, B-2020 Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp, Biomed Informat Res Ctr Antwerp Biomina, B-2020 Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp Hosp, Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp, Dept Math & Comp Sci, Adv Database Res & Modelling ADReM, B-2020 Antwerp, Belgium; [Gerlo, Sarah] VIB UGent, Dept Med Prot Res, Ghent, Belgium; [Mestdagh, Pieter; Vandesompele, Joke] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital	Vanden Berghe, W (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signalling PPES, B-2020 Antwerp, Belgium.	wim.vandenberghe@ua.ac.be	de Beeck, Ken Op/J-5248-2016; Vanden Berghe, Wim/HGE-4696-2022; Laukens, Kris/V-1121-2018; Palagani, Ajay/ABG-9147-2020; Berghe, Wim Vanden/S-6425-2018; Van Camp, Guy/F-3386-2013; Vandesompele, Jo/W-3411-2018	de Beeck, Ken Op/0000-0001-5527-6838; Laukens, Kris/0000-0002-8217-2564; Berghe, Wim Vanden/0000-0003-0161-7355; Van Camp, Guy/0000-0001-5105-9000; Vandesompele, Jo/0000-0001-6274-0184; Naulaerts, Stefan/0000-0002-1880-6374; Mestdagh, Pieter/0000-0001-7821-9684	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium); Multiple Myeloma Research Foundation (MMRF, US); FWO; NOI/DOCPRO (UA) research grants	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium); Multiple Myeloma Research Foundation (MMRF, US); FWO(FWO); NOI/DOCPRO (UA) research grants	Research has been supported by the Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium), the Multiple Myeloma Research Foundation (MMRF, US), FWO and NOI/DOCPRO (UA) research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Almanza G, 2013, P NATL ACAD SCI USA, V110, P20182, DOI 10.1073/pnas.1311145110; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Baghdassarian N, 1998, EXP CELL RES, V240, P263, DOI 10.1006/excr.1998.3942; Bao L, 2013, LEUKEMIA RES, V37, P1083, DOI 10.1016/j.leukres.2013.06.002; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Bladh LG, 2005, MOL ENDOCRINOL, V19, P632, DOI 10.1210/me.2004-0294; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Chen SH, 2013, CANCER SCI, V104, P826, DOI 10.1111/cas.12156; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Das I, 2013, J EXP MED, V210, P1201, DOI 10.1084/jem.20121268; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; De Iudicibus S, 2011, WORLD J GASTROENTERO, V17, P1095, DOI 10.3748/wjg.v17.i9.1095; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Gay F, 2010, AM J HEMATOL, V85, P664, DOI 10.1002/ajh.21777; Geng CD, 2011, MOL ENDOCRINOL, V25, P44, DOI 10.1210/me.2010-0249; Gentleman R, 2005, BIOINFORMATICS COMPU, p[xix, 473]; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Granes F, 2004, EUR J IMMUNOL, V34, P2781, DOI 10.1002/eji.200425154; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Gross KL, 2011, MOL ENDOCRINOL, V25, P1087, DOI 10.1210/me.2010-0051; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Han TT, 2014, CANCER BIOL THER, V15, P3, DOI 10.4161/cbt.26607; Hattori T, 2013, NAGOYA J MED SCI, V75, P81; He Y, 2014, ONCOGENE, V33, P3887, DOI 10.1038/onc.2013.346; He Y, 2013, ONCOGENE; Hong YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069926; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; Kfir-Erenfeld S, 2014, CANCER IMMUNOL IMMUN, V63, P37, DOI 10.1007/s00262-013-1477-8; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Li XJ, 2013, BR J CANC; Liang KL, 2013, BLOOD, V121, P4265, DOI 10.1182/blood-2012-12-471300; Lu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040676; Manoharan P, 2014, J BIOL CHEM; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Murray MY, 2013, CELL CYCLE, V12, P2144, DOI 10.4161/cc.25251; Nicholson L, 2010, LEUKEMIA RES, V34, P1366, DOI 10.1016/j.leukres.2009.12.014; Niesvizky R, 2008, BLOOD, V111, P1101, DOI 10.1182/blood-2007-05-090258; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Polman JAE, 2012, ENDOCRINOLOGY, V153, P4317, DOI 10.1210/en.2012-1255; Pore SK, 2013, BIOMATERIALS, V34, P6804, DOI 10.1016/j.biomaterials.2013.05.054; Protiva P, 2008, INT J CANCER, V123, P687, DOI 10.1002/ijc.23515; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Robertson S, 2013, STEROIDS, V78, P182, DOI 10.1016/j.steroids.2012.10.016; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Rossi A, 2013, BLOOD, V121, P1982, DOI 10.1182/blood-2012-08-448563; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-Vega B, 2006, MOL CANCER THER, V5, P3062, DOI 10.1158/1535-7163.MCT-06-0344; Sarvaiya PJ, 2012, MOL CELL ENDOCRINOL, V361, P124, DOI 10.1016/j.mce.2012.03.024; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Sengul A, 2013, PHYSIOL RES, V62, P221, DOI 10.33549/physiolres.932410; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suttana W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-99; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tessel Michael A., 2011, Hormones & Cancer, V2, P182, DOI 10.1007/s12672-011-0072-8; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang J, 2013, INT J CLIN EXP PATHO, V6, P2366; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	93	48	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113842	10.1371/journal.pone.0113842	http://dx.doi.org/10.1371/journal.pone.0113842			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474406	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500095
J	Okun, MS; Wu, SS; Fayad, S; Ward, H; Bowers, D; Rosado, C; Bowen, L; Jacobson, C; Butson, C; Foote, KD				Okun, Michael S.; Wu, Samuel S.; Fayad, Sarah; Ward, Herbert; Bowers, Dawn; Rosado, Christian; Bowen, Lauren; Jacobson, Charles; Butson, Christopher; Foote, Kelly D.			Acute and Chronic Mood and Apathy Outcomes from a Randomized Study of Unilateral STN and GPi DBS	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; RATING-SCALE; TRIAL; RELIABILITY; DEPRESSION; BEHAVIORS; INVENTORY; SURGERY	Objective: To study mood and behavioral effects of unilateral and staged bilateral subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) for Parkinson's disease (PD). Background: There are numerous reports of mood changes following DBS, however, most have focused on bilateral simultaneous STN implants with rapid and aggressive post-operative medication reduction. Methods: A standardized evaluation was applied to a subset of patients undergoing STN and GPi DBS and who were also enrolled in the NIH COMPARE study. The Unified Parkinson Disease Rating Scale (UPDRS III), the Hamilton depression (HAM-D) and anxiety rating scales (HAM-A), the Yale-Brown obsessive-compulsive rating scale (YBOCS), the Apathy Scale (AS), and the Young mania rating scale (YMRS) were used. The scales were repeated at acute and chronic intervals. A post-operative strategy of non-aggressive medication reduction was employed. Results: Thirty patients were randomized and underwent unilateral DBS (16 STN, 14 GPi). There were no baseline differences. The GPi group had a higher mean dopaminergic dosage at 1-year, however the between group difference in changes from baseline to 1-year was not significant. There were no differences between groups in mood and motor outcomes. When combining STN and GPi groups, the HAM-A scores worsened at 2-months, 4-months, 6-months and 1-year when compared with baseline; the HAM-D and YMRS scores worsened at 4-months, 6-months and 1-year; and the UPDRS Motor scores improved at 4-months and 1-year. Psychiatric diagnoses (DSM-IV) did not change. No between group differences were observed in the cohort of bilateral cases. Conclusions: There were few changes in mood and behavior with STN or GPi DBS. The approach of staging STN or GPi DBS without aggressive medication reduction could be a viable option for managing PD surgical candidates. A study of bilateral DBS and of medication reduction will be required to better understand risks and benefits of a bilateral approach.	[Okun, Michael S.; Bowers, Dawn; Rosado, Christian; Bowen, Lauren; Jacobson, Charles] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Okun, Michael S.; Foote, Kelly D.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Wu, Samuel S.] Univ Florida, Dept Biostat, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Fayad, Sarah; Ward, Herbert] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Psychiat, Gainesville, FL USA; [Bowers, Dawn] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Butson, Christopher] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin	Okun, MS (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	okun@neurology.ufl.edu		Okun, Michael/0000-0002-6247-9358; Reoma, Lauren/0000-0001-6305-7723; Jacobson, Charles/0000-0002-7598-5217; Foote, Kelly/0000-0002-2436-4138	National Parkinson Foundation; National Institutes of Health NIH [NS044997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079767, K23NS044997] Funding Source: NIH RePORTER	National Parkinson Foundation; National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This study was supported by a grant from the National Parkinson Foundation (PI, Okun) and the National Institutes of Health NIH (NS044997, PI, Okun). The sponsor had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernal-Pacheco O, 2013, NEUROMODULATION, V16, P35, DOI 10.1111/j.1525-1403.2012.00477.x; Chopra A, 2012, J NEUROPSYCH CLIN N, V24, P102, DOI 10.1176/appi.neuropsych.10070109; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Kirsch-Darrow L, 2011, PARKINSONISM RELAT D, V17, P182, DOI 10.1016/j.parkreldis.2010.12.011; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Lukasiewicz M, 2013, INT J METH PSYCH RES, V22, P46, DOI 10.1002/mpr.1379; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Schilbach L, 2012, NEUROCASE, V18, P152, DOI 10.1080/13554794.2011.568502; Schneider F, 2010, STEREOT FUNCT NEUROS, V88, P367, DOI 10.1159/000319046; Sudhyadhom A, 2007, CURR NEUROL NEUROSCI, V7, P278, DOI 10.1007/s11910-007-0043-1; Taba HA, 2010, J NEUROSURG, V113, P1224, DOI 10.3171/2010.8.JNS10312; Thobois S, 2013, BRAIN, V136, P1568, DOI 10.1093/brain/awt067; Ulla M, 2006, J NEUROL NEUROSUR PS, V77, P1363, DOI 10.1136/jnnp.2006.096628; Ulla M, 2011, J NEUROL NEUROSUR PS, V82, P607, DOI 10.1136/jnnp.2009.199323; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Weintraub D, 2013, J NEUROL NEUROSUR PS, V84, P1113, DOI 10.1136/jnnp-2012-304396; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4	26	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114140	10.1371/journal.pone.0114140	http://dx.doi.org/10.1371/journal.pone.0114140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469706	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700076
J	Sanabria, NM; Vetten, M; Andraos, C; Boodhia, K; Gulumian, M				Sanabria, Natasha M.; Vetten, Melissa; Andraos, Charlene; Boodhia, Kailen; Gulumian, Mary			Gold Nanoparticle Interference Study during the Isolation, Quantification, Purity and Integrity Analysis of RNA	PLOS ONE			English	Article							ABSORPTION-SPECTRA; PROTEIN; DNA; DEPENDENCE; NM	Investigations have been conducted regarding the interference of nanoparticles (NPs) with different toxicological assay systems, but there is a lack of validation when conducting routine tests for nucleic acid isolation, quantification, integrity, and purity analyses. The interference of citrate-capped gold nanoparticles (AuNPs) was investigated herein. The AuNPs were added to either BEAS-2B bronchial human cells for 24 h, the isolated pure RNA, or added during the isolation procedure, and the resultant interaction was assessed. Total RNA that was isolated from untreated BEAS-2B cells was spiked with various concentrations (v/v%) of AuNPs and quantified. A decrease in the absorbance spectrum (220-340 nm) was observed in a concentration-dependent manner. The 260 and 280 nm absorbance ratios that traditionally infer RNA purity were also altered. Electrophoresis was performed to determine RNA integrity, but could not differentiate between AuNP-exposed samples. However, the spiked post-isolation samples did produce differences in spectra (190-220 nm), where shifts were observed at a shorter wavelength. These shifts could be due to alterations to chromophores found in nucleic acids. The co-isolation samples, spiked with 100 mu L AuNP during the isolation procedure, displayed a peak shift to a longer wavelength and were similar to the results obtained from a 24 h AuNP treatment, under non-cytotoxic test conditions. Moreover, hyperspectral imaging using CytoViva dark field microscopy did not detect AuNP spectral signatures in the RNA isolated from treated cells. However, despite the lack of AuNPs in the final RNA product, structural changes in RNA could still be observed between 190-220 nm. Consequently, full spectral analyses should replace the traditional ratios based on readings at 230, 260, and 280 nm. These are critical points of analyses, validation, and optimization for RNA-based techniques used to assess AuNPs effects.	[Sanabria, Natasha M.; Vetten, Melissa; Andraos, Charlene; Boodhia, Kailen; Gulumian, Mary] NIOH, Dept Biol Toxicol, Johannesburg, South Africa; [Vetten, Melissa; Andraos, Charlene; Gulumian, Mary] WITS, Johannesburg, South Africa		Gulumian, M (corresponding author), NIOH, Dept Biol Toxicol, Johannesburg, South Africa.	Mary.Gulumian@nioh.nhls.ac.za	Sanabria, Natasha/AAY-4665-2020	Sanabria, Natasha/0000-0002-1613-6178; Vetten, Melissa/0000-0001-5438-5813	South African Department of Science and Technology; National Institute for Occupational Health	South African Department of Science and Technology; National Institute for Occupational Health	Funding: MG received funding for this work from the South African Department of Science and Technology (http://www.dst.gov.za/) and the National Institute for Occupational Health (http://www.nioh.ac.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian SK, 2010, BIOMATERIALS, V31, P9023, DOI 10.1016/j.biomaterials.2010.08.012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Egli M, 2010, STRUCTURE AND FUNCTION, P177, DOI 10.1007/978-90-481-2888-4_7; Frens G, 1973, PHYS SCI, V241, P20; GOLDFARB AR, 1951, J BIOL CHEM, V193, P397; Goodman CM, 2006, CHEM BIOL DRUG DES, V67, P297, DOI 10.1111/j.1747-0285.2006.00372.x; ITO A, 1986, PHOTOCHEM PHOTOBIOL, V44, P355, DOI 10.1111/j.1751-1097.1986.tb04675.x; ITO T, 1991, PHOTOBIOLOGY, P105; Jang NH, 2002, B KOR CHEM SOC, V23, P1790; KISELEVA MN, 1975, BIOFIZIKA+, V20, P561; Kreumers P, 1969, EUROPEAN J BIOCH, V9, P275; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Martin LA, 2002, MOL BIOL PROBLEM SOL, P197; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Phillips GF, 1995, TABLES PHYS CHEM CON; Railsback JG, 2012, ADV MATER, V24, P4261, DOI 10.1002/adma.201104891; ROSENHECK K, 1961, P NATL ACAD SCI USA, V47, P1775, DOI 10.1073/pnas.47.11.1775; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Schmid F.-X, 2001, ENCY LIFE SCI; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Tan ZJ, 2008, BIOPHYS J, V95, P738, DOI 10.1529/biophysj.108.131524; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Vetten MA, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-50; Warburg O., 1942, BIOCHEM Z, V310, P384; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Xu X, 2012, NUCLEIC ACIDS RES, V40, P7622, DOI 10.1093/nar/gks517	29	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114123	10.1371/journal.pone.0114123	http://dx.doi.org/10.1371/journal.pone.0114123			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470814	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700073
J	Schroeder, L; Roseman, CC; Cheverud, JM; Ackermann, RR				Schroeder, Lauren; Roseman, Charles C.; Cheverud, James M.; Ackermann, Rebecca R.			Characterizing the Evolutionary Path(s) to Early Homo	PLOS ONE			English	Article							NATURAL-SELECTION; GENETIC DRIFT; GREAT APE; NEANDERTHAL; AFRICA; DIFFERENTIATION; SPANDRELS; DIVERSITY; FOSSILS; TURKANA	Numerous studies suggest that the transition from Australopithecus to Homo was characterized by evolutionary innovation, resulting in the emergence and coexistence of a diversity of forms. However, the evolutionary processes necessary to drive such a transition have not been examined. Here, we apply statistical tests developed from quantitative evolutionary theory to assess whether morphological differences among late australopith and early Homo species in Africa have been shaped by natural selection. Where selection is demonstrated, we identify aspects of morphology that were most likely under selective pressure, and determine the nature (type, rate) of that selection. Results demonstrate that selection must be invoked to explain an Au. africanus-Au. sediba-Homo transition, while transitions from late australopiths to various early Homo species that exclude Au. sediba can be achieved through drift alone. Rate tests indicate that selection is largely directional, acting to rapidly differentiate these taxa. Reconstructions of patterns of directional selection needed to drive the Au. africanus-Au. sediba-Homo transition suggest that selection would have affected all regions of the skull. These results may indicate that an evolutionary path to Homo without Au. sediba is the simpler path and/or provide evidence that this pathway involved more reliance on cultural adaptations to cope with environmental change.	[Schroeder, Lauren; Ackermann, Rebecca R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Roseman, Charles C.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Cheverud, James M.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	University of Cape Town; University of Illinois System; University of Illinois Urbana-Champaign; Loyola University Chicago	Ackermann, RR (corresponding author), Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa.	becky.ackermann@uct.ac.za	Roseman, Charles/AAL-6141-2021	Roseman, Charles/0000-0002-4589-0401	Palaeontological Scientific Trust; L.S.B. Leakey Foundation; South African National Research Foundation; University Research Council at the University of Cape Town	Palaeontological Scientific Trust; L.S.B. Leakey Foundation; South African National Research Foundation(National Research Foundation - South Africa); University Research Council at the University of Cape Town	Funding provided by the Palaeontological Scientific Trust (LS), the L.S.B. Leakey Foundation (Baldwin Fellowship; LS), the South African National Research Foundation (LS, RRA), and the University Research Council at the University of Cape Town (RRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2002, AM J PHYS ANTHROPOL, V117, P260, DOI 10.1002/ajpa.10038; Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ACKERMANN RR, 1998, THESIS WASHINGTON U; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Anton SC, 2012, CURR ANTHROPOL, V53, pS278, DOI 10.1086/667695; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; CHEVERUD JM, 1986, SYST ZOOL, V35, P381, DOI 10.2307/2413389; CLYDE WC, 1994, PALEOBIOLOGY, V20, P506, DOI 10.1017/S0094837300012963; Curnoe D, 2010, HOMO, V61, P151, DOI 10.1016/j.jchb.2010.04.002; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; deMenocal PB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P262; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Harvati K, 2003, J HUM EVOL, V44, P107, DOI 10.1016/S0047-2484(02)00208-7; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M, 1984, NEUTRAL THEORY MOL E; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lewontin R.C., 1991, BIOL IDEOLOGY DOCTRI, VReprint ed.; LEWONTIN RC, 1979, BEHAV SCI, V24, P5, DOI 10.1002/bs.3830240103; Lockwood CA, 2004, P NATL ACAD SCI USA, V101, P4356, DOI 10.1073/pnas.0306235101; LOFSVOLD D, 1988, EVOLUTION, V42, P54, DOI [10.2307/2409115, 10.1111/j.1558-5646.1988.tb04107.x]; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2004, AM NAT, V163, P417, DOI 10.1086/381693; Marroig G, 2012, EVOLUTION, V66, P1506, DOI 10.1111/j.1558-5646.2011.01555.x; MAYR E, 1983, AM NAT, V121, P324, DOI 10.1086/284064; Pigliucci M, 2000, TRENDS ECOL EVOL, V15, P66, DOI 10.1016/S0169-5347(99)01762-0; Potts R., 2002, PROBING HUMAN ORIGIN, P33; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2010, AM J PHYS ANTHROPOL, V143, P1, DOI 10.1002/ajpa.21341; Shackleton NJ, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P242; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; von Cramon-Taubadel N, 2012, J HUM EVOL, V62, P640, DOI 10.1016/j.jhevol.2012.02.007; von Cramon-Taubadel N, 2009, J HUM EVOL, V57, P179, DOI 10.1016/j.jhevol.2009.05.009; Vrba Elisabeth S., 2007, P1441, DOI 10.1007/978-3-540-33761-4_47; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Williams FL, 2003, CLIN ANAT, V16, P494, DOI 10.1002/ca.10095; Willmore KE, 2009, EVOL BIOL, V36, P19, DOI 10.1007/s11692-009-9056-9; Wood B. A., 1991, HOMINID CRANIAL REMA, V4; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375	56	28	28	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114307	10.1371/journal.pone.0114307	http://dx.doi.org/10.1371/journal.pone.0114307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470780	Green Published, gold			2022-12-27	WOS:000349128700100
J	Tian, Y; Linden, J; French, BA; Yang, ZQ				Tian, Yikui; Linden, Joel; French, Brent A.; Yang, Zequan			Atorvastatin at Reperfusion Reduces Myocardial Infarct Size in Mice by Activating eNOS in Bone Marrow-Derived Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COA REDUCTASE INHIBITORS; PERCUTANEOUS CORONARY INTERVENTION; RAT HEARTS; HYPERCHOLESTEROLEMIC PATIENTS; ISCHEMIA/REPERFUSION INJURY; RECEPTOR ACTIVATION; ISCHEMIA; PRETREATMENT; PROTECTION	Background: The current study was designed to test our hypothesis that atorvastatin could reduce infarct size in intact mice by activating eNOS, specifically the eNOS in bone marrow-derived cells. C57BL/6J mice (B6) and congenic eNOS knockout (KO) mice underwent 45 min LAD occlusion and 60 min reperfusion. Chimeric mice, created by bone marrow transplantation between B6 and eNOS KO mice, underwent 40 min LAD occlusion and 60 min reperfusion. Mice were treated either with vehicle or atorvastatin in 5% ethanol at a dose of 10 mg/kg IV 5 min before initiating reperfusion. Infarct size was evaluated by TTC and Phthalo blue staining. Results: Atorvastatin treatment reduced infarct size in B6 mice by 19% (p<0.05). In eNOS KO vehicle-control mice, infarct size was comparable to that of B6 vehicle-control mice (p=NS). Atorvastatin treatment had no effect on infarct size in eNOS KO mice (p=NS). In chimeras, atorvastatin significantly reduced infarct size in B6/B6 (donor/recipient) mice and B6/KO mice (p<0.05), but not in KO/KO mice or KO/B6 mice (p=NS). Conclusions: The results demonstrate that acute administration of atorvastatin significantly reduces myocardial ischemia/reperfusion injury in an eNOS-dependent manner, probably through the post-transcriptional activation of eNOS in bone marrow-derived cells.	[Tian, Yikui; Yang, Zequan] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA; [Linden, Joel; French, Brent A.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA; [French, Brent A.; Yang, Zequan] Univ Virginia Hlth Syst, Dept Biomed Sci, Charlottesville, VA USA; [Linden, Joel] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Tian, Yikui] Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin, Peoples R China	University of Virginia; University of Virginia; University of Virginia; La Jolla Institute for Immunology; Tianjin Medical University	Yang, ZQ (corresponding author), Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA.	zy6b@virginia.edu	Tian, Yikui/U-2247-2018; Linden, Joel/AAH-5690-2020	Tian, Yikui/0000-0003-0311-4794; 	ARA Award; Pfizer Inc.;  [R01 HL69494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069494] Funding Source: NIH RePORTER	ARA Award; Pfizer Inc.(Pfizer); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an ARA Award (sponsored by Pfizer Inc.) to ZY and by R01 HL69494 to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2012, CARDIOVASC RES, V94, P501, DOI 10.1093/cvr/cvs121; Barrabes JA, 2010, THROMB HAEMOSTASIS, V104, P128, DOI 10.1160/TH09-07-0440; Bauer T, 2009, J CARDIOVASC PHARM, V53, P132, DOI 10.1097/FJC.0b013e3181976a3c; Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4; Chen M, 2013, J CARDIOVASC PHARM, V62, P320, DOI 10.1097/FJC.0b013e31829be05b; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Gaddam V., 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P247, DOI 10.1177/107424840200700408; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0253-9; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Hahn JY, 2011, AM HEART J, V162, P1026, DOI 10.1016/j.ahj.2011.08.011; Harris MB, 2004, AM J PHYSIOL-HEART C, V287, pH560, DOI 10.1152/ajpheart.00214.2004; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jayachandran M, 2003, PLATELETS, V14, P75, DOI 10.1080/0953710031000080562; Jialal I, 2001, CIRCULATION, V103, P1933; Jones SP, 2001, ACTA PHYSIOL SCAND, V173, P139, DOI 10.1046/j.1365-201X.2001.00899.x; Jones SP, 2002, J AM COLL CARDIOL, V40, P1172, DOI 10.1016/S0735-1097(02)02115-0; Kupatt C, 2002, J LEUKOCYTE BIOL, V72, P455; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Lefer AM, 1999, CIRCULATION, V100, P178, DOI 10.1161/01.CIR.100.2.178; LEUNG WH, 1993, LANCET, V341, P1496, DOI 10.1016/0140-6736(93)90634-S; Li XD, 2012, ACTA PHARMACOL SIN, V33, P879, DOI 10.1038/aps.2012.27; Marzilli M, 2010, AM J CARDIOVASC DRUG, V10, P3, DOI 10.2165/1153644-S0-000000000-00000; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; Mensah K, 2005, J AM COLL CARDIOL, V45, P1287, DOI 10.1016/j.jacc.2005.01.021; Mirabet M, 2002, AM J PHYSIOL-HEART C, V283, pH1134, DOI 10.1152/ajpheart.00065.2002; Olsson AG, 2002, ACTA PHYSIOL SCAND, V176, P147, DOI 10.1046/j.1365-201X.2002.01017.x; Olsson AG, 2002, ANN MED, V34, P37, DOI 10.1080/078538902317338625; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rork TH, 2008, AM J PHYSIOL-HEART C, V295, pH1825, DOI 10.1152/ajpheart.495.2008; Sanguigni V, 2005, CIRCULATION, V111, P412, DOI 10.1161/01.CIR.0000153810.81187.7D; Teupser D, 2001, BIOCHEM BIOPH RES CO, V289, P838, DOI 10.1006/bbrc.2001.6066; Undas A, 2001, CIRCULATION, V103, P2248; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wassmann S, 2003, CIRC RES, V93, pE98, DOI 10.1161/01.RES.0000099503.13312.7B; Waters D, 2001, CURR CONTR TRIALS C, V2, P111; Wolfrum S, 2004, J CARDIOVASC PHARM, V44, P348, DOI 10.1097/01.fjc.0000137162.14735.30; Wright DG, 2005, VASC PHARMACOL, V42, P265, DOI 10.1016/j.vph.2005.02.006; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH343, DOI 10.1152/ajpheart.01350.2007; Zuidema MY, 2010, WORLD J CARDIOL, V2, P325, DOI 10.4330/wjc.v2.i10.325	45	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114375	10.1371/journal.pone.0114375	http://dx.doi.org/10.1371/journal.pone.0114375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470018	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700107
J	Catalao, MJ; Figueiredo, J; Henriques, MX; Gomes, JP; Filipe, SR				Catalao, Maria Joao; Figueiredo, Joana; Henriques, Mafalda X.; Gomes, Joao Paulo; Filipe, Sergio R.			Optimization of Fluorescent Tools for Cell Biology Studies in Gram-Positive Bacteria	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; GENE-EXPRESSION; PROTEIN; IDENTIFICATION; TRANSFORMATION; COLONIZATION; PNEUMOCOCCUS; DISEASE; SYSTEM; OPERON	The understanding of how Gram-positive bacteria divide and ensure the correct localization of different molecular machineries, such as those involved in the synthesis of the bacterial cell surface, is crucial to design strategies to fight bacterial infections. In order to determine the correct subcellular localization of fluorescent proteins in Streptococcus pneumoniae, we have previously described tools to express derivatives of four fluorescent proteins, mCherry, Citrine, CFP and GFP, to levels that allow visualization by fluorescence microscopy, by fusing the first ten amino acids of the S. pneumoniae protein Wze (the i-tag), upstream of the fluorescent protein. Here, we report that these tools can also be used in other Gram-positive bacteria, namely Lactococcus lactis, Staphylococcus aureus and Bacillus subtilis, possibly due to optimized translation rates. Additionally, we have optimized the i-tag by testing the effect of the first ten amino acids of other pneumococcal proteins in the increased expression of the fluorescent protein Citrine. We found that manipulating the structure and stability of the 5' end of the mRNA molecule, which may influence the accessibility of the ribosome, is determinant to ensure the expression of a strong fluorescent signal.	[Catalao, Maria Joao; Figueiredo, Joana; Henriques, Mafalda X.; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, P-2781901 Oeiras, Portugal; [Gomes, Joao Paulo] Natl Inst Hlth, Dept Infect Dis, P-1649016 Lisbon, Portugal	Universidade Nova de Lisboa	Filipe, SR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Ave Republ,Apartado 127, P-2781901 Oeiras, Portugal.	sfilipe@itqb.unl.pt	Catalão, Maria João/B-6731-2017; Filipe, Sergio Raposo/B-9167-2008; iMed.ULisboa, HPI/B-4239-2014; Catalao, Maria Joao/P-3248-2019; Figueiredo, Joana/T-9046-2017	Catalão, Maria João/0000-0002-3794-457X; Filipe, Sergio Raposo/0000-0002-4485-832X; iMed.ULisboa, HPI/0000-0001-5934-0198; Catalao, Maria Joao/0000-0002-3794-457X; Figueiredo, Joana/0000-0002-6804-0522; Gomes, Joao Paulo/0000-0002-2697-2399	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-MIC/111817/2009]; FCT [PEst-OE/EQB/LA0004/2011, SFRH/BD/43797/2008, SFRH/BPD/77758/2011]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/111817/2009 awarded to SRF. The work performed at Instituto de Tecnologia Quimica e Biologica was supported additionally by FCT through grant PEst-OE/EQB/LA0004/2011. MXH and MJC were supported by FCT fellowships SFRH/BD/43797/2008 and SFRH/BPD/77758/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; de Palencia PF, 2000, FEMS MICROBIOL LETT, V183, P229, DOI 10.1111/j.1574-6968.2000.tb08963.x; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Henriques MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055049; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Veening JW, 2004, APPL ENVIRON MICROB, V70, P6809, DOI 10.1128/AEM.70.11.6809-6815.2004; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	21	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113796	10.1371/journal.pone.0113796	http://dx.doi.org/10.1371/journal.pone.0113796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464377	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700053
J	Silva, YJ; Costa, L; Pereira, C; Mateus, C; Cunha, A; Calado, R; Gomes, NCM; Pardo, MA; Hernandez, I; Almeida, A				Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Pardo, Miguel A.; Hernandez, Igor; Almeida, Adelaide			Phage Therapy as an Approach to Prevent Vibrio anguillarum Infections in Fish Larvae Production	PLOS ONE			English	Article							PSEUDOMONAS-PLECOGLOSSICIDA; BACTERIOPHAGE CONTROL; LYTIC BACTERIOPHAGE; ATLANTIC SALMON; COLONIZATION; ENVIRONMENTS; BIOCONTROL; EFFICACY; DISEASE; SKIN	Fish larvae in aquaculture have high mortality rates due to pathogenic bacteria, especially the Vibrio species, and ineffective prophylactic strategies. Vaccination is not feasible in larvae and antibiotics have reduced efficacy against multidrug resistant bacteria. A novel approach to controlling Vibrio infections in aquaculture is needed. The potential of phage therapy to combat vibriosis in fish larvae production has not yet been examined. We describe the isolation and characterization of two bacteriophages capable of infecting pathogenic Vibrio and their application to prevent bacterial infection in fish larvae. Two groups of zebrafish larvae were infected with V. anguillarum (similar to 10(6) CFU mL(-1)) and one was later treated with a phage lysate (similar to 10(8) PFU mL(-1)). A third group was only added with phages. A fourth group received neither bacteria nor phages (fish control). Larvae mortality, after 72 h, in the infected and treated group was similar to normal levels and significantly lower than that of the infected but not treated group, indicating that phage treatment was effective. Thus, directly supplying phages to the culture water could be an effective and inexpensive approach toward reducing the negative impact of vibriosis in larviculture.	[Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Almeida, Adelaide] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal; [Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Almeida, Adelaide] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Pardo, Miguel A.; Hernandez, Igor] Food Res Div AZTI Tecnalia, Derio 48160, Spain	Universidade de Aveiro; Universidade de Aveiro; AZTI	Almeida, A (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago 11, P-3810193 Aveiro, Portugal.	aalmeida@ua.pt	Calado, Ricardo Jorge Guerra/C-7035-2008; Cunha, Angela/AAC-3830-2019; Pereira, Carla Sofia Gomes/L-8589-2019; Gomes, Newton CM/F-7430-2012; Hernandez, Igor/AAG-6235-2020; Gomes, Newton Carlos Marcial/K-3211-2015; Almeida, Adelaide/D-9899-2011; Gomes, Newton Carlos Marcial/AAV-4603-2021; Pereira, Carla S.G/F-3373-2019; Hernandez, Igor/ADV-0198-2022; Cunha, Angela/E-9537-2011; Pardo, Miguel Angel/H-5133-2015	Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Cunha, Angela/0000-0002-9118-3521; Pereira, Carla Sofia Gomes/0000-0001-9209-7687; Gomes, Newton CM/0000-0003-1934-0091; Hernandez, Igor/0000-0002-4363-448X; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Almeida, Adelaide/0000-0002-8422-8664; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Cunha, Angela/0000-0002-9118-3521; Pardo, Miguel Angel/0000-0002-3395-3380	FEDER COMPETE (Competitiveness Factors Operational Program); FCT (Portuguese Foundation for Science and Technology) [FCOMP-01-0124-FEDER-013934]; Center for Environmental and Marine Studies (CESAM) [Pest-C/MAR/LA0017/2013]; FCTFCT [SFRH/BD/65147/2009, SFRH/BD/ 76414/2011, BI/UI88/5319/2011]	FEDER COMPETE (Competitiveness Factors Operational Program); FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); Center for Environmental and Marine Studies (CESAM); FCTFCT	This work was supported by FEDER COMPETE (Competitiveness Factors Operational Program) and by FCT (Portuguese Foundation for Science and Technology), under the research project FCOMP-01-0124-FEDER-013934; and Center for Environmental and Marine Studies (CESAM) for funding (Project Pest-C/MAR/LA0017/2013). Financial support to Y. J. Silva, C. Pereira, and L. Costa was provided by FCT in the form of PhD grants (SFRH/BD/65147/2009 and SFRH/BD/ 76414/2011) and a BI grant (BI/UI88/5319/2011), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Almeida A, 1994, MORFOLOGIA INFECCAO; Almeida A, 2009, MAR DRUGS, V7, P268, DOI 10.3390/md7030268; ALMEIDA MA, 1992, MAR ECOL PROG SER, V89, P165, DOI 10.3354/meps089165; [Anonymous], 1983, LANCET, V2, P1287; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; BEVERIDGE MCM, 1991, J FISH BIOL, V39, P825, DOI 10.1111/j.1095-8649.1991.tb04412.x; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Crothers-Stomps C, 2010, J APPL MICROBIOL, V108, P1744, DOI 10.1111/j.1365-2672.2009.04578.x; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Filippov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025486; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HANSEN GH, 1989, APPL ENVIRON MICROB, V55, P1435, DOI 10.1128/AEM.55.6.1435-1446.1989; Higuera G, 2013, AQUACULTURE, V392, P128, DOI 10.1016/j.aquaculture.2013.02.013; Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Lan CC, 2012, ISRN MICROBIOL, V14; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Louvado A, 2012, J MICROBIOL BIOTECHN, V22, P283, DOI 10.4014/jmb.1110.10041; Martinez JL, 2003, MOL GENETICS MARINE, V10; Martinez-Diaz SF, 2013, AQUACULTURE, V400, P120, DOI 10.1016/j.aquaculture.2013.03.007; Mateus L, 2014, AQUACULTURE, V424, P167, DOI 10.1016/j.aquaculture.2014.01.001; MERINO S, 1990, FEMS MICROBIOL LETT, V68, P239, DOI 10.1016/S0378-1097(05)80047-3; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Nakai T, 1999, DIS AQUAT ORGAN, V37, P33, DOI 10.3354/dao037033; Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3; Noorlis A., 2011, INT FOOD RES J, V18, P689; NOYA M, 1995, P 5 NAT C AQ SANT CA, P734; Olafsen J.A., 1984, Flodevigen Rapportserie, V1, P627; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; OLAFSEN JA, 1992, J FISH BIOL, V40, P141, DOI 10.1111/j.1095-8649.1992.tb02562.x; Oyarbide U, 2012, ZEBRAFISH, V9, P74, DOI 10.1089/zeb.2011.0724; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000; Pasqualina L., 2011, NEW MICROBIOL, V34, P53; Pereira C, 2011, MAR DRUGS, V9, P2236, DOI 10.3390/md9112236; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shao ZZJ, 2001, ADV DRUG DELIVER REV, V50, P229, DOI 10.1016/S0169-409X(01)00159-4; Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x; Silva YJ, 2014, MICROB BIOTECHNOL, V7, P401, DOI 10.1111/1751-7915.12090; STEVENSON RMW, 1984, APPL ENVIRON MICROB, V47, P1201, DOI 10.1128/AEM.47.6.1201-1205.1984; TORANZO AE, 1991, AQUACULTURE, V99, P1, DOI 10.1016/0044-8486(91)90284-E; Vadstein O, 1997, AQUACULTURE, V155, P401, DOI 10.1016/S0044-8486(97)00114-2; Verner-Jeffreys DW, 2007, AQUACULTURE, V270, P475, DOI 10.1016/j.aquaculture.2007.05.023; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wahli T, 2002, J FISH DIS, V25, P491, DOI 10.1046/j.1365-2761.2002.00401.x; Weber B, 2010, ENV MICROBIOL REP, V2, P133, DOI 10.1111/j.1758-2229.2009.00120.x; WU J-L, 1981, Fish Pathology, V15, P271; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603	51	90	93	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114197	10.1371/journal.pone.0114197	http://dx.doi.org/10.1371/journal.pone.0114197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464504	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700114
J	Xu, RJ; Liu, XQ; Yang, J				Xu, Ruijuan; Liu, Xiaoquan; Yang, Jin			A Semi-Physiologically Based Pharmacokinetic Pharmacodynamic Model for Glycyrrhizin-Induced Pseudoaldosteronism and Prediction of the Dose Limit Causing Hypokalemia in a Virtual Elderly Population	PLOS ONE			English	Article							BETA-D-GLUCURONIDASE; GLYCYRRHETINIC ACID; GASTROINTESTINAL ABSORPTION; PRESYSTEMIC METABOLISM; DEHYDROGENASE-ACTIVITY; COMPOUND SUBJECT; RATS; ALDOSTERONE; LICORICE; PLASMA	Glycyrrhizin (GL) is a widely used food additive which can cause severe pseudoaldosteronism at high doses or after a long period of consumption. The aim of the present study was to develop a physiologically based pharmacokinetic (PBPK) pharmacodynamic (PD) model for GL-induced pseudoaldosteronism to improve the safe use of GL. Since the major metabolite of GL, glycyrrhetic acid (GA), is largely responsible for pseudoaldosteronism via inhibition of the kidney enzyme 11 beta-hydroxysteroiddehydrogenase 2 (11 beta-HSD 2), a semi-PBPK model was first developed in rat to predict the systemic pharmacokinetics of and the kidney exposure to GA. A human PBPK model was then developed using parameters either from the rat model or from in vitro studies in combination with essential scaling factors. Kidney exposure to GA was further linked to an I-max model in the 11b-HSD 2 module of the PD model to predict the urinary excretion of cortisol and cortisone. Subsequently, activation of the mineralocorticoid receptor in the renin-angiotensin-aldosterone-electrolyte system was associated with an increased cortisol level. Experimental data for various scenarios were used to optimize and validate the model which was finally able to predict the plasma levels of angiotensin II, aldosterone, potassium and sodium. The Monte Carlo method was applied to predict the probability distribution of the individual dose limits of GL causing pseudoaldosteronism in the elderly according to the distribution of sensitivity factors using serum potassium as an indicator. The critical value of the dose limit was found to be 101 mg with a probability of 3.07%.	[Xu, Ruijuan; Liu, Xiaoquan; Yang, Jin] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Liu, XQ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	lxq_cpu@yahoo.com.cn; yjcpu@yahoo.com	xu, rui/GRX-5734-2022		Chinese foundation for hepatitis prevention and control-TianQing liver disease research fund subject [TQGB2011017]	Chinese foundation for hepatitis prevention and control-TianQing liver disease research fund subject	Funding provided by Chinese foundation for hepatitis prevention and control-TianQing liver disease research fund subject TQGB2011017 URLs: http://www.cfhpc.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 1997, BIOL PHARM BULL, V20, P1245; AKAO T, 1991, BIOCHEM PHARMACOL, V41, P1025; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Austin RP, 2002, DRUG METAB DISPOS, V30, P1497, DOI 10.1124/dmd.30.12.1497; BERETTAPICCOLI C, 1984, J CLIN ENDOCR METAB, V59, P316, DOI 10.1210/jcem-59-2-316; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Campino C, 2013, AM J HYPERTENS, V26, P481, DOI 10.1093/ajh/hps080; Costa A, 1996, J ENDOCRINOL INVEST, V19, P463, DOI 10.1007/BF03349892; EPSTEIN MT, 1977, BMJ-BRIT MED J, V1, P488, DOI 10.1136/bmj.1.6059.488; European Conmmission Health & Consumer Protection Directorate-General and Scientific Committee on Food, OP SCI COMM FOOD GLY; FARESE RV, 1991, NEW ENGL J MED, V325, P1223, DOI 10.1056/NEJM199110243251706; FENWICK GR, 1990, FOOD CHEM, V38, P119, DOI 10.1016/0308-8146(90)90159-2; Furihata T, 2007, PHARM RES-DORDR, V24, P2327, DOI 10.1007/s11095-007-9458-2; Guillaud F, 2010, ACTA BIOTHEOR, V58, P143, DOI 10.1007/s10441-010-9098-5; HIMATHONGKAM T, 1975, J CLIN ENDOCR METAB, V41, P153, DOI 10.1210/jcem-41-1-153; Homma M, 2006, YAKUGAKU ZASSHI, V126, P973, DOI 10.1248/yakushi.126.973; ICHIKAWA T, 1984, CHEM PHARM BULL, V32, P3734, DOI 10.1248/cpb.32.3734; IKEDA N, 1979, ANN BIOMED ENG, V7, P135, DOI 10.1007/BF02363132; ISHIDA S, 1988, CHEM PHARM BULL, V36, P440; ISHIDA S, 1994, BIOL PHARM BULL, V17, P960; ISHIDA S, 1993, BIOL PHARM BULL, V16, P293; ISHIDA S, 1992, CHEM PHARM BULL, V40, P1917; ISHIDA S, 1990, CHEM PHARM BULL, V38, P212; Ismair MG, 2003, HEPATOL RES, V26, P343, DOI 10.1016/S1386-6346(03)00154-2; KAWAKAMI J, 1993, J PHARM SCI, V82, P301, DOI 10.1002/jps.2600820317; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lu Y, 2009, DRUG METAB PHARMACOK, V24, P523, DOI 10.2133/dmpk.24.523; MACKENZIE MA, 1990, J CLIN ENDOCR METAB, V70, P1637, DOI 10.1210/jcem-70-6-1637; MADSEN JL, 1992, DIGEST DIS SCI, V37, P1548, DOI 10.1007/BF01296501; Makino T, 2008, DRUG METAB DISPOS, V36, P1438, DOI 10.1124/dmd.108.021089; Makino T, 2012, J PHARMACOL EXP THER, V342, P297, DOI 10.1124/jpet.111.190009; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Omar HR, 2012, THER ADV ENDOCRINOL, V3, P125, DOI 10.1177/2042018812454322; Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x; PARKE DV, 1963, J PHARM PHARMACOL, V15, P500, DOI 10.1111/j.2042-7158.1963.tb12825.x; Pippal JB, 2008, J MOL ENDOCRINOL, V41, P405, DOI 10.1677/JME-08-0093; Ploeger B, 2000, PHARMACEUT RES, V17, P1516, DOI 10.1023/A:1007661209921; Ploeger B, 2001, TOXICOL APPL PHARM, V170, P46, DOI 10.1006/taap.2000.9078; Ploeger BA, 2000, TOXICOL APPL PHARM, V162, P177, DOI 10.1006/taap.1999.8843; Poulin P, 2000, J PHARM SCI-US, V89, P16, DOI 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E; Poulin P., 2011, J PHARM SCI; Shimamura H, 1996, PHARMACEUT RES, V13, P1833, DOI 10.1023/A:1016033124819; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; WANG Z, 1994, BIOL PHARM BULL, V17, P1399, DOI 10.1248/bpb.17.1399; WANG Z, 1995, BIOL PHARM BULL, V18, P1238, DOI 10.1248/bpb.18.1238; Williams G, 2005, HEART FAIL REV, V10, P7, DOI 10.1007/s10741-005-2343-3; Xu R, 2013, Drug Res (Stuttg), V63, P620, DOI 10.1055/s-0033-1349837; Xu RJ, 2012, BIOPHARM DRUG DISPOS, V33, P235, DOI 10.1002/bdd.1789; Yamamoto Takeshi, 2010, Nihon Jinzo Gakkai Shi, V52, P80; YAMAMURA Y, 1992, J PHARM SCI, V81, P1042, DOI 10.1002/jps.2600811018	50	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114049	10.1371/journal.pone.0114049	http://dx.doi.org/10.1371/journal.pone.0114049			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463381	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700089
J	Sterpenich, V; Schwartz, S; Maquet, P; Desseilles, M				Sterpenich, Virginie; Schwartz, Sophie; Maquet, Pierre; Desseilles, Martin			Ability to Maintain Internal Arousal and Motivation Modulates Brain Responses to Emotions	PLOS ONE			English	Article							PERSONALITY-TRAITS; INDIVIDUAL-DIFFERENCES; PARTIAL-REINFORCEMENT; ORBITOFRONTAL CORTEX; DEPRESSIVE SYMPTOMS; MAJOR DEPRESSION; AFFECTIVE STYLE; ANXIETY; TEMPERAMENT; MECHANISMS	Persistence (PS) is defined as the ability to generate and maintain arousal and motivation internally in the absence of immediate external reward. Low PS individuals tend to become discouraged when expectations are not rapidly fulfilled. The goal of this study was to investigate whether individual differences in PS influence the recruitment of brain regions involved in emotional processing and regulation. In a functional MRI study, 35 subjects judged the emotional intensity of displayed pictures. When processing negative pictures, low PS (vs. high PS) subjects showed higher amygdala and right orbito-frontal cortex (OFC) activity but lower left OFC activity. This dissociation in OFC activity suggests greater prefrontal cortical asymmetry for approach/avoidance motivation, suggesting an avoidance response to aversive stimuli in low PS. For positive or neutral stimuli, low PS subjects showed lower activity in the amygdala, striatum, and hippocampus. These results suggest that low PS may involve an imbalance in processing distinct emotional inputs, with greater reactivity to aversive information in regions involved in avoidance behaviour (amygdala, OFC) and dampened response to positive and neutral stimuli across circuits subserving motivated behaviour (striatum, hippocampus, amygdala). Low PS affective style was associated with depression vulnerability. These findings in non-depressed subjects point to a neural mechanism whereby some individuals are more likely to show systematic negative emotional biases, as frequently observed in depression. The assessment of these individual differences, including those that may cause vulnerability to depressive disorders, would therefore constitute a promising approach to risk assessment for depression.	[Sterpenich, Virginie; Maquet, Pierre; Desseilles, Martin] Univ Liege B30, Cyclotron Res Ctr, Liege, Belgium; [Sterpenich, Virginie; Schwartz, Sophie; Desseilles, Martin] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Maquet, Pierre] Univ Liege, Dept Neurol, CHU Sart Tilman, Liege, Belgium	University of Liege; University of Geneva; University of Geneva; University of Liege	Sterpenich, V (corresponding author), Univ Liege B30, Cyclotron Res Ctr, Liege, Belgium.	Virginie.Sterpenich@unige.ch; m.desseilles@ulg.ac.be		, Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X; Schwartz, Sophie/0000-0001-7718-4053; Desseilles, Martin/0000-0003-4748-3401	Fonds National de la Recherche Scientifique (FNRS) Beige; Fondation Medicale Reine Elisabeth (FMRE); Research Fund of the University of Liege; F.N.R.S.; Swiss National Science Fundation; Mercier Foundation; Boninchi Foundation; Belgian American Educational Fundation; Fonds Leon Fredericq	Fonds National de la Recherche Scientifique (FNRS) Beige(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth (FMRE); Research Fund of the University of Liege(University of Liege); F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Fundation(Swiss National Science Foundation (SNSF)); Mercier Foundation; Boninchi Foundation; Belgian American Educational Fundation; Fonds Leon Fredericq	Funding: This research was supported by the Fonds National de la Recherche Scientifique (FNRS) Beige, the Fondation Medicale Reine Elisabeth (FMRE), and the Research Fund of the University of Liege. VS, MD and PM are supported by the F.N.R.S. SS is supported by the Swiss National Science Fundation, Mercier Foundation, and Boninchi Foundation. Additional supports come from the Belgian American Educational Fundation and the Fonds Leon Fredericq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anand A, 2003, ANN NY ACAD SCI, V985, P370; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; AstonJones G, 1996, PROG BRAIN RES, V107, P379; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bermond B, 1999, PSYCHOTHER PSYCHOSOM, V68, P241, DOI 10.1159/000012340; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Carlson JM, 2011, NEUROIMAGE; Chang EC, 2001, J COUNS PSYCHOL, V48, P490, DOI 10.1037/0022-0167.48.4.490; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; DAVIDSON RJ, 1993, BEHAV NEUROSCI, V107, P1106, DOI 10.1037/0735-7044.107.6.1106; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Faraone SV, 2009, PSYCHOL MED, V39, P685, DOI 10.1017/S0033291708003917; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Garcia D, 2011, PERS INDIV DIFFER, V50, P1208, DOI 10.1016/j.paid.2011.02.009; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Gross JJ, 1998, PERS SOC PSYCHOL B, V24, P279, DOI 10.1177/0146167298243005; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hansenne M, 2009, PSYCHIAT RES, V166, P63, DOI 10.1016/j.psychres.2008.03.015; Jylha P, 2011, PSYCHOL MED, V41, P1579, DOI 10.1017/S0033291710002606; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kawamura KY, 2001, COGNITIVE THER RES, V25, P291, DOI 10.1023/A:1010736529013; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lau MA, 2004, BEHAV RES THER, V42, P1001, DOI 10.1016/j.brat.2004.03.003; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Matsudaira T, 2006, J CLIN PSYCHOL, V62, P97, DOI 10.1002/jclp.20215; Meehl PE, 1975, B MENNINGER CLIN, P295; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nash MW, 2004, HUM MOL GENET, V13, P2173, DOI 10.1093/hmg/ddh239; NATION JR, 1980, J EXP PSYCHOL GEN, V109, P175, DOI 10.1037/0096-3445.109.2.175; NATION JR, 1978, J EXP PSYCHOL GEN, V107, P436, DOI 10.1037/0096-3445.107.4.436; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Osher Y, 1996, J PSYCHIAT RES, V30, P353, DOI 10.1016/0022-3956(96)00023-4; Peirson AR, 2001, PERS INDIV DIFFER, V30, P391, DOI 10.1016/S0191-8869(00)00031-3; Pelissolo A, 2005, ACTA PSYCHIAT SCAND, V112, P126, DOI 10.1111/j.1600-0447.2005.00551.x; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; POLINE JB, 1994, J CEREBR BLOOD F MET, V14, P639, DOI 10.1038/jcbfm.1994.79; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Siegle G. J., 2004, DEPRESSIVE RUMINATIO, P79; Simpson JR, 2000, J COGNITIVE NEUROSCI, V12, P157, DOI 10.1162/089892900564019; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; TAI CT, 1991, EXP BRAIN RES, V86, P333; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092	78	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112999	10.1371/journal.pone.0112999	http://dx.doi.org/10.1371/journal.pone.0112999			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438046	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900025
J	Leiherer, A; Muendlein, A; Rein, P; Saely, CH; Kinz, E; Vonbank, A; Fraunberger, P; Drexel, H				Leiherer, Andreas; Muendlein, Axel; Rein, Philipp; Saely, Christoph H.; Kinz, Elena; Vonbank, Alexander; Fraunberger, Peter; Drexel, Heinz			Genome-Wide Association Study Reveals a Polymorphism in the Podocyte Receptor RANK for the Decline of Renal Function in Coronary Patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CELL CARCINOMA; VASCULAR CALCIFICATION; POPULATION; ATHEROSCLEROSIS; ANGIOGRAPHY; MECHANISMS; CREATININE; EXPRESSION	Impaired kidney function is a significant health problem and a major concern in clinical routine and is routinely determined by decreased glomerular filtration rate (GFR). In contrast to single assessment of a patients' kidney function providing only limited information on patients' health, serial measurements of GFR clearly improves the validity of diagnosis. The decline of kidney function has recently been reported to be predictive for mortality and vascular events in coronary patients. However, it has not been investigated for genetic association in GWA studies. This study investigates for the first time the association of cardiometabolic polymorphisms with the decline of estimated GFR during a 4 year follow up in 583 coronary patients, using the Cardio-Metabo Chip. We revealed a suggestive association with 3 polymorphisms, surpassing genome-wide significance (p=4.0 e-7). The top hit rs17069906 (p=5.6 e-10) is located within the genomic region of RANK, recently demonstrated to be an important player in the adaptive recovery response in podocytes and suggested as a promising therapeutic target in glomerular diseases.	[Leiherer, Andreas; Muendlein, Axel; Rein, Philipp; Saely, Christoph H.; Kinz, Elena; Vonbank, Alexander; Drexel, Heinz] VIVIT, Feldkirch, Austria; [Rein, Philipp; Saely, Christoph H.; Vonbank, Alexander; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Leiherer, Andreas; Saely, Christoph H.; Kinz, Elena; Fraunberger, Peter; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Leiherer, Andreas; Fraunberger, Peter] Med Cent Labs, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Drexel, H (corresponding author), VIVIT, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021; Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Muendlein, Axel/0000-0002-5582-4125; Vonbank, Alexander/0000-0001-5648-5623	Land Vorarlberg; College of Physicians in Vorarlberg	Land Vorarlberg; College of Physicians in Vorarlberg	This study was supported by grants from the "Land Vorarlberg" and the "College of Physicians in Vorarlberg", but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 1987, AM J PHYSIOL, V253, pF783; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ANGLARD P, 1991, CANCER RES, V51, P1071; Bharti AC, 2004, APOPTOSIS, V9, P677, DOI 10.1023/B:APPT.0000045780.10463.c6; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gayrard N, 2008, ARCH PATHOL LAB MED, V132, P965, DOI 10.1043/1543-2165(2008)132[965:CSORET]2.0.CO;2; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Goek ON, 2012, AM J KIDNEY DIS, V60, P197, DOI 10.1053/j.ajkd.2012.01.014; Hadaczek P, 1998, CANCER RES, V58, P2946; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Liu SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041331; Liu YW, 2011, FRONT BIOSCI-LANDMRK, V16, P1302, DOI 10.2741/3790; Malliga DE, 2011, WIEN MED WOCHENSCHR, V161, P565, DOI 10.1007/s10354-011-0022-7; Mogensen Mette Sloth, 2012, Frontiers in Genetics, V3, P225, DOI 10.3389/fgene.2012.00225; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Muendlein A, 2012, CLIN CHIM ACTA, V413, P287, DOI 10.1016/j.cca.2011.10.008; Murata K, 2011, CLIN J AM SOC NEPHRO, V6, P1963, DOI 10.2215/CJN.02300311; Ndip A, 2014, DIABETOLOGIA; Okumura H, 2009, CANCER SCI, V100, P1145, DOI 10.1111/j.1349-7006.2009.01168.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebholz CM, 2014, NEPHROL DIAL TRANSPL; Rein P, 2014, AM J CARDIOL, V113, P215, DOI 10.1016/j.amjcard.2013.08.032; Rein P, 2010, ATHEROSCLEROSIS, V211, P348, DOI 10.1016/j.atherosclerosis.2010.02.031; Risch L, 2007, CLIN CHIM ACTA, V378, P71, DOI 10.1016/j.cca.2006.10.015; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saely CH, 2006, EUR J CLIN INVEST, V36, P91, DOI 10.1111/j.1365-2362.2006.01604.x; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SMEETS DFCM, 1986, HUM GENET, V72, P215, DOI 10.1007/BF00291880; Strefford JC, 2005, CANCER GENET CYTOGEN, V159, P1, DOI 10.1016/j.cancergencyto.2004.09.020; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z	42	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114240	10.1371/journal.pone.0114240	http://dx.doi.org/10.1371/journal.pone.0114240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478860	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200052
J	Alados, CL; Errea, P; Gartzia, M; Saiz, H; Escos, J				Alados, Concepcion L.; Errea, Paz; Gartzia, Maite; Saiz, Hugo; Escos, Juan			Positive and Negative Feedbacks and Free-Scale Pattern Distribution in Rural-Population Dynamics	PLOS ONE			English	Article							SPATIAL VEGETATION PATTERNS; LAND-USE CHANGE; CARRYING-CAPACITY; WORLD-POPULATION; DESERTIFICATION; CONSEQUENCES; DEPOPULATION; ABANDONMENT; DENSITY; HISTORY	Depopulation of rural areas is a widespread phenomenon that has occurred in most industrialized countries, and has contributed significantly to a reduction in the productivity of agro-ecological resources. In this study, we identified the main trends in the dynamics of rural populations in the Central Pyrenees in the 20th C and early 21st C, and used density independent and density dependent models and identified the main factors that have influenced the dynamics. In addition, we investigated the change in the power law distribution of population size in those periods. Populations exhibited density-dependent positive feedback between 1960 and 2010, and a long-term positive correlation between agricultural activity and population size, which has resulted in a free-scale population distribution that has been disrupted by the collapse of the traditional agricultural society and by emigration to the industrialized cities. We concluded that complex socio-ecological systems that have strong feedback mechanisms can contribute to disruptive population collapses, which can be identified by changes in the pattern of population distribution.	[Alados, Concepcion L.; Errea, Paz; Saiz, Hugo] CSIC, Pyrenean Inst Ecol, Zaragoza, Spain; [Gartzia, Maite] CSIC, Pyrenean Inst Ecol, Jaca, Huesca, Spain; [Escos, Juan] Univ Zaragoza, Dept Anim Prod & Food Technol, Huesca Polytech Sch, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Zaragoza	Alados, CL (corresponding author), CSIC, Pyrenean Inst Ecol, Zaragoza, Spain.	alados@ipe.csic.es	Escos, Juan/L-4207-2014; Errea, Maria Paz/K-5738-2014; Alados, Concepción L/K-8085-2014; Gartzia, Maite/L-5801-2014; Saiz, Hugo/K-8724-2014	Escos, Juan/0000-0003-2852-2911; Errea, Maria Paz/0000-0003-3346-1957; Alados, Concepción L/0000-0002-6227-861X; Saiz, Hugo/0000-0002-7568-2996	EU project FP7 [243857]	EU project FP7	The authors gratefully acknowledge the support of the EU project FP7-ENV 2009-1, Ref. 243857 `` Land and Ecosystem Degradation and Desertification: Assessing the Fit of Responses''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; ALADOS CL, 1985, Z TIERPSYCHOL, V68, P58; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Alados CL, MOUNTAIN RE IN PRESS; Allee W.C, 1931, ANIMAL AGGREGATION S; Altieri MA, 2011, AGROECOLOGICALLY EFF; Andre MF, 1998, AMBIO, V27, P351; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bauch CT, 2008, OIKOS, V117, P1824, DOI 10.1111/j.1600-0706.2008.17063.x; BEALE CL, 1964, DEMOGRAPHY, V1, P264, DOI 10.1007/BF03208467; Berryman A., 1999, PRINCIPLES POPULATIO; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Boserup Ester, 1981, POPULATION TECHNOLOG; Burnham K. P., 1998, MODEL SELECTION INFE; Clarke JI, 2002, BIOSOCIAL S, V14, P41, DOI 10.1017/CBO9780511542480.005; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; Colizza V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198701; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; DAUMAS M., 1976, VIE RURALE HAUT ARAG; Dullinger S, 2003, ARCT ANTARCT ALP RES, V35, P434, DOI 10.1657/1523-0430(2003)035[0434:POSIIH]2.0.CO;2; Galop D., 2011, PAGES (Past Global Changes) News, V19, P53; Galor O, 1999, AM ECON REV, V89, P150, DOI 10.1257/aer.89.2.150; GARCIARUIZ JM, 1990, MT RES DEV, V10, P267, DOI 10.2307/3673606; Gartzia M, 2014, PROGR PHYS GEOGRAPHY; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Gotelli N.J., 1998, PRIMER ECOLOGY; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P4765, DOI 10.1073/pnas.0611197104; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Haraldsson HV, 2006, SCI TOTAL ENVIRON, V372, P109, DOI 10.1016/j.scitotenv.2006.08.013; Headey DD, 2013, WORLD BANK ECON REV, V27, P1, DOI 10.1093/wber/lhs033; Heitschmidt R.K., 1991, GRAZING MANAGEMENT E, P161; Hill RA, 2008, BIOL LETTERS, V4, P748, DOI 10.1098/rsbl.2008.0393; Hoggart K, 2001, J RURAL STUD, V17, P63, DOI 10.1016/S0743-0167(00)00037-1; Hopfenberg R, 2003, POPUL ENVIRON, V25, P109, DOI 10.1023/B:POEN.0000015560.69479.c1; Huber R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05499-180336; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kelly RL, 2013, P NATL ACAD SCI USA, V110, P443, DOI 10.1073/pnas.1201341110; LAMONT BB, 1993, OECOLOGIA, V94, P446, DOI 10.1007/BF00317122; Lasanta T, 2010, CUAD INVESTIG GEOGR, V36, P145, DOI 10.18172/cig.1242; Lasanta-Martinez T, 2005, APPL GEOGR, V25, P47, DOI 10.1016/j.apgeog.2004.11.001; Liermann M, 2001, FISH FISH, V2, P33, DOI 10.1046/j.1467-2979.2001.00029.x; Lima M, 2011, OIKOS, V120, P1301, DOI 10.1111/j.1600-0706.2010.19112.x; Lin Y, 2010, LANDSCAPE ECOL, V25, P1519, DOI 10.1007/s10980-010-9520-z; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 2002, PHILOS T ROY SOC B, V357, P1197, DOI 10.1098/rstb.2002.1121; Lutz W, 2006, POPUL ENVIRON, V28, P69, DOI 10.1007/s11111-007-0037-6; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Malacarne LC, 2001, PHYS REV E, V65, P1, DOI DOI 10.1103/PHYSREVE.65.017106; Marin-Yaseli ML, 2003, MT RES DEV, V23, P169, DOI 10.1659/0276-4741(2003)023[0169:CFM]2.0.CO;2; Morris WF, 2002, QUANTITATIVE CONSERV; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Navarro V.P, 2002, ARAGON AGER, V2, P101; Pinheiro J., 2011, NLME LINEAR NONLINEA; Population Reference Bureau, 2008, WORLD POP CLOCK 2008; Price D, 1999, POPUL ENVIRON, V21, P5, DOI 10.1007/BF02436118; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; ROMANO B, 1995, MT RES DEV, V15, P121, DOI 10.2307/3673876; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shennan S, 2009, HUM BIOL, V81, P339, DOI 10.3378/027.081.0312; Sole R.V., 2006, SELF ORG COMPLEX SYS, P373; Turchin P, 2009, ANN NY ACAD SCI, V1162, P1, DOI 10.1111/j.1749-6632.2009.04447.x; Vicente-Serrano SM, 2004, ENVIRON MANAGE, V34, P802, DOI 10.1007/s00267-003-0022-5; Weerman EJ, 2012, ECOLOGY, V93, P608, DOI 10.1890/11-0625.1; West BJ, 2012, COMPLEX WORLDS UNCER; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zhang DD, 2011, GLOBAL ECOL BIOGEOGR, V20, P520, DOI 10.1111/j.1466-8238.2010.00625.x; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970; Zuur Alain F., 2009, P1	72	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114561	10.1371/journal.pone.0114561	http://dx.doi.org/10.1371/journal.pone.0114561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474704	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500047
J	Tam, WWS; Tang, JL; Di, MY; Tsoi, KKF				Tam, Wilson W. S.; Tang, Jin-Ling; Di, Meng-yang; Tsoi, Kelvin K. F.			How Often Does an Individual Trial Agree with Its Corresponding Meta-Analysis? A Meta-Epidemiologic Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS	Objective: A meta-analysis may provide more conclusive results than a single trial. The major cost of meta-analysis is the time of waiting before the meta-analysis becomes available and resources spent on consequent trials that may not be necessary. The objective of this study is to address how often the result of a single trial, in particular the first trial, differs from that of its corresponding meta-analysis so as to reduce unnecessary waiting time and subsequent trials. Study Design and Settings: A meta-epidemiologic study was conducted by collecting meta-analyses from the Cochrane Database of Systematic Reviews and five major medical journals. Effect size of a single trial was compared with that of its corresponding meta-analysis. The single trial includes the first trial, last trial and any trial randomly selected from the meta-analysis. Results: 647 meta-analyses are included and the median number of trials in a meta-analysis is 5.233 (36.0%) meta-analyses have the first trial with a statistically significant result. When the first trial is statistically significant, 84.1% (95% CI: 79.4%, 88.8%) of the corresponding meta-analyses is both in the same direction and statistically significant. When the first trial is statistically insignificant, 57.9% (95% CI: 53.2%, 62.8%) of the meta-analysis is also statistically insignificant regardless of direction. The median number of years is 6.5 years from the first to the 5th trial. Conclusion: The conclusion of the first trial that the treatment is effective or harmful is mostly likely correct. A statistically significant trial agrees more often with its corresponding meta-analysis than a large trial. These findings imply that particularly in some urgent, life-saving or other critical circumstances for which no other effective methods are available, cautious recommendation based on the significant result of the first trial seems justifiable and could start use of an effective intervention by 5-8 years earlier.	[Tam, Wilson W. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore; [Tang, Jin-Ling; Di, Meng-yang; Tsoi, Kelvin K. F.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Tang, Jin-Ling] Chinese Univ Hong Kong, Fac Med, Chinese Cochrane Ctr, Hong Kong Branch, Shatin, Hong Kong, Peoples R China; [Tang, Jin-Ling; Di, Meng-yang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Key Lab Hlth Risk Anal, Shenzhen, Peoples R China; [Tsoi, Kelvin K. F.] Chinese Univ Hong Kong, Big Data Decis Analyt Res Ctr, Shatin, Hong Kong, Peoples R China	National University of Singapore; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong	Tang, JL (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	jltang@cuhk.edu.hk	Tam, Wilson/K-1664-2019; TAM, Wilson W.S./H-5890-2019; Di, Mengyang/U-4847-2018	TAM, Wilson W.S./0000-0003-0641-3060; Di, Mengyang/0000-0001-6165-2617				ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Baum M, 1999, BRIT MED J, V319, P568, DOI 10.1136/bmj.319.7209.568; Borenstein M, 2009, INTRO METAANALYSIS, Vxxviii; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Furukawa TA, 2002, BMJ-BRIT MED J, V325, P991, DOI 10.1136/bmj.325.7371.991; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Hailey D, 2000, INT J TECHNOL ASSESS, V16, P651, DOI 10.1017/S0266462300101205; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P145, DOI 10.1016/j.jclinepi.2010.02.017; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000011.pub2:MR000011, DOI 10.1002/14651858.MR000011.PUB2:MR000011]; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; Kristensen SD, 2014, EUR J ANAESTH, V31, P517, DOI 10.1097/EJA.0000000000000150; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Luo XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052159; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Rennie D, 2009, JAMA-J AM MED ASSOC, V301, P1819, DOI 10.1001/jama.2009.559; *SAS I, 2004, SAS IML 9 1 US GUID; SPIEGEL D, 1983, PSYCHOSOM MED, V45, P333, DOI 10.1097/00006842-198308000-00007; Straus SE, 2005, EVIDENCE BASED MED P; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tetreault L, 1966, Union Med Can, V95, P546; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113994	10.1371/journal.pone.0113994	http://dx.doi.org/10.1371/journal.pone.0113994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474198	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500102
J	Wiman, NG; Walton, VM; Shearer, PW; Rondon, SI				Wiman, Nik G.; Walton, Vaughn M.; Shearer, Peter W.; Rondon, Silvia I.			Electronically Monitored Labial Dabbing and Stylet 'Probing' Behaviors of Brown Marmorated Stink Bug, Halyomorpha halys, in Simulated Environments	PLOS ONE			English	Article							HILARIS HEMIPTERA-PENTATOMIDAE; FEEDING-ACTIVITY; HOMALODISCA-COAGULATA; HETEROPTERA; DAMAGE; PENETRATION; DURATION; GROWTH; TEMPERATURE; MORPHOLOGY	Brown marmorated stink bug, Halyomorpha halys (Stal), (Hemiptera: Pentatomidae) is an invasive polyphagous agricultural and urban nuisance pest of Asian origin that is becoming widespread in North America and Europe. Despite the economic importance of pentatomid pests worldwide, their feeding behavior is poorly understood. Electronically monitored insect feeding (EMIF) technology is a useful tool in studies of feeding behavior of Hemiptera. Here we examined H. halys feeding behavior using an EMIF system designed for high throughput studies in environmental chambers. Our objectives were to quantify feeding activity by monitoring proboscis contacts with green beans, including labial dabbing and stylet penetration of the beans, which we collectively define as 'probes'. We examined frequency and duration of 'probes' in field-collected H. halys over 48 hours and we determined how environmental conditions could affect diel and seasonal periodicity of ` probing' activity. We found differences in 'probing' activity between months when the assays were conducted. These differences in activity may have reflected different environmental conditions, and they also coincide with what is known about the phenology of H. halys. While a substantial number of ` probes' occurred during scotophase, including some of the longest mean 'probe' durations, activity was either lower or similar to '[probing' activity levels during photophase on average. We found that temperature had a significant impact on H. halys probing' behavior and may influence periodicity of activity. Our data suggest that the minimal temperature at which 'probing' of H. halys occurs is between 3.5 and 6.1 degrees C (95% CI), and that ` probing' does not occur at temperatures above 26.5 to 29.6 degrees C (95% CI). We estimated that the optimal temperature for ` probing' is between 16 and 17 degrees C.	[Wiman, Nik G.; Walton, Vaughn M.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Shearer, Peter W.] Oregon State Univ, Mid Columbia Agr Res & Extens Ctr, Hood River, OR 97031 USA; [Rondon, Silvia I.] Oregon State Univ, Hermiston Agr Res & Extens Ctr, Hermiston, OR USA	Oregon State University; Oregon State University; Oregon State University	Wiman, NG (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	nik.wiman@oregonstate.edu	Wiman, Nik/J-4998-2019; Rondon, Silvia I./A-7033-2011; Rondon, Silvia I/AAC-4676-2021	Wiman, Nik/0000-0003-0890-5050; Rondon, Silvia I./0000-0002-7819-6934; 	USDA-NIFA Specialty Crops Research Initiative Award [201151181-30937]	USDA-NIFA Specialty Crops Research Initiative Award	Work supported by USDA-NIFA Specialty Crops Research Initiative Award 201151181-30937 (http://www.nifa.usda. gov/fo/specialtycropresearchinitiative.cfm) with funding going to VW, PS, and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APRIYANTO D, 1989, J KANSAS ENTOMOL SOC, V62, P392; Backus E.A., 1985, P163; Backus EA, 2005, ANN ENTOMOL SOC AM, V98, P787, DOI 10.1603/0013-8746(2005)098[0787:SPBAHC]2.0.CO;2; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Backus Elaine A., 2000, P1; Baptist BA, 1941, Q J MICROSC SCI, V83, P91; Boethel DJ, 2000, J ECON ENTOMOL, V93, P707, DOI 10.1603/0022-0493-93.3.707; BOWLING CC, 1979, J ECON ENTOMOL, V72, P259, DOI 10.1093/jee/72.2.259; BOWLING CC, 1980, J ECON ENTOMOL, V73, P1, DOI 10.1093/jee/73.1.1; Brown MW, 2003, J AGR URBAN ENTOMOL, V20, P193; Bundy CS, 2012, SOUTHWEST ENTOMOL, V37, P411, DOI 10.3958/059.037.0317; *CABI, 2014, HAL HAL BROWN MARM S; CERVANTES F, 2014, P HEM PLANT INT S, P40; Chapman R.F., 1998, INSECTS STRUCTURE FU; Chesley LC, 1934, BIOL BULL-US, V66, P330, DOI 10.2307/1537386; COBBEN R H, 1978, Mededelingen Landbouwhogeschool Wageningen, V78, P5; COHEN AC, 1993, J INSECT PHYSIOL, V39, P823, DOI 10.1016/0022-1910(93)90114-7; COOP L, IPPC SYNTHESIS ANAL; Corpuz L. R., 1969, Philippine Entomologist, V1, P225; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Esquivel JF, 2010, SOUTHWEST ENTOMOL, V35, P457, DOI 10.3958/059.035.0332; HAYE T, 2014, J PEST SCI, V87, P1, DOI DOI 10.1007/S10340-014-0560-Z.; Hedstrom CS., 2014, THESIS OREGON STATE; HOLLAY ME, 1987, ANN ENTOMOL SOC AM, V80, P212, DOI 10.1093/aesa/80.2.212; Hori K, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P11; HORI K, 1975, COMP BIOCHEM PHYSIOL, V50, P145, DOI 10.1016/0305-0491(75)90314-4; Huang TI, 2014, ARTHROPOD-PLANT INTE, V8, P89, DOI 10.1007/s11829-014-9289-0; Huang TI, 2013, J ECON ENTOMOL, V106, P1726, DOI 10.1603/EC13048; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; KASHIN P, 1966, J INSECT PHYSIOL, V12, P281, DOI 10.1016/0022-1910(66)90143-0; KASHIN P, 1965, NATURE, V208, P462, DOI 10.1038/208462a0; KESTER KM, 1984, ENTOMOL EXP APPL, V35, P75, DOI 10.1007/BF00343462; Krupke CH, 2006, ANN ENTOMOL SOC AM, V99, P169, DOI 10.1603/0013-8746(2006)099[0169:DPOECH]2.0.CO;2; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; LESKEY TC, 2012, PSYCHE STUTTG, V2012; LOCKWOOD JA, 1986, J ENTOMOL SCI, V21, P175, DOI 10.18474/0749-8004-21.2.175; LYE BH, 1988, J ECON ENTOMOL, V81, P189, DOI 10.1093/jee/81.1.189; MADHUSUDHAN VV, 1994, ANN APPL BIOL, V124, P405, DOI 10.1111/j.1744-7348.1994.tb04146.x; Martinson HM, 2013, ANN ENTOMOL SOC AM, V106, P47, DOI 10.1603/AN12088; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; McPherson JE., 2000, FLA ENTOMOL; Medrano EG, 2011, SOUTHWEST ENTOMOL, V36, P233, DOI 10.3958/059.036.0302; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; MILES PW, 1969, ENTOMOL EXP APPL, V12, P736, DOI 10.1007/BF00297100; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; *NAT INSTR, 2009, DAQ M SER NI USB 621; *NAT INSTR, 2009, NI USB 621X SPEC; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2011, ENVIRON ENTOMOL, V40, P231, DOI 10.1603/EN10187; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; PALUMBO JC, 2010, PLANT HLTH PROG; PANIZZI A, 2000, STINK BUGS PENTATOMI; Panizzi Antonio, 1995, Anais da Sociedade Entomologica do Brasil, V24, P437; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; R Core Team, 2021, R LANGUAGE ENV STAT; Ruberson JR, 2013, APPL ENTOMOL ZOOL, V48, P3, DOI 10.1007/s13355-012-0146-2; RYAN JA, 2012, XTS EXTENSIBLE TIME; SEVACHERIAN V, 1975, ANN ENTOMOL SOC AM, V68, P557, DOI 10.1093/aesa/68.3.557; Shearer PW, 1996, ENVIRON ENTOMOL, V25, P599, DOI 10.1093/ee/25.3.599; SHEARER PW, 2014, PACIFIC NW INSECT MA; SIMMONS AM, 1988, J ECON ENTOMOL, V81, P812, DOI 10.1093/jee/81.3.812; Son Y, 2012, ENVIRON ENTOMOL, V41, P1215, DOI 10.1603/EN11319; Suiter DR, 2010, J INTEGR PEST MANAG, V1, DOI 10.1603/IPM10009; Tjallingii W.F., 1988, P95; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; WALKER GP, 2000, P S 19 INT C ENT BEI; Watanabe Mamoru, 1994, Japanese Journal of Sanitary Zoology, V45, P311; Williams L, 2005, ARCH INSECT BIOCHEM, V58, P84, DOI 10.1002/arch.20035; Wiman NG, 2015, J PEST SCI, V88, P37, DOI 10.1007/s10340-014-0582-6; WOODSIDE AM, 1950, B VA AGR EXP STN, V435; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	78	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113514	10.1371/journal.pone.0113514	http://dx.doi.org/10.1371/journal.pone.0113514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474148	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500083
J	Parra, ES; Panzoldo, NB; Zago, VHD; Scherrer, DZ; Alexandre, F; Bakkarat, J; Nunes, VS; Nakandakare, ER; Quintao, ECR; Nadruz, W; de Faria, EC; Sposito, AC				Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; Nunes, Valeria Sutti; Nakandakare, Edna Regina; Rocha Quintao, Eder Carlos; Nadruz-, Wilson, Jr.; de Faria, Eliana Cotta; Sposito, Andrei C.			HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LIPOPROTEIN; MASS; SUBCLASSES; EFFLUX	Background: Misclassification of patients as low cardiovascular risk (LCR) remains a major concern and challenges the efficacy of traditional risk markers. Due to its strong association with cholesterol acceptor capacity, high-density lipoprotein (HDL) size has been appointed as a potential risk marker. Hence, we investigate whether HDL size improves the predictive value of HDL-cholesterol in the identification of carotid atherosclerotic burden in individuals stratified to be at LCR. Methods and Findings: 284 individuals (40-75 years) classified as LCR by the current US guidelines were selected in a three-step procedure from primary care centers of the cities of Campinas and Americana, SP, Brazil. Apolipoprotein B-containing lipoproteins were precipitated by polyethylene glycol and HDL size was measured by dynamic light scattering (DLS) technique. Participants were classified in tertiles of HDL size (<7.57; 7.57-8.22; >8.22 nm). Carotid intima-media thickness (cIMT) <0.90 mm (80th percentile) was determined by high resolution ultrasonography and multivariate ordinal regression models were used to assess the association between cIMT across HDL size and levels of lipid parameters. HDLcholesterol was not associated with cIMT. In contrast, HDL size >8.22 nm was independently associated with low cIMT in either unadjusted and adjusted models for age, gender and Homeostasis Model Assessment 2 index for insulin sensitivity, ethnicity and body mass index (Odds ratio 0.23; 95% confidence interval 0.07-0.74, p=0.013). Conclusion: The mean HDL size estimated with DLS constitutes a better predictor for subclinical carotid atherosclerosis than the conventional measurements of plasma HDL-cholesterol in individuals classified as LCR.	[Parra, Eliane Soler; Panzoldo, Natalia Baratella; Nadruz-, Wilson, Jr.; Sposito, Andrei C.] Univ Estadual Campinas, Fac Med Sci, Dept Cardiol, Campinas, SP, Brazil; [Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; de Faria, Eliana Cotta] Univ Estadual Campinas, Dept Clin Pathol, Fac Med Sci, Lipid Lab, Campinas, SP, Brazil; [Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; de Faria, Eliana Cotta] Univ Estadual Campinas, Ctr Med & Expt Surg, Fac Med Sci, Campinas, SP, Brazil; [Nunes, Valeria Sutti; Nakandakare, Edna Regina; Rocha Quintao, Eder Carlos] Univ Sao Paulo, Lipid Lab, Fac Med Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Sposito, AC (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Cardiol, Campinas, SP, Brazil.	andreisposito@gmail.com	Sposito, Andrei C/G-4116-2013; Nakandakare, Edna R/D-6625-2012; Nadruz, Wilson/I-3643-2013; Nunes, Valeria S./G-4778-2012; Zago, V/C-3497-2015	Sposito, Andrei C/0000-0001-7127-2052; Nadruz, Wilson/0000-0002-0003-5102; Nunes, Valeria S./0000-0002-6769-5412; Zago, V/0000-0003-2488-0199; Cotta de Faria, Eliana/0000-0002-5208-1274; Quintao, Eder/0000-0001-9810-3259	Brazilian National Research Council (CNPq); State of Sao Paulo Research Foundation (Fapesp) [2006/60585-9, 2011/16476-9]; CNPq [143384/2011-2]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ACS and WN were supported by a fellowship grant of productivity in research from the Brazilian National Research Council (CNPq). This work was supported by the State of Sao Paulo Research Foundation (Fapesp), grant numbers 2006/60585-9 and 2011/16476-9, and by the CNPq, grant number 143384/2011-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung MC, 2009, BBA-MOL CELL BIOL L, V1791, P206, DOI 10.1016/j.bbalip.2008.12.010; Chisholm JW, 1999, J LIPID RES, V40, P1512; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P304, DOI 10.1097/HJR.0b013e3283213140; de Beer MC, 2001, J LIPID RES, V42, P309; de Vries Rindert, 2003, Clin Lab, V49, P601; de Vries R, 2011, ATHEROSCLEROSIS, V217, P253, DOI 10.1016/j.atherosclerosis.2011.03.021; DIAS VC, 1988, CLIN CHEM, V34, P2322; DOBIASOVA M, 1992, J LIPID RES, V33, P1411; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Ehnholm C, 1986, Methods Enzymol, V129, P716; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Jarauta E, 2012, NUTR METAB CARDIOVAS, V22, P591, DOI 10.1016/j.numecd.2010.10.011; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kleemola P, 2002, ATHEROSCLEROSIS, V160, P425, DOI 10.1016/S0021-9150(01)00594-9; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lagrost L, 1998, Methods Mol Biol, V110, P231; Lee JY, 2007, J LIPID RES, V48, P1052, DOI 10.1194/jlr.M600417-JLR200; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Lima ES, 2004, CLIN CHEM, V50, P1086, DOI 10.1373/clinchem.2004.032383; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Oka T, 2002, J LIPID RES, V43, P1236, DOI 10.1194/jlr.M100349-JLR200; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Silbernagel G, 2013, EUR HEART J, V34, P3563, DOI 10.1093/eurheartj/eht343; Sposito AC, 2011, ATHEROSCLEROSIS, V214, P148, DOI 10.1016/j.atherosclerosis.2010.10.034; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114212	10.1371/journal.pone.0114212	http://dx.doi.org/10.1371/journal.pone.0114212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470778	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700086
J	Apthorp, D; Nagle, F; Palmisano, S				Apthorp, Deborah; Nagle, Fintan; Palmisano, Stephen			Chaos in Balance: Non-Linear Measures of Postural Control Predict Individual Variations in Visual Illusions of Motion	PLOS ONE			English	Article							RECURRENCE QUANTIFICATION ANALYSIS; DETRENDED FLUCTUATION ANALYSIS; SENSORIMOTOR INTEGRATION; CORTICAL AREA; SELF-MOTION; OPTIC FLOW; SWAY; PRESSURE; STANCE; EEG	Visually-induced illusions of self-motion (vection) can be compelling for some people, but they are subject to large individual variations in strength. Do these variations depend, at least in part, on the extent to which people rely on vision to maintain their postural stability? We investigated by comparing physical posture measures to subjective vection ratings. Using a Bertec balance plate in a brightly-lit room, we measured 13 participants' excursions of the centre of foot pressure (CoP) over a 60-second period with eyes open and with eyes closed during quiet stance. Subsequently, we collected vection strength ratings for large optic flow displays while seated, using both verbal ratings and online throttle measures. We also collected measures of postural sway (changes in anterior-posterior CoP) in response to the same visual motion stimuli while standing on the plate. The magnitude of standing sway in response to expanding optic flow (in comparison to blank fixation periods) was predictive of both verbal and throttle measures for seated vection. In addition, the ratio between eyes-open and eyes-closed CoP excursions during quiet stance (using the area of postural sway) significantly predicted seated vection for both measures. Interestingly, these relationships were weaker for contracting optic flow displays, though these produced both stronger vection and more sway. Next we used a non-linear analysis (recurrence quantification analysis, RQA) of the fluctuations in anterior-posterior position during quiet stance (both with eyes closed and eyes open); this was a much stronger predictor of seated vection for both expanding and contracting stimuli. Given the complex multisensory integration involved in postural control, our study adds to the growing evidence that non-linear measures drawn from complexity theory may provide a more informative measure of postural sway than the conventional linear measures.	[Apthorp, Deborah] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Psychol, Canberra, ACT, Australia; [Apthorp, Deborah; Palmisano, Stephen] Univ Wollongong, Fac Social Sci, Sch Psychol, Wollongong, NSW, Australia; [Nagle, Fintan] UCL, Ctr Math Phys & Engn Life Sci & Expt Biol, London, England	Australian National University; University of Wollongong; University of London; University College London	Apthorp, D (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Psychol, Canberra, ACT, Australia.	deborah.apthorp@anu.edu.au	Palmisano, Stephen/O-1553-2018; Apthorp, Deborah/N-5623-2014	Palmisano, Stephen/0000-0002-9140-5681; Apthorp, Deborah/0000-0001-5785-024X	Australian Research Council [DP0772398]	Australian Research Council(Australian Research Council)	Funding provided to SP: Australian Research Council Grant no. DP0772398 - http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Becker K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008876; Berthoz A, 1975, EXPT BRAIN RES, V23; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cardin V, 2010, CEREB CORTEX, V20, P1964, DOI 10.1093/cercor/bhp268; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Doyle TL, 2005, ARCH PHYS MED REHAB, V86, P2034, DOI 10.1016/j.apmr.2005.05.014; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Hamadene W, 2005, CAN C EL COMP ENG, V2005, P354; Hasson CJ, 2008, GAIT POSTURE, V27, P416, DOI 10.1016/j.gaitpost.2007.05.010; Huang LY, 2006, LECT NOTES COMPUT SC, V4234, P58; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kim G, 2009, AM J BIOMEDICAL SCI, P364; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Kuno S, 1999, JPN J PHYSIOL, V49, P417, DOI 10.2170/jjphysiol.49.417; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Masson G, 1995, EXPT BRAIN RES, V103; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mazaheri M, 2010, MED ENG PHYS, V32, P808, DOI 10.1016/j.medengphy.2010.04.019; Mesin L, 2014, J CLIN MONIT COMPUT, V28, P377, DOI 10.1007/s10877-013-9544-4; Mitchell SL, 1995, NEUROSCIENCE; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Negahban H, 2010, GAIT POSTURE, V31, P450, DOI 10.1016/j.gaitpost.2010.01.020; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Palm S., 2014, EUSAR 2014 10 EUR C, P1; Palmisano S, 2009, PERCEPTION, V38, P442, DOI 10.1068/p6159; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060241; Ramdani S, 2013, ANN BIOMED ENG, V41, P1713, DOI 10.1007/s10439-013-0790-x; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Riley MA, 2003, NEUROSCIENCE LETT; RONNQVIST L, 1995, NEUROPSYCHOLOGIA, V33, P713, DOI 10.1016/0028-3932(95)00006-O; Schinkel S, 2009, J PHYSIOLOGY-PARIS, V103, P315, DOI 10.1016/j.jphysparis.2009.05.007; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Seno T, 2013, PERCEPTION, V42, P173; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Smith AT, 2011, J VISION, V11, P740; Talebi N, 2010, LECT NOTES ARTIF INT, V6334, P124, DOI 10.1007/978-3-642-15314-3_12; Tallon G, 2013, GAIT POSTURE, V38, P92, DOI 10.1016/j.gaitpost.2012.10.021; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Trulla LL, 1996, PHYS LETT A, V223, P255, DOI 10.1016/S0375-9601(96)00741-4; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; Wei KL, 2010, J VISION, V10, DOI 10.1167/10.14.4; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zhu TQ, 2008, LECT NOTES COMPUT SC, V5226, P438	67	14	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113897	10.1371/journal.pone.0113897	http://dx.doi.org/10.1371/journal.pone.0113897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462216	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700065
J	Asmat, TM; Tenenbaum, T; Jonsson, AB; Schwerk, C; Schroten, H				Asmat, Tauseef M.; Tenenbaum, Tobias; Jonsson, Ann-Beth; Schwerk, Christian; Schroten, Horst			Impact of Calcium Signaling during Infection of Neisseria meningitidis to Human Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							PILUS-MEDIATED ADHERENCE; EPITHELIAL-CELLS; ESCHERICHIA-COLI; IV PILI; LISTERIA-MONOCYTOGENES; BINDING-PROTEIN; INVASION; CD46; GONORRHOEAE; BIOGENESIS	The pili and outer membrane proteins of Neisseria meningitidis (meningococci) facilitate bacterial adhesion and invasion into host cells. In this context expression of meningococcal PilC1 protein has been reported to play a crucial role. Intracellular calcium mobilization has been implicated as an important signaling event during internalization of several bacterial pathogens. Here we employed time lapse calcium-imaging and demonstrated that PilC1 of meningococci triggered a significant increase in cytoplasmic calcium in human brain microvascular endothelial cells, whereas PilC1-deficient meningococci could not initiate this signaling process. The increase in cytosolic calcium in response to PilC1-expressing meningococci was due to efflux of calcium from host intracellular stores as demonstrated by using 2-APB, which inhibits the release of calcium from the endoplasmic reticulum. Moreover, pre-treatment of host cells with U73122 (phospholipase C inhibitor) abolished the cytosolic calcium increase caused by PilC1-expressing meningococci demonstrating that active phospholipase C (PLC) is required to induce calcium transients in host cells. Furthermore, the role of cytosolic calcium on meningococcal adherence and internalization was documented by gentamicin protection assay and double immunofluorescence (DIF) staining. Results indicated that chelation of intracellular calcium by using BAPTA-AM significantly impaired PilC1-mediated meningococcal adherence to and invasion into host endothelial cells. However, buffering of extracellular calcium by BAPTA or EGTA demonstrated no significant effect on meningococcal adherence to and invasion into host cells. Taken together, these results indicate that meningococci induce calcium release from intracellular stores of host endothelial cells via PilC1 and cytoplasmic calcium concentrations play a critical role during PilC1 mediated meningococcal adherence to and subsequent invasion into host endothelial cells.	[Asmat, Tauseef M.; Tenenbaum, Tobias; Schwerk, Christian; Schroten, Horst] Heidelberg Univ, Dept Pediat, Med Fac Mannheim, Mannheim, Germany; [Jonsson, Ann-Beth] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Ruprecht Karls University Heidelberg; Stockholm University	Asmat, TM (corresponding author), Heidelberg Univ, Dept Pediat, Med Fac Mannheim, Mannheim, Germany.	tauseef.asmat@medma.uni-heidelberg.de	Schwerk, Christian/GNP-5375-2022; Asmat, Tauseef M/Q-3801-2019					Appleby PA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0487; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cheng Y, 2013, INFECT IMMUN, V81, P4280, DOI 10.1128/IAI.00493-13; Coureuil M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012393; Coureuil M, 2012, VIRULENCE, V3, P164, DOI 10.4161/viru.18639; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gill DB, 2004, TRENDS MOL MED, V10, P459, DOI 10.1016/j.molmed.2004.07.002; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Johnson M., 2011, Proceedings 2011 International Symposium on Network Coding (NetCod 2011), DOI 10.1109/ISNETCOD.2011.5978948; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; JONSSON AB, 1995, MICROBIOL-SGM, V141, P2367, DOI 10.1099/13500872-141-10-2367; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Ko Y, 2011, MICROB PATHOGENESIS, V50, P326, DOI 10.1016/j.micpath.2011.02.007; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Lindqvist SM, 1998, GASTROENTEROLOGY, V115, P1131, DOI 10.1016/S0016-5085(98)70084-8; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Maiden MCJ, 2012, VACCINE, V30, pB52, DOI 10.1016/j.vaccine.2011.12.068; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Nagata K, 1992, Nihon Rinsho, V50, P223; Nikulin J, 2006, INT J MED MICROBIOL, V296, P553, DOI 10.1016/j.ijmm.2006.06.006; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Porsch EA, 2013, J BACTERIOL, V195, P886, DOI 10.1128/JB.02186-12; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Shah Sanket, 2013, WMJ, V112, P28; Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Son SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.129; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Verkhratsky A, 2004, BIOL RES, V37, P693; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Zeerleder S, 2012, CRIT CARE MED, V40, P3224, DOI 10.1097/CCM.0b013e318265695f; Zhao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075652	69	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114474	10.1371/journal.pone.0114474	http://dx.doi.org/10.1371/journal.pone.0114474			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464500	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700133
J	Esteva, MJ; Affranchino, JL; Gonzalez, SA				Esteva, Maria J.; Affranchino, Jose L.; Gonzalez, Silvia A.			Lentiviral Gag Assembly Analyzed through the Functional Characterization of Chimeric Simian Immunodeficiency Viruses Expressing Different Domains of the Feline Immunodeficiency Virus Capsid Protein	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN INCORPORATION; NUCLEAR IMPORT; INTERSUBUNIT INTERACTIONS; CYTOPLASMIC DOMAIN; PARTICLE FORMATION; FUSION ACTIVITY; MATRIX PROTEIN; TYPE-1 CORE; N-TERMINUS; ORF-A	To gain insight into the functional relationship between the capsid (CA) domains of the Gag polyproteins of simian and feline immunodeficiency viruses (SIV and FIV, respectively), we constructed chimeric SIVs in which the CA-coding region was partially or totally replaced by the equivalent region of the FIV CA. The phenotypic characterization of the chimeras allowed us to group them into three categories: the chimeric viruses that, while being assembly-competent, exhibit a virion-associated unstable FIV CA; a second group represented only by the chimeric SIV carrying the N-terminal domain (NTD) of the FIV CA which proved to be assembly-defective; and a third group constituted by the chimeric viruses that produce virions exhibiting a mature and stable FIV CA protein, and which incorporate the envelope glycoprotein and contain wild-type levels of viral genome RNA and reverse transcriptase. Further analysis of the latter group of chimeric SIVs demonstrated that they are non-infectious due to a post-entry impairment, such as uncoating of the viral core, reverse transcription or nuclear import of the preintegration complex. Furthermore, we show here that the carboxyl-terminus domain (CTD) of the FIV CA has an intrinsic ability to dimerize in vitro and form high-molecular-weight oligomers, which, together with our finding that the FIV CA-CTD is sufficient to confer assembly competence to the resulting chimeric SIV Gag polyprotein, provides evidence that the CA-CTD exhibits more functional plasticity than the CA-NTD. Taken together, our results provide relevant information on the biological relationship between the CA proteins of primate and nonprimate lentiviruses.	[Gonzalez, Silvia A.] Univ Belgrano, Virol Lab, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, SA (corresponding author), Univ Belgrano, Virol Lab, Buenos Aires, DF, Argentina.	silvia.gonzalez@comunidad.ub.edu.ar		Gonzalez, Silvia Adriana/0000-0001-8744-0874; Affranchino, Jose/0000-0002-1287-9636	National Research Council of Argentina (CONICET) [PIP 0600]; Fundacion Universidad de Belgrano (UB)	National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Universidad de Belgrano (UB)	This work was supported by the National Research Council of Argentina (CONICET) Grant PIP 0600 and Fundacion Universidad de Belgrano (UB) to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerfoglio JCA, 2014, J GEN VIROL, V95, P2050, DOI 10.1099/vir.0.065151-0; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Affranchino JL, 2014, VIRUSES-BASEL, V6, P264, DOI 10.3390/v6010264; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cara A, 2004, VIROLOGY, V324, P531, DOI 10.1016/j.virol.2004.04.006; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Celma CCP, 2004, AIDS RES HUM RETROV, V20, P733, DOI 10.1089/0889222041524580; Celma CCP, 2007, VIROLOGY, V366, P405, DOI 10.1016/j.virol.2007.05.019; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; DELCHAMBRE M, 1989, EMBO J, V8, P2653, DOI 10.1002/j.1460-2075.1989.tb08405.x; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Edinger AL, 1997, P NATL ACAD SCI USA, V94, P4005, DOI 10.1073/pnas.94.8.4005; Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Frey SCS, 2001, J VIROL, V75, P5433, DOI 10.1128/JVI.75.11.5433-5440.2001; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gemeniano MC, 2004, VIROLOGY, V325, P167, DOI 10.1016/j.virol.2004.05.007; Gemeniano MC, 2003, J VIROL, V77, P8819, DOI 10.1128/JVI.77.16.8819-8830.2003; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gonzalez SA, 1998, VIROLOGY, V240, P27, DOI 10.1006/viro.1997.8919; Gonzalez SA, 2012, VIROLOGY, V428, P1, DOI 10.1016/j.virol.2012.03.005; Huseby D, 2005, J BIOL CHEM, V280, P17664, DOI 10.1074/jbc.M412325200; Kahl CA, 2008, GENE THER, V15, P1079, DOI 10.1038/gt.2008.50; KLIKOVA M, 1995, J VIROL, V69, P1093, DOI 10.1128/JVI.69.2.1093-1098.1995; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Lee SK, 2009, J VIROL, V83, P8536, DOI 10.1128/JVI.00317-09; Luttge BG, 2008, J VIROL, V82, P2106, DOI 10.1128/JVI.02337-07; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Manrique JM, 2003, J VIROL, V77, P10881, DOI 10.1128/JVI.77.20.10881-10888.2003; Manrique JM, 2008, VIROLOGY, V374, P273, DOI 10.1016/j.virol.2008.01.015; Manrique ML, 2004, VIROLOGY, V327, P83, DOI 10.1016/j.virol.2004.06.019; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Rauddi ML, 2011, AIDS RES HUM RETROV, V27, P303, DOI 10.1089/aid.2010.0137; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Sanz-Ramos M, 2013, J GEN VIROL, V94, P2587, DOI 10.1099/vir.0.058180-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scholz I, 2005, J VIROL, V79, P1470, DOI 10.1128/JVI.79.3.1470-1479.2005; Serriere J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056424; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Sloan RD, 2011, ROLE UNINTEGRATED DN, V8, P52; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yufenyuy EL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-29; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	84	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114299	10.1371/journal.pone.0114299	http://dx.doi.org/10.1371/journal.pone.0114299			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462889	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700127
J	Ma, CH; Yang, L; Li, W; Yue, JQ; Li, J; Zu, YG				Ma, Chunhui; Yang, Lei; Li, Wei; Yue, Jinquan; Li, Jian; Zu, Yuangang			Ultrasound-Assisted Extraction of Arabinogalactan and Dihydroquercetin Simultaneously from Larix gmelinii as a Pretreatment for Pulping and Papermaking	PLOS ONE			English	Article							FLAVONOIDS; TAXIFOLIN	An ultrasound-assisted extraction (UAE) method using ethanol was applied for extracting arabinogalactan (AG) and dihydroquercetin (DHQ) simultaneously from larch wood, as a pretreatment for pulping and papermaking. The extraction parameters were optimized by a Box-Behnken experimental design with the yields of AG and DHQ as the response values. Under optimum conditions (three extractions, each using 40% ethanol, for 50 min, 200 W ultrasound power and 1: 18 solid-liquid ratio), the yields of AG and DHQ were 183.4 and 36.76 mg/g, respectively. After UAE pretreated, the wood chips were used for Kraft pulping (KP) and high boiling solvent pulping (HBSP). The pulping yield after pretreatment was higher than that of untreated (the pulping yields of untreated HBSP and KP were 42.37% and 39.60%, and the pulping yields of HBSP and KP after UAE-pretreated were 44.23% and 41.50% respectively), as indicated by a lower kappa number (77.91 and 27.30 for untreated HBSP and KP; 77.01 and 26.83 for UAE-pretreated HBSP and KP). Furthermore, the characteristics of paper produced from pretreated wood chips were superior to those from the untreated chips: the basis weight was lower (85.67 and 82.48 g.cm(-2) for paper from untreated KP and HBSP; 79.94 and 80.25 g.cm(-2) for paper from UAE-pretreated KP and HBSP), and the tensile strengths, tearing strengths, bursting strengths, and folding strengths were higher than these of paper after UAE-pretreated, respectively.	[Ma, Chunhui; Li, Wei; Yue, Jinquan; Li, Jian] Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin 150040, Peoples R China; [Ma, Chunhui; Yang, Lei; Zu, Yuangang] Northeast Forestry Univ, Key Lab Forest Plant Ecol, Minist Educ, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Li, J (corresponding author), Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin 150040, Peoples R China.	nefulijian@163.com; zygorl@163.com			National Natural Science Foundation of China [31470612]; Fundamental Research Funds for the Central Universities [2572014EB01]; Hei Long Jiang Postdoctoral Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hei Long Jiang Postdoctoral Foundation	This study was funded by the National Natural Science Foundation of China (31470612), Fundamental Research Funds for the Central Universities (2572014EB01), and the Hei Long Jiang Postdoctoral Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2008, PHYTOTHER RES, V22, P1200, DOI 10.1002/ptr.2435; Chen S, 1989, T CHINA PULP PAPER, V4, P61; Chen W, 2012, CARBOHYD POLYM, V87, P614, DOI 10.1016/j.carbpol.2011.08.029; CHU SC, 1992, J NAT PROD, V55, P179, DOI 10.1021/np50080a005; Currier NL, 2003, PHYTOMEDICINE, V10, P145, DOI 10.1078/094471103321659852; Domini C, 2009, ULTRASON SONOCHEM, V16, P564, DOI 10.1016/j.ultsonch.2008.12.006; Gernandt DS, 1999, AM J BOT, V86, P711, DOI 10.2307/2656581; Goellner EM, 2011, CARBOHYD POLYM, V86, P1739, DOI 10.1016/j.carbpol.2011.07.006; Groman EV, 1997, CARBOHYD RES, V301, P69, DOI 10.1016/S0008-6215(97)00077-3; Gros-Louis MC, 2005, TREE GENET GENOMES, V1, P50, DOI 10.1007/s11295-005-0007-z; Hu Y, 2008, CHEM ENG PROCESS, V47, P2256, DOI 10.1016/j.cep.2007.12.013; Iida Y, 2008, INNOV FOOD SCI EMERG, V9, P140, DOI 10.1016/j.ifset.2007.03.029; Josephson L, US Patent, Patent No. [5.336.506, 5336506]; Kawaii S, 1999, ANTICANCER RES, V19, P1261; Li Z, 2012, CHINA PULP PAPER, V31, P6; Liu TT, 2012, IND CROP PROD, V36, P47, DOI 10.1016/j.indcrop.2011.08.004; Ma CH, 2012, CHEM ENG PROCESS, V57-58, P59, DOI 10.1016/j.cep.2012.03.008; Ma CH, 2011, ANAL CHIM ACTA, V689, P110, DOI 10.1016/j.aca.2011.01.012; Marett R, 2004, J AM DIET ASSOC, V104, P636, DOI 10.1016/j.jada.2004.01.017; Maroziene A, 2000, CANCER LETT, V157, P39, DOI 10.1016/S0304-3835(00)00469-9; Ostroukhova EN, 2003, CHEM PLANT STOCK, V1, P27; Peng JY, 2006, J CHROMATOGR A, V1102, P44, DOI 10.1016/j.chroma.2005.10.045; Pietarinen SP, 2006, J WOOD CHEM TECHNOL, V26, P245, DOI 10.1080/02773810601023487; Schinor EC, 2004, ULTRASON SONOCHEM, V11, P415, DOI 10.1016/j.ultsonch.2003.09.005; Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7; Svetlana AM, 2002, CHEM COMPUTATIONAL S, V2, P47; Trouillas P, 2004, FOOD CHEM, V88, P571, DOI 10.1016/j.foodchem.2004.02.009; Wang Y, 2011, FOOD CHEM, V126, P1178, DOI 10.1016/j.foodchem.2010.11.155; Zhang J, 2001, J CELLULOSE SCI TECH, V9, P16, DOI DOI 10.3969/J.ISSN.1004-8405.2001.04.003; Zu G, 2012, INT J MOL SCI, V13, P11027, DOI 10.3390/ijms130911027	30	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114105	10.1371/journal.pone.0114105	http://dx.doi.org/10.1371/journal.pone.0114105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460911	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700100
J	Fresno, N; Perez-Fernandez, R; Goicoechea, C; Alkorta, I; Fernandez-Carvajal, A; De la Torre-Martinez, R; Quirce, S; Ferrer-Montiel, A; Martin, MI; Goya, P; Elguero, J				Fresno, Nieves; Perez-Fernandez, Ruth; Goicoechea, Carlos; Alkorta, Ibon; Fernandez-Carvajal, Asia; De la Torre-Martinez, Roberto; Quirce, Susana; Ferrer-Montiel, Antonio; Martin, M. Isabel; Goya, Pilar; Elguero, Jose			Adamantyl Analogues of Paracetamol as Potent Analgesic Drugs via Inhibition of TRPA1	PLOS ONE			English	Article							COVALENT BINDING; CHEMICAL-SHIFTS; ACETAMINOPHEN; PAIN; HEPATOTOXICITY; METABOLISM; MECHANISM; DESIGN	Paracetamol also known as acetaminophen, is a widely used analgesic and antipyretic agent. We report the synthesis and biological evaluation of adamantyl analogues of paracetamol with important analgesic properties. The mechanism of nociception of compound 6a/b, an analog of paracetamol, is not exerted through direct interaction with cannabinoid receptors, nor by inhibiting COX. It behaves as an interesting selective TRPA1 channel antagonist, which may be responsible for its analgesic properties, whereas it has no effect on the TRPM8 nor TRPV1 channels. The possibility of replacing a phenyl ring by an adamantyl ring opens new avenues in other fields of medicinal chemistry.	[Fresno, Nieves; Perez-Fernandez, Ruth; Alkorta, Ibon; Goya, Pilar; Elguero, Jose] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Goicoechea, Carlos; Martin, M. Isabel] Univ Rey Juan Carlos, Fac Ciencias Salud, Unidad Asociada I D i CSIC, Dept Farmacol & Nutr, Madrid, Spain; [Fernandez-Carvajal, Asia; De la Torre-Martinez, Roberto; Quirce, Susana; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Mol & Cellular Biol, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Rey Juan Carlos; Universidad Miguel Hernandez de Elche	Alkorta, I (corresponding author), CSIC, Inst Quim Med, Juan Cierva 3, E-28006 Madrid, Spain.	ibon@iqm.csic.es	Carvajal, Asia Fernandez/G-8877-2015; Ferrer-Montiel, Antonio/C-3072-2015; Elguero, Jose/G-8749-2015; alkorta, ibon/I-7828-2014; de la Torre Martinez, Roberto/AAB-2253-2021; Goya, Pilar/I-3243-2015; Pérez-Fernández, Ruth/G-8382-2015; Goicoechea, Carlos/H-6890-2015	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Elguero, Jose/0000-0002-9213-6858; alkorta, ibon/0000-0001-6876-6211; Pérez-Fernández, Ruth/0000-0003-0148-6455; Goicoechea, Carlos/0000-0002-6226-6934; de la Torre-Martinez, Roberto/0000-0001-9872-6050; Fernandez-Carvajal, Asia/0000-0003-2741-1427	grants RTA (RED Trastornos Adictivos) [RD06/001/0014]; CONSOLIDER INGENIO Program [CSD2008-00005];  [SAF2012-40075-C02];  [BFU2009-08346];  [BFU2012-39092-C02-01];  [PROMETEO/2010/046]	grants RTA (RED Trastornos Adictivos); CONSOLIDER INGENIO Program(Spanish Government); ; ; ; 	The present work has been supported by grants RTA (RED Trastornos Adictivos RD06/001/0014), SAF2012-40075-C02, BFU2009-08346, and BFU2012-39092-C02-01, CONSOLIDER INGENIO2010 Program (CSD2008-00005), and PROMETEO/2010/046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Beyer RP, 2007, TOXICOL SCI, V99, P326, DOI 10.1093/toxsci/kfm150; Blanco F, 2007, MAGN RESON CHEM, V45, P797, DOI 10.1002/mrc.2053; Blough ER, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00072; Broom DC, 2008, J PHARMACOL EXP THER, V327, P620, DOI 10.1124/jpet.108.141853; CROSBY NJ, 2008, AMANTADINE FOR DYSKI; Dania M, 2007, EUR J PHARMACOL, V573, P214, DOI 10.1016/j.ejphar.2007.07.012; DONETTI A, 1973, SYNTHETIC COMMUN, V3, P165, DOI DOI 10.1080/00397917308062027; Fernandez-Carvajal A, 2012, PHARMACEUTICALS, V5, P16, DOI 10.3390/ph5010016; Ferrer-Montiel A, 2012, EXPERT OPIN THER PAT, V22, P999, DOI 10.1517/13543776.2012.711320; Fischer J., 2006, ANALOGUE BASED DRUG, P419; Gonzalez-Nunez ME, 2000, ORG LETT, V2, P831, DOI 10.1021/ol000017m; Graham Garry G., 2003, Inflammopharmacology, V11, P401, DOI 10.1163/156856003322699573; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Guile SD, 2009, J MED CHEM, V52, P3123, DOI 10.1021/jm801528x; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jaroskova L, 2006, TETRAHEDRON LETT, V47, P8063, DOI 10.1016/j.tetlet.2006.09.056; Kolesov BA, 2011, PHYS CHEM CHEM PHYS, V13, P14243, DOI 10.1039/c1cp20139e; Kutchukian PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048476; Lamoureux G, 2010, CURR MED CHEM, V17, P2967, DOI 10.2174/092986710792065027; Liu J, 2011, EUR J MED CHEM, V46, P1949, DOI 10.1016/j.ejmech.2011.01.047; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; Miao L, 2009, ORG PROCESS RES DEV, V13, P820, DOI 10.1021/op900113b; MOISEEV IK, 1973, B ACAD SCI USSR CH, P2325, DOI DOI 10.1007/BF01199650; Nam TG, 2007, J AM CHEM SOC, V129, P10211, DOI 10.1021/ja072371m; Nam TG, 2009, ORG BIOMOL CHEM, V7, P5103, DOI 10.1039/b912528k; Nelson DW, 2008, J MED CHEM, V51, P3030, DOI 10.1021/jm701516f; Nelyubina YV, 2010, CHEM COMMUN, V46, P3469, DOI 10.1039/b927429d; Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s; Orr STM, 2012, J MED CHEM, V55, P4896, DOI 10.1021/jm300065h; Oscier C., 2007, ANAESTHESIA, V23, P112; Pasquini S, 2008, J MED CHEM, V51, P5075, DOI 10.1021/jm800552f; Planells-Cases R, 2007, EXPERT OPIN DRUG DIS, V2, P1053, DOI 10.1517/17460441.2.8.1053; Shchepin RV, 2013, ACS MED CHEM LETT, V4, P710, DOI 10.1021/ml4000904; Silva AMS, 2008, MAGN RESON CHEM, V46, P859, DOI 10.1002/mrc.2272; Sinning C, 2008, J MED CHEM, V51, P7800, DOI 10.1021/jm800807k; Song H, 2001, J BIOCHEM MOL TOXIC, V15, P34, DOI 10.1002/1099-0461(2001)15:1<34::AID-JBT4>3.0.CO;2-U; STREETER AJ, 1984, DRUG METAB DISPOS, V12, P565; Thibault K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091297; Umathe SN, 2009, PROG NEURO-PSYCHOPH, V33, P1191, DOI 10.1016/j.pnpbp.2009.06.020; Vaccarino AL, 2007, BIOORGAN MED CHEM, V15, P2206, DOI 10.1016/j.bmc.2006.07.054; Viana F, 2009, EXPERT OPIN THER PAT, V19, P1787, DOI 10.1517/13543770903393771; Wanka L, 2013, CHEM REV, V113, P3516, DOI 10.1021/cr100264t; Wu ZQ, 2010, BIOORG MED CHEM LETT, V20, P3851, DOI 10.1016/j.bmcl.2010.05.050; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113841	10.1371/journal.pone.0113841	http://dx.doi.org/10.1371/journal.pone.0113841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438056	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900085
J	Zhang, Y; Zhang, YZ; Yun, HL; Lai, R; Su, M				Zhang, Ying; Zhang, Yaozhong; Yun, Hailong; Lai, Raymond; Su, Min			Correlation of STAT1 with Apoptosis and Cell-Cycle Markers in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							BCL-X EXPRESSION; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; CANCER; SURVIVIN; ASSOCIATION; PROGNOSIS; BCL-X(L); D1	We recently found evidence that STAT1 in esophageal squamous carcinoma (ESCC) cells exerts tumor suppressor function, and it regulates five key regulators of apoptosis or cell-cycle progression, including Bcl-2, Bcl-xL, survivin, cyclin D1 and p21. In this study, we confirmed these findings in four ESCC cell lines. Using immunohistochemistry, we also assessed the expression of these proteins in 62 primary tumors. The expression of these markers was heterogeneous, ranging 39 to 69% of the cohort. Significant correlation was found between STAT1 and three proteins (p21, Bcl-xL and survivin), whereas only a trend was identified for cyclin D1 and Bcl-2. We then correlated the expression of these proteins with several clinicopathologic parameters including lymph node metastasis, depth of invasion, clinical stage and overall survival. Significant correlations were found between Bcl-2 and deep invasion (p=0.033), survivin and lymph node metastasis (p=0.006), as well as cyclin D1 and clinical stage (p=0.014). Patients with p21-positive tumors had a significantly longer survival compared to those with p21-negative tumors (p=0.031). To conclude, our findings support the concept that STAT1 exerts its tumor suppressor effects in ESCC via modulating the expression of key regulators of apoptosis and cell-cycle progression.	[Zhang, Ying; Zhang, Yaozhong; Yun, Hailong; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China; [Zhang, Ying; Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Lai, Raymond] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Shantou University; University of Alberta; University of Alberta	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rlai@ualberta.ca; minsu@stu.edu.cn			NSFC-Guangdong joint fund key project [U1132004]; NSFC [31171226, 31240077]; Canadian Institute of Health Research; Guangdong International Cooperative Technical Innovation Platform [gihz1106]	NSFC-Guangdong joint fund key project; NSFC(National Natural Science Foundation of China (NSFC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Guangdong International Cooperative Technical Innovation Platform	This study was supported by NSFC-Guangdong joint fund key project (Certificates U1132004), NSFC (Certificates 31171226 and 31240077), an operating research grant from the Canadian Institute of Health Research awarded to RL, and Guangdong International Cooperative Technical Innovation Platform (Certificates gihz1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahn Myung-Ju, 1998, Journal of Korean Medical Science, V13, P513; Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chang E, 2010, J THORAC CARDIOV SUR, V140, P225, DOI 10.1016/j.jtcvs.2009.11.038; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Deng H, 2012, ONCOL LETT, V3, P193, DOI 10.3892/ol.2011.423; Fukuchi M, 2006, INT J ONCOL, V29, P329; Grimminger P, 2009, J SURG ONCOL, V100, P447, DOI 10.1002/jso.21355; He HY, 2013, CARCINOGENESIS, V34, P139, DOI 10.1093/carcin/bgs301; Hui MKC, 2012, MED ONCOL, V29, P3009, DOI 10.1007/s12032-012-0225-9; Kamel Azza, 2006, J Egypt Natl Canc Inst, V18, P93; Kato J, 2001, INT J CANCER, V95, P92; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Koide N, 1997, SURG TODAY, V27, P685, DOI 10.1007/BF02384977; Kondo S, 1996, INT J CANCER, V68, P727, DOI 10.1002/(SICI)1097-0215(19961211)68:6<727::AID-IJC6>3.0.CO;2-5; Kovarik J, 2003, INT J MOL MED, V12, P335; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044764; Lin De-Chen, 2010, Yichuan, V32, P455, DOI 10.3724/SP.J.1005.2010.00455; Liu J, 2012, DIS ESOPHAGUS, V25, P67, DOI 10.1111/j.1442-2050.2011.01217.x; Marone M, 1998, CLIN CANCER RES, V4, P517; Matsumoto M, 2001, ANN SURG ONCOL, V8, P598, DOI 10.1245/aso.2001.8.7.598; Ohbu M, 1997, CANCER, V79, P1287, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1287::AID-CNCR3>3.0.CO;2-E; Sarbia M, 1998, CLIN CANCER RES, V4, P2615; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Su M, 2004, WORLD J GASTROENTERO, V10, P2163; Takayama T, 2001, J SURG ONCOL, V78, P116, DOI 10.1002/jso.1130; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Troussard X, 2000, Hematol J, V1, P181, DOI 10.1038/sj.thj.6200025; Tu YP, 1998, CANCER RES, V58, P256; Xerri L, 1996, BRIT J HAEMATOL, V92, P900, DOI 10.1046/j.1365-2141.1996.423958.x; Xie YE, 2006, WORLD J GASTROENTERO, V12, P7472, DOI 10.3748/wjg.v12.i46.7472; Zhang Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-791; Zhao J, 2012, DIS ESOPHAGUS, V25, P520, DOI 10.1111/j.1442-2050.2011.01278.x	36	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113928	10.1371/journal.pone.0113928	http://dx.doi.org/10.1371/journal.pone.0113928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438156	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900096
J	Li, W; Long, JA; Watts, LT; Jiang, Z; Shen, Q; Li, YX; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.			A Quantitative MRI Method for Imaging Blood-Brain Barrier Leakage in Experimental Traumatic Brain Injury	PLOS ONE			English	Article							REPERFUSION INJURY; MODEL SELECTION; PATLAK PLOTS; RAT MODEL; GD-DTPA; PERMEABILITY; STROKE; PARAMETERS; DIFFUSION; BREAKDOWN	Blood-brain barrier (BBB) disruption is common following traumatic brain injury (TBI). Dynamic contrast enhanced (DCE) MRI can longitudinally measure the transport coefficient K-trans which reflects BBB permeability. K-trans measurements however are not widely used in TBI research because it is generally considered to be noisy and possesses low spatial resolution. We improved spatiotemporal resolution and signal sensitivity of K-trans MRI in rats by using a high-sensitivity surface transceiver coil. To overcome the signal drop off profile of the surface coil, a pre-scan module was used to map the flip angle (B-1 field) and magnetization (M-0) distributions. A series of T-1-weighted gradient echo images were acquired and fitted to the extended Kety model with reversible or irreversible leakage, and the best model was selected using F-statistics. We applied this method to study the rat brain one hour following controlled cortical impact (mild to moderate TBI), and observed clear depiction of the BBB damage around the impact regions, which matched that outlined by Evans Blue extravasation. Unlike the relatively uniform T-2 contrast showing cerebral edema, K-trans shows a pronounced heterogeneous spatial profile in and around the impact regions, displaying a nonlinear relationship with T-2. This improved K-trans MRI method is also compatible with the use of high-sensitivity surface coil and the high-contrast two-coil arterial spin-labeling method for cerebral blood flow measurement, enabling more comprehensive investigation of the pathophysiology in TBI.	[Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Li, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	liw5@uthscsa.edu; duongt@uthscsa.edu	Watts, Lora Talley/A-2724-2012; Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Watts, Lora Talley/0000-0002-2337-1504; Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827; jiang, zhao/0000-0002-8192-9908	NIH/NINDS [R01 NS45879, UL1 TR001119, TL1TR001119, KL2 TR001118]; NIH/NINDS via the Clinical Translational Science Awards (CTSA) [TL1TR001119, UL1TR001119, 8UL1TR000149]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120, TL1TR001119, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045879] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS via the Clinical Translational Science Awards (CTSA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported in part by grants from NIH/NINDS R01 NS45879 (TQD), UL1 TR001119 (WL), TL1TR001119 (JAL), and KL2 TR001118 (LTW) via the Clinical Translational Science Awards (CTSA, parent grant UL1TR001119, 8UL1TR000149, and TL1TR001119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1998, ACT NEUR S, V71, P104; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Nagaraja TN, 2010, MAGN RESON MED, V63, P1502, DOI 10.1002/mrm.22339; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts P. S., 2010, SIGNAL, V500, P400; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131	26	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114173	10.1371/journal.pone.0114173	http://dx.doi.org/10.1371/journal.pone.0114173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478693	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200050
J	Liu, CR; Li, DQ; Zio, E; Kang, R				Liu, Chaoran; Li, Daqing; Zio, Enrico; Kang, Rui			A Modeling Framework for System Restoration from Cascading Failures	PLOS ONE			English	Article							NETWORK	System restoration from cascading failures is an integral part of the overall defense against catastrophic breakdown in networked critical infrastructures. From the outbreak of cascading failures to the system complete breakdown, actions can be taken to prevent failure propagation through the entire network. While most analysis efforts have been carried out before or after cascading failures, restoration during cascading failures has been rarely studied. In this paper, we present a modeling framework to investigate the effects of in-process restoration, which depends strongly on the timing and strength of the restoration actions. Furthermore, in the model we also consider additional disturbances to the system due to restoration actions themselves. We demonstrate that the effect of restoration is also influenced by the combination of system loading level and restoration disturbance. Our modeling framework will help to provide insights on practical restoration from cascading failures and guide improvements of reliability and resilience of actual network systems.	[Liu, Chaoran; Li, Daqing; Kang, Rui] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Liu, Chaoran; Li, Daqing; Kang, Rui] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China; [Zio, Enrico] European Fdn New Energy Elect France, Chair Syst Sci & Energet Challenge, Ecole Cent Paris & Supelec, Paris, France; [Zio, Enrico] Politecn Milan, Dipartimento Energia, I-20133 Milan, Italy	Beihang University; Electricite de France (EDF); UDICE-French Research Universities; Universite Paris Saclay; Polytechnic University of Milan	Li, DQ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	li.daqing.biu@gmail.com; enrico.zio@ecp.fr		Zio, Enrico/0000-0002-7108-637X	National Natural Science Foundation of China [61104144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	DL was supported by National Natural Science Foundation of China under Grant No. 61104144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M. M., 2006, IEEE Power & Energy Magazine, V4, P68, DOI 10.1109/MPAE.2006.1687819; Adibi M.M., 2008, P IEEE POW EN SOC GE, P1, DOI [10.1109/PES.2008.4596495, DOI 10.1109/PES.2008.4596495]; Ahsan MQ, 2012, IEEE T POWER SYST, V27, P198, DOI 10.1109/TPWRS.2011.2158594; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 1987, IEEE T POWER SYST, V2, P271; [Anonymous], 1987, IEEE Transactions on Power Systems, VPWRS-2, P927; Asztalos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084563; Atputharajah A, 2009, 2009 INTERNATIONAL CONFERENCE ON INDUSTRIAL AND INFORMATION SYSTEMS, P460, DOI 10.1109/ICIINFS.2009.5429818; Balderer C, 2009, INT J CRIT INFRASTRU, V5, P51, DOI 10.1504/IJCIS.2009.022849; Barrett C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045406; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Morales SOC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059039; Cadini F, 2010, RELIAB ENG SYST SAFE, V95, P173, DOI 10.1016/j.ress.2009.09.007; Cohen R., 2010, COMPLEX NETWORKS STR; Dobson I, 2005, PROBAB ENG INFORM SC, V19, P15, DOI 10.1017/S0269964805050023; Dobson I., 2002, Proceedings of the 35th Annual Hawaii International Conference on System Sciences, DOI 10.1109/HICSS.2002.993975; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Dobson Ian, 2004, P 37 ANN HAW INT C S, P10, DOI DOI 10.1109/HICSS.2004.1265185; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; FINK LH, 1995, IEEE T POWER SYST, V10, P745, DOI 10.1109/59.387912; Francis R, 2014, RELIAB ENG SYST SAFE, V121, P90, DOI 10.1016/j.ress.2013.07.004; Gutfraind A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013448; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Henderson M., 2012, P IEEE PES GEN M, P1; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Koch S., 2010, P IREP S BULK POW SY, DOI DOI 10.1109/IREP.2010.5563284; Kroger W, 2011, VULNERABLE SYSTEMS, P1; Lee KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018443; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Moreira CL, 2007, IEEE T POWER SYST, V22, P395, DOI 10.1109/TPWRS.2006.888989; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Pecas Lopes JA, 2005, P 15 PSCC; Quattrociocchi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087986; Ren H, 2008, IEEE T POWER SYST, V23, P1217, DOI 10.1109/TPWRS.2008.926417; Shuang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088445; Talukdar SN, 2003, ELECT J, V16, P25, DOI DOI 10.1016/j.tej.2003.09.003; Vaiman M., 2013, 2013 IEEE POW EN SOC, P1, DOI DOI 10.1109/PESMG.2013.6672795; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Xiaofeng Weng, 2006, Journal of Control Theory and Applications, V4, P235, DOI 10.1007/s11768-006-5082-7; Yadav G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041827; Zhang N, 2006, TRANS DISTRIB CONF, P847; Zima M, 2004, 2004 INTERNATIONAL CONFERENCE ON PROBABILISTIC METHODS APPLIED TO POWER SYSTEMS, P663; Zio E, 2012, RELIAB ENG SYST SAFE, V103, P72, DOI 10.1016/j.ress.2012.03.007; Zio E, 2011, P EUR SAF REL C ESRE, P2515	46	25	26	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112363	10.1371/journal.pone.0112363	http://dx.doi.org/10.1371/journal.pone.0112363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474408	gold, Green Published			2022-12-27	WOS:000346382500068
J	Qi, J; Yang, ZY				Qi, Jin; Yang, Zhiyong			Learning Dictionaries of Sparse Codes of 3D Movements of Body Joints for Real-Time Human Activity Understanding	PLOS ONE			English	Article							ACTION RECOGNITION; DEFICITS; VISION; HMM	Real-time human activity recognition is essential for human-robot interactions for assisted healthy independent living. Most previous work in this area is performed on traditional two-dimensional (2D) videos and both global and local methods have been used. Since 2D videos are sensitive to changes of lighting condition, view angle, and scale, researchers begun to explore applications of 3D information in human activity understanding in recently years. Unfortunately, features that work well on 2D videos usually don't perform well on 3D videos and there is no consensus on what 3D features should be used. Here we propose a model of human activity recognition based on 3D movements of body joints. Our method has three steps, learning dictionaries of sparse codes of 3D movements of joints, sparse coding, and classification. In the first step, space-time volumes of 3D movements of body joints are obtained via dense sampling and independent component analysis is then performed to construct a dictionary of sparse codes for each activity. In the second step, the space-time volumes are projected to the dictionaries and a set of sparse histograms of the projection coefficients are constructed as feature representations of the activities. Finally, the sparse histograms are used as inputs to a support vector machine to recognize human activities. We tested this model on three databases of human activities and found that it outperforms the state-of-the-art algorithms. Thus, this model can be used for real-time human activity recognition in many applications.	[Qi, Jin; Yang, Zhiyong] Georgia Regents Univ, Brain & Behav Discovery Inst, James & Jean Culver Vis Discovery Inst, Dept Ophthalmol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Yang, ZY (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, James & Jean Culver Vis Discovery Inst, Dept Ophthalmol, Augusta, GA 30912 USA.	zhyang@gru.edu						Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; [Anonymous], P 21 ACM INT C MULT, DOI DOI 10.1145/2502081.2502099; Bengio Yoshua, 2007, P ADV NEUR INF PROC, P153; CAMPBELL LW, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P624, DOI 10.1109/ICCV.1995.466880; Camplani M, 2012, P SOC PHOTO-OPT INS, V8290; Cook DJ, 2005, SMART ENV TECHNOLOGI, P1; Das B, 2012, PERS UBIQUIT COMPUT, V16, P859, DOI 10.1007/s00779-011-0445-6; Dollar P., 2005, Proceedings. 2nd Joint IEEE International Workshop on Visual Surveillance and Performance Evaluation of Tracking and Surveillance (VS-PETS) (IEEE Cat. No. 05EX1178), P65; Farias ST, 2006, ALZ DIS ASSOC DIS, V20, P217, DOI 10.1097/01.wad.0000213849.51495.d9; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Jalal A, 2011, LECT NOTES COMPUT SC, V6719, P25, DOI 10.1007/978-3-642-21535-3_4; Jhuang HH, 2013, IEEE I CONF COMP VIS, P3192, DOI 10.1109/ICCV.2013.396; Jia XF, 2012, INT C PATT RECOG, P3001; JOHANSSON G, 1975, SCI AM, V232, P76, DOI 10.1038/scientificamerican0675-76; Kaushik P, 2008, METHOD INFORM MED, V47, P203, DOI 10.3414/ME9111; Klaser A., 2008, BMVC, V275, P1; Koppula HS, 2013, INT J ROBOT RES, V32, P951, DOI 10.1177/0278364913478446; Laptev I, 2005, INT J COMPUT VISION, V64, P107, DOI 10.1007/s11263-005-1838-7; Le Q.V., 2011, NEURIPS, P1017; Lei JN, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P208; Li WB, 2010, 2010 THE 3RD INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND INDUSTRIAL APPLICATION (PACIIA2010), VOL I, P9, DOI 10.1109/cvprw.2010.5543273; Lu Xia, 2012, IEEE COMP SOC C COMP, P20, DOI DOI 10.1109/CVPRW.2012.6239233; Lv F, 2006, LECT NOTES COMPUT SC, V3954, P359; Mao Ye, 2013, Time-Of-Flight and Depth Imaging. Sensors, Algorithms and Applications. Dagstuhl 2012 Seminar on Time-of-Flight Imaging and GCPR 2013 Workshop on Imaging New Modalities: LNCS 8200, P149, DOI 10.1007/978-3-642-44964-2_8; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mualler M., 2006, P 2006 ACM SIGGRAPH, P137; Ngiam J, ICML, P265; Ni BB, 2012, LECT NOTES COMPUT SC, V7573, P173, DOI 10.1007/978-3-642-33709-3_13; Ni BB, 2013, IEEE T CYBERNETICS, V43, P1383, DOI 10.1109/TCYB.2013.2276433; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Oreifej O, 2013, PROC CVPR IEEE, P716, DOI 10.1109/CVPR.2013.98; Piyathilaka L, 2013, C IND ELECT APPL, P567; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Reisberg B, 2001, INT PSYCHOGERIATR, V13, P163, DOI 10.1017/S1041610201007566; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Shotton J., 2013, MACH LEARN COMPUT VI, V411, P119, DOI DOI 10.1007/978-3-642-28661-2_5; Sung J., 2011, P 16 AAAI C PLAN ACT, P47; Sung JY, 2012, IEEE INT CONF ROBOT, P842, DOI 10.1109/ICRA.2012.6224591; Vedaldi A, 2012, IEEE T PATTERN ANAL, V34, P480, DOI 10.1109/TPAMI.2011.153; Vieira Antonio W., 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P252, DOI 10.1007/978-3-642-33275-3_31; Wadley VG, 2008, AM J GERIAT PSYCHIAT, V16, P416, DOI 10.1097/JGP.0b013e31816b7303; Wang J, 2014, IEEE T PATTERN ANAL, V36, P914, DOI 10.1109/TPAMI.2013.198; Wang J, 2012, LECT NOTES COMPUT SC, V7573, P872, DOI 10.1007/978-3-642-33709-3_62; Wang J, 2012, PROC CVPR IEEE, P1290, DOI 10.1109/CVPR.2012.6247813; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Yang XD, 2014, J VIS COMMUN IMAGE R, V25, P2, DOI 10.1016/j.jvcir.2013.03.001; Yao A, 2012, INT J COMPUT VISION, V100, P16, DOI 10.1007/s11263-012-0532-9; Zhang C., 2012, J COMPUTER VISION IM, V2; Zhang H., 2011, INTELLIGENT ROBOTS S, P2044, DOI DOI 10.1109/IROS.2011.6094489; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114147	10.1371/journal.pone.0114147	http://dx.doi.org/10.1371/journal.pone.0114147			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473850	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500117
J	Schmidt, JH; Klokker, M				Schmidt, Jesper Hvass; Klokker, Mads			Health Effects Related to Wind Turbine Noise Exposure: A Systematic Review	PLOS ONE			English	Review							LOW-FREQUENCY NOISE; ROAD TRAFFIC NOISE; AMPLITUDE-MODULATION; METEOROLOGICAL CONDITIONS; VIBROACOUSTIC DISEASE; FARM DEVELOPMENT; INFRASOUND; ANNOYANCE; SOUND; IMPACT	Background: Wind turbine noise exposure and suspected health-related effects thereof have attracted substantial attention. Various symptoms such as sleep-related problems, headache, tinnitus and vertigo have been described by subjects suspected of having been exposed to wind turbine noise. Objective: This review was conducted systematically with the purpose of identifying any reported associations between wind turbine noise exposure and suspected health-related effects. Data Sources: A search of the scientific literature concerning the health-related effects of wind turbine noise was conducted on PubMed, Web of Science, Google Scholar and various other Internet sources. Study Eligibility Criteria: All studies investigating suspected health-related outcomes associated with wind turbine noise exposure were included. Results: Wind turbines emit noise, including low-frequency noise, which decreases incrementally with increases in distance from the wind turbines. Likewise, evidence of a dose-response relationship between wind turbine noise linked to noise annoyance, sleep disturbance and possibly even psychological distress was present in the literature. Currently, there is no further existing statistically-significant evidence indicating any association between wind turbine noise exposure and tinnitus, hearing loss, vertigo or headache. Limitations: Selection bias and information bias of differing magnitudes were found to be present in all current studies investigating wind turbine noise exposure and adverse health effects. Only articles published in English, German or Scandinavian languages were reviewed. Conclusions: Exposure to wind turbines does seem to increase the risk of annoyance and self-reported sleep disturbance in a dose-response relationship. Conclusions: Exposure to wind turbines does seem to increase the risk of annoyance and self-reported sleep disturbance in a dose-response relationship. There appears, though, to be a tolerable level of around L-Aeq of 35 dB. Of the many other claimed health effects of wind turbine noise exposure reported in the literature, however, no conclusive evidence could be found. Future studies should focus on investigations aimed at objectively demonstrating whether or not measureable health-related outcomes can be proven to fluctuate depending on exposure to wind turbines.	[Schmidt, Jesper Hvass] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Schmidt, Jesper Hvass] Odense Univ Hosp, Dept Audiol, DK-5000 Odense, Denmark; [Schmidt, Jesper Hvass] Odense Univ Hosp, Dept ENT Head & Neck Surg, DK-5000 Odense, Denmark; [Klokker, Mads] Copenhagen Univ Hosp, Dept ENT Head & Neck Surg & Audiol, Copenhagen, Denmark; [Klokker, Mads] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen	Schmidt, JH (corresponding author), Univ Southern Denmark, Inst Clin Res, Odense, Denmark.	jesper.schmidt@rsyd.dk	Schmidt, Jesper H./J-3842-2014	Schmidt, Jesper H./0000-0001-7683-1407				Alves-Pereira M, 2007, PROG BIOPHYS MOL BIO, V93, P256, DOI 10.1016/j.pbiomolbio.2006.07.011; Ambrose S. E., 2012, Bulletin of Science, Technology and Society, V32, P128, DOI 10.1177/0270467612455734; Aslund MLW, 2013, ENERG POLICY, V62, P44, DOI 10.1016/j.enpol.2013.07.070; Bakker RH, 2012, SCI TOTAL ENVIRON, V425, P42, DOI 10.1016/j.scitotenv.2012.03.005; Barnard M, 2013, NOISE HEALTH, V15, P150, DOI 10.4103/1463-1741.110305; Bjorkman M, 2004, J SOUND VIB, V277, P567, DOI 10.1016/j.jsv.2004.03.018; Bolin K, 2012, ACTA ACUST UNITED AC, V98, P741, DOI 10.3813/AAA.918555; Bolin K, 2010, ACTA ACUST UNITED AC, V96, P131, DOI 10.3813/AAA.918264; Botha P, 2013, ACTA ACUST UNITED AC, V99, P537, DOI 10.3813/AAA.918633; Branco N A A Castelo, 2004, Noise Health, V6, P3; Chapman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076584; Chapman S, 2013, AUST NZ J PUBL HEAL, V37, P244, DOI 10.1111/1753-6405.12066; Chapman S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3366; Cook A, 2012, ACOUST AUST, V40, P144; Crichton F, 2014, HEALTH PSYCHOL, V33, P1588, DOI 10.1037/hea0000037; Crichton F, 2014, HEALTH PSYCHOL, V33, P360, DOI 10.1037/a0031760; Deignan B, 2013, HEALTH RISK SOC, V15, P234, DOI 10.1080/13698575.2013.776015; Di Napoli C, 2011, NOISE CONTROL ENG J, V59, P30, DOI 10.3397/1.3531793; Dommes E, 2009, BRAIN RES, V1304, P129, DOI 10.1016/j.brainres.2009.09.089; Doolan CJ, 2012, ACOUST AUST, V40, P7; Enbom Hakan, 2013, Lakartidningen, V110, P1388; Evans T, 2012, ACOUST AUST, V40, P28; Farboud A, 2013, J LARYNGOL OTOL, V127, P222, DOI 10.1017/S0022215112002964; Fukushima A, 2013, INTERNOISE NOISE CON, P3117; Hanning CD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1527; Harding G, 2008, EPILEPSIA, V49, P1095, DOI 10.1111/j.1528-1167.2008.01563.x; Harry A., 2007, WIND TURBINES NOISE; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Hensel J, 2007, HEARING RES, V233, P67, DOI 10.1016/j.heares.2007.07.004; Hessler DM, 2011, NOISE CONTROL ENG J, V59, P94, DOI 10.3397/1.3531795; Hume KI, 2012, NOISE HEALTH, V14, P297, DOI 10.4103/1463-1741.104897; Iser DJ, 2004, RESULTS LOCAL WIND F; Jakobsen J, 2005, J LOW FREQ NOISE V A, V24, P145, DOI 10.1260/026309205775374451; Jakobsen J, 2012, J LOW FREQ NOISE V A, V31, P239, DOI 10.1260/0263-0923.31.4.239; Janssen S, 2010, INTERNOISE NOISE CON, P4476; Janssen SA, 2009, P I AC 8 EUR C NOIS, P1472; Janssen SA, 2011, J ACOUST SOC AM, V130, P3746, DOI 10.1121/1.3653984; Jeffery RD, 2013, CAN FAM PHYSICIAN, V59, P473; Jones TF, 2000, NEW ENGL J MED, V342, P96, DOI 10.1056/NEJM200001133420206; Jung SS, 2008, J KOREAN PHYS SOC, V53, P1897, DOI 10.3938/jkps.53.1897; Kelley N., 1987, PROPOSED METRIC ASSE; KELLEY ND, 1982, J SOL ENERG-T ASME, V104, P104; King EA, 2012, ENERG POLICY, V41, P548, DOI 10.1016/j.enpol.2011.11.016; Knopper LD, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-78; Krogh CME, 2011, B SCI TECHNOL SOC, V31, P334, DOI DOI 10.1177/0270467611412551; Krohn S, 1999, RENEW ENERG, V16, P954, DOI 10.1016/S0960-1481(98)00339-5; Kuwano S, 2013, INTERNOISE NOISE CON, P3362; Lane J, 2013, ASS IND WIND TURBINE; Larsson C, 2014, J ACOUST SOC AM, V135, P67, DOI 10.1121/1.4836135; Lee S, 2011, NOISE CONTROL ENG J, V59, P38, DOI 10.3397/1.3531797; Lenchine VV, 2009, P ANN C AUSTR AC SOC, P1; Leventhall G, 2007, PROG BIOPHYS MOL BIO, V93, P130, DOI 10.1016/j.pbiomolbio.2006.07.006; Lichtenhan J, 2013, P M AC ICA 2013 2 7; McBride D, 2013, INTERNOISE NOISE CON, P2529; Meir R, 1996, ASSESMENT RATING NOI; Minor LB, 2000, AM J OTOL, V21, P9; Moller H, 2004, Noise Health, V6, P37; Moller H, 2011, J ACOUST SOC AM, V129, P3727, DOI 10.1121/1.3543957; Morris M, 2013, WATERLOO CASE SERIES; Morris M., 2012, WATERLOO WIND FARM S; Nissenbaum M, 2011, P 10 INT C NOIS PUBL, P1; Nissenbaum MA, 2012, NOISE HEALTH, V14, P237, DOI 10.4103/1463-1741.102961; O'Neal RD, 2011, NOISE CONTROL ENG J, V59, P135, DOI 10.3397/1.3549200; Oerlemans S, 2007, J SOUND VIB, V299, P869, DOI 10.1016/j.jsv.2006.07.032; Ontariro WC, 2009, SELF REPORTING SURVE; Paller C., 2014, EXPLORING ASS PROXIM; Pawlaczyk-Luszczynska M, 2013, P M AC ICA 2013 2 7; Pawlaczyk-Luszczynska M, 2014, INT J OCCUP MED ENV, V27, P364, DOI 10.2478/s13382-014-0252-1; Pedersen E, 2004, J ACOUST SOC AM, V116, P3460, DOI 10.1121/1.1815091; Pedersen E, 2010, INTERNOISE NOISE CON, P2291; Pedersen E., 2007, QUAL RES PSYCHOL, V4, P49, DOI DOI 10.1080/14780880701473409; Pedersen E., 2007, HUMAN RESPONSE WIND; Pedersen E, 2008, P 7 EUR C NOIS CONTR, P4049; Pedersen E, 2006, P 6 EUR C NOIS CONTR; Pedersen E, 2009, P 3 INT M WIND TURB, P11; Pedersen E, 2007, OCCUP ENVIRON MED, V64, P480, DOI 10.1136/oem.2006.031039; Pedersen E, 2011, NOISE CONTROL ENG J, V59, P47, DOI 10.3397/1.3533898; Pedersen E, 2010, ENERG POLICY, V38, P2520, DOI 10.1016/j.enpol.2010.01.001; Pedersen E, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/015002; Pedersen E, 2008, J ENVIRON PSYCHOL, V28, P379, DOI 10.1016/j.jenvp.2008.02.009; Pedersen E, 2009, J ACOUST SOC AM, V126, P634, DOI 10.1121/1.3160293; Phillips CV, 2011, B SCI TECHNOL SOC, V31, P303, DOI DOI 10.1177/0270467611412554; Pierpont N., 2009, WIND TURBINE SYNDROM; Punch J, 2010, AUDIOLOGY TODAY, P20; Roberts JD, 2013, J ENVIRON HEALTH, V75, P8; Rubin GJ, 2014, NOISE HEALTH, V16, P116, DOI 10.4103/1463-1741.132099; Salt A, 2012, INTERNOISE NOISE CON, P3999; Salt AN, 2013, J ACOUST SOC AM, V133, P1561, DOI 10.1121/1.4789005; Salt AN, 2010, HEARING RES, V268, P12, DOI 10.1016/j.heares.2010.06.007; Schiff MT, 2013, NOISE CONTROL ENG J, V61, P509; Schneider P, 2012, CULLERIN RANGE WIND; Schneider P, 2013, CULLERIN RANGE WIND; Seltenrich N, 2014, ENVIRON HEALTH PERSP, V122, pA20, DOI 10.1289/ehp.122-A20; Seong Y, 2013, INTERNOISE NOISE CON, P2699; Shepherd D, 2011, NOISE HEALTH, V13, P333, DOI 10.4103/1463-1741.85502; SHEPHERD KP, 1983, NOISE CONTROL ENG, V21, P30, DOI 10.3397/1.2827612; Smedley ARD, 2010, EPILEPSIA, V51, P1146, DOI 10.1111/j.1528-1167.2009.02402.x; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Sorensen M, 2011, EUR HEART J, V32, P737, DOI 10.1093/eurheartj/ehq466; Swinbanks M, 2011, P 4 INT M WIND TURB; Thomsen J, 2005, OTOL NEUROTOL, V26, P68, DOI 10.1097/00129492-200501000-00012; Thorne B, 2012, WIND FARM GENERATED; Tickell C, 2012, ACOUST AUST, V40, P64; Tonin R, 2012, ACOUST AUST, V40, P20; Turnbull C, 2012, ACOUST AUST, V40, P45; van den Berg F., 2008, EURONOISE 2008, P4043; van den Berg GP, 2005, J LOW FREQ NOISE V A, V24, P1, DOI 10.1260/0263092054037702; van den Berg GP, 2004, J SOUND VIB, V277, P955, DOI 10.1016/j.jsv.2003.09.050; Van Renterghem T, 2013, SCI TOTAL ENVIRON, V456, P333, DOI 10.1016/j.scitotenv.2013.03.095; Verheijen E, 2011, NOISE HEALTH, V13, P459, DOI 10.4103/1463-1741.90331; Wolsink M, 2000, RENEW ENERG, V21, P49, DOI 10.1016/S0960-1481(99)00130-5; Yano T, 2013, INTERNOISE NOISE CON, P2715; Yokoyama S, 2013, INTERNOISE NOISE CON, P3136	113	62	63	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114183	10.1371/journal.pone.0114183	http://dx.doi.org/10.1371/journal.pone.0114183			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474326	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500121
J	Yu, XN; Lyu, DN; Dong, XR; He, JL; Yao, K				Yu, Xiaoning; Lyu, Danni; Dong, Xinran; He, Jiliang; Yao, Ke			Hypertension and Risk of Cataract: A Meta-Analysis	PLOS ONE			English	Article							AGE-RELATED CATARACT; C-REACTIVE PROTEIN; LONG-TERM INCIDENCE; LENS OPACITIES; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SYSTEMIC HYPERTENSION; VISUAL IMPAIRMENT; 5-YEAR INCIDENCE; EYE DISEASES	Background: Cataract is the major cause of blindness across the world. Many epidemiologic studies indicated that hypertension might play an important role in the development of cataract, while others not. We therefore conducted this meta-analysis to determine the relationship between risk of cataract and hypertension. Methods: Retrieved studies on the association of hypertension with cataract risk were collected from PubMed, Web of Science and the Cochrane Library during June 2014 and were included into the final analysis according to the definite inclusion criteria. Odds ratio (OR) or risk ratio (RR) were pooled with 95% confidence interval (CI) to evaluate the relationship between hypertension and cataract risk. Subgroup analyses were carried out on the basis of cataract type, race and whether studies were adjusted for main components of metabolic syndrome (MS). Results: The final meta-analysis included 25 studies (9 cohort, 5 case-control and 11 cross-sectional) from 23 articles. The pooled results showed that cataract risk in populations with hypertension significantly increased among cohort studies (RR 1.08; 95% CI: 1.05-1.12) and case-control or cross-sectional studies (OR 1.28; 95% CI: 1.12-1.45). This association was proved to be true among both Mongolians and Caucasians, and the significance was not altered by the adjustment of main components of MS. Subgroup analysis on cataract types indicated that an increased incidence of posterior subcapsular cataract (PSC) resulted among cohort studies (RR 1.22; 95% CI: 1.03-1.46) and cross-sectional/case-control studies (OR 1.23; 95% CI: 1.09-1.39). No association of hypertension with risk of nuclear cataract was found. Conclusions: The present meta-analysis suggests that hypertension increases the risk of cataract, especially PSC. Further efforts should be made to explore the potential biological mechanisms.	[Yu, Xiaoning; Lyu, Danni; Dong, Xinran; Yao, Ke] Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [He, Jiliang] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China; [Yao, Ke] Zhejiang Prov Key Lab Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Key Program of National Science Foundation of China [81130018]; National "Twelfth Five-Year" Plan for Science & Technology Support of China [2012BAI08B01]; Project of National Clinical Key Discipline of Chinese Ministry of Health	Key Program of National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support of China; Project of National Clinical Key Discipline of Chinese Ministry of Health	The present study was supported by Key Program of National Science Foundation of China (No. 81130018), National "Twelfth Five-Year" Plan for Science & Technology Support of China (NO. 2012BAI08B01) and Project of National Clinical Key Discipline of Chinese Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angra SK, 2000, ANN OPHTHALMOL, V32, P101, DOI 10.1007/s12009-000-0025-2; Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BURGESS CA, 1992, OPTOMETRY VISION SCI, V69, P320, DOI 10.1097/00006324-199204000-00011; Chen KJ, 2011, J NUTR HEALTH AGING, V15, P304, DOI 10.1007/s12603-010-0282-8; Cumming RG, 1998, OPHTHALMOLOGY, V105, P1751, DOI 10.1016/S0161-6420(98)99049-2; Delcourt C, 2003, OPHTHALMOLOGY, V110, P2318, DOI 10.1016/S0161-6420(03)00713-9; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galeone C, 2010, ANN EPIDEMIOL, V20, P380, DOI 10.1016/j.annepidem.2010.01.009; GHAEM MH, 2014, INVEST OPHTH VIS SCI, V5, P641, DOI DOI 10.1167/IOVS.12-10980; Goldacre MJ, 2012, BRIT J OPHTHALMOL, V96, P872, DOI 10.1136/bjophthalmol-2012-301519; Goodrich M E, 1999, Ophthalmic Epidemiol, V6, P279, DOI 10.1076/opep.6.4.279.4188; GREW J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI DOI 10.1167/IOVS.10-7113; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; IRELAND ME, 1991, INVEST OPHTH VIS SCI, V32, P541; ISAAC NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P256, DOI 10.1001/archopht.1991.01080020102053; Johnson AC, 2013, MAMM GENOME, V24, P95, DOI 10.1007/s00335-013-9447-1; Kanthan GL, 2009, BRIT J OPHTHALMOL, V93, P1210, DOI 10.1136/bjo.2008.153379; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P640, DOI 10.1016/S0002-9394(14)70223-5; Klein BEK, 2001, OPHTHALMOLOGY, V108, P1670, DOI 10.1016/S0161-6420(01)00656-X; Lee SM, 1997, OPHTHALMIC RES, V29, P83, DOI 10.1159/000268001; Leske MC, 1998, AM J EPIDEMIOL, V147, P36; Leske MC, 1999, OPHTHALMOLOGY, V106, P35, DOI 10.1016/S0161-6420(99)90003-9; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; Machan CM, 2012, OPTOMETRY VISION SCI, V89, P1165, DOI 10.1097/OPX.0b013e3182644cd1; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; Maralani HG, 2013, INVEST OPHTH VIS SCI, V54, P641, DOI 10.1167/iovs.12-10980; McCarty CA, 2000, INVEST OPHTH VIS SCI, V41, P3720; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukesh BN, 2006, ARCH OPHTHALMOL-CHIC, V124, P79, DOI 10.1001/archopht.124.1.79; NETMET AY, 2010, EYE, V24, P1352; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P989, DOI 10.1136/bjo.2003.038380; Ornek K, 2003, EXP EYE RES, V76, P23, DOI 10.1016/S0014-4835(02)00268-3; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Paunksnis A, 2007, EUR J OPHTHALMOL, V17, P605, DOI 10.1177/112067210701700420; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rim THT, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-4; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; SAGENT CR, 1987, HYPERTENSION, V9, P304; SARGENT CR, 1996, HYPERTENSION, V28, P440; Schaumberg DA, 2001, ANN EPIDEMIOL, V11, P104, DOI 10.1016/S1047-2797(00)00178-2; Schaumberg DA, 1999, ANN EPIDEMIOL, V9, P166, DOI 10.1016/S1047-2797(98)00049-0; SCREENIVAS V, 1999, J EPIDEMIOL, V9, P327, DOI DOI 10.2188/JEA.9.327; Shah SP, 2007, OPHTHAL EPIDEMIOL, V14, P381, DOI 10.1080/09286580701375179; SPECTOR A, 1985, P NATL ACAD SCI USA, V82, P4712, DOI 10.1073/pnas.82.14.4712; Storey P, 2013, INVEST OPHTH VIS SCI, V54, P3010, DOI 10.1167/iovs.12-11412; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; Tavani Alessandra, 1995, Annals of Epidemiology, V5, P234, DOI 10.1016/1047-2797(94)00111-6; Tsai SY, 2003, OPHTHALMOLOGY, V110, P1089, DOI 10.1016/S0161-6420(03)00243-4; Ughade Suresh N., 1998, Indian Journal of Ophthalmology, V46, P221; Wang S, 2009, OPHTHALMOLOGY, V116, P2373, DOI 10.1016/j.ophtha.2009.05.041; Wells G., 2012, THE NEWCASTLE OTTAWA; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; YE JJ, 1992, EXP EYE RES, V55, P797, DOI 10.1016/0014-4835(92)90006-E; Younan C, 2003, OPHTHALMIC EPIDEMIOL, V10, P227, DOI 10.1076/opep.10.4.227.15905; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	67	56	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114012	10.1371/journal.pone.0114012	http://dx.doi.org/10.1371/journal.pone.0114012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474403	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500104
J	Charlson, M; Wells, MT; Ullman, R; King, F; Shmukler, C				Charlson, Mary; Wells, Martin T.; Ullman, Ralph; King, Fionnuala; Shmukler, Celia			The Charlson Comorbidity Index Can Be Used Prospectively to Identify Patients Who Will Incur High Future Costs	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; DISEASE MANAGEMENT; CARE MANAGEMENT; RISK ADJUSTMENT; PREDICT COSTS; OUTCOMES; HOSPITALIZATION; MULTIMORBIDITY; MORBIDITY; QUALITY	Background: Reducing health care costs requires the ability to identify patients most likely to incur high costs. Our objective was to evaluate the ability of the Charlson comorbidity score to predict the individuals who would incur high costs in the subsequent year and to contrast its predictive ability with other commonly used predictors. Methods: We contrasted the prior year Charlson comorbidity index, costs, Diagnostic Cost Group (DCG) and hospitalization as predictors of subsequent year costs from claims data of fund that provides comprehensive health benefits to a large union of health care workers. Total costs in the subsequent year was the principal outcome. Results: Of the 181,764 predominantly Black and Latino beneficiaries, 70% were adults (mean age 45.7 years; 62% women). As the comorbidity index increased, total yearly costs increased significantly (P<001). At lower comorbidity, the costs were similar across different chronic diseases. Using regression to predict total costs, top 5th and 10th percentile of costs, the comorbidity index, prior costs and DCG achieved almost identical explained variance in both adults and children. Conclusions and Relevance: The comorbidity index predicted health costs in the subsequent year, performing as well as prior cost and DCG in identifying those in the top 5% or 10%. The comorbidity index can be used prospectively to identify patients who are likely to incur high costs.	[Wells, Martin T.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Ullman, Ralph; King, Fionnuala; Shmukler, Celia] 1199SEIU Benefit & Pens Funds, New York, NY USA	Cornell University	Charlson, M (corresponding author), Weill Cornell Med Coll, Ctr Integrat Med, New York, NY USA.	mecharl@med.cornell.edu						[Anonymous], 2012, EMPLOYER HLTH BENEFI; Application Guidelines, 2012, PAT CTR OUTC RES I; Arora RR, 2008, DESIGNING IMPLEMENTI; Ash AS, 2000, HEALTH CARE FINANC R, V21, P7; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Claxton G, 2010, HEALTH AFFAIR, V29, P1942, DOI 10.1377/hlthaff.2010.0725; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Di Bari M, 2006, J AM GERIATR SOC, V54, P210, DOI 10.1111/j.1532-5415.2005.00572.x; Duan N., 1984, J BUS ECON STAT, V2, P283, DOI [10.1080/07350015.1984.10509396, DOI 10.1080/07350015.1984.10509396]; Fleishman JA, 2010, HEALTH SERV RES, V45, P532, DOI 10.1111/j.1475-6773.2009.01080.x; Forrest CB, 2009, AM J MANAG CARE, V15, P41; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Goodell S., 2011, MENTAL DISORDERS MED; Goodman RA, 2012, ANN FAM MED, V10, P100, DOI 10.1370/afm.1391; Haas LR, 2013, AM J MANAG CARE, V19, P725; Health and Human Services, 2012, ID STRAT IN MULT CHR; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; HOLTZEAKIN D, 2004, ANAL LIT DIS MANAGEM; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Ivanova JI, 2012, J ALLERGY CLIN IMMUN, V129, P1229, DOI 10.1016/j.jaci.2012.01.039; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kleinman NL, 2009, ANN ALLERG ASTHMA IM, V103, P114, DOI 10.1016/S1081-1206(10)60163-9; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Lee J, 2005, HIGH COST MEDICARE B; LeRoy L, 2014, MED CARE, V52, pS15, DOI 10.1097/MLR.0000000000000095; Li J, 2005, MED CARE, V43, P979, DOI 10.1097/01.mlr.0000178197.32439.ae; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; McCall N, 2011, EVALUATION MEDICARE; Nelson L., 2012, WORKING PAPER SERIES; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez M, 2013, JAMA SURG, V148, P76, DOI 10.1001/2013.jamasurg.3; Rula E, 2009, OUTCOMES INSIGHTS HL, V1, P1; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Soni A, 2009, 5 MOSTLY COSTLY CHIL; Tinetti ME, 2014, MED CARE, V52, pS3, DOI 10.1097/MLR.0000000000000093; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; WILCOX VL, 1994, HEALTH PSYCHOL, V13, P170, DOI 10.1037/0278-6133.13.2.170; Yoon J, 2014, MED CARE, V52, pS31, DOI 10.1097/MLR.0000000000000061	46	148	154	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112479	10.1371/journal.pone.0112479	http://dx.doi.org/10.1371/journal.pone.0112479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469987	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700009
J	Chun, KT; Li, BH; Dobrota, E; Tate, C; Lee, JH; Khan, S; Haneline, L; HogenEsch, H; Skalnik, DG				Chun, Kristin T.; Li, Binghui; Dobrota, Erika; Tate, Courtney; Lee, Jeong-Heon; Khan, Shehnaz; Haneline, Laura; HogenEsch, Harm; Skalnik, David G.			The Epigenetic Regulator CXXC Finger Protein 1 is Essential for Murine Hematopoiesis	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; GENOMIC CYTOSINE METHYLATION; STEM-CELLS; DNA METHYLTRANSFERASE; SELF-RENEWAL; HUMAN TRITHORAX; IDENTIFICATION; DIFFERENTIATION; PROLIFERATION; INACTIVATION	CXXC finger protein 1 (Cfp1), encoded by the Cxxc1 gene, binds to DNA sequences containing an unmethylated CpG dinucleotide and is an epigenetic regulator of both cytosine and histone methylation. Cxxc1-null mouse embryos fail to gastrulate, and Cxxc1-null embryonic stem cells are viable but cannot differentiate, suggesting that Cfp1 is required for chromatin remodeling associated with stem cell differentiation and embryogenesis. Mice homozygous for a conditional Cxxc1 deletion allele and carrying the inducible Mx1-Cre transgene were generated to assess Cfp1 function in adult animals. Induction of Cre expression in adult animals led to Cfp1 depletion in hematopoietic cells, a failure of hematopoiesis with a nearly complete loss of lineage-committed progenitors and mature cells, elevated levels of apoptosis, and death within two weeks. A similar pathology resulted following transplantation of conditional Cxxc1 bone marrow cells into wild type recipients, demonstrating this phenotype is intrinsic to Cfp1 function within bone marrow cells. Remarkably, the Lin(-)Sca-1(+)c-Kit(+) population of cells in the bone marrow, which is enriched for hematopoietic stem cells and multi-potential progenitor cells, persists and expands in the absence of Cfp1 during this time frame. Thus, Cfp1 is necessary for hematopoietic stem and multi-potential progenitor cell function and for the developmental potential of differentiating hematopoietic cells.	[Chun, Kristin T.; Li, Binghui; Dobrota, Erika; Tate, Courtney; Lee, Jeong-Heon; Khan, Shehnaz; Haneline, Laura; Skalnik, David G.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chun, Kristin T.; Tate, Courtney; Skalnik, David G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Chun, Kristin T.; Skalnik, David G.] Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA; [Haneline, Laura] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Haneline, Laura] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Skalnik, DG (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	dskalnik@iupui.edu		HogenEsch, Harm/0000-0002-2738-9189	Riley Children's Foundation; Lilly Endowment; National Science Foundation [MCB-0641851]; National Institutes of Health [RO1 DK66603, T32 AI060519]; Department of Education; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066603] Funding Source: NIH RePORTER	Riley Children's Foundation; Lilly Endowment; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the Riley Children's Foundation, the Lilly Endowment, the National Science Foundation grant MCB-0641851 (to DS), and National Institutes of Health grant RO1 DK66603 (to KC). CT was supported by a pre-doctoral fellowship from National Institutes of Health grant T32 AI060519 and a Department of Education training grant in Graduate Assistance in Areas of National Need. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Butler JS, 2009, DNA CELL BIOL, V28, P223, DOI 10.1089/dna.2009.0854; Butler JS, 2008, DNA CELL BIOL, V27, P533, DOI 10.1089/dna.2007.0714; Carlone DL, 2002, GENE, V295, P71, DOI 10.1016/S0378-1119(02)00820-X; Carlone DL, 2001, MOL CELL BIOL, V21, P7601, DOI 10.1128/MCB.21.22.7601-7606.2001; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; DEGRE M, 1974, INT J CANCER, V14, P699, DOI 10.1002/ijc.2910140602; GRESSER I, 1981, J IMMUNOL, V127, P1569; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li BH, 2003, BLOOD, V101, P1769, DOI 10.1182/blood-2002-05-1517; Li BH, 2007, BLOOD, V110, P2704, DOI 10.1182/blood-2006-12-064154; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Savill J, 1997, BRIT MED BULL, V53, P491; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suzuki M, 2004, AM J HEMATOL, V77, P313, DOI 10.1002/ajh.20178; Tate CM, 2010, FEBS J, V277, P210, DOI 10.1111/j.1742-4658.2009.07475.x; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Young SRL, 2007, DNA CELL BIOL, V26, P80, DOI 10.1089/dna.2006.0535; Young SRL, 2006, J BIOL CHEM, V281, P37034, DOI 10.1074/jbc.M604546200; Zardo G, 2008, LEUKEMIA, V22, P1503, DOI 10.1038/leu.2008.141	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113745	10.1371/journal.pone.0113745	http://dx.doi.org/10.1371/journal.pone.0113745			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470594	Green Published, gold			2022-12-27	WOS:000349128700042
J	Kuduk, K; Babik, W; Bellemain, E; Valentini, A; Zedrosser, A; Taberlet, P; Kindberg, J; Swenson, JE; Radwan, J				Kuduk, Katarzyna; Babik, Wieslaw; Bellemain, Eva; Valentini, Alice; Zedrosser, Andreas; Taberlet, Pierre; Kindberg, Jonas; Swenson, Jon E.; Radwan, Jacek			No Evidence for the Effect of MHC on Male Mating Success in the Brown Bear	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LIFETIME REPRODUCTIVE SUCCESS; MATE CHOICE; PARASITE RESISTANCE; CLASS-I; SEXUAL SELECTION; GENETIC COMPATIBILITY; DIVERSITY; POLYMORPHISM; PREFERENCES	Mate choice is thought to contribute to the maintenance of the spectacularly high polymorphism of the Major Histocompatibility Complex (MHC) genes, along with balancing selection from parasites, but the relative contribution of the former mechanism is debated. Here, we investigated the association between male MHC genotype and mating success in the brown bear. We analysed fragments of sequences coding for the peptide-binding region of the highly polymorphic MHC class I and class II DRB genes, while controlling for genome-wide effects using a panel of 18 microsatellite markers. Male mating success did not depend on the number of alleles shared with the female or amino-acid distance between potential mates at either locus. Furthermore, we found no indication of female mating preferences for MHC similarity being contingent on the number of alleles the females carried. Finally, we found no significant association between the number of MHC alleles a male carried and his mating success. Thus, our results provided no support for the role of mate choice in shaping MHC polymorphism in the brown bear.	[Kuduk, Katarzyna; Babik, Wieslaw; Radwan, Jacek] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland; [Bellemain, Eva; Valentini, Alice] Savoie Technolac, SPYGEN, F-73375 Le Bourget Du Lac, France; [Zedrosser, Andreas; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, NO-1432 As, Norway; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, AT-1180 Vienna, Austria; [Taberlet, Pierre] CNRS, LECA, F-38000 Grenoble, France; [Taberlet, Pierre] Univ Grenoble Alpes, LECA, F-38000 Grenoble, France; [Kindberg, Jonas] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, SE-90183 Umea, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, NO-7485 Trondheim, Norway	Jagiellonian University; Norwegian University of Life Sciences; University of Natural Resources & Life Sciences, Vienna; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Radwan, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	jradwan@amu.edu.pl	valentini, alice/S-2040-2019; Taberlet, Pierre/D-1178-2010; Swenson, Jon/AAE-2890-2019; Valentini, Alice/AFS-1389-2022; Kindberg, Jonas/AAA-5058-2020	Taberlet, Pierre/0000-0002-3554-5954; Valentini, Alice/0000-0001-5829-5479; Kindberg, Jonas/0000-0003-1445-4524; Radwan, Jacek/0000-0001-8503-5701; Babik, Wieslaw/0000-0002-1698-6615	Polish Ministry of Science and Higher Education [N N303 457338]; Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation; Research Council of Norway; SPYGEN	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation(Austrian Science Fund (FWF)); Research Council of Norway(Research Council of Norway); SPYGEN	Funding: This work was supported by grant N N303 457338 from the Polish Ministry of Science and Higher Education to JR. The Scandinavian Brown Bear Research Project (SBBRP) is funded by the Swedish Environmental Protection Agency, Norwegian Directorate for Nature Management, Swedish Association for Hunting and Wildlife Management, the Austrian Science Foundation, and the Research Council of Norway. SPYGEN provided support in the form of salaries for authors EB and EV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biedrzycka A, 2011, MAMM BIOL, V76, P672, DOI 10.1016/j.mambio.2011.05.002; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Dahle B, 2003, BEHAV ECOL SOCIOBIOL, V54, P352, DOI 10.1007/s00265-003-0638-8; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Dunn PO, 2013, EVOLUTION, V67, P679, DOI 10.1111/j.1558-5646.2012.01799.x; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Ejsmond MJ, 2014, P R SOC L B IN PRESS; Ekblom R, 2004, MOL ECOL, V13, P3821, DOI 10.1111/j.1365-294X.2004.02361.x; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Friebe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101410; Furlong RF, 2008, J MOL EVOL, V66, P384, DOI 10.1007/s00239-008-9092-6; Hadfield JD, J STAT SOFTWARE, V33, P1; HEDRICK PW, 1992, GENETICS, V132, P575; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; Huchard E, 2013, MOL ECOL, V19, P2545; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Janeway C.A., 2004, IMMUNOBIOLOGY IMMUNE; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; Kuduk K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-197; Lampert KP, 2006, BEHAV ECOL SOCIOBIOL, V59, P796, DOI 10.1007/s00265-005-0125-5; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lanyon CV, 2007, FEMS MICROBIOL ECOL, V59, P576, DOI 10.1111/j.1574-6941.2006.00252.x; Lariviere S, 2003, J MAMMAL, V84, P937, DOI 10.1644/BME-003; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lighten J, 2014, MOL ECOLOGY RESOURCE; Madsen T, 2006, J EVOLUTION BIOL, V19, P1973, DOI 10.1111/j.1420-9101.2006.01158.x; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; POTTS WK, 1990, IMMUNOL TODAY, V11, P39, DOI 10.1016/0167-5699(90)90014-Z; Radwan J, 2008, ETHOLOGY, V114, P827, DOI 10.1111/j.1439-0310.2008.01528.x; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Sepil I, 2013, MOL ECOL, V22, P384, DOI 10.1111/mec.12123; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sommer S, 2005, BEHAV ECOL SOCIOBIOL, V58, P181, DOI 10.1007/s00265-005-0909-7; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Strandh M, 2012, P ROY SOC B-BIOL SCI, V279, P4457, DOI 10.1098/rspb.2012.1562; Swenson JE, 2001, URSUS-SERIES, V12, P69; TAKAHATA N, 1990, GENETICS, V124, P967; Thonhauser KE, 2014, ANIM BEHAV, V93, P135, DOI 10.1016/j.anbehav.2014.04.028; Thoss M, 2011, MOL ECOL, V20, P1546, DOI 10.1111/j.1365-294X.2011.05009.x; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Winternitz JC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1605; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1981, BEHAV GENET, V11, P616; Zedrosser A, 2013, ECOLOGY, V94, P231, DOI 10.1890/12-0229.1	70	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113414	10.1371/journal.pone.0113414	http://dx.doi.org/10.1371/journal.pone.0113414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470381	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000349128700026
J	Lieverse, AR; Temple, DH; Bazaliiskii, VI				Lieverse, Angela R.; Temple, Daniel H.; Bazaliiskii, Vladimir I.			Paleopathological Description and Diagnosis of Metastatic Carcinoma in an Early Bronze Age (4588+34 Cal. BP) Forager from the Cis-Baikal Region of Eastern Siberia	PLOS ONE			English	Article							MIDDLE HOLOCENE; HUMAN SKELETON; CANCER; ANTIQUITY; MENINGIOMA; DISEASE; REMAINS; LESIONS; PEOPLE; TUMORS	Extensive osteolytic and osteoblastic lesions were observed on the skeletal remains of an adult male excavated from an Early Bronze Age cemetery dated to 4556+32 years BP, located in the Cis-Baikal region of Siberia (Russian Federation). Lytic lesions ranged in size from several mm to over 60 mm in diameter and had irregular, moth-eaten borders. Many of these lesions destroyed trabecular bone, though a hollowed shell of cortical bone often remained observable. Radiographic analysis revealed numerous lytic lesions within trabecular bone that had not yet affected the cortex. Blastic lesions were identified as spiculated lines, bands, or nodules of mostly immature (woven) bone formed at irregular intervals. Anatomical elements with the greatest involvement included those of the axial skeleton (skull, vertebrae, sacrum, ribs, and sternum) as well as proximal appendicular elements (ossa coxae, proximal femora, clavicles, scapulae, and proximal humeri). Osteocoalescence of destructive foci was observed on the ilium and frontal bone, with the largest lesion found on the right ilium. Differential diagnoses include metastatic carcinoma, mycotic infections, tuberculosis, Langerhan's cell histiocytosis, and multiple myeloma. Based on lesion appearance and distribution, age and sex of the individual, as well as pathogen endemism, the most likely diagnostic option for this set of lesions is metastatic carcinoma. The age and sex of this individual and appearance of the lesions may reflect carcinoma of the lung or, possibly, prostate. This represents one of the earliest cases of metastatic carcinoma worldwide and the oldest case documented thus far from Northeast Asia.	[Lieverse, Angela R.] Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK S7N 5B1, Canada; [Temple, Daniel H.] George Mason Univ, Dept Sociol & Anthropol, Fairfax, VA 22030 USA; [Bazaliiskii, Vladimir I.] Irkutsk State Univ, Dept Archaeol & Ethnog, Irkutsk 664003, Russia	University of Saskatchewan; George Mason University; Irkutsk State University	Lieverse, AR (corresponding author), Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK S7N 5B1, Canada.	angela.lieverse@usask.ca	Bazaliiskii, Vladimir/K-9972-2017; Lieverse, Angela R./AAL-7397-2021	Lieverse, Angela/0000-0003-0711-1793	Social Sciences and Humanities Research Council of Canada [412-2011-1001]; University of Saskatchewan; University of North Carolina Wilmington	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of Saskatchewan; University of North Carolina Wilmington	Funding: This research is part of the Baikal-Hokkaido Archaeology Project funded largely by the Social Sciences and Humanities Research Council of Canada (grant #412-2011-1001). Funding was also provided by the University of Saskatchewan and the University of North Carolina Wilmington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 2002, INT J OSTEOARCHAEOL, V12, P442, DOI 10.1002/oa.647; Assis S, 2010, INT J OSTEOARCHAEOL, V20, P603, DOI 10.1002/oa.1084; Aufderheide AC, 1998, CAMBRIDGE ENCY HUMAN, P373; Baker BJ, 1999, TUBERCULOSIS PRESENT, P301; Binder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090924; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brothwell D., 1967, DIS ANTIQUITY, P320; Brothwell D, 2012, BLACKW COMPANION ANT, P420; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Buikstra J.E., 1994, STANDARDS DATA COLLE; Buikstra J. E., 1981, PREHISTORIC TUBERCUL, P115; Capasso LL, 2005, INT J CANCER, V113, P2, DOI 10.1002/ijc.20610; Chard C.S., 1974, NE ASIA PREHISTORY; Chick EW, 1971, HUMAN INFECT FUNGI A, P405; Collins Conor D, 2004, Cancer Imaging, V4 Spec No A, pS47, DOI 10.1102/1470-7330.2004.0010; COLLINS VP, 1950, AM J ROENTGENOL, V63, P102; Copeland MM, 1931, RADIOLOGY, V16, P198; CZARNETZKI A, 1980, J HUM EVOL, V9, P15, DOI 10.1016/0047-2484(80)90037-8; David AR, 2010, NAT REV CANCER, V10, P728, DOI 10.1038/nrc2914; DELARUA C, 1995, INT J OSTEOARCHAEOL, V5, P254, DOI 10.1002/oa.1390050304; Domett KM, 2012, INT J OSTEOARCHAEOL, V22, P731, DOI 10.1002/oa.1234; Dorfman H.D., 1998, BONE TUMORS; DRUTZ DJ, 1978, AM REV RESPIR DIS, V117, P559; El-Najjar MY, 1981, PREHISTORIC TUBERCUL, P85; Fink TM, 1985, HLTH DIS PREHISTORIC, P324; Gerszten PC, 2001, NEUROSURGERY, V48, P208, DOI 10.1097/00006123-200101000-00039; Greenspan A, 1998, DIFFERENTIAL DIAGNOS, P368; Grmek M. D., 1975, HIST SCI MED, V1, P1; Halperin EC, 2004, PERSPECT BIOL MED, V47, P1, DOI 10.1353/pbm.2004.0010; Hershkovitz I, 1998, AM J PHYS ANTHROPOL, V106, P47, DOI 10.1002/(SICI)1096-8644(199805)106:1<47::AID-AJPA4>3.0.CO;2-A; Hill K., 1996, ACHE LIFE HIST DEMOG; Holloway KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062798; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jonsdottir B, 2003, AM J PHYS ANTHROPOL, V122, P232, DOI 10.1002/ajpa.10285; KELLEY MA, 1987, MIDCONTINENTAL J ARC, V12, P89; Konigsberg LW, 2006, SCH AM RES, P267; Kozlowski T, 2012, BLACKW COMPANION ANT, P401; Lieverse A. R., 2007, NO HUNTER GATHERERS, V3, P11; Lieverse A.R., 2005, THESIS CORNELL U ITH; Long JC, 1981, PREHISTORIC TUBERCUL, P69; Luna LH, 2008, INT J OSTEOARCHAEOL, V18, P492, DOI 10.1002/oa.950; MANN RW, 1987, J FORENSIC SCI, V32, P148; Marks MK, 2007, INT J OSTEOARCHAEOL, V17, P217, DOI 10.1002/oa.874; Meindl R.S., 1989, AGE MARKERS HUMAN SK, P137; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; MICOZZI MS, 1991, ARCH PATHOL LAB MED, V115, P838; Monge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064539; Mulligan M E, 2000, Semin Musculoskelet Radiol, V4, P127, DOI 10.1055/s-2000-6860; MUNDY GR, 1974, NEW ENGL J MED, V291, P1041, DOI 10.1056/NEJM197411142912001; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nagaoka T, 2008, ANTHROPOL SCI, V116, P161, DOI 10.1537/ase.070724; Nagaoka T, 2012, ANTHROPOL SCI, V120, P103, DOI 10.1537/ase.1107311; Nerlich AG, 2006, ONCOL REP, V16, P197; Okladnikov AP, 1950, NEOLIT BRONZOVYI V 3, V18; Okladnikov AP, 1955, NEOLIT BRONZOVYI V 3, V43; Ortner D. J., 2003, IDENTIFICATION PATHO, V2nd, P45, DOI [10.1016/B978-012528628-2/50041-7, DOI 10.1016/B978-012528628-2/50041-7]; Ortner DJ, 2012, INT J OSTEOARCHAEOL, V22, P245, DOI 10.1002/oa.1196; Paine RR, 2007, PALEODEMOGRAPHIC DAT; Prates C, 2011, INT J PALEOPATHOL, V1, P98, DOI 10.1016/j.ijpp.2011.09.002; RESNICK D., 1995, DIAGNOSIS BONE JOINT, P2325; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Rothschild BM, 1998, AM J PHYS ANTHROPOL, V105, P241, DOI 10.1002/(SICI)1096-8644(199802)105:2<241::AID-AJPA10>3.0.CO;2-0; ROTHSCHILD BM, 1995, AM J PHYS ANTHROPOL, V96, P357, DOI 10.1002/ajpa.1330960404; Salfelder K, 1971, HUMAN INFECTION FUNG, P383; SANDISON AT, 1975, LANCET, V1, P279; Santos AL, 2001, AM J PHYS ANTHROPOL, V115, P38, DOI 10.1002/ajpa.1054; Schillaci M.A., 1999, J PALEOPATHOL, V11, P41; Schultz M., 1997, FORENSIC TAPHONOMY P, P201; Schultz M, 2007, INT J CANCER, V121, P2591, DOI 10.1002/ijc.23073; Sefcakova A, 2001, AM J PHYS ANTHROPOL, V116, P216, DOI 10.1002/ajpa.1117; Smith MO, 2002, INT J OSTEOARCHAEOL, V12, P235, DOI 10.1002/oa.618; STATHOPOULOS G, 1975, LANCET, V1, P165; Steinbock R., 1976, PALEOPATHOLOGICAL DI; STROUHAL E, 1978, B NEW YORK ACAD MED, V54, P290; Strouhal E, 1998, J PALEOPATHOLOGY, V19, P101; SUZUKI T, 1989, Zeitschrift fuer Morphologie und Anthropologie, V78, P73; Temple DH, 2006, INT J OSTEOARCHAEOL, V16, P316, DOI 10.1002/oa.827; TOBIAS PV, 1960, NATURE, V185, P946, DOI 10.1038/185946a0; Turner-Walker G., 2008, ADV HUM PALAEOPATHOL, P3, DOI [10.1002/9780470724187.ch1, DOI 10.1002/9780470724187.CH1]; Ubelaker DH., 1997, FORENSIC TAPHONOMY P, P77; WADA Y, 1987, J ANTHROPOL SOC NIP, V95, P107; WAKELY J, 1995, J ARCHAEOL SCI, V22, P469, DOI 10.1006/jasc.1995.0046; Wasterlain SN, 2011, INT J OSTEOARCHAEOL, V21, P336, DOI 10.1002/oa.1130; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; Weber AW, 2011, J ANTHROPOL ARCHAEOL, V30, P523, DOI 10.1016/j.jaa.2011.06.006; Weber AW, 2006, RADIOCARBON, V48, P127, DOI 10.1017/S0033822200035463; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber J, 2002, INT J OSTEOARCHAEOL, V12, P385, DOI 10.1002/oa.637; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Zimmerman M.L., 1956, CRYPTOCOCCOSIS TORUL; ZIMMERMAN MR, 1977, CANCER, V40, P1358, DOI 10.1002/1097-0142(197709)40:3<1358::AID-CNCR2820400354>3.0.CO;2-J	91	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113919	10.1371/journal.pone.0113919	http://dx.doi.org/10.1371/journal.pone.0113919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470373	Green Published, gold			2022-12-27	WOS:000349128700054
J	Naville, M; Chalopin, D; Volff, JN				Naville, Magali; Chalopin, Domitille; Volff, Jean-Nicolas			Interspecies Insertion Polymorphism Analysis Reveals Recent Activity of Transposable Elements in Extant Coelacanths	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; EVOLUTIONARY HISTORY; GENOME; GENES; SEQUENCE; ALIGNMENT; PROVIDES; FISH; DNA	Coelacanths are lobe-finned fish represented by two extant species, Latimeria chalumnae in South Africa and Comoros and L. menadoensis in Indonesia. Due to their intermediate phylogenetic position between ray-finned fish and tetrapods in the vertebrate lineage, they are of great interest from an evolutionary point of view. In addition, extant specimens look similar to 300 million-year-old fossils; because of their apparent slowly evolving morphology, coelacanths have been often described as "living fossils". As an underlying cause of such a morphological stasis, several authors have proposed a slow evolution of the coelacanth genome. Accordingly, sequencing of the L. chalumnae genome has revealed a globally low substitution rate for protein-coding regions compared to other vertebrates. However, genome and gene evolution can also be influenced by transposable elements, which form a major and dynamic part of vertebrate genomes through their ability to move, duplicate and recombine. In this work, we have searched for evidence of transposition activity in coelacanth genomes through the comparative analysis of orthologous genomic regions from both Latimeria species. Comparison of 5.7 Mb (0.2%) of the L. chalumnae genome with orthologous Bacterial Artificial Chromosome clones from L. menadoensis allowed the identification of 27 species-specific transposable element insertions, with a strong relative contribution of CR1 non-LTR retrotransposons. Species-specific homologous recombination between the long terminal repeats of a new coelacanth endogenous retrovirus was also detected. Our analysis suggests that transposon activity is responsible for at least 0.6% of genome divergence between both Latimeria species. Taken together, this study demonstrates that coelacanth genomes are not evolutionary inert: they contain recently active transposable elements, which have significantly contributed to post-speciation genome divergence in Latimeria.	[Naville, Magali; Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Volff, JN (corresponding author), Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France.	jean-nicolas.volff@ens-lyon.fr			Ecole Normale Superieure de Lyon; French Ministry for Higher Education and Research; "Ligue Contre le Cancer"	Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); French Ministry for Higher Education and Research; "Ligue Contre le Cancer"(Ligue nationale contre le cancer)	Funding: MN is supported by the Ecole Normale Superieure de Lyon; DC is supported by a PhD grant from the French Ministry for Higher Education and Research, and by the "Ligue Contre le Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casane D, 2013, BIOESSAYS, V35, P332, DOI 10.1002/bies.201200145; Chalopin D, 2014, J EXP ZOOL PART B, V322, P322, DOI 10.1002/jez.b.22521; CHARLESWORTH B, 1983, GENET RES, V42, P1, DOI 10.1017/S0016672300021455; Cloutier R, 1996, MORPHOLOGY CHARACTER; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Forconi M, 2014, J EXP ZOOL PART B, V322, P379, DOI 10.1002/jez.b.22527; Fricke H, 2011, MAR BIOL, V158, P1511, DOI 10.1007/s00227-011-1667-x; Friedman M, 2006, P ROY SOC B-BIOL SCI, V273, P245, DOI 10.1098/rspb.2005.3316; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gwee PC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-93; Haas NB, 1997, GENE, V197, P305, DOI 10.1016/S0378-1119(97)00276-X; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Higasa K, 2012, GENE, V505, P324, DOI 10.1016/j.gene.2012.05.047; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P38, DOI 10.1093/molbev/msg011; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Le Rouzic A, 2005, GENETICS, V169, P1033, DOI 10.1534/genetics.104.031211; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maisey J.G., 1996, DISCOVERING FOSSIL F; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Pallavicini A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-538; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Smit A, 1996, REPEATMASKER OPEN 30; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Smith JLB, 1956, OLD FOURLEGS STORY C; Thomson KS, 1992, LIVING FOSSIL STORY; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	46	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114382	10.1371/journal.pone.0114382	http://dx.doi.org/10.1371/journal.pone.0114382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470617	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700112
J	Townsend, PD; Jungwirth, B; Pojer, F; Bussmann, M; Money, VA; Cole, ST; Puhler, A; Tauch, A; Bott, M; Cann, MJ; Pohl, E				Townsend, Philip D.; Jungwirth, Britta; Pojer, Florence; Bussmann, Michael; Money, Victoria A.; Cole, Stewart T.; Puehler, Alfred; Tauch, Andreas; Bott, Michael; Cann, Martin J.; Pohl, Ehmke			The Crystal Structures of Apo and cAMP-Bound GlxR from Corynebacterium glutamicum Reveal Structural and Dynamic Changes upon cAMP Binding in CRP/FNR Family Transcription Factors	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; CAP-DNA COMPLEX; ESCHERICHIA-COLI; BIOTECHNOLOGICAL PRODUCTION; REGULATOR GLXR; IDENTIFICATION; ACTIVATION; RESOLUTION; GENES; SITES	The cyclic AMP-dependent transcriptional regulator GlxR from Corynebacterium glutamicum is a member of the super-family of CRP/FNR (cyclic AMP receptor protein/fumarate and nitrate reduction regulator) transcriptional regulators that play central roles in bacterial metabolic regulatory networks. In C. glutamicum, which is widely used for the industrial production of amino acids and serves as a nonpathogenic model organism for members of the Corynebacteriales including Mycobacterium tuberculosis, the GlxR homodimer controls the transcription of a large number of genes involved in carbon metabolism. GlxR therefore represents a key target for understanding the regulation and coordination of C. glutamicum metabolism. Here we investigate cylic AMP and DNA binding of GlxR from C. glutamicum and describe the crystal structures of apo GlxR determined at a resolution of 2.5 angstrom, and two crystal forms of holo GlxR at resolutions of 2.38 and 1.82 angstrom, respectively. The detailed structural analysis and comparison of GlxR with CRP reveals that the protein undergoes a distinctive conformational change upon cyclic AMP binding leading to a dimer structure more compatible to DNA-binding. As the two binding sites in the GlxR homodimer are structurally identical dynamic changes upon binding of the first ligand are responsible for the allosteric behavior. The results presented here show how dynamic and structural changes in GlxR lead to optimization of orientation and distance of its two DNA-binding helices for optimal DNA recognition.	[Townsend, Philip D.; Money, Victoria A.; Cann, Martin J.; Pohl, Ehmke] Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England; [Townsend, Philip D.; Money, Victoria A.; Cann, Martin J.; Pohl, Ehmke] Univ Durham, Biophys Sci Inst, Dept Chem, Durham, England; [Jungwirth, Britta; Puehler, Alfred; Tauch, Andreas] Univ Bielefeld, Ctr Biotechnol CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Pojer, Florence; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Prot Crystallog Core Facil, Lausanne, Switzerland; [Bussmann, Michael; Bott, Michael] Forschungszentrum Julich, IBG Biotechnol 1, Inst Bio & Geosci, D-52425 Julich, Germany	Durham University; Durham University; University of Bielefeld; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Research Center Julich	Pohl, E (corresponding author), Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England.	ehmke.pohl@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012; Townsend, Phiip/J-3761-2018; Bott, Michael/E-8004-2011	Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Townsend, Phiip/0000-0001-9235-3492; Bott, Michael/0000-0002-4701-8254; Puhler, Alfred/0000-0003-4723-2960	Engineering and Physical Sciences Research Council [EP/H051759/1]; Swiss National Science Foundation [31003A_140778]; EPSRC [EP/H051759/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), EP/H051759/1 to MJC and EP and Swiss National Science Foundation (www.snf.ch), 31003A_140778 to STC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bussmann M, 2009, J BIOTECHNOL, V143, P173, DOI 10.1016/j.jbiotec.2009.06.025; Chu SY, 2001, J BIOL CHEM, V276, P11230, DOI 10.1074/jbc.M010428200; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Han SO, 2007, MICROBIOL-SGM, V153, P2190, DOI 10.1099/mic.0.2006/004366-0; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jungwirth B, 2013, MICROBIOL-SGM, V159, P12, DOI 10.1099/mic.0.062059-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HJ, 2004, J BACTERIOL, V186, P3453, DOI 10.1128/JB.186.11.3453-3460.2004; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2001, J BIOCHEM-TOKYO, V130, P57, DOI 10.1093/oxfordjournals.jbchem.a002962; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Litsanov B, 2012, APPL ENVIRON MICROB, V78, P3325, DOI 10.1128/AEM.07790-11; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Moore JL, 1996, J BIOL CHEM, V271, P21273, DOI 10.1074/jbc.271.35.21273; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Panhorst M, 2011, J BIOTECHNOL, V154, P149, DOI 10.1016/j.jbiotec.2010.07.015; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Pohl E, 1998, J BIOL CHEM, V273, P22420, DOI 10.1074/jbc.273.35.22420; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Rodgers TL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-183; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toncrova H, 2010, BIOPHYS J, V98, P2317, DOI 10.1016/j.bpj.2010.01.039; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Utagawa T, 2004, J NUTR, V134, p2854S, DOI 10.1093/jn/134.10.2854S; Vertes AA, 2008, J MOL MICROB BIOTECH, V15, P16, DOI 10.1159/000111989; Vogt M, 2014, METAB ENG, V22, P40, DOI 10.1016/j.ymben.2013.12.001; Wendisch VF, 2006, CURR OPIN MICROBIOL, V9, P268, DOI 10.1016/j.mib.2006.03.001; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166; Yukawa H, 2004, ABSTR PAP AM CHEM S, V227, pU301	59	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113265	10.1371/journal.pone.0113265	http://dx.doi.org/10.1371/journal.pone.0113265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469635	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000349128700019
J	Kashiwagi, T; Hara, K; Nakazono, Y; Uemura, Y; Imamura, Y; Hamada, N; Watanabe, H				Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Uemura, Yusaku; Imamura, Yoshihiro; Hamada, Nobuyuki; Watanabe, Hiroshi			The N-Terminal Fragment of a PB2 Subunit from the Influenza A Virus (A/Hong Kong/156/1997 H5N1) Effectively Inhibits RNP Activity and Viral Replication	PLOS ONE			English	Article							POLYMERASE PA SUBUNIT; NEURAMINIDASE INHIBITOR; PROMOTER-BINDING; PROTEIN; IDENTIFICATION; MECHANISM; SITES; REASSORTMENT; OSELTAMIVIR; RWJ-270201	Background: Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1, PB2 and PA subunit), which assemble with nucleoproteins (NP) and a viral RNA (vRNA) to form a RNP complex in the host nucleus. Recently, we demonstrated that the combination of influenza ribonucleoprotein (RNP) components is important for both its assembly and activity. Therefore, we questioned whether the inhibition of the RNP combination via an incompatible component in the RNP complex could become a methodology for an anti-influenza drug. Methodology/Principal Findings: We found that a H5N1 PB2 subunit efficiently inhibits H1N1 RNP assembly and activity. Moreover, we determined the domains and important amino acids on the N-terminus of the PB2 subunit that are required for a strong inhibitory effect. The NP binding site of the PB2 subunit is important for the inhibition of RNP activity by another strain. A plaque assay also confirmed that a fragment of the PB2 subunit could inhibit viral replication. Conclusions/Significance: Our results suggest that the N-terminal fragment of a PB2 subunit becomes an inhibitor that targets influenza RNP activity that is different from that targeted by current drugs such as M2 and NA inhibitors.	[Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Uemura, Yusaku; Imamura, Yoshihiro; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Control & Prevent, Fukuoka, Japan	Kurume University	Kashiwagi, T (corresponding author), Kurume Univ, Sch Med, Dept Infect Control & Prevent, Fukuoka, Japan.	takahito@med.kurume-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [24591590]; Ishibashi Foundation for the Promotion of Science	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ishibashi Foundation for the Promotion of Science	This study was supported by grants from the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 24591590, 2012-2015, and the Ishibashi Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Chase G, 2011, METHODS, V55, P188, DOI 10.1016/j.ymeth.2011.08.007; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hara K, 2013, J GEN VIROL, V94, P2406, DOI 10.1099/vir.0.053959-0; HAYDEN FG, 1994, ANTIVIR RES, V25, P123, DOI 10.1016/0166-3542(94)90101-5; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li CF, 2013, FEBS J, V280, P1139, DOI 10.1111/febs.12107; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Reuther P, 2011, J VIROL, V85, P13298, DOI 10.1128/JVI.00868-11; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; Sidwell RW, 2001, ANTIMICROB AGENTS CH, V45, P749, DOI 10.1128/AAC.45.3.749-757.2001; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004	39	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114502	10.1371/journal.pone.0114502	http://dx.doi.org/10.1371/journal.pone.0114502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460916	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700140
J	Wong, BX; Tsatsanis, A; Lim, LQ; Adlard, PA; Bush, AI; Duce, JA				Wong, Bruce X.; Tsatsanis, Andrew; Lim, Linh Q.; Adlard, Paul A.; Bush, Ashley I.; Duce, James A.			beta-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin	PLOS ONE			English	Article							OXIDATIVE STRESS; CEREBROSPINAL-FLUID; EXPRESSION; CERULOPLASMIN; INCREASES; ROLES; TRANSPORTER; TRANSFERRIN; PHOSPHATE; COMPLEX	Ceruloplasmin is a ferroxidase that interacts with ferroportin to export cellular iron, but is not expressed in neurons. We recently reported that the amyloid precursor protein (APP) is the analogous iron-exporting chaperone for neurons and other cells. The ferroxidase activity of APP has since been called into question. Using a triplex Fe2+ oxidation assay, we analyzed the activity of a soluble form of APP (sAPP alpha) within a buffer of physiological pH and anionic charge, and determined that iron oxidation originated from phosphate. Using various techniques such as flow-cytometry to measure surface presented proteins, we confirmed that endogenous APP is essential for ferroportin persistence on the neuronal surface. Therefore, despite lacking ferroxidase activity, APP still supports iron export from neurons.	[Wong, Bruce X.; Lim, Linh Q.; Adlard, Paul A.; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Tsatsanis, Andrew; Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Lim, Linh Q.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia; [Adlard, Paul A.; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Leeds; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	ashley.bush@florey.edu.au; J.A.Duce@leeds.ac.uk	Wong, Bruce/AAY-5884-2020; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Wong, Bruce/0000-0002-1687-4138; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245	National Health & Medical Research Council (NHMRC) [1025774, 1044542]; Alzheimer's Research UK fellowship; Victorian Government; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Research UK fellowship; Victorian Government; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The work carried out in Australia by BXW, LQL, PAA, AIB and JAD was supported by funding from the National Health & Medical Research Council (NHMRC) (Project grant #1025774 and #1044542). Work based in the United Kingdom by AT and JAD was funded by Alzheimer's Research UK fellowship. The Florey Institute of Neuroscience and Mental Health acknowledges support from the Victorian Government for funding from the Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1967, J BIOL CHEM, V242, P2484; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; Caldwell JH, 2013, MECH DEVELOP, V130, P433, DOI 10.1016/j.mod.2012.11.001; Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Crichton R. R., 2009, INORGANIC BIOCH IRON; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Ebrahimi KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040287; Erel O, 1998, CLIN CHEM, V44, P2313; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; GORDEUK VR, 1988, J CLIN INVEST, V82, P1934, DOI 10.1172/JCI113812; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Guerreiro PM, 2014, AM J PHYSIOL-RENAL, V306, pF1275, DOI 10.1152/ajprenal.00458.2013; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; Harris WR, 2012, BBA-GEN SUBJECTS, V1820, P348, DOI 10.1016/j.bbagen.2011.07.017; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hilton RJ, 2012, J INORG BIOCHEM, V110, P1, DOI 10.1016/j.jinorgbio.2012.02.017; Honarnejad K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080645; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; Hruska KA, 2011, ADV CHRONIC KIDNEY D, V18, P98, DOI 10.1053/j.ackd.2011.01.001; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; JANDL JH, 1963, J CLIN INVEST, V42, P314, DOI 10.1172/JCI104718; JOHNSON DA, 1967, CLIN CHEM, V13, P142; Kaneko K, 2002, FREE RADICAL RES, V36, P303, DOI 10.1080/10715760290019327; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; MINOTTI G, 1992, J BIOL CHEM, V267, P7611; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Patel BN, 2002, J NEUROSCI, V22, P6578; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wan L, 2012, J ALZHEIMERS DIS, V30, P523, DOI 10.3233/JAD-2012-111169; Wan L, 2011, FREE RADICAL BIO MED, V50, P122, DOI 10.1016/j.freeradbiomed.2010.10.707; Weiss G, 2013, NAT REV RHEUMATOL, V9, P205, DOI 10.1038/nrrheum.2012.183; White AR, 1998, J NEUROSCI, V18, P6207; Wong BX, 2014, BBA-GEN SUBJECTS, V1840, P3299, DOI 10.1016/j.bbagen.2014.08.006; Wong BX, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00081; Wong BX, 2014, BBA IN PRESS; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Yang FM, 2002, AM J PHYSIOL-LUNG C, V283, pL932, DOI 10.1152/ajplung.00114.2002; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Yoshida K, 2000, J NEUROL SCI, V175, P91, DOI 10.1016/S0022-510X(00)00295-1	55	108	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114174	10.1371/journal.pone.0114174	http://dx.doi.org/10.1371/journal.pone.0114174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464026	Green Published, gold			2022-12-27	WOS:000345869700112
J	Patel, V; Oh, A; Voit, A; Sultatos, LG; Babu, GJ; Wilson, BA; Ho, MF; McArdle, JJ				Patel, Vishwendra; Oh, Anne; Voit, Antanina; Sultatos, Lester G.; Babu, Gopal J.; Wilson, Brenda A.; Ho, Mengfei; McArdle, Joseph J.			Altered Active Zones, Vesicle Pools, Nerve Terminal Conductivity, and Morphology during Experimental MuSK Myasthenia Gravis	PLOS ONE			English	Article							MUSCLE-SPECIFIC KINASE; NEUROMUSCULAR-JUNCTION FORMATION; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; CLINICAL FINDINGS; DISTINCT ROLES; SAFETY FACTOR; MOTOR-NERVE; END-PLATES; COLLAGEN Q	Recent studies demonstrate reduced motor-nerve function during autoimmune muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG). To further understand the basis of motor-nerve dysfunction during MuSK-MG, we immunized female C57/B6 mice with purified rat MuSK ectodomain. Nerve-muscle preparations were dissected and neuromuscular junctions (NMJs) studied electrophysiologically, morphologically, and biochemically. While all mice produced antibodies to MuSK, only 40% developed respiratory muscle weakness. In vitro study of respiratory nerve-muscle preparations isolated from these affected mice revealed that 78% of NMJs produced endplate currents (EPCs) with significantly reduced quantal content, although potentiation and depression at 50 Hz remained qualitatively normal. EPC and mEPC amplitude variability indicated significantly reduced number of vesicle-release sites (active zones) and reduced probability of vesicle release. The readily releasable vesicle pool size and the frequency of large amplitude mEPCs also declined. The remaining NMJs had intermittent (4%) or complete (18%) failure of neurotransmitter release in response to 50 Hz nerve stimulation, presumably due to blocked action potential entry into the nerve terminal, which may arise from nerve terminal swelling and thinning. Since MuSK-MG-affected muscles do not express the AChR gamma subunit, the observed prolongation of EPC decay time was not due to inactivity-induced expression of embryonic acetylcholine receptor, but rather to reduced catalytic activity of acetylcholinesterase. Muscle protein levels of MuSK did not change. These findings provide novel insight into the pathophysiology of autoimmune MuSK-MG.	[Patel, Vishwendra; Oh, Anne; Sultatos, Lester G.; McArdle, Joseph J.] Rutgers State Univ, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07102 USA; [Voit, Antanina; Babu, Gopal J.] Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA; [Wilson, Brenda A.; Ho, Mengfei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign	McArdle, JJ (corresponding author), Rutgers State Univ, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07102 USA.	mcardle@njms.rutgers.edu	Ho, Mengfei/Q-6844-2019; Patel, Vishwendra/AAC-6817-2022; Babu, Gopal/AAB-7787-2021	Babu, Gopal/0000-0001-7833-5300; Ho, Mengfei/0000-0002-8315-8158	FM Kirby Foundation, Inc.	FM Kirby Foundation, Inc.	Funding: This research was supported by the FM Kirby Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGAUTPETIT D, 1982, PROC R SOC SER B-BIO, V215, P117, DOI 10.1098/rspb.1982.0031; ARGENTIERI TM, 1992, PFLUG ARCH EUR J PHY, V421, P256, DOI 10.1007/BF00374835; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Cole RN, 2010, J PHYSIOL-LONDON, V588, P3217, DOI 10.1113/jphysiol.2010.190298; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Court FA, 2008, GLIA, V56, P471, DOI 10.1002/glia.20620; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2013, J PHYSIOL-LONDON, V591, P2377, DOI 10.1113/jphysiol.2013.254599; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Evoli A, 2008, ANN NY ACAD SCI, V1132, P76, DOI 10.1196/annals.1405.012; Evoli A, 2013, AUTOIMMUN REV, V12, P931, DOI 10.1016/j.autrev.2013.03.004; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; Ghazanfari N, 2014, J PHYSIOL-LONDON, V592, P2881, DOI 10.1113/jphysiol.2013.270207; Ghazanfari N, 2011, INT J BIOCHEM CELL B, V43, P295, DOI 10.1016/j.biocel.2010.10.008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Guptill JT, 2011, MUSCLE NERVE, V44, P36, DOI 10.1002/mus.22006; Guptill JT, 2010, CURR OPIN NEUROL, V23, P530, DOI 10.1097/WCO.0b013e32833c0982; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Isabel MPV, 2005, J BIOL CHEM, V280, P31801, DOI 10.1074/jbc.M502874200; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Kawakami Y, 2011, NEUROLOGY, V77, P1819, DOI 10.1212/WNL.0b013e318237f660; Keung B, 2013, J NEUROL NEUROSUR PS, V84, P1407, DOI 10.1136/jnnp-2012-303664; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Klooster R, 2012, BRAIN, V135, P1081, DOI 10.1093/brain/aws025; Koneczny I, 2014, J ANAT, V224, P29, DOI 10.1111/joa.12034; Koneczny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080695; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; MCARDLE JJ, 1983, PROG NEUROBIOL, V21, P135, DOI 10.1016/0301-0082(83)90001-1; MCARDLE JJ, 1981, J NEUROSCI METH, V4, P109, DOI 10.1016/0165-0270(81)90044-3; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Mori S, 2013, AUTOIMMUN REV, V12, P912, DOI 10.1016/j.autrev.2013.03.005; Mori S, 2012, J NEUROIMMUNOL, V245, P75, DOI 10.1016/j.jneuroim.2012.02.010; Mori S, 2012, AM J PATHOL, V180, P798, DOI 10.1016/j.ajpath.2011.10.031; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Morsch M, 2012, EXP NEUROL, V237, P286, DOI 10.1016/j.expneurol.2012.06.034; Niks EH, 2010, MUSCLE NERVE, V42, P283, DOI 10.1002/mus.21642; Nishimune H, 2012, MOL NEUROBIOL, V45, P1, DOI 10.1007/s12035-011-8216-y; Ohara-Imaizumi M, 2005, MOL BIOL CELL, V16, P3289, DOI 10.1091/mbc.E04-09-0816; Ohno K, 2014, J MOL NEUROSCI, V53, P359, DOI 10.1007/s12031-013-0170-x; Ono F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe3; Pasnoor M, 2010, MUSCLE NERVE, V41, P370, DOI 10.1002/mus.21533; PATON WDM, 1967, J PHYSIOL-LONDON, V191, P59, DOI 10.1113/jphysiol.1967.sp008237; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; PLOMP JJ, 1995, ANN NEUROL, V37, P627, DOI 10.1002/ana.410370513; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Richman DP, 2012, ANN NY ACAD SCI, V1274, P140, DOI 10.1111/j.1749-6632.2012.06782.x; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P453, DOI 10.1001/archneurol.2011.2200; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Ruff RL, 2008, J NEUROIMMUNOL, V201, P13, DOI 10.1016/j.jneuroim.2008.04.038; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; Selcen D, 2004, NEUROLOGY, V62, P1945, DOI 10.1212/01.WNL.0000128048.23930.1D; Serra A, 2012, ANN NY ACAD SCI, V1275, P129, DOI 10.1111/j.1749-6632.2012.06841.x; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Shiraishi H, 2005, ANN NEUROL, V57, P289, DOI 10.1002/ana.20341; Slater CR, 2008, ANN NY ACAD SCI, V1132, P1, DOI 10.1196/annals.1405.003; Slater Clarke R, 2008, Handb Clin Neurol, V91, P27, DOI 10.1016/S0072-9752(07)01502-3; Slater CR, 2003, J NEUROCYTOL, V32, P505, DOI 10.1023/B:NEUR.0000020607.17881.9b; Sommer Norbert, 2008, Handb Clin Neurol, V91, P169, DOI 10.1016/S0072-9752(07)01505-9; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Sultatos LG, 2008, TOXICOL APPL PHARM, V230, P390, DOI 10.1016/j.taap.2008.03.006; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Ulusoy C, 2014, CLIN IMMUNOL, V151, P155, DOI 10.1016/j.clim.2014.02.012; Viegas S, 2012, EXP NEUROL, V234, P506, DOI 10.1016/j.expneurol.2012.01.025; Wang XY, 2006, J NEUROSCI, V26, P8983, DOI 10.1523/JNEUROSCI.2493-06.2006; WAUD DR, 1975, AM J PHYSIOL, V229, P1632, DOI 10.1152/ajplegacy.1975.229.6.1632; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wolfe GI, 2008, ANN NY ACAD SCI, V1132, P71, DOI 10.1196/annals.1405.005; Yumoto N, 2012, NATURE, V489, P438, DOI 10.1038/nature11348; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou L, 2004, MUSCLE NERVE, V30, P55, DOI 10.1002/mus.20069	88	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e110571	10.1371/journal.pone.0110571	http://dx.doi.org/10.1371/journal.pone.0110571			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438154	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900005
J	Peters, BA; Hall, MN; Liu, XH; Neugut, YD; Pilsner, JR; Levy, D; Ilievski, V; Slavkovich, V; Islam, T; Factor-Litvak, P; Graziano, JH; Gamble, MV				Peters, Brandilyn A.; Hall, Megan N.; Liu, Xinhua; Neugut, Y. Dana; Pilsner, J. Richard; Levy, Diane; Ilievski, Vesna; Slavkovich, Vesna; Islam, Tariqul; Factor-Litvak, Pam; Graziano, Joseph H.; Gamble, Mary V.			Creatinine, Arsenic Metabolism, and Renal Function in an Arsenic-Exposed Population in Bangladesh	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; DRINKING-WATER; CYSTATIN-C; URINARY CREATININE; OXIDATIVE STRESS; SERUM CREATININE; NATIONAL-HEALTH; METHYL BALANCE; US POPULATION; SKIN-LESIONS	Kidney disease is emerging as an arsenic (As)-linked disease outcome, however further evidence of this association is warranted. Our first objective for this paper was to examine the potential renal toxicity of As exposure in Bangladesh. Our second objective relates to examining whether the previously reported positive association between urinary creatinine (uCrn) and As methylation may be explained by renal function. We had hypothesized that these associations relate to supply and demand for s-adenosylmethionine, the methyl donor for both creatine synthesis and As methylation. Alternatively, renal function could influence both As and creatinine excretion, or the As metabolites may influence renal function, which in turn influences uCrn. We conducted a cross-sectional study (N=478) of adults, composed of a sample recruited in 2001 and a sample recruited in 2003. We assessed renal function using plasma cystatin C, and calculated the estimated glomerular filtration rate (eGFR). Consistent with renal toxicity of As, log-uAs had a marginal inverse association with eGFR in the 2003 sample (b=-5.6, p=0.07), however this association was not significant in the 2001 sample (b=-1.9, p=0.24). Adjustment for eGFR did not alter the associations between uCrn and the % uAs metabolites, indicating that GFR does not explain these associations. Increased eGFR was associated with increased odds of having % uInAs>12.2% (2001: OR=1.01, 95% CI (1.00,1.03); 2003: OR=1.04, 95% CI (1.01,1.07)). In the 2003 sample only, there was a negative association between eGFR and % uDMA (b=-0.08, p=0.02). These results may indicate differential effects of renal function on excretion of InAs and DMA. Alternatively, a certain methylation pattern, involving decreased % InAs and increased % DMA, may reduce renal function. Given that these studies were cross-sectional, we cannot distinguish between these two possibilities. Discrepancies between the samples may be due to the higher As exposure, poorer nutrition, and lower As methylation capacity in the 2003 sample.	[Peters, Brandilyn A.; Neugut, Y. Dana; Ilievski, Vesna; Slavkovich, Vesna; Graziano, Joseph H.; Gamble, Mary V.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Hall, Megan N.; Factor-Litvak, Pam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Liu, Xinhua; Levy, Diane] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA; [Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Islam, Tariqul] Columbia Univ, Arsen Project Bangladesh, Dhaka, Bangladesh	Columbia University; Columbia University; Columbia University; University of Massachusetts System; University of Massachusetts Amherst	Gamble, MV (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mvg7@columbia.edu		Peters, Brandilyn/0000-0002-1534-2578	National Institutes of Health [R01 ES017875, R01 ES011601, 5P30ES09089, R01 CA133595, 1 P42 ES10349]; NATIONAL CANCER INSTITUTE [R01CA133595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P30ES009089, R01ES017875, R01ES011601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants R01 ES017875, R01 ES011601, 5P30ES09089, R01 CA133595, and 1 P42 ES10349 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basu A, 2011, ENVIRON HEALTH PERSP, V119, P1308, DOI 10.1289/ehp.1003393; Bera AK, 2011, HUM EXP TOXICOL, V30, P940, DOI 10.1177/0960327110384521; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Brosnan JT, 2011, AMINO ACIDS, V40, P1325, DOI 10.1007/s00726-011-0853-y; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; BROWN MM, 1976, J TOXICOL ENV HEALTH, V1, P505, DOI 10.1080/15287397609529349; BUCHET JP, 1981, INT ARCH OCC ENV HEA, V48, P71, DOI 10.1007/BF00405933; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; Challenger F., 1952, ADV ENZYMOLOGY RELAT, P429, DOI 10.1002/9780470122570.ch8; Chen JW, 2011, CHEMOSPHERE, V84, P17, DOI 10.1016/j.chemosphere.2011.02.091; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P832, DOI 10.1289/ehp.1205797; Chen Y, 2011, INT J EPIDEMIOL, V40, P828, DOI 10.1093/ije/dyr022; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Eom SY, 2011, HUM EXP TOXICOL, V30, P1885, DOI 10.1177/0960327111402239; Gamble MV, 2006, AM J CLIN NUTR, V84, P1093, DOI 10.1093/ajcn/84.5.1093; Gamble MV, 2012, ENVIRON HEALTH PERSP, V120, pA145, DOI 10.1289/ehp.1104807; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, P1683, DOI 10.1289/ehp.8084; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; GINSBURG JM, 1967, AM J PHYSIOL, V212, P1334, DOI 10.1152/ajplegacy.1967.212.6.1334; GINSBURG JM, 1965, AM J PHYSIOL, V208, P832, DOI 10.1152/ajplegacy.1965.208.5.832; GINSBURG JM, 1963, AM J PHYSIOL, V205, P707, DOI 10.1152/ajplegacy.1963.205.4.707; Halatek T, 2009, TOXICOL APPL PHARM, V239, P193, DOI 10.1016/j.taap.2009.04.022; Hall MN, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/595307; Hall MN, 2009, ENVIRON HEALTH PERSP, V117, P825, DOI 10.1289/ehp.0800164; Hawkesworth S, 2013, INT J EPIDEMIOL, V42, P176, DOI 10.1093/ije/dys215; Hsueh YM, 2009, AM J KIDNEY DIS, V54, P859, DOI 10.1053/j.ajkd.2009.06.016; Huda MN, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/267329; IARC (International Agency for Research on Cancer), 2012, REV HUM CARC ARS MET; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kielstein JT, 2008, KIDNEY BLOOD PRESS R, V31, P259, DOI 10.1159/000142725; Kile ML, 2009, ENVIRON HEALTH PERSP, V117, P455, DOI 10.1289/ehp.11251; Kinniburgh D., 2001, ARSENIC CONTAMINATIO; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.me.39.020188.002341; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Liu J, 2000, TOXICOLOGY, V147, P157, DOI 10.1016/S0300-483X(00)00194-3; Liu J, 2002, TOXICOLOGY, V170, P55, DOI 10.1016/S0300-483X(01)00532-7; Liu J, 2001, MOL PHARMACOL, V60, P302, DOI 10.1124/mol.60.2.302; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NIXON DE, 1991, CLIN CHEM, V37, P1575; Nordberg GF, 2005, TOXICOL APPL PHARM, V206, P191, DOI 10.1016/j.taap.2004.11.028; Peraza MA, 2003, CELL BIOL TOXICOL, V19, P253, DOI 10.1023/B:CBTO.0000003970.60896.49; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P254, DOI 10.1289/ehp.11872; Poreba R, 2011, TOXICOLOGY, V283, P88, DOI 10.1016/j.tox.2011.02.008; Prabu SM, 2012, MOL BIOL REP, V39, P11201, DOI 10.1007/s11033-012-2029-6; Reuter W, 2003, SPECIATION 5 ARSENIC; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Sinha Mahua, 2008, Pathophysiology, V15, P147, DOI 10.1016/j.pathophys.2008.03.001; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Smith AH, 2012, ENVIRON HEALTH PERSP, V120, P1527, DOI 10.1289/ehp.1104867; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Stead LM, 2001, AM J PHYSIOL-ENDOC M, V281, pE1095, DOI 10.1152/ajpendo.2001.281.5.E1095; Steinmaus C, 2010, TOXICOL APPL PHARM, V247, P138, DOI 10.1016/j.taap.2010.06.006; Styblo M, 2002, ENVIRON HEALTH PERSP, V110, P767, DOI 10.1289/ehp.02110s5767; Swan SK, 1997, CLIN CHEM, V43, P913; Sweeney CJ, 2010, CANCER CHEMOTH PHARM, V66, P345, DOI 10.1007/s00280-009-1169-4; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; TSUKAMOTO H, 1983, AM J VET RES, V44, P2324; Urakami Y, 2004, PHARM RES-DORDR, V21, P976, DOI 10.1023/B:PHAM.0000029286.45788.ad; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Wu Fen, 2014, Curr Environ Health Rep, V1, P148; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zheng Laura, 2014, Curr Environ Health Rep, V1, P192; Zheng LY, 2013, AM J KIDNEY DIS, V61, P385, DOI 10.1053/j.ajkd.2012.09.011; Zubairi Adnan Mustafa, 2008, J Pak Med Assoc, V58, P182	84	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113760	10.1371/journal.pone.0113760	http://dx.doi.org/10.1371/journal.pone.0113760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438247	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900076
J	Harrison, SL; Ding, J; Tang, EYH; Siervo, M; Robinson, L; Jagger, C; Stephan, BCM				Harrison, Stephanie L.; Ding, Jie; Tang, Eugene Y. H.; Siervo, Mario; Robinson, Louise; Jagger, Carol; Stephan, Blossom C. M.			Cardiovascular Disease Risk Models and Longitudinal Changes in Cognition: A Systematic Review	PLOS ONE			English	Article							DEMENTIA RISK; ALZHEIMERS-DISEASE; STROKE RISK; DECLINE; POPULATION; SCORE; IMPAIRMENT; PREDICTION; PREVENTION; PROFILE	Background: Cardiovascular disease and its risk factors have consistently been associated with poor cognitive function and incident dementia. Whether cardiovascular disease prediction models, developed to predict an individual's risk of future cardiovascular disease or stroke, are also informative for predicting risk of cognitive decline and dementia is not known. Objective: The objective of this systematic review was to compare cohort studies examining the association between cardiovascular disease risk models and longitudinal changes in cognitive function or risk of incident cognitive impairment or dementia. Materials and Methods: Medline, PsychINFO, and Embase were searched from inception to March 28, 2014. From 3,413 records initially screened, 21 were included. Results: The association between numerous different cardiovascular disease risk models and cognitive outcomes has been tested, including Framingham and non-Framingham risk models. Five studies examined dementia as an outcome; fourteen studies examined cognitive decline or incident cognitive impairment as an outcome; and two studies examined both dementia and cognitive changes as outcomes. In all studies, higher cardiovascular disease risk scores were associated with cognitive changes or risk of dementia. Only four studies reported model prognostic performance indices, such as Area Under the Curve (AUC), for predicting incident dementia or cognitive impairment and these studies all examined non-Framingham Risk models (AUC range: 0.74 to 0.78). Conclusions: Cardiovascular risk prediction models are associated with cognitive changes over time and risk of dementia. Such models are easily obtainable in clinical and research settings and may be useful for identifying individuals at high risk of future cognitive decline and dementia.	[Harrison, Stephanie L.; Tang, Eugene Y. H.; Robinson, Louise; Stephan, Blossom C. M.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ding, Jie] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Siervo, Mario; Jagger, Carol] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Newcastle University - UK	Harrison, SL (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	s.harrison@newcastle.ac.uk	Ding, Jie/K-9943-2015; Siervo, Mario/AAB-9302-2019	Jagger, Carol/0000-0002-6377-9926; Siervo, Mario/0000-0001-5515-0944; Tang, Eugene/0000-0003-1030-9311; Harrison, Stephanie/0000-0002-8846-0946; Robinson, Louise/0000-0003-0209-2503	Newcastle University; Medical Research Council [MR/J50001X/1, G0500997] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-043, ACF-2012-01-012] Funding Source: researchfish; MRC [G0500997, MR/J50001X/1] Funding Source: UKRI	Newcastle University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This systematic review was completed as part of a PhD requirement for SLH, who receives a studentship from Newcastle University. These authors have no additional support or funding to report.	Al Hazzouri AZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004978; Brady CB, 2001, J GERONTOL B-PSYCHOL, V56, pP340, DOI 10.1093/geronb/56.6.P340; Calvert MJ, 2005, EUR J HEART FAIL, V7, P243, DOI 10.1016/j.ejheart.2005.01.012; Carmasin JS, 2014, INT J GERIATR PSYCH, V29, P291, DOI 10.1002/gps.4007; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dregan A, 2013, AGE AGEING, V42, P338, DOI 10.1093/ageing/afs166; Elkins JS, 2004, NEUROLOGY, V63, P793, DOI 10.1212/01.WNL.0000137014.36689.7F; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Higgins JPT, 2009, COCHRANE HDB SYSTEMA, Vxxi; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; Kaffashian S, 2013, ALZHEIMERS DEMENT, V9, P572, DOI 10.1016/j.jalz.2012.07.001; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Kaffashian S, 2011, EUR HEART J, V32, P2326, DOI 10.1093/eurheartj/ehr133; Katsumata Y, 2012, J GERONTOL A-BIOL, V67, P126, DOI 10.1093/gerona/glr189; Kelley BJ, 2013, NEUROLOGY, V81, P113, DOI 10.1212/WNL.0b013e31829a352e; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Klages JD, 2005, DEMENT GERIATR COGN, V20, P292, DOI 10.1159/000088317; Laughlin GA, 2011, PSYCHOSOM MED, V73, P683, DOI 10.1097/PSY.0b013e31822f9089; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Mitnitski A, 2006, EUR J NEUROL, V13, P514, DOI 10.1111/j.1468-1331.2006.01297.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P293, DOI 10.3233/JAD-2010-1361; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Reijmer YD, 2011, DEMENT GERIATR COGN, V31, P152, DOI 10.1159/000324437; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Savva GM, 2010, STROKE, V41, pE41, DOI 10.1161/STROKEAHA.109.559880; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Stephan BCM, 2008, INT REV PSYCHIATR, V20, P344, DOI 10.1080/09540260802094456; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; Virta JJ, 2013, EUR J EPIDEMIOL, V28, P405, DOI 10.1007/s10654-013-9794-y; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2	34	50	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114431	10.1371/journal.pone.0114431	http://dx.doi.org/10.1371/journal.pone.0114431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478916	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200087
J	Kuhn, KA; Manieri, NA; Liu, TC; Stappenbeck, TS				Kuhn, Kristine A.; Manieri, Nicholas A.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.			IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; INTERLEUKIN-6 RECEPTOR; CLINICAL-RELEVANCE; RANDOMIZED-TRIAL; COLON-CANCER; MOUSE MODEL; CELLS	IL-6 is a pleiotropic cytokine often associated with inflammation. Inhibition of this pathway has led to successful treatment of rheumatoid arthritis, but one unforeseen potential complication of anti-IL-6 therapy is bowel perforation. Within the intestine, IL-6 has been shown to prevent epithelial apoptosis during prolonged inflammation. The role of IL-6 in the intestine during an initial inflammatory insult is unknown. Here, we evaluate the role of IL-6 at the onset of an inflammatory injury. Using two murine models of bowel injury - wound by biopsy and bacterial triggered colitis - we demonstrated that IL-6 is induced soon after injury by multiple cell types including intraepithelial lymphocytes. Inhibition of IL-6 resulted in impaired wound healing due to decreased epithelial proliferation. Using intestinal tissue obtained from patients who underwent surgical resection of the colon due to traumatic perforation, we observed cells with detectable IL-6 within the area of perforation and not at distant sites. Our data demonstrate the important role of IL-6 produced in part by intraepithelial lymphocytes at the onset of an inflammatory injury for epithelial proliferation and wound repair.	[Kuhn, Kristine A.; Manieri, Nicholas A.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Kuhn, Kristine A.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	stappenb@wustl.edu		Liu, Ta-Chiang/0000-0002-2800-9360; Manieri, Nicholas/0000-0002-5648-5989	Pfizer; National Institutes of Health (NIH) [DK071619]; Crohns and Colitis Foundation of America Genetics Consortium; W.M. Keck Foundation for research in molecular medicine; American College of Rheumatology Research Foundation; NIH [T32 AR007279]; National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [P30DK052574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK071619] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America Genetics Consortium; W.M. Keck Foundation for research in molecular medicine; American College of Rheumatology Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Pfizer, the National Institutes of Health (NIH) (DK071619), and the Crohns and Colitis Foundation of America Genetics Consortium (TSS). KAK was supported by the W.M. Keck Foundation for research in molecular medicine, the American College of Rheumatology Research Foundation, and an NIH training grant (T32 AR007279). The Washington University Digestive Disease Research Core Center is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) (P30DK052574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Gout T, 2011, CLIN RHEUMATOL, V30, P1471, DOI 10.1007/s10067-011-1827-x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Kitamura K, 2004, J LEUKOCYTE BIOL, V76, P1111, DOI 10.1189/jlb.0604328; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Manieri NA, 2012, GASTROENTEROLOGY, V143, P110, DOI 10.1053/j.gastro.2012.03.037; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Reinisch W, 1999, AM J GASTROENTEROL, V94, P2156; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; STARNES HF, 1990, J IMMUNOL, V145, P4185; SUZUKI Y, 1990, LIFE SCI, V47, P2193, DOI 10.1016/0024-3205(90)90149-L; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; WOODROOFE C, 1992, DNA CELL BIOL, V11, P587, DOI 10.1089/dna.1992.11.587	33	154	154	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114195	10.1371/journal.pone.0114195	http://dx.doi.org/10.1371/journal.pone.0114195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478789	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200051
J	Novelli, EM; Hildesheim, M; Rosano, C; Vanderpool, R; Simon, M; Kato, GJ; Gladwin, MT				Novelli, Enrico M.; Hildesheim, Mariana; Rosano, Caterina; Vanderpool, Rebecca; Simon, Marc; Kato, Gregory J.; Gladwin, Mark T.			Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease	PLOS ONE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; RELATIVE HYPERTENSION; CARDIOVASCULAR RISK; ANEMIA; HEMOGLOBIN; STROKE; COHORT; ADULTS	A seeming paradox of sickle cell disease is that patients do not suffer from a high prevalence of systemic hypertension in spite of endothelial dysfunction, chronic inflammation and vasculopathy. However, some patients do develop systolic hypertension and increased pulse pressure, an increasingly recognized major cardiovascular risk factor in other populations. Hence, we hypothesized that pulse pressure, unlike other blood pressure parameters, is independently associated with markers of hemolytic anemia and cardiovascular risk in sickle cell disease. We analyzed the correlates of pulse pressure in patients (n = 661) enrolled in a multicenter international sickle cell trial. Markers of hemolysis were analyzed as independent variables and as a previously validated hemolytic index that includes multiple variables. We found that pulse pressure, not systolic, diastolic or mean arterial pressure, independently correlated with high reticulocyte count (beta = 2.37, p = 0.02) and high hemolytic index (beta = 1.53, p=0.002) in patients with homozygous sickle cell disease in two multiple linear regression models which include the markers of hemolysis as independent variables or the hemolytic index, respectively. Pulse pressure was also independently associated with elevated serum creatinine (beta = 3.21, p = 0.02), and with proteinuria (beta = 2.52, p = 0.04). These results from the largest sickle cell disease cohort to date since the Cooperative Study of Sickle Cell Disease show that pulse pressure is independently associated with hemolysis, proteinuria and chronic kidney disease. We propose that high pulse pressure may be a risk factor for clinical complications of vascular dysfunction in sickle cell disease. Longitudinal and mechanistic studies should be conducted to confirm these hypotheses.	[Novelli, Enrico M.; Vanderpool, Rebecca; Simon, Marc; Kato, Gregory J.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Novelli, Enrico M.; Kato, Gregory J.] Univ Pittsburgh, Div Hematol & Oncol, Pittsburgh, PA USA; [Hildesheim, Mariana] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Rosano, Caterina] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA; [Vanderpool, Rebecca; Simon, Marc] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Div Pulm Allergy Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Novelli, EM (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA.	novellie@upmc.edu	Kato, Gregory J/I-7615-2014; Simon, Marc/AAH-3404-2020	Kato, Gregory J/0000-0003-4465-3217; Simon, Marc/0000-0003-3080-3675; Rosano, Caterina/0000-0002-0909-1506; Rosano, Caterina/0000-0002-4271-6010	Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania	Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania	EMN, MH, RV, MS, GJK and MTG are supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderibigbe A, 1999, West Afr J Med, V18, P114; Aslan M, 2000, ANN NY ACAD SCI, V899, P375; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Belizna C, 2012, STROKE, V43, P1129, DOI 10.1161/STROKEAHA.111.635383; Benetos A, 2010, J AM COLL CARDIOL, V55, P1032, DOI 10.1016/j.jacc.2009.09.061; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; Desai PC, 2012, AM J HEMATOL, V87, pE65, DOI 10.1002/ajh.23278; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; Fernandez-Fresnedo G, 2006, J AM SOC NEPHROL, V17, pS246, DOI 10.1681/ASN.2006080921; FOUCAN L, 1995, PRESSE MED, V24, P1428; Franklin SS, 2001, J HYPERTENS, V19, pS3; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; HOMI J, 1993, ARCH INTERN MED, V153, P1233, DOI 10.1001/archinte.153.10.1233; JAMES MA, 1995, HYPERTENSION, V26, P301, DOI 10.1161/01.HYP.26.2.301; JOHNSON CS, 1981, ARCH INTERN MED, V141, P891, DOI 10.1001/archinte.141.7.891; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; Kwagyan J, 2005, J HYPERTENS, V23, P619, DOI 10.1097/01.hjh.0000160220.71350.5f; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laurent S, 2009, HYPERTENSION, V54, P388, DOI 10.1161/HYPERTENSIONAHA.109.133116; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 1997, AM J MED, V102, P171; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; RODGERS GP, 1993, AM J MED SCI, V305, P150, DOI 10.1097/00000441-199303000-00004; Rosano C, 2013, HYPERTENSION, V61, P160, DOI 10.1161/HYPERTENSIONAHA.112.198069; Sachdev V, 2011, CIRCULATION; Safar ME, 2013, J AM COLL CARDIOL, V61, P12, DOI 10.1016/j.jacc.2012.01.088; Saraf SL, 2014, BRIT J HAEMATOL, V164, P729, DOI 10.1111/bjh.12690; Sasongko TH, 2013, COCHRANE DB SYST REV, V3; Thompson J, 2007, ARCH INTERN MED, V167, P701, DOI 10.1001/archinte.167.7.701; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	36	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114309	10.1371/journal.pone.0114309	http://dx.doi.org/10.1371/journal.pone.0114309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478953	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346907200071
J	Rao, A; Padhy, D				Rao, Aparna; Padhy, Debananda			Pattern of Pseudoexfoliation Deposits on the Lens and Their Clinical Correlation-Clinical Study and Review of Literature	PLOS ONE			English	Article							EXFOLIATION SYNDROME; FLUORESCEIN ANGIOGRAPHY; IRIS	Purpose: To study the clinical correlates of pattern of deposits over the lens in patients with pseudoexfoliation syndrome (PXF) or pseudoexfoliation glaucoma. Methods: This retrospective observational study screened 346 patients with PXF seen in glaucoma clinic of a tertiary hospital from 2011-2013. Details like pattern of deposits, location on the lens surface and pupillary abnormalities in slit lamp photographs and their correlation with clinical and demographic variables, were analysed. Results: A total of 84 eyes of 42 patients with bilateral PXF were included for the study. Glaucoma was seen in 30 eyes with baseline IOP of 24+3.8 mm Hg. Comparing the type of deposits, namely classical (n=39 eyes), radial pigmentary (RP) form (n=39 eyes) and combined classical and radial pigmentary (CR) forms (n=6 eyes) of deposits, pupillary ruff atrophy was common in all forms while poor dilatation was rare in the RP type (n=5 vs n=25 in classical forms, p<0.001). Mean deviation (MD) was worse in the classical and CR form as compared to RP type with the latter presenting much earlier, 43 +/- 3.2 years vs 48 +/- 4.1 years in CR and 56 +/- 5.7 years in classical form, p<0.001. The baseline IOP in the RP group (18 +/- 2.3 mm Hg) was significantly lower than the other two forms (CR 20 +/- 3.2 mm Hg, classical 28 +/- 2.3 mm Hg), p<0.001, with only 2 eyes on anti-glaucoma drugs at presentation. Conclusion: Pattern of exfoliation deposits may indicate the stage and severity of the disease process in evolution with the RP representing an earlier/less severe form of pseudoexfoliation syndrome.	[Rao, Aparna; Padhy, Debananda] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India	L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740				ASANO N, 1995, OPHTHALMOLOGY, V102, P1279, DOI 10.1016/S0161-6420(95)30873-1; BARTHOLOMEW RS, 1971, BRIT J OPHTHALMOL, V55, P693, DOI 10.1136/bjo.55.10.693; BERTELSEN TI, 1969, ACTA OPHTHALMOL, V47, P476; BROOKS AMV, 1983, BRIT J OPHTHALMOL, V67, P249, DOI 10.1136/bjo.67.4.249; BROOKS AMV, 1987, OPHTHALMOLOGY, V94, P1090; CARPEL EF, 1988, AM J OPHTHALMOL, V105, P692, DOI 10.1016/0002-9394(88)90073-6; Cobb CJ, 2004, BRIT J OPHTHALMOL, V88, P1002, DOI 10.1136/bjo.2003.031732; DARK AJ, 1990, BRIT J OPHTHALMOL, V74, P717, DOI 10.1136/bjo.74.12.717; DARK AJ, 1977, BRIT J OPHTHALMOL, V61, P462, DOI 10.1136/bjo.61.7.462; LAYDEN WE, 1974, AM J OPHTHALMOL, V78, P835, DOI 10.1016/0002-9394(74)90307-9; Mitchell P, 1997, AM J OPHTHALMOL, V124, P685, DOI 10.1016/S0002-9394(14)70908-0; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Parodi MB, 2008, EYE, V22, P49, DOI 10.1038/sj.eye.6702602; Parodi MB, 1999, EUR J OPHTHALMOL, V9, P284; Parodi MB, 2000, ACTA OPHTHALMOL SCAN, V78, P437, DOI 10.1034/j.1600-0420.2000.078004437.x; PRINCE AM, 1986, OPHTHALMOLOGY, V93, P803; PRINCE AM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1076; PUSKA P, 1995, ACTA OPHTHALMOL SCAN, V73, P226; Rao Aparna, 2012, J Ophthalmic Vis Res, V7, P197; Rao A, 2012, SEMIN OPHTHALMOL, V27, P1, DOI 10.3109/08820538.2011.626356; Repo LP, 1996, GRAEF ARCH CLIN EXP, V234, P171, DOI 10.1007/BF00462029; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritch R, 2001, CURR OPIN OPHTHALMOL, V12, P124, DOI 10.1097/00055735-200104000-00008; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; TAYLOR HR, 1979, T OPHTHAL SOC UK, V99, P302; TETSUMOTO K, 1992, GRAEF ARCH CLIN EXP, V230, P252, DOI 10.1007/BF00176300; Vannas A, 1969, Acta Ophthalmol Suppl, V105, P1; Vesti E, 2000, PROG RETIN EYE RES, V19, P345, DOI 10.1016/S1350-9462(99)00019-1	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113329	10.1371/journal.pone.0113329	http://dx.doi.org/10.1371/journal.pone.0113329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478872	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200018
J	Zhao, BW; Jiang, SS; Chen, YM; Huang, CY; Li, YF				Zhao, Bai-Wei; Jiang, Shan-Shan; Chen, Yong-Ming; Huang, Chun-Yu; Li, Yuan-Fang			Reduced NKX2.1 Expression Predicts Poor Prognosis of Gastric Carcinoma	PLOS ONE			English	Article							LUNG; GENES	Thyroid transcription factor-1 (NKX2.1/TITF-1) is a member of the thyroid tissue-specific transcription factor family that has been proven to be closely associated with many human diseases. Recently, it was reported that NKX2.1 expression is lost or reduced in some human cancers such as lung cancer and thyroid cancer. However, there was insufficient data to suggest that NKX2.1 functionality could be used as a prognostic factor. Therefore, this study aims to investigate NKX2.1 expression and its prognostic significance in primary gastric carcinoma. Then, we attempted to investigate if NKX2.1 expression was related to the clinicopathological characteristics and prognosis of gastric carcinoma (GC) patients. The expression levels of NKX2.1 were analyzed in tissue samples from 205 gastric carcinoma patients by real-time quantitative PCR (qRT-PCR), Western blotting, and immunohistochemical staining(IHC). Our qRT-PCR results showed that the expression of NKX2.1 mRNA was reduced in tumor tissue samples compared with that in matched adjacent non-tumor tissue samples (P<0.001); this finding was confirmed by Western blot analysis (P<0.001). Our immunohistochemical staining data indicated that NKX2.1 expression was significantly decreased in 87 of 205 (42.4%) gastric carcinoma cases. Kaplan-Meier survival curves revealed that the decreased expression of NKX2.1 was significantly associated with poor prognosis in gastric carcinoma patients (P<0.001). Multivariate Cox analysis identified NKX2.1 expression as an independent prognostic factor for overall survival (P=0.005). Furthermore, the functions of Nkx2.1 were analyzed with respect to the proliferation, migration, and invasion of GC cell lines. Our data suggest that NKX2.1 may function as a tumor suppressor in primary gastric carcinoma and that its reduced expression independently predicts an unsatisfactory prognosis in gastric carcinoma patients.	[Zhao, Bai-Wei; Jiang, Shan-Shan; Chen, Yong-Ming; Huang, Chun-Yu; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Bai-Wei; Jiang, Shan-Shan; Chen, Yong-Ming; Huang, Chun-Yu; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Bai-Wei; Chen, Yong-Ming; Huang, Chun-Yu; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	liyuanf@sysucc.org.cn	Chen, Yongming/E-3656-2015; Li, Yuan/GXV-1310-2022	Chen, Yongming/0000-0003-2843-5543; 				Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Awais D, 2009, GUT, V58, P1498, DOI 10.1136/gut.2008.169714; Bang YJ, 2010, LANCET, V376, P1302; Blum MA, 2013, J SURG ONCOL, V107, P265, DOI 10.1002/jso.23183; Cantara S, 2010, THYROID RES, V3, DOI 10.1186/1756-6614-3-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujiwara S, 2010, HUM PATHOL, V41, P560, DOI 10.1016/j.humpath.2009.09.010; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kimura S, 2011, THYROID RES, V2011; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Peddanna N, 1995, ANTICANCER RES, V15, P2055; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; STANBRIDGE EJ, 1990, SCIENCE, V247, P12, DOI 10.1126/science.2403692; Tiozzo C, 2012, ENDOCR-RELAT CANCER, V19, P111, DOI 10.1530/ERC-10-0327; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114556	10.1371/journal.pone.0114556	http://dx.doi.org/10.1371/journal.pone.0114556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478793	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200102
J	Neal-McKinney, JM; Samuelson, DR; Eucker, TP; Nissen, MS; Crespo, R; Konkel, ME				Neal-McKinney, Jason M.; Samuelson, Derrick R.; Eucker, Tyson P.; Nissen, Mark S.; Crespo, Rocio; Konkel, Michael E.			Reducing Campylobacter jejuni Colonization of Poultry via Vaccination	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HUMAN EPITHELIAL-CELLS; CECAL COLONIZATION; BROILER-CHICKENS; FLAGELLIN GENES; C. JEJUNI; IDENTIFICATION; FIBRONECTIN; SALMONELLA; INFECTION	Campylobacter jejuni is a leading bacterial cause of human gastrointestinal disease worldwide. While C. jejuni is a commensal organism in chickens, case-studies have demonstrated a link between infection with C. jejuni and the consumption of foods that have been cross-contaminated with raw or undercooked poultry. We hypothesized that vaccination of chickens with C. jejuni surface-exposed colonization proteins (SECPs) would reduce the ability of C. jejuni to colonize chickens, thereby reducing the contamination of poultry products at the retail level and potentially providing a safer food product for consumers. To test our hypothesis, we injected chickens with recombinant C. jejuni peptides from CadF, FlaA, FlpA, CmeC, and a CadF-FlaA-FlpA fusion protein. Seven days following challenge, chickens were necropsied and cecal contents were serially diluted and plated to determine the number of C. jejuni per gram of material. The sera from the chickens were also analyzed to determine the concentration and specificity of antibodies reactive against the C. jejuni SECPs. Vaccination of chickens with the CadF, FlaA, and FlpA peptides resulted in a reduction in the number of C. jejuni in the ceca compared to the non-vaccinated C. jejuni-challenged group. The greatest reduction in C. jejuni colonization was observed in chickens injected with the FlaA, FlpA, or CadF-FlaA-FlpA fusion proteins. Vaccination of chickens with different SECPs resulted in the production of C. jejuni-specific IgY antibodies. In summary, we show that the vaccination of poultry with individual C. jejuni SECPs or a combination of SECPs provides protection of chickens from C. jejuni colonization.	[Neal-McKinney, Jason M.; Samuelson, Derrick R.; Eucker, Tyson P.; Nissen, Mark S.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Crespo, Rocio] Washington State Univ, Coll Vet Med, Avian Hlth & Food Safety Lab, Pullman, WA 99164 USA	Washington State University; Washington State University	Konkel, ME (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Samuelson, Derrick/AAR-4230-2021; Samuelson, Derrick/AAC-9132-2019	Samuelson, Derrick/0000-0002-5356-1413; Konkel, Michael/0000-0002-8950-0903; Crespo, Rocio/0000-0002-6286-1004	United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30772]; National Institutes of General Medical Sciences Training Grant [T32GM083864, T32GM008336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336, T32GM083864] Funding Source: NIH RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of General Medical Sciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds awarded to MEK from the United States Department of Agriculture, National Institute of Food and Agriculture (Award Number 2011-67015-30772) (www.nifa.usda.gov). DRS was partially supported by the National Institutes of General Medical Sciences Training Grant #T32GM083864 (www.nigms.nih.gov). TPE was partially supported by National Institutes of General Medical Sciences Training Grant #T32GM008336 (www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar VF, 2013, FOODBORNE PATHOG DIS, V10, P435, DOI 10.1089/fpd.2012.1302; Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Allen VM, 2008, BRIT POULTRY SCI, V49, P233, DOI 10.1080/00071660802094206; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Annamalai T, 2013, POULTRY SCI, V92, P2201, DOI 10.3382/ps.2012-03004; [Anonymous], J VACCINES VACCIN; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Baffoni L, 2012, INT J FOOD MICROBIOL, V157, P156, DOI 10.1016/j.ijfoodmicro.2012.04.024; Bahrndorff S, 2013, EMERG INFECT DIS, V19, P425, DOI 10.3201/eid1903.111593; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boysen L, 2009, J FOOD PROTECT, V72, P497, DOI 10.4315/0362-028X-72.3.497; Buckley AM, 2010, VACCINE, V28, P1094, DOI 10.1016/j.vaccine.2009.10.018; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Cox JM, 2010, J APPL MICROBIOL, V108, P745, DOI 10.1111/j.1365-2672.2009.04456.x; DOYLE MP, 1992, CAMPLYLOBACTER JEJUNI, P45; Dupuis L, 2006, ANN NY ACAD SCI, V1081, P202, DOI 10.1196/annals.1373.024; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078543; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Havelaar AH, 2007, RISK ANAL, V27, P831, DOI 10.1111/j.1539-6924.2007.00926.x; Hermans D, 2012, POULTRY SCI, V91, P1733, DOI 10.3382/ps.2011-02106; Hermans D, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-27; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Janez N, 2013, J MICROBIOL METH, V95, P68, DOI 10.1016/j.mimet.2013.06.024; Konkel ME, 2005, MOL MICROBIOL, V57, P1022, DOI 10.1111/j.1365-2958.2005.04744.x; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KONKEL ME, 1992, INFECT IMMUN, V60, P4945, DOI 10.1128/IAI.60.11.4945-4949.1992; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Laniewski P, 2014, WORLD J MICROB BIOT, V30, P281, DOI 10.1007/s11274-013-1447-5; Larson CL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.65; Layton SL, 2011, CLIN VACCINE IMMUNOL, V18, P449, DOI 10.1128/CVI.00379-10; Lehner Y, 2014, CURR MICROBIOL, V69, P240, DOI 10.1007/s00284-014-0575-y; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Meredith H, 2013, INT J FOOD MICROBIOL, V166, P309, DOI 10.1016/j.ijfoodmicro.2013.07.005; Metcalf JH, 2011, POULTRY SCI, V90, P494, DOI 10.3382/ps.2010-00891; MOROOKA T, 1985, J GEN MICROBIOL, V131, P1973; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Musavian HS, 2014, INT J FOOD MICROBIOL, V176, P23, DOI 10.1016/j.ijfoodmicro.2014.02.001; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Nagel GM, 2013, INT J FOOD MICROBIOL, V165, P281, DOI 10.1016/j.ijfoodmicro.2013.05.016; Nair DVT, 2014, POULTRY SCI, V93, P2636, DOI 10.3382/ps.2013-03858; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; NEWELL DG, 1986, J HYG-CAMBRIDGE, V96, P131, DOI 10.1017/S0022172400065906; PALERMO MS, 1991, CLIN IMMUNOL IMMUNOP, V58, P343, DOI 10.1016/0090-1229(91)90125-T; PAVLOVSKIS OR, 1991, INFECT IMMUN, V59, P2259, DOI 10.1128/IAI.59.7.2259-2264.1991; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; Robyn J, 2013, POULTRY SCI, V92, P1408, DOI 10.3382/ps.2012-02863; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rowan NJ, 2007, J FOOD PROTECT, V70, P2805, DOI 10.4315/0362-028X-70.12.2805; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Schroder W, 1997, FEMS MICROBIOL LETT, V150, P141, DOI 10.1016/S0378-1097(97)00111-0; Schwerer B, 2002, MICROBES INFECT, V4, P373, DOI 10.1016/S1286-4579(02)01550-2; Shoaf-Sweeney KD, 2008, APPL ENVIRON MICROB, V74, P6867, DOI 10.1128/AEM.01097-08; Skanseng B, 2010, J APPL MICROBIOL, V109, P1265, DOI 10.1111/j.1365-2672.2010.04766.x; STERN NJ, 1992, CAMPLYLOBACTER JEJUNI, P49; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; van Gerwe T, 2010, VET MICROBIOL, V143, P314, DOI 10.1016/j.vetmic.2009.11.029; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2013, CLIN INFECT DIS, V57, P1600, DOI 10.1093/cid/cit555; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	75	49	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114254	10.1371/journal.pone.0114254	http://dx.doi.org/10.1371/journal.pone.0114254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474206	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500006
J	Parenti, R; Cardile, V; Graziano, ACE; Parenti, C; Venuti, A; Bertuccio, MP; Lo Furno, D; Magro, G				Parenti, Rosalba; Cardile, Venera; Graziano, Adriana Carol Eleonora; Parenti, Carmela; Venuti, Assunta; Bertuccio, Maria Paola; Lo Furno, Debora; Magro, Gaetano			Wilms' Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line	PLOS ONE			English	Article							PROTEIN WT1; SUPPRESSOR WT1; TRANSCRIPTIONAL REGULATION; MAMMALIAN TARGET; DOWN-REGULATION; GROWTH-FACTOR; UP-REGULATION; IN-VITRO; EXPRESSION; CANCER	Wilms' tumor gene 1 (WT1) plays complex roles in tumorigenesis, acting as tumor suppressor gene or an oncogene depending on the cellular context. WT1 expression has been variably reported in both benign and malignant peripheral nerve sheath tumors (MPNSTs) by means of immunohistochemistry. The aim of the present study was to characterize its potential pathogenetic role in these relatively uncommon malignant tumors. Firstly, immunohistochemical analyses in MPNST sNF96.2 cell line showed strong WT1 staining in nuclear and perinuclear areas of neoplastic cells. Thus, we investigated the effects of silencing WT1 by RNA interference. Through Western Blot analysis and proliferation assay we found that WT1 knockdown leads to the reduction of cell growth in a time- and dose-dependent manner. siWT1 inhibited proliferation of sNF96.2 cell lines likely by influencing cell cycle progression through a decrease in the protein levels of cyclin D1 and inhibition of Akt phosphorylation compared to the control cells. These results indicate that WT1 knockdown attenuates the biological behavior of MPNST cells by decreasing Akt activity, demonstrating that WT1 is involved in the development and progression of MPNSTs. Thus, WT1 is suggested to serve as a potential therapeutic target for MPNSTs.	[Parenti, Rosalba; Cardile, Venera; Graziano, Adriana Carol Eleonora; Lo Furno, Debora] Univ Catania, Physiol Sect, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy; [Parenti, Carmela] Univ Catania, Pharmacol & Toxicol Sect, Dept Drug Sci, I-95125 Catania, Italy; [Venuti, Assunta; Bertuccio, Maria Paola] Nerviano Med Sci Srl, Business Unit Oncol, I-20014 Nerviano Milano, Italy; [Magro, Gaetano] Univ Catania, Azienda Osped Univ Policlin Vittorio Emanuele Ana, Dept GF Ingrassia, I-95125 Catania, Italy	University of Catania; University of Catania; Nerviano Medical Sciences S.r.l; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania	Parenti, R (corresponding author), Univ Catania, Physiol Sect, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy.	parenti@unict.it	Parenti, Carmela/AAH-6439-2021; loreto, carla/AAC-2711-2019; Graziano, Adriana C E/J-9952-2016; Parenti, Rosalba/AAS-5489-2020; Bertuccio, Maria Paola/K-9814-2016; Furno, Debora Lo/P-1667-2019; Parenti, Rosalba/ABC-5780-2020; Venuti, Assunta/AFA-2281-2022	Graziano, Adriana C E/0000-0003-1652-9577; Bertuccio, Maria Paola/0000-0002-0644-8418; Furno, Debora Lo/0000-0002-1971-8990; Parenti, Rosalba/0000-0002-1614-4696; Venuti, Assunta/0000-0001-5438-1724; Magro, Gaetano Giuseppe/0000-0003-3244-6827; CARDILE, Venera/0000-0001-9902-3736	Ricerca e Competitivita, ASSE I [PON 01_02418F1]	Ricerca e Competitivita, ASSE I	The authors Venuti A and Bertuccio MP were supported by a grant under the project PON 01_02418F1 "Ricerca e Competitivita 2007-2013'', ASSE I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar EM, 1996, ONCOGENE, V12, P1005; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpentieri DF, 2002, MODERN PATHOL, V15, P1080, DOI 10.1097/01.MP.0000028646.03760.6B; Carroll SL, 2012, ACTA NEUROPATHOL, V123, P321, DOI 10.1007/s00401-011-0928-6; Chen MY, 2011, J NEURO-ONCOL, V103, P87, DOI 10.1007/s11060-010-0374-7; Chen ZX, 2001, INT J HEMATOL, V73, P39, DOI 10.1007/BF02981901; Clark AJ, 2010, J NEUROSURG, V112, P18, DOI 10.3171/2008.11.JNS08368; Dudnakova T, 2010, ONCOGENE, V29, P1085, DOI 10.1038/onc.2009.444; Ellisen LW, 2002, INT J HEMATOL, V76, P110, DOI 10.1007/BF02982572; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Fieber LA, 2003, NEUROBIOL DIS, V13, P136, DOI 10.1016/S0969-9961(03)00031-7; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Grobmyer SR, 2008, J SURG ONCOL, V97, P340, DOI 10.1002/jso.20971; Hartkamp J, 2008, BIOCHEM SOC T, V36, P629, DOI 10.1042/BST0360629; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Inagaki Takuya, 2011, Jikeikai Medical Journal, V58, P95; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Katz D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001227; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Koesters R, 2004, INT J CANCER, V109, P385, DOI 10.1002/ijc.11721; Lee PR, 2004, NEURON GLIA BIOL, V1, P135, DOI 10.1017/S1740925X04000274; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li YW, 2004, ONCOGENE, V23, P1146, DOI 10.1038/sj.onc.1207068; Liu XW, 2001, J BIOL CHEM, V276, P5068, DOI 10.1074/jbc.M008776200; Loeb DM, 2001, CANCER RES, V61, P921; Loeb DM, 2006, CELL CYCLE, V5, P1249, DOI 10.4161/cc.5.12.2807; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Lovell MA, 2003, BRAIN RES, V983, P84, DOI 10.1016/S0006-8993(03)03032-4; Magro G, 2014, ACTA HISTOCHEM, V116, P905, DOI 10.1016/j.acthis.2014.03.001; Mahzouni Parvin, 2013, Adv Biomed Res, V2, P33, DOI 10.4103/2277-9175.108772; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; MIWA H, 1992, LEUKEMIA, V6, P405; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Navakanit Ruxapon, 2007, Journal of the Medical Association of Thailand, V90, P2416; Nik SA, 2005, INT J CANCER, V114, P202, DOI 10.1002/ijc.20717; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Oue T, 2011, J PEDIATR SURG, V46, P2233, DOI 10.1016/j.jpedsurg.2011.09.004; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Parenti R, 2014, ACTA HISTOCHEM, V116, P48, DOI 10.1016/j.acthis.2013.05.003; Parenti R, 2013, ACTA HISTOCHEM, V115, P70, DOI 10.1016/j.acthis.2012.04.006; Park HJ, 2013, INT J ONCOL, V42, P657, DOI 10.3892/ijo.2012.1751; Roberts SGE, 2006, BIOCHEM SOC SYMP, V73, P191; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Salvatorelli L, 2011, PATHOLOGICA, V103, P186; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Schittenhelm J, 2010, CANCER BIOMARK, V7, P73, DOI 10.3233/CBM-2010-0149; Singh A, 2012, PATHOL ONCOL RES, V18, P383, DOI 10.1007/s12253-011-9456-x; Spurlock G, 2010, J CANCER RES CLIN, V136, P1869, DOI 10.1007/s00432-010-0846-3; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Tatsumi N, 2008, INT J ONCOL, V32, P701; Tuna M, 2005, ONCOGENE, V24, P1648, DOI 10.1038/sj.onc.1208345; Ueda T, 2003, CANCER SCI, V94, P271, DOI 10.1111/j.1349-7006.2003.tb01432.x; Upadhyaya M, 2011, FRONT BIOSCI-LANDMRK, V16, P937, DOI 10.2741/3727; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Wagner N, 2002, CELL GROWTH DIFFER, V13, P297; Wagner N, 2008, PFLUG ARCH EUR J PHY, V455, P839, DOI 10.1007/s00424-007-0340-1; Wang JF, 2011, J PEDIATR SURG, V46, P326, DOI 10.1016/j.jpedsurg.2010.11.011; Wang X, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-114; Weiss SW, 2008, ENZINGER WEISSS SOFT, P903; Wilm B, 2010, INT J MOL EPIDEMIOL, V1, P75; Wu J, 2014, ONCOGENE, V33, P173, DOI 10.1038/onc.2012.579; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068837; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zamora-Avila DE, 2009, CANCER GENE THER, V16, P892, DOI 10.1038/cgt.2009.35; Zamora-Avila DE, 2007, MELANOMA RES, V17, P341, DOI 10.1097/CMR.0b013e3282efd3ae; Zapata-Benavides P, 2002, BIOCHEM BIOPH RES CO, V295, P784, DOI 10.1016/S0006-291X(02)00751-9; Zapata-Benavides P, 2012, ONCOL LETT, V3, P751, DOI 10.3892/ol.2012.578; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	83	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114333	10.1371/journal.pone.0114333	http://dx.doi.org/10.1371/journal.pone.0114333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474318	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500016
J	Chen, JQ; Shu, TJ; Lv, ZB; Nie, ZM; Chen, J; Chen, H; Yu, W; Gai, QJ; Zhang, YZ				Chen, Jianqing; Shu, Tejun; Lv, Zhengbing; Nie, Zuoming; Chen, Jian; Chen, Hao; Yu, Wei; Gai, Qijing; Zhang, Yaozhou			Purification and Functional Characterization of a Protein: Bombyx mori Human Growth Hormone Like Protein in Silkworm Pupa	PLOS ONE			English	Article							PROLACTIN-LIKE; SUBSTANCE; CELLS; K562	Human growth hormone (hGH) is a peptide hormone secreted by eosinophils of the human anterior pituitary, and a regulatory factor for a variety of metabolic pathways. A 30-kD protein from the pupa stage of silkworm was detected by Western blotting and confirmed by immunoprecipitation based on its ability to bind to anti-hGH antibody. This protein, named BmhGH-like protein, was purified from fresh silkworm pupas through low-temperature homogenization, filtration, and centrifugation to remove large impurity particles. The supernatants were precipitated, resuspended, and passed through a molecular sieve. Further purification by affinity chromatography and two-dimensional electrophoresis resulted in pure protein for analysis by MS MALDI-TOF-MS analysis. An alignment with predicted proteins indicated that BmhGH-like protein consisted of two lipoproteins, which we named hGH-L1 and hGH-L2. These proteins belong to the beta-trefoil superfamily, with beta domains similar to the spatial structure of hGH. Assays with K562 cells demonstrated that these proteins could promote cell division in vitro. To further validate the growth-promoting effects, hGH-L2 was cloned from pupa cDNA to create recombinant silkworm baculovirus vBmNPV-hGH-L2, which was used to infect silkworm BmN cells at low titer. Flow cytometric analysis demonstrated that the protein shortened the G0/G1 phase of the cells, and enabled the cells to rapidly traverse the G1/S phase transition point to enter S phase and promote cell division. Discovery of hGH-like protein in silkworm will once again arouse people's interest in the potential medicinal value of silkworm and establish the basis for the development of new hormone drugs.	[Chen, Jianqing; Shu, Tejun; Lv, Zhengbing; Nie, Zuoming; Chen, Jian; Chen, Hao; Yu, Wei; Gai, Qijing; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China; [Zhang, Yaozhou] Tianjin Univ, Coll Pharm, Tianjin 300073, Peoples R China	Zhejiang Sci-Tech University; Tianjin University	Zhang, YZ (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China.	18822001388@126.com			National High Technology Research and Development Program [2011AA100603, 2012ZX09102301-009]; National Basic Research Program of China [2012CB114600]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by financial grants from the National High Technology Research and Development Program (No. 2011AA100603), the National Basic Research Program of China (No. 2012CB114600), the National High Technology Research and Development Program (No. 2012ZX09102301-009). The authors would like to thank the Bombyx mori Bioreactor Pharmaceutical Platform of Tianjin International Joint Academy of Biomedicine in the experimental sites and experimental equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DH, 2000, CHINESE J IMMUNOLOGY, V16, P651; EMMART EW, 1968, GEN COMP ENDOCR, V11, P515, DOI 10.1016/0016-6480(68)90066-X; Gallardo WG, 2006, FISHERIES SCI, V72, P781, DOI 10.1111/j.1444-2906.2006.01218.x; GAUWERKY C, 1980, J CLIN ENDOCR METAB, V51, P1208, DOI 10.1210/jcem-51-5-1208; KAPLAN GW, 1967, J UROLOGY, V97, P494, DOI 10.1016/S0022-5347(17)63067-2; Lan HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/306462; LECHAN RM, 1981, ENDOCRINOLOGY, V109, P1950, DOI 10.1210/endo-109-6-1950; Lin Ling CG, 2006, CHINESE J TRADITIONA, V17, P1556; Obermayr RP, 2003, GERONTOLOGY, V49, P191, DOI 10.1159/000069175; Ominato K, 2002, ZOOL SCI, V19, P1055, DOI 10.2108/zsj.19.1055; Peng HW, 2013, EUR J PHARMACOL, V718, P459, DOI 10.1016/j.ejphar.2013.07.038; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SWINNEN K, 1990, COMP BIOCHEM PHYS A, V95, P373, DOI 10.1016/0300-9629(90)90235-K; Yang JP, 2011, J STRUCT BIOL, V175, P97, DOI 10.1016/j.jsb.2011.04.003	14	1	2	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114351	10.1371/journal.pone.0114351	http://dx.doi.org/10.1371/journal.pone.0114351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469649	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700103
J	Klemetti, EW; Clynne, MA				Klemetti, Erik W.; Clynne, Michael A.			Localized Rejuvenation of a Crystal Mush Recorded in Zircon Temporal and Compositional Variation at the Lassen Volcanic Center, Northern California	PLOS ONE			English	Article							MAGMATIC EVOLUTION; TRACE-ELEMENT; THERMAL REJUVENATION; SPIRIT MOUNTAIN; SIERRA-NEVADA; CRUSTAL; CONSTRAINTS; TIMESCALES; BATHOLITH; RHYOLITES	Zircon ages and trace element compositions from recent silicic eruptions in the Lassen Volcanic Center (LVC) allow for an evaluation of the timing and conditions of rejuvenation (reheating and mobilization of crystals) within the LVC magmatic system. The LVC is the southernmost active Cascade volcano and, prior to the 1980 eruption of Mount St. Helens, was the site of the only eruption in the Cascade arc during the last century. The three most recent silicic eruptions from the LVC were very small to moderate-sized lava flows and domes of dacite (1915 and 27 ka eruptions of Lassen Peak) and rhyodacite (1.1 ka eruption of Chaos Crags). These eruptions produced mixed and mingled lavas that contain a diverse crystal cargo, including zircon. U-238-Th-230 model ages from interior and surface analyses of zircon reveal ages from similar to 17 ka to secular equilibrium (>350 ka), with most zircon crystallizing during a period between similar to 60-200 ka. These data support a model for localized rejuvenation of crystal mush beneath the LVC. This crystal mush evidently is the remnant of magmatism that ended similar to 190 ka. Most zircon are thought to have been captured from "cold storage" in the crystal mush (670-725 degrees C, Hf.10,000 ppm, Eu/Eu* 0.25-0.4) locally remobilized by intrusion of mafic magma. A smaller population of zircon (>730 degrees C, Hf <10,000 ppm, Eu/Eu*>0.4) grew in, and are captured from, rejuvenation zones. These data suggest the dominant method to produce eruptible melt within the LVC is small-scale, local rejuvenation of the crystal mush accompanied by magma mixing and mingling. Based on zircon stability, the time required to heat, erupt and then cool to background conditions is relatively short, lasting a maximum of 10 s-1000 s years. Rejuvenation events in the LVC are ephemeral and permit eruption within an otherwise waning and cooling magmatic body.	[Klemetti, Erik W.] Denison Univ, Dept Geosci, Granville, OH 43023 USA; [Clynne, Michael A.] US Geol Survey, Volcano Sci Ctr, Menlo Pk, CA 94025 USA	Denison University; United States Department of the Interior; United States Geological Survey	Klemetti, EW (corresponding author), Denison Univ, Dept Geosci, Granville, OH 43023 USA.	klemettie@denison.edu		Klemetti, Erik/0000-0002-0539-979X	National Science Foundation (EAR) [1250323]; Denison University Anderson Scholarship; Directorate For Geosciences [1250256] Funding Source: National Science Foundation	National Science Foundation (EAR); Denison University Anderson Scholarship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	National Science Foundation (EAR # 1250323 to EWK) http://www.nsf.gov/. Denison University Anderson Scholarship (to EWK) http://www.denison.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann O, 2007, J VOLCANOL GEOTH RES, V167, P1, DOI 10.1016/j.jvolgeores.2007.08.002; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; Bachmann O, 2002, J PETROL, V43, P1469, DOI 10.1093/petrology/43.8.1469; Bacon CR, 2005, EARTH PLANET SC LETT, V233, P277, DOI 10.1016/j.epsl.2005.02.012; Barth AP, 2013, GEOLOGY, V41, P223, DOI 10.1130/G33619.1; BENZ HM, 1992, J GEOPHYS RES-SOL EA, V97, P4791, DOI 10.1029/92JB00067; BERGE PA, 1987, J GEOPHYS RES-SOLID, V92, P10571, DOI 10.1029/JB092iB10p10571; Boehnke P, 2013, CHEM GEOL, V351, P324, DOI 10.1016/j.chemgeo.2013.05.028; BULLEN TD, 1990, J GEOPHYS RES-SOLID, V95, P19671, DOI 10.1029/JB095iB12p19671; Chamberlain KJ, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1034-2; Christiansen RL, 2002, GEOLOGIC MAP LASSEN; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Claiborne LL, 2010, CONTRIB MINERAL PETR, V160, P511, DOI 10.1007/s00410-010-0491-5; Clynne M, 2001, VOLCANO HAZARDS LASS; Clynne M. A., 2012, VOLCANO HAZARDS ASSE; Clynne M.A., 2010, GEOLOGIC MAP LASSEN, DOI [10.3133/sim2899, DOI 10.3133/SIM2899]; Clynne MA, 1999, J PETROL, V40, P105, DOI 10.1093/petrology/40.1.105; CLYNNE MA, 1990, J GEOPHYS RES-SOLID, V95, P19651, DOI 10.1029/JB095iB12p19651; Clynne MA, 2008, MAJOR EDXRF TRACE EL; Cole JW, 2014, EARTH-SCI REV, V128, P1, DOI 10.1016/j.earscirev.2013.10.008; Cooper K.M., 2008, VOLCANO REKINDLED 1, P827; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Feeley TC, 2008, J PETROL, V49, P971, DOI 10.1093/petrology/egn013; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Ghiorso MS, 2013, CONTRIB MINERAL PETR, V165, P73, DOI 10.1007/s00410-012-0792-y; Girard G, 2009, J PETROL, V50, P2095, DOI 10.1093/petrology/egp070; Glazner AF, 2008, GEOLOGY, V36, P183, DOI 10.1130/G24496A.1; Grunder AL, 2006, T ROY SOC EDIN-EARTH, V97, P415, DOI 10.1017/S0263593300001541; Gualda GAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037492; Guffanti M, 1996, J GEOPHYS RES-SOL EA, V101, P3003, DOI 10.1029/95JB03463; Klemetti EW, 2014, GEOSPHERE, V10, P66, DOI 10.1130/GES00920.1; Klemetti EW, 2011, EARTH PLANET SC LETT, V305, P185, DOI 10.1016/j.epsl.2011.02.054; Lanphere MA, 2004, QUATERNARY RES, V62, P94, DOI 10.1016/j.yqres.2004.03.001; Lipman PW, 2007, GEOSPHERE, V3, P42, DOI 10.1130/GES00061.1; Matthews NE, 2012, J PETROL, V53, P1385, DOI 10.1093/petrology/egs020; Mazdab FK, 2006, GEOCHIM COSMOCHIM AC, V70, pA405, DOI 10.1016/j.gca.2006.06.817; Memeti V, 2010, GEOL SOC AM BULL, V122, P1912, DOI 10.1130/B30004.1; Molloy C, 2008, J GEOL SOC LONDON, V165, P435, DOI 10.1144/0016-76492007-071; Murphy MD, 2000, J PETROL, V41, P21, DOI 10.1093/petrology/41.1.21; Newman S, 1983, 230TH 238U DISEQUILI; Paterson SR, 2009, GEOSPHERE, V5, P496, DOI 10.1130/GES00214.1; Putirka KD, 2008, MINERAL INCLUSIONS V; Quinn ET, 2014, EXPT DETERMINATION P; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; Rusk BG, 2014, GEOL SOC AM ANN M PR; SHERROD DR, 1990, J GEOPHYS RES-SOLID, V95, P19465, DOI 10.1029/JB095iB12p19465; Stelten ME, 2012, EARTH PLANET SC LETT, V313, P1, DOI 10.1016/j.epsl.2011.10.035; Storm S, 2012, CONTRIB MINERAL PETR, V163, P505, DOI 10.1007/s00410-011-0682-8; Storm S, 2011, EARTH PLANET SC LETT, V301, P511, DOI 10.1016/j.epsl.2010.11.034; Trimble DA, 1984, 84371 USGS; Vazquez JA, 2004, SCIENCE, V305, P991, DOI 10.1126/science.1096994; Walker BA, 2007, J VOLCANOL GEOTH RES, V167, P239, DOI 10.1016/j.jvolgeores.2006.12.008; Walker BA, 2010, GEOLOGY, V38, P1007, DOI 10.1130/G31226.1; Watson EB, 1996, T ROY SOC EDIN-EARTH, V87, P43, DOI 10.1017/S0263593300006465; Watts KE, 2012, CONTRIB MINERAL PETR, V164, P45, DOI 10.1007/s00410-012-0724-x; Wiebe RA, 2004, J PETROL, V45, P2133, DOI 10.1093/petrology/egh050; Zellmer GF, 2005, J VOLCANOL GEOTH RES, V140, P171, DOI 10.1016/j.jvolgeores.2004.07.020; Zellmer GF, 2003, J PETROL, V44, P1413, DOI 10.1093/petrology/44.8.1413	58	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113157	10.1371/journal.pone.0113157	http://dx.doi.org/10.1371/journal.pone.0113157			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470726	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700015
J	McGraw, KL; Basiorka, AA; Johnson, JO; Clark, J; Caceres, G; Padron, E; Heaton, R; Ozawa, Y; Wei, S; Sokol, L; List, AF				McGraw, Kathy L.; Basiorka, Ashley A.; Johnson, Joseph O.; Clark, Justine; Caceres, Gisela; Padron, Eric; Heaton, Ruth; Ozawa, Yukiyasu; Wei, Sheng; Sokol, Lubomir; List, Alan F.			Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors	PLOS ONE			English	Article							DESTRUCTION; DEGRADATION; ACTIVATION; CEREBLON; TARGET; IKAROS; STAT5	Anemia remains the principal management challenge for patients with lower risk Myelodysplastic Syndromes (MDS). Despite appropriate cytokine production and cellular receptor display, erythropoietin receptor (EpoR) signaling is impaired. We reported that EpoR signaling is dependent upon receptor localization within lipid raft microdomains, and that disruption of raft integrity abolishes signaling capacity. Here, we show that MDS erythroid progenitors display markedly diminished raft assembly and smaller raft aggregates compared to normal controls (p=0.005, raft number; p=0.023, raft size). Because lenalidomide triggers raft coalescence in T-lymphocytes promoting immune synapse formation, we assessed effects of lenalidomide on raft assembly in MDS erythroid precursors and UT7 cells. Lenalidomide treatment rapidly induced lipid raft formation accompanied by EpoR recruitment into raft fractions together with STAT5, JAK2, and Lyn kinase. The JAK2 phosphatase, CD45, a key negative regulator of EpoR signaling, was displaced from raft fractions. Lenalidomide treatment prior to Epo stimulation enhanced both JAK2 and STAT5 phosphorylation in UT7 and primary MDS erythroid progenitors, accompanied by increased STAT5 DNA binding in UT7 cells, and increased erythroid colony forming capacity in both UT7 and primary cells. Raft induction was associated with F-actin polymerization, which was blocked by Rho kinase inhibition. These data indicate that deficient raft integrity impairs EpoR signaling, and provides a novel strategy to enhance EpoR signal fidelity in non-del(5q) MDS.	[McGraw, Kathy L.; Clark, Justine; Padron, Eric; Sokol, Lubomir; List, Alan F.] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA; [Basiorka, Ashley A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Canc Biol PhD Program, Tampa, FL 33612 USA; [Johnson, Joseph O.] H Lee Moffitt Canc Ctr & Res Inst, Analyt Microscopy Core Facil, Tampa, FL 33612 USA; [Caceres, Gisela] H Lee Moffitt Canc Ctr & Res Inst, Morsani Mol Diagnost Lab, Tampa, FL 33612 USA; [Heaton, Ruth] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Ozawa, Yukiyasu] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nakamura Ku, Aichi 4538511, Japan; [Wei, Sheng] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Arizona; Red Cross Nagoya Daiichi Hospital; H Lee Moffitt Cancer Center & Research Institute	List, AF (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Alan.List@moffitt.org		LIST, ALAN/0000-0002-1647-2972	National Institutes of Health [R01 CA131076]; NATIONAL CANCER INSTITUTE [T32CA115308, R01CA131076, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded through National Institutes of Health grant number R01 CA131076 and generous support provided by Martin Schaffel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng SS, 2014, CELL ADHES MIGR, V8, P49, DOI 10.4161/cam.27480; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hoefsloot LH, 1997, BLOOD, V89, P1690, DOI 10.1182/blood.V89.5.1690.1690_1690_1700; Huang M, 2002, ONCOGENE, V21, P8804, DOI 10.1038/sj.onc.1206028; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jobling MG, 2002, INFECT IMMUN, V70, P1260, DOI 10.1128/IAI.70.3.1260-1271.2002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lou ZK, 2001, J IMMUNOL, V167, P5749, DOI 10.4049/jimmunol.167.10.5749; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; McGraw KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034477; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Padron E, 2013, BLOOD, V121, P5068, DOI 10.1182/blood-2012-10-460170; Raza A, 2008, BLOOD, V111, P86, DOI 10.1182/blood-2007-01-068833; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sundaravel S, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.924.924; Toma A, 2013, J CLIN ONCOL S, V15, P7002; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Wei S, 2012, ONCOGENE; Wu SD, 2009, MOL CELL, V35, P735, DOI 10.1016/j.molcel.2009.09.012; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu YB, 2009, BLOOD, V114, P338, DOI 10.1182/blood-2009-02-200543; Zhou L, 2011, J BIOL CHEM, V286, P25211, DOI 10.1074/jbc.M111.235028	31	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114249	10.1371/journal.pone.0114249	http://dx.doi.org/10.1371/journal.pone.0114249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469886	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700092
J	Tudor, CS; Bruns, H; Daniel, C; Distel, LV; Hartmann, A; Gerbitz, A; Buettner, MJ				Tudor, Christiane Silke; Bruns, Heiko; Daniel, Christoph; Distel, Luitpold Valentin; Hartmann, Arndt; Gerbitz, Armin; Buettner, Maike Julia			Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; REED-STERNBERG CELLS; ANTICANCER EFFECTOR FUNCTION; HUMAN BREAST-CANCER; EPSTEIN-BARR-VIRUS; MOLECULAR-MECHANISMS; TUMORICIDAL ACTIVITY; NECROSIS-FACTOR; GROWTH-FACTOR	Background: The inflammatory infiltrate plays a pivotal role in classical Hodgkin lymphoma (cHL). Here, we focussed on the role of macrophages (M Phi) and dendritic cells (DC). Methods: M Phi and DC infiltration was investigated in 106 cHL specimens using immunohistochemistry and cytokine expression was analyzed in a subset by realtime PCR. Human peripheral blood-derived monocytes, DC, M Phi stimulated with GM-CSF (M Phi(GM-CSF), pro-inflammatory M Phi-1-model) or M-CSF (M Phi(M-CSF), immunomodulatory M Phi-2-model) were incubated with cHL cell line (L1236, HDLM2) supernatants (SN). DC maturation or M Phi polarization were investigated by flow cytometry. Furthermore, the impact of DC or M Phi on cHL cell proliferation was analyzed by BrdU/CFSE assay. Results: In cHL tissues mature myeloid (m) DC and M Phi predominated. High numbers of CD83+ mDC and low numbers of CD163+ M Phi were associated with improved disease specific survival. In numerous cHL specimens increased levels of both pro-and anti-inflammatory cytokines and of IL13 and GM-CSF were observed compared to reactive lymphadenopathies. Maturation of DC and induction and maintenance of an immunomodulatory M Phi phenotype were promoted by SN derived from cHL cell lines. TNF alpha neutralization in SN resulted in a significant inhibition of mDC maturation. DC and pro-inflammatory M Phi inhibited the proliferation of cHL cells. Conclusion: Adopting an immunomodulatory phenotype is a potential mechanism for how MW promote immune evasion in cHL. Mature DC, in contrast, might participate in antitumoral immunity.	[Tudor, Christiane Silke; Daniel, Christoph; Buettner, Maike Julia] Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Dept Nephropathol, D-91054 Erlangen, Germany; [Bruns, Heiko; Gerbitz, Armin] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Univ Hosp, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Distel, Luitpold Valentin] Univ Erlangen Nurnberg, Univ Hosp, Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Hartmann, Arndt] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Pathol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Buettner, MJ (corresponding author), Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Dept Nephropathol, D-91054 Erlangen, Germany.	maike.buettner@uk-erlangen.de	Daniel, Christoph/AAK-2136-2021; Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226; Daniel, Christoph/0000-0002-6803-4755	GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany; ELAN Fond of the University Hospital of Erlangen, Germany; Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany; BayImmunNet consortium of the Government of Bavaria; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany; ELAN Fond of the University Hospital of Erlangen, Germany; Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany; BayImmunNet consortium of the Government of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	MJB and CST were supported by the GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany, the ELAN Fond of the University Hospital of Erlangen, Germany and the Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany. HB was supported by the BayImmunNet consortium of the Government of Bavaria. The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2013, J ENVIRON PATHOL TOX, V32, P289, DOI 10.1615/JEnvironPatholToxicolOncol.2013007930; Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Benharroch D, 2010, VIRCHOWS ARCH, V457, P63, DOI 10.1007/s00428-010-0931-7; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Brower V, 2005, J NATL CANCER I, V97, P1175, DOI 10.1093/jnci/dji269; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; COPPLESON LW, 1973, JNCI-J NATL CANCER I, V51, P379; Coventry BJ, 2003, BRIT J CANCER, V89, P533, DOI 10.1038/sj.bjc.6601114; Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132; Demoulin S, 2013, J LEUKOCYTE BIOL, V93, P343, DOI 10.1189/jlb.0812397; Dinarello CA, 2006, CANCER METAST REV, V25, P307, DOI 10.1007/s10555-006-9000-8; Dufresne M, 2011, MOL IMMUNOL, V48, P1556, DOI 10.1016/j.molimm.2011.04.022; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gottfried E, 2008, CYTOKINE GROWTH F R, V19, P65, DOI 10.1016/j.cytogfr.2007.10.008; GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; HSU PL, 1991, INT J HEMATOL, V54, P315; Inoshima N, 2002, CLIN CANCER RES, V8, P3480; Ishigami S, 2003, ONCOL REP, V10, P1237; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Janjic BM, 2002, J IMMUNOL, V168, P1823, DOI 10.4049/jimmunol.168.4.1823; Jones K, 2013, CLIN CANCER RES, V19, P731, DOI 10.1158/1078-0432.CCR-12-2693; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kim R, 2007, IMMUNOLOGY, V121, P149, DOI 10.1111/j.1365-2567.2007.02579.x; KLEIN S, 1992, HEMATOL ONCOL, V10, P319, DOI 10.1002/hon.2900100605; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lu GW, 2002, J IMMUNOL, V168, P1831, DOI 10.4049/jimmunol.168.4.1831; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Natoli A, 2013, INT J CANCER, V133, P1945, DOI 10.1002/ijc.28189; PAIETTA E, 1990, CANCER RES, V50, P2049; REE HJ, 1985, CANCER, V56, P333, DOI 10.1002/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0.CO;2-0; REED SG, 1987, J EXP MED, V166, P1734, DOI 10.1084/jem.166.6.1734; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tsutsui S, 2005, ONCOL REP, V14, P425; Tudor CS, 2013, HUM PATHOL, V44, P2475, DOI 10.1016/j.humpath.2013.06.006; Vanderheyde N, 2004, IMMUNOL LETT, V91, P99, DOI 10.1016/j.imlet.2003.11.011; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Williams MA, 1997, BRIT J HAEMATOL, V98, P960, DOI 10.1046/j.1365-2141.1997.2923108.x; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Yung L, 2003, LANCET, V361, P943, DOI 10.1016/S0140-6736(03)12777-8; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	65	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114345	10.1371/journal.pone.0114345	http://dx.doi.org/10.1371/journal.pone.0114345			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470820	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700101
J	Cardi, V; Corfield, F; Leppanen, J; Rhind, C; Deriziotis, S; Hadjimichalis, A; Hibbs, R; Micali, N; Treasure, J				Cardi, Valentina; Corfield, Freya; Leppanen, Jenni; Rhind, Charlotte; Deriziotis, Stephanie; Hadjimichalis, Alexandra; Hibbs, Rebecca; Micali, Nadia; Treasure, Janet			Emotional Processing of Infants Displays in Eating Disorders	PLOS ONE			English	Article							INTERPERSONAL MAINTENANCE MODEL; ANOREXIA-NERVOSA; VALIDATION; ADOLESCENTS; EXPERIENCE; PREGNANCY; ATTENTION; INTERVIEW; PICTURES; ANXIETY	Aim: The aim of this study is to examine emotional processing of infant displays in people with Eating Disorders (EDs). Background: Social and emotional factors are implicated as causal and maintaining factors in EDs. Difficulties in emotional regulation have been mainly studied in relation to adult interactions, with less interest given to interactions with infants. Method: A sample of 138 women were recruited, of which 49 suffered from Anorexia Nervosa (AN), 16 from Bulimia Nervosa (BN), and 73 were healthy controls (HCs). Attentional responses to happy and sad infant faces were tested with the visual probe detection task. Emotional identification of, and reactivity to, infant displays were measured using self-report measures. Facial expressions to video clips depicting sad, happy and frustrated infants were also recorded. Results: No significant differences between groups were observed in the attentional response to infant photographs. However, there was a trend for patients to disengage from happy faces. People with EDs also reported lower positive ratings of happy infant displays and greater subjective negative reactions to sad infants. Finally, patients showed a significantly lower production of facial expressions, especially in response to the happy infant video clip. Insecure attachment was negatively correlated with positive facial expressions displayed in response to the happy infant and positively correlated with the intensity of negative emotions experienced in response to the sad infant video clip. Conclusion: People with EDs do not have marked abnormalities in their attentional processing of infant emotional faces. However, they do have a reduction in facial affect particularly in response to happy infants. Also, they report greater negative reactions to sadness, and rate positive emotions less intensively than HCs. This pattern of emotional responsivity suggests abnormalities in social reward sensitivity and might indicate new treatment targets.	[Cardi, Valentina; Corfield, Freya; Leppanen, Jenni; Rhind, Charlotte; Deriziotis, Stephanie; Hadjimichalis, Alexandra; Hibbs, Rebecca; Treasure, Janet] Kings Coll London, Inst Psychiat, Dept Psychol Med, Sect Eating Disorders, London, England; [Micali, Nadia] UCL, Inst Child Hlth, Behav & Brain Sci Unit, London, England	University of London; King's College London; University of London; University College London	Cardi, V (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, Sect Eating Disorders, London, England.	valentina.cardi@kcl.ac.uk	Micali, Nadia/E-6829-2010	Micali, Nadia/0000-0001-5571-2273; Treasure, Janet/0000-0003-0871-4596; Leppanen, Jenni/0000-0003-2814-4375; Cardi, Valentina/0000-0002-7763-7099	Psychiatry Research Trust Fellowships; Marie Curie fellowship; National Institute of Health Research (NIHR) Clinician Scientist Award [DHCS/08/08/012]; National Institute for Health Research (NIHR), Mental Health Biomedical Research at South London and Maudsley NHS Foundation Trust; King's College London	Psychiatry Research Trust Fellowships; Marie Curie fellowship(European Commission); National Institute of Health Research (NIHR) Clinician Scientist Award(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR), Mental Health Biomedical Research at South London and Maudsley NHS Foundation Trust; King's College London	FC and CR are supported by Psychiatry Research Trust Fellowships. VC is supported by a Marie Curie fellowship. NM is funded by a National Institute of Health Research (NIHR) Clinician Scientist Award (DHCS/08/08/012). JT receives salary support from the National Institute for Health Research (NIHR), Mental Health Biomedical Research at South London and Maudsley NHS Foundation Trust, and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arcelus J, 2013, CLIN PSYCHOL REV, V33, P156, DOI 10.1016/j.cpr.2012.10.009; Barrett J, 2012, SOC NEUROSCI-UK, V7, P252, DOI 10.1080/17470919.2011.609907; Beadle JN, 2013, ANN CLIN PSYCHIATRY, V25, P107; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; Bifulco A, 2003, PSYCHOL MED, V33, P1099, DOI 10.1017/S0033291703008237; Cagar-Nazai HP, 2014, NEUROSCI BIOBEHAV R, V42, P55, DOI 10.1016/j.neubiorev.2013.12.002; Calderoni S, 2013, NEUROPSYCH DIS TREAT, V9, P1583, DOI 10.2147/NDT.S50214; Cardi V, 2014, INT J EAT DISORDER, V47, P543, DOI 10.1002/eat.22261; Cardi V, 2013, WORLD J BIOL PSYCHIA, V14, P622, DOI 10.3109/15622975.2012.665479; CARLSON CR, 1989, J PSYCHOPATHOL BEHAV, V11, P313, DOI 10.1007/BF00961530; Claes L, 2012, EUR EAT DISORD REV, V20, P484, DOI 10.1002/erv.2212; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corfield F, ATTENTION AVOI UNPUB; Corstorphine E, 2006, EUR EAT DISORD REV, V14, P448, DOI 10.1002/erv.747; Davies H, 2011, INT J EAT DISORDER, V44, P531, DOI 10.1002/eat.20852; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; First MB, 2002, STRUCTURED CLIN INTE; Fox JRE, 2009, CLIN PSYCHOL PSYCHOT, V16, P240, DOI 10.1002/cpp.626; Giel KE, 2013, BIOL PSYCHOL, V94, P575, DOI 10.1016/j.biopsycho.2013.10.004; Kring A.M., 1991, FACIAL EXPRESS UNPUB; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Laurent HK, 2013, SOC NEUROSCI-UK, V8, P228, DOI 10.1080/17470919.2012.762039; Leerkes EM, 2010, PARENT-SCI PRACT, V10, P219, DOI 10.1080/15295190903290840; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Oldershaw A, 2012, EUR EAT DISORD REV, V20, P502, DOI 10.1002/erv.2153; Pearson RM, 2011, INFANT BEHAV DEV, V34, P200, DOI 10.1016/j.infbeh.2010.12.009; Pearson RM, 2010, PSYCHOL MED, V40, P621, DOI 10.1017/S0033291709990961; Pearson RM, 2013, J AFFECT DISORDERS, V145, P208, DOI 10.1016/j.jad.2012.07.033; Pearson RM, 2011, ARCH WOMEN MENT HLTH, V14, P23, DOI 10.1007/s00737-010-0180-4; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reichel VA, 2014, PSYCHOPHYSIOLOGY, V51, P168, DOI 10.1111/psyp.12160; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Soussignan R, 2010, PSYCHOL MED, V40, P503, DOI 10.1017/S0033291709990377; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; Tchanturia K, 2012, INT J EAT DISORDER, V45, P962, DOI 10.1002/eat.22032; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wildes JE, 2010, INT J EAT DISORDER, V43, P398, DOI 10.1002/eat.20730	42	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113191	10.1371/journal.pone.0113191	http://dx.doi.org/10.1371/journal.pone.0113191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25463051	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700028
J	Mosca, E; Alfieri, R; Milanesi, L				Mosca, Ettore; Alfieri, Roberta; Milanesi, Luciano			Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C Virus	PLOS ONE			English	Article							DISCOVERY; LIVER; INHIBITION; INTERFERON; INITIATION; INFECTION; PACKAGE; AP-1	Hepatitis C virus infection is one of the most common and chronic in the world, and hepatitis associated with HCV infection is a major risk factor for the development of cirrhosis and hepatocellular carcinoma (HCC). The rapidly growing number of viral-host and host protein-protein interactions is enabling more and more reliable network-based analyses of viral infection supported by omics data. The study of molecular interaction networks helps to elucidate the mechanistic pathways linking HCV molecular activities and the host response that modulates the stepwise hepatocarcinogenic process from preneoplastic lesions (cirrhosis and dysplasia) to HCC. Simulating the impact of HCV-host molecular interactions throughout the host protein-protein interaction (PPI) network, we ranked the host proteins in relation to their network proximity to viral targets. We observed that the set of proteins in the neighborhood of HCV targets in the host interactome is enriched in key players of the host response to HCV infection. In opposition to HCV targets, subnetworks of proteins in network proximity to HCV targets are significantly enriched in proteins reported as differentially expressed in preneoplastic and neoplastic liver samples by two independent studies. Using multi-objective optimization, we extracted subnetworks that are simultaneously "guilt-by-association" with HCV proteins and enriched in proteins differentially expressed. These subnetworks contain established, recently proposed and novel candidate proteins for the regulation of the mechanisms of liver cells response to chronic HCV infection.	[Mosca, Ettore; Alfieri, Roberta; Milanesi, Luciano] CNR, Inst Biomed Technol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Mosca, E (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ettore.mosca@itb.cnr.it	Mosca, Ettore/D-6275-2017; Mosca, Ettore/H-8694-2013; Milanesi, Luciano/AAE-7230-2019; Alfieri, Roberta/AAX-5553-2020	Mosca, Ettore/0000-0002-3102-5150; Mosca, Ettore/0000-0002-3102-5150; Milanesi, Luciano/0000-0002-1201-3939; Alfieri, Roberta/0000-0001-6922-9696	Italian Ministry of Education and Research through the Flagship InterOmics project [PB05]; Italian Ministry of Education and Research through HIRMA project [RBAP11YS7K]; European MIMOmics project [305280]	Italian Ministry of Education and Research through the Flagship InterOmics project; Italian Ministry of Education and Research through HIRMA project; European MIMOmics project	The work has been supported by the Italian Ministry of Education and Research through the Flagship InterOmics (PB05) and HIRMA (RBAP11YS7K) projects, and the European MIMOmics (305280) project to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Behnke MK, 2014, ANN HEPATOL, V13, P45, DOI 10.1016/S1665-2681(19)30903-2; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Chau TKH, 2000, LIFE SCI, V67, P1719, DOI 10.1016/S0024-3205(00)00757-8; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Dolan PT, 2013, MOL BIOSYST, V9, P3199, DOI 10.1039/c3mb70343f; Drozdov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035510; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jackson MA, 2006, TOXICOL SCI, V90, P400, DOI 10.1093/toxsci/kfj101; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Maass T, 2010, CURR GENOMICS, V11, P261, DOI 10.2174/138920210791233063; Marshall A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059459; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Matteucci C, 2014, HEPATOL RES, V44, P1008, DOI 10.1111/hepr.12239; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Mosca E, 2013, MOL BIOSYST, V9, P2971, DOI 10.1039/c3mb70327d; Mukhopadhyay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094029; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Parisi GF, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.11215; Pramhas S, 2010, ANTIVIR THER, V15, P831, DOI 10.3851/IMP1654; Qian Y, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S1-S6; Raphael BJ, 2013, NAT METHODS, V10, P1077, DOI 10.1038/nmeth.2704; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steuer R. E., 1986, MULTIPLE CRITERIA OP; Stokes ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-282; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Wei L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S13; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhao H, 1996, VIROLOGY, V220, P330, DOI 10.1006/viro.1996.0321; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62; Zhou Dengyong, 2003, ADV NEURAL INFORM PR, V16; Zhu ZW, 2010, J MED VIROL, V82, P239, DOI 10.1002/jmv.21644	67	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113660	10.1371/journal.pone.0113660	http://dx.doi.org/10.1371/journal.pone.0113660			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461596	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700042
J	Nouwens, E; van Lieshout, J; Bouma, M; Braspenning, J; Wensing, M				Nouwens, Elvira; van Lieshout, Jan; Bouma, Margriet; Braspenning, Joze; Wensing, Michel			Effectiveness of Improvement Plans in Primary Care Practice Accreditation: A Clustered Randomized Trial	PLOS ONE			English	Article							CARDIOVASCULAR RISK-MANAGEMENT; GENERAL-PRACTICE; QUALITY; GUIDELINES; PROGRAM; SUPPORT; DISEASE	Background: Accreditation of healthcare organizations is a widely used method to assess and improve quality of healthcare. Our aim was to determine the effectiveness of improvement plans in practice accreditation of primary care practices, focusing on cardiovascular risk management (CVRM). Method: A two-arm cluster randomized controlled trial with a block design was conducted with measurements at baseline and follow-up. Primary care practices allocated to the intervention group (n=22) were instructed to focus improvement plans during the intervention period on CVRM, while practices in the control group (n=23) could focus on any domain except on CVRM and diabetes mellitus. Primary outcomes were systolic blood pressure <140 mmHg, LDL cholesterol <2.5 mmol/l and prescription of antiplatelet drugs. Secondary outcomes were 17 indicators of CVRM and physician's perceived goal attainment for the chosen improvement project. Results: No effect was found on the primary outcomes. Blood pressure targets were reached in 39.8% of patients in the intervention and 38.7% of patients in the control group; cholesterol target levels were reached in 44.5% and 49.0% respectively; antiplatelet drugs were prescribed in 82.7% in both groups. Six secondary outcomes improved: smoking status, exercise control, diet control, registration of alcohol intake, measurement of waist circumference, and fasting glucose. Participants' perceived goal attainment was high in both arms: mean scores of 7.9 and 8.2 on the 10-point scale. Conclusions: The focus of improvement plans on CVRM in the practice accreditation program led to some improvements of CVRM, but not on the primary outcomes.	[Nouwens, Elvira; van Lieshout, Jan; Braspenning, Joze; Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6525 ED Nijmegen, Netherlands; [Bouma, Margriet] Dutch Coll Gen Practitioners, Utrecht, Netherlands	Radboud University Nijmegen	Nouwens, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6525 ED Nijmegen, Netherlands.	elvira.nouwens@radboudumc.nl	Wensing, Michel/H-8113-2014; Braspenning, Jozé CC/D-4268-2009; Braspenning, Jozé/AAG-7612-2021; Van Lieshout, J./L-4490-2015	Wensing, Michel/0000-0001-6569-8137; Braspenning, Jozé CC/0000-0003-0800-0630; Braspenning, Jozé/0000-0003-0800-0630; 	ZonMW - the Netherlands Organization for Health Research and Development [170883001]	ZonMW - the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This intervention is funded by ZonMW - the Netherlands Organization for Health Research and Development, project number 170883001; http://www.zonmw.nl/nl/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhenizan A, 2011, ANN SAUDI MED, V31, P407, DOI 10.4103/0256-4947.83204; [Anonymous], 2006, NHG STANDAARD CARDIO; Braithwaite Jeffrey, 2011, BMC Res Notes, V4, P390, DOI 10.1186/1756-0500-4-390; Braspenning JCC, 2005, WERKEN KWALITEIT HUI; Buetow SA, 2003, QUAL SAF HEALTH CARE, V12, P129, DOI 10.1136/qhc.12.2.129; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Engels Y., 2005, ASSESSING IMPROVING; Frijling BD, 2003, BRIT J GEN PRACT, V53, P934; Frijling BD, 2003, QUAL SAF HEALTH CARE, V12, P181, DOI 10.1136/qhc.12.3.181; Furthauer J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-47; Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005; Greenfield D, 2009, QUAL SAF HEALTH CARE, V18, P162, DOI 10.1136/qshc.2009.032359; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2000, BRIT J GEN PRACT, V50, P882; in 't Veld C J, 2007, Ned Tijdschr Geneeskd, V151, P2916; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Lester HE, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X641627; Nouwens E, 2012, NETH J MED, V70, P298; Nouwens E, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-94; Rogers EM, 1983, DIFFUSION INNOVATION; Smeele I. J. M., 2012, HUISARTS WETENSCHAP, V55, P194; Soler JK, 2008, FAM PRACT, V25, P312, DOI 10.1093/fampra/cmn028; Szecsenyi J, 2011, CAN MED ASSOC J, V183, pE1326, DOI 10.1503/cmaj.110412; Van Althuis T, 2008, OVERZICHT DEFINITIE; Van den Hombergh P, 1998, PRACTICE VISITS ASSE; van den Hombergh P, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-23; Van Doorn A, 2010, HUISARTS WET, V53, P141; Van Doorn-Klomberg AL, 2011, HUISARTS WETENSCHAP, V54, P360; van Lieshout J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-96	29	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114045	10.1371/journal.pone.0114045	http://dx.doi.org/10.1371/journal.pone.0114045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463149	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700088
J	Straneo, M; Fogliati, P; Azzimonti, G; Mangi, S; Kisika, F				Straneo, Manuela; Fogliati, Piera; Azzimonti, Gaetano; Mangi, Sabina; Kisika, Firma			Where Do the Rural Poor Deliver When High Coverage of Health Facility Delivery Is Achieved? Findings from a Community and Hospital Survey in Tanzania	PLOS ONE			English	Article							SOUTHERN TANZANIA; SURVIVAL; CARE; CHILDBIRTH; MATERNITY; MORTALITY	Introduction: As part of maternal mortality reducing strategies, coverage of delivery care among sub-Saharan African rural poor will improve, with a range of facilities providing services. Whether high coverage will benefit all socio-economic groups is unknown. Iringa rural District, Southern Tanzania, with high facility delivery coverage, offers a paradigm to address this question. Delivery services are available in first-line facilities (dispensaries, health centres) and one hospital. We assessed whether all socio-economic groups access the only comprehensive emergency obstetric care facility equally, and surveyed existing delivery services. Methods: District population characteristics were obtained from a household community survey (n=463). A Hospital survey collected data on women who delivered in this facility (n=1072). Principal component analysis on household assets was used to assess socio-economic status. Hospital population socio-demographic characteristics were compared to District population using multivariable logistic regression. Deliveries' distribution in District facilities and staffing were analysed using routine data. Results: Women from the hospital compared to the District population were more likely to be wealthier. Adjusted odds ratio of hospital delivery increased progressively across socio-economic groups, from 1.73 for the poorer (p=0.0031) to 4.53 (p<0.0001) for the richest. Remarkable dispersion of deliveries and poor staffing were found. In 2012, 5505/7645 (72%) institutional deliveries took place in 68 first-line facilities, the remaining in the hospital. 56/68 (67.6%) first-line facilities reported <= 100 deliveries/year, attending 33% of deliveries. Insufficient numbers of skilled birth attendants were found in 42.9% of facilities. Discussion: Poorer women remain disadvantaged in high coverage, as they access lower level facilities and are under-represented where life-saving transfusions and caesarean sections are available. Tackling the challenges posed by low caseloads and staffing on first-line rural care requires confronting a dilemma between coverage and quality. Reducing number of delivery sites is recommended to improve quality and equity of care.	[Straneo, Manuela; Fogliati, Piera; Azzimonti, Gaetano] Iringa Dist Council, Council Med Off, Iringa, Tanzania; [Mangi, Sabina] Tosamaganga Council Designated Hosp, Iringa, Tanzania; [Kisika, Firma] Iringa Dist Council, Council Med Off, Iringa, Tanzania		Straneo, M (corresponding author), Iringa Dist Council, Council Med Off, Iringa, Tanzania.	m.straneo@cuamm.org		Straneo, Manuela/0000-0002-2464-1633	 [8797/CUAMM/TZA]		The study was conducted as part of a development project funded by the Italian Cooperation (http://www.cooperazioneallosviluppo.esteri.it), project identification code 8797/CUAMM/TZA; and implemented by the non-governmental organization Doctors with Africa-CUAMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; [Anonymous], 2007, PRIM HLTH SERV DEV P; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; District Planning Team. Iringa District Council Health Department, 2011, COMPR COUNC HLTH PLA; Ferry GA, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-7; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Hanson Claudia, 2013, BMC Res Notes, V6, P435, DOI 10.1186/1756-0500-6-435; Hatt L, 2007, B WORLD HEALTH ORGAN, V85, P774, DOI 10.2471/BLT.06.033472; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manzi F, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-3; Martineau T, 2013, MAPPING HUMAN RESOUR; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, PUBL EXP REV HUM RES; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; National Bureau of Statistics (Tanzania) Office of Chief Government Statistician (Zanzibar), 2013, 2012 POP HOUS CENS; Nyamtema A S, 2008, Afr J Reprod Health, V12, P113; Penfold S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-61; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2008, MAK PREGN SAF CRIT R; World Health Organization, 2010, WISN WORKL IND STAFF; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	30	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113995	10.1371/journal.pone.0113995	http://dx.doi.org/10.1371/journal.pone.0113995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460007	Green Submitted, gold, Green Published			2022-12-27	WOS:000345869700076
J	Sun, MC; Li, MS				Sun, Mu-Chien; Li, Meng-Shan			Intervention for Diagnosis of Deep Vein Thrombosis in Acute Stroke Patients: A Hospital-Based Study	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; KNEE ARTHROPLASTY; AMERICAN-COLLEGE; MANAGEMENT; THERAPY; ASIA	Background: Immobile stroke patients are at high risk of deep vein thrombosis (DVT). Demographic studies suggest a low incidence of DVT in Asian patients, but that might be underestimated. Objective: Intervention by in-hospital case management for diagnosis of DVT in patients with acute stroke. Patients and Methods: Intervention was defined as: recommendation of D-dimer test for patients who are immobile by day 4 after stroke onset and compression ultrasonography if the level of D-dimer is >= 500 ng/ml. Treating physicians were notified by case managers before they failed to do so for qualified patients. Data of patients hospitalized 12 months before and 8 months after the intervention, including basic demographics, Glasgow Coma Scale score, National Institute of Health Stroke Scale (NIHSS) score, laboratory results, and examination reports, was retrieved from electronic medical records for analysis by code searches for acute stroke. Results: A total of 2523 patients were identified. 1528 were before and 995 after intervention. More patients after intervention had D-dimer test and ultrasound examination than that before intervention (22.1% vs 8.6%, P<0.001 and 15.1% vs 1.2%, P<0.001, respectively). Ultrasound diagnosis of DVT was significantly more after than before intervention (2.0% vs 0.3%, P<0.001). DVT was 55.7 per 1000 in patients with a NIHSS score >= 18. Male sex (Odds ratio 0.33, 95% confidence intervals: 0.11-0.98), NIHSS score (Odds ratio 1.05, 95% confidence intervals: 1.00-1.09), and intervention (Odds ratio 5.39, 95% confidence intervals: 1.88-15.44) were independent predictors of ultrasound diagnosis of DVT. Conclusions: Intervention by in-hospital case management may be an effective strategy for improvement of under-diagnosis of DVT in acute stroke patients.	[Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital	Sun, MC (corresponding author), Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan.	sunmc@yahoo.com						[Anonymous], 2010, VEN THROMB RED RISK; Cohen A, 2012, THROMB RES, V130, P291, DOI 10.1016/j.thromres.2012.05.025; Douma RA, 2012, HAEMATOL-HEMATOL J, V97, P1507, DOI 10.3324/haematol.2011.060657; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; Mahan CE, 2012, THROMB RES, V130, P586, DOI 10.1016/j.thromres.2012.07.001; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Sun MC, 2013, J FORMOS MED ASSOC, V112, P263, DOI 10.1016/j.jfma.2012.02.016; Wu PK, 2014, THROMB RES, V133, P719, DOI 10.1016/j.thromres.2014.01.039; Wu PK, 2014, J CHIN MED ASSOC, V77, P155, DOI 10.1016/j.jcma.2013.11.005	15	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114094	10.1371/journal.pone.0114094	http://dx.doi.org/10.1371/journal.pone.0114094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460006	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700096
J	Xiao, ZS; Cao, L; Liang, YJ; Huang, JS; Stern, AR; Dallas, M; Johnson, M; Quarles, LD				Xiao, Zhousheng; Cao, Li; Liang, Yingjuan; Huang, Jinsong; Stern, Amber Rath; Dallas, Mark; Johnson, Mark; Quarles, Leigh Darryl			Osteoblast-Specific Deletion of Pkd2 Leads to Low-Turnover Osteopenia and Reduced Bone Marrow Adiposity	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MECHANICAL-PROPERTIES; IMAGE-ANALYSIS; HIPPO PATHWAY; RUNX2-II; GROWTH; TAZ; YAP; DIFFERENTIATION; SKELETOGENESIS	Polycystin-1 (Pkd1) interacts with polycystin-2 (Pkd2) to form an interdependent signaling complex. Selective deletion of Pkd1 in the osteoblast lineage reciprocally regulates osteoblastogenesis and adipogenesis. The role of Pkd2 in skeletal development has not been defined. To this end, we conditionally inactivated Pkd2 in mature osteoblasts by crossing Osteocalcin (Oc)-Cre; Pkd2(+/null) mice with floxed Pkd2 (Pkd2(flox/flox)) mice. Oc-Cre; Pkd2(flox/null) (Pkd2(Oc-cKO)) mice exhibited decreased bone mineral density, trabecular bone volume, cortical thickness, mineral apposition rate and impaired biomechanical properties of bone. Pkd2 deficiency resulted in diminished Runt-related transcription factor 2 (Runx2) expressions in bone and impaired osteoblastic differentiation ex vivo. Expression of osteoblast-related genes, including, Osteocalcin, Osteopontin, Bone sialoprotein (Bsp), Phosphate-regulating gene with homologies to endopeptidases on the X chromosome (Phex), Dentin matrix protein 1 (Dmp1), Sclerostin (Sost), and Fibroblast growth factor 23 (FGF23) were reduced proportionate to the reduction of Pkd2 gene dose in bone of Oc-Cre;Pkd2(flox/+) and Oc-Cre; Pkd2(flox/null) mice. Loss of Pkd2 also resulted in diminished peroxisome proliferator-activated receptor gamma (PPAR gamma) expression and reduced bone marrow fat in vivo and reduced adipogenesis in osteoblast culture ex vivo. Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes-associated protein (YAP), reciprocally acting as co-activators and co-repressors of Runx2 and PPAR gamma, were decreased in bone of Oc-Cre; Pkd2(flox/null) mice. Thus, Pkd1 and Pkd2 have coordinate effects on osteoblast differentiation and opposite effects on adipogenesis, suggesting that Pkd1 and Pkd2 signaling pathways can have independent effects on mesenchymal lineage commitment in bone.	[Xiao, Zhousheng; Cao, Li; Liang, Yingjuan; Huang, Jinsong; Quarles, Leigh Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA; [Stern, Amber Rath; Dallas, Mark; Johnson, Mark] Univ Missouri, Dept Oral Biol, Sch Dent, Kansas City, MO 64108 USA; [Stern, Amber Rath] Engn Syst Inc, Charlotte, NC 28227 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City	Quarles, LD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; Stern, Amber/0000-0002-1013-8818; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [R01-DK083303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant R01-DK083303 to LDQ from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Dai B, 2012, KIDNEY INT, V82, P1061, DOI 10.1038/ki.2012.222; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; Harris P.C., 1993, GENEREVIEWS; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Khonsari RH, 2013, HUM MOL GENET, V22, P1873, DOI 10.1093/hmg/ddt041; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Low BC, 2014, FEBS LETT; Mekahli D, 2013, PEDIATR NEPHROL, V28, P2089, DOI 10.1007/s00467-012-2384-5; Mesner LD, 2014, J CLIN INVEST; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Pavik I, 2012, CLIN J AM SOC NEPHRO, V7, P248, DOI 10.2215/CJN.09020911; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Xiao Z, 2008, J BIOL CHEM; Xiao ZS, 2007, J BONE MINER RES, V22, pS41; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056585; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu J, 2011, P NATL ACAD SCI USA, V108, P10133, DOI 10.1073/pnas.1017669108	51	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114198	10.1371/journal.pone.0114198	http://dx.doi.org/10.1371/journal.pone.0114198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464512	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700115
J	Ainy, E; Soori, H; Ganjali, M; Le, H; Baghfalaki, T				Ainy, Elaheh; Soori, Hamid; Ganjali, Mojtaba; Le, Henry; Baghfalaki, Taban			Estimating Cost of Road Traffic Injuries in Iran Using Willingness to Pay (WTP) Method	PLOS ONE			English	Article							STATISTICAL LIFE; SAFETY; RISK	We aimed to use the willingness to pay (WTP) method to calculate the cost of traffic injuries in Iran in 2013. We conducted a cross-sectional questionnaire-based study of 846 randomly selected road users. WTP data was collected for four scenarios for vehicle occupants, pedestrians, vehicle drivers, and motorcyclists. Final analysis was carried out using Weibull and maximum likelihood method. Mean WTP was 2,612,050 Iranian rials (IRR). Statistical value of life was estimated according to 20,408 fatalities 402,314,106,073,648 IRR (US$13,410,470,202 based on purchasing power parity at (February 27th, 2014). Injury cost was US$25,637,870,872 (based on 318,802 injured people in 2013, multiple daily traffic volume of 311, and multiple daily payment of 31,030 IRR for 250 working days). The total estimated cost of injury and death cases was 39,048,341,074$. Gross national income of Iran was, US$604,300,000,000 in 2013 and the costs of traffic injuries constituted 6.46% of gross national income. WTP was significantly associated with age, gender, monthly income, daily payment, more payment for time reduction, trip mileage, drivers and occupants from road users. The costs of traffic injuries in Iran in 2013 accounted for 6.64% of gross national income, much higher than the global average. Policymaking and resource allocation to reduce traffic-related death and injury rates have the potential to deliver a huge economic benefit.	[Ainy, Elaheh; Soori, Hamid] Univ Med Sci, Safety Promot & Injury Prevent Res Ctr Shahid Beh, Tehran, Iran; [Ganjali, Mojtaba; Baghfalaki, Taban] Shahid Beheshti Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Le, Henry] Transport Modeling AECOM, Melbourne, Vic, Australia	Tehran University of Medical Sciences; Shahid Beheshti University	Soori, H (corresponding author), Univ Med Sci, Safety Promot & Injury Prevent Res Ctr Shahid Beh, Tehran, Iran.	hsoori@yahoo.com	Ainy, Elaheh/AAX-2567-2021; Baghfalaki, Taban/R-7017-2019	Ainy, Elaheh/0000-0002-6423-0310	Rahvar Research Center of NAJA	Rahvar Research Center of NAJA	Funding: Funding provided by Traffic Police of Iran (Rahvar Research Center of NAJA) funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson, 2008, ESTABLISHING MONETAR; Antoniou C, 2014, EUR TRANSP RES REV, V6, P31, DOI 10.1007/s12544-013-0103-3; Belin MA, 2012, INT J INJ CONTROL SA, V19, P171, DOI 10.1080/17457300.2011.635213; Bhattacharya S, 2007, J RISK UNCERTAINTY, V34, P21, DOI 10.1007/s11166-006-9002-5; Chhotu AK., 2014, INT J CIVIL ENG RES, V5, P407; de Blaeij A, 2003, ACCIDENT ANAL PREV, V35, P973, DOI 10.1016/S0001-4575(02)00105-7; Dionne G, 2004, J TRANSP ECON POLICY, V38, P247; Gibson J, 2007, WORLD DEV, V35, P512, DOI 10.1016/j.worlddev.2006.05.003; Hensher DA, 2009, TRANSPORT RES A-POL, V43, P692, DOI 10.1016/j.tra.2009.06.001; Hiselius L, 2003, VALUE ROAD RAILWAY S; Hultkrantz L, 2012, HEALTH POLICY, V108, P302, DOI 10.1016/j.healthpol.2012.09.007; Jennings, 2000, J INSURANCE ISSUES, V23, P180; Khosravi A, 2013, MORTALITY PROFILE IR; Le H., 2011, 34 AUSTR TRANSP RES; Leon G, 2013, TRANSPORTATION CHOIC; Litman T, 2007, VALUING TRANSIT SERV; Litman T, 2010, MORE COMPREHENSIVE M; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McMahon K., 2008, TRUE COST ROAD CRASH; Ministry of Science Research and Technology of Science and Technology University Transportation research center, 2012, THEOR APPL; Organization W. H., 2013, WHO GLOB STAT REP RO; Peden M., 2004, WORLD REPORT ROAD TR; Perovic J, 2009, P 13 ROAD ENG ASS AS, P23; Perovic J, 2008, AUSTR ROAD SAF RES P; Pitel S. G. A., 2013, ESTIMATING NUMBER CO; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Thailand National Sentinel Injury Surveillance Program, 2007, NCD EP; Trawen A, 2001, INT C TRAFF SAF 3 CO; van Wee B, 2013, TRANSPORTATION, V40, P295, DOI 10.1007/s11116-012-9425-6; Wang Yan, 2008, Journal of Tongji University (Natural Science), V36, P47; WHO, 2011, GLOBAL BURDEN DIS	31	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112721	10.1371/journal.pone.0112721	http://dx.doi.org/10.1371/journal.pone.0112721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438150	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900015
J	Albrecht, L; Angeletti, D; Moll, K; Blomqvist, K; Valentini, D; D'Alexandri, FL; Maurer, M; Wahlgren, M				Albrecht, Letusa; Angeletti, Davide; Moll, Kirsten; Blomqvist, Karin; Valentini, Davide; D'Alexandri, Fabio Luiz; Maurer, Markus; Wahlgren, Mats			B-Cell Epitopes in NTS-DBL1 alpha of PfEMP1 Recognized by Human Antibodies in Rosetting Plasmodium falciparum	PLOS ONE			English	Article							BRAIN ENDOTHELIAL-CELLS; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; VAR GENES; VARIANT ANTIGENS; ACQUIRED-IMMUNITY; CEREBRAL MALARIA; BINDING; EXPRESSION; CHILDREN	Plasmodium falciparum is the most lethal of the human malaria parasites. The virulence is associated with the capacity of the infected red blood cell (iRBC) to sequester inside the deep microvasculature where it may cause obstruction of the blood-flow when binding is excessive. Rosetting, the adherence of the iRBC to uninfected erythrocytes, has been found associated with severe malaria and found to be mediated by the NTS-DBL1 alpha-domain of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1). Here we show that the reactivity of plasma of Cameroonian children with the surface of the FCR3S1.2-iRBC correlated with the capacity to disrupt rosettes and with the antibody reactivity with a recombinant PfEMP1 (NTS-DBL1 alpha of IT4(var60)) expressed by parasite FCR3S1.2. The plasma-reactivity in a microarray, consisting of 96 overlapping 15-mer long peptides covering the NTS-DBL1 alpha domain from IT4var60 sequence, was compared with their capacity to disrupt rosettes and we identified five peptides where the reactivity were correlated. Three of the peptides were localized in subdomain-1 and 2. The other two peptide-sequences were localized in the NTS-domain and in subdomain-3. Further, principal component analysis and orthogonal partial least square analysis generated a model that supported these findings. In conclusion, human antibody reactivity with short linear-peptides of NTS-DBL1 alpha of PfEMP1 suggests subdomains 1 and 2 to hold anti-rosetting epitopes recognized by anti-rosetting antibodies. The data suggest rosetting to be mediated by the variable areas of PfEMP1 but also to involve structurally relatively conserved areas of the molecule that may induce biologically active antibodies.	[Albrecht, Letusa; Angeletti, Davide; Moll, Kirsten; Blomqvist, Karin; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Valentini, Davide; Maurer, Markus] Karolinska Inst, Dept Lab Med, Therapeut Immunol TIM, Stockholm, Sweden; [Valentini, Davide; Maurer, Markus] Karolinska Univ Hosp, CAST, Huddinge, Sweden; [D'Alexandri, Fabio Luiz] Univ Estadual Campinas, Dept Biochem, Campinas, SP, Brazil	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universidade Estadual de Campinas	Albrecht, L (corresponding author), Univ Fed Sao Paulo, UNIFESP, Sao Paulo, Brazil.	letusaa@gmail.com; mats.wahlgren@ki.se	Albrecht, Letusa/I-1837-2012; Angeletti, Davide/H-7350-2019	Albrecht, Letusa/0000-0001-6406-2057; Angeletti, Davide/0000-0002-5256-1972	Swedish Research Council (VR); Swedish Academy of Sciences (KVA, Soderberg Foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); Swedish Academy of Sciences (KVA, Soderberg Foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Funding: This work was supported by Swedish Research Council (VR), The Swedish Academy of Sciences (KVA, Soderberg Foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2008, METHODS MALARIA RES; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Giha HA, 1999, PARASITOLOGY, V119, P7, DOI 10.1017/S0031182099004485; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; KAUL DK, 1991, BLOOD, V78, P812; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Luginbuhl A, 2007, INFECT IMMUN, V75, P1771, DOI 10.1128/IAI.01514-06; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nilsson S, 2011, MALARIA RES TREAT, V2011; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; Reilly M, 2009, METHODS MOL BIOL, V570, P373, DOI 10.1007/978-1-60327-394-7_21; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-267; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; WAHLGREN M, 1990, AM J TROP MED HYG, V43, P333, DOI 10.4269/ajtmh.1990.43.333	55	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113248	10.1371/journal.pone.0113248	http://dx.doi.org/10.1371/journal.pone.0113248			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438249	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900036
J	Bogachev, MI; Kayumov, AR; Bunde, A				Bogachev, Mikhail I.; Kayumov, Airat R.; Bunde, Armin			Universal Internucleotide Statistics in Full Genomes: A Footprint of the DNA Structure and Packaging?	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; SEQUENCES	Uncovering the fundamental laws that govern the complex DNA structural organization remains challenging and is largely based upon reconstructions from the primary nucleotide sequences. Here we investigate the distributions of the internucleotide intervals and their persistence properties in complete genomes of various organisms from Archaea and Bacteria to H. Sapiens aiming to reveal the manifestation of the universal DNA architecture. We find that in all considered organisms the internucleotide interval distributions exhibit the same q-exponential form. While in prokaryotes a single q-exponential function makes the best fit, in eukaryotes the PDF contains additionally a second q-exponential, which in the human genome makes a perfect approximation over nearly 10 decades. We suggest that this functional form is a footprint of the heterogeneous DNA structure, where the first q-exponential reflects the universal helical pitch that appears both in pro- and eukaryotic DNA, while the second q-exponential is a specific marker of the large-scale eukaryotic DNA organization.	[Bogachev, Mikhail I.] St Petersburg Electrotech Univ, Radio Syst Dept, St Petersburg, Russia; [Bogachev, Mikhail I.] St Petersburg Electrotech Univ, Biomed Engn Res Ctr, St Petersburg, Russia; [Kayumov, Airat R.] Kazan Volga Reg Fed Univ, Dept Genet, Kazan, Tatarstan, Russia; [Kayumov, Airat R.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Tatarstan, Russia; [Bunde, Armin] Univ Giessen, Inst Theoret Phys, Giessen, Hessen, Germany	Saint Petersburg State Electrotechnical University; Saint Petersburg State Electrotechnical University; Kazan Federal University; Kazan Federal University; Justus Liebig University Giessen	Bogachev, MI (corresponding author), St Petersburg Electrotech Univ, Radio Syst Dept, St Petersburg, Russia.	Mikhail.Bogachev@physik.uni-giessen.de	Bogachev, Mikhail/C-1229-2011; Kayumov, Airat/M-6725-2013	Bogachev, Mikhail/0000-0002-0356-5651; Kayumov, Airat/0000-0001-7195-1557	Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen) [BU 534/24-1]; Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University) [2014/187]; Russian Government	Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen)(German Research Foundation (DFG)); Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University); Russian Government	Funding: The financial support of this work was provided by the Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen, project No. BU 534/24-1, AB), by the Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University, assignment No. 2014/187, MB) and by the subsidy of the Russian Government to support the Program of competitive development of the leading academic centers (Kazan Federal University, AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EG, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056106; Andrade JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.260601; Antonopoulos CG, 2014, PHYSICA A, V409, P71, DOI 10.1016/j.physa.2014.04.042; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Audit B, 2002, J MOL BIOL, V316, P903, DOI 10.1006/jmbi.2001.5363; Audit B, 2001, PHYS REV LETT, V86, P2471, DOI 10.1103/PhysRevLett.86.2471; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bogachev MI, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.240601; Bogachev MI, 2008, PURE APPL GEOPHYS, V165, P1195, DOI 10.1007/s00024-008-0353-5; Bogachev MI, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063036; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Bunde A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048701; CHATZIDIMITRIOUDREISMANN CA, 1993, NATURE, V361, P212, DOI 10.1038/361212b0; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Goodsell DS, NUCL ACIDS RES, V22; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; Guerra CF, 2000, J AM CHEM SOC, V122, P4117; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Lennartz S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066101; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; Ludescher J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68002; Ludescher J, 2014, PREPRINT; Malacarne LC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.017106; Nobre FD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.140601; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; PANDITA TK, 1995, INT J CANCER, V61, P738, DOI 10.1002/ijc.2910610524; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Peterson J, 2013, P NATL ACAD SCI USA, V110, P20380, DOI 10.1073/pnas.1320578110; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C., 2009, SPRINGER; Vaillant C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.068101; Vaillant C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.032901; Watson J.D., 2014, MOL BIOL GENE	40	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112534	10.1371/journal.pone.0112534	http://dx.doi.org/10.1371/journal.pone.0112534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438044	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900014
J	Desalegn, A; Mossie, A; Gedefaw, L				Desalegn, Amare; Mossie, Andualem; Gedefaw, Lealem			Nutritional Iron Deficiency Anemia: Magnitude and Its Predictors among School Age Children, Southwest Ethiopia: A Community Based Cross-Sectional Study	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; ANIMAL SOURCE FOODS; DIETARY DIVERSITY; NUTRIENT ADEQUACY; SCHOOLCHILDREN; COUNTRIES; QUALITY; ADULTS	Background: Iron deficiency anemia (IDA) is a global public health problem among school age children, which retards psychomotor development and impairs cognitive performance. There is limited data on prevalence and risk factors for IDA. Objective: The aim of this study was to determine the prevalence, severity, and predictors of nutritional IDA in school age children in Southwest Ethiopia. Methodology: A community based cross-sectional study was conducted in Jimma Town, Southwest Ethiopia from April to July 2013. A total of 616 school children aged 6 to 12 years were included in the study using multistage sampling technique. A structured questionnaire was used to collect sociodemographic data. Five milliliter venous blood was collected from each child for hematological examinations. Anemia was defined as a hemoglobin level lower than 11.5 g/dl and 12 g/dl for age group of 5-11 years and 12-15 years, respectively. Iron deficiency anemia was defined when serum iron and ferritin levels are below 10 mu mol/l and 15 mu g/dl, respectively. Moreover, fresh stool specimen was collected for diagnosis of intestinal parasitic infection. Stained thick and thin blood films were examined for detection of Plasmodium infection and study of red blood cell morphology. Dietary patterns of the study subjects were assessed using food frequency questionnaire and anthropometric measurements were done. Data were analyzed using SPSS V-20.0 for windows. Result: Overall, prevalence of anemia was 43.7%, and that of IDA was 37.4%. Not-consuming protein source foods [AOR=2.30, 95% CI(1.04,5.14)], not-consuming dairy products [AOR=1.83, 95% CI(1.14,5.14)], not-consuming discretionary calories [AOR=2.77, 95% CI(1.42,5.40)], low family income [AOR=6.14, 95% CI(2.90,12.9)] and intestinal parasitic infections [AOR51.45, 95% CI(1.23, 5. 27)] were predictors of IDA. Conclusion: Iron deficiency anemia is a moderate public health problem in the study site. Dietary deficiencies and intestinal parasitic infections were predictors of IDA. Therefore, emphasis should be given to the strategies for the prevention of risk factors for IDA.	[Desalegn, Amare; Mossie, Andualem] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Biomed Sci, Jimma, Ethiopia; [Gedefaw, Lealem] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia	Jimma University; Jimma University	Gedefaw, L (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	lealem.gedefaw@ju.edu.et	Wolide, Amare Desalegn/L-9020-2019	Wolide, Amare Desalegn/0000-0002-6056-4364	Jimma University College of Public Health and Medical Sciences	Jimma University College of Public Health and Medical Sciences	This research article was funded by Jimma University College of Public Health and Medical Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2012, INT J ENV RES PUB HE, V9, P3506, DOI 10.3390/ijerph9103506; Alemayehu N, 2005, PREVALENCE HOOK WORM; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Almaz S, 2000, ANEMIA TESTING POPUL; [Anonymous], [No title captured]; Azadbakht L, 2005, EUR J CLIN NUTR, V59, P1233, DOI 10.1038/sj.ejcn.1602234; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fryar CD, 2012, VITAL HLTH STAT, V11; Hall A, 2001, PUBLIC HEALTH NUTR, V4, P749, DOI 10.1079/PHN2000111; HALLBERG L, 1981, ANNU REV NUTR, V1, P123, DOI 10.1146/annurev.nu.01.070181.001011; Hashizume M, 2003, J TROP PEDIATRICS, V49, P172, DOI 10.1093/tropej/49.3.172; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; Le HT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-32; Julie M, 2005, AM J CLIN NUTR, V82, P1269; Jyothsna Kudaravalli, 2011, Annals of Biological Research, V2, P209; Kant AK, 1997, NUTR RES, V17, P1443, DOI 10.1016/S0271-5317(97)00135-8; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Lee R, 1999, CLIN HEMATOLOGY NUTR, P228; Leenstra T, 2006, AM J CLIN NUTR, V83, P371; Leenstra T, 2004, EUR J CLIN NUTR, V58, P681, DOI 10.1038/sj.ejcn.1601865; Masahiro H, 2004, PUBLIC HEALTH NUTR, V8, P564; Mohamed EI, 2008, PAK J NUTR, V7, P400; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; Onimawo I. A., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2570; Osazuwa F, 2010, J NEW YORK SCI, V2, P212; Osorio MM, 2004, BRIT J NUTR, V91, P307, DOI 10.1079/BJN20031042; Rodriguez MM, 2002, PUBLIC HEALTH NUTR, V5, P691, DOI 10.1079/PHN2002333; Skalicky A, 2006, MATERN CHILD HLTH J, V10, P177, DOI 10.1007/s10995-005-0036-0; Stang J, 2005, LEADERSHIP ED TRAINI; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Tatala S, 2008, TANZAN J HLTH RES, V10, P7; Tefera B, 2012, BMC PUBLIC HLTH, V12, P604; Tefera B, 2011, BMC NUTR J, V10, P29; Tefera B, 2013, PLOS ONE, V8, pe5764; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; USDA, 2005, HOM GARD B; WHO, 2011, HEM CONC DIAGN AN; WHO, 2000, REP WORLD NUTR SIT; WHO, 2009, ANTHROPLUS PERS COMP; WHO/CDC, 2008, WORLDW PREV AN 1993; WHO UNCF UNU, 2001, IR DEF AN ASS PREV C; ZEIN ZA, 1987, ETHIOPIAN MED J, V25, P105; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615	47	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114059	10.1371/journal.pone.0114059	http://dx.doi.org/10.1371/journal.pone.0114059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438147	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900116
J	Corbex, M; Bouzbid, S; Traverse-Glehen, A; Aouras, H; McKay-Chopin, S; Carreira, C; Lankar, A; Tommasino, M; Gheit, T				Corbex, Marilys; Bouzbid, Sabiha; Traverse-Glehen, Alexandra; Aouras, Hayette; McKay-Chopin, Sandrine; Carreira, Christine; Lankar, Abdelaziz; Tommasino, Massimo; Gheit, Tarik			Prevalence of Papillomaviruses, Polyomaviruses, and Herpesviruses in Triple-Negative and Inflammatory Breast Tumors from Algeria Compared with Other Types of Breast Cancer Tumors	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MICROARRAY PRIMER EXTENSION; MULTIPLEX PCR; CARCINOMA; WOMEN; RISK; DNA; ASSOCIATION; SEQUENCES; SUBTYPES	Background: The possible role of viruses in breast cancer etiology remains an unresolved question. We hypothesized that if some viruses are involved, it may be in a subgroup of breast cancers only. Epidemiological arguments drove our interest in breast cancer subgroups that are more frequent in Africa, namely inflammatory breast cancer (IBC) and triple-negative breast cancer. We tested whether viral prevalence was significantly higher in these subgroups. Materials and Methods: One hundred fifty-five paraffin-embedded malignant breast tumors were randomly selected at the pathology laboratory of the University Hospital of Annaba (Algeria) to include one third of IBC and two thirds of non-IBC. They were tested for the presence of DNA from 61 viral agents (46 human papillomaviruses, 10 polyomaviruses, and 5 herpesviruses) using type-specific multiplex genotyping assays, which combine multiplex PCR and bead-based Luminex technology. Results: Viral DNA was found in 22 (17.9%) of 123 tumors. The most prevalent viruses were EBV1 and HPV16. IBC tumors carried significantly more viruses (any type) than non-IBC tumors (30% vs. 13%, p < 0.04). Similarly, triple-negative tumors displayed higher virus-positivity than non-triple-negative tumors (44% vs. 14%, p < 0.009). Conclusions: Our results suggest an association between the presence of viral DNA and aggressive breast cancer phenotypes (IBC, triple-negative). While preliminary, they underline the importance of focusing on subgroups when studying viral etiology in breast cancer. Further studies on viruses in breast cancer should be conducted in much larger samples to confirm these initial findings.	[Corbex, Marilys] Univ Libre Bruxelles, Brussels, Belgium; [Bouzbid, Sabiha; Aouras, Hayette; Lankar, Abdelaziz] Badji Mokhtar Univ, Fac Med, Annaba, Algeria; [Bouzbid, Sabiha; Aouras, Hayette; Lankar, Abdelaziz] Univ Hosp, Annaba, Algeria; [Traverse-Glehen, Alexandra] Univ Lyon 1, Hosp Civils Lyon, Lab Anat Pathol, F-69365 Lyon, France; [McKay-Chopin, Sandrine; Tommasino, Massimo; Gheit, Tarik] Int Agcy Res Canc, Infect & Canc Biol Grp, F-69372 Lyon, France; [Carreira, Christine] Int Agcy Res Canc, Mol Pathol Grp, F-69372 Lyon, France; [Lankar, Abdelaziz] Univ Hosp, Cytol & Pathol Lab, Annaba, Algeria	Universite Libre de Bruxelles; Universite Badji Mokhtar - Annaba; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC)	Gheit, T (corresponding author), Int Agcy Res Canc, Infect & Canc Biol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	gheit@iarc.fr		Tommasino, Massimo/0000-0002-0890-8596; CORBEX, Marilys/0000-0001-5755-7326; BOUZBID, Sabiha/0000-0002-7253-551X				Aguayo F, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-7; Al-Tamimi DM, 2009, ULTRASTRUCT PATHOL, V33, P141, DOI 10.1080/01913120903183135; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Anderson William F, 2005, Breast Dis, V22, P9; Barnum CP, 1944, SCIENCE, V100, P575, DOI 10.1126/science.100.2608.575; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Boussen H, 2008, SEMIN ONCOL, V35, P17, DOI 10.1053/j.seminoncol.2007.11.017; Chaher N, 2012, BREAST CANCER RES TR, V131, P437, DOI 10.1007/s10549-011-1422-5; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; Dawood S, 2011, CANCER-AM CANCER SOC, V117, P1819, DOI 10.1002/cncr.25682; De Paoli P, 2013, INT J CANCER, V133, P1517, DOI 10.1002/ijc.27995; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; Devi CRB, 2012, INT J CANCER, V131, P2869, DOI 10.1002/ijc.27527; DI LEONARDO A, 1992, MUTAT RES, V269, P319, DOI 10.1016/0027-5107(92)90214-M; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; El-Shinawi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055755; Eng A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001720; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Ferlay J, 2014, INT J CANC; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; Ford CE, 2004, CANCER RES, V64, P4755, DOI 10.1158/0008-5472.CAN-03-3804; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gheit T, 2007, J CLIN MICROBIOL, V45, P2537, DOI 10.1128/JCM.00747-07; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Grenier J, 2007, ANTICANCER RES, V27, P547; Hippocrate A, 2011, CANCER LETT, V305, P144, DOI 10.1016/j.canlet.2010.11.007; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Huo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031656; Incrocci R, 2013, J GEN VIROL, V94, P1127, DOI 10.1099/vir.0.049221-0; Joshi D, 2012, BREAST CANCER RES TR, V135, P1, DOI 10.1007/s10549-011-1921-4; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Lawson James S., 2009, V471, P421, DOI 10.1007/978-1-59745-416-2_21; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Mazouni C, 2011, BRIT J CANCER, V104, P332, DOI 10.1038/sj.bjc.6606048; Mok MTS, 2008, INT J CANCER, V122, P2864, DOI 10.1002/ijc.23372; Pogo BGT, 2010, CANCER-AM CANCER SOC, V116, P2741, DOI 10.1002/cncr.25179; Ribeiro-Silva A, 2004, BRAZ J MED BIOL RES, V37, P89, DOI 10.1590/S0100-879X2004000100013; Rickinson AB, 2014, SEMIN CANCER BIOL, V26, P99, DOI 10.1016/j.semcancer.2014.04.004; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Stewart B, 2014, WORLD CANC REPORT 20; Trabelsi A, 2008, ANN BIOL CLIN-PARIS, V66, P59, DOI 10.1684/abc.2008.0191; Wang FL, 2014, AM J TRANSL RES, V6, P248; Xing P, 2010, MED ONCOL, V27, P926, DOI 10.1007/s12032-009-9308-7	50	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114559	10.1371/journal.pone.0114559	http://dx.doi.org/10.1371/journal.pone.0114559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478862	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200103
J	Tazoe, T; Endoh, T; Kitamura, T; Ogata, T				Tazoe, Toshiki; Endoh, Takashi; Kitamura, Taku; Ogata, Toru			Polarity Specific Effects of Transcranial Direct Current Stimulation on Interhemispheric Inhibition	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; LATENCY AFFERENT INHIBITION; THETA-BURST-STIMULATION; TRANSCALLOSAL INHIBITION; INTRACORTICAL CIRCUITS; BRAIN-STIMULATION; EXCITABILITY; HEMISPHERE; PATHWAYS; RECOVERY	Transcranial direct current stimulation (tDCS) has been used as a useful interventional brain stimulation technique to improve unilateral upper-limb motor function in healthy humans, as well as in stroke patients. Although tDCS applications are supposed to modify the interhemispheric balance between the motor cortices, the tDCS after-effects on interhemispheric interactions are still poorly understood. To address this issue, we investigated the tDCS after-effects on interhemispheric inhibition (IHI) between the primary motor cortices (M1) in healthy humans. Three types of tDCS electrode montage were tested on separate days; anodal tDCS over the right M1, cathodal tDCS over the left M1, bilateral tDCS with anode over the right M1 and cathode over the left M1. Single-pulse and paired-pulse transcranial magnetic stimulations were given to the left M1 and right M1 before and after tDCS to assess the bilateral corticospinal excitabilities and mutual direction of IHI. Regardless of the electrode montages, corticospinal excitability was increased on the same side of anodal stimulation and decreased on the same side of cathodal stimulation. However, neither unilateral tDCS changed the corticospinal excitability at the unstimulated side. Unilateral anodal tDCS increased IHI from the facilitated side M1 to the unchanged side M1, but it did not change IHI in the other direction. Unilateral cathodal tDCS suppressed IHI both from the inhibited side M1 to the unchanged side M1 and from the unchanged side M1 to the inhibited side M1. Bilateral tDCS increased IHI from the facilitated side M1 to the inhibited side M1 and attenuated IHI in the opposite direction. Sham-tDCS affected neither corticospinal excitability nor IHI. These findings indicate that tDCS produced polarity-specific after-effects on the interhemispheric interactions between M1 and that those after-effects on interhemispheric interactions were mainly dependent on whether tDCS resulted in the facilitation or inhibition of the M1 sending interhemispheric volleys.	[Tazoe, Toshiki; Endoh, Takashi; Kitamura, Taku; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Tazoe, Toshiki] Japan Soc Promot Sci, Tokyo, Japan; [Endoh, Takashi] Uekusa Gakuen Univ, Fac Child Dev & Educ, Chiba, Japan; [Kitamura, Taku] Shibaura Inst Technol, Div Funct Control Syst, Grad Sch Engn & Sci, Saitama, Japan	Japan Society for the Promotion of Science; Shibaura Institute of Technology	Tazoe, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.	Tot12@pitt.edu	Ogata, Toru/ADC-3560-2022	Ogata, Toru/0000-0001-9011-8640	 [23.10759];  [24700612]	; 	This research was supported by Grants-in-Aid for Research Fellow of the Japan Society for the Promotion of Science to TT (#23.10759) and by Grants-in-Aids for Young Scientist B to TE (#24700612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bradnam LV, 2012, CEREB CORTEX, V22, P2662, DOI 10.1093/cercor/bhr344; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; CATSMANBERREVOETS CE, 1980, EXP BRAIN RES, V39, P433; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2012, J NEURAL TRANSM, V119, P1499, DOI 10.1007/s00702-012-0845-4; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Hinder MR, 2010, EXP BRAIN RES, V205, P423, DOI 10.1007/s00221-010-2379-z; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kidgell DJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-64; Kim DY, 2010, AM J PHYS MED REHAB, V89, P879, DOI 10.1097/PHM.0b013e3181f70aa7; Kobayashi M, 2009, EUR J NEUROSCI, V29, P833, DOI 10.1111/j.1460-9568.2009.06628.x; Kukaswadia S, 2005, J PHYSIOL-LONDON, V563, P915, DOI 10.1113/jphysiol.2004.080010; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lee H, 2007, J PHYSIOL-LONDON, V580, P1021, DOI 10.1113/jphysiol.2006.126011; Li JY, 2013, J NEUROPHYSIOL, V109, P659, DOI 10.1152/jn.01044.2011; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Mahmoudi H, 2011, DISABIL REHABIL, V33, P1383, DOI 10.3109/09638288.2010.532283; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; Nelson AJ, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-31; NETZ J, 1995, EXP BRAIN RES, V104, P527; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; O'Shea J, 2014, NEUROIMAGE, V85, P924, DOI 10.1016/j.neuroimage.2013.05.096; Pal PK, 2005, J NEUROPHYSIOL, V94, P1668, DOI 10.1152/jn.01306.2004; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Roche N, 2012, CLIN NEUROPHYSIOL, V123, P1027, DOI 10.1016/j.clinph.2011.09.011; Roche N, 2009, J PHYSIOL-LONDON, V587, P5653, DOI 10.1113/jphysiol.2009.177550; Scelzo E, 2011, NEUROSCI LETT, V498, P167, DOI 10.1016/j.neulet.2011.05.007; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183; Shin HW, 2011, NEUROREPORT, V22, P166, DOI 10.1097/WNR.0b013e3283439511; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Tazoe T, 2014, J NEUROSCI, V34, P13924, DOI 10.1523/JNEUROSCI.1648-14.2014; Tazoe T, 2013, J NEUROSCI, V33, P16178, DOI 10.1523/JNEUROSCI.2638-13.2013; Tazoe T, 2013, EUR J NEUROSCI, V37, P96, DOI 10.1111/ejn.12026; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Trompetto C, 2003, CLIN NEUROPHYSIOL, V114, P2181, DOI 10.1016/S1388-2457(03)00213-X; Tsutsumi R, 2014, J NEUROPHYSIOL, V111, P26, DOI 10.1152/jn.00515.2013; Tsutsumi R, 2012, J NEUROPHYSIOL, V108, P1130, DOI 10.1152/jn.00300.2012; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; Zimerman M, 2012, STROKE, V43, P2185, DOI 10.1161/STROKEAHA.111.645382	62	53	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114244	10.1371/journal.pone.0114244	http://dx.doi.org/10.1371/journal.pone.0114244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478912	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200053
J	Ahanda, MLE; Zerjal, T; Dhorne-Pollet, S; Rau, A; Cooksey, A; Giuffra, E				Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Cooksey, Amanda; Giuffra, Elisabetta			Impact of the Genetic Background on the Composition of the Chicken Plasma MiRNome in Response to a Stress	PLOS ONE			English	Article							RESIDUAL FOOD-INTAKE; CIRCULATING MICRORNAS; CORRELATED RESPONSES; DIVERGENT SELECTION; SKELETAL-MUSCLE; FEED-INTAKE; EXPRESSION; IDENTIFICATION; TRANSCRIPTOME; TISSUES	Circulating extra-cellular microRNAs (miRNAs) have emerged as promising minimally invasive markers in human medicine. We evaluated miRNAs isolated from total plasma as biomarker candidates of a response to an abiotic stress (feed deprivation) in a livestock species. Two chicken lines selected for high (R+) and low (R-) residual feed intake were chosen as an experimental model because of their extreme divergence in feed intake and energy metabolism. Adult R+ and R-cocks were sampled after 16 hours of feed deprivation and again four hours after refeeding. More than 292 million sequence reads were generated by small RNA-seq of total plasma RNA. A total of 649 mature miRNAs were identified; after quality filtering, 148 miRNAs were retained for further analyses. We identified 23 and 19 differentially abundant miRNAs between feeding conditions and between lines respectively, with only two miRNAs identified in both comparisons. We validated a panel of six differentially abundant miRNAs by RT-qPCR on a larger number of plasma samples and checked their response to feed deprivation in liver. Finally, we evaluated the conservation and tissue distribution of differentially abundant miRNAs in plasma across a variety of red jungle fowl tissues. We show that the chicken plasma miRNome reacts promptly to the alteration of the animal physiological condition driven by a feed deprivation stress. The plasma content of stress-responsive miRNAs is strongly influenced by the genetic background, with differences reflecting the phenotypic divergence acquired through long-term selection, as evidenced by the profiles of conserved miRNAs with a regulatory role in energy metabolism (gga-miR-204, gga-miR-let-7f-5p and gga-miR-122-5p). These results reinforce the emerging view in human medicine that even small genetic differences can have a considerable impact on the resolution of biomarker studies, and provide support for the emerging interest in miRNAs as potential novel and minimally invasive biomarkers for livestock species.	[Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Giuffra, Elisabetta] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Giuffra, Elisabetta] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Giuffra, Elisabetta] AgroParisTech, UMR Genet Anim & Biol Integrat 1313, Paris, France; [Cooksey, Amanda] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA; [Cooksey, Amanda] Univ Arizona, Inst BIO5, Tucson, AZ USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; University of Arizona; University of Arizona	Giuffra, E (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	elisabetta.giuffra@jouy.inra.fr	Giuffra, Elisabetta/J-8080-2014; zerjal, tatiana/AAO-9473-2020	Endale Ahanda, Marie-Laure/0000-0002-0861-1565; Giuffra, Elisabetta/0000-0001-9568-2056	INRA through the ''miRmarkers'' project (Animal Genetics Div.); ''INRA Package'' grant of EG	INRA through the ''miRmarkers'' project (Animal Genetics Div.); ''INRA Package'' grant of EG	The work was supported by INRA through the ''miRmarkers'' project (Animal Genetics Div.) and the ''INRA Package'' grant of EG (salaries of MLEA and EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2013, BRIEF FUNCT GENOMICS, V12, P254, DOI 10.1093/bfgp/elt016; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; BORDAS A, 1992, BRIT POULTRY SCI, V33, P741, DOI 10.1080/00071669208417515; BORDAS A, 1984, ANN AGR FENN, V23, P233; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chemonges S, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-12; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Daval S, 2000, GENET SEL EVOL, V32, P521, DOI 10.1051/gse:2000134; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; ELKAZZI M, 1995, BRIT POULTRY SCI, V36, P719, DOI 10.1080/00071669508417816; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gabarrou JF, 2000, BRIT J NUTR, V83, P645, DOI 10.1017/S0007114500000829; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hale A, 2014, BBA-MOL CELL RES, V1843, P2528, DOI 10.1016/j.bbamcr.2014.06.012; Hendrix D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r39; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luo GZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-727; Martin M, 2011, CUTADAPT REMOVES ADA; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rau A, 2011, RR7786 INR SACL; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soares AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039417; Sturkie P.D., 1976, AVIAN PHYSIOL; Sun GZ, 2012, ROUTL STUD HIST ECON, V142, P11; Swennen Q, 2007, POULTRY SCI, V86, P895, DOI 10.1093/ps/86.5.895; TixierBoichard M, 1996, ANIM GENET, V27, P163, DOI 10.1111/j.1365-2052.1996.tb00944.x; Tryndyak VP, 2012, TOXICOL APPL PHARM, V262, P52, DOI 10.1016/j.taap.2012.04.018; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Wang Wang-Xia, 2014, Genomics Proteomics & Bioinformatics, V12, P19, DOI 10.1016/j.gpb.2013.10.003; Wang X, 2013, ANIMAL, V7, P1567, DOI 10.1017/S1751731113001183; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	63	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114598	10.1371/journal.pone.0114598	http://dx.doi.org/10.1371/journal.pone.0114598			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473826	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500048
J	Grady, JP; Murphy, JL; Blakely, EL; Haller, RG; Taylor, RW; Turnbull, DM; Tuppen, HAL				Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Haller, Ronald G.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.			Accurate Measurement of Mitochondrial DNA Deletion Level and Copy Number Differences in Human Skeletal Muscle	PLOS ONE			English	Article							REAL-TIME PCR; INDIVIDUAL CELLS; DISEASE; QUANTIFICATION; SINGLE; MTDNA; DEPLETION; ASSAY	Accurate and reliable quantification of the abundance of mitochondrial DNA (mtDNA) molecules, both wild-type and those harbouring pathogenic mutations, is important not only for understanding the progression of mtDNA disease but also for evaluating novel therapeutic approaches. A clear understanding of the sensitivity of mtDNA measurement assays under different experimental conditions is therefore critical, however it is routinely lacking for most published mtDNA quantification assays. Here, we comprehensively assess the variability of two quantitative Taqman real-time PCR assays, a widely-applied MT-ND1/MT-ND4 multiplex mtDNA deletion assay and a recently developed MT-ND1/B2M singleplex mtDNA copy number assay, across a range of DNA concentrations and mtDNA deletion/copy number levels. Uniquely, we provide a specific guide detailing necessary numbers of sample and real-time PCR plate replicates for accurately and consistently determining a given difference in mtDNA deletion levels and copy number in homogenate skeletal muscle DNA.	[Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Haller, Ronald G.] VA North Texas Med Ctr, Dallas, TX USA; [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX USA	Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Tuppen, HAL (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.tuppen@ncl.ac.uk		Tuppen, Helen/0000-0001-8762-0824; Turnbull, Doug/0000-0002-8878-9901; Grady, John/0000-0001-9667-3872	Wellcome Trust Centre for Mitochondrial Research [906919]; National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS) [RO1-AR050597]; Medical Research Council [G0700718, MR/K000608/1, MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10187] Funding Source: researchfish; MRC [MR/K000608/1, MR/K006312/1, G0700718] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050597] Funding Source: NIH RePORTER	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Wellcome Trust Centre for Mitochondrial Research (906919; www.wellcome.ac.uk) and the National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS, RO1-AR050597 to RGH; www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072; BRUGGER RM, 1969, AM STAT, V23, P32; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024; Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; Rotig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sochivko DG, 2013, DOKL BIOCHEM BIOPHYS, V449, P105, DOI 10.1134/S1607672913020154; Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327; Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282; Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22; Wong LJC, 2003, J MED GENET, V40; Zhang GJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-173	31	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114462	10.1371/journal.pone.0114462	http://dx.doi.org/10.1371/journal.pone.0114462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474153	gold, Green Submitted, Green Published			2022-12-27	WOS:000346382500032
J	Kortekaas, KE; Meijer, CA; Hinnen, JW; Dalman, RL; Xu, BH; Hamming, JF; Lindeman, JH				Kortekaas, Kim E.; Meijer, C. Arnoud; Hinnen, Jan Willem; Dalman, Ronald L.; Xu, Baohui; Hamming, Jaap F.; Lindeman, Jan H.			ACE Inhibitors Potently Reduce Vascular Inflammation, Results of an Open Proof-Of-Concept Study in the Abdominal Aortic Aneurysm	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; NF-KAPPA-B; RABBIT MODEL; EXPRESSION; MACROPHAGES; RAT; MATRIX-METALLOPROTEINASE-9; ATHEROSCLEROSIS; METAANALYSIS; DEGRADATION	Background: Independent of their blood pressure lowering effect, ACE inhibitors are thought to reduce vascular inflammation. The clinical relevance of this effect is unclear with the current knowledge. Abdominal aortic aneurysms (AAA) are characterized by a broad, non-specific inflammatory response, and thus provide a clinical platform to evaluate the anti-inflammatory potential of ACE inhibitors. Methods and Results: Eleven patients scheduled for open AAA repair received ramipril (5 mg/day) during 2-4 weeks preceding surgery. Aortic wall samples were collected during surgery, and compared to matched samples obtained from a biobank. An anti-inflammatory potential was evaluated in a comprehensive analysis that included immunohistochemistry, mRNA and protein analysis. A putative effect of ACE inhibitors on AAA growth was tested separately by comparing 18-month growth rate of patients on ACE inhibitors (n=82) and those not taking ACE inhibitors (n=204). Ramipril reduces mRNA expression of multiple pro-inflammatory cytokines such as IL-1 beta, IL-6, IL-8, TNF-alpha, Interferon-gamma, and MCP-1, as well as aortic wall IL-8 and MCP-1 (P=0.017 and 0.008, respectively) protein content. The is followed by clear effects on cell activation that included a shift towards anti-inflammatory macrophage (M2) subtype. Evaluation of data from the PHAST cohort did not indicate an effect of ACE inhibitors on 18-month aneurysm progression (mean difference at 18 months: -0.24 mm (95% CI: -0.90-0.45, P=NS). Conclusions: ACE inhibition quenches multiple aspects of vascular inflammation in AAA. However, this does not translate into reduced aneurysm growth.	[Kortekaas, Kim E.; Meijer, C. Arnoud; Hinnen, Jan Willem; Hamming, Jaap F.; Lindeman, Jan H.] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands; [Kortekaas, Kim E.; Dalman, Ronald L.; Xu, Baohui] Stanford Med Sch, Div Vasc Surg, Stanford, CA USA; [Hinnen, Jan Willem] Jeroen Bosch Ziekenhuis, Dept Vasc Surg, Shertogenbosch, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University; Jeroen Bosch Ziekenhuis	Lindeman, JH (corresponding author), Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands.	lindeman@lumc.nl		Meijer, Arnoud/0000-0001-5521-1575; Xu, Baohui/0000-0002-2857-7464	National Heart, Lung and Blood Institute [1R21HL112122-01]; ZonMw (The Netherlands Organization for Health Research and Development) [40-41200-98-052]; NutsOhra Fund [0701-061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112122] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ZonMw (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government); NutsOhra Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the authors institutions. Additional support was obtained through grant from the National Heart, Lung and Blood Institute (1R21HL112122-01) (RLD). The PHAST study is supported by grants from ZonMw (The Netherlands Organization for Health Research and Development) grant 40-41200-98-052 www.zonmw.nl, and NutsOhra Fund (project 0701-061, http://www.stichtingnutsohra.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; BENDER N, 1990, CLIN PHYSIOL BIOCH, V8, P44; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Di Raimondo D, 2012, CURR PHARM DESIGN, V18, P4385, DOI 10.2174/138161212802481282; Elewaut D, 1999, J IMMUNOL, V163, P1457; Ferrari R, 2009, DRUGS, V69, P265, DOI 10.2165/00003495-200969030-00003; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Goeman JJ, 2011, STAT SCI, V26, P584; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Hernandez-Presa MA, 1998, AM J PATHOL, V153, P1825, DOI 10.1016/S0002-9440(10)65697-0; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Kowalewski R, 2006, J VASC RES, V43, P95, DOI 10.1159/000089790; Krysiak R, 2008, PHARMACOL REP, V60, P514; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lederle FA, 2013, ANN INTERN MED, V159, P852, DOI 10.7326/0003-4819-159-12-201312170-00012; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; Lindeman JHN, 2008, CLIN SCI, V114, P687, DOI 10.1042/CS20070352; Lindeman JHN, 2011, CIRCULATION, V124, pE463, DOI 10.1161/CIRCULATIONAHA.110.008573; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Luoma JS, 1998, ARTERIOSCL THROM VAS, V18, P157, DOI 10.1161/01.ATV.18.2.157; McMillan WD, 1999, J VASC SURG, V29, P122, DOI 10.1016/S0741-5214(99)70363-0; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; OSBORNEPELLEGRIN MJ, 1994, INT J EXP PATHOL, V75, P179; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Ruiz-Ortega M, 2000, NEPHROL DIAL TRANSPL, V15, P561, DOI 10.1093/ndt/15.5.561; Schmeisser A, 2004, BIOCHEM BIOPH RES CO, V325, P532, DOI 10.1016/j.bbrc.2004.10.059; Soehnlein O, 2005, J VASC RES, V42, P399, DOI 10.1159/000087340; Sweeting MJ, 2010, J VASC SURG, V52, P1, DOI 10.1016/j.jvs.2010.02.264; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; van der Meij E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053882; Watanabe T, 2006, ANN VASC SURG, V20, P317, DOI 10.1007/s10016-006-9038-7; Wilmink ABM, 2002, J VASC SURG, V36, P751, DOI 10.1067/mva.2002.126550; Xiong F, 2014, J SURG RES, V189, P166, DOI 10.1016/j.jss.2014.01.057; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yoshimura K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/648167; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	42	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111952	10.1371/journal.pone.0111952	http://dx.doi.org/10.1371/journal.pone.0111952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474105	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500065
J	Petersen, SB; Olsen, SF; Molgaard, C; Granstrom, C; Cohen, A; Vestergaard, P; Strom, M				Petersen, Sesilje Bondo; Olsen, Sjurdur Frodi; Molgaard, Christian; Granstrom, Charlotta; Cohen, Arieh; Vestergaard, Peter; Strom, Marin			Maternal Vitamin D Status and Offspring Bone Fractures: Prospective Study over Two Decades in Aarhus City, Denmark	PLOS ONE			English	Article							MINERAL CONTENT; PREGNANCY; MASS; ASSOCIATION; CHILDHOOD; CHILDREN; EPIDEMIOLOGY; SERUM; DIET	Background: Studies investigating the association between maternal vitamin D status and offspring bone mass measured by dual-energy X-ray absorptiometry (DXA) during childhood have shown conflicting results. Purpose: We used occurrence of bone fractures up to the age of 18 as a measure reflecting offspring bone mass and related that to maternal vitamin D status. Methods: The Danish Fetal Origins 1988 Cohort recruited 965 pregnant women during 1988-89 at their 30th gestation week antenatal midwife visit. A blood sample was drawn and serum was stored, which later was analyzed for the concentration of 25-hydroxyvitamin D (25(OH)D) by the liquid chromatography coupled with a tandem mass spectrometric method (LC-MS/MS). Outcome was diagnosis of first time bone fractures extracted from the Danish National Patient Register. Results: Vitamin D status was available for 850 women. The median (5th-95th percentile) 25(OH)D was 76.2 (23.0-152.1) nmol/l. During follow up 294 children were registered with at least one bone fracture diagnosis. Multivariable Cox regression models using age as the underlying time scale indicated no overall association between maternal vitamin D status and first time bone fractures. However, there was a significantly increased hazard ratio (HR) during childhood for those who had maternal blood drawn in Dec/Jan/Feb compared with Jun/Jul/Aug (HR: 1.75, 95% CI: 1.11-2.74). Adjustment for vitamin D status strengthened this association (1.82, 1.12-2.97), which indicated a potential seasonal impact on offspring fractures independent of maternal vitamin D status. In a sensitivity analysis we found a borderline significant inverse association between continuous concentrations of 25(OH)D and offspring forearm fractures (P=0.054). Conclusion: Overall, our results did not substantiate an association between maternal vitamin D status and offspring bone fractures. Further studies on this subject are needed, but the study populations must be large enough to allow for subdivision of fractures.	[Petersen, Sesilje Bondo; Olsen, Sjurdur Frodi; Granstrom, Charlotta; Strom, Marin] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark; [Molgaard, Christian] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Cohen, Arieh] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Vestergaard, Peter] Aalborg Univ Hosp, Dept Endocrinol, Aalborg, Denmark; [Vestergaard, Peter] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Statens Serum Institut; University of Copenhagen; Statens Serum Institut; Aalborg University; Aalborg University Hospital; Aalborg University	Petersen, SB (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.	ssp@ssi.dk	Petersen, Steffen b/E-8727-2015; Mølgaard, Christian/D-2052-2014	Petersen, Steffen b/0000-0002-0739-2751; Mølgaard, Christian/0000-0002-5311-9457; Olsen, Sjurdur/0000-0003-3017-7096; Strom, Marin/0000-0003-1926-6610	Danish Council for Strategic Research [09-067124]; Novo Nordic Foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordic Foundation(Novo Nordisk Foundation)	Supported by the Danish Council for Strategic Research (09-067124, Center for Fetal Programming) (SFO) and the Novo Nordic Foundation (SFO). No personal benefits in any form have been received or will be received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen Bo, 2012, Front Endocrinol (Lausanne), V3, P2, DOI 10.3389/fendo.2012.00002; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2010, RATIONEL FARMAK 0606; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Clark EM, 2006, J BONE MINER RES, V21, P1489, DOI 10.1359/JBMR.060601; Cole ZA, 2009, J BONE MINER RES, V24, P663, DOI 10.1359/JBMR.081212; Cooper C, 2005, RHEUMATOLOGY, V44, P36, DOI 10.1093/rheumatology/kei060; Cooper C, 2009, ADV EXP MED BIOL, V639, P217, DOI 10.1007/978-1-4020-8749-3_16; Dam H, 1998, ACTA PSYCHIAT SCAND, V97, P1, DOI 10.1111/j.1600-0447.1998.tb09954.x; Ford L, 2013, METHODS MOL BIOL, V1065, P245, DOI 10.1007/978-1-62703-616-0_16; Institute of Medicine IOM, 2011, DIEAT REF RANG CALC; Ioannou C, 2012, J CLIN ENDOCR METAB, V97, pE2070, DOI 10.1210/jc.2012-2538; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Jensen CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053059; Kimball S, 2008, CRIT REV CL LAB SCI, V45, P339, DOI [10.1080/10408360802165295, 10.1080/10408360802165295 ]; Lapillonne A, 2000, ACTA PAEDIATR, V89, P772, DOI 10.1080/080352500750043620; Lawlor DA, 2013, LANCET, V382, P767, DOI 10.1016/S0140-6736(13)61830-9; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; LISSNER D, 1981, CLIN CHEM, V27, P773; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mathison DJ, 2010, PEDIATR EMERG CARE, V26, P594, DOI 10.1097/PEC.0b013e3181eb838d; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Pitukcheewanont P, 2013, PEDIATR ENDOCR REV P, V10, P318; Prasad M, 2010, PUBLIC HEALTH NUTR, V13, P939, DOI 10.1017/S1368980010001138; Ryan LM, 2010, CURR OPIN ENDOCRINOL, V17, P530, DOI 10.1097/MED.0b013e32833e9c8b; Sayers A, 2009, J CLIN ENDOCR METAB, V94, P765, DOI 10.1210/jc.2008-2146; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Streym SV, 2013, EUR J CLIN NUTR, V67, P1022, DOI 10.1038/ejcn.2013.152; Swart KMA, 2013, CURR OSTEOPOROS REP, V11, P213, DOI 10.1007/s11914-013-0155-2; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Tobias JH, 2005, OSTEOPOROSIS INT, V16, P1731, DOI 10.1007/s00198-005-1912-6; Vestergaard P, 2002, AM J EPIDEMIOL, V156, P1, DOI 10.1093/aje/kwf007; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114334	10.1371/journal.pone.0114334	http://dx.doi.org/10.1371/journal.pone.0114334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474409	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500017
J	Umetsu, D; Dunst, S; Dahmann, C				Umetsu, Daiki; Dunst, Sebastian; Dahmann, Christian			An RNA Interference Screen for Genes Required to Shape the Anteroposterior Compartment Boundary in Drosophila Identifies the Eph Receptor	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; LINEAGE RESTRICTION; IMAGINAL DISCS; CELL AFFINITY; WING DISC; HINDBRAIN; HEDGEHOG; EXPRESSION; ZEBRAFISH; MAINTENANCE	The formation of straight compartment boundaries separating groups of cells with distinct fates and functions is an evolutionarily conserved strategy during animal development. The physical mechanisms that shape compartment boundaries have recently been further elucidated, however, the molecular mechanisms that underlie compartment boundary formation and maintenance remain poorly understood. Here, we report on the outcome of an RNA interference screen aimed at identifying novel genes involved in maintaining the straight shape of the anteroposterior compartment boundary in Drosophila wing imaginal discs. Out of screening 3114 transgenic RNA interference lines targeting a total of 2863 genes, we identified a single novel candidate that interfered with the formation of a straight anteroposterior compartment boundary. Interestingly, the targeted gene encodes for the Eph receptor tyrosine kinase, an evolutionarily conserved family of signal transducers that has previously been shown to be important for maintaining straight compartment boundaries in vertebrate embryos. Our results identify a hitherto unknown role of the Eph receptor tyrosine kinase in Drosophila and suggest that Eph receptors have important functions in shaping compartment boundaries in both vertebrate and insect development.	[Umetsu, Daiki; Dahmann, Christian] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Dunst, Sebastian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Dahmann, C (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	christian.dahmann@tu-dresden.de	Dahmann, Christian/B-5841-2017	Dunst, Sebastian/0000-0002-3414-1640	EMBO long-term fellowship; Deutsche Forschungsgemeinschaft [DA586/8-1, DA586/10-1, DA586/14-1]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the EMBO long-term fellowship (to DU) and the Deutsche Forschungsgemeinschaft (DA586/8-1, DA586/10-1, and DA586/14-1 to CD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Blair SS, 2003, NATURE, V424, P379, DOI 10.1038/424379a; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Blair SS, 1997, DEVELOPMENT, V124, P4053; Bossing T, 2002, DEVELOPMENT, V129, P4205; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; HAY BA, 1994, DEVELOPMENT, V120, P2121; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; Klein Thomas, 2008, V420, P253, DOI 10.1007/978-1-59745-583-1_15; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Langenberg T, 2005, DEVELOPMENT, V132, P3209, DOI 10.1242/dev.01862; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Martin AC, 2010, NAT CELL BIOL, V12, P5, DOI 10.1038/ncb0110-5; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Monier B, 2011, CELL MOL LIFE SCI, V68, P1897, DOI 10.1007/s00018-011-0668-8; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; NIETO MA, 1992, DEVELOPMENT, V116, P1137; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Scully AL, 1999, MOL CELL NEUROSCI, V13, P337, DOI 10.1006/mcne.1999.0752; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Umetsu D, 2014, CURR BIOL, V24, P1798, DOI 10.1016/j.cub.2014.06.052; Umetsu D, 2010, FLY, V4, P241, DOI 10.4161/fly.4.3.12173; Vegh M, 2003, GENETICS, V163, P1427; Vincent JP, 2009, CURR BIOL, V19, pR1028, DOI 10.1016/j.cub.2009.10.030; Vincent JP, 1998, INT J DEV BIOL, V42, P311; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Xu QL, 1995, DEVELOPMENT, V121, P4005	65	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114340	10.1371/journal.pone.0114340	http://dx.doi.org/10.1371/journal.pone.0114340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473846	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500021
J	Watanobe, H; Furutani, T; Nihei, M; Sakuma, Y; Yanai, R; Takahashi, M; Sato, H; Sagawa, F				Watanobe, Hajime; Furutani, Tomoyuki; Nihei, Masahiko; Sakuma, Yu; Yanai, Rie; Takahashi, Miyuki; Sato, Hideo; Sagawa, Fumihiko			The Thyroid Status of Children and Adolescents in Fukushima Prefecture Examined during 20-30 Months after the Fukushima Nuclear Power Plant Disaster: A Cross-Sectional, Observational Study	PLOS ONE			English	Article							EXPOSED IN-UTERO; CHERNOBYL ACCIDENT; CANCER INCIDENCE; I-131; THYROGLOBULIN; TIME; RADIATION; BYELARUS; DISEASES; FALLOUT	Background: A possible increase in thyroid cancer in the young represents the most critical health problem to be considered after the nuclear accident in Fukushima, Japan (March 2011), which is an important lesson from the Chernobyl disaster (April 1986). Although it was reported that childhood thyroid cancer had started to increase 3-5 yr after the Chernobyl accident, we speculate that the actual period of latency might have been shorter than reported, considering the delay in initiating thyroid surveillance in the then Soviet Union and also the lower quality of ultrasonographic testing in the 1980s. Our primary objectives in the present study were to identify any possible thyroid abnormality in young Fukushima citizens at a relatively early timepoint (20-30 months) after the accident, and also to strive to find a possible relationship among thyroid ultrasonographic findings, thyroid-relevant biochemical markers, and iodine-131 ground deposition in the locations of residence where they stayed during very early days after the accident. Methods and Findings: This is a cross-sectional study. We targeted the Fukushima residents who were 18 yr old or younger (including fetuses) at the time of the accident. Our examinations comprised a questionnaire, thyroid ultrasonography, thyroid-related blood tests, and urinary iodine measurement. We analyzed a possible relationship among thyroid ultrasonographic findings (1,137 subjects), serum hormonal data (731 subjects), urinary iodine concentrations (770 subjects), and iodine-131 ground deposition (1,137 subjects). We did not find any significant relationship among these indicators, and no participant was diagnosed to contract thyroid cancer. Conclusions: At the timepoint of 20-30 months after the accident, we did not confirm any discernible deleterious effects of the emitted radioactivity on the thyroid of young Fukushima residents. This is the first report in English detailing the thyroid status of young Fukushima residents after the nuclear disaster.	[Watanobe, Hajime; Nihei, Masahiko; Sakuma, Yu; Sagawa, Fumihiko] Radiat Countermeasures Res Inst Earthquake Disast, Hirata, Fukushima, Japan; [Watanobe, Hajime] Kasukabe Kousei Hosp, Kasukabe, Saitama, Japan; [Furutani, Tomoyuki] Keio Univ, Fac Policy Management, Fujisawa, Kanagawa, Japan; [Nihei, Masahiko; Sakuma, Yu; Sagawa, Fumihiko] Hirata Cent Clin, Hirata, Fukushima, Japan; [Yanai, Rie; Takahashi, Miyuki; Sato, Hideo; Sagawa, Fumihiko] Hirata Cent Hosp, Hirata, Fukushima, Japan	Keio University	Watanobe, H (corresponding author), Radiat Countermeasures Res Inst Earthquake Disast, Hirata, Fukushima, Japan.	hajime.watanobe@kenkyujyo.net						[Anonymous], 2013, REP UN SCI COMM EFF; [Anonymous], 2010, REP UN SCI COMM EFF; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Hatch M, 2009, J CLIN ENDOCR METAB, V94, P899, DOI 10.1210/jc.2008-2049; Heidenreich WF, 1999, RADIAT RES, V151, P617, DOI 10.2307/3580038; Hou XL, 2009, ANAL CHIM ACTA, V632, P181, DOI 10.1016/j.aca.2008.11.013; Imaizumi M, 2008, J CLIN ENDOCR METAB, V93, P1641, DOI 10.1210/jc.2008-0042; Japan Atomic Energy Agency, HEADQ FUK PARTN OP; Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Kirichenko VA, 2012, BIOSECUR BIOTERROR, V10, P314, DOI 10.1089/bsp.2012.0019; Krivoruchko K, 2011, SPATIAL STAT DATA AN; Likhtarov I, 2014, HEALTH PHYS, V106, P370, DOI 10.1097/HP.0b013e31829f3096; Muramatsu Y, 2015, J ENVIRON RADIOACTIV, V139, P344, DOI 10.1016/j.jenvrad.2014.05.007; NEDVECKAITE T, 1993, J RADIOAN NUCL CH AR, V174, P43, DOI 10.1007/BF02040331; NIKIFOROV Y, 1994, CANCER-AM CANCER SOC, V74, P748, DOI 10.1002/1097-0142(19940715)74:2<748::AID-CNCR2820740231>3.0.CO;2-H; NOGUCHI H, 1988, J ENVIRON RADIOACTIV, V7, P65, DOI 10.1016/0265-931X(88)90042-2; Nuclear Regulation Authority Ministry of the Environment, 2012, RES RES DISTR RAD SU; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Spencer CA, 2004, J CLIN ENDOCR METAB, V89, P3702, DOI 10.1210/jc.2004-0986; The Japan Society of Clinical Oncology, 2010, GUID DIAGN TREAT THY; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Torii T, 2013, HEALTH PHYS, V105, P192, DOI 10.1097/HP.0b013e318294444e; United Nations, 2011, REP UN SCI COMM EFF, VII; Vejbjerg P, 2009, EUR J ENDOCRINOL, V161, P475, DOI 10.1530/EJE-09-0262; WHO/UNICEF/ICCIDD, 2007, ASS IOD DEF DIS MON; World Health Organization, 1999, GUID IOD PROPH FOLL; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Zanzonico PB, 2000, HEALTH PHYS, V78, P660, DOI 10.1097/00004032-200006000-00008; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	33	10	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113804	10.1371/journal.pone.0113804	http://dx.doi.org/10.1371/journal.pone.0113804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474311	gold, Green Published, Green Submitted			2022-12-27	WOS:000346382500094
J	Nijmeijer, RM; Schaap, FG; Smits, AJJ; Kremer, AE; Akkermans, LMA; Kroese, ABA; Rijkers, GT; Schipper, MEI; Verheem, A; Wijmenga, C; Gooszen, HG; van Erpecum, KJ				Nijmeijer, Rian M.; Schaap, Frank G.; Smits, Alexander J. J.; Kremer, Andreas E.; Akkermans, Louis M. A.; Kroese, Alfons B. A.; Rijkers, Ger. T.; Schipper, Marguerite E. I.; Verheem, Andre; Wijmenga, Cisca; Gooszen, Hein G.; van Erpecum, Karel J.			Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis	PLOS ONE			English	Article							INTESTINAL BARRIER DYSFUNCTION; NUCLEAR RECEPTOR FXR; GROWTH-FACTOR 19; GALLSTONE DISEASE; EXOCRINE PANCREAS; BINDING PROTEIN; ORGAN FAILURE; BILE; EXPRESSION; MICE	Background: Infectious complications often occur in acute pancreatitis, related to impaired intestinal barrier function, with prolonged disease course and even mortality as a result. The bile salt nuclear receptor farnesoid X receptor (FXR), which is expressed in the ileum, liver and other organs including the pancreas, exhibits anti-inflammatory effects by inhibiting NF-kappa B activation and is implicated in maintaining intestinal barrier integrity and preventing bacterial overgrowth and translocation. Here we explore, with the aid of complementary animal and human experiments, the potential role of FXR in acute pancreatitis. Methods: Experimental acute pancreatitis was induced using the CCK-analogue cerulein in wild-type and Fxr(-/-) mice. Severity of acute pancreatitis was assessed using histology and a semi-quantitative scoring system. Ileal permeability was analyzed in vitro by Ussing chambers and an in vivo permeability assay. Gene expression of Fxr and Fxr target genes was studied by quantitative RT-PCR. Serum FGF19 levels were determined by ELISA in acute pancreatitis patients and healthy volunteers. A genetic association study in 387 acute pancreatitis patients and 853 controls was performed using 9 tagging single nucleotide polymorphisms (SNPs) covering the complete FXR gene and two additional functional SNPs. Results: In wild-type mice with acute pancreatitis, ileal transepithelial resistance was reduced and ileal mRNA expression of Fxr target genes Fgf15, SHP, and IBABP was decreased. Nevertheless, Fxr(-/-) mice did not exhibit a more severe acute pancreatitis than wild-type mice. In patients with acute pancreatitis, FGF19 levels were lower than in controls. However, there were no associations of FXR SNPs or haplotypes with susceptibility to acute pancreatitis, or its course, outcome or etiology. Conclusion: We found no evidence for a major role of FXR in acute human or murine pancreatitis. The observed altered Fxr activity during the course of disease may be a secondary phenomenon.	[Nijmeijer, Rian M.; Akkermans, Louis M. A.; Kroese, Alfons B. A.; Verheem, Andre; Gooszen, Hein G.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Schaap, Frank G.; Kremer, Andreas E.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Frank G.] Maastricht Univ, Dept Gen Surg, NL-6200 MD Maastricht, Netherlands; [Smits, Alexander J. J.; Schipper, Marguerite E. I.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Kremer, Andreas E.] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Kroese, Alfons B. A.] Univ Utrecht, Inst Risk Assessment Sci, Neurotoxicol Res Grp, Utrecht, Netherlands; [Rijkers, Ger. T.; Gooszen, Hein G.] Radboud Univ Nijmegen Med Ctr, Dept Operating Rooms, Nijmegen, Netherlands; [Rijkers, Ger. T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Erpecum, Karel J.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Utrecht University; Utrecht University Medical Center; University of Erlangen Nuremberg; Utrecht University; Radboud University Nijmegen; St. Antonius Hospital Utrecht; University of Groningen; Utrecht University; Utrecht University Medical Center	van Erpecum, KJ (corresponding author), Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.	K.J.vanErpecum@umcutrecht.nl	Wijmenga, Cisca/AAE-7719-2019; Gooszen, H.G./H-8036-2014; Rijkers, Ger/AAW-6143-2020; Wijmenga, Cisca/D-2173-2009; Rijkers, Ger/R-7236-2019	Wijmenga, Cisca/0000-0002-5635-1614; Rijkers, Ger/0000-0001-6948-6123; Kremer, Andreas/0000-0002-9263-948X; Schaap, Frank/0000-0002-1597-572X	University Medical Center Utrecht	University Medical Center Utrecht	Funding: RMN was supported by an Alexandre Suerman stipend from the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beger HG, 1997, WORLD J SURG, V21, P130, DOI 10.1007/s002689900204; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; Besselink MG, 2009, BRIT J SURG, V96, P267, DOI 10.1002/bjs.6447; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; FALLON MB, 1995, GASTROENTEROLOGY, V108, P1863, DOI 10.1016/0016-5085(95)90151-5; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gadaleta RM, 2011, BBA-MOL BASIS DIS, V1812, P851, DOI 10.1016/j.bbadis.2011.04.005; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Nierman MC, 2005, METABOLISM, V54, P1499, DOI 10.1016/j.metabol.2005.05.016; Nijmeijer RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085870; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Renner O, 2008, J LIPID RES, V49, P2045, DOI 10.1194/jlr.M800162-JLR200; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Rychter JW, 2009, SURGERY, V145, P157, DOI 10.1016/j.surg.2008.09.011; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Schmitt M, 2004, PANCREAS, V28, P181, DOI 10.1097/00006676-200403000-00010; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Venneman NG, 2005, HEPATOLOGY, V41, P738, DOI 10.1002/hep.20616; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Zweers SJLB, 2012, HEPATOLOGY, V55, P575, DOI 10.1002/hep.24702	42	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114393	10.1371/journal.pone.0114393	http://dx.doi.org/10.1371/journal.pone.0114393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470824	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700115
J	Weber, DG; Casjens, S; Johnen, G; Bryk, O; Raiko, I; Pesch, B; Kollmeier, J; Bauer, TT; Bruning, T				Weber, Daniel G.; Casjens, Swaantje; Johnen, Georg; Bryk, Oleksandr; Raiko, Irina; Pesch, Beate; Kollmeier, Jens; Bauer, Torsten T.; Bruening, Thomas			Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis	PLOS ONE			English	Article							PLEURAL MESOTHELIOMA; LUNG-CANCER; MICRORNAS; CA125; BLOOD; SERUM; MORTALITY; PLASMA; TRENDS; GPRC5A	Background: For the detection of malignant mesothelioma no single biomarker with reasonable sensitivity and specificity has been described so far. Mesothelin, the most prominent blood-based biomarker, is characterized by high specificity but low sensitivity. It might be reasonable to combine biomarkers of different molecular classes in order to improve the overall performance. The aim of this study was to assess the performance of the combination of mesothelin and miR-103a-3p as blood-based biomarker for mesothelioma. Methods/Principal Findings: Mesothelin concentration in plasma and miR-103a-3p levels in the cellular blood fraction were analyzed in 43 male mesothelioma patients and 52 male controls formerly exposed to asbestos. For the discrimination of epithelioid and biphasic mesothelioma from asbestos-exposed controls mesothelin and miR-103a-3p showed 74% and 89% sensitivity and 85% and 63% specificity, respectively. For the combination of mesothelin and miR-103a-3p a sensitivity of 95% and a specificity of 81% were calculated. Conclusions/Significance: The results of this study show that the combination of mesothelin and miR-103a-3p improves the diagnostic performance of individual blood-based biomarker to detect malignant mesothelioma. The obtained results indicate that the use of biomarkers of different molecular classes might be a reasonable approach to assemble a biomarker panel.	[Weber, Daniel G.; Casjens, Swaantje; Johnen, Georg; Bryk, Oleksandr; Raiko, Irina; Pesch, Beate; Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Ctr Mol Med, Bochum, Germany; [Kollmeier, Jens; Bauer, Torsten T.] HELIOS Clin Emil von Behring, Resp Dis Clin Heckeshorn, Berlin, Germany	Ruhr University Bochum	Weber, DG (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Ctr Mol Med, Bochum, Germany.	weber@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946; Kollmeier, Jens/0000-0002-8048-3895				Acquafreda T, 2009, CANCER BIOL THER, V8, P963, DOI 10.4161/cbt.8.10.8417; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corradi M, 2013, ANTICANCER RES, V33, P5517; Creaney J, 2007, CHEST, V132, P1239, DOI 10.1378/chest.07-0013; Cristaudo A, 2011, J THORAC ONCOL, V6, P1587, DOI 10.1097/JTO.0b013e31821e1c08; Cui A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004145; Di Serio F, 2007, CLIN CHEM LAB MED, V45, P634, DOI 10.1515/CCLM.2007.112; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Grigoriu B D, 2009, Monaldi Arch Chest Dis, V71, P31; Gube M, 2011, ARCH TOXICOL, V85, P185, DOI 10.1007/s00204-010-0580-2; Henderson DW, 2013, J CLIN PATHOL, V66, P854, DOI 10.1136/jclinpath-2013-201609; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; Jakubec P, 2014, BIOMED PAP IN PRESS; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2012, J THORAC ONCOL, V7, P1184, DOI 10.1097/JTO.0b013e3182572e83; Liu X, 2013, ONCOL REP, V29, P1415, DOI 10.3892/or.2013.2263; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Muley T, 2013, J THORAC ONCOL, V8, P947, DOI 10.1097/JTO.0b013e31828f696b; Myojin T, 2012, IND HEALTH, V50, P197, DOI 10.2486/indhealth.MS1184; Ordonez NG, 2014, HUM PATHOL, V45, P1529, DOI 10.1016/j.humpath.2014.03.006; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Pesch B, 2014, BBA-PROTEINS PROTEOM, V1844, P874, DOI 10.1016/j.bbapap.2013.12.007; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Raiko I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-242; Robinson BM, 2012, ANN CARDIOTHORAC SUR, V1, P491, DOI 10.3978/j.issn.2225-319X.2012.11.04; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Shen SJ, 2014, CHEM RES TOXICOL, V27, P27, DOI 10.1021/tx400305w; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Tsongalis GJ, 2013, CLIN CHEM, V59, P343, DOI 10.1373/clinchem.2012.185009; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weber Daniel G., 2007, Cancer Biomarkers, V3, P287; Weber DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030221; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Yoneda K, 2013, ANN SURG ON IN PRESS; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	37	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114483	10.1371/journal.pone.0114483	http://dx.doi.org/10.1371/journal.pone.0114483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469901	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700120
J	Williams, LB; Tessier, L; Koenig, JB; Koch, TG				Williams, Lynn B.; Tessier, Laurence; Koenig, Judith B.; Koch, Thomas G.			Post-Thaw Non-Cultured and Post-Thaw Cultured Equine Cord Blood Mesenchymal Stromal Cells Equally Suppress Lymphocyte Proliferation In Vitro	PLOS ONE			English	Article							STEM-CELLS; INTRAARTICULAR INJECTION; ARTHRITIS; CRYOPRESERVATION; FUSION; SHOCK	Multipotent mesenchymal stromal cells (MSC) are receiving increased attention for their non-progenitor immunomodulatory potential. Cryopreservation is commonly used for long-term storage of MSC. Post-thaw MSC proliferation is associated with a lag-phase in vitro. How this lag-phase affect MSC immunomodulatory properties is unknown. We hypothesized that in vitro there is no difference in lymphocyte suppression potential between quick-thawed cryopreserved equine cord blood (CB) MSC immediately included in mixed lymphocyte reaction (MLR) and same MSC allowed post-thaw culture time prior to inclusion in MLR. Cryopreserved CB-MSC from five unrelated foals were compared using two-way MLR. For each of the five unrelated MSC cultures, paired MLR assays of MSC allowed five days of post-thaw culture and MSC included in MLR assay immediately post-thawing were evaluated. We report no difference in the suppression of lymphocyte proliferation by CB-MSC that had undergone post-thaw culture and MSC not cultured post-thaw (p<0.0001). Also, there was no inter-donor variability between the lymphocyte suppressive properties of MSC harvested from the five different donors (p=0.13). These findings suggest that cryopreserved CB-MSC may have clinical utility immediately upon thawing. One implication hereof is the possibility of using cryopreserved CB-MSC at third party locations without the need for cell culture equipment or competencies.	[Williams, Lynn B.; Koenig, Judith B.] Univ Guelph, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Tessier, Laurence; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Dept Clin Studies, Orthopaed Res Lab, Copenhagen, Denmark	University of Guelph; University of Guelph; Aarhus University	Koch, TG (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkoch@uoguelph.ca			Danish Council for Independent Research - Council for Technology and Production Sciences [902539]; Equine Guelph Research Foundation [EG 2012 12]	Danish Council for Independent Research - Council for Technology and Production Sciences; Equine Guelph Research Foundation	These studies were supported by The Danish Council for Independent Research - Council for Technology and Production Sciences (TGK grant #902539; http://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes/dff-the-danish-council-for-independent-research) and the Equine Guelph Research Foundation (TGK grant #EG 2012 12; http://www.equineguelph.ca/ research/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Frisbie DD., 2012, EQUINE SURG, V4th, P1096; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Kang JG, 2013, J VET SCI, V14, P367, DOI 10.4142/jvs.2013.14.3.367; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CYTOTHERAPY, V11, P443, DOI 10.1080/14653240902887259; Lehle K, 2005, CRYOBIOLOGY, V50, P154, DOI 10.1016/j.cryobiol.2004.12.006; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Nyamandi VZ, 2014, OBESITY, V22, P721, DOI 10.1002/oby.20580; Osteoarthritis CJ, 2003, DIAGNOSIS MANAGEMENT, P572; Park JE, 2013, NEUROCHEM INT, V62, P418, DOI 10.1016/j.neuint.2013.02.002; Pigott JH, 2013, VET IMMUNOL IMMUNOP, V156, P99, DOI 10.1016/j.vetimm.2013.09.003; Quintanilha LF, 2014, HEPATOL RES, V44, pE206, DOI 10.1111/hepr.12204; Ricco S, 2013, INT J IMMUNOPATH PH, V26, P61, DOI 10.1177/03946320130260S108; ROY S, 1975, ARCH PATHOL, V99, P44; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Sutton EJ, 2009, OPT EXPRESS, V17, P24403, DOI 10.1364/OE.17.024403; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tessier L, 2013, THESIS U GUELPH; Torrente D., 2013, HUM EXP TOXICOL; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhou YZ, 2013, CYTOTHERAPY, V15, P1195, DOI 10.1016/j.jcyt.2013.05.009	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113615	10.1371/journal.pone.0113615	http://dx.doi.org/10.1371/journal.pone.0113615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438145	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900056
J	Kim, H; Keum, DJ; Kwak, JW; Chung, HS; Bae, H				Kim, Hyunseong; Keum, Dong June; Kwak, Jung Won; Chung, Hwan-Suck; Bae, Hyunsu			Bee Venom Phospholipase A2 Protects against Acetaminophen-Induced Acute Liver Injury by Modulating Regulatory T Cells and IL-10 in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; INDUCED HEPATOTOXICITY; A(2) SUPERFAMILY; HEPATIC-INJURY; TOLERANCE; INTERLEUKIN-10; DAMAGE; MOUSE; RAT; INFLAMMATION	The aim of this study was to investigate the protective effects of phospholipase A2 (PLA2) from bee venom against acetaminophen-induced hepatotoxicity through CD4(+)CD25(+)Foxp3(+) T cells (Treg) in mice. Acetaminophen (APAP) is a widely used antipyretic and analgesic, but an acute or cumulative overdose of acetaminophen can cause severe hepatic failure. Tregs have been reported to possess protective effects in various liver diseases and kidney toxicity. We previously found that bee venom strongly increased the Treg population in splenocytes and subsequently suppressed immune disorders. More recently, we found that the effective component of bee venom is PLA2. Thus, we hypothesized that PLA2 could protect against liver injury induced by acetaminophen. To evaluate the hepatoprotective effects of PLA2, C57BL/6 mice or interleukin-10-deficient (IL-10(-/-)) mice were injected with PLA2 once a day for five days and sacrificed 24 h (h) after acetaminophen injection. The blood sera were collected 0, 6, and 24 h after acetaminophen injection for the analysis of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). PLA2-injected mice showed reduced levels of serum AST, ALT, proinflammatory cytokines, and nitric oxide (NO) compared with the PBS-injected control mice. However, IL-10 was significantly increased in the PLA2-injected mice. These hepatic protective effects were abolished in Treg-depleted mice by antibody treatment and in IL-10 (/) mice. Based on these findings, it can be concluded that the protective effects of PLA2 against acetaminophen-induced hepatotoxicity can be mediated by modulating the Treg and IL-10 production.	[Kim, Hyunseong; Keum, Dong June; Kwak, Jung Won; Chung, Hwan-Suck; Bae, Hyunsu] Kyung Hee Univ, Dept Physiol, Coll Korean Med, Seoul 130701, South Korea; [Bae, Hyunsu] Kyung Hee Univ, Inst Korean Med, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Chung, HS (corresponding author), Kyung Hee Univ, Dept Physiol, Coll Korean Med, 1 Hoeki Dong, Seoul 130701, South Korea.	sock21@hanmail.net; hbae@khu.ac.kr	Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582	Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST) [2009-0063466]	Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering FoundationKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedda S, 2003, J HEPATOL, V39, P765, DOI 10.1016/S0168-8278(03)00325-8; Bleibel W, 2007, DIGEST DIS SCI, V52, P2463, DOI 10.1007/s10620-006-9472-y; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Choi MS, 2013, CYTOKINE, V61, P256, DOI 10.1016/j.cyto.2012.10.005; Chung ES, 2012, BRAIN BEHAV IMMUN, V26, P1322, DOI 10.1016/j.bbi.2012.08.013; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Darwish SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079284; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DUDLER T, 1995, J IMMUNOL, V155, P2605; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Ito Y, 2004, AM J PHYSIOL-GASTR L, V286, pG60, DOI 10.1152/ajpgi.00217.2003; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jeong JK, 2011, INT J MOL MED, V28, P867, DOI 10.3892/ijmm.2011.730; Kim H, 2013, EVID BASED; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Kuo PC, 1997, J PHARMACOL EXP THER, V282, P1072; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Lee WM, 2008, HEPATOL RES, V38, pS3, DOI 10.1111/j.1872-034X.2008.00419.x; LIU J, 1993, J PHARMACOL EXP THER, V266, P1607; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; Louis H, 1997, GASTROENTEROLOGY, V112, P935, DOI 10.1053/gast.1997.v112.pm9041256; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Monti MC, 2006, CHEMBIOCHEM, V7, P971, DOI 10.1002/cbic.200500454; Nguyen K, 2012, J HEPATOL, V56, P626, DOI 10.1016/j.jhep.2011.09.014; Olaleye MT, 2008, EXP TOXICOL PATHOL, V59, P319, DOI 10.1016/j.etp.2007.10.003; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Patterson AD, 2012, HEPATOLOGY, V56, P281, DOI 10.1002/hep.25645; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Speletas M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/827565; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang AY, 2010, WORLD J GASTROENTERO, V16, P384, DOI 10.3748/wjg.v16.i3.384; Wang WH, 2010, WORLD J GASTROENTERO, V16, P5502, DOI 10.3748/wjg.v16.i43.5502; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Whyte IM, 2007, CURR MED RES OPIN, V23, P2359, DOI 10.1185/030079907X219715; Yin H, 2010, HEPATOLOGY, V51, P1007, DOI 10.1002/hep.23476; Zhao HX, 2003, ANTIMICROB AGENTS CH, V47, P965, DOI 10.1128/AAC.47.3.965-971.2003; Zhao XM, 2012, TOXICOL LETT, V214, P69, DOI 10.1016/j.toxlet.2012.08.005	50	28	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114726	10.1371/journal.pone.0114726	http://dx.doi.org/10.1371/journal.pone.0114726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478691	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200118
J	Wong, ST; Browne, AJ; Varcoe, C; Lavoie, J; Fridkin, A; Smye, V; Godwin, O; Tu, D				Wong, Sabrina T.; Browne, Annette J.; Varcoe, Colleen; Lavoie, Josee; Fridkin, Alycia; Smye, Victoria; Godwin, Olive; Tu, David			Development of Health Equity Indicators in Primary Health Care Organizations Using a Modified Delphi	PLOS ONE			English	Article							PATIENT ACTIVATION	Objective: The purpose of this study was to develop a core set of indicators that could be used for measuring and monitoring the performance of primary health care organizations' capacity and strategies for enhancing equity-oriented care. Methods: Indicators were constructed based on a review of the literature and a thematic analysis of interview data with patients and staff (n=114) using procedures for qualitatively derived data. We used a modified Delphi process where the indicators were circulated to staff at the Health Centers who served as participants (n=63) over two rounds. Indicators were considered part of a priority set of health equity indicators if they received an overall importance rating of >8.0, on a scale of 1-9, where a higher score meant more importance. Results: Seventeen indicators make up the priority set. Items were eliminated because they were rated as low importance (<8.0) in both rounds and were either redundant or more than one participant commented that taking action on the indicator was highly unlikely. In order to achieve health care equity, performance at the organizational level is as important as assessing the performance of staff. Two of the highest rated "treatment" or processes of care indicators reflects the need for culturally safe and trauma and violence-informed care. There are four indicators that can be used to measure outcomes which can be directly attributable to equity responsive primary health care. Discussion: These indicators and subsequent development of items can be used to measure equity in the domains of treatment and outcomes. These areas represent targets for higher performance in relation to equity for organizations (e.g., funding allocations to ongoing training in equity-oriented care provision) and providers (e.g., reflexive practice, skill in working with the health effects of trauma).	[Wong, Sabrina T.; Browne, Annette J.; Varcoe, Colleen; Fridkin, Alycia; Smye, Victoria] Univ British Columbia, Sch Nursing, Crit Res Hlth & Healthcare Inequ Unit, Vancouver, BC V5Z 1M9, Canada; [Wong, Sabrina T.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Lavoie, Josee] Univ Manitoba, Manitoba Nations Ctr Aboriginal Hlth Res 1, Winnipeg, MB, Canada; [Lavoie, Josee] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Smye, Victoria] Univ Western Ontario, Inst Technol, Oshawa, ON, Canada; [Godwin, Olive] Prince George Div Family Practice, Prince George, BC, Canada; [Tu, David] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of Manitoba; University of Manitoba; Western University (University of Western Ontario); University of British Columbia	Wong, ST (corresponding author), Univ British Columbia, Sch Nursing, Crit Res Hlth & Healthcare Inequ Unit, Vancouver, BC V5Z 1M9, Canada.	Sabrina.wong@nursing.ubc.ca	Wong, Sabrina T./AFQ-2663-2022	Wong, Sabrina T./0000-0002-9619-9012; Varcoe, Colleen/0000-0001-9090-2793; Lavoie, Josee G./0000-0003-2483-431X	Canadian Institutes for Health Research [173182]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research #173182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL M, 2012, TOWARD A PRIMARY CAR; Boeckxstaens P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-209; Bradshaw J., 1994, RES PEOPLES HLTH, P45; BRADSHAW JA, 1972, PROBLEMS AND PROGRES; Browne AJ, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-59; *CAN I HLTH INF, 2009, THE HEALTH INDICATOR; CLAIR M, 2000, COMMISSION D ETUDE S; Denzin N., 2011, SAGE HDB QUALITATIVE, V4th; Farmer P, 2005, PATHOLOGIES OF POWER; Gillies JCM, 2009, BRIT J GEN PRACT, V59, P356, DOI 10.3399/bjgp09X420626; Haggerty J, 2007, ANN FAM MED, V5, P336, DOI 10.1370/afm.682; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2009, MED CARE RES REV, V66, p9S, DOI 10.1177/1077558708326969; Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65; *QSR INT, 2012, NVIVO QUALITATIVE SO; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; Starfield B, 2006, J HEALTH POLIT POLIC, V31, P11, DOI 10.1215/03616878-31-1-11; Stewart AL, 2003, MED CARE, V41, P1207, DOI 10.1097/01.MLR.0000093420.27745.48; Stuber J, 2008, SOC SCI MED, V67, P351, DOI 10.1016/j.socscimed.2008.03.023; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Varcoe C, 2009, SOC SCI MED, V68, P1659, DOI 10.1016/j.socscimed.2009.02.034; Ward Paul R, 2009, Qual Prim Care, V17, P49; Wathen C Nadine, 2007, Open Med, V1, pe113; WHO, 2008, THE WORLD HEALTH REP; Wong ST, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-38; Wong ST, 2011, MED CARE, V49, P469, DOI 10.1097/MLR.0b013e31820bf970; Wong ST, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-91; World Health Organization, 2008, COMMISSION ON SOCIAL; Wuest J, 2009, PAIN MED, V10, P739, DOI 10.1111/j.1526-4637.2009.00624.x	29	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114563	10.1371/journal.pone.0114563	http://dx.doi.org/10.1371/journal.pone.0114563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478914	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200104
J	Markman, S				Markman, Shai			Parental Self-Feeding Effects on Parental Care Levels and Time Allocation in Palestine Sunbirds	PLOS ONE			English	Article							ORANGE-TUFTED SUNBIRD; NITROGEN REQUIREMENTS; FOOD SUPPLEMENTATION; STURNUS-VULGARIS; DIET; CURRENCIES; LIMITATION; FITNESS; POLLEN; NECTAR	The trade-off between parents feeding themselves and their young is an important life history problem that can be considered in terms of optimal behavioral strategies. Recent studies on birds have tested how parents allocate the food between themselves and their young. Until now the effect of food consumption by parent birds on their food delivery to their young as well as other parental activities has rarely been studied. I have previously shown that parent Palestine sunbirds (Nectarinia osea) will consume nectar and liquidized arthropods from artificial feeders. However, they will only feed their young with whole arthropods. This provided a unique opportunity to experimentally manipulate the food eaten by parents independent of that fed to their offspring. Here, I hypothesized that parents invest in their current young according to the quality of food that they themselves consume. Breeding pairs with two or three nestlings were provided with feeders containing water (control), sucrose solution (0.75 mol) or liquidized mealworms mixed with sucrose solution (0.75 mol). As food quality in feeders increased (from water up to liquidized mealworms mixed with sucrose solution): 1) Parents (especially females) increased their food delivery of whole arthropod prey to their young. 2) Only males increased their nest guarding effort. Nestling food intake and growth rate increased with increasing food quality of parents and decreasing brood size. These results imply that increasing the nutrient content of foods consumed by parent sunbirds allow them to increase the rate at which other foods are delivered to their young and to increase the time spent on other parental care activities.	Univ Haifa, Dept Biol & Environm, Tivon, Israel	University of Haifa	Markman, S (corresponding author), Univ Haifa, Dept Biol & Environm, Tivon, Israel.	markmans@research.haifa.ac.il			Israel Science Foundation [1338/11]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation number 1338/11 awarded to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Beauchamp G, 1991, BEHAV ECOL, V2, P21, DOI 10.1093/beheco/2.1.21; Bell G.P., 1990, Studies in Avian Biology, P416; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BRICE AT, 1992, COMP BIOCHEM PHYS A, V101, P151, DOI 10.1016/0300-9629(92)90643-5; CARLSON A, 1985, ANIM BEHAV, V33, P664, DOI 10.1016/S0003-3472(85)80090-7; Crook SL, 2009, WATERBIRDS, V32, P548, DOI 10.1675/063.032.0408; Dawson RD, 2002, BEHAV ECOL SOCIOBIOL, V52, P43, DOI 10.1007/s00265-002-0486-y; Gill F. B., 1990, ORNITHOLOGY; GOLDSTEIN H, 1988, ARDEA, V76, P169; GREIGSMITH PW, 1988, IBIS, V130, P1, DOI 10.1111/j.1474-919X.1988.tb00950.x; Harrison C., 1975, FIELD GUIDE NESTS EG; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; HOUSTON AI, 1987, J THEOR BIOL, V124, P251, DOI 10.1016/S0022-5193(87)80115-7; Ilmonen P, 1999, OIKOS, V86, P79, DOI 10.2307/3546571; KACELNIK A, 1990, J ANIM ECOL, V59, P655, DOI 10.2307/4887; Kokko H, 1998, P ROY SOC B-BIOL SCI, V265, P1871, DOI 10.1098/rspb.1998.0515; KREBS JR, 1985, J ANIM ECOL, V54, P459, DOI 10.2307/4491; Litzow MA, 2002, OECOLOGIA, V132, P286, DOI 10.1007/s00442-002-0945-1; Markman S, 1996, ANIM BEHAV, V52, P437, DOI 10.1006/anbe.1996.0188; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; Markman S, 2004, J ANIM ECOL, V73, P747, DOI 10.1111/j.0021-8790.2004.00847.x; Markman S, 1999, AUK, V116, P257, DOI 10.2307/4089476; Markman S, 2002, P ROY SOC B-BIOL SCI, V269, P1931, DOI 10.1098/rspb.2002.2118; Martinez del Rio Carlos, 1994, P103, DOI 10.1017/CBO9780511661716.009; McNamara JM, 1997, AM NAT, V150, P603, DOI 10.1086/286084; Nahari N, 1980, THESIS TEL AVIV U; PATON DC, 1982, AUST J ECOL, V7, P279, DOI 10.1111/j.1442-9993.1982.tb01506.x; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; PYKE GH, 1980, AUST J ECOL, V5, P343, DOI 10.1111/j.1442-9993.1980.tb01258.x; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; RICHARDSON KC, 1990, AUST J ZOOL, V38, P581, DOI 10.1071/ZO9900581; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Roxburgh L, 2000, PHYSIOL BIOCHEM ZOOL, V73, P638, DOI 10.1086/317747; Roxburgh L, 2000, THESIS BEN GURION U; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; Smiseth PT, 2003, BEHAV ECOL, V14, P793, DOI 10.1093/beheco/arg083; Sofaer HR, 2013, BEHAV ECOL, V24, P698, DOI 10.1093/beheco/ars212; Sokal RR, 1997, BIOMETRY; SONERUD GA, 1989, ORNIS SCAND, V20, P69, DOI 10.2307/3676711; Stephens D.W., 1986, pi; Stephens David W., 2007, FORAGING; STILES FG, 1971, SCIENCE, V173, P818, DOI 10.1126/science.173.3999.818; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Thompson AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0558; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; van Tets IG, 2000, AUK, V117, P826, DOI 10.1642/0004-8038(2000)117[0826:PATNRO]2.0.CO;2; WELHAM CVJ, 1993, ECOLOGY, V74, P1893, DOI 10.2307/1939946; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Ydenberg RC, 1994, ECOSCIENCE, V1, P1; Zanette L, 2006, ECOLOGY, V87, P2459, DOI 10.1890/0012-9658(2006)87[2459:FAPAEP]2.0.CO;2; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zar JH, 1996, BIOSTATISTIACL ANAL	53	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113890	10.1371/journal.pone.0113890	http://dx.doi.org/10.1371/journal.pone.0113890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474620	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500097
J	Zhang, XH; Zhang, L; Cheng, X; Guo, YX; Sun, XH; Chen, G; Li, HM; Li, PC; Lu, XH; Tian, ML; Qin, JB; Zhou, H; Jin, GH				Zhang, Xinhua; Zhang, Lei; Cheng, Xiang; Guo, Yuxiu; Sun, Xiaohui; Chen, Geng; Li, Haoming; Li, Pengcheng; Lu, Xiaohui; Tian, Meiling; Qin, Jianbing; Zhou, Hui; Jin, Guohua			IGF-1 Promotes Brn-4 Expression and Neuronal Differentiation of Neural Stem Cells via the PI3K/Akt Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; PROGENITOR CELLS; TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; MAMMALIAN TARGET; PC12 CELLS; INSULIN	Our previous studies indicated that transcription factor Brn-4 is upregulated in the surgically denervated hippocampus in vivo, promoting neuronal differentiation of hippocampal neural stem cells (NSCs) in vitro. The molecules mediating Brn-4 upregulation in the denervated hippocampus remain unknown. In this study we examined the levels of insulin-like growth factor-1 (IGF-1) in hippocampus following denervation. Surgical denervation led to a significant increase in IGF-1 expression in vivo. We also report that IGF-1 treatment on NSCs in vitro led to a marked acceleration of Brn-4 expression and cell differentiation down neuronal pathways. The promotion effects were blocked by PI3K-specific inhibitor (LY294002), but not MAPK inhibitor (PD98059); levels of phospho-Akt were increased by IGF-1 treatment. In addition, inhibition of IGF-1 receptor (AG1024) and mTOR (rapamycin) both attenuated the increased expression of Brn-4 induced by IGF-1. Together, the results demonstrated that upregulation of IGF-1 induced by hippocampal denervation injury leads to activation of the PI3K/Akt signaling pathway, which in turn gives rise to upregulation of the Brn-4 and subsequent stem cell differentiation down neuronal pathways.	[Zhang, Xinhua; Zhang, Lei; Cheng, Xiang; Chen, Geng; Li, Haoming; Tian, Meiling; Qin, Jianbing; Jin, Guohua] Nantong Univ, Dept Anat, Nantong, Jiangsu, Peoples R China; [Guo, Yuxiu; Li, Pengcheng; Zhou, Hui] Nantong Univ, Affiliated Hosp, Dept Pediat, Nantong, Jiangsu, Peoples R China; [Sun, Xiaohui] Nantong Rehibilitat Hosp Agings, Vasculocardiol Dept, Nantong, Jiangsu, Peoples R China; [Lu, Xiaohui] Nantong Univ, Affiliated Hosp, Dept Stomatol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University	Zhou, H (corresponding author), Nantong Univ, Affiliated Hosp, Dept Pediat, Nantong, Jiangsu, Peoples R China.	jguohua@ntu.edu.cn; nthuihui@126.com	Li, Hao/GPS-9834-2022	Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of China [31171038]; Jiangsu Natural Science Foundation [BK2011385]; Jiangsu Natural College Foundation [11KJB180008, 13KJB310010]; National Training Programs of Innovation and Entrepreneurship for Undergraduates [201210304031]; Grant of Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Natural College Foundation; National Training Programs of Innovation and Entrepreneurship for Undergraduates; Grant of Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Grant 31171038), Jiangsu Natural Science Foundation (BK2011385), Jiangsu Natural College Foundation (11KJB180008, 13KJB310010), the Grant of Nantong University for Innovation Talent, National Training Programs of Innovation and Entrepreneurship for Undergraduates (201210304031), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Colucci-D'Amato L, 2006, NEUROL SCI, V27, P266, DOI 10.1007/s10072-006-0682-z; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Heumann Rolf, 1994, Current Opinion in Neurobiology, V4, P668, DOI 10.1016/0959-4388(94)90008-6; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kalluri HSG, 2007, EUR J NEUROSCI, V25, P1041, DOI 10.1111/j.1460-9568.2007.05336.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; MARSH HN, 1993, J NEUROSCI, V13, P4281; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Murray PS, 2011, INT J PEPTIDES, V2011; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; Schreiber J, 1997, J BIOL CHEM, V272, P32286, DOI 10.1074/jbc.272.51.32286; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sekulic A, 2000, CANCER RES, V60, P3504; Shi JH, 2010, NEUROSCI RES, V67, P8, DOI 10.1016/j.neures.2010.01.007; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Sung SM, 2007, NEUROCHEM RES, V32, P1932, DOI 10.1007/s11064-007-9390-1; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Wang HT, 2012, NEUROSCI LETT, V516, P105, DOI 10.1016/j.neulet.2012.03.068; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhang H, 2011, NEUROCHEM RES, V36, P49, DOI 10.1007/s11064-010-0260-x; Zhang XH, 2007, NEUROSCI LETT, V414, P115, DOI 10.1016/j.neulet.2006.07.078; Zhang XH, 2009, HIPPOCAMPUS, V19, P176, DOI 10.1002/hipo.20498; Zou LQ, 2010, INT J NEUROSCI, V120, P192, DOI 10.3109/00207450903464579	55	36	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113801	10.1371/journal.pone.0113801	http://dx.doi.org/10.1371/journal.pone.0113801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474202	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500093
J	Bhattacharya, S; Pal, K; Sharma, AK; Dutta, SK; Lau, JS; Yan, IK; Wang, E; Elkhanany, A; Alkharfy, KM; Sanyal, A; Patel, TC; Chari, ST; Spaller, MR; Mukhopadhyay, D				Bhattacharya, Santanu; Pal, Krishnendu; Sharma, Anil K.; Dutta, Shamit K.; Lau, Julie S.; Yan, Irene K.; Wang, Enfeng; Elkhanany, Ahmed; Alkharfy, Khalid M.; Sanyal, Arunik; Patel, Tushar C.; Chari, Suresh T.; Spaller, Mark R.; Mukhopadhyay, Debabrata			GAIP Interacting Protein C-Terminus Regulates Autophagy and Exosome Biogenesis of Pancreatic Cancer through Metabolic Pathways	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; MYOSIN-VI; PDZ DOMAIN; GIPC; AMPK; PHOSPHORYLATION; DEGRADATION; EXPRESSION; BINDING; BREAST	GAIP interacting protein C terminus (GIPC) is known to play an important role in a variety of physiological and disease states. In the present study, we have identified a novel role for GIPC as a master regulator of autophagy and the exocytotic pathways in cancer. We show that depletion of GIPC-induced autophagy in pancreatic cancer cells, as evident from the upregulation of the autophagy marker LC3II. We further report that GIPC regulates cellular trafficking pathways by modulating the secretion, biogenesis, and molecular composition of exosomes. We also identified the involvement of GIPC on metabolic stress pathways regulating autophagy and microvesicular shedding, and observed that GIPC status determines the loading of cellular cargo in the exosome. Furthermore, we have shown the overexpression of the drug resistance gene ABCG2 in exosomes from GIPC-depleted pancreatic cancer cells. We also demonstrated that depletion of GIPC from cancer cells sensitized them to gemcitabine treatment, an avenue that can be explored as a potential therapeutic strategy to overcome drug resistance in cancer.	[Bhattacharya, Santanu; Pal, Krishnendu; Sharma, Anil K.; Dutta, Shamit K.; Lau, Julie S.; Wang, Enfeng; Elkhanany, Ahmed; Alkharfy, Khalid M.; Sanyal, Arunik; Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Alkharfy, Khalid M.] King Saud Univ, Dept Pharm, Riyadh, Saudi Arabia; [Yan, Irene K.; Patel, Tushar C.] Mayo Clin, Dept Transplantat, Jacksonville, FL USA; [Yan, Irene K.; Patel, Tushar C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL USA; [Chari, Suresh T.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH USA; [Spaller, Mark R.] Norris Cotton Canc Ctr, Lebanon, NH USA	Mayo Clinic; King Saud University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College; Norris Cotton Cancer Center	Mukhopadhyay, D (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Sharma, Anil K./AAP-1909-2020; patel, tushar/J-3976-2013; Chari, Suresh/K-9297-2015	Sharma, Anil K./0000-0002-9768-1644; patel, tushar/0000-0001-7021-9532; Chari, Suresh/0000-0002-3924-0971; Elkhanany, Ahmed/0000-0001-7681-6872; Sharma, Anil/0000-0002-4471-7172; Pal, Krishnendu/0000-0002-4006-213X	National Institutes of Health [CA78383, CA150190]; NATIONAL CANCER INSTITUTE [R01CA078383, R01CA150190, R29CA078383] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work is supported by National Institutes of Health grants CA78383 and CA150190(DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Chittenden TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015581; Choi JS, 2010, CANCER LETT, V294, P254, DOI 10.1016/j.canlet.2010.02.007; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Favre-Bonvin A, 2005, J VIROL, V79, P4229, DOI 10.1128/JVI.79.7.4229-4237.2005; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jeanneteau F, 2004, MOL BIOL CELL, V15, P696, DOI 10.1091/mbc.E03-05-0293; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim MS, 2011, APMIS, V119, P802, DOI 10.1111/j.1600-0463.2011.02812.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirikoshi H, 2002, INT J MOL MED, V9, P509; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Pal K, 2014, MOL CANCER THER, V13, P285, DOI 10.1158/1535-7163.MCT-13-0681; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; SAITO H, 1993, CANCER RES, V53, P3382; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sinha S, 2013, INT J CANCER, V132, P1201, DOI 10.1002/ijc.27724; Spicer E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010665; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Wang L, 2010, MOL CANCER RES, V8, P1591, DOI 10.1158/1541-7786.MCR-10-0209; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yavelsky V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-247	55	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114409	10.1371/journal.pone.0114409	http://dx.doi.org/10.1371/journal.pone.0114409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469510	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700116
J	Cao, BY; Liu, XQ; Yu, X; Chen, M; Feng, L; Wang, L				Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei			A New Oligonucleotide Microarray for Detection of Pathogenic and Non-Pathogenic Legionella spp.	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; REAL-TIME PCR; SPACER REGION; LEGIONNAIRES-DISEASE; PNEUMOPHILA; IDENTIFICATION; 16S-23S; MIP; INFECTION; SEQUENCES	Legionella pneumophila has been recognized as the major cause of legionellosis since the discovery of the deadly disease. Legionella spp. other than L. pneumophila were later found to be responsible to many non-pneumophila infections. The non-L. pneumophila infections are likely under-detected because of a lack of effective diagnosis. In this report, we have sequenced the 16S-23S rRNA gene internal transcribed spacer (ITS) of 10 Legionella species and subspecies, including L. anisa, L. bozemanii, L. dumoffii, L. fairfieldensis, L. gormanii, L. jordanis, L. maceachernii, L. micdadei, L. pneumophila subspp. fraseri and L. pneumophila subspp. pasculleii, and developed a rapid oligonucleotide microarray detection technique accordingly to identify 12 most common Legionella spp., which consist of 11 pathogenic species of L. anisa, L. bozemanii, L. dumoffii, L. gormanii, L. jordanis, L. longbeachae, L. maceachernii, L. micdadei, and L. pneumophila (including subspp. pneumophila, subspp. fraseri, and subspp. pasculleii) and one non-pathogenic species, L. fairfieldensis. Twenty-nine probes that reproducibly detected multiple Legionella species with high specificity were included in the array. A total of 52 strains, including 30 target pathogens and 22 non-target bacteria, were used to verify the oligonucleotide microarray assay. The sensitivity of the detection was at 1.0 ng with genomic DNA or 13 CFU/100 mL with Legionella cultures. The microarray detected seven samples of air conditioner-condensed water with 100% accuracy, validating the technique as a promising method for applications in basic microbiology, clinical diagnosis, food safety, and epidemiological surveillance. The phylogenetic study based on the ITS has also revealed that the non-pathogenic L. fairfieldensis is the closest to L. pneumophila than the nine other pathogenic Legionella spp.	[Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, TEDA Coll, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, L (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, TEDA Coll, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Wang, Lei/C-5176-2009; feng, lu/M-5113-2015	Wang, Lei/0000-0003-4427-0881; 	National Key Program for Infectious Diseases of China [2013ZX10004216-001-001]; National 863 Program of China [2012AA020103, 2011AA100901-2]; National 973 Program of China [2011CB504900]; National Natural Science Foundation of China (NSFC) [81171524, 31270144, 31170094, 31030002, 31270003]; Tianjin Research Program of Application Foundation; Advanced Technology [13JCQNJC09400, 12JCYBJC15100, 10JCYBJC10000]	National Key Program for Infectious Diseases of China; National 863 Program of China(National High Technology Research and Development Program of China); National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation; Advanced Technology	Funding: This work was supported by grants from the National Key Program for Infectious Diseases of China (2013ZX10004216-001-001), the National 863 Program of China (2012AA020103, 2011AA100901-2), the National 973 Program of China (2011CB504900), the National Natural Science Foundation of China (NSFC) Program (81171524, 31270144, 31170094, 31030002 and 31270003), and the Tianjin Research Program of Application Foundation and Advanced Technology (13JCQNJC09400, 12JCYBJC15100 and 10JCYBJC10000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger P, 2006, EMERG INFECT DIS, V12, P248; Cao BY, 2013, APPL ENVIRON MICROB, V79, P6647, DOI 10.1128/AEM.01957-13; Cao BY, 2009, J MICROBIOL METH, V77, P109, DOI 10.1016/j.mimet.2009.01.024; Carvalho FRS, 2008, CURR MICROBIOL, V57, P294, DOI 10.1007/s00284-008-9192-y; Chun J, 2002, Methods Mol Biol, V179, P171; CIANCIOTTO NP, 1995, CURR MICROBIOL, V30, P149, DOI 10.1007/BF00296200; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Guan W, 2012, J MICROBIOL, V50, P127, DOI 10.1007/s12275-012-1243-1; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Herpers BL, 2003, J CLIN MICROBIOL, V41, P4815, DOI 10.1128/JCM.41.10.4815-4816.2003; Inoue Hiroaki, 2006, Biocontrol Science, V11, P69; Ko KS, 2003, J MICROBIOL METH, V54, P325, DOI 10.1016/S0167-7012(03)00065-4; Luz SP, 1998, J BACTERIOL, V180, P2144, DOI 10.1128/JB.180.8.2144-2151.1998; Maggi RG, 2006, MOL CELL PROBE, V20, P128, DOI 10.1016/j.mcp.2005.11.002; Magray MSUD, 2011, BIOINFORMATION, V6, P370, DOI 10.6026/97320630006370; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; Murdoch DR, 2003, CLIN INFECT DIS, V36, P64, DOI 10.1086/345529; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Palusinska-Szysz M, 2009, ARCH IMMUNOL THER EX, V57, P279, DOI 10.1007/s00005-009-0035-8; Qin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059018; Ratcliff RM, 1997, MOL MICROBIOL, V25, P1149, DOI 10.1046/j.1365-2958.1997.5471908.x; Stolhaug A, 2006, APPL ENVIRON MICROB, V72, P6394, DOI 10.1128/AEM.02839-05; Su HP, 2009, J CLIN MICROBIOL, V47, P1386, DOI 10.1128/JCM.02225-08; THACKER WL, 1991, J CLIN MICROBIOL, V29, P475, DOI 10.1128/JCM.29.3.475-478.1991; Wang M, 2008, J CLIN MICROBIOL, V46, P3555, DOI 10.1128/JCM.00927-08; Wilson DA, 2003, J CLIN MICROBIOL, V41, P3327, DOI 10.1128/JCM.41.7.3327-3330.2003; Wojciech L, 2004, J VET MED B, V51, P238, DOI 10.1111/j.1439-0450.2004.00762.x; Wright AJ, 2012, TRANSPL INFECT DIS, V14, pE30, DOI 10.1111/j.1399-3062.2012.00755.x; Xiong LK, 2006, J CLIN MICROBIOL, V44, P3544, DOI 10.1128/JCM.00633-06; Yang G, 2010, CLIN MICROBIOL INFEC, V16, P255, DOI 10.1111/j.1469-0691.2009.02766.x; Zhou GP, 2011, APPL MICROBIOL BIOT, V91, P777, DOI 10.1007/s00253-011-3283-6; Zhou GP, 2011, INT J FOOD MICROBIOL, V145, P293, DOI 10.1016/j.ijfoodmicro.2011.01.014	36	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113863	10.1371/journal.pone.0113863	http://dx.doi.org/10.1371/journal.pone.0113863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469776	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700049
J	Prusty, BK; Siegl, C; Gulve, N; Mori, Y; Rudel, T				Prusty, Bhupesh K.; Siegl, Christine; Gulve, Nitish; Mori, Yasuko; Rudel, Thomas			GP96 Interacts with HHV-6 during Viral Entry and Directs It for Cellular Degradation	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; HUMAN-HERPESVIRUS-6 VARIANT-A; NEISSERIA-GONORRHOEAE; HUMAN HERPESVIRUS-6; SURFACE EXPRESSION; DNA-POLYMERASE; GLYCOPROTEIN-H; RECEPTOR; CD46; CELLS	CD46 and CD134 mediate attachment of Human Herpesvirus 6A (HHV-6A) and HHV-6B to host cell, respectively. But many cell types interfere with viral infection through rapid degradation of viral DNA. Hence, not all cells expressing these receptors are permissive to HHV-6 DNA replication and production of infective virions suggesting the involvement of additional factors that influence HHV-6 propagation. Here, we used a proteomics approach to identify other host cell proteins necessary for HHV-6 binding and entry. We found host cell chaperone protein GP96 to interact with HHV-6A and HHV-6B and to interfere with virus propagation within the host cell. In human peripheral blood mononuclear cells (PBMCs), GP96 is transported to the cell surface upon infection with HHV-6 and interacts with HHV-6A and -6B through its C-terminal end. Suppression of GP96 expression decreased initial viral binding but increased viral DNA replication. Transient expression of human GP96 allowed HHV-6 entry into CHO-K1 cells even in the absence of CD46. Thus, our results suggest an important role for GP96 during HHV-6 infection, which possibly supports the cellular degradation of the virus.	[Prusty, Bhupesh K.; Siegl, Christine; Gulve, Nitish; Rudel, Thomas] Univ Wurzburg, Chair Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan	University of Wurzburg; Kobe University	Prusty, BK (corresponding author), Univ Wurzburg, Chair Microbiol, Bioctr, D-97074 Wurzburg, Germany.	bhupesh.prusty@biozentrum.uni-wuerzburg.de; thomas.rudel@biozentrum.uni-wuerzburg.de	Prusty, Bhupesh/AAF-4843-2020; Gulve, Nitish/AAL-3006-2021	Prusty, Bhupesh/0000-0001-7051-4670; Gulve, Nitish/0000-0001-8511-1065	Deutsch-Israelische Projektkooperation (DIP) [RU 631/5-1]; VolkswagenStiftung under Volkswagen Foundation's funding initiative 'Experiment!' [88773]; German Research Foundation (DFG); University of Wuerzburg	Deutsch-Israelische Projektkooperation (DIP); VolkswagenStiftung under Volkswagen Foundation's funding initiative 'Experiment!'; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	Funding: This work was supported by the Deutsch-Israelische Projektkooperation (DIP) project RU 631/5-1 to TR. This work was also supported by a grant from the VolkswagenStiftung (grant number 88773) to BKP under Volkswagen Foundation's funding initiative 'Experiment!' This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULNICK AD, 1993, J GEN VIROL, V74, P1003, DOI 10.1099/0022-1317-74-6-1003; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Campadelli-Fiume G, 2000, TRENDS MICROBIOL, V8, P436, DOI 10.1016/S0966-842X(00)01804-7; Cassiani-Ingoni R, 2005, GLIA, V52, P252, DOI 10.1002/glia.20219; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Evlashev A, 2000, J VIROL, V74, P1373, DOI 10.1128/JVI.74.3.1373-1382.2000; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; Iacobelli-Martinez M, 2007, J VIROL, V81, P1305, DOI 10.1128/JVI.01926-06; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kawabata A, 2011, J VIROL, V85, P12962, DOI 10.1128/JVI.05622-11; Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Loveland B E, 1993, Transpl Immunol, V1, P101, DOI 10.1016/0966-3274(93)90002-P; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Morales H, 2003, CELL STRESS CHAPERON, V8, P265, DOI 10.1379/1466-1268(2003)008<0265:BSUTSE>2.0.CO;2; Mori Y, 2003, J VIROL, V77, P4992, DOI 10.1128/JVI.77.8.4992-4999.2003; Mori Y, 2002, J VIROL, V76, P6750, DOI 10.1128/JVI.76.13.6750-6761.2002; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Murakami Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-91; NANICHE D, 1993, J GEN VIROL, V74, P1073, DOI 10.1099/0022-1317-74-6-1073; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Prusty BK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004033; Prusty BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061400; Prusty BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047427; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Robert J, 1999, J IMMUNOL, V163, P4133; Santoro F, 2003, J BIOL CHEM, V278, P25964, DOI 10.1074/jbc.M302373200; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Thulke S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-77; Toledo-Arana A, 2010, NATURE, P1; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	45	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113962	10.1371/journal.pone.0113962	http://dx.doi.org/10.1371/journal.pone.0113962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470779	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700058
J	Ratnarajah, L; Bowie, AR; Lannuzel, D; Meiners, KM; Nicol, S				Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Meiners, Klaus M.; Nicol, Stephen			The Biogeochemical Role of Baleen Whales and Krill in Southern Ocean Nutrient Cycling	PLOS ONE			English	Article							TRACE-METALS; IRON FERTILIZATION; ANTARCTIC KRILL; PHYTOPLANKTON BLOOM; TOP PREDATORS; WATER COLUMN; ROSS SEA; PLANKTON; CADMIUM; SECTOR	The availability of micronutrients is a key factor that affects primary productivity in High Nutrient Low Chlorophyll (HNLC) regions of the Southern Ocean. Nutrient supply is governed by a range of physical, chemical and biological processes, and there are significant feedbacks within the ecosystem. It has been suggested that baleen whales form a crucial part of biogeochemical cycling processes through the consumption of nutrient-rich krill and subsequent defecation, but data on their contribution are scarce. We analysed the concentration of iron, cadmium, manganese, cobalt, copper, zinc, phosphorus and carbon in baleen whale faeces and muscle, and krill tissue using inductively coupled plasma mass spectrometry. Metal concentrations in krill tissue were between 20 thousand and 4.8 million times higher than typical Southern Ocean HNLC seawater concentrations, while whale faecal matter was between 276 thousand and 10 million times higher. These findings suggest that krill act as a mechanism for concentrating and retaining elements in the surface layer, which are subsequently released back into the ocean, once eaten by whales, through defecation. Trace metal to carbon ratios were also higher in whale faeces compared to whale muscle indicating that whales are concentrating carbon and actively defecating trace elements. Consequently, recovery of the great whales may facilitate the recycling of nutrients via defecation, which may affect productivity in HNLC areas.	[Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Nicol, Stephen] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Meiners, Klaus M.; Nicol, Stephen] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Meiners, Klaus M.] Australian Antarctic Div, Kingston, Tas, Australia	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division	Ratnarajah, L (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Lavenia.Ratnarajah@utas.edu.au	Lannuzel, Delphine/J-7937-2014; Bowie, Andrew/C-8677-2013	Lannuzel, Delphine/0000-0001-6154-1837; Ratnarajah, Lavenia/0000-0002-1021-1923; Bowie, Andrew/0000-0002-5144-7799	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre; Australian Antarctic Division; Australian Marine Mammal Centre	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Antarctic Division; Australian Marine Mammal Centre	This work was supported by the Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre, by the Australian Antarctic Division and by the Australian Marine Mammal Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1978, LIMNOL OCEANOGR, V23, P283, DOI 10.4319/lo.1978.23.2.0283; Annett AL, 2008, LIMNOL OCEANOGR, V53, P2451, DOI 10.4319/lo.2008.53.6.2451; Baden SP, 2006, OCEANOGR MAR BIOL, V44, P61; Barbante C, 2000, J ANAL ATOM SPECTROM, V15, P377, DOI 10.1039/a907403a; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Chester R., 1990, MARINE GEOCHEM, P346, DOI [10.1007/978-94-010-9488-7_11, DOI 10.1007/978-94-010-9488-7_11]; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Corami F, 2005, J ENVIRON MONITOR, V7, P1256, DOI 10.1039/b507323p; Cullen JT, 2003, LIMNOL OCEANOGR, V48, P1079, DOI 10.4319/lo.2003.48.3.1079; Cullen JT, 1999, MAR CHEM, V67, P233, DOI 10.1016/S0304-4203(99)00060-2; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Espejo W, 2014, POLAR BIOL, V37, P675, DOI 10.1007/s00300-014-1468-z; FADELY BS, 1990, J WILDLIFE MANAGE, V54, P246, DOI 10.2307/3809037; Fitzwater SE, 2000, DEEP-SEA RES PT II, V47, P3159, DOI 10.1016/S0967-0645(00)00063-1; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Frew R, 2001, DEEP-SEA RES PT II, V48, P2467, DOI 10.1016/S0967-0645(01)00004-2; Grotti M, 2001, MAR CHEM, V76, P189, DOI 10.1016/S0304-4203(01)00063-9; Henderson GM, 2007, CHEM ERDE-GEOCHEM, V67, P85, DOI 10.1016/j.chemer.2007.02.001; Hendry KR, 2010, ESTUAR COAST SHELF S, V87, P103, DOI 10.1016/j.ecss.2009.12.017; Honda K., 1987, Proceedings of the NIPR Symposium on Polar Biology, P184; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; IWC, 2000, J CETACEAN RES MAN S, V2, P167; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Jennings S, 2009, J APPL ECOL, V46, P976, DOI 10.1111/j.1365-2664.2009.01682.x; Katija K, 2012, J EXP BIOL, V215, P1040, DOI 10.1242/jeb.059279; KOOYMAN GL, 1981, ANNU REV PHYSIOL, V43, P343, DOI 10.1146/annurev.ph.43.030181.002015; LANDING WM, 1987, GEOCHIM COSMOCHIM AC, V51, P29, DOI 10.1016/0016-7037(87)90004-4; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lannuzel D, 2011, MAR CHEM, V124, P134, DOI 10.1016/j.marchem.2011.01.004; Lavery TJ, 2014, MAR MAMMAL SCI, V30, P888, DOI 10.1111/mms.12108; Lavery TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3527, DOI 10.1098/rspb.2010.0863; Loscher BM, 1998, MAR CHEM, V62, P259, DOI 10.1016/S0304-4203(98)00045-0; Loscher BM, 1999, MAR CHEM, V67, P67, DOI 10.1016/S0304-4203(99)00050-X; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, VVolume 6, P625, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Morel F.M.M., 1991, OCEANOGRAPHY, V4, P56, DOI [10.5670/oceanog.1991.03, DOI 10.5670/0CEAN0G.1991.03]; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Nemoto T., 1988, P292; NICOL S, 1991, J CRUSTACEAN BIOL, V11, P10, DOI 10.2307/1548539; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; ORIANS KJ, 1986, EARTH PLANET SC LETT, V78, P397, DOI 10.1016/0012-821X(86)90006-3; Perissinotto R, 1997, MAR ECOL PROG SER, V160, P77, DOI 10.3354/meps160077; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; Planquette H, 2013, MAR CHEM, V153, P15, DOI 10.1016/j.marchem.2013.04.006; REDFIELD AC, 1958, AM SCI, V46, P205; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Roman J, 2014, FRONTIERS ECOLOGY EN; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; SHELDON RW, 1977, J FISH RES BOARD CAN, V34, P2344, DOI 10.1139/f77-314; Smetacek V, 2008, IMPACTS GOBAL WARMIN; Smith LV, 2013, J EXP MAR BIOL ECOL, V446, P1, DOI 10.1016/j.jembe.2013.04.010; Spicer JI, 2010, ADV MAR BIOL, V57, P91, DOI 10.1016/S0065-2881(10)57004-4; SUNDA WG, 1979, J MAR RES, V37, P761; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; SZEFER P, 1994, ENVIRON POLLUT, V83, P341, DOI 10.1016/0269-7491(94)90156-2; Townsend AT, 2000, J ANAL ATOM SPECTROM, V15, P307, DOI 10.1039/a904933i; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; WESTERLUND S, 1991, MAR CHEM, V35, P199, DOI 10.1016/S0304-4203(09)90018-4; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Yamamoto Y., 1987, Proceedings of the NIPR Symposium on Polar Biology, P198	69	43	44	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114067	10.1371/journal.pone.0114067	http://dx.doi.org/10.1371/journal.pone.0114067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469984	Green Published, gold			2022-12-27	WOS:000349128700065
J	Strier, KB; Lee, PC; Ives, AR				Strier, Karen B.; Lee, Phyllis C.; Ives, Anthony R.			Behavioral Flexibility and the Evolution of Primate Social States	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; OBSERVATIONAL DATA; FEMALE DISPERSAL; MATING SYSTEMS; RED COLOBUS; GROUP-SIZE; MONKEYS; PATTERNS; ECOLOGY; MAMMALS	Comparative approaches to the evolution of primate social behavior have typically involved two distinct lines of inquiry. One has focused on phylogenetic analyses that treat social traits as static, species-specific characteristics; the other has focused on understanding the behavioral flexibility of particular populations or species in response to local ecological or demographic variables. Here, we combine these approaches by distinguishing between constraining traits such as dispersal regimes (male, female, or bi-sexual), which are relatively invariant, and responding traits such as grouping patterns (stable, fission-fusion, sometimes fission-fusion), which can reflect rapid adjustments to current conditions. Using long-term and cross-sectional data from 29 studies of 22 species of wild primates, we confirm that dispersal regime exhibits a strong phylogenetic signal in our sample. We then show that primate species with high variation in group size and adult sex ratios exhibit variability in grouping pattern (i.e., sometimes fission-fusion) with dispersal regime constraining the grouping response. When assessing demographic variation, we found a strong positive relationship between the variability in group size over time and the number of observation years, which further illustrates the importance of long-term demographic data to interpretations of social behavior. Our approach complements other comparative efforts to understand the role of behavioral flexibility by distinguishing between constraining and responding traits, and incorporating these distinctions into analyses of social states over evolutionary and ecological time.	[Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53705 USA; [Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Stirling; University of Wisconsin System; University of Wisconsin Madison	Strier, KB (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53705 USA.	kbstrier@wisc.edu	Strier, Karen B./AAJ-3482-2020	Strier, Karen/0000-0003-2520-9110; Lee, Phyllis/0000-0002-4296-3513	University of Wisconsin-Madison; CAPES/BRASIL Special Visiting Researcher award; National Science Foundation [DEB-0816613]	University of Wisconsin-Madison; CAPES/BRASIL Special Visiting Researcher award; National Science Foundation(National Science Foundation (NSF))	Partial support for this work was provided by a Vilas Research Professorship from the University of Wisconsin-Madison and a CAPES/BRASIL Special Visiting Researcher award to KBS, and National Science Foundation grant DEB-0816613 to ARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman S.J, 1986, P201; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Borries C, 2000, PRIMATE MALES, P146; Clutton-Brock T, 2012, EVOL ANTHROPOL, V21, P136, DOI 10.1002/evan.21316; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; EISENBER.JF, 1972, SCIENCE, V176, P863, DOI 10.1126/science.176.4037.863; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOLEY RA, 1989, SCIENCE, V243, P901, DOI 10.1126/science.2493158; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Gittleman JL., 1989, SPRINGER, DOI [10.1007/978-1-4757-4716-4, DOI 10.1007/978-1-4757-4716-4]; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hall KRL, 1965, PRIMATE BEHAV; Harris TR, 2009, MOL ECOL, V18, P1777, DOI 10.1111/j.1365-294X.2009.04139.x; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Izar P, 2012, AM J PRIMATOL, V74, P315, DOI 10.1002/ajp.20968; Jack KM, 2004, ANIM BEHAV, V67, P761, DOI 10.1016/j.anbehav.2003.04.015; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kamilar JM, 2008, AM J PRIMATOL, V70, P816, DOI 10.1002/ajp.20553; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kappeler PM, 2012, LONG TERM FIELD STUD; Korstjens AH, 2010, ANIM BEHAV, V79, P361, DOI 10.1016/j.anbehav.2009.11.012; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lee PC, 2010, AM J PRIMATOL, V72, P925, DOI 10.1002/ajp.20789; Lee P.C., 1994, P266; Lee Phyllis C., 2003, P41; Lehmann J, 2010, J BIOGEOGR, V37, P2217, DOI 10.1111/j.1365-2699.2010.02373.x; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2011, J EVOLUTION BIOL, V24, P2624, DOI 10.1111/j.1420-9101.2011.02385.x; Mabry KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057980; McFarland R, 2014, AM J PHYS ANTHROPOL, V154, P357, DOI 10.1002/ajpa.22518; Miyamoto MM, 2013, AM J PRIMATOL, V75, P478, DOI 10.1002/ajp.22124; MOORE J, 1984, INT J PRIMATOL, V5, P537, DOI 10.1007/BF02692285; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; PACKER C, 1979, FOLIA PRIMATOL, V31, P212, DOI 10.1159/000155884; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Strier KB, 2009, CURR ANTHROPOL, V50, P213, DOI 10.1086/592026; Strier Karen B., 1994, Yearbook of Physical Anthropology, V37, P233; Strier KB, DISPERSING IN PRESS; Struhsaker TT, 2004, INT J PRIMATOL, V25, P615, DOI 10.1023/B:IJOP.0000023578.08343.4e; Struhsaker TT, 2000, PRIMATE MALES, P108; Thierry B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0342; Yamagiwa J, 2014, PRIMATES CETACEANS F	53	16	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114099	10.1371/journal.pone.0114099	http://dx.doi.org/10.1371/journal.pone.0114099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470593	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700070
J	Suzuki, E; Ochiai-Shino, H; Aoki, H; Onodera, S; Saito, A; Saito, A; Azuma, T				Suzuki, Eiichi; Ochiai-Shino, Hiromi; Aoki, Hideto; Onodera, Shoko; Saito, Akiko; Saito, Atsushi; Azuma, Toshifumi			Akt Activation is Required for TGF-beta 1-Induced Osteoblast Differentiation of MC3T3-E1 Pre-Osteoblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOGENIC DIFFERENTIATION; IN-VITRO; EXPRESSION; SMAD3	Background: We have previously reported that repeated treatment of human periodontal ligament cells and murine pre-osteoblast MC3T3-E1 cells with transforming growth factor-beta 1 (TGF-beta 1) inhibited their osteoblastic differentiation because of decreased insulin-like growth factor-1 (IGF-1) secretion. We also found that IGF-1/PI3K signaling plays an important role in osteoblast differentiation induced by TGF-beta 1 treatment; however, the downstream signaling controlling this remains unknown. The aim of this current study is to investigate whether Akt activation is required for osteoblast differentiation. Methodology/Principal Findings: MC3T3-E1 cells were cultured in osteoblast differentiation medium (OBM) with or without 0.1 ng/mL TGF-beta 1. OBM containing TGF-beta 1 was changed every 12 h to provide repeated TGF-beta 1 administration. MC3T3-E1 cells were infected with retroviral vectors expressing constitutively active (CA) or dominant-negative (DN)-Akt. Alkaline phosphatase (ALP) activity and osteoblastic marker mRNA levels were substantially decreased by repeated TGF-beta 1 treatment compared with a single TGF-beta 1 treatment. However, expression of CA-Akt restored ALP activity following TGF-beta 1 treatment. Surprisingly, ALP activity increased following multiple TGF-beta 1 treatments as the number of administrations of TGF-beta 1 increased. Activation of Akt significantly enhanced expression of osteocalcin, but TGF-beta 1 treatment inhibited this. Mineralization of MC3T3-E1 cells was markedly enhanced by CA-Akt expression under all medium conditions. Exogenous IGF-1 restored the down-regulation of osteoblast-related gene expression by repeated TGF-beta 1 administration. However, in cells expressing DN-Akt, these levels remained inhibited regardless of IGF-1 treatment. These findings indicate that Akt activation is required for the early phase of osteoblast differentiation of MC3T3-E1 cells induced by TGF-beta 1. However, Akt activation is insufficient to reverse the inhibitory effects of TGF-beta 1 in the late stages of osteoblast differentiation. Conclusions: TGF-beta 1 could be an inducer or an inhibitor of osteoblastic differentiation of MC3T3-E1 cells depending on the state of Akt phosphorylation. Our results indicate that Akt is the molecular switch for TGF-beta 1-induced osteoblastic differentiation of MC3T3-E1 cells.	[Suzuki, Eiichi; Aoki, Hideto; Saito, Atsushi] Tokyo Dent Coll, Dept Periodontol, Tokyo, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Suzuki, Eiichi; Saito, Atsushi; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.	tazuma@tdc.ac.jp		Onodera, Shoko/0000-0003-0673-3400	Japan Society for Promotion of Science [25463228, 25462900]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research (C) 25463228 (to AS) 25462900 (to TA) from Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantrell DA, 2001, J CELL SCI, V114, P1439; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen LL, 2013, TISSUE ENG PT A, V19, P2226, DOI [10.1089/ten.tea.2012.0469, 10.1089/ten.TEA.2012.0469]; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kadowaki Takashi, 1996, Endocrine Journal, V43, pS33, DOI 10.1507/endocrj.43.Suppl_S33; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164; Lee JY, 2006, J BIOMED MATER RES A, V76A, P530, DOI 10.1002/jbm.a.30434; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Matarese G, 2012, INT J MOL MED, V30, P502, DOI 10.3892/ijmm.2012.1024; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; NODA M, 1989, ENDOCRINOLOGY, V124, P612, DOI 10.1210/endo-124-2-612; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Ota K, 2013, ENDOCRINOLOGY, V154, P3745, DOI 10.1210/en.2013-1272; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ramirez-Yanez GO, 2006, PROSTAG LEUKOTR ESS, V74, P183, DOI 10.1016/j.plefa.2006.01.003; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rios HF, 2011, J PERIODONTOL, V82, P1223, DOI 10.1902/jop.2011.100710; Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Stavropoulos A, 2012, J PERIODONTAL RES, V47, P545, DOI 10.1111/j.1600-0765.2012.01478.x; Susin C, 2013, PERIODONTOL 2000, V62, P232, DOI 10.1111/prd.12003; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Yokota J, 2014, INT J MOL MED, V33, P534, DOI 10.3892/ijmm.2013.1606; Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	44	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112566	10.1371/journal.pone.0112566	http://dx.doi.org/10.1371/journal.pone.0112566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470129	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700010
J	Carter, E; Miron-Buchacra, G; Goldoni, S; Danahay, H; Westwick, J; Watson, ML; Tosh, D; Ward, SG				Carter, Edward; Miron-Buchacra, Gabriela; Goldoni, Silvia; Danahay, Henry; Westwick, John; Watson, Malcolm L.; Tosh, David; Ward, Stephen G.			Phosphoinositide 3-Kinase Alpha-Dependent Regulation of Branching Morphogenesis in Murine Embryonic Lung: Evidence for a Role in Determining Morphogenic Properties of FGF7	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; MOUSE LUNG; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIATION; INHIBITION; EXPRESSION; EPITHELIUM; TARGET; AKT; ORGANOGENESIS	Branching morphogenesis is a critical step in the development of many epithelial organs. The phosphoinositide-3-kinase (PI3K) pathway has been identified as a central component of this process but the precise role has not been fully established. Herein we sought to determine the role of PI3K in murine lung branching using a series of pharmacological inhibitors directed at this pathway. The pan-class I PI3K inhibitor ZSTK474 greatly enhanced the branching potential of whole murine lung explants as measured by an increase in the number of terminal branches compared with controls over 48 hours. This enhancement of branching was also observed following inhibition of the downstream signalling components of PI3K, Akt and mTOR. Isoform selective inhibitors of PI3K identified that the alpha isoform of PI3K is a key driver in branching morphogenesis. To determine if the effect of PI3K inhibition on branching was specific to the lung epithelium or secondary to an effect on the mesenchyme we assessed the impact of PI3K inhibition in cultures of mesenchyme-free lung epithelium. Isolated lung epithelium cultured with FGF7 formed large cyst-like structures, whereas co-culture with FGF7 and ZSTK474 induced the formation of defined branches with an intact lumen. Together these data suggest a novel role for PI3K in the branching program of the murine embryonic lung contradictory to that reported in other branching organs. Our observations also point towards PI3K acting as a morphogenic switch for FGF7 signalling.	[Carter, Edward; Watson, Malcolm L.; Ward, Stephen G.] Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Carter, Edward; Miron-Buchacra, Gabriela; Tosh, David] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Goldoni, Silvia; Danahay, Henry; Westwick, John] Novartis Inst Biomed Res, Horsham, W Sussex, England	University of Bath; University of Bath; Novartis	Ward, SG (corresponding author), Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	S.G.Ward@bath.ac.uk	Ward, Stephen/AAE-4341-2020; Watson, Malcolm/AAA-6435-2020	Watson, Malcolm/0000-0001-9902-9521; Ward, Stephen G./0000-0002-6795-6002; Carter, Edward/0000-0003-4499-1101	Medical Research Council Doctoral Training Grant; Novartis Institute of Biomedical Research; Medical Research Council [1220724] Funding Source: researchfish	Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis Institute of Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported my a Medical Research Council Doctoral Training Grant and Novartis Institute of Biomedical Research. Novartis provided reagents for this work and helped in the preparation of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bouwens L, 1998, J PATHOL, V184, P234; Cardoso WV, 1997, DEV DYNAM, V208, P398, DOI 10.1002/(SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2-X; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; del Moral PM, 2010, METHODS MOL BIOL, V633, P71, DOI 10.1007/978-1-59745-019-5_5; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; Foster JG, 2012, PHARMACOL REV, V64, P1027, DOI 10.1124/pr.110.004051; Francavilla C, 2013, MOL CELL, V51, P707, DOI 10.1016/j.molcel.2013.08.002; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Izvolsky KI, 2003, DEV BIOL, V258, P185, DOI 10.1016/S0012-1606(03)00114-3; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Sanchez RM, 2012, BIOORG MED CHEM LETT, V22, P3198, DOI 10.1016/j.bmcl.2012.03.039; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Turcatel G, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-117; Utermark T, 2012, GENE DEV, V26, P1573, DOI 10.1101/gad.191973.112; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Volckaert T, 2013, DEVELOPMENT, V140, P3731, DOI 10.1242/dev.096560; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Xing YM, 2008, DEV BIOL, V320, P340, DOI 10.1016/j.ydbio.2008.04.044; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu WT, 2013, DEV BIOL, V379, P235, DOI 10.1016/j.ydbio.2013.04.029; Zhu WT, 2012, BIOSYSTEMS, V109, P403, DOI 10.1016/j.biosystems.2012.04.004	44	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113555	10.1371/journal.pone.0113555	http://dx.doi.org/10.1371/journal.pone.0113555			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460003	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700036
J	Dong, J; Gao, LQ; Lu, WQ; Xu, ZF; Zheng, JJ				Dong, Jing; Gao, Lingqi; Lu, Wenqing; Xu, Zifeng; Zheng, Jijian			Pharmacological Interventions for Acceleration of the Onset Time of Rocuronium: A Meta-Analysis	PLOS ONE			English	Article							SUCCINYLCHOLINE-INDUCED HYPERKALEMIA; DIFFERENT PRIMING TECHNIQUES; INDUCED NEUROMUSCULAR BLOCK; RAPID-SEQUENCE INDUCTION; INTUBATING CONDITIONS; MAGNESIUM-SULFATE; MIVACURIUM; COMBINATION; EPHEDRINE; PROPOFOL	Background: Rocuronium is an acceptable alternative when succinylcholine is contraindicated for facilitating the endotracheal intubation. However, the onset time of rocuronium for good intubation condition is still slower than that condition of succinylcholine. This study systematically investigated the most efficacious pharmacological interventions for accelerating the onset time of rocuronium. Methods: Medline, Embase, Cochrane Library databases, www.clinicaltrials.gov, and hand searching from the reference lists of identified papers were searched for randomized controlled trials comparing drug interventions with placebo or another drug to shorten the onset time of rocuronium. Statistical analyses were performed using RevMan5.2 and ADDIS 1.16.5 softwares. Mean differences (MDs) with their 95% confidence intervals (95% CIs) were used to analyze the effects of drug interventions on the onset time of rocuronium. Results: 43 randomized controlled trials with 2,465 patients were analyzed. The average onset time of rocuronium was 102.4 +/- 24.9 s. Priming with rocuronium [Mean difference (MD) -21.0 s, 95% confidence interval (95% CI) (-27.6 to -14.3 s)], pretreatment with ephedrine [-22.3 s (-29.1 to -15.5 s)], pretreatment with magnesium sulphate [-28.2 s (-50.9 to -5.6 s)] were all effective in reducing the onset time of rocuronium. Statistical testing of indirect comparisons showed that rocuronium priming, pretreatment with ephedrine, and pretreatment with magnesium sulphate had the similar efficacy. Conclusion: Rocuronium priming, pretreatment with ephedrine, and pretreatment with magnesium sulphate were all effective in accelerating the onset time of rocuronium, and furthermore their efficacies were similar. Considering the convenience and efficacy, priming with rocuronium is recommended for accelerating the onset time of rocuronium. However, more strict clinical trials are still needed to reach a more solid conclusion due to the large heterogeneities exist among different studies.	[Dong, Jing; Gao, Lingqi; Lu, Wenqing; Zheng, Jijian] Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Xu, Zifeng] Int Peace Maternal & Child Hlth Hosp, Dept Anesthesiol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zheng, JJ (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	zhengjijian626@sina.com						Abdellatif AA, 2011, SAUDI J ANAESTH, V5, P360, DOI 10.4103/1658-354X.87263; Al-Khafaji AH, 2001, CRIT CARE MED, V29, P1274, DOI 10.1097/00003246-200106000-00040; BARTKOWSKI RR, 1993, ANESTH ANALG, V77, P574; Bock M, 2007, CAN J ANAESTH, V54, P538, DOI 10.1007/BF03022317; Breslin DS, 2004, ANESTH ANALG, V98, P107, DOI 10.1213/01.ANE.0000093387.15263.48; Czarnetzki C, 2012, ACTA ANAESTH SCAND, V56, P474, DOI 10.1111/j.1399-6576.2011.02625.x; Czarnetzki C, 2010, ACTA ANAESTH SCAND, V54, P299, DOI 10.1111/j.1399-6576.2009.02160.x; DUBOIS MY, 1995, J CLIN ANESTH, V7, P44, DOI 10.1016/0952-8180(94)00002-L; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; Ezri T, 2003, ACTA ANAESTH SCAND, V47, P1067, DOI 10.1034/j.1399-6576.2003.00218.x; Fletcher JE, 2004, PAEDIATR ANAESTH, V14, P152, DOI 10.1111/j.1460-9592.2004.01166.x; FOLDES FF, 1991, ANESTHESIOLOGY, V75, P191, DOI 10.1097/00000542-199108000-00004; Griffith KE, 1997, J CLIN ANESTH, V9, P204, DOI 10.1016/S0952-8180(97)00034-2; Han DW, 2008, ANAESTHESIA, V63, P856, DOI 10.1111/j.1365-2044.2008.05497.x; Han DW, 2007, J CLIN ANESTH, V19, P418, DOI 10.1016/j.jclinane.2007.02.012; Han TH, 2009, BRIT J ANAESTH, V102, P55, DOI 10.1093/bja/aen332; Han TH, 2004, ANESTH ANALG, V99, P386; Hepaguslar H, 2002, J INT MED RES, V30, P318, DOI 10.1177/147323000203000314; Hernandez-Palazon J, 2001, J NEUROSURG ANESTH, V13, P79, DOI 10.1097/00008506-200104000-00003; HOFMOCKEL R, 1995, EUR J ANAESTH, V12, P69; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ittichaikulthol Wichai, 2004, Journal of the Medical Association of Thailand, V87, P264; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kararmaz A, 2003, ACTA ANAESTH SCAND, V47, P180, DOI 10.1034/j.1399-6576.2003.00052.x; Kim MH, 2012, ANAESTHESIA, V67, P748, DOI 10.1111/j.1365-2044.2012.07102.x; Kim SY, 1996, ANAESTHESIA, V51, P929, DOI 10.1111/j.1365-2044.1996.tb14959.x; Koenig HM, 1999, J NEUROSURG ANESTH, V11, P86, DOI 10.1097/00008506-199904000-00003; Kussman B, 1997, BRIT J ANAESTH, V79, P122, DOI 10.1093/bja/79.1.122; Lee HJ, 2010, ANAESTHESIA, V65, P899, DOI 10.1111/j.1365-2044.2010.06380.x; Levine M, 2012, J EMERG MED, V43, P279, DOI 10.1016/j.jemermed.2011.06.062; Leykin Y, 2005, ANAESTH INTENS CARE, V33, P462, DOI 10.1177/0310057X0503300407; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; MAGORIAN T, 1993, ANESTHESIOLOGY, V79, P913, DOI 10.1097/00000542-199311000-00007; Martin R, 1998, CAN J ANAESTH, V45, P521, DOI 10.1007/BF03012701; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Motamed C, 2000, CAN J ANAESTH, V47, P225, DOI 10.1007/BF03018917; Munoz HR, 1997, ANESTH ANALG, V85, P437, DOI 10.1097/00000539-199708000-00034; NAGUIB M, 1994, ANESTHESIOLOGY, V81, P388, DOI 10.1097/00000542-199408000-00017; Naguib M, 1997, BRIT J ANAESTH, V79, P450, DOI 10.1093/bja/79.4.450; NAGUIB M, 1994, CAN J ANAESTH, V41, P902, DOI 10.1007/BF03010932; Nava-Ocampo AA, 2006, CLIN EXP PHARMACOL P, V33, P125, DOI 10.1111/j.1440-1681.2006.04338.x; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Perry J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002788; PINCHAK AC, 1994, CAN J ANAESTH, V41, P206, DOI 10.1007/BF03009832; Rao MH, 2011, INDIAN J ANAESTH, V55, P494, DOI 10.4103/0019-5049.89882; Robertson EN, 2004, EUR J ANAESTH, V21, P734, DOI 10.1017/S0265021504009111; Rotava P, 2013, EUR J ANAESTH, V30, P599, DOI 10.1097/EJA.0b013e328361d342; Schmidt J, 2005, CAN J ANAESTH, V52, P50, DOI 10.1007/BF03018580; So SY, 2013, KOREAN J ANESTHESIOL, V64, P29, DOI 10.4097/kjae.2013.64.1.29; Spacek A, 1999, ANESTHESIOLOGY, V90, P109, DOI 10.1097/00000542-199901000-00016; Steinberg David, 2003, Acta Cientifica Venezolana, V54, P115; Stevens JB, 1996, J CLIN ANESTH, V8, P486, DOI 10.1016/0952-8180(96)00108-0; Stout Robert G., 2004, Yale Journal of Biology and Medicine, V77, P149; Szmuk P, 2000, ANESTH ANALG, V90, P1217, DOI 10.1097/00000539-200005000-00041; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; Topcuoglu PT, 2010, CAN J ANAESTH, V57, P113, DOI 10.1007/s12630-009-9217-4; van Valkenhoef G, 2013, DECIS SUPPORT SYST, V55, P459, DOI 10.1016/j.dss.2012.10.005; Won YJ, 2010, KOREAN J ANESTHESIOL, V59, P244, DOI 10.4097/kjae.2010.59.4.244; Yavascaoglu B, 2002, EUR J ANAESTH, V19, P517, DOI 10.1017/S0265021502000844	60	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114231	10.1371/journal.pone.0114231	http://dx.doi.org/10.1371/journal.pone.0114231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460931	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700120
J	Hiroshima, Y; Maawy, A; Zhang, Y; Murakami, T; Momiyama, M; Mori, R; Matsuyama, R; Katz, MHG; Fleming, JB; Chishima, T; Tanaka, K; Ichikawa, Y; Endo, I; Hoffman, RM; Bouvet, M				Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Katz, Matthew H. G.; Fleming, Jason B.; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru; Hoffman, Robert M.; Bouvet, Michael			Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore	PLOS ONE			English	Article							GEMCITABINE-BASED CHEMORADIATION; HUMAN COLON-CANCER; CEA ANTIBODY; IMAGING-SYSTEM; SURVIVAL; MICE; ADENOCARCINOMA; SPECIMENS; RESECTION; THERAPY	The aim of this study is to determine the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine (GEM) in combination with fluorescence-guided surgery (FGS) on a pancreatic cancer patient derived orthotopic xenograft (PDOX) model. A PDOX model was established from a CA19-9-positive, CEA-negative tumor from a patient who had undergone a pancreaticoduodenectomy for pancreatic adenocarcinoma. Mice were randomized to 4 groups: bright light surgery (BLS) only; BLS+NAC; FGS only; and FGS+NAC. An anti-CA19-9 or anti-CEA antibody conjugated to DyLight 650 was administered intravenously via the tail vein of mice with the pancreatic cancer PDOX 24 hours before surgery. The PDOX was brightly labeled with fluorophore-conjugated anti-CA19-9, but not with a fluorophore-conjugated anti-CEA antibody. FGS was performed using the fluorophore-conjugated anti-CA19-9 antibody. FGS had no benefit over BLS to prevent metastatic recurrence. NAC in combination with BLS did not convey an advantage over BLS to prevent metastatic recurrence. However, FGS+NAC significantly reduced the metastatic recurrence frequency to one of 8 mice, compared to FGS only after which metastasis recurred in 6 out of 8 mice, and BLS+NAC with metastatic recurrence in 7 out of 8 mice (p=0.041). Thus NAC in combination with FGS can reduce or even eliminate metastatic recurrence of pancreatic cancer sensitive to NAC. The present study further emphasizes the power of the PDOX model which enables metastasis to occur and thereby identify the efficacy of NAC in combination with FGS on metastatic recurrence.	[Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko; Maawy, Ali; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Katz, Matthew H. G.; Fleming, Jason B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg, Houston, TX 77030 USA	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu		Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971, 142669]; Japanese Ministry of Education, Culture, Sports, Science and Technology [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grants CA132971 and 142669 (to MB and AntiCancer, Inc.); and Japanese Ministry of Education, Culture, Sports, Science and Technology for Fundamental Research Grant Numbers 26830081 to YH; and 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet M, 2011, SCI TRANSL MED, V3, P110; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Katz MHG, 2010, ANN SURG ONCOL, V17, P1794, DOI 10.1245/s10434-010-0943-1; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Rosenthal EL, 2013, MOL IMAGING BIOL, V15, P647, DOI 10.1007/s11307-013-0662-7; Takahashi H, 2010, ANN SURG, V251, P461, DOI 10.1097/SLA.0b013e3181cc90a3; WANG XO, 1992, INT J CANCER, V51, P992	23	74	74	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114310	10.1371/journal.pone.0114310	http://dx.doi.org/10.1371/journal.pone.0114310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463150	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700128
J	Thompson, LA; Spoon, TR; Goertz, CEC; Hobbs, RC; Romano, TA				Thompson, Laura A.; Spoon, Tracey R.; Goertz, Caroline E. C.; Hobbs, Roderick C.; Romano, Tracy A.			Blow Collection as a Non-Invasive Method for Measuring Cortisol in the Beluga (Delphinapterus leucas)	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; CORTICOSTEROID-BINDING GLOBULIN; SALIVARY CORTISOL; STEROID-HORMONES; WHALES; BLUBBER; STRESS; TESTOSTERONE; PHYSIOLOGY; PREGNANCY	Non-invasive sampling techniques are increasingly being used to monitor glucocorticoids, such as cortisol, as indicators of stressor load and fitness in zoo and wildlife conservation, research and medicine. For cetaceans, exhaled breath condensate (blow) provides a unique sampling matrix for such purposes. The purpose of this work was to develop an appropriate collection methodology and validate the use of a commercially available EIA for measuring cortisol in blow samples collected from belugas (Delphinapterus leucas). Nitex membrane stretched over a petri dish provided the optimal method for collecting blow. A commercially available cortisol EIA for measuring human cortisol (detection limit 35 pg ml(-1)) was adapted and validated for beluga cortisol using tests of parallelism, accuracy and recovery. Blow samples were collected from aquarium belugas during monthly health checks and during out of water examination, as well as from wild belugas. Two aquarium belugas showed increased blow cortisol between baseline samples and 30 minutes out of water (Baseline, 0.21 and 0.04 mu g dl(-1); 30 minutes, 0.95 and 0.14 mu g dl(-1)). Six wild belugas also showed increases in blow cortisol between pre and post 1.5 hour examination (Pre 0.03, 0.23, 0.13, 0.19, 0.13, 0.04 mu g dl(-1), Post 0.60, 0.31, 0.36, 0.24, 0.14, 0.16 mu g dl(-1)). Though this methodology needs further investigation, this study suggests that blow sampling is a good candidate for non-invasive monitoring of cortisol in belugas. It can be collected from both wild and aquarium animals efficiently for the purposes of health monitoring and research, and may ultimately be useful in obtaining data on wild populations, including endangered species, which are difficult to handle directly.	[Thompson, Laura A.; Spoon, Tracey R.; Romano, Tracy A.] Mystic Aquarium, Mystic, CT 06365 USA; [Thompson, Laura A.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Goertz, Caroline E. C.] Alaska Sea Life Ctr, Seward, AK USA; [Hobbs, Roderick C.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Washington, DC USA	University of Connecticut; National Oceanic Atmospheric Admin (NOAA) - USA	Romano, TA (corresponding author), Mystic Aquarium, Mystic, CT 06365 USA.	tromano@searesearch.org		Goertz, Caroline/0000-0002-1282-5654	Office of Naval Research [N00014-11-1-0437]; Interdisciplinary Research Initiative in Coastal Health (IRICH); NOAA Oceans and Human Health Initiative (OHHI)	Office of Naval Research(Office of Naval Research); Interdisciplinary Research Initiative in Coastal Health (IRICH); NOAA Oceans and Human Health Initiative (OHHI)	Funding for this work was provided by the Office of Naval Research award #N00014-11-1-0437 awarded to TR. Additional funding for LT was provided by the Interdisciplinary Research Initiative in Coastal Health (IRICH) and NOAA Oceans and Human Health Initiative (OHHI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acevedo-Whitehouse K, 2010, ANIM CONSERV, V13, P217, DOI 10.1111/j.1469-1795.2009.00326.x; Amadei E, 2008, P 22 ANN C EUR CET S; Amaral RS, 2010, AQUAT MAMM, V36, P162, DOI 10.1578/AM.36.2.2010.162; Anderson PA, 2011, AQUACULTURE, V311, P129, DOI 10.1016/j.aquaculture.2010.11.013; [Anonymous], 2011, SAL HIGH SENS SAL CO; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; CLERICO A, 1982, CLIN CHEM, V28, P1343; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Dunstan J., 2012, WATERS APPL NOTE WAT, P1, DOI DOI 10.1038/S41598-018-28200-8; Effros RM, 2004, AM J PHYSIOL-LUNG C, V287, pL1073, DOI 10.1152/ajplung.00069.2004; Frere CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012299; Gozansky WS, 2005, CLIN ENDOCRINOL, V63, P336, DOI 10.1111/j.1365-2265.2005.02349.x; Hogg CJ, 2009, MAR MAMMAL SCI, V25, P605, DOI 10.1111/j.1748-7692.2008.00277.x; Hogg CJ, 2005, J CHROMATOGR B, V814, P339, DOI 10.1016/j.jchromb.2004.10.058; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hunt KE, 2014, MAR MAMMAL SCI, V30, P796, DOI 10.1111/mms.12073; Hunt KE, 2013, M ABSTR SOC INT COMP; Katial RK, 2012, UPDATE BIOMAKERS ALL; Kellar NM, 2009, MAR MAMMAL SCI, V25, P507, DOI 10.1111/j.1748-7692.2009.00291.x; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Lewis JG, 2005, CLIN CHIM ACTA, V359, P189, DOI 10.1016/j.cccn.2005.03.044; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Mutlu GM, 2001, AM J RESP CRIT CARE, V164, P731, DOI 10.1164/ajrccm.164.5.2101032; Norman SA, 2012, J WILDLIFE DIS, V48, P21, DOI 10.7589/0090-3558-48.1.21; Orlando EF, 2001, HUM REPROD UPDATE, V7, P265, DOI 10.1093/humupd/7.3.265; Pretorius CJ, 2011, CLIN CHIM ACTA, V412, P1043, DOI 10.1016/j.cca.2011.02.019; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Schmitt TL, 2010, MAR MAMMAL SCI, V26, P635, DOI 10.1111/j.1748-7692.2009.00366.x; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Suzuki M, 1998, FISHERIES SCI, V64, P643, DOI 10.2331/fishsci.64.643; VINING RF, 1983, CLIN CHEM, V29, P1752	37	35	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114062	10.1371/journal.pone.0114062	http://dx.doi.org/10.1371/journal.pone.0114062			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464121	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700092
J	Volkova, E; de la Rosa, S; Bulthoff, HH; Mohler, B				Volkova, Ekaterina; de la Rosa, Stephan; Buelthoff, Heinrich H.; Mohler, Betty			The MPI Emotional Body Expressions Database for Narrative Scenarios	PLOS ONE			English	Article							POINT-LIGHT; PERCEPTION; MOTION; RECOGNITION; CORPUS; MOVEMENT; LANGUAGE; BODIES	Emotion expression in human-human interaction takes place via various types of information, including body motion. Research on the perceptual-cognitive mechanisms underlying the processing of natural emotional body language can benefit greatly from datasets of natural emotional body expressions that facilitate stimulus manipulation and analysis. The existing databases have so far focused on few emotion categories which display predominantly prototypical, exaggerated emotion expressions. Moreover, many of these databases consist of video recordings which limit the ability to manipulate and analyse the physical properties of these stimuli. We present a new database consisting of a large set (over 1400) of natural emotional body expressions typical of monologues. To achieve close-to-natural emotional body expressions, amateur actors were narrating coherent stories while their body movements were recorded with motion capture technology. The resulting 3-dimensional motion data recorded at a high frame rate (120 frames per second) provides fine-grained information about body movements and allows the manipulation of movement on a body joint basis. For each expression it gives the positions and orientations in space of 23 body joints for every frame. We report the results of physical motion properties analysis and of an emotion categorisation study. The reactions of observers from the emotion categorisation study are included in the database. Moreover, we recorded the intended emotion expression for each motion sequence from the actor to allow for investigations regarding the link between intended and perceived emotions. The motion sequences along with the accompanying information are made available in a searchable MPI Emotional Body Expression Database. We hope that this database will enable researchers to study expression and perception of naturally occurring emotional body expressions in greater depth.	[Volkova, Ekaterina; de la Rosa, Stephan; Buelthoff, Heinrich H.; Mohler, Betty] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Volkova, Ekaterina] Grad Sch Neural & Behav Sci, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Korea University	Volkova, E (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	ekaterina.volkova@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607; de la Rosa, Stephan/0000-0003-2759-9589	Max Planck Society; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Max Planck Society(Max Planck Society); Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Funding provided to EV: Max Planck Society, SdlR: Max Planck Society, BJM: Max Planck Society and HHB: Max Planck Society and Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2007, COGNITION, V104, P59, DOI 10.1016/j.cognition.2006.05.005; Atkinson AP, 2012, NEUROIMAGE, V59, P1700, DOI 10.1016/j.neuroimage.2011.08.073; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Aubrey AJ, 2013, IEEE COMPUT SOC CONF, P277, DOI 10.1109/CVPRW.2013.48; Aung MSH, 2014, 8 INT C PERV COMP TE; Banziger T, 2007, LECT NOTES COMPUT SC, V4738, P476; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Banziger T, 2006, P LREC, V6, P15; Beck A, 2012, ACM T INTERACT INTEL, V2, DOI 10.1145/2133366.2133368; Burkhardt F., 2005, P 9 EUR C SPEECH COM, DOI 10.21437/ interspeech.2005-446; Busso C, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P1670; Busso C, 2008, LANG RESOUR EVAL, V42, P335, DOI 10.1007/s10579-008-9076-6; Campione E, 2002, SPEECH PROSODY, V2002, P199; Castellano G, 2007, LECT NOTES COMPUT SC, V4738, P71; Clavel C, 2006, 1 INT WORKSH EM CORP, P76; Cowie R, 2005, NEURAL NETWORKS, V18, P371, DOI 10.1016/j.neunet.2005.03.002; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; GOLDMANEISLER F, 1972, LANG SPEECH, V15, P103, DOI 10.1177/002383097201500201; GRIFFIN HJ, 2013, AFFECTIVE COMPUTING, P349, DOI DOI 10.1109/ACII.2013.64; Gross R., 2001, CMU MOTION BODY MOBO; Gunes H, 2006, INT C PATT RECOG, P1148; Hwang BW, 2006, 7 INT C AUT FAC GEST; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kamachi M., 1998, JAPANESE FEMALE FACI; Karg M, 2013, IEEE T AFFECT COMPUT, V4, P341, DOI 10.1109/T-AFFC.2013.29; Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321; Kleinsmith A, 2006, INTERACT COMPUT, V18, P1371, DOI 10.1016/j.intcom.2006.04.003; Kleinsmith A, 2011, IEEE T SYST MAN CY B, V41, P1027, DOI 10.1109/TSMCB.2010.2103557; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; KUDOH T, 1985, J PERS SOC PSYCHOL, V48, P1440, DOI 10.1037/0022-3514.48.6.1440; Ma YL, 2006, BEHAV RES METHODS, V38, P134, DOI 10.3758/BF03192758; MCDONNELL R., 2009, ACM T APPL PERCEPT, V6, p[14, 1, 11]; Metallinou A., 2010, WORKSH MULT CORP LRE; Metallinou A, 2013, IMAGE VISION COMPUT, V31, P137, DOI 10.1016/j.imavis.2012.08.018; Niewiadomski R, 2013, LECT NOTES COMPUT SC, V8212, P184, DOI 10.1007/978-3-319-02714-2_16; Oertel C, 2013, J MULTIMODAL USER IN, V7, P19, DOI 10.1007/s12193-012-0108-6; Pantic M, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO (ICME), VOLS 1 AND 2, P317, DOI 10.1109/ICME.2005.1521424; Parkinson B, 2013, EMOT REV, V5, P97, DOI 10.1177/1754073912457230; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Roetenberg D., 2009, XSENS MOTION TECH BV, V1, P1; Roether CL, 2010, DYNAMICS OF VISUAL MOTION PROCESSING: NEURONAL, BEHAVIORAL, AND COMPUTATIONAL APPROACHES, P313, DOI 10.1007/978-1-4419-0781-3_14; Russell JA., 1997, PSYCHOL FACIAL EXPRE; Savva N, 2012, IEEE T COMP INTEL AI, V4, P199, DOI 10.1109/TCIAIG.2012.2202663; Sneddon I, 2012, IEEE T AFFECT COMPUT, V3, P32, DOI 10.1109/T-AFFC.2011.26; Volkova EP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00623; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Yin L., 2008, AUTOMATIC FACE GESTU, V08, P1, DOI DOI 10.1109/AFGR.2008.4813324; Zara A, 2007, LECT NOTES COMPUT SC, V4738, P464; Zellner B., 1994, FUNDAMENTALS SPEECH, P41	57	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113647	10.1371/journal.pone.0113647	http://dx.doi.org/10.1371/journal.pone.0113647			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461382	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700041
J	Zhang, L; Wang, H; Xiao, M; Kudinha, T; Mao, LL; Zhao, HR; Kong, FR; Xu, YC				Zhang, Li; Wang, He; Xiao, Meng; Kudinha, Timothy; Mao, Lei-Li; Zhao, Hao-Ran; Kong, Fanrong; Xu, Ying-Chun			The Widely Used ATB FUNGUS 3 Automated Readings in China and Its Misleading High MICs of Candida spp. to Azoles: Challenges for Developing Countries' Clinical Microbiology Labs	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITIES; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; CLONAL STRAIN; SURVEILLANCE; VORICONAZOLE; FLUCONAZOLE; ALBICANS; AURIS	The rapid development in the clinical microbiology diagnostic assays presents more challenges for developing countries than for the developed world, especially in the area of test validation before the introduction of new tests. Here we report on the misleading high MICs of Candida spp. to azoles using the ATB FUNGUS 3 (bioMerieux, La Balme-les Grottes, France) with automated readings in China to highlight the dangers of introducing a diagnostic assay without validation. ATB FUNGUS 3 is the most commonly used commercial antifungal susceptibility testing method in China. An in-depth analysis of data showed higher levels of resistance to azoles when ATB FUNGUS 3 strips were read automatically than when read visually. Based on this finding, the performance of ATB FUNGUS 3, read both visually and automatically, was evaluated by testing 218 isolates of five clinically important Candida species, using broth microdilution (BMD) following CLSI M27-A3 as the gold-standard. The overall essential agreement (EA) between ATB visual readings and BMD was 99.1%. In contrast, the ATB automated readings showed higher discrepancies with BMD, with overall EA of 86.2%, and specifically lower EA was observed for fluconazole (80.7%), voriconazole (77.5%), and itraconazole (73.4%), which was most likely due to the trailing effect of azoles. The major errors in azole drug susceptibilities by ATB automated readings is a concern in China that can result in misleading clinical antifungal drug selection and pseudo high rates of antifungal resistance. Therefore, the ATB visual reading is generally recommended. In the meantime, we propose a practical algorithm to be followed for ATB FUNGUS 3 antifungal susceptibility for Candida spp. before the improvement in the automated reading system.	[Zhang, Li; Wang, He; Xiao, Meng; Mao, Lei-Li; Zhao, Hao-Ran; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Zhang, Li; Wang, He] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Kudinha, Timothy; Kong, Fanrong] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	Peking Union Medical College [2012-1002-023]	Peking Union Medical College	The work was supported by Innovation Fund of Peking Union Medical College (2012-1002-023). LZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Abdeljelil J, 2012, MYCOSES, V55, P493, DOI 10.1111/j.1439-0507.2012.02189.x; Chen PL, 2011, MYCOSES, V54, pE17, DOI 10.1111/j.1439-0507.2009.01818.x; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Clinical and Laboratory Standard Institute, 2012, REF METH BROTH DIL A; Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A; Eraso E, 2008, REV IBEROAM MICOL, V25, P3, DOI 10.1016/S1130-1406(08)70002-0; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Horta JA, 2002, MED MYCOL, V40, P565; Hou DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101447; Huang H, 2012, PRACTICAL PREVENT ME, V19, P1536; Lee MK, 2004, J ANTIMICROB CHEMOTH, V53, P217, DOI 10.1093/jac/dkh040; Li F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-353; Mi RS, 2008, LAB MED CLIN, V19, P1173; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Torres-Rodriguez JM, 2007, J ANTIMICROB CHEMOTH, V60, P658, DOI 10.1093/jac/dkm247; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wang W, 2012, CHIN MOD MED, V19, P98; Yu JH, 2007, CLIN J MED OFFIC, V35, P268	24	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114004	10.1371/journal.pone.0114004	http://dx.doi.org/10.1371/journal.pone.0114004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460351	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700078
J	Cui, YC; Li, K; Tian, Y; Yuan, WM; Peng, P; Yang, JZ; Zhang, BJ; Zhang, HD; Wu, AL; Tang, Y				Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue			A Pig Model of Ischemic Mitral Regurgitation Induced by Mitral Chordae Tendinae Rupture and Implantation of an Ameroid Constrictor	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; VENA CONTRACTA; QUANTIFICATION; MANAGEMENT; PATHOLOGY; REPAIR; VALVE	A miniature pig model of ischemic mitral regurgitation (IMR) was developed by posterior mitral chordae tendinae rupture and implantation of an ameroid constrictor. A 2.5-mm ameroid constrictor was placed around the left circumflex coronary artery (LCX) of male Tibetan miniature pigs to induce ischemia, while the posterior mitral chordae tendinae was also ruptured. X-ray coronary angiography, ECG analysis, echocardiography, and magnetic resonance imaging (MRI) were used to evaluate heart structure and function in pigs at baseline and one, two, four and eight weeks after the operation. Blood velocity of the mitral regurgitation was found to be between medium and high levels. Angiographic analyses revealed that the LCX closure was 10-20% at one week, 30-40% at two weeks and 90-100% at four weeks subsequent ameroid constrictor implantation. ECG analysis highlighted an increase in the diameter of the left atria (LA) at two weeks post-operation as well as ischemic changes in the left ventricle (LV) and LA wall at four weeks post-operation. Echocardiography and MRI further detected a gradual increase in LA and LV volumes from two weeks post-operation. LV end diastolic and systolic volumes as well as LA end diastolic and systolic volume were also significantly higher in pig hearts post-operation when compared to baseline. Pathological changes were observed in the heart, which included scar tissue in the ischemic central area of the LV. Transmission electron microscopy highlighted the presence of contraction bands and edema surrounding the ischemia area, including inflammatory cell infiltration within the ischemic area. We have developed a pig dmodel of IMR using the posterior mitral chordae tendineae rupture technique and implantation of an ameroid constrictor. The pathological features of this pig IMR model were found to mimic the natural history and progression of IMR in patients.	[Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis,Beijing Municipal Ke, Beijing 100037, Peoples R China; [Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue] Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tang, Y (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis,Beijing Municipal Ke, Beijing 100037, Peoples R China.; Tang, Y (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	tangyue1226@vip.sina.com	Cui, Yong/AAF-9300-2020; Tian, Yi/AFQ-7590-2022		Beijing Science and Technology Committee [Z101107052210004]; Natural Science Foundation of China [81370190]	Beijing Science and Technology Committee; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is sponsored by the Beijing Science and Technology Committee (Project No: Z101107052210004) and Natural Science Foundation of China (Project No: 81370190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP SP, 1966, PATHOL VET, V3, P137, DOI 10.1177/030098586600300203; Borger MA, 2006, ANN THORAC SURG, V81, P1153, DOI 10.1016/j.athoracsur.2005.08.080; Borger MA, 2012, CIRCULATION, V126, P2674, DOI 10.1161/CIRCULATIONAHA.112.147777; Bouma W, 2010, EUR J CARDIO-THORAC, V37, P170, DOI 10.1016/j.ejcts.2009.07.008; Boyd JH, 2013, CIRC J, V77, P1952, DOI 10.1253/circj.CJ-13-0743; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eisenman Arie, 2006, Expert Rev Cardiovasc Ther, V4, P509, DOI 10.1586/14779072.4.4.509; FEHSKE W, 1994, AM J CARDIOL, V73, P268, DOI 10.1016/0002-9149(94)90232-1; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; GUTHRIE RB, 1976, MINN MED, V59, P637; Hammersting C, 2013, INTERNIST, V54, P39, DOI 10.1007/s00108-012-3093-7; Hammerstingl C, 2013, DER INTERNIST, V54, P49; Hammerstingl C, 2013, DER INTERNIST, V54, P42; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; HICKEY MS, 1988, CIRCULATION, V78, P51; Huang L, 2008, CHIN J COMP MED, V18, P23; Huang WL, 2013, CHINESE MED J-PEKING, V126, P1766, DOI 10.3760/cma.j.issn.0366-6999.20123171; Khanna D, 2004, ECHOCARDIOGR-J CARD, V21, P737, DOI 10.1111/j.0742-2822.2004.40027.x; Lamas GA, 1997, CIRCULATION, V96, P827; Lancellotti P, 2005, EUR HEART J, V26, P1528, DOI 10.1093/eurheartj/ehi189; Lancellotti P, 2003, CIRCULATION, V108, P447; Leroux AA, 2012, J HEART VALVE DIS, V21, P416; Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720; Lin JH, 1999, CONTEMP TOP LAB ANIM, V38, P36; Lukacs E, 2013, CAN J PHYSIOL PHARM, V91, P617, DOI 10.1139/cjpp-2012-0410; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Markert Michael, 2009, Journal of Pharmacological and Toxicological Methods, V60, P79, DOI 10.1016/j.vascn.2008.12.004; Nahas K, 2002, COMPARATIVE MED, V52, P258; Robb JD, 2011, EUR J CARDIO-THORAC, V40, P1501, DOI 10.1016/j.ejcts.2011.02.079; Schirmer SH, 2014, J AM COLL CARDIOL, V63, P1916, DOI 10.1016/j.jacc.2013.10.073; Schnurer C, 2011, J CARDIOVASC SURG, V52, P105; Shakil O, 2012, J CARDIOTHOR VASC AN, V26, P756, DOI [10.1053/j.jvca.2012.01.041, 10.1053/j.jvca.2012.03.007]	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111689	10.1371/journal.pone.0111689	http://dx.doi.org/10.1371/journal.pone.0111689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479001	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200004
J	Koyanagi, A; Garin, N; Olaya, B; Ayuso-Mateos, JL; Chatterji, S; Leonardi, M; Koskinen, S; Tobiasz-Adamczyk, B; Haro, JM				Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Luis Ayuso-Mateos, Jose; Chatterji, Somnath; Leonardi, Matilde; Koskinen, Seppo; Tobiasz-Adamczyk, Beata; Maria Haro, Josep			Chronic Conditions and Sleep Problems among Adults Aged 50 years or over in Nine Countries: A Multi-Country Study	PLOS ONE			English	Article							CHRONIC DISEASES; OLDER-ADULTS; MENTAL-HEALTH; INSOMNIA; PREVALENCE; ASSOCIATION; COMPLAINTS; DISORDERS; DIAGNOSIS; RISK	Background: Data on the association between chronic conditions or the number of chronic conditions and sleep problems in low- or middle-income countries is scarce, and global comparisons of these associations with high-income countries have not been conducted. Methods: Data on 42116 individuals 50 years and older from nationally-representative samples of the Collaborative Research on Ageing in Europe (Finland, Poland, Spain) and the World Health Organization's Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, South Africa) conducted between 2011-2012 and 2007-2010 respectively were analyzed. Results: The association between nine chronic conditions (angina, arthritis, asthma, chronic lung disease, depression, diabetes, hypertension, obesity, and stroke) and self-reported severe/extreme sleep problems in the past 30 days was estimated by logistic regression with multiple variables. The age-adjusted prevalence of sleep problems ranged from 2.8% (China) to 17.0% (Poland). After adjustment for confounders, angina (OR 1.75-2.78), arthritis (OR 1.39-2.46), and depression (OR 1.75-5.12) were significantly associated with sleep problems in the majority or all of the countries. Sleep problems were also significantly associated with: asthma in Finland, Spain, and India; chronic lung disease in Poland, Spain, Ghana, and South Africa; diabetes in India; and stroke in China, Ghana, and India. A linear dose-dependent relationship between the number of chronic conditions and sleep problems was observed in all countries. Compared to no chronic conditions, the OR (95% CI) for 1,2,3, and >= 4 chronic conditions was 1.41 (1.09-1.82), 2.55 (1.99-3.27), 3.22 (2.52-4.11), and 7.62 (5.88-9.87) respectively in the overall sample. Conclusions: Identifying co-existing sleep problems among patients with chronic conditions and treating them simultaneously may lead to better treatment outcome. Clinicians should be aware of the high risk for sleep problems among patients with multimorbidity. Future studies are needed to elucidate the best treatment options for comorbid sleep problems especially in developing country settings.	[Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Maria Haro, Josep] Fundacio St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Luis Ayuso-Mateos, Jose; Maria Haro, Josep] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III, Barcelona, Spain; [Luis Ayuso-Mateos, Jose] Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Leonardi, Matilde] IRCCS Fdn, Neurol Inst Carlo Besta, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Koskinen, Seppo] Natl Inst Hlth & Welf, Helsinki, Finland; [Tobiasz-Adamczyk, Beata] Jagiellonian Univ, Coll Med, Dept Med Sociol, Krakow, Poland	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona; World Health Organization; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Finland National Institute for Health & Welfare; Jagiellonian University; Collegium Medicum Jagiellonian University	Koyanagi, A (corresponding author), Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain.	a.koyanagi@pssjd.org	Koyanagi, Ai/D-3833-2018; Olaya, Beatriz/AAB-1952-2020; CHATTERJI, Somnath/ABE-6832-2020; leonardi, matilde/J-9997-2018; Haro, Josep Maria/D-1423-2011	Koyanagi, Ai/0000-0002-9565-5004; Olaya, Beatriz/0000-0003-2046-3929; leonardi, matilde/0000-0003-0552-8923; Haro, Josep Maria/0000-0002-3984-277X; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Garin, Noe/0000-0002-1559-9453	Miguel Servet; United States National Institute on Aging's Division of Behavioral and Social Research [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; World Health Organization's Department of Health Statistics and Information Systems; European Community [223071]; Instituto de Salud Carlos III-FIS [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation ACI-Promociona [ACI2009-1010]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	Miguel Servet; United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; European Community(European Commission); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation ACI-Promociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ai Koyanagi's work was supported by the Miguel Servet contract by CIBERSAM. WHO's Study on Global AGEing and Adult Health is supported by the United States National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479) and the World Health Organization's Department of Health Statistics and Information Systems. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe), from the Instituto de Salud Carlos III-FIS research grants number PS09/00295 and PS09/01845, and from the Spanish Ministry of Science and Innovation ACI-Promociona (ACI2009-1010). The study was also supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. The views expressed in this paper are those of the author(s) and do not necessarily represent the views or policies of the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Becker P. M., 2014, CURR MED RES OPIN; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chennaoui M, 2014, SLEEP MED REV; Coryell VT, 2013, INT HEART J, V54, P258, DOI 10.1536/ihj.54.258; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; D'Aniello GE, 2014, J NEUROL SCI, V338, P191, DOI 10.1016/j.jns.2014.01.005; Depner CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0507-z; Di Milia L, 2013, SLEEP MED, V14, P319, DOI 10.1016/j.sleep.2012.12.007; Ferre A, 2013, NEUROLOGIA, V28, P103, DOI 10.1016/j.nrl.2010.09.016; Garcia AD, 2008, CLIN GERIATR MED, V24, P27, DOI 10.1016/j.cger.2007.08.008; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Ghodse H, 2003, BRIT J PSYCHIAT, V183, P15, DOI 10.1192/bjp.183.1.15; GISLASON T, 1987, ACTA MED SCAND, V221, P475; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Gureje O, 2007, SOC PSYCH PSYCH EPID, V42, P495, DOI 10.1007/s00127-007-0183-2; Gureje O, 2011, SLEEP, V34, P965, DOI 10.5665/SLEEP.1138; Iyer S Ramnathan, 2012, J Assoc Physicians India, V60, P42; Kinsella K, 2009, INT POPULATION REPOR; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Levesque JF, 2013, INT J PUBLIC HEALTH, V58, P435, DOI 10.1007/s00038-013-0446-5; Louie GH, 2011, ARTHRIT CARE RES, V63, P247, DOI 10.1002/acr.20362; Manini Todd, 2011, Curr Aging Sci, V4, P184; McCrae CS, 2009, AM J MANAG CARE, V15, pS14; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; McNamara JPH, 2014, PSYCHOL HEALTH MED, V19, P410, DOI 10.1080/13548506.2013.832782; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; MONANE M, 1992, J CLIN PSYCHIAT, V53, P23; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Institute of Health, 2005, NIH STAT OF THE SCI; Neubauer DN, 2009, AM J MANAG CARE, V15, pS24; Newman AB, 1997, J AM GERIATR SOC, V45, P1; Ohayon MM, 2014, J PSYCHIATR RES, V54, P79, DOI 10.1016/j.jpsychires.2014.02.023; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; PHILLIPS BA, 1987, CHEST, V91, P29, DOI 10.1378/chest.91.1.29; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; Plantinga L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110244; Pollak C P, 1991, J Geriatr Psychiatry Neurol, V4, P204, DOI 10.1177/089198879100400405; POOLEWILSON PA, 1983, POSTGRAD MED J, V59, P11; Power JD, 2005, ARTHRIT RHEUM-ARTHR, V53, P911, DOI 10.1002/art.21584; Raggi A, 2013, CLIN PSYCHOL PSYCHOT; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Roth Thomas, 2009, Prim Care Companion J Clin Psychiatry, V11, P292, DOI 10.4088/PCC.08m00749bro; Roth T, 2009, AM J MANAG CARE, V15, pS6; Santos-Silva R, 2010, SLEEP MED, V11, P520, DOI 10.1016/j.sleep.2009.12.011; Schubert CR, 2002, SLEEP, V25, P889; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Stone KL, 2014, J AM GERIATR SOC, V62, P299, DOI 10.1111/jgs.12649; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Tjepkema Michael, 2005, Health Rep, V17, P9; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Vitiello MV, 2009, J CLIN SLEEP MED, V5, P355; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675	66	112	115	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114742	10.1371/journal.pone.0114742	http://dx.doi.org/10.1371/journal.pone.0114742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478876	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200120
J	Attia, A; Hachana, Y; Chaabene, H; Gaddour, A; Neji, Z; Shephard, RJ; Chelly, MS				Attia, Ahmed; Hachana, Younes; Chaabene, Helmi; Gaddour, Abdelmajid; Neji, Zied; Shephard, Roy J.; Chelly, Mohamed Souhaiel			Reliability and Validity of a 20-s Alternative to the Wingate Anaerobic Test in Team Sport Male Athletes	PLOS ONE			English	Article							STATISTICAL-METHODS; ASSESSING AGREEMENT; MEDICINE; POWER; PERFORMANCE; PREDICTION; EXERCISE; FATIGUE; SCIENCE	The intent of this study was to evaluate relative and absolute reliability of the 20-s anaerobic test (WAnT(20)) versus the WAnT(30) and to verify how far the various indices of the 30-s Wingate anaerobic test (WAnT(30)) could be predicted from the WAnT(20) data in male athletes. The participants were Exercise Science majors (age: 21.5 +/- 1.6 yrs, stature: 0.183 +/- 0.08 m, body mass: 81.2 +/- 10.9 kg) who participated regularly in team sports. In Phase I, 41 participants performed duplicate WAnT(20) and WAnT(30) tests to assess reliability. In Phase II, 31 participants performed one trial each of the WAnT(20) and WAnT(30) to determine the ability of the WAnT(20) to predict components of the WAnT(30). In Phase III, 31 participants were used to cross-validate the prediction equations developed in Phase II. Respective intra-class correlation coefficients (ICC) for peak power output (PPO) (ICC=0.98 and 0.95) and mean power output (MPO) (ICC 0.98 and 0.90) did not differ significantly between WAnT(20) and WAnT(30). ICCs for minimal power output (POmin) and fatigue index (FI) were poor for both tests (range 0.53 to 0.76). Standard errors of the means (SEM) for PPO and MPO were less than their smallest worthwhile changes (SWC) in both tests; however, POmin and FI values were "marginal,'' with SEM values greater than their respective SWCs for both tests values. Stepwise regression analysis showed that MPO had the highest coefficient of predictability (R=0.97), with POmin and FI considerable lower (R=0.71 and 0.41 respectively). Cross-validation showed insignificant bias with limits of agreement of 0.99 +/- 1.04, 6.5 +/- 92.7 W, and 1.6 +/- 9.8% between measured and predicted MPO, POmin, and FI, respectively. WAnT(20) offers a reliable and valid test of leg anaerobic power in male athletes and could replace the classic WAnT(30).	[Attia, Ahmed; Hachana, Younes; Chaabene, Helmi; Gaddour, Abdelmajid; Neji, Zied; Chelly, Mohamed Souhaiel] Univ Manouba, High Inst Sport & Phys Educ Ksar Said, Res Unit Sport Performance & Hlth, Tunis, Tunisia; [Attia, Ahmed; Hachana, Younes; Chaabene, Helmi; Gaddour, Abdelmajid; Neji, Zied; Chelly, Mohamed Souhaiel] Univ Manouba, High Inst Sport & Phys Educ Ksar Said, Tunis, Tunisia; [Shephard, Roy J.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	Universite de la Manouba; Universite de la Manouba; University of Toronto	Chelly, MS (corresponding author), Univ Manouba, High Inst Sport & Phys Educ Ksar Said, Res Unit Sport Performance & Hlth, Tunis, Tunisia.	csouhaiel@yahoo.fr	Chelly, Souhaiel/I-6329-2019; Chaabene, Helmi/I-7317-2019	Chelly, Souhaiel/0000-0002-0713-1308; Chaabene, Helmi/0000-0001-7812-7931	"le ministere de l'enseignement superieur et de la recherche scientifique'' Tunisia	"le ministere de l'enseignement superieur et de la recherche scientifique'' Tunisia	The present study was financed by "le ministere de l'enseignement superieur et de la recherche scientifique'' Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1992, SPORTS MED, V13, P116, DOI 10.2165/00007256-199213020-00007; Andersen KL, 1971, FUNDAMENTALS EXERICE; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BAROR O, 1977, ISRAEL J MED SCI, V13, P326; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cooper SM, 2004, BRIT J SPORT MED, V38, P784, DOI 10.1136/bjsm.2004.012229; Dal Pupo J, 2014, J SCI MED SPORT, V17, P650, DOI 10.1016/j.jsams.2013.09.007; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Graham JE, 2003, J STRENGTH COND RES, V17, P338; Hachana Y, 2012, J STRENGTH COND RES, V26, P1324, DOI 10.1519/JSC.0b013e3182305485; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JACOBS I, 1982, MED SCI SPORT EXER, V14, P457, DOI 10.1249/00005768-198206000-00009; Jacobs PL, 2003, J SPINAL CORD MED, V26, P141, DOI 10.1080/10790268.2003.11753674; KAVANAGH MF, 1988, CAN J SPORT SCI, V13, P91; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; MEDBO JI, 1989, J APPL PHYSIOL, V67, P1881, DOI 10.1152/jappl.1989.67.5.1881; Nevill A, 1996, J SPORT SCI, V14, P199, DOI 10.1080/02640419608727704; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Oliver JL, 2009, J SCI MED SPORT, V12, P20, DOI 10.1016/j.jsams.2007.10.010; Ozkaya O, 2014, J STRENGTH COND RES, V28, P643, DOI 10.1519/JSC.0b013e3182a20f77; SERRESSE O, 1988, INT J SPORTS MED, V9, P456, DOI 10.1055/s-2007-1025051; SHEPHARD RJ, 1982, PHYSL BIOCH EXERCISE; Smith J C, 1991, Br J Sports Med, V25, P196; Stevens GHJ, 1986, MED SCI SPORTS EXE S, V18; Stickley CD, 2008, J STRENGTH COND RES, V22, P958, DOI 10.1519/JSC.0b013e31816a906e; Vanderford ML, 2004, J STRENGTH COND RES, V18, P334, DOI 10.1519/R-11922.1; Vincent S, 2004, EUR J APPL PHYSIOL, V91, P15, DOI 10.1007/s00421-003-0957-5; Wang C. Y., 2009, ASIAN J GERONTOL GER, V4, P8, DOI DOI 10.1053/APMR.2002.32743; Zagatto AM, 2009, J STRENGTH COND RES, V23, P1820, DOI 10.1519/JSC.0b013e3181b3df32	31	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114444	10.1371/journal.pone.0114444	http://dx.doi.org/10.1371/journal.pone.0114444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474744	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500029
J	Chen, NT; Chen, MJ; Guo, CY; Chen, KT; Su, HJ				Chen, Nai-Tzu; Chen, Mu-Jean; Guo, Chao-Yu; Chen, Kow-Tong; Su, Huey-Jen			Precipitation Increases the Occurrence of Sporadic Legionnaires' Disease in Taiwan	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; FLOWER SHOW; RISK; RAINFALL; OUTBREAK; SURVEILLANCE; NETHERLANDS; MORTALITY; SURVIVAL; HUMIDITY	Legionnaires' disease (LD) is an acute form of pneumonia, and changing weather is considered a plausible risk factor. Yet, the relationship between weather and LD has rarely been investigated, especially using long-term daily data. In this study, daily data was used to evaluate the impacts of precipitation, temperature, and relative humidity on LD occurrence in Taiwan from 1995-2011. A time-stratified 2:1 matched-period case-crossover design was used to compare each case with self-controlled data using a conditional logistic regression analysis, and odds ratios (ORs) for LD occurrence was estimated. The city, gender and age were defined as a stratum for each matched set to modify the effects. For lag day- 0 to 15, the precipitation at lag day-11 significantly affected LD occurrence (p<0.05), and a 2.5% (95% CIs=0.3-4.7%) increased risk of LD occurrence was associated with every 5-mm increase in precipitation. In addition, stratified analyses further showed that positive associations of precipitation with LD incidence were only significant in male and elderly groups and during the warm season ORs=1.023-1.029). However, such an effect was not completely linear. Only precipitations at 21-40 (OR=1.643 (95% CIs=1.074-2.513)) and 61-80 mm (OR=2.572 (1.106-5.978)) significantly increased the risk of LD occurrence. Moreover, a negative correlation between mean temperature at an 11-day lag and LD occurrence was also found (OR=0.975 (0.953-0.996)). No significant association between relative humidity and LD occurrence was identified (p>0.05). In conclusion, in warm, humid regions, an increase of daily precipitation is likely to be a critical weather factor triggering LD occurrence where the risk is found particularly significant at an 11-day lag. Additionally, precipitation at 21-40 and 61-80 mm might make LD occurrence more likely.	[Chen, Nai-Tzu; Chen, Mu-Jean; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Mu-Jean] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Coll Med, Inst Publ Hlth, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Coll Med, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Kow-Tong] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw		Guo, Chao-Yu/0000-0002-9066-9933	Taiwan National Science Council [NSC102-2621-M-006-001, NSC101-2625-M-006-009, NSC101-2621-M-006-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This supplement received financial support from the Taiwan National Science Council (NSC102-2621-M-006-001, NSC101-2625-M-006-009, NSC101-2621-M-006-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherholt TB, 1998, J AM WATER WORKS ASS, V90, P66; BERENDT RF, 1980, J INFECT DIS, V141, P689, DOI 10.1093/infdis/141.5.689; Casati S, 2009, CLIN MICROBIOL INFEC, V15, P571, DOI 10.1111/j.1469-0691.2009.02742.x; Conza L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002428; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; Dominguez A, 2009, INT J TUBERC LUNG D, V13, P407; Figueiras A, 2005, EPIDEMIOLOGY, V16, P239, DOI 10.1097/01.ede.0000152915.58564.d3; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Garcia-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061036; HAMBLETON P, 1983, J HYG-CAMBRIDGE, V90, P451, DOI 10.1017/S0022172400029090; Heath CH, 1996, EUR J CLIN MICROBIOL, V15, P286, DOI 10.1007/BF01695659; HELMS CM, 1984, AM J MED SCI, V288, P2, DOI 10.1097/00000441-198407000-00001; Hicks LA, 2007, EPIDEMIOL INFECT, V135, P811, DOI 10.1017/S0950268806007552; Hong PY, 2013, APPL ENVIRON MICROB, V79, P2620, DOI 10.1128/AEM.03760-12; Jones TF, 2003, CLIN INFECT DIS, V37, P1292, DOI 10.1086/379017; Joseph CA, 2010, EUROSURVEILLANCE, V15, P9; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P181, DOI 10.1017/S095026880800099X; Krojgaard LH, 2011, EUROSURVEILLANCE, V16, P11; Lettinga KD, 2002, EMERG INFECT DIS, V8, P1448, DOI 10.3201/eid0812.020035; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Ng V, 2008, ECOHEALTH, V5, P482, DOI 10.1007/s10393-009-0218-0; Pravinkumar SJ, 2010, EUROSURVEILLANCE, V15, P4; Richardson HY, 2009, WATER RES, V43, P2159, DOI 10.1016/j.watres.2009.02.035; Ricketts KD, 2009, EPIDEMIOL INFECT, V137, P1003, DOI 10.1017/S095026880800157X; Rivera JM, 2009, INFECT CONT HOSP EP, V30, P306, DOI 10.1086/595981; Sakamoto R, 2009, EMERG INFECT DIS, V15, P1295, DOI 10.3201/eid1508.090317; Ferre MRS, 2009, EUR J CLIN MICROBIOL, V28, P153, DOI 10.1007/s10096-008-0603-6; Travis TC, 2012, INT J MICROBIOL, V2012	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114337	10.1371/journal.pone.0114337	http://dx.doi.org/10.1371/journal.pone.0114337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474539	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500018
J	Feriche, B; Garcia-Ramos, A; Calderon-Soto, C; Drobnic, F; Bonitch-Gongora, JG; Galilea, PA; Riera, J; Padial, P				Feriche, Belen; Garcia-Ramos, Amador; Calderon-Soto, Carmen; Drobnic, Franchek; Bonitch-Gongora, Juan G.; Galilea, Pedro A.; Riera, Joan; Padial, Paulino			Effect of Acute Exposure to Moderate Altitude on Muscle Power: Hypobaric Hypoxia vs. Normobaric Hypoxia	PLOS ONE			English	Article							UPPER-BODY MOVEMENTS; EXERCISE PERFORMANCE; SKELETAL-MUSCLE; ADAPTATIONS; STRENGTH; OXYGENATION; ACTIVATION; KINEMATICS; RESPONSES; KINETICS	When ascending to a higher altitude, changes in air density and oxygen levels affect the way in which explosive actions are executed. This study was designed to compare the effects of acute exposure to real or simulated moderate hypoxia on the dynamics of the force-velocity relationship observed in bench press exercise. Twenty-eight combat sports athletes were assigned to two groups and assessed on two separate occasions: G1 (n=17) in conditions of normoxia (N1) and hypobaric hypoxia (HH) and G2 (n=11) in conditions of normoxia (N2) and normobaric hypoxia (NH). Individual and complete force-velocity relationships in bench press were determined on each assessment day. For each exercise repetition, we obtained the mean and peak velocity and power shown by the athletes. Maximum power (P-max) was recorded as the highest P-mean obtained across the complete force-velocity curve. Our findings indicate a significantly higher absolute load linked to P-max (similar to 3%) and maximal strength (1RM) (similar to 6%) in G1 attributable to the climb to altitude (P<0.05). We also observed a stimulating effect of natural hypoxia on Pmean and P-peak in the middle-high part of the curve (>= 60 kg; P<0.01) and a 7.8% mean increase in barbell displacement velocity (P<0.001). No changes in any of the variables examined were observed in G2. According to these data, we can state that acute exposure to natural moderate altitude as opposed to simulated normobaric hypoxia leads to gains in 1RM, movement velocity and power during the execution of a force-velocity curve in bench press.	[Feriche, Belen; Garcia-Ramos, Amador; Bonitch-Gongora, Juan G.; Padial, Paulino] Univ Granada, Dept Phys Educ & Sport, Granada, Spain; [Calderon-Soto, Carmen] High Sport Council, High Performance Ctr Sierra Nevada, Granada, Spain; [Drobnic, Franchek; Galilea, Pedro A.; Riera, Joan] High Sport Council, Ctr Alt Rendiment, Dept Sport Physiol, Grp Invest Rendiment & Salut Esportista Alt Nivel, Barcelona, Spain	University of Granada	Feriche, B (corresponding author), Univ Granada, Dept Phys Educ & Sport, Granada, Spain.	mbelen@ugr.es	Bonitch-Góngora, Juan/AAG-5406-2020; Feriche, Belén/K-2783-2012; Ramos, Amador Garcia/S-6982-2016; Bonitch-Góngora, Juan/P-8233-2019	Feriche, Belén/0000-0002-3933-6041; Ramos, Amador Garcia/0000-0003-0608-8755; Bonitch-Góngora, Juan/0000-0003-0083-0138; Galilea, Pedro/0000-0002-4163-3125; Padial, Paulino/0000-0002-0847-7378	Ministry of education, culture and Sport of Spain [14/UPB10/07]	Ministry of education, culture and Sport of Spain	This study has been supported by a Grant from the Ministry of education, culture and Sport of Spain, Reference 14/UPB10/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; [Anonymous], 2014, THE J; [Anonymous], 2006, ARCH MED DEPORT; Billaut F, 2012, SPORTS MED, V42, P751, DOI 10.2165/11634050-000000000-00000; Bonetti DL, 2009, SPORTS MED, V39, P107, DOI 10.2165/00007256-200939020-00002; Chawla S, 2014, RESONANCE, V19, P538, DOI 10.1007/s12045-014-0057-3; Cronin JB, 2003, J STRENGTH COND RES, V17, P148; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; ELLIOTT BC, 1989, MED SCI SPORT EXER, V21, P450; FERRETTI G, 1990, INT J SPORTS MED, V11, pS31, DOI 10.1055/s-2007-1024851; Fiori G, 2000, AM J PHYS ANTHROPOL, V113, P47, DOI 10.1002/1096-8644(200009)113:1<47::AID-AJPA5>3.0.CO;2-K; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Hahn AG, 2001, SPORTS MED, V31, P533, DOI 10.2165/00007256-200131070-00008; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kon M, 2012, J STRENGTH COND RES, V26, P611, DOI 10.1519/JSC.0b013e3182281c69; Levine BD, 2008, SCAND J MED SCI SPOR, V18, P76, DOI 10.1111/j.1600-0838.2008.00835.x; MERCADE JJ, 2006, PROCEEDINGS OF THE 1, P148; MERCADE JJ, 2013, PROCEEDINGS OF THE 1, P817; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; NARICI MV, 1995, EUR J APPL PHYSIOL O, V70, P213, DOI 10.1007/BF00238566; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; PERONNET F, 1991, J APPL PHYSIOL, V70, P399, DOI 10.1152/jappl.1991.70.1.399; Raguso CA, 2004, CURR OPIN CLIN NUTR, V7, P411, DOI 10.1097/01.mco.0000134372.78438.09; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Scott BR, 2015, J STRENGTH COND RES, V29, P807, DOI 10.1519/JSC.0000000000000680; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9	31	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114072	10.1371/journal.pone.0114072	http://dx.doi.org/10.1371/journal.pone.0114072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474104	Green Published, gold			2022-12-27	WOS:000346382500110
J	Marques, PAM; Magalhaes, DM; Pereira, SF; Jorge, PE				Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.; Jorge, Paulo E.			From the Past to the Future: Natural Sound Recordings and the Preservation of the Bioacoustics Legacy in Portugal	PLOS ONE			English	Article								The preservation of historical and contemporary data safeguards our scientific legacy. Bioacoustic recordings can have historical as well as scientific value and should be assessed for their conservation requirements. Unpreserved bioacoustics recordings are generally not referenced and are frequently at high risk of loss by material degradation and/or by misplacement. In this study we investigated the preservation status of sets of natural sound recordings made in Portugal from 1983 until 2010 inclusive. We evaluated the recordings on the basis of their rate of loss, the degree to which unpreserved recordings could be preserved, and their risk of loss. Recordists of animal sounds were surveyed (by questionnaire or interview) to identify sets of recordings and to collect information on their quality and state of preservation. Of the 78 recordists identified, we found that 32% of the recordings have an unclear status and that only 9% of the recordings are lost. Of the c. 6 terabytes of unpreserved sound recordings discovered, an estimated 49% were recoverable. Moreover, 95% of the recoverable sets of recordings were at high risk of loss by their being misplaced. These risks can be minimized if recordists are persuaded to deposit their material in an institution committed to long-term curation of such data (e. g. sound archives). Overall, the study identified a considerable body of unpreserved animal sound recordings that could contribute to our scientific heritage and knowledge of the biodiversity found in Portugal. It highlights the need to implement effective policies to promote the deposit of recordings for preservation and to reverse the present scenario so that scientific material can be preserved for future generations.	[Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.; Jorge, Paulo E.] ISPA IU, Unidade Invest Ecoetol, Lisbon, Portugal; [Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa	Marques, PAM (corresponding author), ISPA IU, Unidade Invest Ecoetol, Lisbon, Portugal.	pamarques@ispa.pt	Jorge, Paulo/I-7049-2013	Jorge, Paulo/0000-0001-9348-6510	Fundacao para a Ciencia e a Tecnologia, MEC (Portugal) [SFRH/BPD/34846/2007, HC/0009/2009 (2010-2012)]	Fundacao para a Ciencia e a Tecnologia, MEC (Portugal)	The study was funded by project HC/0009/2009 (2010-2012), and PAMM was supported by grant SFRH/BPD/34846/2007 both from the Fundacao para a Ciencia e a Tecnologia, MEC (Portugal; http://www.fct.pt/index.phtml.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 03 IASATC; Baptista LF., 2001, HDB BIRDS WORLD, P11; Breen M, 2002, TASK FORCE ESTABLISH; Fletcher N.H., 2007, SPRINGER HDB ACOUSTI, P785, DOI [10.1007/978-1-4939-0755-7_19, DOI 10.1007/978-1-4939-0755-7_19]; Kettle R, 1991, BIOACOUSTICS, V3, P235, DOI DOI 10.1080/09524622.1991.9753183; Marques PAM, 2014, P INV PLAC IN PRESS; Marques PAM, 2011, INVENTARIO AUTORES G; National Recording Preservation Board (Library of Congress), 2006, CAPT AN SOUND DIG PR; Nelson-Strauss B., 2012, LIB C NAT REC PRES P; Obrist Martin K., 2010, Abc Taxa, V8, P68; Ranft R, 2004, AN ACAD BRAS CIENC, V76, P455; Royal Society, 2012, SCI OP ENT OP DAT OP; Vielliard JME, 2003, BRIEF HIST BIOACOUST; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Voronin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027868; Wren JD, 2006, EMBO REP, V7, P122, DOI 10.1038/sj.embor.7400631	16	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114303	10.1371/journal.pone.0114303	http://dx.doi.org/10.1371/journal.pone.0114303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473829	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500012
J	Urriola-Munoz, P; Lagos-Cabre, R; Moreno, RD				Urriola-Munoz, Paulina; Lagos-Cabre, Raul; Moreno, Ricardo D.			A Mechanism of Male Germ Cell Apoptosis Induced by Bisphenol-A and Nonylphenol Involving ADAM17 and p38 MAPK Activation	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; PUBERTAL RAT TESTES; TNF-ALPHA; BINDING AFFINITIES; DIRECT EXPOSURE; POTENTIAL ROLE; SERTOLI-CELLS; P-NONYLPHENOL; SEMEN QUALITY; UP-REGULATION	Germ cell apoptosis regulation is pivotal in order to maintain proper daily sperm production. Several reports have shown that endocrine disruptors such as Bisphenol-A (BPA) and Nonylphenol (NP) induce germ cell apoptosis along with a decrease in sperm production. Given their ubiquitous distribution in plastic products used by humans it is important to clarify their mechanism of action. TACE/ADAM17 is a widely distributed extracellular metalloprotease and participates in the physiological apoptosis of germ cells during spermatogenesis. The aims of this work were: 1) to determine whether BPA and NP induce ADAM17 activation; and 2) to study whether ADAM17 and/or ADAM10 are involved in germ cell apoptosis induced by BPA and NP in the pubertal rat testis. A single dose of BPA or NP (50 mg/kg) induces germ cell apoptosis in 21-day-old male rats, which was prevented by a pharmacological inhibitor of ADAM17, but not by an inhibitor of ADAM10. In vitro, we showed that BPA and NP, at similar concentrations to those found in human samples, induce the shedding of exogenous and endogenous (TNF-alpha) ADAM17 substrates in primary rat Sertoli cell cultures and TM4 cell line. In addition, pharmacological inhibitors of metalloproteases and genetic silencing of ADAM17 prevent the shedding induced in vitro by BPA and NP. Finally, we showed that in vivo BPA and NP induced early activation (phosphorylation) of p38 MAPK and translocation of ADAM17 to the cell surface. Interestingly, the inhibition of p38 MAPK prevents germ cell apoptosis and translocation of ADAM17 to the cell surface. These results show for the first time that xenoestrogens can induce activation of ADAM17 at concentrations similar to those found in human samples, suggesting a mechanism by which they could imbalance para/juxtacrine cell-to-cell-communication and induce germ cell apoptosis.	[Urriola-Munoz, Paulina; Lagos-Cabre, Raul; Moreno, Ricardo D.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Moreno, RD (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Alameda 340, Santiago, Chile.	rmoreno@bio.puc.cl	Moreno, Ricardo R/C-6802-2011	Moreno, Ricardo/0000-0002-7499-5501; Urriola-Munoz, Paulina/0000-0002-2492-2240	Chilean research council (FONDECYT) [1110778]; CONICYT	Chilean research council (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant from the Chilean research council (FONDECYT) Grant number 1110778 to RDM (http://www.conicyt.cl/fondecyt/). RLC and PUM are PhD fellows from CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Choi MS, 2014, J APPL TOXICOL, V34, P628, DOI 10.1002/jat.2886; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Codelia VA, 2008, MOL REPROD DEV, V75, P881, DOI 10.1002/mrd.20822; Daidoji T, 2003, DRUG METAB DISPOS, V31, P993, DOI 10.1124/dmd.31.8.993; de Jager C, 1999, ANDROLOGIA, V31, P107, DOI 10.1046/j.1439-0272.1999.00246.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Feng HL, 1999, FERTIL STERIL, V71, P85, DOI 10.1016/S0015-0282(98)00401-4; Gong Y, 2006, REPROD TOXICOL, V22, P623, DOI 10.1016/j.reprotox.2006.04.019; Gong Y, 2009, TOXICOL LETT, V186, P84, DOI 10.1016/j.toxlet.2009.01.010; Gong Y, 2008, TOXICOL LETT, V183, P10, DOI 10.1016/j.toxlet.2008.08.011; Grady R, 2012, CURR UROL REP, V13, P307, DOI 10.1007/s11934-012-0261-1; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Han SW, 2009, J TOXICOL ENV HEAL A, V72, P1463, DOI 10.1080/15287390903212972; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Inoue K, 2002, J CHROMATOGR B, V773, P97, DOI 10.1016/S1570-0232(02)00101-0; Jenkins LK, 2007, REPROD FERT DEVELOP, V19, P461, DOI 10.1071/RD06079; Ji GX, 2009, HUM REPROD, V24, P2439, DOI 10.1093/humrep/dep223; Jin PP, 2013, J BIOMED RES, V27, P135, DOI 10.7555/JBR.27.20120076; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Lee J, 2010, N-S ARCH PHARMACOL, V382, P51, DOI 10.1007/s00210-010-0527-4; Li YJ, 2009, TOXICOL SCI, V108, P427, DOI 10.1093/toxsci/kfp024; Liu C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.203; Lizama C, 2012, J CELL PHYSIOL, V227, P829, DOI 10.1002/jcp.22795; Lizama C, 2011, BBA-MOL CELL RES, V1813, P120, DOI 10.1016/j.bbamcr.2010.08.003; Lizama C, 2010, REPRODUCTION, V140, P305, DOI 10.1530/REP-10-0104; Lizama C, 2009, J CELL PHYSIOL, V221, P296, DOI 10.1002/jcp.21868; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; McClusky LM, 2007, TOXICOL SCI, V95, P249, DOI 10.1093/toxsci/kfl141; Moreno RD, 2006, CELL TISSUE RES, V325, P533, DOI 10.1007/s00441-006-0186-4; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Nassar N, 2007, ARCH DIS CHILD, V92, P580, DOI 10.1136/adc.2006.112862; Nelson CP, 2005, J UROLOGY, V174, P1573, DOI 10.1097/01.ju.0000179249.21944.7e; Obama T, 2014, AM J HYPERTENS; Ortiz RJ, 2009, MOL HUM REPROD, V15, P363, DOI 10.1093/molehr/gap024; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Phillips KP, 2008, J TOXICOL ENV HEAL B, V11, P188, DOI 10.1080/10937400701873472; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Qian WY, 2014, TOXICOLOGY, V324, P27, DOI 10.1016/j.tox.2014.06.001; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Salian S, 2009, TOXICOLOGY, V265, P56, DOI 10.1016/j.tox.2009.09.012; Satoh K, 2001, J HEALTH SCI, V47, P495, DOI 10.1248/jhs.47.495; Schlondorff J, 1999, J CELL SCI, V112, P3603; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Urriola-Munoz P, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-31; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wang C, 2014, ENV TOXICOL; Weikert S, 2004, INT J ANDROL, V27, P161, DOI 10.1111/j.1365-2605.2004.00467.x; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Yan Y, 2009, CELL BIOL INT, V33, P158, DOI 10.1016/j.cellbi.2008.10.008; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122; Zhang YH, 2009, J PEDIATR-US, V155, P500, DOI 10.1016/j.jpeds.2009.04.007	68	54	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113793	10.1371/journal.pone.0113793	http://dx.doi.org/10.1371/journal.pone.0113793			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474107	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500092
J	Zhao, TT; Compton, SG; Yang, YJ; Wang, R; Chen, Y				Zhao, Ting-Ting; Compton, Stephen G.; Yang, Yong-Jiang; Wang, Rong; Chen, Yan			Phenological Adaptations in Ficus tikoua Exhibit Convergence with Unrelated Extra-Tropical Fig Trees	PLOS ONE			English	Article							FLOWERING PHENOLOGY; HOST SANCTIONS; POLLINATION; CONSEQUENCES; MUTUALISM; WASPS; EVOLUTION; PATTERNS; DIVERSITY; SELECTION	Flowering phenology is central to the ecology and evolution of most flowering plants. In highly-specific nursery pollination systems, such as that involving fig trees (Ficus species) and fig wasps (Agaonidae), any mismatch in timing has serious consequences because the plants must balance seed production with maintenance of their pollinator populations. Most fig trees are found in tropical or subtropical habitats, but the dioecious Chinese Ficus tikoua has a more northerly distribution. We monitored how its fruiting phenology has adapted in response to a highly seasonal environment. Male trees (where fig wasps reproduce) had one to three crops annually, whereas many seed-producing female trees produced only one fig crop. The timing of release of Ceratosolen fig wasps from male figs in late May and June was synchronized with the presence of receptive figs on female trees, at a time when there were few receptive figs on male trees, thereby ensuring seed set while allowing remnant pollinator populations to persist. F. tikoua phenology has converged with those of other (unrelated) northern Ficus species, but there are differences. Unlike F. carica in Europe, all F. tikoua male figs contain male flowers, and unlike F. pumila in China, but like F. carica, it is the second annual generation of adult wasps that pollinate female figs. The phenologies of all three temperate fig trees generate annual bottlenecks in the size of pollinator populations and for female F. tikoua also a shortage of fig wasps that results in many figs failing to be pollinated.	[Zhao, Ting-Ting; Yang, Yong-Jiang; Chen, Yan] Mianyang Normal Univ, Coll Life Sci & Biotechnol, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang 621000, Sichuan, Peoples R China; [Compton, Stephen G.; Wang, Rong] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Mianyang Teachers' College; University of Leeds; Rhodes University	Chen, Y (corresponding author), Mianyang Normal Univ, Coll Life Sci & Biotechnol, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang 621000, Sichuan, Peoples R China.	goose_01@163.com		Compton, Stephen/0000-0002-1247-8058	Natural Science Foundation of China [31270387]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (31270387) to YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Aizen MA, 2003, ECOLOGY, V84, P2613, DOI 10.1890/02-0521; Armbruster WS, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu003; Bain A, 2014, ACTA OECOL, V57, P124, DOI 10.1016/j.actao.2013.10.004; Berg C.C., 2005, FLORA MALESIANA 1; BRONSTEIN JL, 1988, ECOLOGY, V69, P207, DOI 10.2307/1943176; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chang X-S, 1998, FLORA REIPUBLICAE PO; Chen Y, 2012, MOL ECOL, V21, P1687, DOI 10.1111/j.1365-294X.2012.05491.x; Chen Y, 2011, BIOCHEM SYST ECOL, V39, P441, DOI 10.1016/j.bse.2011.06.006; COMPTON SG, 1994, BIOTROPICA, V26, P180, DOI 10.2307/2388807; Compton SG, 2010, BIOL LETTERS, V6, P838, DOI 10.1098/rsbl.2010.0389; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; GRAFEN A, 1991, P ROY SOC B-BIOL SCI, V245, P73, DOI 10.1098/rspb.1991.0090; Greeff JM, 2002, OIKOS, V96, P386, DOI 10.1034/j.1600-0706.2002.960221.x; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; Hauser TP, 2000, HEREDITAS, V132, P95, DOI 10.1111/j.1601-5223.2000.00095.x; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Jander KC, 2012, ECOL LETT, V15, P1362, DOI 10.1111/j.1461-0248.2012.01857.x; Jander KC, 2010, P ROY SOC B-BIOL SCI, V277, P1481, DOI 10.1098/rspb.2009.2157; Jousselin E, 2001, ECOL LETT, V4, P151, DOI 10.1046/j.1461-0248.2001.00209.x; Kang H, 2004, J PLANT BIOL, V47, P348, DOI 10.1007/BF03030550; KJELLBERG F, 1987, EVOLUTION, V41, P693, DOI 10.1111/j.1558-5646.1987.tb05846.x; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; KJELLBERG F, 1989, EXPERIENTIA, V45, P653, DOI 10.1007/BF01975682; Kjellberg F, 2001, P ROY SOC B-BIOL SCI, V268, P1113, DOI 10.1098/rspb.2001.1633; KJELLBERG F, 1990, BIOL INVASIONS EUROP, P371; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097783; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; Patel A, 1997, J TROP ECOL, V13, P681, DOI 10.1017/S0266467400010865; R Development Core Team, 2012, R LANG ENV STAT COMP; Raja S, 2008, SYMBIOSIS, V45, P25; Rathcke B., 1983, P305; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Ronsted N, 2008, SYMBIOSIS, V45, P45; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Smith CM, 1996, J BIOGEOGR, V23, P477, DOI 10.1111/j.1365-2699.1996.tb00009.x; Suleman N, 2011, PLANT SYST EVOL, V296, P245, DOI 10.1007/s00606-011-0491-6; Tarachai Y, 2008, SYMBIOSIS, V45, P29; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Tzeng HY, 2006, BOT STUD, V47, P307; VALDEYRON G, 1979, EVOLUTION, V33, P673, DOI 10.1111/j.1558-5646.1979.tb04720.x; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Whipple AV, 2009, J EVOLUTION BIOL, V22, P793, DOI 10.1111/j.1420-9101.2009.01690.x; Zhao R, 2010, THESIS E CHINA NORMA	55	10	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114344	10.1371/journal.pone.0114344	http://dx.doi.org/10.1371/journal.pone.0114344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474008	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500022
J	Giuliano, S; Agresta, AM; De Palma, A; Viglio, S; Mauri, P; Fumagalli, M; Iadarola, P; Montalbetti, L; Salvini, R; Bardoni, A				Giuliano, Serena; Agresta, Anna Maria; De Palma, Antonella; Viglio, Simona; Mauri, Pierluigi; Fumagalli, Marco; Iadarola, Paolo; Montalbetti, Lorenza; Salvini, Roberta; Bardoni, Anna			Proteomic Analysis of Lymphoblastoid Cells from Nasu-Hakola Patients: A Step Forward in Our Understanding of This Neurodegenerative Disorder	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; BINDING ALCOHOL-DEHYDROGENASE; OXIDATIVELY MODIFIED PROTEINS; AMYLOID-BETA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PARKINSONS-DISEASE; SCLEROSING LEUKOENCEPHALOPATHY; FRONTAL-CORTEX; MITOCHONDRIAL DYSFUNCTION	Nasu-Hakola disease (NHD) is a recessively inherited rare disorder characterized by a combination of neuropsychiatric and bone symptoms which, while being unique to this disease, do not provide a rationale for the unambiguous identification of patients. These individuals, in fact, are likely to go unrecognized either because they are considered to be affected by other kinds of dementia or by fibrous dysplasia of bone. Given that dementia in NHD has much in common with Alzheimer's disease and other neurodegenerative disorders, it cannot be expected to achieve the differential diagnosis of this disease without performing a genetic analysis. Under this scenario, the availability of protein biomarkers would indeed provide a novel context to facilitate interpretation of symptoms and to make the precise identification of this disease possible. The work here reported was designed to generate, for the first time, protein profiles of lymphoblastoid cells from NHD patients. Two-dimensional electrophoresis (2-DE) and nano liquid chromatography-tandem mass spectrometry (nLC-MS/MS) have been applied to all components of an Italian family (seven subjects) and to five healthy subjects included as controls. Comparative analyses revealed differences in the expression profile of 21 proteins involved in glucose metabolism and information pathways as well as in stress responses.	[Giuliano, Serena; Viglio, Simona; Salvini, Roberta; Bardoni, Anna] Univ Pavia, Dept Mol Med, Biochem Unit, I-27100 Pavia, Italy; [Giuliano, Serena] CNRS, UMR, Lab Excellence Ion Channel Sci & Therapeut, F-06034 Nice, France; [Agresta, Anna Maria; De Palma, Antonella; Mauri, Pierluigi] CNR, Inst Biochem Technol, Prote & Metabol Unit, Segrate, Milano, Italy; [Fumagalli, Marco; Iadarola, Paolo] Univ Pavia, Dept Biol & Biotechnol, Biochem Unit, I-27100 Pavia, Italy; [Montalbetti, Lorenza] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Pavia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia	Iadarola, P (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Biochem Unit, Via Palestro 3, I-27100 Pavia, Italy.	piadarol@unipv.it	De Palma, Antonella/K-8451-2016; Mauri, Pietro Luigi/AAC-3095-2019; Agresta, Anna Maria/Q-5650-2018	De Palma, Antonella/0000-0001-5937-8604; Mauri, Pietro Luigi/0000-0003-4364-0393; Agresta, Anna Maria/0000-0002-1173-3205; Giuliano, Serena/0000-0001-8734-3724; Viglio, Simona/0000-0001-5020-478X	Italian Ministry of University and Research for the PON project [01_01426]; CARE-G project - Regione Lombardia; Biochemistry Unit of the Department of Molecular Medicine; Laura Fossati Onlus (Montesegale, Pavia, Italy)	Italian Ministry of University and Research for the PON project; CARE-G project - Regione Lombardia; Biochemistry Unit of the Department of Molecular Medicine; Laura Fossati Onlus (Montesegale, Pavia, Italy)	This study was supported by the Italian Ministry of University and Research for the PON project (01_01426, AMA, PM) and by CARE-G project financed by Regione Lombardia (ADP, PM). The authors are deeply grateful to Laura Fossati Onlus (Montesegale, Pavia, Italy) for the generous financial support provided to the Biochemistry Unit of the Department of Molecular Medicine for the realization of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio T, 2012, IUBMB LIFE, V64, P846, DOI 10.1002/iub.1073; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Bigl M, 2003, J NEURAL TRANSM, V110, P77, DOI 10.1007/s00702-002-0772-x; Bock V, 2013, J NEUROL SCI, V326, P115, DOI 10.1016/j.jns.2013.01.021; Borger E, 2013, CURR ALZHEIMER RES, V10, P21; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Caron M, 2002, J CHROMATOGR B, V771, P197, DOI 10.1016/S1570-0232(02)00040-5; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; Chen W, 2005, J NEUROPSYCH CLIN N, V17, P364, DOI 10.1176/appi.neuropsych.17.3.364; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; DODDS RA, 1994, J HISTOCHEM CYTOCHEM, V42, P599, DOI 10.1177/42.5.8157931; Donn RP, 2004, J ENDOCRINOL, V182, P1, DOI 10.1677/joe.0.1820001; Doragna D, 2003, J NEUROL NEUROSUR PS, V74, P825, DOI 10.1136/jnnp.74.6.825-a; Drabik A, 2007, MASS SPECTROM REV, V26, P432, DOI 10.1002/mas.20131; Fiszer U, 2001, BIODRUGS, V15, P351, DOI 10.2165/00063030-200115060-00001; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Furukawa A, 2010, MECH AGEING DEV, V131, P379, DOI 10.1016/j.mad.2010.05.002; Gomez A, 2009, J NEUROSCI RES, V87, P1002, DOI 10.1002/jnr.21904; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; HAKOLA HPA, 1970, ACTA NEUROL SCAND, V46, P79; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Hargreaves GA, 2009, ALCOHOL CLIN EXP RES, V33, P86, DOI 10.1111/j.1530-0277.2008.00814.x; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Kim JE, 2008, EXP NEUROL, V211, P128, DOI 10.1016/j.expneurol.2008.01.029; Kim JM, 2007, CELL PHYSIOL BIOCHEM, V20, P935, DOI 10.1159/000110454; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lawen A, 2005, INT J BIOCHEM CELL B, V37, P277, DOI 10.1016/j.biocel.2004.05.013; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Linnartz B, 2010, INT J ALZHEIMERS DIS, V2010; Liu J, 2010, ELECTROPHORESIS, V31, P1302, DOI 10.1002/elps.200900733; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lyon RC, 2013, NEUROCHEM INT, V62, P113, DOI 10.1016/j.neuint.2012.10.007; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Martinez A, 2008, J NEURAL TRANSM, V115, P59, DOI 10.1007/s00702-007-0800-y; Mila S, 2009, BIOMARK MED, V3, P117, DOI 10.2217/BMM.09.4; Montalbetti L, 2004, FUNCT NEUROL, V19, P171; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Ohgidani M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04957; Orphanet, 2014, PORT RAR DIS ORPH DR; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Raghavan A, 2012, BBA-BIOMEMBRANES, V1818, P1477, DOI 10.1016/j.bbamem.2011.10.019; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Salonen JM, 2006, PROTEOMICS, V6, P5152, DOI 10.1002/pmic.200600156; Seigle JL, 2008, GENETICS, V179, P855, DOI 10.1534/genetics.108.087551; Shalova IN, 2007, BBA-GEN SUBJECTS, V1770, P826, DOI 10.1016/j.bbagen.2007.01.014; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Stewart JM, 2000, BBA-MOL CELL BIOL L, V1484, P278, DOI 10.1016/S1388-1981(00)00008-1; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Sultana R, 2006, J NEUROSCI RES, V84, P409, DOI 10.1002/jnr.20876; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Takano M, 2013, NEUROSCI LETT, V534, P85, DOI 10.1016/j.neulet.2012.11.010; Toda T, 2003, J CHROMATOGR B, V787, P197, DOI 10.1016/S1570-0232(02)00495-6; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069320; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; United States National Library of Medicine, 2014, GENES; van Serooskerken AMV, 2011, J INVEST DERMATOL, V131, P2249, DOI 10.1038/jid.2011.186; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Whetstone H, 2003, BIOCHEMISTRY-US, V42, P1611, DOI 10.1021/bi026735t; Wu HL, 2011, MOL CELL BIOCHEM, V357, P209, DOI 10.1007/s11010-011-0891-5; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yoon S, 2009, NEUROTOXICOLOGY, V30, P666, DOI 10.1016/j.neuro.2009.04.013; Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	98	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110073	10.1371/journal.pone.0110073	http://dx.doi.org/10.1371/journal.pone.0110073			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470616	Green Published, gold, Green Submitted			2022-12-27	WOS:000349128700002
J	Kothari, H; Keshava, S; Vatsyayan, R; Mackman, N; Rao, LVM; Pendurthi, UR				Kothari, Hema; Keshava, Shiva; Vatsyayan, Rit; Mackman, Nigel; Rao, L. Vijaya Mohan; Pendurthi, Usha R.			Role of Tissue Factor in Mycobacterium tuberculosis-Induced Inflammation and Disease Pathogenesis	PLOS ONE			English	Article							PROCOAGULANT ACTIVITY; COAGULATION; INFECTION; HEMOSTASIS; EXPRESSION; FIBRIN; CELLS; PROTECTION; PATHWAY; GRANULOMAS	Tuberculosis (TB) is a chronic lung infectious disease characterized by severe inflammation and lung granulomatous lesion formation. Clinical manifestations of TB include hypercoagulable states and thrombotic complications. We previously showed that Mycobacterium tuberculosis (M.tb) infection induces tissue factor (TF) expression in macrophages in vitro. TF plays a key role in coagulation and inflammation. In the present study, we investigated the role of TF in M.tb-induced inflammatory responses, mycobacterial growth in the lung and dissemination to other organs. Wild-type C57BL/6 and transgenic mice expressing human TF, either very low levels (low TF) or near to the level of wild-type (HTF), in place of murine TF were infected with M.tb via aerosol exposure. Levels of TF expression, proinflammatory cytokines and thrombin-antithrombin complexes were measured post M.tb infection and mycobacterial burden in the tissue homogenates were evaluated. Our results showed that M.tb infection did not increase the overall TF expression in lungs. However, macrophages in the granulomatous lung lesions in all M.tb-infected mice, including low TF mice, showed increased levels of TF expression. Conspicuous fibrin deposition in the granuloma was detected in wild-type and HTF mice but not in low TF mice. M.tb infection significantly increased expression levels of cytokines IFN-gamma, TNF-alpha, IL-6 and IL-1 beta in lung tissues. However, no significant differences were found in proinflammatory cytokines among the three experimental groups. Mycobacterial burden in lungs and dissemination into spleen and liver were essentially similar in all three genotypes. Our data indicate, in contrast to that observed in acute bacterial infections, that TF-mediated coagulation and/or signaling does not appear to contribute to the host-defense in experimental tuberculosis.	[Kothari, Hema; Keshava, Shiva; Vatsyayan, Rit; Rao, L. Vijaya Mohan; Pendurthi, Usha R.] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Mackman, Nigel] Univ N Carolina, Dept Med, McAllister Heart Inst, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of North Carolina; University of North Carolina Chapel Hill	Kothari, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Hema.Kothari@uthct.edu; Vijay.rao@uthct.edu			American Heart Association [11POST7430095, 13SDG1690030]; National Heart, Lung, and Blood Institute [HL1074830]	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association 11POST7430095 and 13SDG1690030 (HK); National Heart, Lung, and Blood Institute HL1074830 (LVMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENHOLZ DH, 1980, SURGERY, V88, P41; Ambrosetti M, 2006, RESPIRATION, V73, P396, DOI 10.1159/000091188; Antoniak S, 2014, BLOOD, V123, P2605, DOI 10.1182/blood-2013-09-526277; Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Apt AS, 2011, IMMUNOLOGY, V134, P109, DOI 10.1111/j.1365-2567.2011.03472.x; BEHLING CA, 1993, ANN CLIN LAB SCI, V23, P256; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; El Fekih Leila, 2009, Tunis Med, V87, P328; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Goncalves Ivone M, 2009, Cases J, V2, P9333, DOI 10.1186/1757-1626-2-9333; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Gupta UD, 2009, INDIAN J MED RES, V129, P11; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Kager LM, 2013, THROMB HAEMOSTASIS, V109, P726, DOI 10.1160/TH12-11-0859; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kothari H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045700; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; LYBERG T, 1982, INFECT IMMUN, V38, P855, DOI 10.1128/IAI.38.3.855-859.1982; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; Moller ASW, 2001, THROMB RES, V102, P273, DOI 10.1016/S0049-3848(01)00248-1; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Pawlinski R, 2004, CRIT CARE MED, V32, pS293, DOI 10.1097/01.CCM.0000128445.95144.B8; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RAO LVM, 1988, THROMB RES, V51, P373, DOI 10.1016/0049-3848(88)90373-8; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; RICKLES FR, 1973, J CLIN INVEST, V52, P1427, DOI 10.1172/JCI107316; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Roh IS, 2013, YONSEI MED J, V54, P707, DOI 10.3349/ymj.2013.54.3.707; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; SELVARAJ P, 1994, EUR RESPIR J, V7, P1227, DOI 10.1183/09031936.94.07071227; Shitrit David, 2012, Harefuah, V151, P208; Shrivastava S, 2013, IMMUNOLOGY, V139, P219, DOI 10.1111/imm.12073; Tapper H, 2000, BLOOD, V96, P2329; Wang JY, 2005, THROMB HAEMOSTASIS, V93, P729, DOI 10.1160/TH04-09-0562; Weijer S, 2005, BLOOD, V106, P2761, DOI 10.1182/blood-2004-12-4623; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; World Health Organization, 2014, GLOB TUB REP; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	58	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114141	10.1371/journal.pone.0114141	http://dx.doi.org/10.1371/journal.pone.0114141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462128	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700105
J	Voss, U; Ekblad, E				Voss, Ulrikke; Ekblad, Eva			Lipopolysaccharide-Induced Loss of Cultured Rat Myenteric Neurons - Role of AMP-Activated Protein Kinase	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CELL-DEATH; INHIBITION; METFORMIN; TAK1; EXPRESSION; MECHANISM; HEALTH; DRUGS; NEUROPROTECTION	Objective: Intestinal barrier function is vital for homeostasis. Conditions where the mucosal barrier is compromised lead to increased plasma content of lipopolysaccharide (LPS). LPS acts on Toll-like receptor 4 (TLR4) and initiates cellular inflammatory responses. TLR4 receptors have been identified on enteric neurons and LPS exposure causes neuronal loss, counteracted by vasoactive intestinal peptide (VIP), by unknown mechanisms. In addition AMP activated protein kinase (AMPK) stimulation causes loss of enteric neurons. This study investigated a possible role of AMPK activation in LPS-induced neuronal loss. Design: Primary cultures of myenteric neurons isolated from rat small intestine were used. Cultures were treated with LPS (0.2-20 mu g/mL) with and without TAK1-inhibitor (5Z)-7-Oxozeaenol (10(-6) M) or AMPK inhibitor compound C (10(-5) M). AMPK-induced neuronal loss was verified treating cultures with three different AMPK activators, AICAR (10(-4)-3x10(-3) M), metformin (0.2-20 mu g/mL) and A-769662 (10(-5)-3x10(-4) M) with or without the presence of compound C (10(-5) M). Upstream activation of AMPK-induced neuronal loss was tested by treating cultures with AICAR (10(-3) M) in the presence of TAK1 inhibitor (5Z)-7-Oxozeaenol (10(-6) M). Neuronal survival and relative numbers of neurons immunoreactive (IR) for VIP were evaluated using immunocytochemistry. Results: LPS caused a concentration dependent loss of neurons. All AMPK activators induced loss of myenteric neurons in a concentration dependent manner. LPS-, AICAR- and metformin-, but not A-769662-, induced neuronal losses were inhibited by presence of compound C. LPS, AICAR or metformin exposure increased the relative number of VIP-IR neurons; co-treatment with (5Z)-7-Oxozeaenol or compound C reversed the relative increase in VIP-IR neurons induced by LPS. (5Z)-7-Oxozeaenol, compound C or A-769662 did not per se change neuronal survival or relative numbers of VIP-IR neurons. Conclusion: AMPK activation mimics LPS-induced loss of cultured myenteric neurons and LPS-induced neuronal loss is counteracted by TAK1 and AMPK inhibition. This suggests enteric neuroimmune interactions involving AMPK regulation.	[Voss, Ulrikke; Ekblad, Eva] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Voss, U (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Ulrikke.voss@med.lu.se			Pahlsson Foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	Pahlsson Foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	This study was supported by the Pahlsson Foundation, Royal Physiographic Society and Faculty of Medicine, Lund University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Arciszewski M, 2005, DIGEST DIS SCI, V50, P1661, DOI 10.1007/s10620-005-2912-2; Arciszewski MB, 2008, REGUL PEPTIDES, V146, P218, DOI 10.1016/j.regpep.2007.09.021; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; EKBLAD E, 1988, NEUROSCIENCE, V27, P655, DOI 10.1016/0306-4522(88)90296-5; Ekblad E, 1996, REGUL PEPTIDES, V63, P113; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; GOODMAN RH, 1990, ANNU REV NEUROSCI, V13, P111, DOI 10.1146/annurev.neuro.13.1.111; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Jiang PZ, 2013, NEUROBIOL AGING, V34, P1504, DOI 10.1016/j.neurobiolaging.2012.11.001; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Labuzek K, 2010, NEUROTOXICOLOGY, V31, P134, DOI 10.1016/j.neuro.2009.10.006; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P41, DOI 10.1007/s00210-009-0472-2; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Leff T, 2003, BIOCHEM SOC T, V31, P224; Maeshima N, 2013, FRONTIERS CELLULAR I, V3, P13; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Neubert M, 2011, CELL DEATH DIFFER, V18, P1521, DOI 10.1038/cdd.2011.29; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sand E, 2012, CELL TISSUE RES; Sandgren K, 2003, J NEUROSCI RES, V72, P595, DOI 10.1002/jnr.10612; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Voss U, 2013, PLOS ONE UNPUB; Voss U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081413; Voss U, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-30; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wouters MM, 2011, NETH J MED, V69, P55; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114044	10.1371/journal.pone.0114044	http://dx.doi.org/10.1371/journal.pone.0114044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462874	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700087
J	Domina, M; Cariccio, VL; Benfatto, S; D'Aliberti, D; Venza, M; Borgogni, E; Castellino, F; Biondo, C; D'Andrea, D; Grassi, L; Tramontano, A; Teti, G; Felici, F; Beninati, C				Domina, Maria; Cariccio, Veronica Lanza; Benfatto, Salvatore; D'Aliberti, Deborah; Venza, Mario; Borgogni, Erica; Castellino, Flora; Biondo, Carmelo; D'Andrea, Daniel; Grassi, Luigi; Tramontano, Anna; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen-Specific Libraries	PLOS ONE			English	Article							NEXT-GENERATION; PHAGE DISPLAY; VACCINES; GP120; REPERTOIRE; SELECTION; EPITOPES; STRATEGY; NADA	There is a need for techniques capable of identifying the antigenic epitopes targeted by polyclonal antibody responses during deliberate or natural immunization. Although successful, traditional phage library screening is laborious and can map only some of the epitopes. To accelerate and improve epitope identification, we have employed massive sequencing of phage-displayed antigen-specific libraries using the Illumina MiSeq platform. This enabled us to precisely identify the regions of a model antigen, the meningococcal NadA virulence factor, targeted by serum antibodies in vaccinated individuals and to rank hundreds of antigenic fragments according to their immunoreactivity. We found that next generation sequencing can significantly empower the analysis of antigen-specific libraries by allowing simultaneous processing of dozens of library/serum combinations in less than two days, including the time required for antibody-mediated library selection. Moreover, compared with traditional plaque picking, the new technology (named Phage-based Representation OF Immuno-Ligand Epitope Repertoire or PROFILER) provides superior resolution in epitope identification. PROFILER seems ideally suited to streamline and guide rational antigen design, adjuvant selection, and quality control of newly produced vaccines. Furthermore, this method is also susceptible to find important applications in other fields covered by traditional quantitative serology.	[Domina, Maria; Cariccio, Veronica Lanza; Benfatto, Salvatore; D'Aliberti, Deborah; Biondo, Carmelo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, SPGMB Dept, Messina, Italy; [Venza, Mario] Univ Messina, SSMCSO Dept, Messina, Italy; [Borgogni, Erica; Castellino, Flora] Novartis Vaccines & Diagnost, Siena, Italy; [D'Andrea, Daniel; Grassi, Luigi; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, Rome, Italy; [Teti, Giuseppe; Beninati, Concetta] Charybdis Vaccines Srl, Messina, Italy; [Felici, Franco] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Messina; University of Messina; Novartis; Sapienza University Rome; University of Molise	Teti, G (corresponding author), Univ Messina, SPGMB Dept, Messina, Italy.	gteti@unime.it	D'Andrea, Daniel/G-3014-2018; Tramontano, anna/D-5378-2009; Biondo, Carmelo/AAA-3391-2019; Domina, Maria/K-7883-2016; Felici, Franco/H-5693-2012; Grassi, Luigi/E-5877-2011	Tramontano, anna/0000-0002-5610-3338; Felici, Franco/0000-0003-2205-5195; Domina, Maria/0000-0002-0445-8356; Grassi, Luigi/0000-0002-6308-7540; D'Andrea, Daniel/0000-0002-7843-3856; Benfatto, Salvatore/0000-0003-4439-3136; BENINATI, Concetta/0000-0001-8305-1337	CLUSTER MEDINTECH [CTN01_00177_962865]; PANLab [PON a3_00166]; King Abdullah University of Science and Technology [KUK I1-012-43]; Progetti di Ricerca di Rilevante Interesse Nazionale [20108XYHJS]; Flagship EPIGEN	CLUSTER MEDINTECH; PANLab; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Progetti di Ricerca di Rilevante Interesse Nazionale; Flagship EPIGEN	Funding for this work came from CLUSTER MEDINTECH (Project CTN01_00177_962865), PANLab (PON a3_00166), King Abdullah University of Science and Technology (Award KUK I1-012-43), Progetti di Ricerca di Rilevante Interesse Nazionale (20108XYHJS), and the Flagship EPIGEN. All funding for this project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Busse CE, 2013, EUR J IMMUNOL; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Chong L, 2001, SCIENCE, V292, P446, DOI 10.1126/science.1060677; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Durbin R., 1999, BIOL SEQUENCE ANAL P; Felici F, 1996, METHOD ENZYMOL, V267, P116; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Heyduk E, 2014, ANAL BIOCHEM, V464, P73, DOI 10.1016/j.ab.2014.07.014; Holtappels R, 2005, BIF FUTURA, V20, p[157, 157]; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kimura A, 2011, CLIN VACCINE IMMUNOL, V18, P483, DOI 10.1128/CVI.00304-10; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Mathonet P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00265; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; McLaughlin ME, 2013, METHOD ENZYMOL, V523, P327, DOI 10.1016/B978-0-12-394292-0.00015-1; Mehr R, 2012, IMMUNOL LETT, V148, P11, DOI 10.1016/j.imlet.2012.08.002; Minenkova O, 2003, INT J CANCER, V106, P534, DOI 10.1002/ijc.11269; Nara PL, 1998, VACCINE, V16, P1780, DOI 10.1016/S0264-410X(98)00168-6; PAIGE CJ, 1989, FASEB J, V3, P1818, DOI 10.1096/fasebj.3.7.2497040; Pantophlet R, 2003, TRENDS MOL MED, V9, P468, DOI 10.1016/j.molmed.2003.09.001; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173; PIZZI E, 1995, BIOPOLYMERS, V36, P675, DOI 10.1002/bip.360360513; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Stalhammar-Carlemalm M, 2007, CELL HOST MICROBE, V2, P427, DOI 10.1016/j.chom.2007.10.003; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Tavano R, 2011, J BACTERIOL, V193, P107, DOI 10.1128/JB.00430-10; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114159	10.1371/journal.pone.0114159	http://dx.doi.org/10.1371/journal.pone.0114159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473968	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500118
J	Zhang, YJ; Guo, SL; Liu, QF; Jiang, JS				Zhang, Yanjun; Guo, Shengli; Liu, Qingfang; Jiang, Jishao			Influence of Soil Moisture on Litter Respiration in the Semiarid Loess Plateau	PLOS ONE			English	Article							BELOW-GROUND LITTER; ABOVEGROUND LITTER; CO2 EFFLUX; RHIZOSPHERE RESPIRATION; TEMPERATURE-DEPENDENCE; FOREST ECOSYSTEMS; ORGANIC-MATTER; WATER-CONTENT; DECOMPOSITION; CARBON	Understanding the response mechanisms of litter respiration to soil moisture in water-limited semi-arid regions is of vital importance to better understanding the interplay between ecological processes and the local carbon cycle. In situ soil respiration was monitored during 2010-2012 under various conditions (normal litter, no litter, and double litter treatments) in a 30-year-old artificial black locust plantation (Robinia pseudoacacia L.) on the Loess Plateau. Litter respiration with normal and double litter treatments exhibited similar seasonal variation, with the maximum value obtained in summer (0.57 and 1.51 mmol m(-2) s(-1) under normal and double litter conditions, respectively) and the minimum in spring (0.27 and 0.69 mu mol m(-2) s(-1) under normal and double litter conditions, respectively). On average, annual cumulative litter respiration was 115 and 300 g C m(-2) y-(1) under normal and double litter conditions, respectively. Using a soil temperature of 17 degrees C as the critical point, the relationship between litter respiration and soil moisture was found to follow quadratic functions well, whereas the determination coefficient was much greater at high soil temperature than at low soil temperature (33-35% vs. 2224%). Litter respiration was significantly higher in 2010 and 2012 than in 2011 under both normal litter (132-165 g C m(-2) y(-1) vs. 48 g C m(-2) y(-1)) and double litter (389-418 g C m(-2) y(-1) vs. 93 g C m(-2) y(-1)) conditions. Such significant interannual variations were largely ascribed to the differences in summer rainfall. Our study demonstrates that, apart from soil temperature, moisture	[Zhang, Yanjun; Guo, Shengli] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Peoples R China; [Guo, Shengli; Jiang, Jishao] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Guo, Shengli; Jiang, Jishao] Minist Water Resource, Yangling, Peoples R China; [Guo, Shengli; Liu, Qingfang] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Guo, SL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Peoples R China.	slguo@ms.iswc.ac.cn			National Natural Science Foundation of China [41071338]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundation of China (Grant No. 41071338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M, 2009, SOIL BIOL BIOCHEM, V41, P594, DOI 10.1016/j.soilbio.2008.12.021; Balogh J, 2011, SOIL BIOL BIOCHEM, V43, P1006, DOI 10.1016/j.soilbio.2011.01.017; Berryman EM, 2014, CAN J FOREST RES, V44, P432, DOI 10.1139/cjfr-2013-0334; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; [邓琦 DENG Qi], 2007, [地球科学进展, Advance in Earth Sciences], V22, P976; Ge X., 2013, ACTA ECOL SIN, V33, P102, DOI [10.1016/j.chnaes.2013.01.006, DOI 10.1016/J.CHNAES.2013.01.006]; Goebes P, 2013, EGU GEN ASS C, P7565; Hibbard KA, 2005, BIOGEOCHEMISTRY, V73, P29, DOI 10.1007/s10533-004-2946-0; Jiang H, 2013, BIOGEOSCIENCES, V10, P3963, DOI 10.5194/bg-10-3963-2013; Jongen M, 2013, PLANT SOIL, P1; Kavvadias VA, 2001, FOREST ECOL MANAG, V144, P113, DOI 10.1016/S0378-1127(00)00365-0; Kim H, 2005, PHYTON-ANN REI BOT A, V45, P385; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Liang N, 2010, BIOGEOSCIENCES, V7, P3447, DOI 10.5194/bg-7-3447-2010; [刘迎春 LIU Yingchun], 2011, [生态学报, Acta Ecologica Sinica], V31, P4277; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Nadelhoffer K.J., 2004, FORESTS TIME ENV CON, P300, DOI DOI 10.1890/0012-9623-96.3.492; Palviainen M, 2004, PLANT SOIL, V259, P123, DOI 10.1023/B:PLSO.0000020938.78215.bd; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rey A, 2011, SOIL BIOL BIOCHEM, V43, P393, DOI 10.1016/j.soilbio.2010.11.007; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Shiels AB, 2006, BIOTROPICA, V38, P348, DOI 10.1111/j.1744-7429.2006.00140.x; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Wang QK, 2013, AGR FOREST METEOROL, V178, P152, DOI 10.1016/j.agrformet.2013.04.021; Wang YD, 2009, ASIA-PAC J ATMOS SCI, V45, P137; Wilson TB, 2014, AGR FOREST METEOROL, V192, P42, DOI 10.1016/j.agrformet.2014.02.005; Xu S, 2013, BIOGEOSCIENCES, V10, P7423, DOI 10.5194/bg-10-7423-2013; Yan WD, 2013, CHINESE SCI BULL, V58, P750, DOI 10.1007/s11434-012-5474-7; Zheng FL., 2013, RESTORATION DEV DEGR, P77; Zhou P, 2013, ENVIRON EARTH SCI, V68, P633, DOI 10.1007/s12665-012-1766-0; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zhu B, 2013, SOIL BIOL BIOCHEM, V63, P89, DOI 10.1016/j.soilbio.2013.03.027; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	47	7	10	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114558	10.1371/journal.pone.0114558	http://dx.doi.org/10.1371/journal.pone.0114558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474633	Green Published, Green Submitted, gold			2022-12-27	WOS:000346382500046
J	Pan, JM; Yang, YF; Yang, B; Yu, YH				Pan, Jinming; Yang, Yefeng; Yang, Bo; Yu, Yonghua			Artificial Polychromatic Light Affects Growth and Physiology in Chicks	PLOS ONE			English	Article							BODY-TEMPERATURE; BROILER-CHICKENS; MONOCHROMATIC LIGHT; LOCOMOTOR-ACTIVITY; AMBIENT-TEMPERATURE; CIRCADIAN-RHYTHM; VISUAL PIGMENTS; COLOR-VISION; BIRDS; PHOTORECEPTORS	Despite the overwhelming use of artificial light on captive animals, its effect on those animals has rarely been studied experimentally. Housing animals in controlled light conditions is useful for assessing the effects of light. The chicken is one of the best-studied animals in artificial light experiments, and here, we evaluate the effect of polychromatic light with various green and blue components on the growth and physiology in chicks. The results indicate that green-blue dual light has two side-effects on chick body mass, depending on the various green to blue ratios. Green-blue dual light with depleted and medium blue component decreased body mass, whereas enriched blue component promoted body mass in chicks compared with monochromatic green-or blue spectra-treated chicks. Moreover, progressive changes in the green to blue ratios of green-blue dual light could give rise to consistent progressive changes in body mass, as suggested by polychromatic light with higher blue component resulting in higher body mass. Correlation analysis confirmed that food intake was positively correlated with final body mass in chicks (R-2=0.7664, P=0.0001), suggesting that increased food intake contributed to the increased body mass in chicks exposed to higher blue component. We also found that chicks exposed to higher blue component exhibited higher blood glucose levels. Furthermore, the glucose level was positively related to the final body mass (R-2=0.6406, P=0.0001) and food intake (R-2=0.784, P=0.0001). These results demonstrate that spectral composition plays a crucial role in affecting growth and physiology in chicks. Moreover, consistent changes in spectral components might cause the synchronous response of growth and physiology.	[Pan, Jinming; Yang, Yefeng; Yang, Bo; Yu, Yonghua] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Yu, YH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yhyu@zju.edu.cn	Pan, Jinming/A-7377-2018; Yang, Yefeng/AAB-8118-2022	Pan, Jinming/0000-0003-0228-4564; Yang, Yefeng/0000-0002-8610-4016	Chinese Special Fund for Agro-scientific Research in the Public Interest [201303091]	Chinese Special Fund for Agro-scientific Research in the Public Interest	Funding: This work was supported by the Chinese Special Fund for Agro-scientific Research in the Public Interest (grant numbers 201303091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeldoorn EJ, 1999, POULTRY SCI, V78, P223, DOI 10.1093/ps/78.2.223; Benstaali C, 2002, PFLUG ARCH EUR J PHY, V444, P73, DOI 10.1007/s00424-002-0795-z; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Cao J, 2012, POULTRY SCI, V91, P3013, DOI 10.3382/ps.2012-02413; Cassone VM, 2009, GEN COMP ENDOCR, V163, P109, DOI 10.1016/j.ygcen.2009.01.003; Chellappa S. L, 2011, PLOS ONE, V6; Collins S, 2011, APPL ANIM BEHAV SCI, V133, P60, DOI 10.1016/j.applanim.2011.04.013; Davis JF, 1996, AVIAN DIS, V40, P158, DOI 10.2307/1592385; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Dominoni D, 2013, P ROY SOC LND B, V280; DONKOH A, 1989, INT J BIOMETEOROL, V33, P259, DOI 10.1007/BF01051087; Dumont M, 2007, SLEEP MED, V8, P557, DOI 10.1016/j.sleep.2006.11.008; Ellis JL, 2009, J ANIM SCI, V87, P1334, DOI 10.2527/jas.2007-0725; Fiske VM, 1941, ENDOCRINOLOGY, V29, P187; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Holker F, 2010, ECOL SOC, V15; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Jennissen K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002867; Ke YY, 2011, POULTRY SCI, V90, P2632, DOI 10.3382/ps.2011-01523; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kohyama J, 2009, BRAIN DEV-JPN, V31, P255, DOI 10.1016/j.braindev.2008.07.006; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Kuhi HD, 2003, POULTRY SCI, V82, P1536, DOI 10.1093/ps/82.10.1536; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Lewis PD, 2000, WORLD POULTRY SCI J, V56, P189, DOI 10.1079/WPS20000015; MELLOR S., 2001, WORLD POULTRY, V17, P33; Murakami N, 2001, BRAIN RES, V889, P220, DOI 10.1016/S0006-8993(00)03205-4; Nahashon SN, 2010, POULTRY SCI, V89, P52, DOI 10.3382/ps.2009-00219; Olanrewaju H, 2012, INT J POULT SCI, V11; Olanrewaju HA, 2010, POULTRY SCI, V89, P2668, DOI 10.3382/ps.2010-00806; Olanrewaju HA, 2008, POULTRY SCI, V87, P167; ONIKI Y, 1981, IBIS, V123, P349, DOI 10.1111/j.1474-919X.1981.tb04038.x; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Prayitno DS, 1997, POULTRY SCI, V76, P452, DOI 10.1093/ps/76.3.452; Prescott NB, 1999, BRIT POULTRY SCI, V40, P332, DOI 10.1080/00071669987412; Prescott NB, 2003, ANIM WELFARE, V12, P269; Pruitt BA, 2002, ANN SURG, V235, P160; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; REFINETTI R, 1994, PHYSIOL BEHAV, V56, P829, DOI 10.1016/0031-9384(94)90251-8; Rodenboog H., 2001, WORLD POULTRY SCI J, V17, P22; Romero LF, 2009, POULTRY SCI, V88, P227, DOI 10.3382/ps.2008-00141; Rozenboim I, 1999, POULTRY SCI, V78, P135, DOI 10.1093/ps/78.1.135; Rozenboim I, 2013, GEN COMP ENDOCR, V190, P214, DOI 10.1016/j.ygcen.2013.06.027; Sadrzadeh A, 2011, AFR J BIOTECHNOL, V10, P9528; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; SALDANHA CJ, 1994, PSYCHONEUROENDOCRINO, V19, P641, DOI 10.1016/0306-4530(94)90047-7; SILVER R, 1988, CELL TISSUE RES, V253, P189; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; SUWINDRA N, 1986, BRIT POULTRY SCI, V27, P225, DOI 10.1080/00071668608416875; Takahashi H, 2005, DEV BRAIN RES, V157, P58, DOI 10.1016/j.devbrainres.2005.03.004; Thomas BB, 2001, J EXP ZOOL, V289, P59, DOI 10.1002/1097-010X(20010101/31)289:1&lt;59::AID-JEZ6&gt;3.0.CO;2-L; Titulaer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037377; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Xie D, 2011, POULTRY SCI, V90, P2697, DOI 10.3382/ps.2011-01416; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x; Zhaoping L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019248	64	14	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113595	10.1371/journal.pone.0113595	http://dx.doi.org/10.1371/journal.pone.0113595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469877	gold, Green Submitted, Green Published			2022-12-27	WOS:000349128700036
J	Angus, SD; Piotrowska, MJ				Angus, Simon D.; Piotrowska, Monika Joanna			A Matter of Timing: Identifying Significant Multi-Dose Radiotherapy Improvements by Numerical Simulation and Genetic Algorithm Search	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; STRAND BREAK REPAIR; ACCELERATED RADIOTHERAPY; RADIATION RESPONSE; MULTICELLULAR SPHEROIDS; INCOMPLETE-REPAIR; NORMAL TISSUE; LUNG-CANCER; SOLID TUMOR; CELLS	Multi-dose radiotherapy protocols (fraction dose and timing) currently used in the clinic are the product of human selection based on habit, received wisdom, physician experience and intra-day patient timetabling. However, due to combinatorial considerations, the potential treatment protocol space for a given total dose or treatment length is enormous, even for relatively coarse search; well beyond the capacity of traditional in-vitro methods. In constrast, high fidelity numerical simulation of tumor development is well suited to the challenge. Building on our previous single-dose numerical simulation model of EMT6/Ro spheroids, a multi-dose irradiation response module is added and calibrated to the effective dose arising from 18 independent multi-dose treatment programs available in the experimental literature. With the developed model a constrained, non-linear, search for better performing cadidate protocols is conducted within the vicinity of two benchmarks by genetic algorithm (GA) techniques. After evaluating less than 0.01% of the potential benchmark protocol space, candidate protocols were identified by the GA which conferred an average of 9.4% (max benefit 16.5%) and 7.1% (13.3%) improvement (reduction) on tumour cell count compared to the two benchmarks, respectively. Noticing that a convergent phenomenon of the top performing protocols was their temporal synchronicity, a further series of numerical experiments was conducted with periodic time-gap protocols (10 h to 23 h), leading to the discovery that the performance of the GA search candidates could be replicated by 17-18 h periodic candidates. Further dynamic irradiation-response cell-phase analysis revealed that such periodicity cohered with latent EMT6/Ro cell-phase temporal patterning. Taken together, this study provides powerful evidence towards the hypothesis that even simple inter-fraction timing variations for a given fractional dose program may present a facile, and highly cost-effecitive means of significantly improving clinical efficacy.	[Angus, Simon D.] Monash Univ, Dept Econ, Melbourne, Vic 3004, Australia; [Piotrowska, Monika Joanna] Univ Warsaw, Inst Appl Math & Mech, Fac Math Informat & Mech, Warsaw, Mazowieckie, Poland	Monash University; University of Warsaw	Angus, SD (corresponding author), Monash Univ, Dept Econ, Melbourne, Vic 3004, Australia.	simon.angus@monash.edu	Angus, Simon D/AAR-1871-2021	Angus, Simon D/0000-0001-7095-5054; Piotrowska, Monika/0000-0003-0156-8290	Polish Ministry of Science and Higher Education [IP2011041971]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was financed in part by the Polish Ministry of Science and Higher Education within the Iuventus Plus Grant: "Mathematical modelling of neoplastic processes" (grant No. IP2011041971) from the budget for science in years the 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SU, 2010, BIOMED SIGNAL PROCES, V5, P189, DOI 10.1016/j.bspc.2010.03.001; Angus SD, 2010, APPL MATH WARSAW, V37, P69; Angus SD, 2013, J THEOR BIOL, V320, P23, DOI 10.1016/j.jtbi.2012.11.035; Bertuzzi A, 2010, B MATH BIOL, V72, P1069, DOI 10.1007/s11538-009-9482-y; Bevilacqua V, 2007, IMAGE VISION COMPUT, V25, P196, DOI 10.1016/j.imavis.2006.01.027; Bhide SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-25; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Board of the Faculty of Clinical Oncology, 2006, RAD DOS FRACT; Bortfeld T, 1999, SEMIN RADIAT ONCOL, V9, P20, DOI 10.1016/S1053-4296(99)80052-6; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carabe-Fernandez A, 2011, BRIT J RADIOL, V84, P546, DOI 10.1259/bjr/19934996; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Cotrutz C, 2003, PHYS MED BIOL, V48, P2987, DOI 10.1088/0031-9155/48/18/303; Crone C., 1984, HDB PHYSL CARDIOVASC, P411; DAIRKEE SH, 1995, CANCER RES, V55, P2516; Duchting W, 1996, APPL MATH COMPUT, V74, P191, DOI 10.1016/0096-3003(95)00092-5; DURAND RE, 1984, BRIT J CANCER, V49, P203; DURAND RE, 1980, RADIAT RES, V81, P85, DOI 10.2307/3575364; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Engelhart M, 2011, MATH BIOSCI, V229, P123, DOI 10.1016/j.mbs.2010.11.007; Ezzell GA, 1996, MED PHYS, V23, P293, DOI 10.1118/1.597660; Fowler J F, 1992, BJR Suppl, V24, P187; Fowler JF, 2002, RADIAT RES, V158, P141, DOI 10.1667/0033-7587(2002)158[0141:RBDFAS]2.0.CO;2; Fowler JF, 1999, RADIAT RES, V152, P124, DOI 10.2307/3580085; FREYER JP, 1980, CANCER RES, V40, P3956; FREYER JP, 1986, CANCER RES, V46, P3513; FREYER JP, 1986, CANCER RES, V46, P3504; FREYER JP, 1985, J CELL PHYSIOL, V124, P516, DOI 10.1002/jcp.1041240323; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Haas OCL, 2006, STUD MULTIDISCIP, V3, P447; Haasbeek CJA, 2009, LUNG CANCER, V64, P1, DOI 10.1016/j.lungcan.2008.07.008; HAHN GM, 1974, CANCER RES, V34, P351; HAHN GM, 1973, RADIAT RES, V55, P280, DOI 10.2307/3573683; Hendry J H, 1996, Clin Oncol (R Coll Radiol), V8, P297, DOI 10.1016/S0936-6555(05)80715-0; Holland J.H., 1975, ADAPTATION NATURAL A; Holland JH, 2012, SCHOLARPEDIA, V7, P1482, DOI [DOI 10.4249/SCHOLARPEDIA.1482, DOI 10.4249/SCH0LARPEDIA.1482]; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; KAL HB, 1976, CANCER RES, V36, P1923; Kehwar T S, 2005, J Cancer Res Ther, V1, P168; KELLEY SD, 1981, CELL TISSUE KINET, V14, P611, DOI 10.1111/j.1365-2184.1981.tb00846.x; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Kempf H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003295; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Lei J, 2009, COMPUTER METHODS PRO, V93; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Longo JA, 1997, RADIAT RES, V147, P35, DOI 10.2307/3579440; Alfonso JCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089380; LUK CK, 1986, BRIT J CANCER, V54, P25, DOI 10.1038/bjc.1986.148; LUK CK, 1987, INT J RADIAT ONCOL, V13, P885, DOI 10.1016/0360-3016(87)90104-0; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mangar SA, 2005, EUR J CANCER, V41, P908, DOI 10.1016/j.ejca.2004.12.028; Mortensen HR, 2012, RADIOTHER ONCOL, V103, P69, DOI 10.1016/j.radonc.2012.01.002; MUSTAFIN AT, 1982, BIOSYSTEMS, V15, P111, DOI 10.1016/0303-2647(82)90025-9; O'Rourke SFC, 2009, J MATH BIOL, V58, P799, DOI 10.1007/s00285-008-0222-y; Otsuka S, 2011, INT J RADIAT ONCOL, V81, P1538, DOI 10.1016/j.ijrobp.2011.05.034; Patel AA, 2001, J THEOR BIOL, V213, P315, DOI 10.1006/jtbi.2001.2385; Petrovic D, 2011, EXPERT SYST APPL, V38, P6994, DOI 10.1016/j.eswa.2010.12.015; Petrovic S, 2011, EXPERT SYST APPL, V38, P10759, DOI 10.1016/j.eswa.2011.01.109; Piotrowska MJ, 2009, J THEOR BIOL, V258, P165, DOI 10.1016/j.jtbi.2009.02.008; Powathil GG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003120; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; ROCKWELL S, 1980, BRIT J CANCER, V41, P118; Rosenstein BS, 2004, INT J RADIAT ONCOL, V60, P1393, DOI 10.1016/j.ijrobp.2004.05.072; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saunders M, 1997, LANCET, V350, P161, DOI 10.1016/S0140-6736(97)06305-8; Sugie C, 2006, INT J RADIAT ONCOL, V64, P619, DOI 10.1016/j.ijrobp.2005.03.032; THAMES HD, 1985, INT J RADIAT BIOL, V47, P319, DOI 10.1080/09553008514550461; UK CR, 2010, RAD BRIEFSH; Venkatasubramanian R, 2006, J THEOR BIOL, V242, P440, DOI 10.1016/j.jtbi.2006.03.011; Wein LM, 2000, INT J RADIAT ONCOL, V47, P1073, DOI 10.1016/S0360-3016(00)00534-4; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Yu Y, 1997, MED PHYS, V24, P1742, DOI 10.1118/1.597951; Zacharaki EI, 2004, COMPUT METH PROG BIO, V76, P193, DOI 10.1016/j.cmpb.2004.07.003	75	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114098	10.1371/journal.pone.0114098	http://dx.doi.org/10.1371/journal.pone.0114098			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460164	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700097
J	Canello, T; Ovadia, H; Refael, M; Zrihan, D; Siegal, T; Lavon, I				Canello, Tamar; Ovadia, Haim; Refael, Miri; Zrihan, Daniel; Siegal, Tali; Lavon, Iris			Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer	PLOS ONE			English	Article							NF-KAPPA-B; PHASE-II TRIAL; HUMAN O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ALKYLATING-AGENTS; MALIGNANT GLIOMA; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; ANTISENSE OLIGONUCLEOTIDES; ADVANCED MELANOMA	Silencing of O(6)-methylguanine-DNA-methyltransferase (MGMT) in tumors, mainly through promoter methylation, correlates with a better therapeutic response and with increased survival. Therefore, it is conceivable to consider MGMT as a potential therapeutic target for the treatment of cancers. Our previous results demonstrated the pivotal role of NF-kappaB in MGMTexpression, mediated mainly through p65/NF-kappaB homodimers. Here we show that the non-canonical NF-KappaB motif (MGMT-kappaB1) within MGMT enhancer is probably the major inducer of MGMTexpression following NF-kappaB activation. Thus, in an attempt to attenuate the transcription activity of MGMT in tumors we designed locked nucleic acids (LNA) modified decoy oligonucleotides corresponding to the specific sequence of MGMT-kappaB1 (MGMT-kB1-LODN). Following confirmation of the ability of MGMT-kB1-LODN to interfere with the binding of p65/NF-kappaB to the NF-KappaB motif within MGMTenhancer, the efficacy of the decoy was studied in-vitro and in-vivo. The results of these experiments show that the decoy MGMT-kB1-LODN have a substantial antineoplastic effect when used either in combination with temozolomide or as monotherapy. Our results suggest that MGMT-kB1-LODN may provide a novel strategy for cancer therapy.	[Lavon, Iris] Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Leslie & Michael Gaffin Ctr Neurooncol, Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Lavon, I (corresponding author), Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Leslie & Michael Gaffin Ctr Neurooncol, Jerusalem, Israel.	Irisl@hadassah.org.il	Lavon, Iris/ABE-6651-2021		Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist [49040]	Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist	This work was supported by 49040: Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batts ED, 2007, CANCER CHEMOTH PHARM, V60, P415, DOI 10.1007/s00280-007-0442-7; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cesinaro AM, 2012, PATHOLOGY, V44, P313, DOI 10.1097/PAT.0b013e328353a0ff; Chen FY, 1997, P NATL ACAD SCI USA, V94, P4348, DOI 10.1073/pnas.94.9.4348; CITRON M, 1995, ONCOL RES, V7, P49; Dias N, 2002, MOL CANCER THER, V1, P347; DOLAN ME, 1990, CANCER COMMUN, V2, P371, DOI 10.3727/095535490820873985; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frieden M, 2003, NUCLEIC ACIDS RES, V31, P6365, DOI 10.1093/nar/gkg820; Friedman HS, 1998, J CLIN ONCOL, V16, P3570, DOI 10.1200/JCO.1998.16.11.3570; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; Gajewski TF, 2005, CLIN CANCER RES, V11, P7861, DOI 10.1158/1078-0432.CCR-05-0060; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hao Tian-zhi, 2003, Zhonghua Shao Shang Za Zhi, V19, P175; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kefford RF, 2009, BRIT J CANCER, V100, P1245, DOI 10.1038/sj.bjc.6605016; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Kokkinakis DM, 1997, CANCER RES, V57, P5360; Konduri SD, 2009, CLIN CANCER RES, V15, P6087, DOI 10.1158/1078-0432.CCR-09-0887; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lavon I, 2007, CANC RES, V67; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Malik PS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00076; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.ymthe.2005.02.010; Niture SK, 2005, BIOCHEM BIOPH RES CO, V337, P1176, DOI 10.1016/j.bbrc.2005.09.177; Plummer R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2877; Quinn JA, 2005, J CLIN ONCOL, V23, P7178, DOI 10.1200/JCO.2005.06.502; Ranson M, 2006, CLIN CANCER RES, V12, P1577, DOI 10.1158/1078-0432.CCR-05-2198; Ranson M, 2007, J CLIN ONCOL, V25, P2540, DOI 10.1200/JCO.2007.10.8217; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Ryan CW, 2006, CANCER CHEMOTH PHARM, V58, P634, DOI 10.1007/s00280-006-0210-0; Schilsky RL, 2000, CLIN CANCER RES, V6, P3025; SCHOLD SC, 1989, J NEUROSURG, V70, P573, DOI 10.3171/jns.1989.70.4.0573; Schold SC, 2004, NEURO-ONCOLOGY, V6, P28, DOI 10.1215/S115285170300019X; Schraml P, ONCOL REP, V28, P654; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Spiro T, 2000, Forum (Genova), V10, P274; Spiro TP, 1999, CANCER RES, V59, P2402; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tawbi HA, 2011, BRIT J CANCER, V105, P773, DOI 10.1038/bjc.2011.285; Wang HF, 2008, INT J MOL SCI, V9, P1851, DOI 10.3390/ijms9091851; Warren KE, 2005, J CLIN ONCOL, V23, P7646, DOI 10.1200/JCO.2005.02.0024; Weingart J, 2007, J CLIN ONCOL, V25, P399, DOI 10.1200/JCO.2006.06.6290; WU ZN, 1992, CANCER RES, V52, P32; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113854	10.1371/journal.pone.0113854	http://dx.doi.org/10.1371/journal.pone.0113854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460932	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700060
J	Fujita, Y; Okamoto, M; Goda, H; Tano, T; Nakashiro, K; Sugita, A; Fujita, T; Koido, S; Homma, S; Kawakami, Y; Hamakawa, H				Fujita, Yohei; Okamoto, Masato; Goda, Hiroyuki; Tano, Tomoyuki; Nakashiro, Koh-ichi; Sugita, Atsuro; Fujita, Tomonobu; Koido, Shigeo; Homma, Sadamu; Kawakami, Yutaka; Hamakawa, Hiroyuki			Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							T-CELLS; CANCER; RECURRENCE; EXPRESSION; HEAD	Purpose: We investigated whether serum interleukin (IL)-8 reflects the tumor microenvironment and has prognostic value in patients with oral squamous cell carcinoma (OSCC). Experimental Design: Fifty OSCC patients who received radical resection of their tumor(s) were enrolled. Preoperative sera were measured for IL-8 by ELISA. Expression of IL-8 and the infiltration of immune cells in tumor tissues were analyzed by an immunohistochemical staining of surgical specimens. Results: We found that disease-free survival (DFS) was significantly longer in the Stage I/II OSCC patients with low serum IL-8 levels compared to those with high levels (p=0.001). The tumor expression of IL-8, i.e., IL-8(T) and the density of CD163-positive cells in the tumor invasive front, i.e., CD163(IF) were correlated with the serum IL-8 level (p=0.033 and p=0.038, respectively), and they were associated with poor clinical outcome (p=0.007 and p=0.002, respectively, in DFS) in all patients. A multivariate analysis revealed that N status, IL-8(T) and CD163(IF) significantly affected the DFS of the patients. Further analysis suggested that combination of N status with serum IL-8, IL-8(T) or CD163(IF) may be a new criterion for discriminating between OSCC patients at high and low risk for tumor relapse. Interestingly, the in vitro experiments demonstrated that IL-8 enhanced generation of CD163-positive M2 macrophages from peripheral blood monocytes, and that the cells produced IL-10. Conclusions: These findings indicate that IL-8 may be involved in poor clinical outcomes via generation of CD163-positive M2 macrophages, and that these factors in addition to N status may have prognostic value in patients with resectable OSCSS.	[Fujita, Yohei; Goda, Hiroyuki; Tano, Tomoyuki; Nakashiro, Koh-ichi; Hamakawa, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime 790, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Okamoto, Masato; Fujita, Tomonobu; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Homma, Sadamu] Jikei Univ, Dept Oncol, Inst DNA Med, Sch Med, Tokyo, Japan	Ehime University; Kitasato University; Keio University; Jikei University; Jikei University	Okamoto, M (corresponding author), Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan.	okamotom@pharm.kitasato-u.ac.jp	Nakashiro, Koichi/AAV-6317-2020; Kawakami, Yutaka/E-7429-2013	Kawakami, Yutaka/0000-0003-4836-2855; Nakashiro, Koh-ichi/0000-0002-9975-902X	Ministry of Education, Cultures, Sports, Science and Technology of Japan [25293412]; Grants-in-Aid for Scientific Research [25463119, 26670866] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Cultures, Sports, Science and Technology of Japan (No. 25293412) (http://www.mext.go.jp/english/) (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2008, CURR OPIN OTOLARYNGO, V16, P117, DOI 10.1097/MOO.0b013e3282f6a4b0; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fridman WH, 2013, CANCER MICROENVIRON, V6, P117, DOI 10.1007/s12307-012-0124-9; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Kreppel M, 2011, HEAD NECK-J SCI SPEC, V33, P1467, DOI 10.1002/hed.21630; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Tano T, 2013, NEOPLASIA, V15, P305, DOI 10.1593/neo.121528; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Woolgar JA, 2009, FUTURE ONCOL, V5, P51, DOI 10.2217/14796694.5.1.51; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang T, 2010, CANCER IMMUNOL IMMUN, V59, P1097, DOI 10.1007/s00262-010-0836-y	25	44	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110378	10.1371/journal.pone.0110378	http://dx.doi.org/10.1371/journal.pone.0110378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461761	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700003
J	Ravinet, M; Takeuchi, N; Kume, M; Mori, S; Kitano, J				Ravinet, Mark; Takeuchi, Naoko; Kume, Manabu; Mori, Seiichi; Kitano, Jun			Comparative Analysis of Japanese Three-Spined Stickleback Clades Reveals the Pacific Ocean Lineage Has Adapted to Freshwater Environments while the Japan Sea Has Not	PLOS ONE			English	Article							LAKE-STREAM STICKLEBACK; THREESPINE STICKLEBACK; GASTEROSTEUS-ACULEATUS; ECOLOGICAL OPPORTUNITY; FORAGING EFFICIENCY; FEEDING PERFORMANCE; GENETIC-DIVERGENCE; STABLE-ISOTOPES; TRADE-OFFS; SPECIATION	Divergent selection and adaptive divergence can increase phenotypic diversification amongst populations and lineages. Yet adaptive divergence between different environments, habitats or niches does not occur in all lineages. For example, the colonization of freshwater environments by ancestral marine species has triggered adaptive radiation and phenotypic diversification in some taxa but not in others. Studying closely related lineages differing in their ability to diversify is an excellent means of understanding the factors promoting and constraining adaptive evolution. A well-known example of the evolution of increased phenotypic diversification following freshwater colonization is the three-spined stickleback. Two closely related stickleback lineages, the Pacific Ocean and the Japan Sea occur in Japan. However, Japanese freshwater stickleback populations are derived from the Pacific Ocean lineage only, suggesting the Japan Sea lineage is unable to colonize freshwater. Using stable isotope data and trophic morphology, we first show higher rates of phenotypic and ecological diversification between marine and freshwater populations within the Pacific Ocean lineage, confirming adaptive divergence has occurred between the two lineages and within the Pacific Ocean lineage but not in the Japan Sea lineage. We further identified consistent divergence in diet and foraging behaviour between marine forms from each lineage, confirming Pacific Ocean marine sticklebacks, from which all Japanese freshwater populations are derived, are better adapted to freshwater environments than Japan Sea sticklebacks. We suggest adaptive divergence between ancestral marine populations may have played a role in constraining phenotypic diversification and adaptive evolution in Japanese sticklebacks.	[Ravinet, Mark; Takeuchi, Naoko; Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan; [Kume, Manabu; Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Ogaki, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ravinet, M (corresponding author), Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan.	mravinet@nig.ac.jp; jkitano@lab.nig.ac.jp	Kume, Manabu/Y-5237-2018; Kume, Manabu/AAI-7926-2020	Kume, Manabu/0000-0001-7287-029X; Kume, Manabu/0000-0001-7287-029X; Ravinet, Mark/0000-0002-2841-1798	Japan Science and Technology Agency PRESTO program; Center for the Promotion of Integrated Sciences (CPIS) of Sokendai; Ministry of Education, Science, Sports, and Culture [23113007, 23113001]; Japanese Society for the Promotion of Science; NIG Collaborative Research Program [2013-A33, A34]	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Center for the Promotion of Integrated Sciences (CPIS) of Sokendai(Graduate University for Advanced Studies - Japan); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIG Collaborative Research Program	This research was supported by the Japan Science and Technology Agency PRESTO program, Center for the Promotion of Integrated Sciences (CPIS) of Sokendai, and Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) from the Ministry of Education, Science, Sports, and Culture to JK. MR was kindly funded by the Japanese Society for the Promotion of Science on a Short-term Postdoctoral Fellowship and the NIG Collaborative Research Program (2013-A33 and A34). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bell Michael A., 1994, P1; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2010, MOL ECOL, V19, P4963, DOI 10.1111/j.1365-294X.2010.04858.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Boettiger C, 2012, EVOLUTION, V66, P2240, DOI 10.1111/j.1558-5646.2011.01574.x; Bolnick DI, 2009, EVOLUTION, V63, P2004, DOI 10.1111/j.1558-5646.2009.00699.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cassidy LM, 2013, EVOL ECOL RES, V15, P295; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Deagle BE, 2013, MOL ECOL, V22, P1917, DOI 10.1111/mec.12215; DeFaveri J, 2012, J FISH BIOL, V80, P61, DOI 10.1111/j.1095-8649.2011.03147.x; DeFaveri J, 2011, EVOLUTION, V65, P1800, DOI 10.1111/j.1558-5646.2011.01247.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Flohr RCE, 2013, P NATL ACAD SCI USA, V110, P20663, DOI 10.1073/pnas.1310310110; Gill AB, 1996, J FISH BIOL, V48, P878; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goto A., 2003, NATURAL HIST STICKLE; Gould S. J., 1990, WONDERFUL LIFE BURGE; Grey J., 2000, INT VER F R THEOR AN, V27, P3187, DOI [10.1080/03680770.1998.11898266, DOI 10.1080/03680770.1998.11898266]; Grey J, 2006, POL J ECOL, V54, P563; HAMADA K, 1975, Japanese Journal of Ichthyology, V21, P183; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2004, EVOLUTION, V58, P2319; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HONMA Y, 1977, JPN J ICHTHYOL, V24, P17; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; IBRAHIM AA, 1988, J FISH BIOL, V33, P823, DOI 10.1111/j.1095-8649.1988.tb05528.x; Ikeda K, 1933, ZOOL MAG, V45, P141; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; Kume M, 2010, J EVOLUTION BIOL, V23, P1436, DOI 10.1111/j.1420-9101.2010.02009.x; Langella O, 2013, POPULATIONS; Lee CE, 1999, TRENDS ECOL EVOL, V14, P284, DOI 10.1016/S0169-5347(99)01596-7; Losos J.B., 2010, EVOLUTION DARWIN 1 1, P381; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.1890/0012-9658(1999)080[0252:DCSAAI]2.0.CO;2; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lucek K, 2013, J EVOLUTION BIOL, P1; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; MORI S, 1987, JPN J ICHTHYOL, V34, P33, DOI 10.1007/BF02904141; Nazarkin MV, 2013, PALEONTOL RES, V16, P318, DOI 10.2517/1342-8144-16.4.318; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 2000, MOL EVOLUTION PHYLOG; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Meara BC, 2006, EVOLUTION, V60, P922; Ord TJ, 2012, J EVOLUTION BIOL, V25, P2047, DOI 10.1111/j.1420-9101.2012.02582.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Roesch C, 2013, J EVOLUTION BIOL, V26, P1578, DOI 10.1111/jeb.12166; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rutschmann S, 2011, MOL ECOL, V20, P4707, DOI 10.1111/j.1365-294X.2011.05279.x; Schindler DE, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P25; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; SHORROCKS B, 1994, J ANIM ECOL, V63, P799, DOI 10.2307/5257; Spoljaric MA, 2007, J FISH BIOL, V70, P1484, DOI 10.1111/j.1095-8649.2007.01425.x; Tsuruta T, 2006, J FISH BIOL, V69, P155, DOI 10.1111/j.1095-8649.2006.01154.x; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260	89	19	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112404	10.1371/journal.pone.0112404	http://dx.doi.org/10.1371/journal.pone.0112404			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460163	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700017
J	Ru, J; Sun, HH; Fan, HX; Wang, CM; Li, YX; Liu, M; Tang, H				Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua			MiR-23a Facilitates the Replication of HSV-1 through the Suppression of Interferon Regulatory Factor 1	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; REAL-TIME PCR; TRANSCRIPTION FACTOR; ANTIVIRAL DEFENSE; CANCER CELLS; IFN-BETA; MICRORNAS TARGET; INDUCIBLE GENES; DOWN-REGULATION	MicroRNAs (miRNAs) are small, non-coding RNAs that negatively regulate gene expression. It has been reported that miRNAs are involved in host-virus interaction, but evidence that cellular miRNAs promote virus replication has been limited. Here, we found that miR-23a promoted the replication of human herpes simplex virus type 1 (HSV-1) in HeLa cells, as demonstrated by a plaque-formation assay and quantitative real-time PCR. Furthermore, interferon regulatory factor 1 (IRF1), an innate antiviral molecule, is targeted by miR-23a to facilitate viral replication. MiR-23a binds to the 3'UTR of IRF1 and down-regulates its expression. Suppression of IRF1 expression reduced RSAD2 gene expression, augmenting HSV-1 replication. Ectopic expression of IRF1 abrogated the promotion of HSV-1 replication induced by miR-23a. Notably, IRF1 contributes to innate antiviral immunity by binding to IRF-response elements to regulate the expression of interferon-stimulated genes (ISGs) and apoptosis, revealing a complex interaction between miR-23a and HSV-1. MiR-23a thus contributes to HSV-1 replication through the regulation of the IRF1-mediated antiviral signal pathway, which suggests that miR-23a may represent a promising target for antiviral treatments.	[Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin 300070, Peoples R China; [Ru, Jing] Yunnan Univ Tradit Chinese Med, Sch Basic Med Sci, Dept Pathophysiol, Kunming 650500, Peoples R China	Tianjin Medical University; Tianjin Medical University; Yunnan University of Chinese Medicine	Tang, H (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China.	htang2002@yahoo.com	li, yixuan/P-5376-2016		National Natural Science Foundation of China [31100933, 31270818, 91029714, 31071191, 81201281/H1904]; Natural Science Foundation of Tianjin [12JCZDJC25100, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (No: 31100933; 31270818; 91029714; 31071191; 81201281/H1904), and the Natural Science Foundation of Tianjin (No: 12JCZDJC25100; 09JCZDJC17500).	An J, 2013, J CELL BIOCHEM, V114, P2160, DOI 10.1002/jcb.24565; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Guo XK, 2013, J VIROL, V87, P1159, DOI 10.1128/JVI.02386-12; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; Havelange V, 2011, CANCER-AM CANCER SOC, V117, P4696, DOI 10.1002/cncr.26096; Hong S, 2013, J BIOL CHEM, V288, P3560, DOI 10.1074/jbc.M112.400408; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; Koller K, 2013, GENE CHROMOSOME CANC, V52, P709, DOI 10.1002/gcc.22066; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lian SZ, 2013, CURR PHARM DESIGN, V19, P6382; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Matzinger SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029255; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; Nystrom K, 2004, J VIROL METHODS, V118, P83, DOI 10.1016/j.jviromet.2004.01.019; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Sanfilippo CM, 2006, J VIROL, V80, P6810, DOI 10.1128/JVI.00334-06; Saumet A, 2012, MOL BIOSYST, V8, P3242, DOI 10.1039/c2mb25298h; SCHMIDT OW, 1979, J CLIN MICROBIOL, V9, P722; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen GH, 2014, J VIROL, V88, P12163, DOI 10.1128/JVI.01380-14; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yang XK, 2012, REPRODUCTION, V144, P235, DOI 10.1530/REP-11-0371; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	51	45	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114021	10.1371/journal.pone.0114021	http://dx.doi.org/10.1371/journal.pone.0114021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461762	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700083
J	Vielma, AH; Agurto, A; Valdes, J; Palacios, AG; Schmachtenberg, O				Vielma, Alex H.; Agurto, Adolfo; Valdes, Joaquin; Palacios, Adrian G.; Schmachtenberg, Oliver			Nitric Oxide Modulates the Temporal Properties of the Glutamate Response in Type 4 OFF Bipolar Cells	PLOS ONE			English	Article							SYNTHASE-IMMUNOREACTIVE NEURONS; AMINOBUTYRIC-ACID RELEASE; RETINAL GANGLION-CELLS; CGMP-DEPENDENT KINASE; INNER PLEXIFORM LAYER; MOUSE RETINA; RAT RETINA; KAINATE RECEPTORS; MAMMALIAN RETINA; S-NITROSYLATION	Nitric oxide (NO) is involved in retinal signal processing, but its cellular actions are only partly understood. An established source of retinal NO are NOACs, a group of nNOS-expressing amacrine cells which signal onto bipolar, other amacrine and ganglion cells in the inner plexiform layer. Here, we report that NO regulates glutamate responses in morphologically and electrophysiologically identified type 4 OFF cone bipolar cells through activation of the soluble guanylyl cyclase-cGMP-PKG pathway. The glutamate response of these cells consists of two components, a fast phasic current sensitive to kainate receptor agonists, and a secondary component with slow kinetics, inhibited by AMPA receptor antagonists. NO shortened the duration of the AMPA receptor-dependent component of the glutamate response, while the kainate receptor-dependent component remained unchanged. Application of 8-Br-cGMP mimicked this effect, while inhibition of soluble guanylate cyclase or protein kinase G prevented it, supporting a mechanism involving a cGMP signaling pathway. Notably, perfusion with a NOS-inhibitor prolonged the duration of the glutamate response, while the NO precursor L-arginine shortened it, in agreement with a modulation by endogenous NO. Furthermore, NO accelerated the response recovery during repeated stimulation of type 4 cone bipolar cells, suggesting that the temporal response properties of this OFF bipolar cell type are regulated by NO. These results reveal a novel cellular mechanism of NO signaling in the retina, and represent the first functional evidence of NO modulating OFF cone bipolar cells.	[Vielma, Alex H.; Agurto, Adolfo; Valdes, Joaquin; Palacios, Adrian G.; Schmachtenberg, Oliver] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile	Universidad de Valparaiso	Vielma, AH (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	alexvielma@gmail.com	Valdés, Joaquín/O-8478-2019; Palacios, Adrian G/E-9846-2015	Valdés, Joaquín/0000-0003-3222-8440; Palacios, Adrian G/0000-0003-1532-7527; Schmachtenberg, Oliver/0000-0001-7854-5009	CONICYT, Chile [1120513, 3140599]; Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso [P09-022-F]	CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso	Regular FONDECYT grant 1120513 from CONICYT, Chile (to OS), Postdoctoral FONDECYT grant 3140599 from CONICYT, Chile (to AHV) and Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso P09-022-F from ICM-1114 ECONOMIA, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; Arman AC, 2012, J NEUROPHYSIOL, V107, P2649, DOI 10.1152/jn.01202.2011; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Baldridge WH, 2001, VISUAL NEUROSCI, V18, P849, DOI 10.1017/S0952523801186013; Blom J, 2012, J COMP NEUROL, V520, P4204, DOI 10.1002/cne.23148; Blute TA, 2000, VISUAL NEUROSCI, V17, P557, DOI 10.1017/S0952523800174061; Blute TA, 1998, VISUAL NEUROSCI, V15, P485; Borda E, 2005, EXP EYE RES, V80, P391, DOI 10.1016/j.exer.2004.09.016; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Cao LX, 2001, VISUAL NEUROSCI, V18, P949, DOI 10.1017/S0952523801186128; da Costa BLDA, 2001, NEUROSCI LETT, V302, P21; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Ding JD, 2007, J COMP NEUROL, V500, P734, DOI 10.1002/cne.21206; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; Euler T, 1996, J NEUROSCI, V16, P2934; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Garthwaite J, 2005, FRONT BIOSCI-LANDMRK, V10, P1868; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Giove TJ, 2009, J NEUROSCI RES, V87, P3134, DOI 10.1002/jnr.22133; Gotzes S, 1998, VISUAL NEUROSCI, V15, P945, DOI 10.1017/S0952523898155141; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Haverkamp S, 1998, NEUROREPORT, V9, P2231, DOI 10.1097/00001756-199807130-00015; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2008, J COMP NEUROL, V507, P1087, DOI 10.1002/cne.21612; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Ivanova E, 2006, EUR J NEUROSCI, V23, P350, DOI 10.1111/j.1460-9568.2005.04557.x; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Johansson K, 2000, INVEST OPHTH VIS SCI, V41, P305; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim IB, 1999, NEUROSCI LETT, V267, P193, DOI 10.1016/S0304-3940(99)00363-8; Kim IB, 2000, MICROSC RES TECHNIQ, V50, P112, DOI 10.1002/1097-0029(20000715)50:2<112::AID-JEMT3>3.0.CO;2-S; KOISTINAHO J, 1993, NEUROSCIENCE, V57, P587, DOI 10.1016/0306-4522(93)90008-4; Li W, 2010, NAT NEUROSCI, V13, P414, DOI 10.1038/nn.2507; Lindstrom SH, 2014, J PHYSIOL-LONDON, V592, P1457, DOI 10.1113/jphysiol.2013.265033; Lu Q, 2009, NEUROSCIENCE, V163, P662, DOI 10.1016/j.neuroscience.2009.07.002; MAGUIRE G, 1994, J NEUROSCI, V14, P6094; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mastrodimou N, 2006, REGUL PEPTIDES, V133, P41, DOI 10.1016/j.regpep.2005.09.034; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Oh SJ, 1999, CELL TISSUE RES, V297, P397, DOI 10.1007/s004410051367; Pang JJ, 2010, J COMP NEUROL, V518, P2456, DOI 10.1002/cne.22347; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PEREZ MTR, 1995, EXP BRAIN RES, V104, P207; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; SAITO T, 1983, J GEN PHYSIOL, V81, P589, DOI 10.1085/jgp.81.4.589; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Tooker RE, 2013, J NEUROSCI, V33, P19176, DOI 10.1523/JNEUROSCI.2792-13.2013; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014; Vielma AH, 2012, BRAIN RES, V1430, P112, DOI 10.1016/j.brainres.2011.10.045; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Walter LT, 2014, EXP NEUROL, V261, P510, DOI 10.1016/j.expneurol.2014.07.019; Wang GY, 2003, J NEUROPHYSIOL, V90, P1304, DOI 10.1152/jn.00243.2003; Wexler EM, 1998, J NEUROSCI, V18, P2342; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416	64	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114330	10.1371/journal.pone.0114330	http://dx.doi.org/10.1371/journal.pone.0114330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463389	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700129
J	Wong, KK; Shi, JR; Gao, HJ; Zheteyeva, YA; Lane, K; Copeland, D; Hendricks, J; McMurray, L; Sliger, K; Rainey, JJ; Uzicanin, A				Wong, Karen K.; Shi, Jianrong; Gao, Hongjiang; Zheteyeva, Yenlik A.; Lane, Kimberly; Copeland, Daphne; Hendricks, Jennifer; McMurray, LaFrancis; Sliger, Kellye; Rainey, Jeanette J.; Uzicanin, Amra			Why Is School Closed Today? Unplanned K-12 School Closures in the United States, 2011-2013	PLOS ONE			English	Article							INFLUENZA-A H1N1; PANDEMIC INFLUENZA; OUTBREAK; LESSONS; SANDY	Introduction: We describe characteristics of unplanned school closures (USCs) in the United States over two consecutive academic years during a non-pandemic period to provide context for implementation of school closures during a pandemic. Methods: From August 1, 2011 through June 30, 2013, daily systematic internet searches were conducted for publicly announced USCs lasting >= 1 day. The reason for closure and the closure dates were recorded. Information on school characteristics was obtained from the National Center for Education Statistics. Results: During the two-year study period, 20,723 USCs were identified affecting 27,066,426 students. Common causes of closure included weather (79%), natural disasters (14%), and problems with school buildings or utilities (4%). Only 771 (4%) USCs lasted >= 4 school days. Illness was the cause of 212 (1%) USCs; of these, 126 (59%) were related to respiratory illnesses and showed seasonal variation with peaks in February 2012 and January 2013. Conclusions: USCs are common events resulting in missed school days for millions of students. Illness causes few USCs compared with weather and natural disasters. Few communities have experience with prolonged closures for illness.	[Wong, Karen K.; Shi, Jianrong; Gao, Hongjiang; Zheteyeva, Yenlik A.; Copeland, Daphne; Rainey, Jeanette J.; Uzicanin, Amra] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Lane, Kimberly] Chenega Govt Consulting, Chesapeake, VA USA; [Hendricks, Jennifer; McMurray, LaFrancis; Sliger, Kellye] Oak Ridge Associated Univ, Oak Ridge, TN USA	Centers for Disease Control & Prevention - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory	Uzicanin, A (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	auzicanin@cdc.gov		Wong, Karen/0000-0002-5287-6456	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov/). Several co-authors are or were employees (KW HG YZ DC JR AU) or contractors (JS KL) of the US CDC at the time of the study, and their roles in the study design, data collection and analysis, decision to publish, and preparation of the manuscript are described in the Author Contributions.	Awofisayo A, 2013, PUBLIC HEALTH, V127, P637, DOI 10.1016/j.puhe.2013.04.014; Behr JG, 2013, J PUBLIC HEALTH MAN, V19, pS55, DOI 10.1097/PHH.0b013e318297226a; Berg R., 2013, TROPICAL CYCLONE REP; Bivand R, 2013, RGDAL BINDINGS GEOSP; Bivand RS, 2008, USE R, P1; Casey-Lockyer M, 2013, MMWR-MORBID MORTAL W, V62, P393; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Centers for Disease Control and Prevention FluView, FLUVIEW INFL LIK ILL; Community Preventive Services Task Force, 2012, EM PREP RESP SCH DIS; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Hansen B, 2008, SCH YEAR LENGT UNPUB; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Kann L, 2012, DISASTER MED PUBLIC, V6, P104, DOI 10.1001/dmp.2012.13; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Marchbanks TL, 2011, CLIN INFECT DIS, V52, pS154, DOI 10.1093/cid/ciq058; Marcotte DE, 2007, ECON EDUC REV, V26, P629, DOI 10.1016/j.econedurev.2006.08.001; Marcotte DE, 2008, EDUC FINANC POLICY, V3, P316, DOI 10.1162/edfp.2008.3.3.316; National Center for Education Statistics, 2011, COMM COR DAT PUBL SC; National Weather Service Forecast Office, 2014, SNOWF INF MAPS; Pebesma E., 2005, R NEWS, V5, P9; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redlener I, 2012, NEW ENGL J MED, V367, P2269, DOI 10.1056/NEJMp1213486; Steelfisher G. K., 2010, Morbidity and Mortality Weekly Report, V59, P1131; SteelFisher GK, 2012, LANCET INFECT DIS, V12, P845, DOI 10.1016/S1473-3099(12)70206-2; Sugisaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074716; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	29	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113755	10.1371/journal.pone.0113755	http://dx.doi.org/10.1371/journal.pone.0113755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463353	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700049
J	Hoare, DJ; Edmondson-Jones, M; Gander, PE; Hall, DA				Hoare, Derek J.; Edmondson-Jones, Mark; Gander, Phillip E.; Hall, Deborah A.			Agreement and Reliability of Tinnitus Loudness Matching and Pitch Likeness Rating	PLOS ONE			English	Article							RESIDUAL INHIBITION FUNCTIONS; AUDITORY-CORTEX; VARIABILITY; SPECTRA	The ability to reproducibly match tinnitus loudness and pitch is important to research and clinical management. Here we examine agreement and reliability of tinnitus loudness matching and pitch likeness ratings when using a computer-based method to measure the tinnitus spectrum and estimate a dominant tinnitus pitch, using tonal or narrowband sounds. Group level data indicated a significant effect of time between test session 1 and 2 for loudness matching, likely procedural or perceptual learning, which needs to be accounted in study design. Pitch likeness rating across multiple frequencies appeared inherently more variable and with no systematic effect of time. Dominant pitch estimates reached a level of clinical acceptability when sessions were spaced two weeks apart. However when dominant tinnitus pitch assessments were separated by three months, acceptable agreement was achieved only for group mean data, not for individual estimates. This has implications for prescription of some sound-based interventions that rely on accurate measures of individual dominant tinnitus pitch.	[Hoare, Derek J.; Edmondson-Jones, Mark; Gander, Phillip E.; Hall, Deborah A.] Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham, England; [Hoare, Derek J.; Edmondson-Jones, Mark; Hall, Deborah A.] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham, England; [Gander, Phillip E.] Univ Iowa, Carver Coll Med, Dept Neurosurg, Iowa City, IA USA	University of Nottingham; University of Nottingham; University of Iowa	Hoare, DJ (corresponding author), Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham, England.	derek.hoare@nottingham.ac.uk		Hall, Deborah/0000-0002-3804-1452; Hoare, Derek/0000-0002-8768-1392; Gander, Phillip Evan/0000-0003-3945-8820	National Institute for Health Research (NIHR) Biomedical Research Unit Programme	National Institute for Health Research (NIHR) Biomedical Research Unit Programme(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health Research (NIHR) Biomedical Research Unit Programme. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Amitay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009816; Basile CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082995; Brannstrom KJ, 2014, INT J AUDIOL, V53, P21, DOI 10.3109/14992027.2013.824116; BURNS EM, 1984, AUDIOLOGY, V23, P426; Davies J, 2014, INT J AUDIOL, V53, P192, DOI 10.3109/14992027.2013.846482; Henry James A, 2005, Am J Audiol, V14, P21, DOI 10.1044/1059-0889(2005/004); Hoare DJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-207; Hoare DJ, 2012, JARO-J ASSOC RES OTO, V13, P543, DOI 10.1007/s10162-012-0323-6; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Landgrebe M, 2012, J PSYCHOSOM RES, V73, P112, DOI 10.1016/j.jpsychores.2012.05.002; Moore David R., 2007, Seminars in Hearing, V28, P99, DOI 10.1055/s-2007-973436; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pantev C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00050; PENNER MJ, 1994, EAR HEARING, V15, P416, DOI 10.1097/00003446-199412000-00002; PENNER MJ, 1983, J SPEECH HEAR RES, V26, P263, DOI 10.1044/jshr.2602.263; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tyler R S, 1983, Br J Audiol, V17, P101, DOI 10.3109/03005368309078916; Wright BA, 2005, AUDITORY SIGNAL PROCESSINGP: PHYSIOLOGY, PSYCHOACOUSTICS, AND MODELS, P510; Zhou X, 2011, HEARING RES, V277, P107, DOI 10.1016/j.heares.2011.02.006	26	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114553	10.1371/journal.pone.0114553	http://dx.doi.org/10.1371/journal.pone.0114553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478690	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200101
J	Alpay, F; Zare, Y; Kamalludin, MH; Huang, XX; Shi, XW; Shook, GE; Collins, MT; Kirkpatrick, BW				Alpay, Fazli; Zare, Yalda; Kamalludin, Mamat H.; Huang, Xixia; Shi, Xianwei; Shook, George E.; Collins, Michael T.; Kirkpatrick, Brian W.			Genome-Wide Association Study of Susceptibility to Infection by Mycobacterium avium Subspecies paratuberculosis in Holstein Cattle	PLOS ONE			English	Article							JOHNES-DISEASE; ANTIBODY-RESPONSE; GENETIC-VARIATION; CROHNS-DISEASE; DAIRY HERDS; HERITABILITY; LOCI; PREVALENCE; VARIANTS; PERFORMANCE	Paratuberculosis, or Johne's disease, is a chronic, granulomatous, gastrointestinal tract disease of cattle and other ruminants caused by the bacterium Mycobacterium avium, subspecies paratuberculosis (MAP). Control of Johne's disease is based on programs of testing and culling animals positive for infection with MAP while concurrently modifying management to reduce the likelihood of infection. The current study is motivated by the hypothesis that genetic variation in host susceptibility to MAP infection can be dissected and quantifiable associations with genetic markers identified. For this purpose, a case-control, genome-wide association study was conducted using US Holstein cattle phenotyped for MAP infection using a serum ELISA and/or fecal culture test. Cases included cows positive for either serum ELISA, fecal culture or both. Controls consisted of animals negative for the serum ELISA test or both serum ELISA and fecal culture when both were available. Controls were matched by herd and proximal birth date with cases. A total of 856 cows (451 cases and 405 controls) were used in initial discovery analyses, and an additional 263 cows (159 cases and 104 controls) from the same herds were used as a validation data set. Data were analyzed in a single marker analysis controlling for relatedness of individuals (GRAMMAR-GC) and also in a Bayesian analysis in which multiple marker effects were estimated simultaneously (GenSel). For the latter, effects of non-overlapping 1 Mb marker windows across the genome were estimated. Results from the two discovery analyses were generally concordant; however, discovery results were generally not well supported in analysis of the validation data set. A combined analysis of discovery and validation data sets provided strongest support for SNPs and 1 Mb windows on chromosomes 1, 2, 6, 7, 17 and 29.	[Alpay, Fazli] Uludag Univ, Dept Anim Sci, Fac Vet Med, TR-16059 Bursa, Turkey; [Zare, Yalda; Kamalludin, Mamat H.; Shi, Xianwei; Kirkpatrick, Brian W.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Kamalludin, Mamat H.] Univ Putra Malaysia, Fac Agr, Dept Anim Sci, Upm Serdang, Selangor, Malaysia; [Huang, Xixia] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Shook, George E.; Kirkpatrick, Brian W.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Collins, Michael T.] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Madison, WI 53706 USA	Uludag University; University of Wisconsin System; University of Wisconsin Madison; Universiti Putra Malaysia; Xinjiang Agricultural University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kirkpatrick, BW (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	bwkirkpa@wisc.edu	Kamalludin, Mamat H/W-1626-2017; Alpay, Fazlı/AAE-4562-2019	Kamalludin, Mamat H/0000-0001-9728-8212; Alpay, Fazlı/0000-0002-3612-1002	United States Department of Agriculture National Institute of Food and Agriculture [2010-65205-20442, 2007-35205-17884]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by grants from United States Department of Agriculture National Institute of Food and Agriculture (grant #2010-65205-20442 and 2007-35205-17884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Brazil JC, 2013, J IMMUNOL, V191, P4804, DOI 10.4049/jimmunol.1301307; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Carter MA, 2011, VET CLIN N AM-FOOD A, V27, P637, DOI 10.1016/j.cvfa.2011.07.010; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; COLLINS MT, 1990, J CLIN MICROBIOL, V28, P2514, DOI 10.1128/JCM.28.11.2514-2519.1990; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Dargatz DA, 2001, J AM VET MED ASSOC, V219, P497, DOI 10.2460/javma.2001.219.497; ELMGREEN J, 1984, GUT, V25, P737, DOI 10.1136/gut.25.7.737; Fernando R. L., 2008, ANIMAL BREEDING GENE; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flanders WD, 1996, AM J EPIDEMIOL, V144, P696; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034349; Gomez-Rodriguez J, 2011, FEBS J, V278, P1980, DOI 10.1111/j.1742-4658.2011.08072.x; Gonda MG, 2006, J DAIRY SCI, V89, P1804, DOI 10.3168/jds.S0022-0302(06)72249-4; Groenendaal H, 2003, PREV VET MED, V60, P69, DOI 10.1016/S0167-5877(03)00083-7; Gunnarsson E, 2003, ACTA VET SCAND, V44, P255; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hinger M, 2008, J DAIRY SCI, V91, P3237, DOI 10.3168/jds.2008-1021; Jubb T, 2000, VET MICROBIOL, V77, P423, DOI 10.1016/S0378-1135(00)00327-8; Kennedy DJ, 2000, VET MICROBIOL, V77, P443, DOI 10.1016/S0378-1135(00)00329-1; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kirkpatrick BW, 2010, ANIM GENET; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Koets AP, 2000, J DAIRY SCI, V83, P2702, DOI 10.3168/jds.S0022-0302(00)75164-2; Kosaka Y, 2006, TRENDS IMMUNOL, V27, P453, DOI 10.1016/j.it.2006.08.006; Kupper J, 2012, J DAIRY SCI, V95, P2734, DOI 10.3168/jds.2011-4994; Lee Sang-Yull, 2004, Cancer Immun, V4, P13; Lombard JE, 2013, PREV VET MED, V108, P234, DOI 10.1016/j.prevetmed.2012.08.006; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Momotani E, 2012, JPN J VET RES, V60, pS19; Moon CM, 2013, J GASTROEN HEPATOL, V28, P1588, DOI 10.1111/jgh.12214; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; National Animal Health Monitoring System, 2008, JOHN DIS US DAIR 199; Neibergs HL, 2010, MAMM GENOME, V21, P419, DOI 10.1007/s00335-010-9278-2; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Salzberg SL, 1997, COMP CLASSIFIERS PIT; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shook GE, 2012, ANIM GENET, V43, P56, DOI 10.1111/j.1365-2052.2012.02349.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sweeney RW, 2012, J VET INTERN MED, V26, P1239, DOI 10.1111/j.1939-1676.2012.01019.x; Tharaldsen J, 2003, ACTA VET SCAND, V44, P243; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; van Hulzen KJE, 2011, J DAIRY SCI, V94, P992, DOI 10.3168/jds.2010-3472; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Zare Y, 2014, J DAIRY SCI; Zare Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088380	65	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111704	10.1371/journal.pone.0111704	http://dx.doi.org/10.1371/journal.pone.0111704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473852	Green Submitted, gold, Green Published			2022-12-27	WOS:000346382500063
J	Jiang, YF; Lan, XJ; Luo, W; Kong, XC; Qi, PF; Wang, JR; Wei, YM; Jiang, QT; Liu, YX; Peng, YY; Chen, GY; Dai, SF; Zheng, YL				Jiang, Yun-Feng; Lan, Xiu-Jin; Luo, Wei; Kong, Xing-Chen; Qi, Peng-Fei; Wang, Ji-Rui; Wei, Yu-Ming; Jiang, Qian-Tao; Liu, Ya-Xi; Peng, Yuan-Ying; Chen, Guo-Yue; Dai, Shou-Fen; Zheng, You-Liang			Genome-Wide Quantitative Trait Locus Mapping Identifies Multiple Major Loci for Brittle Rachis and Threshability in Tibetan Semi-Wild Wheat (Triticum aestivum ssp tibetanum Shao)	PLOS ONE			English	Article							MAP-BASED ANALYSIS; FREE-THRESHING HABIT; DOMESTICATION GENE-Q; HEXAPLOID WHEATS; COMMON WHEAT; CHROMOSOME LOCATION; AEGILOPS-TAUSCHII; POLYPLOID WHEAT; GLUME TENACITY; WEEDRACE	Tibetan semi-wild wheat (Triticum aestivum ssp. tibetanum Shao) is a semi-wild hexaploid wheat resource that is only naturally distributed in the Qinghai-Tibet Plateau. Brittle rachis and hard threshing are two important characters of Tibetan semi-wild wheat. A whole-genome linkage map of T. aestivum ssp. tibetanum was constructed using a recombinant inbred line population (Q1028 x ZM9023) with 186 lines, 564 diversity array technology markers, and 117 simple sequence repeat markers. Phenotypic data on brittle rachis and threshability, as two quantitative traits, were evaluated on the basis of the number of average spike rachis fragments per spike and percent threshability in 2012 and 2013, respectively. Quantitative trait locus (QTL) mapping performed using inclusive composite interval mapping analysis clearly identified four QTLs for brittle rachis and three QTLs for threshability. However, three loci on 2DS, 2DL, and 5AL showed pleiotropism for brittle rachis and threshability; they respectively explained 5.3%, 18.6%, and 18.6% of phenotypic variation for brittle rachis and 17.4%, 13.2%, and 35.2% of phenotypic variation for threshability. A locus on 3DS showed an independent effect on brittle rachis, which explained 38.7% of the phenotypic variation. The loci on 2DS and 3DS probably represented the effect of Tg and Br1, respectively. The locus on 5AL was in very close proximity to the Q gene, but was different from the predicted q in Tibetan semi-wild wheat. To our knowledge, the locus on 2DL has never been reported in common wheat but was prominent in T. aestivum ssp. tibetanum accession Q1028. It remarkably interacted with the locus on 5AL to affect brittle rachis. Several major loci for brittle rachis and threshability were identified in Tibetan semi-wild wheat, improving the understanding of these two characters and suggesting the occurrence of special evolution in Tibetan semi-wild wheat.	[Jiang, Yun-Feng; Lan, Xiu-Jin; Luo, Wei; Kong, Xing-Chen; Qi, Peng-Fei; Wang, Ji-Rui; Wei, Yu-Ming; Jiang, Qian-Tao; Liu, Ya-Xi; Peng, Yuan-Ying; Chen, Guo-Yue; Dai, Shou-Fen; Zheng, You-Liang] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Zheng, You-Liang] Sichuan Agr Univ, Minist Educ, Key Lab Southwestern Crop Germplasm Utilizat, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zheng, YL (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.	ylzheng@sicau.edu.cn	Jiang, Qiantao/C-6229-2017	Jiang, Qiantao/0000-0003-3192-3732	State Key Program of National Natural Science of China [31230053]; National Natural Science Foundation of China [30471088, 30370883]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the State Key Program of National Natural Science of China (Grant No. 31230053) and the National Natural Science Foundation of China (30471088; 30370883) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao WG, 1997, EUPHYTICA, V94, P119, DOI 10.1023/A:1002933608249; Chen QF, 1998, GENET RESOUR CROP EV, V45, P407, DOI 10.1023/A:1008635208146; Chen QF, 1999, GENET RESOUR CROP EV, V46, P543, DOI 10.1023/A:1008738423817; Chen QF, 2001, GENET RESOUR CROP EV, V48, P21, DOI 10.1023/A:1011291914213; DEVOS KM, 1992, THEOR APPL GENET, V84, P567, DOI 10.1007/BF00224153; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Faris JD, 2003, GENETICS, V164, P311; Faris JD, 2002, GENOME, V45, P706, DOI 10.1139/G02-036; Faris JD, 2005, WHEAT INFORM SERV, V100, P129; Faris JD, 2014, GENE, V542, P198, DOI 10.1016/j.gene.2014.03.034; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Kato K, 2003, PLANT BREEDING, V122, P489, DOI 10.1111/j.1439-0523.2003.00886.x; Lan Xiu-Jin, 2005, Journal of Applied Genetics, V46, P133; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Liu DengCai, 2003, Southwest China Journal of Agricultural Sciences, V16, P32; MacKey J, 1954, NEUTRON XRAY EXPT WH; MURAMATSU M, 1986, CAN J GENET CYTOL, V28, P30, DOI 10.1139/g86-006; Nalam VJ, 2007, THEOR APPL GENET, V116, P135, DOI 10.1007/s00122-007-0653-7; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Sears E.R., 1954, ANEUPLOIDS COMMON WH; Shao Q. Q., 1980, ACTA GENET SIN, V7, P150, DOI DOI 10.1098/RSPB.2009.1015; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Sood S, 2009, THEOR APPL GENET, V119, P341, DOI 10.1007/s00122-009-1043-0; VO JW, 2006, JOINTMAP 4 SOFTW CAL; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang Haiyan, 2007, Journal of Genetics and Genomics, V34, P623, DOI 10.1016/S1673-8527(07)60071-X; Wang J., 2012, USERS MANUAL QTL ICI; Watanabe N, 2006, EUPHYTICA, V151, P63, DOI 10.1007/s10681-006-9128-1; Watanabe N, 2005, EUPHYTICA, V144, P119, DOI 10.1007/s10681-005-5193-0; Watanabe N, 2002, HEREDITAS, V137, P180, DOI 10.1034/j.1601-5223.2002.01609.x; Watanabe N, 2006, J APPL GENET, V47, P93, DOI 10.1007/BF03194606; Wei YM, 2002, GENET RESOUR CROP EV, V49, P327, DOI 10.1023/A:1015544403431; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yoshiya K, 2012, GENET RESOUR CROP EV, V59, P67, DOI 10.1007/s10722-011-9668-7; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108	39	19	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114066	10.1371/journal.pone.0114066	http://dx.doi.org/10.1371/journal.pone.0114066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474652	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500107
J	Reifsnyder, PC; Doty, R; Harrison, DE				Reifsnyder, Peter C.; Doty, Rosalinda; Harrison, David E.			Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ	PLOS ONE			English	Article							GENETICALLY HETEROGENEOUS MICE; EXTENDS LIFE-SPAN; INSULIN-RESISTANCE; SIGNALING PATHWAY; BETA-CELLS; TOR; OBESITY; DIET; HYPERTENSION; METABOLISM	While rapamycin treatment has been reported to have a putatively negative effect on glucose homeostasis in mammals, it has not been tested in polygenic models of type 2 diabetes. One such mouse model, NONcNZO10/LtJ, was treated chronically with rapamycin (14 ppm encapsulated in diet) and monitored for the development of diabetes. As expected, rapamycin treatment accelerated the onset and severity of hyperglycemia. However, development of nephropathy was ameliorated, as both glomerulonephritis and IgG deposition in the subendothelial tuft were markedly reduced. Insulin production and secretion appeared to be inhibited, suppressing the developing hyperinsulinemia present in untreated controls. Rapamycin treatment also reduced body weight gain. Thus, rapamycin reduced some of the complications of diabetes despite elevating hyperglycemia. These results suggest that multiple factors must be evaluated when assessing the benefit vs. hazard of rapamycin treatment in patients that have overt, or are at risk for, type 2 diabetes. Testing of rapamycin in combination with insulin sensitizers is warranted, as such compounds may ameliorate the putative negative effects of rapamycin in the type 2 diabetes environment.	[Reifsnyder, Peter C.; Doty, Rosalinda; Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	david.harrison@jax.org			National Institutes of Health [AG022308]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038560, U01AG022308, R01AG032333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (AG022308 to DEH). http://www.nia.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; Das A, 2014, J BIOL CHEM, V289, P4145, DOI 10.1074/jbc.M113.521062; Deepa Sathyaseelan S, 2013, J Biochem Pharmacol Res, V1, P114; Duarte JMN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0021899; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Le Bacquer O, 2013, J ENDOCRINOL, V216, P21, DOI 10.1530/JOE-12-0351; Leiter EH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/165327; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reifsnyder PC, 2002, DIABETES, V51, P825, DOI 10.2337/diabetes.51.3.825; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Xun PC, 2013, AM J CLIN NUTR, V98, P1543, DOI 10.3945/ajcn.113.065565; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Zahr E, 2007, TRANSPLANTATION, V84, P1576, DOI 10.1097/01.tp.0000296035.48728.28	28	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114324	10.1371/journal.pone.0114324	http://dx.doi.org/10.1371/journal.pone.0114324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473963	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500013
J	Turner, CR; Miller, DJ; Coyne, KJ; Corush, J				Turner, Cameron R.; Miller, Derryl J.; Coyne, Kathryn J.; Corush, Joel			Improved Methods for Capture, Extraction, and Quantitative Assay of Environmental DNA from Asian Bigheaded Carp (Hypophthalmichthys spp.)	PLOS ONE			English	Article							SILVER CARP; MITOCHONDRIAL-DNA; GREAT-LAKES; PCR ASSAYS; PRESERVATION; DIVERSITY; PLANT; QUANTIFICATION; HYBRIDIZATION; CONSERVATION	Indirect, non-invasive detection of rare aquatic macrofauna using aqueous environmental DNA (eDNA) is a relatively new approach to population and biodiversity monitoring. As such, the sensitivity of monitoring results to different methods of eDNA capture, extraction, and detection is being investigated in many ecosystems and species. One of the first and largest conservation programs with eDNA-based monitoring as a central instrument focuses on Asian bigheaded carp (Hypophthalmichthys spp.), an invasive fish spreading toward the Laurentian Great Lakes. However, the standard eDNA methods of this program have not advanced since their development in 2010. We developed new, quantitative, and more cost-effective methods and tested them against the standard protocols. In laboratory testing, our new quantitative PCR (qPCR) assay for bigheaded carp eDNA was one to two orders of magnitude more sensitive than the existing endpoint PCR assays. When applied to eDNA samples from an experimental pond containing bigheaded carp, the qPCR assay produced a detection probability of 94.8% compared to 4.2% for the endpoint PCR assays. Also, the eDNA capture and extraction method we adapted from aquatic microbiology yielded five times more bigheaded carp eDNA from the experimental pond than the standard method, at a per sample cost over forty times lower. Our new, more sensitive assay provides a quantitative tool for eDNA-based monitoring of bigheaded carp, and the higher-yielding eDNA capture and extraction method we describe can be used for eDNA-based monitoring of any aquatic species.	[Turner, Cameron R.; Miller, Derryl J.; Corush, Joel] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Coyne, Kathryn J.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	University of Notre Dame; University of Delaware	Turner, CR (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	crt343@gmail.com		Coyne, Kathryn/0000-0001-8846-531X; Miller, Derryl/0000-0002-4226-4835; Corush, Joel/0000-0001-8192-4691	Great Lakes Restoration Initiative [FY10-S-T0240-O169-2]; Great Lakes Fishery Trust [2011.1197]; National Science Foundation (NSF) IGERT grant award [0504495]	Great Lakes Restoration Initiative; Great Lakes Fishery Trust; National Science Foundation (NSF) IGERT grant award(National Science Foundation (NSF))	Funding was provided by the Great Lakes Restoration Initiative (FY10-S-T0240-O169-2) and the Great Lakes Fishery Trust (2011.1197). CRT was supported by National Science Foundation (NSF) IGERT grant award #0504495 to the GLOBES graduate training program at the University of Notre Dame. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amberg J. J., 2013, 20131080 US GEOL SUR; [Anonymous], 2014, R LANG ENV STAT COMP; Ballantyne KN, 2008, GENOMICS, V91, P301, DOI 10.1016/j.ygeno.2007.10.016; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bellete B, 2003, J MICROBIOL METH, V55, P213, DOI 10.1016/S0167-7012(03)00141-6; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; CHAPMAN DC, 2011, AFS S BETH MAR US AM, V74; Cooke SL, 2010, FRESHWATER BIOL, V55, P2138, DOI 10.1111/j.1365-2427.2010.02474.x; Coyne KJ, 2005, LIMNOL OCEANOGR-METH, V3, P381, DOI 10.4319/lom.2005.3.381; Coyne KJ, 2001, AQUAT MICROB ECOL, V24, P275, DOI 10.3354/ame024275; CUDDINGTON K, 2013, BIOL INVASIONS, DOI DOI 10.1007/S10530-013-0547; Cudmore B, 2012, 2011114 DFO; de Lipthay JR, 2004, SOIL BIOL BIOCHEM, V36, P1607, DOI 10.1016/j.soilbio.2004.03.011; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dempster EL, 1999, BIOTECHNIQUES, V27, P66, DOI 10.2144/99271bm13; Dimichele Luke J., 1993, Journal of the American Society of Brewing Chemists, V51, P63; DROPPO IG, 2006, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A1506; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fusillo R, 2007, ACTA THERIOL, V52, P251, DOI 10.1007/BF03194221; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hamilton KM, 2011, J EUKARYOT MICROBIOL, V58, P446, DOI 10.1111/j.1550-7408.2011.00570.x; Herrera A, 2007, J MICROBIOL METH, V70, P1, DOI 10.1016/j.mimet.2007.04.005; Hetzer A, 2007, EXTREMOPHILES, V11, P605, DOI 10.1007/s00792-007-0073-2; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; HOCHMEISTER MN, 1991, INT J LEGAL MED, V104, P229, DOI 10.1007/BF01369812; HOROWITZ AJ, 1988, CHEM BIOL CHARACTERI, P102, DOI DOI 10.1520/STP26702S; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kennedy S, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P1; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kolar C.S., 2007, AM FISHERIES SOC SPE; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lamer JT, 2014, MOL ECOL RESOUR, V14, P79, DOI 10.1111/1755-0998.12152; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; Li SF, 2009, J FISH BIOL, V74, P1787, DOI 10.1111/j.1095-8649.2009.02258.x; Lindquist HDA, 2011, ENVIRONMENTAL MICROBIOLOGY: CURRENT TECHNOLOGY AND WATER APPLICATIONS, P39; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; Liu HZ, 2003, CAN J ZOOL, V81, P1938, DOI [10.1139/z03-169, 10.1139/Z03-169]; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Luna GM, 2006, ENVIRON MICROBIOL, V8, P308, DOI 10.1111/j.1462-2920.2005.00896.x; Martellini A, 2005, WATER RES, V39, P541, DOI 10.1016/j.watres.2004.11.012; McDonald Lyman L., 2004, P11; MIFFLIN TE, 2007, SETTING PCR LAB COLD, V2007, P5, DOI DOI 10.1101/PDB.TOP14; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Nagy ZT, 2010, ORG DIVERS EVOL, V10, P91, DOI 10.1007/s13127-010-0012-4; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niu C, 2008, AFR J BIOTECHNOL, V7, P2818; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; ROGSTAD SH, 1992, TAXON, V41, P701, DOI 10.2307/1222395; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P494, DOI 10.4319/lo.1972.17.3.0494; Siuda W, 1996, AQUAT MICROB ECOL, V11, P193, DOI 10.3354/ame011193; Stark KDC, 1998, APPL ENVIRON MICROB, V64, P543; STUCK JG, 2012, THESIS E ILLINOIS U; Sun J, 2010, CHIN J OCEANOL LIMN, V28, P315, DOI 10.1007/s00343-010-9285-x; Sutherland WJ, 2013, TRENDS ECOL EVOL, V28, P16, DOI 10.1016/j.tree.2012.10.022; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomson John A., 2002, Telopea, V9, P755; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; *US ARM CORPS ENG, 2013, INT TECHN REV REP; Widmer F, 1997, MOL ECOL, V6, P1, DOI 10.1046/j.1365-294X.1997.00145.x; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yao Y, 2006, MOL CELL PROBE, V20, P311, DOI 10.1016/j.mcp.2006.03.003; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	84	55	60	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114329	10.1371/journal.pone.0114329	http://dx.doi.org/10.1371/journal.pone.0114329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474207	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500015
J	Zhang, NW; Zhao, JJ; Lens, F; de Visser, J; Menamo, T; Fang, W; Xiao, D; Bucher, J; Basnet, RK; Lin, K; Cheng, F; Wang, XW; Bonnema, G				Zhang, Ningwen; Zhao, Jianjun; Lens, Frederic; de Visser, Joan; Menamo, Temesgen; Fang, Wen; Xiao, Dong; Bucher, Johan; Basnet, Ram Kumar; Lin, Ke; Cheng, Feng; Wang, Xiaowu; Bonnema, Guusje			Morphology, Carbohydrate Composition and Vernalization Response in a Genetically Diverse Collection of Asian and European Turnips (Brassica rapa subsp rapa)	PLOS ONE			English	Article							SUCROSE METABOLIZING ENZYMES; STORAGE ORGAN DEVELOPMENT; RAPHANUS-SATIVUS L; FLOWERING-TIME; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; CAMBIAL ACTIVITY; VAR. RAPA; POTATO; ROOTS	Brassica rapa displays enormous morphological diversity, with leafy vegetables, turnips and oil crops. Turnips (Brassica rapa subsp. rapa) represent one of the morphotypes, which form tubers and can be used to study the genetics underlying storage organ formation. In the present study we investigated several characteristics of an extensive turnip collection comprising 56 accessions from both Asia (mainly Japanese origin) and Europe. Population structure was calculated using data from 280 evenly distributed SNP markers over 56 turnip accessions. We studied the anatomy of turnip tubers and measured carbohydrate composition of the mature turnip tubers of a subset of the collection. The variation in 16 leaf traits, 12 tuber traits and flowering time was evaluated in five independent experiments for the entire collection. The effect of vernalization on flowering and tuber formation was also investigated. SNP marker profiling basically divided the turnip accessions into two subpopulations, with admixture, generally corresponding with geographical origin (Europe or Asia). The enlarged turnip tuber consists of both hypocotyl and root tissue, but the proportion of the two tissues differs between accessions. The ratio of sucrose to fructose and glucose differed among accessions, while generally starch content was low. The evaluated traits segregated in both subpopulations, with leaf shape, tuber colour and number of shoots per tuber explaining most variation between the two subpopulations. Vernalization resulted in reduced flowering time and smaller tubers for the Asian turnips whereas the European turnips were less affected by vernalization.	[Zhang, Ningwen; Zhao, Jianjun; de Visser, Joan; Menamo, Temesgen; Fang, Wen; Xiao, Dong; Bucher, Johan; Basnet, Ram Kumar; Lin, Ke; Bonnema, Guusje] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Cheng, Feng; Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Zhao, Jianjun] Hebei Agr Univ, Hort Coll, Baoding, Peoples R China; [Xiao, Dong] Nanjing Agr Univ, Hort Coll, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Lens, Frederic] Nat Biodivers Ctr, Leiden, Netherlands	Wageningen University & Research; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Hebei Agricultural University; Nanjing Agricultural University; Naturalis Biodiversity Center	Bonnema, G (corresponding author), Wageningen UR Plant Breeding, Wageningen, Netherlands.	Guusje.Bonnema@wur.nl	Lens, Frederic/B-8482-2011; Wang, Xiaowu/L-2579-2019; Menamo, Temesgen/AAI-2042-2019; Cheng, Feng/P-3233-2015	Lens, Frederic/0000-0002-5001-0149; Cheng, Feng/0000-0003-2982-9675; Menamo, Temesgen/0000-0003-4856-3147	Funding PSA program "Genomics of developmental and nutritional traits in Brassica rapa" [08-PSA-BD-02]	Funding PSA program "Genomics of developmental and nutritional traits in Brassica rapa"	The project is funded by Funding PSA program 08-PSA-BD-02 "Genomics of developmental and nutritional traits in Brassica rapa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Axelsson T, 2001, GENOME, V44, P856, DOI 10.1139/gen-44-5-856; Bellin D, 2002, PLANT BIOLOGY, V4, P700, DOI 10.1055/s-2002-37405; Bonnema AB, 2011, GENETICS GENOMICS BR, P81; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; de Candolle A., 1886, ORIGIN CULTIVATED PL, VXLIX, P376; de Souza CRB, 2004, PROTEIN PEPTIDE LETT, V11, P577; Del Carpio DP, 2011, THEOR APPL GENET, V122, P1105, DOI 10.1007/s00122-010-1516-1; ELLIOTT MC, 1986, BIOL PLANTARUM, V28, P1, DOI 10.1007/BF02885310; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GIAQUINTA RT, 1979, PLANT PHYSIOL, V63, P828, DOI 10.1104/pp.63.5.828; GOWERS S, 1988, EUPHYTICA, V37, P275; Grubben G., 2004, PLANT RESOURCES TROP, V61, P108; Gupta AK, 2001, ACTA PHYSIOL PLANT, V23, P31, DOI 10.1007/s11738-001-0019-8; HATCH MD, 1963, PLANT PHYSIOL, V38, P344, DOI 10.1104/pp.38.3.348; Hopkins R, 2008, NEW PHYTOL, V179, P155, DOI 10.1111/j.1469-8137.2008.02447.x; Huaman Z., 1986, SYSTEMATIC BOT MORPH; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Kloosterman B, 2005, PLANT BIOTECHNOL J, V3, P505, DOI 10.1111/j.1467-7652.2005.00141.x; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Lee JG, 2013, J AGR FOOD CHEM, V61, P3984, DOI 10.1021/jf400890p; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Lu G, 2008, J APPL GENET, V49, P23, DOI 10.1007/BF03195245; Lukaszewska E, 2012, PLANT BIOLOGY, V14, P216, DOI 10.1111/j.1438-8677.2011.00477.x; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Osborn TC, 1997, GENETICS, V146, P1123; Persson K, 2001, HEREDITAS, V134, P43, DOI 10.1111/j.1601-5223.2001.00043.x; PETERSON RL, 1973, CAN J BOT, V51, P475, DOI 10.1139/b73-055; PRAT S, 1990, FEBS LETT, V268, P334, DOI 10.1016/0014-5793(90)81281-R; RICARDO C P P, 1970, Phytochemistry (Oxford), V9, P239, DOI 10.1016/S0031-9422(00)85130-4; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Saito H, 2001, J JPN SOC HORTIC SCI, V70, P629, DOI 10.2503/jjshs.70.629; SALEHUZZAMAN SNIM, 1992, PLANT MOL BIOL, V20, P809, DOI 10.1007/BF00027152; Sharma N, 1998, PLANT GROWTH REGUL, V26, P97, DOI 10.1023/A:1006087729077; SHATTUCK VI, 1991, J AM SOC HORTIC SCI, V116, P818, DOI 10.21273/JASHS.116.5.818; SIRJUCHARRAN G, 1988, ANN BOT-LONDON, V61, P99, DOI 10.1093/oxfordjournals.aob.a087533; Sojikul P, 2010, PHYSIOL PLANTARUM, V140, P189, DOI 10.1111/j.1399-3054.2010.01389.x; TAKAHASHI H, 1994, J JPN SOC HORTIC SCI, V63, P99, DOI 10.2503/jjshs.63.99; Teutonico RA, 1995, THEOR APPL GENET, V91, P1279, DOI 10.1007/BF00220941; TING FST, 1980, ANN BOT-LONDON, V46, P277, DOI 10.1093/oxfordjournals.aob.a085918; TING FST, 1980, ANN BOT-LONDON, V46, P267, DOI 10.1093/oxfordjournals.aob.a085917; Trebbi D, 2009, PHYSIOL PLANTARUM, V135, P84, DOI 10.1111/j.1399-3054.2008.01169.x; Vogl-Lukasser B., 2008, ETHNOBOTANY RES APPL, V5, P305; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Y, 2013, PLANT PHYSIOL BIOCH, V70, P269, DOI 10.1016/j.plaphy.2013.05.041; YELLE S, 1991, PLANT PHYSIOL, V95, P1026, DOI 10.1104/pp.95.4.1026; Yildirim E, 2010, GENET MOL RES, V9, P987, DOI 10.4238/vol9-2gmr786; Zhang P, 2003, PLANTA, V218, P192, DOI 10.1007/s00425-003-1098-0; Zhao JJ, 2010, GENOME, V53, P884, DOI 10.1139/G10-082; Zhao JJ, 2010, J EXP BOT, V61, P1817, DOI 10.1093/jxb/erq048; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	56	86	86	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114241	10.1371/journal.pone.0114241	http://dx.doi.org/10.1371/journal.pone.0114241			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474111	Green Published, gold			2022-12-27	WOS:000346382500005
J	Arcaro, CA; Gutierres, VO; Assis, RP; Moreira, TF; Costa, PI; Baviera, AM; Brunetti, IL				Arcaro, Carlos Alberto; Gutierres, Vania Ortega; Assis, Renata Pires; Moreira, Thais Fernanda; Costa, Paulo Inacio; Baviera, Amanda Martins; Brunetti, Iguatemy Lourenco			Piperine, a Natural Bioenhancer, Nullifies the Antidiabetic and Antioxidant Activities of Curcumin in Streptozotocin-Diabetic Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; TISSUE DISTRIBUTION; INSULIN-RESISTANCE; BIOAVAILABILITY; TETRAHYDROCURCUMIN; PHARMACOKINETICS; GLUCURONIDATION; ABSORPTION	Knowing that curcumin has low bioavailability when administered orally, and that piperine has bioenhancer activity by inhibition of hepatic and intestinal biotransformation processes, the aim of this study was to investigate the antidiabetic and antioxidant activities of curcumin (90 mg/kg) and piperine (20 or 40 mg/kg), alone or co-administered, incorporated in yoghurt, in streptozotocin (STZ)-diabetic rats. The treatment for 45 days of STZ-diabetic rats with curcuminenriched yoghurt improved all parameters altered in this experimental model of diabetes: the body weight was increased in association with the weight of skeletal muscles and white adipose tissues; the progressive increase in the glycemia levels was avoided, as well as in the glycosuria, urinary urea, dyslipidemia, and markers of liver (alanine and aspartate aminotransferases and alkaline phosphatase) and kidney (urinary protein) dysfunction; the hepatic oxidative stress was decreased, since the activities of the antioxidant enzymes superoxide dismutase, catalase and gluthatione peroxidase were increased, and the levels of malondialdehyde and protein carbonyl groups were reduced. The dose of 20 mg/kg piperine also showed antidiabetic and antioxidant activities. The treatment of STZ-diabetic rats with both curcumin and 20 mg/kg piperine in yoghurt did not change the antidiabetic and antioxidant activities of curcumin; notably, the treatment with both curcumin and 40 mg/kg piperine abrogated the beneficial effects of curcumin. In addition, the alanine aminotransferase levels were further increased in diabetic rats treated with curcumin and 40 mg/kg piperine in comparison with untreated diabetic rats. These findings support that the co-administration of curcumin with a bioenhancer did not bring any advantage to the curcumin effects, at least about the antidiabetic and antioxidant activities, which could be related to changes on its biotransformation.	[Arcaro, Carlos Alberto; Gutierres, Vania Ortega; Assis, Renata Pires; Moreira, Thais Fernanda; Costa, Paulo Inacio; Baviera, Amanda Martins; Brunetti, Iguatemy Lourenco] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil	Universidade Estadual Paulista	Brunetti, IL (corresponding author), Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil.	brunetti@fcfar.unesp.br	Baviera, Amanda Martins/O-2028-2019; Brunetti, Iguatemy/AAS-8362-2021; Assis, Renata/HGD-9366-2022; Costa, Paulo I/D-7039-2018; Baviera, Amanda M/C-2737-2013	Baviera, Amanda Martins/0000-0003-0987-5295; Costa, Paulo I/0000-0002-3350-8308; Baviera, Amanda M/0000-0003-0987-5295; Brunetti, Iguatemy Lourenco/0000-0003-4927-7599; Arcaro Filho, Carlos Alberto/0000-0003-4642-2551; Pires de Assis, Renata/0000-0003-1070-9569	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the financial support and the scholarship for C. A. Arcaro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; ATAL CK, 1985, J PHARMACOL EXP THER, V232, P258; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEERS RF, 1952, J BIOL CHEM, V195, P133; Best L, 2007, BIOCHEM PHARMACOL, V73, P1768, DOI 10.1016/j.bcp.2007.02.006; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; Burgos-Moron E, 2010, INT J CANCER, V126, P1771, DOI 10.1002/ijc.24967; Choi S, 2013, FOOD CHEM, V141, P3627, DOI 10.1016/j.foodchem.2013.06.028; Cubero FJ, 2011, MOL PATHOL LIB, V5, P427, DOI 10.1007/978-1-4419-7107-4_28; Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]; DUBOWSKI KM, 1962, CLIN CHEM, V8, P215; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gutierres VO, 2012, BRIT J NUTR, V108, P440, DOI 10.1017/S0007114511005769; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation (IDF, 2014, IDF DIABETES ATLAS, P29; Kim T, 2009, BIOCHEM BIOPH RES CO, V388, P377, DOI 10.1016/j.bbrc.2009.08.018; Kohn HI, 1944, J PHARMACOL EXP THER, V82, P292; KONO Y, 1983, J BIOL CHEM, V258, P3646; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucchesi AN, 2013, ACTA CIR BRAS, V28, P505; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Meghana K, 2007, EUR J PHARMACOL, V577, P183, DOI 10.1016/j.ejphar.2007.09.002; Meng B, 2013, CURR PHARM DESIGN, V19, P2101; Mori DM, 2003, BIOTECHNOL APPL BIOC, V38, P183, DOI 10.1042/BA20030034; Morsy MA, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/387071; Murugan P, 2007, BASIC CLIN PHARMACOL, V101, P241, DOI 10.1111/j.1742-7843.2007.00109.x; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Nabavi SF, 2012, BIOL TRACE ELEM RES, V145, P369, DOI 10.1007/s12011-011-9194-7; Neyrinck AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081252; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5; Perera Pathirage Kamal, 2012, Pharmacogn Rev, V6, P37, DOI 10.4103/0973-7847.95863; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; PIYACHATURAWAT P, 1983, TOXICOL LETT, V16, P351, DOI 10.1016/0378-4274(83)90198-4; Prabhakar PK, 2013, PHYTOMEDICINE, V20, P488, DOI 10.1016/j.phymed.2012.12.004; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Rush JWE, 2003, CLIN BIOCHEM, V36, P345, DOI 10.1016/S0009-9120(03)00039-0; Sahebkar A, 2013, BIOFACTORS, V39, P197, DOI 10.1002/biof.1062; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330; Singh DV, 2013, J MOL MODEL, V19, P227, DOI 10.1007/s00894-012-1535-8; SINGH J, 1986, J PHARMACOL EXP THER, V236, P488; Solano Maria P, 2006, Cardiol Rev, V14, P125, DOI 10.1097/01.crd.0000188034.76283.5e; Sun M, 2012, NANOMEDICINE-UK, V7, P1085, DOI [10.2217/NNM.12.80, 10.2217/nnm.12.80]; Suresh D, 2006, CAN J PHYSIOL PHARM, V84, P1259, DOI 10.1139/Y06-074; Suresh D, 2010, INDIAN J MED RES, V131, P682; Taniguchi N, 1996, DIABETES, V45, pS81, DOI 10.2337/diab.45.3.S81; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Videla LA, 2009, WORLD J HEPATOL, V1, P72, DOI 10.4254/wjh.v1.i1.72; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Wang CZ, 2007, AM J CHINESE MED, V35, P543, DOI 10.1142/S0192415X07005053	70	42	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113993	10.1371/journal.pone.0113993	http://dx.doi.org/10.1371/journal.pone.0113993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469699	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700062
J	Liu, YG; Guo, QS; Sun, YG; Ma, XY				Liu, Yuangang; Guo, Qingsheng; Sun, Yageng; Ma, Xiaoya			A Combined Approach to Cartographic Displacement for Buildings Based on Skeleton and Improved Elastic Beam Algorithm	PLOS ONE			English	Article							MAP GENERALIZATION	Scale reduction from source to target maps inevitably leads to conflicts of map symbols in cartography and geographic information systems (GIS). Displacement is one of the most important map generalization operators and it can be used to resolve the problems that arise from conflict among two or more map objects. In this paper, we propose a combined approach based on constraint Delaunay triangulation (CDT) skeleton and improved elastic beam algorithm for automated building displacement. In this approach, map data sets are first partitioned. Then the displacement operation is conducted in each partition as a cyclic and iterative process of conflict detection and resolution. In the iteration, the skeleton of the gap spaces is extracted using CDT. It then serves as an enhanced data model to detect conflicts and construct the proximity graph. Then, the proximity graph is adjusted using local grouping information. Under the action of forces derived from the detected conflicts, the proximity graph is deformed using the improved elastic beam algorithm. In this way, buildings are displaced to find an optimal compromise between related cartographic constraints. To validate this approach, two topographic map data sets (i.e., urban and suburban areas) were tested. The results were reasonable with respect to each constraint when the density of the map was not extremely high. In summary, the improvements include (1) an automated parameter-setting method for elastic beams, (2) explicit enforcement regarding the positional accuracy constraint, added by introducing drag forces, (3) preservation of local building groups through displacement over an adjusted proximity graph, and (4) an iterative strategy that is more likely to resolve the proximity conflicts than the one used in the existing elastic beam algorithm.	[Liu, Yuangang; Guo, Qingsheng; Sun, Yageng; Ma, Xiaoya] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China; [Guo, Qingsheng] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Liu, Yuangang] Yangtze Univ, Sch Geosci, Wuhan, Peoples R China	Wuhan University; Wuhan University; Yangtze University	Guo, QS (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China.	guoqingsheng@whu.edu.cn			National Natural Science Foundation of China [41471384, 41171350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This research was supported in part by the National Natural Science Foundation of China (Grant No. 41471384, No. 41171350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENT CONS, 2001, DD3 AGENT CONS; Ai T., 2002, P JOINT WORKSH MULT; Ai T.H., 2000, ACTA GEODAETICAET CA, V29, P348, DOI DOI 10.3321/J.1001-1595.2000.04.012; Ai TH, 2007, LECT NOTES GEOINF CA, P153, DOI 10.1007/978-3-540-72385-1_9; [艾廷华 AI Tinghua], 2007, [测绘学报, Acta Geodetica et Cartographica Sinica], V36, P231; Bader M, 2005, INT J GEOGR INF SCI, V19, P915, DOI 10.1080/13658810500161237; Bader M, 2000, P 5 INT C GEOCOMPUTA; Bader M, 2001, THESIS U ZURICH SWIT; Basaraner M, 2011, B CIENC GEOD, V17, P161, DOI 10.1590/S1982-21702011000200001; Beard K., 1991, MAP GENERALISATION M, P121; Bobrich J, 2001, P 3 20 INT CART C BE, V3, P2032; Bundy GL, 1995, GIS GEN METHODOLOGY, P106; Burghardt D., 1997, SMATI 97 SEMANTIC MO, P114; CECCONI A, 2003, THESIS U ZURICH SWIT; Fei LF, 2004, THESIS U HANNOVER HA; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guo QS, 2007, SPATIAL REASONING PR, P152; Harrie L, 2003, CARTOGR J, V40, P221, DOI 10.1179/000870403225012925; Harrie L, 2002, GEOINFORMATICA, V6, P233, DOI 10.1023/A:1019765902987; Harrie L.E., 1999, CARTOGR GEOGR INF SC, V26, P55, DOI DOI 10.1559/152304099782424884; Hojholt P., 2000, CARTOGR GEOGRAPH INF, V27, P65, DOI [DOI 10.1559/152304000783548028, 10.1559/152304000783548028]; Jager E., 1991, 15 C ICA, P245; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Jones C.B., 1995, CARTOGR GEOGR INF SC, V22, P317, DOI [DOI 10.1559/152304095782540221, 10.1559/152304095782540221]; Jones C.B., 1997, GEOGRAPHICAL INFORM, DOI 10.4324/9781315846231; Jones CB, 2005, INT J GEOGR INF SCI, V19, P859, DOI 10.1080/13658810500161104; Jones CB, 1999, VISUAL COMPUT, V15, P235, DOI 10.1007/s003710050175; Li Z, 2004, INT J GEOGR INF SCI, V18, P513, DOI 10.1080/13658810410001702021; LICHTNER W, 1979, GEO-PROCESSING, V1, P183; Lonergan M, 2001, ALGORITHMICA, V30, P287, DOI 10.1007/s00453-001-0011-0; Mackaness W.A., 1994, CARTOGR GEOGR INF SC, V21, P219, DOI [https://doi.org/10.1559/152304094782540646, DOI 10.1559/152304094782540646]; Nickerson B.G., 1988, CARTOGR INT J GEOGR, V25, P15, DOI [10.3138/4144-3U7G-MW01-1Q72, DOI 10.3138/4144-3U7G-MW01-1Q72]; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Regnauld N, 2001, ALGORITHMICA, V30, P312, DOI 10.1007/s00453-001-0008-8; Roosta SH, 2000, PARALLEL PROCESSING, P114; Ruas A, 1998, INT J GEOGR INF SCI, V12, P789, DOI 10.1080/136588198241509; Sester M, 2005, INT J GEOGR INF SCI, V19, P871, DOI 10.1080/13658810500161179; Steiniger S, 2007, THESIS U ZURICH SWIT; Stoter J, 2014, CARTOGR GEOGR INF SC, V41, P1, DOI 10.1080/15230406.2013.824637; Swiss Society of Cartography, 2005, TOP MAPS MAP GRAPH G; Thom S, 2006, P 12 INT S SPAT DAT, P659; van der Poorten PM, 2002, INT J GEOGR INF SCI, V16, P773, DOI 10.1080/13658810210149434; Ware J., 2002, P 10 ACM INT S ADV G, P101; Ware J. M., 1998, GeoInformatica, V2, P383, DOI 10.1023/A:1009713606524; Ware JM, 2003, INT J GEOGR INF SCI, V17, P743, DOI 10.1080/13658810310001596085; Weibel R., 1998, P 8 INT S SPAT DAT H, P214; Wilson ID, 2003, COMPUT IND, V52, P291, DOI 10.1016/S0166-3615(03)00132-5; Yan HW, 2008, COMPUT GEOSCI-UK, V34, P939, DOI 10.1016/j.cageo.2007.07.008; Zhang X, 2013, GEOINFORMATICA, V17, P1, DOI 10.1007/s10707-011-0146-3	53	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113953	10.1371/journal.pone.0113953	http://dx.doi.org/10.1371/journal.pone.0113953			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470727	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700057
J	Bautista-Amorocho, H; Castellanos-Dominguez, YZ; Rodriguez-Villamizar, LA; Velandia-Cruz, SA; Becerra-Pena, JA; Farfan-Garcia, AE				Bautista-Amorocho, Henry; Zulay Castellanos-Dominguez, Yeny; Andrea Rodriguez-Villamizar, Laura; Alejandra Velandia-Cruz, Sindi; Andrey Becerra-Pena, Jeysson; Elvira Farfan-Garcia, Ana			Epidemiology, Risk Factors and Genotypes of HBV in HIV-Infected Patients in the Northeast Region of Colombia: High Prevalence of Occult Hepatitis B and F3 Subgenotype Dominance	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; MOLECULAR CHARACTERIZATION; OUTCOMES; ASSOCIATION; COINFECTION; PREDICTORS; FREQUENCY; MUTANTS; AGE	Introduction: Chronic hepatitis B virus (HBV) infection is an increasing cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected individuals. HIV-positive patients are commonly co-infected with HBV due to shared routes of transmission. Objectives: Our aim was to determine the risk factors, prevalence, genotypes, and mutations of the Surface S gene of HBV, and occult hepatitis B infection (OBI) among patients infected with HIV in a northeastern Colombian city. Methods: A cross-sectional study was conducted with 275 HIV-positive patients attending an outpatient clinic in Bucaramanga, Colombia during 2009-2010. Blood samples were collected and screened for serological markers of HBV (anti-HBs, anti-HBc and HBsAg) through ELISA assay. Regardless of their serological profile, all samples were tested for the HBV S gene by nested-PCR and HBV genotypes were determined by phylogenetic inference. Clinical records were used to examine demographic, clinical, virological, immunological and antiretroviral therapy (ART) variables of HIV infection. Results: Participants were on average 37 +/- 11 years old and 65.1% male. The prevalence of HIV-HBV coinfection was 12% (95% CI 8.4-16.4) of which 3.3% had active HBV infection and 8.7% OBI. The prevalence of HIV-HBV coinfection was associated with AIDS stage and ART treatment. Sequence analysis identified genotype F, subgenotype F3 in 93.8% of patients and genotype A in 6.2% of patients. A C149R mutation, which may have resulted from failure in HBsAg detection, was found in one patient with OBI. Conclusions: The present study found a high prevalence of HIV-HBV coinfection with an incidence of OBI 2.6-fold higher compared to active HBV infection. These findings suggest including HBV DNA testing to detect OBI in addition to screening for HBV serological markers in HIV patients.	[Bautista-Amorocho, Henry; Zulay Castellanos-Dominguez, Yeny; Alejandra Velandia-Cruz, Sindi; Andrey Becerra-Pena, Jeysson; Elvira Farfan-Garcia, Ana] Univ Santander UDES, Bacteriol & Clin Lab Program, Dept Hlth Sci, CliniUDES Res Grp,Lab Biomed & Biotechnol Res, Santander, Spain; [Andrea Rodriguez-Villamizar, Laura] Ind Univ Santander UIS, Dept Publ Hlth, Sch Med, Res Grp Demog Publ Hlth & Hlth Syst GUINDESS, Santander, Spain		Bautista-Amorocho, H (corresponding author), Univ Santander UDES, Bacteriol & Clin Lab Program, Dept Hlth Sci, CliniUDES Res Grp,Lab Biomed & Biotechnol Res, Santander, Spain.	henrybau33@gmail.com	Rodriguez, Laura/GWC-8446-2022	Castellanos-Dominguez, Yeny Zulay/0000-0001-5881-1998; Farfan Garcia, Ana Elvira/0000-0002-9691-0759; Rodriguez-Villamizar, Laura Andrea/0000-0002-5551-2586; Velandia, Sindi/0000-0001-8953-6124	Universidad de Santander - UDES [001-12-2012, 025-13 2013]	Universidad de Santander - UDES	The study was funded by Universidad de Santander - UDES research grant numbers 001-12-2012 and 025-13 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Alvarado-Mora MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018888; [Anonymous], 2013, GLOBAL REPORT UNAIDS; Attia KA, 2012, WORLD J HEPATOL, V4, P218, DOI 10.4254/wjh.v4.i7.218; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Awerkiew S, 2007, J CLIN VIROL, V38, P83, DOI 10.1016/j.jcv.2006.10.006; Badur S, 2001, J CLIN VIROL, V21, P229, DOI 10.1016/S1386-6532(01)00147-0; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Day SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059346; Gupta S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-53; Hoyos-Orrego Alvaro, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P321, DOI 10.1590/S0036-46652006000600004; Ikeda K, 2009, J VIRAL HEPATITIS, V16, P437, DOI 10.1111/j.1365-2893.2009.01085.x; Kew MC, 2010, WORLD J HEPATOL, V2, P65, DOI 10.4254/wjh.v2.i2.65; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kwei K, 2013, J VIROL, V87, P2352, DOI 10.1128/JVI.02701-12; Liang SH, 2010, JAIDS-J ACQ IMM DEF, V54, P122, DOI 10.1097/QAI.0b013e3181daafd5; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Marchesini Angela Mattos, 2007, Rev. Saúde Pública, V41, P57, DOI 10.1590/S0034-89102007000900010; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; Mendes-Correa Maria Cassia J., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P81, DOI 10.1590/S0036-46652000000200004; Ministerio de Salud y Proteccion Social. Instituto Nacional de Salud, 2014, PROT VIG SAL PUBL HE; Braga WSM, 2006, REV SOC BRAS MED TRO, V39, P519, DOI 10.1590/S0037-86822006000600001; Moradi A, 2012, VIRUS GENES, V44, P382, DOI 10.1007/s11262-012-0715-z; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; Opaleye OO, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/796121; Otero JA, 2013, REV OBSERVATORIO SAL, V2, P3; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Pereira RARD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-34; Quarleri J, 2007, AIDS RES HUM RETROV, V23, P525, DOI 10.1089/aid.2006.0172; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Rodriguez L, 2000, MEM I OSWALDO CRUZ, V95, P243, DOI 10.1590/S0074-02762000000200019; RUSTGI VK, 1984, ANN INTERN MED, V101, P795, DOI 10.7326/0003-4819-101-6-795; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Shi Y, 2012, LIVER INT, V32, P231, DOI 10.1111/j.1478-3231.2011.02481.x; Souza Milta Gomes de, 2004, Rev. Soc. Bras. Med. Trop., V37, P391; Stuart JWTC, 2009, J MED VIROL, V81, P441, DOI 10.1002/jmv.21422; Sucupira MVF, 2006, MEM I OSWALDO CRUZ, V101, P655, DOI 10.1590/S0074-02762006000600013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Torres-Baranda Rodrigo, 2006, Ann Hepatol, V5, P34; Tyson GL, 2013, HEPATOLOGY, V58, P538, DOI 10.1002/hep.26400; WHO | Age Groups And Populations, 2019, WHO AG GROUPS POP; Zahn A, 2008, J GEN VIROL, V89, P409, DOI 10.1099/vir.0.83347-0; Zobeiri M, 2013, HEPAT RES TREAT, V259148, P1	50	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114272	10.1371/journal.pone.0114272	http://dx.doi.org/10.1371/journal.pone.0114272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462190	gold, Green Submitted, Green Published			2022-12-27	WOS:000345869700125
J	Kim, S; Jin, B; Choi, SH; Han, KH; Ahn, SH				Kim, Seungtaek; Jin, Bora; Choi, Sung Hoon; Han, Kwang-Hyub; Ahn, Sang Hoon			Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S)	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; PLUS RIBAVIRIN; CK2; PHOSPHORYLATION; REPLICATION; CULTURE; ENTRY; NS2	Genotype 2a JFH1 virus has substantially contributed to the progress of HCV biology by allowing entire viral life cycle of HCV in cell culture. Using this genotype 2a virus, casein kinase II (CKII) was previously identified as a crucial host factor in virus assembly by phosphorylating NS5A. Since most of the prior studies employed genotype 2a JFH1 or JFH1-based intragenotypic chimera, we used genotype 1a H77S to study virus assembly. CKII inhibition by chemical inhibitors enhanced H77S virus production in contrast to that of JFH1 virus, but genetic inhibition of CKII by siRNA did not change H77S virus titer significantly. The different outcomes from these two approaches of CKII inhibition suggested that nonspecific target kinase of CKII inhibitors plays a role in increasing H77S virus production and both viral and host factors were investigated in this study. Our results emphasize substantial differences among the HCV genotypes that should be considered in both basic research and clinical practices.	[Kim, Seungtaek; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Seungtaek; Han, Kwang-Hyub; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Jin, Bora; Choi, Sung Hoon; Han, Kwang-Hyub; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, S (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	kimst@yuhs.ac		Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2008346]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2008346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cozza G, 2011, CURR MED CHEM, V18, P2867, DOI 10.2174/092986711796150423; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Kim J, 1999, BIOCHEM BIOPH RES CO, V257, P777, DOI 10.1006/bbrc.1999.0460; Kim S, 2013, J VIROL, V87, P4214, DOI 10.1128/JVI.00954-12; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Lange CM, 2013, J HEPATOL, V58, P583, DOI 10.1016/j.jhep.2012.10.019; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemon SM, 2007, FIELDS VIROLOGY, V1, P1253; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marjuki Henju, 2008, J Mol Signal, V3, P13, DOI 10.1186/1750-2187-3-13; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Sambrook J., 2001, MOL CLONING LAB MANU; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113938	10.1371/journal.pone.0113938	http://dx.doi.org/10.1371/journal.pone.0113938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464014	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700071
J	Liao, H; Xiao, R; Cimini, G; Medo, M				Liao, Hao; Xiao, Rui; Cimini, Giulio; Medo, Matus			Network-Driven Reputation in Online Scientific Communities	PLOS ONE			English	Article							SYSTEMS; TRUST	The ever-increasing quantity and complexity of scientific production have made it difficult for researchers to keep track of advances in their own fields. This, together with growing popularity of online scientific communities, calls for the development of effective information filtering tools. We propose here an algorithm which simultaneously computes reputation of users and fitness of papers in a bipartite network representing an online scientific community. Evaluation on artificially-generated data and real data from the Econophysics Forum is used to determine the method's best-performing variants. We show that when the input data is extended to a multilayer network including users, papers and authors and the algorithm is correspondingly modified, the resulting performance improves on multiple levels. In particular, top papers have higher citation count and top authors have higher h-index than top papers and top authors chosen by other algorithms. We finally show that our algorithm is robust against persistent authors (spammers) which makes the method readily applicable to the existing online scientific communities.	[Liao, Hao; Xiao, Rui; Cimini, Giulio; Medo, Matus] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Cimini, Giulio] Univ Roma La Sapienza, Inst Complex Syst, ISC CNR, I-00185 Rome, Italy; [Cimini, Giulio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	University of Fribourg; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; Sapienza University Rome	Medo, M (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	matus.medo@unifr.ch	Cimini, Giulio/HGC-2758-2022; Medo, Matus/J-6660-2019; Cimini, Giulio/I-7413-2019	Medo, Matus/0000-0001-8865-9085; Cimini, Giulio/0000-0001-5698-8597	European Union [231200, 611272]; Swiss National Science Foundation [200020143272]; Opening Foundation of Alibaba Research Center for Complex Sciences [PD12001003002003]; National Natural Science Foundation of China [71273093]	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Opening Foundation of Alibaba Research Center for Complex Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by European Union 7th Framework Programme (http://cordis. europa. eu/fp7/home_en. html), Grant No. 231200 (project QLectives): GC, MM, European Union 7th Framework Programme (http://cordis. europa. eu/ fp7/home_en. html), Grant No. 611272 (project Growthcom): MM, Swiss National Science Foundation (www. snf. ch), Grant No. 200020143272: GC, Opening Foundation of Alibaba Research Center for Complex Sciences, Grant No. PD12001003002003: HL, RX and National Natural Science Foundation of China, Grant No. 71273093: HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Adomavicius G, 2012, IEEE T KNOWL DATA EN, V24, P896, DOI 10.1109/TKDE.2011.15; [Anonymous], FDN INTELLIGENT SYST; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brembs B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00291; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Castillo C, 2007, LECT NOTES COMPUT SC, V4726, P107, DOI 10.1007/978-3-540-75530-2_10; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Deng HB, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P239; Franceschet M, 2011, COMMUN ACM, V54, P92, DOI 10.1145/1953122.1953146; Fujimura K, 2005, LECT NOTES ARTIF INT, V3577, P59; Gilbert N., 2008, AGENT BASED MODELS; Gualdi S, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/20008; Hanrahan B. V., 2012, P ACM C COMP SUPP CO, P91, DOI [10.1145/2141512.2141550, DOI 10.1145/2141512.2141550]; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lariviere V, 2008, J AM SOC INF SCI TEC, V59, P288, DOI 10.1002/asi.20744; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Masum H., 2004, First Monday, V9, DOI 10.5210/fm.v9i7.1158; Maxmen A, 2010, CELL, V141, P387, DOI 10.1016/j.cell.2010.04.019; Medo M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238701; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Petersen AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00181; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Sabater J, 2005, ARTIF INTELL REV, V24, P33, DOI 10.1007/s10462-004-0041-5; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	33	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112022	10.1371/journal.pone.0112022	http://dx.doi.org/10.1371/journal.pone.0112022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463148	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000345869700008
J	Morales-Cano, D; Menendez, C; Moreno, E; Moral-Sanz, J; Barreira, B; Galindo, P; Pandolfi, R; Jimenez, R; Moreno, L; Cogolludo, A; Duarte, J; Perez-Vizcaino, F				Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Galindo, Pilar; Pandolfi, Rachele; Jimenez, Rosario; Moreno, Laura; Cogolludo, Angel; Duarte, Juan; Perez-Vizcaino, Francisco			The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; 5-HT2A RECEPTORS; NITRIC-OXIDE; EXPRESSION; SEROTONIN; APOPTOSIS; 5-HYDROXYTRYPTAMINE; PROLIFERATION; INHIBITION	Quercetin is a dietary flavonoid which exerts vasodilator, antiplatelet and antiproliferative effects and reduces blood pressure, oxidative status and end-organ damage in humans and animal models of systemic hypertension. We hypothesized that oral quercetin treatment might be protective in a rat model of pulmonary arterial hypertension. Three weeks after injection of monocrotaline, quercetin (10 mg/kg/d per os) or vehicle was administered for 10 days to adult Wistar rats. Quercetin significantly reduced mortality. In surviving animals, quercetin decreased pulmonary arterial pressure, right ventricular hypertrophy and muscularization of small pulmonary arteries. Classic biomarkers of pulmonary arterial hypertension such as the downregulated expression of lung BMPR2, Kv1.5, Kv2.1, upregulated survivin, endothelial dysfunction and hyperresponsiveness to 5-HT were unaffected by quercetin. Quercetin significantly restored the decrease in Kv currents, the upregulation of 5-HT2A receptors and reduced the Akt and S6 phosphorylation. In vitro, quercetin induced pulmonary artery vasodilator effects, inhibited pulmonary artery smooth muscle cell proliferation and induced apoptosis. In conclusion, quercetin is partially protective in this rat model of PAH. It delayed mortality by lowering PAP, RVH and vascular remodeling. Quercetin exerted effective vasodilator effects in isolated PA, inhibited cell proliferation and induced apoptosis in PASMCs. These effects were associated with decreased 5-HT2A receptor expression and Akt and S6 phosphorylation and partially restored Kv currents. Therefore, quercetin could be useful in the treatment of PAH.	[Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Pandolfi, Rachele; Moreno, Laura; Cogolludo, Angel; Perez-Vizcaino, Francisco] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Pandolfi, Rachele; Moreno, Laura; Cogolludo, Angel; Perez-Vizcaino, Francisco] Ciber Enfermedades Resp CIBERES, Madrid, Spain; [Menendez, Carmen] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Galindo, Pilar; Jimenez, Rosario; Duarte, Juan] Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad Autonoma de Chile; University of Granada	Perez-Vizcaino, F (corresponding author), Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain.	fperez@med.ucm.es	Moral-Sanz, Javier/AAB-1371-2019; JIMENEZ, ROSARIO/K-9701-2014; Moreno, Laura/A-9433-2010; Cogolludo, Angel/A-6129-2011; Duarte, Juan/AAH-1574-2020; Duarte, Juan/K-6472-2014; Perez-Vizcaino, Francisco/A-9735-2011; Cano, Daniel Morales/A-3550-2017	Moral-Sanz, Javier/0000-0001-8602-8554; JIMENEZ, ROSARIO/0000-0003-3872-2669; Moreno, Laura/0000-0001-9028-2299; Duarte, Juan/0000-0002-9153-5857; Duarte, Juan/0000-0002-9153-5857; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Cano, Daniel Morales/0000-0002-1692-4633; Cogolludo, Angel/0000-0002-1382-1698; Barreira, Bianca/0000-0002-0338-8456; Pandolfi, Rachele/0000-0001-7476-2305	Spanish Ministerio de Economia y Competitividad [SAF2011-28150, SAF2010-22066-C02-01, 202]; Instituto de Salud Carlos III Red HERACLES [RD06/0009]; Miguel Servet Program [CP12/03304]; Junta de Andalucia (Proyecto de excelencia) [P12-CTS2722];  [BES-2012-051904]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III Red HERACLES(Instituto de Salud Carlos III); Miguel Servet Program; Junta de Andalucia (Proyecto de excelencia)(Junta de Andalucia); 	This work was supported by grants and fellowships by the Spanish Ministerio de Economia y Competitividad (SAF2011-28150 to F.P-V, SAF2010-22066-C02-01 to JD, and 202 to AC); Instituto de Salud Carlos III Red HERACLES RD06/0009 to JD; Miguel Servet Program CP12/03304 to LM; predoctoral grants BES-2012-051904 to DMS, CM, JMS, and PG; and Junta de Andalucia (Proyecto de excelencia, P12-CTS2722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bruning A, 2013, ANTI-CANCER AGENT ME, V13, P1025, DOI 10.2174/18715206113139990114; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Cogolludo A, 2007, CARDIOVASC RES, V73, P424, DOI 10.1016/j.cardiores.2006.09.008; DUARTE J, 1993, EUR J PHARMACOL, V239, P1, DOI 10.1016/0014-2999(93)90968-N; Gao HH, 2012, J BIOMED RES, V26, P98, DOI 10.1016/S1674-8301(12)60018-9; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; Henriques-Coelho T, 2008, ENDOCRINOLOGY, V149, P4367, DOI 10.1210/en.2008-0018; Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Liu Y, 2013, EXP LUNG RES, V39, P70, DOI 10.3109/01902148.2012.758191; Lopez-Lopez JG, 2011, J PHARMACOL EXP THER, V338, P400, DOI 10.1124/jpet.111.179515; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Menendez C, 2011, BRIT J NUTR, V105, P1287, DOI 10.1017/S0007114510004952; Moon SK, 2003, BIOCHEM BIOPH RES CO, V301, P1069, DOI 10.1016/S0006-291X(03)00091-3; Moral-Sanz J, 2012, EXP PHYSIOL, V97, P676, DOI 10.1113/expphysiol.2011.062257; Morecroft I, 2005, J PHARMACOL EXP THER, V313, P539, DOI 10.1124/jpet.104.081182; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Nakamura T, 2011, AM J RESP CELL MOL, V44, P614, DOI 10.1165/rcmb.2010-0338OC; Nasim MT, 2012, HUM MOL GENET, V21, P2548, DOI 10.1093/hmg/dds073; O'Callaghan DS, 2011, NAT REV CARDIOL, V8, P526, DOI 10.1038/nrcardio.2011.104; Perez-Vizcaino F, 2006, FREE RADICAL RES, V40, P1054, DOI 10.1080/10715760600823128; Perez-Vizcaino F, 2006, BIOCHEM BIOPH RES CO, V346, P919, DOI 10.1016/j.bbrc.2006.05.198; Perez-Vizcaino F, 2010, MOL ASPECTS MED, V31, P478, DOI 10.1016/j.mam.2010.09.002; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Ramos M, 2007, VASC PHARMACOL, V46, P439, DOI 10.1016/j.vph.2007.01.005; Sahara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033367; Sanchez M, 2006, J HYPERTENS, V24, P75, DOI 10.1097/01.hjh.0000198029.22472.d9; Sato K, 2000, J SURG RES, V90, P138, DOI 10.1006/jsre.2000.5869; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Thomas BJ, 2003, EUR J PHARMACOL, V477, P153, DOI 10.1016/j.ejphar.2003.08.015; Tribolo S, 2013, J AGR FOOD CHEM, V61, P8589, DOI 10.1021/jf402511c; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; Zhang Y, 2012, MOL BIOL REP, V39, P7785, DOI 10.1007/s11033-012-1621-0	47	59	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114492	10.1371/journal.pone.0114492	http://dx.doi.org/10.1371/journal.pone.0114492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460361	Green Published, gold			2022-12-27	WOS:000345869700138
J	Westernstroer, B; Terwort, N; Ehmcke, J; Wistuba, J; Schlatt, S; Neuhaus, N				Westernstroeer, Birgit; Terwort, Nicole; Ehmcke, Jens; Wistuba, Joachim; Schlatt, Stefan; Neuhaus, Nina			Profiling of Cxcl12 Receptors, Cxcr4 and Cxcr7 in Murine Testis Development and a Spermatogenic Depletion Model Indicates a Role for Cxcr7 in Controlling Cxcl12 Activity	PLOS ONE			English	Article							GERM-CELL MIGRATION; ATYPICAL CHEMOKINE RECEPTORS; MOUSE SERTOLI-CELLS; STEM-CELLS; UNDIFFERENTIATED SPERMATOGONIA; SELF-RENEWAL; BETA-ARRESTIN; EXPRESSION PATTERNS; NICHE; RECOVERY	In mice the chemokine Cxcl12 and its receptor Cxcr4 participate in maintenance of the spermatogonial population during postnatal development. More complexity arises since Cxcl12 also binds to the non-classical/atypical chemokine receptor Cxcr7. We explored the expression pattern of Cxcl12, Cxcr4 and Cxcr7 during postnatal development in mouse testes and investigated the response of Cxcl12, Cxcr4, Cxcr7 and SSC-niche associated factors to busulfan-induced germ cell depletion and subsequent recovery by RNA expression analysis and localization of the proteins. In neonatal testes transcript levels of Cxcl12, Cxcr4 and Cxcr7 were relatively low and protein expression of Cxcr7 was restricted to gonocytes and spermatogonia. During development, RNA expression of Cxcl12 remained stable but that of Cxcr4 and Cxcr7 increased. Cxcr7 was expressed in germ cells located at the basement membrane of the seminiferous tubules. In adult testes, transcript levels of Cxcl12 were highest while the localization of Cxcr7 did not change. Following germ cell depletion, a significantly increased expression of Cxcl12 and a decreased expression of Cxcr7 were observed. Germ cells repopulating the seminiferous tubules were immunopositive for Cxcr7. We conclude that Cxcr7 expression to be restricted to premeiotic germ cells throughout postnatal testicular development and during testicular recovery. Hence, the spermatogonial population may not only be simply controlled by interaction of Cxcl12 with Cxcr4 but may also involve Cxcr7 as an important player.	[Westernstroeer, Birgit; Terwort, Nicole; Wistuba, Joachim; Schlatt, Stefan; Neuhaus, Nina] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Ehmcke, Jens] Univ Munster, Fac Med, Cent Anim Facil, D-48149 Munster, Germany	University of Munster; University of Munster	Schlatt, S (corresponding author), Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, D-48149 Munster, Germany.	Stefan.Schlatt@ukmuenster.de		Schlatt, Stefan/0000-0002-7571-5313; Neuhaus, Nina/0000-0003-0181-6194	Innovative Medical Research of the Medical Faculty, University Munster (IMF) [KO 111014]	Innovative Medical Research of the Medical Faculty, University Munster (IMF)	The study was primarily supported by a grant from the Innovative Medical Research of the Medical Faculty, University Munster (IMF, KO 111014). Additional funds for animal handling and histological aspects of the experimental work were provided by the DFG Sachbeihilfen SCHL394/9-1 and 11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cancellieri C, 2013, BIOCHEM SOC T, V41, P231, DOI 10.1042/BST20120246; Comerford I, 2007, BIOESSAYS, V29, P237, DOI 10.1002/bies.20537; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; Ebata KT, 2005, MOL REPROD DEV, V72, P171, DOI 10.1002/mrd.20324; Ehmcke J, 2007, REPRODUCTION, V133, P75, DOI 10.1530/REP-06-0148; EVA C, 1993, DNA CELL BIOL, V12, P393, DOI 10.1089/dna.1993.12.393; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Gaytan F, 2013, ENDOCRINOLOGY, V154, P1321, DOI 10.1210/en.2012-1745; Georgiou KR, 2012, INT J EXP PATHOL, V93, P104, DOI 10.1111/j.1365-2613.2011.00800.x; Hess RA, 2006, CELL CYCLE, V5, P1164, DOI 10.4161/cc.5.11.2775; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Kostereva N, 2008, REPROD DOMEST ANIM, V43, P386, DOI 10.1111/j.1439-0531.2008.01189.x; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; Mahabaleshwar H, 2008, CELL ADHES MIGR, V2, P69, DOI 10.4161/cam.2.2.6027; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; McIver SC, 2013, ANDROLOGY-US, V1, P517, DOI 10.1111/j.2047-2927.2013.00081.x; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; Pellegrino J, 2012, DEV BIOL, V369, P349, DOI 10.1016/j.ydbio.2012.07.006; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Shetty G, 2007, CELL STEM CELL, V1, P361, DOI 10.1016/j.stem.2007.09.013; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; VANKEULEN CJ, 1974, CELL TISSUE KINET, V7, P549, DOI 10.1111/j.1365-2184.1974.tb00438.x; VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543, DOI 10.1111/j.1365-2184.1975.tb01240.x; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Yang QE, 2013, J CELL SCI, V126, P1009, DOI 10.1242/jcs.119826; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoon KB, 2009, TOP CATAL, V52, P1, DOI 10.1007/s11244-008-9132-x; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	52	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112598	10.1371/journal.pone.0112598	http://dx.doi.org/10.1371/journal.pone.0112598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460567	Green Published, Green Submitted, gold			2022-12-27	WOS:000345869700019
J	Samson-Robert, O; Labrie, G; Chagnon, M; Fournier, V				Samson-Robert, Olivier; Labrie, Genevieve; Chagnon, Madeleine; Fournier, Valerie			Neonicotinoid-Contaminated Puddles of Water Represent a Risk of Intoxication for Honey Bees	PLOS ONE			English	Article							INSECT MEMBRANES; MYZUS-PERSICAE; POLLINATORS; PESTICIDE; TOXICITY; DECLINES; EXPOSURE; BINDING; TRENDS; MODE	In recent years, populations of honey bees and other pollinators have been reported to be in decline worldwide. A number of stressors have been identified as potential contributing factors, including the extensive prophylactic use of neonicotinoid insecticides, which are highly toxic to bees, in agriculture. While multiple routes of exposure to these systemic insecticides have been documented for honey bees, contamination from puddle water has not been investigated. In this study, we used a multi-residue method based on LC-MS/MS to analyze samples of puddle water taken in the field during the planting of treated corn and one month later. If honey bees were to collect and drink water from these puddles, our results showed that they would be exposed to various agricultural pesticides. All water samples collected from corn fields were contaminated with at least one neonicotinoid compound, although most contained more than one systemic insecticide. Concentrations of neonicotinoids were higher in early spring, indicating that emission and drifting of contaminated dust during sowing raises contamination levels of puddles. Although the overall average acute risk of drinking water from puddles was relatively low, concentrations of neonicotinoids ranged from 0.01 to 63 mg/L and were sufficient to potentially elicit a wide array of sublethal effects in individuals and colony alike. Our results also suggest that risk assessment of honey bee water resources underestimates the foragers' exposure and consequently miscalculates the risk. In fact, our data shows that honey bees and native pollinators are facing unprecedented cumulative exposure to these insecticides from combined residues in pollen, nectar and water. These findings not only document the impact of this route of exposure for honey bees, they also have implications for the cultivation of a wide variety of crops for which the extensive use of neonicotinoids is currently promoted.	[Samson-Robert, Olivier; Fournier, Valerie] Univ Laval, Ctr Rech Hort, Quebec City, PQ, Canada; [Labrie, Genevieve] Ctr Rech Grains Inc, CEROM, St Mathieu De Beloeil, PQ, Canada; [Chagnon, Madeleine] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Laval University; University of Quebec; University of Quebec Montreal	Fournier, V (corresponding author), Univ Laval, Ctr Rech Hort, Quebec City, PQ, Canada.	valerie.fournier@fsaa.ulaval.ca	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	Ministere de l'Agriculture, des Pecheries et de l'Alimentation; Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ)	Ministere de l'Agriculture, des Pecheries et de l'Alimentation; Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ)	Funding: This research was supported by grants from Prime-Vert sous volet 11,1-Appui a la Strategie phytosanitaire quebecoise en agriculture of the Ministere de l'Agriculture, des Pecheries et de l'Alimentation and the Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Anastassiades M, 2003, J AOAC INT, V86, P412; Baur P., 2007, Pflanzenschutz-Nachrichten Bayer, V60, P27; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Biocca M, 2011, J ENVIRON SCI HEAL B, V46, P438, DOI 10.1080/03601234.2011.583825; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Butler CG, 1940, J EXP BIOL, V17, P253; CONNER WE, 1978, PESTIC BIOCHEM PHYS, V9, P131, DOI 10.1016/0048-3575(78)90073-1; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Cutler P, 2013, PEST MANAG SCI, V69, P607, DOI 10.1002/ps.3413; Desjardins EC, 2006, J ECON ENTOMOL, V99, P443, DOI 10.1603/0022-0493-99.2.443; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; *EC, 2005, CLOTHIANIDIN SANCO 1; *EFSA, 2013, GUIDANCE DOCUMENT ON, DOI DOI 10.2903/J.EFSA.2013.3295; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Ellis J., 2012, OUTLOOKS PEST MANAG, V23, P35, DOI [DOI 10.1016/j.scitotenv.2019.03.184, 10.1564/22feb10, DOI 10.1564/22FEB10]; Elston C, 2013, APIDOLOGIE, V44, P563, DOI 10.1007/s13592-013-0206-9; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3067; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; GARY NE, 2005, THE HIVE AND THE HON, P332; Girolami V, 2013, J APPL ENTOMOL, V137, P35, DOI 10.1111/j.1439-0418.2012.01718.x; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; GIROUX I, 2012, PRESENCE DE PESTICID; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Greatti Moreno, 2003, Bulletin of Insectology, V56, P69; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hopwood J., 2012, ARE NEONICOTINOIDS K; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; JOHANSSON TSK, 1978, BEE WORLD, V59, P11, DOI 10.1080/0005772X.1978.11097681; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kayser H, 2004, PEST MANAG SCI, V60, P945, DOI 10.1002/ps.919; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S, 2010, GLOBAL HONEY BEE COL; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kuhnholz S, 1997, BEHAV ECOL SOCIOBIOL, V41, P407, DOI 10.1007/s002650050402; Laurino D, 2013, B INSECTOL, V66, P119; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Marzaro M, 2011, B INSECTOL, V64, P119; MAUS C, 2012, 11TH INTERNATIONAL S, V437, P199, DOI DOI 10.5073/JKA.2012.437.056; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; *NASS, 2010, UNITED STATES DEPART; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; *PANNA, 2012, PESTICIDES AND HONEY; *PMRA, 2013, EVALUATION OF CANADI; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; ROUBIK DW, 1995, FAO AGRICULTURAL SER, V118; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sanchez-Bayo F, 2014, CHEMOSPHERE, V99, P143, DOI 10.1016/j.chemosphere.2013.10.051; Schmaranzer S, 2000, J INSECT PHYSIOL, V46, P1187, DOI 10.1016/S0022-1910(00)00039-1; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SEELEY TD, 1996, THE WISDOM OF THE HI; SIMON G, 2013, DRIPPING POISON AN A; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Sur Robin, 2003, Bulletin of Insectology, V56, P35; *SYNG GROUP, 2005, SYNGENTA CROP PROTEC; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; *US EPA, 2003, EPA PUBLICATION C, V7501; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vijver MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089837; Visscher PK, 1996, J INSECT PHYSIOL, V42, P1089, DOI 10.1016/S0022-1910(96)00058-3; Wellmann H, 2004, PEST MANAG SCI, V60, P959, DOI 10.1002/ps.920; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; 2006, DRAFT ASSESSMENT REP, V3	82	88	91	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e108443	10.1371/journal.pone.0108443	http://dx.doi.org/10.1371/journal.pone.0108443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438051	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900004
J	Koch, P; Lohr, HB; Driever, W				Koch, Peter; Loehr, Heiko B.; Driever, Wolfgang			A Mutation in cnot8, Component of the Ccr4-Not Complex Regulating Transcript Stability, Affects Expression Levels of Developmental Regulators and Reveals a Role of Fgf3 in Development of Caudal Hypothalamic Dopaminergic Neurons	PLOS ONE			English	Article							MESSENGER-RNA DECAY; DEVELOPING ZEBRAFISH BRAIN; ISOTOCIN CELL-DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; CATECHOLAMINERGIC SYSTEM; MONOAMINERGIC NEURONS; HOMEODOMAIN PROTEIN; DEADENYLASE COMPLEX; GENETIC-ANALYSIS; CAF1 PROTEINS	While regulation of the activity of developmental control genes at the transcriptional level as well as by specific miRNA-based degradation are intensively studied, little is known whether general cellular mechanisms controlling mRNA decay may contribute to differential stability of mRNAs of developmental control genes. Here, we investigate whether a mutation in the deadenylation dependent mRNA decay pathway may reveal differential effects on developmental mechanisms, using dopaminergic differentiation in the zebrafish brain as model system. In a zebrafish genetic screen aimed at identifying genes controlling dopaminergic neuron development we isolated the m1061 mutation that selectively caused increased dopaminergic differentiation in the caudal hypothalamus, while other dopaminergic groups were not affected. Positional cloning revealed that m1061 causes a premature stop codon in the cnot8 open reading frame. Cnot8 is a component of the Ccr4-Not complex and displays deadenylase activity, which is required for removal of the poly (A) tail in bulk mRNA turnover. Analyses of expression of developmental regulators indicate that loss of Cnot8 activity results in increased mRNA in situ hybridization signal levels for a subset of developmental control genes. We show that in the area of caudal hypothalamic dopaminergic differentiation, mRNA levels for several components of the FGF signaling pathway, including Fgf3, FGF receptors, and FGF target genes, are increased. Pharmacological inhibition of FGF signaling or a mutation in the fgf3 gene can compensate the gain of caudal hypothalamic dopaminergic neurons in cnot8(m1061) mutants, indicating a role for Fgf3 in control of development of this dopaminergic population. The cnot8m1061 mutant phenotype provides an in vivo system to study roles of the Cnot8 deadenylase component of the mRNA decay pathway in vertebrate development. Our data indicate that attenuation of Cnot8 activity differentially affects mRNA levels of developmental control genes.	[Koch, Peter; Loehr, Heiko B.; Driever, Wolfgang] Univ Freiburg, Fac Biol, Inst Biol 1, D-79104 Freiburg, Germany; [Driever, Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Koch, P (corresponding author), Univ Cologne, Inst Pharmacol, Gleuelerstr 24, D-50931 Cologne, Germany.	peter.koch@uk-koeln.de; driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	DFG [GRK 843]; EC program EU-FP6 IP ZF-MODELS; EC program EU-FP7 IP ZF-HEALTH; EC program FP7 IP mesDANEURODEV; GIF [926-183.1/2006]; Excellence Initiative of the German Federal Government [BIOSS - EXC 294]; Excellence Initiative of the German State Government [BIOSS - EXC 294]	DFG(German Research Foundation (DFG)); EC program EU-FP6 IP ZF-MODELS; EC program EU-FP7 IP ZF-HEALTH; EC program FP7 IP mesDANEURODEV; GIF(German-Israeli Foundation for Scientific Research and Development); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by DFG - GRK 843 "Mechanisms of Neuronal Signal Transduction - from Protein to Network" (PK), by the EC programs EU-FP6 IP ZF-MODELS, EU-FP7 IP ZF-HEALTH, and FP7 IP mesDANEURODEV, by GIF 926-183.1/2006, and the Excellence Initiative of the German Federal and State Governments (BIOSS - EXC 294).	Acampora D, 2000, INT J DEV BIOL, V44, P669; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Bellipanni G, 2002, MECH DEVELOP, V119, pS215, DOI 10.1016/S0925-4773(03)00119-9; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Borodovsky N, 2009, DEV DYNAM, V238, P826, DOI 10.1002/dvdy.21894; Bosco A, 2013, DEVELOPMENT, V140, P372, DOI 10.1242/dev.089094; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Chen C, 2011, BIOCHEM BIOPH RES CO, V411, P360, DOI 10.1016/j.bbrc.2011.06.148; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Eaton JL, 2007, DEV GENES EVOL, V217, P149, DOI 10.1007/s00427-006-0123-2; Eaton JL, 2006, DEV DYNAM, V235, P2071, DOI 10.1002/dvdy.20848; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Flames N, 2011, ANNU REV NEUROSCI, V34, P153, DOI 10.1146/annurev-neuro-061010-113824; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Holzschuh J, 2003, J NEUROSCI, V23, P5507; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; KANE DA, 1993, DEVELOPMENT, V119, P447; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Lillesaar C, 2007, DEV DYNAM, V236, P1072, DOI 10.1002/dvdy.21095; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Munchberg SR, 1999, MECH DEVELOP, V88, P233, DOI 10.1016/S0925-4773(99)00179-3; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rohr KB, 2000, MECH DEVELOP, V95, P267, DOI 10.1016/S0925-4773(00)00345-2; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Ryu S, 2006, J NEURAL TRANSM-SUPP, P61; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Thisse B., 2001, EXPRESSION ZEBRAFISH; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf A, 2013, DEVELOPMENT, V140, P1762, DOI 10.1242/dev.085357; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	77	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113829	10.1371/journal.pone.0113829	http://dx.doi.org/10.1371/journal.pone.0113829			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478689	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200033
J	Safavi, S; Shukur, Z				Safavi, Seyedmostafa; Shukur, Zarina			Conceptual Privacy Framework for Health Information on Wearable Device	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS	Wearable health tech provides doctors with the ability to remotely supervise their patients' wellness. It also makes it much easier to authorize someone else to take appropriate actions to ensure the person's wellness than ever before. Information Technology may soon change the way medicine is practiced, improving the performance, while reducing the price of healthcare. We analyzed the secrecy demands of wearable devices, including Smartphone, smart watch and their computing techniques, that can soon change the way healthcare is provided. However, before this is adopted in practice, all devices must be equipped with sufficient privacy capabilities related to healthcare service. In this paper, we formulated a new improved conceptual framework for wearable healthcare systems. This framework consists of ten principles and nine checklists, capable of providing complete privacy protection package to wearable device owners. We constructed this framework based on the analysis of existing mobile technology, the results of which are combined with the existing security standards. The approach also incorporates the market share percentage level of every app and its respective OS. This framework is evaluated based on the stringent CIA and HIPAA principles for information security. This evaluation is followed by testing the capability to revoke rights of subjects to access objects and ability to determine the set of available permissions for a particular subject for all models Finally, as the last step, we examine the complexity of the required initial setup.	[Safavi, Seyedmostafa; Shukur, Zarina] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Unit Cyber Secur, Bangi 43600, Malaysia	Universiti Kebangsaan Malaysia	Safavi, S (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Unit Cyber Secur, Bangi 43600, Malaysia.	Safavi@takhosting.info	safavi, Seyedmostafa/N-8493-2014	safavi, Seyedmostafa/0000-0003-3984-5169	National University of Malaysia (UKM) [ERGS/1/2013/ICT04/UKM/01/1]	National University of Malaysia (UKM)	This research was supported by The National University of Malaysia (UKM) grant ERGS/1/2013/ICT04/UKM/01/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ameen M, 2012, J MED SYST, V36, P93, DOI 10.1007/s10916-010-9449-4; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2006, PRIVACY CONFIDENTIAL; Aylward R, 2007, COMPACT HIGH SPEED W, P380; Bernstein WS, 2008, EXPANDEING CONSUMER; Brown B., 2008, J HLTH CARE COMPLIAN, V10, P41; Castro D., 2007, ITIF REPORTS, P1; cdt.org, 2014, COMPR PRIV SEC CRIT; comScore I, 2014, COMSCORE REP MAY 201; Dailystrength.org, 2014, ONL SUPP GROUPS FOR; Detmer D, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-45; Express TF, 2014, GOOGL ANDR LORDS 85; Gaylin DS, 2011, HEALTH SERV RES, V46, P920, DOI 10.1111/j.1475-6773.2010.01233.x; Giannetsos T, 2011, SECUR COMMUN NETW, V4, P1295, DOI 10.1002/sec.313; Hhs.gov, 2014, ACCR ONC HLTH IT CER; Intel, 2014, INT LAB RES; Kay MS., 2011, MHEALTH NEW HORIZONS; Lollipop A, 2014, ANDR LOLL ANDR DEV; Markle.org, 2014, CONN CONS; Organizedwisdom.com, 2014, CONN YOU HLTH EXP TH; Rochester.edu, 2014, ROCH REV; Rwjf, 2014, WHOSE DATA IS IT ANY; Safavi S, 2013, PROC TECH, V11, P650, DOI 10.1016/j.protcy.2013.12.241; Safavi Seyedmostafa, 2014, LIFE SCI J, V11, P109; Wang Q, 2006, IEEE SYS MAN CYBERN, P4268, DOI 10.1109/ICSMC.2006.384805; Wu FJ, 2011, PERVASIVE MOB COMPUT, V7, P397, DOI 10.1016/j.pmcj.2011.03.003	26	38	39	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114306	10.1371/journal.pone.0114306	http://dx.doi.org/10.1371/journal.pone.0114306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478915	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200070
J	Skeff, MA; Brito, GAC; de Oliveira, MG; Braga, CM; Cavalcante, MM; Baldim, V; Holanda-Afonso, RC; Silva-Boghossian, CM; Colombo, AP; Ribeiro, RA; Moura-Neto, V; Leita, RFC				Skeff, Maria Adriana; Brito, Gerly A. C.; de Oliveira, Marcelo G.; Braga, Cintia M.; Cavalcante, Matheus M.; Baldim, Victor; Holanda-Afonso, Rosenilde C.; Silva-Boghossian, Carina M.; Colombo, Ana Paula; Ribeiro, Ronaldo A.; Moura-Neto, Vivaldo; Leita, Renata F. C.			S-Nitrosoglutathione Accelerates Recovery from 5-Fluorouracil-Induced Oral Mucositis	PLOS ONE			English	Article							NITRIC-OXIDE DONORS; BONE-RESORPTION; EXPERIMENTAL PERIODONTITIS; PORPHYROMONAS-GINGIVALIS; COLLAGEN-SYNTHESIS; IN-VITRO; HYDROGEL; STRESS; BETA; RATS	Introduction: Mucositis induced by anti-neoplastic drugs is an important, dose-limiting and costly side-effect of cancer therapy. Aim: To evaluate the effect of the topical application of S-nitrosoglutathione (GSNO), a nitric oxide donor, on 5-fluorouracil (5-FU)-induced oral mucositis in hamsters. Materials and Methods: Oral mucositis was induced in male hamsters by two intraperitoneal administrations of 5-FU on the first and second days of the experiment (60 and 40 mg/kg, respectively) followed by mechanical trauma on the fourth day. Animals received saline, HPMC or HPMC/GSNO (0.1, 0.5 or 2.0 mM) 1 h prior to the 5-FU injection and twice a day for 10 or 14 days. Samples of cheek pouches were harvested for: histopathological analysis, TNF-alpha and IL-1 beta levels, immunohistochemical staining for iNOS, TNF-alpha, IL-1 beta, Ki67 and TGF-beta RII and a TUNEL assay. The presence and levels of 39 bacterial taxa were analyzed using the Checkerboard DNA-DNA hybridization method. The profiles of NO released from the HPMC/GSNO formulations were characterized using chemiluminescence. Results: The HPMC/GSNO formulations were found to provide sustained release of NO for more than 4 h at concentration-dependent rates of 14 to 80 nmol/mL/h. Treatment with HPMC/GSNO (0.5 mM) significantly reduced mucosal damage, inflammatory alterations and cell death associated with 5-FU-induced oral mucositis on day 14 but not on day 10. HPMC/GSNO administration also reversed the inhibitory effect of 5-FU on cell proliferation on day 14. In addition, we observed that the chemotherapy significantly increased the levels and/or prevalence of several bacterial species. Conclusion: Topical HPMC/GSNO accelerates mucosal recovery, reduces inflammatory parameters, speeds up re-epithelization and decreases levels of periodontopathic species in mucosal ulcers.	[Skeff, Maria Adriana; Holanda-Afonso, Rosenilde C.; Moura-Neto, Vivaldo] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Cell Morphogenesis, Rio De Janeiro, RJ, Brazil; [Skeff, Maria Adriana; Brito, Gerly A. C.; Braga, Cintia M.; Cavalcante, Matheus M.; Leita, Renata F. C.] Univ Fed Ceara, Sch Med, Dept Morphol, Fortaleza, Ceara, Brazil; [Silva-Boghossian, Carina M.; Colombo, Ana Paula] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, RJ, Brazil; [Ribeiro, Ronaldo A.] Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [de Oliveira, Marcelo G.; Baldim, Victor] Univ Estadual Campinas, UNICAMP, Inst Chem, Campinas, SP, Brazil; [Silva-Boghossian, Carina M.] Univ Grande Rio, Fac Dent, Duque De Caxias, RJ, Brazil; [Moura-Neto, Vivaldo] Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Estadual de Campinas; Universidade do Grande Rio	Leita, RFC (corresponding author), Univ Fed Ceara, Sch Med, Dept Morphol, Fortaleza, Ceara, Brazil.	renata.carvalho@ufc.br	de Castro Brito, Gerly Anne/C-8597-2013; Leitao, Renata/ABF-9158-2020; Moura-Neto, VIVALDO/V-9913-2019; Miranda, Maria ASP/B-9137-2015; de Oliveira, Marcelo/B-4709-2013; Silva-Boghossian, Carina Maciel/G-9440-2012; Colombo, Ana Paula Vieira/B-9188-2019; Leitão, Renata FC/GQI-3555-2022; Brito, Gerly/AHB-3965-2022; Leitao, Renata/ABG-7682-2020	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Moura-Neto, VIVALDO/0000-0002-6266-043X; Miranda, Maria ASP/0000-0002-7504-4732; de Oliveira, Marcelo/0000-0002-9371-9975; Silva-Boghossian, Carina Maciel/0000-0002-4500-4350; Colombo, Ana Paula Vieira/0000-0002-2061-1840; Leitão, Renata FC/0000-0003-0202-771X; Brito, Gerly/0000-0002-8214-4379; Baldim, Victor/0000-0002-3003-7328	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES); National Council for Scientific and Technological Development (CNPq); Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB); National Institute for Translational Neuroscience (INNT); Rio de Janeiro State Research Foundation (FAPERJ); Sao Paulo Research Foundation (FAPESP); PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ); Frauzino Foundation to Cancer Research; CNPq [309390/2011-7, 478380/2011-9]; FAPESP [2008/57560-0]	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB); National Institute for Translational Neuroscience (INNT); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ); Frauzino Foundation to Cancer Research; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants from Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES), The National Council for Scientific and Technological Development (CNPq), Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB), National Institute for Translational Neuroscience (INNT), Rio de Janeiro State Research Foundation (FAPERJ), Sao Paulo Research Foundation (FAPESP), PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ) and Frauzino Foundation to Cancer Research. Oliveira MG would like to acknowledge grants from CNPq (project #309390/2011-7) and FAPESP (project #2008/57560-0). Leitao RF would like to acknowledge a grant from CNPq (project #478380/2011-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu TP, 2007, J EUR ACAD DERMATOL, V21, P629, DOI 10.1111/j.1468-3083.2006.02032.x; Amadeu TP, 2008, J SURG RES, V149, P84, DOI 10.1016/j.jss.2007.10.015; de Menezes AMA, 2012, J PERIODONTOL, V83, P514, DOI 10.1902/jop.2011.110332; Bauer Joseph A., 1998, Wound Repair and Regeneration, V6, P569, DOI 10.1046/j.1524-475X.1998.60609.x; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boutrin MC, 2012, J BACTERIOL, V194, P1582, DOI 10.1128/JB.06457-11; Cariello AJ, 2013, ARQ BRAS OFTALMOL, V76, P38, DOI 10.1590/S0004-27492013000100011; Cariello AJ, 2012, CLIN OPHTHALMOL, V6, P1907, DOI 10.2147/OPTH.S34830; Cariello AJ, 2010, J ANTIMICROB CHEMOTH, V65, P588, DOI 10.1093/jac/dkp485; Chang AHK, 2014, CHEM RES TOXICOL, V27, P794, DOI 10.1021/tx400462r; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Colombo APV, 2005, J PERIODONTOL, V76, P778, DOI 10.1902/jop.2005.76.5.778; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Dugina V, 2001, J CELL SCI, V114, P3285; Enoch S, 2008, ORAL SURG, V1, P11, DOI DOI 10.1111/J.1752-248X.2007.00005.X; ESTRADA C, 1992, BIOCHEM BIOPH RES CO, V186, P475, DOI 10.1016/S0006-291X(05)80832-0; Eyden B, 2003, SEMIN DIAGN PATHOL, V20, P13, DOI 10.1053/sdia.2003.50004; de Souza GFP, 2006, NITRIC OXIDE-BIOL CH, V15, P209, DOI 10.1016/j.niox.2006.01.011; Georgii JL, 2011, J TISSUE ENG REGEN M, V5, P612, DOI 10.1002/term.353; GERDES J, 1991, AM J PATHOL, V138, P867; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2009, ANTIOXID REDOX SIGN, V11, P725, DOI [10.1089/ars.2008.2155, 10.1089/ARS.2008.2155]; Laheij AMGA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/154532; Laheij AMGA, 2012, SUPPORT CARE CANCER, V20, P3231, DOI 10.1007/s00520-012-1463-2; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; Leitao RFC, 2004, J PERIODONTOL, V75, P1227, DOI 10.1902/jop.2004.75.9.1227; Lewis JP, 2012, INFECT IMMUN, V80, P3319, DOI 10.1128/IAI.00561-12; Lima V, 2005, EUR J ORAL SCI, V113, P210, DOI 10.1111/j.1600-0722.2005.00216.x; Luo Yang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2070; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Raber-Durlacher JE, 2010, ORAL ONCOL, V46, P452, DOI 10.1016/j.oraloncology.2010.03.012; RALSTON SH, 1995, J BONE MINER RES, V10, P1040; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seabra AB, 2007, BRIT J DERMATOL, V156, P814, DOI 10.1111/j.1365-2133.2006.07718.x; Shukla A, 1999, MOL CELL BIOCHEM, V200, P27, DOI 10.1023/A:1006977513146; SOCRANSKY SS, 1994, BIOTECHNIQUES, V17, P788; Soneja A, 2005, PHARMACOL REP, V57, P108; Sonis S, 1991, Oncology (Williston Park), V5, P11; Sonis S, 1991, ONCOLOGY WILLISTON P, V5, P18; Sonis Stephen T, 2004, J Support Oncol, V2, P21; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Vercelino R, 2013, J MATER SCI-MATER M, V24, P2157, DOI 10.1007/s10856-013-4973-7; Wang Y, 2013, J FORMOS MED ASS; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; Weller R, 2006, NITRIC OXIDE-BIOL CH, V15, P395, DOI 10.1016/j.niox.2006.04.002; Witte MB, 2002, J SURG RES, V105, P35, DOI 10.1006/jsre.2002.6443; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; Ye Y, 2013, CLIN MICROBIOL INFEC, V19, pE559, DOI 10.1111/1469-0691.12287; Zur Eyal, 2012, Int J Pharm Compd, V16, P22	55	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113378	10.1371/journal.pone.0113378	http://dx.doi.org/10.1371/journal.pone.0113378			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478918	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200019
J	Lysenko, LV; Kim, J; Henry, C; Tyrtyshnaia, A; Kohnz, RA; Madamba, F; Simon, GM; Kleschevnikova, NE; Nomura, DK; Ezekowitz, RAB; Kleschevnikov, AM				Lysenko, Larisa V.; Kim, Jeesun; Henry, Cassandra; Tyrtyshnaia, Anna; Kohnz, Rebecca A.; Madamba, Francisco; Simon, Gabriel M.; Kleschevnikova, Natalia E.; Nomura, Daniel K.; Ezekowitz, R. Alan B.; Kleschevnikov, Alexander M.			Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; MOUSE MODEL; ALZHEIMERS-DISEASE; WORKING-MEMORY; SYNAPTIC PLASTICITY; APP EXPRESSION; MOTOR BEHAVIOR; RECEPTOR; DEFICITS; IMPAIRMENT	Genetic alterations or pharmacological treatments affecting endocannabinoid signaling have profound effects on synaptic and neuronal properties and, under certain conditions, may improve higher brain functions. Down syndrome (DS), a developmental disorder caused by triplication of chromosome 21, is characterized by deficient cognition and inevitable development of the Alzheimer disease (AD) type pathology during aging. Here we used JZL184, a selective inhibitor of monoacylglycerol lipase (MAGL), to examine the effects of chronic MAGL inhibition on the behavioral, biochemical, and synaptic properties of aged Ts65Dn mice, a genetic model of DS. In both Ts65Dn mice and their normosomic (2N) controls, JZL184-treatment increased brain levels of 2-arachidonoylglycerol (2-AG) and decreased levels of its metabolites such as arachidonic acid, prostaglandins PGD2, PGE2, PGF alpha, and PGJ2. Enhanced spontaneous locomotor activity of Ts65Dn mice was reduced by the JZL184-treatement to the levels observed in 2N animals. Deficient long-term memory was also improved, while short-term and working types of memory were unaffected. Furthermore, reduced hippocampal long-term potentiation (LTP) was increased in the JZL184-treated Ts65Dn mice to the levels observed in 2N mice. Interestingly, changes in synaptic plasticity and behavior were not observed in the JZL184-treated 2N mice suggesting that the treatment specifically attenuated the defects in the trisomic animals. The JZL184-treatment also reduced the levels of A beta 40 and A beta 42, but had no effect on the levels of full length APP and BACE1 in both Ts65Dn and 2N mice. These data show that chronic MAGL inhibition improves the behavior and brain functions in a DS model suggesting that pharmacological targeting of MAGL may be considered as a perspective new approach for improving cognition in DS.	[Lysenko, Larisa V.; Kim, Jeesun; Madamba, Francisco; Kleschevnikova, Natalia E.; Kleschevnikov, Alexander M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Henry, Cassandra; Simon, Gabriel M.; Ezekowitz, R. Alan B.] Abide Therapeut Inc, San Diego, CA USA; [Tyrtyshnaia, Anna] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Kohnz, Rebecca A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Diego; Far Eastern Federal University; University of California System; University of California Berkeley	Kleschevnikov, AM (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	akleschevnikov@ucsd.edu	Lysenko, Larisa/ABF-2485-2020; Lysenko, Larisa/C-1802-2014	Lysenko, Larisa/0000-0002-0861-2904	Cure Alzheimer's Foundation; LuMind Foundation; Jerome Lejeune Foundation; NIH [5R01NS066072]; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066072] Funding Source: NIH RePORTER	Cure Alzheimer's Foundation; LuMind Foundation; Jerome Lejeune Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The Cure Alzheimer's Foundation (LVL, JK, FM, AMK); LuMind Foundation (AMK); Jerome Lejeune Foundation (FM, AMK); and NIH 5R01NS066072 (LVL, JK, FM, AMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Aliczki M, 2012, BEHAV PHARMACOL, V23, P348, DOI 10.1097/FBP.0b013e3283564dfa; Alldred MJ, 2014, BRAIN STRUCT FUNCT; Baddeley A, 2007, J INTELL DISABIL RES, V51, P925, DOI 10.1111/j.1365-2788.2007.00979.x; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Beauquis J, 2013, HIPPOCAMPUS; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Best TK, 2012, EXP NEUROL, V233, P749, DOI 10.1016/j.expneurol.2011.11.033; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Carlesimo GA, 1997, NEUROPSYCHOLOGIA, V35, P71, DOI 10.1016/S0028-3932(96)00055-3; Chaouloff F, 2011, PHYSIOLOGY, V26, P76, DOI 10.1152/physiol.00050.2010; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Counts SE, 2011, J CHEM NEUROANAT, V42, P111, DOI 10.1016/j.jchemneu.2011.02.004; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Edgin JO, 2012, PROG BRAIN RES, V197, P123, DOI 10.1016/B978-0-444-54299-1.00007-8; Ekstein S, 2011, J CHILD NEUROL, V26, P1290, DOI 10.1177/0883073811405201; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Ferguson SA, 2013, BEHAV BRAIN RES, V242, P125, DOI 10.1016/j.bbr.2012.12.055; Fernandez F, 2008, BEHAV BRAIN RES, V188, P233, DOI 10.1016/j.bbr.2007.09.015; Fernandez F, 2007, TRENDS NEUROSCI, V30, P497, DOI 10.1016/j.tins.2007.07.005; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Gagnon LG, 2011, NEUROPSYCHOLOGY, V25, P226, DOI 10.1037/a0020919; GATH A, 1986, BRIT J PSYCHIAT, V149, P156, DOI 10.1192/bjp.149.2.156; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Herault Y, 2012, PROG BRAIN RES, V197, P169, DOI 10.1016/B978-0-444-54299-1.00009-1; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Ikonomovic MD, 1995, HIPPOCAMPUS, V5, P469, DOI 10.1002/hipo.450050509; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 1999, J NEUROSCI, V19, P4544; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Kleschevnikov AM, 2012, PROG BRAIN RES, V197, P199, DOI 10.1016/B978-0-444-54299-1.00010-8; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lanfranchi S, 2013, CHILD NEUROPSYCHOL; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P397, DOI 10.1080/09297040902740652; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Lesser JM, 2006, GERIATRICS, V61, P14; Lok K, 2013, J NEUROL SCI, V335, P145, DOI 10.1016/j.jns.2013.09.018; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Martinez-Cue C, 2014, NEUROSCI BIOBEHAV RE; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Reilly TJ, 2011, BEHAV BRAIN RES, V222, P375, DOI 10.1016/j.bbr.2011.04.003; Rodgers SP, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-28; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith GK, 2013, HIPPOCAMPUS; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Thomazeau A, 2014, J NEUROSCI, V34, P1138, DOI 10.1523/JNEUROSCI.2852-13.2014; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Whitney KN, 2012, BEHAV BRAIN RES, V232, P202, DOI 10.1016/j.bbr.2012.03.042; Wirths O, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00373.x; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Zhang SY, 2009, J NEUROSCI, V29, P13222, DOI 10.1523/JNEUROSCI.1710-09.2009	87	40	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114521	10.1371/journal.pone.0114521	http://dx.doi.org/10.1371/journal.pone.0114521			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474204	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500042
J	Ulas, A; Turkoz, FP; Silay, K; Tokluoglu, S; Avci, N; Oksuzoglu, B; Alkis, N				Ulas, Arife; Turkoz, Fatma Paksoy; Silay, Kamile; Tokluoglu, Saadet; Avci, Nilufer; Oksuzoglu, Berna; Alkis, Necati			A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SURVIVAL; NSCLC; SCORE; CHEMOTHERAPY; TRIALS; BIOMARKERS; TISSUES; LDH-5; YOUNG	Purpose: We aimed to establish a laboratory prognostic index (LPI) in advanced non-small cell lung cancer (NSCLC) patients based on hematologic and biochemical parameters and to analyze the predictive value of LPI on NSCLC survival. Patients and Methods: The study retrospectively reviewed 462 patients with advanced NSCLC diagnosed between 2000 and 2010 in a single institution. We developed an LPI that included serum levels of white blood cells (WBC), lactate dehydrogenase (LDH), albumin, calcium, and alkaline phosphatase (ALP), based on the results of a Cox regression analysis. The patients were classified into 3 LPI groups as follows: LPI 0: normal; LPI 1: one abnormal laboratory finding; and LPI 2: at least 2 abnormal laboratory findings. Results: The median follow up period was 44 months; the median overall survival (OS) and median progression-free survival (PFS) were 11 and 6 months, respectively. A multivariate analysis revealed that the following could be used as independent prognostic factors: an Eastern Cooperative Oncology Group performance status score (ECOG PS) >= 2, a high LDH level, serum albumin <3 g/dL, serum calcium>10.5 g/dL, number of metastases >2, presence of liver metastases, malignant pleural effusion, or receiving chemotherapy >= 4 cycles. The 1-year OS rates according to LPI 0, LPI 1, and LPI 2 were 54%, 34%, and 17% (p<0.001), respectively and 6-month PFS rates were 44%, 27%, and 15% (p<0.001), respectively. The LPI was a significant predictor for OS (Hazard Ratio (HR): 1.41; 1.05-1.88, p<0.001) and PFS (HR: 1.48; 1.14-1.93, p<0.001). Conclusion: An LPI is an inexpensive, easily accessible and independent prognostic index for advanced NSCLC and may be helpful in making individualized treatment plans and predicting survival rates when combined with clinical parameters.	[Ulas, Arife] Ankara Ataturk Training & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Turkoz, Fatma Paksoy; Tokluoglu, Saadet; Oksuzoglu, Berna; Alkis, Necati] Ankara Oncol Teaching & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Silay, Kamile] Yildirim Beyazit Univ, Ataturk Res & Training Hosp, Fac Med, Dept Internal Med & Geriatr, Ankara, Turkey; [Avci, Nilufer] Balikesir Govt Hosp, Dept Med Oncol, Balikesir, Turkey	Ankara Ataturk Training & Research Hospital; Dr. Abdurrahman Yurtaslan Oncology Hospital; Ankara Ataturk Training & Research Hospital; Ankara Yildirim Beyazit University; Balikesir Ataturk State Hospital	Ulas, A (corresponding author), Ankara Ataturk Training & Res Hosp, Dept Med Oncol, Ankara, Turkey.	drarifeulas@hotmail.com	Ulas, Arife/HGD-4686-2022	Ulas, Arife/0000-0003-2918-2592				ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; Arinc S, 2009, SOUTH MED J, V102, P1019, DOI 10.1097/SMJ.0b013e3181b66b11; Arrieta O, 2010, BMC CANCER, V10, P1471; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Danner BC, 2010, ANTICANCER RES, V30, P1347; Ferrigno D, 2003, Monaldi Arch Chest Dis, V59, P193; FINKELSTEIN DM, 1986, J CLIN ONCOL, V4, P702, DOI 10.1200/JCO.1986.4.5.702; Forrest LM, 2005, BRIT J CANCER, V92, P1834, DOI 10.1038/sj.bjc.6602591; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Gagnon B, 2013, BRIT J CANCER, V109, P2066, DOI 10.1038/bjc.2013.515; GOLDMAN RD, 1964, CANCER RES, V24, P389; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Kasymjanova G, 2010, CURR ONCOL, V17, P52; Kawai H, 2012, WORLD J SURG, V36, P2853, DOI 10.1007/s00268-012-1766-y; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kulesza P, 2011, AM J CLIN PATHOL, V136, P228, DOI 10.1309/AJCPO66OIRULFNLZ; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Mandrekar SJ, 2006, CANCER-AM CANCER SOC, V107, P781, DOI 10.1002/cncr.22049; MUNDY GR, 1988, J CLIN INVEST, V82, P1, DOI 10.1172/JCI113555; Odell WD, 1997, SEMIN ONCOL, V24, P299; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Rosell R, 2002, LUNG CANCER, V38, pS43, DOI 10.1016/S0169-5002(02)00171-X; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; STANLEY KE, 1980, J NATL CANCER I, V65, P25; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Trape J, 2012, INT J BIOL MARKER, V27, P257, DOI 10.5301/JBM.2012.9314; Travis W, 2004, WHO CLASSIFICATION T; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Wigren T, 1997, RADIOTHER ONCOL, V44, P9, DOI 10.1016/S0167-8140(97)00087-X	36	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114471	10.1371/journal.pone.0114471	http://dx.doi.org/10.1371/journal.pone.0114471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474743	Green Submitted, Green Published, gold			2022-12-27	WOS:000346382500038
J	Chen, YL; Cheng, LL; Yao, HH; Chen, HY; Wang, YS; Zhao, WP; Pan, CZ; Shu, XH				Chen, Yongle; Cheng, Leilei; Yao, Haohua; Chen, Haiyan; Wang, Yongshi; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong			The Myocardial Ischemia Evaluated by Real-Time Contrast Echocardiography May Predict the Response to Cardiac Resynchronization Therapy: A Large Animal Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSSYNCHRONY; CORONARY FLOW RESERVE; HEART-FAILURE; BLOOD-FLOW; STRAIN; MORTALITY	Evidence-based criteria for applying cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy are still scarce. The aim of the present study was to evaluate the predictive value of real-time myocardial contrast echocardiography (RT-MCE) in a preclinical canine model of ischemic cardiomyopathy who received CRT. Ischemic cardiomyopathy was produced by ligating the first diagonal branch in 20 beagles. Dogs were subsequently divided into two groups that were either treated with bi-ventricular pacing (CRT group) or left untreated (control group). RT-MCE was performed at baseline, before CRT, and 4 weeks after CRT. Two-dimensional speckle tracking imaging was used to evaluate the standard deviation of circumferential (Cir12SD), radial (R12SD), and longitudinal (L12SD) strains of left ventricular segments at basal as well as middle levels. Four weeks later, the Cir12SD, R12SD, and myocardial blood flow (MBF) of the treated group were significantly improved compared to their non-CRT counterparts. Furthermore, MBF values measured before CRT were significantly higher in responders than in non-responders to bi-ventricular pacing. Meanwhile, no significant differences were observed between the responder and nonresponder groups in terms of Cir12SD, R12SD, and L12SD. A high degree of correlation was found between MBF values before CRT and LVEF after CRT. When MBF value >24.9 dB/s was defined as a cut-off point before CRT, the sensitivity and specificity of RT-MCE in predicting the response to CRT were 83.3% and 100%, respectively. Besides, MBF values increased significantly in the CRT group compared with the control group after 4 weeks of pacing (49.8 +/- 15.5 dB/s vs. 28.5 +/- 4.6 dB/s, p<0.05). Therefore, we considered that myocardial perfusion may be superior to standard metrics of LV synchrony in selecting appropriate candidates for CRT. In addition, CRT can improve myocardial perfusion in addition to cardiac synchrony, especially in the setting of ischemic cardiomyopathy.	[Chen, Yongle; Cheng, Leilei; Yao, Haohua; Chen, Haiyan; Wang, Yongshi; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong] Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Cheng, LL (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China.	cheng.leilei@zs-hospital.sh.cn; shu.xianhong@zs-hospital.sh.cn	Wang, Yongshi/GLT-9336-2022; Chen, Haiyan/HGB-6216-2022	Wang, Yongshi/0000-0002-7851-1623; 	Chinese National Scientific Fund [81371576, 81201095]	Chinese National Scientific Fund	The work was supported by Chinese National Scientific Fund (No. 81371576 and No. 81201095) http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Fernandes DRA, 2011, ECHOCARDIOGR-J CARD, V28, P342, DOI 10.1111/j.1540-8175.2010.01317.x; Anantharam B, 2011, EUR J ECHOCARDIOGR, V12, P69, DOI 10.1093/ejechocard/jeq109; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Chakir K, 2008, CIRCULATION, V117, P1369, DOI 10.1161/CIRCULATIONAHA.107.706291; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Choi JO, 2009, EUR J ECHOCARDIOGR, V10, P695, DOI 10.1093/ejechocard/jep041; Chung Eugene S, 2007, Congest Heart Fail, V13, P9, DOI 10.1111/j.1527-5299.2007.05868.x; Chung ES, 2010, CIRC-HEART FAIL, V3, P650, DOI 10.1161/CIRCHEARTFAILURE.110.945881; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dohi K, 2005, AM J CARDIOL, V96, P112, DOI 10.1016/j.amjcard.2005.03.032; Erol-Yilmaz A, 2007, J CARD FAIL, V13, P95, DOI 10.1016/j.cardfail.2006.10.016; Flevari P, 2006, EUROPACE, V8, P44, DOI 10.1093/europace/euj015; Gorcsan J, 2007, J AM COLL CARDIOL, V50, P1476, DOI 10.1016/j.jacc.2007.06.043; Helm RH, 2005, CIRCULATION, V111, P2760, DOI 10.1161/CIRCULATIONAHA.104.508457; Hickman M, 2010, EUR J ECHOCARDIOGR, V11, P756, DOI 10.1093/ejechocard/jeq062; Hillis GS, 2003, J AM SOC ECHOCARDIOG, V16, P638, DOI 10.1016/S0894-7317(03)00212-8; Holzmeister J, 2011, LANCET, V378, P722, DOI 10.1016/S0140-6736(11)61228-2; Kass DA, 2003, J AM COLL CARDIOL, V42, P2125, DOI 10.1016/j.jacc.2003.09.021; Kydd AC, 2014, JACC-HEART FAIL, V2, P205, DOI 10.1016/j.jchf.2013.11.010; Olszowska M, 2010, ECHOCARDIOGR-J CARD, V27, P430, DOI 10.1111/j.1540-8175.2009.01034.x; Parsai C, 2009, EUR HEART J, V30, P940, DOI 10.1093/eurheartj/ehn481; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pouleur AC, 2011, EUR HEART J, V32, P1720, DOI 10.1093/eurheartj/ehr185; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shanks M, 2010, J AM COLL CARDIOL, V56, P1567, DOI 10.1016/j.jacc.2010.01.077; Valzania C, 2008, EUR J HEART FAIL, V10, P514, DOI 10.1016/j.ejheart.2008.03.011; Wei K, 1998, CIRCULATION, V97, P473	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113992	10.1371/journal.pone.0113992	http://dx.doi.org/10.1371/journal.pone.0113992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469632	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700061
J	Cusick, SE; Opoka, RO; Lund, TC; John, CC; Polgreen, LE				Cusick, Sarah E.; Opoka, Robert O.; Lund, Troy C.; John, Chandy C.; Polgreen, Lynda E.			Vitamin D Insufficiency Is Common in Ugandan Children and Is Associated with Severe Malaria	PLOS ONE			English	Article							D-BINDING PROTEIN; TUBERCULOSIS; MACROPHAGES; INFANTS	Vitamin D plays an increasingly recognized role in the innate and adaptive immune response to infection. Based on demonstrated roles in up-regulating innate immunity, decreasing inflammation, and reducing the severity of disease in illnesses such as tuberculosis and influenza, we hypothesized that poor vitamin D status would be associated with severe malaria. We measured 25-hydroxyvitamin D [25(OH)D] by immunoassay in a sample of Ugandan children aged 18 months 12 years with severe malaria (cerebral malaria or severe malarial anemia, n=40) and in healthy community children (n=20). Ninety-five percent of children with severe malaria (n=38) and 80% of control children (n=16) were vitamin Dinsufficient [ plasma 25(OH)D <30 ng/mL]. Mean plasma 25(OH)D levels were significantly lower in children with severe malaria than in community children (21.2 vs. 25.3 ng/mL, p=0.03). Logistic regression revealed that for every 1 ng/mL increase in plasma 25(OH)D, the odds of having severe malaria declined by 9% [OR50.91 (95% CI: 0.84, 1.0)]. These preliminary results suggest that vitamin D insufficiency may play a role in the development of severe malaria. Further prospective studies in larger cohorts are indicated to confirm the relationship of vitamin D levels to severity of malaria infection and to investigate causality.	[Cusick, Sarah E.; Opoka, Robert O.; Lund, Troy C.; John, Chandy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Opoka, Robert O.] Makerere Univ, Coll Hlth Sci, Dept Paediat, Kampala, Uganda; [Polgreen, Lynda E.] Univ Calif Los Angeles, Dept Pediat, Los Angeles Biomed Res Inst Habor, Los Angeles, CA 90024 USA	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; University of California System; University of California Los Angeles	Cusick, SE (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	scusick@umn.edu	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD064698-05]; National Institute of Neurological Disorders and Stroke [R01 NS055349-05]; National Center for Advancing Translational Sciences of the National Institutes of Health Award [UL1TR000114, KL2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD064698] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055349] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences of the National Institutes of Health Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [grant number U01 HD064698-05]; the National Institute of Neurological Disorders and Stroke [grant number R01 NS055349-05]; and the National Center for Advancing Translational Sciences of the National Institutes of Health Award [UL1TR000114 to SEC, KL2 Scholar]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amukele TK, 2013, ARCH DIS CHILD, V98, P180, DOI 10.1136/archdischild-2012-302377; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; He X, 2014, J IMMUNOL; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Khare D, 2013, EUR J NUTR, V52, P1405, DOI 10.1007/s00394-012-0449-7; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Newens K, 2006, T ROY SOC TROP MED H, V100, P41, DOI 10.1016/j.trstmh.2005.06.022; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Parra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066115; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Weintraub SJ, 2014, NEW ENGL J MED, V370, P878, DOI 10.1056/NEJMc1315850	19	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113185	10.1371/journal.pone.0113185	http://dx.doi.org/10.1371/journal.pone.0113185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470777	gold, Green Published, Green Submitted			2022-12-27	WOS:000349128700016
J	Price, MR; Hadfield, MG				Price, Melissa R.; Hadfield, Michael G.			Population Genetics and the Effects of a Severe Bottleneck in an Ex Situ Population of Critically Endangered Hawaiian Tree Snails	PLOS ONE			English	Article							INBREEDING DEPRESSION; ACHATINELLA-LILA; COMPUTER-PROGRAM; EXTINCTION; SOFTWARE	As wild populations decline, ex situ propagation provides a potential bank of genetic diversity and a hedge against extinction. These programs are unlikely to succeed if captive populations do not recover from the severe bottleneck imposed when they are founded with a limited number of individuals from remnant populations. In small captive populations allelic richness may be lost due to genetic drift, leading to a decline in fitness. Wild populations of the Hawaiian tree snail Achatinella lila, a hermaphroditic snail with a long life history, have declined precipitously due to introduced predators and other human impacts. A captive population initially thrived after its founding with seven snails, exceeding 600 captive individuals in 2009, but drastically declined in the last five years. Measures of fitness were examined from 2,018 captive snails that died between 1998 and 2012, and compared with genotypic data for six microsatellite loci from a subset of these deceased snails (N=335), as well as live captive snails (N=198) and wild snails (N=92). Surprisingly, the inbreeding coefficient (F-is) declined over time in the captive population, and is now approaching values observed in the 2013 wild population, despite a significant decrease in allelic richness. However, adult annual survival and fecundity significantly declined in the second generation. These measures of fitness were positively correlated with heterozygosity. Snails with higher measures of heterozygosity had more offspring, and third generation offspring with higher measures of heterozygosity were more likely to reach maturity. These results highlight the importance of maintaining genetic diversity in captive populations, particularly those initiated with a small number of individuals from wild remnant populations. Genetic rescue may allow for an increase in genetic diversity in the captive population, as measures of heterozygosity and rarified allelic richness were higher in wild tree snails.	[Price, Melissa R.; Hadfield, Michael G.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Price, Melissa R.; Hadfield, Michael G.] Kewalo Marine Labs, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Price, MR (corresponding author), Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	melrprice@gmail.com	Price, Melissa/AAM-7749-2020	Price, Melissa/0000-0003-1836-3769; Hadfield, Michael/0000-0002-8808-5197	United States Fish and Wildlife Service (USFWS);  [12200-B-G009 (F11AP00028)]	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); 	The work was supported by United States Fish and Wildlife Service (USFWS) Grant Agreement and 12200-B-G009 (F11AP00028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1994, J FORENSIC SCI, V39, P362; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; AWAD DA, 2014, PLOS ONE, V0009; Bijlsma R, 2001, EVOLUTIONAR BIOL, V13, P502; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Coron C, 2013, AM NAT, V181, P623, DOI 10.1086/670022; Coutellec MA, 2011, J EVOLUTION BIOL, V24, P2248, DOI 10.1111/j.1420-9101.2011.02355.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Cunningham AA, 1998, CONSERV BIOL, V12, P1139, DOI 10.1046/j.1523-1739.1998.97485.x; Dabrowski MJ, 2014, MOL ECOL RESOUR, V14, P361, DOI 10.1111/1755-0998.12177; de Cara MAR, 2013, HEREDITY, V110, P530, DOI 10.1038/hdy.2012.119; Erickson PB, 2008, MOL ECOL RESOUR, V8, P808, DOI 10.1111/j.1755-0998.2007.02071.x; Erickson PB, 2014, CONSERV GENET, V15, P1209, DOI 10.1007/s10592-014-0612-1; Escobar JS, 2008, CURR BIOL, V18, P906, DOI 10.1016/j.cub.2008.04.070; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; HADFIELD MG, 1993, AM ZOOL, V33, P610; HADFIELD MG, 1986, MALACOLOGIA, V27, P67; HADFIELD MG, 1980, PAC SCI, V34, P345; Hadfield Michael G., 2004, P16; Holland BS, 2012, AM MALACOL BULL, V30, P153; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; NEW TR, 1995, INTRO INVERTEBRATE C; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; Pascua MT, 2010, INTEGR COMP BIOL, V50, pE279; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; ROSSGILLESPIE A, 2007, EVOLUTION, V61, P2268; SEVERNS RM, 1981, NAUTILUS, V95, P140; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Swindell WR, 2006, EVOLUTION, V60, P1014; Thacker RW, 2000, MOL PHYLOGENET EVOL, V16, P263, DOI 10.1006/mpev.2000.0793; U.S. Fish and Wildlife Service, 1981, FED REGISTER, V46, P3178; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Zheng HP, 2012, AQUACULTURE, V366, P27, DOI 10.1016/j.aquaculture.2012.08.029	36	10	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114377	10.1371/journal.pone.0114377	http://dx.doi.org/10.1371/journal.pone.0114377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470182	Green Submitted, gold, Green Published			2022-12-27	WOS:000349128700108
J	Zeng, Z; de Gorter, DJJ; Kowalski, M; ten Dijke, P; Shimmi, O				Zeng, Zhao; de Gorter, David J. J.; Kowalski, Maria; ten Dijke, Peter; Shimmi, Osamu			Ter94/VCP Is a Novel Component Involved in BMP Signaling	PLOS ONE			English	Article							TGF-BETA; AAA-ATPASE; DROSOPHILA; IDENTIFICATION; PROTEIN; MORPHOGEN; DIFFERENTIATION; SPECIFICATION; DISEASE; PATTERN	Bone morphogenetic proteins (BMPs), a subgroup of the transforming growth factor (TGF)-beta family, transduce their signal through multiple components downstream of their receptors. Even though the components involved in the BMP signaling pathway have been intensely studied, many molecules mediating BMP signaling remain to be addressed. To identify novel components that participate in BMP signaling, RNA interference (RNAi)-based screening was established by detecting phosphorylated Mad (pMad) in Drosophila S2 cells. Ter94, a member of the family of AAA ATPases, was identified as a novel mediator of BMP signaling, which is required for the phosphorylation of Mad in Drosophila S2 cells. Moreover, the mammalian orthlog of Ter94 valosin-containing protein (VCP) plays a critical role in the BMP-Smad1/5/8 signaling pathway in mammalian cells. Genetic evidence suggests that Ter94 is involved in the dorsal-ventral patterning of the Drosophila early embryo through regulating decapentaplegic (Dpp)/BMP signals. Taken together, our data suggest that Ter94/VCP appears to be an evolutionarily conserved component that regulates BMP-Smad1/5/8 signaling.	[Zeng, Zhao; Kowalski, Maria; Shimmi, Osamu] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [de Gorter, David J. J.; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [de Gorter, David J. J.; ten Dijke, Peter] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Leiden, Netherlands	University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Shimmi, O (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	osamu.shimmi@helsinki.fi	Dijke, Peter ten/AAG-4660-2021; , 0000-0001-6341-9130/P-9094-2018	Dijke, Peter ten/0000-0002-7234-342X; , 0000-0001-6341-9130/0000-0001-6341-9130; Kowalski-Jahn, Maria/0000-0003-1442-3656	Academy of Finland; Sigrid Juselius Foundation; Cancer Genomics Centre Netherlands; Le Ducq Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Genomics Centre Netherlands; Le Ducq Foundation(Leducq Foundation); Helsinki Graduate School in Biotechnology and Molecular Biology	Funding: This work was supported by grants from Academy of Finland and Sigrid Juselius Foundation to O.S., and Cancer Genomics Centre Netherlands and Le Ducq Foundation "Multidisciplinary Program to Elucidate the Role of Bone Morphogenic Protein Signaling in the Pathogenesis of Pulmonary and Systemic Vascular Diseases" to P.tD. Z.Z was supported by Helsinki Graduate School in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Cayli S, 2012, REPROD SCI, V19, P190, DOI 10.1177/1933719111417886; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Eivers E, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002034; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Gavin-Smyth J, 2013, CURR BIOL, V23, P2296, DOI 10.1016/j.cub.2013.09.055; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pinto BS, 2008, GENETICS, V180, P133, DOI 10.1534/genetics.108.091371; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Ruden DM, 2000, DEV BIOL, V218, P314, DOI 10.1006/dbio.1999.9583; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Wagner N, 2010, DEV BIOL, V339, P1, DOI 10.1016/j.ydbio.2009.11.036; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4	40	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114475	10.1371/journal.pone.0114475	http://dx.doi.org/10.1371/journal.pone.0114475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469707	Green Submitted, Green Published, gold			2022-12-27	WOS:000349128700118
J	Heldal, AT; Eide, GE; Romi, F; Owe, JF; Gilhus, NE				Heldal, Anne Taraldsen; Eide, Geir Egil; Romi, Fredrik; Owe, Jone Furlund; Gilhus, Nils Erik			Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development	PLOS ONE			English	Article							PROTEIN 4; AUTOANTIBODIES; MECHANISMS; KINASE; ASSAYS	Introduction: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinical severity and concentration of acetylcholine receptor (AChR)-antibodies to evaluate if AChR-antibody variations correlate to disease severity. A positive AChR-antibody test is specific for MG. Material and Methods: All patients from western Norway who had two or more AChR-antibody tests in the period 1983-2013 were identified. The Myasthenia Gravis Foundation of America (MGFA) Clinical Classification was used to grade disease development. Multiple ordinal logistic regression analysis was used to estimate a possible predictive effect for AChR-antibody concentration on MGFA classification result. Results: In 67 patients two or more AChR-antibody tests with a corresponding MGFA-score were performed, with a total of 309 tests. 56 patients were treated with immunosuppressive drugs and 11 by pyridostigmine only. There was a positive association between concentration of AChR-antibodies and longitudinal MGFA-score for the subgroup with immunosuppressive treatment, but not for those treated with pyridostigmine only. This association between AChR-antibody concentration and MGFA score declined with increasing time since onset (p=0.005 for the interaction of group x time x concentration). Conclusions: For MG patients with immunosuppressive treatment, repeated AChR-antibody measurements give information about clinical development, and can therefore be of support in therapeutic decisions.	[Heldal, Anne Taraldsen; Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Romi, Fredrik; Owe, Jone Furlund; Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Heldal, AT (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	anne.taraldsen.heldal@helse-bergen.no						Godoy DA, 2013, ARQ NEURO-PSIQUIAT, V71, P627, DOI 10.1590/0004-282X20130108; Andersen JB, 2010, EUR J NEUROL, V17, P1445, DOI 10.1111/j.1468-1331.2010.03089.x; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Baggi F, 2012, ARCH IMMUNOL THER EX, V60, P19, DOI 10.1007/s00005-011-0158-6; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; DRACHMAN DB, 1987, ANN NY ACAD SCI, V505, P90; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI DOI 10.1111/J.1749-6632.1987.TB51301.X; Ferrero B, 1997, CLIN CHEM, V43, P824; Gilhus NE, 2012, CURR OPIN NEUROL, V25, P523, DOI 10.1097/WCO.0b013e3283572588; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; Heldal AT, 2009, NEUROLOGY, V73, P150, DOI 10.1212/WNL.0b013e3181ad53c2; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jahn K, 2000, NEUROLOGY, V54, P474, DOI 10.1212/WNL.54.2.474; Jaretzki A, 2000, ANN THORAC SURG, V70, P327, DOI 10.1016/S0003-4975(00)01595-2; Kim JY, 2011, J CLIN NEUROL, V7, P173, DOI 10.3988/jcn.2011.7.4.173; Kirmani Jawad F., 2004, Curr Treat Options Neurol, V6, P3, DOI 10.1007/s11940-004-0034-3; Kleinbaum DG, 2010, LOGISTIC REGRESSION, Vxvii; Leite MI, 2010, AUTOIMMUNITY, V43, P371, DOI 10.3109/08916930903541208; Maddison P, 2011, J NEUROL NEUROSUR PS, V82, P671, DOI 10.1136/jnnp.2009.197632; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Mori S, 2013, AUTOIMMUN REV, V12, P912, DOI 10.1016/j.autrev.2013.03.005; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Sanders DB, 2013, MUSCLE NERVE; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Tsinzerling N, 2007, J NEUROL NEUROSUR PS, V78, P1109, DOI 10.1136/jnnp.2006.109488; Tuzun E, 2013, AUTOIMMUN REV, V12, P904, DOI 10.1016/j.autrev.2013.03.003; Verschuuren JJGM, 2010, AUTOIMMUNITY, V43, P344, DOI 10.3109/08916931003602130; Viera AJ, 2005, FAM MED, V37, P360; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2003, J NEUROL NEUROSUR PS, V74, P1105, DOI 10.1136/jnnp.74.8.1105; VINCENT A, 1988, MONOGR ALLERGY, V25, P33; Vincent A, 2012, ANN NY ACAD SCI, V1274, P92, DOI 10.1111/j.1749-6632.2012.06789.x; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393	36	32	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114060	10.1371/journal.pone.0114060	http://dx.doi.org/10.1371/journal.pone.0114060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464006	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700091
J	Langone, F; Cannata, S; Fuoco, C; Lettieri, D; Barbato, DL; Testa, S; Nardozza, AP; Ciriolo, MR; Castagnoli, L; Gargioli, C; Cesareni, G				Langone, Francesca; Cannata, Stefano; Fuoco, Claudia; Lettieri, Daniele; Barbato, Daniele Lettieri; Testa, Stefano; Nardozza, Aurelio Pio; Ciriolo, Maria Rosa; Castagnoli, Luisa; Gargioli, Cesare; Cesareni, Gianni			Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration	PLOS ONE			English	Article							DIABETIC-PATIENTS; MUSCULAR-DYSTROPHY; MAMMALIAN TARGET; BREAST-CANCER; KINASE-C; CALCIUM; CELLS; CA2+; INHIBITION; VENOM	The skeletal muscle tissue has a remarkable capacity to regenerate upon injury. Recent studies have suggested that this regenerative process is improved when AMPK is activated. In the muscle of young and old mice a low calorie diet, which activates AMPK, markedly enhances muscle regeneration. Remarkably, intraperitoneal injection of AICAR, an AMPK agonist, improves the structural integrity of muscles of dystrophin-deficient mdx mice. Building on these observations we asked whether metformin, a powerful anti-hyperglycemic drug, which indirectly activates AMPK, affects the response of skeletal muscle to damage. In our conditions, metformin treatment did not significantly influence muscle regeneration. On the other hand we observed that the muscles of metformin treated mice are more resilient to cardiotoxin injury displaying lesser muscle damage. Accordingly myotubes, originated in vitro from differentiated C2C12 myoblast cell line, become more resistant to cardiotoxin damage after pre-incubation with metformin. Our results indicate that metformin limits cardiotoxin damage by protecting myotubes from necrosis. Although the details of the molecular mechanisms underlying the protective effect remain to be elucidated, we report a correlation between the ability of metformin to promote resistance to damage and its capacity to counteract the increment of intracellular calcium levels induced by cardiotoxin treatment. Since increased cytoplasmic calcium concentrations characterize additional muscle pathological conditions, including dystrophies, metformin treatment could prove a valuable strategy to ameliorate the conditions of patients affected by dystrophies.	[Langone, Francesca; Cannata, Stefano; Fuoco, Claudia; Lettieri, Daniele; Barbato, Daniele Lettieri; Testa, Stefano; Nardozza, Aurelio Pio; Ciriolo, Maria Rosa; Castagnoli, Luisa; Gargioli, Cesare; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cesareni, Gianni] Fdn Santa Lucia Ist Ricovero & Cura Carattere Sci, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Gargioli, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	cesare.gargioli@uniroma2.it; cesareni@uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016; Cesareni, Gianni/AAW-1382-2020; Testa, Stefano/L-1652-2018; Fuoco, Claudia/AAB-2268-2019; Lettieri Barbato, Daniele/K-8759-2016	Testa, Stefano/0000-0002-5981-504X; Castagnoli, Luisa/0000-0001-5283-8671; Lettieri Barbato, Daniele/0000-0002-1172-814X; Ciriolo, Maria Rosa/0000-0002-7863-9029; Fuoco, Claudia/0000-0001-8372-305X; Langone, Francesca/0000-0002-3623-3004	Italian Ministry of Education [RBAP11LP2W]; European Research Council [322749]	Italian Ministry of Education; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Oncodiet project of the Italian Ministry of Education (RBAP11LP2W) and by the DEPTH project of the European Research Council (grant agreement 322749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset O, 2004, J BIOL CHEM, V279, P47092, DOI 10.1074/jbc.M405054200; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BHATTACHARYYA J, 1993, AM J PHYSIOL, V265, pR487, DOI 10.1152/ajpregu.1993.265.3.R487; Bissonnette SL, 2010, TOXICOL SCI, V118, P108, DOI 10.1093/toxsci/kfq256; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; *DIAB PREV PROGR R, 2009, THE LANCET, V374, P1677; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; DUCHEN LW, 1974, J NEUROL SCI, V21, P391, DOI 10.1016/0022-510X(74)90041-0; DUNCAN CJ, 1987, J CELL SCI, V87, P183; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HIDALGO C, 1986, BIOCHIM BIOPHYS ACTA, V854, P279, DOI 10.1016/0005-2736(86)90121-5; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mendez I, 2011, TOXICON, V58, P558, DOI 10.1016/j.toxicon.2011.08.018; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nethery D, 2000, J APPL PHYSIOL, V89, P72, DOI 10.1152/jappl.2000.89.1.72; Overgaard K, 2002, J APPL PHYSIOL, V92, P1891, DOI 10.1152/japplphysiol.00669.2001; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; SCHAFER G, 1976, BIOCHEM PHARMACOL, V25, P2015, DOI 10.1016/0006-2952(76)90424-X; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Suh BC, 1996, J BIOL CHEM, V271, P32753, DOI 10.1074/jbc.271.51.32753; SUWA M, 2005, JOURNAL OF APPLIED P, V101, P1685, DOI DOI 10.1152/JAPPLPHYSIOL.00255.2006; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x; *UKPDS, 1998, THE LANCET, V352, P854; Wang HX, 1997, J MOL CELL CARDIOL, V29, P2759, DOI 10.1006/jmcc.1997.0511; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	45	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114018	10.1371/journal.pone.0114018	http://dx.doi.org/10.1371/journal.pone.0114018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461598	Green Submitted, Green Published, gold			2022-12-27	WOS:000345869700082
J	Martinez-Tur, V; Penarroja, V; Serrano, MA; Hidalgo, V; Moliner, C; Salvador, A; Alacreu-Crespo, A; Gracia, E; Molina, A				Martinez-Tur, Vicente; Penarroja, Vicente; Serrano, Miguel A.; Hidalgo, Vanesa; Moliner, Carolina; Salvador, Alicia; Alacreu-Crespo, Adrian; Gracia, Esther; Molina, Agustin			Intergroup Conflict and Rational Decision Making	PLOS ONE			English	Article							COOPERATIVE BEHAVIOR; INDIVIDUALS; PERSPECTIVE; COMPETITION; PSYCHOLOGY; EMOTION; FITNESS	The literature has been relatively silent about post-conflict processes. However, understanding the way humans deal with post-conflict situations is a challenge in our societies. With this in mind, we focus the present study on the rationality of cooperative decision making after an intergroup conflict, i.e., the extent to which groups take advantage of post-conflict situations to obtain benefits from collaborating with the other group involved in the conflict. Based on dual-process theories of thinking and affect heuristic, we propose that intergroup conflict hinders the rationality of cooperative decision making. We also hypothesize that this rationality improves when groups are involved in an in-group deliberative discussion. Results of a laboratory experiment support the idea that intergroup conflict -associated with indicators of the activation of negative feelings (negative affect state and heart rate)- has a negative effect on the aforementioned rationality over time and on both group and individual decision making. Although intergroup conflict leads to sub-optimal decision making, rationality improves when groups and individuals subjected to intergroup conflict make decisions after an in-group deliberative discussion. Additionally, the increased rationality of the group decision making after the deliberative discussion is transferred to subsequent individual decision making.	[Martinez-Tur, Vicente; Penarroja, Vicente; Hidalgo, Vanesa; Moliner, Carolina; Salvador, Alicia; Gracia, Esther; Molina, Agustin] Univ Valencia, IDOCAL, Valencia, Spain; [Serrano, Miguel A.; Alacreu-Crespo, Adrian] Univ Valencia, Dept Psychobiol, Valencia, Spain; [Hidalgo, Vanesa; Salvador, Alicia] Univ Valencia, Lab Social Neurosci, Dept Psychobiol, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Martinez-Tur, V (corresponding author), Univ Valencia, IDOCAL, Valencia, Spain.	vicente.martinez-tur@uv.es	Gracia, Esther/C-6073-2011; Molina, Agustin/F-8036-2016; Peñarroja, Vicente/Q-7049-2018; Alacreu-Crespo, Adrian/N-9186-2018; MARTINEZ-TUR, VICENTE/H-2602-2013; Salvador, Alicia/B-6045-2011; Moliner, Carolina/E-9764-2011; Hidalgo, Vanesa/AAU-7736-2021; Serrano, Miguel-Angel/ABE-7279-2021; Serrano, Miguel-Angel/AAZ-4393-2020	Gracia, Esther/0000-0002-1354-4061; Peñarroja, Vicente/0000-0001-6827-2086; Alacreu-Crespo, Adrian/0000-0002-0633-2810; MARTINEZ-TUR, VICENTE/0000-0002-6388-569X; Moliner, Carolina/0000-0002-2265-8028; Hidalgo, Vanesa/0000-0003-3920-1099; Serrano, Miguel-Angel/0000-0002-6574-4532; Molina, Agustin/0000-0001-8862-5715; Salvador, Alicia/0000-0002-8686-8083	Spanish Agency of Economy and Competitiveness [PSI2010-21891, PSI2013-48509-P]; FEDER	Spanish Agency of Economy and Competitiveness; FEDER(European Commission)	This research study was carried out under the framework of the research projects supported by the Spanish Agency of Economy and Competitiveness (I+D+i project, PSI2010-21891; PSI2013-48509-P); and FEDER (https://sede.mineco.gob.es/portal/site/sede/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams' David, 2008, HIST CULTURE WAR; Al Ramiah A, 2013, AM PSYCHOL, V68, P527, DOI 10.1037/a0032603; Allport G. W., 1954, NATURE PREJUDICE; [Anonymous], [No title captured]; Bodtker AM, 2001, INT J CONFL MANAGE, V12, P259, DOI 10.1108/eb022858; Boehm C, 1996, CURR ANTHROPOL, V37, P763, DOI 10.1086/204561; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Collier Paul, 2009, WARS GUNS VOTES DEMO; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; De Dreu C. K. W., 2010, HDB SOCIAL PSYCHOL, V2, P983, DOI [10.1002/9780470561119.socpsy002027, DOI 10.1002/9780470561119.SOCPSY002027]; De Dreu CKW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046751; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; De Dreu CKW, 2001, J ORGAN BEHAV, V22, P645, DOI 10.1002/job.107; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Fujii LA, 2010, J PEACE RES, V47, P231, DOI 10.1177/0022343309353097; Heck R. H., 2000, INTRO MULTILEVEL MOD; Hine DW, 2007, J ENVIRON PSYCHOL, V27, P26, DOI 10.1016/j.jenvp.2007.01.001; Horowitz Donald., 1985, ETHNIC GROUPS CONFLI; Howard ES, 2007, J PERS SOC PSYCHOL, V93, P614, DOI 10.1037/0022-3514.93.4.614; Institute for Economic and Peace, 2012, GLOB TERR IND REP, P6; Janis IL, 1981, GROUPTHINK; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Joreskog KG, 2006, LISREL 8 80 COMPUTER; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kelly RC, 2004, PNAS, V102, P15294; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Kugler T, 2012, WIRES COGN SCI, V3, P471, DOI 10.1002/wcs.1184; Maciejovsky B, 2013, MANAGE SCI, V59, P1255, DOI 10.1287/mnsc.1120.1668; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Nair N, 2008, INT J CONFL MANAGE, V19, P359, DOI 10.1108/10444060810909301; Newton TL, 2003, HEALTH PSYCHOL, V22, P270, DOI 10.1037/0278-6133.22.3.270; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Pinker S., 2011, BETTER ANGELS OUR NA; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Sherrow HM, 2012, OXFORD HDB EVOLUTION, P23; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Slovic P, 2001, SMOKING: RISK, PERCEPTION, & POLICY, P97; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Song F, 2009, ORGAN BEHAV HUM DEC, V108, P164, DOI 10.1016/j.obhdp.2008.06.005; Staub E, 2006, POLIT PSYCHOL, V27, P867, DOI 10.1111/j.1467-9221.2006.00541.x; Sumner Seirian, 2011, Commun Integr Biol, V4, P755; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Wagner U., 2012, OXFORD HDB INTERGROU, P193, DOI [DOI 10.1093/OXFORDHB/9780199747672.013.0012, 10.1093/oxfordhb/9780199747672.013.0012]; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yamagishi T, 2009, EVOL HUM BEHAV, V30, P229, DOI 10.1016/j.evolhumbehav.2009.02.004; Yang TT, 2007, NEUROSCI LETT, V428, P109, DOI 10.1016/j.neulet.2007.09.039; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	59	5	5	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114013	10.1371/journal.pone.0114013	http://dx.doi.org/10.1371/journal.pone.0114013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461384	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700081
J	Olliac, B; Birmes, P; Bui, E; Allenou, C; Brunet, A; Claudet, I; de Gauzy, JS; Grandjean, H; Raynaud, JP				Olliac, Bertrand; Birmes, Philippe; Bui, Eric; Allenou, Charlotte; Brunet, Alain; Claudet, Isabelle; de Gauzy, Jerome Sales; Grandjean, Helene; Raynaud, Jean-Philippe			Validation of the French Version of the Child Post-Traumatic Stress Reaction Index: Psychometric Properties in French Speaking School-Aged Children	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; ADOLESCENT SURVIVORS; BEHAVIOR PROBLEMS; SNIPER ATTACK; DSM-III; DISORDER; SYMPTOMS; DISASTER; PTSD; TRAUMA	Background: Although the reliable and valid Child Post-Traumatic Stress Reaction Index (CPTS-RI) is a widely used measure of posttraumatic stress disorder (PTSD) symptoms in children, it has not been validated in French-speaking populations. The present study aims to assess the psychometric properties of the CPTS-RI in three samples of French-speaking school-children. Methods: Data was obtained from three samples. Sample 1 was composed of 106 children (mean (SD) age=11.7(0.7), 50% females) victims of an industrial disaster. Sample 2 was composed of 50 children (mean (SD) age=10.8(2.6), 44% females) who had received an orthopaedic surgical procedure after an accident. Sample 3 was composed of 106 children (mean (SD) age=11.7(2.2), 44% females) admitted to an emergency department after a road traffic accident. We tested internal consistency using Cronbach's alpha. We examined test-retest reliability using intraclass correlation coefficient. In order to assess the convergent validity of the French version of the CPTS-RI and the Clinician Administered PTS Scale-Child and Adolescent (CAPS-CA), spearman-correlation coefficient was computed. To verify the validity of the cut-off scores, a ROC curve was constructed which evaluated the sensitivity and specificity of each score compared to the diagnosis with the CAPS-CA. We also used principal components analysis with varimax rotation to study the structure of the French version of the CPTS-RI. Results: Cronbach's alpha coefficient was 0.87 for the French version of the CPTS-RI. Two-week test-retest intraclass correlation coefficient (n=30) was 0.67. The French version of the CPTS-RI was well correlated with the CAPS-CA (r=0.76, p<0.001). Taking the CAPS-CA as the diagnostic reference, with a diagnostic cutoff of >24 for the CPTS-RI, the sensitivity and specificities were 100% and 62.6%, respectively. The French version of the CPTS-RI demonstrated a three-factor structure. Conclusions: The CPTS-RI is reliable and valid in French-speaking children.	[Olliac, Bertrand] INSERM, Unite Mixte Rech 1094, Limoges, France; [Olliac, Bertrand] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS,FR GEIST 3503, Limoges, France; [Olliac, Bertrand; Grandjean, Helene] Univ Toulouse 3, INSERM, Unite Mixte Rech 1027, F-31062 Toulouse, France; [Olliac, Bertrand] Ctr Hosp Esquirol, Pole Hosp, Univ Psychiat Enfant & Adolescent, Limoges, France; [Birmes, Philippe; Bui, Eric; Allenou, Charlotte] Univ Toulouse, Univ Toulouse 3, Ctr Hosp Univ Toulouse, Hop Casselardit,Lab Stress Traumat LST EA 4560, Toulouse, France; [Bui, Eric] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bui, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Brunet, Alain] McGill Univ, Montreal, PQ, Canada; [Brunet, Alain] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Claudet, Isabelle] Ctr Hosp Univ Toulouse, Hop Enfants, Unite Urgences Pediat, Toulouse, France; [de Gauzy, Jerome Sales] Ctr Hosp Univ Toulouse, Hop Enfants, Serv Chirurg Orthoped Traumatol & Plast, Toulouse, France; [Raynaud, Jean-Philippe] Univ Toulouse 3, CHU Toulouse, Hop La Grave, INSERM,Unite Mixte Rech 1027, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; McGill University; CHU de Toulouse; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Olliac, B (corresponding author), INSERM, Unite Mixte Rech 1094, Limoges, France.	bertrand.olliac@ch-esquirol-limoges.fr	CLAUDET, ISABELLE/N-4195-2019; Claudet, Isabelle/G-9457-2016; Bui, Eric/J-8347-2015	CLAUDET, ISABELLE/0000-0002-3868-8483; Claudet, Isabelle/0000-0002-3868-8483; Bui, Eric/0000-0002-1413-6473; Raynaud, Jean-Philippe/0000-0002-6101-7370	Ministry of Health, PHRC	Ministry of Health, PHRC	This study was supported by the Ministry of Health, PHRC (Programme Hospitalier de Recherche Clinique) 2002 and 2004. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DSM 4 TR MANUEL DIAG; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Beriault M, 2008, ECHELLES QUESTIONNAI, P71; Bernstein IH, 1988, APPL MULTIVARIATE AN; Birmes P, 2009, COMMUNITY MENT HLT J, V45, P290, DOI 10.1007/s10597-008-9166-3; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Bui E, 2010, GEN HOSP PSYCHIAT, V32, P330, DOI 10.1016/j.genhosppsych.2010.01.014; BURKE JD, 1982, AM J PSYCHIAT, V139, P1010; Charney DS, 1998, CNS SPECTRUMS, V7, P7; Cohen Judith A, 2009, Dialogues Clin Neurosci, V11, P91; Drake EB, 2001, REV PSYCHIAT SER, V20, P1; EARLS F, 1988, J AM ACAD CHILD PSY, V27, P90, DOI 10.1097/00004583-198801000-00014; FAMULARO R, 1990, CHILD ABUSE NEGLECT, V14, P439, DOI 10.1016/0145-2134(90)90015-L; Frederick CJ, 1985, POSTTRAUMATIC STRESS; GISLASON IL, 1982, J AM ACAD CHILD PSY, V21, P203, DOI 10.1016/S0002-7138(09)60921-3; Godeau E, 2005, ARCH PEDIAT ADOL MED, V159, P579, DOI 10.1001/archpedi.159.6.579; GOENJIAN AK, 1995, J AM ACAD CHILD PSY, V34, P1174, DOI 10.1097/00004583-199509000-00015; Grych JH, 2000, J CONSULT CLIN PSYCH, V68, P84, DOI 10.1037/0022-006X.68.1.84; HAVILAND MG, 1995, J AM ACAD CHILD PSY, V34, P1054, DOI 10.1097/00004583-199508000-00015; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; Heiney S P, 1994, Oncol Nurs Forum, V21, P843; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HUBBARD J, 1995, J AM ACAD CHILD PSY, V34, P1167, DOI 10.1097/00004583-199509000-00014; Husain SA, 1998, AM J PSYCHIAT, V155, P1718, DOI 10.1176/ajp.155.12.1718; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kassam-Adams N, 2006, J AM ACAD CHILD PSY, V45, P1485, DOI 10.1097/01.chi.0000237703.97518.12; Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P1276, DOI 10.1097/01.chi.0000181045.13960.67; LONIGAN CJ, 1991, ADV BEHAV RES THER, V13, P135, DOI 10.1016/0146-6402(91)90002-R; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; McDermott BM, 2000, AUST NZ J PSYCHIAT, V34, P446, DOI 10.1046/j.1440-1614.2000.00753.x; Meiser-Stedman R, 2007, J ABNORM CHILD PSYCH, V35, P191, DOI 10.1007/s10802-006-9068-1; NADER K, 1990, AM J PSYCHIAT, V147, P1526; Nader K, 2008, CHILDREN ADOLESCENTS, P6; Nader K., 2004, CLIN ADMINISTERED PT; Nader K, 1996, MEASUREMENT STRESS T, P83; NADER KO, 1993, BRIT J CLIN PSYCHOL, V32, P407, DOI 10.1111/j.2044-8260.1993.tb01075.x; Nader KO., 1996, CLIN ADM PTSD SCALE; National Institute of Clinical Excellence, 2005, CLIN GUID 26 POSTTR; Nunnally JC, 1978, PSYCHOMTRIC THEORY; Perrin S, 2000, J CHILD PSYCHOL PSYC, V41, P277, DOI 10.1017/S0021963099005454; Putnam SP., 2001, ADV RES TEMPERAMENT, P165; Pynoos R, 1991, PREVENTION MENTAL HL; Pynoos R, 2002, CHILD POSTTRAUMATIC; PYNOOS RS, 1986, J AM ACAD CHILD PSY, V25, P306, DOI 10.1016/S0002-7138(09)60252-1; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; PYNOOS RS, 1987, ISRAEL J PSYCHIAT, V24, P53; REALMUTO GM, 1992, J TRAUMA STRESS, V5, P589, DOI 10.1002/jts.2490050408; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; SAIGH PA, 1991, BEHAV RES THER, V29, P213, DOI 10.1016/0005-7967(91)90110-O; SAIGH PA, 1989, J ABNORM PSYCHOL, V98, P189, DOI 10.1037/0021-843X.98.2.189; Salloum A, 2001, J AM ACAD CHILD PSY, V40, P1261, DOI 10.1097/00004583-200111000-00005; Sanders Michael B, 2005, J Orthop Trauma, V19, P623, DOI 10.1097/01.bot.0000174709.95732.1b; Sauter J, 1998, RES SOCIAL WORK PRAC, V8, P251, DOI 10.1177/104973159800800301; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; SCHWARZ ED, 1991, AM J PSYCHIAT, V148, P592; SHANNON MP, 1994, J AM ACAD CHILD PSY, V33, P80, DOI 10.1097/00004583-199401000-00012; SPSS Inc, 2008, SPSS STAT 17 0; Stuber J, 2005, AM J ORTHOPSYCHIAT, V75, P190, DOI 10.1037/0002-9432.75.2.190; STUBER ML, 1991, J AM ACAD CHILD PSY, V30, P952, DOI 10.1097/00004583-199111000-00013; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; TERR L, 1988, J AM ACAD CHILD PSY, V27, P96, DOI 10.1097/00004583-198801000-00015; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Vila G, 2003, STRESS TRAUMA, V3, P89; Walker AM, 1999, J CHILD PSYCHOL PSYC, V40, P363, DOI 10.1017/S0021963098003606; Wolmer L, 2000, J NERV MENT DIS, V188, P409, DOI 10.1097/00005053-200007000-00003; Yates TM, 2003, DEV PSYCHOPATHOL, V15, P199, DOI 10.1017/S0954579403000117; YULE W, 1992, PSYCHOTHER PSYCHOSOM, V57, P200, DOI 10.1159/000288599; Yule W, 1990, J TRAUMA STRESS, V3, P279, DOI DOI 10.1002/JTS.2490030209	70	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112603	10.1371/journal.pone.0112603	http://dx.doi.org/10.1371/journal.pone.0112603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25460912	Green Published, gold			2022-12-27	WOS:000345869700020
J	Wu, CS; Lai, MS; Gau, SSF; Wang, SC; Tsai, HJ				Wu, Chi-Shin; Lai, Mei-Shu; Gau, Susan Shur-Fen; Wang, Sheng-Chang; Tsai, Hui-Ju			Concordance between Patient Self-Reports and Claims Data on Clinical Diagnoses, Medication Use, and Health System Utilization in Taiwan	PLOS ONE			English	Article							EPIDEMIOLOGIC RESEARCH; ADMINISTRATIVE DATA; PHARMACY DATA; AGREEMENT; PREVALENCE; INSURANCE; RECORDS; CARE; VALIDATION; DATABASES	Purpose: The aim of this study was to evaluate the concordance between claims records in the National Health Insurance Research Database and patient self-reports on clinical diagnoses, medication use, and health system utilization. Methods: In this study, we used the data of 15,574 participants collected from the 2005 Taiwan National Health Interview Survey. We assessed positive agreement, negative agreement, and Cohen's kappa statistics to examine the concordance between claims records and patient self-reports. Results: Kappa values were 0.43, 0.64, and 0.61 for clinical diagnoses, medication use, and health system utilization, respectively. Using a strict algorithm to identify the clinical diagnoses recorded in claims records could improve the negative agreement; however, the effect on positive agreement and kappa was diverse across various conditions. Conclusion: We found that the overall concordance between claims records in the National Health Insurance Research Database and patient self-reports in the Taiwan National Health Interview Survey was moderate for clinical diagnosis and substantial for both medication use and health system utilization.	[Wu, Chi-Shin] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Wu, Chi-Shin; Lai, Mei-Shu; Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Publ Hlth, Taipei 10764, Taiwan; [Wu, Chi-Shin; Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Wu, Chi-Shin; Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wang, Sheng-Chang] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan; [Tsai, Hui-Ju] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Northwestern University; Feinberg School of Medicine	Tsai, HJ (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan.	tsaihj@nhri.org.tw	Wu, Chi-Shin/GQP-4970-2022; Tsai, Hui-Ju/E-3937-2010; Gau, Susan Shur-Fen/P-4726-2017; Wang, Sheng-Chang/G-9350-2011	Gau, Susan Shur-Fen/0000-0002-2718-8221; Lai, Mei-shu/0000-0001-6130-3468; WU, CHI-SHIN/0000-0003-2762-7295	National Science Council, Taiwan [NSC 102-2314-B-418 002]; National Health Research Institutes, Taiwan [PH-100-PP-14, PH-102-PP-14, PH-101SP-14, PH-102-SP-5]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	No potential financial conflicts of interest relevant to this study were reported. Dr. Wu is supported in part by a grant from National Science Council, Taiwan (PI: Wu, NSC 102-2314-B-418 002). Dr. Tsai is supported in part by grants from the National Health Research Institutes, Taiwan (PI: Tsai, PH-100-PP-14, PH-102-PP-14, PH-101SP-14, PH-102-SP-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau DM, 2004, AM J EPIDEMIOL, V159, P308, DOI 10.1093/aje/kwh038; Chang HY, 2002, CHINESE J PHYSIOL, V45, P187; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; Curtis JR, 2006, PHARMACOEPIDEM DR S, V15, P710, DOI 10.1002/pds.1226; Haapea M, 2010, INT J METH PSYCH RES, V19, P88, DOI 10.1002/mpr.304; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x; Kwon A, 2003, MED CARE, V41, P368, DOI 10.1097/00005650-200303000-00005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Liu TC, 2002, SOC SCI MED, V55, P755, DOI 10.1016/S0277-9536(01)00201-5; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Muhajarine N, 1997, J CLIN EPIDEMIOL, V50, P711, DOI 10.1016/S0895-4356(97)00019-X; Pit SW, 2008, DRUG AGING, V25, P71, DOI 10.2165/00002512-200825010-00008; QUAM L, 1993, MED CARE, V31, P498, DOI 10.1097/00005650-199306000-00003; Rhodes AE, 2002, INT J METH PSYCH RES, V11, P125, DOI 10.1002/mpr.130; Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Tu Karen, 2007, Open Med, V1, pe18; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Yu ST, 2009, J CLIN EPIDEMIOL, V62, P1316, DOI 10.1016/j.jclinepi.2009.01.016	27	140	140	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112257	10.1371/journal.pone.0112257	http://dx.doi.org/10.1371/journal.pone.0112257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464005	Green Published, gold, Green Submitted			2022-12-27	WOS:000345869700011
J	Yu, XL; Lu, L; Chen, GZ; Liu, ZG; Lei, H; Song, YZ; Zhang, SL				Yu, Xiao-li; Lu, Lian; Chen, Gao-zhan; Liu, Zhi-Guo; Lei, Hang; Song, Yan-zheng; Zhang, Shu-lin			Identification and Characterization of Non-Tuberculous Mycobacteria Isolated from Tuberculosis Suspects in Southern-Central China	PLOS ONE			English	Article							GROWING MYCOBACTERIA; INFECTIONS; DIFFERENTIATION; PREVALENCE; TAIWAN; SPP.	The incidence of non-tuberculous mycobacteria (NTM)-related death has increased globally recently. To obtain information of the species and characterization of pathogens involved in NTM pulmonary infection in Southern-central China, we identified 160 non-tuberculous infection cases from 3995 acid-fast bacilli (AFB)-positive tuberculous suspects. We then randomly selected 101 non-tuberculous patients, isolated bacteria from their sputa and genotyped the pathogens using the 16S rRNA gene and 16S-23S rRNA internal transcribed spacer sequences. M. intracellulare (32.67%, 33/101), M. abscessus (32.67%, 33/101) and M. fortuitum (7.92%, 8/101) are identified in these isolates. Surprisingly, non-mycobacteria including Gordonia (8.91%, 9/101), Nocardia (5.94%, 6/101) and Tsukamurella (0.99%, 1/101) are also discovered, and the case of Tsukamurella pulmonis infection is first discovered in Southern-central China. Moreover, species of M. mucogenicum group, M. chubuense, M. kansasii, M. gastri, M. avium, M. porcinum and M. smegmatis are identified. In addition, nine immune compromised cases (8.91%, 9/101), including type two diabetes mellitus and HIV/AIDS are found to be infected with non-tuberculous bacteria. This study revealed the distribution and characteristics of non-tuberculous AFB pathogen infection occurred in Southern-central China, and suggested that physicians should be alert of the emerging of NTM and non-mycobacteria infection in AFB positive cases and take caution when choosing chemotherapy for tuberculosis-like pulmonary infections. Generally, this study may help with the development of new strategy for the diagnosis and treatment of mycobacterial infection.	[Yu, Xiao-li; Lu, Lian; Chen, Gao-zhan; Liu, Zhi-Guo; Lei, Hang] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China; [Song, Yan-zheng] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Zhang, Shu-lin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China	Wuhan Polytechnic University; Shanghai Jiao Tong University	Zhang, SL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China.	shulinzhang@sjtu.edu.cn			China Mega-Projects of Science Research [2012ZX10003002002, 2013ZX10003002-005]; Educational Commission of Hubei, China [D20121809]	China Mega-Projects of Science Research; Educational Commission of Hubei, China	SLZ received Grant 2012ZX10003002002 and 2013ZX10003002-005 from China Mega-Projects of Science Research for the 12th Five Year Plan, http://www.gov.cn/. XLY received Grant D20121809 from Educational Commission of Hubei, China, http://www.hbe.gov.cn/search_list.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chen Y, 2010, MICROBES INFECT, V5, P93; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Jing H, 2012, EMERG INFECT DIS, V18, P527, DOI 10.3201/eid1803.110175; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lai CC, 2010, CLIN MICROBIOL INFEC, V16, P1448, DOI [10.1111/j.1469-0691.2010.03085.x, 10.1111/j.1469-0691.2009.03085.x]; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Liu CY, 2011, INT J ANTIMICROB AG, V38, P534, DOI 10.1016/j.ijantimicag.2011.07.018; McGrath EE, 2010, PULM PHARMACOL THER, V23, P389, DOI 10.1016/j.pupt.2010.06.002; Montessori V, 1996, CLIN INFECT DIS, V22, P989, DOI 10.1093/clinids/22.6.989; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Simmon KE, 2011, EMERG INFECT DIS, V17, P1692, DOI 10.3201/eid1709.101667; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tachezy M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-194; Tan CK, 2010, CLIN MICROBIOL INFEC, V16, P966, DOI 10.1111/j.1469-0691.2009.02950.x; Wallace R, 2010, HIST OF MAC; Wang HX, 2010, CHINESE MED J-PEKING, V123, P184, DOI 10.3760/cma.j.issn.0366-6999.2010.02.011; Woo PCY, 2009, J CLIN MICROBIOL, V47, P1953, DOI 10.1128/JCM.00424-09; Yu XL, 2014, J ANTIBIOT, V67, P291, DOI 10.1038/ja.2013.133; Zhang SL, 2007, WORLD J MICROB BIOT, V23, P1779, DOI 10.1007/s11274-007-9428-1	25	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114353	10.1371/journal.pone.0114353	http://dx.doi.org/10.1371/journal.pone.0114353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463697	gold, Green Published, Green Submitted			2022-12-27	WOS:000345869700130
J	Fan, WN; Zhang, SH; Du, HQ; Sun, XG; Shi, YH; Wang, CZ				Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang			Genome-Wide Identification of Different Dormant Medicago sativa L. MicroRNAs in Response to Fall Dormancy	PLOS ONE			English	Article							SMALL RNAS; ALFALFA VARIETIES; PLANT MICRORNAS; GENE-EXPRESSION; TRUNCATULA; PHYTOCHROME; PATHWAY; ROOTS; CARBOHYDRATE; ANNOTATION	Background: MicroRNAs (miRNAs) are a class of regulatory small RNAs (sRNAs) that regulate gene post-transcriptional expression in plants and animals. Highthroughput sequencing technology is capable of identifying small RNAs in plant species. Alfalfa (Medicago sativa L.) is one of the most widely cultivated perennial forage legumes worldwide, and fall dormancy is an adaptive characteristic related to the biomass production and winter survival in alfalfa. Here, we applied highthroughput sRNA sequencing to identify some miRNAs that were responsive to fall dormancy in standard variety (Maverick and CUF101) of alfalfa. Results: Four sRNA libraries were generated and sequenced from alfalfa leaves in two typical varieties at distinct seasons. Through integrative analysis, we identified 51 novel miRNA candidates of 206 families. Additionally, we identified 28 miRNAs associated with fall dormancy in standard variety (Maverick and CUF101), including 20 known miRNAs and eight novel miRNAs. Both high-throughput sequencing and RT-qPCR confirmed that eight known miRNA members were up-regulated and six known miRNA members were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101). Among the 51 novel miRNA candidates, five miRNAs were up-regulated and three miRNAs were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101), and five of them were confirmed by Northern blot analysis. Conclusion: We identified 20 known miRNAs and eight new miRNA candidates that were responsive to fall dormancy in standard variety (Maverick and CUF101) by high-throughput sequencing of small RNAs from Medicago sativa. Our data provide a useful resource for investigating miRNA-mediated regulatory mechanisms of fall dormancy in alfalfa, and these findings are important for our understanding of the roles played by miRNAs in the response of plants to abiotic stress in general and fall dormancy in alfalfa.	[Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn		Zhang, Senhao/0000-0002-9231-9750	China Forage and Grass Research System [CARS-35]; National Natural Science Foundation of China [31172261]	China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by China Forage and Grass Research System (CARS-35) and the National Natural Science Foundation of China (No. 31172261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BULA RJ, 1954, AGRON J, V46, P397, DOI 10.2134/agronj1954.00021962004600090001x; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; Cunningham SM, 1998, J PLANT PHYSIOL, V153, P220, DOI 10.1016/S0176-1617(98)80069-2; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Du H, 2013, ACTA AGRESTIA SINICA, V21, P708; Fairey DT, 1996, CAN J PLANT SCI, V76, P429, DOI 10.4141/cjps96-076; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HEINRICHS D. H., 1960, CANADIAN JOUR PLANT SCI, V40, P638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSEN K. L., 1963, CROP SCI, V3, P234, DOI 10.2135/cropsci1963.0011183X000300030018x; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Samac DA, 2006, CHEM IND-SER, V112, P79; Schneider M, 1984, UNIFOLIATE INTERNODE, P96; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sharma R, 2001, CURR SCI INDIA, V80, P178; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMITH D., 1961, Canadian Journal of Plant Science, V41, P244; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teuber L, 1998, FALL DORMANCY, P2; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; VOLENEC JJ, 1991, PLANT PHYSIOL, V96, P786, DOI 10.1104/pp.96.3.786; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang TZ, 2014, PLANT CELL, V18, P2051; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yifen C, 1990, PRATACULTURAL SCI, V7, P60; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	70	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114612	10.1371/journal.pone.0114612	http://dx.doi.org/10.1371/journal.pone.0114612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473944	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500049
J	Zhu, LS; Xing, ZL; Gai, XC; Li, SJ; San, ZH; Wang, XP				Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping			Identification of a Novel Enterovirus E Isolates HY12 from Cattle with Severe Respiratory and Enteric Diseases	PLOS ONE			English	Article							BOVINE ENTEROVIRUSES; CLASSIFICATION; DIVERSITY; ETIOLOGY; VIRUSES; REGION; CALF	In this study, a virus strain designated as HY12 was isolated from cattle with a disease of high morbidity and mortality in Jilin province. Biological and physiochemical properties showed that HY12 isolates is cytopathic with an extremely high infectivity. HY12 is resistant to treatment of organic solvent and acid, and unstable at 60 degrees C for 1 h. Electron microscopy observation revealed the virus is an approximately 22-28 nm in diameter. The complete genome sequence of HY12 consists of 7416 nucleotides, with a typical picornavirus genome organization including a 5'-untranslated region (UTR), a large single ORF encoding a polyprotein of 2176 amino acids, and a 3'-UTR. Phylogenetic analysis clustered HY12 isolates to a new serotype/genotype within the clade of enterovirus E (formerly BEV-A). Alignment analysis revealed a unique insertion of 2 amino acid residues (NF) at the C-terminal of VP1 protein between aa 825 and 826, and several rare mutations in VP1 and VP4 of HY12 isolates in relation to known bovine enterovirus (BEV) strains. This is the first report of an enterovirus E in China, which is potentially associated with an outbreak in cattle with severe respiratory and enteric diseases.	[Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	Jilin Province Scientific and Technology Program [20140204064NY]; program fund of Jilin province for high-level creative and talented individuals	Jilin Province Scientific and Technology Program; program fund of Jilin province for high-level creative and talented individuals	This study is supported by the Key Science and Technology projects from Jilin Province Scientific and Technology Program (20140204064NY); program fund of Jilin province for high-level creative and talented individuals to Xinping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas-Machado U, 2007, VET PATHOL, V44, P110, DOI 10.1354/vp.44-1-110; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; BUCZEK J, 1970, ARCH GES VIRUSFORSCH, V30, P408, DOI 10.1007/BF01258371; BUERKI F, 1962, Pathol Microbiol (Basel), V25, P789; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Dubois E, 2004, INT J FOOD MICROBIOL, V92, P35, DOI 10.1016/j.ijfoodmicro.2003.06.001; DUNNE HW, 1974, J AM VET MED ASSOC, V164, P290; DUNNE HW, 1973, AM J VET RES, V34, P1121; Fong TT, 2005, APPL ENVIRON MICROB, V71, P2070, DOI 10.1128/AEM.71.4.2070-2078.2005; IDE PR, 1970, CANADIAN VET J, V11, P194; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068081; KNOWLES NJ, 1985, ARCH VIROL, V83, P141, DOI 10.1007/BF01309912; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Ley V, 2002, APPL ENVIRON MICROB, V68, P3455, DOI 10.1128/AEM.68.7.3455-3461.2002; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; McCarthy FM, 1999, VET MICROBIOL, V68, P71, DOI 10.1016/S0378-1135(99)00062-0; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; McFERRAN J. B., 1958, Veterinary Record, V70, P999; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MOLL T, 1959, AM J VET RES, V20, P27; Nollens HH, 2009, VET MICROBIOL, V139, P170, DOI 10.1016/j.vetmic.2009.05.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROVOZZO GC, 1965, CORNELL VET, V55, P121; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Straub O C, 1965, Berl Munch Tierarztl Wochenschr, V78, P386; STRAUB O. C., 1964, ARCH GESAMTE VIRUS FORSCH, V14, P272, DOI 10.1007/BF01555099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMAATEN MJ, 1967, AM J VET RES, V28, P677; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; WELDON SL, 1979, J AM VET MED ASSOC, V174, P168; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zell R, 1997, VIRUS RES, V51, P213, DOI 10.1016/S0168-1702(97)00096-8; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zheng T, 2007, ARCH VIROL, V152, P191, DOI 10.1007/s00705-006-0838-4	38	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97730	10.1371/journal.pone.0097730	http://dx.doi.org/10.1371/journal.pone.0097730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830424	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500108
J	Fan, W; Xu, L; Xie, LC; Yang, DC; Liu, XZ; Zhang, JJ; Li, YR; Yi, CJ				Fan, Wen; Xu, Lei; Xie, Liangcai; Yang, Decai; Liu, Xuezheng; Zhang, Jiajun; Li, Yirong; Yi, Cunjian			Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays	PLOS ONE			English	Article							HEART-FAILURE; SERUM; ANTIBODIES; DIAGNOSIS; ARTHRITIS; VALUES; BRAIN; NEED	Background: The chemiluminescent microparticle immunoassay (CMIA) is widely used for the quantitative determination of B-type natriuretic peptide (BNP) in human ethylenediaminetetraacetic acid plasma. Rheumatoid factor (RF) is usually thought to result in a positive interference in immunoassays, but it is not clear whether its presence in plasma can lead to interferences in the CMIA of BNP. Methods: The estimation of BNP recovery was carried out by diluting high-concentration BNP samples with RF-positive or RF-negative plasma at a ratio of 1:9. The diluted samples were then tested using the ARCHITECT i2000 System and ARCHITECT BNP Reagent Kits and the recovery was then calculated. Results: When the RF level ranged from 48 to 1420 IU/mL, the average recovery of BNP was 79.29% and 91.61% in the RF-positive and RF-negative plasma samples, respectively, and was thus significantly lower in the group of RF-positive plasma samples than in the group of RF-negative plasma samples. At a dilution of 1:16, the measured BNP level increased by >36% in six of the seven RF-positive plasma samples. The recovery of BNP increased significantly in the RF-positive plasma samples after pretreatment with IgG-sensitive latex particles. In addition, The BNP recovery was not significantly related to the plasma RF at concentrations ranging from 48 to 2720 IU/mL. Conclusions: Measurement of BNP by CMIA is susceptible to interference from RF leading to predominantly (but not exclusively) lower results. Pretreatment of samples with blocking reagents is advisable prior to the initiation of denying patient's necessary treatment.	[Fan, Wen; Xie, Liangcai; Liu, Xuezheng; Zhang, Jiajun] Jingzhou First Peoples Hosp, Dept Lab Med, Jinzhou, Hubei, Peoples R China; [Xu, Lei; Yang, Decai; Li, Yirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China; [Yi, Cunjian] Jingzhou First Peoples Hosp, Dept Obstet & Gynecol, Jinzhou, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, YR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China.	liyirong838@163.com; cunjiany@163.com		Zhang, Senhao/0000-0002-9231-9750	National Natural Science Foundation of China [30970060]; Scientific Research Foundation of the Education Ministry of China [2008890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the Education Ministry of China	This study was supported by grants 30970060 from the National Natural Science Foundation of China and 2008890 from the Scientific Research Foundation of the Education Ministry of China for Returned Chinese Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Eriksson S, 2003, CLIN CHEM, V49, P1095, DOI 10.1373/49.7.1095; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Ismail AAA, 2011, ANN CLIN BIOCHEM, V48, P65, DOI 10.1258/acb.2010.010197; Ismail Y, 2007, CLIN MED, V7, P357, DOI 10.7861/clinmedicine.7-4-357; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Li YR, 2014, LABMEDICINE, V45, P82, DOI 10.1309/LMO7HLI8EODNAZSG; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Marks V, 2002, CLIN CHEM, V48, P2008; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; MOORE TL, 1993, CLIN BIOCHEM, V26, P75, DOI 10.1016/0009-9120(93)90032-2; Norden AGW, 1997, CLIN CHEM, V43, P957; Onuska KD, 2000, CLIN CHEM, V46, P307; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tsavaris N, 2007, ANN RHEUM DIS, V66, P980, DOI 10.1136/ard.2007.070052; Wieczorek SJ, 2002, AM HEART J, V144, P834, DOI 10.1067/mhj.2002.125623; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080620; Xu L, 2013, CLIN BIOCHEM, V46, P799, DOI 10.1016/j.clinbiochem.2013.03.013; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	21	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105304	10.1371/journal.pone.0105304	http://dx.doi.org/10.1371/journal.pone.0105304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25473944	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100048
J	Gai, XP; Wang, HY; Liu, J; Zhai, LM; Liu, S; Ren, TZ; Liu, HB				Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Ren, Tianzhi; Liu, Hongbin			Effects of Feedstock and Pyrolysis Temperature on Biochar Adsorption of Ammonium and Nitrate	PLOS ONE			English	Article							BLACK CARBON; NUTRIENT AVAILABILITY; SOIL; SORPTION; RESIDUE; MANURE; SULFAMETHOXAZOLE; PHOSPHATE; AMENDMENT; DYNAMICS	Biochar produced by pyrolysis of biomass can be used to counter nitrogen (N) pollution. The present study investigated the effects of feedstock and temperature on characteristics of biochars and their adsorption ability for ammonium N (NH4+-N) and nitrate N (NO3--N). Twelve biochars were produced from wheat-straw (W-BC), corn-straw (C-BC) and peanut-shell (P-BC) at pyrolysis temperatures of 400, 500, 600 and 700 degrees C. Biochar physical and chemical properties were determined and the biochars were used for N sorption experiments. The results showed that biochar yield and contents of N, hydrogen and oxygen decreased as pyrolysis temperature increased from 400 degrees C to 700 degrees C, whereas contents of ash, pH and carbon increased with greater pyrolysis temperature. All biochars could sorb substantial amounts of NH4+-N, and the sorption characteristics were well fitted to the Freundlich isotherm model. The ability of biochars to adsorb NH4+-N followed: C-BC. P-BC. W-BC, and the adsorption amount decreased with higher pyrolysis temperature. The ability of C-BC to sorb NH4+-N was the highest because it had the largest cation exchange capacity (CEC) among all biochars (e.g., C-BC400 with a CEC of 38.3 cmol kg(-1) adsorbed 2.3 mg NH4+-N g(-1) in solutions with 50 mg NH4+ L-1). Compared with NH4+-N, none of NO3 -N was adsorbed to biochars at different NO3 concentrations. Instead, some NO3- -N was even released from the biochar materials. We conclude that biochars can be used under conditions where NH4+-N (or NH3) pollution is a concern, but further research is needed in terms of applying biochars to reduce NO3--N pollution.	[Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Liu, Hongbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China; [Liu, Jian] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Ren, Tianzhi] Minist Agr, Inst Agroenvironm Protect, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, HB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China.	liuhongbin@caas.cn	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	National Natural Science Foundation of China [41301311, 41203072]; Special Fund for Agro-scientific Research in the Public Interest [201303095-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	Funding: This study was financially supported by the National Natural Science Foundation of China (41301311), the Special Fund for Agro-scientific Research in the Public Interest (201303095-10), and the National Natural Science Foundation of China (41203072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami A, 2007, J HAZARD MATER, V144, P427, DOI 10.1016/j.jhazmat.2006.10.062; Ahmad M, 2013, BIORESOURCE TECHNOL, V143, P615, DOI 10.1016/j.biortech.2013.06.033; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Ding Y, 2010, WATER AIR SOIL POLL, V213, P47, DOI 10.1007/s11270-010-0366-4; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Gell K, 2011, J HAZARD MATER, V186, P2017, DOI 10.1016/j.jhazmat.2010.12.105; Hollister CC, 2013, J ENVIRON QUAL, V42, P137, DOI 10.2134/jeq2012.0033; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; IFA/IFDC/IPI/PPI/FAO, 2009, FERT US CROP; Ji LL, 2011, ENVIRON SCI TECHNOL, V45, P5580, DOI 10.1021/es200483b; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Knowles OA, 2011, SCI TOTAL ENVIRON, V409, P3206, DOI 10.1016/j.scitotenv.2011.05.011; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Mimmo T, 2014, BIOMASS BIOENERG, V62, P149, DOI 10.1016/j.biombioe.2014.01.004; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Ohe K, 2003, J CHEM ENG JPN, V36, P511, DOI 10.1252/jcej.36.511; Ok YS, 2007, J HAZARD MATER, V147, P91, DOI 10.1016/j.jhazmat.2006.12.046; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038; Sun L, 2013, BIORESOURCE TECHNOL, V140, P406, DOI 10.1016/j.biortech.2013.04.116; Wu WX, 2012, BIOMASS BIOENERG, V47, P268, DOI 10.1016/j.biombioe.2012.09.034; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhai LM, 2014, BIOL FERT SOILS; Zhang AF, 2013, AGR ECOSYST ENVIRON, V173, P37, DOI 10.1016/j.agee.2013.04.001; Zhao XC, 2013, BIORESOURCE TECHNOL, V147, P338, DOI 10.1016/j.biortech.2013.08.042; Zheng H, 2013, ENVIRON POLLUT, V181, P60, DOI 10.1016/j.envpol.2013.05.056; Zheng H, 2013, BIORESOURCE TECHNOL, V130, P463, DOI 10.1016/j.biortech.2012.12.044; Zhu AN, 2005, ENVIRON INT, V31, P904, DOI 10.1016/j.envint.2005.05.038	42	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113888	10.1371/journal.pone.0113888	http://dx.doi.org/10.1371/journal.pone.0113888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	24830424	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700050
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
